The table below lists the options of the executed module.
| Option | Value |
|---|---|
| analyze.sites | yes |
| region.types | tiling1kb, tiling200bp, genes, promoters, cpgislands, ensembleRegBuildBPall |
| differential.permutations | 0 |
| differential.comparison.columns | disease_type, disease_type_detailed, sample_source, tumor_location, tumor_size, relapse, metastases_at_diagnosis, comp.column, Tissue_vs_MSC |
| differential.comparison.columns.all.pairwise | default |
| columns.pairing | default |
| differential.site.test.method | limma |
| covariate.adjustment.columns | default |
| differential.adjustment.sva | yes |
| differential.adjustment.celltype | yes |
| differential.enrichment.go | yes |
| differential.enrichment.lola | yes |
| differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
| Rank Cutoff | |
| Ewing vs. Healthy (based on disease_type) | 91956 |
| Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 71879 |
| Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 75419 |
| MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 73210 |
| MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 91956 |
| Graz vs. non.Graz (based on sample_source) | 331571 |
| Münster vs. non.Münster (based on sample_source) | 273050 |
| Paris vs. non.Paris (based on sample_source) | 222226 |
| Vienna vs. non.Vienna (based on sample_source) | 201492 |
| abdomen vs. non.abdomen (based on tumor_location) | 283168 |
| head_and_neck vs. non.head_and_neck (based on tumor_location) | 335505 |
| lower_extremity vs. non.lower_extremity (based on tumor_location) | 231115 |
| pelvis vs. non.pelvis (based on tumor_location) | 244007 |
| spine vs. non.spine (based on tumor_location) | 255517 |
| thorax vs. non.thorax (based on tumor_location) | 228900 |
| upper_extremity vs. non.upper_extremity (based on tumor_location) | 249541 |
| greater_than_200mL vs. less_than_200mL (based on tumor_size) | 409269 |
| no_relapse vs. relapse (based on relapse) | 156026 |
| metastases vs. no_metastases (based on metastases_at_diagnosis) | 164839 |
| Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 59565 |
| Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 123532 |
| comparison | |
| differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differentially variable sites were computed with diffVar. For more information about the method, have a look at the missMethyl Bioconductor package.[1] This section contains plots and tables describing the results of this test and further analyses of the sites that were selected as differentially variable. Please note that missing methylation values have been imputed with none.
The following rank cutoffs have been automatically selected for the analysis of differentially variable sites:
| Rank Cutoff | |
| Ewing vs. Healthy (based on disease_type) | 37696 |
| Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 41266 |
| Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 49972 |
| MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 95107 |
| MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 37696 |
| Graz vs. non.Graz (based on sample_source) | 165164 |
| Münster vs. non.Münster (based on sample_source) | 117306 |
| Paris vs. non.Paris (based on sample_source) | 91799 |
| Vienna vs. non.Vienna (based on sample_source) | 76835 |
| abdomen vs. non.abdomen (based on tumor_location) | 40305 |
| head_and_neck vs. non.head_and_neck (based on tumor_location) | 84587 |
| lower_extremity vs. non.lower_extremity (based on tumor_location) | 86053 |
| pelvis vs. non.pelvis (based on tumor_location) | 76683 |
| spine vs. non.spine (based on tumor_location) | 97190 |
| thorax vs. non.thorax (based on tumor_location) | 81168 |
| upper_extremity vs. non.upper_extremity (based on tumor_location) | 42071 |
| greater_than_200mL vs. less_than_200mL (based on tumor_size) | 80857 |
| no_relapse vs. relapse (based on relapse) | 85233 |
| metastases vs. no_metastases (based on metastases_at_diagnosis) | 54706 |
| Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 59148 |
| Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 70237 |
| comparison | |
| differential variability measure |
Scatterplot for differential variable sites. The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling. The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points). Additionally, the colored points represent differentially variable sites (according to the selected criterion).
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [2]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
| tiling1kb | tiling200bp | genes | promoters | cpgislands | ensembleRegBuildBPall | |
| Ewing vs. Healthy (based on disease_type) | 14628 | 27135 | 1516 | 1506 | 1660 | 8924 |
| Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 13654 | 21984 | 3468 | 3783 | 2805 | 7581 |
| Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 20230 | 38124 | 1896 | 2628 | 3129 | 7167 |
| MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 16058 | 35395 | 1446 | 1776 | 843 | 8438 |
| MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 14628 | 27135 | 1516 | 1506 | 1660 | 8924 |
| Graz vs. non.Graz (based on sample_source) | 48701 | 95930 | 1194 | 2150 | 559 | 13033 |
| Münster vs. non.Münster (based on sample_source) | 5985 | 21828 | 116 | 397 | 456 | 1516 |
| Paris vs. non.Paris (based on sample_source) | 3906 | 21131 | 32 | 135 | 250 | 167 |
| Vienna vs. non.Vienna (based on sample_source) | 322 | 2800 | 63 | 51 | 134 | 176 |
| abdomen vs. non.abdomen (based on tumor_location) | 14835 | 40170 | 395 | 625 | 555 | 3839 |
| head_and_neck vs. non.head_and_neck (based on tumor_location) | 19429 | 48273 | 653 | 1197 | 362 | 4327 |
| lower_extremity vs. non.lower_extremity (based on tumor_location) | 248 | 3527 | 46 | 83 | 73 | 96 |
| pelvis vs. non.pelvis (based on tumor_location) | 560 | 4485 | 34 | 85 | 80 | 207 |
| spine vs. non.spine (based on tumor_location) | 9122 | 23494 | 220 | 313 | 85 | 1679 |
| thorax vs. non.thorax (based on tumor_location) | 184 | 3006 | 21 | 24 | 51 | 145 |
| upper_extremity vs. non.upper_extremity (based on tumor_location) | 3686 | 12265 | 161 | 182 | 181 | 766 |
| greater_than_200mL vs. less_than_200mL (based on tumor_size) | 1624 | 12738 | 156 | 188 | 123 | 431 |
| no_relapse vs. relapse (based on relapse) | 540 | 3372 | 63 | 129 | 84 | 252 |
| metastases vs. no_metastases (based on metastases_at_diagnosis) | 4104 | 27127 | 130 | 118 | 129 | 329 |
| Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 5226 | 12430 | 3188 | 3212 | 3108 | 3330 |
| Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 32569 | 63613 | 1615 | 964 | 2025 | 8194 |
| comparison | |
| regions | |
| differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| regions | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
| tiling1kb | tiling200bp | genes | promoters | cpgislands | ensembleRegBuildBPall | |
| Ewing vs. Healthy (based on disease_type) | csv | csv | csv | csv | csv | csv |
| Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
| Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
| MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
| MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
| Graz vs. non.Graz (based on sample_source) | csv | csv | csv | csv | csv | csv |
| Münster vs. non.Münster (based on sample_source) | csv | csv | csv | csv | csv | csv |
| Paris vs. non.Paris (based on sample_source) | csv | csv | csv | csv | csv | csv |
| Vienna vs. non.Vienna (based on sample_source) | csv | csv | csv | csv | csv | csv |
| abdomen vs. non.abdomen (based on tumor_location) | csv | csv | csv | csv | csv | csv |
| head_and_neck vs. non.head_and_neck (based on tumor_location) | csv | csv | csv | csv | csv | csv |
| lower_extremity vs. non.lower_extremity (based on tumor_location) | csv | csv | csv | csv | csv | csv |
| pelvis vs. non.pelvis (based on tumor_location) | csv | csv | csv | csv | csv | csv |
| spine vs. non.spine (based on tumor_location) | csv | csv | csv | csv | csv | csv |
| thorax vs. non.thorax (based on tumor_location) | csv | csv | csv | csv | csv | csv |
| upper_extremity vs. non.upper_extremity (based on tumor_location) | csv | csv | csv | csv | csv | csv |
| greater_than_200mL vs. less_than_200mL (based on tumor_size) | csv | csv | csv | csv | csv | csv |
| no_relapse vs. relapse (based on relapse) | csv | csv | csv | csv | csv | csv |
| metastases vs. no_metastases (based on metastases_at_diagnosis) | csv | csv | csv | csv | csv | csv |
| Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | csv | csv | csv | csv | csv | csv |
| Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | csv | csv | csv | csv | csv | csv |
Differential variability on the region level was computed similar to differential methylation, but the mean of variances, the log-ratio of the quotient of variances as well as the p-values from the differentiality test were employed. Ranking was performed in line with the ranking of differential methylation.
The following rank cutoffs have been automatically selected for the analysis of differentially variable regions:
| tiling1kb | tiling200bp | genes | promoters | cpgislands | ensembleRegBuildBPall | |
| Ewing vs. Healthy (based on disease_type) | 13373 | 11502 | 1548 | 1322 | 476 | 6485 |
| Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 8047 | 13189 | 830 | 1281 | 1595 | 2035 |
| Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 10763 | 19445 | 952 | 1195 | 1018 | 3128 |
| MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 18272 | 27660 | 1170 | 2833 | 2352 | 7037 |
| MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 13373 | 11324 | 1548 | 1459 | 604 | 6473 |
| Graz vs. non.Graz (based on sample_source) | 24441 | 61810 | 3474 | 2552 | 3353 | 6790 |
| Münster vs. non.Münster (based on sample_source) | 14623 | 27321 | 2242 | 2351 | 1887 | 3630 |
| Paris vs. non.Paris (based on sample_source) | 8541 | 20263 | 1075 | 2483 | 1152 | 3415 |
| Vienna vs. non.Vienna (based on sample_source) | 6278 | 18665 | 1568 | 1771 | 1084 | 6349 |
| abdomen vs. non.abdomen (based on tumor_location) | 15556 | 10277 | 2213 | 2911 | 3246 | 6112 |
| head_and_neck vs. non.head_and_neck (based on tumor_location) | 24311 | 32741 | 1970 | 3794 | 2479 | 4857 |
| lower_extremity vs. non.lower_extremity (based on tumor_location) | 14380 | 16144 | 89 | 1203 | 229 | 2556 |
| pelvis vs. non.pelvis (based on tumor_location) | 11406 | 27821 | 132 | 1224 | 329 | 3363 |
| spine vs. non.spine (based on tumor_location) | 19903 | 39972 | 797 | 1485 | 967 | 4524 |
| thorax vs. non.thorax (based on tumor_location) | 8378 | 27482 | 284 | 2880 | 2428 | 1928 |
| upper_extremity vs. non.upper_extremity (based on tumor_location) | 9879 | 21115 | 2229 | 1964 | 1775 | 5223 |
| greater_than_200mL vs. less_than_200mL (based on tumor_size) | 18493 | 24864 | 132 | 664 | 427 | 3631 |
| no_relapse vs. relapse (based on relapse) | 11832 | 20200 | 96 | 1558 | 367 | 5716 |
| metastases vs. no_metastases (based on metastases_at_diagnosis) | 11641 | 20847 | 215 | 1638 | 949 | 3524 |
| Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 8323 | 14858 | 766 | 1444 | 869 | 2949 |
| Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 12233 | 26203 | 1214 | 2763 | 1412 | 4450 |
| comparison | |
| regions | |
| differential variability measure |
Scatterplot for differential variable regions. The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly. Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
| comparison | |
| regions | |
| difference metric | |
| significance metric |
Volcano plot for differential variability quantified by various metrics. Color scale according to combined ranking.
| comparison | |
| regions | |
| rankCutoff |
Scatterplot comparing differentially methylated (DMRs) and variable regions (DVRs), as well as regions that are both differentially methylated and variable. The dotted lines corrspond to the respective rank cutoffs used to call a region differentially methylated/variable.
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
Wordclouds for GO enrichment terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903706 | 4e-04 | 9.6333 | 0.6451 | 5 | 409 | regulation of hemopoiesis |
| GO:0060216 | 4e-04 | 81.1551 | 0.03 | 2 | 19 | definitive hemopoiesis |
| GO:0048534 | 0.0012 | 6.0289 | 1.2649 | 6 | 802 | hematopoietic or lymphoid organ development |
| GO:0071345 | 0.0013 | 6.0209 | 1.2665 | 6 | 803 | cellular response to cytokine stimulus |
| GO:0010734 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of protein glutathionylation |
| GO:1902867 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:0030099 | 0.0021 | 8.457 | 0.5599 | 4 | 355 | myeloid cell differentiation |
| GO:0045596 | 0.0022 | 6.4116 | 0.9526 | 5 | 604 | negative regulation of cell differentiation |
| GO:0050902 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | leukocyte adhesive activation |
| GO:0071461 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | cellular response to redox state |
| GO:1901003 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of fermentation |
| GO:0051239 | 0.0042 | 3.4436 | 4.1322 | 10 | 2620 | regulation of multicellular organismal process |
| GO:0071560 | 0.0043 | 10.2919 | 0.3328 | 3 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0070315 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | G1 to G0 transition involved in cell differentiation |
| GO:1990791 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | dorsal root ganglion development |
| GO:0045652 | 0.0048 | 21.4901 | 0.1041 | 2 | 66 | regulation of megakaryocyte differentiation |
| GO:0007275 | 0.0049 | 3.1352 | 7.4191 | 14 | 4704 | multicellular organism development |
| GO:0050793 | 0.0052 | 3.4841 | 3.5345 | 9 | 2241 | regulation of developmental process |
| GO:0001501 | 0.0057 | 6.3771 | 0.735 | 4 | 466 | skeletal system development |
| GO:0050768 | 0.0057 | 9.2529 | 0.3691 | 3 | 234 | negative regulation of neurogenesis |
| GO:1903273 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | regulation of sodium ion export |
| GO:1903278 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of sodium ion export across plasma membrane |
| GO:0048869 | 0.0075 | 2.9835 | 6.0343 | 12 | 3826 | cellular developmental process |
| GO:0061056 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | sclerotome development |
| GO:0090259 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | regulation of retinal ganglion cell axon guidance |
| GO:0060842 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | arterial endothelial cell differentiation |
| GO:0061074 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | regulation of neural retina development |
| GO:0045664 | 0.0097 | 5.4375 | 0.8564 | 4 | 543 | regulation of neuron differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 104.0247 | 0.0712 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 48.5425 | 0.1448 | 5 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 43.4159 | 0.1611 | 5 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 42.3819 | 0.1648 | 5 | 132 | sensory perception of chemical stimulus |
| GO:0050877 | 5e-04 | 7.7234 | 1.0775 | 6 | 863 | nervous system process |
| GO:0002041 | 0.0012 | Inf | 0.0012 | 1 | 1 | intussusceptive angiogenesis |
| GO:0140076 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of lipoprotein transport |
| GO:0007186 | 0.0031 | 6.1511 | 1.0476 | 5 | 839 | G-protein coupled receptor signaling pathway |
| GO:0002803 | 0.0037 | 422.1111 | 0.0037 | 1 | 3 | positive regulation of antibacterial peptide production |
| GO:0002249 | 0.005 | 281.3889 | 0.005 | 1 | 4 | lymphocyte anergy |
| GO:0002667 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of T cell anergy |
| GO:0002760 | 0.005 | 281.3889 | 0.005 | 1 | 4 | positive regulation of antimicrobial humoral response |
| GO:0002784 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of antimicrobial peptide production |
| GO:0010961 | 0.005 | 281.3889 | 0.005 | 1 | 4 | cellular magnesium ion homeostasis |
| GO:0031133 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of axon diameter |
| GO:0060591 | 0.0062 | 211.0278 | 0.0062 | 1 | 5 | chondroblast differentiation |
| GO:0030198 | 0.0068 | 8.8589 | 0.3971 | 3 | 318 | extracellular matrix organization |
| GO:0010811 | 0.0071 | 17.7624 | 0.1274 | 2 | 102 | positive regulation of cell-substrate adhesion |
| GO:0003278 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0060842 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | arterial endothelial cell differentiation |
| GO:0090370 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | negative regulation of cholesterol efflux |
| GO:0052548 | 0.0081 | 8.3188 | 0.422 | 3 | 338 | regulation of endopeptidase activity |
| GO:0060710 | 0.0087 | 140.6667 | 0.0087 | 1 | 7 | chorio-allantoic fusion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010469 | 4e-04 | 15.2402 | 0.384 | 4 | 487 | regulation of receptor activity |
| GO:2000872 | 8e-04 | Inf | 8e-04 | 1 | 1 | positive regulation of progesterone secretion |
| GO:0042221 | 0.0022 | 6.2658 | 2.9075 | 8 | 3687 | response to chemical |
| GO:0008628 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0007195 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0030223 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | neutrophil differentiation |
| GO:0060842 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | arterial endothelial cell differentiation |
| GO:0061074 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | regulation of neural retina development |
| GO:0031017 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | exocrine pancreas development |
| GO:0035881 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | amacrine cell differentiation |
| GO:0042117 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | monocyte activation |
| GO:2000252 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | negative regulation of feeding behavior |
| GO:0060158 | 0.0071 | 172.6932 | 0.0071 | 1 | 9 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0097305 | 0.0075 | 18.0096 | 0.1333 | 2 | 169 | response to alcohol |
| GO:0001553 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | luteinization |
| GO:0051481 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | negative regulation of cytosolic calcium ion concentration |
| GO:0051967 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | negative regulation of synaptic transmission, glutamatergic |
| GO:1905941 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | positive regulation of gonad development |
| GO:2001214 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | positive regulation of vasculogenesis |
| GO:0002573 | 0.0079 | 17.5836 | 0.1364 | 2 | 173 | myeloid leukocyte differentiation |
| GO:0048149 | 0.0086 | 138.1364 | 0.0087 | 1 | 11 | behavioral response to ethanol |
| GO:0007268 | 0.0089 | 8.6213 | 0.4487 | 3 | 569 | chemical synaptic transmission |
| GO:0099537 | 0.009 | 8.5898 | 0.4503 | 3 | 571 | trans-synaptic signaling |
| GO:0071280 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | cellular response to copper ion |
| GO:1901386 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | negative regulation of voltage-gated calcium channel activity |
| GO:2000194 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | regulation of female gonad development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035066 | 3e-04 | 97.2949 | 0.0256 | 2 | 26 | positive regulation of histone acetylation |
| GO:0031960 | 4e-04 | 26.3269 | 0.1439 | 3 | 146 | response to corticosteroid |
| GO:0003203 | 4e-04 | 86.4672 | 0.0286 | 2 | 29 | endocardial cushion morphogenesis |
| GO:1901985 | 4e-04 | 80.4934 | 0.0306 | 2 | 31 | positive regulation of protein acetylation |
| GO:0031099 | 5e-04 | 22.9238 | 0.1646 | 3 | 167 | regeneration |
| GO:0031103 | 7e-04 | 63.0561 | 0.0384 | 2 | 39 | axon regeneration |
| GO:0002152 | 0.001 | Inf | 0.001 | 1 | 1 | bile acid conjugation |
| GO:2000756 | 0.0012 | 46.6215 | 0.0513 | 2 | 52 | regulation of peptidyl-lysine acetylation |
| GO:0071385 | 0.0012 | 45.7044 | 0.0522 | 2 | 53 | cellular response to glucocorticoid stimulus |
| GO:0050911 | 0.0014 | 42.3692 | 0.0562 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0060411 | 0.0018 | 36.9695 | 0.0641 | 2 | 65 | cardiac septum morphogenesis |
| GO:0032024 | 0.0019 | 36.3894 | 0.0651 | 2 | 66 | positive regulation of insulin secretion |
| GO:0036304 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | umbilical cord morphogenesis |
| GO:0046452 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | dihydrofolate metabolic process |
| GO:0071657 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:2000820 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
| GO:1901214 | 0.0021 | 14.2006 | 0.2622 | 3 | 266 | regulation of neuron death |
| GO:0003208 | 0.0022 | 33.7414 | 0.07 | 2 | 71 | cardiac ventricle morphogenesis |
| GO:1905269 | 0.0029 | 29.0808 | 0.0808 | 2 | 82 | positive regulation of chromatin organization |
| GO:0003095 | 0.003 | 542.8571 | 0.003 | 1 | 3 | pressure natriuresis |
| GO:0021524 | 0.003 | 542.8571 | 0.003 | 1 | 3 | visceral motor neuron differentiation |
| GO:0048936 | 0.003 | 542.8571 | 0.003 | 1 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0060913 | 0.003 | 542.8571 | 0.003 | 1 | 3 | cardiac cell fate determination |
| GO:0042221 | 0.0039 | 5.1754 | 3.0742 | 8 | 3571 | response to chemical |
| GO:0031427 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | response to methotrexate |
| GO:0032730 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | positive regulation of interleukin-1 alpha production |
| GO:0036101 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | leukotriene B4 catabolic process |
| GO:0042360 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | vitamin E metabolic process |
| GO:1901256 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:0051101 | 0.0048 | 22.3343 | 0.1045 | 2 | 106 | regulation of DNA binding |
| GO:0048880 | 0.0049 | 271.3929 | 0.0049 | 1 | 5 | sensory system development |
| GO:0090074 | 0.0049 | 271.3929 | 0.0049 | 1 | 5 | negative regulation of protein homodimerization activity |
| GO:1901523 | 0.0049 | 271.3929 | 0.0049 | 1 | 5 | icosanoid catabolic process |
| GO:0046887 | 0.0054 | 20.9161 | 0.1114 | 2 | 113 | positive regulation of hormone secretion |
| GO:0045471 | 0.0056 | 20.5432 | 0.1134 | 2 | 115 | response to ethanol |
| GO:0009593 | 0.0057 | 20.3617 | 0.1143 | 2 | 116 | detection of chemical stimulus |
| GO:0006545 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | glycine biosynthetic process |
| GO:0019530 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | taurine metabolic process |
| GO:0030223 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | neutrophil differentiation |
| GO:0060842 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | arterial endothelial cell differentiation |
| GO:0006766 | 0.006 | 19.8356 | 0.1173 | 2 | 119 | vitamin metabolic process |
| GO:0031056 | 0.0062 | 19.4997 | 0.1193 | 2 | 121 | regulation of histone modification |
| GO:0003190 | 0.0069 | 180.9048 | 0.0069 | 1 | 7 | atrioventricular valve formation |
| GO:0006729 | 0.0069 | 180.9048 | 0.0069 | 1 | 7 | tetrahydrobiopterin biosynthetic process |
| GO:0046654 | 0.0069 | 180.9048 | 0.0069 | 1 | 7 | tetrahydrofolate biosynthetic process |
| GO:0001837 | 0.007 | 18.2617 | 0.1272 | 2 | 129 | epithelial to mesenchymal transition |
| GO:0050906 | 0.007 | 18.2617 | 0.1272 | 2 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0.0073 | 17.8367 | 0.1301 | 2 | 132 | sensory perception of chemical stimulus |
| GO:0018393 | 0.0075 | 17.5641 | 0.1321 | 2 | 134 | internal peptidyl-lysine acetylation |
| GO:0007186 | 0.0077 | 6.2567 | 0.827 | 4 | 839 | G-protein coupled receptor signaling pathway |
| GO:0051100 | 0.0077 | 17.2997 | 0.1341 | 2 | 136 | negative regulation of binding |
| GO:0033993 | 0.0078 | 6.233 | 0.83 | 4 | 842 | response to lipid |
| GO:2000113 | 0.0079 | 5.122 | 1.3376 | 5 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0035912 | 0.0079 | 155.051 | 0.0079 | 1 | 8 | dorsal aorta morphogenesis |
| GO:0006544 | 0.0083 | 146.0481 | 0.0083 | 1 | 9 | glycine metabolic process |
| GO:0003139 | 0.0088 | 135.6607 | 0.0089 | 1 | 9 | secondary heart field specification |
| GO:0003266 | 0.0088 | 135.6607 | 0.0089 | 1 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0061314 | 0.0088 | 135.6607 | 0.0089 | 1 | 9 | Notch signaling involved in heart development |
| GO:0051222 | 0.0089 | 8.2713 | 0.4426 | 3 | 449 | positive regulation of protein transport |
| GO:0003205 | 0.0097 | 15.3347 | 0.1508 | 2 | 153 | cardiac chamber development |
| GO:0003263 | 0.0098 | 120.5794 | 0.0099 | 1 | 10 | cardioblast proliferation |
| GO:2000121 | 0.0098 | 120.5794 | 0.0099 | 1 | 10 | regulation of removal of superoxide radicals |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010665 | 0.0014 | 41.7631 | 0.0552 | 2 | 35 | regulation of cardiac muscle cell apoptotic process |
| GO:0003327 | 0.0016 | Inf | 0.0016 | 1 | 1 | type B pancreatic cell fate commitment |
| GO:0031989 | 0.0016 | Inf | 0.0016 | 1 | 1 | bombesin receptor signaling pathway |
| GO:0060450 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of hindgut contraction |
| GO:0060580 | 0.0016 | Inf | 0.0016 | 1 | 1 | ventral spinal cord interneuron fate determination |
| GO:0051094 | 0.0016 | 5.0093 | 1.8311 | 7 | 1161 | positive regulation of developmental process |
| GO:0010658 | 0.0018 | 36.256 | 0.0631 | 2 | 40 | striated muscle cell apoptotic process |
| GO:0032570 | 0.0023 | 32.0296 | 0.071 | 2 | 45 | response to progesterone |
| GO:0000320 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | re-entry into mitotic cell cycle |
| GO:0003326 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | pancreatic PP cell fate commitment |
| GO:0014718 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | positive regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0048627 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | myoblast development |
| GO:0051965 | 0.0034 | 25.9691 | 0.0867 | 2 | 55 | positive regulation of synapse assembly |
| GO:0010660 | 0.0035 | 25.4865 | 0.0883 | 2 | 56 | regulation of muscle cell apoptotic process |
| GO:0002125 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | maternal aggressive behavior |
| GO:0003245 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | cardiac muscle tissue growth involved in heart morphogenesis |
| GO:0007525 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | somatic muscle development |
| GO:0021530 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0045925 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | positive regulation of female receptivity |
| GO:0061737 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | leukotriene signaling pathway |
| GO:0060415 | 0.0062 | 18.8294 | 0.1183 | 2 | 75 | muscle tissue morphogenesis |
| GO:0010701 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of norepinephrine secretion |
| GO:0035811 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | negative regulation of urine volume |
| GO:0060406 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of penile erection |
| GO:0070318 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of G0 to G1 transition |
| GO:1905205 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of connective tissue replacement |
| GO:0021779 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | glial cell fate specification |
| GO:0060455 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | negative regulation of gastric acid secretion |
| GO:0009744 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | response to sucrose |
| GO:0014719 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | skeletal muscle satellite cell activation |
| GO:0042713 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | sperm ejaculation |
| GO:0060179 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | male mating behavior |
| GO:0070141 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | response to UV-A |
| GO:1904684 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | negative regulation of metalloendopeptidase activity |
| GO:0007200 | 0.0097 | 14.7605 | 0.1498 | 2 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051412 | 3e-04 | 96.3746 | 0.0257 | 2 | 17 | response to corticosterone |
| GO:0019098 | 9e-04 | 51.585 | 0.0453 | 2 | 30 | reproductive behavior |
| GO:0007618 | 0.0013 | 43.7547 | 0.0529 | 2 | 35 | mating |
| GO:0071444 | 0.0015 | Inf | 0.0015 | 1 | 1 | cellular response to pheromone |
| GO:0035176 | 0.0021 | 33.557 | 0.068 | 2 | 45 | social behavior |
| GO:0045851 | 0.0024 | 31.3623 | 0.0726 | 2 | 48 | pH reduction |
| GO:0050801 | 0.0029 | 6.031 | 1.0187 | 5 | 674 | ion homeostasis |
| GO:0055082 | 0.003 | 6.0028 | 1.0233 | 5 | 677 | cellular chemical homeostasis |
| GO:0042322 | 0.003 | 690.5909 | 0.003 | 1 | 2 | negative regulation of circadian sleep/wake cycle, REM sleep |
| GO:0060468 | 0.003 | 690.5909 | 0.003 | 1 | 2 | prevention of polyspermy |
| GO:2000854 | 0.003 | 690.5909 | 0.003 | 1 | 2 | positive regulation of corticosterone secretion |
| GO:0075733 | 0.0033 | 26.2147 | 0.0862 | 2 | 57 | intracellular transport of virus |
| GO:0009988 | 0.004 | 23.6269 | 0.0952 | 2 | 63 | cell-cell recognition |
| GO:1904063 | 0.004 | 23.6269 | 0.0952 | 2 | 63 | negative regulation of cation transmembrane transport |
| GO:0006811 | 0.0044 | 4.1628 | 2.1947 | 7 | 1452 | ion transport |
| GO:0002125 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | maternal aggressive behavior |
| GO:0031394 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | positive regulation of prostaglandin biosynthetic process |
| GO:0033685 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | negative regulation of luteinizing hormone secretion |
| GO:0042631 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | cellular response to water deprivation |
| GO:0046968 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | peptide antigen transport |
| GO:0070093 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | negative regulation of glucagon secretion |
| GO:0071314 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | cellular response to cocaine |
| GO:0051952 | 0.005 | 21.1849 | 0.1058 | 2 | 70 | regulation of amine transport |
| GO:0042310 | 0.0051 | 20.8765 | 0.1073 | 2 | 71 | vasoconstriction |
| GO:0044766 | 0.0051 | 20.8765 | 0.1073 | 2 | 71 | multi-organism transport |
| GO:0050886 | 0.0055 | 20.0026 | 0.1118 | 2 | 74 | endocrine process |
| GO:0001992 | 0.006 | 230.1667 | 0.006 | 1 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0007621 | 0.006 | 230.1667 | 0.006 | 1 | 4 | negative regulation of female receptivity |
| GO:0008628 | 0.006 | 230.1667 | 0.006 | 1 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0010841 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of circadian sleep/wake cycle, wakefulness |
| GO:0010961 | 0.006 | 230.1667 | 0.006 | 1 | 4 | cellular magnesium ion homeostasis |
| GO:0031133 | 0.006 | 230.1667 | 0.006 | 1 | 4 | regulation of axon diameter |
| GO:0032811 | 0.006 | 230.1667 | 0.006 | 1 | 4 | negative regulation of epinephrine secretion |
| GO:0032849 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of cellular pH reduction |
| GO:0043315 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of neutrophil degranulation |
| GO:0051461 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of corticotropin secretion |
| GO:0051464 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of cortisol secretion |
| GO:1901842 | 0.006 | 230.1667 | 0.006 | 1 | 4 | negative regulation of high voltage-gated calcium channel activity |
| GO:1902527 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of protein monoubiquitination |
| GO:0034763 | 0.0064 | 18.4567 | 0.1209 | 2 | 80 | negative regulation of transmembrane transport |
| GO:0051970 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | negative regulation of transmission of nerve impulse |
| GO:1902255 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:1903232 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | melanosome assembly |
| GO:2000987 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | positive regulation of behavioral fear response |
| GO:2001279 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0051453 | 0.0076 | 16.9289 | 0.1315 | 2 | 87 | regulation of intracellular pH |
| GO:0030003 | 0.0082 | 5.7462 | 0.8177 | 4 | 541 | cellular cation homeostasis |
| GO:0014062 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | regulation of serotonin secretion |
| GO:0042713 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | sperm ejaculation |
| GO:0048241 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | epinephrine transport |
| GO:0060179 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | male mating behavior |
| GO:0014902 | 0.0097 | 14.8228 | 0.1496 | 2 | 99 | myotube differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061760 | 0 | 1519.4 | 0.0043 | 2 | 3 | antifungal innate immune response |
| GO:0009620 | 0 | 66.4868 | 0.0564 | 3 | 39 | response to fungus |
| GO:0070098 | 1e-04 | 44.2719 | 0.0824 | 3 | 57 | chemokine-mediated signaling pathway |
| GO:0050829 | 1e-04 | 39.8289 | 0.0911 | 3 | 63 | defense response to Gram-negative bacterium |
| GO:0030593 | 1e-04 | 36.753 | 0.0983 | 3 | 68 | neutrophil chemotaxis |
| GO:0050830 | 2e-04 | 33.1645 | 0.1084 | 3 | 75 | defense response to Gram-positive bacterium |
| GO:0098542 | 2e-04 | 11.6235 | 0.5494 | 5 | 380 | defense response to other organism |
| GO:0097530 | 4e-04 | 24.8339 | 0.1431 | 3 | 99 | granulocyte migration |
| GO:0071346 | 6e-04 | 21.2636 | 0.1663 | 3 | 115 | cellular response to interferon-gamma |
| GO:0007186 | 0.001 | 6.4655 | 1.213 | 6 | 839 | G-protein coupled receptor signaling pathway |
| GO:0061844 | 0.0013 | 43.3143 | 0.0535 | 2 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0048247 | 0.0014 | 40.9676 | 0.0564 | 2 | 39 | lymphocyte chemotaxis |
| GO:0031640 | 0.0017 | 37.8875 | 0.0607 | 2 | 42 | killing of cells of other organism |
| GO:0002548 | 0.0018 | 36.0786 | 0.0636 | 2 | 44 | monocyte chemotaxis |
| GO:0045087 | 0.0023 | 6.5574 | 0.9728 | 5 | 740 | innate immune response |
| GO:0043207 | 0.0029 | 6.0541 | 1.025 | 5 | 709 | response to external biotic stimulus |
| GO:0009617 | 0.0036 | 7.3658 | 0.6491 | 4 | 449 | response to bacterium |
| GO:0060326 | 0.0039 | 10.6983 | 0.3238 | 3 | 224 | cell chemotaxis |
| GO:0045918 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | negative regulation of cytolysis |
| GO:0010469 | 0.0048 | 6.7688 | 0.7041 | 4 | 487 | regulation of receptor activity |
| GO:0002690 | 0.0048 | 21.6071 | 0.1041 | 2 | 72 | positive regulation of leukocyte chemotaxis |
| GO:0071347 | 0.0052 | 20.7151 | 0.1084 | 2 | 75 | cellular response to interleukin-1 |
| GO:0002376 | 0.0053 | 3.558 | 3.5912 | 9 | 2484 | immune system process |
| GO:0002249 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | lymphocyte anergy |
| GO:0002667 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | regulation of T cell anergy |
| GO:0019732 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | antifungal humoral response |
| GO:0016525 | 0.0065 | 18.4305 | 0.1214 | 2 | 84 | negative regulation of angiogenesis |
| GO:0045347 | 0.0072 | 180.8452 | 0.0072 | 1 | 5 | negative regulation of MHC class II biosynthetic process |
| GO:1901343 | 0.0077 | 16.7833 | 0.133 | 2 | 92 | negative regulation of vasculature development |
| GO:0007195 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0043950 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | positive regulation of cAMP-mediated signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 65.4749 | 0.1572 | 7 | 92 | embryonic skeletal system morphogenesis |
| GO:0043009 | 0 | 20.2066 | 0.9278 | 11 | 543 | chordate embryonic development |
| GO:0048568 | 0 | 19.6774 | 0.6954 | 9 | 407 | embryonic organ development |
| GO:0048598 | 0 | 16.482 | 0.9654 | 10 | 565 | embryonic morphogenesis |
| GO:0007389 | 0 | 16.5193 | 0.6937 | 8 | 406 | pattern specification process |
| GO:0009888 | 0 | 11.9817 | 1.4933 | 10 | 1033 | tissue development |
| GO:0009952 | 0 | 23.941 | 0.3315 | 6 | 194 | anterior/posterior pattern specification |
| GO:0021545 | 0 | 64.0507 | 0.0803 | 4 | 47 | cranial nerve development |
| GO:0072358 | 0 | 10.6967 | 1.0491 | 8 | 614 | cardiovascular system development |
| GO:0030878 | 0 | 94.2236 | 0.041 | 3 | 24 | thyroid gland development |
| GO:0001525 | 0 | 14.9283 | 0.5329 | 6 | 336 | angiogenesis |
| GO:0021615 | 0 | 632.875 | 0.0068 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0009887 | 0 | 8.1179 | 1.4029 | 8 | 886 | animal organ morphogenesis |
| GO:0048869 | 1e-04 | 4.7794 | 6.5372 | 16 | 3826 | cellular developmental process |
| GO:0060837 | 1e-04 | 180.7619 | 0.0154 | 2 | 9 | blood vessel endothelial cell differentiation |
| GO:0007275 | 2e-04 | 6.3759 | 5.2234 | 13 | 4298 | multicellular organism development |
| GO:0051216 | 2e-04 | 16.3571 | 0.2922 | 4 | 171 | cartilage development |
| GO:0001568 | 2e-04 | 8.5775 | 0.9058 | 6 | 574 | blood vessel development |
| GO:0030855 | 2e-04 | 10.9703 | 0.5748 | 5 | 374 | epithelial cell differentiation |
| GO:0045944 | 2e-04 | 6.0725 | 1.7838 | 8 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:2001212 | 3e-04 | 105.4097 | 0.0239 | 2 | 14 | regulation of vasculogenesis |
| GO:0001501 | 8e-04 | 11.2509 | 0.4313 | 4 | 295 | skeletal system development |
| GO:0003158 | 8e-04 | 18.3876 | 0.1879 | 3 | 110 | endothelium development |
| GO:0003203 | 0.0011 | 46.8025 | 0.0495 | 2 | 29 | endocardial cushion morphogenesis |
| GO:1903508 | 0.0013 | 4.6167 | 2.293 | 8 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0031328 | 0.0013 | 4.2605 | 2.8841 | 9 | 1688 | positive regulation of cellular biosynthetic process |
| GO:2000113 | 0.0014 | 4.5604 | 2.3186 | 8 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0048665 | 0.0014 | 40.7527 | 0.0564 | 2 | 33 | neuron fate specification |
| GO:0031424 | 0.0016 | 14.6564 | 0.2341 | 3 | 137 | keratinization |
| GO:0006355 | 0.0017 | 3.5184 | 5.7666 | 13 | 3375 | regulation of transcription, DNA-templated |
| GO:0003327 | 0.0017 | Inf | 0.0017 | 1 | 1 | type B pancreatic cell fate commitment |
| GO:0060580 | 0.0017 | Inf | 0.0017 | 1 | 1 | ventral spinal cord interneuron fate determination |
| GO:0071444 | 0.0017 | Inf | 0.0017 | 1 | 1 | cellular response to pheromone |
| GO:0110023 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
| GO:1903769 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:1905322 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
| GO:2001141 | 0.0018 | 3.4838 | 5.811 | 13 | 3401 | regulation of RNA biosynthetic process |
| GO:0051254 | 0.0018 | 4.3678 | 2.4109 | 8 | 1411 | positive regulation of RNA metabolic process |
| GO:0031960 | 0.0019 | 13.7258 | 0.2495 | 3 | 146 | response to corticosteroid |
| GO:0021983 | 0.0021 | 33.2303 | 0.0683 | 2 | 40 | pituitary gland development |
| GO:1903507 | 0.0021 | 4.6873 | 1.9034 | 7 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0019219 | 0.0021 | 3.3568 | 6.7183 | 14 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0003205 | 0.0022 | 13.0791 | 0.2614 | 3 | 153 | cardiac chamber development |
| GO:0021517 | 0.0024 | 30.7927 | 0.0735 | 2 | 43 | ventral spinal cord development |
| GO:0034654 | 0.0025 | 3.2942 | 6.8122 | 14 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0060711 | 0.0027 | 29.3566 | 0.0769 | 2 | 45 | labyrinthine layer development |
| GO:0009890 | 0.0028 | 4.0446 | 2.5834 | 8 | 1512 | negative regulation of biosynthetic process |
| GO:0051253 | 0.003 | 4.3745 | 2.0281 | 7 | 1187 | negative regulation of RNA metabolic process |
| GO:0048729 | 0.0031 | 5.851 | 1.0235 | 5 | 599 | tissue morphogenesis |
| GO:0031102 | 0.0031 | 26.8511 | 0.0837 | 2 | 49 | neuron projection regeneration |
| GO:0042692 | 0.0032 | 7.448 | 0.6254 | 4 | 366 | muscle cell differentiation |
| GO:0051173 | 0.0033 | 3.3728 | 4.6543 | 11 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0021515 | 0.0034 | 25.7517 | 0.0871 | 2 | 51 | cell differentiation in spinal cord |
| GO:0003326 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | pancreatic PP cell fate commitment |
| GO:0036304 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | umbilical cord morphogenesis |
| GO:0060764 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0071657 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:2000820 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
| GO:0010557 | 0.0035 | 3.9058 | 2.6654 | 8 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0002066 | 0.0035 | 25.235 | 0.0888 | 2 | 52 | columnar/cuboidal epithelial cell development |
| GO:0071385 | 0.0037 | 24.7386 | 0.0906 | 2 | 53 | cellular response to glucocorticoid stimulus |
| GO:0007420 | 0.0041 | 5.4489 | 1.0952 | 5 | 641 | brain development |
| GO:0050911 | 0.0042 | 22.9333 | 0.0974 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0048645 | 0.0045 | 22.1257 | 0.1008 | 2 | 59 | animal organ formation |
| GO:0010159 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | specification of animal organ position |
| GO:0014707 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | branchiomeric skeletal muscle development |
| GO:0021524 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | visceral motor neuron differentiation |
| GO:0021530 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0048936 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0060435 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | bronchiole development |
| GO:0060913 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | cardiac cell fate determination |
| GO:0003281 | 0.0051 | 20.6694 | 0.1076 | 2 | 63 | ventricular septum development |
| GO:0060411 | 0.0055 | 20.0106 | 0.1111 | 2 | 65 | cardiac septum morphogenesis |
| GO:0010629 | 0.0058 | 3.5553 | 2.8978 | 8 | 1696 | negative regulation of gene expression |
| GO:0010628 | 0.0059 | 3.5388 | 2.9098 | 8 | 1703 | positive regulation of gene expression |
| GO:1901342 | 0.0064 | 8.8548 | 0.3852 | 3 | 244 | regulation of vasculature development |
| GO:0003208 | 0.0065 | 18.2633 | 0.1213 | 2 | 71 | cardiac ventricle morphogenesis |
| GO:0000122 | 0.0068 | 4.8337 | 1.2356 | 5 | 752 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0032730 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | positive regulation of interleukin-1 alpha production |
| GO:0060480 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | lung goblet cell differentiation |
| GO:0060535 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | intestinal epithelial cell maturation |
| GO:1901256 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:0060485 | 0.0069 | 8.5601 | 0.3947 | 3 | 231 | mesenchyme development |
| GO:0031016 | 0.0072 | 17.258 | 0.1281 | 2 | 75 | pancreas development |
| GO:0048513 | 0.008 | 5.3274 | 1.3685 | 5 | 1433 | animal organ development |
| GO:0060255 | 0.0085 | 2.7731 | 9.5238 | 16 | 5574 | regulation of macromolecule metabolic process |
| GO:0007406 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of neuroblast proliferation |
| GO:0021779 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | glial cell fate specification |
| GO:0048625 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | myoblast fate commitment |
| GO:0048880 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | sensory system development |
| GO:0090074 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of protein homodimerization activity |
| GO:0031623 | 0.0088 | 15.5453 | 0.1418 | 2 | 83 | receptor internalization |
| GO:0009913 | 0.0088 | 7.8271 | 0.4306 | 3 | 252 | epidermal cell differentiation |
| GO:0051961 | 0.0089 | 7.7953 | 0.4323 | 3 | 253 | negative regulation of nervous system development |
| GO:0016525 | 0.009 | 15.3547 | 0.1435 | 2 | 84 | negative regulation of angiogenesis |
| GO:0001843 | 0.0092 | 15.1687 | 0.1452 | 2 | 85 | neural tube closure |
| GO:0048522 | 0.0098 | 2.7106 | 7.834 | 14 | 4585 | positive regulation of cellular process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002152 | 0.0018 | Inf | 0.0018 | 1 | 1 | bile acid conjugation |
| GO:0021763 | 0.0018 | Inf | 0.0018 | 1 | 1 | subthalamic nucleus development |
| GO:0042404 | 0.0018 | Inf | 0.0018 | 1 | 1 | thyroid hormone catabolic process |
| GO:0060127 | 0.0018 | Inf | 0.0018 | 1 | 1 | prolactin secreting cell differentiation |
| GO:0060578 | 0.0018 | Inf | 0.0018 | 1 | 1 | superior vena cava morphogenesis |
| GO:0048536 | 0.002 | 34.2873 | 0.0662 | 2 | 36 | spleen development |
| GO:0002503 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | peptide antigen assembly with MHC class II protein complex |
| GO:0007506 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | gonadal mesoderm development |
| GO:0060460 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | left lung morphogenesis |
| GO:0060577 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | pulmonary vein morphogenesis |
| GO:2000355 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | negative regulation of ovarian follicle development |
| GO:2001190 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0055013 | 0.0054 | 20.0676 | 0.1104 | 2 | 60 | cardiac muscle cell development |
| GO:0000454 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | snoRNA guided rRNA pseudouridine synthesis |
| GO:0001546 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | preantral ovarian follicle growth |
| GO:0003245 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | cardiac muscle tissue growth involved in heart morphogenesis |
| GO:0003350 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | pulmonary myocardium development |
| GO:0035993 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | deltoid tuberosity development |
| GO:0061031 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | endodermal digestive tract morphogenesis |
| GO:0009653 | 0.0068 | 3.0521 | 4.3223 | 10 | 2349 | anatomical structure morphogenesis |
| GO:0001880 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | Mullerian duct regression |
| GO:0002396 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | MHC protein complex assembly |
| GO:0019732 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | antifungal humoral response |
| GO:0021855 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | hypothalamus cell migration |
| GO:0060126 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | somatotropin secreting cell differentiation |
| GO:0061325 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:1905205 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | positive regulation of connective tissue replacement |
| GO:0060415 | 0.0083 | 15.9283 | 0.138 | 2 | 75 | muscle tissue morphogenesis |
| GO:0002074 | 0.0092 | 140.6019 | 0.0092 | 1 | 5 | extraocular skeletal muscle development |
| GO:0048731 | 0.0095 | 2.639 | 7.7061 | 14 | 4188 | system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060706 | 8e-04 | 55.1564 | 0.0426 | 2 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0018149 | 9e-04 | 51.064 | 0.0457 | 2 | 29 | peptide cross-linking |
| GO:0043616 | 0.0015 | 40.5321 | 0.0568 | 2 | 36 | keratinocyte proliferation |
| GO:0003144 | 0.0016 | Inf | 0.0016 | 1 | 1 | embryonic heart tube formation |
| GO:0008544 | 0.0021 | 8.5316 | 0.5552 | 4 | 352 | epidermis development |
| GO:0030855 | 0.0026 | 6.1751 | 0.9873 | 5 | 626 | epithelial cell differentiation |
| GO:0048588 | 0.0026 | 12.3309 | 0.2792 | 3 | 177 | developmental cell growth |
| GO:0003218 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | cardiac left ventricle formation |
| GO:0003290 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | atrial septum secundum morphogenesis |
| GO:0038195 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | urokinase plasminogen activator signaling pathway |
| GO:0060354 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of cell adhesion molecule production |
| GO:0061044 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of vascular wound healing |
| GO:0001947 | 0.0036 | 25.0215 | 0.0899 | 2 | 57 | heart looping |
| GO:0030216 | 0.0039 | 10.6553 | 0.3217 | 3 | 204 | keratinocyte differentiation |
| GO:0060411 | 0.0047 | 21.8326 | 0.1025 | 2 | 65 | cardiac septum morphogenesis |
| GO:0035054 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0045590 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | negative regulation of regulatory T cell differentiation |
| GO:0003208 | 0.0055 | 19.9262 | 0.112 | 2 | 71 | cardiac ventricle morphogenesis |
| GO:0035050 | 0.0057 | 19.6403 | 0.1136 | 2 | 72 | embryonic heart tube development |
| GO:0003219 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | cardiac right ventricle formation |
| GO:0090298 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | negative regulation of mitochondrial DNA replication |
| GO:0097476 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | spinal cord motor neuron migration |
| GO:1903026 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1905205 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of connective tissue replacement |
| GO:0003300 | 0.0063 | 18.5737 | 0.1199 | 2 | 76 | cardiac muscle hypertrophy |
| GO:1903035 | 0.0063 | 18.5737 | 0.1199 | 2 | 76 | negative regulation of response to wounding |
| GO:0014896 | 0.0068 | 17.8465 | 0.1246 | 2 | 79 | muscle hypertrophy |
| GO:0003289 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | atrial septum primum morphogenesis |
| GO:0016098 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | monoterpenoid metabolic process |
| GO:0051891 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | positive regulation of cardioblast differentiation |
| GO:1902565 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | positive regulation of neutrophil activation |
| GO:1903244 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:1904995 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0003008 | 0.0079 | 3.6691 | 2.4289 | 7 | 1540 | system process |
| GO:0048562 | 0.0091 | 7.7784 | 0.4369 | 3 | 277 | embryonic organ morphogenesis |
| GO:0048675 | 0.0092 | 15.2556 | 0.1451 | 2 | 92 | axon extension |
| GO:0031642 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | negative regulation of myelination |
| GO:0070268 | 0.0095 | 14.9219 | 0.1483 | 2 | 94 | cornification |
| GO:0050905 | 0.0097 | 14.7605 | 0.1498 | 2 | 95 | neuromuscular process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 1e-04 | 39.1841 | 0.0967 | 3 | 92 | embryonic skeletal system morphogenesis |
| GO:0030878 | 3e-04 | 98.5649 | 0.0252 | 2 | 24 | thyroid gland development |
| GO:0035176 | 0.001 | 50.3588 | 0.0473 | 2 | 45 | social behavior |
| GO:0009952 | 0.001 | 18.1353 | 0.204 | 3 | 194 | anterior/posterior pattern specification |
| GO:0021754 | 0.0011 | Inf | 0.0011 | 1 | 1 | facial nucleus development |
| GO:0071444 | 0.0011 | Inf | 0.0011 | 1 | 1 | cellular response to pheromone |
| GO:0007417 | 0.0014 | 7.7224 | 0.8937 | 5 | 850 | central nervous system development |
| GO:0021546 | 0.002 | 1085.5 | 0.002 | 1 | 2 | rhombomere development |
| GO:0021570 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | rhombomere 4 development |
| GO:0042495 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | detection of triacyl bacterial lipopeptide |
| GO:0042496 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | detection of diacyl bacterial lipopeptide |
| GO:0060764 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0021675 | 0.0025 | 31.3292 | 0.0747 | 2 | 71 | nerve development |
| GO:0050830 | 0.0028 | 29.6047 | 0.0789 | 2 | 75 | defense response to Gram-positive bacterium |
| GO:0002125 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | maternal aggressive behavior |
| GO:0014005 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | microglia development |
| GO:0021571 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | rhombomere 5 development |
| GO:0031394 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | positive regulation of prostaglandin biosynthetic process |
| GO:0032289 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | central nervous system myelin formation |
| GO:0038123 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
| GO:0042631 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | cellular response to water deprivation |
| GO:0060435 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | bronchiole development |
| GO:0071727 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:0045944 | 0.0035 | 6.1956 | 1.0977 | 5 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001992 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0007621 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | negative regulation of female receptivity |
| GO:0019732 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | antifungal humoral response |
| GO:0021615 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0032741 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | positive regulation of interleukin-18 production |
| GO:0032849 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | positive regulation of cellular pH reduction |
| GO:0038124 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | toll-like receptor TLR6:TLR2 signaling pathway |
| GO:0042494 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | detection of bacterial lipoprotein |
| GO:0060480 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | lung goblet cell differentiation |
| GO:0060535 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | intestinal epithelial cell maturation |
| GO:0071726 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0006690 | 0.0049 | 21.7922 | 0.1062 | 2 | 101 | icosanoid metabolic process |
| GO:0045110 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | intermediate filament bundle assembly |
| GO:0051970 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | negative regulation of transmission of nerve impulse |
| GO:2001279 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0031328 | 0.0055 | 4.8225 | 1.7749 | 6 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0010628 | 0.0058 | 4.7745 | 1.7906 | 6 | 1703 | positive regulation of gene expression |
| GO:0042713 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | sperm ejaculation |
| GO:0051964 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | negative regulation of synapse assembly |
| GO:0060482 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | lobar bronchus development |
| GO:0070339 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | response to bacterial lipopeptide |
| GO:0071220 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | cellular response to bacterial lipoprotein |
| GO:0021612 | 0.0073 | 168.8333 | 0.0074 | 1 | 7 | facial nerve structural organization |
| GO:0006887 | 0.0078 | 6.1545 | 0.8254 | 4 | 785 | exocytosis |
| GO:0007389 | 0.0082 | 8.4738 | 0.4269 | 3 | 406 | pattern specification process |
| GO:0048568 | 0.0082 | 8.4522 | 0.4279 | 3 | 407 | embryonic organ development |
| GO:0045647 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | negative regulation of erythrocyte differentiation |
| GO:0060638 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | mesenchymal-epithelial cell signaling |
| GO:0071223 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | cellular response to lipoteichoic acid |
| GO:0032502 | 0.0088 | 3.842 | 5.8314 | 11 | 5546 | developmental process |
| GO:0010870 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | positive regulation of receptor biosynthetic process |
| GO:0014049 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | positive regulation of glutamate secretion |
| GO:0021561 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | facial nerve development |
| GO:0043084 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | penile erection |
| GO:0060180 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | female mating behavior |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061760 | 0 | 1519.4 | 0.0043 | 2 | 3 | antifungal innate immune response |
| GO:0009620 | 0.0014 | 40.9676 | 0.0564 | 2 | 39 | response to fungus |
| GO:0006952 | 0.0021 | 4.8529 | 1.9373 | 7 | 1340 | defense response |
| GO:0060468 | 0.0029 | 723.5238 | 0.0029 | 1 | 2 | prevention of polyspermy |
| GO:0050911 | 0.003 | 27.5273 | 0.0824 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0070098 | 0.003 | 27.5273 | 0.0824 | 2 | 57 | chemokine-mediated signaling pathway |
| GO:0050829 | 0.0037 | 24.8098 | 0.0911 | 2 | 63 | defense response to Gram-negative bacterium |
| GO:0050830 | 0.0052 | 20.7151 | 0.1084 | 2 | 75 | defense response to Gram-positive bacterium |
| GO:0071611 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | granulocyte colony-stimulating factor production |
| GO:0007186 | 0.006 | 5.0645 | 1.213 | 5 | 839 | G-protein coupled receptor signaling pathway |
| GO:0051606 | 0.0073 | 8.5349 | 0.4034 | 3 | 279 | detection of stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 192.8055 | 0.0674 | 7 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 88.0984 | 0.1372 | 7 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 78.6431 | 0.1526 | 7 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 76.7404 | 0.1561 | 7 | 132 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 13.832 | 0.9924 | 8 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 10.6628 | 1.0208 | 7 | 863 | nervous system process |
| GO:0070227 | 0.0024 | 31.5396 | 0.0733 | 2 | 62 | lymphocyte apoptotic process |
| GO:0035990 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | tendon cell differentiation |
| GO:0035993 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | deltoid tuberosity development |
| GO:0036112 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
| GO:0002249 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | lymphocyte anergy |
| GO:0002667 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | regulation of T cell anergy |
| GO:0035989 | 0.0059 | 223.4559 | 0.0059 | 1 | 5 | tendon development |
| GO:0061056 | 0.0059 | 223.4559 | 0.0059 | 1 | 5 | sclerotome development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903706 | 4e-04 | 9.6333 | 0.6451 | 5 | 409 | regulation of hemopoiesis |
| GO:0060216 | 4e-04 | 81.1551 | 0.03 | 2 | 19 | definitive hemopoiesis |
| GO:0048534 | 0.0012 | 6.0289 | 1.2649 | 6 | 802 | hematopoietic or lymphoid organ development |
| GO:0071345 | 0.0013 | 6.0209 | 1.2665 | 6 | 803 | cellular response to cytokine stimulus |
| GO:0010734 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of protein glutathionylation |
| GO:1902867 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:0030099 | 0.0021 | 8.457 | 0.5599 | 4 | 355 | myeloid cell differentiation |
| GO:0045596 | 0.0022 | 6.4116 | 0.9526 | 5 | 604 | negative regulation of cell differentiation |
| GO:0050902 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | leukocyte adhesive activation |
| GO:0071461 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | cellular response to redox state |
| GO:1901003 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of fermentation |
| GO:0051239 | 0.0042 | 3.4436 | 4.1322 | 10 | 2620 | regulation of multicellular organismal process |
| GO:0071560 | 0.0043 | 10.2919 | 0.3328 | 3 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0070315 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | G1 to G0 transition involved in cell differentiation |
| GO:1990791 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | dorsal root ganglion development |
| GO:0045652 | 0.0048 | 21.4901 | 0.1041 | 2 | 66 | regulation of megakaryocyte differentiation |
| GO:0007275 | 0.0049 | 3.1352 | 7.4191 | 14 | 4704 | multicellular organism development |
| GO:0050793 | 0.0052 | 3.4841 | 3.5345 | 9 | 2241 | regulation of developmental process |
| GO:0001501 | 0.0057 | 6.3771 | 0.735 | 4 | 466 | skeletal system development |
| GO:0050768 | 0.0057 | 9.2529 | 0.3691 | 3 | 234 | negative regulation of neurogenesis |
| GO:1903273 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | regulation of sodium ion export |
| GO:1903278 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of sodium ion export across plasma membrane |
| GO:0048869 | 0.0075 | 2.9835 | 6.0343 | 12 | 3826 | cellular developmental process |
| GO:0061056 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | sclerotome development |
| GO:0090259 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | regulation of retinal ganglion cell axon guidance |
| GO:0060842 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | arterial endothelial cell differentiation |
| GO:0061074 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | regulation of neural retina development |
| GO:0045664 | 0.0097 | 5.4375 | 0.8564 | 4 | 543 | regulation of neuron differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032570 | 5e-04 | 78.3618 | 0.0325 | 2 | 45 | response to progesterone |
| GO:0002152 | 7e-04 | Inf | 7e-04 | 1 | 1 | bile acid conjugation |
| GO:0042495 | 0.0014 | 1520.5 | 0.0014 | 1 | 2 | detection of triacyl bacterial lipopeptide |
| GO:0042496 | 0.0014 | 1520.5 | 0.0014 | 1 | 2 | detection of diacyl bacterial lipopeptide |
| GO:0014005 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | microglia development |
| GO:0032289 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | central nervous system myelin formation |
| GO:0038123 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
| GO:0071727 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:0032741 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | positive regulation of interleukin-18 production |
| GO:0038124 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | toll-like receptor TLR6:TLR2 signaling pathway |
| GO:0042494 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | detection of bacterial lipoprotein |
| GO:0071726 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0009593 | 0.003 | 29.4191 | 0.0839 | 2 | 116 | detection of chemical stimulus |
| GO:0019530 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | taurine metabolic process |
| GO:0051964 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | negative regulation of synapse assembly |
| GO:0070339 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | response to bacterial lipopeptide |
| GO:0071220 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | cellular response to bacterial lipoprotein |
| GO:0071223 | 0.0058 | 217.1286 | 0.0058 | 1 | 8 | cellular response to lipoteichoic acid |
| GO:0031284 | 0.0079 | 151.96 | 0.008 | 1 | 11 | positive regulation of guanylate cyclase activity |
| GO:0051770 | 0.0079 | 151.96 | 0.008 | 1 | 11 | positive regulation of nitric-oxide synthase biosynthetic process |
| GO:0007252 | 0.0086 | 138.1364 | 0.0087 | 1 | 12 | I-kappaB phosphorylation |
| GO:0098543 | 0.0086 | 138.1364 | 0.0087 | 1 | 12 | detection of other organism |
| GO:0034134 | 0.0094 | 126.6167 | 0.0094 | 1 | 13 | toll-like receptor 2 signaling pathway |
| GO:0006909 | 0.0097 | 15.9458 | 0.1525 | 2 | 211 | phagocytosis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001764 | 9e-04 | 18.2976 | 0.1923 | 3 | 133 | neuron migration |
| GO:0031989 | 0.0014 | Inf | 0.0014 | 1 | 1 | bombesin receptor signaling pathway |
| GO:0035847 | 0.0014 | Inf | 0.0014 | 1 | 1 | uterine epithelium development |
| GO:0035849 | 0.0014 | Inf | 0.0014 | 1 | 1 | nephric duct elongation |
| GO:0035852 | 0.0014 | Inf | 0.0014 | 1 | 1 | horizontal cell localization |
| GO:0045407 | 0.0014 | Inf | 0.0014 | 1 | 1 | positive regulation of interleukin-5 biosynthetic process |
| GO:0005978 | 0.0017 | 36.961 | 0.0622 | 2 | 43 | glycogen biosynthetic process |
| GO:0021517 | 0.0017 | 36.961 | 0.0622 | 2 | 43 | ventral spinal cord development |
| GO:0021515 | 0.0024 | 30.9102 | 0.0737 | 2 | 51 | cell differentiation in spinal cord |
| GO:0060067 | 0.0029 | 723.5238 | 0.0029 | 1 | 2 | cervix development |
| GO:2000744 | 0.0029 | 723.5238 | 0.0029 | 1 | 2 | positive regulation of anterior head development |
| GO:0033692 | 0.0029 | 28.0389 | 0.081 | 2 | 56 | cellular polysaccharide biosynthetic process |
| GO:0002088 | 0.0038 | 24.4081 | 0.0925 | 2 | 64 | lens development in camera-type eye |
| GO:0007525 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | somatic muscle development |
| GO:0038113 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | interleukin-9-mediated signaling pathway |
| GO:0038123 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
| GO:0060066 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | oviduct development |
| GO:0061205 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | paramesonephric duct development |
| GO:0071104 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | response to interleukin-9 |
| GO:0071727 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:0097477 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | lateral motor column neuron migration |
| GO:2000768 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | positive regulation of nephron tubule epithelial cell differentiation |
| GO:0006073 | 0.0045 | 22.2456 | 0.1012 | 2 | 70 | cellular glucan metabolic process |
| GO:0001705 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | ectoderm formation |
| GO:0038124 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | toll-like receptor TLR6:TLR2 signaling pathway |
| GO:0071726 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0072278 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | metanephric comma-shaped body morphogenesis |
| GO:0006112 | 0.0062 | 18.8938 | 0.1186 | 2 | 82 | energy reserve metabolic process |
| GO:0009953 | 0.0077 | 16.7833 | 0.133 | 2 | 92 | dorsal/ventral pattern formation |
| GO:0005976 | 0.0082 | 16.2387 | 0.1373 | 2 | 95 | polysaccharide metabolic process |
| GO:0055114 | 0.0083 | 4.6661 | 1.3099 | 5 | 906 | oxidation-reduction process |
| GO:0021937 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
| GO:0034128 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0035502 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | metanephric part of ureteric bud development |
| GO:0070339 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | response to bacterial lipopeptide |
| GO:0071220 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | cellular response to bacterial lipoprotein |
| GO:0072284 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | metanephric S-shaped body morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060429 | 2e-04 | 11.0442 | 0.9406 | 6 | 1101 | epithelium development |
| GO:0001837 | 2e-04 | 35.9 | 0.1102 | 3 | 129 | epithelial to mesenchymal transition |
| GO:0031424 | 2e-04 | 33.7388 | 0.117 | 3 | 137 | keratinization |
| GO:0003203 | 3e-04 | 102.202 | 0.0248 | 2 | 29 | endocardial cushion morphogenesis |
| GO:0030154 | 7e-04 | 7.1044 | 3.1319 | 9 | 3666 | cell differentiation |
| GO:0032812 | 9e-04 | Inf | 9e-04 | 1 | 1 | positive regulation of epinephrine secretion |
| GO:0060485 | 9e-04 | 19.7053 | 0.1973 | 3 | 231 | mesenchyme development |
| GO:0071385 | 9e-04 | 54.0214 | 0.0453 | 2 | 53 | cellular response to glucocorticoid stimulus |
| GO:0009913 | 0.0011 | 18.0181 | 0.2153 | 3 | 252 | epidermal cell differentiation |
| GO:0060411 | 0.0014 | 43.697 | 0.0555 | 2 | 65 | cardiac septum morphogenesis |
| GO:0003208 | 0.0016 | 39.8814 | 0.0607 | 2 | 71 | cardiac ventricle morphogenesis |
| GO:0036304 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | umbilical cord morphogenesis |
| GO:0060468 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | prevention of polyspermy |
| GO:0071657 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:2000820 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
| GO:0043588 | 0.0021 | 14.4612 | 0.2665 | 3 | 312 | skin development |
| GO:0021524 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | visceral motor neuron differentiation |
| GO:0048936 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0060913 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | cardiac cell fate determination |
| GO:0070093 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | negative regulation of glucagon secretion |
| GO:0032730 | 0.0034 | 422.25 | 0.0034 | 1 | 4 | positive regulation of interleukin-1 alpha production |
| GO:0070253 | 0.0034 | 422.25 | 0.0034 | 1 | 4 | somatostatin secretion |
| GO:1901256 | 0.0034 | 422.25 | 0.0034 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:0051101 | 0.0036 | 26.3986 | 0.0906 | 2 | 106 | regulation of DNA binding |
| GO:0045471 | 0.0042 | 24.2816 | 0.0982 | 2 | 115 | response to ethanol |
| GO:0048880 | 0.0043 | 316.6667 | 0.0043 | 1 | 5 | sensory system development |
| GO:0090074 | 0.0043 | 316.6667 | 0.0043 | 1 | 5 | negative regulation of protein homodimerization activity |
| GO:0030223 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | neutrophil differentiation |
| GO:0048241 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | epinephrine transport |
| GO:0060842 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | arterial endothelial cell differentiation |
| GO:0051100 | 0.0058 | 20.4478 | 0.1162 | 2 | 136 | negative regulation of binding |
| GO:0003190 | 0.006 | 211.0833 | 0.006 | 1 | 7 | atrioventricular valve formation |
| GO:0051971 | 0.006 | 211.0833 | 0.006 | 1 | 7 | positive regulation of transmission of nerve impulse |
| GO:0031960 | 0.0067 | 19.0152 | 0.1247 | 2 | 146 | response to corticosteroid |
| GO:0008343 | 0.0068 | 180.9167 | 0.0068 | 1 | 8 | adult feeding behavior |
| GO:0035912 | 0.0068 | 180.9167 | 0.0068 | 1 | 8 | dorsal aorta morphogenesis |
| GO:0003205 | 0.0073 | 18.1252 | 0.1307 | 2 | 153 | cardiac chamber development |
| GO:0003139 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | secondary heart field specification |
| GO:0003266 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0061314 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | Notch signaling involved in heart development |
| GO:0050731 | 0.0078 | 17.4256 | 0.1358 | 2 | 159 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0051099 | 0.0079 | 17.3142 | 0.1367 | 2 | 160 | positive regulation of binding |
| GO:0050796 | 0.0081 | 17.0955 | 0.1384 | 2 | 162 | regulation of insulin secretion |
| GO:0045937 | 0.0084 | 6.2994 | 0.8594 | 4 | 1006 | positive regulation of phosphate metabolic process |
| GO:0003263 | 0.0085 | 140.6944 | 0.0085 | 1 | 10 | cardioblast proliferation |
| GO:0071396 | 0.0092 | 8.388 | 0.4511 | 3 | 528 | cellular response to lipid |
| GO:0002573 | 0.0092 | 15.9841 | 0.1478 | 2 | 173 | myeloid leukocyte differentiation |
| GO:0045935 | 0.0093 | 5.1236 | 1.4164 | 5 | 1658 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0021559 | 0.0094 | 126.6167 | 0.0094 | 1 | 11 | trigeminal nerve development |
| GO:0060379 | 0.0094 | 126.6167 | 0.0094 | 1 | 11 | cardiac muscle cell myoblast differentiation |
| GO:0045944 | 0.0095 | 6.053 | 0.8919 | 4 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:1901215 | 0.0098 | 15.5248 | 0.1521 | 2 | 178 | negative regulation of neuron death |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002264 | 7e-04 | Inf | 7e-04 | 1 | 1 | endothelial cell activation involved in immune response |
| GO:0007495 | 7e-04 | Inf | 7e-04 | 1 | 1 | visceral mesoderm-endoderm interaction involved in midgut development |
| GO:0060764 | 0.0013 | 1689.5556 | 0.0013 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0060435 | 0.002 | 844.7222 | 0.002 | 1 | 3 | bronchiole development |
| GO:0061146 | 0.002 | 844.7222 | 0.002 | 1 | 3 | Peyer's patch morphogenesis |
| GO:0060480 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | lung goblet cell differentiation |
| GO:0060535 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | intestinal epithelial cell maturation |
| GO:0048565 | 0.003 | 30.164 | 0.0835 | 2 | 127 | digestive tract development |
| GO:1900020 | 0.0033 | 422.3056 | 0.0033 | 1 | 5 | positive regulation of protein kinase C activity |
| GO:0048537 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | mucosal-associated lymphoid tissue development |
| GO:0060482 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | lobar bronchus development |
| GO:0048251 | 0.0046 | 281.5 | 0.0046 | 1 | 7 | elastic fiber assembly |
| GO:0045647 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | negative regulation of erythrocyte differentiation |
| GO:0060638 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | mesenchymal-epithelial cell signaling |
| GO:0071493 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | cellular response to UV-B |
| GO:0010870 | 0.0059 | 211.0972 | 0.0059 | 1 | 9 | positive regulation of receptor biosynthetic process |
| GO:0010739 | 0.0066 | 187.6296 | 0.0066 | 1 | 10 | positive regulation of protein kinase A signaling |
| GO:0060484 | 0.0066 | 187.6296 | 0.0066 | 1 | 10 | lung-associated mesenchyme development |
| GO:0060033 | 0.0072 | 168.8556 | 0.0072 | 1 | 11 | anatomical structure regression |
| GO:2000353 | 0.0079 | 153.4949 | 0.0079 | 1 | 12 | positive regulation of endothelial cell apoptotic process |
| GO:0009650 | 0.0085 | 140.6944 | 0.0085 | 1 | 13 | UV protection |
| GO:1902259 | 0.0092 | 129.8632 | 0.0092 | 1 | 14 | regulation of delayed rectifier potassium channel activity |
| GO:0048534 | 0.0095 | 9.0851 | 0.471 | 3 | 796 | hematopoietic or lymphoid organ development |
| GO:0002070 | 0.0098 | 120.5794 | 0.0099 | 1 | 15 | epithelial cell maturation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009952 | 0 | 23.941 | 0.3315 | 6 | 194 | anterior/posterior pattern specification |
| GO:0048704 | 0 | 68.6591 | 0.0759 | 4 | 48 | embryonic skeletal system morphogenesis |
| GO:0021675 | 0 | 41.0421 | 0.1213 | 4 | 71 | nerve development |
| GO:0021615 | 0 | 632.875 | 0.0068 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0043009 | 0 | 10.0732 | 0.9278 | 7 | 543 | chordate embryonic development |
| GO:0045944 | 0 | 7.2409 | 1.7838 | 9 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0007389 | 1e-04 | 11.0932 | 0.6937 | 6 | 406 | pattern specification process |
| GO:0048568 | 1e-04 | 11.0648 | 0.6954 | 6 | 407 | embryonic organ development |
| GO:0048598 | 2e-04 | 8.3111 | 0.9235 | 6 | 562 | embryonic morphogenesis |
| GO:1903508 | 2e-04 | 5.5038 | 2.293 | 9 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0048589 | 2e-04 | 8.2024 | 0.9261 | 6 | 542 | developmental growth |
| GO:0009889 | 3e-04 | 4.288 | 7.0805 | 16 | 4144 | regulation of biosynthetic process |
| GO:0051254 | 4e-04 | 5.2069 | 2.4109 | 9 | 1411 | positive regulation of RNA metabolic process |
| GO:0009887 | 4e-04 | 7.6915 | 1.0301 | 6 | 701 | animal organ morphogenesis |
| GO:0021602 | 6e-04 | 65.6623 | 0.0363 | 2 | 23 | cranial nerve morphogenesis |
| GO:0010557 | 8e-04 | 4.6558 | 2.6654 | 9 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0030878 | 8e-04 | 57.4583 | 0.041 | 2 | 24 | thyroid gland development |
| GO:0048646 | 9e-04 | 5.4736 | 1.6488 | 7 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0001501 | 0.001 | 10.658 | 0.451 | 4 | 295 | skeletal system development |
| GO:0040018 | 0.0013 | 43.569 | 0.053 | 2 | 31 | positive regulation of multicellular organism growth |
| GO:0031328 | 0.0013 | 4.2605 | 2.8841 | 9 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0043010 | 0.0014 | 9.5094 | 0.4938 | 4 | 289 | camera-type eye development |
| GO:0010628 | 0.0014 | 4.2181 | 2.9098 | 9 | 1703 | positive regulation of gene expression |
| GO:0009888 | 0.0016 | 4.1627 | 2.9439 | 9 | 1723 | tissue development |
| GO:0006355 | 0.0017 | 3.5184 | 5.7666 | 13 | 3375 | regulation of transcription, DNA-templated |
| GO:0007634 | 0.0017 | Inf | 0.0017 | 1 | 1 | optokinetic behavior |
| GO:0021754 | 0.0017 | Inf | 0.0017 | 1 | 1 | facial nucleus development |
| GO:0036321 | 0.0017 | Inf | 0.0017 | 1 | 1 | ghrelin secretion |
| GO:0042404 | 0.0017 | Inf | 0.0017 | 1 | 1 | thyroid hormone catabolic process |
| GO:2001141 | 0.0018 | 3.4838 | 5.811 | 13 | 3401 | regulation of RNA biosynthetic process |
| GO:0019219 | 0.0021 | 3.3568 | 6.7183 | 14 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0034654 | 0.0025 | 3.2942 | 6.8122 | 14 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0048701 | 0.0025 | 30.0575 | 0.0752 | 2 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0060173 | 0.0029 | 11.7344 | 0.2905 | 3 | 170 | limb development |
| GO:0051216 | 0.003 | 11.6638 | 0.2922 | 3 | 171 | cartilage development |
| GO:0060324 | 0.0031 | 26.8511 | 0.0837 | 2 | 49 | face development |
| GO:0021546 | 0.0033 | 632.7917 | 0.0033 | 1 | 2 | rhombomere development |
| GO:0006711 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | estrogen catabolic process |
| GO:0021560 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | abducens nerve development |
| GO:0021570 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | rhombomere 4 development |
| GO:0021599 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | abducens nerve formation |
| GO:0030824 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of cGMP metabolic process |
| GO:0031283 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of guanylate cyclase activity |
| GO:0043134 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | regulation of hindgut contraction |
| GO:0060876 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | semicircular canal formation |
| GO:0090327 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of locomotion involved in locomotory behavior |
| GO:0120054 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | intestinal motility |
| GO:0120058 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | positive regulation of small intestinal transit |
| GO:1904008 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | response to monosodium glutamate |
| GO:1901360 | 0.0044 | 3.0712 | 9.9134 | 17 | 5802 | organic cyclic compound metabolic process |
| GO:0050795 | 0.0048 | 21.3729 | 0.1042 | 2 | 61 | regulation of behavior |
| GO:0010159 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | specification of animal organ position |
| GO:0021571 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | rhombomere 5 development |
| GO:0060672 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | epithelial cell morphogenesis involved in placental branching |
| GO:1904000 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | positive regulation of eating behavior |
| GO:1904349 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | positive regulation of small intestine smooth muscle contraction |
| GO:1905333 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | regulation of gastric motility |
| GO:1901576 | 0.0052 | 3.0035 | 10.0501 | 17 | 5882 | organic substance biosynthetic process |
| GO:0009653 | 0.0061 | 6.8032 | 0.7807 | 4 | 760 | anatomical structure morphogenesis |
| GO:0032100 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | positive regulation of appetite |
| GO:1905564 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | positive regulation of vascular endothelial cell proliferation |
| GO:0051289 | 0.0068 | 17.7465 | 0.1247 | 2 | 73 | protein homotetramerization |
| GO:0007423 | 0.0073 | 8.4756 | 0.404 | 3 | 263 | sensory organ development |
| GO:0090596 | 0.008 | 8.1255 | 0.4152 | 3 | 243 | sensory organ morphogenesis |
| GO:0045409 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of interleukin-6 biosynthetic process |
| GO:1904304 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | regulation of gastro-intestinal system smooth muscle contraction |
| GO:2000110 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of macrophage apoptotic process |
| GO:0006725 | 0.0089 | 2.7535 | 9.5665 | 16 | 5599 | cellular aromatic compound metabolic process |
| GO:0001942 | 0.009 | 15.3547 | 0.1435 | 2 | 84 | hair follicle development |
| GO:0022404 | 0.0094 | 14.9871 | 0.1469 | 2 | 86 | molting cycle process |
| GO:0048522 | 0.0098 | 2.7106 | 7.834 | 14 | 4585 | positive regulation of cellular process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050877 | 1e-04 | 8.3762 | 1.191 | 7 | 863 | nervous system process |
| GO:0048704 | 3e-04 | 28.2903 | 0.127 | 3 | 92 | embryonic skeletal system morphogenesis |
| GO:0032501 | 4e-04 | 7.0547 | 6.7766 | 14 | 5904 | multicellular organismal process |
| GO:0030878 | 5e-04 | 72.6029 | 0.0331 | 2 | 24 | thyroid gland development |
| GO:0003016 | 6e-04 | 66.5439 | 0.0359 | 2 | 26 | respiratory system process |
| GO:0050906 | 7e-04 | 19.9339 | 0.178 | 3 | 129 | detection of stimulus involved in sensory perception |
| GO:0051216 | 0.0016 | 14.9087 | 0.236 | 3 | 171 | cartilage development |
| GO:0007389 | 0.0021 | 8.6591 | 0.5603 | 4 | 406 | pattern specification process |
| GO:0009952 | 0.0023 | 13.0934 | 0.2677 | 3 | 194 | anterior/posterior pattern specification |
| GO:0050976 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | detection of mechanical stimulus involved in sensory perception of touch |
| GO:0060163 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | subpallium neuron fate commitment |
| GO:0060764 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0050911 | 0.0028 | 28.978 | 0.0787 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0010159 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | specification of animal organ position |
| GO:0014707 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | branchiomeric skeletal muscle development |
| GO:0046010 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | positive regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0060435 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | bronchiole development |
| GO:0021615 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0060480 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | lung goblet cell differentiation |
| GO:0060535 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | intestinal epithelial cell maturation |
| GO:0048598 | 0.0068 | 6.1382 | 0.7797 | 4 | 565 | embryonic morphogenesis |
| GO:0048625 | 0.0069 | 189.9 | 0.0069 | 1 | 5 | myoblast fate commitment |
| GO:0019233 | 0.0069 | 17.8675 | 0.1256 | 2 | 91 | sensory perception of pain |
| GO:0048856 | 0.0079 | 3.1792 | 7.1113 | 13 | 5153 | anatomical structure development |
| GO:0023041 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | neuronal signal transduction |
| GO:0033603 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | positive regulation of dopamine secretion |
| GO:0060482 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | lobar bronchus development |
| GO:0071286 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | cellular response to magnesium ion |
| GO:0010038 | 0.0083 | 8.1645 | 0.4237 | 3 | 307 | response to metal ion |
| GO:0021798 | 0.0096 | 126.5833 | 0.0097 | 1 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0060017 | 0.0096 | 126.5833 | 0.0097 | 1 | 7 | parathyroid gland development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050877 | 8e-04 | 9.2884 | 0.794 | 5 | 863 | nervous system process |
| GO:0002264 | 9e-04 | Inf | 9e-04 | 1 | 1 | endothelial cell activation involved in immune response |
| GO:0009913 | 0.0014 | 16.379 | 0.2318 | 3 | 252 | epidermal cell differentiation |
| GO:0003335 | 0.0018 | 1169.3846 | 0.0018 | 1 | 2 | corneocyte development |
| GO:0060468 | 0.0018 | 1169.3846 | 0.0018 | 1 | 2 | prevention of polyspermy |
| GO:0043588 | 0.0026 | 13.1456 | 0.287 | 3 | 312 | skin development |
| GO:2000503 | 0.0028 | 584.6538 | 0.0028 | 1 | 3 | positive regulation of natural killer cell chemotaxis |
| GO:0019233 | 0.0031 | 28.3034 | 0.0837 | 2 | 91 | sensory perception of pain |
| GO:0043308 | 0.0037 | 389.7436 | 0.0037 | 1 | 4 | eosinophil degranulation |
| GO:0043307 | 0.0046 | 292.2885 | 0.0046 | 1 | 5 | eosinophil activation |
| GO:0043615 | 0.0046 | 292.2885 | 0.0046 | 1 | 5 | astrocyte cell migration |
| GO:1900020 | 0.0046 | 292.2885 | 0.0046 | 1 | 5 | positive regulation of protein kinase C activity |
| GO:0010536 | 0.0055 | 233.8154 | 0.0055 | 1 | 6 | positive regulation of activation of Janus kinase activity |
| GO:0008037 | 0.0064 | 19.1756 | 0.1224 | 2 | 133 | cell recognition |
| GO:0031424 | 0.0068 | 18.6025 | 0.126 | 2 | 137 | keratinization |
| GO:0048245 | 0.0073 | 166.989 | 0.0074 | 1 | 8 | eosinophil chemotaxis |
| GO:0043901 | 0.0078 | 17.308 | 0.1352 | 2 | 147 | negative regulation of multi-organism process |
| GO:0010739 | 0.0092 | 129.8632 | 0.0092 | 1 | 10 | positive regulation of protein kinase A signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 104.0247 | 0.0712 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 48.5425 | 0.1448 | 5 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 43.4159 | 0.1611 | 5 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 42.3819 | 0.1648 | 5 | 132 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 12.5737 | 1.0476 | 8 | 839 | G-protein coupled receptor signaling pathway |
| GO:0003095 | 0 | 1787.8824 | 0.0037 | 2 | 3 | pressure natriuresis |
| GO:0036101 | 0 | 893.8824 | 0.005 | 2 | 4 | leukotriene B4 catabolic process |
| GO:1901523 | 0 | 595.8824 | 0.0062 | 2 | 5 | icosanoid catabolic process |
| GO:0019373 | 3e-04 | 93.9876 | 0.0262 | 2 | 21 | epoxygenase P450 pathway |
| GO:0003071 | 4e-04 | 85.0252 | 0.0287 | 2 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0006691 | 6e-04 | 63.7395 | 0.0375 | 2 | 30 | leukotriene metabolic process |
| GO:0055080 | 7e-04 | 8.7195 | 0.7529 | 5 | 603 | cation homeostasis |
| GO:0098771 | 8e-04 | 8.5119 | 0.7704 | 5 | 617 | inorganic ion homeostasis |
| GO:0003091 | 8e-04 | 55.7574 | 0.0425 | 2 | 34 | renal water homeostasis |
| GO:0048247 | 0.0011 | 48.2067 | 0.0487 | 2 | 39 | lymphocyte chemotaxis |
| GO:0055078 | 0.0011 | 46.935 | 0.0499 | 2 | 40 | sodium ion homeostasis |
| GO:0002548 | 0.0014 | 42.4538 | 0.0549 | 2 | 44 | monocyte chemotaxis |
| GO:0070098 | 0.0023 | 32.3914 | 0.0712 | 2 | 57 | chemokine-mediated signaling pathway |
| GO:0030104 | 0.0028 | 28.7211 | 0.0799 | 2 | 64 | water homeostasis |
| GO:0030593 | 0.0032 | 26.9733 | 0.0849 | 2 | 68 | neutrophil chemotaxis |
| GO:0050877 | 0.0035 | 5.969 | 1.0775 | 5 | 863 | nervous system process |
| GO:0071347 | 0.0039 | 24.3755 | 0.0936 | 2 | 75 | cellular response to interleukin-1 |
| GO:0002249 | 0.005 | 281.3889 | 0.005 | 1 | 4 | lymphocyte anergy |
| GO:0002667 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of T cell anergy |
| GO:0007198 | 0.005 | 281.3889 | 0.005 | 1 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0042360 | 0.005 | 281.3889 | 0.005 | 1 | 4 | vitamin E metabolic process |
| GO:0001676 | 0.0057 | 19.9722 | 0.1136 | 2 | 91 | long-chain fatty acid metabolic process |
| GO:0033559 | 0.006 | 19.3171 | 0.1174 | 2 | 94 | unsaturated fatty acid metabolic process |
| GO:0002933 | 0.0062 | 211.0278 | 0.0062 | 1 | 5 | lipid hydroxylation |
| GO:0009062 | 0.0063 | 18.9036 | 0.1199 | 2 | 96 | fatty acid catabolic process |
| GO:0097530 | 0.0067 | 18.3153 | 0.1236 | 2 | 99 | granulocyte migration |
| GO:0007195 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0071346 | 0.0089 | 15.7054 | 0.1436 | 2 | 115 | cellular response to interferon-gamma |
| GO:0006874 | 0.0097 | 7.7502 | 0.452 | 3 | 362 | cellular calcium ion homeostasis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 247.3469 | 0.0674 | 8 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 111.7852 | 0.1372 | 8 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 99.6893 | 0.1526 | 8 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 97.2581 | 0.1561 | 8 | 132 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 17.312 | 0.9924 | 9 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 16.7974 | 1.0208 | 9 | 863 | nervous system process |
| GO:0070227 | 0.0024 | 31.5396 | 0.0733 | 2 | 62 | lymphocyte apoptotic process |
| GO:0036112 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
| GO:0002249 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | lymphocyte anergy |
| GO:0002667 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | regulation of T cell anergy |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001077 | 8e-04 | 11.0035 | 0.4313 | 4 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0000978 | 0.0023 | 8.2375 | 0.5706 | 4 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0001159 | 0.0027 | 7.863 | 0.5969 | 4 | 364 | core promoter proximal region DNA binding |
| GO:0004174 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
| GO:0061629 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
| GO:0004028 | 0.0082 | 158.5104 | 0.0082 | 1 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0004111 | 0.0098 | 126.8 | 0.0098 | 1 | 6 | creatine kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001530 | 0.0021 | 33.6608 | 0.0677 | 2 | 24 | lipopolysaccharide binding |
| GO:0031855 | 0.0028 | Inf | 0.0028 | 1 | 1 | oxytocin receptor binding |
| GO:0005185 | 0.0056 | 361.9524 | 0.0056 | 1 | 2 | neurohypophyseal hormone activity |
| GO:0004740 | 0.0084 | 180.9643 | 0.0085 | 1 | 3 | pyruvate dehydrogenase (acetyl-transferring) kinase activity |
| GO:0070891 | 0.0084 | 180.9643 | 0.0085 | 1 | 3 | lipoteichoic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 104.2239 | 0.071 | 5 | 57 | olfactory receptor activity |
| GO:0004930 | 1e-04 | 12.7155 | 0.5247 | 5 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 0.0031 | 6.1169 | 1.0531 | 5 | 845 | transmembrane receptor activity |
| GO:0004867 | 0.0037 | 25.1135 | 0.091 | 2 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0038023 | 0.0042 | 5.6853 | 1.1278 | 5 | 905 | signaling receptor activity |
| GO:0004222 | 0.0074 | 17.2747 | 0.1309 | 2 | 105 | metalloendopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008260 | 0.0018 | 1171.6154 | 0.0018 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0031708 | 0.0018 | 1171.6154 | 0.0018 | 1 | 2 | endothelin B receptor binding |
| GO:0001588 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 8e-04 | 56.2815 | 0.042 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0031249 | 0.0013 | Inf | 0.0013 | 1 | 1 | denatured protein binding |
| GO:0005546 | 0.0026 | 30.0992 | 0.0761 | 2 | 58 | phosphatidylinositol-4,5-bisphosphate binding |
| GO:0005153 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | interleukin-8 receptor binding |
| GO:0031708 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | endothelin B receptor binding |
| GO:0001664 | 0.003 | 11.8726 | 0.2965 | 3 | 226 | G-protein coupled receptor binding |
| GO:0005094 | 0.0039 | 400.6316 | 0.0039 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0001588 | 0.0052 | 267.0702 | 0.0052 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0005047 | 0.0065 | 200.2895 | 0.0066 | 1 | 5 | signal recognition particle binding |
| GO:0042826 | 0.0075 | 17.1519 | 0.1312 | 2 | 100 | histone deacetylase binding |
| GO:0055131 | 0.0078 | 160.2211 | 0.0079 | 1 | 6 | C3HC4-type RING finger domain binding |
| GO:0008312 | 0.0091 | 133.5088 | 0.0092 | 1 | 7 | 7S RNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 1e-04 | 24.9832 | 0.2624 | 4 | 400 | receptor regulator activity |
| GO:0005130 | 7e-04 | Inf | 7e-04 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0005179 | 0.002 | 37.4629 | 0.0676 | 2 | 103 | hormone activity |
| GO:0001591 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0005125 | 0.0052 | 22.5584 | 0.1108 | 2 | 169 | cytokine activity |
| GO:0035240 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | dopamine binding |
| GO:0005102 | 0.0084 | 6.8517 | 0.8888 | 4 | 1355 | receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001228 | 1e-04 | 10.3966 | 0.7254 | 6 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0003700 | 9e-04 | 4.834 | 2.1506 | 8 | 1171 | DNA binding transcription factor activity |
| GO:0004506 | 0.0018 | Inf | 0.0018 | 1 | 1 | squalene monooxygenase activity |
| GO:0031700 | 0.0018 | Inf | 0.0018 | 1 | 1 | adrenomedullin receptor binding |
| GO:0001567 | 0.0037 | 563.5926 | 0.0037 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0035939 | 0.0055 | 281.7778 | 0.0055 | 1 | 3 | microsatellite binding |
| GO:0070891 | 0.0055 | 281.7778 | 0.0055 | 1 | 3 | lipoteichoic acid binding |
| GO:0001847 | 0.0073 | 187.8395 | 0.0073 | 1 | 4 | opsonin receptor activity |
| GO:1990837 | 0.0083 | 4.529 | 1.2893 | 5 | 702 | sequence-specific double-stranded DNA binding |
| GO:0046982 | 0.0087 | 5.5202 | 0.8264 | 4 | 450 | protein heterodimerization activity |
| GO:0016019 | 0.0092 | 140.8704 | 0.0092 | 1 | 5 | peptidoglycan receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005130 | 0.001 | Inf | 0.001 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0018169 | 0.001 | Inf | 0.001 | 1 | 1 | ribosomal S6-glutamic acid ligase activity |
| GO:0033560 | 0.001 | Inf | 0.001 | 1 | 1 | folate reductase activity |
| GO:0047963 | 0.001 | Inf | 0.001 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0052817 | 0.001 | Inf | 0.001 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0004984 | 0.0014 | 42.4503 | 0.0561 | 2 | 57 | olfactory receptor activity |
| GO:0004146 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | dihydrofolate reductase activity |
| GO:0051870 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | methotrexate binding |
| GO:0052815 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
| GO:0035939 | 0.0029 | 543.8929 | 0.003 | 1 | 3 | microsatellite binding |
| GO:0051431 | 0.0029 | 543.8929 | 0.003 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
| GO:0018685 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0019788 | 0.0059 | 217.5143 | 0.0059 | 1 | 6 | NEDD8 transferase activity |
| GO:0004930 | 0.0074 | 8.8594 | 0.4142 | 3 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 0.0078 | 6.222 | 0.8314 | 4 | 845 | transmembrane receptor activity |
| GO:0019957 | 0.0078 | 155.3469 | 0.0079 | 1 | 8 | C-C chemokine binding |
| GO:0102991 | 0.0078 | 155.3469 | 0.0079 | 1 | 8 | myristoyl-CoA hydrolase activity |
| GO:0005542 | 0.0088 | 135.9196 | 0.0089 | 1 | 9 | folic acid binding |
| GO:1990825 | 0.0088 | 135.9196 | 0.0089 | 1 | 9 | sequence-specific mRNA binding |
| GO:0051427 | 0.0099 | 15.1614 | 0.1525 | 2 | 155 | hormone receptor binding |
| GO:0038023 | 0.0099 | 5.7835 | 0.8904 | 4 | 905 | signaling receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005212 | 3e-04 | 95.05 | 0.026 | 2 | 18 | structural constituent of eye lens |
| GO:0004946 | 0.0014 | Inf | 0.0014 | 1 | 1 | bombesin receptor activity |
| GO:0031855 | 0.0014 | Inf | 0.0014 | 1 | 1 | oxytocin receptor binding |
| GO:0004930 | 0.0028 | 7.8908 | 0.6075 | 4 | 421 | G-protein coupled receptor activity |
| GO:0001632 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0005185 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | neurohypophyseal hormone activity |
| GO:0047025 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity |
| GO:0070404 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | NADH binding |
| GO:0001588 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0047035 | 0.0086 | 144.9429 | 0.0087 | 1 | 6 | testosterone dehydrogenase (NAD+) activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003924 | 7e-04 | 11.6459 | 0.4109 | 4 | 261 | GTPase activity |
| GO:0017045 | 0.0016 | Inf | 0.0016 | 1 | 1 | corticotropin-releasing hormone activity |
| GO:0003854 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GO:0031894 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | V1A vasopressin receptor binding |
| GO:0036461 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | BLOC-2 complex binding |
| GO:1990932 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | 5.8S rRNA binding |
| GO:0048306 | 0.0034 | 26.0189 | 0.0866 | 2 | 55 | calcium-dependent protein binding |
| GO:0004024 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | alcohol dehydrogenase activity, zinc-dependent |
| GO:0030369 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | ICAM-3 receptor activity |
| GO:0035651 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0051431 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
| GO:0000213 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | tRNA-intron endonuclease activity |
| GO:0032190 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | acrosin binding |
| GO:0035650 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0051430 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0005000 | 0.0094 | 132.3217 | 0.0094 | 1 | 6 | vasopressin receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 0 | Inf | 0.0024 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0005126 | 0 | 27.3733 | 0.255 | 5 | 216 | cytokine receptor binding |
| GO:0001664 | 0 | 26.1173 | 0.2668 | 5 | 226 | G-protein coupled receptor binding |
| GO:0008009 | 0 | 112.6 | 0.0354 | 3 | 30 | chemokine activity |
| GO:0048020 | 2e-04 | 108.6286 | 0.0231 | 2 | 22 | CCR chemokine receptor binding |
| GO:0001530 | 4e-04 | 86.3977 | 0.0283 | 2 | 24 | lipopolysaccharide binding |
| GO:0008201 | 6e-04 | 20.95 | 0.1736 | 3 | 147 | heparin binding |
| GO:0048018 | 8e-04 | 11.4101 | 0.4439 | 4 | 376 | receptor ligand activity |
| GO:0008502 | 0.0024 | 895.7059 | 0.0024 | 1 | 2 | melatonin receptor activity |
| GO:0048248 | 0.0024 | 895.7059 | 0.0024 | 1 | 2 | CXCR3 chemokine receptor binding |
| GO:0001591 | 0.0047 | 298.5294 | 0.0047 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0005502 | 0.0047 | 298.5294 | 0.0047 | 1 | 4 | 11-cis retinal binding |
| GO:0035240 | 0.0094 | 127.9076 | 0.0094 | 1 | 8 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 76.3472 | 0.071 | 4 | 57 | olfactory receptor activity |
| GO:0034899 | 0.0012 | Inf | 0.0012 | 1 | 1 | trimethylamine monooxygenase activity |
| GO:0050661 | 0.0013 | 43.5753 | 0.0536 | 2 | 43 | NADP binding |
| GO:0004930 | 0.0016 | 9.4708 | 0.5247 | 4 | 421 | G-protein coupled receptor activity |
| GO:0004096 | 0.0037 | 422.9167 | 0.0037 | 1 | 3 | catalase activity |
| GO:0035939 | 0.0037 | 422.9167 | 0.0037 | 1 | 3 | microsatellite binding |
| GO:0003839 | 0.005 | 281.9259 | 0.005 | 1 | 4 | gamma-glutamylcyclotransferase activity |
| GO:0004499 | 0.005 | 281.9259 | 0.005 | 1 | 4 | N,N-dimethylaniline monooxygenase activity |
| GO:0004046 | 0.0062 | 211.4306 | 0.0062 | 1 | 5 | aminoacylase activity |
| GO:0004872 | 0.0099 | 4.5777 | 1.3796 | 5 | 1107 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033798 | 0.002 | Inf | 0.002 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0047963 | 0.002 | Inf | 0.002 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0052817 | 0.002 | Inf | 0.002 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0004522 | 0.0039 | 524.6552 | 0.0039 | 1 | 2 | ribonuclease A activity |
| GO:0052815 | 0.0039 | 524.6552 | 0.0039 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
| GO:0004800 | 0.0059 | 262.3103 | 0.0059 | 1 | 3 | thyroxine 5'-deiodinase activity |
| GO:0034513 | 0.0078 | 174.8621 | 0.0079 | 1 | 4 | box H/ACA snoRNA binding |
| GO:0015057 | 0.0098 | 131.1379 | 0.0098 | 1 | 5 | thrombin-activated receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001567 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0008502 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | melatonin receptor activity |
| GO:0030549 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | acetylcholine receptor activator activity |
| GO:0043565 | 0.0045 | 4.574 | 1.6217 | 6 | 989 | sequence-specific DNA binding |
| GO:0034875 | 0.0049 | 317.0625 | 0.0049 | 1 | 3 | caffeine oxidase activity |
| GO:0046848 | 0.0049 | 317.0625 | 0.0049 | 1 | 3 | hydroxyapatite binding |
| GO:0000981 | 0.0059 | 5.0131 | 1.1938 | 5 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0030197 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | extracellular matrix constituent, lubricant activity |
| GO:0030345 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | structural constituent of tooth enamel |
| GO:0051525 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | NFAT protein binding |
| GO:0001077 | 0.0088 | 7.8467 | 0.4313 | 3 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0140110 | 0.0088 | 3.5599 | 2.4695 | 7 | 1506 | transcription regulator activity |
| GO:0046983 | 0.0092 | 3.8895 | 1.8841 | 6 | 1149 | protein dimerization activity |
| GO:0004497 | 0.0093 | 15.1264 | 0.1459 | 2 | 89 | monooxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 0 | Inf | 0.0018 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0042379 | 0 | 112.0025 | 0.0367 | 3 | 40 | chemokine receptor binding |
| GO:0001530 | 2e-04 | 115.2273 | 0.022 | 2 | 24 | lipopolysaccharide binding |
| GO:0060089 | 3e-04 | 9.2273 | 1.0569 | 6 | 1151 | molecular transducer activity |
| GO:0004506 | 9e-04 | Inf | 9e-04 | 1 | 1 | squalene monooxygenase activity |
| GO:0038023 | 9e-04 | 8.8469 | 0.831 | 5 | 905 | signaling receptor activity |
| GO:0004984 | 0.0012 | 45.9909 | 0.0523 | 2 | 57 | olfactory receptor activity |
| GO:0001791 | 0.0018 | 1171.6154 | 0.0018 | 1 | 2 | IgM binding |
| GO:0004867 | 0.002 | 35.5892 | 0.067 | 2 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0031014 | 0.0028 | 585.7692 | 0.0028 | 1 | 3 | troponin T binding |
| GO:0005502 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | 11-cis retinal binding |
| GO:0032190 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | acrosin binding |
| GO:0004930 | 0.0046 | 10.8667 | 0.3515 | 3 | 412 | G-protein coupled receptor activity |
| GO:0099600 | 0.006 | 6.8447 | 0.7759 | 4 | 845 | transmembrane receptor activity |
| GO:0030414 | 0.007 | 18.3637 | 0.1276 | 2 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0.007 | 18.3637 | 0.1276 | 2 | 139 | endopeptidase regulator activity |
| GO:0019957 | 0.0073 | 167.3077 | 0.0073 | 1 | 8 | C-C chemokine binding |
| GO:0008201 | 0.0078 | 17.3414 | 0.135 | 2 | 147 | heparin binding |
| GO:0008020 | 0.0082 | 146.3846 | 0.0083 | 1 | 9 | G-protein coupled photoreceptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0.0014 | 5.5405 | 1.2397 | 6 | 450 | protein heterodimerization activity |
| GO:1903231 | 0.0035 | 25.29 | 0.0882 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0043565 | 0.005 | 3.4114 | 2.7245 | 8 | 989 | sequence-specific DNA binding |
| GO:0031492 | 0.0051 | 20.4959 | 0.1074 | 2 | 39 | nucleosomal DNA binding |
| GO:0001078 | 0.0055 | 9.132 | 0.3581 | 3 | 130 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:1990430 | 0.0082 | 185.3902 | 0.0083 | 1 | 3 | extracellular matrix protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005523 | 8e-04 | 58.8721 | 0.0413 | 2 | 14 | tropomyosin binding |
| GO:0001530 | 0.0023 | 32.0909 | 0.0708 | 2 | 24 | lipopolysaccharide binding |
| GO:0017024 | 0.003 | Inf | 0.003 | 1 | 1 | myosin I binding |
| GO:0031855 | 0.003 | Inf | 0.003 | 1 | 1 | oxytocin receptor binding |
| GO:0002020 | 0.0052 | 9.2888 | 0.3512 | 3 | 119 | protease binding |
| GO:0005185 | 0.0059 | 345.4545 | 0.0059 | 1 | 2 | neurohypophyseal hormone activity |
| GO:0032090 | 0.0059 | 345.4545 | 0.0059 | 1 | 2 | Pyrin domain binding |
| GO:0004740 | 0.0088 | 172.7159 | 0.0089 | 1 | 3 | pyruvate dehydrogenase (acetyl-transferring) kinase activity |
| GO:0070891 | 0.0088 | 172.7159 | 0.0089 | 1 | 3 | lipoteichoic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001077 | 0.0047 | 10.1579 | 0.345 | 3 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0000977 | 0.0064 | 6.2792 | 0.77 | 4 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 8e-04 | 56.2815 | 0.042 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0031249 | 0.0013 | Inf | 0.0013 | 1 | 1 | denatured protein binding |
| GO:0005546 | 0.0026 | 30.0992 | 0.0761 | 2 | 58 | phosphatidylinositol-4,5-bisphosphate binding |
| GO:0005153 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | interleukin-8 receptor binding |
| GO:0031708 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | endothelin B receptor binding |
| GO:0001664 | 0.003 | 11.8726 | 0.2965 | 3 | 226 | G-protein coupled receptor binding |
| GO:0005094 | 0.0039 | 400.6316 | 0.0039 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0001588 | 0.0052 | 267.0702 | 0.0052 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0005047 | 0.0065 | 200.2895 | 0.0066 | 1 | 5 | signal recognition particle binding |
| GO:0042826 | 0.0075 | 17.1519 | 0.1312 | 2 | 100 | histone deacetylase binding |
| GO:0055131 | 0.0078 | 160.2211 | 0.0079 | 1 | 6 | C3HC4-type RING finger domain binding |
| GO:0008312 | 0.0091 | 133.5088 | 0.0092 | 1 | 7 | 7S RNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 212.506 | 0.0636 | 7 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 25.0495 | 0.4694 | 7 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 15.2842 | 0.9422 | 8 | 845 | transmembrane receptor activity |
| GO:0038023 | 0 | 14.2024 | 1.0091 | 8 | 905 | signaling receptor activity |
| GO:0060089 | 0 | 10.9544 | 1.2834 | 8 | 1151 | molecular transducer activity |
| GO:0004867 | 0.0029 | 28.4657 | 0.0814 | 2 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0042608 | 0.0067 | 190.3 | 0.0067 | 1 | 6 | T cell receptor binding |
| GO:0004321 | 0.0078 | 158.5729 | 0.0078 | 1 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | butyrate-CoA ligase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004953 | 3e-04 | 101.38 | 0.0248 | 2 | 14 | icosanoid receptor activity |
| GO:0060089 | 0.0032 | 4.3062 | 2.0384 | 7 | 1151 | molecular transducer activity |
| GO:0001632 | 0.0035 | 585.3077 | 0.0035 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0031708 | 0.0035 | 585.3077 | 0.0035 | 1 | 2 | endothelin B receptor binding |
| GO:0038023 | 0.0043 | 4.5511 | 1.6027 | 6 | 905 | signaling receptor activity |
| GO:0001588 | 0.0071 | 195.0769 | 0.0071 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0050833 | 0.0071 | 195.0769 | 0.0071 | 1 | 4 | pyruvate transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003854 | 0.0021 | 1015.2667 | 0.0021 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001077 | 8e-04 | 11.0035 | 0.4313 | 4 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0000978 | 0.0023 | 8.2375 | 0.5706 | 4 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0001159 | 0.0027 | 7.863 | 0.5969 | 4 | 364 | core promoter proximal region DNA binding |
| GO:0004174 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
| GO:0061629 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
| GO:0004028 | 0.0082 | 158.5104 | 0.0082 | 1 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0004111 | 0.0098 | 126.8 | 0.0098 | 1 | 6 | creatine kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005549 | 0 | 281.9074 | 0.0101 | 2 | 11 | odorant binding |
| GO:0042056 | 3e-04 | 97.4744 | 0.0257 | 2 | 28 | chemoattractant activity |
| GO:0004984 | 0.0012 | 45.9909 | 0.0523 | 2 | 57 | olfactory receptor activity |
| GO:0004035 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | alkaline phosphatase activity |
| GO:0043199 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | sulfate binding |
| GO:0004465 | 0.0073 | 167.3077 | 0.0073 | 1 | 8 | lipoprotein lipase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042497 | 7e-04 | Inf | 7e-04 | 1 | 1 | triacyl lipopeptide binding |
| GO:0047963 | 7e-04 | Inf | 7e-04 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0052817 | 7e-04 | Inf | 7e-04 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0052815 | 0.0013 | 1692.7778 | 0.0013 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
| GO:0038023 | 0.0019 | 10.6067 | 0.5936 | 4 | 905 | signaling receptor activity |
| GO:0001875 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | lipopolysaccharide receptor activity |
| GO:0008048 | 0.0033 | 423.1111 | 0.0033 | 1 | 5 | calcium sensitive guanylate cyclase activator activity |
| GO:0042608 | 0.0039 | 338.4667 | 0.0039 | 1 | 6 | T cell receptor binding |
| GO:0010853 | 0.0046 | 282.037 | 0.0046 | 1 | 7 | cyclase activator activity |
| GO:0060089 | 0.0047 | 8.1889 | 0.755 | 4 | 1151 | molecular transducer activity |
| GO:0005125 | 0.0052 | 22.5584 | 0.1108 | 2 | 169 | cytokine activity |
| GO:0030249 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | guanylate cyclase regulator activity |
| GO:0035325 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | Toll-like receptor binding |
| GO:0102991 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | myristoyl-CoA hydrolase activity |
| GO:0015643 | 0.0065 | 187.9877 | 0.0066 | 1 | 10 | toxic substance binding |
| GO:0042834 | 0.0065 | 187.9877 | 0.0066 | 1 | 10 | peptidoglycan binding |
| GO:0045295 | 0.0065 | 187.9877 | 0.0066 | 1 | 10 | gamma-catenin binding |
| GO:0005509 | 0.007 | 9.8869 | 0.4172 | 3 | 636 | calcium ion binding |
| GO:0016290 | 0.0072 | 169.1778 | 0.0072 | 1 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0005149 | 0.0078 | 153.7879 | 0.0079 | 1 | 12 | interleukin-1 receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004506 | 0.0015 | Inf | 0.0015 | 1 | 1 | squalene monooxygenase activity |
| GO:0004946 | 0.0015 | Inf | 0.0015 | 1 | 1 | bombesin receptor activity |
| GO:0005140 | 0.0015 | Inf | 0.0015 | 1 | 1 | interleukin-9 receptor binding |
| GO:0047025 | 0.003 | 691.9091 | 0.003 | 1 | 2 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity |
| GO:0070404 | 0.0045 | 345.9318 | 0.0045 | 1 | 3 | NADH binding |
| GO:0070891 | 0.0045 | 345.9318 | 0.0045 | 1 | 3 | lipoteichoic acid binding |
| GO:0001847 | 0.006 | 230.6061 | 0.006 | 1 | 4 | opsonin receptor activity |
| GO:0016019 | 0.0075 | 172.9432 | 0.0075 | 1 | 5 | peptidoglycan receptor activity |
| GO:0047035 | 0.009 | 138.3455 | 0.0091 | 1 | 6 | testosterone dehydrogenase (NAD+) activity |
| GO:0071723 | 0.009 | 138.3455 | 0.0091 | 1 | 6 | lipopeptide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005130 | 7e-04 | Inf | 7e-04 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0008502 | 0.0013 | 1692.7778 | 0.0013 | 1 | 2 | melatonin receptor activity |
| GO:0035939 | 0.002 | 846.3333 | 0.002 | 1 | 3 | microsatellite binding |
| GO:0032190 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | acrosin binding |
| GO:1990254 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | keratin filament binding |
| GO:0008134 | 0.0036 | 12.6833 | 0.3286 | 3 | 501 | transcription factor binding |
| GO:1990837 | 0.0091 | 8.9129 | 0.4604 | 3 | 702 | sequence-specific double-stranded DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032393 | 0.005 | 253.8167 | 0.0051 | 1 | 7 | MHC class I receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0 | 135.6964 | 0.042 | 4 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0001604 | 0.0013 | Inf | 0.0013 | 1 | 1 | urotensin II receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 10.0625 | 1.4271 | 9 | 989 | sequence-specific DNA binding |
| GO:0003700 | 9e-04 | 5.6369 | 1.6898 | 7 | 1171 | DNA binding transcription factor activity |
| GO:0015361 | 0.0014 | Inf | 0.0014 | 1 | 1 | low-affinity sodium:dicarboxylate symporter activity |
| GO:0004984 | 0.003 | 27.58 | 0.0823 | 2 | 57 | olfactory receptor activity |
| GO:0001601 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | peptide YY receptor activity |
| GO:0046848 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | hydroxyapatite binding |
| GO:0004784 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | superoxide dismutase activity |
| GO:0030197 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | extracellular matrix constituent, lubricant activity |
| GO:0030345 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | structural constituent of tooth enamel |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070888 | 0.0012 | 45.6842 | 0.051 | 2 | 37 | E-box binding |
| GO:0033798 | 0.0014 | Inf | 0.0014 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0001228 | 0.0019 | 8.9267 | 0.5441 | 4 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0004984 | 0.0028 | 29.0335 | 0.0785 | 2 | 57 | olfactory receptor activity |
| GO:0004800 | 0.0041 | 380.575 | 0.0041 | 1 | 3 | thyroxine 5'-deiodinase activity |
| GO:0001591 | 0.0055 | 253.7 | 0.0055 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0000977 | 0.0077 | 5.9094 | 0.8085 | 4 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015361 | 9e-04 | Inf | 9e-04 | 1 | 1 | low-affinity sodium:dicarboxylate symporter activity |
| GO:0005148 | 0.0017 | 1269.3333 | 0.0017 | 1 | 2 | prolactin receptor binding |
| GO:0031726 | 0.0026 | 634.625 | 0.0026 | 1 | 3 | CCR1 chemokine receptor binding |
| GO:0004698 | 0.0034 | 423.0556 | 0.0034 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0032190 | 0.0034 | 423.0556 | 0.0034 | 1 | 4 | acrosin binding |
| GO:0005131 | 0.0043 | 317.2708 | 0.0043 | 1 | 5 | growth hormone receptor binding |
| GO:0031730 | 0.0043 | 317.2708 | 0.0043 | 1 | 5 | CCR5 chemokine receptor binding |
| GO:0016004 | 0.0085 | 140.963 | 0.0085 | 1 | 10 | phospholipase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0.0026 | 29.7647 | 0.0756 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0016779 | 0.0032 | 11.2429 | 0.2952 | 3 | 125 | nucleotidyltransferase activity |
| GO:0001632 | 0.0047 | 434.5429 | 0.0047 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0070891 | 0.0071 | 217.2571 | 0.0071 | 1 | 3 | lipoteichoic acid binding |
| GO:0001847 | 0.0094 | 144.8286 | 0.0094 | 1 | 4 | opsonin receptor activity |
| GO:0010385 | 0.0094 | 144.8286 | 0.0094 | 1 | 4 | double-stranded methylated DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 112.2485 | 0.0673 | 5 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 17.847 | 0.497 | 6 | 421 | G-protein coupled receptor activity |
| GO:0018685 | 0 | 951.625 | 0.0047 | 2 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 0 | 951.625 | 0.0047 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0099600 | 0 | 10.9275 | 0.9976 | 7 | 845 | transmembrane receptor activity |
| GO:0004497 | 1e-04 | 35.214 | 0.1051 | 3 | 89 | monooxygenase activity |
| GO:0008392 | 2e-04 | 126.775 | 0.0201 | 2 | 17 | arachidonic acid epoxygenase activity |
| GO:0060089 | 2e-04 | 7.8344 | 1.3589 | 7 | 1151 | molecular transducer activity |
| GO:0020037 | 4e-04 | 25.8308 | 0.1417 | 3 | 120 | heme binding |
| GO:0048020 | 4e-04 | 86.3977 | 0.0283 | 2 | 24 | CCR chemokine receptor binding |
| GO:0008009 | 6e-04 | 67.8571 | 0.0354 | 2 | 30 | chemokine activity |
| GO:0016705 | 7e-04 | 20.8041 | 0.1747 | 3 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0005506 | 7e-04 | 20.6603 | 0.1759 | 3 | 149 | iron ion binding |
| GO:0019825 | 0.0011 | 48.6827 | 0.0484 | 2 | 41 | oxygen binding |
| GO:0102116 | 0.0012 | Inf | 0.0012 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0012 | Inf | 0.0012 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0038023 | 0.0013 | 7.9049 | 0.8744 | 5 | 829 | signaling receptor activity |
| GO:0030594 | 0.0036 | 25.598 | 0.0897 | 2 | 76 | neurotransmitter receptor activity |
| GO:0001591 | 0.0047 | 298.5294 | 0.0047 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0035240 | 0.0094 | 127.9076 | 0.0094 | 1 | 8 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 275.3741 | 0.0636 | 8 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 31.8881 | 0.4694 | 8 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 19.3686 | 0.9422 | 9 | 845 | transmembrane receptor activity |
| GO:0038023 | 0 | 17.9962 | 1.0091 | 9 | 905 | signaling receptor activity |
| GO:0060089 | 0 | 13.8773 | 1.2834 | 9 | 1151 | molecular transducer activity |
| GO:0004867 | 0.0029 | 28.4657 | 0.0814 | 2 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0042608 | 0.0067 | 190.3 | 0.0067 | 1 | 6 | T cell receptor binding |
| GO:0004321 | 0.0078 | 158.5729 | 0.0078 | 1 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | butyrate-CoA ligase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031249 | 0.001 | Inf | 0.001 | 1 | 1 | denatured protein binding |
| GO:0031708 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | endothelin B receptor binding |
| GO:0001588 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0042826 | 0.0042 | 23.7567 | 0.0984 | 2 | 100 | histone deacetylase binding |
| GO:0055131 | 0.0059 | 217.5143 | 0.0059 | 1 | 6 | C3HC4-type RING finger domain binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001955 | 5e-04 | 84.9355 | 0.0339 | 2 | 7 | blood vessel maturation |
| GO:0030199 | 7e-04 | 19.5782 | 0.1741 | 3 | 36 | collagen fibril organization |
| GO:0061042 | 0.0015 | 42.4516 | 0.058 | 2 | 12 | vascular wound healing |
| GO:0030574 | 0.0016 | 14.3443 | 0.2321 | 3 | 48 | collagen catabolic process |
| GO:0006954 | 0.0017 | 3.9922 | 2.2391 | 8 | 463 | inflammatory response |
| GO:0006590 | 0.0017 | 38.5894 | 0.0629 | 2 | 13 | thyroid hormone generation |
| GO:0045600 | 0.002 | 13.1693 | 0.2515 | 3 | 52 | positive regulation of fat cell differentiation |
| GO:0048771 | 0.0025 | 7.7032 | 0.5658 | 4 | 117 | tissue remodeling |
| GO:0008217 | 0.0032 | 7.1301 | 0.6093 | 4 | 126 | regulation of blood pressure |
| GO:0018958 | 0.0047 | 9.6181 | 0.3385 | 3 | 70 | phenol-containing compound metabolic process |
| GO:0098869 | 0.0047 | 9.6181 | 0.3385 | 3 | 70 | cellular oxidant detoxification |
| GO:0006599 | 0.0048 | Inf | 0.0048 | 1 | 1 | phosphagen metabolic process |
| GO:0009115 | 0.0048 | Inf | 0.0048 | 1 | 1 | xanthine catabolic process |
| GO:0019732 | 0.0048 | Inf | 0.0048 | 1 | 1 | antifungal humoral response |
| GO:0019805 | 0.0048 | Inf | 0.0048 | 1 | 1 | quinolinate biosynthetic process |
| GO:0033477 | 0.0048 | Inf | 0.0048 | 1 | 1 | S-methylmethionine metabolic process |
| GO:0042128 | 0.0048 | Inf | 0.0048 | 1 | 1 | nitrate assimilation |
| GO:0046314 | 0.0048 | Inf | 0.0048 | 1 | 1 | phosphocreatine biosynthetic process |
| GO:0061760 | 0.0048 | Inf | 0.0048 | 1 | 1 | antifungal innate immune response |
| GO:2000494 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
| GO:0072359 | 0.0051 | 2.8749 | 3.9027 | 10 | 807 | circulatory system development |
| GO:0001578 | 0.0059 | 8.8235 | 0.3675 | 3 | 76 | microtubule bundle formation |
| GO:0098754 | 0.0059 | 8.8235 | 0.3675 | 3 | 76 | detoxification |
| GO:0051216 | 0.0065 | 5.7867 | 0.7447 | 4 | 154 | cartilage development |
| GO:0097237 | 0.0068 | 8.3626 | 0.3869 | 3 | 80 | cellular response to toxic substance |
| GO:0048646 | 0.0072 | 2.7252 | 4.101 | 10 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0070286 | 0.0075 | 16.9613 | 0.1306 | 2 | 27 | axonemal dynein complex assembly |
| GO:0044259 | 0.0091 | 7.4823 | 0.4304 | 3 | 89 | multicellular organismal macromolecule metabolic process |
| GO:0043537 | 0.0092 | 15.1406 | 0.1451 | 2 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0003050 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | regulation of systemic arterial blood pressure by atrial natriuretic peptide |
| GO:0007525 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | somatic muscle development |
| GO:0035669 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
| GO:0042418 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | epinephrine biosynthetic process |
| GO:0060354 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | negative regulation of cell adhesion molecule production |
| GO:2000669 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | negative regulation of dendritic cell apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043112 | 2e-04 | 16.4724 | 0.2871 | 4 | 131 | receptor metabolic process |
| GO:0022603 | 3e-04 | 5.6988 | 1.8135 | 8 | 800 | regulation of anatomical structure morphogenesis |
| GO:0048589 | 4e-04 | 9.3586 | 0.6492 | 5 | 314 | developmental growth |
| GO:0002009 | 4e-04 | 7.2353 | 1.0133 | 6 | 447 | morphogenesis of an epithelium |
| GO:0001763 | 4e-04 | 12.9519 | 0.3604 | 4 | 159 | morphogenesis of a branching structure |
| GO:0001759 | 5e-04 | 72.478 | 0.034 | 2 | 15 | organ induction |
| GO:0035295 | 8e-04 | 6.3919 | 1.1402 | 6 | 503 | tube development |
| GO:0048704 | 9e-04 | 17.7805 | 0.1927 | 3 | 85 | embryonic skeletal system morphogenesis |
| GO:0009888 | 0.0011 | 3.9851 | 3.3595 | 10 | 1482 | tissue development |
| GO:0030878 | 0.0012 | 44.8401 | 0.0521 | 2 | 23 | thyroid gland development |
| GO:0001838 | 0.0021 | 13.1061 | 0.2584 | 3 | 114 | embryonic epithelial tube formation |
| GO:0007495 | 0.0023 | Inf | 0.0023 | 1 | 1 | visceral mesoderm-endoderm interaction involved in midgut development |
| GO:0038129 | 0.0023 | Inf | 0.0023 | 1 | 1 | ERBB3 signaling pathway |
| GO:0110023 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
| GO:1903769 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:1905243 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular response to 3,3',5-triiodo-L-thyronine |
| GO:1905322 | 0.0023 | Inf | 0.0023 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
| GO:0051241 | 0.0023 | 4.4969 | 1.9133 | 7 | 844 | negative regulation of multicellular organismal process |
| GO:0048754 | 0.0029 | 11.7204 | 0.2879 | 3 | 127 | branching morphogenesis of an epithelial tube |
| GO:0007507 | 0.003 | 5.8155 | 1.0065 | 5 | 444 | heart development |
| GO:0035148 | 0.0034 | 11.0882 | 0.3038 | 3 | 134 | tube formation |
| GO:0090102 | 0.0035 | 25.4189 | 0.0884 | 2 | 39 | cochlea development |
| GO:0051093 | 0.0045 | 4.4523 | 1.605 | 6 | 708 | negative regulation of developmental process |
| GO:0006624 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | vacuolar protein processing |
| GO:0017186 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase |
| GO:0021842 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
| GO:0060480 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | lung goblet cell differentiation |
| GO:0060764 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:2000729 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | positive regulation of mesenchymal cell proliferation involved in ureter development |
| GO:0043009 | 0.005 | 5.1242 | 1.1357 | 5 | 501 | chordate embryonic development |
| GO:0050877 | 0.0051 | 4.3411 | 1.6435 | 6 | 725 | nervous system process |
| GO:2000026 | 0.0053 | 3.3042 | 3.457 | 9 | 1525 | regulation of multicellular organismal development |
| GO:0001568 | 0.0053 | 5.0397 | 1.1538 | 5 | 509 | blood vessel development |
| GO:0048598 | 0.0053 | 5.0397 | 1.1538 | 5 | 509 | embryonic morphogenesis |
| GO:0030166 | 0.0057 | 19.5774 | 0.1133 | 2 | 50 | proteoglycan biosynthetic process |
| GO:0048645 | 0.0057 | 19.5774 | 0.1133 | 2 | 50 | animal organ formation |
| GO:0030855 | 0.0059 | 4.9079 | 1.1833 | 5 | 522 | epithelial cell differentiation |
| GO:1901185 | 0.0061 | 18.7914 | 0.1179 | 2 | 52 | negative regulation of ERBB signaling pathway |
| GO:0072358 | 0.0065 | 4.7826 | 1.2128 | 5 | 535 | cardiovascular system development |
| GO:0060675 | 0.0066 | 18.0659 | 0.1224 | 2 | 54 | ureteric bud morphogenesis |
| GO:0008582 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | regulation of synaptic growth at neuromuscular junction |
| GO:0045213 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | neurotransmitter receptor metabolic process |
| GO:0060435 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | bronchiole development |
| GO:0061146 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | Peyer's patch morphogenesis |
| GO:0061551 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | trigeminal ganglion development |
| GO:0072095 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:0072193 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | ureter smooth muscle cell differentiation |
| GO:0072513 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | positive regulation of secondary heart field cardioblast proliferation |
| GO:0090191 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:0097647 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | amylin receptor signaling pathway |
| GO:2000821 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | regulation of grooming behavior |
| GO:0060560 | 0.007 | 8.4685 | 0.3944 | 3 | 174 | developmental growth involved in morphogenesis |
| GO:0001570 | 0.0084 | 15.914 | 0.1383 | 2 | 61 | vasculogenesis |
| GO:0072078 | 0.0086 | 15.6476 | 0.1405 | 2 | 62 | nephron tubule morphogenesis |
| GO:0001525 | 0.0088 | 5.4889 | 0.8251 | 4 | 364 | angiogenesis |
| GO:0030910 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | olfactory placode formation |
| GO:0060482 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | lobar bronchus development |
| GO:0060535 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | intestinal epithelial cell maturation |
| GO:0060638 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | mesenchymal-epithelial cell signaling |
| GO:0061055 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | myotome development |
| GO:0061197 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | fungiform papilla morphogenesis |
| GO:0071698 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | olfactory placode development |
| GO:0072107 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | positive regulation of ureteric bud formation |
| GO:0098706 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | ferric iron import across plasma membrane |
| GO:0048663 | 0.0092 | 15.1406 | 0.1451 | 2 | 64 | neuron fate commitment |
| GO:0072028 | 0.0092 | 15.1406 | 0.1451 | 2 | 64 | nephron morphogenesis |
| GO:0048568 | 0.0094 | 5.3813 | 0.841 | 4 | 371 | embryonic organ development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007416 | 3e-04 | 13.6688 | 0.3355 | 4 | 120 | synapse assembly |
| GO:0007156 | 4e-04 | 13.0989 | 0.3495 | 4 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0033197 | 4e-04 | 83.7333 | 0.0308 | 2 | 11 | response to vitamin E |
| GO:0016339 | 0.0019 | 35.8531 | 0.0643 | 2 | 23 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0009645 | 0.0028 | Inf | 0.0028 | 1 | 1 | response to low light intensity stimulus |
| GO:0046690 | 0.0028 | Inf | 0.0028 | 1 | 1 | response to tellurium ion |
| GO:0097254 | 0.0028 | Inf | 0.0028 | 1 | 1 | renal tubular secretion |
| GO:0000023 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | maltose metabolic process |
| GO:0007506 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | gonadal mesoderm development |
| GO:0010159 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | specification of animal organ position |
| GO:0031022 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | nuclear migration along microfilament |
| GO:0098609 | 0.0068 | 3.9801 | 1.7278 | 6 | 618 | cell-cell adhesion |
| GO:0003221 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | right ventricular cardiac muscle tissue morphogenesis |
| GO:0015742 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | alpha-ketoglutarate transport |
| GO:0015747 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | urate transport |
| GO:0021615 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | glossopharyngeal nerve morphogenesis |
| GO:0021817 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration |
| GO:0031427 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | response to methotrexate |
| GO:0090292 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | nuclear matrix anchoring at nuclear membrane |
| GO:0097116 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | gephyrin clustering involved in postsynaptic density assembly |
| GO:0099560 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | synaptic membrane adhesion |
| GO:2000821 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | regulation of grooming behavior |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048247 | 0 | 84.5321 | 0.046 | 3 | 29 | lymphocyte chemotaxis |
| GO:0016045 | 1e-04 | 231.7018 | 0.0127 | 2 | 8 | detection of bacterium |
| GO:0050900 | 1e-04 | 14.0245 | 0.4649 | 5 | 293 | leukocyte migration |
| GO:0098581 | 1e-04 | 154.4327 | 0.0175 | 2 | 11 | detection of external biotic stimulus |
| GO:0045087 | 2e-04 | 8.8886 | 0.9124 | 6 | 575 | innate immune response |
| GO:0031424 | 6e-04 | 21.008 | 0.1698 | 3 | 107 | keratinization |
| GO:0061844 | 9e-04 | 51.4074 | 0.046 | 2 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0031640 | 0.001 | 49.5677 | 0.0476 | 2 | 30 | killing of cells of other organism |
| GO:0048006 | 0.0016 | Inf | 0.0016 | 1 | 1 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
| GO:0060326 | 0.0027 | 12.3456 | 0.284 | 3 | 179 | cell chemotaxis |
| GO:0030593 | 0.0029 | 28.2793 | 0.0809 | 2 | 51 | neutrophil chemotaxis |
| GO:0050830 | 0.003 | 27.7116 | 0.0825 | 2 | 52 | defense response to Gram-positive bacterium |
| GO:0001775 | 0.0032 | 5.0883 | 1.5376 | 6 | 969 | cell activation |
| GO:0006740 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | NADPH regeneration |
| GO:0044657 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0051714 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | positive regulation of cytolysis in other organism |
| GO:0052043 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0060468 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | prevention of polyspermy |
| GO:0009913 | 0.0036 | 11.1265 | 0.3142 | 3 | 198 | epidermal cell differentiation |
| GO:0044419 | 0.0047 | 5.4303 | 1.1489 | 5 | 724 | interspecies interaction between organisms |
| GO:0051673 | 0.0048 | 330.275 | 0.0048 | 1 | 3 | membrane disruption in other organism |
| GO:0009253 | 0.0063 | 220.1667 | 0.0063 | 1 | 4 | peptidoglycan catabolic process |
| GO:0048007 | 0.0063 | 220.1667 | 0.0063 | 1 | 4 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0097530 | 0.0065 | 18.4393 | 0.1222 | 2 | 77 | granulocyte migration |
| GO:0043588 | 0.0074 | 8.5375 | 0.4062 | 3 | 256 | skin development |
| GO:0071346 | 0.0086 | 15.8814 | 0.1412 | 2 | 89 | cellular response to interferon-gamma |
| GO:0002475 | 0.0095 | 132.08 | 0.0095 | 1 | 6 | antigen processing and presentation via MHC class Ib |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001955 | 5e-04 | 82.2687 | 0.0349 | 2 | 7 | blood vessel maturation |
| GO:0030199 | 8e-04 | 18.9538 | 0.1795 | 3 | 36 | collagen fibril organization |
| GO:0061042 | 0.0016 | 41.1187 | 0.0598 | 2 | 12 | vascular wound healing |
| GO:0030574 | 0.0017 | 13.8868 | 0.2394 | 3 | 48 | collagen catabolic process |
| GO:0046394 | 0.0018 | 5.1047 | 1.2917 | 6 | 259 | carboxylic acid biosynthetic process |
| GO:0006590 | 0.0018 | 37.3778 | 0.0648 | 2 | 13 | thyroid hormone generation |
| GO:0045600 | 0.0022 | 12.7493 | 0.2593 | 3 | 52 | positive regulation of fat cell differentiation |
| GO:0048771 | 0.0027 | 7.4536 | 0.5835 | 4 | 117 | tissue remodeling |
| GO:0008217 | 0.0036 | 6.899 | 0.6284 | 4 | 126 | regulation of blood pressure |
| GO:0006599 | 0.005 | Inf | 0.005 | 1 | 1 | phosphagen metabolic process |
| GO:0009115 | 0.005 | Inf | 0.005 | 1 | 1 | xanthine catabolic process |
| GO:0019732 | 0.005 | Inf | 0.005 | 1 | 1 | antifungal humoral response |
| GO:0019805 | 0.005 | Inf | 0.005 | 1 | 1 | quinolinate biosynthetic process |
| GO:0033477 | 0.005 | Inf | 0.005 | 1 | 1 | S-methylmethionine metabolic process |
| GO:0042128 | 0.005 | Inf | 0.005 | 1 | 1 | nitrate assimilation |
| GO:0046314 | 0.005 | Inf | 0.005 | 1 | 1 | phosphocreatine biosynthetic process |
| GO:0061760 | 0.005 | Inf | 0.005 | 1 | 1 | antifungal innate immune response |
| GO:2000494 | 0.005 | Inf | 0.005 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
| GO:0018958 | 0.0051 | 9.3113 | 0.3491 | 3 | 70 | phenol-containing compound metabolic process |
| GO:0098869 | 0.0051 | 9.3113 | 0.3491 | 3 | 70 | cellular oxidant detoxification |
| GO:0022900 | 0.0052 | 6.1822 | 0.6982 | 4 | 140 | electron transport chain |
| GO:0098754 | 0.0064 | 8.5421 | 0.379 | 3 | 76 | detoxification |
| GO:0002700 | 0.0072 | 8.203 | 0.394 | 3 | 79 | regulation of production of molecular mediator of immune response |
| GO:0051216 | 0.0073 | 5.5991 | 0.768 | 4 | 154 | cartilage development |
| GO:0097237 | 0.0074 | 8.0959 | 0.399 | 3 | 80 | cellular response to toxic substance |
| GO:0070286 | 0.0079 | 16.4288 | 0.1347 | 2 | 27 | axonemal dynein complex assembly |
| GO:0006954 | 0.0081 | 3.3075 | 2.3091 | 7 | 463 | inflammatory response |
| GO:0043537 | 0.0097 | 14.6652 | 0.1496 | 2 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0044259 | 0.0099 | 7.2436 | 0.4439 | 3 | 89 | multicellular organismal macromolecule metabolic process |
| GO:0003050 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | regulation of systemic arterial blood pressure by atrial natriuretic peptide |
| GO:0035669 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
| GO:0042418 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | epinephrine biosynthetic process |
| GO:0060354 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | negative regulation of cell adhesion molecule production |
| GO:2000669 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | negative regulation of dendritic cell apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019265 | 8e-04 | Inf | 8e-04 | 1 | 1 | glycine biosynthetic process, by transamination of glyoxylate |
| GO:0019481 | 8e-04 | Inf | 8e-04 | 1 | 1 | L-alanine catabolic process, by transamination |
| GO:0042361 | 8e-04 | Inf | 8e-04 | 1 | 1 | menaquinone catabolic process |
| GO:0042377 | 8e-04 | Inf | 8e-04 | 1 | 1 | vitamin K catabolic process |
| GO:0009436 | 0.0017 | 1322.2 | 0.0017 | 1 | 2 | glyoxylate catabolic process |
| GO:0038060 | 0.0017 | 1322.2 | 0.0017 | 1 | 2 | nitric oxide-cGMP-mediated signaling pathway |
| GO:0042376 | 0.0017 | 1322.2 | 0.0017 | 1 | 2 | phylloquinone catabolic process |
| GO:0002249 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | lymphocyte anergy |
| GO:0002667 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | regulation of T cell anergy |
| GO:0021759 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | globus pallidus development |
| GO:0042851 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | L-alanine metabolic process |
| GO:0006524 | 0.0033 | 440.6667 | 0.0033 | 1 | 4 | alanine catabolic process |
| GO:0009078 | 0.0033 | 440.6667 | 0.0033 | 1 | 4 | pyruvate family amino acid metabolic process |
| GO:0042182 | 0.005 | 264.36 | 0.005 | 1 | 6 | ketone catabolic process |
| GO:0002517 | 0.0058 | 220.2833 | 0.0058 | 1 | 7 | T cell tolerance induction |
| GO:0071241 | 0.0066 | 19.6321 | 0.1247 | 2 | 150 | cellular response to inorganic substance |
| GO:0009109 | 0.0066 | 188.8 | 0.0066 | 1 | 8 | coenzyme catabolic process |
| GO:0009111 | 0.0066 | 188.8 | 0.0066 | 1 | 8 | vitamin catabolic process |
| GO:0090026 | 0.0075 | 165.1875 | 0.0075 | 1 | 9 | positive regulation of monocyte chemotaxis |
| GO:0009642 | 0.0083 | 146.8222 | 0.0083 | 1 | 10 | response to light intensity |
| GO:0002643 | 0.0099 | 120.1091 | 0.01 | 1 | 12 | regulation of tolerance induction |
| GO:1903818 | 0.0099 | 120.1091 | 0.01 | 1 | 12 | positive regulation of voltage-gated potassium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1900131 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of lipid binding |
| GO:0031338 | 0.0016 | 39.8818 | 0.0609 | 2 | 62 | regulation of vesicle fusion |
| GO:1901475 | 0.002 | 1101.6667 | 0.002 | 1 | 2 | pyruvate transmembrane transport |
| GO:0090630 | 0.0028 | 30.2463 | 0.0796 | 2 | 81 | activation of GTPase activity |
| GO:0002351 | 0.0029 | 550.7917 | 0.0029 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0029 | 550.7917 | 0.0029 | 1 | 3 | serotonin secretion by platelet |
| GO:0006003 | 0.0029 | 550.7917 | 0.0029 | 1 | 3 | fructose 2,6-bisphosphate metabolic process |
| GO:0002778 | 0.0039 | 367.1667 | 0.0039 | 1 | 4 | antibacterial peptide production |
| GO:0035873 | 0.0039 | 367.1667 | 0.0039 | 1 | 4 | lactate transmembrane transport |
| GO:0098528 | 0.0049 | 275.3542 | 0.0049 | 1 | 5 | skeletal muscle fiber differentiation |
| GO:0045046 | 0.0059 | 220.2667 | 0.0059 | 1 | 6 | protein import into peroxisome membrane |
| GO:0001820 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | serotonin secretion |
| GO:0003056 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | regulation of vascular smooth muscle contraction |
| GO:0016559 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | peroxisome fission |
| GO:0033234 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | negative regulation of protein sumoylation |
| GO:0090174 | 0.0081 | 17.1118 | 0.1385 | 2 | 141 | organelle membrane fusion |
| GO:0072321 | 0.0088 | 137.6354 | 0.0088 | 1 | 9 | chaperone-mediated protein transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007339 | 7e-04 | 59.6787 | 0.0402 | 2 | 28 | binding of sperm to zona pellucida |
| GO:0009988 | 0.0019 | 35.2166 | 0.066 | 2 | 46 | cell-cell recognition |
| GO:0009644 | 0.0029 | 734.1111 | 0.0029 | 1 | 2 | response to high light intensity |
| GO:0010845 | 0.0029 | 734.1111 | 0.0029 | 1 | 2 | positive regulation of reciprocal meiotic recombination |
| GO:0060468 | 0.0029 | 734.1111 | 0.0029 | 1 | 2 | prevention of polyspermy |
| GO:0006311 | 0.0043 | 367.0278 | 0.0043 | 1 | 3 | meiotic gene conversion |
| GO:0043605 | 0.0043 | 367.0278 | 0.0043 | 1 | 3 | cellular amide catabolic process |
| GO:0043588 | 0.0055 | 9.6062 | 0.3675 | 3 | 256 | skin development |
| GO:2000275 | 0.0057 | 244.6667 | 0.0057 | 1 | 4 | regulation of oxidative phosphorylation uncoupler activity |
| GO:0031642 | 0.0072 | 183.4861 | 0.0072 | 1 | 5 | negative regulation of myelination |
| GO:0007338 | 0.0082 | 16.4218 | 0.1378 | 2 | 96 | single fertilization |
| GO:2000241 | 0.0096 | 15.1246 | 0.1493 | 2 | 104 | regulation of reproductive process |
| GO:0044236 | 0.0098 | 14.9766 | 0.1507 | 2 | 105 | multicellular organism metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 45.3176 | 0.1798 | 6 | 85 | embryonic skeletal system morphogenesis |
| GO:0048568 | 0 | 11.7601 | 0.7849 | 7 | 371 | embryonic organ development |
| GO:0001501 | 0 | 10.6169 | 0.8653 | 7 | 409 | skeletal system development |
| GO:0009952 | 0 | 16.4737 | 0.3745 | 5 | 177 | anterior/posterior pattern specification |
| GO:0048598 | 1e-04 | 8.4356 | 1.0769 | 7 | 509 | embryonic morphogenesis |
| GO:0007389 | 1e-04 | 9.7877 | 0.7701 | 6 | 364 | pattern specification process |
| GO:0009887 | 2e-04 | 6.1295 | 1.7286 | 8 | 817 | animal organ morphogenesis |
| GO:0043009 | 5e-04 | 7.0033 | 1.06 | 6 | 501 | chordate embryonic development |
| GO:0045446 | 6e-04 | 20.1969 | 0.1714 | 3 | 81 | endothelial cell differentiation |
| GO:0002215 | 0.0021 | Inf | 0.0021 | 1 | 1 | defense response to nematode |
| GO:0003336 | 0.0021 | Inf | 0.0021 | 1 | 1 | corneocyte desquamation |
| GO:0019265 | 0.0021 | Inf | 0.0021 | 1 | 1 | glycine biosynthetic process, by transamination of glyoxylate |
| GO:0019481 | 0.0021 | Inf | 0.0021 | 1 | 1 | L-alanine catabolic process, by transamination |
| GO:0021754 | 0.0021 | Inf | 0.0021 | 1 | 1 | facial nucleus development |
| GO:0043538 | 0.0021 | Inf | 0.0021 | 1 | 1 | regulation of actin phosphorylation |
| GO:0097254 | 0.0021 | Inf | 0.0021 | 1 | 1 | renal tubular secretion |
| GO:0110023 | 0.0021 | Inf | 0.0021 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
| GO:1903769 | 0.0021 | Inf | 0.0021 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:1905322 | 0.0021 | Inf | 0.0021 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
| GO:1905716 | 0.0021 | Inf | 0.0021 | 1 | 1 | negative regulation of cornification |
| GO:0021545 | 0.003 | 27.3784 | 0.0825 | 2 | 39 | cranial nerve development |
| GO:0021546 | 0.0041 | 507.8077 | 0.0041 | 1 | 2 | rhombomere development |
| GO:0009436 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | glyoxylate catabolic process |
| GO:0021570 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | rhombomere 4 development |
| GO:0021571 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | rhombomere 5 development |
| GO:0015742 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | alpha-ketoglutarate transport |
| GO:0015747 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | urate transport |
| GO:0021615 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | glossopharyngeal nerve morphogenesis |
| GO:0030047 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | actin modification |
| GO:0031427 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | response to methotrexate |
| GO:0032714 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | negative regulation of interleukin-5 production |
| GO:0042851 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | L-alanine metabolic process |
| GO:0006524 | 0.0084 | 163 | 0.0085 | 1 | 4 | alanine catabolic process |
| GO:0009078 | 0.0084 | 163 | 0.0085 | 1 | 4 | pyruvate family amino acid metabolic process |
| GO:0021612 | 0.0084 | 163 | 0.0085 | 1 | 4 | facial nerve structural organization |
| GO:0042989 | 0.0084 | 163 | 0.0085 | 1 | 4 | sequestering of actin monomers |
| GO:0072593 | 0.0089 | 7.7642 | 0.4316 | 3 | 204 | reactive oxygen species metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045671 | 5e-04 | 72.4835 | 0.0339 | 2 | 16 | negative regulation of osteoclast differentiation |
| GO:0042930 | 0.0021 | Inf | 0.0021 | 1 | 1 | enterobactin transport |
| GO:0009566 | 0.0023 | 12.7639 | 0.2666 | 3 | 126 | fertilization |
| GO:0006749 | 0.0032 | 26.6559 | 0.0846 | 2 | 40 | glutathione metabolic process |
| GO:0050915 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | sensory perception of sour taste |
| GO:0060468 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | prevention of polyspermy |
| GO:0002249 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | lymphocyte anergy |
| GO:0002667 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | regulation of T cell anergy |
| GO:0015688 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | iron chelate transport |
| GO:0050968 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:1902106 | 0.0073 | 17.1408 | 0.1291 | 2 | 61 | negative regulation of leukocyte differentiation |
| GO:0032414 | 0.0075 | 16.8538 | 0.1312 | 2 | 62 | positive regulation of ion transmembrane transporter activity |
| GO:0043255 | 0.0083 | 16.0476 | 0.1375 | 2 | 65 | regulation of carbohydrate biosynthetic process |
| GO:0032962 | 0.0084 | 163 | 0.0085 | 1 | 4 | positive regulation of inositol trisphosphate biosynthetic process |
| GO:0045638 | 0.0095 | 14.862 | 0.1481 | 2 | 70 | negative regulation of myeloid cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0014059 | 5e-04 | 69.8042 | 0.0348 | 2 | 23 | regulation of dopamine secretion |
| GO:0006953 | 7e-04 | 58.6178 | 0.0408 | 2 | 27 | acute-phase response |
| GO:0048247 | 9e-04 | 54.2675 | 0.0438 | 2 | 29 | lymphocyte chemotaxis |
| GO:0006874 | 9e-04 | 11.1414 | 0.4443 | 4 | 294 | cellular calcium ion homeostasis |
| GO:0006022 | 0.001 | 17.4893 | 0.204 | 3 | 135 | aminoglycan metabolic process |
| GO:0015872 | 0.0011 | 47.2509 | 0.0499 | 2 | 33 | dopamine transport |
| GO:0072507 | 0.0013 | 9.946 | 0.4957 | 4 | 328 | divalent inorganic cation homeostasis |
| GO:0050432 | 0.0017 | 37.5356 | 0.062 | 2 | 41 | catecholamine secretion |
| GO:0032501 | 0.0021 | 4.3506 | 8.1729 | 15 | 5408 | multicellular organismal process |
| GO:0030593 | 0.0026 | 29.8526 | 0.0771 | 2 | 51 | neutrophil chemotaxis |
| GO:0051714 | 0.003 | 695.4211 | 0.003 | 1 | 2 | positive regulation of cytolysis in other organism |
| GO:0007204 | 0.0032 | 11.7209 | 0.3007 | 3 | 199 | positive regulation of cytosolic calcium ion concentration |
| GO:0055065 | 0.0034 | 7.5782 | 0.6438 | 4 | 426 | metal ion homeostasis |
| GO:0015844 | 0.0034 | 26.1071 | 0.0877 | 2 | 58 | monoamine transport |
| GO:0000271 | 0.0038 | 24.774 | 0.0922 | 2 | 61 | polysaccharide biosynthetic process |
| GO:0030003 | 0.0039 | 7.2922 | 0.668 | 4 | 442 | cellular cation homeostasis |
| GO:0070887 | 0.004 | 3.8581 | 3.5076 | 9 | 2321 | cellular response to chemical stimulus |
| GO:0051952 | 0.0041 | 23.5699 | 0.0967 | 2 | 64 | regulation of amine transport |
| GO:0034637 | 0.0043 | 23.194 | 0.0982 | 2 | 65 | cellular carbohydrate biosynthetic process |
| GO:0002249 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | lymphocyte anergy |
| GO:0002667 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | regulation of T cell anergy |
| GO:0045226 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | extracellular polysaccharide biosynthetic process |
| GO:0097006 | 0.0051 | 21.1675 | 0.1073 | 2 | 71 | regulation of plasma lipoprotein particle levels |
| GO:0031279 | 0.0053 | 20.5681 | 0.1103 | 2 | 73 | regulation of cyclase activity |
| GO:0051339 | 0.0056 | 20.0015 | 0.1133 | 2 | 75 | regulation of lyase activity |
| GO:0097530 | 0.0059 | 19.4652 | 0.1164 | 2 | 77 | granulocyte migration |
| GO:0009253 | 0.006 | 231.7719 | 0.006 | 1 | 4 | peptidoglycan catabolic process |
| GO:0019800 | 0.006 | 231.7719 | 0.006 | 1 | 4 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
| GO:0098967 | 0.006 | 231.7719 | 0.006 | 1 | 4 | exocytic insertion of neurotransmitter receptor to postsynaptic membrane |
| GO:0044264 | 0.0062 | 18.9567 | 0.1194 | 2 | 79 | cellular polysaccharide metabolic process |
| GO:0006828 | 0.0075 | 173.8158 | 0.0076 | 1 | 5 | manganese ion transport |
| GO:0045937 | 0.0076 | 4.8486 | 1.2921 | 5 | 855 | positive regulation of phosphate metabolic process |
| GO:0050801 | 0.0084 | 5.8004 | 0.8312 | 4 | 550 | ion homeostasis |
| GO:1903510 | 0.0085 | 16.0232 | 0.1405 | 2 | 93 | mucopolysaccharide metabolic process |
| GO:0055082 | 0.0088 | 5.7238 | 0.8418 | 4 | 557 | cellular chemical homeostasis |
| GO:0001666 | 0.0089 | 7.977 | 0.4368 | 3 | 289 | response to hypoxia |
| GO:0007195 | 0.009 | 139.0421 | 0.0091 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0035865 | 0.009 | 139.0421 | 0.0091 | 1 | 6 | cellular response to potassium ion |
| GO:0045785 | 0.0092 | 7.8923 | 0.4413 | 3 | 292 | positive regulation of cell adhesion |
| GO:0050921 | 0.0096 | 15.0252 | 0.1496 | 2 | 99 | positive regulation of chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038060 | 0.0014 | 1653 | 0.0014 | 1 | 2 | nitric oxide-cGMP-mediated signaling pathway |
| GO:0002249 | 0.002 | 826.4375 | 0.002 | 1 | 3 | lymphocyte anergy |
| GO:0002667 | 0.002 | 826.4375 | 0.002 | 1 | 3 | regulation of T cell anergy |
| GO:0021759 | 0.002 | 826.4375 | 0.002 | 1 | 3 | globus pallidus development |
| GO:0045950 | 0.0027 | 550.9167 | 0.0027 | 1 | 4 | negative regulation of mitotic recombination |
| GO:0002517 | 0.0048 | 275.3958 | 0.0048 | 1 | 7 | T cell tolerance induction |
| GO:0090026 | 0.0061 | 206.5156 | 0.0061 | 1 | 9 | positive regulation of monocyte chemotaxis |
| GO:0009642 | 0.0068 | 183.5556 | 0.0068 | 1 | 10 | response to light intensity |
| GO:0002643 | 0.0081 | 150.1591 | 0.0082 | 1 | 12 | regulation of tolerance induction |
| GO:1903818 | 0.0081 | 150.1591 | 0.0082 | 1 | 12 | positive regulation of voltage-gated potassium channel activity |
| GO:0002724 | 0.0095 | 127.0385 | 0.0095 | 1 | 14 | regulation of T cell cytokine production |
| GO:0071732 | 0.0095 | 127.0385 | 0.0095 | 1 | 14 | cellular response to nitric oxide |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016501 | 0.002 | Inf | 0.002 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.002 | Inf | 0.002 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0033791 | 0.002 | Inf | 0.002 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0038182 | 0.002 | Inf | 0.002 | 1 | 1 | G-protein coupled bile acid receptor activity |
| GO:0004174 | 0.0041 | 510 | 0.0041 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
| GO:0015333 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | peptide:proton symporter activity |
| GO:0016402 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | pristanoyl-CoA oxidase activity |
| GO:0050660 | 0.0068 | 17.901 | 0.1239 | 2 | 61 | flavin adenine dinucleotide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 2e-04 | 157.4643 | 0.0218 | 2 | 5 | molybdopterin cofactor binding |
| GO:0005201 | 0.0013 | 15.2994 | 0.2182 | 3 | 50 | extracellular matrix structural constituent |
| GO:0048037 | 0.0029 | 5.5789 | 0.9821 | 5 | 225 | cofactor binding |
| GO:0000334 | 0.0044 | Inf | 0.0044 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
| GO:0004031 | 0.0044 | Inf | 0.0044 | 1 | 1 | aldehyde oxidase activity |
| GO:0004603 | 0.0044 | Inf | 0.0044 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
| GO:0008482 | 0.0044 | Inf | 0.0044 | 1 | 1 | sulfite oxidase activity |
| GO:0061627 | 0.0044 | Inf | 0.0044 | 1 | 1 | S-methylmethionine-homocysteine S-methyltransferase activity |
| GO:0098625 | 0.0044 | Inf | 0.0044 | 1 | 1 | methylselenol reductase activity |
| GO:0098626 | 0.0044 | Inf | 0.0044 | 1 | 1 | methylseleninic acid reductase activity |
| GO:0102797 | 0.0044 | Inf | 0.0044 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0044 | Inf | 0.0044 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0009055 | 0.0061 | 8.7459 | 0.371 | 3 | 85 | electron transfer activity |
| GO:0004601 | 0.007 | 17.4643 | 0.1266 | 2 | 29 | peroxidase activity |
| GO:0003875 | 0.0087 | 232.0877 | 0.0087 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0020037 | 2e-04 | 33.8256 | 0.1097 | 3 | 81 | heme binding |
| GO:0017020 | 0.0014 | Inf | 0.0014 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0033791 | 0.0014 | Inf | 0.0014 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0004517 | 0.0027 | 780.5294 | 0.0027 | 1 | 2 | nitric-oxide synthase activity |
| GO:0050660 | 0.003 | 27.9894 | 0.0826 | 2 | 61 | flavin adenine dinucleotide binding |
| GO:0002950 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | ceramide phosphoethanolamine synthase activity |
| GO:0016402 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | pristanoyl-CoA oxidase activity |
| GO:0033188 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | sphingomyelin synthase activity |
| GO:0034617 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | tetrahydrobiopterin binding |
| GO:0047493 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | ceramide cholinephosphotransferase activity |
| GO:0003958 | 0.0068 | 195.0882 | 0.0068 | 1 | 5 | NADPH-hemoprotein reductase activity |
| GO:0004966 | 0.0068 | 195.0882 | 0.0068 | 1 | 5 | galanin receptor activity |
| GO:0034618 | 0.0068 | 195.0882 | 0.0068 | 1 | 5 | arginine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005147 | 0.0018 | Inf | 0.0018 | 1 | 1 | oncostatin-M receptor binding |
| GO:0047747 | 0.0018 | Inf | 0.0018 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0018 | Inf | 0.0018 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0005153 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | interleukin-8 receptor binding |
| GO:0005094 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0015501 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | glutamate:sodium symporter activity |
| GO:0017034 | 0.0072 | 192.1884 | 0.0072 | 1 | 4 | Rap guanyl-nucleotide exchange factor activity |
| GO:0005096 | 0.0075 | 8.3543 | 0.4082 | 3 | 226 | GTPase activator activity |
| GO:0098772 | 0.0086 | 3.6101 | 2.4654 | 7 | 1365 | molecular function regulator |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031732 | 0.0023 | Inf | 0.0023 | 1 | 1 | CCR7 chemokine receptor binding |
| GO:0038182 | 0.0023 | Inf | 0.0023 | 1 | 1 | G-protein coupled bile acid receptor activity |
| GO:0005085 | 0.0041 | 6.8661 | 0.6626 | 4 | 284 | guanyl-nucleotide exchange factor activity |
| GO:0003873 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | 6-phosphofructo-2-kinase activity |
| GO:0004063 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | aryldialkylphosphatase activity |
| GO:0005412 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | glucose:sodium symporter activity |
| GO:0047894 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | flavonol 3-sulfotransferase activity |
| GO:0005543 | 0.0055 | 6.2912 | 0.7209 | 4 | 309 | phospholipid binding |
| GO:0004331 | 0.007 | 220.9167 | 0.007 | 1 | 3 | fructose-2,6-bisphosphate 2-phosphatase activity |
| GO:0008823 | 0.007 | 220.9167 | 0.007 | 1 | 3 | cupric reductase activity |
| GO:0052851 | 0.007 | 220.9167 | 0.007 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0102007 | 0.007 | 220.9167 | 0.007 | 1 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
| GO:0004984 | 0.007 | 17.5133 | 0.126 | 2 | 54 | olfactory receptor activity |
| GO:0001591 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0005176 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | ErbB-2 class receptor binding |
| GO:0043125 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | ErbB-3 class receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001965 | 0.0016 | 39.8854 | 0.0598 | 2 | 15 | G-protein alpha-subunit binding |
| GO:0004364 | 0.0018 | 37.0336 | 0.0638 | 2 | 16 | glutathione transferase activity |
| GO:0031716 | 0.004 | Inf | 0.004 | 1 | 1 | calcitonin receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004842 | 8e-04 | 12.1404 | 0.4402 | 4 | 390 | ubiquitin-protein transferase activity |
| GO:0018169 | 0.0011 | Inf | 0.0011 | 1 | 1 | ribosomal S6-glutamic acid ligase activity |
| GO:0043739 | 0.0011 | Inf | 0.0011 | 1 | 1 | G/U mismatch-specific uracil-DNA glycosylase activity |
| GO:0004750 | 0.0023 | 948 | 0.0023 | 1 | 2 | ribulose-phosphate 3-epimerase activity |
| GO:0004996 | 0.0023 | 948 | 0.0023 | 1 | 2 | thyroid-stimulating hormone receptor activity |
| GO:0000700 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | mismatch base pair DNA N-glycosylase activity |
| GO:0005280 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | hydrogen:amino acid symporter activity |
| GO:0051431 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
| GO:0097506 | 0.0056 | 236.9464 | 0.0056 | 1 | 5 | deaminated base DNA N-glycosylase activity |
| GO:0005314 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | high-affinity glutamate transmembrane transporter activity |
| GO:0019788 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | NEDD8 transferase activity |
| GO:0031404 | 0.0079 | 157.9405 | 0.0079 | 1 | 7 | chloride ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004953 | 4e-04 | 90.0476 | 0.0298 | 2 | 9 | icosanoid receptor activity |
| GO:0001632 | 0.0033 | Inf | 0.0033 | 1 | 1 | leukotriene B4 receptor activity |
| GO:0004946 | 0.0033 | Inf | 0.0033 | 1 | 1 | bombesin receptor activity |
| GO:0005147 | 0.0033 | Inf | 0.0033 | 1 | 1 | oncostatin-M receptor binding |
| GO:0016501 | 0.0033 | Inf | 0.0033 | 1 | 1 | prostacyclin receptor activity |
| GO:0031370 | 0.0033 | Inf | 0.0033 | 1 | 1 | eukaryotic initiation factor 4G binding |
| GO:0036403 | 0.0033 | Inf | 0.0033 | 1 | 1 | arachidonate 8(S)-lipoxygenase activity |
| GO:0045029 | 0.0033 | Inf | 0.0033 | 1 | 1 | UDP-activated nucleotide receptor activity |
| GO:0071553 | 0.0033 | Inf | 0.0033 | 1 | 1 | G-protein coupled pyrimidinergic nucleotide receptor activity |
| GO:1903924 | 0.0033 | Inf | 0.0033 | 1 | 1 | estradiol binding |
| GO:0004365 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
| GO:0016165 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0017018 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | myosin phosphatase activity |
| GO:0070401 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | NADP+ binding |
| GO:0008374 | 0.007 | 17.4709 | 0.1258 | 2 | 38 | O-acyltransferase activity |
| GO:0004321 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | fatty-acyl-CoA synthase activity |
| GO:0047192 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 1-alkylglycerophosphocholine O-acetyltransferase activity |
| GO:0050473 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | arachidonate 15-lipoxygenase activity |
| GO:1990599 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 3' overhang single-stranded DNA endodeoxyribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033560 | 0.0036 | Inf | 0.0036 | 1 | 1 | folate reductase activity |
| GO:0000406 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004119 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GO:0004146 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | dihydrofolate reductase activity |
| GO:0005223 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | intracellular cGMP activated cation channel activity |
| GO:0032142 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0036461 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | BLOC-2 complex binding |
| GO:0051870 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | methotrexate binding |
| GO:0070735 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | protein-glycine ligase activity |
| GO:0043168 | 0.009 | 2.2872 | 7.9831 | 15 | 2210 | anion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030676 | 6e-04 | 68.9688 | 0.0358 | 2 | 14 | Rac guanyl-nucleotide exchange factor activity |
| GO:0008009 | 0.0011 | 48.6654 | 0.0486 | 2 | 19 | chemokine activity |
| GO:0046906 | 0.0014 | 14.9932 | 0.2252 | 3 | 88 | tetrapyrrole binding |
| GO:0005115 | 0.0026 | Inf | 0.0026 | 1 | 1 | receptor tyrosine kinase-like orphan receptor binding |
| GO:0032500 | 0.0026 | Inf | 0.0026 | 1 | 1 | muramyl dipeptide binding |
| GO:0048248 | 0.0026 | Inf | 0.0026 | 1 | 1 | CXCR3 chemokine receptor binding |
| GO:1902379 | 0.0026 | Inf | 0.0026 | 1 | 1 | chemoattractant activity involved in axon guidance |
| GO:0004980 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
| GO:0005110 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | frizzled-2 binding |
| GO:0008502 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | melatonin receptor activity |
| GO:0005539 | 0.0054 | 9.2656 | 0.3582 | 3 | 140 | glycosaminoglycan binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 2e-04 | 5.7782 | 1.6568 | 8 | 512 | calcium ion binding |
| GO:0009400 | 0.0032 | Inf | 0.0032 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
| GO:0052593 | 0.0032 | Inf | 0.0032 | 1 | 1 | tryptamine:oxygen oxidoreductase (deaminating) activity |
| GO:0052594 | 0.0032 | Inf | 0.0032 | 1 | 1 | aminoacetone:oxygen oxidoreductase(deaminating) activity |
| GO:0052595 | 0.0032 | Inf | 0.0032 | 1 | 1 | aliphatic-amine oxidase activity |
| GO:0052596 | 0.0032 | Inf | 0.0032 | 1 | 1 | phenethylamine:oxygen oxidoreductase (deaminating) activity |
| GO:0019894 | 0.0063 | 18.4111 | 0.1197 | 2 | 37 | kinesin binding |
| GO:0004063 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | aryldialkylphosphatase activity |
| GO:0004332 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | fructose-bisphosphate aldolase activity |
| GO:0008131 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | primary amine oxidase activity |
| GO:0005507 | 0.007 | 17.4133 | 0.1262 | 2 | 39 | copper ion binding |
| GO:0043565 | 0.0079 | 3.1352 | 2.9383 | 8 | 908 | sequence-specific DNA binding |
| GO:0102007 | 0.0097 | 157.6548 | 0.0097 | 1 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031700 | 0.002 | Inf | 0.002 | 1 | 1 | adrenomedullin receptor binding |
| GO:0042922 | 0.002 | Inf | 0.002 | 1 | 1 | neuromedin U receptor binding |
| GO:0016603 | 0.0041 | 510 | 0.0041 | 1 | 2 | glutaminyl-peptide cyclotransferase activity |
| GO:0018479 | 0.0041 | 510 | 0.0041 | 1 | 2 | benzaldehyde dehydrogenase (NAD+) activity |
| GO:0008823 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | cupric reductase activity |
| GO:0019958 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | C-X-C chemokine binding |
| GO:0052851 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0004028 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0005176 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | ErbB-2 class receptor binding |
| GO:0043125 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | ErbB-3 class receptor binding |
| GO:0047756 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | chondroitin 4-sulfotransferase activity |
| GO:0019905 | 0.0081 | 16.2412 | 0.1361 | 2 | 67 | syntaxin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 4e-04 | 6.0928 | 1.3871 | 7 | 512 | calcium ion binding |
| GO:0004421 | 0.0027 | Inf | 0.0027 | 1 | 1 | hydroxymethylglutaryl-CoA synthase activity |
| GO:0050661 | 0.004 | 23.5633 | 0.0948 | 2 | 35 | NADP binding |
| GO:0003826 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | alpha-ketoacid dehydrogenase activity |
| GO:0003863 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity |
| GO:0004096 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | catalase activity |
| GO:0004558 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | alpha-1,4-glucosidase activity |
| GO:0005135 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | interleukin-3 receptor binding |
| GO:0032450 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | maltose alpha-glucosidase activity |
| GO:0001588 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0003960 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | NADPH:quinone reductase activity |
| GO:0004321 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | fatty-acyl-CoA synthase activity |
| GO:0015143 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | urate transmembrane transporter activity |
| GO:0071987 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | WD40-repeat domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050429 | 0.0032 | Inf | 0.0032 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0070002 | 0.0032 | Inf | 0.0032 | 1 | 1 | glutamic-type peptidase activity |
| GO:0004911 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | interleukin-2 receptor activity |
| GO:0005412 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | glucose:sodium symporter activity |
| GO:0019976 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | interleukin-2 binding |
| GO:0047844 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | deoxycytidine deaminase activity |
| GO:0008083 | 0.0065 | 8.563 | 0.3818 | 3 | 118 | growth factor activity |
| GO:0005160 | 0.007 | 17.4133 | 0.1262 | 2 | 39 | transforming growth factor beta receptor binding |
| GO:0005125 | 0.0071 | 8.2727 | 0.3948 | 3 | 122 | cytokine activity |
| GO:0004464 | 0.0097 | 157.6548 | 0.0097 | 1 | 3 | leukotriene-C4 synthase activity |
| GO:0005127 | 0.0097 | 157.6548 | 0.0097 | 1 | 3 | ciliary neurotrophic factor receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000048 | 0.0029 | Inf | 0.0029 | 1 | 1 | peptidyltransferase activity |
| GO:0002951 | 0.0029 | Inf | 0.0029 | 1 | 1 | leukotriene-C(4) hydrolase |
| GO:0004102 | 0.0029 | Inf | 0.0029 | 1 | 1 | choline O-acetyltransferase activity |
| GO:0016501 | 0.0029 | Inf | 0.0029 | 1 | 1 | prostacyclin receptor activity |
| GO:0030977 | 0.0029 | Inf | 0.0029 | 1 | 1 | taurine binding |
| GO:0005412 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | glucose:sodium symporter activity |
| GO:0005427 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
| GO:0008502 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | melatonin receptor activity |
| GO:0016934 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | extracellularly glycine-gated chloride channel activity |
| GO:0043199 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | sulfate binding |
| GO:0102953 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | hypoglycin A gamma-glutamyl transpeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003957 | 0.0017 | Inf | 0.0017 | 1 | 1 | NAD(P)+ transhydrogenase (B-specific) activity |
| GO:0008750 | 0.0017 | Inf | 0.0017 | 1 | 1 | NAD(P)+ transhydrogenase (AB-specific) activity |
| GO:0016652 | 0.0017 | Inf | 0.0017 | 1 | 1 | oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor |
| GO:0030246 | 0.0031 | 11.6762 | 0.298 | 3 | 180 | carbohydrate binding |
| GO:0030883 | 0.0033 | 631.6667 | 0.0033 | 1 | 2 | endogenous lipid antigen binding |
| GO:0030884 | 0.0033 | 631.6667 | 0.0033 | 1 | 2 | exogenous lipid antigen binding |
| GO:0004321 | 0.005 | 315.8095 | 0.005 | 1 | 3 | fatty-acyl-CoA synthase activity |
| GO:0008048 | 0.005 | 315.8095 | 0.005 | 1 | 3 | calcium sensitive guanylate cyclase activator activity |
| GO:0008745 | 0.005 | 315.8095 | 0.005 | 1 | 3 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:1905576 | 0.005 | 315.8095 | 0.005 | 1 | 3 | ganglioside GT1b binding |
| GO:0003996 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | acyl-CoA ligase activity |
| GO:0016019 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | peptidoglycan receptor activity |
| GO:0032190 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | acrosin binding |
| GO:0047760 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | butyrate-CoA ligase activity |
| GO:0071723 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | lipopeptide binding |
| GO:0010853 | 0.0083 | 157.881 | 0.0083 | 1 | 5 | cyclase activator activity |
| GO:0042834 | 0.0083 | 157.881 | 0.0083 | 1 | 5 | peptidoglycan binding |
| GO:0050733 | 0.0083 | 157.881 | 0.0083 | 1 | 5 | RS domain binding |
| GO:0030249 | 0.0099 | 126.2952 | 0.0099 | 1 | 6 | guanylate cyclase regulator activity |
| GO:0030881 | 0.0099 | 126.2952 | 0.0099 | 1 | 6 | beta-2-microglobulin binding |
| GO:0043208 | 0.0099 | 126.2952 | 0.0099 | 1 | 6 | glycosphingolipid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004603 | 0.0041 | Inf | 0.0041 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
| GO:0003873 | 0.0083 | 245.037 | 0.0083 | 1 | 2 | 6-phosphofructo-2-kinase activity |
| GO:0016603 | 0.0083 | 245.037 | 0.0083 | 1 | 2 | glutaminyl-peptide cyclotransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005201 | 1e-04 | 20.1083 | 0.2295 | 4 | 50 | extracellular matrix structural constituent |
| GO:0043546 | 2e-04 | 149.4237 | 0.023 | 2 | 5 | molybdopterin cofactor binding |
| GO:0048037 | 0.0037 | 5.2788 | 1.0329 | 5 | 225 | cofactor binding |
| GO:0000334 | 0.0046 | Inf | 0.0046 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
| GO:0001567 | 0.0046 | Inf | 0.0046 | 1 | 1 | cholesterol 25-hydroxylase activity |
| GO:0004031 | 0.0046 | Inf | 0.0046 | 1 | 1 | aldehyde oxidase activity |
| GO:0004042 | 0.0046 | Inf | 0.0046 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0004603 | 0.0046 | Inf | 0.0046 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
| GO:0008482 | 0.0046 | Inf | 0.0046 | 1 | 1 | sulfite oxidase activity |
| GO:0061627 | 0.0046 | Inf | 0.0046 | 1 | 1 | S-methylmethionine-homocysteine S-methyltransferase activity |
| GO:0098625 | 0.0046 | Inf | 0.0046 | 1 | 1 | methylselenol reductase activity |
| GO:0098626 | 0.0046 | Inf | 0.0046 | 1 | 1 | methylseleninic acid reductase activity |
| GO:0102797 | 0.0046 | Inf | 0.0046 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0046 | Inf | 0.0046 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0103045 | 0.0046 | Inf | 0.0046 | 1 | 1 | methione N-acyltransferase activity |
| GO:0009055 | 0.007 | 8.2916 | 0.3902 | 3 | 85 | electron transfer activity |
| GO:0004601 | 0.0078 | 16.5725 | 0.1331 | 2 | 29 | peroxidase activity |
| GO:0003875 | 0.0092 | 220.4333 | 0.0092 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016501 | 0.0017 | Inf | 0.0017 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.0017 | Inf | 0.0017 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0033791 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0004174 | 0.0033 | 631.6667 | 0.0033 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
| GO:0050660 | 0.0045 | 22.3847 | 0.101 | 2 | 61 | flavin adenine dinucleotide binding |
| GO:0016402 | 0.005 | 315.8095 | 0.005 | 1 | 3 | pristanoyl-CoA oxidase activity |
| GO:0020037 | 0.0078 | 16.6924 | 0.1341 | 2 | 81 | heme binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005147 | 0.0018 | Inf | 0.0018 | 1 | 1 | oncostatin-M receptor binding |
| GO:0047747 | 0.0018 | Inf | 0.0018 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0018 | Inf | 0.0018 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0005153 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | interleukin-8 receptor binding |
| GO:0005094 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0015501 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | glutamate:sodium symporter activity |
| GO:0017034 | 0.0072 | 192.1884 | 0.0072 | 1 | 4 | Rap guanyl-nucleotide exchange factor activity |
| GO:0005096 | 0.0075 | 8.3543 | 0.4082 | 3 | 226 | GTPase activator activity |
| GO:0098772 | 0.0086 | 3.6101 | 2.4654 | 7 | 1365 | molecular function regulator |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047305 | 8e-04 | Inf | 8e-04 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0008453 | 0.0025 | 663.75 | 0.0025 | 1 | 3 | alanine-glyoxylate transaminase activity |
| GO:0097153 | 0.0083 | 147.4222 | 0.0083 | 1 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0008093 | 0.0091 | 132.67 | 0.0091 | 1 | 11 | cytoskeletal adaptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004042 | 0.0034 | Inf | 0.0034 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0005147 | 0.0034 | Inf | 0.0034 | 1 | 1 | oncostatin-M receptor binding |
| GO:0047747 | 0.0034 | Inf | 0.0034 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0034 | Inf | 0.0034 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0098625 | 0.0034 | Inf | 0.0034 | 1 | 1 | methylselenol reductase activity |
| GO:0098626 | 0.0034 | Inf | 0.0034 | 1 | 1 | methylseleninic acid reductase activity |
| GO:0103045 | 0.0034 | Inf | 0.0034 | 1 | 1 | methione N-acyltransferase activity |
| GO:0030414 | 0.0039 | 10.3234 | 0.3183 | 3 | 94 | peptidase inhibitor activity |
| GO:0098772 | 0.0049 | 2.8408 | 4.6226 | 11 | 1365 | molecular function regulator |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017020 | 0.0017 | Inf | 0.0017 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0004517 | 0.0035 | 602.9091 | 0.0035 | 1 | 2 | nitric-oxide synthase activity |
| GO:0070891 | 0.0035 | 602.9091 | 0.0035 | 1 | 2 | lipoteichoic acid binding |
| GO:0034617 | 0.0052 | 301.4318 | 0.0052 | 1 | 3 | tetrahydrobiopterin binding |
| GO:0071723 | 0.0069 | 200.9394 | 0.0069 | 1 | 4 | lipopeptide binding |
| GO:1903231 | 0.0081 | 16.3117 | 0.1367 | 2 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0020037 | 0.0085 | 15.8963 | 0.1402 | 2 | 81 | heme binding |
| GO:0003958 | 0.0086 | 150.6932 | 0.0087 | 1 | 5 | NADPH-hemoprotein reductase activity |
| GO:0034618 | 0.0086 | 150.6932 | 0.0087 | 1 | 5 | arginine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016501 | 0.002 | Inf | 0.002 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.002 | Inf | 0.002 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0033791 | 0.002 | Inf | 0.002 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0038182 | 0.002 | Inf | 0.002 | 1 | 1 | G-protein coupled bile acid receptor activity |
| GO:0004174 | 0.0041 | 510 | 0.0041 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
| GO:0015333 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | peptide:proton symporter activity |
| GO:0016402 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | pristanoyl-CoA oxidase activity |
| GO:0050660 | 0.0068 | 17.901 | 0.1239 | 2 | 61 | flavin adenine dinucleotide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047305 | 0.0013 | Inf | 0.0013 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0004750 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | ribulose-phosphate 3-epimerase activity |
| GO:0008453 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | alanine-glyoxylate transaminase activity |
| GO:0050544 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | arachidonic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001594 | 0.0011 | Inf | 0.0011 | 1 | 1 | trace-amine receptor activity |
| GO:0005477 | 0.0011 | Inf | 0.0011 | 1 | 1 | pyruvate secondary active transmembrane transporter activity |
| GO:0036105 | 0.0011 | Inf | 0.0011 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
| GO:0003873 | 0.0023 | 948 | 0.0023 | 1 | 2 | 6-phosphofructo-2-kinase activity |
| GO:0004331 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | fructose-2,6-bisphosphate 2-phosphatase activity |
| GO:0000268 | 0.0045 | 315.9524 | 0.0045 | 1 | 4 | peroxisome targeting sequence binding |
| GO:0015129 | 0.0045 | 315.9524 | 0.0045 | 1 | 4 | lactate transmembrane transporter activity |
| GO:0004931 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | extracellularly ATP-gated cation channel activity |
| GO:0019203 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | carbohydrate phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004364 | 0.001 | 49.7519 | 0.0482 | 2 | 16 | glutathione transferase activity |
| GO:0001635 | 0.003 | Inf | 0.003 | 1 | 1 | calcitonin gene-related peptide receptor activity |
| GO:0003837 | 0.003 | Inf | 0.003 | 1 | 1 | beta-ureidopropionase activity |
| GO:0004946 | 0.003 | Inf | 0.003 | 1 | 1 | bombesin receptor activity |
| GO:0031732 | 0.003 | Inf | 0.003 | 1 | 1 | CCR7 chemokine receptor binding |
| GO:0001784 | 0.0041 | 23.1895 | 0.0963 | 2 | 32 | phosphotyrosine residue binding |
| GO:0008374 | 0.0058 | 19.3158 | 0.1144 | 2 | 38 | O-acyltransferase activity |
| GO:0004365 | 0.006 | 339.6667 | 0.006 | 1 | 2 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
| GO:0005080 | 0.0061 | 18.7923 | 0.1174 | 2 | 39 | protein kinase C binding |
| GO:0030971 | 0.0084 | 15.7943 | 0.1385 | 2 | 46 | receptor tyrosine kinase binding |
| GO:0004321 | 0.009 | 169.8205 | 0.009 | 1 | 3 | fatty-acyl-CoA synthase activity |
| GO:0008823 | 0.009 | 169.8205 | 0.009 | 1 | 3 | cupric reductase activity |
| GO:0047192 | 0.009 | 169.8205 | 0.009 | 1 | 3 | 1-alkylglycerophosphocholine O-acetyltransferase activity |
| GO:0052851 | 0.009 | 169.8205 | 0.009 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033791 | 0.0013 | Inf | 0.0013 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0016402 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | pristanoyl-CoA oxidase activity |
| GO:0032190 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | acrosin binding |
| GO:0099104 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | potassium channel activator activity |
| GO:0042608 | 0.0077 | 165.825 | 0.0077 | 1 | 6 | T cell receptor binding |
| GO:0008201 | 0.0081 | 16.7187 | 0.1369 | 2 | 107 | heparin binding |
| GO:0004252 | 0.0096 | 15.2533 | 0.1497 | 2 | 117 | serine-type endopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008389 | 0.0014 | Inf | 0.0014 | 1 | 1 | coumarin 7-hydroxylase activity |
| GO:0052593 | 0.0014 | Inf | 0.0014 | 1 | 1 | tryptamine:oxygen oxidoreductase (deaminating) activity |
| GO:0052594 | 0.0014 | Inf | 0.0014 | 1 | 1 | aminoacetone:oxygen oxidoreductase(deaminating) activity |
| GO:0052595 | 0.0014 | Inf | 0.0014 | 1 | 1 | aliphatic-amine oxidase activity |
| GO:0052596 | 0.0014 | Inf | 0.0014 | 1 | 1 | phenethylamine:oxygen oxidoreductase (deaminating) activity |
| GO:0004047 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | aminomethyltransferase activity |
| GO:0008131 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | primary amine oxidase activity |
| GO:0071987 | 0.0043 | 368.5278 | 0.0043 | 1 | 3 | WD40-repeat domain binding |
| GO:0008392 | 0.0086 | 147.3778 | 0.0086 | 1 | 6 | arachidonic acid epoxygenase activity |
| GO:0055056 | 0.01 | 122.8056 | 0.01 | 1 | 7 | D-glucose transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001228 | 0.0022 | 6.1806 | 0.9298 | 5 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0030251 | 0.0026 | Inf | 0.0026 | 1 | 1 | guanylate cyclase inhibitor activity |
| GO:0031732 | 0.0026 | Inf | 0.0026 | 1 | 1 | CCR7 chemokine receptor binding |
| GO:0030550 | 0.0079 | 194.8676 | 0.0079 | 1 | 3 | acetylcholine receptor inhibitor activity |
| GO:0000979 | 0.0079 | 16.3315 | 0.1343 | 2 | 51 | RNA polymerase II core promoter sequence-specific DNA binding |
| GO:0043565 | 0.0085 | 3.4273 | 2.3916 | 7 | 908 | sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047305 | 0.0021 | Inf | 0.0021 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0008453 | 0.0063 | 245.5185 | 0.0063 | 1 | 3 | alanine-glyoxylate transaminase activity |
| GO:0015143 | 0.0063 | 245.5185 | 0.0063 | 1 | 3 | urate transmembrane transporter activity |
| GO:0019958 | 0.0063 | 245.5185 | 0.0063 | 1 | 3 | C-X-C chemokine binding |
| GO:0001733 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0015057 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | thrombin-activated receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005338 | 1e-04 | 169.9231 | 0.0169 | 2 | 8 | nucleotide-sugar transmembrane transporter activity |
| GO:0005459 | 0.0021 | Inf | 0.0021 | 1 | 1 | UDP-galactose transmembrane transporter activity |
| GO:0050051 | 0.0021 | Inf | 0.0021 | 1 | 1 | leukotriene-B4 20-monooxygenase activity |
| GO:0052871 | 0.0021 | Inf | 0.0021 | 1 | 1 | alpha-tocopherol omega-hydroxylase activity |
| GO:0097258 | 0.0021 | Inf | 0.0021 | 1 | 1 | 20-hydroxy-leukotriene B4 omega oxidase activity |
| GO:0097259 | 0.0021 | Inf | 0.0021 | 1 | 1 | 20-aldehyde-leukotriene B4 20-monooxygenase activity |
| GO:0004980 | 0.0042 | 491.0741 | 0.0042 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
| GO:0005412 | 0.0042 | 491.0741 | 0.0042 | 1 | 2 | glucose:sodium symporter activity |
| GO:0005427 | 0.0042 | 491.0741 | 0.0042 | 1 | 2 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
| GO:0008020 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | G-protein coupled photoreceptor activity |
| GO:0035673 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | oligopeptide transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005539 | 0.0063 | 8.7027 | 0.3793 | 3 | 140 | glycosaminoglycan binding |
| GO:0005201 | 0.0081 | 16.1814 | 0.1355 | 2 | 50 | extracellular matrix structural constituent |
| GO:0031013 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | troponin I binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003944 | 0.002 | Inf | 0.002 | 1 | 1 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity |
| GO:0051424 | 0.002 | Inf | 0.002 | 1 | 1 | corticotropin-releasing hormone binding |
| GO:0005135 | 0.0039 | 530.44 | 0.0039 | 1 | 2 | interleukin-3 receptor binding |
| GO:0050544 | 0.0078 | 176.7867 | 0.0078 | 1 | 4 | arachidonic acid binding |
| GO:0070290 | 0.0078 | 176.7867 | 0.0078 | 1 | 4 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO:0004630 | 0.0097 | 132.58 | 0.0098 | 1 | 5 | phospholipase D activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005115 | 0.0019 | Inf | 0.0019 | 1 | 1 | receptor tyrosine kinase-like orphan receptor binding |
| GO:0039552 | 0.0019 | Inf | 0.0019 | 1 | 1 | RIG-I binding |
| GO:0070002 | 0.0019 | Inf | 0.0019 | 1 | 1 | glutamic-type peptidase activity |
| GO:1902379 | 0.0019 | Inf | 0.0019 | 1 | 1 | chemoattractant activity involved in axon guidance |
| GO:0005105 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | type 1 fibroblast growth factor receptor binding |
| GO:0005110 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | frizzled-2 binding |
| GO:0008017 | 0.0054 | 9.4329 | 0.3612 | 3 | 192 | microtubule binding |
| GO:0005111 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | type 2 fibroblast growth factor receptor binding |
| GO:0015386 | 0.0094 | 138.1146 | 0.0094 | 1 | 5 | potassium:proton antiporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004364 | 4e-04 | 82.2919 | 0.0301 | 2 | 16 | glutathione transferase activity |
| GO:0004769 | 0.0019 | Inf | 0.0019 | 1 | 1 | steroid delta-isomerase activity |
| GO:0015603 | 0.0019 | Inf | 0.0019 | 1 | 1 | iron chelate transmembrane transporter activity |
| GO:0042931 | 0.0019 | Inf | 0.0019 | 1 | 1 | enterobactin transmembrane transporter activity |
| GO:0102294 | 0.0019 | Inf | 0.0019 | 1 | 1 | cholesterol dehydrogenase activity |
| GO:0044736 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | acid-sensing ion channel activity |
| GO:0004872 | 0.0046 | 4.5374 | 1.6349 | 6 | 869 | receptor activity |
| GO:0003854 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GO:0099094 | 0.0062 | 18.8197 | 0.1185 | 2 | 63 | ligand-gated cation channel activity |
| GO:0032190 | 0.0075 | 184.1667 | 0.0075 | 1 | 4 | acrosin binding |
| GO:0001602 | 0.0094 | 138.1146 | 0.0094 | 1 | 5 | pancreatic polypeptide receptor activity |
| GO:0004969 | 0.0094 | 138.1146 | 0.0094 | 1 | 5 | histamine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001632 | 0.0035 | Inf | 0.0035 | 1 | 1 | leukotriene B4 receptor activity |
| GO:0004825 | 0.0069 | 294.2444 | 0.0069 | 1 | 2 | methionine-tRNA ligase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008201 | 5e-04 | 22.3371 | 0.161 | 3 | 107 | heparin binding |
| GO:0004507 | 0.0015 | Inf | 0.0015 | 1 | 1 | steroid 11-beta-monooxygenase activity |
| GO:0047783 | 0.0015 | Inf | 0.0015 | 1 | 1 | corticosterone 18-monooxygenase activity |
| GO:0070405 | 0.0023 | 31.9372 | 0.0722 | 2 | 48 | ammonium ion binding |
| GO:0005135 | 0.003 | 698.2632 | 0.003 | 1 | 2 | interleukin-3 receptor binding |
| GO:0030594 | 0.0035 | 25.7524 | 0.0888 | 2 | 59 | neurotransmitter receptor activity |
| GO:0008048 | 0.0045 | 349.1053 | 0.0045 | 1 | 3 | calcium sensitive guanylate cyclase activator activity |
| GO:0008745 | 0.0045 | 349.1053 | 0.0045 | 1 | 3 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0001591 | 0.006 | 232.7193 | 0.006 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0016019 | 0.006 | 232.7193 | 0.006 | 1 | 4 | peptidoglycan receptor activity |
| GO:0050501 | 0.006 | 232.7193 | 0.006 | 1 | 4 | hyaluronan synthase activity |
| GO:0050544 | 0.006 | 232.7193 | 0.006 | 1 | 4 | arachidonic acid binding |
| GO:0010853 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | cyclase activator activity |
| GO:0042834 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | peptidoglycan binding |
| GO:0048018 | 0.0083 | 8.1857 | 0.4259 | 3 | 283 | receptor ligand activity |
| GO:0030414 | 0.0087 | 15.913 | 0.1415 | 2 | 94 | peptidase inhibitor activity |
| GO:0030249 | 0.009 | 139.6105 | 0.009 | 1 | 6 | guanylate cyclase regulator activity |
| GO:0070679 | 0.009 | 139.6105 | 0.009 | 1 | 6 | inositol 1,4,5 trisphosphate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097153 | 0.0068 | 184.3056 | 0.0068 | 1 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0048020 | 0.0088 | 138.1979 | 0.0088 | 1 | 13 | CCR chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005147 | 0.0016 | Inf | 0.0016 | 1 | 1 | oncostatin-M receptor binding |
| GO:0047747 | 0.0016 | Inf | 0.0016 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0016 | Inf | 0.0016 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0005094 | 0.0047 | 331.625 | 0.0047 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0015501 | 0.0047 | 331.625 | 0.0047 | 1 | 3 | glutamate:sodium symporter activity |
| GO:0005096 | 0.0051 | 9.7489 | 0.3572 | 3 | 226 | GTPase activator activity |
| GO:0017034 | 0.0063 | 221.0667 | 0.0063 | 1 | 4 | Rap guanyl-nucleotide exchange factor activity |
| GO:0005314 | 0.0094 | 132.62 | 0.0095 | 1 | 6 | high-affinity glutamate transmembrane transporter activity |
| GO:0070679 | 0.0094 | 132.62 | 0.0095 | 1 | 6 | inositol 1,4,5 trisphosphate binding |
| GO:0060589 | 0.0098 | 7.6466 | 0.452 | 3 | 286 | nucleoside-triphosphatase regulator activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048646 | 0 | 2.8712 | 13.5076 | 34 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0003002 | 0 | 4.1941 | 4.4932 | 17 | 321 | regionalization |
| GO:0060485 | 0 | 4.794 | 3.2334 | 14 | 231 | mesenchyme development |
| GO:0072359 | 0 | 2.6029 | 12.8637 | 30 | 919 | circulatory system development |
| GO:0009792 | 0 | 3.0105 | 7.6566 | 21 | 547 | embryo development ending in birth or egg hatching |
| GO:0001944 | 0 | 2.839 | 8.4965 | 22 | 607 | vasculature development |
| GO:0048856 | 1e-04 | 1.742 | 71.4152 | 99 | 5149 | anatomical structure development |
| GO:2001199 | 1e-04 | 71.4333 | 0.084 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0035909 | 1e-04 | 12.413 | 0.4759 | 5 | 34 | aorta morphogenesis |
| GO:0051240 | 1e-04 | 2.1086 | 19.0174 | 36 | 1389 | positive regulation of multicellular organismal process |
| GO:0008284 | 1e-04 | 2.4382 | 11.212 | 25 | 801 | positive regulation of cell proliferation |
| GO:0048562 | 1e-04 | 3.6292 | 3.8773 | 13 | 277 | embryonic organ morphogenesis |
| GO:0048514 | 3e-04 | 2.7516 | 7.0687 | 18 | 505 | blood vessel morphogenesis |
| GO:0045165 | 3e-04 | 4.1705 | 2.5918 | 10 | 189 | cell fate commitment |
| GO:0001655 | 4e-04 | 3.298 | 4.2412 | 13 | 303 | urogenital system development |
| GO:0060037 | 4e-04 | 13.655 | 0.3499 | 4 | 25 | pharyngeal system development |
| GO:0035050 | 5e-04 | 6.5604 | 1.0078 | 6 | 72 | embryonic heart tube development |
| GO:0055014 | 6e-04 | 142.2085 | 0.042 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0060741 | 6e-04 | 142.2085 | 0.042 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0021879 | 6e-04 | 8.1731 | 0.6859 | 5 | 49 | forebrain neuron differentiation |
| GO:0060415 | 6e-04 | 6.2739 | 1.0498 | 6 | 75 | muscle tissue morphogenesis |
| GO:0090596 | 6e-04 | 3.4673 | 3.4014 | 11 | 243 | sensory organ morphogenesis |
| GO:0043066 | 7e-04 | 2.2532 | 11.03 | 23 | 788 | negative regulation of apoptotic process |
| GO:2000026 | 9e-04 | 2.1692 | 12.0325 | 24 | 912 | regulation of multicellular organismal development |
| GO:0060562 | 0.001 | 3.0723 | 4.1713 | 12 | 298 | epithelial tube morphogenesis |
| GO:0010660 | 0.0011 | 7.048 | 0.7839 | 5 | 56 | regulation of muscle cell apoptotic process |
| GO:0048665 | 0.0011 | 9.8829 | 0.4619 | 4 | 33 | neuron fate specification |
| GO:0021764 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | amygdala development |
| GO:0072107 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0090191 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905205 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:0001947 | 0.0012 | 6.912 | 0.7979 | 5 | 57 | heart looping |
| GO:0007498 | 0.0014 | 4.5592 | 1.6517 | 7 | 118 | mesoderm development |
| GO:0060548 | 0.0014 | 2.0936 | 12.3458 | 24 | 882 | negative regulation of cell death |
| GO:0010665 | 0.0014 | 9.244 | 0.4899 | 4 | 35 | regulation of cardiac muscle cell apoptotic process |
| GO:0048738 | 0.0014 | 3.613 | 2.6595 | 9 | 190 | cardiac muscle tissue development |
| GO:0045944 | 0.0015 | 1.9964 | 14.6134 | 27 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0030858 | 0.0015 | 6.5337 | 0.8399 | 5 | 60 | positive regulation of epithelial cell differentiation |
| GO:0071542 | 0.0015 | 8.9545 | 0.5039 | 4 | 36 | dopaminergic neuron differentiation |
| GO:0048706 | 0.0016 | 4.4383 | 1.6937 | 7 | 121 | embryonic skeletal system development |
| GO:1903707 | 0.0016 | 4.4383 | 1.6937 | 7 | 121 | negative regulation of hemopoiesis |
| GO:0001759 | 0.0019 | 14.2752 | 0.252 | 3 | 18 | organ induction |
| GO:0051122 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0060455 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0071502 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | cellular response to temperature stimulus |
| GO:2000609 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | regulation of thyroid hormone generation |
| GO:2001188 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0030803 | 0.0021 | 8.1854 | 0.5459 | 4 | 39 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0003215 | 0.0022 | 13.3821 | 0.266 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0023019 | 0.0022 | 13.3821 | 0.266 | 3 | 19 | signal transduction involved in regulation of gene expression |
| GO:0042403 | 0.0022 | 13.3821 | 0.266 | 3 | 19 | thyroid hormone metabolic process |
| GO:0001709 | 0.0023 | 7.9575 | 0.5599 | 4 | 40 | cell fate determination |
| GO:0010658 | 0.0023 | 7.9575 | 0.5599 | 4 | 40 | striated muscle cell apoptotic process |
| GO:0048863 | 0.0025 | 3.0826 | 3.4434 | 10 | 246 | stem cell differentiation |
| GO:0030815 | 0.0025 | 7.7419 | 0.5739 | 4 | 41 | negative regulation of cAMP metabolic process |
| GO:1900372 | 0.0028 | 7.5376 | 0.5879 | 4 | 42 | negative regulation of purine nucleotide biosynthetic process |
| GO:0008630 | 0.0028 | 4.5976 | 1.3998 | 6 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0021902 | 0.0028 | 35.545 | 0.084 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0034128 | 0.0028 | 35.545 | 0.084 | 2 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0048699 | 0.0029 | 1.8139 | 18.4627 | 31 | 1319 | generation of neurons |
| GO:0008543 | 0.0029 | 4.5489 | 1.4137 | 6 | 101 | fibroblast growth factor receptor signaling pathway |
| GO:0007369 | 0.0037 | 3.3851 | 2.5056 | 8 | 179 | gastrulation |
| GO:0003151 | 0.0038 | 5.2031 | 1.0358 | 5 | 74 | outflow tract morphogenesis |
| GO:0060042 | 0.0038 | 6.818 | 0.6439 | 4 | 46 | retina morphogenesis in camera-type eye |
| GO:0001826 | 0.0039 | 28.4341 | 0.098 | 2 | 7 | inner cell mass cell differentiation |
| GO:0002118 | 0.0039 | 28.4341 | 0.098 | 2 | 7 | aggressive behavior |
| GO:0002645 | 0.0039 | 28.4341 | 0.098 | 2 | 7 | positive regulation of tolerance induction |
| GO:0055010 | 0.0042 | 6.659 | 0.6579 | 4 | 47 | ventricular cardiac muscle tissue morphogenesis |
| GO:0007517 | 0.0042 | 2.5672 | 4.9411 | 12 | 353 | muscle organ development |
| GO:0048771 | 0.0042 | 3.6875 | 2.0156 | 7 | 144 | tissue remodeling |
| GO:0060537 | 0.0043 | 2.5595 | 4.9551 | 12 | 354 | muscle tissue development |
| GO:0010628 | 0.0044 | 1.6831 | 23.8377 | 37 | 1703 | positive regulation of gene expression |
| GO:0030878 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | thyroid gland development |
| GO:0060487 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | lung epithelial cell differentiation |
| GO:0060914 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | heart formation |
| GO:0061217 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | regulation of mesonephros development |
| GO:0048869 | 0.0044 | 1.5257 | 47.428 | 64 | 3588 | cellular developmental process |
| GO:0030509 | 0.0045 | 3.634 | 2.0436 | 7 | 146 | BMP signaling pathway |
| GO:0007368 | 0.0049 | 4.0738 | 1.5677 | 6 | 112 | determination of left/right symmetry |
| GO:0030817 | 0.0051 | 4.0355 | 1.5817 | 6 | 113 | regulation of cAMP biosynthetic process |
| GO:0001955 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | blood vessel maturation |
| GO:0010940 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | positive regulation of necrotic cell death |
| GO:0042756 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | drinking behavior |
| GO:0051584 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
| GO:0060836 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | lymphatic endothelial cell differentiation |
| GO:0060840 | 0.0053 | 4.7849 | 1.1198 | 5 | 80 | artery development |
| GO:0045765 | 0.0053 | 2.9376 | 3.2334 | 9 | 231 | regulation of angiogenesis |
| GO:0045597 | 0.0055 | 1.9807 | 10.7314 | 20 | 782 | positive regulation of cell differentiation |
| GO:0007194 | 0.0055 | 9.305 | 0.3639 | 3 | 26 | negative regulation of adenylate cyclase activity |
| GO:0045471 | 0.0056 | 3.9609 | 1.6097 | 6 | 115 | response to ethanol |
| GO:0045995 | 0.0056 | 3.9609 | 1.6097 | 6 | 115 | regulation of embryonic development |
| GO:0009605 | 0.0056 | 1.6249 | 26.7212 | 40 | 1909 | response to external stimulus |
| GO:0016477 | 0.006 | 1.765 | 16.979 | 28 | 1213 | cell migration |
| GO:0040011 | 0.0062 | 1.674 | 21.8781 | 34 | 1563 | locomotion |
| GO:0022414 | 0.0062 | 1.7433 | 17.8188 | 29 | 1273 | reproductive process |
| GO:0001656 | 0.0065 | 4.5414 | 1.1758 | 5 | 84 | metanephros development |
| GO:0060284 | 0.0065 | 1.9476 | 10.8901 | 20 | 778 | regulation of cell development |
| GO:0003206 | 0.0066 | 3.8197 | 1.6657 | 6 | 119 | cardiac chamber morphogenesis |
| GO:0072172 | 0.0066 | 20.3074 | 0.126 | 2 | 9 | mesonephric tubule formation |
| GO:0071772 | 0.0066 | 3.365 | 2.1976 | 7 | 157 | response to BMP |
| GO:0051674 | 0.0069 | 1.7122 | 18.7707 | 30 | 1341 | localization of cell |
| GO:0060993 | 0.0071 | 4.4287 | 1.2038 | 5 | 86 | kidney morphogenesis |
| GO:0051094 | 0.0072 | 2.6313 | 4.0097 | 10 | 308 | positive regulation of developmental process |
| GO:0010033 | 0.0072 | 1.5113 | 39.291 | 54 | 2807 | response to organic substance |
| GO:0009799 | 0.0074 | 3.7201 | 1.7077 | 6 | 122 | specification of symmetry |
| GO:0090200 | 0.0076 | 8.2297 | 0.4059 | 3 | 29 | positive regulation of release of cytochrome c from mitochondria |
| GO:0048666 | 0.0076 | 1.8319 | 13.3396 | 23 | 953 | neuron development |
| GO:0072080 | 0.0079 | 4.3214 | 1.2318 | 5 | 88 | nephron tubule development |
| GO:0021700 | 0.0081 | 2.7371 | 3.4574 | 9 | 247 | developmental maturation |
| GO:0003211 | 0.0081 | 17.7678 | 0.14 | 2 | 10 | cardiac ventricle formation |
| GO:0061042 | 0.0081 | 17.7678 | 0.14 | 2 | 10 | vascular wound healing |
| GO:0097499 | 0.0081 | 17.7678 | 0.14 | 2 | 10 | protein localization to non-motile cilium |
| GO:0052548 | 0.0082 | 2.4442 | 4.7312 | 11 | 338 | regulation of endopeptidase activity |
| GO:0034142 | 0.0083 | 7.9243 | 0.4199 | 3 | 30 | toll-like receptor 4 signaling pathway |
| GO:0090130 | 0.0083 | 2.7255 | 3.4714 | 9 | 248 | tissue migration |
| GO:0050794 | 0.0086 | 1.4348 | 130.9046 | 148 | 9352 | regulation of cellular process |
| GO:0030324 | 0.0086 | 3.1929 | 2.3096 | 7 | 165 | lung development |
| GO:0051937 | 0.0088 | 5.2986 | 0.8119 | 4 | 58 | catecholamine transport |
| GO:0051960 | 0.0089 | 1.9178 | 10.4701 | 19 | 748 | regulation of nervous system development |
| GO:0042462 | 0.0091 | 7.6408 | 0.4339 | 3 | 31 | eye photoreceptor cell development |
| GO:0051954 | 0.0091 | 7.6408 | 0.4339 | 3 | 31 | positive regulation of amine transport |
| GO:0050769 | 0.0093 | 2.2976 | 5.487 | 12 | 392 | positive regulation of neurogenesis |
| GO:0045664 | 0.0096 | 2.077 | 7.6006 | 15 | 543 | regulation of neuron differentiation |
| GO:0042472 | 0.0099 | 4.0745 | 1.3018 | 5 | 93 | inner ear morphogenesis |
| GO:0072164 | 0.0099 | 4.0745 | 1.3018 | 5 | 93 | mesonephric tubule development |
| GO:2000117 | 0.0099 | 4.0745 | 1.3018 | 5 | 93 | negative regulation of cysteine-type endopeptidase activity |
| GO:0010454 | 0.0099 | 15.7925 | 0.154 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0021903 | 0.0099 | 15.7925 | 0.154 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0060675 | 0.0099 | 5.1087 | 0.8399 | 4 | 60 | ureteric bud morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009790 | 0 | 3.3834 | 10.9312 | 32 | 818 | embryo development |
| GO:0010648 | 0 | 2.7083 | 16.6326 | 39 | 1211 | negative regulation of cell communication |
| GO:0023057 | 0 | 2.6983 | 16.6876 | 39 | 1215 | negative regulation of signaling |
| GO:0007423 | 0 | 3.7186 | 6.9497 | 23 | 506 | sensory organ development |
| GO:0048585 | 0 | 2.5716 | 18.9401 | 42 | 1379 | negative regulation of response to stimulus |
| GO:0045597 | 0 | 2.9301 | 11.5646 | 30 | 842 | positive regulation of cell differentiation |
| GO:0043009 | 0 | 3.4452 | 7.4579 | 23 | 543 | chordate embryonic development |
| GO:0045944 | 0 | 2.6927 | 14.339 | 34 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048729 | 0 | 3.2563 | 8.227 | 24 | 599 | tissue morphogenesis |
| GO:0048562 | 0 | 5.8486 | 2.2894 | 12 | 173 | embryonic organ morphogenesis |
| GO:1902679 | 0 | 2.5941 | 15.3141 | 35 | 1115 | negative regulation of RNA biosynthetic process |
| GO:1903508 | 0 | 2.413 | 18.4319 | 39 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0001501 | 0 | 3.4551 | 6.4003 | 20 | 466 | skeletal system development |
| GO:0001706 | 0 | 11.0309 | 0.7417 | 7 | 54 | endoderm formation |
| GO:0001947 | 0 | 10.3669 | 0.7829 | 7 | 57 | heart looping |
| GO:0021872 | 0 | 9.9669 | 0.8103 | 7 | 59 | forebrain generation of neurons |
| GO:0097154 | 0 | 36.5854 | 0.1648 | 4 | 12 | GABAergic neuron differentiation |
| GO:0009890 | 0 | 2.2459 | 20.7668 | 41 | 1512 | negative regulation of biosynthetic process |
| GO:0051254 | 0 | 2.2801 | 19.3796 | 39 | 1411 | positive regulation of RNA metabolic process |
| GO:0031328 | 0 | 2.1677 | 23.1841 | 44 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0010628 | 0 | 2.1457 | 23.3901 | 44 | 1703 | positive regulation of gene expression |
| GO:0046533 | 0 | 109.267 | 0.0687 | 3 | 5 | negative regulation of photoreceptor cell differentiation |
| GO:0080090 | 0 | 1.7747 | 76.186 | 105 | 5547 | regulation of primary metabolic process |
| GO:0021756 | 0 | 29.2644 | 0.1923 | 4 | 14 | striatum development |
| GO:0007267 | 0 | 2.1952 | 20.0388 | 39 | 1459 | cell-cell signaling |
| GO:0009952 | 0 | 4.838 | 2.4912 | 11 | 183 | anterior/posterior pattern specification |
| GO:0021544 | 0 | 74.2327 | 0.0809 | 3 | 6 | subpallium development |
| GO:0035050 | 1e-04 | 7.9666 | 0.9889 | 7 | 72 | embryonic heart tube development |
| GO:0045934 | 1e-04 | 2.2073 | 18.2533 | 36 | 1329 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0003407 | 1e-04 | 9.7067 | 0.7076 | 6 | 52 | neural retina development |
| GO:0034654 | 1e-04 | 1.7621 | 54.76 | 80 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0048665 | 1e-04 | 13.1127 | 0.4532 | 5 | 33 | neuron fate specification |
| GO:0022008 | 1e-04 | 2.1431 | 19.3109 | 37 | 1406 | neurogenesis |
| GO:0061303 | 1e-04 | 54.6262 | 0.0961 | 3 | 7 | cornea development in camera-type eye |
| GO:2000678 | 1e-04 | 20.8976 | 0.2472 | 4 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0001764 | 1e-04 | 5.4015 | 1.8267 | 9 | 133 | neuron migration |
| GO:0048468 | 1e-04 | 1.9983 | 25.5052 | 45 | 1857 | cell development |
| GO:0000122 | 1e-04 | 2.5374 | 10.3559 | 24 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0007517 | 1e-04 | 3.3559 | 4.8483 | 15 | 353 | muscle organ development |
| GO:0051173 | 1e-04 | 1.8217 | 37.4132 | 59 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0014032 | 2e-04 | 8.34 | 0.8103 | 6 | 59 | neural crest cell development |
| GO:0048645 | 2e-04 | 8.34 | 0.8103 | 6 | 59 | animal organ formation |
| GO:0007368 | 2e-04 | 5.7038 | 1.5383 | 8 | 112 | determination of left/right symmetry |
| GO:0010557 | 2e-04 | 2.0342 | 21.426 | 39 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0021953 | 2e-04 | 4.9904 | 1.9654 | 9 | 145 | central nervous system neuron differentiation |
| GO:2000112 | 2e-04 | 1.7253 | 52.329 | 76 | 3810 | regulation of cellular macromolecule biosynthetic process |
| GO:0060675 | 2e-04 | 8.185 | 0.8241 | 6 | 60 | ureteric bud morphogenesis |
| GO:0048839 | 2e-04 | 4.4389 | 2.4448 | 10 | 178 | inner ear development |
| GO:0016331 | 2e-04 | 4.9209 | 1.9915 | 9 | 145 | morphogenesis of embryonic epithelium |
| GO:0060993 | 2e-04 | 6.5486 | 1.1812 | 7 | 86 | kidney morphogenesis |
| GO:0021882 | 2e-04 | Inf | 0.0275 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
| GO:0021893 | 2e-04 | Inf | 0.0275 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
| GO:1902868 | 2e-04 | Inf | 0.0275 | 2 | 2 | positive regulation of retina development in camera-type eye |
| GO:1902871 | 2e-04 | Inf | 0.0275 | 2 | 2 | positive regulation of amacrine cell differentiation |
| GO:2001111 | 2e-04 | Inf | 0.0275 | 2 | 2 | positive regulation of lens epithelial cell proliferation |
| GO:0001763 | 2e-04 | 4.2593 | 2.5409 | 10 | 185 | morphogenesis of a branching structure |
| GO:0048704 | 3e-04 | 6.0839 | 1.2636 | 7 | 92 | embryonic skeletal system morphogenesis |
| GO:0009799 | 3e-04 | 5.2 | 1.6756 | 8 | 122 | specification of symmetry |
| GO:0001708 | 3e-04 | 9.7221 | 0.5855 | 5 | 44 | cell fate specification |
| GO:0072164 | 3e-04 | 6.0128 | 1.2773 | 7 | 93 | mesonephric tubule development |
| GO:0032502 | 3e-04 | 1.7141 | 56.8929 | 79 | 4581 | developmental process |
| GO:0071310 | 3e-04 | 1.822 | 31.0265 | 50 | 2259 | cellular response to organic substance |
| GO:0072359 | 4e-04 | 2.2457 | 12.6221 | 26 | 919 | circulatory system development |
| GO:0060537 | 4e-04 | 3.0973 | 4.8621 | 14 | 354 | muscle tissue development |
| GO:0060042 | 4e-04 | 8.9473 | 0.6318 | 5 | 46 | retina morphogenesis in camera-type eye |
| GO:0008285 | 4e-04 | 2.4977 | 8.6528 | 20 | 630 | negative regulation of cell proliferation |
| GO:0021766 | 5e-04 | 6.6914 | 0.9889 | 6 | 72 | hippocampus development |
| GO:0061333 | 5e-04 | 6.5911 | 1.0026 | 6 | 73 | renal tubule morphogenesis |
| GO:0060766 | 5e-04 | 24.2702 | 0.1648 | 3 | 12 | negative regulation of androgen receptor signaling pathway |
| GO:0031323 | 6e-04 | 1.5891 | 77.7518 | 101 | 5661 | regulation of cellular metabolic process |
| GO:0048762 | 7e-04 | 7.8458 | 0.7096 | 5 | 53 | mesenchymal cell differentiation |
| GO:0007399 | 7e-04 | 2.4697 | 8.3742 | 19 | 679 | nervous system development |
| GO:2000243 | 7e-04 | 7.8019 | 0.7142 | 5 | 52 | positive regulation of reproductive process |
| GO:0048592 | 7e-04 | 4.4514 | 1.9366 | 8 | 141 | eye morphogenesis |
| GO:0042475 | 9e-04 | 5.8849 | 1.1125 | 6 | 81 | odontogenesis of dentin-containing tooth |
| GO:0061053 | 9e-04 | 5.8071 | 1.1262 | 6 | 82 | somite development |
| GO:0045746 | 9e-04 | 10.439 | 0.4395 | 4 | 32 | negative regulation of Notch signaling pathway |
| GO:2000026 | 9e-04 | 1.9579 | 17.9713 | 32 | 1385 | regulation of multicellular organismal development |
| GO:0048857 | 9e-04 | 7.3324 | 0.7554 | 5 | 55 | neural nucleus development |
| GO:0010605 | 0.001 | 1.7144 | 33.3614 | 51 | 2429 | negative regulation of macromolecule metabolic process |
| GO:0070848 | 0.001 | 2.3725 | 8.5979 | 19 | 626 | response to growth factor |
| GO:0001656 | 0.001 | 5.6574 | 1.1537 | 6 | 84 | metanephros development |
| GO:0003308 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0042662 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0042663 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | regulation of endodermal cell fate specification |
| GO:0048866 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | stem cell fate specification |
| GO:0060729 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | intestinal epithelial structure maintenance |
| GO:0097476 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | spinal cord motor neuron migration |
| GO:1902412 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | regulation of mitotic cytokinesis |
| GO:1902746 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | regulation of lens fiber cell differentiation |
| GO:1905903 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0009887 | 0.0012 | 3.0342 | 4.2367 | 12 | 344 | animal organ morphogenesis |
| GO:0051937 | 0.0012 | 6.9159 | 0.7966 | 5 | 58 | catecholamine transport |
| GO:0001711 | 0.0013 | 16.798 | 0.2198 | 3 | 16 | endodermal cell fate commitment |
| GO:0072175 | 0.0013 | 4.6116 | 1.6332 | 7 | 120 | epithelial tube formation |
| GO:0051962 | 0.0013 | 2.6151 | 6.1256 | 15 | 446 | positive regulation of nervous system development |
| GO:0072080 | 0.0013 | 5.38 | 1.2086 | 6 | 88 | nephron tubule development |
| GO:0071542 | 0.0014 | 9.1317 | 0.4944 | 4 | 36 | dopaminergic neuron differentiation |
| GO:0007420 | 0.0015 | 2.4224 | 7.5086 | 17 | 557 | brain development |
| GO:0042053 | 0.0015 | 15.5971 | 0.2335 | 3 | 17 | regulation of dopamine metabolic process |
| GO:0048486 | 0.0015 | 15.5971 | 0.2335 | 3 | 17 | parasympathetic nervous system development |
| GO:0090190 | 0.0015 | 15.5971 | 0.2335 | 3 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0048608 | 0.0016 | 3.5713 | 2.6896 | 9 | 201 | reproductive structure development |
| GO:0050789 | 0.0016 | 1.6031 | 136.797 | 157 | 9960 | regulation of biological process |
| GO:0045744 | 0.0016 | 8.8544 | 0.5082 | 4 | 37 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0009953 | 0.0017 | 5.1284 | 1.2636 | 6 | 92 | dorsal/ventral pattern formation |
| GO:1901576 | 0.0017 | 1.5219 | 80.7871 | 102 | 5882 | organic substance biosynthetic process |
| GO:0001759 | 0.0018 | 14.5563 | 0.2472 | 3 | 18 | organ induction |
| GO:0072077 | 0.0018 | 14.5563 | 0.2472 | 3 | 18 | renal vesicle morphogenesis |
| GO:0060023 | 0.0018 | 48.3253 | 0.0687 | 2 | 5 | soft palate development |
| GO:0061009 | 0.0018 | 48.3253 | 0.0687 | 2 | 5 | common bile duct development |
| GO:0002088 | 0.0018 | 6.2101 | 0.879 | 5 | 64 | lens development in camera-type eye |
| GO:0048565 | 0.0019 | 4.2993 | 1.7443 | 7 | 127 | digestive tract development |
| GO:0044344 | 0.0019 | 4.2635 | 1.758 | 7 | 128 | cellular response to fibroblast growth factor stimulus |
| GO:0001837 | 0.002 | 4.2283 | 1.7718 | 7 | 129 | epithelial to mesenchymal transition |
| GO:0001502 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | cartilage condensation |
| GO:0003215 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0021895 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | cerebral cortex neuron differentiation |
| GO:0023019 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | signal transduction involved in regulation of gene expression |
| GO:0048557 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:0072079 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | nephron tubule formation |
| GO:0014014 | 0.0021 | 8.1149 | 0.5494 | 4 | 40 | negative regulation of gliogenesis |
| GO:0072006 | 0.0024 | 4.093 | 1.8267 | 7 | 133 | nephron development |
| GO:1902532 | 0.0025 | 2.4344 | 6.5514 | 15 | 477 | negative regulation of intracellular signal transduction |
| GO:0000003 | 0.0025 | 1.8544 | 17.4979 | 30 | 1274 | reproduction |
| GO:0072073 | 0.0025 | 4.0605 | 1.8404 | 7 | 134 | kidney epithelium development |
| GO:0033603 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | positive regulation of dopamine secretion |
| GO:0035502 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | metanephric part of ureteric bud development |
| GO:0060022 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | hard palate development |
| GO:0061074 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | regulation of neural retina development |
| GO:2000138 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | positive regulation of cell proliferation involved in heart morphogenesis |
| GO:0021517 | 0.0028 | 7.4892 | 0.5906 | 4 | 43 | ventral spinal cord development |
| GO:0050433 | 0.0028 | 7.4892 | 0.5906 | 4 | 43 | regulation of catecholamine secretion |
| GO:0021516 | 0.0028 | 12.1278 | 0.2884 | 3 | 21 | dorsal spinal cord development |
| GO:0048485 | 0.0028 | 12.1278 | 0.2884 | 3 | 21 | sympathetic nervous system development |
| GO:0033993 | 0.0029 | 2.0356 | 11.5646 | 22 | 842 | response to lipid |
| GO:0042310 | 0.0029 | 5.5489 | 0.9752 | 5 | 71 | vasoconstriction |
| GO:0043010 | 0.0031 | 3.2091 | 2.9747 | 9 | 222 | camera-type eye development |
| GO:0048646 | 0.0032 | 2.0155 | 11.6966 | 22 | 890 | anatomical structure formation involved in morphogenesis |
| GO:0051241 | 0.0033 | 1.9783 | 12.4592 | 23 | 931 | negative regulation of multicellular organismal process |
| GO:0048754 | 0.0033 | 3.8465 | 1.9366 | 7 | 141 | branching morphogenesis of an epithelial tube |
| GO:0007275 | 0.0034 | 1.7055 | 28.0856 | 42 | 2483 | multicellular organism development |
| GO:0051101 | 0.0034 | 4.4063 | 1.4559 | 6 | 106 | regulation of DNA binding |
| GO:0003151 | 0.0035 | 5.3066 | 1.0164 | 5 | 74 | outflow tract morphogenesis |
| GO:0060562 | 0.0036 | 6.9364 | 0.6318 | 4 | 48 | epithelial tube morphogenesis |
| GO:0042481 | 0.0037 | 10.9136 | 0.3159 | 3 | 23 | regulation of odontogenesis |
| GO:0090103 | 0.0037 | 10.9136 | 0.3159 | 3 | 23 | cochlea morphogenesis |
| GO:0061448 | 0.0037 | 3.1109 | 3.0628 | 9 | 223 | connective tissue development |
| GO:0001826 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | inner cell mass cell differentiation |
| GO:0002645 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | positive regulation of tolerance induction |
| GO:0002692 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | negative regulation of cellular extravasation |
| GO:0003357 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | noradrenergic neuron differentiation |
| GO:2000096 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0042221 | 0.0038 | 1.5177 | 50.6396 | 68 | 3687 | response to chemical |
| GO:0045165 | 0.0039 | 3.7319 | 1.9919 | 7 | 153 | cell fate commitment |
| GO:0000188 | 0.0042 | 10.3932 | 0.3296 | 3 | 24 | inactivation of MAPK activity |
| GO:0061037 | 0.0042 | 10.3932 | 0.3296 | 3 | 24 | negative regulation of cartilage development |
| GO:0061217 | 0.0042 | 10.3932 | 0.3296 | 3 | 24 | regulation of mesonephros development |
| GO:0042220 | 0.0042 | 6.6359 | 0.6593 | 4 | 48 | response to cocaine |
| GO:0007626 | 0.0042 | 3.316 | 2.5546 | 8 | 186 | locomotory behavior |
| GO:0007519 | 0.0044 | 3.6539 | 2.0327 | 7 | 148 | skeletal muscle tissue development |
| GO:0045992 | 0.0047 | 9.9201 | 0.3434 | 3 | 25 | negative regulation of embryonic development |
| GO:0072273 | 0.0047 | 9.9201 | 0.3434 | 3 | 25 | metanephric nephron morphogenesis |
| GO:0060541 | 0.0048 | 3.2423 | 2.6096 | 8 | 190 | respiratory system development |
| GO:0030916 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | otic vesicle formation |
| GO:0033085 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | negative regulation of T cell differentiation in thymus |
| GO:0051584 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
| GO:0060052 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | neurofilament cytoskeleton organization |
| GO:0097084 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | vascular smooth muscle cell development |
| GO:1902669 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | positive regulation of axon guidance |
| GO:1905770 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | regulation of mesodermal cell differentiation |
| GO:2000698 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | positive regulation of epithelial cell differentiation involved in kidney development |
| GO:0009719 | 0.005 | 1.7435 | 19.1461 | 31 | 1394 | response to endogenous stimulus |
| GO:0009798 | 0.0051 | 4.8155 | 1.1125 | 5 | 81 | axis specification |
| GO:0021515 | 0.0052 | 6.2111 | 0.7005 | 4 | 51 | cell differentiation in spinal cord |
| GO:0060425 | 0.0052 | 6.2111 | 0.7005 | 4 | 51 | lung morphogenesis |
| GO:0061005 | 0.0052 | 6.2111 | 0.7005 | 4 | 51 | cell differentiation involved in kidney development |
| GO:0003007 | 0.0052 | 3.5271 | 2.1016 | 7 | 156 | heart morphogenesis |
| GO:0021884 | 0.0053 | 9.4882 | 0.3571 | 3 | 26 | forebrain neuron development |
| GO:0048870 | 0.0053 | 1.751 | 18.4182 | 30 | 1341 | cell motility |
| GO:0032231 | 0.0054 | 4.7527 | 1.1262 | 5 | 82 | regulation of actin filament bundle assembly |
| GO:0009966 | 0.0055 | 1.5385 | 38.8004 | 54 | 2825 | regulation of signal transduction |
| GO:0008406 | 0.0057 | 3.1375 | 2.692 | 8 | 196 | gonad development |
| GO:0007498 | 0.0058 | 3.931 | 1.6207 | 6 | 118 | mesoderm development |
| GO:0060706 | 0.0059 | 9.0922 | 0.3708 | 3 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0061311 | 0.0059 | 9.0922 | 0.3708 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0030901 | 0.006 | 4.6317 | 1.1537 | 5 | 84 | midbrain development |
| GO:0071773 | 0.006 | 3.4325 | 2.1563 | 7 | 157 | cellular response to BMP stimulus |
| GO:0045596 | 0.0062 | 2.193 | 7.2309 | 15 | 537 | negative regulation of cell differentiation |
| GO:0007050 | 0.0062 | 2.866 | 3.31 | 9 | 241 | cell cycle arrest |
| GO:0016202 | 0.0062 | 3.8616 | 1.6482 | 6 | 120 | regulation of striated muscle tissue development |
| GO:0071901 | 0.0062 | 3.8616 | 1.6482 | 6 | 120 | negative regulation of protein serine/threonine kinase activity |
| GO:0070472 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | regulation of uterine smooth muscle contraction |
| GO:0070561 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | vitamin D receptor signaling pathway |
| GO:1901203 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | positive regulation of extracellular matrix assembly |
| GO:2000543 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | positive regulation of gastrulation |
| GO:0048522 | 0.0064 | 1.5137 | 46.6085 | 62 | 3743 | positive regulation of cellular process |
| GO:0097746 | 0.0068 | 3.7945 | 1.6756 | 6 | 122 | regulation of blood vessel diameter |
| GO:0048863 | 0.007 | 2.8046 | 3.3787 | 9 | 246 | stem cell differentiation |
| GO:0035270 | 0.007 | 3.7618 | 1.6894 | 6 | 123 | endocrine system development |
| GO:0007548 | 0.0072 | 2.7926 | 3.3925 | 9 | 247 | sex differentiation |
| GO:0030217 | 0.0073 | 3.0078 | 2.8019 | 8 | 204 | T cell differentiation |
| GO:0003002 | 0.0075 | 5.5582 | 0.7743 | 4 | 60 | regionalization |
| GO:0010470 | 0.0077 | 8.1558 | 0.4083 | 3 | 30 | regulation of gastrulation |
| GO:0030856 | 0.0078 | 3.6721 | 1.7281 | 6 | 127 | regulation of epithelial cell differentiation |
| GO:0000050 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | urea cycle |
| GO:0003211 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | cardiac ventricle formation |
| GO:0021877 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | forebrain neuron fate commitment |
| GO:0030432 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | peristalsis |
| GO:0033623 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | regulation of integrin activation |
| GO:0048715 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | negative regulation of oligodendrocyte differentiation |
| GO:0060174 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | limb bud formation |
| GO:0060767 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | epithelial cell proliferation involved in prostate gland development |
| GO:0001892 | 0.0079 | 5.4749 | 0.7866 | 4 | 58 | embryonic placenta development |
| GO:0045664 | 0.0081 | 2.1204 | 7.4579 | 15 | 543 | regulation of neuron differentiation |
| GO:0051240 | 0.0085 | 1.8711 | 11.9586 | 21 | 943 | positive regulation of multicellular organismal process |
| GO:2000027 | 0.0086 | 2.9136 | 2.8879 | 8 | 213 | regulation of organ morphogenesis |
| GO:0051954 | 0.0086 | 7.7913 | 0.4258 | 3 | 31 | positive regulation of amine transport |
| GO:0001933 | 0.0087 | 2.3198 | 5.4389 | 12 | 396 | negative regulation of protein phosphorylation |
| GO:0051148 | 0.0087 | 5.3048 | 0.8103 | 4 | 59 | negative regulation of muscle cell differentiation |
| GO:0033673 | 0.0088 | 2.7004 | 3.5023 | 9 | 255 | negative regulation of kinase activity |
| GO:0030534 | 0.0088 | 3.5768 | 1.7718 | 6 | 129 | adult behavior |
| GO:0061572 | 0.0088 | 3.5768 | 1.7718 | 6 | 129 | actin filament bundle organization |
| GO:0045936 | 0.0091 | 2.0917 | 7.5541 | 15 | 550 | negative regulation of phosphate metabolic process |
| GO:0035150 | 0.0091 | 3.5478 | 1.7855 | 6 | 130 | regulation of tube size |
| GO:0001655 | 0.0092 | 2.5237 | 4.1616 | 10 | 303 | urogenital system development |
| GO:0050672 | 0.0093 | 5.2098 | 0.8241 | 4 | 60 | negative regulation of lymphocyte proliferation |
| GO:0045892 | 0.0093 | 2.5248 | 4.17 | 10 | 326 | negative regulation of transcription, DNA-templated |
| GO:0000165 | 0.0094 | 1.8744 | 11.2899 | 20 | 822 | MAPK cascade |
| GO:0002087 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0003128 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | heart field specification |
| GO:0003413 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0010454 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0021903 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0048484 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | enteric nervous system development |
| GO:0090009 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | primitive streak formation |
| GO:2000047 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | regulation of cell-cell adhesion mediated by cadherin |
| GO:0030804 | 0.0095 | 4.1086 | 1.2911 | 5 | 94 | positive regulation of cyclic nucleotide biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 28.9556 | 0.3484 | 8 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009913 | 0 | 8.2842 | 1.5401 | 11 | 252 | epidermal cell differentiation |
| GO:0009593 | 0 | 13.0858 | 0.7089 | 8 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 11.6698 | 0.7884 | 8 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 11.3852 | 0.8067 | 8 | 132 | sensory perception of chemical stimulus |
| GO:0070268 | 0 | 14.0683 | 0.5745 | 7 | 94 | cornification |
| GO:0043588 | 0 | 6.6062 | 1.9068 | 11 | 312 | skin development |
| GO:0007186 | 0 | 3.6107 | 5.1276 | 16 | 839 | G-protein coupled receptor signaling pathway |
| GO:0031424 | 1e-04 | 18.7592 | 0.2445 | 4 | 43 | keratinization |
| GO:0003095 | 1e-04 | 332.3736 | 0.0183 | 2 | 3 | pressure natriuresis |
| GO:0061760 | 1e-04 | 332.3736 | 0.0183 | 2 | 3 | antifungal innate immune response |
| GO:0036101 | 2e-04 | 166.1758 | 0.0244 | 2 | 4 | leukotriene B4 catabolic process |
| GO:0019373 | 3e-04 | 27.9741 | 0.1283 | 3 | 21 | epoxygenase P450 pathway |
| GO:0030825 | 3e-04 | 27.9741 | 0.1283 | 3 | 21 | positive regulation of cGMP metabolic process |
| GO:0030826 | 3e-04 | 26.5 | 0.1345 | 3 | 22 | regulation of cGMP biosynthetic process |
| GO:1901523 | 4e-04 | 110.7766 | 0.0306 | 2 | 5 | icosanoid catabolic process |
| GO:0050877 | 7e-04 | 2.9797 | 5.2743 | 14 | 863 | nervous system process |
| GO:0032501 | 9e-04 | 2.0452 | 33.5667 | 48 | 6173 | multicellular organismal process |
| GO:0031103 | 0.0017 | 13.9704 | 0.2384 | 3 | 39 | axon regeneration |
| GO:0031284 | 0.002 | 36.9109 | 0.0672 | 2 | 11 | positive regulation of guanylate cyclase activity |
| GO:0001676 | 0.0023 | 7.768 | 0.5562 | 4 | 91 | long-chain fatty acid metabolic process |
| GO:0033559 | 0.0026 | 7.5076 | 0.5745 | 4 | 94 | unsaturated fatty acid metabolic process |
| GO:0060429 | 0.0027 | 2.4858 | 6.7289 | 15 | 1101 | epithelium development |
| GO:0032645 | 0.0032 | 27.6777 | 0.0856 | 2 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:1900017 | 0.0032 | 27.6777 | 0.0856 | 2 | 14 | positive regulation of cytokine production involved in inflammatory response |
| GO:0031099 | 0.0036 | 5.2476 | 1.0206 | 5 | 167 | regeneration |
| GO:0006544 | 0.0037 | 25.5469 | 0.0917 | 2 | 15 | glycine metabolic process |
| GO:0051101 | 0.004 | 6.6191 | 0.6478 | 4 | 106 | regulation of DNA binding |
| GO:0070098 | 0.0051 | 9.3025 | 0.3484 | 3 | 57 | chemokine-mediated signaling pathway |
| GO:2000678 | 0.0053 | 20.7527 | 0.11 | 2 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0043496 | 0.0059 | 19.5307 | 0.1161 | 2 | 19 | regulation of protein homodimerization activity |
| GO:0002152 | 0.0061 | Inf | 0.0061 | 1 | 1 | bile acid conjugation |
| GO:0019408 | 0.0061 | Inf | 0.0061 | 1 | 1 | dolichol biosynthetic process |
| GO:0048264 | 0.0061 | Inf | 0.0061 | 1 | 1 | determination of ventral identity |
| GO:0072616 | 0.0061 | Inf | 0.0061 | 1 | 1 | interleukin-18 secretion |
| GO:1902867 | 0.0061 | Inf | 0.0061 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.0061 | Inf | 0.0061 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:1903965 | 0.0061 | Inf | 0.0061 | 1 | 1 | monounsaturated fatty acid catabolic process |
| GO:0050829 | 0.0067 | 8.3689 | 0.385 | 3 | 63 | defense response to Gram-negative bacterium |
| GO:0031290 | 0.0072 | 17.4725 | 0.1283 | 2 | 21 | retinal ganglion cell axon guidance |
| GO:0001837 | 0.0081 | 5.3929 | 0.7884 | 4 | 129 | epithelial to mesenchymal transition |
| GO:0006501 | 0.0083 | 7.7226 | 0.4156 | 3 | 68 | C-terminal protein lipidation |
| GO:0030593 | 0.0083 | 7.7226 | 0.4156 | 3 | 68 | neutrophil chemotaxis |
| GO:0003071 | 0.0086 | 15.8064 | 0.1406 | 2 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0035902 | 0.0086 | 15.8064 | 0.1406 | 2 | 23 | response to immobilization stress |
| GO:0010469 | 0.0098 | 2.8776 | 2.9763 | 8 | 487 | regulation of receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022404 | 0 | 10.5371 | 0.989 | 9 | 86 | molting cycle process |
| GO:0006355 | 0 | 2.2006 | 38.8135 | 67 | 3375 | regulation of transcription, DNA-templated |
| GO:0007389 | 0 | 4.3301 | 4.6691 | 18 | 406 | pattern specification process |
| GO:0043009 | 0 | 3.7931 | 6.2447 | 21 | 543 | chordate embryonic development |
| GO:2001141 | 0 | 2.1786 | 39.1125 | 67 | 3401 | regulation of RNA biosynthetic process |
| GO:0048731 | 0 | 2.1136 | 47.1982 | 76 | 4171 | system development |
| GO:0009952 | 0 | 6.0109 | 2.2311 | 12 | 194 | anterior/posterior pattern specification |
| GO:0042633 | 0 | 8.6216 | 1.1845 | 9 | 103 | hair cycle |
| GO:0010628 | 0 | 2.4632 | 19.585 | 41 | 1703 | positive regulation of gene expression |
| GO:0019219 | 0 | 2.025 | 45.2192 | 72 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0060322 | 0 | 3.1583 | 7.7857 | 22 | 677 | head development |
| GO:0048646 | 0 | 2.7431 | 11.0978 | 27 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0043588 | 0 | 4.3023 | 3.5881 | 14 | 312 | skin development |
| GO:1903508 | 0 | 2.4381 | 15.4334 | 33 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0045944 | 0 | 2.6295 | 12.0063 | 28 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0009888 | 0 | 2.476 | 14.849 | 32 | 1371 | tissue development |
| GO:0051254 | 0 | 2.393 | 16.2269 | 34 | 1411 | positive regulation of RNA metabolic process |
| GO:0048704 | 0 | 8.6411 | 0.9102 | 7 | 80 | embryonic skeletal system morphogenesis |
| GO:2001012 | 1e-04 | 65.5727 | 0.0805 | 3 | 7 | mesenchymal cell differentiation involved in renal system development |
| GO:0030900 | 1e-04 | 3.8059 | 4.0251 | 14 | 350 | forebrain development |
| GO:0008544 | 1e-04 | 3.7829 | 4.0481 | 14 | 352 | epidermis development |
| GO:0060231 | 1e-04 | 23.4339 | 0.2185 | 4 | 19 | mesenchymal to epithelial transition |
| GO:0009887 | 1e-04 | 2.6475 | 10.0913 | 24 | 895 | animal organ morphogenesis |
| GO:0009889 | 1e-04 | 2.0591 | 28.2309 | 48 | 2632 | regulation of biosynthetic process |
| GO:0021544 | 1e-04 | 21.9678 | 0.23 | 4 | 20 | subpallium development |
| GO:0031328 | 1e-04 | 2.1746 | 19.4125 | 37 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0034654 | 1e-04 | 1.8482 | 45.8517 | 69 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0001964 | 1e-04 | 18.4955 | 0.2645 | 4 | 23 | startle response |
| GO:0048663 | 1e-04 | 8.578 | 0.782 | 6 | 68 | neuron fate commitment |
| GO:0048736 | 2e-04 | 5.0112 | 1.9551 | 9 | 170 | appendage development |
| GO:0051216 | 2e-04 | 4.9799 | 1.9666 | 9 | 171 | cartilage development |
| GO:0007416 | 2e-04 | 5.6259 | 1.5525 | 8 | 135 | synapse assembly |
| GO:0031069 | 2e-04 | 16.7318 | 0.2875 | 4 | 25 | hair follicle morphogenesis |
| GO:0010557 | 2e-04 | 2.1358 | 17.9405 | 34 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0048598 | 2e-04 | 3.6927 | 3.5266 | 12 | 322 | embryonic morphogenesis |
| GO:0048468 | 3e-04 | 2.0272 | 20.6717 | 37 | 1825 | cell development |
| GO:0021515 | 3e-04 | 9.5882 | 0.5865 | 5 | 51 | cell differentiation in spinal cord |
| GO:0014707 | 4e-04 | 173.8844 | 0.0345 | 2 | 3 | branchiomeric skeletal muscle development |
| GO:0021558 | 4e-04 | 173.8844 | 0.0345 | 2 | 3 | trochlear nerve development |
| GO:0060435 | 4e-04 | 173.8844 | 0.0345 | 2 | 3 | bronchiole development |
| GO:0001942 | 5e-04 | 8.3484 | 0.6641 | 5 | 59 | hair follicle development |
| GO:0035113 | 6e-04 | 5.2251 | 1.449 | 7 | 126 | embryonic appendage morphogenesis |
| GO:0009953 | 7e-04 | 6.1742 | 1.058 | 6 | 92 | dorsal/ventral pattern formation |
| GO:0021557 | 8e-04 | 86.9364 | 0.046 | 2 | 4 | oculomotor nerve development |
| GO:0002009 | 8e-04 | 3.9665 | 2.4393 | 9 | 225 | morphogenesis of an epithelium |
| GO:1904888 | 8e-04 | 7.4691 | 0.736 | 5 | 64 | cranial skeletal system development |
| GO:0048568 | 9e-04 | 2.9834 | 4.6806 | 13 | 407 | embryonic organ development |
| GO:0048486 | 9e-04 | 18.7226 | 0.1955 | 3 | 17 | parasympathetic nervous system development |
| GO:0072074 | 0.0011 | 17.4733 | 0.207 | 3 | 18 | kidney mesenchyme development |
| GO:0051253 | 0.0011 | 2.0863 | 13.6509 | 26 | 1187 | negative regulation of RNA metabolic process |
| GO:1901576 | 0.0011 | 1.6145 | 67.6447 | 88 | 5882 | organic substance biosynthetic process |
| GO:0021879 | 0.0012 | 16.7411 | 0.2139 | 3 | 19 | forebrain neuron differentiation |
| GO:0051952 | 0.0013 | 6.7769 | 0.805 | 5 | 70 | regulation of amine transport |
| GO:0035482 | 0.0013 | 57.9538 | 0.0575 | 2 | 5 | gastric motility |
| GO:0072162 | 0.0013 | 57.9538 | 0.0575 | 2 | 5 | metanephric mesenchymal cell differentiation |
| GO:0045843 | 0.0013 | 9.2361 | 0.483 | 4 | 42 | negative regulation of striated muscle tissue development |
| GO:0042127 | 0.0014 | 1.9528 | 16.9169 | 30 | 1471 | regulation of cell proliferation |
| GO:0016331 | 0.0014 | 4.5 | 1.6675 | 7 | 145 | morphogenesis of embryonic epithelium |
| GO:0035108 | 0.0014 | 4.5 | 1.6675 | 7 | 145 | limb morphogenesis |
| GO:0021517 | 0.0015 | 8.9987 | 0.4945 | 4 | 43 | ventral spinal cord development |
| GO:0007186 | 0.0016 | 2.2408 | 9.6487 | 20 | 839 | G-protein coupled receptor signaling pathway |
| GO:0001708 | 0.0016 | 6.3639 | 0.853 | 5 | 75 | cell fate specification |
| GO:0010629 | 0.0017 | 1.8696 | 19.5045 | 33 | 1696 | negative regulation of gene expression |
| GO:0035239 | 0.0017 | 3.0565 | 3.8411 | 11 | 334 | tube morphogenesis |
| GO:0007617 | 0.0017 | 14.5581 | 0.2415 | 3 | 21 | mating behavior |
| GO:0035176 | 0.0017 | 8.5586 | 0.5175 | 4 | 45 | social behavior |
| GO:0007156 | 0.0019 | 4.2807 | 1.748 | 7 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0009996 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | negative regulation of cell fate specification |
| GO:0045617 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | negative regulation of keratinocyte differentiation |
| GO:0046958 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | nonassociative learning |
| GO:0060022 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | hard palate development |
| GO:0060255 | 0.0021 | 1.5692 | 64.1026 | 83 | 5574 | regulation of macromolecule metabolic process |
| GO:1903507 | 0.0021 | 2.0344 | 12.8113 | 24 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0030878 | 0.0025 | 12.4759 | 0.276 | 3 | 24 | thyroid gland development |
| GO:2000542 | 0.0027 | 34.7676 | 0.0805 | 2 | 7 | negative regulation of gastrulation |
| GO:0051966 | 0.0028 | 7.463 | 0.5865 | 4 | 51 | regulation of synaptic transmission, glutamatergic |
| GO:0060425 | 0.0028 | 7.463 | 0.5865 | 4 | 51 | lung morphogenesis |
| GO:0090304 | 0.0028 | 1.5612 | 55.2129 | 73 | 4801 | nucleic acid metabolic process |
| GO:0030901 | 0.0028 | 5.5707 | 0.966 | 5 | 84 | midbrain development |
| GO:0001843 | 0.003 | 5.5007 | 0.9775 | 5 | 85 | neural tube closure |
| GO:0003016 | 0.0032 | 11.3895 | 0.299 | 3 | 26 | respiratory system process |
| GO:0021884 | 0.0032 | 11.3895 | 0.299 | 3 | 26 | forebrain neuron development |
| GO:0048522 | 0.0033 | 1.5544 | 52.7289 | 70 | 4585 | positive regulation of cellular process |
| GO:0007405 | 0.0034 | 7.0138 | 0.621 | 4 | 54 | neuroblast proliferation |
| GO:0060638 | 0.0035 | 28.9711 | 0.092 | 2 | 8 | mesenchymal-epithelial cell signaling |
| GO:0021602 | 0.0036 | 10.9142 | 0.3105 | 3 | 27 | cranial nerve morphogenesis |
| GO:0045923 | 0.0036 | 10.9142 | 0.3105 | 3 | 27 | positive regulation of fatty acid metabolic process |
| GO:0072175 | 0.0036 | 4.3418 | 1.472 | 6 | 128 | epithelial tube formation |
| GO:0030278 | 0.0036 | 3.78 | 1.9666 | 7 | 171 | regulation of ossification |
| GO:0007267 | 0.0038 | 1.8473 | 16.5049 | 28 | 1451 | cell-cell signaling |
| GO:0061138 | 0.0039 | 3.7339 | 1.9896 | 7 | 173 | morphogenesis of a branching epithelium |
| GO:0035116 | 0.004 | 10.477 | 0.322 | 3 | 28 | embryonic hindlimb morphogenesis |
| GO:0070098 | 0.0042 | 6.6155 | 0.6555 | 4 | 57 | chemokine-mediated signaling pathway |
| GO:0007043 | 0.0042 | 5.0558 | 1.058 | 5 | 92 | cell-cell junction assembly |
| GO:0032501 | 0.0043 | 1.5694 | 57.8512 | 74 | 5780 | multicellular organismal process |
| GO:2000026 | 0.0043 | 1.7609 | 19.8725 | 32 | 1728 | regulation of multicellular organismal development |
| GO:0051928 | 0.0044 | 4.998 | 1.0695 | 5 | 93 | positive regulation of calcium ion transport |
| GO:0001764 | 0.0044 | 4.1695 | 1.5295 | 6 | 133 | neuron migration |
| GO:0021772 | 0.0044 | 10.0733 | 0.3335 | 3 | 29 | olfactory bulb development |
| GO:0042755 | 0.0044 | 10.0733 | 0.3335 | 3 | 29 | eating behavior |
| GO:0021892 | 0.0045 | 24.8307 | 0.1035 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0072239 | 0.0045 | 24.8307 | 0.1035 | 2 | 9 | metanephric glomerulus vasculature development |
| GO:2000543 | 0.0045 | 24.8307 | 0.1035 | 2 | 9 | positive regulation of gastrulation |
| GO:0034645 | 0.0046 | 1.6149 | 36.4712 | 51 | 3395 | cellular macromolecule biosynthetic process |
| GO:0030855 | 0.0048 | 2.3395 | 6.3695 | 14 | 575 | epithelial cell differentiation |
| GO:0032502 | 0.005 | 1.979 | 13.235 | 23 | 1510 | developmental process |
| GO:0046888 | 0.0053 | 6.1496 | 0.7015 | 4 | 61 | negative regulation of hormone secretion |
| GO:0009954 | 0.0053 | 9.3526 | 0.3565 | 3 | 31 | proximal/distal pattern formation |
| GO:0048713 | 0.0053 | 9.3526 | 0.3565 | 3 | 31 | regulation of oligodendrocyte differentiation |
| GO:0022008 | 0.0055 | 1.8075 | 16.1694 | 27 | 1406 | neurogenesis |
| GO:0050966 | 0.0056 | 21.7254 | 0.115 | 2 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0007626 | 0.0058 | 3.4597 | 2.1391 | 7 | 186 | locomotory behavior |
| GO:0098751 | 0.0058 | 9.0295 | 0.368 | 3 | 32 | bone cell development |
| GO:0001841 | 0.0059 | 4.6276 | 1.15 | 5 | 100 | neural tube formation |
| GO:0042733 | 0.0059 | 5.9403 | 0.7245 | 4 | 63 | embryonic digit morphogenesis |
| GO:0051173 | 0.006 | 1.5974 | 31.3268 | 45 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0000122 | 0.0062 | 2.0884 | 8.6712 | 17 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0001662 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | behavioral fear response |
| GO:0038111 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | interleukin-7-mediated signaling pathway |
| GO:0048333 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | mesodermal cell differentiation |
| GO:0098760 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | response to interleukin-7 |
| GO:2000113 | 0.0067 | 1.7975 | 15.6059 | 26 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0034765 | 0.0067 | 2.5199 | 4.6116 | 11 | 401 | regulation of ion transmembrane transport |
| GO:0021521 | 0.0068 | 19.3102 | 0.1265 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0030509 | 0.0068 | 3.779 | 1.679 | 6 | 146 | BMP signaling pathway |
| GO:0033555 | 0.007 | 5.6518 | 0.759 | 4 | 66 | multicellular organismal response to stress |
| GO:0030857 | 0.0075 | 8.1813 | 0.4025 | 3 | 35 | negative regulation of epithelial cell differentiation |
| GO:0060795 | 0.0075 | 8.1813 | 0.4025 | 3 | 35 | cell fate commitment involved in formation of primary germ layer |
| GO:0009890 | 0.0077 | 1.7402 | 17.3884 | 28 | 1512 | negative regulation of biosynthetic process |
| GO:0032099 | 0.008 | 17.378 | 0.138 | 2 | 12 | negative regulation of appetite |
| GO:0060272 | 0.008 | 17.378 | 0.138 | 2 | 12 | embryonic skeletal joint morphogenesis |
| GO:2000726 | 0.008 | 17.378 | 0.138 | 2 | 12 | negative regulation of cardiac muscle cell differentiation |
| GO:0071542 | 0.0081 | 7.9329 | 0.414 | 3 | 36 | dopaminergic neuron differentiation |
| GO:0019226 | 0.0082 | 5.3898 | 0.7935 | 4 | 69 | transmission of nerve impulse |
| GO:0009612 | 0.0082 | 3.2227 | 2.2886 | 7 | 199 | response to mechanical stimulus |
| GO:0048869 | 0.0088 | 1.716 | 19.406 | 30 | 1946 | cellular developmental process |
| GO:0021675 | 0.009 | 5.2282 | 0.8165 | 4 | 71 | nerve development |
| GO:0055024 | 0.009 | 5.2282 | 0.8165 | 4 | 71 | regulation of cardiac muscle tissue development |
| GO:0021953 | 0.0091 | 4.1523 | 1.2737 | 5 | 115 | central nervous system neuron differentiation |
| GO:0044057 | 0.0093 | 2.3027 | 5.4971 | 12 | 478 | regulation of system process |
| GO:0060428 | 0.0094 | 7.4786 | 0.437 | 3 | 38 | lung epithelium development |
| GO:0021978 | 0.0094 | 15.7972 | 0.1495 | 2 | 13 | telencephalon regionalization |
| GO:0060044 | 0.0094 | 15.7972 | 0.1495 | 2 | 13 | negative regulation of cardiac muscle cell proliferation |
| GO:0006334 | 0.0095 | 4.1053 | 1.288 | 5 | 112 | nucleosome assembly |
| GO:0071772 | 0.0096 | 3.5012 | 1.8055 | 6 | 157 | response to BMP |
| GO:0030001 | 0.0099 | 1.9807 | 9.1082 | 17 | 792 | metal ion transport |
| GO:0048332 | 0.0099 | 5.076 | 0.8395 | 4 | 73 | mesoderm morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 0 | 5.0656 | 2.6749 | 12 | 391 | pattern specification process |
| GO:0048562 | 0 | 5.7912 | 1.9296 | 10 | 277 | embryonic organ morphogenesis |
| GO:0050706 | 1e-04 | 21.1246 | 0.2229 | 4 | 32 | regulation of interleukin-1 beta secretion |
| GO:0007610 | 1e-04 | 3.8836 | 3.7477 | 13 | 538 | behavior |
| GO:0048663 | 1e-04 | 11.8246 | 0.4737 | 5 | 68 | neuron fate commitment |
| GO:0009790 | 2e-04 | 3.009 | 6.4017 | 17 | 919 | embryo development |
| GO:0050701 | 2e-04 | 15.5552 | 0.2926 | 4 | 42 | interleukin-1 secretion |
| GO:0003215 | 3e-04 | 27.4788 | 0.1324 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0009952 | 4e-04 | 5.643 | 1.3514 | 7 | 194 | anterior/posterior pattern specification |
| GO:0055123 | 4e-04 | 6.7061 | 0.9752 | 6 | 140 | digestive system development |
| GO:0021510 | 6e-04 | 8.171 | 0.6687 | 5 | 96 | spinal cord development |
| GO:0001947 | 7e-04 | 11.1417 | 0.3971 | 4 | 57 | heart looping |
| GO:0021902 | 7e-04 | 72.6298 | 0.0418 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0032611 | 9e-04 | 10.3571 | 0.4249 | 4 | 61 | interleukin-1 beta production |
| GO:0032652 | 9e-04 | 10.3571 | 0.4249 | 4 | 61 | regulation of interleukin-1 production |
| GO:0051674 | 9e-04 | 2.4277 | 9.3413 | 20 | 1341 | localization of cell |
| GO:0001826 | 0.001 | 58.1 | 0.0488 | 2 | 7 | inner cell mass cell differentiation |
| GO:0060017 | 0.001 | 58.1 | 0.0488 | 2 | 7 | parathyroid gland development |
| GO:0040011 | 0.001 | 2.3063 | 10.8877 | 22 | 1563 | locomotion |
| GO:0001708 | 0.0011 | 9.5467 | 0.4583 | 4 | 67 | cell fate specification |
| GO:0043009 | 0.0014 | 3.1731 | 3.7825 | 11 | 543 | chordate embryonic development |
| GO:0001707 | 0.0015 | 8.8054 | 0.4946 | 4 | 71 | mesoderm formation |
| GO:0007369 | 0.0016 | 5.1808 | 1.2469 | 6 | 179 | gastrulation |
| GO:0002690 | 0.0016 | 8.6753 | 0.5015 | 4 | 72 | positive regulation of leukocyte chemotaxis |
| GO:0048617 | 0.0017 | 41.4945 | 0.0627 | 2 | 9 | embryonic foregut morphogenesis |
| GO:0044057 | 0.0018 | 3.2592 | 3.3297 | 10 | 478 | regulation of system process |
| GO:0007186 | 0.002 | 2.6351 | 5.8444 | 14 | 839 | G-protein coupled receptor signaling pathway |
| GO:1904627 | 0.0021 | 36.3053 | 0.0697 | 2 | 10 | response to phorbol 13-acetate 12-myristate |
| GO:0045944 | 0.0023 | 2.4355 | 7.2724 | 16 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001764 | 0.0024 | 5.7948 | 0.9265 | 5 | 133 | neuron migration |
| GO:0042475 | 0.0025 | 7.6567 | 0.5642 | 4 | 81 | odontogenesis of dentin-containing tooth |
| GO:0021521 | 0.0025 | 32.2692 | 0.0766 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0001709 | 0.0027 | 11.8662 | 0.2786 | 3 | 40 | cell fate determination |
| GO:0048514 | 0.0027 | 3.0758 | 3.5178 | 10 | 505 | blood vessel morphogenesis |
| GO:0030217 | 0.003 | 4.5191 | 1.421 | 6 | 204 | T cell differentiation |
| GO:0003207 | 0.003 | 29.0404 | 0.0836 | 2 | 12 | cardiac chamber formation |
| GO:0060536 | 0.003 | 29.0404 | 0.0836 | 2 | 12 | cartilage morphogenesis |
| GO:0002685 | 0.0033 | 5.3323 | 1.0031 | 5 | 144 | regulation of leukocyte migration |
| GO:0001944 | 0.0033 | 2.8199 | 4.2283 | 11 | 607 | vasculature development |
| GO:0032501 | 0.0034 | 1.8028 | 36.6733 | 50 | 5904 | multicellular organismal process |
| GO:0051270 | 0.0035 | 2.5614 | 5.5379 | 13 | 795 | regulation of cellular component movement |
| GO:2000026 | 0.0036 | 2.0579 | 12.0371 | 22 | 1728 | regulation of multicellular organismal development |
| GO:0021520 | 0.0036 | 26.3986 | 0.0906 | 2 | 13 | spinal cord motor neuron cell fate specification |
| GO:0030502 | 0.0036 | 26.3986 | 0.0906 | 2 | 13 | negative regulation of bone mineralization |
| GO:0050707 | 0.0036 | 5.2186 | 1.024 | 5 | 147 | regulation of cytokine secretion |
| GO:0048872 | 0.0037 | 4.3413 | 1.4768 | 6 | 212 | homeostasis of number of cells |
| GO:0006874 | 0.0038 | 3.403 | 2.5217 | 8 | 362 | cellular calcium ion homeostasis |
| GO:0009953 | 0.0039 | 6.6947 | 0.6409 | 4 | 92 | dorsal/ventral pattern formation |
| GO:0050863 | 0.0039 | 3.7452 | 1.9992 | 7 | 287 | regulation of T cell activation |
| GO:0007501 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | mesodermal cell fate specification |
| GO:0060850 | 0.0047 | 22.5512 | 0.1035 | 2 | 15 | regulation of transcription involved in cell fate commitment |
| GO:0048546 | 0.0047 | 9.6324 | 0.3381 | 3 | 49 | digestive tract morphogenesis |
| GO:0050920 | 0.0047 | 4.9046 | 1.0867 | 5 | 156 | regulation of chemotaxis |
| GO:0050729 | 0.0047 | 6.3327 | 0.6757 | 4 | 97 | positive regulation of inflammatory response |
| GO:0060581 | 0.0048 | 22.3343 | 0.1045 | 2 | 15 | cell fate commitment involved in pattern specification |
| GO:0021879 | 0.0048 | 9.5388 | 0.3413 | 3 | 49 | forebrain neuron differentiation |
| GO:0060413 | 0.0054 | 20.7376 | 0.1115 | 2 | 16 | atrial septum morphogenesis |
| GO:0045765 | 0.0055 | 3.9696 | 1.6091 | 6 | 231 | regulation of angiogenesis |
| GO:0009605 | 0.0056 | 1.9431 | 13.2979 | 23 | 1909 | response to external stimulus |
| GO:0021514 | 0.0061 | 19.3538 | 0.1184 | 2 | 17 | ventral spinal cord interneuron differentiation |
| GO:0001706 | 0.0063 | 8.6008 | 0.3762 | 3 | 54 | endoderm formation |
| GO:0050877 | 0.0069 | 2.3453 | 6.0116 | 13 | 863 | nervous system process |
| GO:0009891 | 0.0069 | 1.9581 | 11.9395 | 21 | 1714 | positive regulation of biosynthetic process |
| GO:0003142 | 0.007 | Inf | 0.007 | 1 | 1 | cardiogenic plate morphogenesis |
| GO:0003144 | 0.007 | Inf | 0.007 | 1 | 1 | embryonic heart tube formation |
| GO:0003322 | 0.007 | Inf | 0.007 | 1 | 1 | pancreatic A cell development |
| GO:0021905 | 0.007 | Inf | 0.007 | 1 | 1 | forebrain-midbrain boundary formation |
| GO:0021918 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment |
| GO:0034972 | 0.007 | Inf | 0.007 | 1 | 1 | histone H3-R26 methylation |
| GO:0036306 | 0.007 | Inf | 0.007 | 1 | 1 | embryonic heart tube elongation |
| GO:0038115 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 19 signaling pathway |
| GO:0038116 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 21 signaling pathway |
| GO:0048621 | 0.007 | Inf | 0.007 | 1 | 1 | post-embryonic digestive tract morphogenesis |
| GO:0051296 | 0.007 | Inf | 0.007 | 1 | 1 | establishment of meiotic spindle orientation |
| GO:0060807 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
| GO:0060817 | 0.007 | Inf | 0.007 | 1 | 1 | inactivation of paternal X chromosome |
| GO:0097022 | 0.007 | Inf | 0.007 | 1 | 1 | lymphocyte migration into lymph node |
| GO:1904325 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of inhibitory G-protein coupled receptor phosphorylation |
| GO:2000522 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of immunological synapse formation |
| GO:2000525 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of T cell costimulation |
| GO:2000526 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
| GO:2000872 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of progesterone secretion |
| GO:0072507 | 0.0071 | 3.0413 | 2.8073 | 8 | 403 | divalent inorganic cation homeostasis |
| GO:0023019 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | signal transduction involved in regulation of gene expression |
| GO:0030828 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | positive regulation of cGMP biosynthetic process |
| GO:0060575 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | intestinal epithelial cell differentiation |
| GO:0007368 | 0.0078 | 5.4477 | 0.7802 | 4 | 112 | determination of left/right symmetry |
| GO:0032845 | 0.0079 | 4.2997 | 1.233 | 5 | 177 | negative regulation of homeostatic process |
| GO:0032760 | 0.0081 | 7.8303 | 0.411 | 3 | 59 | positive regulation of tumor necrosis factor production |
| GO:0048645 | 0.0081 | 7.8303 | 0.411 | 3 | 59 | animal organ formation |
| GO:2000147 | 0.0081 | 2.9717 | 2.8699 | 8 | 412 | positive regulation of cell motility |
| GO:0007159 | 0.0083 | 3.2372 | 2.2987 | 7 | 330 | leukocyte cell-cell adhesion |
| GO:0009913 | 0.0084 | 3.6256 | 1.7554 | 6 | 252 | epidermal cell differentiation |
| GO:0051254 | 0.0084 | 2.0143 | 9.8289 | 18 | 1411 | positive regulation of RNA metabolic process |
| GO:0001824 | 0.0084 | 7.6924 | 0.418 | 3 | 60 | blastocyst development |
| GO:0007498 | 0.0093 | 5.1589 | 0.822 | 4 | 118 | mesoderm development |
| GO:0045596 | 0.0094 | 2.5458 | 4.2074 | 10 | 604 | negative regulation of cell differentiation |
| GO:2000021 | 0.0097 | 4.0835 | 1.2957 | 5 | 186 | regulation of ion homeostasis |
| GO:0048534 | 0.0099 | 2.3142 | 5.5866 | 12 | 802 | hematopoietic or lymphoid organ development |
| GO:0002521 | 0.0099 | 2.8624 | 2.9744 | 8 | 427 | leukocyte differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007416 | 0 | 13.3985 | 1.1711 | 13 | 135 | synapse assembly |
| GO:0048704 | 0 | 16.8395 | 0.7981 | 11 | 92 | embryonic skeletal system morphogenesis |
| GO:0009952 | 0 | 9.8244 | 1.6829 | 14 | 194 | anterior/posterior pattern specification |
| GO:0007156 | 0 | 10.675 | 1.3185 | 12 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0032502 | 0 | 2.7332 | 47.2984 | 79 | 5531 | developmental process |
| GO:0016339 | 0 | 32.6039 | 0.2429 | 6 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0007389 | 0 | 5.1972 | 3.5219 | 16 | 406 | pattern specification process |
| GO:0048568 | 0 | 5.1835 | 3.5305 | 16 | 407 | embryonic organ development |
| GO:0048731 | 0 | 2.5066 | 21.7089 | 41 | 2982 | system development |
| GO:0009887 | 0 | 3.0652 | 8.2061 | 22 | 946 | animal organ morphogenesis |
| GO:0032501 | 0 | 2.1951 | 43.6331 | 65 | 5769 | multicellular organismal process |
| GO:0048598 | 0 | 3.652 | 4.9011 | 16 | 565 | embryonic morphogenesis |
| GO:0001501 | 1e-04 | 3.841 | 4.0423 | 14 | 466 | skeletal system development |
| GO:0021570 | 1e-04 | Inf | 0.0173 | 2 | 2 | rhombomere 4 development |
| GO:0045944 | 1e-04 | 2.7521 | 9.0562 | 22 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001764 | 2e-04 | 6.6484 | 1.1537 | 7 | 133 | neuron migration |
| GO:0021520 | 2e-04 | 35.0581 | 0.1128 | 3 | 13 | spinal cord motor neuron cell fate specification |
| GO:0060429 | 2e-04 | 2.5961 | 9.5506 | 22 | 1101 | epithelium development |
| GO:0043009 | 3e-04 | 3.2646 | 4.7103 | 14 | 543 | chordate embryonic development |
| GO:0010628 | 3e-04 | 2.2556 | 14.7727 | 29 | 1703 | positive regulation of gene expression |
| GO:0048486 | 4e-04 | 25.0349 | 0.1475 | 3 | 17 | parasympathetic nervous system development |
| GO:0051412 | 4e-04 | 25.0349 | 0.1475 | 3 | 17 | response to corticosterone |
| GO:0019219 | 4e-04 | 1.8771 | 34.1082 | 52 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0007268 | 4e-04 | 3.1061 | 4.9358 | 14 | 569 | chemical synaptic transmission |
| GO:0099537 | 4e-04 | 3.0945 | 4.9531 | 14 | 571 | trans-synaptic signaling |
| GO:0021615 | 4e-04 | 116.0231 | 0.0347 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0032811 | 4e-04 | 116.0231 | 0.0347 | 2 | 4 | negative regulation of epinephrine secretion |
| GO:0050877 | 5e-04 | 2.6609 | 7.4861 | 18 | 863 | nervous system process |
| GO:0034654 | 6e-04 | 1.8418 | 34.5853 | 52 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0007267 | 7e-04 | 2.2242 | 12.6561 | 25 | 1459 | cell-cell signaling |
| GO:0009889 | 8e-04 | 1.8029 | 35.9472 | 53 | 4144 | regulation of biosynthetic process |
| GO:0006355 | 0.0011 | 1.8259 | 29.2765 | 45 | 3375 | regulation of transcription, DNA-templated |
| GO:0048241 | 0.0011 | 58.0038 | 0.052 | 2 | 6 | epinephrine transport |
| GO:0030878 | 0.0011 | 16.6822 | 0.2082 | 3 | 24 | thyroid gland development |
| GO:1903508 | 0.0012 | 2.2022 | 11.6412 | 23 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0031328 | 0.0012 | 2.0782 | 14.6426 | 27 | 1688 | positive regulation of cellular biosynthetic process |
| GO:2001141 | 0.0013 | 1.8077 | 29.502 | 45 | 3401 | regulation of RNA biosynthetic process |
| GO:0007420 | 0.0013 | 2.7358 | 5.5604 | 14 | 641 | brain development |
| GO:0010700 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:0021612 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | facial nerve structural organization |
| GO:0032661 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | regulation of interleukin-18 production |
| GO:0060017 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | parathyroid gland development |
| GO:0033141 | 0.002 | 38.6641 | 0.0694 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0051254 | 0.0023 | 2.0823 | 12.2397 | 23 | 1411 | positive regulation of RNA metabolic process |
| GO:0030154 | 0.0025 | 1.7421 | 30.5039 | 45 | 3614 | cell differentiation |
| GO:0021561 | 0.0026 | 33.1385 | 0.0781 | 2 | 9 | facial nerve development |
| GO:0043330 | 0.0026 | 12.0738 | 0.2776 | 3 | 32 | response to exogenous dsRNA |
| GO:0051952 | 0.0032 | 7.1113 | 0.6072 | 4 | 70 | regulation of amine transport |
| GO:0050830 | 0.0041 | 6.6083 | 0.6506 | 4 | 75 | defense response to Gram-positive bacterium |
| GO:0021545 | 0.0041 | 10.1528 | 0.3248 | 3 | 38 | cranial nerve development |
| GO:0097300 | 0.0046 | 9.7216 | 0.3383 | 3 | 39 | programmed necrotic cell death |
| GO:0007252 | 0.0047 | 23.1923 | 0.1041 | 2 | 12 | I-kappaB phosphorylation |
| GO:0042063 | 0.0049 | 3.5696 | 2.0819 | 7 | 240 | gliogenesis |
| GO:0001709 | 0.005 | 9.4582 | 0.347 | 3 | 40 | cell fate determination |
| GO:0032757 | 0.005 | 9.4582 | 0.347 | 3 | 40 | positive regulation of interleukin-8 production |
| GO:0009893 | 0.0055 | 1.6879 | 26.3792 | 39 | 3041 | positive regulation of metabolic process |
| GO:0061548 | 0.0055 | 21.0825 | 0.1128 | 2 | 13 | ganglion development |
| GO:0098609 | 0.0056 | 2.3131 | 6.5059 | 14 | 750 | cell-cell adhesion |
| GO:0043588 | 0.0059 | 3.1369 | 2.7064 | 8 | 312 | skin development |
| GO:0098542 | 0.0059 | 2.902 | 3.2963 | 9 | 380 | defense response to other organism |
| GO:0021517 | 0.0061 | 8.7471 | 0.373 | 3 | 43 | ventral spinal cord development |
| GO:0034356 | 0.0063 | 19.3244 | 0.1214 | 2 | 14 | NAD biosynthesis via nicotinamide riboside salvage pathway |
| GO:0042711 | 0.0063 | 19.3244 | 0.1214 | 2 | 14 | maternal behavior |
| GO:0009913 | 0.0064 | 3.392 | 2.186 | 7 | 252 | epidermal cell differentiation |
| GO:0031424 | 0.0068 | 4.4599 | 1.1884 | 5 | 137 | keratinization |
| GO:0032655 | 0.0069 | 8.3295 | 0.3904 | 3 | 45 | regulation of interleukin-12 production |
| GO:0035176 | 0.0069 | 8.3295 | 0.3904 | 3 | 45 | social behavior |
| GO:0007417 | 0.0071 | 3.7619 | 1.692 | 6 | 209 | central nervous system development |
| GO:0048532 | 0.0073 | 17.8367 | 0.1301 | 2 | 15 | anatomical structure arrangement |
| GO:0010557 | 0.0077 | 1.86 | 13.5322 | 23 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0002067 | 0.0078 | 7.9498 | 0.4077 | 3 | 47 | glandular epithelial cell differentiation |
| GO:0032722 | 0.0078 | 7.9498 | 0.4077 | 3 | 47 | positive regulation of chemokine production |
| GO:0002323 | 0.0083 | 16.5615 | 0.1388 | 2 | 16 | natural killer cell activation involved in immune response |
| GO:0007625 | 0.0083 | 16.5615 | 0.1388 | 2 | 16 | grooming behavior |
| GO:0003311 | 0.0087 | Inf | 0.0087 | 1 | 1 | pancreatic D cell differentiation |
| GO:0003322 | 0.0087 | Inf | 0.0087 | 1 | 1 | pancreatic A cell development |
| GO:0016077 | 0.0087 | Inf | 0.0087 | 1 | 1 | snoRNA catabolic process |
| GO:0021723 | 0.0087 | Inf | 0.0087 | 1 | 1 | medullary reticular formation development |
| GO:0021754 | 0.0087 | Inf | 0.0087 | 1 | 1 | facial nucleus development |
| GO:0021905 | 0.0087 | Inf | 0.0087 | 1 | 1 | forebrain-midbrain boundary formation |
| GO:0021918 | 0.0087 | Inf | 0.0087 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment |
| GO:0032197 | 0.0087 | Inf | 0.0087 | 1 | 1 | transposition, RNA-mediated |
| GO:0032685 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0034346 | 0.0087 | Inf | 0.0087 | 1 | 1 | positive regulation of type III interferon production |
| GO:0035863 | 0.0087 | Inf | 0.0087 | 1 | 1 | dITP catabolic process |
| GO:0048894 | 0.0087 | Inf | 0.0087 | 1 | 1 | efferent axon development in a lateral line nerve |
| GO:0061452 | 0.0087 | Inf | 0.0087 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
| GO:0071444 | 0.0087 | Inf | 0.0087 | 1 | 1 | cellular response to pheromone |
| GO:0071881 | 0.0087 | Inf | 0.0087 | 1 | 1 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway |
| GO:0071882 | 0.0087 | Inf | 0.0087 | 1 | 1 | phospholipase C-activating adrenergic receptor signaling pathway |
| GO:0072274 | 0.0087 | Inf | 0.0087 | 1 | 1 | metanephric glomerular basement membrane development |
| GO:0090104 | 0.0087 | Inf | 0.0087 | 1 | 1 | pancreatic epsilon cell differentiation |
| GO:0110023 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
| GO:1901639 | 0.0087 | Inf | 0.0087 | 1 | 1 | XDP catabolic process |
| GO:1902867 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:1903769 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:0051928 | 0.0087 | 5.2654 | 0.8067 | 4 | 93 | positive regulation of calcium ion transport |
| GO:0061178 | 0.0088 | 7.6031 | 0.4251 | 3 | 49 | regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:2000738 | 0.0093 | 15.4564 | 0.1475 | 2 | 17 | positive regulation of stem cell differentiation |
| GO:0019933 | 0.0097 | 5.0927 | 0.8328 | 4 | 96 | cAMP-mediated signaling |
| GO:0021761 | 0.0097 | 5.0927 | 0.8328 | 4 | 96 | limbic system development |
| GO:0021515 | 0.0098 | 7.2854 | 0.4424 | 3 | 51 | cell differentiation in spinal cord |
| GO:0010469 | 0.0099 | 2.5102 | 4.2245 | 10 | 487 | regulation of receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 45.6727 | 0.3746 | 12 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 23.9637 | 0.7623 | 14 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 21.2364 | 0.8477 | 14 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 20.6924 | 0.8675 | 14 | 132 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 3.8223 | 5.5136 | 18 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 3.7075 | 5.6713 | 18 | 863 | nervous system process |
| GO:0007565 | 0 | 7.7844 | 1.15 | 8 | 175 | female pregnancy |
| GO:0061760 | 1e-04 | 308.4898 | 0.0197 | 2 | 3 | antifungal innate immune response |
| GO:0045087 | 3e-04 | 3.3035 | 4.7667 | 14 | 740 | innate immune response |
| GO:0050829 | 8e-04 | 10.6342 | 0.414 | 4 | 63 | defense response to Gram-negative bacterium |
| GO:0035865 | 0.0012 | 51.398 | 0.0526 | 2 | 8 | cellular response to potassium ion |
| GO:0019730 | 0.0012 | 9.3595 | 0.4666 | 4 | 71 | antimicrobial humoral response |
| GO:0050830 | 0.0014 | 9.0508 | 0.4815 | 4 | 74 | defense response to Gram-positive bacterium |
| GO:0032342 | 0.0015 | 44.0525 | 0.0591 | 2 | 9 | aldosterone biosynthetic process |
| GO:0034651 | 0.0015 | 44.0525 | 0.0591 | 2 | 9 | cortisol biosynthetic process |
| GO:0008212 | 0.0019 | 38.5434 | 0.0657 | 2 | 10 | mineralocorticoid metabolic process |
| GO:0009620 | 0.0021 | 12.9562 | 0.2563 | 3 | 39 | response to fungus |
| GO:0031640 | 0.0026 | 11.9572 | 0.276 | 3 | 42 | killing of cells of other organism |
| GO:0098542 | 0.0035 | 3.4467 | 2.4972 | 8 | 380 | defense response to other organism |
| GO:0001977 | 0.0055 | 20.5469 | 0.1117 | 2 | 17 | renal system process involved in regulation of blood volume |
| GO:0001580 | 0.0061 | 19.2615 | 0.1183 | 2 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0070098 | 0.0062 | 8.6271 | 0.3746 | 3 | 57 | chemokine-mediated signaling pathway |
| GO:0060118 | 0.0066 | Inf | 0.0066 | 1 | 1 | vestibular receptor cell development |
| GO:0070292 | 0.0066 | Inf | 0.0066 | 1 | 1 | N-acylphosphatidylethanolamine metabolic process |
| GO:0070946 | 0.0066 | Inf | 0.0066 | 1 | 1 | neutrophil mediated killing of gram-positive bacterium |
| GO:0071663 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of granzyme B production |
| GO:1901318 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of flagellated sperm motility |
| GO:0008211 | 0.0083 | 16.217 | 0.138 | 2 | 21 | glucocorticoid metabolic process |
| GO:0050776 | 0.0088 | 2.3593 | 5.507 | 12 | 838 | regulation of immune response |
| GO:0002376 | 0.0089 | 1.8095 | 16.3238 | 26 | 2484 | immune system process |
| GO:0001895 | 0.009 | 7.51 | 0.4272 | 3 | 65 | retina homeostasis |
| GO:0016338 | 0.0091 | 15.4051 | 0.1446 | 2 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0051346 | 0.0092 | 3.1757 | 2.3461 | 7 | 357 | negative regulation of hydrolase activity |
| GO:0009617 | 0.0094 | 2.8938 | 2.9506 | 8 | 449 | response to bacterium |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009952 | 0 | 7.0595 | 2.439 | 15 | 180 | anterior/posterior pattern specification |
| GO:0009790 | 0 | 3.2279 | 12.1813 | 34 | 894 | embryo development |
| GO:0048646 | 0 | 3.2847 | 11.2304 | 32 | 839 | anatomical structure formation involved in morphogenesis |
| GO:0048704 | 0 | 9.1006 | 1.2696 | 10 | 92 | embryonic skeletal system morphogenesis |
| GO:0072359 | 0 | 2.7536 | 12.6825 | 31 | 919 | circulatory system development |
| GO:0045944 | 0 | 2.581 | 14.4076 | 33 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0010454 | 0 | 41.6089 | 0.1518 | 4 | 11 | negative regulation of cell fate commitment |
| GO:0030878 | 0 | 19.2401 | 0.3312 | 5 | 24 | thyroid gland development |
| GO:0010628 | 0 | 2.1326 | 23.502 | 44 | 1703 | positive regulation of gene expression |
| GO:0051094 | 0 | 2.3719 | 15.5669 | 33 | 1143 | positive regulation of developmental process |
| GO:0021515 | 1e-04 | 9.7791 | 0.7038 | 6 | 51 | cell differentiation in spinal cord |
| GO:0009653 | 1e-04 | 3.5042 | 4.7215 | 15 | 407 | anatomical structure morphogenesis |
| GO:0060485 | 1e-04 | 4.0924 | 3.1879 | 12 | 231 | mesenchyme development |
| GO:0021953 | 1e-04 | 4.8224 | 2.2633 | 10 | 164 | central nervous system neuron differentiation |
| GO:0023019 | 1e-04 | 19.4071 | 0.2622 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0022603 | 1e-04 | 2.4118 | 11.835 | 26 | 872 | regulation of anatomical structure morphogenesis |
| GO:0048562 | 2e-04 | 4.4361 | 2.4463 | 10 | 185 | embryonic organ morphogenesis |
| GO:2000824 | 2e-04 | Inf | 0.0276 | 2 | 2 | negative regulation of androgen receptor activity |
| GO:0016338 | 2e-04 | 16.1694 | 0.3036 | 4 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0051254 | 2e-04 | 2.0512 | 19.4723 | 36 | 1411 | positive regulation of RNA metabolic process |
| GO:0006355 | 2e-04 | 1.732 | 46.5762 | 69 | 3375 | regulation of transcription, DNA-templated |
| GO:0014706 | 3e-04 | 3.2472 | 4.6507 | 14 | 337 | striated muscle tissue development |
| GO:0060562 | 3e-04 | 3.4088 | 4.1125 | 13 | 298 | epithelial tube morphogenesis |
| GO:2001141 | 3e-04 | 1.7147 | 46.935 | 69 | 3401 | regulation of RNA biosynthetic process |
| GO:0048514 | 3e-04 | 2.9413 | 5.8742 | 16 | 434 | blood vessel morphogenesis |
| GO:0021517 | 3e-04 | 9.6078 | 0.5934 | 5 | 43 | ventral spinal cord development |
| GO:0060914 | 3e-04 | 14.5505 | 0.3312 | 4 | 24 | heart formation |
| GO:0048513 | 3e-04 | 1.8259 | 32.7321 | 52 | 2519 | animal organ development |
| GO:1903508 | 4e-04 | 2.0232 | 18.5201 | 34 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0048484 | 4e-04 | 27.1721 | 0.1518 | 3 | 11 | enteric nervous system development |
| GO:0060573 | 4e-04 | 27.1721 | 0.1518 | 3 | 11 | cell fate specification involved in pattern specification |
| GO:2000736 | 4e-04 | 4.8723 | 1.7802 | 8 | 129 | regulation of stem cell differentiation |
| GO:0050789 | 5e-04 | 1.7002 | 137.4515 | 160 | 9960 | regulation of biological process |
| GO:0035050 | 5e-04 | 6.6582 | 0.9936 | 6 | 72 | embryonic heart tube development |
| GO:0042659 | 5e-04 | 24.1514 | 0.1656 | 3 | 12 | regulation of cell fate specification |
| GO:0003151 | 5e-04 | 6.4615 | 1.0212 | 6 | 74 | outflow tract morphogenesis |
| GO:0019219 | 5e-04 | 1.6402 | 54.263 | 76 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0003285 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | septum secundum development |
| GO:0021912 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035054 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0060913 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | cardiac cell fate determination |
| GO:0061010 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | gall bladder development |
| GO:0048663 | 8e-04 | 7.7078 | 0.7217 | 5 | 53 | neuron fate commitment |
| GO:0001708 | 8e-04 | 7.6592 | 0.7252 | 5 | 54 | cell fate specification |
| GO:2000026 | 0.001 | 1.9308 | 18.7972 | 33 | 1439 | regulation of multicellular organismal development |
| GO:0060579 | 0.001 | 18.1099 | 0.207 | 3 | 15 | ventral spinal cord interneuron fate commitment |
| GO:0001947 | 0.0011 | 7.0145 | 0.7866 | 5 | 57 | heart looping |
| GO:0003308 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0021764 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | amygdala development |
| GO:0021913 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0042662 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0060920 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | cardiac pacemaker cell differentiation |
| GO:0061055 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | myotome development |
| GO:0072107 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0090191 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905903 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0055003 | 0.0013 | 16.7157 | 0.2208 | 3 | 16 | cardiac myofibril assembly |
| GO:0060541 | 0.0013 | 3.6677 | 2.6221 | 9 | 190 | respiratory system development |
| GO:0003002 | 0.0014 | 5.3305 | 1.2163 | 6 | 97 | regionalization |
| GO:0030858 | 0.0014 | 6.6306 | 0.828 | 5 | 60 | positive regulation of epithelial cell differentiation |
| GO:1903507 | 0.0015 | 1.9721 | 15.3736 | 28 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0048486 | 0.0015 | 15.5207 | 0.2346 | 3 | 17 | parasympathetic nervous system development |
| GO:0009890 | 0.0016 | 1.8321 | 20.8661 | 35 | 1512 | negative regulation of biosynthetic process |
| GO:0000122 | 0.0018 | 2.1637 | 10.4055 | 21 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0032501 | 0.0018 | 1.58 | 62.7829 | 82 | 4896 | multicellular organismal process |
| GO:0001759 | 0.0018 | 14.485 | 0.2484 | 3 | 18 | organ induction |
| GO:0051891 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0061009 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | common bile duct development |
| GO:0071502 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | cellular response to temperature stimulus |
| GO:0051253 | 0.0019 | 1.9161 | 16.381 | 29 | 1187 | negative regulation of RNA metabolic process |
| GO:2000113 | 0.0019 | 1.8564 | 18.7271 | 32 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0001667 | 0.0019 | 2.8452 | 4.4851 | 12 | 325 | ameboidal-type cell migration |
| GO:0010470 | 0.002 | 8.3062 | 0.5382 | 4 | 39 | regulation of gastrulation |
| GO:0048729 | 0.0021 | 2.4045 | 7.0942 | 16 | 524 | tissue morphogenesis |
| GO:0003215 | 0.0021 | 13.5788 | 0.2622 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0034654 | 0.0022 | 1.5427 | 55.022 | 74 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0031497 | 0.0023 | 4.1388 | 1.8078 | 7 | 131 | chromatin assembly |
| GO:0045766 | 0.0023 | 4.1388 | 1.8078 | 7 | 131 | positive regulation of angiogenesis |
| GO:0001944 | 0.0024 | 2.7614 | 4.6194 | 12 | 349 | vasculature development |
| GO:0060284 | 0.0026 | 2.0916 | 10.7367 | 21 | 778 | regulation of cell development |
| GO:0010557 | 0.0026 | 1.7681 | 21.5286 | 35 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0021902 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0030240 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | skeletal muscle thin filament assembly |
| GO:0033603 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | positive regulation of dopamine secretion |
| GO:0034128 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:2001199 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | negative regulation of dendritic cell differentiation |
| GO:1905207 | 0.0029 | 7.4523 | 0.5934 | 4 | 43 | regulation of cardiocyte differentiation |
| GO:0007263 | 0.0029 | 12.0684 | 0.2898 | 3 | 21 | nitric oxide mediated signal transduction |
| GO:0001570 | 0.003 | 5.5214 | 0.9798 | 5 | 71 | vasculogenesis |
| GO:0034728 | 0.0032 | 3.8858 | 1.9182 | 7 | 139 | nucleosome organization |
| GO:0030154 | 0.0034 | 1.6118 | 36.4541 | 52 | 2954 | cell differentiation |
| GO:0042127 | 0.0035 | 1.7593 | 20.3003 | 33 | 1471 | regulation of cell proliferation |
| GO:0032989 | 0.0036 | 1.9353 | 13.2759 | 24 | 962 | cellular component morphogenesis |
| GO:0045664 | 0.0036 | 2.2661 | 7.4936 | 16 | 543 | regulation of neuron differentiation |
| GO:0007517 | 0.0037 | 2.6066 | 4.8715 | 12 | 353 | muscle organ development |
| GO:0060415 | 0.0038 | 5.2045 | 1.035 | 5 | 75 | muscle tissue morphogenesis |
| GO:0001826 | 0.0038 | 28.85 | 0.0966 | 2 | 7 | inner cell mass cell differentiation |
| GO:0007492 | 0.0042 | 5.0593 | 1.0626 | 5 | 77 | endoderm development |
| GO:0006335 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0021511 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | spinal cord patterning |
| GO:0060487 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | lung epithelial cell differentiation |
| GO:0061217 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | regulation of mesonephros development |
| GO:0030097 | 0.0044 | 2.0266 | 10.5021 | 20 | 761 | hemopoiesis |
| GO:0007368 | 0.0046 | 4.1346 | 1.5456 | 6 | 112 | determination of left/right symmetry |
| GO:0045992 | 0.0048 | 9.8715 | 0.345 | 3 | 25 | negative regulation of embryonic development |
| GO:1905770 | 0.005 | 24.0401 | 0.1104 | 2 | 8 | regulation of mesodermal cell differentiation |
| GO:0031328 | 0.0053 | 1.6726 | 23.295 | 36 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0000183 | 0.0053 | 9.4417 | 0.3588 | 3 | 26 | chromatin silencing at rDNA |
| GO:0003231 | 0.0054 | 3.9832 | 1.6008 | 6 | 116 | cardiac ventricle development |
| GO:0035295 | 0.0056 | 2.2885 | 6.4664 | 14 | 480 | tube development |
| GO:0007498 | 0.0059 | 3.9115 | 1.6284 | 6 | 118 | mesoderm development |
| GO:0048523 | 0.0061 | 1.4636 | 58.0167 | 75 | 4204 | negative regulation of cellular process |
| GO:0016525 | 0.0061 | 4.6088 | 1.1592 | 5 | 84 | negative regulation of angiogenesis |
| GO:0071773 | 0.0062 | 3.4154 | 2.1667 | 7 | 157 | cellular response to BMP stimulus |
| GO:0001714 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | endodermal cell fate specification |
| GO:0003139 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | secondary heart field specification |
| GO:0048617 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | embryonic foregut morphogenesis |
| GO:0070863 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | positive regulation of protein exit from endoplasmic reticulum |
| GO:0072172 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | mesonephric tubule formation |
| GO:1903430 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | negative regulation of cell maturation |
| GO:2000288 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | positive regulation of myoblast proliferation |
| GO:0048706 | 0.0065 | 8.7265 | 0.3835 | 3 | 29 | embryonic skeletal system development |
| GO:0002520 | 0.0065 | 1.9149 | 11.6475 | 21 | 844 | immune system development |
| GO:0043403 | 0.0066 | 8.6852 | 0.3864 | 3 | 28 | skeletal muscle tissue regeneration |
| GO:0060441 | 0.0066 | 8.6852 | 0.3864 | 3 | 28 | epithelial tube branching involved in lung morphogenesis |
| GO:0001704 | 0.0066 | 3.8087 | 1.6698 | 6 | 121 | formation of primary germ layer |
| GO:0060993 | 0.0067 | 4.4944 | 1.1868 | 5 | 86 | kidney morphogenesis |
| GO:0009799 | 0.0069 | 3.7756 | 1.6836 | 6 | 122 | specification of symmetry |
| GO:0030855 | 0.007 | 2.1601 | 7.3352 | 15 | 547 | epithelial cell differentiation |
| GO:0071276 | 0.0073 | 8.3506 | 0.4002 | 3 | 29 | cellular response to cadmium ion |
| GO:0072080 | 0.0074 | 4.3855 | 1.2144 | 5 | 88 | nephron tubule development |
| GO:1901342 | 0.0075 | 3.2821 | 2.2499 | 7 | 166 | regulation of vasculature development |
| GO:0021520 | 0.0078 | 18.2015 | 0.1367 | 2 | 10 | spinal cord motor neuron cell fate specification |
| GO:0003211 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | cardiac ventricle formation |
| GO:0030238 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | male sex determination |
| GO:0051967 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | negative regulation of synaptic transmission, glutamatergic |
| GO:0061042 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | vascular wound healing |
| GO:0034142 | 0.008 | 8.0408 | 0.414 | 3 | 30 | toll-like receptor 4 signaling pathway |
| GO:0051240 | 0.0082 | 1.6907 | 19.0126 | 30 | 1396 | positive regulation of multicellular organismal process |
| GO:0003209 | 0.0088 | 7.7531 | 0.4278 | 3 | 31 | cardiac atrium morphogenesis |
| GO:0021872 | 0.0089 | 5.2787 | 0.8142 | 4 | 59 | forebrain generation of neurons |
| GO:0035282 | 0.0089 | 4.1828 | 1.2696 | 5 | 92 | segmentation |
| GO:1901343 | 0.0089 | 4.1828 | 1.2696 | 5 | 92 | negative regulation of vasculature development |
| GO:0060429 | 0.0091 | 2.3113 | 5.4736 | 12 | 428 | epithelium development |
| GO:0097305 | 0.0091 | 3.1599 | 2.3323 | 7 | 169 | response to alcohol |
| GO:0042472 | 0.0093 | 4.135 | 1.2834 | 5 | 93 | inner ear morphogenesis |
| GO:0001655 | 0.0095 | 2.5109 | 4.1815 | 10 | 303 | urogenital system development |
| GO:0043009 | 0.0095 | 2.2923 | 5.507 | 12 | 422 | chordate embryonic development |
| GO:0003161 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | cardiac conduction system development |
| GO:0007512 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | adult heart development |
| GO:0021903 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0090009 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | primitive streak formation |
| GO:2000774 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | positive regulation of cellular senescence |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048646 | 0 | 2.8076 | 13.7613 | 34 | 965 | anatomical structure formation involved in morphogenesis |
| GO:2000026 | 0 | 2.3141 | 24.6419 | 49 | 1728 | regulation of multicellular organismal development |
| GO:0003002 | 0 | 3.8352 | 4.5776 | 16 | 321 | regionalization |
| GO:0051240 | 0 | 2.276 | 19.3831 | 39 | 1389 | positive regulation of multicellular organismal process |
| GO:0072359 | 0 | 2.5465 | 13.1053 | 30 | 919 | circulatory system development |
| GO:0001944 | 0 | 2.9266 | 8.656 | 23 | 607 | vasculature development |
| GO:0060485 | 0 | 4.3211 | 3.2941 | 13 | 231 | mesenchyme development |
| GO:2001199 | 1e-04 | 70.0794 | 0.0856 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0035909 | 1e-04 | 12.1755 | 0.4849 | 5 | 34 | aorta morphogenesis |
| GO:0048514 | 1e-04 | 2.8658 | 7.2015 | 19 | 505 | blood vessel morphogenesis |
| GO:0021872 | 2e-04 | 8.0195 | 0.8414 | 6 | 59 | forebrain generation of neurons |
| GO:0008284 | 2e-04 | 2.3867 | 11.4226 | 25 | 801 | positive regulation of cell proliferation |
| GO:0030858 | 2e-04 | 7.8705 | 0.8556 | 6 | 60 | positive regulation of epithelial cell differentiation |
| GO:0051241 | 3e-04 | 2.1886 | 13.9609 | 28 | 979 | negative regulation of multicellular organismal process |
| GO:0043066 | 4e-04 | 2.3171 | 11.2372 | 24 | 788 | negative regulation of apoptotic process |
| GO:0060741 | 6e-04 | 139.5256 | 0.0428 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0060041 | 7e-04 | 4.4474 | 1.9394 | 8 | 136 | retina development in camera-type eye |
| GO:0051094 | 8e-04 | 3.1789 | 4.0526 | 12 | 308 | positive regulation of developmental process |
| GO:0060548 | 8e-04 | 2.1488 | 12.5776 | 25 | 882 | negative regulation of cell death |
| GO:0048468 | 8e-04 | 1.7964 | 26.4815 | 43 | 1857 | cell development |
| GO:0048665 | 0.0012 | 9.6947 | 0.4706 | 4 | 33 | neuron fate specification |
| GO:0021764 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | amygdala development |
| GO:0072107 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0090191 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905205 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:0045165 | 0.0012 | 3.4163 | 3.1253 | 10 | 222 | cell fate commitment |
| GO:0001655 | 0.0014 | 2.9588 | 4.3209 | 12 | 303 | urogenital system development |
| GO:0060850 | 0.0014 | 16.1614 | 0.2282 | 3 | 16 | regulation of transcription involved in cell fate commitment |
| GO:0007498 | 0.0015 | 4.4712 | 1.6827 | 7 | 118 | mesoderm development |
| GO:0045765 | 0.0018 | 3.2306 | 3.2941 | 10 | 231 | regulation of angiogenesis |
| GO:0051122 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0060455 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0071502 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | cellular response to temperature stimulus |
| GO:2000609 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | regulation of thyroid hormone generation |
| GO:2001188 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0001759 | 0.002 | 14.0047 | 0.2567 | 3 | 18 | organ induction |
| GO:0009792 | 0.0022 | 2.3207 | 7.8004 | 17 | 547 | embryo development ending in birth or egg hatching |
| GO:0030803 | 0.0022 | 8.0295 | 0.5562 | 4 | 39 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0023019 | 0.0023 | 13.1285 | 0.2709 | 3 | 19 | signal transduction involved in regulation of gene expression |
| GO:0042403 | 0.0023 | 13.1285 | 0.2709 | 3 | 19 | thyroid hormone metabolic process |
| GO:0048729 | 0.0024 | 2.2448 | 8.542 | 18 | 599 | tissue morphogenesis |
| GO:0007423 | 0.0025 | 2.3572 | 7.2157 | 16 | 506 | sensory organ development |
| GO:0030815 | 0.0027 | 7.5945 | 0.5847 | 4 | 41 | negative regulation of cAMP metabolic process |
| GO:0051093 | 0.0028 | 2.0402 | 11.5224 | 22 | 808 | negative regulation of developmental process |
| GO:0034128 | 0.0029 | 34.8744 | 0.0856 | 2 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:1900372 | 0.0029 | 7.3941 | 0.5989 | 4 | 42 | negative regulation of purine nucleotide biosynthetic process |
| GO:0045597 | 0.003 | 2.0602 | 10.8862 | 21 | 782 | positive regulation of cell differentiation |
| GO:0035050 | 0.0036 | 5.2566 | 1.0267 | 5 | 72 | embryonic heart tube development |
| GO:0060562 | 0.0037 | 2.7374 | 4.2496 | 11 | 298 | epithelial tube morphogenesis |
| GO:0001826 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | inner cell mass cell differentiation |
| GO:0002118 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | aggressive behavior |
| GO:0002645 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | positive regulation of tolerance induction |
| GO:0044332 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:0045686 | 0.0041 | 10.5 | 0.328 | 3 | 23 | negative regulation of glial cell differentiation |
| GO:0048592 | 0.0041 | 3.698 | 2.0107 | 7 | 141 | eye morphogenesis |
| GO:0009605 | 0.0046 | 1.6377 | 27.223 | 41 | 1909 | response to external stimulus |
| GO:0048771 | 0.0046 | 3.6163 | 2.0535 | 7 | 144 | tissue remodeling |
| GO:0060914 | 0.0046 | 9.9993 | 0.3422 | 3 | 24 | heart formation |
| GO:0061217 | 0.0046 | 9.9993 | 0.3422 | 3 | 24 | regulation of mesonephros development |
| GO:0003158 | 0.0049 | 4.0729 | 1.5686 | 6 | 110 | endothelium development |
| GO:0030509 | 0.005 | 3.5638 | 2.082 | 7 | 146 | BMP signaling pathway |
| GO:0060037 | 0.0052 | 9.5442 | 0.3565 | 3 | 25 | pharyngeal system development |
| GO:0001955 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | blood vessel maturation |
| GO:0042756 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | drinking behavior |
| GO:0051584 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
| GO:0060836 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | lymphatic endothelial cell differentiation |
| GO:0006334 | 0.0054 | 3.9955 | 1.5972 | 6 | 112 | nucleosome assembly |
| GO:0030817 | 0.0056 | 3.9579 | 1.6114 | 6 | 113 | regulation of cAMP biosynthetic process |
| GO:0060840 | 0.0057 | 4.6934 | 1.1408 | 5 | 80 | artery development |
| GO:0007194 | 0.0058 | 9.1286 | 0.3708 | 3 | 26 | negative regulation of adenylate cyclase activity |
| GO:0060541 | 0.006 | 3.1165 | 2.7095 | 8 | 190 | respiratory system development |
| GO:0045471 | 0.0061 | 3.8848 | 1.6399 | 6 | 115 | response to ethanol |
| GO:0060706 | 0.0065 | 8.7477 | 0.385 | 3 | 27 | cell differentiation involved in embryonic placenta development |
| GO:1902230 | 0.0065 | 8.7477 | 0.385 | 3 | 27 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0048562 | 0.0065 | 2.6657 | 3.9501 | 10 | 277 | embryonic organ morphogenesis |
| GO:0010033 | 0.0068 | 1.511 | 40.0288 | 55 | 2807 | response to organic substance |
| GO:0042363 | 0.0068 | 19.9243 | 0.1283 | 2 | 9 | fat-soluble vitamin catabolic process |
| GO:0072172 | 0.0068 | 19.9243 | 0.1283 | 2 | 9 | mesonephric tubule formation |
| GO:0001656 | 0.007 | 4.4546 | 1.1979 | 5 | 84 | metanephros development |
| GO:0001667 | 0.0071 | 2.4975 | 4.6346 | 11 | 325 | ameboidal-type cell migration |
| GO:0071772 | 0.0073 | 3.3 | 2.2389 | 7 | 157 | response to BMP |
| GO:0060993 | 0.0077 | 4.344 | 1.2264 | 5 | 86 | kidney morphogenesis |
| GO:0046530 | 0.0078 | 5.5046 | 0.7843 | 4 | 55 | photoreceptor cell differentiation |
| GO:0090132 | 0.008 | 2.7423 | 3.451 | 9 | 242 | epithelium migration |
| GO:0010660 | 0.0083 | 5.3983 | 0.7986 | 4 | 56 | regulation of muscle cell apoptotic process |
| GO:0048583 | 0.0084 | 1.4519 | 51.2803 | 67 | 3596 | regulation of response to stimulus |
| GO:0021877 | 0.0084 | 17.4326 | 0.1426 | 2 | 10 | forebrain neuron fate commitment |
| GO:0061042 | 0.0084 | 17.4326 | 0.1426 | 2 | 10 | vascular wound healing |
| GO:0097499 | 0.0084 | 17.4326 | 0.1426 | 2 | 10 | protein localization to non-motile cilium |
| GO:0072080 | 0.0085 | 4.2387 | 1.2549 | 5 | 88 | nephron tubule development |
| GO:0034142 | 0.0087 | 7.7741 | 0.4278 | 3 | 30 | toll-like receptor 4 signaling pathway |
| GO:0072604 | 0.0087 | 7.7741 | 0.4278 | 3 | 30 | interleukin-6 secretion |
| GO:0001947 | 0.0088 | 5.2961 | 0.8128 | 4 | 57 | heart looping |
| GO:0021953 | 0.0092 | 3.1514 | 2.3387 | 7 | 164 | central nervous system neuron differentiation |
| GO:0051937 | 0.0094 | 5.1977 | 0.8271 | 4 | 58 | catecholamine transport |
| GO:0042462 | 0.0096 | 7.496 | 0.4421 | 3 | 31 | eye photoreceptor cell development |
| GO:0043537 | 0.0096 | 7.496 | 0.4421 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0051954 | 0.0096 | 7.496 | 0.4421 | 3 | 31 | positive regulation of amine transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 44.052 | 0.427 | 13 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 19.4069 | 0.9889 | 15 | 132 | sensory perception of chemical stimulus |
| GO:0009593 | 0 | 20.5896 | 0.869 | 14 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 18.2463 | 0.9664 | 14 | 129 | detection of stimulus involved in sensory perception |
| GO:0016579 | 0 | 7.7365 | 1.9512 | 13 | 265 | protein deubiquitination |
| GO:0007565 | 0 | 7.7127 | 1.311 | 9 | 175 | female pregnancy |
| GO:0007186 | 0 | 3.4837 | 6.2855 | 19 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 3.3789 | 6.4653 | 19 | 863 | nervous system process |
| GO:0045087 | 0 | 3.4706 | 5.5663 | 17 | 743 | innate immune response |
| GO:0043632 | 1e-04 | 3.6905 | 4.2403 | 14 | 566 | modification-dependent macromolecule catabolic process |
| GO:0019730 | 2e-04 | 10.4511 | 0.5319 | 5 | 71 | antimicrobial humoral response |
| GO:0006511 | 7e-04 | 3.2794 | 4.0129 | 12 | 545 | ubiquitin-dependent protein catabolic process |
| GO:0071947 | 8e-04 | 67.4062 | 0.0449 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0090279 | 0.0012 | 16.3005 | 0.2098 | 3 | 28 | regulation of calcium ion import |
| GO:0035865 | 0.0015 | 44.9315 | 0.0599 | 2 | 8 | cellular response to potassium ion |
| GO:0032342 | 0.0019 | 38.5102 | 0.0674 | 2 | 9 | aldosterone biosynthetic process |
| GO:0034651 | 0.0019 | 38.5102 | 0.0674 | 2 | 9 | cortisol biosynthetic process |
| GO:0051603 | 0.0022 | 2.8261 | 4.6167 | 12 | 627 | proteolysis involved in cellular protein catabolic process |
| GO:0008212 | 0.0024 | 33.6942 | 0.0749 | 2 | 10 | mineralocorticoid metabolic process |
| GO:0042742 | 0.0025 | 4.7118 | 1.3635 | 6 | 182 | defense response to bacterium |
| GO:0043207 | 0.0025 | 2.6643 | 5.3116 | 13 | 709 | response to external biotic stimulus |
| GO:0030163 | 0.0029 | 2.5196 | 6.0607 | 14 | 809 | protein catabolic process |
| GO:0009913 | 0.0029 | 3.9674 | 1.8879 | 7 | 252 | epidermal cell differentiation |
| GO:0048247 | 0.0031 | 11.3116 | 0.2922 | 3 | 39 | lymphocyte chemotaxis |
| GO:0031424 | 0.0037 | 10.4951 | 0.3128 | 3 | 43 | keratinization |
| GO:0050776 | 0.0039 | 2.426 | 6.278 | 14 | 838 | regulation of immune response |
| GO:0002548 | 0.0043 | 9.9288 | 0.3296 | 3 | 44 | monocyte chemotaxis |
| GO:0002376 | 0.0044 | 1.8409 | 18.6092 | 30 | 2484 | immune system process |
| GO:0070268 | 0.0054 | 6.0659 | 0.7042 | 4 | 94 | cornification |
| GO:0032604 | 0.0055 | 20.728 | 0.1124 | 2 | 15 | granulocyte macrophage colony-stimulating factor production |
| GO:0001977 | 0.007 | 17.9619 | 0.1274 | 2 | 17 | renal system process involved in regulation of blood volume |
| GO:0007635 | 0.007 | 17.9619 | 0.1274 | 2 | 17 | chemosensory behavior |
| GO:0006037 | 0.0075 | Inf | 0.0075 | 1 | 1 | cell wall chitin metabolic process |
| GO:0038156 | 0.0075 | Inf | 0.0075 | 1 | 1 | interleukin-3-mediated signaling pathway |
| GO:0046296 | 0.0075 | Inf | 0.0075 | 1 | 1 | glycolate catabolic process |
| GO:1901318 | 0.0075 | Inf | 0.0075 | 1 | 1 | negative regulation of flagellated sperm motility |
| GO:0002221 | 0.0078 | 4.3113 | 1.2286 | 5 | 164 | pattern recognition receptor signaling pathway |
| GO:0070098 | 0.0089 | 7.532 | 0.427 | 3 | 57 | chemokine-mediated signaling pathway |
| GO:0043588 | 0.0091 | 3.1741 | 2.3374 | 7 | 312 | skin development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0014717 | 4e-04 | 162.4757 | 0.0369 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0048706 | 7e-04 | 5.0883 | 1.487 | 7 | 121 | embryonic skeletal system development |
| GO:1905205 | 9e-04 | 81.2324 | 0.0492 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:2000026 | 0.001 | 1.8794 | 21.2352 | 36 | 1728 | regulation of multicellular organismal development |
| GO:0001944 | 0.0013 | 2.4475 | 7.4594 | 17 | 607 | vasculature development |
| GO:0048514 | 0.0015 | 2.5878 | 6.2059 | 15 | 505 | blood vessel morphogenesis |
| GO:0008630 | 0.0015 | 5.2672 | 1.2289 | 6 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0060455 | 0.0015 | 54.1514 | 0.0614 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0060216 | 0.0015 | 15.2996 | 0.2335 | 3 | 19 | definitive hemopoiesis |
| GO:0048646 | 0.0017 | 2.0974 | 11.8588 | 23 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0042100 | 0.0018 | 6.2288 | 0.8725 | 5 | 71 | B cell proliferation |
| GO:0048771 | 0.002 | 4.2275 | 1.7696 | 7 | 144 | tissue remodeling |
| GO:0072359 | 0.0021 | 2.1008 | 11.2935 | 22 | 919 | circulatory system development |
| GO:0014719 | 0.0022 | 40.6108 | 0.0737 | 2 | 6 | skeletal muscle satellite cell activation |
| GO:0030817 | 0.0027 | 4.6232 | 1.3886 | 6 | 113 | regulation of cAMP biosynthetic process |
| GO:0010469 | 0.0028 | 2.4905 | 5.9847 | 14 | 487 | regulation of receptor activity |
| GO:0048583 | 0.0031 | 1.5743 | 44.1908 | 61 | 3596 | regulation of response to stimulus |
| GO:0009792 | 0.0031 | 2.3766 | 6.722 | 15 | 547 | embryo development ending in birth or egg hatching |
| GO:0050671 | 0.0032 | 4.4554 | 1.4378 | 6 | 117 | positive regulation of lymphocyte proliferation |
| GO:0030216 | 0.0038 | 3.3825 | 2.5069 | 8 | 204 | keratinocyte differentiation |
| GO:0070665 | 0.004 | 4.262 | 1.4992 | 6 | 122 | positive regulation of leukocyte proliferation |
| GO:0001955 | 0.004 | 27.0703 | 0.0983 | 2 | 8 | blood vessel maturation |
| GO:0033141 | 0.004 | 27.0703 | 0.0983 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0035912 | 0.004 | 27.0703 | 0.0983 | 2 | 8 | dorsal aorta morphogenesis |
| GO:0030855 | 0.0046 | 2.2119 | 7.6928 | 16 | 626 | epithelial cell differentiation |
| GO:0060837 | 0.0051 | 23.2015 | 0.1106 | 2 | 9 | blood vessel endothelial cell differentiation |
| GO:0045321 | 0.0053 | 1.9003 | 12.9771 | 23 | 1056 | leukocyte activation |
| GO:0009605 | 0.0055 | 1.6747 | 23.4595 | 36 | 1909 | response to external stimulus |
| GO:0045766 | 0.0056 | 3.9527 | 1.6098 | 6 | 131 | positive regulation of angiogenesis |
| GO:0072604 | 0.0058 | 9.0598 | 0.3687 | 3 | 30 | interleukin-6 secretion |
| GO:0070268 | 0.006 | 4.612 | 1.1552 | 5 | 94 | cornification |
| GO:0021877 | 0.0063 | 20.3 | 0.1229 | 2 | 10 | forebrain neuron fate commitment |
| GO:0009888 | 0.0064 | 1.6915 | 21.1738 | 33 | 1723 | tissue development |
| GO:0043537 | 0.0064 | 8.7356 | 0.381 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0003002 | 0.0064 | 2.6739 | 3.9447 | 10 | 321 | regionalization |
| GO:0032943 | 0.0067 | 3.0508 | 2.765 | 8 | 225 | mononuclear cell proliferation |
| GO:0043330 | 0.007 | 8.4338 | 0.3932 | 3 | 32 | response to exogenous dsRNA |
| GO:0045746 | 0.007 | 8.4338 | 0.3932 | 3 | 32 | negative regulation of Notch signaling pathway |
| GO:0045765 | 0.0071 | 4.4288 | 1.1998 | 5 | 100 | regulation of angiogenesis |
| GO:0030183 | 0.0072 | 4.4124 | 1.2043 | 5 | 98 | B cell differentiation |
| GO:0090084 | 0.0077 | 18.0432 | 0.1352 | 2 | 11 | negative regulation of inclusion body assembly |
| GO:2000774 | 0.0077 | 18.0432 | 0.1352 | 2 | 11 | positive regulation of cellular senescence |
| GO:0046058 | 0.0079 | 3.6575 | 1.7327 | 6 | 141 | cAMP metabolic process |
| GO:0032501 | 0.0081 | 1.4511 | 73.6336 | 90 | 6166 | multicellular organismal process |
| GO:0006954 | 0.0081 | 2.1232 | 7.4716 | 15 | 608 | inflammatory response |
| GO:0030808 | 0.0082 | 3.6303 | 1.745 | 6 | 142 | regulation of nucleotide biosynthetic process |
| GO:0006955 | 0.0083 | 1.6685 | 20.7314 | 32 | 1687 | immune response |
| GO:0010633 | 0.0083 | 5.3638 | 0.7988 | 4 | 65 | negative regulation of epithelial cell migration |
| GO:0001959 | 0.0085 | 3.6036 | 1.7573 | 6 | 143 | regulation of cytokine-mediated signaling pathway |
| GO:0052652 | 0.0085 | 3.6036 | 1.7573 | 6 | 143 | cyclic purine nucleotide metabolic process |
| GO:0048566 | 0.009 | 7.6416 | 0.4301 | 3 | 35 | embryonic digestive tract development |
| GO:0048518 | 0.0091 | 1.4426 | 63.1157 | 79 | 5136 | positive regulation of biological process |
| GO:0045835 | 0.0091 | 16.2378 | 0.1475 | 2 | 12 | negative regulation of meiotic nuclear division |
| GO:0090197 | 0.0091 | 16.2378 | 0.1475 | 2 | 12 | positive regulation of chemokine secretion |
| GO:0002687 | 0.0092 | 4.1434 | 1.278 | 5 | 104 | positive regulation of leukocyte migration |
| GO:0006950 | 0.0093 | 1.4933 | 41.7945 | 56 | 3401 | response to stress |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033690 | 0 | 62.846 | 0.0697 | 3 | 10 | positive regulation of osteoblast proliferation |
| GO:2000502 | 0 | Inf | 0.0139 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0043588 | 1e-04 | 5.108 | 2.1734 | 10 | 312 | skin development |
| GO:0032502 | 1e-04 | 2.2174 | 29.5714 | 47 | 4581 | developmental process |
| GO:0042335 | 1e-04 | 290.5769 | 0.0209 | 2 | 3 | cuticle development |
| GO:0060429 | 2e-04 | 3.0255 | 6.4112 | 17 | 967 | epithelium development |
| GO:0072073 | 3e-04 | 7.0233 | 0.9334 | 6 | 134 | kidney epithelium development |
| GO:0031424 | 4e-04 | 6.8611 | 0.9543 | 6 | 137 | keratinization |
| GO:0072164 | 5e-04 | 8.4513 | 0.6478 | 5 | 93 | mesonephric tubule development |
| GO:0008544 | 5e-04 | 8.1828 | 0.6682 | 5 | 100 | epidermis development |
| GO:0061217 | 6e-04 | 20.9293 | 0.1672 | 3 | 24 | regulation of mesonephros development |
| GO:0072273 | 7e-04 | 19.9766 | 0.1741 | 3 | 25 | metanephric nephron morphogenesis |
| GO:0003407 | 7e-04 | 10.9346 | 0.404 | 4 | 58 | neural retina development |
| GO:2000489 | 7e-04 | 72.6298 | 0.0418 | 2 | 6 | regulation of hepatic stellate cell activation |
| GO:0048729 | 9e-04 | 3.1587 | 4.1726 | 12 | 599 | tissue morphogenesis |
| GO:2000402 | 0.001 | 58.1 | 0.0488 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0042127 | 0.0011 | 2.3276 | 10.2468 | 21 | 1471 | regulation of cell proliferation |
| GO:0046427 | 0.0014 | 8.9394 | 0.4876 | 4 | 70 | positive regulation of JAK-STAT cascade |
| GO:0001501 | 0.0015 | 3.3477 | 3.2461 | 10 | 466 | skeletal system development |
| GO:2000026 | 0.0016 | 2.1788 | 12.0371 | 23 | 1728 | regulation of multicellular organismal development |
| GO:0072537 | 0.0017 | 41.4945 | 0.0627 | 2 | 9 | fibroblast activation |
| GO:0048762 | 0.0017 | 5.0915 | 1.2678 | 6 | 182 | mesenchymal cell differentiation |
| GO:0045429 | 0.0018 | 13.7248 | 0.2438 | 3 | 35 | positive regulation of nitric oxide biosynthetic process |
| GO:0044057 | 0.0018 | 3.2592 | 3.3297 | 10 | 478 | regulation of system process |
| GO:0090288 | 0.002 | 6.0324 | 0.8916 | 5 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0050665 | 0.0021 | 36.3053 | 0.0697 | 2 | 10 | hydrogen peroxide biosynthetic process |
| GO:0060394 | 0.0021 | 36.3053 | 0.0697 | 2 | 10 | negative regulation of pathway-restricted SMAD protein phosphorylation |
| GO:1904892 | 0.0021 | 5.935 | 0.9056 | 5 | 130 | regulation of STAT cascade |
| GO:0032924 | 0.0023 | 12.5459 | 0.2647 | 3 | 38 | activin receptor signaling pathway |
| GO:0045777 | 0.0023 | 12.5459 | 0.2647 | 3 | 38 | positive regulation of blood pressure |
| GO:0090184 | 0.0023 | 12.5459 | 0.2647 | 3 | 38 | positive regulation of kidney development |
| GO:0072006 | 0.0024 | 5.7948 | 0.9265 | 5 | 133 | nephron development |
| GO:0006068 | 0.0025 | 32.2692 | 0.0766 | 2 | 11 | ethanol catabolic process |
| GO:2000379 | 0.0026 | 7.5581 | 0.5712 | 4 | 82 | positive regulation of reactive oxygen species metabolic process |
| GO:0098869 | 0.0027 | 7.4619 | 0.5782 | 4 | 83 | cellular oxidant detoxification |
| GO:0055078 | 0.0027 | 11.8662 | 0.2786 | 3 | 40 | sodium ion homeostasis |
| GO:0072001 | 0.0027 | 4.0074 | 1.8738 | 7 | 269 | renal system development |
| GO:0001656 | 0.0028 | 7.3681 | 0.5851 | 4 | 84 | metanephros development |
| GO:0001942 | 0.0028 | 7.3681 | 0.5851 | 4 | 84 | hair follicle development |
| GO:0030154 | 0.0029 | 1.926 | 19.2053 | 31 | 2966 | cell differentiation |
| GO:0060707 | 0.003 | 29.0404 | 0.0836 | 2 | 12 | trophoblast giant cell differentiation |
| GO:0022404 | 0.003 | 7.1875 | 0.5991 | 4 | 86 | molting cycle process |
| GO:0060993 | 0.003 | 7.1875 | 0.5991 | 4 | 86 | kidney morphogenesis |
| GO:0040007 | 0.0031 | 2.5062 | 6.123 | 14 | 879 | growth |
| GO:0072080 | 0.0033 | 7.0154 | 0.613 | 4 | 88 | nephron tubule development |
| GO:0090092 | 0.0033 | 4.4284 | 1.4489 | 6 | 208 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0030509 | 0.0035 | 5.256 | 1.017 | 5 | 146 | BMP signaling pathway |
| GO:0098754 | 0.0037 | 6.7721 | 0.6339 | 4 | 91 | detoxification |
| GO:0060042 | 0.004 | 10.2064 | 0.3204 | 3 | 46 | retina morphogenesis in camera-type eye |
| GO:0002689 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | negative regulation of leukocyte chemotaxis |
| GO:0034616 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | response to laminar fluid shear stress |
| GO:1901623 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | regulation of lymphocyte chemotaxis |
| GO:0097237 | 0.0045 | 6.402 | 0.6687 | 4 | 96 | cellular response to toxic substance |
| GO:0043009 | 0.0046 | 2.849 | 3.7825 | 10 | 543 | chordate embryonic development |
| GO:0009790 | 0.0046 | 2.3887 | 6.4017 | 14 | 919 | embryo development |
| GO:0050920 | 0.0047 | 4.9046 | 1.0867 | 5 | 156 | regulation of chemotaxis |
| GO:0032516 | 0.0048 | 22.3343 | 0.1045 | 2 | 15 | positive regulation of phosphoprotein phosphatase activity |
| GO:0071772 | 0.0048 | 4.872 | 1.0936 | 5 | 157 | response to BMP |
| GO:0030336 | 0.005 | 4.0612 | 1.5743 | 6 | 226 | negative regulation of cell migration |
| GO:0060688 | 0.0051 | 9.3353 | 0.3483 | 3 | 50 | regulation of morphogenesis of a branching structure |
| GO:0035904 | 0.0054 | 9.1402 | 0.3553 | 3 | 51 | aorta development |
| GO:0006590 | 0.0054 | 20.7376 | 0.1115 | 2 | 16 | thyroid hormone generation |
| GO:0019218 | 0.0058 | 5.9465 | 0.7175 | 4 | 103 | regulation of steroid metabolic process |
| GO:0042633 | 0.0058 | 5.9465 | 0.7175 | 4 | 103 | hair cycle |
| GO:0048513 | 0.0061 | 1.8492 | 17.5512 | 28 | 2725 | animal organ development |
| GO:0003198 | 0.0061 | 19.3538 | 0.1184 | 2 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0090190 | 0.0061 | 19.3538 | 0.1184 | 2 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0031099 | 0.0062 | 4.5682 | 1.1633 | 5 | 167 | regeneration |
| GO:0048608 | 0.0065 | 3.0894 | 2.7655 | 8 | 397 | reproductive structure development |
| GO:0019229 | 0.0066 | 8.4348 | 0.3831 | 3 | 55 | regulation of vasoconstriction |
| GO:0048146 | 0.0066 | 8.4348 | 0.3831 | 3 | 55 | positive regulation of fibroblast proliferation |
| GO:0000003 | 0.0068 | 2.1052 | 8.8745 | 17 | 1274 | reproduction |
| GO:0045954 | 0.0068 | 18.143 | 0.1254 | 2 | 18 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0072074 | 0.0068 | 18.143 | 0.1254 | 2 | 18 | kidney mesenchyme development |
| GO:0072077 | 0.0068 | 18.143 | 0.1254 | 2 | 18 | renal vesicle morphogenesis |
| GO:0030278 | 0.0069 | 4.4569 | 1.1912 | 5 | 171 | regulation of ossification |
| GO:0007199 | 0.007 | Inf | 0.007 | 1 | 1 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
| GO:0010734 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of protein glutathionylation |
| GO:0010805 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of lysine import |
| GO:0010963 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of L-arginine import |
| GO:0014905 | 0.007 | Inf | 0.007 | 1 | 1 | myoblast fusion involved in skeletal muscle regeneration |
| GO:0048855 | 0.007 | Inf | 0.007 | 1 | 1 | adenohypophysis morphogenesis |
| GO:0051134 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of NK T cell activation |
| GO:0060101 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of phagocytosis, engulfment |
| GO:0060739 | 0.007 | Inf | 0.007 | 1 | 1 | mesenchymal-epithelial cell signaling involved in prostate gland development |
| GO:0060806 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of cell differentiation involved in embryonic placenta development |
| GO:0060857 | 0.007 | Inf | 0.007 | 1 | 1 | establishment of glial blood-brain barrier |
| GO:0060981 | 0.007 | Inf | 0.007 | 1 | 1 | cell migration involved in coronary angiogenesis |
| GO:0097275 | 0.007 | Inf | 0.007 | 1 | 1 | cellular ammonia homeostasis |
| GO:0097276 | 0.007 | Inf | 0.007 | 1 | 1 | cellular creatinine homeostasis |
| GO:0097277 | 0.007 | Inf | 0.007 | 1 | 1 | cellular urea homeostasis |
| GO:0140076 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of lipoprotein transport |
| GO:1902567 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of eosinophil activation |
| GO:1902569 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of activation of Janus kinase activity |
| GO:1902867 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:1905010 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of L-lysine import across plasma membrane |
| GO:1905589 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of L-arginine import across plasma membrane |
| GO:0048646 | 0.007 | 2.2658 | 6.7221 | 14 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0090596 | 0.0071 | 3.7656 | 1.6927 | 6 | 243 | sensory organ morphogenesis |
| GO:0001503 | 0.0071 | 4.4214 | 1.2016 | 5 | 179 | ossification |
| GO:0006575 | 0.0072 | 4.4033 | 1.2051 | 5 | 173 | cellular modified amino acid metabolic process |
| GO:0061138 | 0.0072 | 4.4033 | 1.2051 | 5 | 173 | morphogenesis of a branching epithelium |
| GO:0051241 | 0.0072 | 2.2577 | 6.7488 | 14 | 978 | negative regulation of multicellular organismal process |
| GO:0001568 | 0.0074 | 2.6429 | 4.0611 | 10 | 583 | blood vessel development |
| GO:0035809 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | regulation of urine volume |
| GO:0035813 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | regulation of renal sodium excretion |
| GO:0042744 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | hydrogen peroxide catabolic process |
| GO:0060193 | 0.0077 | 7.9732 | 0.404 | 3 | 58 | positive regulation of lipase activity |
| GO:0006936 | 0.0079 | 3.2682 | 2.2778 | 7 | 327 | muscle contraction |
| GO:0051271 | 0.0082 | 3.6407 | 1.7484 | 6 | 251 | negative regulation of cellular component movement |
| GO:0009913 | 0.0084 | 3.6256 | 1.7554 | 6 | 252 | epidermal cell differentiation |
| GO:0035929 | 0.0084 | 16.125 | 0.1393 | 2 | 20 | steroid hormone secretion |
| GO:0060675 | 0.0084 | 7.6924 | 0.418 | 3 | 60 | ureteric bud morphogenesis |
| GO:0045596 | 0.0087 | 2.5771 | 4.1611 | 10 | 603 | negative regulation of cell differentiation |
| GO:0009611 | 0.0088 | 2.5728 | 4.1656 | 10 | 598 | response to wounding |
| GO:0050896 | 0.0092 | 1.6242 | 52.4462 | 65 | 7529 | response to stimulus |
| GO:0046209 | 0.0092 | 7.4306 | 0.4319 | 3 | 62 | nitric oxide metabolic process |
| GO:0048844 | 0.0092 | 7.4306 | 0.4319 | 3 | 62 | artery morphogenesis |
| GO:1901687 | 0.0093 | 15.2753 | 0.1463 | 2 | 21 | glutathione derivative biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 25.7429 | 0.3334 | 7 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0002430 | 0 | 101.6538 | 0.0643 | 4 | 11 | complement receptor mediated signaling pathway |
| GO:0009593 | 0 | 11.7625 | 0.6785 | 7 | 116 | detection of chemical stimulus |
| GO:0050900 | 0 | 5.8183 | 2.1582 | 11 | 369 | leukocyte migration |
| GO:0050906 | 0 | 10.5 | 0.7545 | 7 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 10.246 | 0.772 | 7 | 132 | sensory perception of chemical stimulus |
| GO:0031424 | 2e-04 | 8.2757 | 0.8013 | 6 | 137 | keratinization |
| GO:0007200 | 2e-04 | 9.9458 | 0.5556 | 5 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0043588 | 5e-04 | 4.8161 | 1.8248 | 8 | 312 | skin development |
| GO:0009913 | 7e-04 | 5.1857 | 1.4739 | 7 | 252 | epidermal cell differentiation |
| GO:0060326 | 0.002 | 4.9442 | 1.3101 | 6 | 224 | cell chemotaxis |
| GO:0007186 | 0.0027 | 2.9407 | 4.1328 | 11 | 744 | G-protein coupled receptor signaling pathway |
| GO:0042330 | 0.0033 | 3.2246 | 3.0355 | 9 | 519 | taxis |
| GO:0050918 | 0.0043 | 9.9221 | 0.3275 | 3 | 56 | positive chemotaxis |
| GO:0060429 | 0.0046 | 2.4112 | 6.4394 | 14 | 1101 | epithelium development |
| GO:0017198 | 0.0058 | Inf | 0.0058 | 1 | 1 | N-terminal peptidyl-serine acetylation |
| GO:0018002 | 0.0058 | Inf | 0.0058 | 1 | 1 | N-terminal peptidyl-glutamic acid acetylation |
| GO:0034156 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of toll-like receptor 7 signaling pathway |
| GO:0035759 | 0.0058 | Inf | 0.0058 | 1 | 1 | mesangial cell-matrix adhesion |
| GO:1900035 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of cellular response to heat |
| GO:1901625 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular response to ergosterol |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0021515 | 1e-04 | 22.7288 | 0.2226 | 4 | 20 | cell differentiation in spinal cord |
| GO:0048663 | 1e-04 | 8.7347 | 0.7686 | 6 | 68 | neuron fate commitment |
| GO:0021517 | 3e-04 | 30.1365 | 0.1335 | 3 | 12 | ventral spinal cord development |
| GO:0001708 | 3e-04 | 7.2145 | 0.9156 | 6 | 81 | cell fate specification |
| GO:0021953 | 7e-04 | 5.1067 | 1.4801 | 7 | 133 | central nervous system neuron differentiation |
| GO:0010662 | 8e-04 | 10.8312 | 0.4182 | 4 | 37 | regulation of striated muscle cell apoptotic process |
| GO:0043415 | 0.0012 | 58.9882 | 0.0565 | 2 | 5 | positive regulation of skeletal muscle tissue regeneration |
| GO:0021516 | 0.0016 | 14.8195 | 0.2374 | 3 | 21 | dorsal spinal cord development |
| GO:0046469 | 0.0018 | 44.2382 | 0.0678 | 2 | 6 | platelet activating factor metabolic process |
| GO:2001199 | 0.0018 | 44.2382 | 0.0678 | 2 | 6 | negative regulation of dendritic cell differentiation |
| GO:0071157 | 0.0019 | 14.0386 | 0.2487 | 3 | 22 | negative regulation of cell cycle arrest |
| GO:0007186 | 0.0023 | 2.2155 | 9.2463 | 19 | 827 | G-protein coupled receptor signaling pathway |
| GO:0033601 | 0.0026 | 35.3882 | 0.0791 | 2 | 7 | positive regulation of mammary gland epithelial cell proliferation |
| GO:0010657 | 0.0047 | 6.3729 | 0.6782 | 4 | 60 | muscle cell apoptotic process |
| GO:0021522 | 0.0051 | 9.5205 | 0.3504 | 3 | 31 | spinal cord motor neuron differentiation |
| GO:0097421 | 0.0055 | 9.1916 | 0.3617 | 3 | 32 | liver regeneration |
| GO:0038111 | 0.006 | 8.8846 | 0.373 | 3 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.006 | 8.8846 | 0.373 | 3 | 33 | response to interleukin-7 |
| GO:0021521 | 0.0065 | 19.6549 | 0.1243 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0015980 | 0.0068 | 3.0479 | 2.7693 | 8 | 245 | energy derivation by oxidation of organic compounds |
| GO:0051290 | 0.0071 | 8.3282 | 0.3956 | 3 | 35 | protein heterotetramerization |
| GO:0071392 | 0.0071 | 8.3282 | 0.3956 | 3 | 35 | cellular response to estradiol stimulus |
| GO:0003376 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | sphingosine-1-phosphate signaling pathway |
| GO:0010666 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | positive regulation of cardiac muscle cell apoptotic process |
| GO:0060707 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | trophoblast giant cell differentiation |
| GO:0090026 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | positive regulation of monocyte chemotaxis |
| GO:0006334 | 0.0088 | 4.1799 | 1.266 | 5 | 112 | nucleosome assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009913 | 0 | 8.8906 | 1.7223 | 13 | 252 | epidermal cell differentiation |
| GO:0043588 | 0 | 7.7334 | 2.1324 | 14 | 312 | skin development |
| GO:0070268 | 0 | 14.561 | 0.6424 | 8 | 94 | cornification |
| GO:0031424 | 0 | 21.6729 | 0.273 | 5 | 43 | keratinization |
| GO:0060429 | 0 | 3.2875 | 7.5247 | 21 | 1101 | epithelium development |
| GO:0010469 | 0 | 4.412 | 3.3284 | 13 | 487 | regulation of receptor activity |
| GO:0061760 | 1e-04 | 296.3137 | 0.0205 | 2 | 3 | antifungal innate immune response |
| GO:0006346 | 3e-04 | 26.3762 | 0.1367 | 3 | 20 | methylation-dependent chromatin silencing |
| GO:0098868 | 4e-04 | 23.5967 | 0.1504 | 3 | 22 | bone growth |
| GO:0071385 | 5e-04 | 12.2971 | 0.3622 | 4 | 53 | cellular response to glucocorticoid stimulus |
| GO:0030823 | 9e-04 | 17.9263 | 0.1914 | 3 | 28 | regulation of cGMP metabolic process |
| GO:0050829 | 9e-04 | 10.2061 | 0.4306 | 4 | 63 | defense response to Gram-negative bacterium |
| GO:0006952 | 0.0017 | 2.3338 | 9.1582 | 19 | 1340 | defense response |
| GO:0050830 | 0.0017 | 8.4744 | 0.5126 | 4 | 75 | defense response to Gram-positive bacterium |
| GO:0071347 | 0.0017 | 8.4744 | 0.5126 | 4 | 75 | cellular response to interleukin-1 |
| GO:0009605 | 0.002 | 2.1053 | 13.047 | 24 | 1909 | response to external stimulus |
| GO:0048247 | 0.0024 | 12.4398 | 0.2665 | 3 | 39 | lymphocyte chemotaxis |
| GO:0031960 | 0.0033 | 5.3628 | 0.9978 | 5 | 146 | response to corticosteroid |
| GO:0002548 | 0.0034 | 10.9191 | 0.3007 | 3 | 44 | monocyte chemotaxis |
| GO:0032645 | 0.0034 | 27.1863 | 0.088 | 2 | 13 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0003417 | 0.0034 | 26.9198 | 0.0888 | 2 | 13 | growth plate cartilage development |
| GO:0030072 | 0.0046 | 4.1446 | 1.5446 | 6 | 226 | peptide hormone secretion |
| GO:0050796 | 0.0051 | 4.8112 | 1.1072 | 5 | 162 | regulation of insulin secretion |
| GO:0060413 | 0.0052 | 21.1471 | 0.1094 | 2 | 16 | atrial septum morphogenesis |
| GO:0070372 | 0.0061 | 3.893 | 1.6403 | 6 | 240 | regulation of ERK1 and ERK2 cascade |
| GO:0061458 | 0.0061 | 3.1295 | 2.7338 | 8 | 400 | reproductive system development |
| GO:0002791 | 0.0066 | 3.089 | 2.768 | 8 | 405 | regulation of peptide secretion |
| GO:0002041 | 0.0068 | Inf | 0.0068 | 1 | 1 | intussusceptive angiogenesis |
| GO:0003421 | 0.0068 | Inf | 0.0068 | 1 | 1 | growth plate cartilage axis specification |
| GO:0006742 | 0.0068 | Inf | 0.0068 | 1 | 1 | NADP catabolic process |
| GO:0007495 | 0.0068 | Inf | 0.0068 | 1 | 1 | visceral mesoderm-endoderm interaction involved in midgut development |
| GO:0021509 | 0.0068 | Inf | 0.0068 | 1 | 1 | roof plate formation |
| GO:0032646 | 0.0068 | Inf | 0.0068 | 1 | 1 | regulation of hepatocyte growth factor production |
| GO:0032685 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0032812 | 0.0068 | Inf | 0.0068 | 1 | 1 | positive regulation of epinephrine secretion |
| GO:0048178 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of hepatocyte growth factor biosynthetic process |
| GO:1903403 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:2001051 | 0.0068 | Inf | 0.0068 | 1 | 1 | positive regulation of tendon cell differentiation |
| GO:0070098 | 0.0069 | 8.2833 | 0.3896 | 3 | 57 | chemokine-mediated signaling pathway |
| GO:0046887 | 0.007 | 5.6135 | 0.7581 | 4 | 112 | positive regulation of hormone secretion |
| GO:0002227 | 0.0073 | 17.4118 | 0.1299 | 2 | 19 | innate immune response in mucosa |
| GO:0030828 | 0.0073 | 17.4118 | 0.1299 | 2 | 19 | positive regulation of cGMP biosynthetic process |
| GO:0071346 | 0.008 | 5.4061 | 0.786 | 4 | 115 | cellular response to interferon-gamma |
| GO:0060716 | 0.0081 | 16.4434 | 0.1367 | 2 | 20 | labyrinthine layer blood vessel development |
| GO:0003181 | 0.0089 | 15.5769 | 0.1435 | 2 | 21 | atrioventricular valve morphogenesis |
| GO:0019373 | 0.0089 | 15.5769 | 0.1435 | 2 | 21 | epoxygenase P450 pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 17.1196 | 0.9492 | 13 | 92 | embryonic skeletal system morphogenesis |
| GO:0007389 | 0 | 5.5497 | 4.1889 | 20 | 406 | pattern specification process |
| GO:0048568 | 0 | 5.535 | 4.1992 | 20 | 407 | embryonic organ development |
| GO:0009952 | 0 | 8.0932 | 2.0016 | 14 | 194 | anterior/posterior pattern specification |
| GO:0043009 | 0 | 4.3005 | 5.6024 | 21 | 543 | chordate embryonic development |
| GO:0009887 | 0 | 3.254 | 8.4507 | 24 | 852 | animal organ morphogenesis |
| GO:0030878 | 0 | 26.0405 | 0.2476 | 5 | 24 | thyroid gland development |
| GO:0021615 | 0 | 293.3571 | 0.0413 | 3 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0048598 | 0 | 3.7482 | 4.4217 | 15 | 439 | embryonic morphogenesis |
| GO:0001501 | 0 | 4.4901 | 2.941 | 12 | 295 | skeletal system development |
| GO:0045944 | 1e-04 | 2.6097 | 10.7714 | 25 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0021675 | 1e-04 | 9.1666 | 0.7325 | 6 | 71 | nerve development |
| GO:0021570 | 1e-04 | Inf | 0.0206 | 2 | 2 | rhombomere 4 development |
| GO:0035116 | 2e-04 | 16.3791 | 0.2889 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0008544 | 3e-04 | 3.583 | 3.6317 | 12 | 352 | epidermis development |
| GO:0014707 | 3e-04 | 194.3097 | 0.031 | 2 | 3 | branchiomeric skeletal muscle development |
| GO:0060435 | 3e-04 | 194.3097 | 0.031 | 2 | 3 | bronchiole development |
| GO:0048869 | 4e-04 | 1.8048 | 39.4744 | 59 | 3826 | cellular developmental process |
| GO:0032100 | 6e-04 | 97.1484 | 0.0413 | 2 | 4 | positive regulation of appetite |
| GO:1905205 | 6e-04 | 97.1484 | 0.0413 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:0032691 | 7e-04 | 20.936 | 0.1754 | 3 | 17 | negative regulation of interleukin-1 beta production |
| GO:0009888 | 7e-04 | 2.1727 | 13.3734 | 26 | 1371 | tissue development |
| GO:0032095 | 8e-04 | 19.539 | 0.1857 | 3 | 18 | regulation of response to food |
| GO:0045409 | 0.001 | 64.7613 | 0.0516 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
| GO:0030855 | 0.0012 | 2.6568 | 6.102 | 15 | 602 | epithelial cell differentiation |
| GO:1903508 | 0.0013 | 2.0728 | 13.846 | 26 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0030216 | 0.0013 | 4.0718 | 2.1048 | 8 | 204 | keratinocyte differentiation |
| GO:0032109 | 0.0015 | 48.5677 | 0.0619 | 2 | 6 | positive regulation of response to nutrient levels |
| GO:0021602 | 0.0016 | 14.9394 | 0.2328 | 3 | 23 | cranial nerve morphogenesis |
| GO:0032104 | 0.0019 | 13.9508 | 0.2476 | 3 | 24 | regulation of response to extracellular stimulus |
| GO:0060487 | 0.0019 | 13.9508 | 0.2476 | 3 | 24 | lung epithelial cell differentiation |
| GO:0060425 | 0.0019 | 8.351 | 0.5262 | 4 | 51 | lung morphogenesis |
| GO:0060173 | 0.0019 | 4.265 | 1.754 | 7 | 170 | limb development |
| GO:0051216 | 0.002 | 4.2387 | 1.7643 | 7 | 171 | cartilage development |
| GO:0002645 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | positive regulation of tolerance induction |
| GO:0010700 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:0021612 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | facial nerve structural organization |
| GO:2000253 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | positive regulation of feeding behavior |
| GO:0021884 | 0.0024 | 12.736 | 0.2683 | 3 | 26 | forebrain neuron development |
| GO:0051254 | 0.0026 | 1.9597 | 14.5579 | 26 | 1411 | positive regulation of RNA metabolic process |
| GO:0042129 | 0.0026 | 4.6722 | 1.3722 | 6 | 133 | regulation of T cell proliferation |
| GO:0008343 | 0.0028 | 32.3742 | 0.0825 | 2 | 8 | adult feeding behavior |
| GO:0010940 | 0.0028 | 32.3742 | 0.0825 | 2 | 8 | positive regulation of necrotic cell death |
| GO:0021872 | 0.0032 | 7.1325 | 0.6087 | 4 | 59 | forebrain generation of neurons |
| GO:0048645 | 0.0032 | 7.1325 | 0.6087 | 4 | 59 | animal organ formation |
| GO:0042755 | 0.0032 | 11.2642 | 0.2992 | 3 | 29 | eating behavior |
| GO:0031326 | 0.0033 | 1.6078 | 42.095 | 58 | 4080 | regulation of cellular biosynthetic process |
| GO:0032652 | 0.0036 | 6.8813 | 0.6294 | 4 | 61 | regulation of interleukin-1 production |
| GO:0021561 | 0.0036 | 27.7475 | 0.0929 | 2 | 9 | facial nerve development |
| GO:0072239 | 0.0036 | 27.7475 | 0.0929 | 2 | 9 | metanephric glomerulus vasculature development |
| GO:0009653 | 0.0038 | 2.0934 | 10.5239 | 20 | 1204 | anatomical structure morphogenesis |
| GO:0010628 | 0.0045 | 1.8117 | 17.5705 | 29 | 1703 | positive regulation of gene expression |
| GO:0042447 | 0.0045 | 24.2774 | 0.1032 | 2 | 10 | hormone catabolic process |
| GO:0061042 | 0.0045 | 24.2774 | 0.1032 | 2 | 10 | vascular wound healing |
| GO:0051239 | 0.0056 | 1.6537 | 27.0316 | 40 | 2620 | regulation of multicellular organismal process |
| GO:0048731 | 0.0058 | 1.6196 | 34.3524 | 48 | 3691 | system development |
| GO:0048536 | 0.006 | 8.8707 | 0.3714 | 3 | 36 | spleen development |
| GO:1903531 | 0.0063 | 3.846 | 1.6508 | 6 | 160 | negative regulation of secretion by cell |
| GO:0032099 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | negative regulation of appetite |
| GO:0043568 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | positive regulation of insulin-like growth factor receptor signaling pathway |
| GO:0045019 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | negative regulation of nitric oxide biosynthetic process |
| GO:0060576 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | intestinal epithelial cell development |
| GO:0048522 | 0.0075 | 1.5204 | 47.3053 | 62 | 4585 | positive regulation of cellular process |
| GO:0050830 | 0.0075 | 5.5193 | 0.7738 | 4 | 75 | defense response to Gram-positive bacterium |
| GO:0048608 | 0.0082 | 2.5792 | 4.096 | 10 | 397 | reproductive structure development |
| GO:0048483 | 0.0086 | 7.701 | 0.423 | 3 | 41 | autonomic nervous system development |
| GO:0006355 | 0.0088 | 1.553 | 34.8213 | 48 | 3375 | regulation of transcription, DNA-templated |
| GO:0032108 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | negative regulation of response to nutrient levels |
| GO:1904467 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | regulation of tumor necrosis factor secretion |
| GO:2001212 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | regulation of vasculogenesis |
| GO:0045843 | 0.0092 | 7.503 | 0.4333 | 3 | 42 | negative regulation of striated muscle tissue development |
| GO:0010557 | 0.0095 | 1.75 | 16.0952 | 26 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0032720 | 0.0098 | 7.3149 | 0.4436 | 3 | 43 | negative regulation of tumor necrosis factor production |
| GO:0035113 | 0.0099 | 4.0613 | 1.3 | 5 | 126 | embryonic appendage morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007275 | 0 | 2.2165 | 41.2983 | 68 | 4069 | multicellular organism development |
| GO:0007423 | 0 | 3.6295 | 5.5199 | 18 | 506 | sensory organ development |
| GO:0035108 | 0 | 6.2868 | 1.5818 | 9 | 145 | limb morphogenesis |
| GO:0007601 | 0 | 5.4808 | 2.0072 | 10 | 184 | visual perception |
| GO:0048568 | 0 | 3.7148 | 4.4399 | 15 | 407 | embryonic organ development |
| GO:0008284 | 1e-04 | 2.799 | 8.738 | 22 | 801 | positive regulation of cell proliferation |
| GO:0035113 | 1e-04 | 6.4076 | 1.3745 | 8 | 126 | embryonic appendage morphogenesis |
| GO:0035195 | 1e-04 | 5.5819 | 1.7672 | 9 | 162 | gene silencing by miRNA |
| GO:0043010 | 1e-04 | 4.156 | 3.1527 | 12 | 289 | camera-type eye development |
| GO:0016441 | 1e-04 | 5.3352 | 1.8436 | 9 | 169 | posttranscriptional gene silencing |
| GO:0048736 | 1e-04 | 5.3017 | 1.8545 | 9 | 170 | appendage development |
| GO:0008544 | 1e-04 | 3.6874 | 3.8399 | 13 | 352 | epidermis development |
| GO:0034249 | 2e-04 | 4.0852 | 2.9236 | 11 | 268 | negative regulation of cellular amide metabolic process |
| GO:0048598 | 2e-04 | 3.3188 | 4.5962 | 14 | 439 | embryonic morphogenesis |
| GO:0035116 | 2e-04 | 15.4599 | 0.3054 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0031047 | 3e-04 | 4.6574 | 2.0945 | 9 | 192 | gene silencing by RNA |
| GO:0001942 | 3e-04 | 7.1986 | 0.9163 | 6 | 84 | hair follicle development |
| GO:0022404 | 4e-04 | 7.0177 | 0.9382 | 6 | 86 | molting cycle process |
| GO:0003099 | 4e-04 | 183.5366 | 0.0327 | 2 | 3 | positive regulation of the force of heart contraction by chemical signal |
| GO:0048869 | 4e-04 | 1.7822 | 40.4119 | 60 | 3786 | cellular developmental process |
| GO:0051241 | 4e-04 | 2.3714 | 10.6798 | 23 | 979 | negative regulation of multicellular organismal process |
| GO:0051171 | 5e-04 | 1.7005 | 58.9296 | 80 | 5402 | regulation of nitrogen compound metabolic process |
| GO:0007517 | 5e-04 | 3.3614 | 3.8508 | 12 | 353 | muscle organ development |
| GO:0009887 | 5e-04 | 2.4301 | 9.4797 | 21 | 887 | animal organ morphogenesis |
| GO:0048704 | 5e-04 | 6.5254 | 1.0036 | 6 | 92 | embryonic skeletal system morphogenesis |
| GO:0032502 | 6e-04 | 2.2549 | 14.2536 | 27 | 1646 | developmental process |
| GO:0034653 | 7e-04 | 91.7622 | 0.0436 | 2 | 4 | retinoic acid catabolic process |
| GO:1905205 | 7e-04 | 91.7622 | 0.0436 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:0007600 | 8e-04 | 2.7815 | 5.8253 | 15 | 534 | sensory perception |
| GO:0003002 | 8e-04 | 3.9682 | 2.4376 | 9 | 229 | regionalization |
| GO:0006417 | 8e-04 | 2.9966 | 4.669 | 13 | 428 | regulation of translation |
| GO:0001709 | 9e-04 | 10.2984 | 0.4364 | 4 | 40 | cell fate determination |
| GO:0042633 | 9e-04 | 5.7812 | 1.1236 | 6 | 103 | hair cycle |
| GO:0009792 | 0.001 | 2.7111 | 5.9671 | 15 | 547 | embryo development ending in birth or egg hatching |
| GO:0045944 | 0.001 | 2.2102 | 11.3888 | 23 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0051122 | 0.0012 | 61.1707 | 0.0545 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0003008 | 0.0012 | 1.9781 | 16.7996 | 30 | 1540 | system process |
| GO:0080090 | 0.0012 | 1.6308 | 60.5114 | 80 | 5547 | regulation of primary metabolic process |
| GO:0061436 | 0.0013 | 16.2764 | 0.2182 | 3 | 20 | establishment of skin barrier |
| GO:0097696 | 0.0013 | 4.5897 | 1.6363 | 7 | 150 | STAT cascade |
| GO:0010628 | 0.0015 | 1.9122 | 18.5778 | 32 | 1703 | positive regulation of gene expression |
| GO:0006935 | 0.0017 | 2.653 | 5.6617 | 14 | 519 | chemotaxis |
| GO:0021545 | 0.0017 | 8.6179 | 0.5127 | 4 | 47 | cranial nerve development |
| GO:0016115 | 0.0017 | 45.875 | 0.0655 | 2 | 6 | terpenoid catabolic process |
| GO:1901894 | 0.0017 | 45.875 | 0.0655 | 2 | 6 | regulation of calcium-transporting ATPase activity |
| GO:0060537 | 0.0018 | 3.0431 | 3.8617 | 11 | 354 | muscle tissue development |
| GO:0001568 | 0.0018 | 2.5329 | 6.3599 | 15 | 583 | blood vessel development |
| GO:0007498 | 0.0019 | 5.0019 | 1.2872 | 6 | 118 | mesoderm development |
| GO:1901342 | 0.0021 | 3.4077 | 2.8145 | 9 | 258 | regulation of vasculature development |
| GO:0035270 | 0.0023 | 4.7865 | 1.3418 | 6 | 123 | endocrine system development |
| GO:0043542 | 0.0023 | 4.1234 | 1.8109 | 7 | 166 | endothelial cell migration |
| GO:0048518 | 0.0023 | 1.5872 | 56.0279 | 74 | 5136 | positive regulation of biological process |
| GO:0048513 | 0.0023 | 1.9747 | 15.3576 | 27 | 1646 | animal organ development |
| GO:0009605 | 0.0025 | 1.81 | 20.825 | 34 | 1909 | response to external stimulus |
| GO:0016101 | 0.0027 | 5.6005 | 0.96 | 5 | 88 | diterpenoid metabolic process |
| GO:0070207 | 0.0028 | 12.0256 | 0.2836 | 3 | 26 | protein homotrimerization |
| GO:0007411 | 0.0028 | 3.5611 | 2.389 | 8 | 219 | axon guidance |
| GO:0072358 | 0.003 | 2.3967 | 6.698 | 15 | 614 | cardiovascular system development |
| GO:0046425 | 0.003 | 4.5142 | 1.4182 | 6 | 130 | regulation of JAK-STAT cascade |
| GO:0001667 | 0.003 | 2.9988 | 3.5454 | 10 | 325 | ameboidal-type cell migration |
| GO:0042572 | 0.0031 | 11.5238 | 0.2945 | 3 | 27 | retinol metabolic process |
| GO:0045766 | 0.0031 | 4.4778 | 1.4291 | 6 | 131 | positive regulation of angiogenesis |
| GO:0051093 | 0.0032 | 2.1955 | 8.8144 | 18 | 808 | negative regulation of developmental process |
| GO:0010940 | 0.0032 | 30.5793 | 0.0873 | 2 | 8 | positive regulation of necrotic cell death |
| GO:0033141 | 0.0032 | 30.5793 | 0.0873 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0001501 | 0.0033 | 2.9656 | 3.588 | 10 | 345 | skeletal system development |
| GO:0009953 | 0.0033 | 5.3416 | 1.0036 | 5 | 92 | dorsal/ventral pattern formation |
| GO:0048706 | 0.0035 | 10.9792 | 0.3068 | 3 | 29 | embryonic skeletal system development |
| GO:0045446 | 0.0035 | 5.2806 | 1.0145 | 5 | 93 | endothelial cell differentiation |
| GO:0070268 | 0.0037 | 5.2209 | 1.0254 | 5 | 94 | cornification |
| GO:0001525 | 0.0037 | 3.1176 | 3.0651 | 9 | 289 | angiogenesis |
| GO:0048523 | 0.0039 | 1.5701 | 45.8608 | 62 | 4204 | negative regulation of cellular process |
| GO:0048645 | 0.0039 | 6.7322 | 0.6436 | 4 | 59 | animal organ formation |
| GO:0010459 | 0.004 | 26.2091 | 0.0982 | 2 | 9 | negative regulation of heart rate |
| GO:0048387 | 0.004 | 26.2091 | 0.0982 | 2 | 9 | negative regulation of retinoic acid receptor signaling pathway |
| GO:2000543 | 0.004 | 26.2091 | 0.0982 | 2 | 9 | positive regulation of gastrulation |
| GO:0055002 | 0.0042 | 4.2062 | 1.5163 | 6 | 139 | striated muscle cell development |
| GO:0002064 | 0.0042 | 3.6786 | 2.0181 | 7 | 185 | epithelial cell development |
| GO:0010556 | 0.0045 | 1.5701 | 42.4791 | 58 | 3894 | regulation of macromolecule biosynthetic process |
| GO:0003209 | 0.0046 | 9.8749 | 0.3382 | 3 | 31 | cardiac atrium morphogenesis |
| GO:0043537 | 0.0046 | 9.8749 | 0.3382 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:1903524 | 0.0049 | 6.2741 | 0.6873 | 4 | 63 | positive regulation of blood circulation |
| GO:0006690 | 0.005 | 4.8379 | 1.1018 | 5 | 101 | icosanoid metabolic process |
| GO:0090132 | 0.0051 | 3.2061 | 2.6399 | 8 | 242 | epithelium migration |
| GO:0061045 | 0.0055 | 6.0676 | 0.7091 | 4 | 65 | negative regulation of wound healing |
| GO:0007519 | 0.0057 | 3.9372 | 1.6145 | 6 | 148 | skeletal muscle tissue development |
| GO:0040011 | 0.0058 | 1.7866 | 17.0505 | 28 | 1563 | locomotion |
| GO:0045652 | 0.0058 | 5.9693 | 0.72 | 4 | 66 | regulation of megakaryocyte differentiation |
| GO:0051101 | 0.0061 | 4.5969 | 1.1563 | 5 | 106 | regulation of DNA binding |
| GO:0009111 | 0.0061 | 20.3821 | 0.12 | 2 | 11 | vitamin catabolic process |
| GO:0009886 | 0.0061 | 20.3821 | 0.12 | 2 | 11 | post-embryonic animal morphogenesis |
| GO:2000774 | 0.0061 | 20.3821 | 0.12 | 2 | 11 | positive regulation of cellular senescence |
| GO:2000113 | 0.0065 | 1.8262 | 14.8033 | 25 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0032269 | 0.0066 | 1.9253 | 11.7161 | 21 | 1074 | negative regulation of cellular protein metabolic process |
| GO:0042692 | 0.0069 | 2.646 | 3.9926 | 10 | 366 | muscle cell differentiation |
| GO:0048536 | 0.007 | 8.3759 | 0.3927 | 3 | 36 | spleen development |
| GO:0071542 | 0.007 | 8.3759 | 0.3927 | 3 | 36 | dopaminergic neuron differentiation |
| GO:0030216 | 0.0071 | 3.3195 | 2.2254 | 7 | 204 | keratinocyte differentiation |
| GO:0060322 | 0.0072 | 2.1592 | 7.3853 | 15 | 677 | head development |
| GO:0003093 | 0.0073 | 18.3427 | 0.1309 | 2 | 12 | regulation of glomerular filtration |
| GO:0042471 | 0.0074 | 4.3786 | 1.2109 | 5 | 111 | ear morphogenesis |
| GO:0021536 | 0.0075 | 5.522 | 0.7745 | 4 | 71 | diencephalon development |
| GO:0045595 | 0.0075 | 1.7472 | 17.3887 | 28 | 1594 | regulation of cell differentiation |
| GO:0035295 | 0.0077 | 2.2789 | 6.0435 | 13 | 554 | tube development |
| GO:0050789 | 0.008 | 1.7033 | 44.0242 | 56 | 4824 | regulation of biological process |
| GO:0031326 | 0.008 | 1.5125 | 44.5081 | 59 | 4080 | regulation of cellular biosynthetic process |
| GO:0021520 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | spinal cord motor neuron cell fate specification |
| GO:0021984 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | adenohypophysis development |
| GO:0090196 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | regulation of chemokine secretion |
| GO:0061564 | 0.0089 | 2.4189 | 4.7999 | 11 | 440 | axon development |
| GO:0060415 | 0.0091 | 5.2095 | 0.8182 | 4 | 75 | muscle tissue morphogenesis |
| GO:0021953 | 0.0092 | 3.5347 | 1.7891 | 6 | 164 | central nervous system neuron differentiation |
| GO:0043043 | 0.0093 | 2.0929 | 7.6035 | 15 | 697 | peptide biosynthetic process |
| GO:0006720 | 0.0095 | 4.1054 | 1.2872 | 5 | 118 | isoprenoid metabolic process |
| GO:0003300 | 0.0095 | 5.1368 | 0.8291 | 4 | 76 | cardiac muscle hypertrophy |
| GO:0016049 | 0.0097 | 2.3902 | 4.8544 | 11 | 445 | cell growth |
| GO:0030855 | 0.0099 | 2.5048 | 4.2131 | 10 | 405 | epithelial cell differentiation |
| GO:2000291 | 0.0099 | 15.2835 | 0.1527 | 2 | 14 | regulation of myoblast proliferation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043266 | 1e-04 | 9.9159 | 0.6763 | 6 | 83 | regulation of potassium ion transport |
| GO:0010960 | 1e-04 | 53.4333 | 0.0815 | 3 | 10 | magnesium ion homeostasis |
| GO:0050906 | 1e-04 | 7.3418 | 1.0512 | 7 | 129 | detection of stimulus involved in sensory perception |
| GO:0003008 | 1e-04 | 2.4983 | 12.5491 | 27 | 1540 | system process |
| GO:0002724 | 3e-04 | 28.7603 | 0.1304 | 3 | 16 | regulation of T cell cytokine production |
| GO:0009593 | 4e-04 | 6.9259 | 0.9453 | 6 | 116 | detection of chemical stimulus |
| GO:0007389 | 5e-04 | 3.6222 | 3.3084 | 11 | 406 | pattern specification process |
| GO:1903232 | 6e-04 | 82.459 | 0.0407 | 2 | 5 | melanosome assembly |
| GO:0015672 | 7e-04 | 3.2618 | 4.0092 | 12 | 492 | monovalent inorganic cation transport |
| GO:0048598 | 7e-04 | 3.0851 | 4.6041 | 13 | 565 | embryonic morphogenesis |
| GO:0007606 | 7e-04 | 6.04 | 1.0756 | 6 | 132 | sensory perception of chemical stimulus |
| GO:0001964 | 8e-04 | 18.6855 | 0.1874 | 3 | 23 | startle response |
| GO:0048704 | 9e-04 | 7.2472 | 0.7497 | 5 | 92 | embryonic skeletal system morphogenesis |
| GO:0071804 | 9e-04 | 4.8746 | 1.5483 | 7 | 190 | cellular potassium ion transport |
| GO:0050911 | 0.0012 | 9.4591 | 0.4645 | 4 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007628 | 0.0013 | 15.5671 | 0.22 | 3 | 27 | adult walking behavior |
| GO:0086028 | 0.0013 | 49.4689 | 0.057 | 2 | 7 | bundle of His cell to Purkinje myocyte signaling |
| GO:0001501 | 0.0015 | 3.1317 | 3.7973 | 11 | 466 | skeletal system development |
| GO:0060306 | 0.0015 | 14.9435 | 0.2282 | 3 | 28 | regulation of membrane repolarization |
| GO:0021772 | 0.0017 | 14.3678 | 0.2363 | 3 | 29 | olfactory bulb development |
| GO:0045188 | 0.0018 | 41.2213 | 0.0652 | 2 | 8 | regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0060638 | 0.0018 | 41.2213 | 0.0652 | 2 | 8 | mesenchymal-epithelial cell signaling |
| GO:0009887 | 0.002 | 2.4558 | 7.1406 | 16 | 895 | animal organ morphogenesis |
| GO:0099622 | 0.002 | 13.3397 | 0.2526 | 3 | 31 | cardiac muscle cell membrane repolarization |
| GO:0034762 | 0.0021 | 3.1732 | 3.3899 | 10 | 416 | regulation of transmembrane transport |
| GO:1901381 | 0.0022 | 12.8789 | 0.2608 | 3 | 32 | positive regulation of potassium ion transmembrane transport |
| GO:0086018 | 0.0023 | 35.3302 | 0.0733 | 2 | 9 | SA node cell to atrial cardiac muscle cell signaling |
| GO:0032502 | 0.0024 | 1.6961 | 45.1931 | 61 | 5546 | developmental process |
| GO:0001662 | 0.0024 | 12.4488 | 0.2689 | 3 | 33 | behavioral fear response |
| GO:0048665 | 0.0024 | 12.4488 | 0.2689 | 3 | 33 | neuron fate specification |
| GO:0019226 | 0.0024 | 7.7067 | 0.5623 | 4 | 69 | transmission of nerve impulse |
| GO:0003231 | 0.0026 | 5.6711 | 0.9453 | 5 | 116 | cardiac ventricle development |
| GO:0034767 | 0.0026 | 5.6711 | 0.9453 | 5 | 116 | positive regulation of ion transmembrane transport |
| GO:0035646 | 0.0028 | 30.9119 | 0.0815 | 2 | 10 | endosome to melanosome transport |
| GO:0048757 | 0.0028 | 30.9119 | 0.0815 | 2 | 10 | pigment granule maturation |
| GO:0086091 | 0.0029 | 11.6692 | 0.2852 | 3 | 35 | regulation of heart rate by cardiac conduction |
| GO:0003206 | 0.0029 | 5.5208 | 0.9697 | 5 | 119 | cardiac chamber morphogenesis |
| GO:0035137 | 0.0031 | 11.3148 | 0.2934 | 3 | 36 | hindlimb morphogenesis |
| GO:0003151 | 0.0031 | 7.1538 | 0.603 | 4 | 74 | outflow tract morphogenesis |
| GO:0035270 | 0.0033 | 5.3322 | 1.0023 | 5 | 123 | endocrine system development |
| GO:0043476 | 0.0035 | 27.4754 | 0.0896 | 2 | 11 | pigment accumulation |
| GO:0015837 | 0.0036 | 6.8584 | 0.6275 | 4 | 77 | amine transport |
| GO:0060428 | 0.0036 | 10.6668 | 0.3097 | 3 | 38 | lung epithelium development |
| GO:0001508 | 0.0037 | 5.199 | 1.0267 | 5 | 126 | action potential |
| GO:0007626 | 0.0042 | 4.2127 | 1.5157 | 6 | 186 | locomotory behavior |
| GO:1904062 | 0.0046 | 3.6259 | 2.0535 | 7 | 252 | regulation of cation transmembrane transport |
| GO:0021978 | 0.0048 | 22.4769 | 0.1059 | 2 | 13 | telencephalon regionalization |
| GO:0071435 | 0.0048 | 22.4769 | 0.1059 | 2 | 13 | potassium ion export |
| GO:1903818 | 0.0048 | 22.4769 | 0.1059 | 2 | 13 | positive regulation of voltage-gated potassium channel activity |
| GO:0008284 | 0.0056 | 2.3135 | 6.5272 | 14 | 801 | positive regulation of cell proliferation |
| GO:0048568 | 0.0061 | 2.8896 | 3.3166 | 9 | 407 | embryonic organ development |
| GO:0035743 | 0.0065 | 19.0164 | 0.1222 | 2 | 15 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0051546 | 0.0065 | 19.0164 | 0.1222 | 2 | 15 | keratinocyte migration |
| GO:0055075 | 0.0065 | 19.0164 | 0.1222 | 2 | 15 | potassium ion homeostasis |
| GO:0035107 | 0.0067 | 4.4877 | 1.1816 | 5 | 145 | appendage morphogenesis |
| GO:0009953 | 0.0068 | 5.6837 | 0.7497 | 4 | 92 | dorsal/ventral pattern formation |
| GO:0043269 | 0.007 | 2.5216 | 4.6611 | 11 | 572 | regulation of ion transport |
| GO:0007600 | 0.0071 | 3.0388 | 2.8 | 8 | 360 | sensory perception |
| GO:0060413 | 0.0073 | 17.6569 | 0.1304 | 2 | 16 | atrial septum morphogenesis |
| GO:1901016 | 0.0074 | 8.1101 | 0.3993 | 3 | 49 | regulation of potassium ion transmembrane transporter activity |
| GO:0001503 | 0.0079 | 2.9746 | 2.8521 | 8 | 350 | ossification |
| GO:0030900 | 0.0079 | 2.9746 | 2.8521 | 8 | 350 | forebrain development |
| GO:0003294 | 0.0081 | Inf | 0.0081 | 1 | 1 | atrial ventricular junction remodeling |
| GO:0016077 | 0.0081 | Inf | 0.0081 | 1 | 1 | snoRNA catabolic process |
| GO:0032980 | 0.0081 | Inf | 0.0081 | 1 | 1 | keratinocyte activation |
| GO:0035863 | 0.0081 | Inf | 0.0081 | 1 | 1 | dITP catabolic process |
| GO:0051867 | 0.0081 | Inf | 0.0081 | 1 | 1 | general adaptation syndrome, behavioral process |
| GO:0072168 | 0.0081 | Inf | 0.0081 | 1 | 1 | specification of anterior mesonephric tubule identity |
| GO:0072169 | 0.0081 | Inf | 0.0081 | 1 | 1 | specification of posterior mesonephric tubule identity |
| GO:0072184 | 0.0081 | Inf | 0.0081 | 1 | 1 | renal vesicle progenitor cell differentiation |
| GO:0072259 | 0.0081 | Inf | 0.0081 | 1 | 1 | metanephric interstitial fibroblast development |
| GO:0086044 | 0.0081 | Inf | 0.0081 | 1 | 1 | atrial cardiac muscle cell to AV node cell communication by electrical coupling |
| GO:0086050 | 0.0081 | Inf | 0.0081 | 1 | 1 | membrane repolarization during bundle of His cell action potential |
| GO:0086052 | 0.0081 | Inf | 0.0081 | 1 | 1 | membrane repolarization during SA node cell action potential |
| GO:0086054 | 0.0081 | Inf | 0.0081 | 1 | 1 | bundle of His cell to Purkinje myocyte communication by electrical coupling |
| GO:0086055 | 0.0081 | Inf | 0.0081 | 1 | 1 | Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling |
| GO:0097275 | 0.0081 | Inf | 0.0081 | 1 | 1 | cellular ammonia homeostasis |
| GO:0097276 | 0.0081 | Inf | 0.0081 | 1 | 1 | cellular creatinine homeostasis |
| GO:0097277 | 0.0081 | Inf | 0.0081 | 1 | 1 | cellular urea homeostasis |
| GO:0098906 | 0.0081 | Inf | 0.0081 | 1 | 1 | regulation of Purkinje myocyte action potential |
| GO:1901639 | 0.0081 | Inf | 0.0081 | 1 | 1 | XDP catabolic process |
| GO:1904325 | 0.0081 | Inf | 0.0081 | 1 | 1 | positive regulation of inhibitory G-protein coupled receptor phosphorylation |
| GO:1990029 | 0.0081 | Inf | 0.0081 | 1 | 1 | vasomotion |
| GO:0008544 | 0.0082 | 2.9569 | 2.8684 | 8 | 352 | epidermis development |
| GO:0002029 | 0.0083 | 16.4787 | 0.1385 | 2 | 17 | desensitization of G-protein coupled receptor protein signaling pathway |
| GO:0023058 | 0.0083 | 16.4787 | 0.1385 | 2 | 17 | adaptation of signaling pathway |
| GO:0086014 | 0.0083 | 16.4787 | 0.1385 | 2 | 17 | atrial cardiac muscle cell action potential |
| GO:0021515 | 0.0083 | 7.7712 | 0.4156 | 3 | 51 | cell differentiation in spinal cord |
| GO:0060425 | 0.0083 | 7.7712 | 0.4156 | 3 | 51 | lung morphogenesis |
| GO:0007423 | 0.0084 | 2.5815 | 4.1233 | 10 | 506 | sensory organ development |
| GO:0001580 | 0.0093 | 15.4477 | 0.1467 | 2 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0060307 | 0.0093 | 15.4477 | 0.1467 | 2 | 18 | regulation of ventricular cardiac muscle cell membrane repolarization |
| GO:1901380 | 0.0093 | 15.4477 | 0.1467 | 2 | 18 | negative regulation of potassium ion transmembrane transport |
| GO:0032675 | 0.0097 | 5.1003 | 0.8312 | 4 | 102 | regulation of interleukin-6 production |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007606 | 0 | 11.3597 | 0.7026 | 7 | 132 | sensory perception of chemical stimulus |
| GO:0050911 | 0 | 19.084 | 0.3034 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0003091 | 0 | 26.1576 | 0.181 | 4 | 34 | renal water homeostasis |
| GO:0009593 | 0 | 10.928 | 0.6175 | 6 | 116 | detection of chemical stimulus |
| GO:0003008 | 0 | 3.1376 | 8.1974 | 21 | 1540 | system process |
| GO:0050906 | 1e-04 | 9.7646 | 0.6867 | 6 | 129 | detection of stimulus involved in sensory perception |
| GO:0061760 | 1e-04 | 383.1646 | 0.016 | 2 | 3 | antifungal innate immune response |
| GO:0050829 | 3e-04 | 13.2749 | 0.3353 | 4 | 63 | defense response to Gram-negative bacterium |
| GO:0030104 | 4e-04 | 13.0528 | 0.3407 | 4 | 64 | water homeostasis |
| GO:0018149 | 5e-04 | 22.3521 | 0.1544 | 3 | 29 | peptide cross-linking |
| GO:0009620 | 0.0012 | 16.1325 | 0.2076 | 3 | 39 | response to fungus |
| GO:0043588 | 0.0014 | 4.5998 | 1.6608 | 7 | 312 | skin development |
| GO:0003334 | 0.0018 | 38.2937 | 0.0639 | 2 | 12 | keratinocyte development |
| GO:0007600 | 0.0019 | 4.3259 | 1.7709 | 7 | 360 | sensory perception |
| GO:0009913 | 0.0022 | 4.8423 | 1.3414 | 6 | 252 | epidermal cell differentiation |
| GO:0055075 | 0.0028 | 29.4508 | 0.0798 | 2 | 15 | potassium ion homeostasis |
| GO:0060397 | 0.0028 | 29.4508 | 0.0798 | 2 | 15 | JAK-STAT cascade involved in growth hormone signaling pathway |
| GO:0006833 | 0.0036 | 25.5207 | 0.0905 | 2 | 17 | water transport |
| GO:0007635 | 0.0036 | 25.5207 | 0.0905 | 2 | 17 | chemosensory behavior |
| GO:0070723 | 0.005 | 21.263 | 0.1065 | 2 | 20 | response to cholesterol |
| GO:0031644 | 0.0052 | 9.2021 | 0.3513 | 3 | 66 | regulation of neurological system process |
| GO:0002264 | 0.0053 | Inf | 0.0053 | 1 | 1 | endothelial cell activation involved in immune response |
| GO:0009645 | 0.0053 | Inf | 0.0053 | 1 | 1 | response to low light intensity stimulus |
| GO:0032980 | 0.0053 | Inf | 0.0053 | 1 | 1 | keratinocyte activation |
| GO:0046690 | 0.0053 | Inf | 0.0053 | 1 | 1 | response to tellurium ion |
| GO:0052182 | 0.0053 | Inf | 0.0053 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
| GO:0097275 | 0.0053 | Inf | 0.0053 | 1 | 1 | cellular ammonia homeostasis |
| GO:0097276 | 0.0053 | Inf | 0.0053 | 1 | 1 | cellular creatinine homeostasis |
| GO:0097277 | 0.0053 | Inf | 0.0053 | 1 | 1 | cellular urea homeostasis |
| GO:1905322 | 0.0053 | Inf | 0.0053 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
| GO:0031424 | 0.0061 | 5.86 | 0.7293 | 4 | 137 | keratinization |
| GO:0071378 | 0.0066 | 18.2218 | 0.1224 | 2 | 23 | cellular response to growth hormone stimulus |
| GO:0006955 | 0.0068 | 2.1419 | 8.9799 | 17 | 1687 | immune response |
| GO:0048871 | 0.007 | 3.7886 | 1.698 | 6 | 319 | multicellular organismal homeostasis |
| GO:0050716 | 0.0072 | 17.3924 | 0.1278 | 2 | 24 | positive regulation of interleukin-1 secretion |
| GO:0050830 | 0.0075 | 8.047 | 0.3992 | 3 | 75 | defense response to Gram-positive bacterium |
| GO:0001654 | 0.0086 | 3.623 | 1.7726 | 6 | 333 | eye development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 19.2693 | 1.9378 | 27 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0098609 | 0 | 4.405 | 9.5617 | 35 | 750 | cell-cell adhesion |
| GO:0022610 | 0 | 2.9839 | 16.3058 | 41 | 1279 | biological adhesion |
| GO:0032501 | 0 | 2.1822 | 71.7521 | 106 | 5904 | multicellular organismal process |
| GO:0032502 | 0 | 2.231 | 51.1223 | 82 | 4380 | developmental process |
| GO:0048731 | 0 | 2.6081 | 22.3362 | 46 | 2076 | system development |
| GO:0007399 | 0 | 2.3667 | 26.9257 | 53 | 2112 | nervous system development |
| GO:0007267 | 0 | 2.3317 | 18.6006 | 38 | 1459 | cell-cell signaling |
| GO:2001199 | 0 | 78.6387 | 0.0765 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0009952 | 2e-04 | 4.383 | 2.4733 | 10 | 194 | anterior/posterior pattern specification |
| GO:0009792 | 2e-04 | 2.8022 | 6.9736 | 18 | 547 | embryo development ending in birth or egg hatching |
| GO:0061737 | 5e-04 | 156.4792 | 0.0382 | 2 | 3 | leukotriene signaling pathway |
| GO:0007389 | 7e-04 | 2.903 | 5.1761 | 14 | 406 | pattern specification process |
| GO:0051094 | 8e-04 | 2.0679 | 14.8015 | 28 | 1161 | positive regulation of developmental process |
| GO:0008078 | 0.001 | 78.2344 | 0.051 | 2 | 4 | mesodermal cell migration |
| GO:0048704 | 0.0011 | 5.5432 | 1.1729 | 6 | 92 | embryonic skeletal system morphogenesis |
| GO:0051122 | 0.0016 | 52.1528 | 0.0637 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0060216 | 0.0017 | 14.732 | 0.2422 | 3 | 19 | definitive hemopoiesis |
| GO:0006334 | 0.0031 | 4.4913 | 1.4279 | 6 | 112 | nucleosome assembly |
| GO:0070206 | 0.0032 | 7.167 | 0.6119 | 4 | 48 | protein trimerization |
| GO:0006333 | 0.0036 | 3.7881 | 1.9633 | 7 | 154 | chromatin assembly or disassembly |
| GO:0001955 | 0.0043 | 26.0712 | 0.102 | 2 | 8 | blood vessel maturation |
| GO:0030916 | 0.0043 | 26.0712 | 0.102 | 2 | 8 | otic vesicle formation |
| GO:0009887 | 0.0046 | 1.9517 | 12.0605 | 22 | 946 | animal organ morphogenesis |
| GO:0016339 | 0.0053 | 9.4228 | 0.357 | 3 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0035116 | 0.0053 | 9.4228 | 0.357 | 3 | 28 | embryonic hindlimb morphogenesis |
| GO:0007218 | 0.0053 | 4.7619 | 1.1219 | 5 | 88 | neuropeptide signaling pathway |
| GO:0048706 | 0.0054 | 9.3 | 0.3605 | 3 | 29 | embryonic skeletal system development |
| GO:2000849 | 0.0055 | 22.3452 | 0.1147 | 2 | 9 | regulation of glucocorticoid secretion |
| GO:0010660 | 0.0056 | 6.0611 | 0.7139 | 4 | 56 | regulation of muscle cell apoptotic process |
| GO:0048598 | 0.0059 | 2.2051 | 7.2031 | 15 | 565 | embryonic morphogenesis |
| GO:0006323 | 0.006 | 3.4339 | 2.1546 | 7 | 169 | DNA packaging |
| GO:0048568 | 0.0061 | 2.4417 | 5.1888 | 12 | 407 | embryonic organ development |
| GO:0045595 | 0.0063 | 1.7023 | 20.3217 | 32 | 1594 | regulation of cell differentiation |
| GO:0009266 | 0.0064 | 3.0785 | 2.741 | 8 | 215 | response to temperature stimulus |
| GO:2000026 | 0.0066 | 1.672 | 22.0301 | 34 | 1728 | regulation of multicellular organismal development |
| GO:0045766 | 0.0067 | 3.8037 | 1.6701 | 6 | 131 | positive regulation of angiogenesis |
| GO:0045446 | 0.0067 | 4.4898 | 1.1856 | 5 | 93 | endothelial cell differentiation |
| GO:0043588 | 0.0068 | 2.6492 | 3.9777 | 10 | 312 | skin development |
| GO:0043537 | 0.0071 | 8.4116 | 0.3952 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0030858 | 0.0072 | 5.6267 | 0.7649 | 4 | 60 | positive regulation of epithelial cell differentiation |
| GO:0010454 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0016322 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | neuron remodeling |
| GO:0060033 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | anatomical structure regression |
| GO:0090084 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | negative regulation of inclusion body assembly |
| GO:2000774 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | positive regulation of cellular senescence |
| GO:0045165 | 0.0083 | 2.9373 | 2.8662 | 8 | 227 | cell fate commitment |
| GO:0010633 | 0.0095 | 5.1638 | 0.8287 | 4 | 65 | negative regulation of epithelial cell migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 57.2416 | 0.4083 | 15 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 25.8202 | 0.8309 | 16 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 22.83 | 0.924 | 16 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 22.2351 | 0.9455 | 16 | 132 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 4.9517 | 6.0098 | 24 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 3.3388 | 6.1817 | 18 | 863 | nervous system process |
| GO:0045087 | 1e-04 | 3.4929 | 5.2044 | 16 | 740 | innate immune response |
| GO:0003095 | 2e-04 | 282.3738 | 0.0215 | 2 | 3 | pressure natriuresis |
| GO:0061760 | 2e-04 | 282.3738 | 0.0215 | 2 | 3 | antifungal innate immune response |
| GO:0007565 | 3e-04 | 6.1029 | 1.2535 | 7 | 175 | female pregnancy |
| GO:0036101 | 3e-04 | 141.1776 | 0.0287 | 2 | 4 | leukotriene B4 catabolic process |
| GO:1901523 | 5e-04 | 94.1121 | 0.0358 | 2 | 5 | icosanoid catabolic process |
| GO:0016579 | 6e-04 | 4.6683 | 1.8641 | 8 | 265 | protein deubiquitination |
| GO:0003071 | 6e-04 | 21.3509 | 0.1647 | 3 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0070098 | 7e-04 | 10.8212 | 0.4083 | 4 | 57 | chemokine-mediated signaling pathway |
| GO:0071947 | 7e-04 | 70.5794 | 0.043 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0050829 | 0.0011 | 9.7169 | 0.4513 | 4 | 63 | defense response to Gram-negative bacterium |
| GO:0035865 | 0.0014 | 47.0467 | 0.0573 | 2 | 8 | cellular response to potassium ion |
| GO:0098542 | 0.0016 | 3.575 | 2.722 | 9 | 380 | defense response to other organism |
| GO:0032342 | 0.0018 | 40.3231 | 0.0645 | 2 | 9 | aldosterone biosynthetic process |
| GO:0034651 | 0.0018 | 40.3231 | 0.0645 | 2 | 9 | cortisol biosynthetic process |
| GO:0003091 | 0.0018 | 13.7648 | 0.2435 | 3 | 34 | renal water homeostasis |
| GO:0050830 | 0.002 | 8.0681 | 0.5372 | 4 | 75 | defense response to Gram-positive bacterium |
| GO:0002376 | 0.0021 | 1.9582 | 17.793 | 30 | 2484 | immune system process |
| GO:0008212 | 0.0022 | 35.2804 | 0.0716 | 2 | 10 | mineralocorticoid metabolic process |
| GO:0050776 | 0.0026 | 2.5546 | 6.0026 | 14 | 838 | regulation of immune response |
| GO:0009620 | 0.0027 | 11.8491 | 0.2794 | 3 | 39 | response to fungus |
| GO:0048247 | 0.0027 | 11.8491 | 0.2794 | 3 | 39 | lymphocyte chemotaxis |
| GO:0055078 | 0.0029 | 11.528 | 0.2865 | 3 | 40 | sodium ion homeostasis |
| GO:0002548 | 0.0038 | 10.4006 | 0.3152 | 3 | 44 | monocyte chemotaxis |
| GO:0009617 | 0.0049 | 3.0003 | 3.2162 | 9 | 449 | response to bacterium |
| GO:0019941 | 0.0066 | 2.6889 | 3.9898 | 10 | 557 | modification-dependent protein catabolic process |
| GO:0052182 | 0.0072 | Inf | 0.0072 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
| GO:1901318 | 0.0072 | Inf | 0.0072 | 1 | 1 | negative regulation of flagellated sperm motility |
| GO:0006508 | 0.009 | 1.9309 | 11.4251 | 20 | 1595 | proteolysis |
| GO:0044257 | 0.0092 | 2.434 | 4.8494 | 11 | 677 | cellular protein catabolic process |
| GO:0008211 | 0.0098 | 14.8441 | 0.1504 | 2 | 21 | glucocorticoid metabolic process |
| GO:0019373 | 0.0098 | 14.8441 | 0.1504 | 2 | 21 | epoxygenase P450 pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 57.1774 | 0.3739 | 14 | 57 | olfactory receptor activity |
| GO:0036459 | 0 | 19.3762 | 0.7018 | 11 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 12.4573 | 1.1544 | 12 | 176 | cysteine-type peptidase activity |
| GO:0038023 | 0 | 4.2886 | 5.936 | 21 | 905 | signaling receptor activity |
| GO:0004930 | 0 | 5.8953 | 2.7614 | 14 | 421 | G-protein coupled receptor activity |
| GO:0060089 | 0 | 3.7121 | 7.5495 | 23 | 1151 | molecular transducer activity |
| GO:0099600 | 0 | 4.0666 | 5.5424 | 19 | 845 | transmembrane receptor activity |
| GO:0008233 | 0 | 4.1553 | 3.8371 | 14 | 585 | peptidase activity |
| GO:0020037 | 0.0012 | 6.8792 | 0.7871 | 5 | 120 | heme binding |
| GO:0008201 | 0.0028 | 5.5612 | 0.9642 | 5 | 147 | heparin binding |
| GO:0030246 | 0.005 | 4.0676 | 1.5742 | 6 | 240 | carbohydrate binding |
| GO:0008392 | 0.0054 | 20.5864 | 0.1115 | 2 | 17 | arachidonic acid epoxygenase activity |
| GO:0031704 | 0.0066 | Inf | 0.0066 | 1 | 1 | apelin receptor binding |
| GO:0042164 | 0.0066 | Inf | 0.0066 | 1 | 1 | interleukin-12 alpha subunit binding |
| GO:0102116 | 0.0066 | Inf | 0.0066 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0066 | Inf | 0.0066 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 1e-04 | Inf | 0.0178 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0008009 | 1e-04 | 17.5804 | 0.2676 | 4 | 30 | chemokine activity |
| GO:0005132 | 8e-04 | 75.1592 | 0.0446 | 2 | 5 | type I interferon receptor binding |
| GO:0055131 | 0.0012 | 56.3657 | 0.0535 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0048018 | 0.002 | 3.1972 | 3.3541 | 10 | 376 | receptor ligand activity |
| GO:0042379 | 0.002 | 38.6564 | 0.0694 | 2 | 8 | chemokine receptor binding |
| GO:0045236 | 0.0041 | 25.0431 | 0.0981 | 2 | 11 | CXCR chemokine receptor binding |
| GO:0004888 | 0.0052 | 2.2592 | 7.1452 | 15 | 801 | transmembrane signaling receptor activity |
| GO:0004631 | 0.0089 | Inf | 0.0089 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0005147 | 0.0089 | Inf | 0.0089 | 1 | 1 | oncostatin-M receptor binding |
| GO:0008518 | 0.0089 | Inf | 0.0089 | 1 | 1 | reduced folate carrier activity |
| GO:0031249 | 0.0089 | Inf | 0.0089 | 1 | 1 | denatured protein binding |
| GO:0033735 | 0.0089 | Inf | 0.0089 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0034353 | 0.0089 | Inf | 0.0089 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0035755 | 0.0089 | Inf | 0.0089 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0003735 | 0.0097 | 4.0812 | 1.2935 | 5 | 145 | structural constituent of ribosome |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003700 | 3e-04 | 2.8756 | 7.2199 | 18 | 1171 | DNA binding transcription factor activity |
| GO:0030545 | 8e-04 | 3.9973 | 2.4662 | 9 | 400 | receptor regulator activity |
| GO:0043565 | 0.001 | 2.7639 | 6.0977 | 15 | 989 | sequence-specific DNA binding |
| GO:0036122 | 0.0013 | 47.0342 | 0.0555 | 2 | 9 | BMP binding |
| GO:0001228 | 0.003 | 3.5491 | 2.4354 | 8 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0005179 | 0.0035 | 6.9039 | 0.6222 | 4 | 102 | hormone activity |
| GO:0001604 | 0.0062 | Inf | 0.0062 | 1 | 1 | urotensin II receptor activity |
| GO:0004063 | 0.0062 | Inf | 0.0062 | 1 | 1 | aryldialkylphosphatase activity |
| GO:0004946 | 0.0062 | Inf | 0.0062 | 1 | 1 | bombesin receptor activity |
| GO:0005130 | 0.0062 | Inf | 0.0062 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0005140 | 0.0062 | Inf | 0.0062 | 1 | 1 | interleukin-9 receptor binding |
| GO:0005276 | 0.0062 | Inf | 0.0062 | 1 | 1 | vesicular hydrogen:amino acid antiporter activity |
| GO:0015495 | 0.0062 | Inf | 0.0062 | 1 | 1 | gamma-aminobutyric acid:proton symporter activity |
| GO:0017174 | 0.0062 | Inf | 0.0062 | 1 | 1 | glycine N-methyltransferase activity |
| GO:0030354 | 0.0062 | Inf | 0.0062 | 1 | 1 | melanin-concentrating hormone activity |
| GO:0031773 | 0.0062 | Inf | 0.0062 | 1 | 1 | kisspeptin receptor binding |
| GO:0016799 | 0.008 | 16.4478 | 0.1356 | 2 | 22 | hydrolase activity, hydrolyzing N-glycosyl compounds |
| GO:0005102 | 0.0084 | 2.1161 | 8.3543 | 16 | 1355 | receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 30.452 | 0.3327 | 8 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 5.0725 | 2.4576 | 11 | 421 | G-protein coupled receptor activity |
| GO:0031727 | 0 | Inf | 0.0117 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0018685 | 2e-04 | 174.1954 | 0.0234 | 2 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 2e-04 | 174.1954 | 0.0234 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0008048 | 3e-04 | 116.1226 | 0.0292 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
| GO:0020037 | 7e-04 | 7.7857 | 0.7005 | 5 | 120 | heme binding |
| GO:0010853 | 7e-04 | 69.6644 | 0.0409 | 2 | 7 | cyclase activator activity |
| GO:0030249 | 9e-04 | 58.0498 | 0.0467 | 2 | 8 | guanylate cyclase regulator activity |
| GO:0102991 | 9e-04 | 58.0498 | 0.0467 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0048018 | 0.0016 | 3.9691 | 2.1949 | 8 | 376 | receptor ligand activity |
| GO:0004497 | 0.0017 | 8.5448 | 0.508 | 4 | 88 | monooxygenase activity |
| GO:0019825 | 0.0017 | 13.8791 | 0.2393 | 3 | 41 | oxygen binding |
| GO:0005506 | 0.0018 | 6.2058 | 0.8698 | 5 | 149 | iron ion binding |
| GO:0016290 | 0.0018 | 38.6922 | 0.0642 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0001664 | 0.0021 | 4.9081 | 1.3193 | 6 | 226 | G-protein coupled receptor binding |
| GO:0099600 | 0.0036 | 2.6798 | 4.9328 | 12 | 845 | transmembrane receptor activity |
| GO:0008392 | 0.0038 | 25.1545 | 0.0924 | 2 | 16 | arachidonic acid epoxygenase activity |
| GO:0016289 | 0.0054 | 20.4733 | 0.1109 | 2 | 19 | CoA hydrolase activity |
| GO:0004508 | 0.0058 | Inf | 0.0058 | 1 | 1 | steroid 17-alpha-monooxygenase activity |
| GO:0005130 | 0.0058 | Inf | 0.0058 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0008404 | 0.0058 | Inf | 0.0058 | 1 | 1 | arachidonic acid 14,15-epoxygenase activity |
| GO:0008405 | 0.0058 | Inf | 0.0058 | 1 | 1 | arachidonic acid 11,12-epoxygenase activity |
| GO:0018169 | 0.0058 | Inf | 0.0058 | 1 | 1 | ribosomal S6-glutamic acid ligase activity |
| GO:0030273 | 0.0058 | Inf | 0.0058 | 1 | 1 | melanin-concentrating hormone receptor activity |
| GO:0033560 | 0.0058 | Inf | 0.0058 | 1 | 1 | folate reductase activity |
| GO:0047442 | 0.0058 | Inf | 0.0058 | 1 | 1 | 17-alpha-hydroxyprogesterone aldolase activity |
| GO:0047963 | 0.0058 | Inf | 0.0058 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0052817 | 0.0058 | Inf | 0.0058 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0071614 | 0.0058 | Inf | 0.0058 | 1 | 1 | linoleic acid epoxygenase activity |
| GO:0102116 | 0.0058 | Inf | 0.0058 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0058 | Inf | 0.0058 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0038023 | 0.0062 | 2.4893 | 5.283 | 12 | 905 | signaling receptor activity |
| GO:0070330 | 0.0066 | 18.3158 | 0.1226 | 2 | 21 | aromatase activity |
| GO:0060089 | 0.0066 | 2.3017 | 6.7191 | 14 | 1151 | molecular transducer activity |
| GO:0048020 | 0.0069 | 17.8082 | 0.1256 | 2 | 22 | CCR chemokine receptor binding |
| GO:0005126 | 0.0081 | 4.2877 | 1.2411 | 5 | 215 | cytokine receptor binding |
| GO:0001530 | 0.0086 | 15.815 | 0.1401 | 2 | 24 | lipopolysaccharide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 16.1314 | 0.3552 | 5 | 57 | olfactory receptor activity |
| GO:0031727 | 0 | Inf | 0.0125 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0004497 | 2e-04 | 9.9649 | 0.5546 | 5 | 89 | monooxygenase activity |
| GO:0004930 | 3e-04 | 4.2193 | 2.6233 | 10 | 421 | G-protein coupled receptor activity |
| GO:0008201 | 3e-04 | 7.1767 | 0.916 | 6 | 147 | heparin binding |
| GO:0001530 | 4e-04 | 23.4938 | 0.1495 | 3 | 24 | lipopolysaccharide binding |
| GO:0008009 | 8e-04 | 18.2657 | 0.1869 | 3 | 30 | chemokine activity |
| GO:0035240 | 0.001 | 54.2832 | 0.0498 | 2 | 8 | dopamine binding |
| GO:0033691 | 0.0013 | 46.5253 | 0.0561 | 2 | 9 | sialic acid binding |
| GO:0019825 | 0.0021 | 12.9688 | 0.2555 | 3 | 41 | oxygen binding |
| GO:0005126 | 0.0023 | 4.7965 | 1.3459 | 6 | 216 | cytokine receptor binding |
| GO:0016705 | 0.0023 | 5.8306 | 0.9222 | 5 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0048018 | 0.0024 | 3.6939 | 2.3429 | 8 | 376 | receptor ligand activity |
| GO:0001664 | 0.0029 | 4.5754 | 1.4082 | 6 | 226 | G-protein coupled receptor binding |
| GO:0008392 | 0.0049 | 21.7004 | 0.1059 | 2 | 17 | arachidonic acid epoxygenase activity |
| GO:0099600 | 0.0061 | 2.4851 | 5.2653 | 12 | 845 | transmembrane receptor activity |
| GO:0004506 | 0.0062 | Inf | 0.0062 | 1 | 1 | squalene monooxygenase activity |
| GO:0004511 | 0.0062 | Inf | 0.0062 | 1 | 1 | tyrosine 3-monooxygenase activity |
| GO:0004556 | 0.0062 | Inf | 0.0062 | 1 | 1 | alpha-amylase activity |
| GO:0005276 | 0.0062 | Inf | 0.0062 | 1 | 1 | vesicular hydrogen:amino acid antiporter activity |
| GO:0008891 | 0.0062 | Inf | 0.0062 | 1 | 1 | glycolate oxidase activity |
| GO:0015495 | 0.0062 | Inf | 0.0062 | 1 | 1 | gamma-aminobutyric acid:proton symporter activity |
| GO:0047016 | 0.0062 | Inf | 0.0062 | 1 | 1 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity |
| GO:0047969 | 0.0062 | Inf | 0.0062 | 1 | 1 | glyoxylate oxidase activity |
| GO:0102116 | 0.0062 | Inf | 0.0062 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0062 | Inf | 0.0062 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0103025 | 0.0062 | Inf | 0.0062 | 1 | 1 | alpha-amylase activity (releasing maltohexaose) |
| GO:0048020 | 0.0079 | 16.6275 | 0.1342 | 2 | 22 | CCR chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 39.8363 | 0.4225 | 12 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 6.4561 | 3.1204 | 17 | 421 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 3.2502 | 6.7077 | 19 | 905 | signaling receptor activity |
| GO:0099600 | 0 | 3.2776 | 6.263 | 18 | 845 | transmembrane receptor activity |
| GO:0060089 | 3e-04 | 2.6624 | 8.531 | 20 | 1151 | molecular transducer activity |
| GO:0004867 | 0.0021 | 8.0117 | 0.5411 | 4 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0002113 | 0.0074 | Inf | 0.0074 | 1 | 1 | interleukin-33 binding |
| GO:0008613 | 0.0074 | Inf | 0.0074 | 1 | 1 | diuretic hormone activity |
| GO:0034899 | 0.0074 | Inf | 0.0074 | 1 | 1 | trimethylamine monooxygenase activity |
| GO:0022840 | 0.0086 | 16.0212 | 0.1408 | 2 | 19 | leak channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 0 | Inf | 0.0139 | 2 | 2 | melatonin receptor activity |
| GO:0000977 | 1e-04 | 3.8686 | 4.0812 | 14 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1990837 | 4e-04 | 3.1965 | 4.8808 | 14 | 702 | sequence-specific double-stranded DNA binding |
| GO:0044212 | 5e-04 | 2.9743 | 5.6316 | 15 | 810 | transcription regulatory region DNA binding |
| GO:0001067 | 5e-04 | 2.9625 | 5.6525 | 15 | 813 | regulatory region nucleic acid binding |
| GO:0001077 | 5e-04 | 4.7651 | 1.8285 | 8 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0000981 | 5e-04 | 3.0746 | 5.0615 | 14 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0140110 | 6e-04 | 2.4101 | 10.4707 | 22 | 1506 | transcription regulator activity |
| GO:0099600 | 7e-04 | 2.8419 | 5.875 | 15 | 845 | transmembrane receptor activity |
| GO:0038023 | 0.0015 | 2.6392 | 6.2921 | 15 | 905 | signaling receptor activity |
| GO:0070410 | 0.0017 | 41.5742 | 0.0626 | 2 | 9 | co-SMAD binding |
| GO:0004930 | 0.0023 | 3.4036 | 2.8586 | 9 | 419 | G-protein coupled receptor activity |
| GO:0043565 | 0.0023 | 4.1682 | 1.8155 | 7 | 287 | sequence-specific DNA binding |
| GO:0030955 | 0.0047 | 22.3772 | 0.1043 | 2 | 15 | potassium ion binding |
| GO:0097159 | 0.0053 | 1.682 | 38.6845 | 52 | 5564 | organic cyclic compound binding |
| GO:0004252 | 0.006 | 4.6058 | 1.1541 | 5 | 166 | serine-type endopeptidase activity |
| GO:0071837 | 0.0068 | 18.1779 | 0.1251 | 2 | 18 | HMG box domain binding |
| GO:1901363 | 0.0069 | 1.652 | 38.1978 | 51 | 5494 | heterocyclic compound binding |
| GO:0001604 | 0.007 | Inf | 0.007 | 1 | 1 | urotensin II receptor activity |
| GO:0035757 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0038117 | 0.007 | Inf | 0.007 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 0.007 | Inf | 0.007 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0097621 | 0.007 | Inf | 0.007 | 1 | 1 | monoamine oxidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 55.2183 | 0.3178 | 12 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 7.7876 | 2.3472 | 15 | 421 | G-protein coupled receptor activity |
| GO:0060089 | 0 | 4.3402 | 6.4171 | 22 | 1151 | molecular transducer activity |
| GO:0038023 | 0 | 4.6382 | 5.0456 | 19 | 905 | signaling receptor activity |
| GO:0099600 | 0 | 4.3276 | 4.7111 | 17 | 845 | transmembrane receptor activity |
| GO:0004321 | 0 | 138.6311 | 0.039 | 3 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 0 | 110.8976 | 0.0446 | 3 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0 | 110.8976 | 0.0446 | 3 | 8 | butyrate-CoA ligase activity |
| GO:0004507 | 0 | Inf | 0.0112 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0031727 | 0 | Inf | 0.0112 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0047783 | 0 | Inf | 0.0112 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0004497 | 1e-04 | 11.218 | 0.4962 | 5 | 89 | monooxygenase activity |
| GO:0015645 | 2e-04 | 32.5911 | 0.1115 | 3 | 20 | fatty acid ligase activity |
| GO:0008233 | 4e-04 | 3.7776 | 3.2615 | 11 | 585 | peptidase activity |
| GO:0004867 | 7e-04 | 10.8012 | 0.407 | 4 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0030414 | 0.0011 | 7.0089 | 0.775 | 5 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0.0011 | 7.0089 | 0.775 | 5 | 139 | endopeptidase regulator activity |
| GO:0016705 | 0.0014 | 6.5638 | 0.8251 | 5 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0004252 | 0.0023 | 5.823 | 0.9255 | 5 | 166 | serine-type endopeptidase activity |
| GO:0036459 | 0.003 | 7.2195 | 0.5965 | 4 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0.003 | 5.4788 | 0.9812 | 5 | 176 | cysteine-type peptidase activity |
| GO:0061783 | 0.0035 | 26.0706 | 0.0892 | 2 | 16 | peptidoglycan muralytic activity |
| GO:0020037 | 0.0045 | 6.4049 | 0.669 | 4 | 120 | heme binding |
| GO:0019865 | 0.0049 | 21.4656 | 0.1059 | 2 | 19 | immunoglobulin binding |
| GO:0017171 | 0.005 | 4.8472 | 1.1039 | 5 | 198 | serine hydrolase activity |
| GO:0004506 | 0.0056 | Inf | 0.0056 | 1 | 1 | squalene monooxygenase activity |
| GO:0102116 | 0.0056 | Inf | 0.0056 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0056 | Inf | 0.0056 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0048020 | 0.0063 | 18.6926 | 0.1198 | 2 | 22 | CCR chemokine receptor binding |
| GO:0001530 | 0.0078 | 16.5816 | 0.1338 | 2 | 24 | lipopolysaccharide binding |
| GO:0005506 | 0.0096 | 5.114 | 0.8307 | 4 | 149 | iron ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 1e-04 | 2.3177 | 13.2982 | 28 | 989 | sequence-specific DNA binding |
| GO:0016165 | 2e-04 | Inf | 0.0269 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0005179 | 0.0027 | 4.6451 | 1.385 | 6 | 103 | hormone activity |
| GO:0046982 | 0.0031 | 2.4553 | 6.0508 | 14 | 450 | protein heterodimerization activity |
| GO:0004952 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | dopamine neurotransmitter receptor activity |
| GO:0102991 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0005501 | 0.0082 | 7.963 | 0.4168 | 3 | 31 | retinoid binding |
| GO:0016290 | 0.0091 | 16.4554 | 0.1479 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0000981 | 0.0095 | 1.9429 | 9.7888 | 18 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 1e-04 | Inf | 0.0178 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0008009 | 1e-04 | 17.5804 | 0.2676 | 4 | 30 | chemokine activity |
| GO:0005132 | 8e-04 | 75.1592 | 0.0446 | 2 | 5 | type I interferon receptor binding |
| GO:0055131 | 0.0012 | 56.3657 | 0.0535 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0048018 | 0.002 | 3.1972 | 3.3541 | 10 | 376 | receptor ligand activity |
| GO:0042379 | 0.002 | 38.6564 | 0.0694 | 2 | 8 | chemokine receptor binding |
| GO:0045236 | 0.0041 | 25.0431 | 0.0981 | 2 | 11 | CXCR chemokine receptor binding |
| GO:0004888 | 0.0052 | 2.2592 | 7.1452 | 15 | 801 | transmembrane signaling receptor activity |
| GO:0004631 | 0.0089 | Inf | 0.0089 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0005147 | 0.0089 | Inf | 0.0089 | 1 | 1 | oncostatin-M receptor binding |
| GO:0008518 | 0.0089 | Inf | 0.0089 | 1 | 1 | reduced folate carrier activity |
| GO:0031249 | 0.0089 | Inf | 0.0089 | 1 | 1 | denatured protein binding |
| GO:0033735 | 0.0089 | Inf | 0.0089 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0034353 | 0.0089 | Inf | 0.0089 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0035755 | 0.0089 | Inf | 0.0089 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0003735 | 0.0097 | 4.0812 | 1.2935 | 5 | 145 | structural constituent of ribosome |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 46.9431 | 0.4038 | 13 | 57 | olfactory receptor activity |
| GO:0036459 | 0 | 26.378 | 0.758 | 15 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 16.2804 | 1.2468 | 16 | 176 | cysteine-type peptidase activity |
| GO:0004872 | 0 | 4.3389 | 7.8418 | 27 | 1107 | receptor activity |
| GO:0008233 | 0 | 5.1397 | 4.144 | 18 | 585 | peptidase activity |
| GO:0004930 | 0 | 5.8525 | 2.9823 | 15 | 421 | G-protein coupled receptor activity |
| GO:0004871 | 0 | 3.3735 | 8.5431 | 24 | 1206 | signal transducer activity |
| GO:0004507 | 0 | Inf | 0.0142 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0047783 | 0 | Inf | 0.0142 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0004497 | 4e-04 | 8.6997 | 0.6305 | 5 | 89 | monooxygenase activity |
| GO:0048020 | 6e-04 | 20.5673 | 0.17 | 3 | 24 | CCR chemokine receptor binding |
| GO:0016705 | 6e-04 | 6.2121 | 1.0484 | 6 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0004321 | 0.001 | 57.1057 | 0.0496 | 2 | 7 | fatty-acyl-CoA synthase activity |
| GO:0008009 | 0.0012 | 15.9905 | 0.2125 | 3 | 30 | chemokine activity |
| GO:0003996 | 0.0014 | 47.5849 | 0.0567 | 2 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0.0014 | 47.5849 | 0.0567 | 2 | 8 | butyrate-CoA ligase activity |
| GO:0030246 | 0.0016 | 4.4336 | 1.7001 | 7 | 240 | carbohydrate binding |
| GO:0020037 | 0.0016 | 6.3415 | 0.8501 | 5 | 120 | heme binding |
| GO:0004867 | 0.0018 | 8.3997 | 0.5171 | 4 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0005549 | 0.0026 | 31.717 | 0.0779 | 2 | 11 | odorant binding |
| GO:0003823 | 0.004 | 10.2694 | 0.3188 | 3 | 45 | antigen binding |
| GO:0005506 | 0.0041 | 5.0546 | 1.0555 | 5 | 149 | iron ion binding |
| GO:0008329 | 0.0056 | 20.3827 | 0.1133 | 2 | 16 | signaling pattern recognition receptor activity |
| GO:0061783 | 0.0056 | 20.3827 | 0.1133 | 2 | 16 | peptidoglycan muralytic activity |
| GO:0004912 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-3 receptor activity |
| GO:0008891 | 0.0071 | Inf | 0.0071 | 1 | 1 | glycolate oxidase activity |
| GO:0035375 | 0.0071 | Inf | 0.0071 | 1 | 1 | zymogen binding |
| GO:0042164 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-12 alpha subunit binding |
| GO:0047969 | 0.0071 | Inf | 0.0071 | 1 | 1 | glyoxylate oxidase activity |
| GO:0102116 | 0.0071 | Inf | 0.0071 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0071 | Inf | 0.0071 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0015645 | 0.0087 | 15.8491 | 0.1417 | 2 | 20 | fatty acid ligase activity |
| GO:0004888 | 0.0099 | 3.1334 | 2.3838 | 7 | 380 | transmembrane signaling receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 2e-04 | 3.2671 | 4.6438 | 14 | 400 | receptor regulator activity |
| GO:1903231 | 5e-04 | 12.4203 | 0.3715 | 4 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005179 | 0.0013 | 5.4158 | 1.1958 | 6 | 103 | hormone activity |
| GO:0005132 | 0.0013 | 57.3943 | 0.058 | 2 | 5 | type I interferon receptor binding |
| GO:0051379 | 0.0027 | 34.432 | 0.0813 | 2 | 7 | epinephrine binding |
| GO:0004952 | 0.0036 | 28.6914 | 0.0929 | 2 | 8 | dopamine neurotransmitter receptor activity |
| GO:0102991 | 0.0036 | 28.6914 | 0.0929 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0005125 | 0.0036 | 3.789 | 1.962 | 7 | 169 | cytokine activity |
| GO:0008190 | 0.0046 | 24.591 | 0.1045 | 2 | 9 | eukaryotic initiation factor 4E binding |
| GO:0016290 | 0.0069 | 19.1238 | 0.1277 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030617 | 0 | Inf | 0.0132 | 2 | 2 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity |
| GO:0032394 | 0 | Inf | 0.0132 | 2 | 2 | MHC class Ib receptor activity |
| GO:0070697 | 3e-04 | 152.9596 | 0.0265 | 2 | 4 | activin receptor binding |
| GO:0016174 | 4e-04 | 101.9663 | 0.0331 | 2 | 5 | NAD(P)H oxidase activity |
| GO:0020037 | 0.0012 | 6.8071 | 0.795 | 5 | 120 | heme binding |
| GO:0034713 | 0.0015 | 43.6883 | 0.0596 | 2 | 9 | type I transforming growth factor beta receptor binding |
| GO:0004601 | 0.0018 | 13.7456 | 0.2427 | 3 | 37 | peroxidase activity |
| GO:0070411 | 0.0023 | 33.9753 | 0.0729 | 2 | 11 | I-SMAD binding |
| GO:0033612 | 0.0043 | 23.5152 | 0.0994 | 2 | 15 | receptor serine/threonine kinase binding |
| GO:0042288 | 0.0062 | 19.1023 | 0.1192 | 2 | 18 | MHC class I protein binding |
| GO:0001604 | 0.0066 | Inf | 0.0066 | 1 | 1 | urotensin II receptor activity |
| GO:0004790 | 0.0066 | Inf | 0.0066 | 1 | 1 | thioether S-methyltransferase activity |
| GO:0008112 | 0.0066 | Inf | 0.0066 | 1 | 1 | nicotinamide N-methyltransferase activity |
| GO:0030354 | 0.0066 | Inf | 0.0066 | 1 | 1 | melanin-concentrating hormone activity |
| GO:0030748 | 0.0066 | Inf | 0.0066 | 1 | 1 | amine N-methyltransferase activity |
| GO:0030760 | 0.0066 | Inf | 0.0066 | 1 | 1 | pyridine N-methyltransferase activity |
| GO:0031703 | 0.0066 | Inf | 0.0066 | 1 | 1 | type 2 angiotensin receptor binding |
| GO:0047888 | 0.0066 | Inf | 0.0066 | 1 | 1 | fatty acid peroxidase activity |
| GO:0102707 | 0.0066 | Inf | 0.0066 | 1 | 1 | S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity |
| GO:0004930 | 0.0068 | 3.0684 | 2.789 | 8 | 421 | G-protein coupled receptor activity |
| GO:0060089 | 0.0086 | 2.1509 | 7.625 | 15 | 1151 | molecular transducer activity |
| GO:0099600 | 0.0099 | 2.3166 | 5.5979 | 12 | 845 | transmembrane receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 29.3942 | 0.2954 | 7 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 7.811 | 2.1815 | 14 | 421 | G-protein coupled receptor activity |
| GO:0004875 | 0 | 134.7644 | 0.0518 | 4 | 10 | complement receptor activity |
| GO:0099600 | 0 | 5.1167 | 4.3785 | 18 | 845 | transmembrane receptor activity |
| GO:0004982 | 0 | 598.6579 | 0.0207 | 3 | 4 | N-formyl peptide receptor activity |
| GO:0060089 | 0 | 4.2069 | 5.9641 | 20 | 1151 | molecular transducer activity |
| GO:0005549 | 0 | 74.7977 | 0.057 | 3 | 11 | odorant binding |
| GO:0038023 | 0 | 4.2234 | 3.9158 | 14 | 790 | signaling receptor activity |
| GO:0005124 | 1e-04 | 393.9221 | 0.0155 | 2 | 3 | scavenger receptor binding |
| GO:0001653 | 0.003 | 7.2341 | 0.5959 | 4 | 115 | peptide receptor activity |
| GO:0004838 | 0.0052 | Inf | 0.0052 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
| GO:0015327 | 0.0052 | Inf | 0.0052 | 1 | 1 | cystine:glutamate antiporter activity |
| GO:1901680 | 0.0052 | Inf | 0.0052 | 1 | 1 | sulfur-containing amino acid secondary active transmembrane transporter activity |
| GO:1990190 | 0.0052 | Inf | 0.0052 | 1 | 1 | peptide-glutamate-N-acetyltransferase activity |
| GO:0042056 | 0.0092 | 15.1259 | 0.1451 | 2 | 28 | chemoattractant activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061629 | 0 | Inf | 0.0119 | 2 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
| GO:0008048 | 3e-04 | 113.4981 | 0.0298 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
| GO:0004984 | 4e-04 | 13.1008 | 0.3402 | 4 | 57 | olfactory receptor activity |
| GO:0030545 | 6e-04 | 4.1443 | 2.3875 | 9 | 400 | receptor regulator activity |
| GO:0010853 | 7e-04 | 68.0899 | 0.0418 | 2 | 7 | cyclase activator activity |
| GO:0030249 | 0.001 | 56.7378 | 0.0478 | 2 | 8 | guanylate cyclase regulator activity |
| GO:0099600 | 0.0015 | 2.8692 | 5.0436 | 13 | 845 | transmembrane receptor activity |
| GO:0038023 | 0.0027 | 2.665 | 5.4017 | 13 | 905 | signaling receptor activity |
| GO:0031432 | 0.0031 | 28.3577 | 0.0836 | 2 | 14 | titin binding |
| GO:0005125 | 0.0034 | 5.3144 | 1.0087 | 5 | 169 | cytokine activity |
| GO:0005509 | 0.0046 | 2.8653 | 3.7961 | 10 | 636 | calcium ion binding |
| GO:0004462 | 0.006 | Inf | 0.006 | 1 | 1 | lactoylglutathione lyase activity |
| GO:0005147 | 0.006 | Inf | 0.006 | 1 | 1 | oncostatin-M receptor binding |
| GO:0019767 | 0.006 | Inf | 0.006 | 1 | 1 | IgE receptor activity |
| GO:0030354 | 0.006 | Inf | 0.006 | 1 | 1 | melanin-concentrating hormone activity |
| GO:0031854 | 0.006 | Inf | 0.006 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
| GO:0033560 | 0.006 | Inf | 0.006 | 1 | 1 | folate reductase activity |
| GO:0042497 | 0.006 | Inf | 0.006 | 1 | 1 | triacyl lipopeptide binding |
| GO:0047963 | 0.006 | Inf | 0.006 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0050528 | 0.006 | Inf | 0.006 | 1 | 1 | acyloxyacyl hydrolase activity |
| GO:0052817 | 0.006 | Inf | 0.006 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0080048 | 0.006 | Inf | 0.006 | 1 | 1 | GDP-D-glucose phosphorylase activity |
| GO:0060089 | 0.0081 | 2.2416 | 6.8701 | 14 | 1151 | molecular transducer activity |
| GO:0005126 | 0.0089 | 4.1863 | 1.2693 | 5 | 215 | cytokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000981 | 0.0014 | 2.3803 | 8.1653 | 18 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0038036 | 0.0033 | 29.7219 | 0.0897 | 2 | 8 | sphingosine-1-phosphate receptor activity |
| GO:0005542 | 0.0043 | 25.4742 | 0.1009 | 2 | 9 | folic acid binding |
| GO:0005372 | 0.0053 | 22.2885 | 0.1122 | 2 | 10 | water transmembrane transporter activity |
| GO:0043565 | 0.0076 | 1.9281 | 11.0927 | 20 | 989 | sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 0 | Inf | 0.0134 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0005179 | 1e-04 | 9.6952 | 0.6891 | 6 | 103 | hormone activity |
| GO:0005126 | 1e-04 | 7.1376 | 1.0833 | 7 | 168 | cytokine receptor binding |
| GO:0005198 | 2e-04 | 3.5102 | 4.1346 | 13 | 618 | structural molecule activity |
| GO:0008327 | 3e-04 | 28.6515 | 0.1271 | 3 | 19 | methyl-CpG binding |
| GO:0048020 | 3e-04 | 26.2604 | 0.1364 | 3 | 21 | CCR chemokine receptor binding |
| GO:0001664 | 8e-04 | 5.0216 | 1.512 | 7 | 226 | G-protein coupled receptor binding |
| GO:0032395 | 9e-04 | 60.556 | 0.0468 | 2 | 7 | MHC class II receptor activity |
| GO:0008009 | 0.001 | 16.9663 | 0.2007 | 3 | 30 | chemokine activity |
| GO:0048018 | 0.0017 | 4.3705 | 1.7307 | 7 | 273 | receptor ligand activity |
| GO:0005160 | 0.0038 | 10.3994 | 0.3144 | 3 | 47 | transforming growth factor beta receptor binding |
| GO:0008391 | 0.0056 | 20.172 | 0.1137 | 2 | 17 | arachidonic acid monooxygenase activity |
| GO:0005130 | 0.0067 | Inf | 0.0067 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0008397 | 0.0067 | Inf | 0.0067 | 1 | 1 | sterol 12-alpha-hydroxylase activity |
| GO:0008404 | 0.0067 | Inf | 0.0067 | 1 | 1 | arachidonic acid 14,15-epoxygenase activity |
| GO:0008405 | 0.0067 | Inf | 0.0067 | 1 | 1 | arachidonic acid 11,12-epoxygenase activity |
| GO:0008579 | 0.0067 | Inf | 0.0067 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0030251 | 0.0067 | Inf | 0.0067 | 1 | 1 | guanylate cyclase inhibitor activity |
| GO:0030273 | 0.0067 | Inf | 0.0067 | 1 | 1 | melanin-concentrating hormone receptor activity |
| GO:0031731 | 0.0067 | Inf | 0.0067 | 1 | 1 | CCR6 chemokine receptor binding |
| GO:0033735 | 0.0067 | Inf | 0.0067 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0033778 | 0.0067 | Inf | 0.0067 | 1 | 1 | 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity |
| GO:0046789 | 0.0067 | Inf | 0.0067 | 1 | 1 | host cell surface receptor binding |
| GO:0047395 | 0.0067 | Inf | 0.0067 | 1 | 1 | glycerophosphoinositol glycerophosphodiesterase activity |
| GO:0071614 | 0.0067 | Inf | 0.0067 | 1 | 1 | linoleic acid epoxygenase activity |
| GO:1990439 | 0.0067 | Inf | 0.0067 | 1 | 1 | MAP kinase serine/threonine phosphatase activity |
| GO:0070330 | 0.0086 | 15.9211 | 0.1405 | 2 | 21 | aromatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 0 | Inf | 0.0135 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0008201 | 5e-04 | 6.5813 | 0.9931 | 6 | 147 | heparin binding |
| GO:0043565 | 9e-04 | 2.6783 | 6.6816 | 16 | 989 | sequence-specific DNA binding |
| GO:0000981 | 0.0012 | 2.9147 | 4.9183 | 13 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0001846 | 0.0029 | 29.9663 | 0.0811 | 2 | 12 | opsonin binding |
| GO:0010181 | 0.0039 | 24.9686 | 0.0946 | 2 | 14 | FMN binding |
| GO:0031432 | 0.0039 | 24.9686 | 0.0946 | 2 | 14 | titin binding |
| GO:0001604 | 0.0068 | Inf | 0.0068 | 1 | 1 | urotensin II receptor activity |
| GO:0001850 | 0.0068 | Inf | 0.0068 | 1 | 1 | complement component C3a binding |
| GO:0004531 | 0.0068 | Inf | 0.0068 | 1 | 1 | deoxyribonuclease II activity |
| GO:0004607 | 0.0068 | Inf | 0.0068 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0031686 | 0.0068 | Inf | 0.0068 | 1 | 1 | A1 adenosine receptor binding |
| GO:0045032 | 0.0068 | Inf | 0.0068 | 1 | 1 | ADP-activated adenosine receptor activity |
| GO:0050113 | 0.0068 | Inf | 0.0068 | 1 | 1 | inositol oxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 4.3221 | 10.0548 | 35 | 989 | sequence-specific DNA binding |
| GO:0003700 | 0 | 3.5829 | 11.9051 | 35 | 1171 | DNA binding transcription factor activity |
| GO:0001228 | 0 | 8.935 | 1.2774 | 10 | 132 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0001012 | 1e-04 | 3.1326 | 5.978 | 17 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0003690 | 1e-04 | 2.8013 | 7.9096 | 20 | 778 | double-stranded DNA binding |
| GO:0001077 | 4e-04 | 4.0447 | 2.6738 | 10 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0000976 | 4e-04 | 2.7457 | 6.7608 | 17 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0000975 | 6e-04 | 2.5189 | 8.2553 | 19 | 812 | regulatory region DNA binding |
| GO:0000978 | 9e-04 | 3.3443 | 3.538 | 11 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0001159 | 0.0012 | 3.1893 | 3.7006 | 11 | 364 | core promoter proximal region DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0 | 27.5626 | 0.3358 | 7 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0043565 | 0 | 3.3995 | 10.3791 | 30 | 989 | sequence-specific DNA binding |
| GO:0001077 | 1e-04 | 4.3457 | 2.7601 | 11 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0016165 | 1e-04 | Inf | 0.021 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0000981 | 2e-04 | 2.7325 | 7.64 | 19 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0008191 | 3e-04 | 28.8076 | 0.1364 | 3 | 13 | metalloendopeptidase inhibitor activity |
| GO:0019840 | 4e-04 | 13.313 | 0.3463 | 4 | 33 | isoprenoid binding |
| GO:0140110 | 4e-04 | 2.1279 | 15.8048 | 30 | 1506 | transcription regulator activity |
| GO:0031490 | 5e-04 | 6.6402 | 0.9865 | 6 | 94 | chromatin DNA binding |
| GO:0008401 | 6e-04 | 95.4684 | 0.042 | 2 | 4 | retinoic acid 4-hydroxylase activity |
| GO:0030545 | 0.0011 | 3.0715 | 4.1978 | 12 | 400 | receptor regulator activity |
| GO:0005132 | 0.0011 | 63.6414 | 0.0525 | 2 | 5 | type I interferon receptor binding |
| GO:0001012 | 0.0013 | 2.6201 | 6.1708 | 15 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0001159 | 0.0016 | 3.0812 | 3.82 | 11 | 364 | core promoter proximal region DNA binding |
| GO:0005125 | 0.002 | 4.2148 | 1.7736 | 7 | 169 | cytokine activity |
| GO:0000978 | 0.0037 | 2.9089 | 3.6521 | 10 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0000976 | 0.0043 | 2.2975 | 6.9789 | 15 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0005506 | 0.0049 | 4.0713 | 1.5637 | 6 | 149 | iron ion binding |
| GO:0003676 | 0.0049 | 1.5835 | 39.1027 | 54 | 3726 | nucleic acid binding |
| GO:0000975 | 0.0051 | 2.137 | 8.5216 | 17 | 812 | regulatory region DNA binding |
| GO:0016918 | 0.0092 | 15.9008 | 0.1469 | 2 | 14 | retinal binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 1e-04 | Inf | 0.0195 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0001530 | 0.0016 | 14.7515 | 0.2346 | 3 | 24 | lipopolysaccharide binding |
| GO:0003680 | 0.0026 | 34.22 | 0.0782 | 2 | 8 | AT DNA binding |
| GO:0043565 | 0.0036 | 2.1286 | 9.6656 | 19 | 989 | sequence-specific DNA binding |
| GO:0048018 | 0.0039 | 2.8956 | 3.6747 | 10 | 376 | receptor ligand activity |
| GO:0000981 | 0.0051 | 2.2583 | 7.1148 | 15 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0042379 | 0.0069 | 8.3636 | 0.3909 | 3 | 40 | chemokine receptor binding |
| GO:0005130 | 0.0098 | Inf | 0.0098 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0031732 | 0.0098 | Inf | 0.0098 | 1 | 1 | CCR7 chemokine receptor binding |
| GO:0032003 | 0.0098 | Inf | 0.0098 | 1 | 1 | interleukin-28 receptor binding |
| GO:0033798 | 0.0098 | Inf | 0.0098 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0036105 | 0.0098 | Inf | 0.0098 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
| GO:0036219 | 0.0098 | Inf | 0.0098 | 1 | 1 | GTP diphosphatase activity |
| GO:0044713 | 0.0098 | Inf | 0.0098 | 1 | 1 | 2-hydroxy-adenosine triphosphate pyrophosphatase activity |
| GO:0044714 | 0.0098 | Inf | 0.0098 | 1 | 1 | 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity |
| GO:0047693 | 0.0098 | Inf | 0.0098 | 1 | 1 | ATP diphosphatase activity |
| GO:0050113 | 0.0098 | Inf | 0.0098 | 1 | 1 | inositol oxygenase activity |
| GO:0070009 | 0.0098 | Inf | 0.0098 | 1 | 1 | serine-type aminopeptidase activity |
| GO:0070320 | 0.0098 | Inf | 0.0098 | 1 | 1 | inward rectifier potassium channel inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 18.628 | 0.3103 | 5 | 57 | olfactory receptor activity |
| GO:0031727 | 0 | Inf | 0.0109 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0015250 | 0.001 | 53.4603 | 0.049 | 2 | 9 | water channel activity |
| GO:0042379 | 0.0013 | 15.3304 | 0.2178 | 3 | 40 | chemokine receptor binding |
| GO:0000121 | 0.0054 | Inf | 0.0054 | 1 | 1 | glycerol-1-phosphatase activity |
| GO:0008458 | 0.0054 | Inf | 0.0054 | 1 | 1 | carnitine O-octanoyltransferase activity |
| GO:0015361 | 0.0054 | Inf | 0.0054 | 1 | 1 | low-affinity sodium:dicarboxylate symporter activity |
| GO:0016415 | 0.0054 | Inf | 0.0054 | 1 | 1 | octanoyltransferase activity |
| GO:0043136 | 0.0054 | Inf | 0.0054 | 1 | 1 | glycerol-3-phosphatase activity |
| GO:0005343 | 0.0069 | 17.8036 | 0.1252 | 2 | 23 | organic acid:sodium symporter activity |
| GO:0001530 | 0.0075 | 16.9933 | 0.1307 | 2 | 24 | lipopolysaccharide binding |
| GO:0004930 | 0.008 | 3.2813 | 2.2919 | 7 | 421 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 5.5028 | 7.8426 | 35 | 636 | calcium ion binding |
| GO:0001632 | 2e-04 | Inf | 0.0247 | 2 | 2 | leukotriene B4 receptor activity |
| GO:0016165 | 2e-04 | Inf | 0.0247 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0005179 | 0.0017 | 5.0847 | 1.2701 | 6 | 103 | hormone activity |
| GO:0043565 | 0.0025 | 2.0335 | 12.1955 | 23 | 989 | sequence-specific DNA binding |
| GO:0004966 | 0.003 | 32.372 | 0.0863 | 2 | 7 | galanin receptor activity |
| GO:0003705 | 0.0059 | 4.6479 | 1.1468 | 5 | 93 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
| GO:1903231 | 0.007 | 8.4039 | 0.3946 | 3 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004861 | 0.0092 | 16.1806 | 0.148 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 58.6064 | 0.4 | 15 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 8.449 | 2.9547 | 20 | 421 | G-protein coupled receptor activity |
| GO:0060089 | 0 | 4.872 | 8.078 | 30 | 1151 | molecular transducer activity |
| GO:0099600 | 0 | 5.3238 | 5.9304 | 25 | 845 | transmembrane receptor activity |
| GO:0038023 | 0 | 5.1581 | 6.129 | 25 | 889 | signaling receptor activity |
| GO:0036459 | 0 | 15.9868 | 0.751 | 10 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 10.3986 | 1.2352 | 11 | 176 | cysteine-type peptidase activity |
| GO:0008233 | 0 | 4.1673 | 4.1057 | 15 | 585 | peptidase activity |
| GO:0004507 | 0 | Inf | 0.014 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0031727 | 0 | Inf | 0.014 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0047783 | 0 | Inf | 0.014 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0003823 | 3e-04 | 14.3007 | 0.3158 | 4 | 45 | antigen binding |
| GO:0018685 | 3e-04 | 144.1619 | 0.0281 | 2 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 3e-04 | 144.1619 | 0.0281 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0004497 | 4e-04 | 8.7856 | 0.6246 | 5 | 89 | monooxygenase activity |
| GO:0048020 | 4e-04 | 23.4056 | 0.1515 | 3 | 22 | CCR chemokine receptor binding |
| GO:0004321 | 0.001 | 57.6533 | 0.0491 | 2 | 7 | fatty-acyl-CoA synthase activity |
| GO:0008009 | 0.0012 | 16.1453 | 0.2105 | 3 | 30 | chemokine activity |
| GO:0003996 | 0.0013 | 48.0413 | 0.0561 | 2 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0.0013 | 48.0413 | 0.0561 | 2 | 8 | butyrate-CoA ligase activity |
| GO:0020037 | 0.0016 | 6.4041 | 0.8422 | 5 | 120 | heme binding |
| GO:0004867 | 0.0017 | 8.4818 | 0.5123 | 4 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0016705 | 0.0039 | 5.1405 | 1.0387 | 5 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0005506 | 0.004 | 5.1045 | 1.0457 | 5 | 149 | iron ion binding |
| GO:0008329 | 0.0055 | 20.5782 | 0.1123 | 2 | 16 | signaling pattern recognition receptor activity |
| GO:0008392 | 0.0062 | 19.2051 | 0.1193 | 2 | 17 | arachidonic acid epoxygenase activity |
| GO:0035375 | 0.007 | Inf | 0.007 | 1 | 1 | zymogen binding |
| GO:0102116 | 0.007 | Inf | 0.007 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.007 | Inf | 0.007 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0015645 | 0.0085 | 16.0011 | 0.1404 | 2 | 20 | fatty acid ligase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 50.6564 | 0.415 | 14 | 57 | olfactory receptor activity |
| GO:0036459 | 0 | 27.8431 | 0.779 | 16 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 17.0341 | 1.2814 | 17 | 176 | cysteine-type peptidase activity |
| GO:0004872 | 0 | 4.8344 | 8.0596 | 30 | 1107 | receptor activity |
| GO:0008233 | 0 | 5.6676 | 4.2591 | 20 | 585 | peptidase activity |
| GO:0004930 | 0 | 6.1255 | 3.0651 | 16 | 421 | G-protein coupled receptor activity |
| GO:0004871 | 0 | 3.6174 | 8.7804 | 26 | 1206 | signal transducer activity |
| GO:0004497 | 0 | 10.3628 | 0.648 | 6 | 89 | monooxygenase activity |
| GO:0004507 | 1e-04 | Inf | 0.0146 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0047783 | 1e-04 | Inf | 0.0146 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0016705 | 1e-04 | 7.1575 | 1.0775 | 7 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0020037 | 2e-04 | 7.5293 | 0.8737 | 6 | 120 | heme binding |
| GO:0003823 | 3e-04 | 13.7625 | 0.3276 | 4 | 45 | antigen binding |
| GO:0048020 | 7e-04 | 19.9921 | 0.1747 | 3 | 24 | CCR chemokine receptor binding |
| GO:0005506 | 8e-04 | 5.9908 | 1.0848 | 6 | 149 | iron ion binding |
| GO:0004321 | 0.0011 | 55.5229 | 0.051 | 2 | 7 | fatty-acyl-CoA synthase activity |
| GO:0008009 | 0.0013 | 15.5432 | 0.2184 | 3 | 30 | chemokine activity |
| GO:0003996 | 0.0014 | 46.2661 | 0.0582 | 2 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0.0014 | 46.2661 | 0.0582 | 2 | 8 | butyrate-CoA ligase activity |
| GO:0004867 | 0.002 | 8.1625 | 0.5315 | 4 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0005549 | 0.0028 | 30.8379 | 0.0801 | 2 | 11 | odorant binding |
| GO:0004888 | 0.003 | 3.5491 | 2.4351 | 8 | 380 | transmembrane signaling receptor activity |
| GO:0008329 | 0.0059 | 19.8178 | 0.1165 | 2 | 16 | signaling pattern recognition receptor activity |
| GO:0061783 | 0.0059 | 19.8178 | 0.1165 | 2 | 16 | peptidoglycan muralytic activity |
| GO:0008392 | 0.0067 | 18.4954 | 0.1238 | 2 | 17 | arachidonic acid epoxygenase activity |
| GO:0004912 | 0.0073 | Inf | 0.0073 | 1 | 1 | interleukin-3 receptor activity |
| GO:0035375 | 0.0073 | Inf | 0.0073 | 1 | 1 | zymogen binding |
| GO:0042164 | 0.0073 | Inf | 0.0073 | 1 | 1 | interleukin-12 alpha subunit binding |
| GO:0102116 | 0.0073 | Inf | 0.0073 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0073 | Inf | 0.0073 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0030246 | 0.0082 | 3.6388 | 1.7473 | 6 | 240 | carbohydrate binding |
| GO:0015645 | 0.0092 | 15.4098 | 0.1456 | 2 | 20 | fatty acid ligase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 1e-04 | Inf | 0.0194 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0051380 | 6e-04 | 103.3973 | 0.0388 | 2 | 4 | norepinephrine binding |
| GO:0005132 | 9e-04 | 68.9269 | 0.0485 | 2 | 5 | type I interferon receptor binding |
| GO:0055131 | 0.0014 | 51.6918 | 0.0582 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0001664 | 0.0018 | 4.336 | 1.7277 | 7 | 185 | G-protein coupled receptor binding |
| GO:0051379 | 0.0019 | 41.3507 | 0.068 | 2 | 7 | epinephrine binding |
| GO:0042379 | 0.0024 | 35.1119 | 0.0762 | 2 | 8 | chemokine receptor binding |
| GO:0008009 | 0.003 | 11.5487 | 0.2912 | 3 | 30 | chemokine activity |
| GO:0004935 | 0.0032 | 29.5323 | 0.0874 | 2 | 9 | adrenergic receptor activity |
| GO:0048018 | 0.0037 | 2.9168 | 3.65 | 10 | 376 | receptor ligand activity |
| GO:0045236 | 0.0049 | 22.9665 | 0.1068 | 2 | 11 | CXCR chemokine receptor binding |
| GO:0004527 | 0.0058 | 5.9635 | 0.7184 | 4 | 74 | exonuclease activity |
| GO:0004516 | 0.0097 | Inf | 0.0097 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
| GO:0004631 | 0.0097 | Inf | 0.0097 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0004940 | 0.0097 | Inf | 0.0097 | 1 | 1 | beta1-adrenergic receptor activity |
| GO:0005147 | 0.0097 | Inf | 0.0097 | 1 | 1 | oncostatin-M receptor binding |
| GO:0008311 | 0.0097 | Inf | 0.0097 | 1 | 1 | double-stranded DNA 3'-5' exodeoxyribonuclease activity |
| GO:0008518 | 0.0097 | Inf | 0.0097 | 1 | 1 | reduced folate carrier activity |
| GO:0015052 | 0.0097 | Inf | 0.0097 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0016277 | 0.0097 | Inf | 0.0097 | 1 | 1 | [myelin basic protein]-arginine N-methyltransferase activity |
| GO:0031249 | 0.0097 | Inf | 0.0097 | 1 | 1 | denatured protein binding |
| GO:0031700 | 0.0097 | Inf | 0.0097 | 1 | 1 | adrenomedullin receptor binding |
| GO:0031773 | 0.0097 | Inf | 0.0097 | 1 | 1 | kisspeptin receptor binding |
| GO:0033735 | 0.0097 | Inf | 0.0097 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0034353 | 0.0097 | Inf | 0.0097 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0035755 | 0.0097 | Inf | 0.0097 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0047915 | 0.0097 | Inf | 0.0097 | 1 | 1 | ganglioside galactosyltransferase activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030948 | 1e-04 | 63.2516 | 0.0836 | 3 | 7 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0048514 | 8e-04 | 2.887 | 5.2531 | 14 | 440 | blood vessel morphogenesis |
| GO:0035021 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of Rac protein signal transduction |
| GO:1900747 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of vascular endothelial growth factor signaling pathway |
| GO:0051240 | 0.001 | 2.0798 | 14.3984 | 27 | 1206 | positive regulation of multicellular organismal process |
| GO:0048646 | 0.0011 | 2.2704 | 10.1242 | 21 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0044030 | 0.0016 | 14.8679 | 0.2388 | 3 | 20 | regulation of DNA methylation |
| GO:0048870 | 0.0025 | 1.9872 | 13.7895 | 25 | 1155 | cell motility |
| GO:0016525 | 0.0027 | 5.6649 | 0.9551 | 5 | 80 | negative regulation of angiogenesis |
| GO:0010533 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | regulation of activation of Janus kinase activity |
| GO:0043697 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | cell dedifferentiation |
| GO:0023052 | 0.0029 | 1.5815 | 56.7339 | 74 | 4752 | signaling |
| GO:0060285 | 0.0032 | 11.4845 | 0.2985 | 3 | 25 | cilium-dependent cell motility |
| GO:0022603 | 0.0032 | 2.1519 | 9.5512 | 19 | 800 | regulation of anatomical structure morphogenesis |
| GO:1901343 | 0.0036 | 5.2429 | 1.0267 | 5 | 86 | negative regulation of vasculature development |
| GO:0055002 | 0.0037 | 4.3347 | 1.4804 | 6 | 124 | striated muscle cell development |
| GO:1900239 | 0.0038 | 27.9274 | 0.0955 | 2 | 8 | regulation of phenotypic switching |
| GO:0010719 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of epithelial to mesenchymal transition |
| GO:0048147 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of fibroblast proliferation |
| GO:1901890 | 0.0044 | 10.104 | 0.3343 | 3 | 28 | positive regulation of cell junction assembly |
| GO:0051094 | 0.0045 | 1.9727 | 12.0942 | 22 | 1013 | positive regulation of developmental process |
| GO:0060099 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | regulation of phagocytosis, engulfment |
| GO:0072677 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | eosinophil migration |
| GO:1903726 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | negative regulation of phospholipid metabolic process |
| GO:0072358 | 0.0049 | 2.3429 | 6.3873 | 14 | 535 | cardiovascular system development |
| GO:0032964 | 0.0054 | 9.3541 | 0.3582 | 3 | 30 | collagen biosynthetic process |
| GO:1901342 | 0.0055 | 3.9774 | 1.6059 | 6 | 138 | regulation of vasculature development |
| GO:0050896 | 0.0057 | 1.5239 | 76.7077 | 93 | 6425 | response to stimulus |
| GO:0048266 | 0.006 | 20.9423 | 0.1194 | 2 | 10 | behavioral response to pain |
| GO:0007166 | 0.0067 | 1.6486 | 25.609 | 38 | 2145 | cell surface receptor signaling pathway |
| GO:0010657 | 0.0067 | 5.7306 | 0.7522 | 4 | 63 | muscle cell apoptotic process |
| GO:0051101 | 0.0069 | 4.4654 | 1.1939 | 5 | 100 | regulation of DNA binding |
| GO:0034433 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | steroid esterification |
| GO:0034435 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | cholesterol esterification |
| GO:1902547 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:0007266 | 0.0074 | 3.7281 | 1.7073 | 6 | 143 | Rho protein signal transduction |
| GO:0007154 | 0.0082 | 1.4935 | 56.9368 | 72 | 4769 | cell communication |
| GO:1904892 | 0.0088 | 4.1982 | 1.2655 | 5 | 106 | regulation of STAT cascade |
| GO:0070372 | 0.0089 | 3.178 | 2.3281 | 7 | 195 | regulation of ERK1 and ERK2 cascade |
| GO:0008360 | 0.0091 | 4.1567 | 1.2775 | 5 | 107 | regulation of cell shape |
| GO:0046456 | 0.0096 | 7.4243 | 0.4417 | 3 | 37 | icosanoid biosynthetic process |
| GO:0048856 | 0.0097 | 1.4837 | 53.4865 | 68 | 4480 | anatomical structure development |
| GO:0009968 | 0.0099 | 1.8828 | 11.4126 | 20 | 980 | negative regulation of signal transduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042126 | 0 | 157.0403 | 0.0759 | 3 | 4 | nitrate metabolic process |
| GO:0006805 | 1e-04 | 7.1341 | 1.119 | 7 | 59 | xenobiotic metabolic process |
| GO:0009410 | 3e-04 | 6.179 | 1.2707 | 7 | 67 | response to xenobiotic stimulus |
| GO:1905205 | 4e-04 | 31.3984 | 0.1517 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0061029 | 5e-04 | 26.1633 | 0.1707 | 3 | 9 | eyelid development in camera-type eye |
| GO:1903244 | 5e-04 | 26.1633 | 0.1707 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0072358 | 6e-04 | 2.3353 | 10.147 | 22 | 535 | cardiovascular system development |
| GO:1903671 | 8e-04 | 11.0496 | 0.4362 | 4 | 23 | negative regulation of sprouting angiogenesis |
| GO:2000181 | 9e-04 | 5.0046 | 1.5363 | 7 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0030198 | 9e-04 | 2.9631 | 4.7036 | 13 | 248 | extracellular matrix organization |
| GO:0014744 | 0.001 | 19.6195 | 0.2086 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0033128 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0051410 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | detoxification of nitrogen compound |
| GO:0061044 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0070634 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | transepithelial ammonium transport |
| GO:2001199 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0048646 | 0.0012 | 1.9726 | 15.8496 | 29 | 842 | anatomical structure formation involved in morphogenesis |
| GO:0046500 | 0.0013 | 17.4382 | 0.2276 | 3 | 12 | S-adenosylmethionine metabolic process |
| GO:0006954 | 0.0013 | 2.3128 | 8.7814 | 19 | 463 | inflammatory response |
| GO:0045765 | 0.0014 | 4.5531 | 1.6735 | 7 | 90 | regulation of angiogenesis |
| GO:0070286 | 0.0016 | 9.1252 | 0.5121 | 4 | 27 | axonemal dynein complex assembly |
| GO:0007605 | 0.0016 | 3.9247 | 2.2001 | 8 | 116 | sensory perception of sound |
| GO:0006590 | 0.0017 | 15.6931 | 0.2466 | 3 | 13 | thyroid hormone generation |
| GO:0072593 | 0.0018 | 3.0373 | 3.8691 | 11 | 204 | reactive oxygen species metabolic process |
| GO:0018958 | 0.0021 | 4.9435 | 1.3276 | 6 | 70 | phenol-containing compound metabolic process |
| GO:0051122 | 0.0021 | 52.1325 | 0.0759 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060455 | 0.0021 | 52.1325 | 0.0759 | 2 | 4 | negative regulation of gastric acid secretion |
| GO:0043537 | 0.0023 | 8.0704 | 0.569 | 4 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0010612 | 0.0026 | 13.0756 | 0.2845 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0019372 | 0.0026 | 13.0756 | 0.2845 | 3 | 15 | lipoxygenase pathway |
| GO:0008217 | 0.0027 | 3.5893 | 2.3898 | 8 | 126 | regulation of blood pressure |
| GO:0001568 | 0.0031 | 2.1371 | 9.4502 | 19 | 502 | blood vessel development |
| GO:0006555 | 0.0031 | 12.0689 | 0.3035 | 3 | 16 | methionine metabolic process |
| GO:0010757 | 0.0035 | 34.7523 | 0.0948 | 2 | 5 | negative regulation of plasminogen activation |
| GO:0034112 | 0.0035 | 34.7523 | 0.0948 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0060023 | 0.0035 | 34.7523 | 0.0948 | 2 | 5 | soft palate development |
| GO:0006575 | 0.0037 | 3.414 | 2.5036 | 8 | 132 | cellular modified amino acid metabolic process |
| GO:0045606 | 0.0038 | 11.2059 | 0.3224 | 3 | 17 | positive regulation of epidermal cell differentiation |
| GO:0007610 | 0.0039 | 2.132 | 8.9521 | 18 | 472 | behavior |
| GO:0046394 | 0.0039 | 2.5889 | 4.9123 | 12 | 259 | carboxylic acid biosynthetic process |
| GO:0033555 | 0.0048 | 4.9586 | 1.1 | 5 | 58 | multicellular organismal response to stress |
| GO:0034103 | 0.0048 | 4.9586 | 1.1 | 5 | 58 | regulation of tissue remodeling |
| GO:0048568 | 0.0048 | 2.2544 | 7.0365 | 15 | 371 | embryonic organ development |
| GO:0006082 | 0.005 | 1.7686 | 17.4869 | 29 | 922 | organic acid metabolic process |
| GO:0006681 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | galactosylceramide metabolic process |
| GO:0015917 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | aminophospholipid transport |
| GO:0019062 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | virion attachment to host cell |
| GO:0021603 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | cranial nerve formation |
| GO:0060017 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | parathyroid gland development |
| GO:0060836 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | lymphatic endothelial cell differentiation |
| GO:0055067 | 0.0052 | 3.5527 | 2.1053 | 7 | 111 | monovalent inorganic cation homeostasis |
| GO:0090103 | 0.0052 | 9.8037 | 0.3604 | 3 | 19 | cochlea morphogenesis |
| GO:0051241 | 0.0053 | 1.7949 | 16.0076 | 27 | 844 | negative regulation of multicellular organismal process |
| GO:0045766 | 0.0054 | 3.5186 | 2.1242 | 7 | 112 | positive regulation of angiogenesis |
| GO:0048706 | 0.0054 | 3.5186 | 2.1242 | 7 | 112 | embryonic skeletal system development |
| GO:0030194 | 0.0061 | 9.2263 | 0.3793 | 3 | 20 | positive regulation of blood coagulation |
| GO:0048701 | 0.0062 | 5.991 | 0.7397 | 4 | 39 | embryonic cranial skeleton morphogenesis |
| GO:0001975 | 0.007 | 8.713 | 0.3983 | 3 | 21 | response to amphetamine |
| GO:0060037 | 0.007 | 8.713 | 0.3983 | 3 | 21 | pharyngeal system development |
| GO:0060055 | 0.007 | 8.713 | 0.3983 | 3 | 21 | angiogenesis involved in wound healing |
| GO:0001955 | 0.0071 | 20.8482 | 0.1328 | 2 | 7 | blood vessel maturation |
| GO:0061085 | 0.0071 | 20.8482 | 0.1328 | 2 | 7 | regulation of histone H3-K27 methylation |
| GO:0009605 | 0.0071 | 1.566 | 29.5305 | 43 | 1557 | response to external stimulus |
| GO:0042554 | 0.008 | 8.2538 | 0.4173 | 3 | 22 | superoxide anion generation |
| GO:2000026 | 0.0082 | 1.5583 | 28.9236 | 42 | 1525 | regulation of multicellular organismal development |
| GO:0048839 | 0.0088 | 2.9148 | 2.9018 | 8 | 153 | inner ear development |
| GO:0001841 | 0.0089 | 3.5886 | 1.7828 | 6 | 94 | neural tube formation |
| GO:0042473 | 0.0093 | 17.3722 | 0.1517 | 2 | 8 | outer ear morphogenesis |
| GO:0044406 | 0.0093 | 17.3722 | 0.1517 | 2 | 8 | adhesion of symbiont to host |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051241 | 0 | 2.7389 | 9.8851 | 24 | 844 | negative regulation of multicellular organismal process |
| GO:0007389 | 1e-04 | 3.6111 | 4.2633 | 14 | 364 | pattern specification process |
| GO:0042475 | 1e-04 | 8.8864 | 0.7613 | 6 | 65 | odontogenesis of dentin-containing tooth |
| GO:0009952 | 2e-04 | 4.7374 | 2.0731 | 9 | 177 | anterior/posterior pattern specification |
| GO:0009954 | 3e-04 | 14.4095 | 0.3279 | 4 | 28 | proximal/distal pattern formation |
| GO:0000003 | 3e-04 | 2.2995 | 12.6492 | 26 | 1080 | reproduction |
| GO:0030801 | 3e-04 | 7.1744 | 0.9253 | 6 | 79 | positive regulation of cyclic nucleotide metabolic process |
| GO:0009887 | 6e-04 | 2.4183 | 9.5689 | 21 | 817 | animal organ morphogenesis |
| GO:0035855 | 8e-04 | 19.837 | 0.1874 | 3 | 16 | megakaryocyte development |
| GO:0060638 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | mesenchymal-epithelial cell signaling |
| GO:0007399 | 9e-04 | 1.9104 | 22.0308 | 37 | 1881 | nervous system development |
| GO:0009792 | 9e-04 | 2.7527 | 5.9147 | 15 | 505 | embryo development ending in birth or egg hatching |
| GO:1900020 | 0.0013 | 56.976 | 0.0586 | 2 | 5 | positive regulation of protein kinase C activity |
| GO:1900544 | 0.0014 | 5.3339 | 1.2181 | 6 | 104 | positive regulation of purine nucleotide metabolic process |
| GO:0051093 | 0.0016 | 2.3591 | 8.2923 | 18 | 708 | negative regulation of developmental process |
| GO:0007275 | 0.0017 | 1.7176 | 38.6535 | 55 | 3588 | multicellular organism development |
| GO:0030326 | 0.0018 | 5.073 | 1.2766 | 6 | 109 | embryonic limb morphogenesis |
| GO:0060173 | 0.0018 | 4.3091 | 1.7451 | 7 | 149 | limb development |
| GO:0001501 | 0.0019 | 3.2269 | 3.3272 | 10 | 297 | skeletal system development |
| GO:0061074 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | regulation of neural retina development |
| GO:0060561 | 0.0023 | 12.8872 | 0.2694 | 3 | 23 | apoptotic process involved in morphogenesis |
| GO:0045597 | 0.0025 | 2.252 | 8.6554 | 18 | 739 | positive regulation of cell differentiation |
| GO:0044703 | 0.0026 | 2.2454 | 8.6788 | 18 | 741 | multi-organism reproductive process |
| GO:0002830 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | positive regulation of type 2 immune response |
| GO:2000049 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:0032649 | 0.0032 | 7.1915 | 0.609 | 4 | 52 | regulation of interferon-gamma production |
| GO:0048704 | 0.0032 | 5.4162 | 0.9955 | 5 | 85 | embryonic skeletal system morphogenesis |
| GO:0009953 | 0.0034 | 5.349 | 1.0073 | 5 | 86 | dorsal/ventral pattern formation |
| GO:0048706 | 0.0035 | 11.0332 | 0.308 | 3 | 27 | embryonic skeletal system development |
| GO:0035107 | 0.0036 | 4.3487 | 1.4757 | 6 | 126 | appendage morphogenesis |
| GO:0046629 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | gamma-delta T cell activation |
| GO:0060534 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | trachea cartilage development |
| GO:0002696 | 0.0037 | 3.4008 | 2.5064 | 8 | 214 | positive regulation of leukocyte activation |
| GO:0048598 | 0.0038 | 2.7488 | 4.2763 | 11 | 376 | embryonic morphogenesis |
| GO:0007165 | 0.0041 | 1.5691 | 50.8312 | 67 | 4340 | signal transduction |
| GO:0002682 | 0.0044 | 1.9766 | 12.087 | 22 | 1032 | regulation of immune system process |
| GO:0061035 | 0.0044 | 6.5106 | 0.6676 | 4 | 57 | regulation of cartilage development |
| GO:0045137 | 0.0045 | 3.6349 | 2.0496 | 7 | 175 | development of primary sexual characteristics |
| GO:0007494 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | midgut development |
| GO:0046950 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | cellular ketone body metabolic process |
| GO:0070234 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | positive regulation of T cell apoptotic process |
| GO:0016331 | 0.0047 | 4.1067 | 1.5577 | 6 | 133 | morphogenesis of embryonic epithelium |
| GO:0048589 | 0.0048 | 2.4292 | 5.7156 | 13 | 488 | developmental growth |
| GO:0035148 | 0.0049 | 4.0743 | 1.5694 | 6 | 134 | tube formation |
| GO:0030819 | 0.0053 | 6.1604 | 0.7027 | 4 | 60 | positive regulation of cAMP biosynthetic process |
| GO:0007423 | 0.0055 | 2.4864 | 5.1417 | 12 | 439 | sensory organ development |
| GO:0006955 | 0.0055 | 1.8388 | 15.4368 | 26 | 1318 | immune response |
| GO:0045746 | 0.0056 | 9.1995 | 0.3631 | 3 | 31 | negative regulation of Notch signaling pathway |
| GO:1902224 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | ketone body metabolic process |
| GO:0031076 | 0.0061 | 8.8816 | 0.3748 | 3 | 32 | embryonic camera-type eye development |
| GO:0048869 | 0.0065 | 1.5644 | 38.8144 | 53 | 3314 | cellular developmental process |
| GO:0045747 | 0.0066 | 8.5849 | 0.3865 | 3 | 33 | positive regulation of Notch signaling pathway |
| GO:0007266 | 0.0067 | 3.804 | 1.6749 | 6 | 143 | Rho protein signal transduction |
| GO:0048534 | 0.0069 | 2.1219 | 8.0697 | 16 | 689 | hematopoietic or lymphoid organ development |
| GO:0048609 | 0.007 | 2.1751 | 7.367 | 15 | 629 | multicellular organismal reproductive process |
| GO:0010759 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of macrophage chemotaxis |
| GO:0071621 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | granulocyte chemotaxis |
| GO:0050870 | 0.0072 | 3.7487 | 1.6983 | 6 | 145 | positive regulation of T cell activation |
| GO:0030814 | 0.0072 | 4.4153 | 1.2064 | 5 | 103 | regulation of cAMP metabolic process |
| GO:0021983 | 0.0072 | 8.3073 | 0.3982 | 3 | 34 | pituitary gland development |
| GO:0045785 | 0.0075 | 2.7873 | 3.42 | 9 | 292 | positive regulation of cell adhesion |
| GO:2000241 | 0.0075 | 4.3704 | 1.2181 | 5 | 104 | regulation of reproductive process |
| GO:0050900 | 0.0076 | 2.7772 | 3.4317 | 9 | 293 | leukocyte migration |
| GO:0042981 | 0.0079 | 1.8219 | 14.2772 | 24 | 1219 | regulation of apoptotic process |
| GO:0042035 | 0.0082 | 5.387 | 0.7964 | 4 | 68 | regulation of cytokine biosynthetic process |
| GO:0002374 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | cytokine secretion involved in immune response |
| GO:0032695 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | negative regulation of interleukin-12 production |
| GO:0061138 | 0.0084 | 3.6172 | 1.7568 | 6 | 150 | morphogenesis of a branching epithelium |
| GO:0032720 | 0.0085 | 7.8026 | 0.4216 | 3 | 36 | negative regulation of tumor necrosis factor production |
| GO:0061448 | 0.0087 | 3.1915 | 2.319 | 7 | 198 | connective tissue development |
| GO:0045638 | 0.0091 | 5.223 | 0.8199 | 4 | 70 | negative regulation of myeloid cell differentiation |
| GO:0008584 | 0.0094 | 4.1187 | 1.2883 | 5 | 110 | male gonad development |
| GO:0032502 | 0.0097 | 1.8815 | 13.1869 | 22 | 1343 | developmental process |
| GO:0072148 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | epithelial cell fate commitment |
| GO:0030850 | 0.0098 | 7.3556 | 0.4451 | 3 | 38 | prostate gland development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 1e-04 | 20.9622 | 0.2441 | 4 | 19 | defense response to fungus |
| GO:0044657 | 2e-04 | Inf | 0.0257 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0051610 | 2e-04 | Inf | 0.0257 | 2 | 2 | serotonin uptake |
| GO:0052043 | 2e-04 | Inf | 0.0257 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 2e-04 | Inf | 0.0257 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 2e-04 | Inf | 0.0257 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0007399 | 2e-04 | 2.0028 | 24.1628 | 42 | 1881 | nervous system development |
| GO:0061844 | 5e-04 | 12.5677 | 0.3725 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0032227 | 5e-04 | 155.5119 | 0.0385 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
| GO:0051673 | 5e-04 | 155.5119 | 0.0385 | 2 | 3 | membrane disruption in other organism |
| GO:0007268 | 6e-04 | 2.7596 | 6.2944 | 16 | 490 | chemical synaptic transmission |
| GO:0099537 | 6e-04 | 2.7536 | 6.3072 | 16 | 491 | trans-synaptic signaling |
| GO:0051897 | 7e-04 | 5.2003 | 1.4644 | 7 | 114 | positive regulation of protein kinase B signaling |
| GO:0042221 | 7e-04 | 1.7274 | 40.2456 | 59 | 3133 | response to chemical |
| GO:0015872 | 8e-04 | 10.8309 | 0.4239 | 4 | 33 | dopamine transport |
| GO:0048625 | 0.001 | 77.75 | 0.0514 | 2 | 4 | myoblast fate commitment |
| GO:2000354 | 0.001 | 77.75 | 0.0514 | 2 | 4 | regulation of ovarian follicle development |
| GO:0002227 | 0.001 | 18.0345 | 0.2055 | 3 | 16 | innate immune response in mucosa |
| GO:0042445 | 0.0014 | 4.5557 | 1.6571 | 7 | 129 | hormone metabolic process |
| GO:0007267 | 0.0014 | 1.977 | 16.1856 | 29 | 1260 | cell-cell signaling |
| GO:0010469 | 0.0014 | 2.8251 | 4.9456 | 13 | 385 | regulation of receptor activity |
| GO:0009605 | 0.0015 | 1.8913 | 19.4136 | 33 | 1536 | response to external stimulus |
| GO:0001547 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | antral ovarian follicle growth |
| GO:0003105 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | negative regulation of glomerular filtration |
| GO:0097211 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | cellular response to gonadotropin-releasing hormone |
| GO:0001964 | 0.0023 | 13.02 | 0.2698 | 3 | 21 | startle response |
| GO:0021826 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | substrate-independent telencephalic tangential migration |
| GO:0021830 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | interneuron migration from the subpallium to the cortex |
| GO:0043416 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | regulation of skeletal muscle tissue regeneration |
| GO:0045938 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | positive regulation of circadian sleep/wake cycle, sleep |
| GO:0002251 | 0.0027 | 12.3338 | 0.2826 | 3 | 22 | organ or tissue specific immune response |
| GO:0019731 | 0.0027 | 12.3338 | 0.2826 | 3 | 22 | antibacterial humoral response |
| GO:0060143 | 0.0027 | 12.3338 | 0.2826 | 3 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0007186 | 0.003 | 2.2045 | 8.7865 | 18 | 684 | G-protein coupled receptor signaling pathway |
| GO:0021885 | 0.003 | 7.2967 | 0.6037 | 4 | 47 | forebrain cell migration |
| GO:0014059 | 0.0031 | 11.7162 | 0.2955 | 3 | 23 | regulation of dopamine secretion |
| GO:0033993 | 0.0035 | 2.1735 | 8.9021 | 18 | 693 | response to lipid |
| GO:0007265 | 0.0037 | 2.9174 | 3.6482 | 10 | 284 | Ras protein signal transduction |
| GO:2000344 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | positive regulation of acrosome reaction |
| GO:0003016 | 0.0049 | 9.7605 | 0.3468 | 3 | 27 | respiratory system process |
| GO:0050793 | 0.0056 | 1.6638 | 25.2418 | 38 | 1965 | regulation of developmental process |
| GO:0048149 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | behavioral response to ethanol |
| GO:0051852 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | disruption by host of symbiont cells |
| GO:2000392 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | regulation of lamellipodium morphogenesis |
| GO:0042127 | 0.0056 | 1.8085 | 16.2113 | 27 | 1262 | regulation of cell proliferation |
| GO:1903727 | 0.006 | 9.0083 | 0.3725 | 3 | 29 | positive regulation of phospholipid metabolic process |
| GO:0009719 | 0.0062 | 1.8133 | 15.5305 | 26 | 1209 | response to endogenous stimulus |
| GO:0032501 | 0.0062 | 1.4894 | 69.4695 | 86 | 5408 | multicellular organismal process |
| GO:0014031 | 0.0065 | 5.8054 | 0.7451 | 4 | 58 | mesenchymal cell development |
| GO:0015844 | 0.0065 | 5.8054 | 0.7451 | 4 | 58 | monoamine transport |
| GO:0031640 | 0.0066 | 8.674 | 0.3854 | 3 | 30 | killing of cells of other organism |
| GO:0048870 | 0.0067 | 1.8209 | 14.8368 | 25 | 1155 | cell motility |
| GO:0006067 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | ethanol metabolic process |
| GO:0010960 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | magnesium ion homeostasis |
| GO:0070486 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | leukocyte aggregation |
| GO:0030595 | 0.0071 | 3.7567 | 1.6956 | 6 | 132 | leukocyte chemotaxis |
| GO:0048469 | 0.0076 | 3.6974 | 1.7213 | 6 | 134 | cell maturation |
| GO:0001977 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | renal system process involved in regulation of blood volume |
| GO:0002087 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0010310 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | regulation of hydrogen peroxide metabolic process |
| GO:0021978 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | telencephalon regionalization |
| GO:0032753 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | positive regulation of interleukin-4 production |
| GO:0048663 | 0.0092 | 5.2225 | 0.8221 | 4 | 64 | neuron fate commitment |
| GO:0008037 | 0.0093 | 4.1368 | 1.2846 | 5 | 100 | cell recognition |
| GO:0051716 | 0.0094 | 1.4552 | 69.4439 | 85 | 5406 | cellular response to stimulus |
| GO:0009755 | 0.0099 | 3.1089 | 2.3765 | 7 | 185 | hormone-mediated signaling pathway |
| GO:0010818 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | T cell chemotaxis |
| GO:0051583 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | dopamine uptake involved in synaptic transmission |
| GO:0090493 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | catecholamine uptake |
| GO:1903818 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | positive regulation of voltage-gated potassium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0072272 | 4e-04 | Inf | 0.039 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:1903507 | 7e-04 | 1.917 | 19.8267 | 35 | 1017 | negative regulation of nucleic acid-templated transcription |
| GO:0007186 | 9e-04 | 2.098 | 13.3347 | 26 | 684 | G-protein coupled receptor signaling pathway |
| GO:0021903 | 0.0011 | 19.0706 | 0.2144 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0003002 | 0.0012 | 2.8559 | 4.8682 | 13 | 255 | regionalization |
| GO:0009887 | 0.0013 | 1.9587 | 15.9276 | 29 | 817 | animal organ morphogenesis |
| GO:0007631 | 0.0013 | 4.6116 | 1.6571 | 7 | 85 | feeding behavior |
| GO:0048731 | 0.0016 | 1.4948 | 71.0796 | 93 | 3646 | system development |
| GO:0009954 | 0.002 | 8.4987 | 0.5459 | 4 | 28 | proximal/distal pattern formation |
| GO:0006334 | 0.0021 | 3.7775 | 2.2809 | 8 | 117 | nucleosome assembly |
| GO:0000122 | 0.0021 | 1.9895 | 13.4322 | 25 | 689 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0021915 | 0.0021 | 3.4125 | 2.8268 | 9 | 145 | neural tube development |
| GO:0006323 | 0.0022 | 3.1501 | 3.3922 | 10 | 174 | DNA packaging |
| GO:0051253 | 0.0022 | 1.779 | 21.1913 | 35 | 1087 | negative regulation of RNA metabolic process |
| GO:0072086 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | specification of loop of Henle identity |
| GO:1902412 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | regulation of mitotic cytokinesis |
| GO:0007379 | 0.0023 | 13.8663 | 0.2729 | 3 | 14 | segment specification |
| GO:0009611 | 0.0023 | 2.1459 | 9.9231 | 20 | 509 | response to wounding |
| GO:0006925 | 0.0028 | 12.7098 | 0.2924 | 3 | 15 | inflammatory cell apoptotic process |
| GO:0008217 | 0.0033 | 3.4869 | 2.4564 | 8 | 126 | regulation of blood pressure |
| GO:0048665 | 0.0033 | 7.2823 | 0.6238 | 4 | 32 | neuron fate specification |
| GO:0006333 | 0.0034 | 3.1763 | 3.0218 | 9 | 155 | chromatin assembly or disassembly |
| GO:0003215 | 0.0034 | 11.7312 | 0.3119 | 3 | 16 | cardiac right ventricle morphogenesis |
| GO:0032502 | 0.0034 | 1.4232 | 93.5771 | 115 | 4800 | developmental process |
| GO:0061053 | 0.0036 | 4.3898 | 1.4816 | 6 | 76 | somite development |
| GO:0001709 | 0.0046 | 6.5761 | 0.6823 | 4 | 35 | cell fate determination |
| GO:0003013 | 0.0053 | 2.168 | 7.7981 | 16 | 400 | circulatory system process |
| GO:0018242 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | protein O-linked glycosylation via serine |
| GO:0018243 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | protein O-linked glycosylation via threonine |
| GO:0021796 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | cerebral cortex regionalization |
| GO:0051482 | 0.0056 | 9.5294 | 0.3704 | 3 | 19 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
| GO:0007596 | 0.0059 | 2.4531 | 5.1662 | 12 | 265 | blood coagulation |
| GO:0009948 | 0.0068 | 5.8227 | 0.7603 | 4 | 39 | anterior/posterior axis specification |
| GO:0001838 | 0.0069 | 3.3542 | 2.2225 | 7 | 114 | embryonic epithelial tube formation |
| GO:0032963 | 0.007 | 3.7904 | 1.6961 | 6 | 87 | collagen metabolic process |
| GO:0021517 | 0.0074 | 5.6605 | 0.7798 | 4 | 40 | ventral spinal cord development |
| GO:0032501 | 0.0077 | 1.3686 | 105.4303 | 125 | 5408 | multicellular organismal process |
| GO:0031016 | 0.0081 | 4.3267 | 1.2477 | 5 | 64 | pancreas development |
| GO:0050878 | 0.0082 | 2.1149 | 7.4667 | 15 | 383 | regulation of body fluid levels |
| GO:0046530 | 0.0096 | 5.2239 | 0.8383 | 4 | 43 | photoreceptor cell differentiation |
| GO:0090303 | 0.0096 | 5.2239 | 0.8383 | 4 | 43 | positive regulation of wound healing |
| GO:0042593 | 0.0097 | 2.6593 | 3.5676 | 9 | 183 | glucose homeostasis |
| GO:0003310 | 0.0098 | 16.888 | 0.156 | 2 | 8 | pancreatic A cell differentiation |
| GO:0061004 | 0.0098 | 16.888 | 0.156 | 2 | 8 | pattern specification involved in kidney development |
| GO:1990403 | 0.0098 | 16.888 | 0.156 | 2 | 8 | embryonic brain development |
| GO:2000109 | 0.0098 | 16.888 | 0.156 | 2 | 8 | regulation of macrophage apoptotic process |
| GO:0043524 | 0.0099 | 3.1189 | 2.3784 | 7 | 122 | negative regulation of neuron apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032621 | 6e-04 | 82.5346 | 0.0408 | 2 | 5 | interleukin-18 production |
| GO:0032760 | 8e-04 | 10.7029 | 0.4162 | 4 | 51 | positive regulation of tumor necrosis factor production |
| GO:0007339 | 0.0015 | 14.9726 | 0.2285 | 3 | 28 | binding of sperm to zona pellucida |
| GO:0070268 | 0.0018 | 8.457 | 0.5175 | 4 | 64 | cornification |
| GO:0035562 | 0.0018 | 41.2579 | 0.0653 | 2 | 8 | negative regulation of chromatin binding |
| GO:0032725 | 0.0023 | 35.3612 | 0.0734 | 2 | 9 | positive regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0046164 | 0.0026 | 12.0691 | 0.2775 | 3 | 34 | alcohol catabolic process |
| GO:0008406 | 0.0028 | 4.6207 | 1.3955 | 6 | 171 | gonad development |
| GO:0046185 | 0.0028 | 30.9387 | 0.0816 | 2 | 10 | aldehyde catabolic process |
| GO:0048266 | 0.0028 | 30.9387 | 0.0816 | 2 | 10 | behavioral response to pain |
| GO:0055002 | 0.0034 | 5.3059 | 1.0119 | 5 | 124 | striated muscle cell development |
| GO:0055001 | 0.0038 | 25.7366 | 0.0943 | 2 | 12 | muscle cell development |
| GO:0060009 | 0.0049 | 22.4957 | 0.1061 | 2 | 13 | Sertoli cell development |
| GO:0070200 | 0.0056 | 20.6195 | 0.1143 | 2 | 14 | establishment of protein localization to telomere |
| GO:1903555 | 0.0058 | 5.9716 | 0.7182 | 4 | 88 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0009988 | 0.0062 | 8.693 | 0.3754 | 3 | 46 | cell-cell recognition |
| GO:0061025 | 0.0071 | 3.7635 | 1.6974 | 6 | 208 | membrane fusion |
| GO:0032026 | 0.0073 | 17.6712 | 0.1306 | 2 | 16 | response to magnesium ion |
| GO:0007548 | 0.0076 | 3.7076 | 1.7219 | 6 | 211 | sex differentiation |
| GO:0003336 | 0.0082 | Inf | 0.0082 | 1 | 1 | corneocyte desquamation |
| GO:0019265 | 0.0082 | Inf | 0.0082 | 1 | 1 | glycine biosynthetic process, by transamination of glyoxylate |
| GO:0019481 | 0.0082 | Inf | 0.0082 | 1 | 1 | L-alanine catabolic process, by transamination |
| GO:0045356 | 0.0082 | Inf | 0.0082 | 1 | 1 | positive regulation of interferon-alpha biosynthetic process |
| GO:0045381 | 0.0082 | Inf | 0.0082 | 1 | 1 | regulation of interleukin-18 biosynthetic process |
| GO:0045751 | 0.0082 | Inf | 0.0082 | 1 | 1 | negative regulation of Toll signaling pathway |
| GO:0046296 | 0.0082 | Inf | 0.0082 | 1 | 1 | glycolate catabolic process |
| GO:0046901 | 0.0082 | Inf | 0.0082 | 1 | 1 | tetrahydrofolylpolyglutamate biosynthetic process |
| GO:0061368 | 0.0082 | Inf | 0.0082 | 1 | 1 | behavioral response to formalin induced pain |
| GO:0071799 | 0.0082 | Inf | 0.0082 | 1 | 1 | cellular response to prostaglandin D stimulus |
| GO:1905716 | 0.0082 | Inf | 0.0082 | 1 | 1 | negative regulation of cornification |
| GO:2000612 | 0.0082 | Inf | 0.0082 | 1 | 1 | regulation of thyroid-stimulating hormone secretion |
| GO:0042346 | 0.0083 | 16.4918 | 0.1387 | 2 | 17 | positive regulation of NF-kappaB import into nucleus |
| GO:0019730 | 0.0083 | 7.7845 | 0.4162 | 3 | 51 | antimicrobial humoral response |
| GO:0050911 | 0.0097 | 7.3249 | 0.4407 | 3 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0030216 | 0.01 | 4.0623 | 1.3057 | 5 | 160 | keratinocyte differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1905205 | 0 | 122.1723 | 0.1106 | 5 | 8 | positive regulation of connective tissue replacement |
| GO:0021633 | 2e-04 | Inf | 0.0277 | 2 | 2 | optic nerve structural organization |
| GO:1903244 | 2e-04 | 36.2361 | 0.1245 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0006703 | 3e-04 | 31.0571 | 0.1383 | 3 | 10 | estrogen biosynthetic process |
| GO:0010744 | 3e-04 | 31.0571 | 0.1383 | 3 | 10 | positive regulation of macrophage derived foam cell differentiation |
| GO:0021554 | 3e-04 | 31.0571 | 0.1383 | 3 | 10 | optic nerve development |
| GO:0014744 | 4e-04 | 27.1729 | 0.1521 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0045918 | 6e-04 | 144.1989 | 0.0415 | 2 | 3 | negative regulation of cytolysis |
| GO:0061844 | 6e-04 | 11.6434 | 0.401 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0010612 | 0.001 | 18.1097 | 0.2074 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0030321 | 0.0011 | 72.0939 | 0.0553 | 2 | 4 | transepithelial chloride transport |
| GO:0034103 | 0.0012 | 6.8889 | 0.802 | 5 | 58 | regulation of tissue remodeling |
| GO:0042832 | 0.0013 | 16.7154 | 0.2212 | 3 | 16 | defense response to protozoan |
| GO:0048731 | 0.0017 | 1.6031 | 50.417 | 69 | 3646 | system development |
| GO:0009744 | 0.0019 | 48.0589 | 0.0691 | 2 | 5 | response to sucrose |
| GO:0051351 | 0.0019 | 48.0589 | 0.0691 | 2 | 5 | positive regulation of ligase activity |
| GO:0045765 | 0.002 | 3.446 | 2.7933 | 9 | 202 | regulation of angiogenesis |
| GO:0043950 | 0.0028 | 36.0414 | 0.083 | 2 | 6 | positive regulation of cAMP-mediated signaling |
| GO:0034694 | 0.0029 | 12.0676 | 0.2904 | 3 | 21 | response to prostaglandin |
| GO:0051898 | 0.0031 | 7.2687 | 0.6084 | 4 | 44 | negative regulation of protein kinase B signaling |
| GO:0051094 | 0.0033 | 1.9319 | 14.0078 | 25 | 1013 | positive regulation of developmental process |
| GO:1903671 | 0.0038 | 10.8592 | 0.318 | 3 | 23 | negative regulation of sprouting angiogenesis |
| GO:0042756 | 0.0038 | 28.8309 | 0.0968 | 2 | 7 | drinking behavior |
| GO:0007155 | 0.0046 | 1.8783 | 14.3673 | 25 | 1039 | cell adhesion |
| GO:0003299 | 0.0048 | 9.8705 | 0.3457 | 3 | 25 | muscle hypertrophy in response to stress |
| GO:0090077 | 0.0048 | 9.8705 | 0.3457 | 3 | 25 | foam cell differentiation |
| GO:0055114 | 0.005 | 2.0096 | 10.6614 | 20 | 771 | oxidation-reduction process |
| GO:1990403 | 0.005 | 24.0239 | 0.1106 | 2 | 8 | embryonic brain development |
| GO:0035082 | 0.0057 | 6.0535 | 0.7191 | 4 | 52 | axoneme assembly |
| GO:0044242 | 0.0062 | 3.4207 | 2.171 | 7 | 157 | cellular lipid catabolic process |
| GO:0051852 | 0.0064 | 20.5904 | 0.1245 | 2 | 9 | disruption by host of symbiont cells |
| GO:0048704 | 0.0064 | 4.5544 | 1.1754 | 5 | 85 | embryonic skeletal system morphogenesis |
| GO:0009620 | 0.0066 | 8.684 | 0.3872 | 3 | 28 | response to fungus |
| GO:0001906 | 0.0068 | 4.4978 | 1.1892 | 5 | 86 | cell killing |
| GO:0051149 | 0.0078 | 4.3362 | 1.2307 | 5 | 89 | positive regulation of muscle cell differentiation |
| GO:0014742 | 0.0088 | 7.7518 | 0.4287 | 3 | 31 | positive regulation of muscle hypertrophy |
| GO:0048870 | 0.009 | 1.7488 | 15.9714 | 26 | 1155 | cell motility |
| GO:0051093 | 0.0093 | 1.9543 | 9.7902 | 18 | 708 | negative regulation of developmental process |
| GO:0003012 | 0.0093 | 2.4054 | 4.826 | 11 | 349 | muscle system process |
| GO:0045618 | 0.0096 | 16.0123 | 0.1521 | 2 | 11 | positive regulation of keratinocyte differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007186 | 0 | 2.6266 | 10.9572 | 26 | 684 | G-protein coupled receptor signaling pathway |
| GO:0060290 | 1e-04 | 46.7153 | 0.1121 | 3 | 7 | transdifferentiation |
| GO:0071314 | 8e-04 | 124.0095 | 0.0481 | 2 | 3 | cellular response to cocaine |
| GO:1900449 | 0.0013 | 9.6124 | 0.4806 | 4 | 30 | regulation of glutamate receptor signaling pathway |
| GO:0045683 | 0.0013 | 16.9783 | 0.2243 | 3 | 14 | negative regulation of epidermis development |
| GO:0008628 | 0.0015 | 62 | 0.0641 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0023052 | 0.0019 | 1.5161 | 76.1239 | 97 | 4752 | signaling |
| GO:0021854 | 0.0023 | 13.337 | 0.2723 | 3 | 17 | hypothalamus development |
| GO:0016115 | 0.0025 | 41.3302 | 0.0801 | 2 | 5 | terpenoid catabolic process |
| GO:0045617 | 0.0025 | 41.3302 | 0.0801 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:0051459 | 0.0025 | 41.3302 | 0.0801 | 2 | 5 | regulation of corticotropin secretion |
| GO:0010810 | 0.0025 | 3.6346 | 2.3548 | 8 | 147 | regulation of cell-substrate adhesion |
| GO:0032501 | 0.0027 | 1.4843 | 86.6326 | 107 | 5408 | multicellular organismal process |
| GO:0048705 | 0.003 | 3.2359 | 2.9636 | 9 | 185 | skeletal system morphogenesis |
| GO:0007154 | 0.0033 | 1.4786 | 76.3963 | 96 | 4769 | cell communication |
| GO:0008015 | 0.0048 | 2.3333 | 6.3597 | 14 | 397 | blood circulation |
| GO:0043951 | 0.0051 | 24.7943 | 0.1121 | 2 | 7 | negative regulation of cAMP-mediated signaling |
| GO:0098655 | 0.0059 | 2.0066 | 10.0601 | 19 | 628 | cation transmembrane transport |
| GO:0051928 | 0.0063 | 4.6014 | 1.1694 | 5 | 73 | positive regulation of calcium ion transport |
| GO:0050877 | 0.0063 | 1.9238 | 11.614 | 21 | 725 | nervous system process |
| GO:0071773 | 0.0065 | 3.3863 | 2.1947 | 7 | 137 | cellular response to BMP stimulus |
| GO:0001574 | 0.0067 | 20.6603 | 0.1282 | 2 | 8 | ganglioside biosynthetic process |
| GO:0050907 | 0.007 | 4.4693 | 1.2015 | 5 | 75 | detection of chemical stimulus involved in sensory perception |
| GO:0042634 | 0.008 | 8.1125 | 0.4165 | 3 | 26 | regulation of hair cycle |
| GO:0050856 | 0.008 | 8.1125 | 0.4165 | 3 | 26 | regulation of T cell receptor signaling pathway |
| GO:0072677 | 0.0085 | 17.7075 | 0.1442 | 2 | 9 | eosinophil migration |
| GO:0070838 | 0.0087 | 2.3221 | 5.4466 | 12 | 340 | divalent metal ion transport |
| GO:0045766 | 0.0092 | 3.549 | 1.7942 | 6 | 112 | positive regulation of angiogenesis |
| GO:0006811 | 0.0093 | 1.6729 | 19.1912 | 30 | 1198 | ion transport |
| GO:0007339 | 0.0099 | 7.4624 | 0.4485 | 3 | 28 | binding of sperm to zona pellucida |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060602 | 0 | 31.4702 | 0.1757 | 4 | 15 | branch elongation of an epithelium |
| GO:0007586 | 1e-04 | 6.7896 | 1.3118 | 8 | 112 | digestion |
| GO:0038060 | 1e-04 | Inf | 0.0234 | 2 | 2 | nitric oxide-cGMP-mediated signaling pathway |
| GO:0097530 | 3e-04 | 7.3776 | 0.9018 | 6 | 77 | granulocyte migration |
| GO:1903818 | 3e-04 | 28.6623 | 0.1405 | 3 | 12 | positive regulation of voltage-gated potassium channel activity |
| GO:0035814 | 4e-04 | 170.9542 | 0.0351 | 2 | 3 | negative regulation of renal sodium excretion |
| GO:0070384 | 4e-04 | 170.9542 | 0.0351 | 2 | 3 | Harderian gland development |
| GO:0007588 | 4e-04 | 8.8639 | 0.6325 | 5 | 54 | excretion |
| GO:0006182 | 4e-04 | 12.8055 | 0.3631 | 4 | 31 | cGMP biosynthetic process |
| GO:0071732 | 5e-04 | 23.4474 | 0.164 | 3 | 14 | cellular response to nitric oxide |
| GO:0019935 | 8e-04 | 6.0134 | 1.0892 | 6 | 93 | cyclic-nucleotide-mediated signaling |
| GO:0048593 | 8e-04 | 6.0134 | 1.0892 | 6 | 93 | camera-type eye morphogenesis |
| GO:0071804 | 8e-04 | 4.4222 | 1.9559 | 8 | 167 | cellular potassium ion transport |
| GO:0032414 | 8e-04 | 7.6152 | 0.7262 | 5 | 62 | positive regulation of ion transmembrane transporter activity |
| GO:0030903 | 8e-04 | 19.837 | 0.1874 | 3 | 16 | notochord development |
| GO:0097205 | 8e-04 | 19.837 | 0.1874 | 3 | 16 | renal filtration |
| GO:0038028 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase |
| GO:0060638 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | mesenchymal-epithelial cell signaling |
| GO:0002696 | 9e-04 | 3.8712 | 2.5064 | 9 | 214 | positive regulation of leukocyte activation |
| GO:0060560 | 0.001 | 4.2334 | 2.0379 | 8 | 174 | developmental growth involved in morphogenesis |
| GO:0050921 | 0.0011 | 5.6229 | 1.1595 | 6 | 99 | positive regulation of chemotaxis |
| GO:0043270 | 0.0012 | 4.108 | 2.0965 | 8 | 179 | positive regulation of ion transport |
| GO:0022898 | 0.0013 | 4.0838 | 2.1082 | 8 | 180 | regulation of transmembrane transporter activity |
| GO:0022409 | 0.0013 | 4.0599 | 2.1199 | 8 | 181 | positive regulation of cell-cell adhesion |
| GO:0098528 | 0.0013 | 56.976 | 0.0586 | 2 | 5 | skeletal muscle fiber differentiation |
| GO:1900544 | 0.0014 | 5.3339 | 1.2181 | 6 | 104 | positive regulation of purine nucleotide metabolic process |
| GO:0060688 | 0.0014 | 9.091 | 0.4919 | 4 | 42 | regulation of morphogenesis of a branching structure |
| GO:0090066 | 0.0016 | 2.9148 | 4.4272 | 12 | 378 | regulation of anatomical structure size |
| GO:0060512 | 0.0018 | 14.3213 | 0.246 | 3 | 21 | prostate gland morphogenesis |
| GO:0046877 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | regulation of saliva secretion |
| GO:0060513 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | prostatic bud formation |
| GO:0043266 | 0.0022 | 5.9388 | 0.9136 | 5 | 78 | regulation of potassium ion transport |
| GO:0002685 | 0.0023 | 4.7916 | 1.3469 | 6 | 115 | regulation of leukocyte migration |
| GO:0009190 | 0.0023 | 4.7916 | 1.3469 | 6 | 115 | cyclic nucleotide biosynthetic process |
| GO:0030801 | 0.0023 | 5.8581 | 0.9253 | 5 | 79 | positive regulation of cyclic nucleotide metabolic process |
| GO:0002703 | 0.0026 | 4.6622 | 1.382 | 6 | 118 | regulation of leukocyte mediated immunity |
| GO:0048146 | 0.0027 | 7.5053 | 0.5856 | 4 | 50 | positive regulation of fibroblast proliferation |
| GO:0050795 | 0.0027 | 7.5053 | 0.5856 | 4 | 50 | regulation of behavior |
| GO:0010820 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | positive regulation of T cell chemotaxis |
| GO:0032808 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | lacrimal gland development |
| GO:0060174 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | limb bud formation |
| GO:0070102 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | interleukin-6-mediated signaling pathway |
| GO:0030593 | 0.0029 | 7.3451 | 0.5973 | 4 | 51 | neutrophil chemotaxis |
| GO:1903530 | 0.003 | 2.4876 | 6.0435 | 14 | 516 | regulation of secretion by cell |
| GO:1901701 | 0.003 | 2.1674 | 9.4986 | 19 | 811 | cellular response to oxygen-containing compound |
| GO:0006954 | 0.0031 | 2.5693 | 5.4228 | 13 | 463 | inflammatory response |
| GO:0016049 | 0.0032 | 2.6737 | 4.802 | 12 | 410 | cell growth |
| GO:0032732 | 0.0034 | 11.2037 | 0.3045 | 3 | 26 | positive regulation of interleukin-1 production |
| GO:0090596 | 0.0035 | 3.4347 | 2.483 | 8 | 212 | sensory organ morphogenesis |
| GO:0007193 | 0.0036 | 6.9028 | 0.6325 | 4 | 54 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0016045 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | detection of bacterium |
| GO:0030916 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | otic vesicle formation |
| GO:0051967 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | negative regulation of synaptic transmission, glutamatergic |
| GO:0007159 | 0.0039 | 3.1001 | 3.092 | 9 | 264 | leukocyte cell-cell adhesion |
| GO:0007187 | 0.0042 | 4.2071 | 1.5226 | 6 | 130 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0050865 | 0.0046 | 2.6759 | 4.3804 | 11 | 374 | regulation of cell activation |
| GO:0030595 | 0.0046 | 4.1397 | 1.546 | 6 | 132 | leukocyte chemotaxis |
| GO:1901381 | 0.0046 | 9.9087 | 0.3397 | 3 | 29 | positive regulation of potassium ion transmembrane transport |
| GO:0000463 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0046628 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | positive regulation of insulin receptor signaling pathway |
| GO:0034599 | 0.0049 | 3.2409 | 2.6235 | 8 | 224 | cellular response to oxidative stress |
| GO:0032941 | 0.0051 | 9.5409 | 0.3514 | 3 | 30 | secretion by tissue |
| GO:0045861 | 0.0051 | 3.2106 | 2.647 | 8 | 226 | negative regulation of proteolysis |
| GO:0046068 | 0.0055 | 21.8859 | 0.1144 | 2 | 10 | cGMP metabolic process |
| GO:0006955 | 0.0055 | 1.8388 | 15.4368 | 26 | 1318 | immune response |
| GO:0055078 | 0.0056 | 9.1995 | 0.3631 | 3 | 31 | sodium ion homeostasis |
| GO:0002674 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | negative regulation of acute inflammatory response |
| GO:0003093 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | regulation of glomerular filtration |
| GO:0009642 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | response to light intensity |
| GO:0021889 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | olfactory bulb interneuron differentiation |
| GO:0030238 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | male sex determination |
| GO:0042268 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | regulation of cytolysis |
| GO:1902894 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter |
| GO:0034764 | 0.0064 | 4.5558 | 1.1712 | 5 | 100 | positive regulation of transmembrane transport |
| GO:0002237 | 0.0065 | 3.0812 | 2.7524 | 8 | 235 | response to molecule of bacterial origin |
| GO:0045747 | 0.0066 | 8.5849 | 0.3865 | 3 | 33 | positive regulation of Notch signaling pathway |
| GO:0090184 | 0.0066 | 8.5849 | 0.3865 | 3 | 33 | positive regulation of kidney development |
| GO:0030335 | 0.0069 | 2.6561 | 3.9939 | 10 | 341 | positive regulation of cell migration |
| GO:0032101 | 0.0069 | 2.3177 | 5.9733 | 13 | 510 | regulation of response to external stimulus |
| GO:0002087 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0008595 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | anterior/posterior axis specification, embryo |
| GO:0032753 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of interleukin-4 production |
| GO:0045725 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of glycogen biosynthetic process |
| GO:0098581 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | detection of external biotic stimulus |
| GO:0043491 | 0.007 | 3.333 | 2.2253 | 7 | 190 | protein kinase B signaling |
| GO:0005977 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | glycogen metabolic process |
| GO:0044042 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | glucan metabolic process |
| GO:0008015 | 0.007 | 2.5119 | 4.6498 | 11 | 397 | blood circulation |
| GO:0050870 | 0.0072 | 3.7487 | 1.6983 | 6 | 145 | positive regulation of T cell activation |
| GO:0001754 | 0.0072 | 8.3073 | 0.3982 | 3 | 34 | eye photoreceptor cell differentiation |
| GO:0007589 | 0.0082 | 5.387 | 0.7964 | 4 | 68 | body fluid secretion |
| GO:0002374 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | cytokine secretion involved in immune response |
| GO:0002643 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | regulation of tolerance induction |
| GO:0006833 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | water transport |
| GO:0030277 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | maintenance of gastrointestinal epithelium |
| GO:1900029 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | positive regulation of ruffle assembly |
| GO:1901623 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | regulation of lymphocyte chemotaxis |
| GO:0002683 | 0.0085 | 2.7281 | 3.4903 | 9 | 298 | negative regulation of immune system process |
| GO:0051353 | 0.0085 | 7.8026 | 0.4216 | 3 | 36 | positive regulation of oxidoreductase activity |
| GO:0097756 | 0.0087 | 5.3037 | 0.8081 | 4 | 69 | negative regulation of blood vessel diameter |
| GO:0010951 | 0.009 | 3.5671 | 1.7803 | 6 | 152 | negative regulation of endopeptidase activity |
| GO:0001942 | 0.0091 | 5.223 | 0.8199 | 4 | 70 | hair follicle development |
| GO:0016266 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | O-glycan processing |
| GO:0045776 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | negative regulation of blood pressure |
| GO:0030001 | 0.0095 | 2.0927 | 7.6364 | 15 | 652 | metal ion transport |
| GO:0009798 | 0.0096 | 5.1446 | 0.8316 | 4 | 71 | axis specification |
| GO:0007350 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | blastoderm segmentation |
| GO:0030540 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | female genitalia development |
| GO:0060788 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | ectodermal placode formation |
| GO:0045088 | 0.0098 | 2.6621 | 3.5722 | 9 | 305 | regulation of innate immune response |
| GO:0045123 | 0.0098 | 7.3556 | 0.4451 | 3 | 38 | cellular extravasation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042733 | 1e-04 | 7.5913 | 1.0562 | 7 | 58 | embryonic digit morphogenesis |
| GO:0048736 | 1e-04 | 4.4551 | 2.7134 | 11 | 149 | appendage development |
| GO:0035108 | 1e-04 | 4.8056 | 2.2945 | 10 | 126 | limb morphogenesis |
| GO:0035113 | 2e-04 | 5.0016 | 1.985 | 9 | 109 | embryonic appendage morphogenesis |
| GO:1903244 | 5e-04 | 27.2836 | 0.1639 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0014744 | 9e-04 | 20.4596 | 0.2003 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0070495 | 0.001 | 108.7197 | 0.0546 | 2 | 3 | negative regulation of thrombin-activated receptor signaling pathway |
| GO:0048468 | 0.001 | 1.7526 | 28.2706 | 45 | 1578 | cell development |
| GO:0003203 | 0.001 | 10.4256 | 0.4553 | 4 | 25 | endocardial cushion morphogenesis |
| GO:0009952 | 0.0015 | 3.3248 | 3.2233 | 10 | 177 | anterior/posterior pattern specification |
| GO:0003188 | 0.0019 | 14.8762 | 0.2549 | 3 | 14 | heart valve formation |
| GO:0003253 | 0.0019 | 54.3556 | 0.0728 | 2 | 4 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0006928 | 0.0022 | 1.6833 | 28.5179 | 44 | 1566 | movement of cell or subcellular component |
| GO:0009792 | 0.0023 | 2.2025 | 9.1964 | 19 | 505 | embryo development ending in birth or egg hatching |
| GO:0014742 | 0.0023 | 8.105 | 0.5645 | 4 | 31 | positive regulation of muscle hypertrophy |
| GO:0030857 | 0.0023 | 8.105 | 0.5645 | 4 | 31 | negative regulation of epithelial cell differentiation |
| GO:0010612 | 0.0023 | 13.6355 | 0.2732 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0043069 | 0.0023 | 2.0027 | 12.8203 | 24 | 704 | negative regulation of programmed cell death |
| GO:0006302 | 0.0025 | 3.0815 | 3.46 | 10 | 190 | double-strand break repair |
| GO:0007389 | 0.0028 | 2.4046 | 6.6287 | 15 | 364 | pattern specification process |
| GO:0035482 | 0.0032 | 36.2343 | 0.0911 | 2 | 5 | gastric motility |
| GO:0045617 | 0.0032 | 36.2343 | 0.0911 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:0051459 | 0.0032 | 36.2343 | 0.0911 | 2 | 5 | regulation of corticotropin secretion |
| GO:0007130 | 0.0034 | 11.6858 | 0.3096 | 3 | 17 | synaptonemal complex assembly |
| GO:0048070 | 0.0034 | 11.6858 | 0.3096 | 3 | 17 | regulation of developmental pigmentation |
| GO:0060644 | 0.0034 | 11.6858 | 0.3096 | 3 | 17 | mammary gland epithelial cell differentiation |
| GO:0001501 | 0.0034 | 2.2799 | 7.4482 | 16 | 409 | skeletal system development |
| GO:0071772 | 0.0036 | 3.4239 | 2.4949 | 8 | 137 | response to BMP |
| GO:0032502 | 0.0037 | 1.5517 | 46.3451 | 63 | 2740 | developmental process |
| GO:0048864 | 0.0037 | 5.2726 | 1.038 | 5 | 57 | stem cell development |
| GO:0048731 | 0.0037 | 1.4924 | 56.7895 | 75 | 3237 | system development |
| GO:0051291 | 0.0038 | 3.7807 | 1.985 | 7 | 109 | protein heterooligomerization |
| GO:0030182 | 0.004 | 1.7524 | 19.5947 | 32 | 1076 | neuron differentiation |
| GO:0014031 | 0.004 | 5.1727 | 1.0562 | 5 | 58 | mesenchymal cell development |
| GO:0060485 | 0.0041 | 2.871 | 3.6968 | 10 | 203 | mesenchyme development |
| GO:0022008 | 0.0042 | 1.6916 | 22.909 | 36 | 1258 | neurogenesis |
| GO:0090278 | 0.0044 | 6.6283 | 0.6738 | 4 | 37 | negative regulation of peptide hormone secretion |
| GO:0040011 | 0.0045 | 1.6624 | 24.639 | 38 | 1353 | locomotion |
| GO:0061621 | 0.0047 | 10.2235 | 0.346 | 3 | 19 | canonical glycolysis |
| GO:0043583 | 0.005 | 2.9794 | 3.2051 | 9 | 176 | ear development |
| GO:0014033 | 0.005 | 4.8944 | 1.1109 | 5 | 61 | neural crest cell differentiation |
| GO:0021915 | 0.0051 | 3.222 | 2.6405 | 8 | 145 | neural tube development |
| GO:0031111 | 0.0054 | 9.6214 | 0.3642 | 3 | 20 | negative regulation of microtubule polymerization or depolymerization |
| GO:0061615 | 0.0054 | 9.6214 | 0.3642 | 3 | 20 | glycolytic process through fructose-6-phosphate |
| GO:0001764 | 0.0061 | 3.4404 | 2.1671 | 7 | 119 | neuron migration |
| GO:0048842 | 0.0065 | 21.7372 | 0.1275 | 2 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:2000026 | 0.0067 | 1.5899 | 27.7713 | 41 | 1525 | regulation of multicellular organismal development |
| GO:0043524 | 0.0069 | 3.3499 | 2.2217 | 7 | 122 | negative regulation of neuron apoptotic process |
| GO:0060964 | 0.0074 | 3.7442 | 1.7118 | 6 | 94 | regulation of gene silencing by miRNA |
| GO:0042476 | 0.0077 | 3.7018 | 1.73 | 6 | 95 | odontogenesis |
| GO:0009653 | 0.0078 | 1.5051 | 37.514 | 52 | 2060 | anatomical structure morphogenesis |
| GO:0007156 | 0.0079 | 3.264 | 2.2763 | 7 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007155 | 0.0079 | 1.6887 | 18.9209 | 30 | 1039 | cell adhesion |
| GO:0003148 | 0.0081 | 8.1763 | 0.4188 | 3 | 23 | outflow tract septum morphogenesis |
| GO:0006007 | 0.0081 | 8.1763 | 0.4188 | 3 | 23 | glucose catabolic process |
| GO:0035116 | 0.0081 | 8.1763 | 0.4188 | 3 | 23 | embryonic hindlimb morphogenesis |
| GO:0030509 | 0.0082 | 3.2363 | 2.2945 | 7 | 126 | BMP signaling pathway |
| GO:0000281 | 0.0082 | 5.4654 | 0.8013 | 4 | 44 | mitotic cytokinesis |
| GO:0045840 | 0.0082 | 5.4654 | 0.8013 | 4 | 44 | positive regulation of mitotic nuclear division |
| GO:0051898 | 0.0082 | 5.4654 | 0.8013 | 4 | 44 | negative regulation of protein kinase B signaling |
| GO:0006950 | 0.0083 | 1.438 | 52.8656 | 69 | 2903 | response to stress |
| GO:0010940 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | positive regulation of necrotic cell death |
| GO:0030916 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | otic vesicle formation |
| GO:0060346 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | bone trabecula formation |
| GO:0060363 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | cranial suture morphogenesis |
| GO:0061308 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | cardiac neural crest cell development involved in heart development |
| GO:1905205 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:1905941 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | positive regulation of gonad development |
| GO:0045923 | 0.0091 | 7.7863 | 0.4371 | 3 | 24 | positive regulation of fatty acid metabolic process |
| GO:0048477 | 0.0094 | 4.1497 | 1.293 | 5 | 71 | oogenesis |
| GO:0051241 | 0.0094 | 1.7475 | 15.1577 | 25 | 839 | negative regulation of multicellular organismal process |
| GO:0032103 | 0.0095 | 2.6711 | 3.5511 | 9 | 195 | positive regulation of response to external stimulus |
| GO:0046661 | 0.0097 | 3.1301 | 2.3674 | 7 | 130 | male sex differentiation |
| GO:0030879 | 0.0099 | 3.5036 | 1.8211 | 6 | 100 | mammary gland development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 11.4009 | 1.0405 | 10 | 85 | embryonic skeletal system morphogenesis |
| GO:0007389 | 0 | 4.5975 | 4.4558 | 18 | 364 | pattern specification process |
| GO:0021675 | 0 | 12.5233 | 0.759 | 8 | 62 | nerve development |
| GO:0021602 | 0 | 38.2962 | 0.1935 | 5 | 16 | cranial nerve morphogenesis |
| GO:0048532 | 0 | 41.3418 | 0.1469 | 4 | 12 | anatomical structure arrangement |
| GO:0048486 | 0 | 36.7454 | 0.1591 | 4 | 13 | parasympathetic nervous system development |
| GO:0009887 | 0 | 2.8294 | 10.0011 | 25 | 817 | animal organ morphogenesis |
| GO:0021561 | 0 | 82.195 | 0.0734 | 3 | 6 | facial nerve development |
| GO:0001708 | 0 | 8.2696 | 0.9548 | 7 | 78 | cell fate specification |
| GO:0048568 | 1e-04 | 3.6448 | 4.5415 | 15 | 371 | embryonic organ development |
| GO:0030855 | 1e-04 | 3.1171 | 6.3899 | 18 | 522 | epithelial cell differentiation |
| GO:0043009 | 1e-04 | 3.0492 | 6.1328 | 17 | 501 | chordate embryonic development |
| GO:0021633 | 1e-04 | Inf | 0.0245 | 2 | 2 | optic nerve structural organization |
| GO:0030878 | 2e-04 | 17.3924 | 0.2815 | 4 | 23 | thyroid gland development |
| GO:0021554 | 2e-04 | 35.2156 | 0.1224 | 3 | 10 | optic nerve development |
| GO:0051241 | 2e-04 | 2.4691 | 10.3316 | 23 | 844 | negative regulation of multicellular organismal process |
| GO:0048598 | 3e-04 | 2.97 | 5.8956 | 16 | 490 | embryonic morphogenesis |
| GO:0009952 | 3e-04 | 4.5182 | 2.1667 | 9 | 177 | anterior/posterior pattern specification |
| GO:0061551 | 4e-04 | 163.3875 | 0.0367 | 2 | 3 | trigeminal ganglion development |
| GO:0072513 | 4e-04 | 163.3875 | 0.0367 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
| GO:0001501 | 5e-04 | 3.0359 | 5.0066 | 14 | 409 | skeletal system development |
| GO:0003199 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0021612 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | facial nerve structural organization |
| GO:0021648 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0098706 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | ferric iron import across plasma membrane |
| GO:0007507 | 0.0011 | 2.7811 | 5.4351 | 14 | 444 | heart development |
| GO:0042749 | 0.0013 | 16.4239 | 0.2203 | 3 | 18 | regulation of circadian sleep/wake cycle |
| GO:0048512 | 0.0014 | 9.1674 | 0.4896 | 4 | 40 | circadian behavior |
| GO:0015677 | 0.0015 | 54.4542 | 0.0612 | 2 | 5 | copper ion import |
| GO:0021546 | 0.0015 | 54.4542 | 0.0612 | 2 | 5 | rhombomere development |
| GO:0090103 | 0.0015 | 15.3962 | 0.2326 | 3 | 19 | cochlea morphogenesis |
| GO:0035176 | 0.0017 | 8.6835 | 0.5141 | 4 | 42 | social behavior |
| GO:0001525 | 0.0017 | 2.8909 | 4.4558 | 12 | 364 | angiogenesis |
| GO:0050802 | 0.002 | 13.6834 | 0.2571 | 3 | 21 | circadian sleep/wake cycle, sleep |
| GO:0019233 | 0.0025 | 5.7502 | 0.9426 | 5 | 77 | sensory perception of pain |
| GO:0051093 | 0.0026 | 2.2431 | 8.6668 | 18 | 708 | negative regulation of developmental process |
| GO:0010092 | 0.0027 | 12.3132 | 0.2815 | 3 | 23 | specification of animal organ identity |
| GO:0009888 | 0.0028 | 1.8625 | 17.7885 | 30 | 1470 | tissue development |
| GO:0043587 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | tongue morphogenesis |
| GO:0045188 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0060837 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | blood vessel endothelial cell differentiation |
| GO:2000252 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | negative regulation of feeding behavior |
| GO:1901214 | 0.003 | 3.2272 | 2.9746 | 9 | 243 | regulation of neuron death |
| GO:0050877 | 0.0033 | 2.1862 | 8.8749 | 18 | 725 | nervous system process |
| GO:0048762 | 0.0034 | 3.8387 | 1.9464 | 7 | 159 | mesenchymal cell differentiation |
| GO:0035115 | 0.0038 | 10.7047 | 0.3183 | 3 | 26 | embryonic forelimb morphogenesis |
| GO:0043524 | 0.0039 | 4.2958 | 1.4934 | 6 | 122 | negative regulation of neuron apoptotic process |
| GO:0060982 | 0.004 | 27.2208 | 0.0979 | 2 | 8 | coronary artery morphogenesis |
| GO:0003014 | 0.0041 | 5.1077 | 1.0527 | 5 | 86 | renal system process |
| GO:0009953 | 0.0041 | 5.1077 | 1.0527 | 5 | 86 | dorsal/ventral pattern formation |
| GO:0045907 | 0.0042 | 10.2579 | 0.3305 | 3 | 27 | positive regulation of vasoconstriction |
| GO:0050768 | 0.0043 | 3.3098 | 2.5707 | 8 | 210 | negative regulation of neurogenesis |
| GO:0097286 | 0.0051 | 23.3304 | 0.1102 | 2 | 9 | iron ion import |
| GO:2001054 | 0.0051 | 23.3304 | 0.1102 | 2 | 9 | negative regulation of mesenchymal cell apoptotic process |
| GO:0001944 | 0.0056 | 2.3018 | 6.4878 | 14 | 530 | vasculature development |
| GO:0001822 | 0.0057 | 3.1512 | 2.6931 | 8 | 220 | kidney development |
| GO:0031640 | 0.0057 | 9.116 | 0.3672 | 3 | 30 | killing of cells of other organism |
| GO:0035148 | 0.0061 | 3.8894 | 1.6403 | 6 | 134 | tube formation |
| GO:0003264 | 0.0063 | 20.4125 | 0.1224 | 2 | 10 | regulation of cardioblast proliferation |
| GO:0006703 | 0.0063 | 20.4125 | 0.1224 | 2 | 10 | estrogen biosynthetic process |
| GO:0045987 | 0.0063 | 8.7898 | 0.3795 | 3 | 31 | positive regulation of smooth muscle contraction |
| GO:0035295 | 0.0068 | 2.3233 | 5.9533 | 13 | 492 | tube development |
| GO:0003179 | 0.0069 | 8.486 | 0.3917 | 3 | 32 | heart valve morphogenesis |
| GO:0048589 | 0.007 | 2.3138 | 5.9737 | 13 | 488 | developmental growth |
| GO:0048870 | 0.0071 | 1.8362 | 14.1386 | 24 | 1155 | cell motility |
| GO:0060322 | 0.0072 | 2.1626 | 7.3937 | 15 | 604 | head development |
| GO:0060795 | 0.0075 | 8.2025 | 0.404 | 3 | 33 | cell fate commitment involved in formation of primary germ layer |
| GO:1901998 | 0.0075 | 8.2025 | 0.404 | 3 | 33 | toxin transport |
| GO:0003161 | 0.0076 | 18.1431 | 0.1347 | 2 | 11 | cardiac conduction system development |
| GO:0072189 | 0.0076 | 18.1431 | 0.1347 | 2 | 11 | ureter development |
| GO:0003206 | 0.0086 | 4.2162 | 1.2608 | 5 | 103 | cardiac chamber morphogenesis |
| GO:0001709 | 0.0088 | 7.6887 | 0.4284 | 3 | 35 | cell fate determination |
| GO:0046579 | 0.0088 | 7.6887 | 0.4284 | 3 | 35 | positive regulation of Ras protein signal transduction |
| GO:0061323 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | cell proliferation involved in heart morphogenesis |
| GO:0061548 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | ganglion development |
| GO:0072075 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | metanephric mesenchyme development |
| GO:2001014 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | regulation of skeletal muscle cell differentiation |
| GO:0022603 | 0.0091 | 1.9645 | 9.793 | 18 | 800 | regulation of anatomical structure morphogenesis |
| GO:0003151 | 0.0096 | 5.1456 | 0.8324 | 4 | 68 | outflow tract morphogenesis |
| GO:0031623 | 0.0096 | 5.1456 | 0.8324 | 4 | 68 | receptor internalization |
| GO:0051341 | 0.0096 | 5.1456 | 0.8324 | 4 | 68 | regulation of oxidoreductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051445 | 9e-04 | 10.3603 | 0.4352 | 4 | 40 | regulation of meiotic cell cycle |
| GO:0018149 | 9e-04 | 18.5461 | 0.1959 | 3 | 18 | peptide cross-linking |
| GO:0043009 | 0.0011 | 2.787 | 5.4514 | 14 | 501 | chordate embryonic development |
| GO:0007186 | 0.0012 | 2.4931 | 7.4426 | 17 | 684 | G-protein coupled receptor signaling pathway |
| GO:0007188 | 0.0015 | 5.2262 | 1.2404 | 6 | 114 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:1900040 | 0.0017 | 46.0775 | 0.0653 | 2 | 6 | regulation of interleukin-2 secretion |
| GO:0050808 | 0.002 | 3.772 | 2.2741 | 8 | 209 | synapse organization |
| GO:0048704 | 0.0023 | 5.8498 | 0.9249 | 5 | 85 | embryonic skeletal system morphogenesis |
| GO:0007156 | 0.0024 | 4.7391 | 1.3601 | 6 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0050911 | 0.0028 | 7.4514 | 0.5876 | 4 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0021859 | 0.0032 | 30.7136 | 0.087 | 2 | 8 | pyramidal neuron differentiation |
| GO:0035095 | 0.0032 | 30.7136 | 0.087 | 2 | 8 | behavioral response to nicotine |
| GO:1904861 | 0.0032 | 30.7136 | 0.087 | 2 | 8 | excitatory synapse assembly |
| GO:0009642 | 0.005 | 23.0317 | 0.1088 | 2 | 10 | response to light intensity |
| GO:0099068 | 0.005 | 23.0317 | 0.1088 | 2 | 10 | postsynapse assembly |
| GO:0033197 | 0.0061 | 20.471 | 0.1197 | 2 | 11 | response to vitamin E |
| GO:0045836 | 0.0061 | 20.471 | 0.1197 | 2 | 11 | positive regulation of meiotic nuclear division |
| GO:0071397 | 0.0061 | 20.471 | 0.1197 | 2 | 11 | cellular response to cholesterol |
| GO:0007268 | 0.0072 | 2.3986 | 5.3317 | 12 | 490 | chemical synaptic transmission |
| GO:0099537 | 0.0073 | 2.3934 | 5.3426 | 12 | 491 | trans-synaptic signaling |
| GO:0007625 | 0.0085 | 16.7465 | 0.1415 | 2 | 13 | grooming behavior |
| GO:0043252 | 0.0085 | 16.7465 | 0.1415 | 2 | 13 | sodium-independent organic anion transport |
| GO:2000242 | 0.0087 | 7.7151 | 0.4244 | 3 | 39 | negative regulation of reproductive process |
| GO:0007600 | 0.0092 | 2.4176 | 4.8312 | 11 | 444 | sensory perception |
| GO:0007269 | 0.0093 | 4.131 | 1.284 | 5 | 118 | neurotransmitter secretion |
| GO:0001829 | 0.0098 | 15.3498 | 0.1523 | 2 | 14 | trophectodermal cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 7.3613 | 1.2268 | 8 | 85 | embryonic skeletal system morphogenesis |
| GO:0021602 | 2e-04 | 17.4158 | 0.2887 | 4 | 20 | cranial nerve morphogenesis |
| GO:0009952 | 2e-04 | 4.2598 | 2.5546 | 10 | 177 | anterior/posterior pattern specification |
| GO:0032501 | 6e-04 | 1.6535 | 69.3697 | 91 | 5044 | multicellular organismal process |
| GO:0061044 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0009605 | 8e-04 | 1.8842 | 22.4714 | 38 | 1557 | response to external stimulus |
| GO:0032502 | 8e-04 | 1.6105 | 69.2761 | 91 | 4800 | developmental process |
| GO:0007389 | 8e-04 | 2.8685 | 5.2534 | 14 | 364 | pattern specification process |
| GO:0006954 | 0.0011 | 2.5764 | 6.6823 | 16 | 463 | inflammatory response |
| GO:0009887 | 0.0016 | 2.112 | 11.7914 | 23 | 817 | animal organ morphogenesis |
| GO:0034220 | 0.002 | 2.0731 | 11.9934 | 23 | 831 | ion transmembrane transport |
| GO:0006828 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | manganese ion transport |
| GO:0021546 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | rhombomere development |
| GO:0002684 | 0.0022 | 2.1701 | 9.9151 | 20 | 687 | positive regulation of immune system process |
| GO:0048731 | 0.0022 | 1.567 | 52.621 | 71 | 3646 | system development |
| GO:0016485 | 0.0029 | 3.5424 | 2.4102 | 8 | 167 | protein processing |
| GO:0042060 | 0.0031 | 2.4682 | 6.0472 | 14 | 419 | wound healing |
| GO:1903317 | 0.0032 | 5.4515 | 0.9958 | 5 | 69 | regulation of protein maturation |
| GO:0060143 | 0.0037 | 10.9384 | 0.3175 | 3 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0001955 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | blood vessel maturation |
| GO:0006949 | 0.0043 | 6.6213 | 0.6639 | 4 | 46 | syncytium formation |
| GO:0072376 | 0.0043 | 6.6213 | 0.6639 | 4 | 46 | protein activation cascade |
| GO:0002253 | 0.0045 | 2.447 | 5.6431 | 13 | 391 | activation of immune response |
| GO:0006026 | 0.0046 | 6.4669 | 0.6783 | 4 | 47 | aminoglycan catabolic process |
| GO:0007274 | 0.0048 | 9.8951 | 0.3464 | 3 | 24 | neuromuscular synaptic transmission |
| GO:0006959 | 0.0052 | 4.035 | 1.5876 | 6 | 110 | humoral immune response |
| GO:0050867 | 0.0053 | 2.9505 | 3.2329 | 9 | 224 | positive regulation of cell activation |
| GO:0001820 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | serotonin secretion |
| GO:0006957 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | complement activation, alternative pathway |
| GO:0035095 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | behavioral response to nicotine |
| GO:1905205 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:0030449 | 0.006 | 9.0333 | 0.3752 | 3 | 26 | regulation of complement activation |
| GO:0050776 | 0.0061 | 2.0432 | 9.3811 | 18 | 650 | regulation of immune response |
| GO:0010951 | 0.0065 | 3.384 | 2.1937 | 7 | 152 | negative regulation of endopeptidase activity |
| GO:0051251 | 0.0067 | 3.0551 | 2.771 | 8 | 192 | positive regulation of lymphocyte activation |
| GO:0030207 | 0.007 | 19.7067 | 0.1299 | 2 | 9 | chondroitin sulfate catabolic process |
| GO:0042110 | 0.0078 | 2.4693 | 4.705 | 11 | 326 | T cell activation |
| GO:0048247 | 0.0082 | 7.9892 | 0.4185 | 3 | 29 | lymphocyte chemotaxis |
| GO:0006853 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | carnitine shuttle |
| GO:0030208 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | dermatan sulfate biosynthetic process |
| GO:1903034 | 0.0099 | 3.4927 | 1.8185 | 6 | 126 | regulation of response to wounding |
| GO:0045785 | 0.0099 | 2.5001 | 4.2143 | 10 | 292 | positive regulation of cell adhesion |
| GO:0030198 | 0.01 | 2.6492 | 3.5793 | 9 | 248 | extracellular matrix organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001501 | 1e-04 | 3.3292 | 4.9448 | 15 | 409 | skeletal system development |
| GO:0060536 | 1e-04 | 41.6178 | 0.1088 | 3 | 9 | cartilage morphogenesis |
| GO:0048598 | 1e-04 | 3.0402 | 6.1538 | 17 | 509 | embryonic morphogenesis |
| GO:2000363 | 1e-04 | Inf | 0.0242 | 2 | 2 | positive regulation of prostaglandin-E synthase activity |
| GO:0030878 | 2e-04 | 17.6181 | 0.2781 | 4 | 23 | thyroid gland development |
| GO:0003219 | 4e-04 | 165.481 | 0.0363 | 2 | 3 | cardiac right ventricle formation |
| GO:0048704 | 6e-04 | 6.4088 | 1.0277 | 6 | 85 | embryonic skeletal system morphogenesis |
| GO:0048568 | 6e-04 | 3.1412 | 4.4854 | 13 | 371 | embryonic organ development |
| GO:0002227 | 9e-04 | 19.1979 | 0.1934 | 3 | 16 | innate immune response in mucosa |
| GO:0080154 | 0.001 | 17.8253 | 0.2055 | 3 | 17 | regulation of fertilization |
| GO:0016054 | 0.0011 | 3.7602 | 2.5752 | 9 | 213 | organic acid catabolic process |
| GO:1902565 | 0.0014 | 55.1519 | 0.0605 | 2 | 5 | positive regulation of neutrophil activation |
| GO:0007389 | 0.0016 | 2.9304 | 4.4008 | 12 | 364 | pattern specification process |
| GO:0042482 | 0.0021 | 41.3608 | 0.0725 | 2 | 6 | positive regulation of odontogenesis |
| GO:0002251 | 0.0023 | 13.1294 | 0.266 | 3 | 22 | organ or tissue specific immune response |
| GO:0061140 | 0.0029 | 33.0861 | 0.0846 | 2 | 7 | lung secretory cell differentiation |
| GO:0010611 | 0.0033 | 7.1069 | 0.6166 | 4 | 51 | regulation of cardiac muscle hypertrophy |
| GO:0048856 | 0.0035 | 1.5678 | 54.1635 | 71 | 4480 | anatomical structure development |
| GO:0001574 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | ganglioside biosynthetic process |
| GO:0010911 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | regulation of isomerase activity |
| GO:0016045 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | detection of bacterium |
| GO:0051712 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | positive regulation of killing of cells of other organism |
| GO:2000344 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | positive regulation of acrosome reaction |
| GO:0032963 | 0.004 | 5.1109 | 1.0518 | 5 | 87 | collagen metabolic process |
| GO:0044243 | 0.0041 | 6.679 | 0.6529 | 4 | 54 | multicellular organismal catabolic process |
| GO:0042742 | 0.0044 | 4.1708 | 1.5354 | 6 | 127 | defense response to bacterium |
| GO:0007610 | 0.0048 | 2.4305 | 5.7065 | 13 | 472 | behavior |
| GO:0003207 | 0.0049 | 23.6293 | 0.1088 | 2 | 9 | cardiac chamber formation |
| GO:1903244 | 0.0049 | 23.6293 | 0.1088 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0045595 | 0.0051 | 1.8107 | 16.914 | 28 | 1399 | regulation of cell differentiation |
| GO:0009063 | 0.0056 | 4.7064 | 1.1365 | 5 | 94 | cellular amino acid catabolic process |
| GO:0009952 | 0.0057 | 3.4728 | 2.1399 | 7 | 177 | anterior/posterior pattern specification |
| GO:0003208 | 0.0059 | 5.9606 | 0.7254 | 4 | 60 | cardiac ventricle morphogenesis |
| GO:0014742 | 0.0061 | 8.9031 | 0.3748 | 3 | 31 | positive regulation of muscle hypertrophy |
| GO:0035646 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | endosome to melanosome transport |
| GO:0043476 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | pigment accumulation |
| GO:0048757 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | pigment granule maturation |
| GO:0060707 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | trophoblast giant cell differentiation |
| GO:0001570 | 0.0063 | 5.8556 | 0.7375 | 4 | 61 | vasculogenesis |
| GO:0003008 | 0.0063 | 1.8145 | 15.5841 | 26 | 1289 | system process |
| GO:0006952 | 0.0073 | 1.882 | 12.6099 | 22 | 1043 | defense response |
| GO:0014744 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | positive regulation of muscle adaptation |
| GO:0031645 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | negative regulation of neurological system process |
| GO:0031953 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | negative regulation of protein autophosphorylation |
| GO:0098581 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | detection of external biotic stimulus |
| GO:1900025 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | negative regulation of substrate adhesion-dependent cell spreading |
| GO:2000026 | 0.0088 | 1.7133 | 18.4374 | 29 | 1525 | regulation of multicellular organismal development |
| GO:0002374 | 0.0089 | 16.5367 | 0.1451 | 2 | 12 | cytokine secretion involved in immune response |
| GO:0030277 | 0.0089 | 16.5367 | 0.1451 | 2 | 12 | maintenance of gastrointestinal epithelium |
| GO:0061042 | 0.0089 | 16.5367 | 0.1451 | 2 | 12 | vascular wound healing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 9.215 | 1.8041 | 14 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0048704 | 0 | 8.4372 | 1.2268 | 9 | 85 | embryonic skeletal system morphogenesis |
| GO:0051295 | 0 | 208.117 | 0.0577 | 3 | 4 | establishment of meiotic spindle localization |
| GO:0048568 | 1e-04 | 3.2677 | 5.3545 | 16 | 371 | embryonic organ development |
| GO:0051653 | 2e-04 | 11.2834 | 0.5196 | 5 | 36 | spindle localization |
| GO:0042472 | 2e-04 | 6.6674 | 1.169 | 7 | 81 | inner ear morphogenesis |
| GO:0070649 | 2e-04 | Inf | 0.0289 | 2 | 2 | formin-nucleated actin cable assembly |
| GO:0030878 | 3e-04 | 14.6625 | 0.3319 | 4 | 23 | thyroid gland development |
| GO:0003264 | 3e-04 | 29.7173 | 0.1443 | 3 | 10 | regulation of cardioblast proliferation |
| GO:0021783 | 4e-04 | 26.0007 | 0.1588 | 3 | 11 | preganglionic parasympathetic fiber development |
| GO:0061323 | 6e-04 | 23.1099 | 0.1732 | 3 | 12 | cell proliferation involved in heart morphogenesis |
| GO:0031296 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | B cell costimulation |
| GO:0060435 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | bronchiole development |
| GO:0072513 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
| GO:0071675 | 8e-04 | 11.1384 | 0.4185 | 4 | 29 | regulation of mononuclear cell migration |
| GO:0043433 | 0.001 | 4.8267 | 1.5731 | 7 | 109 | negative regulation of DNA binding transcription factor activity |
| GO:0009887 | 0.0012 | 2.1623 | 11.5472 | 23 | 808 | animal organ morphogenesis |
| GO:0040038 | 0.0012 | 69 | 0.0577 | 2 | 4 | polar body extrusion after meiotic divisions |
| GO:0060638 | 0.0012 | 69 | 0.0577 | 2 | 4 | mesenchymal-epithelial cell signaling |
| GO:0070350 | 0.0012 | 69 | 0.0577 | 2 | 4 | regulation of white fat cell proliferation |
| GO:0060173 | 0.0014 | 4.0002 | 2.1504 | 8 | 149 | limb development |
| GO:0032602 | 0.0015 | 6.5886 | 0.8371 | 5 | 58 | chemokine production |
| GO:0098609 | 0.0015 | 2.2949 | 8.9193 | 19 | 618 | cell-cell adhesion |
| GO:0048483 | 0.0016 | 8.9784 | 0.5051 | 4 | 35 | autonomic nervous system development |
| GO:0021546 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | rhombomere development |
| GO:0036089 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | cleavage furrow formation |
| GO:0051891 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0030850 | 0.0021 | 8.1843 | 0.5484 | 4 | 38 | prostate gland development |
| GO:0022610 | 0.0021 | 1.9489 | 15.0531 | 27 | 1043 | biological adhesion |
| GO:0008589 | 0.0023 | 5.9158 | 0.9237 | 5 | 64 | regulation of smoothened signaling pathway |
| GO:0048663 | 0.0023 | 5.9158 | 0.9237 | 5 | 64 | neuron fate commitment |
| GO:0061448 | 0.0023 | 3.3632 | 2.8576 | 9 | 198 | connective tissue development |
| GO:0035107 | 0.0023 | 4.1317 | 1.8185 | 7 | 126 | appendage morphogenesis |
| GO:0021545 | 0.0023 | 7.9499 | 0.5629 | 4 | 39 | cranial nerve development |
| GO:0060914 | 0.0024 | 12.9924 | 0.2742 | 3 | 19 | heart formation |
| GO:0060485 | 0.0028 | 3.2752 | 2.9298 | 9 | 203 | mesenchyme development |
| GO:0021610 | 0.003 | 34.4947 | 0.0866 | 2 | 6 | facial nerve morphogenesis |
| GO:0042482 | 0.003 | 34.4947 | 0.0866 | 2 | 6 | positive regulation of odontogenesis |
| GO:0070345 | 0.003 | 34.4947 | 0.0866 | 2 | 6 | negative regulation of fat cell proliferation |
| GO:0003002 | 0.0032 | 2.8061 | 4.171 | 11 | 289 | regionalization |
| GO:0003211 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | cardiac ventricle formation |
| GO:0030656 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | regulation of vitamin metabolic process |
| GO:0060290 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | transdifferentiation |
| GO:0061140 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | lung secretory cell differentiation |
| GO:0071476 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | cellular hypotonic response |
| GO:0061005 | 0.0043 | 6.6213 | 0.6639 | 4 | 46 | cell differentiation involved in kidney development |
| GO:0048791 | 0.0048 | 9.8951 | 0.3464 | 3 | 24 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0051294 | 0.0048 | 9.8951 | 0.3464 | 3 | 24 | establishment of spindle orientation |
| GO:0030326 | 0.005 | 4.0745 | 1.5731 | 6 | 109 | embryonic limb morphogenesis |
| GO:0047484 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | regulation of response to osmotic stress |
| GO:0015672 | 0.0064 | 2.3325 | 5.9029 | 13 | 409 | monovalent inorganic cation transport |
| GO:0007267 | 0.0065 | 1.7451 | 17.9429 | 29 | 1256 | cell-cell signaling |
| GO:0022414 | 0.0066 | 1.7942 | 15.5727 | 26 | 1079 | reproductive process |
| GO:0060536 | 0.007 | 19.7067 | 0.1299 | 2 | 9 | cartilage morphogenesis |
| GO:0090026 | 0.007 | 19.7067 | 0.1299 | 2 | 9 | positive regulation of monocyte chemotaxis |
| GO:0051046 | 0.0071 | 2.1047 | 8.0678 | 16 | 559 | regulation of secretion |
| GO:0017158 | 0.0081 | 5.4491 | 0.7938 | 4 | 55 | regulation of calcium ion-dependent exocytosis |
| GO:0030890 | 0.0082 | 7.9892 | 0.4185 | 3 | 29 | positive regulation of B cell proliferation |
| GO:2000826 | 0.0082 | 7.9892 | 0.4185 | 3 | 29 | regulation of heart morphogenesis |
| GO:0002544 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | chronic inflammatory response |
| GO:0010755 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | regulation of plasminogen activation |
| GO:0045073 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | regulation of chemokine biosynthetic process |
| GO:0050755 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | chemokine metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045765 | 0 | 6.1303 | 1.6529 | 9 | 90 | regulation of angiogenesis |
| GO:0001944 | 1e-04 | 2.6426 | 9.932 | 24 | 530 | vasculature development |
| GO:2000026 | 1e-04 | 1.9201 | 28.5779 | 49 | 1525 | regulation of multicellular organismal development |
| GO:0048646 | 1e-04 | 2.2095 | 15.8912 | 32 | 848 | anatomical structure formation involved in morphogenesis |
| GO:2000181 | 1e-04 | 5.8963 | 1.5179 | 8 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0003211 | 2e-04 | 39.7408 | 0.1312 | 3 | 7 | cardiac ventricle formation |
| GO:0045814 | 2e-04 | 4.7566 | 2.0801 | 9 | 111 | negative regulation of gene expression, epigenetic |
| GO:0072359 | 3e-04 | 2.1623 | 15.1229 | 30 | 807 | circulatory system development |
| GO:1905205 | 3e-04 | 31.7902 | 0.1499 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0003342 | 3e-04 | Inf | 0.0375 | 2 | 2 | proepicardium development |
| GO:1903244 | 5e-04 | 26.4898 | 0.1687 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0060055 | 6e-04 | 12.5063 | 0.3935 | 4 | 21 | angiogenesis involved in wound healing |
| GO:0071941 | 7e-04 | 22.7038 | 0.1874 | 3 | 10 | nitrogen cycle metabolic process |
| GO:0034103 | 7e-04 | 6.1669 | 1.0869 | 6 | 58 | regulation of tissue remodeling |
| GO:0014744 | 0.001 | 19.8643 | 0.2061 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0061044 | 0.001 | 105.5691 | 0.0562 | 2 | 3 | negative regulation of vascular wound healing |
| GO:2001199 | 0.001 | 105.5691 | 0.0562 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0046500 | 0.0013 | 17.6558 | 0.2249 | 3 | 12 | S-adenosylmethionine metabolic process |
| GO:0007389 | 0.0014 | 2.5046 | 6.8212 | 16 | 364 | pattern specification process |
| GO:0051093 | 0.0017 | 2.0194 | 13.2676 | 25 | 708 | negative regulation of developmental process |
| GO:0006335 | 0.002 | 8.499 | 0.5434 | 4 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0051122 | 0.002 | 52.7805 | 0.075 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060920 | 0.002 | 52.7805 | 0.075 | 2 | 4 | cardiac pacemaker cell differentiation |
| GO:0061055 | 0.002 | 52.7805 | 0.075 | 2 | 4 | myotome development |
| GO:0097176 | 0.002 | 52.7805 | 0.075 | 2 | 4 | epoxide metabolic process |
| GO:0009888 | 0.0023 | 1.6832 | 27.7721 | 43 | 1482 | tissue development |
| GO:0048514 | 0.0025 | 2.4359 | 6.5506 | 15 | 359 | blood vessel morphogenesis |
| GO:0001759 | 0.0025 | 13.2388 | 0.2811 | 3 | 15 | organ induction |
| GO:0010612 | 0.0025 | 13.2388 | 0.2811 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0019372 | 0.0025 | 13.2388 | 0.2811 | 3 | 15 | lipoxygenase pathway |
| GO:0014742 | 0.0025 | 7.8682 | 0.5809 | 4 | 31 | positive regulation of muscle hypertrophy |
| GO:0000183 | 0.0029 | 7.5867 | 0.5997 | 4 | 32 | chromatin silencing at rDNA |
| GO:0042445 | 0.003 | 3.5441 | 2.4174 | 8 | 129 | hormone metabolic process |
| GO:2000379 | 0.003 | 4.5747 | 1.4242 | 6 | 76 | positive regulation of reactive oxygen species metabolic process |
| GO:0006555 | 0.003 | 12.2195 | 0.2998 | 3 | 16 | methionine metabolic process |
| GO:0048870 | 0.0031 | 1.7409 | 21.6442 | 35 | 1155 | cell motility |
| GO:0038111 | 0.0032 | 7.3245 | 0.6184 | 4 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0032 | 7.3245 | 0.6184 | 4 | 33 | response to interleukin-7 |
| GO:0030858 | 0.0033 | 5.4325 | 1.0119 | 5 | 54 | positive regulation of epithelial cell differentiation |
| GO:0006526 | 0.0034 | 35.1843 | 0.0937 | 2 | 5 | arginine biosynthetic process |
| GO:0010757 | 0.0034 | 35.1843 | 0.0937 | 2 | 5 | negative regulation of plasminogen activation |
| GO:0006575 | 0.0034 | 3.4575 | 2.4736 | 8 | 132 | cellular modified amino acid metabolic process |
| GO:0046394 | 0.0036 | 2.6225 | 4.8536 | 12 | 259 | carboxylic acid biosynthetic process |
| GO:0031497 | 0.0039 | 3.3751 | 2.5298 | 8 | 135 | chromatin assembly |
| GO:0040012 | 0.0046 | 1.9152 | 12.7617 | 23 | 681 | regulation of locomotion |
| GO:0002291 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0003278 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0035360 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0071472 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | cellular response to salt stress |
| GO:0060914 | 0.005 | 9.926 | 0.3561 | 3 | 19 | heart formation |
| GO:0045766 | 0.0051 | 3.5632 | 2.0988 | 7 | 112 | positive regulation of angiogenesis |
| GO:0048706 | 0.0051 | 3.5632 | 2.0988 | 7 | 112 | embryonic skeletal system development |
| GO:0034728 | 0.0057 | 3.1495 | 2.6985 | 8 | 144 | nucleosome organization |
| GO:0048731 | 0.0063 | 1.4786 | 49.7759 | 66 | 2837 | system development |
| GO:0051290 | 0.0065 | 5.8971 | 0.7496 | 4 | 40 | protein heterotetramerization |
| GO:0030334 | 0.0065 | 1.9428 | 10.8877 | 20 | 581 | regulation of cell migration |
| GO:0060037 | 0.0067 | 8.8218 | 0.3935 | 3 | 21 | pharyngeal system development |
| GO:0061085 | 0.0069 | 21.1073 | 0.1312 | 2 | 7 | regulation of histone H3-K27 methylation |
| GO:0006691 | 0.0077 | 8.3568 | 0.4123 | 3 | 22 | leukotriene metabolic process |
| GO:0042554 | 0.0077 | 8.3568 | 0.4123 | 3 | 22 | superoxide anion generation |
| GO:0048538 | 0.0077 | 5.5858 | 0.7871 | 4 | 42 | thymus development |
| GO:0048562 | 0.0083 | 2.4442 | 4.7411 | 11 | 253 | embryonic organ morphogenesis |
| GO:0051216 | 0.0085 | 2.9315 | 2.8859 | 8 | 154 | cartilage development |
| GO:0030878 | 0.0087 | 7.9384 | 0.431 | 3 | 23 | thyroid gland development |
| GO:0061756 | 0.0087 | 7.9384 | 0.431 | 3 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:1903671 | 0.0087 | 7.9384 | 0.431 | 3 | 23 | negative regulation of sprouting angiogenesis |
| GO:0003266 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | regulation of secondary heart field cardioblast proliferation |
| GO:0007512 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | adult heart development |
| GO:0010940 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | positive regulation of necrotic cell death |
| GO:0014841 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | skeletal muscle satellite cell proliferation |
| GO:0045647 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | negative regulation of erythrocyte differentiation |
| GO:0007156 | 0.0092 | 3.1675 | 2.3425 | 7 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042126 | 0 | 150.2432 | 0.0792 | 3 | 4 | nitrate metabolic process |
| GO:0072358 | 1e-04 | 2.5776 | 10.5917 | 25 | 535 | cardiovascular system development |
| GO:0006805 | 2e-04 | 6.8205 | 1.1681 | 7 | 59 | xenobiotic metabolic process |
| GO:0048646 | 3e-04 | 2.1066 | 16.5497 | 32 | 842 | anatomical structure formation involved in morphogenesis |
| GO:0009410 | 3e-04 | 5.9075 | 1.3264 | 7 | 67 | response to xenobiotic stimulus |
| GO:0006954 | 4e-04 | 2.4702 | 9.1662 | 21 | 463 | inflammatory response |
| GO:0001568 | 4e-04 | 2.4047 | 9.8677 | 22 | 502 | blood vessel development |
| GO:1905205 | 4e-04 | 30.0394 | 0.1584 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:1900048 | 6e-04 | 12.5543 | 0.3959 | 4 | 20 | positive regulation of hemostasis |
| GO:0061029 | 6e-04 | 25.0309 | 0.1782 | 3 | 9 | eyelid development in camera-type eye |
| GO:1903244 | 6e-04 | 25.0309 | 0.1782 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0050820 | 7e-04 | 11.8149 | 0.4157 | 4 | 21 | positive regulation of coagulation |
| GO:0042471 | 8e-04 | 4.4094 | 1.9797 | 8 | 100 | ear morphogenesis |
| GO:0048701 | 0.001 | 7.4033 | 0.7721 | 5 | 39 | embryonic cranial skeleton morphogenesis |
| GO:1903671 | 0.001 | 10.5696 | 0.4553 | 4 | 23 | negative regulation of sprouting angiogenesis |
| GO:2000181 | 0.0011 | 4.7846 | 1.6036 | 7 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0014744 | 0.0011 | 18.7703 | 0.2178 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0033128 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0051410 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | detoxification of nitrogen compound |
| GO:0061044 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0070634 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | transepithelial ammonium transport |
| GO:2001199 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0030198 | 0.0013 | 2.8297 | 4.9098 | 13 | 248 | extracellular matrix organization |
| GO:0045766 | 0.0017 | 3.897 | 2.2173 | 8 | 112 | positive regulation of angiogenesis |
| GO:0048706 | 0.0017 | 3.897 | 2.2173 | 8 | 112 | embryonic skeletal system development |
| GO:0045765 | 0.0018 | 4.3654 | 1.7421 | 7 | 90 | regulation of angiogenesis |
| GO:0050896 | 0.0018 | 1.4523 | 127.1989 | 151 | 6425 | response to stimulus |
| GO:0070286 | 0.0018 | 8.7287 | 0.5345 | 4 | 27 | axonemal dynein complex assembly |
| GO:0006590 | 0.0019 | 15.0139 | 0.2574 | 3 | 13 | thyroid hormone generation |
| GO:0007605 | 0.0021 | 3.7515 | 2.2965 | 8 | 116 | sensory perception of sound |
| GO:0010572 | 0.0023 | 49.8846 | 0.0792 | 2 | 4 | positive regulation of platelet activation |
| GO:0051122 | 0.0023 | 49.8846 | 0.0792 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060455 | 0.0023 | 49.8846 | 0.0792 | 2 | 4 | negative regulation of gastric acid secretion |
| GO:0072593 | 0.0025 | 2.9017 | 4.0387 | 11 | 204 | reactive oxygen species metabolic process |
| GO:0018958 | 0.0026 | 4.7271 | 1.3858 | 6 | 70 | phenol-containing compound metabolic process |
| GO:0003158 | 0.0026 | 4.0656 | 1.861 | 7 | 94 | endothelium development |
| GO:0043537 | 0.0027 | 7.7197 | 0.5939 | 4 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0010612 | 0.0029 | 12.5097 | 0.297 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0019372 | 0.0029 | 12.5097 | 0.297 | 3 | 15 | lipoxygenase pathway |
| GO:0048568 | 0.003 | 2.3116 | 7.3449 | 16 | 371 | embryonic organ development |
| GO:0048839 | 0.0034 | 3.169 | 3.029 | 9 | 153 | inner ear development |
| GO:0006629 | 0.0035 | 1.7221 | 21.797 | 35 | 1101 | lipid metabolic process |
| GO:0010757 | 0.0038 | 33.2538 | 0.099 | 2 | 5 | negative regulation of plasminogen activation |
| GO:0034112 | 0.0038 | 33.2538 | 0.099 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0060023 | 0.0038 | 33.2538 | 0.099 | 2 | 5 | soft palate development |
| GO:0050878 | 0.0041 | 2.2339 | 7.5824 | 16 | 383 | regulation of body fluid levels |
| GO:0042445 | 0.0041 | 3.3451 | 2.5539 | 8 | 129 | hormone metabolic process |
| GO:0045606 | 0.0042 | 10.7209 | 0.3366 | 3 | 17 | positive regulation of epidermal cell differentiation |
| GO:0002700 | 0.0047 | 4.1414 | 1.564 | 6 | 79 | regulation of production of molecular mediator of immune response |
| GO:0006575 | 0.0047 | 3.2634 | 2.6133 | 8 | 132 | cellular modified amino acid metabolic process |
| GO:0051270 | 0.005 | 1.8722 | 13.6009 | 24 | 687 | regulation of cellular component movement |
| GO:0046394 | 0.0055 | 2.4729 | 5.1276 | 12 | 259 | carboxylic acid biosynthetic process |
| GO:0055114 | 0.0055 | 1.8081 | 15.2639 | 26 | 771 | oxidation-reduction process |
| GO:0002291 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0006681 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | galactosylceramide metabolic process |
| GO:0015917 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | aminophospholipid transport |
| GO:0019062 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | virion attachment to host cell |
| GO:0021603 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | cranial nerve formation |
| GO:0060017 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | parathyroid gland development |
| GO:0060836 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | lymphatic endothelial cell differentiation |
| GO:0030334 | 0.0058 | 1.9313 | 11.5023 | 21 | 581 | regulation of cell migration |
| GO:0090103 | 0.0059 | 9.3793 | 0.3762 | 3 | 19 | cochlea morphogenesis |
| GO:0050829 | 0.0059 | 6.0789 | 0.7325 | 4 | 37 | defense response to Gram-negative bacterium |
| GO:0010594 | 0.0065 | 3.3965 | 2.1975 | 7 | 111 | regulation of endothelial cell migration |
| GO:0055067 | 0.0065 | 3.3965 | 2.1975 | 7 | 111 | monovalent inorganic cation homeostasis |
| GO:0050793 | 0.0068 | 1.5027 | 38.9021 | 54 | 1965 | regulation of developmental process |
| GO:0030193 | 0.0071 | 4.4872 | 1.2076 | 5 | 61 | regulation of blood coagulation |
| GO:0001955 | 0.0077 | 19.9492 | 0.1386 | 2 | 7 | blood vessel maturation |
| GO:0001975 | 0.0078 | 8.3359 | 0.4157 | 3 | 21 | response to amphetamine |
| GO:0060055 | 0.0078 | 8.3359 | 0.4157 | 3 | 21 | angiogenesis involved in wound healing |
| GO:0009617 | 0.0083 | 2.1761 | 6.7707 | 14 | 342 | response to bacterium |
| GO:0008589 | 0.0086 | 4.2581 | 1.267 | 5 | 64 | regulation of smoothened signaling pathway |
| GO:0006691 | 0.0089 | 7.8966 | 0.4355 | 3 | 22 | leukotriene metabolic process |
| GO:0042554 | 0.0089 | 7.8966 | 0.4355 | 3 | 22 | superoxide anion generation |
| GO:0040017 | 0.009 | 2.0917 | 7.5428 | 15 | 381 | positive regulation of locomotion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0044057 | 0.0013 | 3.0176 | 4.3059 | 12 | 419 | regulation of system process |
| GO:0006936 | 0.002 | 3.4584 | 2.7952 | 9 | 272 | muscle contraction |
| GO:0010533 | 0.0021 | 39.0836 | 0.0719 | 2 | 7 | regulation of activation of Janus kinase activity |
| GO:0043697 | 0.0021 | 39.0836 | 0.0719 | 2 | 7 | cell dedifferentiation |
| GO:1900239 | 0.0028 | 32.5672 | 0.0822 | 2 | 8 | regulation of phenotypic switching |
| GO:0072677 | 0.0036 | 27.9126 | 0.0925 | 2 | 9 | eosinophil migration |
| GO:0010657 | 0.004 | 6.697 | 0.6474 | 4 | 63 | muscle cell apoptotic process |
| GO:1904892 | 0.0047 | 4.9116 | 1.0893 | 5 | 106 | regulation of STAT cascade |
| GO:0034433 | 0.0054 | 21.7065 | 0.113 | 2 | 11 | steroid esterification |
| GO:0034435 | 0.0054 | 21.7065 | 0.113 | 2 | 11 | cholesterol esterification |
| GO:0050729 | 0.0064 | 5.8066 | 0.7399 | 4 | 72 | positive regulation of inflammatory response |
| GO:2000846 | 0.0065 | 19.5343 | 0.1233 | 2 | 12 | regulation of corticosteroid hormone secretion |
| GO:0090288 | 0.0066 | 4.5066 | 1.1818 | 5 | 115 | negative regulation of cellular response to growth factor stimulus |
| GO:0001974 | 0.0069 | 8.4187 | 0.3905 | 3 | 38 | blood vessel remodeling |
| GO:0042692 | 0.007 | 2.8207 | 3.3913 | 9 | 330 | muscle cell differentiation |
| GO:0007200 | 0.007 | 5.6398 | 0.7605 | 4 | 74 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0002028 | 0.0074 | 5.56 | 0.7707 | 4 | 75 | regulation of sodium ion transport |
| GO:0010665 | 0.0079 | 7.9624 | 0.4111 | 3 | 40 | regulation of cardiac muscle cell apoptotic process |
| GO:0007186 | 0.0082 | 2.2747 | 6.1185 | 13 | 610 | G-protein coupled receptor signaling pathway |
| GO:0048771 | 0.0083 | 5.3697 | 0.7962 | 4 | 79 | tissue remodeling |
| GO:0048145 | 0.0085 | 5.3333 | 0.8016 | 4 | 78 | regulation of fibroblast proliferation |
| GO:0019932 | 0.0086 | 3.206 | 2.3122 | 7 | 225 | second-messenger-mediated signaling |
| GO:0007259 | 0.009 | 4.1629 | 1.2743 | 5 | 124 | JAK-STAT cascade |
| GO:0055002 | 0.009 | 4.1629 | 1.2743 | 5 | 124 | striated muscle cell development |
| GO:0060986 | 0.0091 | 7.5529 | 0.4316 | 3 | 42 | endocrine hormone secretion |
| GO:2000677 | 0.0091 | 7.5529 | 0.4316 | 3 | 42 | regulation of transcription regulatory region DNA binding |
| GO:0007166 | 0.0096 | 1.6666 | 22.0432 | 33 | 2145 | cell surface receptor signaling pathway |
| GO:0043392 | 0.0097 | 7.3635 | 0.4419 | 3 | 43 | negative regulation of DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048646 | 0 | 2.5314 | 14.6096 | 33 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0001944 | 1e-04 | 2.6274 | 9.131 | 22 | 530 | vasculature development |
| GO:0072359 | 1e-04 | 2.2904 | 13.9033 | 29 | 807 | circulatory system development |
| GO:1905205 | 3e-04 | 34.6693 | 0.1378 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0040012 | 3e-04 | 2.3185 | 11.7325 | 25 | 681 | regulation of locomotion |
| GO:0051270 | 3e-04 | 2.2964 | 11.8359 | 25 | 687 | regulation of cellular component movement |
| GO:0002696 | 3e-04 | 3.5215 | 3.6869 | 12 | 214 | positive regulation of leukocyte activation |
| GO:1903244 | 4e-04 | 28.8889 | 0.1551 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0006954 | 4e-04 | 2.5721 | 7.9767 | 19 | 463 | inflammatory response |
| GO:0030334 | 5e-04 | 2.378 | 10.0097 | 22 | 581 | regulation of cell migration |
| GO:0061756 | 6e-04 | 12.2058 | 0.3963 | 4 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0048856 | 7e-04 | 1.5652 | 76.4495 | 100 | 4475 | anatomical structure development |
| GO:0051674 | 7e-04 | 1.9245 | 19.8987 | 35 | 1155 | localization of cell |
| GO:0014744 | 8e-04 | 21.6633 | 0.1895 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0050870 | 9e-04 | 3.889 | 2.4981 | 9 | 145 | positive regulation of T cell activation |
| GO:0022409 | 0.0012 | 3.443 | 3.1183 | 10 | 181 | positive regulation of cell-cell adhesion |
| GO:0050671 | 0.0012 | 4.7034 | 1.6195 | 7 | 94 | positive regulation of lymphocyte proliferation |
| GO:0030168 | 0.0012 | 4.1123 | 2.1019 | 8 | 122 | platelet activation |
| GO:0032715 | 0.0013 | 9.6592 | 0.4824 | 4 | 28 | negative regulation of interleukin-6 production |
| GO:2000026 | 0.0014 | 1.7545 | 26.2732 | 42 | 1525 | regulation of multicellular organismal development |
| GO:0070665 | 0.0014 | 4.5456 | 1.6712 | 7 | 97 | positive regulation of leukocyte proliferation |
| GO:0043537 | 0.0017 | 8.9148 | 0.5169 | 4 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0002699 | 0.0017 | 3.9048 | 2.2052 | 8 | 128 | positive regulation of immune effector process |
| GO:0009972 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | cytidine deamination |
| GO:0046087 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | cytidine metabolic process |
| GO:0051122 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0070383 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | DNA cytosine deamination |
| GO:2000354 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | regulation of ovarian follicle development |
| GO:0046394 | 0.0018 | 2.8698 | 4.4621 | 12 | 259 | carboxylic acid biosynthetic process |
| GO:0010612 | 0.002 | 14.4378 | 0.2584 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0002708 | 0.0025 | 5.8099 | 0.9476 | 5 | 55 | positive regulation of lymphocyte mediated immunity |
| GO:2000181 | 0.0027 | 4.6598 | 1.3955 | 6 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0060023 | 0.0029 | 38.3569 | 0.0861 | 2 | 5 | soft palate development |
| GO:0010633 | 0.0029 | 5.5855 | 0.982 | 5 | 57 | negative regulation of epithelial cell migration |
| GO:0090132 | 0.0029 | 3.0136 | 3.5318 | 10 | 205 | epithelium migration |
| GO:2000146 | 0.0031 | 2.998 | 3.549 | 10 | 206 | negative regulation of cell motility |
| GO:0010594 | 0.0031 | 3.9294 | 1.9123 | 7 | 111 | regulation of endothelial cell migration |
| GO:0009611 | 0.0031 | 2.1848 | 8.7692 | 18 | 509 | response to wounding |
| GO:0048514 | 0.0032 | 2.4555 | 6.0593 | 14 | 359 | blood vessel morphogenesis |
| GO:0032101 | 0.0032 | 2.1801 | 8.7865 | 18 | 510 | regulation of response to external stimulus |
| GO:0045766 | 0.0032 | 3.8917 | 1.9296 | 7 | 112 | positive regulation of angiogenesis |
| GO:0032720 | 0.0033 | 7.24 | 0.6202 | 4 | 36 | negative regulation of tumor necrosis factor production |
| GO:0001667 | 0.0033 | 2.6506 | 4.8067 | 12 | 279 | ameboidal-type cell migration |
| GO:0016486 | 0.0034 | 11.5476 | 0.3101 | 3 | 18 | peptide hormone processing |
| GO:0002687 | 0.0037 | 4.3669 | 1.4816 | 6 | 86 | positive regulation of leukocyte migration |
| GO:0045765 | 0.0041 | 4.2581 | 1.5158 | 6 | 90 | regulation of angiogenesis |
| GO:0002291 | 0.0042 | 28.7655 | 0.1034 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0045869 | 0.0042 | 28.7655 | 0.1034 | 2 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 0.0042 | 28.7655 | 0.1034 | 2 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:2000242 | 0.0044 | 6.6179 | 0.6719 | 4 | 39 | negative regulation of reproductive process |
| GO:0006629 | 0.0044 | 1.7554 | 18.9684 | 31 | 1101 | lipid metabolic process |
| GO:0002440 | 0.0045 | 3.6465 | 2.0502 | 7 | 119 | production of molecular mediator of immune response |
| GO:0002230 | 0.0046 | 10.1875 | 0.3446 | 3 | 20 | positive regulation of defense response to virus by host |
| GO:0051094 | 0.0047 | 1.7804 | 17.4523 | 29 | 1013 | positive regulation of developmental process |
| GO:0051249 | 0.0052 | 2.4976 | 5.0824 | 12 | 295 | regulation of lymphocyte activation |
| GO:0042475 | 0.0052 | 4.8378 | 1.1198 | 5 | 65 | odontogenesis of dentin-containing tooth |
| GO:0032496 | 0.0053 | 2.7551 | 3.8419 | 10 | 223 | response to lipopolysaccharide |
| GO:0042104 | 0.0053 | 9.6207 | 0.3618 | 3 | 21 | positive regulation of activated T cell proliferation |
| GO:0060055 | 0.0053 | 9.6207 | 0.3618 | 3 | 21 | angiogenesis involved in wound healing |
| GO:0050865 | 0.0054 | 2.2981 | 6.4434 | 14 | 374 | regulation of cell activation |
| GO:0002263 | 0.0056 | 2.1025 | 8.5625 | 17 | 497 | cell activation involved in immune response |
| GO:0042098 | 0.0056 | 3.4893 | 2.1363 | 7 | 124 | T cell proliferation |
| GO:0003158 | 0.0057 | 3.9674 | 1.6195 | 6 | 94 | endothelium development |
| GO:0001955 | 0.0059 | 23.0106 | 0.1206 | 2 | 7 | blood vessel maturation |
| GO:0006691 | 0.0061 | 9.1137 | 0.379 | 3 | 22 | leukotriene metabolic process |
| GO:0002718 | 0.0063 | 5.9373 | 0.7408 | 4 | 43 | regulation of cytokine production involved in immune response |
| GO:0009164 | 0.0069 | 8.6573 | 0.3963 | 3 | 23 | nucleoside catabolic process |
| GO:1903671 | 0.0069 | 8.6573 | 0.3963 | 3 | 23 | negative regulation of sprouting angiogenesis |
| GO:0002285 | 0.0073 | 3.7527 | 1.7056 | 6 | 99 | lymphocyte activation involved in immune response |
| GO:2001238 | 0.0074 | 5.6468 | 0.7753 | 4 | 45 | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0008283 | 0.0076 | 1.5876 | 27.1691 | 40 | 1577 | cell proliferation |
| GO:0000038 | 0.0078 | 8.2444 | 0.4135 | 3 | 24 | very long-chain fatty acid metabolic process |
| GO:0019221 | 0.0079 | 2.0724 | 8.149 | 16 | 473 | cytokine-mediated signaling pathway |
| GO:1903037 | 0.0085 | 2.5594 | 4.1176 | 10 | 239 | regulation of leukocyte cell-cell adhesion |
| GO:0003299 | 0.0088 | 7.8691 | 0.4307 | 3 | 25 | muscle hypertrophy in response to stress |
| GO:0006955 | 0.0093 | 1.798 | 13.6006 | 23 | 821 | immune response |
| GO:0032501 | 0.0096 | 1.3807 | 93.1709 | 111 | 5408 | multicellular organismal process |
| GO:0016264 | 0.0098 | 16.4336 | 0.1551 | 2 | 9 | gap junction assembly |
| GO:0016553 | 0.0098 | 16.4336 | 0.1551 | 2 | 9 | base conversion or substitution editing |
| GO:0061045 | 0.0099 | 5.1433 | 0.8442 | 4 | 49 | negative regulation of wound healing |
| GO:0034754 | 0.01 | 4.0848 | 1.3094 | 5 | 76 | cellular hormone metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030948 | 1e-04 | 63.2516 | 0.0836 | 3 | 7 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0048514 | 8e-04 | 2.887 | 5.2531 | 14 | 440 | blood vessel morphogenesis |
| GO:0035021 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of Rac protein signal transduction |
| GO:1900747 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of vascular endothelial growth factor signaling pathway |
| GO:0051240 | 0.001 | 2.0798 | 14.3984 | 27 | 1206 | positive regulation of multicellular organismal process |
| GO:0048646 | 0.0011 | 2.2704 | 10.1242 | 21 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0044030 | 0.0016 | 14.8679 | 0.2388 | 3 | 20 | regulation of DNA methylation |
| GO:0048870 | 0.0025 | 1.9872 | 13.7895 | 25 | 1155 | cell motility |
| GO:0016525 | 0.0027 | 5.6649 | 0.9551 | 5 | 80 | negative regulation of angiogenesis |
| GO:0010533 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | regulation of activation of Janus kinase activity |
| GO:0043697 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | cell dedifferentiation |
| GO:0023052 | 0.0029 | 1.5815 | 56.7339 | 74 | 4752 | signaling |
| GO:0060285 | 0.0032 | 11.4845 | 0.2985 | 3 | 25 | cilium-dependent cell motility |
| GO:0022603 | 0.0032 | 2.1519 | 9.5512 | 19 | 800 | regulation of anatomical structure morphogenesis |
| GO:1901343 | 0.0036 | 5.2429 | 1.0267 | 5 | 86 | negative regulation of vasculature development |
| GO:0055002 | 0.0037 | 4.3347 | 1.4804 | 6 | 124 | striated muscle cell development |
| GO:1900239 | 0.0038 | 27.9274 | 0.0955 | 2 | 8 | regulation of phenotypic switching |
| GO:0010719 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of epithelial to mesenchymal transition |
| GO:0048147 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of fibroblast proliferation |
| GO:1901890 | 0.0044 | 10.104 | 0.3343 | 3 | 28 | positive regulation of cell junction assembly |
| GO:0051094 | 0.0045 | 1.9727 | 12.0942 | 22 | 1013 | positive regulation of developmental process |
| GO:0060099 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | regulation of phagocytosis, engulfment |
| GO:0072677 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | eosinophil migration |
| GO:1903726 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | negative regulation of phospholipid metabolic process |
| GO:0072358 | 0.0049 | 2.3429 | 6.3873 | 14 | 535 | cardiovascular system development |
| GO:0032964 | 0.0054 | 9.3541 | 0.3582 | 3 | 30 | collagen biosynthetic process |
| GO:1901342 | 0.0055 | 3.9774 | 1.6059 | 6 | 138 | regulation of vasculature development |
| GO:0050896 | 0.0057 | 1.5239 | 76.7077 | 93 | 6425 | response to stimulus |
| GO:0048266 | 0.006 | 20.9423 | 0.1194 | 2 | 10 | behavioral response to pain |
| GO:0007166 | 0.0067 | 1.6486 | 25.609 | 38 | 2145 | cell surface receptor signaling pathway |
| GO:0010657 | 0.0067 | 5.7306 | 0.7522 | 4 | 63 | muscle cell apoptotic process |
| GO:0051101 | 0.0069 | 4.4654 | 1.1939 | 5 | 100 | regulation of DNA binding |
| GO:0034433 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | steroid esterification |
| GO:0034435 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | cholesterol esterification |
| GO:1902547 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:0007266 | 0.0074 | 3.7281 | 1.7073 | 6 | 143 | Rho protein signal transduction |
| GO:0007154 | 0.0082 | 1.4935 | 56.9368 | 72 | 4769 | cell communication |
| GO:1904892 | 0.0088 | 4.1982 | 1.2655 | 5 | 106 | regulation of STAT cascade |
| GO:0070372 | 0.0089 | 3.178 | 2.3281 | 7 | 195 | regulation of ERK1 and ERK2 cascade |
| GO:0008360 | 0.0091 | 4.1567 | 1.2775 | 5 | 107 | regulation of cell shape |
| GO:0046456 | 0.0096 | 7.4243 | 0.4417 | 3 | 37 | icosanoid biosynthetic process |
| GO:0048856 | 0.0097 | 1.4837 | 53.4865 | 68 | 4480 | anatomical structure development |
| GO:0009968 | 0.0099 | 1.8828 | 11.4126 | 20 | 980 | negative regulation of signal transduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006952 | 0 | 3.5719 | 6.4626 | 19 | 1043 | defense response |
| GO:0050911 | 0 | 17.3642 | 0.3346 | 5 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0051606 | 1e-04 | 6.4441 | 1.3941 | 8 | 225 | detection of stimulus |
| GO:0006955 | 2e-04 | 3.4864 | 4.7054 | 14 | 821 | immune response |
| GO:0007600 | 4e-04 | 4.07 | 2.7511 | 10 | 444 | sensory perception |
| GO:0002764 | 5e-04 | 4.3559 | 2.2988 | 9 | 371 | immune response-regulating signaling pathway |
| GO:0002684 | 0.001 | 3.1688 | 4.2568 | 12 | 687 | positive regulation of immune system process |
| GO:0050908 | 0.0013 | 46.9464 | 0.0558 | 2 | 9 | detection of light stimulus involved in visual perception |
| GO:0043303 | 0.0015 | 14.6515 | 0.2293 | 3 | 37 | mast cell degranulation |
| GO:0050829 | 0.0015 | 14.6515 | 0.2293 | 3 | 37 | defense response to Gram-negative bacterium |
| GO:0002758 | 0.002 | 4.9614 | 1.3136 | 6 | 212 | innate immune response-activating signal transduction |
| GO:0003008 | 0.0021 | 2.4427 | 7.9869 | 17 | 1289 | system process |
| GO:0042742 | 0.0021 | 8.0819 | 0.5388 | 4 | 90 | defense response to bacterium |
| GO:0007166 | 0.0021 | 2.1521 | 13.2908 | 24 | 2145 | cell surface receptor signaling pathway |
| GO:0045576 | 0.0022 | 12.7683 | 0.2602 | 3 | 42 | mast cell activation |
| GO:0051707 | 0.0023 | 3.1823 | 3.4699 | 10 | 560 | response to other organism |
| GO:0002253 | 0.0029 | 3.6043 | 2.4227 | 8 | 391 | activation of immune response |
| GO:0001580 | 0.0033 | 27.375 | 0.0867 | 2 | 14 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0046597 | 0.0033 | 27.375 | 0.0867 | 2 | 14 | negative regulation of viral entry into host cell |
| GO:0002223 | 0.0034 | 6.9744 | 0.6196 | 4 | 100 | stimulatory C-type lectin receptor signaling pathway |
| GO:0002263 | 0.0036 | 3.1994 | 3.0795 | 9 | 497 | cell activation involved in immune response |
| GO:0002275 | 0.0037 | 3.4554 | 2.5218 | 8 | 407 | myeloid cell activation involved in immune response |
| GO:0034341 | 0.0037 | 6.831 | 0.632 | 4 | 102 | response to interferon-gamma |
| GO:0009607 | 0.0037 | 2.973 | 3.6991 | 10 | 597 | response to biotic stimulus |
| GO:0002444 | 0.0039 | 3.4113 | 2.5528 | 8 | 412 | myeloid leukocyte mediated immunity |
| GO:0002429 | 0.0041 | 4.2655 | 1.5181 | 6 | 245 | immune response-activating cell surface receptor signaling pathway |
| GO:0035455 | 0.0043 | 23.4607 | 0.0991 | 2 | 16 | response to interferon-alpha |
| GO:0042346 | 0.0049 | 21.895 | 0.1053 | 2 | 17 | positive regulation of NF-kappaB import into nucleus |
| GO:0046835 | 0.0049 | 21.895 | 0.1053 | 2 | 17 | carbohydrate phosphorylation |
| GO:0045089 | 0.0052 | 4.0578 | 1.5924 | 6 | 257 | positive regulation of innate immune response |
| GO:0002694 | 0.0054 | 3.5492 | 2.1315 | 7 | 344 | regulation of leukocyte activation |
| GO:0023052 | 0.006 | 1.7918 | 29.4442 | 41 | 4752 | signaling |
| GO:0031069 | 0.0061 | 19.3162 | 0.1177 | 2 | 19 | hair follicle morphogenesis |
| GO:0043462 | 0.0061 | 8.7242 | 0.3718 | 3 | 60 | regulation of ATPase activity |
| GO:0003365 | 0.0062 | Inf | 0.0062 | 1 | 1 | establishment of cell polarity involved in ameboidal cell migration |
| GO:0035038 | 0.0062 | Inf | 0.0062 | 1 | 1 | female pronucleus assembly |
| GO:0035039 | 0.0062 | Inf | 0.0062 | 1 | 1 | male pronucleus assembly |
| GO:0035499 | 0.0062 | Inf | 0.0062 | 1 | 1 | carnosine biosynthetic process |
| GO:0045356 | 0.0062 | Inf | 0.0062 | 1 | 1 | positive regulation of interferon-alpha biosynthetic process |
| GO:0050677 | 0.0062 | Inf | 0.0062 | 1 | 1 | positive regulation of urothelial cell proliferation |
| GO:0060436 | 0.0062 | Inf | 0.0062 | 1 | 1 | bronchiole morphogenesis |
| GO:0060496 | 0.0062 | Inf | 0.0062 | 1 | 1 | mesenchymal-epithelial cell signaling involved in lung development |
| GO:0060879 | 0.0062 | Inf | 0.0062 | 1 | 1 | semicircular canal fusion |
| GO:0061033 | 0.0062 | Inf | 0.0062 | 1 | 1 | secretion by lung epithelial cell involved in lung growth |
| GO:0061115 | 0.0062 | Inf | 0.0062 | 1 | 1 | lung proximal/distal axis specification |
| GO:0070075 | 0.0062 | Inf | 0.0062 | 1 | 1 | tear secretion |
| GO:0070488 | 0.0062 | Inf | 0.0062 | 1 | 1 | neutrophil aggregation |
| GO:1900131 | 0.0062 | Inf | 0.0062 | 1 | 1 | negative regulation of lipid binding |
| GO:1990134 | 0.0062 | Inf | 0.0062 | 1 | 1 | epithelial cell apoptotic process involved in palatal shelf morphogenesis |
| GO:0050907 | 0.0066 | 18.3635 | 0.1227 | 2 | 21 | detection of chemical stimulus involved in sensory perception |
| GO:0060333 | 0.0067 | 8.4272 | 0.3842 | 3 | 62 | interferon-gamma-mediated signaling pathway |
| GO:0007141 | 0.0067 | 18.2417 | 0.1239 | 2 | 20 | male meiosis I |
| GO:0051716 | 0.007 | 1.7675 | 33.4964 | 45 | 5406 | cellular response to stimulus |
| GO:0052548 | 0.0071 | 3.781 | 1.7039 | 6 | 275 | regulation of endopeptidase activity |
| GO:0042475 | 0.0076 | 8.0176 | 0.4028 | 3 | 65 | odontogenesis of dentin-containing tooth |
| GO:0070268 | 0.0076 | 8.0176 | 0.4028 | 3 | 65 | cornification |
| GO:0009913 | 0.0077 | 4.3601 | 1.2268 | 5 | 198 | epidermal cell differentiation |
| GO:0001556 | 0.0081 | 16.415 | 0.1363 | 2 | 22 | oocyte maturation |
| GO:0045321 | 0.0093 | 2.9348 | 2.9616 | 8 | 509 | leukocyte activation |
| GO:0051346 | 0.0096 | 3.5389 | 1.8155 | 6 | 293 | negative regulation of hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903796 | 3e-04 | Inf | 0.0358 | 2 | 2 | negative regulation of inorganic anion transmembrane transport |
| GO:2000404 | 7e-04 | 11.7262 | 0.4119 | 4 | 23 | regulation of T cell migration |
| GO:0016051 | 7e-04 | 3.6981 | 2.9191 | 10 | 163 | carbohydrate biosynthetic process |
| GO:0010836 | 9e-04 | 110.6043 | 0.0537 | 2 | 3 | negative regulation of protein ADP-ribosylation |
| GO:0072679 | 9e-04 | 110.6043 | 0.0537 | 2 | 3 | thymocyte migration |
| GO:0048565 | 0.0011 | 4.2085 | 2.0595 | 8 | 115 | digestive tract development |
| GO:0072111 | 0.0018 | 15.1352 | 0.2507 | 3 | 14 | cell proliferation involved in kidney development |
| GO:0070221 | 0.0019 | 55.2979 | 0.0716 | 2 | 4 | sulfide oxidation, using sulfide:quinone oxidoreductase |
| GO:0035264 | 0.0021 | 3.7488 | 2.2923 | 8 | 128 | multicellular organism growth |
| GO:0048535 | 0.0022 | 13.8729 | 0.2686 | 3 | 15 | lymph node development |
| GO:0072676 | 0.0023 | 5.9382 | 0.9312 | 5 | 52 | lymphocyte migration |
| GO:0033692 | 0.0025 | 5.814 | 0.9491 | 5 | 53 | cellular polysaccharide biosynthetic process |
| GO:0019233 | 0.0025 | 4.7287 | 1.3789 | 6 | 77 | sensory perception of pain |
| GO:0007214 | 0.0027 | 12.8047 | 0.2865 | 3 | 16 | gamma-aminobutyric acid signaling pathway |
| GO:0008210 | 0.0027 | 12.8047 | 0.2865 | 3 | 16 | estrogen metabolic process |
| GO:0048469 | 0.0028 | 3.5686 | 2.3997 | 8 | 134 | cell maturation |
| GO:0051351 | 0.0031 | 36.8624 | 0.0895 | 2 | 5 | positive regulation of ligase activity |
| GO:2001023 | 0.0031 | 36.8624 | 0.0895 | 2 | 5 | regulation of response to drug |
| GO:0001709 | 0.0034 | 7.1804 | 0.6268 | 4 | 35 | cell fate determination |
| GO:0045685 | 0.0037 | 5.2635 | 1.0387 | 5 | 58 | regulation of glial cell differentiation |
| GO:0050832 | 0.0044 | 10.4014 | 0.3403 | 3 | 19 | defense response to fungus |
| GO:0061621 | 0.0044 | 10.4014 | 0.3403 | 3 | 19 | canonical glycolysis |
| GO:0050882 | 0.0046 | 27.6447 | 0.1075 | 2 | 6 | voluntary musculoskeletal movement |
| GO:0061615 | 0.0052 | 9.7888 | 0.3582 | 3 | 20 | glycolytic process through fructose-6-phosphate |
| GO:0009581 | 0.0052 | 4.0413 | 1.5938 | 6 | 89 | detection of external stimulus |
| GO:0005978 | 0.0055 | 6.1807 | 0.7163 | 4 | 40 | glycogen biosynthetic process |
| GO:0006749 | 0.0055 | 6.1807 | 0.7163 | 4 | 40 | glutathione metabolic process |
| GO:0055114 | 0.0059 | 1.8478 | 13.8074 | 24 | 771 | oxidation-reduction process |
| GO:0009582 | 0.0061 | 3.8994 | 1.6476 | 6 | 92 | detection of abiotic stimulus |
| GO:0002692 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | negative regulation of cellular extravasation |
| GO:0042756 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | drinking behavior |
| GO:0098711 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | iron ion import across plasma membrane |
| GO:2000510 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
| GO:0006007 | 0.0077 | 8.3186 | 0.4119 | 3 | 23 | glucose catabolic process |
| GO:0043552 | 0.0077 | 8.3186 | 0.4119 | 3 | 23 | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:1990403 | 0.0083 | 18.427 | 0.1433 | 2 | 8 | embryonic brain development |
| GO:0048870 | 0.0087 | 1.6505 | 20.6842 | 32 | 1155 | cell motility |
| GO:0051896 | 0.0091 | 2.8944 | 2.9191 | 8 | 163 | regulation of protein kinase B signaling |
| GO:0065004 | 0.0094 | 2.675 | 3.5459 | 9 | 198 | protein-DNA complex assembly |
| GO:0008038 | 0.0098 | 7.5612 | 0.4477 | 3 | 25 | neuron recognition |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 9.2421 | 1.2653 | 10 | 85 | embryonic skeletal system morphogenesis |
| GO:0032502 | 0 | 1.7913 | 71.4523 | 99 | 4800 | developmental process |
| GO:0022610 | 2e-04 | 2.219 | 15.526 | 31 | 1043 | biological adhesion |
| GO:1905205 | 2e-04 | 40.3052 | 0.1191 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0071469 | 2e-04 | Inf | 0.0298 | 2 | 2 | cellular response to alkaline pH |
| GO:2000404 | 3e-04 | 14.2002 | 0.3424 | 4 | 23 | regulation of T cell migration |
| GO:0009887 | 5e-04 | 2.2472 | 12.1618 | 25 | 817 | animal organ morphogenesis |
| GO:0043009 | 5e-04 | 2.6137 | 7.4578 | 18 | 501 | chordate embryonic development |
| GO:0001568 | 6e-04 | 2.5695 | 7.5769 | 18 | 509 | blood vessel development |
| GO:0021615 | 7e-04 | 133.7026 | 0.0447 | 2 | 3 | glossopharyngeal nerve morphogenesis |
| GO:0036159 | 8e-04 | 20.1448 | 0.1935 | 3 | 13 | inner dynein arm assembly |
| GO:0072358 | 0.0011 | 2.4352 | 7.964 | 18 | 535 | cardiovascular system development |
| GO:0016525 | 0.0012 | 5.5029 | 1.1909 | 6 | 80 | negative regulation of angiogenesis |
| GO:0031532 | 0.0012 | 5.5029 | 1.1909 | 6 | 80 | actin cytoskeleton reorganization |
| GO:0048598 | 0.0016 | 2.4081 | 7.5769 | 17 | 509 | embryonic morphogenesis |
| GO:0034103 | 0.0017 | 6.3797 | 0.8634 | 5 | 58 | regulation of tissue remodeling |
| GO:1901343 | 0.0018 | 5.0878 | 1.2802 | 6 | 86 | negative regulation of vasculature development |
| GO:0007275 | 0.002 | 1.5799 | 53.4844 | 72 | 3741 | multicellular organism development |
| GO:0044259 | 0.0021 | 4.9028 | 1.3248 | 6 | 89 | multicellular organismal macromolecule metabolic process |
| GO:0021546 | 0.0021 | 44.5607 | 0.0744 | 2 | 5 | rhombomere development |
| GO:0045617 | 0.0021 | 44.5607 | 0.0744 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:2000507 | 0.0021 | 44.5607 | 0.0744 | 2 | 5 | positive regulation of energy homeostasis |
| GO:0070098 | 0.0026 | 7.6992 | 0.5806 | 4 | 39 | chemokine-mediated signaling pathway |
| GO:0036336 | 0.0026 | 12.5847 | 0.2828 | 3 | 19 | dendritic cell migration |
| GO:0007156 | 0.0026 | 4.0336 | 1.8607 | 7 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0001525 | 0.0029 | 2.8407 | 4.1238 | 11 | 284 | angiogenesis |
| GO:0007389 | 0.0032 | 2.5535 | 5.4185 | 13 | 364 | pattern specification process |
| GO:0021902 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0060056 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | mammary gland involution |
| GO:1904995 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2000253 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | positive regulation of feeding behavior |
| GO:0001501 | 0.0033 | 2.4485 | 6.0883 | 14 | 409 | skeletal system development |
| GO:0050921 | 0.0036 | 4.3722 | 1.4737 | 6 | 99 | positive regulation of chemotaxis |
| GO:0031589 | 0.0037 | 2.9132 | 3.647 | 10 | 245 | cell-substrate adhesion |
| GO:0048568 | 0.0037 | 2.5022 | 5.5227 | 13 | 371 | embryonic organ development |
| GO:0006954 | 0.0039 | 2.316 | 6.8922 | 15 | 463 | inflammatory response |
| GO:0030198 | 0.004 | 2.8758 | 3.6917 | 10 | 248 | extracellular matrix organization |
| GO:0002688 | 0.0043 | 5.0412 | 1.0718 | 5 | 72 | regulation of leukocyte chemotaxis |
| GO:2000510 | 0.0044 | 26.7323 | 0.1042 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
| GO:0060561 | 0.0046 | 10.0647 | 0.3424 | 3 | 23 | apoptotic process involved in morphogenesis |
| GO:0032652 | 0.0048 | 6.4125 | 0.6848 | 4 | 46 | regulation of interleukin-1 production |
| GO:0009952 | 0.005 | 3.2229 | 2.6348 | 8 | 177 | anterior/posterior pattern specification |
| GO:0050707 | 0.005 | 4.064 | 1.5779 | 6 | 106 | regulation of cytokine secretion |
| GO:0098609 | 0.005 | 2.0844 | 9.1995 | 18 | 618 | cell-cell adhesion |
| GO:0048246 | 0.0052 | 9.5847 | 0.3573 | 3 | 24 | macrophage chemotaxis |
| GO:0060326 | 0.0054 | 3.1848 | 2.6646 | 8 | 179 | cell chemotaxis |
| GO:0030574 | 0.0056 | 6.1201 | 0.7145 | 4 | 48 | collagen catabolic process |
| GO:0001574 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | ganglioside biosynthetic process |
| GO:0040012 | 0.0063 | 1.9954 | 10.1373 | 19 | 681 | regulation of locomotion |
| GO:0042755 | 0.0066 | 8.7499 | 0.387 | 3 | 26 | eating behavior |
| GO:0072604 | 0.0066 | 8.7499 | 0.387 | 3 | 26 | interleukin-6 secretion |
| GO:0009888 | 0.0067 | 1.6694 | 22.0609 | 34 | 1482 | tissue development |
| GO:0048870 | 0.0069 | 1.7509 | 17.1932 | 28 | 1155 | cell motility |
| GO:0051270 | 0.0069 | 1.9765 | 10.2266 | 19 | 687 | regulation of cellular component movement |
| GO:0031644 | 0.0074 | 5.6084 | 0.7741 | 4 | 52 | regulation of neurological system process |
| GO:0032099 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | negative regulation of appetite |
| GO:1903244 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0001952 | 0.0079 | 4.3266 | 1.2355 | 5 | 83 | regulation of cell-matrix adhesion |
| GO:0048771 | 0.0082 | 5.4231 | 0.7975 | 4 | 55 | tissue remodeling |
| GO:0032094 | 0.0089 | 7.7385 | 0.4317 | 3 | 29 | response to food |
| GO:0048247 | 0.0089 | 7.7385 | 0.4317 | 3 | 29 | lymphocyte chemotaxis |
| GO:0002687 | 0.0091 | 4.1654 | 1.2802 | 5 | 86 | positive regulation of leukocyte migration |
| GO:0043537 | 0.0098 | 7.4513 | 0.4466 | 3 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0030155 | 0.01 | 2.0708 | 7.6514 | 15 | 514 | regulation of cell adhesion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032501 | 0 | 2.0207 | 63.3399 | 90 | 5408 | multicellular organismal process |
| GO:2001275 | 0 | 38.4695 | 0.1523 | 4 | 13 | positive regulation of glucose import in response to insulin stimulus |
| GO:0007156 | 0 | 6.8887 | 1.464 | 9 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0051046 | 0 | 3.244 | 6.5472 | 19 | 559 | regulation of secretion |
| GO:0098609 | 1e-04 | 2.9107 | 7.2382 | 19 | 618 | cell-cell adhesion |
| GO:0016339 | 1e-04 | 18.2084 | 0.2694 | 4 | 23 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:1902957 | 1e-04 | Inf | 0.0234 | 2 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:2000502 | 1e-04 | Inf | 0.0234 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0007154 | 3e-04 | 1.7646 | 55.8558 | 77 | 4769 | cell communication |
| GO:0007186 | 4e-04 | 2.608 | 8.0112 | 19 | 684 | G-protein coupled receptor signaling pathway |
| GO:1901856 | 4e-04 | 170.9542 | 0.0351 | 2 | 3 | negative regulation of cellular respiration |
| GO:0023052 | 5e-04 | 1.7288 | 55.6566 | 76 | 4752 | signaling |
| GO:1900076 | 5e-04 | 8.3506 | 0.6676 | 5 | 57 | regulation of cellular response to insulin stimulus |
| GO:0008643 | 7e-04 | 5.151 | 1.4757 | 7 | 126 | carbohydrate transport |
| GO:0032502 | 7e-04 | 1.7015 | 56.2188 | 76 | 4800 | developmental process |
| GO:0007198 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0023061 | 9e-04 | 3.1441 | 4.1227 | 12 | 352 | signal release |
| GO:0010828 | 0.0011 | 9.8725 | 0.4568 | 4 | 39 | positive regulation of glucose transport |
| GO:1903426 | 0.0012 | 6.8868 | 0.7964 | 5 | 68 | regulation of reactive oxygen species biosynthetic process |
| GO:1901701 | 0.0013 | 2.3014 | 9.4986 | 20 | 811 | cellular response to oxygen-containing compound |
| GO:0032890 | 0.0013 | 9.3374 | 0.4802 | 4 | 41 | regulation of organic acid transport |
| GO:0008645 | 0.0014 | 5.3339 | 1.2181 | 6 | 104 | hexose transport |
| GO:0031295 | 0.0019 | 8.4238 | 0.5271 | 4 | 45 | T cell costimulation |
| GO:0031340 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | positive regulation of vesicle fusion |
| GO:0090324 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | negative regulation of oxidative phosphorylation |
| GO:1905446 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | regulation of mitochondrial ATP synthesis coupled electron transport |
| GO:2000402 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | negative regulation of lymphocyte migration |
| GO:0007188 | 0.0022 | 4.8363 | 1.3352 | 6 | 114 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0030072 | 0.0023 | 3.6918 | 2.319 | 8 | 198 | peptide hormone secretion |
| GO:0042269 | 0.0023 | 12.8872 | 0.2694 | 3 | 23 | regulation of natural killer cell mediated cytotoxicity |
| GO:0032102 | 0.0025 | 3.6336 | 2.3542 | 8 | 201 | negative regulation of response to external stimulus |
| GO:0009914 | 0.0027 | 3.2977 | 2.9164 | 9 | 249 | hormone transport |
| GO:0007416 | 0.0029 | 4.5797 | 1.4055 | 6 | 120 | synapse assembly |
| GO:0050866 | 0.0029 | 4.5797 | 1.4055 | 6 | 120 | negative regulation of cell activation |
| GO:0046883 | 0.0029 | 3.5404 | 2.4127 | 8 | 206 | regulation of hormone secretion |
| GO:0003298 | 0.003 | 11.7138 | 0.2928 | 3 | 25 | physiological muscle hypertrophy |
| GO:0061049 | 0.003 | 11.7138 | 0.2928 | 3 | 25 | cell growth involved in cardiac muscle cell development |
| GO:0050830 | 0.0032 | 7.1915 | 0.609 | 4 | 52 | defense response to Gram-positive bacterium |
| GO:0007210 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | serotonin receptor signaling pathway |
| GO:0032000 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | positive regulation of fatty acid beta-oxidation |
| GO:0042535 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0046324 | 0.0039 | 6.7669 | 0.6442 | 4 | 55 | regulation of glucose import |
| GO:0001662 | 0.0046 | 9.9087 | 0.3397 | 3 | 29 | behavioral fear response |
| GO:0002689 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | negative regulation of leukocyte chemotaxis |
| GO:0002862 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | negative regulation of inflammatory response to antigenic stimulus |
| GO:0015780 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | nucleotide-sugar transport |
| GO:0046209 | 0.0047 | 6.3895 | 0.6793 | 4 | 58 | nitric oxide metabolic process |
| GO:0022610 | 0.005 | 1.9535 | 12.2159 | 22 | 1043 | biological adhesion |
| GO:0043270 | 0.0051 | 3.5492 | 2.0965 | 7 | 179 | positive regulation of ion transport |
| GO:0006968 | 0.0056 | 9.1995 | 0.3631 | 3 | 31 | cellular defense response |
| GO:0006837 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | serotonin transport |
| GO:0009642 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | response to light intensity |
| GO:0019896 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | axonal transport of mitochondrion |
| GO:0008284 | 0.0064 | 2.1386 | 8.0112 | 16 | 684 | positive regulation of cell proliferation |
| GO:0051952 | 0.0067 | 5.7479 | 0.7496 | 4 | 64 | regulation of amine transport |
| GO:0045725 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of glycogen biosynthetic process |
| GO:0009617 | 0.007 | 2.6479 | 4.0056 | 10 | 342 | response to bacterium |
| GO:0019217 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | regulation of fatty acid metabolic process |
| GO:0045429 | 0.0072 | 8.3073 | 0.3982 | 3 | 34 | positive regulation of nitric oxide biosynthetic process |
| GO:0033993 | 0.0073 | 2.1087 | 8.1166 | 16 | 693 | response to lipid |
| GO:0048731 | 0.0074 | 1.5379 | 42.7029 | 57 | 3646 | system development |
| GO:0001819 | 0.0075 | 2.7873 | 3.42 | 9 | 292 | positive regulation of cytokine production |
| GO:0051249 | 0.0079 | 2.7574 | 3.4551 | 9 | 295 | regulation of lymphocyte activation |
| GO:1901623 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | regulation of lymphocyte chemotaxis |
| GO:0002697 | 0.0084 | 2.9363 | 2.8812 | 8 | 246 | regulation of immune effector process |
| GO:0002683 | 0.0085 | 2.7281 | 3.4903 | 9 | 298 | negative regulation of immune system process |
| GO:0010676 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | positive regulation of cellular carbohydrate metabolic process |
| GO:0006836 | 0.0092 | 3.5425 | 1.792 | 6 | 153 | neurotransmitter transport |
| GO:1903039 | 0.0095 | 3.5183 | 1.8037 | 6 | 154 | positive regulation of leukocyte cell-cell adhesion |
| GO:0097006 | 0.0096 | 5.1446 | 0.8316 | 4 | 71 | regulation of plasma lipoprotein particle levels |
| GO:0014048 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | regulation of glutamate secretion |
| GO:0006865 | 0.0098 | 4.0796 | 1.3001 | 5 | 111 | amino acid transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008628 | 0.0013 | 67.1959 | 0.0592 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0045606 | 0.0019 | 14.4604 | 0.2518 | 3 | 17 | positive regulation of epidermal cell differentiation |
| GO:0072359 | 0.0019 | 2.078 | 11.9519 | 23 | 807 | circulatory system development |
| GO:0045682 | 0.0025 | 5.7587 | 0.9479 | 5 | 64 | regulation of epidermis development |
| GO:0046503 | 0.0026 | 7.7399 | 0.5776 | 4 | 39 | glycerolipid catabolic process |
| GO:0035360 | 0.0031 | 33.5928 | 0.0889 | 2 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0071472 | 0.0031 | 33.5928 | 0.0889 | 2 | 6 | cellular response to salt stress |
| GO:0032502 | 0.0033 | 1.5013 | 71.0896 | 90 | 4800 | developmental process |
| GO:0050729 | 0.0042 | 5.068 | 1.0663 | 5 | 72 | positive regulation of inflammatory response |
| GO:0010459 | 0.0044 | 26.8722 | 0.1037 | 2 | 7 | negative regulation of heart rate |
| GO:0061085 | 0.0044 | 26.8722 | 0.1037 | 2 | 7 | regulation of histone H3-K27 methylation |
| GO:0006954 | 0.0047 | 2.4331 | 5.674 | 13 | 391 | inflammatory response |
| GO:0017148 | 0.0049 | 2.6417 | 4.4135 | 11 | 298 | negative regulation of translation |
| GO:0048246 | 0.0051 | 9.6351 | 0.3554 | 3 | 24 | macrophage chemotaxis |
| GO:0016045 | 0.0058 | 22.3918 | 0.1185 | 2 | 8 | detection of bacterium |
| GO:1905205 | 0.0058 | 22.3918 | 0.1185 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:0050704 | 0.0058 | 9.1964 | 0.3703 | 3 | 25 | regulation of interleukin-1 secretion |
| GO:0048514 | 0.0059 | 2.2774 | 6.5165 | 14 | 440 | blood vessel morphogenesis |
| GO:0009888 | 0.0062 | 1.6799 | 21.9489 | 34 | 1482 | tissue development |
| GO:0045616 | 0.0072 | 8.4288 | 0.3999 | 3 | 27 | regulation of keratinocyte differentiation |
| GO:0045600 | 0.0073 | 5.638 | 0.7701 | 4 | 52 | positive regulation of fat cell differentiation |
| GO:0016264 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | gap junction assembly |
| GO:2000392 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | regulation of lamellipodium morphogenesis |
| GO:0048839 | 0.0077 | 3.2704 | 2.266 | 7 | 153 | inner ear development |
| GO:0050702 | 0.008 | 8.091 | 0.4147 | 3 | 28 | interleukin-1 beta secretion |
| GO:0007275 | 0.0081 | 1.4474 | 60.7964 | 77 | 4105 | multicellular organism development |
| GO:0032612 | 0.0083 | 5.4117 | 0.7998 | 4 | 54 | interleukin-1 production |
| GO:0010744 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | positive regulation of macrophage derived foam cell differentiation |
| GO:0010755 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | regulation of plasminogen activation |
| GO:0046541 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | saliva secretion |
| GO:0051770 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | positive regulation of nitric-oxide synthase biosynthetic process |
| GO:0048583 | 0.0098 | 1.4698 | 45.4677 | 60 | 3070 | regulation of response to stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046425 | 1e-04 | 6.8052 | 1.1374 | 7 | 106 | regulation of JAK-STAT cascade |
| GO:0031644 | 2e-04 | 10.1297 | 0.558 | 5 | 52 | regulation of neurological system process |
| GO:0098916 | 2e-04 | 3.1373 | 5.2577 | 15 | 490 | anterograde trans-synaptic signaling |
| GO:0099536 | 3e-04 | 3.1304 | 5.2684 | 15 | 491 | synaptic signaling |
| GO:0048704 | 3e-04 | 7.2671 | 0.912 | 6 | 85 | embryonic skeletal system morphogenesis |
| GO:0045987 | 3e-04 | 14.0258 | 0.3326 | 4 | 31 | positive regulation of smooth muscle contraction |
| GO:0097696 | 4e-04 | 5.7502 | 1.3305 | 7 | 124 | STAT cascade |
| GO:0007600 | 0.001 | 2.9604 | 4.7641 | 13 | 444 | sensory perception |
| GO:0033141 | 0.0011 | 62.3286 | 0.0536 | 2 | 5 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0003008 | 0.0012 | 2.0992 | 13.8309 | 26 | 1289 | system process |
| GO:0007204 | 0.0014 | 4.0325 | 2.1353 | 8 | 199 | positive regulation of cytosolic calcium ion concentration |
| GO:0014059 | 0.0018 | 14.1065 | 0.2468 | 3 | 23 | regulation of dopamine secretion |
| GO:0051930 | 0.0018 | 14.1065 | 0.2468 | 3 | 23 | regulation of sensory perception of pain |
| GO:0051281 | 0.0021 | 13.4337 | 0.2575 | 3 | 24 | positive regulation of release of sequestered calcium ion into cytosol |
| GO:2000252 | 0.0023 | 37.3914 | 0.0751 | 2 | 7 | negative regulation of feeding behavior |
| GO:0007187 | 0.0028 | 4.6139 | 1.3949 | 6 | 130 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0048534 | 0.0029 | 2.3433 | 7.3929 | 16 | 689 | hematopoietic or lymphoid organ development |
| GO:1901137 | 0.0029 | 2.4127 | 6.7169 | 15 | 626 | carbohydrate derivative biosynthetic process |
| GO:0032769 | 0.0031 | 31.1571 | 0.0858 | 2 | 8 | negative regulation of monooxygenase activity |
| GO:0006342 | 0.0039 | 5.1571 | 1.0408 | 5 | 97 | chromatin silencing |
| GO:0031115 | 0.0039 | 26.7041 | 0.0966 | 2 | 9 | negative regulation of microtubule polymerization |
| GO:0051239 | 0.0046 | 1.7164 | 24.3248 | 37 | 2267 | regulation of multicellular organismal process |
| GO:0007610 | 0.0048 | 2.5348 | 5.0645 | 12 | 472 | behavior |
| GO:0015872 | 0.0052 | 9.3971 | 0.3541 | 3 | 33 | dopamine transport |
| GO:0009100 | 0.0055 | 2.7499 | 3.8735 | 10 | 361 | glycoprotein metabolic process |
| GO:0051048 | 0.0057 | 3.9392 | 1.6202 | 6 | 151 | negative regulation of secretion |
| GO:0002323 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | natural killer cell activation involved in immune response |
| GO:0019934 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | cGMP-mediated signaling |
| GO:0031643 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | positive regulation of myelination |
| GO:0070493 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | thrombin-activated receptor signaling pathway |
| GO:0050804 | 0.0059 | 3.1306 | 2.7147 | 8 | 253 | modulation of chemical synaptic transmission |
| GO:2000010 | 0.007 | 18.6886 | 0.1288 | 2 | 12 | positive regulation of protein localization to cell surface |
| GO:0007218 | 0.0071 | 5.6349 | 0.7618 | 4 | 71 | neuropeptide signaling pathway |
| GO:0051928 | 0.0078 | 5.4707 | 0.7833 | 4 | 73 | positive regulation of calcium ion transport |
| GO:0001696 | 0.0083 | 16.9883 | 0.1395 | 2 | 13 | gastric acid secretion |
| GO:0098586 | 0.0083 | 7.8273 | 0.4185 | 3 | 39 | cellular response to virus |
| GO:0051607 | 0.009 | 3.5658 | 1.7812 | 6 | 166 | defense response to virus |
| GO:0002724 | 0.0096 | 15.5714 | 0.1502 | 2 | 14 | regulation of T cell cytokine production |
| GO:0035067 | 0.0096 | 15.5714 | 0.1502 | 2 | 14 | negative regulation of histone acetylation |
| GO:0039535 | 0.0096 | 15.5714 | 0.1502 | 2 | 14 | regulation of RIG-I signaling pathway |
| GO:0050432 | 0.0096 | 7.4142 | 0.4399 | 3 | 41 | catecholamine secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048731 | 0 | 2.0897 | 39.3969 | 63 | 3646 | system development |
| GO:0032502 | 1e-04 | 1.8983 | 51.8664 | 74 | 4800 | developmental process |
| GO:0030101 | 1e-04 | 11.8216 | 0.4862 | 5 | 45 | natural killer cell activation |
| GO:0007186 | 1e-04 | 2.8631 | 7.391 | 19 | 684 | G-protein coupled receptor signaling pathway |
| GO:0032501 | 3e-04 | 1.9553 | 39.5418 | 58 | 4101 | multicellular organismal process |
| GO:0055078 | 3e-04 | 13.9238 | 0.335 | 4 | 31 | sodium ion homeostasis |
| GO:0001906 | 3e-04 | 7.1228 | 0.9293 | 6 | 86 | cell killing |
| GO:0003014 | 3e-04 | 7.1228 | 0.9293 | 6 | 86 | renal system process |
| GO:0055075 | 4e-04 | 25.4805 | 0.1513 | 3 | 14 | potassium ion homeostasis |
| GO:0048534 | 4e-04 | 2.6654 | 7.445 | 18 | 689 | hematopoietic or lymphoid organ development |
| GO:0045596 | 5e-04 | 2.9087 | 5.6405 | 15 | 522 | negative regulation of cell differentiation |
| GO:0048640 | 6e-04 | 8.1416 | 0.6807 | 5 | 63 | negative regulation of developmental growth |
| GO:0008628 | 7e-04 | 92.8298 | 0.0432 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0097039 | 7e-04 | 92.8298 | 0.0432 | 2 | 4 | protein linear polyubiquitination |
| GO:0002449 | 9e-04 | 4.9397 | 1.5344 | 7 | 142 | lymphocyte mediated immunity |
| GO:0045981 | 9e-04 | 5.8065 | 1.1238 | 6 | 104 | positive regulation of nucleotide metabolic process |
| GO:0061117 | 0.0011 | 17.5112 | 0.2053 | 3 | 19 | negative regulation of heart growth |
| GO:0002521 | 0.0012 | 3.2325 | 3.6739 | 11 | 340 | leukocyte differentiation |
| GO:0034765 | 0.0014 | 3.1634 | 3.7495 | 11 | 347 | regulation of ion transmembrane transport |
| GO:0007204 | 0.0014 | 4.0023 | 2.1503 | 8 | 199 | positive regulation of cytosolic calcium ion concentration |
| GO:0042592 | 0.0015 | 2.0576 | 14.0688 | 26 | 1302 | homeostatic process |
| GO:0046620 | 0.0015 | 6.4612 | 0.8428 | 5 | 78 | regulation of organ growth |
| GO:0002250 | 0.0016 | 6.4224 | 0.8472 | 5 | 81 | adaptive immune response |
| GO:0014741 | 0.0016 | 14.7429 | 0.2377 | 3 | 22 | negative regulation of muscle hypertrophy |
| GO:0001775 | 0.0017 | 2.2048 | 10.4705 | 21 | 969 | cell activation |
| GO:0051340 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | regulation of ligase activity |
| GO:0060297 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | regulation of sarcomere organization |
| GO:0060373 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | regulation of ventricular cardiac muscle cell membrane depolarization |
| GO:0061052 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | negative regulation of cell growth involved in cardiac muscle cell development |
| GO:0007155 | 0.0017 | 2.1586 | 11.2269 | 22 | 1039 | cell adhesion |
| GO:0050776 | 0.0018 | 2.4754 | 7.0236 | 16 | 650 | regulation of immune response |
| GO:0019933 | 0.0019 | 6.1237 | 0.8861 | 5 | 82 | cAMP-mediated signaling |
| GO:0010562 | 0.0021 | 2.2462 | 9.2387 | 19 | 855 | positive regulation of phosphorus metabolic process |
| GO:0007585 | 0.0022 | 7.9865 | 0.5511 | 4 | 51 | respiratory gaseous exchange |
| GO:0007159 | 0.0023 | 3.3809 | 2.8527 | 9 | 264 | leukocyte cell-cell adhesion |
| GO:0023035 | 0.0023 | 37.1234 | 0.0756 | 2 | 7 | CD40 signaling pathway |
| GO:0045188 | 0.0023 | 37.1234 | 0.0756 | 2 | 7 | regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0009566 | 0.0024 | 4.7339 | 1.3615 | 6 | 126 | fertilization |
| GO:0044703 | 0.0026 | 2.3046 | 8.0069 | 17 | 741 | multi-organism reproductive process |
| GO:0071417 | 0.0027 | 2.7433 | 4.7004 | 12 | 435 | cellular response to organonitrogen compound |
| GO:0000003 | 0.0028 | 2.0679 | 11.6699 | 22 | 1080 | reproduction |
| GO:0055082 | 0.0028 | 2.5079 | 6.0187 | 14 | 557 | cellular chemical homeostasis |
| GO:0050878 | 0.0029 | 2.8492 | 4.1385 | 11 | 383 | regulation of body fluid levels |
| GO:0072507 | 0.003 | 3.0201 | 3.5442 | 10 | 328 | divalent inorganic cation homeostasis |
| GO:0050863 | 0.003 | 3.5322 | 2.4204 | 8 | 224 | regulation of T cell activation |
| GO:0030003 | 0.003 | 2.6972 | 4.776 | 12 | 442 | cellular cation homeostasis |
| GO:0019932 | 0.0031 | 3.5157 | 2.4312 | 8 | 225 | second-messenger-mediated signaling |
| GO:0050852 | 0.0031 | 4.5064 | 1.4263 | 6 | 132 | T cell receptor signaling pathway |
| GO:0098655 | 0.0032 | 2.3854 | 6.7859 | 15 | 628 | cation transmembrane transport |
| GO:0097553 | 0.0033 | 5.3537 | 1.0049 | 5 | 93 | calcium ion transmembrane import into cytosol |
| GO:0002460 | 0.0034 | 4.4006 | 1.4587 | 6 | 135 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0002253 | 0.0034 | 2.7875 | 4.225 | 11 | 391 | activation of immune response |
| GO:0071407 | 0.0036 | 2.64 | 4.8733 | 12 | 451 | cellular response to organic cyclic compound |
| GO:0055026 | 0.0037 | 10.7679 | 0.3134 | 3 | 29 | negative regulation of cardiac muscle tissue development |
| GO:0017187 | 0.004 | 26.5127 | 0.0972 | 2 | 9 | peptidyl-glutamic acid carboxylation |
| GO:0033148 | 0.004 | 26.5127 | 0.0972 | 2 | 9 | positive regulation of intracellular estrogen receptor signaling pathway |
| GO:0045759 | 0.004 | 26.5127 | 0.0972 | 2 | 9 | negative regulation of action potential |
| GO:0002694 | 0.0042 | 2.8718 | 3.7171 | 10 | 344 | regulation of leukocyte activation |
| GO:0050900 | 0.0045 | 3.0288 | 3.166 | 9 | 293 | leukocyte migration |
| GO:0008037 | 0.0045 | 4.9565 | 1.0806 | 5 | 100 | cell recognition |
| GO:0032879 | 0.0046 | 1.7374 | 22.6159 | 35 | 2093 | regulation of localization |
| GO:0006874 | 0.0046 | 3.0179 | 3.1768 | 9 | 294 | cellular calcium ion homeostasis |
| GO:0002762 | 0.0049 | 9.6517 | 0.3458 | 3 | 32 | negative regulation of myeloid leukocyte differentiation |
| GO:2000725 | 0.0049 | 9.6517 | 0.3458 | 3 | 32 | regulation of cardiac muscle cell differentiation |
| GO:0036166 | 0.0049 | 23.1968 | 0.1081 | 2 | 10 | phenotypic switching |
| GO:0006813 | 0.005 | 3.5711 | 2.0855 | 7 | 193 | potassium ion transport |
| GO:0030816 | 0.005 | 6.2499 | 0.6916 | 4 | 64 | positive regulation of cAMP metabolic process |
| GO:0046165 | 0.0056 | 4.7069 | 1.1346 | 5 | 105 | alcohol biosynthetic process |
| GO:0031113 | 0.0058 | 9.0276 | 0.3674 | 3 | 34 | regulation of microtubule polymerization |
| GO:1900542 | 0.0062 | 3.4217 | 2.1719 | 7 | 201 | regulation of purine nucleotide metabolic process |
| GO:0048870 | 0.0062 | 1.919 | 12.4804 | 22 | 1155 | cell motility |
| GO:0001910 | 0.0063 | 8.7449 | 0.3782 | 3 | 35 | regulation of leukocyte mediated cytotoxicity |
| GO:0035036 | 0.0063 | 8.7449 | 0.3782 | 3 | 35 | sperm-egg recognition |
| GO:0008285 | 0.0063 | 2.3515 | 5.9106 | 13 | 547 | negative regulation of cell proliferation |
| GO:0003008 | 0.0065 | 1.9163 | 12.5351 | 22 | 1203 | system process |
| GO:0097756 | 0.0066 | 5.7669 | 0.7456 | 4 | 69 | negative regulation of blood vessel diameter |
| GO:0022407 | 0.0067 | 2.8442 | 3.3605 | 9 | 311 | regulation of cell-cell adhesion |
| GO:0042113 | 0.0067 | 3.804 | 1.6749 | 6 | 155 | B cell activation |
| GO:0006959 | 0.0068 | 4.481 | 1.1886 | 5 | 110 | humoral immune response |
| GO:0002643 | 0.0071 | 18.5546 | 0.1297 | 2 | 12 | regulation of tolerance induction |
| GO:2000021 | 0.0076 | 3.7034 | 1.7181 | 6 | 159 | regulation of ion homeostasis |
| GO:0007188 | 0.0079 | 4.3153 | 1.2318 | 5 | 114 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0048609 | 0.0081 | 2.2016 | 6.7967 | 14 | 629 | multicellular organismal reproductive process |
| GO:0035810 | 0.0084 | 16.8665 | 0.1405 | 2 | 13 | positive regulation of urine volume |
| GO:0048012 | 0.0084 | 16.8665 | 0.1405 | 2 | 13 | hepatocyte growth factor receptor signaling pathway |
| GO:1904754 | 0.0084 | 16.8665 | 0.1405 | 2 | 13 | positive regulation of vascular associated smooth muscle cell migration |
| GO:0002027 | 0.0084 | 5.3529 | 0.7996 | 4 | 74 | regulation of heart rate |
| GO:0009605 | 0.0085 | 1.7588 | 16.8242 | 27 | 1557 | response to external stimulus |
| GO:0002703 | 0.0091 | 4.1612 | 1.275 | 5 | 118 | regulation of leukocyte mediated immunity |
| GO:0007077 | 0.0091 | 7.5602 | 0.4322 | 3 | 40 | mitotic nuclear envelope disassembly |
| GO:1901698 | 0.0091 | 2.0112 | 9.0766 | 17 | 840 | response to nitrogen compound |
| GO:0071805 | 0.0095 | 3.5173 | 1.8045 | 6 | 167 | potassium ion transmembrane transport |
| GO:0042327 | 0.0096 | 2.0441 | 8.3851 | 16 | 776 | positive regulation of phosphorylation |
| GO:0010447 | 0.0097 | 15.4598 | 0.1513 | 2 | 14 | response to acidic pH |
| GO:0050965 | 0.0097 | 15.4598 | 0.1513 | 2 | 14 | detection of temperature stimulus involved in sensory perception of pain |
| GO:0060401 | 0.0097 | 4.0882 | 1.2967 | 5 | 120 | cytosolic calcium ion transport |
| GO:0042267 | 0.0098 | 7.3607 | 0.443 | 3 | 41 | natural killer cell mediated cytotoxicity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048731 | 2e-04 | 1.6497 | 62.5391 | 87 | 3646 | system development |
| GO:0007156 | 3e-04 | 4.5879 | 2.1441 | 9 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0060142 | 6e-04 | 12.2615 | 0.3945 | 4 | 23 | regulation of syncytium formation by plasma membrane fusion |
| GO:0006928 | 6e-04 | 1.8143 | 26.8613 | 44 | 1566 | movement of cell or subcellular component |
| GO:0090132 | 8e-04 | 3.3635 | 3.5163 | 11 | 205 | epithelium migration |
| GO:0051122 | 0.0017 | 57.8 | 0.0686 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0097176 | 0.0017 | 57.8 | 0.0686 | 2 | 4 | epoxide metabolic process |
| GO:0010632 | 0.0018 | 3.5149 | 2.7444 | 9 | 160 | regulation of epithelial cell migration |
| GO:0019372 | 0.0019 | 14.5033 | 0.2573 | 3 | 15 | lipoxygenase pathway |
| GO:0050793 | 0.0023 | 1.6362 | 33.7052 | 50 | 1965 | regulation of developmental process |
| GO:0051674 | 0.0025 | 1.8018 | 19.8115 | 33 | 1155 | localization of cell |
| GO:2000507 | 0.0028 | 38.5304 | 0.0858 | 2 | 5 | positive regulation of energy homeostasis |
| GO:2000818 | 0.0028 | 38.5304 | 0.0858 | 2 | 5 | negative regulation of myoblast proliferation |
| GO:0048240 | 0.0028 | 12.4295 | 0.2916 | 3 | 17 | sperm capacitation |
| GO:0001667 | 0.0032 | 2.6632 | 4.7856 | 12 | 279 | ameboidal-type cell migration |
| GO:0006805 | 0.0034 | 5.4025 | 1.012 | 5 | 59 | xenobiotic metabolic process |
| GO:1901741 | 0.0034 | 11.6 | 0.3088 | 3 | 18 | positive regulation of myoblast fusion |
| GO:0043535 | 0.0039 | 5.2087 | 1.0463 | 5 | 61 | regulation of blood vessel endothelial cell migration |
| GO:1900117 | 0.0039 | 10.8742 | 0.3259 | 3 | 19 | regulation of execution phase of apoptosis |
| GO:0006334 | 0.004 | 3.7305 | 2.0069 | 7 | 117 | nucleosome assembly |
| GO:0048771 | 0.004 | 3.7305 | 2.0069 | 7 | 117 | tissue remodeling |
| GO:0015917 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | aminophospholipid transport |
| GO:0035360 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0043416 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | regulation of skeletal muscle tissue regeneration |
| GO:1904995 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0048646 | 0.0047 | 1.8892 | 13.5613 | 24 | 802 | anatomical structure formation involved in morphogenesis |
| GO:0098609 | 0.0048 | 2.0049 | 10.6004 | 20 | 618 | cell-cell adhesion |
| GO:0071157 | 0.0053 | 9.6644 | 0.3602 | 3 | 21 | negative regulation of cell cycle arrest |
| GO:0006333 | 0.0053 | 3.1957 | 2.6587 | 8 | 155 | chromatin assembly or disassembly |
| GO:2000145 | 0.0055 | 1.9806 | 10.7205 | 20 | 625 | regulation of cell motility |
| GO:0009410 | 0.0058 | 4.7025 | 1.1492 | 5 | 67 | response to xenobiotic stimulus |
| GO:0061085 | 0.0058 | 23.1147 | 0.1201 | 2 | 7 | regulation of histone H3-K27 methylation |
| GO:2000510 | 0.0058 | 23.1147 | 0.1201 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
| GO:0042060 | 0.0058 | 2.2072 | 7.187 | 15 | 419 | wound healing |
| GO:0030335 | 0.006 | 2.3482 | 5.8491 | 13 | 341 | positive regulation of cell migration |
| GO:0071674 | 0.0062 | 5.9644 | 0.7376 | 4 | 43 | mononuclear cell migration |
| GO:0010092 | 0.0068 | 8.6967 | 0.3945 | 3 | 23 | specification of animal organ identity |
| GO:2000404 | 0.0068 | 8.6967 | 0.3945 | 3 | 23 | regulation of T cell migration |
| GO:0032501 | 0.0073 | 1.4088 | 88.7413 | 107 | 5291 | multicellular organismal process |
| GO:0047484 | 0.0077 | 19.2607 | 0.1372 | 2 | 8 | regulation of response to osmotic stress |
| GO:0006949 | 0.0078 | 5.537 | 0.789 | 4 | 46 | syncytium formation |
| GO:0002688 | 0.0078 | 4.3499 | 1.235 | 5 | 72 | regulation of leukocyte chemotaxis |
| GO:0045765 | 0.0081 | 2.741 | 3.4649 | 9 | 202 | regulation of angiogenesis |
| GO:0035023 | 0.0082 | 3.6513 | 1.7496 | 6 | 102 | regulation of Rho protein signal transduction |
| GO:0045597 | 0.0083 | 1.8395 | 12.6759 | 22 | 739 | positive regulation of cell differentiation |
| GO:0030049 | 0.0087 | 7.9048 | 0.4288 | 3 | 25 | muscle filament sliding |
| GO:0040011 | 0.0088 | 1.6167 | 23.2077 | 35 | 1353 | locomotion |
| GO:0048514 | 0.009 | 2.0947 | 7.5472 | 15 | 440 | blood vessel morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051251 | 1e-04 | 4.9214 | 2.2342 | 10 | 192 | positive regulation of lymphocyte activation |
| GO:0050867 | 3e-04 | 4.1751 | 2.6066 | 10 | 224 | positive regulation of cell activation |
| GO:0008588 | 4e-04 | 172.0921 | 0.0349 | 2 | 3 | release of cytoplasmic sequestered NF-kappaB |
| GO:0022610 | 4e-04 | 2.2963 | 12.1371 | 25 | 1043 | biological adhesion |
| GO:1903039 | 4e-04 | 4.8542 | 1.7921 | 8 | 154 | positive regulation of leukocyte cell-cell adhesion |
| GO:0045747 | 6e-04 | 12.0009 | 0.384 | 4 | 33 | positive regulation of Notch signaling pathway |
| GO:0048731 | 7e-04 | 1.7372 | 42.4274 | 61 | 3646 | system development |
| GO:0048523 | 9e-04 | 1.713 | 43.6958 | 62 | 3755 | negative regulation of cellular process |
| GO:0007165 | 0.0012 | 1.6743 | 50.5032 | 69 | 4340 | signal transduction |
| GO:0050863 | 0.0012 | 3.714 | 2.6066 | 9 | 224 | regulation of T cell activation |
| GO:0051241 | 0.0014 | 2.2845 | 9.5754 | 20 | 833 | negative regulation of multicellular organismal process |
| GO:0051125 | 0.0018 | 14.4172 | 0.2444 | 3 | 21 | regulation of actin nucleation |
| GO:0031295 | 0.0018 | 8.4807 | 0.5237 | 4 | 45 | T cell costimulation |
| GO:0048706 | 0.002 | 4.962 | 1.3033 | 6 | 112 | embryonic skeletal system development |
| GO:1903243 | 0.002 | 43.0132 | 0.0698 | 2 | 6 | negative regulation of cardiac muscle hypertrophy in response to stress |
| GO:0045785 | 0.0022 | 3.1516 | 3.3979 | 10 | 292 | positive regulation of cell adhesion |
| GO:0002694 | 0.0023 | 2.9446 | 4.003 | 11 | 344 | regulation of leukocyte activation |
| GO:0006955 | 0.0025 | 1.9414 | 15.3372 | 27 | 1318 | immune response |
| GO:0002830 | 0.0027 | 34.4079 | 0.0815 | 2 | 7 | positive regulation of type 2 immune response |
| GO:0009653 | 0.0031 | 1.9953 | 13.3079 | 24 | 1212 | anatomical structure morphogenesis |
| GO:0022407 | 0.0035 | 2.9483 | 3.619 | 10 | 311 | regulation of cell-cell adhesion |
| GO:0046629 | 0.0036 | 28.6711 | 0.0931 | 2 | 8 | gamma-delta T cell activation |
| GO:0060534 | 0.0036 | 28.6711 | 0.0931 | 2 | 8 | trachea cartilage development |
| GO:0032501 | 0.0039 | 1.6226 | 48.6237 | 64 | 4564 | multicellular organismal process |
| GO:0035194 | 0.0041 | 3.3419 | 2.5484 | 8 | 219 | posttranscriptional gene silencing by RNA |
| GO:0048167 | 0.0041 | 4.2358 | 1.5128 | 6 | 130 | regulation of synaptic plasticity |
| GO:0008283 | 0.0043 | 1.8036 | 18.3511 | 30 | 1577 | cell proliferation |
| GO:0046950 | 0.0046 | 24.5733 | 0.1047 | 2 | 9 | cellular ketone body metabolic process |
| GO:0009952 | 0.0047 | 3.6162 | 2.0597 | 7 | 177 | anterior/posterior pattern specification |
| GO:1901342 | 0.0047 | 3.2633 | 2.6066 | 8 | 224 | regulation of vasculature development |
| GO:0048583 | 0.0052 | 1.6015 | 35.7246 | 50 | 3070 | regulation of response to stimulus |
| GO:0045746 | 0.0055 | 9.2611 | 0.3607 | 3 | 31 | negative regulation of Notch signaling pathway |
| GO:1902224 | 0.0057 | 21.5 | 0.1164 | 2 | 10 | ketone body metabolic process |
| GO:2001241 | 0.0057 | 21.5 | 0.1164 | 2 | 10 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0042345 | 0.006 | 8.9411 | 0.3724 | 3 | 32 | regulation of NF-kappaB import into nucleus |
| GO:0045744 | 0.006 | 8.9411 | 0.3724 | 3 | 32 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0043123 | 0.0061 | 3.8874 | 1.6408 | 6 | 141 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0002684 | 0.0063 | 2.1441 | 7.9944 | 16 | 687 | positive regulation of immune system process |
| GO:0030155 | 0.0064 | 4.5469 | 1.1736 | 5 | 106 | regulation of cell adhesion |
| GO:0034314 | 0.0065 | 8.6424 | 0.384 | 3 | 33 | Arp2/3 complex-mediated actin nucleation |
| GO:0042993 | 0.0065 | 8.6424 | 0.384 | 3 | 33 | positive regulation of transcription factor import into nucleus |
| GO:0022414 | 0.0069 | 1.8958 | 12.556 | 22 | 1079 | reproductive process |
| GO:0042475 | 0.0069 | 5.6914 | 0.7564 | 4 | 65 | odontogenesis of dentin-containing tooth |
| GO:0014745 | 0.0069 | 19.1096 | 0.128 | 2 | 11 | negative regulation of muscle adaptation |
| GO:0032103 | 0.0078 | 3.2655 | 2.2692 | 7 | 195 | positive regulation of response to external stimulus |
| GO:0031623 | 0.0081 | 5.4233 | 0.7913 | 4 | 68 | receptor internalization |
| GO:0017148 | 0.0081 | 2.7471 | 3.4677 | 9 | 298 | negative regulation of translation |
| GO:0051093 | 0.0083 | 2.0756 | 8.2388 | 16 | 708 | negative regulation of developmental process |
| GO:0032502 | 0.0083 | 1.6919 | 24.7141 | 36 | 2473 | developmental process |
| GO:0032720 | 0.0083 | 7.8549 | 0.4189 | 3 | 36 | negative regulation of tumor necrosis factor production |
| GO:0021766 | 0.0089 | 5.2582 | 0.8146 | 4 | 70 | hippocampus development |
| GO:0045638 | 0.0089 | 5.2582 | 0.8146 | 4 | 70 | negative regulation of myeloid cell differentiation |
| GO:0072148 | 0.0096 | 15.6328 | 0.1513 | 2 | 13 | epithelial cell fate commitment |
| GO:0042551 | 0.0097 | 7.4049 | 0.4422 | 3 | 38 | neuron maturation |
| GO:0048646 | 0.0097 | 1.9534 | 9.8679 | 18 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0045766 | 0.0099 | 4.0686 | 1.3033 | 5 | 112 | positive regulation of angiogenesis |
| GO:0030154 | 0.01 | 1.5335 | 36.9116 | 50 | 3172 | cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0.0022 | 2.9687 | 3.9699 | 11 | 336 | G-protein coupled receptor activity |
| GO:0004896 | 0.0035 | 6.9799 | 0.6262 | 4 | 53 | cytokine receptor activity |
| GO:0030547 | 0.0085 | 16.9303 | 0.1418 | 2 | 12 | receptor inhibitor activity |
| GO:0005452 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | inorganic anion exchanger activity |
| GO:0097493 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | structural molecule activity conferring elasticity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 216.4647 | 0.0922 | 4 | 5 | molybdopterin cofactor binding |
| GO:0030151 | 0 | 161.6777 | 0.0738 | 3 | 4 | molybdenum ion binding |
| GO:0016165 | 3e-04 | Inf | 0.0369 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0008940 | 0.001 | 107.3416 | 0.0553 | 2 | 3 | nitrate reductase activity |
| GO:0005201 | 0.0013 | 6.8277 | 0.8232 | 5 | 45 | extracellular matrix structural constituent |
| GO:0015247 | 0.0033 | 35.775 | 0.0922 | 2 | 5 | aminophospholipid transporter activity |
| GO:0030020 | 0.0033 | 35.775 | 0.0922 | 2 | 5 | extracellular matrix structural constituent conferring tensile strength |
| GO:0016701 | 0.0035 | 11.5369 | 0.3134 | 3 | 17 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
| GO:0047617 | 0.0035 | 11.5369 | 0.3134 | 3 | 17 | acyl-CoA hydrolase activity |
| GO:0005179 | 0.004 | 5.1648 | 1.0577 | 5 | 58 | hormone activity |
| GO:0005184 | 0.0041 | 10.7669 | 0.3319 | 3 | 18 | neuropeptide hormone activity |
| GO:0005164 | 0.0056 | 9.4988 | 0.3688 | 3 | 20 | tumor necrosis factor receptor binding |
| GO:1901612 | 0.0067 | 21.4617 | 0.1291 | 2 | 7 | cardiolipin binding |
| GO:0102991 | 0.0088 | 17.8834 | 0.1475 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0 | 6.6812 | 2.4708 | 14 | 335 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 4.231 | 5.3642 | 19 | 720 | signaling receptor activity |
| GO:0099600 | 0 | 4.2868 | 4.9768 | 18 | 668 | transmembrane receptor activity |
| GO:0004984 | 0 | 17.6626 | 0.4023 | 6 | 54 | olfactory receptor activity |
| GO:0060089 | 0 | 3.5112 | 6.7575 | 20 | 907 | molecular transducer activity |
| GO:0071723 | 3e-04 | 135.9485 | 0.0298 | 2 | 4 | lipopeptide binding |
| GO:0001530 | 0.0069 | 18.1086 | 0.1267 | 2 | 17 | lipopolysaccharide binding |
| GO:0001856 | 0.0075 | Inf | 0.0075 | 1 | 1 | complement component C5a binding |
| GO:0003858 | 0.0075 | Inf | 0.0075 | 1 | 1 | 3-hydroxybutyrate dehydrogenase activity |
| GO:0004878 | 0.0075 | Inf | 0.0075 | 1 | 1 | complement component C5a receptor activity |
| GO:0005550 | 0.0075 | Inf | 0.0075 | 1 | 1 | pheromone binding |
| GO:0016501 | 0.0075 | Inf | 0.0075 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.0075 | Inf | 0.0075 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0033791 | 0.0075 | Inf | 0.0075 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0038182 | 0.0075 | Inf | 0.0075 | 1 | 1 | G-protein coupled bile acid receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005094 | 4e-04 | 172.8026 | 0.0348 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0043565 | 8e-04 | 2.304 | 10.5232 | 22 | 908 | sequence-specific DNA binding |
| GO:0048027 | 9e-04 | 18.6187 | 0.197 | 3 | 17 | mRNA 5'-UTR binding |
| GO:0003779 | 0.0011 | 3.2685 | 3.6275 | 11 | 313 | actin binding |
| GO:0000979 | 0.0028 | 7.4252 | 0.5911 | 4 | 51 | RNA polymerase II core promoter sequence-specific DNA binding |
| GO:0005509 | 0.0066 | 2.3345 | 5.9338 | 13 | 512 | calcium ion binding |
| GO:0042923 | 0.0096 | 15.6974 | 0.1507 | 2 | 13 | neuropeptide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005094 | 3e-04 | 205.5781 | 0.0293 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0030246 | 0.0019 | 4.2716 | 1.761 | 7 | 180 | carbohydrate binding |
| GO:0001846 | 0.0049 | 22.8281 | 0.1076 | 2 | 11 | opsonin binding |
| GO:0005070 | 0.006 | 8.8569 | 0.3718 | 3 | 38 | SH3/SH2 adaptor activity |
| GO:0033293 | 0.0074 | 8.1558 | 0.4011 | 3 | 41 | monocarboxylic acid binding |
| GO:1903231 | 0.0075 | 5.5378 | 0.7729 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005159 | 0.008 | 17.1172 | 0.137 | 2 | 14 | insulin-like growth factor receptor binding |
| GO:0008092 | 0.0093 | 2.1708 | 6.9168 | 14 | 707 | cytoskeletal protein binding |
| GO:0001604 | 0.0098 | Inf | 0.0098 | 1 | 1 | urotensin II receptor activity |
| GO:0003937 | 0.0098 | Inf | 0.0098 | 1 | 1 | IMP cyclohydrolase activity |
| GO:0004137 | 0.0098 | Inf | 0.0098 | 1 | 1 | deoxycytidine kinase activity |
| GO:0004643 | 0.0098 | Inf | 0.0098 | 1 | 1 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity |
| GO:0004982 | 0.0098 | Inf | 0.0098 | 1 | 1 | N-formyl peptide receptor activity |
| GO:0005124 | 0.0098 | Inf | 0.0098 | 1 | 1 | scavenger receptor binding |
| GO:0005147 | 0.0098 | Inf | 0.0098 | 1 | 1 | oncostatin-M receptor binding |
| GO:0008579 | 0.0098 | Inf | 0.0098 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0035755 | 0.0098 | Inf | 0.0098 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0036487 | 0.0098 | Inf | 0.0098 | 1 | 1 | nitric-oxide synthase inhibitor activity |
| GO:0039552 | 0.0098 | Inf | 0.0098 | 1 | 1 | RIG-I binding |
| GO:0045485 | 0.0098 | Inf | 0.0098 | 1 | 1 | omega-6 fatty acid desaturase activity |
| GO:0047305 | 0.0098 | Inf | 0.0098 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0047747 | 0.0098 | Inf | 0.0098 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0098 | Inf | 0.0098 | 1 | 1 | calcium-dependent phospholipase C activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 2e-04 | 2.8908 | 6.4347 | 17 | 512 | calcium ion binding |
| GO:0030545 | 5e-04 | 3.4014 | 3.8206 | 12 | 304 | receptor regulator activity |
| GO:0005088 | 6e-04 | 4.5968 | 1.8862 | 8 | 153 | Ras guanyl-nucleotide exchange factor activity |
| GO:0008083 | 7e-04 | 5.1278 | 1.483 | 7 | 118 | growth factor activity |
| GO:0031267 | 0.002 | 2.6005 | 5.7812 | 14 | 460 | small GTPase binding |
| GO:0001106 | 0.0033 | 11.4111 | 0.3016 | 3 | 24 | RNA polymerase II transcription corepressor activity |
| GO:0031406 | 0.0069 | 3.7829 | 1.6841 | 6 | 134 | carboxylic acid binding |
| GO:0098772 | 0.0076 | 1.877 | 12.666 | 22 | 1061 | molecular function regulator |
| GO:0005089 | 0.0095 | 5.1688 | 0.8295 | 4 | 66 | Rho guanyl-nucleotide exchange factor activity |
| GO:0016594 | 0.0095 | 15.8921 | 0.1508 | 2 | 12 | glycine binding |
| GO:0030247 | 0.0095 | 15.8921 | 0.1508 | 2 | 12 | polysaccharide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 1e-04 | 3.0764 | 6.3721 | 18 | 336 | G-protein coupled receptor activity |
| GO:0099600 | 2e-04 | 2.3204 | 12.6683 | 27 | 668 | transmembrane receptor activity |
| GO:0038023 | 6e-04 | 2.1373 | 13.6544 | 27 | 720 | signaling receptor activity |
| GO:0003677 | 0.001 | 1.6404 | 40.6978 | 60 | 2146 | DNA binding |
| GO:0060089 | 0.001 | 1.9471 | 17.2008 | 31 | 907 | molecular transducer activity |
| GO:0097108 | 0.0011 | 104.28 | 0.0569 | 2 | 3 | hedgehog family protein binding |
| GO:0000977 | 0.0014 | 2.2013 | 10.2029 | 21 | 538 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0000981 | 0.002 | 2.0255 | 12.6683 | 24 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0046982 | 0.0022 | 2.3211 | 7.7944 | 17 | 411 | protein heterodimerization activity |
| GO:1990837 | 0.0028 | 2.0012 | 12.2511 | 23 | 646 | sequence-specific double-stranded DNA binding |
| GO:0004364 | 0.0031 | 12.0695 | 0.3034 | 3 | 16 | glutathione transferase activity |
| GO:0004653 | 0.0031 | 12.0695 | 0.3034 | 3 | 16 | polypeptide N-acetylgalactosaminyltransferase activity |
| GO:0001047 | 0.0052 | 3.2052 | 2.655 | 8 | 140 | core promoter binding |
| GO:0005005 | 0.0071 | 20.8496 | 0.1328 | 2 | 7 | transmembrane-ephrin receptor activity |
| GO:0031492 | 0.0074 | 5.6665 | 0.7775 | 4 | 41 | nucleosomal DNA binding |
| GO:0003831 | 0.0093 | 17.3733 | 0.1517 | 2 | 8 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity |
| GO:0015556 | 0.0093 | 17.3733 | 0.1517 | 2 | 8 | C4-dicarboxylate transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004303 | 2e-04 | 38.5559 | 0.1172 | 3 | 9 | estradiol 17-beta-dehydrogenase activity |
| GO:0004095 | 0.001 | 76.6842 | 0.0521 | 2 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0005070 | 0.0015 | 9.1062 | 0.4947 | 4 | 38 | SH3/SH2 adaptor activity |
| GO:0008374 | 0.0015 | 9.1062 | 0.4947 | 4 | 38 | O-acyltransferase activity |
| GO:0016229 | 0.0015 | 15.4118 | 0.2343 | 3 | 18 | steroid dehydrogenase activity |
| GO:0005509 | 0.0028 | 2.4103 | 6.6659 | 15 | 512 | calcium ion binding |
| GO:0016616 | 0.005 | 4.8493 | 1.1066 | 5 | 85 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0004953 | 0.0057 | 21.9014 | 0.1172 | 2 | 9 | icosanoid receptor activity |
| GO:0005229 | 0.0071 | 19.1623 | 0.1302 | 2 | 10 | intracellular calcium activated chloride channel activity |
| GO:0015271 | 0.0071 | 19.1623 | 0.1302 | 2 | 10 | outward rectifier potassium channel activity |
| GO:0003823 | 0.0082 | 7.9631 | 0.4166 | 3 | 32 | antigen binding |
| GO:0017124 | 0.0098 | 4.0789 | 1.3019 | 5 | 100 | SH3 domain binding |
| GO:0005539 | 0.01 | 3.4805 | 1.8227 | 6 | 140 | glycosaminoglycan binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099600 | 0 | 2.8308 | 10.2553 | 26 | 668 | transmembrane receptor activity |
| GO:0060089 | 0 | 2.4972 | 13.9244 | 31 | 907 | molecular transducer activity |
| GO:0038023 | 0 | 2.6077 | 11.0536 | 26 | 720 | signaling receptor activity |
| GO:0004930 | 1e-04 | 3.3947 | 5.1583 | 16 | 336 | G-protein coupled receptor activity |
| GO:0004977 | 0.0014 | 64.7624 | 0.0614 | 2 | 4 | melanocortin receptor activity |
| GO:0005179 | 0.0018 | 6.2649 | 0.8785 | 5 | 58 | hormone activity |
| GO:0005184 | 0.0025 | 13.004 | 0.2763 | 3 | 18 | neuropeptide hormone activity |
| GO:0015079 | 0.0039 | 3.7443 | 1.9958 | 7 | 130 | potassium ion transmembrane transporter activity |
| GO:0005221 | 0.0047 | 25.899 | 0.1075 | 2 | 7 | intracellular cyclic nucleotide activated cation channel activity |
| GO:0015267 | 0.0088 | 2.3216 | 5.45 | 12 | 355 | channel activity |
| GO:0005154 | 0.0097 | 7.496 | 0.4452 | 3 | 29 | epidermal growth factor receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | Inf | 0.0366 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0366 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0015079 | 2e-04 | 5.5372 | 1.5849 | 8 | 130 | potassium ion transmembrane transporter activity |
| GO:0099104 | 9e-04 | 82.025 | 0.0488 | 2 | 4 | potassium channel activator activity |
| GO:0044325 | 0.0011 | 5.5709 | 1.1704 | 6 | 96 | ion channel binding |
| GO:0042834 | 0.0014 | 54.6792 | 0.061 | 2 | 5 | peptidoglycan binding |
| GO:0008201 | 0.002 | 4.96 | 1.3045 | 6 | 107 | heparin binding |
| GO:0005249 | 0.0023 | 5.8558 | 0.9266 | 5 | 76 | voltage-gated potassium channel activity |
| GO:0015250 | 0.003 | 32.8025 | 0.0853 | 2 | 7 | water channel activity |
| GO:0005261 | 0.0033 | 3.1854 | 3.0113 | 9 | 247 | cation channel activity |
| GO:0061134 | 0.0039 | 4.2765 | 1.4995 | 6 | 123 | peptidase regulator activity |
| GO:0015267 | 0.0042 | 2.7068 | 4.328 | 11 | 355 | channel activity |
| GO:0004866 | 0.0048 | 4.8861 | 1.0972 | 5 | 90 | endopeptidase inhibitor activity |
| GO:0008081 | 0.0095 | 5.1669 | 0.829 | 4 | 68 | phosphoric diester hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0.0011 | 2.3093 | 9.286 | 20 | 512 | calcium ion binding |
| GO:0005249 | 0.0025 | 4.7333 | 1.3784 | 6 | 76 | voltage-gated potassium channel activity |
| GO:0070888 | 0.0036 | 7.0864 | 0.6348 | 4 | 35 | E-box binding |
| GO:0070700 | 0.0065 | 21.8276 | 0.127 | 2 | 7 | BMP receptor binding |
| GO:0046982 | 0.0081 | 2.1204 | 7.4542 | 15 | 411 | protein heterodimerization activity |
| GO:0038036 | 0.0085 | 18.1883 | 0.1451 | 2 | 8 | sphingosine-1-phosphate receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 2e-04 | 3.7701 | 3.4895 | 12 | 336 | G-protein coupled receptor activity |
| GO:0099600 | 0.0015 | 2.5139 | 6.9374 | 16 | 668 | transmembrane receptor activity |
| GO:0004984 | 0.0024 | 7.8209 | 0.5608 | 4 | 54 | olfactory receptor activity |
| GO:0030594 | 0.0033 | 7.1072 | 0.6127 | 4 | 59 | neurotransmitter receptor activity |
| GO:0016405 | 0.0046 | 24.1581 | 0.1039 | 2 | 10 | CoA-ligase activity |
| GO:0060089 | 0.006 | 2.0688 | 9.4195 | 18 | 907 | molecular transducer activity |
| GO:0015347 | 0.0066 | 19.3235 | 0.1246 | 2 | 12 | sodium-independent organic anion transmembrane transporter activity |
| GO:0022848 | 0.0066 | 19.3235 | 0.1246 | 2 | 12 | acetylcholine-gated cation-selective channel activity |
| GO:0005452 | 0.0077 | 17.5655 | 0.135 | 2 | 13 | inorganic anion exchanger activity |
| GO:0020037 | 0.01 | 5.068 | 0.8412 | 4 | 81 | heme binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004867 | 4e-04 | 8.751 | 0.6474 | 5 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0001733 | 0.0012 | 70.8054 | 0.0563 | 2 | 4 | galactosylceramide sulfotransferase activity |
| GO:0042043 | 0.0019 | 47.2 | 0.0704 | 2 | 5 | neurexin family protein binding |
| GO:0030414 | 0.0021 | 4.9019 | 1.3228 | 6 | 94 | peptidase inhibitor activity |
| GO:0061135 | 0.0023 | 4.7923 | 1.351 | 6 | 96 | endopeptidase regulator activity |
| GO:0022838 | 0.0026 | 2.7388 | 4.6722 | 12 | 332 | substrate-specific channel activity |
| GO:0070679 | 0.0028 | 35.3973 | 0.0844 | 2 | 6 | inositol 1,4,5 trisphosphate binding |
| GO:0017171 | 0.0038 | 3.7632 | 1.9843 | 7 | 141 | serine hydrolase activity |
| GO:0072509 | 0.0038 | 3.7632 | 1.9843 | 7 | 141 | divalent inorganic cation transmembrane transporter activity |
| GO:0015279 | 0.0039 | 28.3157 | 0.0985 | 2 | 7 | store-operated calcium channel activity |
| GO:0022803 | 0.0046 | 2.5429 | 5.0099 | 12 | 356 | passive transmembrane transporter activity |
| GO:0004252 | 0.0062 | 3.8793 | 1.6465 | 6 | 117 | serine-type endopeptidase activity |
| GO:0015368 | 0.0066 | 20.2224 | 0.1267 | 2 | 9 | calcium:cation antiporter activity |
| GO:0005215 | 0.0072 | 1.8029 | 14.8891 | 25 | 1058 | transporter activity |
| GO:0005261 | 0.0083 | 2.7327 | 3.476 | 9 | 247 | cation channel activity |
| GO:0008329 | 0.01 | 15.7261 | 0.1548 | 2 | 11 | signaling pattern recognition receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010181 | 5e-04 | 24.1325 | 0.1624 | 3 | 13 | FMN binding |
| GO:0001602 | 0.0015 | 53.3293 | 0.0625 | 2 | 5 | pancreatic polypeptide receptor activity |
| GO:0003958 | 0.0015 | 53.3293 | 0.0625 | 2 | 5 | NADPH-hemoprotein reductase activity |
| GO:0042834 | 0.0015 | 53.3293 | 0.0625 | 2 | 5 | peptidoglycan binding |
| GO:0046982 | 0.0055 | 2.4847 | 5.1344 | 12 | 411 | protein heterodimerization activity |
| GO:0001161 | 0.0065 | 19.9909 | 0.1249 | 2 | 10 | intronic transcription regulatory region sequence-specific DNA binding |
| GO:0004745 | 0.0065 | 19.9909 | 0.1249 | 2 | 10 | retinol dehydrogenase activity |
| GO:0050660 | 0.0071 | 5.6595 | 0.762 | 4 | 61 | flavin adenine dinucleotide binding |
| GO:0016491 | 0.0092 | 2.1586 | 6.8834 | 14 | 551 | oxidoreductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 3.5513 | 7.3209 | 23 | 512 | calcium ion binding |
| GO:0001077 | 0.0021 | 3.1785 | 3.3602 | 10 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0003680 | 0.0041 | 27.8574 | 0.1001 | 2 | 7 | AT DNA binding |
| GO:0030553 | 0.0041 | 27.8574 | 0.1001 | 2 | 7 | cGMP binding |
| GO:0000977 | 0.0045 | 2.2154 | 7.6927 | 16 | 538 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0000981 | 0.0073 | 2.0042 | 9.5515 | 18 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:1990837 | 0.0093 | 1.9933 | 9.0454 | 17 | 639 | sequence-specific double-stranded DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008020 | 2e-04 | 165.05 | 0.0247 | 2 | 4 | G-protein coupled photoreceptor activity |
| GO:0042834 | 4e-04 | 110.025 | 0.0309 | 2 | 5 | peptidoglycan binding |
| GO:0010851 | 6e-04 | 82.5125 | 0.037 | 2 | 6 | cyclase regulator activity |
| GO:0031404 | 8e-04 | 66.005 | 0.0432 | 2 | 7 | chloride ion binding |
| GO:0016405 | 0.0016 | 41.2437 | 0.0617 | 2 | 10 | CoA-ligase activity |
| GO:0015347 | 0.0024 | 32.99 | 0.0741 | 2 | 12 | sodium-independent organic anion transmembrane transporter activity |
| GO:0005452 | 0.0028 | 29.9886 | 0.0802 | 2 | 13 | inorganic anion exchanger activity |
| GO:0005267 | 0.0042 | 6.5882 | 0.6541 | 4 | 106 | potassium channel activity |
| GO:0022843 | 0.0046 | 6.3985 | 0.6726 | 4 | 109 | voltage-gated cation channel activity |
| GO:0005215 | 0.005 | 2.3984 | 6.5289 | 14 | 1058 | transporter activity |
| GO:0030246 | 0.0051 | 4.8353 | 1.1108 | 5 | 180 | carbohydrate binding |
| GO:0005251 | 0.0054 | 20.6094 | 0.1111 | 2 | 18 | delayed rectifier potassium channel activity |
| GO:0003957 | 0.0062 | Inf | 0.0062 | 1 | 1 | NAD(P)+ transhydrogenase (B-specific) activity |
| GO:0004463 | 0.0062 | Inf | 0.0062 | 1 | 1 | leukotriene-A4 hydrolase activity |
| GO:0008750 | 0.0062 | Inf | 0.0062 | 1 | 1 | NAD(P)+ transhydrogenase (AB-specific) activity |
| GO:0008891 | 0.0062 | Inf | 0.0062 | 1 | 1 | glycolate oxidase activity |
| GO:0016652 | 0.0062 | Inf | 0.0062 | 1 | 1 | oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor |
| GO:0030251 | 0.0062 | Inf | 0.0062 | 1 | 1 | guanylate cyclase inhibitor activity |
| GO:0032500 | 0.0062 | Inf | 0.0062 | 1 | 1 | muramyl dipeptide binding |
| GO:0043739 | 0.0062 | Inf | 0.0062 | 1 | 1 | G/U mismatch-specific uracil-DNA glycosylase activity |
| GO:0047969 | 0.0062 | Inf | 0.0062 | 1 | 1 | glyoxylate oxidase activity |
| GO:0050051 | 0.0062 | Inf | 0.0062 | 1 | 1 | leukotriene-B4 20-monooxygenase activity |
| GO:0052871 | 0.0062 | Inf | 0.0062 | 1 | 1 | alpha-tocopherol omega-hydroxylase activity |
| GO:0097258 | 0.0062 | Inf | 0.0062 | 1 | 1 | 20-hydroxy-leukotriene B4 omega oxidase activity |
| GO:0097259 | 0.0062 | Inf | 0.0062 | 1 | 1 | 20-aldehyde-leukotriene B4 20-monooxygenase activity |
| GO:0015077 | 0.0069 | 3.8113 | 1.6908 | 6 | 274 | monovalent inorganic cation transmembrane transporter activity |
| GO:0015075 | 0.007 | 2.696 | 4.0543 | 10 | 657 | ion transmembrane transporter activity |
| GO:0061134 | 0.007 | 5.6397 | 0.759 | 4 | 123 | peptidase regulator activity |
| GO:0016878 | 0.0073 | 17.3513 | 0.1296 | 2 | 21 | acid-thiol ligase activity |
| GO:0015301 | 0.008 | 16.4825 | 0.1358 | 2 | 22 | anion:anion antiporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016165 | 3e-04 | Inf | 0.0358 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0016801 | 6e-04 | 23.7866 | 0.1791 | 3 | 10 | hydrolase activity, acting on ether bonds |
| GO:0031492 | 8e-04 | 7.7575 | 0.7343 | 5 | 41 | nucleosomal DNA binding |
| GO:0030020 | 0.0031 | 36.8559 | 0.0896 | 2 | 5 | extracellular matrix structural constituent conferring tensile strength |
| GO:0043546 | 0.0031 | 36.8559 | 0.0896 | 2 | 5 | molybdopterin cofactor binding |
| GO:0001077 | 0.0034 | 2.7747 | 4.2091 | 11 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0003680 | 0.0063 | 22.1102 | 0.1254 | 2 | 7 | AT DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 206.0079 | 0.0967 | 4 | 5 | molybdopterin cofactor binding |
| GO:0030151 | 0 | 153.8976 | 0.0774 | 3 | 4 | molybdenum ion binding |
| GO:0016165 | 4e-04 | Inf | 0.0387 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0005201 | 4e-04 | 7.0556 | 0.967 | 6 | 50 | extracellular matrix structural constituent |
| GO:0005164 | 5e-04 | 12.8607 | 0.3868 | 4 | 20 | tumor necrosis factor receptor binding |
| GO:0008940 | 0.0011 | 102.1961 | 0.058 | 2 | 3 | nitrate reductase activity |
| GO:0015247 | 0.0036 | 34.0601 | 0.0967 | 2 | 5 | aminophospholipid transporter activity |
| GO:0016701 | 0.004 | 10.9817 | 0.3288 | 3 | 17 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
| GO:0047617 | 0.004 | 10.9817 | 0.3288 | 3 | 17 | acyl-CoA hydrolase activity |
| GO:0005184 | 0.0047 | 10.2488 | 0.3481 | 3 | 18 | neuropeptide hormone activity |
| GO:1901612 | 0.0073 | 20.4329 | 0.1354 | 2 | 7 | cardiolipin binding |
| GO:0102991 | 0.0097 | 17.0261 | 0.1547 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0030414 | 0.0097 | 3.5158 | 1.818 | 6 | 94 | peptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038023 | 7e-04 | 2.6418 | 7.0981 | 17 | 720 | signaling receptor activity |
| GO:0099600 | 9e-04 | 2.6684 | 6.5855 | 16 | 668 | transmembrane receptor activity |
| GO:0004966 | 9e-04 | 67.9793 | 0.0493 | 2 | 5 | galanin receptor activity |
| GO:0008528 | 0.002 | 6.0313 | 0.8971 | 5 | 91 | G-protein coupled peptide receptor activity |
| GO:0004930 | 0.0022 | 3.7187 | 2.3113 | 8 | 244 | G-protein coupled receptor activity |
| GO:0004954 | 0.0026 | 33.9819 | 0.0789 | 2 | 8 | prostanoid receptor activity |
| GO:0060089 | 0.0034 | 2.1982 | 8.9417 | 18 | 907 | molecular transducer activity |
| GO:0030547 | 0.006 | 20.3829 | 0.1183 | 2 | 12 | receptor inhibitor activity |
| GO:0004252 | 0.006 | 4.622 | 1.1534 | 5 | 117 | serine-type endopeptidase activity |
| GO:0008307 | 0.0061 | 8.7871 | 0.3746 | 3 | 38 | structural constituent of muscle |
| GO:0097493 | 0.007 | 18.5285 | 0.1282 | 2 | 13 | structural molecule activity conferring elasticity |
| GO:1903231 | 0.0077 | 5.4938 | 0.7788 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004950 | 0.0081 | 16.9832 | 0.138 | 2 | 14 | chemokine receptor activity |
| GO:0003951 | 0.0093 | 15.6756 | 0.1479 | 2 | 15 | NAD+ kinase activity |
| GO:0001785 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostaglandin J receptor activity |
| GO:0003858 | 0.0099 | Inf | 0.0099 | 1 | 1 | 3-hydroxybutyrate dehydrogenase activity |
| GO:0004607 | 0.0099 | Inf | 0.0099 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0004667 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostaglandin-D synthase activity |
| GO:0004956 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostaglandin D receptor activity |
| GO:0008147 | 0.0099 | Inf | 0.0099 | 1 | 1 | structural constituent of bone |
| GO:0008843 | 0.0099 | Inf | 0.0099 | 1 | 1 | endochitinase activity |
| GO:0016501 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.0099 | Inf | 0.0099 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0031703 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 2 angiotensin receptor binding |
| GO:0031764 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 1 galanin receptor binding |
| GO:0031765 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 2 galanin receptor binding |
| GO:0031766 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 3 galanin receptor binding |
| GO:0033791 | 0.0099 | Inf | 0.0099 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0038182 | 0.0099 | Inf | 0.0099 | 1 | 1 | G-protein coupled bile acid receptor activity |
| GO:0097573 | 0.0099 | Inf | 0.0099 | 1 | 1 | glutathione oxidoreductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005094 | 3e-04 | 205.5781 | 0.0293 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0030246 | 0.0019 | 4.2716 | 1.761 | 7 | 180 | carbohydrate binding |
| GO:0001846 | 0.0049 | 22.8281 | 0.1076 | 2 | 11 | opsonin binding |
| GO:0005070 | 0.006 | 8.8569 | 0.3718 | 3 | 38 | SH3/SH2 adaptor activity |
| GO:0033293 | 0.0074 | 8.1558 | 0.4011 | 3 | 41 | monocarboxylic acid binding |
| GO:1903231 | 0.0075 | 5.5378 | 0.7729 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005159 | 0.008 | 17.1172 | 0.137 | 2 | 14 | insulin-like growth factor receptor binding |
| GO:0008092 | 0.0093 | 2.1708 | 6.9168 | 14 | 707 | cytoskeletal protein binding |
| GO:0001604 | 0.0098 | Inf | 0.0098 | 1 | 1 | urotensin II receptor activity |
| GO:0003937 | 0.0098 | Inf | 0.0098 | 1 | 1 | IMP cyclohydrolase activity |
| GO:0004137 | 0.0098 | Inf | 0.0098 | 1 | 1 | deoxycytidine kinase activity |
| GO:0004643 | 0.0098 | Inf | 0.0098 | 1 | 1 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity |
| GO:0004982 | 0.0098 | Inf | 0.0098 | 1 | 1 | N-formyl peptide receptor activity |
| GO:0005124 | 0.0098 | Inf | 0.0098 | 1 | 1 | scavenger receptor binding |
| GO:0005147 | 0.0098 | Inf | 0.0098 | 1 | 1 | oncostatin-M receptor binding |
| GO:0008579 | 0.0098 | Inf | 0.0098 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0035755 | 0.0098 | Inf | 0.0098 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0036487 | 0.0098 | Inf | 0.0098 | 1 | 1 | nitric-oxide synthase inhibitor activity |
| GO:0039552 | 0.0098 | Inf | 0.0098 | 1 | 1 | RIG-I binding |
| GO:0045485 | 0.0098 | Inf | 0.0098 | 1 | 1 | omega-6 fatty acid desaturase activity |
| GO:0047305 | 0.0098 | Inf | 0.0098 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0047747 | 0.0098 | Inf | 0.0098 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0098 | Inf | 0.0098 | 1 | 1 | calcium-dependent phospholipase C activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 37.5567 | 0.2804 | 8 | 54 | olfactory receptor activity |
| GO:0004930 | 1e-04 | 5.9138 | 1.7447 | 9 | 336 | G-protein coupled receptor activity |
| GO:0030414 | 0.0014 | 8.9771 | 0.4881 | 4 | 94 | peptidase inhibitor activity |
| GO:0005198 | 0.0017 | 3.6125 | 2.7833 | 9 | 536 | structural molecule activity |
| GO:0099600 | 0.0022 | 3.2355 | 3.4687 | 10 | 668 | transmembrane receptor activity |
| GO:0038023 | 0.0038 | 2.9862 | 3.7387 | 10 | 720 | signaling receptor activity |
| GO:0004507 | 0.0052 | Inf | 0.0052 | 1 | 1 | steroid 11-beta-monooxygenase activity |
| GO:0004982 | 0.0052 | Inf | 0.0052 | 1 | 1 | N-formyl peptide receptor activity |
| GO:0005124 | 0.0052 | Inf | 0.0052 | 1 | 1 | scavenger receptor binding |
| GO:0047305 | 0.0052 | Inf | 0.0052 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0047783 | 0.0052 | Inf | 0.0052 | 1 | 1 | corticosterone 18-monooxygenase activity |
| GO:0005539 | 0.006 | 5.9199 | 0.727 | 4 | 140 | glycosaminoglycan binding |
| GO:0060089 | 0.0067 | 2.6084 | 4.7097 | 11 | 907 | molecular transducer activity |
| GO:0005249 | 0.0072 | 8.1856 | 0.3946 | 3 | 76 | voltage-gated potassium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005201 | 2e-04 | 8.1824 | 0.8391 | 6 | 50 | extracellular matrix structural constituent |
| GO:0016165 | 3e-04 | Inf | 0.0336 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0004126 | 8e-04 | 118.2262 | 0.0503 | 2 | 3 | cytidine deaminase activity |
| GO:0016701 | 0.0027 | 12.712 | 0.2853 | 3 | 17 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
| GO:0043546 | 0.0027 | 39.4027 | 0.0839 | 2 | 5 | molybdopterin cofactor binding |
| GO:0005164 | 0.0043 | 10.4663 | 0.3356 | 3 | 20 | tumor necrosis factor receptor binding |
| GO:0005031 | 0.005 | 9.8841 | 0.3524 | 3 | 21 | tumor necrosis factor-activated receptor activity |
| GO:0033691 | 0.0056 | 23.638 | 0.1175 | 2 | 7 | sialic acid binding |
| GO:0004871 | 0.0082 | 1.7351 | 16.5807 | 27 | 988 | signal transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038023 | 1e-04 | 3.109 | 6.177 | 17 | 720 | signaling receptor activity |
| GO:0099600 | 2e-04 | 3.1356 | 5.7309 | 16 | 668 | transmembrane receptor activity |
| GO:0060089 | 2e-04 | 2.7671 | 7.7813 | 19 | 907 | molecular transducer activity |
| GO:0004966 | 7e-04 | 78.3988 | 0.0429 | 2 | 5 | galanin receptor activity |
| GO:0004930 | 0.001 | 4.2949 | 2.0236 | 8 | 245 | G-protein coupled receptor activity |
| GO:0008528 | 0.0011 | 6.981 | 0.7807 | 5 | 91 | G-protein coupled peptide receptor activity |
| GO:0050660 | 0.0018 | 8.3681 | 0.5233 | 4 | 61 | flavin adenine dinucleotide binding |
| GO:0004954 | 0.002 | 39.1905 | 0.0686 | 2 | 8 | prostanoid receptor activity |
| GO:0004950 | 0.0062 | 19.5863 | 0.1201 | 2 | 14 | chemokine receptor activity |
| GO:0003951 | 0.0071 | 18.0783 | 0.1287 | 2 | 15 | NAD+ kinase activity |
| GO:0016491 | 0.0077 | 2.4986 | 4.7271 | 11 | 551 | oxidoreductase activity |
| GO:0001785 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostaglandin J receptor activity |
| GO:0004607 | 0.0086 | Inf | 0.0086 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0004667 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostaglandin-D synthase activity |
| GO:0004956 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostaglandin D receptor activity |
| GO:0008147 | 0.0086 | Inf | 0.0086 | 1 | 1 | structural constituent of bone |
| GO:0008445 | 0.0086 | Inf | 0.0086 | 1 | 1 | D-aspartate oxidase activity |
| GO:0008843 | 0.0086 | Inf | 0.0086 | 1 | 1 | endochitinase activity |
| GO:0016501 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.0086 | Inf | 0.0086 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0031703 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 2 angiotensin receptor binding |
| GO:0031764 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 1 galanin receptor binding |
| GO:0031765 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 2 galanin receptor binding |
| GO:0031766 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 3 galanin receptor binding |
| GO:0033791 | 0.0086 | Inf | 0.0086 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0097573 | 0.0086 | Inf | 0.0086 | 1 | 1 | glutathione oxidoreductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0.0022 | 2.9687 | 3.9699 | 11 | 336 | G-protein coupled receptor activity |
| GO:0004896 | 0.0035 | 6.9799 | 0.6262 | 4 | 53 | cytokine receptor activity |
| GO:0030547 | 0.0085 | 16.9303 | 0.1418 | 2 | 12 | receptor inhibitor activity |
| GO:0005452 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | inorganic anion exchanger activity |
| GO:0097493 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | structural molecule activity conferring elasticity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030883 | 1e-04 | Inf | 0.0148 | 2 | 2 | endogenous lipid antigen binding |
| GO:0030884 | 1e-04 | Inf | 0.0148 | 2 | 2 | exogenous lipid antigen binding |
| GO:0005159 | 1e-04 | 37.8344 | 0.1033 | 3 | 14 | insulin-like growth factor receptor binding |
| GO:0004035 | 3e-04 | 137.375 | 0.0295 | 2 | 4 | alkaline phosphatase activity |
| GO:0071723 | 3e-04 | 137.375 | 0.0295 | 2 | 4 | lipopeptide binding |
| GO:0004984 | 7e-04 | 11.183 | 0.3983 | 4 | 54 | olfactory receptor activity |
| GO:0030881 | 8e-04 | 68.6771 | 0.0443 | 2 | 6 | beta-2-microglobulin binding |
| GO:0003823 | 0.0017 | 14.3314 | 0.236 | 3 | 32 | antigen binding |
| GO:0033204 | 0.0074 | Inf | 0.0074 | 1 | 1 | ribonuclease P RNA binding |
| GO:0047305 | 0.0074 | Inf | 0.0074 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0008483 | 0.0075 | 17.3342 | 0.1314 | 2 | 18 | transaminase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 16.7781 | 0.3454 | 5 | 54 | olfactory receptor activity |
| GO:0099600 | 1e-04 | 3.7836 | 4.273 | 14 | 668 | transmembrane receptor activity |
| GO:0038023 | 2e-04 | 3.4904 | 4.6057 | 14 | 720 | signaling receptor activity |
| GO:0060089 | 2e-04 | 3.2042 | 5.8019 | 16 | 907 | molecular transducer activity |
| GO:0032395 | 6e-04 | 79.512 | 0.0384 | 2 | 6 | MHC class II receptor activity |
| GO:0004866 | 0.0026 | 7.532 | 0.5757 | 4 | 90 | endopeptidase inhibitor activity |
| GO:0004930 | 0.0057 | 3.5117 | 2.1493 | 7 | 336 | G-protein coupled receptor activity |
| GO:0001594 | 0.0064 | Inf | 0.0064 | 1 | 1 | trace-amine receptor activity |
| GO:0001792 | 0.0064 | Inf | 0.0064 | 1 | 1 | polymeric immunoglobulin receptor activity |
| GO:0005477 | 0.0064 | Inf | 0.0064 | 1 | 1 | pyruvate secondary active transmembrane transporter activity |
| GO:0019150 | 0.0064 | Inf | 0.0064 | 1 | 1 | D-ribulokinase activity |
| GO:0036105 | 0.0064 | Inf | 0.0064 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
| GO:0047730 | 0.0064 | Inf | 0.0064 | 1 | 1 | carnosine synthase activity |
| GO:0102102 | 0.0064 | Inf | 0.0064 | 1 | 1 | homocarnosine synthase activity |
| GO:0004252 | 0.0067 | 5.7205 | 0.7484 | 4 | 117 | serine-type endopeptidase activity |
| GO:0061134 | 0.008 | 5.4296 | 0.7868 | 4 | 123 | peptidase regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004890 | 8e-04 | 21.5584 | 0.1904 | 3 | 11 | GABA-A receptor activity |
| GO:0004364 | 0.0024 | 13.2616 | 0.2769 | 3 | 16 | glutathione transferase activity |
| GO:0016229 | 0.0034 | 11.4916 | 0.3116 | 3 | 18 | steroid dehydrogenase activity |
| GO:0005005 | 0.0059 | 22.9 | 0.1212 | 2 | 7 | transmembrane-ephrin receptor activity |
| GO:0016723 | 0.0078 | 19.0819 | 0.1385 | 2 | 8 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
| GO:1990825 | 0.0078 | 19.0819 | 0.1385 | 2 | 8 | sequence-specific mRNA binding |
| GO:0046914 | 0.0091 | 1.7757 | 14.3317 | 24 | 828 | transition metal ion binding |
| GO:0000182 | 0.0099 | 16.3546 | 0.1558 | 2 | 9 | rDNA binding |
| GO:0004303 | 0.0099 | 16.3546 | 0.1558 | 2 | 9 | estradiol 17-beta-dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0052689 | 8e-04 | 5.0944 | 1.4968 | 7 | 102 | carboxylic ester hydrolase activity |
| GO:0016493 | 0.0021 | 45.2159 | 0.0734 | 2 | 5 | C-C chemokine receptor activity |
| GO:0019957 | 0.0021 | 45.2159 | 0.0734 | 2 | 5 | C-C chemokine binding |
| GO:0008528 | 0.0022 | 4.8583 | 1.3354 | 6 | 91 | G-protein coupled peptide receptor activity |
| GO:0003680 | 0.0043 | 27.1254 | 0.1027 | 2 | 7 | AT DNA binding |
| GO:0008381 | 0.0057 | 22.6028 | 0.1174 | 2 | 8 | mechanically-gated ion channel activity |
| GO:0005201 | 0.0061 | 5.9399 | 0.7337 | 4 | 50 | extracellular matrix structural constituent |
| GO:0046030 | 0.0072 | 19.3723 | 0.1321 | 2 | 9 | inositol trisphosphate phosphatase activity |
| GO:0001077 | 0.0079 | 2.7549 | 3.4486 | 9 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0005509 | 0.0085 | 2.112 | 7.5135 | 15 | 512 | calcium ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 3e-04 | 3.267 | 4.7393 | 14 | 512 | calcium ion binding |
| GO:0038023 | 3e-04 | 2.843 | 6.6647 | 17 | 720 | signaling receptor activity |
| GO:0099600 | 4e-04 | 2.8698 | 6.1833 | 16 | 668 | transmembrane receptor activity |
| GO:0004930 | 0.0011 | 3.4853 | 3.1102 | 10 | 336 | G-protein coupled receptor activity |
| GO:0060089 | 0.0017 | 2.3672 | 8.3956 | 18 | 907 | molecular transducer activity |
| GO:0015103 | 0.009 | 5.2345 | 0.8146 | 4 | 88 | inorganic anion transmembrane transporter activity |
| GO:0001604 | 0.0093 | Inf | 0.0093 | 1 | 1 | urotensin II receptor activity |
| GO:0004310 | 0.0093 | Inf | 0.0093 | 1 | 1 | farnesyl-diphosphate farnesyltransferase activity |
| GO:0004963 | 0.0093 | Inf | 0.0093 | 1 | 1 | follicle-stimulating hormone receptor activity |
| GO:0004964 | 0.0093 | Inf | 0.0093 | 1 | 1 | luteinizing hormone receptor activity |
| GO:0019782 | 0.0093 | Inf | 0.0093 | 1 | 1 | ISG15 activating enzyme activity |
| GO:0030899 | 0.0093 | Inf | 0.0093 | 1 | 1 | calcium-dependent ATPase activity |
| GO:0035472 | 0.0093 | Inf | 0.0093 | 1 | 1 | choriogonadotropin hormone receptor activity |
| GO:0036105 | 0.0093 | Inf | 0.0093 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
| GO:0038106 | 0.0093 | Inf | 0.0093 | 1 | 1 | choriogonadotropin hormone binding |
| GO:0046556 | 0.0093 | Inf | 0.0093 | 1 | 1 | alpha-L-arabinofuranosidase activity |
| GO:0047305 | 0.0093 | Inf | 0.0093 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0050429 | 0.0093 | Inf | 0.0093 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0051996 | 0.0093 | Inf | 0.0093 | 1 | 1 | squalene synthase activity |
| GO:0090409 | 0.0093 | Inf | 0.0093 | 1 | 1 | malonyl-CoA synthetase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099600 | 1e-04 | 2.9653 | 7.5406 | 20 | 668 | transmembrane receptor activity |
| GO:0060089 | 1e-04 | 2.6436 | 10.2386 | 24 | 907 | molecular transducer activity |
| GO:0032394 | 1e-04 | Inf | 0.0226 | 2 | 2 | MHC class Ib receptor activity |
| GO:0005509 | 2e-04 | 3.0433 | 5.7797 | 16 | 512 | calcium ion binding |
| GO:0004930 | 4e-04 | 3.4391 | 3.7929 | 12 | 336 | G-protein coupled receptor activity |
| GO:0038023 | 0.001 | 2.5454 | 7.295 | 17 | 661 | signaling receptor activity |
| GO:0051378 | 0.0018 | 44.3716 | 0.0677 | 2 | 6 | serotonin binding |
| GO:0004993 | 0.0034 | 29.5766 | 0.0903 | 2 | 8 | G-protein coupled serotonin receptor activity |
| GO:0005338 | 0.0034 | 29.5766 | 0.0903 | 2 | 8 | nucleotide-sugar transmembrane transporter activity |
| GO:0030594 | 0.0044 | 6.5171 | 0.666 | 4 | 59 | neurotransmitter receptor activity |
| GO:0005102 | 0.0085 | 1.8588 | 12.801 | 22 | 1134 | receptor binding |
| GO:0023026 | 0.0091 | 16.1265 | 0.1467 | 2 | 13 | MHC class II protein complex binding |
| GO:0042923 | 0.0091 | 16.1265 | 0.1467 | 2 | 13 | neuropeptide binding |
| GO:0005507 | 0.0096 | 7.4274 | 0.4402 | 3 | 39 | copper ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042169 | 0.005 | 9.6929 | 0.3518 | 3 | 25 | SH2 domain binding |
| GO:1903231 | 0.0051 | 4.8363 | 1.1118 | 5 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005132 | 1e-04 | Inf | 0.0208 | 2 | 2 | type I interferon receptor binding |
| GO:0071855 | 0.0011 | 17.1673 | 0.2077 | 3 | 20 | neuropeptide receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015079 | 3e-04 | 5.0703 | 1.7219 | 8 | 130 | potassium ion transmembrane transporter activity |
| GO:0070405 | 4e-04 | 8.8868 | 0.6358 | 5 | 48 | ammonium ion binding |
| GO:0008569 | 7e-04 | 20.6532 | 0.1854 | 3 | 14 | ATP-dependent microtubule motor activity, minus-end-directed |
| GO:0015057 | 0.001 | 75.3448 | 0.053 | 2 | 4 | thrombin-activated receptor activity |
| GO:0022890 | 0.0015 | 2.6909 | 5.5894 | 14 | 422 | inorganic cation transmembrane transporter activity |
| GO:0005251 | 0.0016 | 15.141 | 0.2384 | 3 | 18 | delayed rectifier potassium channel activity |
| GO:1990239 | 0.0017 | 50.2261 | 0.0662 | 2 | 5 | steroid hormone binding |
| GO:0045503 | 0.0022 | 13.3577 | 0.2649 | 3 | 20 | dynein light chain binding |
| GO:0042623 | 0.0022 | 2.9476 | 3.9868 | 11 | 301 | ATPase activity, coupled |
| GO:0022803 | 0.0028 | 2.7158 | 4.7152 | 12 | 356 | passive transmembrane transporter activity |
| GO:0031681 | 0.0035 | 30.131 | 0.0927 | 2 | 7 | G-protein beta-subunit binding |
| GO:0044183 | 0.0042 | 10.3179 | 0.3311 | 3 | 25 | protein binding involved in protein folding |
| GO:0022838 | 0.0047 | 2.6565 | 4.3974 | 11 | 332 | substrate-specific channel activity |
| GO:0019829 | 0.0049 | 6.3295 | 0.6887 | 4 | 52 | cation-transporting ATPase activity |
| GO:0004930 | 0.0052 | 2.623 | 4.4503 | 11 | 336 | G-protein coupled receptor activity |
| GO:0042626 | 0.0054 | 4.7632 | 1.1258 | 5 | 85 | ATPase activity, coupled to transmembrane movement of substances |
| GO:0005391 | 0.0059 | 21.5189 | 0.1192 | 2 | 9 | sodium:potassium-exchanging ATPase activity |
| GO:0015075 | 0.0064 | 2.0836 | 8.702 | 17 | 657 | ion transmembrane transporter activity |
| GO:0022836 | 0.0064 | 2.8541 | 3.3377 | 9 | 252 | gated channel activity |
| GO:0015485 | 0.0071 | 8.404 | 0.3974 | 3 | 30 | cholesterol binding |
| GO:0030594 | 0.0077 | 5.5209 | 0.7815 | 4 | 59 | neurotransmitter receptor activity |
| GO:0015399 | 0.0078 | 4.3275 | 1.2318 | 5 | 93 | primary active transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060089 | 3e-04 | 2.5505 | 9.2147 | 21 | 907 | molecular transducer activity |
| GO:0099600 | 4e-04 | 2.7667 | 6.7866 | 17 | 668 | transmembrane receptor activity |
| GO:0004930 | 6e-04 | 3.5014 | 3.4136 | 11 | 336 | G-protein coupled receptor activity |
| GO:0016494 | 0.001 | 65.9148 | 0.0508 | 2 | 5 | C-X-C chemokine receptor activity |
| GO:0098634 | 0.0015 | 49.4323 | 0.061 | 2 | 6 | cell-matrix adhesion mediator activity |
| GO:0046873 | 0.0026 | 3.0894 | 3.4746 | 10 | 342 | metal ion transmembrane transporter activity |
| GO:0015026 | 0.0028 | 11.9345 | 0.2845 | 3 | 28 | coreceptor activity |
| GO:0038023 | 0.0037 | 2.3579 | 6.8887 | 15 | 692 | signaling receptor activity |
| GO:0099094 | 0.0038 | 6.7766 | 0.6401 | 4 | 63 | ligand-gated cation channel activity |
| GO:0097153 | 0.0044 | 24.7086 | 0.1016 | 2 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0008324 | 0.0049 | 2.5374 | 5.0696 | 12 | 499 | cation transmembrane transporter activity |
| GO:0032403 | 0.0051 | 2.3389 | 6.4411 | 14 | 634 | protein complex binding |
| GO:0005216 | 0.0062 | 2.883 | 3.3222 | 9 | 327 | ion channel activity |
| GO:0050998 | 0.0063 | 19.7639 | 0.1219 | 2 | 12 | nitric-oxide synthase binding |
| GO:0015077 | 0.0069 | 3.0518 | 2.7837 | 8 | 274 | monovalent inorganic cation transmembrane transporter activity |
| GO:0005249 | 0.0074 | 5.5475 | 0.7721 | 4 | 76 | voltage-gated potassium channel activity |
| GO:0001637 | 0.0086 | 16.4674 | 0.1422 | 2 | 14 | G-protein coupled chemoattractant receptor activity |
| GO:0019956 | 0.0086 | 16.4674 | 0.1422 | 2 | 14 | chemokine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016165 | 3e-04 | Inf | 0.0334 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0005089 | 8e-04 | 6.0213 | 1.1026 | 6 | 66 | Rho guanyl-nucleotide exchange factor activity |
| GO:0005509 | 0.0024 | 2.2455 | 8.5539 | 18 | 512 | calcium ion binding |
| GO:0015247 | 0.0027 | 39.5848 | 0.0835 | 2 | 5 | aminophospholipid transporter activity |
| GO:0016493 | 0.0027 | 39.5848 | 0.0835 | 2 | 5 | C-C chemokine receptor activity |
| GO:0043546 | 0.0027 | 39.5848 | 0.0835 | 2 | 5 | molybdopterin cofactor binding |
| GO:0008307 | 0.0036 | 7.0329 | 0.6349 | 4 | 38 | structural constituent of muscle |
| GO:0031490 | 0.0049 | 4.0966 | 1.5704 | 6 | 94 | chromatin DNA binding |
| GO:0016803 | 0.0093 | 16.9597 | 0.1504 | 2 | 9 | ether hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 2e-04 | 15.4894 | 0.2926 | 4 | 54 | olfactory receptor activity |
| GO:0004952 | 6e-04 | 75.4914 | 0.0379 | 2 | 7 | dopamine neurotransmitter receptor activity |
| GO:0030414 | 0.0017 | 8.5791 | 0.5093 | 4 | 94 | peptidase inhibitor activity |
| GO:0060089 | 0.0033 | 2.7533 | 4.9145 | 12 | 907 | molecular transducer activity |
| GO:0042056 | 0.0042 | 23.5714 | 0.0975 | 2 | 18 | chemoattractant activity |
| GO:0005504 | 0.0052 | 20.9492 | 0.1084 | 2 | 20 | fatty acid binding |
| GO:0038023 | 0.0052 | 2.841 | 3.9013 | 10 | 720 | signaling receptor activity |
| GO:0004507 | 0.0054 | Inf | 0.0054 | 1 | 1 | steroid 11-beta-monooxygenase activity |
| GO:0004982 | 0.0054 | Inf | 0.0054 | 1 | 1 | N-formyl peptide receptor activity |
| GO:0005124 | 0.0054 | Inf | 0.0054 | 1 | 1 | scavenger receptor binding |
| GO:0031727 | 0.0054 | Inf | 0.0054 | 1 | 1 | CCR2 chemokine receptor binding |
| GO:0033560 | 0.0054 | Inf | 0.0054 | 1 | 1 | folate reductase activity |
| GO:0047305 | 0.0054 | Inf | 0.0054 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0047783 | 0.0054 | Inf | 0.0054 | 1 | 1 | corticosterone 18-monooxygenase activity |
| GO:0008324 | 0.0054 | 3.2396 | 2.7038 | 8 | 499 | cation transmembrane transporter activity |
| GO:0005539 | 0.007 | 5.6574 | 0.7586 | 4 | 140 | glycosaminoglycan binding |
| GO:0042379 | 0.0087 | 15.7048 | 0.1409 | 2 | 26 | chemokine receptor binding |
| GO:0022838 | 0.0091 | 3.5945 | 1.7989 | 6 | 332 | substrate-specific channel activity |
| GO:0099600 | 0.0097 | 2.7221 | 3.6195 | 9 | 668 | transmembrane receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005094 | 4e-04 | 178.7483 | 0.0336 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0004871 | 0.0015 | 2.1829 | 11.0786 | 22 | 988 | signal transducer activity |
| GO:1903231 | 0.0019 | 6.1303 | 0.8858 | 5 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0017080 | 0.0045 | 9.9787 | 0.3364 | 3 | 30 | sodium channel regulator activity |
| GO:0030169 | 0.0077 | 17.8626 | 0.1346 | 2 | 12 | low-density lipoprotein particle binding |
| GO:0003779 | 0.0087 | 2.7142 | 3.5097 | 9 | 313 | actin binding |
| GO:0042923 | 0.009 | 16.2375 | 0.1458 | 2 | 13 | neuropeptide binding |
| GO:0098772 | 0.0094 | 1.7752 | 15.3059 | 25 | 1365 | molecular function regulator |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007275 | 0 | 2.7167 | 50.5353 | 100 | 2732 | multicellular organism development |
| GO:0007156 | 0 | 6.6793 | 3.1465 | 18 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0022610 | 0 | 2.5847 | 26.476 | 59 | 1279 | biological adhesion |
| GO:0007399 | 0 | 2.7976 | 18.979 | 46 | 983 | nervous system development |
| GO:0098609 | 0 | 2.8203 | 15.5254 | 39 | 750 | cell-cell adhesion |
| GO:0045944 | 0 | 2.3195 | 21.6114 | 45 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0009888 | 0 | 1.9352 | 32.8493 | 57 | 1611 | tissue development |
| GO:0051254 | 0 | 1.9703 | 29.2085 | 52 | 1411 | positive regulation of RNA metabolic process |
| GO:1903508 | 0 | 1.9876 | 27.7801 | 50 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:2000026 | 0 | 1.8668 | 35.7705 | 60 | 1728 | regulation of multicellular organismal development |
| GO:0048699 | 0 | 1.9773 | 27.304 | 49 | 1319 | generation of neurons |
| GO:0070848 | 0 | 2.4297 | 12.9585 | 29 | 626 | response to growth factor |
| GO:0048513 | 0 | 1.7814 | 46.0457 | 72 | 2387 | animal organ development |
| GO:0009653 | 1e-04 | 1.9759 | 25.1763 | 45 | 1302 | anatomical structure morphogenesis |
| GO:0060538 | 1e-04 | 4.0875 | 3.2086 | 12 | 155 | skeletal muscle organ development |
| GO:0042476 | 1e-04 | 4.6652 | 2.3599 | 10 | 114 | odontogenesis |
| GO:0007267 | 1e-04 | 1.8514 | 30.2021 | 51 | 1459 | cell-cell signaling |
| GO:0042127 | 1e-04 | 2.1522 | 16.662 | 33 | 841 | regulation of cell proliferation |
| GO:0003278 | 2e-04 | 47.7532 | 0.1242 | 3 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0001558 | 2e-04 | 2.7327 | 7.4729 | 19 | 361 | regulation of cell growth |
| GO:0001568 | 2e-04 | 2.317 | 12.0684 | 26 | 583 | blood vessel development |
| GO:0061061 | 2e-04 | 2.317 | 12.0684 | 26 | 583 | muscle structure development |
| GO:0090288 | 3e-04 | 4.1078 | 2.6497 | 10 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0010557 | 4e-04 | 1.7561 | 32.2928 | 52 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0035914 | 4e-04 | 5.8166 | 1.3455 | 7 | 65 | skeletal muscle cell differentiation |
| GO:0031328 | 4e-04 | 1.7189 | 34.9425 | 55 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0072358 | 5e-04 | 2.1901 | 12.7101 | 26 | 614 | cardiovascular system development |
| GO:0009792 | 5e-04 | 2.2675 | 11.3232 | 24 | 547 | embryo development ending in birth or egg hatching |
| GO:0072073 | 5e-04 | 3.9075 | 2.7739 | 10 | 134 | kidney epithelium development |
| GO:0060216 | 5e-04 | 12.7648 | 0.3933 | 4 | 19 | definitive hemopoiesis |
| GO:0010720 | 6e-04 | 2.3699 | 9.4601 | 21 | 457 | positive regulation of cell development |
| GO:0055002 | 6e-04 | 3.7547 | 2.8774 | 10 | 139 | striated muscle cell development |
| GO:0008285 | 7e-04 | 2.1297 | 13.0413 | 26 | 630 | negative regulation of cell proliferation |
| GO:0070886 | 7e-04 | 23.8718 | 0.1863 | 3 | 9 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0042060 | 7e-04 | 2.2756 | 10.3089 | 22 | 498 | wound healing |
| GO:0045596 | 8e-04 | 2.1325 | 12.5031 | 25 | 604 | negative regulation of cell differentiation |
| GO:0023052 | 9e-04 | 1.5143 | 78.0026 | 102 | 4065 | signaling |
| GO:0001649 | 9e-04 | 3.1334 | 4.0987 | 12 | 198 | osteoblast differentiation |
| GO:0048146 | 9e-04 | 5.8859 | 1.1385 | 6 | 55 | positive regulation of fibroblast proliferation |
| GO:0033690 | 9e-04 | 20.4602 | 0.207 | 3 | 10 | positive regulation of osteoblast proliferation |
| GO:0050665 | 9e-04 | 20.4602 | 0.207 | 3 | 10 | hydrogen peroxide biosynthetic process |
| GO:0030198 | 0.001 | 2.587 | 6.5828 | 16 | 318 | extracellular matrix organization |
| GO:0009719 | 0.001 | 1.7194 | 28.8565 | 46 | 1394 | response to endogenous stimulus |
| GO:0051962 | 0.001 | 2.3038 | 9.2324 | 20 | 446 | positive regulation of nervous system development |
| GO:0032924 | 0.0011 | 7.2674 | 0.7866 | 5 | 38 | activin receptor signaling pathway |
| GO:0060348 | 0.0011 | 3.2318 | 3.6433 | 11 | 176 | bone development |
| GO:0035295 | 0.0013 | 2.1318 | 11.4681 | 23 | 554 | tube development |
| GO:0003350 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | pulmonary myocardium development |
| GO:0042335 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | cuticle development |
| GO:2000254 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | regulation of male germ cell proliferation |
| GO:0007512 | 0.0013 | 17.9014 | 0.2277 | 3 | 11 | adult heart development |
| GO:0032964 | 0.0013 | 6.8512 | 0.828 | 5 | 40 | collagen biosynthetic process |
| GO:0007166 | 0.0014 | 1.5361 | 52.1446 | 73 | 2519 | cell surface receptor signaling pathway |
| GO:0030878 | 0.0014 | 9.5704 | 0.4968 | 4 | 24 | thyroid gland development |
| GO:0048762 | 0.0015 | 3.1171 | 3.7675 | 11 | 182 | mesenchymal cell differentiation |
| GO:0014706 | 0.0016 | 2.4705 | 6.8714 | 16 | 334 | striated muscle tissue development |
| GO:0007154 | 0.0016 | 1.4791 | 78.3864 | 101 | 4085 | cell communication |
| GO:0071773 | 0.0016 | 3.291 | 3.25 | 10 | 157 | cellular response to BMP stimulus |
| GO:0010922 | 0.0016 | 9.1141 | 0.5175 | 4 | 25 | positive regulation of phosphatase activity |
| GO:0060415 | 0.0016 | 16.1075 | 0.2455 | 3 | 12 | muscle tissue morphogenesis |
| GO:0060707 | 0.0017 | 15.9113 | 0.2484 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0090596 | 0.0017 | 2.746 | 5.0302 | 13 | 243 | sensory organ morphogenesis |
| GO:0007588 | 0.0017 | 5.1477 | 1.2834 | 6 | 62 | excretion |
| GO:0010718 | 0.0021 | 6.1468 | 0.9108 | 5 | 44 | positive regulation of epithelial to mesenchymal transition |
| GO:0045666 | 0.0022 | 2.4672 | 6.4379 | 15 | 311 | positive regulation of neuron differentiation |
| GO:0043588 | 0.0022 | 2.4588 | 6.4586 | 15 | 312 | skin development |
| GO:0001954 | 0.0023 | 5.9927 | 0.9315 | 5 | 45 | positive regulation of cell-matrix adhesion |
| GO:0001994 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0048852 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | diencephalon morphogenesis |
| GO:0060018 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | astrocyte fate commitment |
| GO:0061325 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0010628 | 0.0026 | 1.5869 | 35.253 | 52 | 1703 | positive regulation of gene expression |
| GO:0003231 | 0.0028 | 3.5696 | 2.4013 | 8 | 116 | cardiac ventricle development |
| GO:0044259 | 0.0028 | 3.5696 | 2.4013 | 8 | 116 | multicellular organismal macromolecule metabolic process |
| GO:0051216 | 0.003 | 3.0019 | 3.5398 | 10 | 171 | cartilage development |
| GO:0030512 | 0.003 | 4.5736 | 1.4283 | 6 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0048869 | 0.0032 | 1.6195 | 31.6481 | 47 | 1722 | cellular developmental process |
| GO:1901890 | 0.0032 | 7.3589 | 0.621 | 4 | 30 | positive regulation of cell junction assembly |
| GO:0030516 | 0.0032 | 4.5018 | 1.449 | 6 | 70 | regulation of axon extension |
| GO:0001667 | 0.0033 | 2.3535 | 6.7277 | 15 | 325 | ameboidal-type cell migration |
| GO:0003206 | 0.0033 | 3.4724 | 2.4634 | 8 | 119 | cardiac chamber morphogenesis |
| GO:0031960 | 0.0034 | 3.1698 | 3.0223 | 9 | 146 | response to corticosteroid |
| GO:0050768 | 0.0036 | 2.6189 | 4.8439 | 12 | 234 | negative regulation of neurogenesis |
| GO:0048706 | 0.0037 | 3.4105 | 2.5048 | 8 | 121 | embryonic skeletal system development |
| GO:0003002 | 0.0037 | 2.3979 | 6.1595 | 14 | 300 | regionalization |
| GO:0048705 | 0.0038 | 2.729 | 4.2643 | 11 | 206 | skeletal system morphogenesis |
| GO:0010810 | 0.0038 | 2.8929 | 3.664 | 10 | 177 | regulation of cell-substrate adhesion |
| GO:0051241 | 0.0039 | 1.7264 | 20.2658 | 33 | 979 | negative regulation of multicellular organismal process |
| GO:0090257 | 0.004 | 2.7149 | 4.285 | 11 | 207 | regulation of muscle system process |
| GO:0021515 | 0.004 | 5.209 | 1.0557 | 5 | 51 | cell differentiation in spinal cord |
| GO:0071260 | 0.004 | 4.2994 | 1.5111 | 6 | 73 | cellular response to mechanical stimulus |
| GO:0006590 | 0.004 | 11.0126 | 0.3312 | 3 | 16 | thyroid hormone generation |
| GO:0045165 | 0.0041 | 2.5718 | 4.9267 | 12 | 238 | cell fate commitment |
| GO:0036093 | 0.0041 | 31.7338 | 0.1035 | 2 | 5 | germ cell proliferation |
| GO:0051270 | 0.0043 | 1.7979 | 16.4569 | 28 | 795 | regulation of cellular component movement |
| GO:0010001 | 0.0043 | 2.8413 | 3.7261 | 10 | 180 | glial cell differentiation |
| GO:0001655 | 0.0044 | 2.3518 | 6.2723 | 14 | 303 | urogenital system development |
| GO:0014902 | 0.0045 | 3.6586 | 2.0494 | 7 | 99 | myotube differentiation |
| GO:0071560 | 0.0046 | 2.6599 | 4.3678 | 11 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0071385 | 0.0047 | 4.9913 | 1.0971 | 5 | 53 | cellular response to glucocorticoid stimulus |
| GO:0048856 | 0.0047 | 24.8897 | 0.1072 | 2 | 8 | anatomical structure development |
| GO:0048666 | 0.0048 | 1.7165 | 19.7276 | 32 | 953 | neuron development |
| GO:0003198 | 0.0048 | 10.2253 | 0.3519 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0106056 | 0.0048 | 10.2253 | 0.3519 | 3 | 17 | regulation of calcineurin-mediated signaling |
| GO:0032526 | 0.005 | 3.5803 | 2.0908 | 7 | 101 | response to retinoic acid |
| GO:0048562 | 0.0052 | 2.3868 | 5.734 | 13 | 277 | embryonic organ morphogenesis |
| GO:0048468 | 0.0053 | 1.8361 | 14.4141 | 25 | 739 | cell development |
| GO:0008016 | 0.0054 | 2.5941 | 4.4713 | 11 | 216 | regulation of heart contraction |
| GO:0032989 | 0.0054 | 1.6988 | 19.9139 | 32 | 962 | cellular component morphogenesis |
| GO:0030220 | 0.0057 | 9.5429 | 0.3726 | 3 | 18 | platelet formation |
| GO:0007417 | 0.0057 | 1.7391 | 17.5955 | 29 | 850 | central nervous system development |
| GO:0045637 | 0.0058 | 2.5687 | 4.5127 | 11 | 218 | regulation of myeloid cell differentiation |
| GO:0046958 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | nonassociative learning |
| GO:0072014 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | proximal tubule development |
| GO:2000489 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | regulation of hepatic stellate cell activation |
| GO:0001501 | 0.0062 | 3.8905 | 1.6534 | 6 | 84 | skeletal system development |
| GO:0060412 | 0.0063 | 5.9767 | 0.7452 | 4 | 36 | ventricular septum morphogenesis |
| GO:0001525 | 0.0067 | 2.0524 | 8.6942 | 17 | 420 | angiogenesis |
| GO:0048593 | 0.0068 | 3.3641 | 2.215 | 7 | 107 | camera-type eye morphogenesis |
| GO:0003407 | 0.0069 | 4.5189 | 1.2006 | 5 | 58 | neural retina development |
| GO:0060193 | 0.0069 | 4.5189 | 1.2006 | 5 | 58 | positive regulation of lipase activity |
| GO:0007162 | 0.0071 | 2.4954 | 4.6369 | 11 | 224 | negative regulation of cell adhesion |
| GO:0030334 | 0.0074 | 1.7997 | 14.0143 | 24 | 677 | regulation of cell migration |
| GO:0030219 | 0.0075 | 3.7385 | 1.7181 | 6 | 83 | megakaryocyte differentiation |
| GO:0030510 | 0.0075 | 3.7385 | 1.7181 | 6 | 83 | regulation of BMP signaling pathway |
| GO:0040012 | 0.0076 | 1.7325 | 16.3948 | 27 | 792 | regulation of locomotion |
| GO:0045777 | 0.0076 | 5.6244 | 0.7866 | 4 | 38 | positive regulation of blood pressure |
| GO:0002695 | 0.0077 | 2.9842 | 2.836 | 8 | 137 | negative regulation of leukocyte activation |
| GO:0035929 | 0.0077 | 8.4191 | 0.414 | 3 | 20 | steroid hormone secretion |
| GO:0051716 | 0.0084 | 1.3231 | 129.7095 | 151 | 6266 | cellular response to stimulus |
| GO:0003253 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0045650 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | negative regulation of macrophage differentiation |
| GO:0060215 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | primitive hemopoiesis |
| GO:0040007 | 0.0084 | 2.1683 | 6.7744 | 14 | 337 | growth |
| GO:0031214 | 0.0087 | 3.2028 | 2.3185 | 7 | 112 | biomineral tissue development |
| GO:0097435 | 0.0087 | 1.8788 | 11.1576 | 20 | 539 | supramolecular fiber organization |
| GO:0003181 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | atrioventricular valve morphogenesis |
| GO:0021516 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | dorsal spinal cord development |
| GO:0060972 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | left/right pattern formation |
| GO:0001775 | 0.0089 | 1.5797 | 24.7371 | 37 | 1195 | cell activation |
| GO:0030003 | 0.0091 | 1.8714 | 11.199 | 20 | 541 | cellular cation homeostasis |
| GO:0048844 | 0.0091 | 4.2006 | 1.2834 | 5 | 62 | artery morphogenesis |
| GO:0003170 | 0.0092 | 5.3112 | 0.828 | 4 | 40 | heart valve development |
| GO:0072210 | 0.0092 | 5.3112 | 0.828 | 4 | 40 | metanephric nephron development |
| GO:0043583 | 0.0092 | 2.5253 | 4.1608 | 10 | 201 | ear development |
| GO:0048589 | 0.0092 | 1.8677 | 11.2197 | 20 | 542 | developmental growth |
| GO:0055008 | 0.0097 | 4.1279 | 1.3041 | 5 | 63 | cardiac muscle tissue morphogenesis |
| GO:0050868 | 0.0098 | 3.5094 | 1.8216 | 6 | 88 | negative regulation of T cell activation |
| GO:0010559 | 0.01 | 5.1673 | 0.8487 | 4 | 41 | regulation of glycoprotein biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045944 | 0 | 2.5086 | 30.942 | 68 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048562 | 0 | 3.8592 | 8.2097 | 28 | 277 | embryonic organ morphogenesis |
| GO:0048706 | 0 | 5.5223 | 3.5862 | 17 | 121 | embryonic skeletal system development |
| GO:0010628 | 0 | 1.916 | 50.4734 | 86 | 1703 | positive regulation of gene expression |
| GO:0051094 | 0 | 2.1003 | 34.4096 | 65 | 1161 | positive regulation of developmental process |
| GO:1903508 | 0 | 2.0188 | 39.7741 | 72 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0051254 | 0 | 1.9715 | 41.8191 | 74 | 1411 | positive regulation of RNA metabolic process |
| GO:0009792 | 0 | 2.5772 | 16.2119 | 38 | 547 | embryo development ending in birth or egg hatching |
| GO:0072358 | 0 | 2.477 | 18.1977 | 41 | 614 | cardiovascular system development |
| GO:0051240 | 0 | 1.9498 | 41.6151 | 73 | 1410 | positive regulation of multicellular organismal process |
| GO:0031328 | 0 | 1.8209 | 50.0288 | 82 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0048536 | 0 | 9.5053 | 1.067 | 8 | 36 | spleen development |
| GO:0090596 | 0 | 4.9642 | 2.9837 | 13 | 102 | sensory organ morphogenesis |
| GO:2000026 | 0 | 1.8831 | 39.2369 | 67 | 1372 | regulation of multicellular organismal development |
| GO:0003151 | 0 | 5.8345 | 2.1932 | 11 | 74 | outflow tract morphogenesis |
| GO:0048468 | 0 | 2.0695 | 25.9209 | 49 | 904 | cell development |
| GO:0010557 | 0 | 1.7839 | 46.2351 | 75 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0051241 | 0 | 2.2063 | 19.1874 | 39 | 665 | negative regulation of multicellular organismal process |
| GO:0001568 | 0 | 2.3453 | 14.754 | 32 | 503 | blood vessel development |
| GO:0008284 | 0 | 2.0402 | 23.3309 | 44 | 792 | positive regulation of cell proliferation |
| GO:0060429 | 0 | 1.9112 | 30.0988 | 53 | 1029 | epithelium development |
| GO:0030878 | 1e-04 | 11.0472 | 0.7113 | 6 | 24 | thyroid gland development |
| GO:0030858 | 1e-04 | 5.875 | 1.7783 | 9 | 60 | positive regulation of epithelial cell differentiation |
| GO:0022603 | 1e-04 | 1.9188 | 27.0001 | 48 | 911 | regulation of anatomical structure morphogenesis |
| GO:0060485 | 1e-04 | 6.6051 | 1.4275 | 8 | 49 | mesenchyme development |
| GO:0021879 | 1e-04 | 6.4857 | 1.4523 | 8 | 49 | forebrain neuron differentiation |
| GO:0048646 | 1e-04 | 2.223 | 15.5062 | 32 | 545 | anatomical structure formation involved in morphogenesis |
| GO:0006355 | 1e-04 | 1.5032 | 100.0279 | 134 | 3375 | regulation of transcription, DNA-templated |
| GO:0019219 | 1e-04 | 1.4775 | 116.5362 | 152 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0032502 | 1e-04 | 1.5446 | 96.0719 | 128 | 3688 | developmental process |
| GO:0048729 | 1e-04 | 2.1186 | 17.7531 | 35 | 599 | tissue morphogenesis |
| GO:2001141 | 1e-04 | 1.4878 | 100.7985 | 134 | 3401 | regulation of RNA biosynthetic process |
| GO:0042474 | 1e-04 | 12.7225 | 0.5335 | 5 | 18 | middle ear morphogenesis |
| GO:0048863 | 1e-04 | 2.8169 | 7.2909 | 19 | 246 | stem cell differentiation |
| GO:0033993 | 2e-04 | 1.8923 | 24.9551 | 44 | 842 | response to lipid |
| GO:0023019 | 2e-04 | 11.8129 | 0.5631 | 5 | 19 | signal transduction involved in regulation of gene expression |
| GO:0060455 | 2e-04 | 49.433 | 0.1482 | 3 | 5 | negative regulation of gastric acid secretion |
| GO:0051954 | 3e-04 | 7.9502 | 0.9188 | 6 | 31 | positive regulation of amine transport |
| GO:0030154 | 3e-04 | 1.8464 | 27.1493 | 46 | 1060 | cell differentiation |
| GO:0048701 | 3e-04 | 6.2761 | 1.3041 | 7 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0009889 | 4e-04 | 1.5152 | 74.7062 | 102 | 2632 | regulation of biosynthetic process |
| GO:0048665 | 4e-04 | 7.3603 | 0.9781 | 6 | 33 | neuron fate specification |
| GO:0035909 | 4e-04 | 7.097 | 1.0077 | 6 | 34 | aorta morphogenesis |
| GO:0021902 | 5e-04 | 32.9531 | 0.1778 | 3 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0042713 | 5e-04 | 32.9531 | 0.1778 | 3 | 6 | sperm ejaculation |
| GO:2001199 | 5e-04 | 32.9531 | 0.1778 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0007368 | 5e-04 | 3.63 | 3.3194 | 11 | 112 | determination of left/right symmetry |
| GO:0045766 | 5e-04 | 3.3645 | 3.8826 | 12 | 131 | positive regulation of angiogenesis |
| GO:0030198 | 5e-04 | 2.3792 | 9.4249 | 21 | 318 | extracellular matrix organization |
| GO:0048644 | 6e-04 | 4.2144 | 2.371 | 9 | 80 | muscle organ morphogenesis |
| GO:0007275 | 6e-04 | 1.5261 | 67.1827 | 92 | 2608 | multicellular organism development |
| GO:0060411 | 6e-04 | 4.6601 | 1.9265 | 8 | 65 | cardiac septum morphogenesis |
| GO:1901342 | 7e-04 | 2.5161 | 7.6466 | 18 | 258 | regulation of vasculature development |
| GO:0001667 | 7e-04 | 2.3233 | 9.6323 | 21 | 325 | ameboidal-type cell migration |
| GO:0060037 | 7e-04 | 8.2657 | 0.7409 | 5 | 25 | pharyngeal system development |
| GO:0045596 | 7e-04 | 1.9467 | 17.471 | 32 | 593 | negative regulation of cell differentiation |
| GO:0008630 | 8e-04 | 3.6977 | 2.9638 | 10 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0007498 | 8e-04 | 3.425 | 3.4973 | 11 | 118 | mesoderm development |
| GO:0071772 | 8e-04 | 3.0138 | 4.6532 | 13 | 157 | response to BMP |
| GO:0034127 | 8e-04 | 24.7132 | 0.2075 | 3 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0002930 | 9e-04 | Inf | 0.0593 | 2 | 2 | trabecular meshwork development |
| GO:1901246 | 9e-04 | Inf | 0.0593 | 2 | 2 | regulation of lung ciliated cell differentiation |
| GO:2000824 | 9e-04 | Inf | 0.0593 | 2 | 2 | negative regulation of androgen receptor activity |
| GO:0043583 | 0.001 | 2.6968 | 5.9572 | 15 | 201 | ear development |
| GO:0009799 | 0.001 | 3.3007 | 3.6158 | 11 | 122 | specification of symmetry |
| GO:0050789 | 0.001 | 1.4401 | 174.6937 | 202 | 6364 | regulation of biological process |
| GO:0001709 | 0.0011 | 5.8422 | 1.1855 | 6 | 40 | cell fate determination |
| GO:0071363 | 0.0012 | 1.8883 | 17.9606 | 32 | 606 | cellular response to growth factor stimulus |
| GO:0016101 | 0.0012 | 3.7855 | 2.6081 | 9 | 88 | diterpenoid metabolic process |
| GO:0009605 | 0.0012 | 1.5012 | 56.5788 | 79 | 1909 | response to external stimulus |
| GO:0034654 | 0.0013 | 1.3759 | 118.1663 | 147 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0035050 | 0.0013 | 4.1484 | 2.1339 | 8 | 72 | embryonic heart tube development |
| GO:0002520 | 0.0013 | 1.7389 | 25.0144 | 41 | 844 | immune system development |
| GO:0010940 | 0.0013 | 19.7692 | 0.2371 | 3 | 8 | positive regulation of necrotic cell death |
| GO:0048486 | 0.0013 | 10.1552 | 0.5038 | 4 | 17 | parasympathetic nervous system development |
| GO:0051173 | 0.0014 | 1.4257 | 80.7337 | 106 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0007417 | 0.0015 | 1.7252 | 25.1922 | 41 | 850 | central nervous system development |
| GO:0010092 | 0.0015 | 6.8862 | 0.8595 | 5 | 29 | specification of animal organ identity |
| GO:0048513 | 0.0015 | 1.5333 | 48.6522 | 69 | 1827 | animal organ development |
| GO:0019098 | 0.0017 | 6.6103 | 0.8891 | 5 | 30 | reproductive behavior |
| GO:0042221 | 0.0018 | 1.7041 | 26.3856 | 42 | 943 | response to chemical |
| GO:0006334 | 0.0018 | 3.26 | 3.3194 | 10 | 112 | nucleosome assembly |
| GO:0030900 | 0.0018 | 2.143 | 10.3733 | 21 | 350 | forebrain development |
| GO:0060180 | 0.0019 | 16.4732 | 0.2667 | 3 | 9 | female mating behavior |
| GO:2000288 | 0.0019 | 16.4732 | 0.2667 | 3 | 9 | positive regulation of myoblast proliferation |
| GO:0060322 | 0.0019 | 1.7908 | 20.0649 | 34 | 677 | head development |
| GO:0035176 | 0.002 | 5.0914 | 1.3337 | 6 | 45 | social behavior |
| GO:0071774 | 0.002 | 3.0008 | 3.9418 | 11 | 133 | response to fibroblast growth factor |
| GO:0003205 | 0.002 | 2.8353 | 4.5346 | 12 | 153 | cardiac chamber development |
| GO:0001525 | 0.0021 | 2.2681 | 8.4099 | 18 | 289 | angiogenesis |
| GO:0003215 | 0.0021 | 8.8 | 0.5631 | 4 | 19 | cardiac right ventricle morphogenesis |
| GO:0042403 | 0.0021 | 8.8 | 0.5631 | 4 | 19 | thyroid hormone metabolic process |
| GO:0060216 | 0.0021 | 8.8 | 0.5631 | 4 | 19 | definitive hemopoiesis |
| GO:0045595 | 0.0022 | 1.6568 | 28.1831 | 44 | 990 | regulation of cell differentiation |
| GO:0007631 | 0.0022 | 3.4356 | 2.8452 | 9 | 96 | feeding behavior |
| GO:0001818 | 0.0023 | 2.4558 | 6.4907 | 15 | 219 | negative regulation of cytokine production |
| GO:0032649 | 0.0023 | 3.7376 | 2.3414 | 8 | 79 | regulation of interferon-gamma production |
| GO:0007399 | 0.0025 | 1.5751 | 35.8227 | 53 | 1258 | nervous system development |
| GO:0021544 | 0.0025 | 8.2494 | 0.5928 | 4 | 20 | subpallium development |
| GO:0043032 | 0.0025 | 8.2494 | 0.5928 | 4 | 20 | positive regulation of macrophage activation |
| GO:0055008 | 0.0025 | 4.1413 | 1.8672 | 7 | 63 | cardiac muscle tissue morphogenesis |
| GO:0002125 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | maternal aggressive behavior |
| GO:0003285 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | septum secundum development |
| GO:0003350 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | pulmonary myocardium development |
| GO:0014717 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0021912 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035054 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0055014 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0060741 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0061010 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | gall bladder development |
| GO:0061031 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:1902869 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | regulation of amacrine cell differentiation |
| GO:2000297 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | negative regulation of synapse maturation |
| GO:0009887 | 0.0026 | 2.0019 | 12.1325 | 23 | 433 | animal organ morphogenesis |
| GO:0007369 | 0.0026 | 2.6104 | 5.3052 | 13 | 179 | gastrulation |
| GO:0001708 | 0.0027 | 4.7826 | 1.4067 | 6 | 48 | cell fate specification |
| GO:0061072 | 0.0027 | 14.1189 | 0.2964 | 3 | 10 | iris morphogenesis |
| GO:0042475 | 0.0027 | 3.6347 | 2.4007 | 8 | 81 | odontogenesis of dentin-containing tooth |
| GO:0042220 | 0.0028 | 4.7268 | 1.4226 | 6 | 48 | response to cocaine |
| GO:0048583 | 0.003 | 1.3501 | 106.5779 | 132 | 3596 | regulation of response to stimulus |
| GO:0007263 | 0.0031 | 7.7637 | 0.6224 | 4 | 21 | nitric oxide mediated signal transduction |
| GO:0043586 | 0.0031 | 7.7637 | 0.6224 | 4 | 21 | tongue development |
| GO:0048762 | 0.0031 | 2.5636 | 5.3941 | 13 | 182 | mesenchymal cell differentiation |
| GO:0008543 | 0.0031 | 3.2477 | 2.9934 | 9 | 101 | fibroblast growth factor receptor signaling pathway |
| GO:1903707 | 0.0032 | 2.9938 | 3.5862 | 10 | 121 | negative regulation of hemopoiesis |
| GO:0048663 | 0.0033 | 5.5716 | 1.0258 | 5 | 35 | neuron fate commitment |
| GO:0007601 | 0.0034 | 2.5332 | 5.4534 | 13 | 184 | visual perception |
| GO:0048705 | 0.0034 | 2.4318 | 6.1054 | 14 | 206 | skeletal system morphogenesis |
| GO:0007618 | 0.0035 | 5.5067 | 1.0373 | 5 | 35 | mating |
| GO:0035295 | 0.0036 | 2.0139 | 10.9855 | 21 | 379 | tube development |
| GO:0010454 | 0.0036 | 12.3532 | 0.326 | 3 | 11 | negative regulation of cell fate commitment |
| GO:0021903 | 0.0036 | 12.3532 | 0.326 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0048484 | 0.0036 | 12.3532 | 0.326 | 3 | 11 | enteric nervous system development |
| GO:0042743 | 0.004 | 5.3287 | 1.067 | 5 | 36 | hydrogen peroxide metabolic process |
| GO:0071542 | 0.004 | 5.3287 | 1.067 | 5 | 36 | dopaminergic neuron differentiation |
| GO:0072009 | 0.004 | 3.1116 | 3.112 | 9 | 105 | nephron epithelium development |
| GO:0030509 | 0.0042 | 2.7094 | 4.3271 | 11 | 146 | BMP signaling pathway |
| GO:0045686 | 0.0043 | 6.9455 | 0.6817 | 4 | 23 | negative regulation of glial cell differentiation |
| GO:0090103 | 0.0043 | 6.9455 | 0.6817 | 4 | 23 | cochlea morphogenesis |
| GO:0060541 | 0.0044 | 2.4464 | 5.6312 | 13 | 190 | respiratory system development |
| GO:0042472 | 0.0044 | 3.7081 | 2.0594 | 7 | 70 | inner ear morphogenesis |
| GO:0030818 | 0.0045 | 5.1619 | 1.0966 | 5 | 37 | negative regulation of cAMP biosynthetic process |
| GO:0030814 | 0.0045 | 2.8391 | 3.764 | 10 | 127 | regulation of cAMP metabolic process |
| GO:0048565 | 0.0045 | 2.8391 | 3.764 | 10 | 127 | digestive tract development |
| GO:0060537 | 0.0045 | 2.0051 | 10.4918 | 20 | 354 | muscle tissue development |
| GO:0061061 | 0.0046 | 1.7629 | 17.2789 | 29 | 583 | muscle structure development |
| GO:0043306 | 0.0047 | 10.9799 | 0.3557 | 3 | 12 | positive regulation of mast cell degranulation |
| GO:0055015 | 0.0047 | 10.9799 | 0.3557 | 3 | 12 | ventricular cardiac muscle cell development |
| GO:0097154 | 0.0047 | 10.9799 | 0.3557 | 3 | 12 | GABAergic neuron differentiation |
| GO:0030099 | 0.0047 | 1.999 | 10.5215 | 20 | 355 | myeloid cell differentiation |
| GO:0001707 | 0.005 | 3.6217 | 2.1043 | 7 | 71 | mesoderm formation |
| GO:0002886 | 0.005 | 5.0051 | 1.1262 | 5 | 38 | regulation of myeloid leukocyte mediated immunity |
| GO:0001975 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | response to amphetamine |
| GO:0042554 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | superoxide anion generation |
| GO:0060487 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | lung epithelial cell differentiation |
| GO:0061217 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | regulation of mesonephros development |
| GO:0001992 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0002580 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0007621 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | negative regulation of female receptivity |
| GO:0010701 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of norepinephrine secretion |
| GO:0021764 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | amygdala development |
| GO:0021913 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0060406 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of penile erection |
| GO:0061055 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | myotome development |
| GO:0072107 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0090191 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905205 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:0009890 | 0.0052 | 1.4637 | 44.8125 | 62 | 1512 | negative regulation of biosynthetic process |
| GO:0003002 | 0.0052 | 2.9681 | 3.2449 | 9 | 113 | regionalization |
| GO:0010469 | 0.0056 | 1.817 | 14.4337 | 25 | 487 | regulation of receptor activity |
| GO:0090132 | 0.0058 | 2.2035 | 7.1724 | 15 | 242 | epithelium migration |
| GO:0039528 | 0.0059 | 6.2832 | 0.7409 | 4 | 25 | cytoplasmic pattern recognition receptor signaling pathway in response to virus |
| GO:0061548 | 0.0059 | 9.8812 | 0.3853 | 3 | 13 | ganglion development |
| GO:0090196 | 0.0059 | 9.8812 | 0.3853 | 3 | 13 | regulation of chemokine secretion |
| GO:0030802 | 0.0062 | 2.6995 | 3.9418 | 10 | 133 | regulation of cyclic nucleotide biosynthetic process |
| GO:0046849 | 0.0062 | 3.4588 | 2.1932 | 7 | 74 | bone remodeling |
| GO:0043300 | 0.0063 | 4.7184 | 1.1855 | 5 | 40 | regulation of leukocyte degranulation |
| GO:0045446 | 0.0063 | 3.1191 | 2.7563 | 8 | 93 | endothelial cell differentiation |
| GO:0060255 | 0.0064 | 1.2805 | 165.2017 | 191 | 5574 | regulation of macromolecule metabolic process |
| GO:0048666 | 0.0065 | 1.5618 | 28.2449 | 42 | 953 | neuron development |
| GO:0001947 | 0.0066 | 3.8903 | 1.6894 | 6 | 57 | heart looping |
| GO:0043066 | 0.0066 | 1.6166 | 23.3547 | 36 | 788 | negative regulation of apoptotic process |
| GO:0050830 | 0.0067 | 3.4077 | 2.2228 | 7 | 75 | defense response to Gram-positive bacterium |
| GO:0050866 | 0.0068 | 2.5209 | 4.6235 | 11 | 156 | negative regulation of cell activation |
| GO:0009952 | 0.0069 | 2.4011 | 5.2805 | 12 | 180 | anterior/posterior pattern specification |
| GO:0021700 | 0.007 | 2.1553 | 7.3206 | 15 | 247 | developmental maturation |
| GO:0010951 | 0.007 | 2.3015 | 5.9572 | 13 | 201 | negative regulation of endopeptidase activity |
| GO:0007611 | 0.0071 | 2.2206 | 6.6389 | 14 | 224 | learning or memory |
| GO:0070887 | 0.0072 | 1.3412 | 81.3264 | 102 | 2744 | cellular response to chemical stimulus |
| GO:0045995 | 0.0072 | 2.8161 | 3.4084 | 9 | 115 | regulation of embryonic development |
| GO:0003407 | 0.0072 | 3.8152 | 1.719 | 6 | 58 | neural retina development |
| GO:0051937 | 0.0072 | 3.8152 | 1.719 | 6 | 58 | catecholamine transport |
| GO:0042711 | 0.0074 | 8.9823 | 0.4149 | 3 | 14 | maternal behavior |
| GO:0030809 | 0.0077 | 4.4628 | 1.2448 | 5 | 42 | negative regulation of nucleotide biosynthetic process |
| GO:0048522 | 0.0077 | 1.3137 | 106.0444 | 128 | 3784 | positive regulation of cellular process |
| GO:0033006 | 0.0078 | 5.736 | 0.8002 | 4 | 27 | regulation of mast cell activation involved in immune response |
| GO:0042572 | 0.0078 | 5.736 | 0.8002 | 4 | 27 | retinol metabolic process |
| GO:0060706 | 0.0078 | 5.736 | 0.8002 | 4 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0042127 | 0.0078 | 1.676 | 18.7764 | 30 | 670 | regulation of cell proliferation |
| GO:0060041 | 0.0079 | 3.2961 | 2.2897 | 7 | 78 | retina development in camera-type eye |
| GO:0051122 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0051891 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0061009 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | common bile duct development |
| GO:0071502 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | cellular response to temperature stimulus |
| GO:1903232 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | melanosome assembly |
| GO:2000609 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | regulation of thyroid hormone generation |
| GO:2001188 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0048870 | 0.0084 | 1.4558 | 39.7444 | 55 | 1341 | cell motility |
| GO:0048699 | 0.0084 | 1.6652 | 18.8758 | 30 | 654 | generation of neurons |
| GO:0006720 | 0.0085 | 2.738 | 3.4973 | 9 | 118 | isoprenoid metabolic process |
| GO:0030800 | 0.0085 | 4.3451 | 1.2744 | 5 | 43 | negative regulation of cyclic nucleotide metabolic process |
| GO:0050433 | 0.0085 | 4.3451 | 1.2744 | 5 | 43 | regulation of catecholamine secretion |
| GO:0050767 | 0.0087 | 1.6452 | 19.7092 | 31 | 665 | regulation of neurogenesis |
| GO:0043403 | 0.0089 | 5.4966 | 0.8299 | 4 | 28 | skeletal muscle tissue regeneration |
| GO:0007224 | 0.0089 | 2.713 | 3.5269 | 9 | 119 | smoothened signaling pathway |
| GO:0009950 | 0.009 | 8.2333 | 0.4446 | 3 | 15 | dorsal/ventral axis specification |
| GO:0033005 | 0.009 | 8.2333 | 0.4446 | 3 | 15 | positive regulation of mast cell activation |
| GO:2000484 | 0.009 | 8.2333 | 0.4446 | 3 | 15 | positive regulation of interleukin-8 secretion |
| GO:0001655 | 0.0091 | 1.9832 | 8.9803 | 17 | 303 | urogenital system development |
| GO:0007423 | 0.0092 | 2.4102 | 4.8156 | 11 | 169 | sensory organ development |
| GO:0048592 | 0.0093 | 2.5333 | 4.1789 | 10 | 141 | eye morphogenesis |
| GO:0048754 | 0.0093 | 2.5333 | 4.1789 | 10 | 141 | branching morphogenesis of an epithelial tube |
| GO:1900371 | 0.0093 | 2.5333 | 4.1789 | 10 | 141 | regulation of purine nucleotide biosynthetic process |
| GO:0002448 | 0.0094 | 4.2334 | 1.3041 | 5 | 44 | mast cell mediated immunity |
| GO:0060840 | 0.0095 | 3.1732 | 2.371 | 7 | 80 | artery development |
| GO:0050877 | 0.0095 | 1.5548 | 25.5775 | 38 | 863 | nervous system process |
| GO:0007389 | 0.0096 | 5.3368 | 0.847 | 4 | 30 | pattern specification process |
| GO:0007409 | 0.0098 | 1.8242 | 12.033 | 21 | 406 | axonogenesis |
| GO:0000122 | 0.0099 | 1.5906 | 22.347 | 34 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 1e-04 | 4.6802 | 2.5771 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0021562 | 3e-04 | 35.1859 | 0.1356 | 3 | 8 | vestibulocochlear nerve development |
| GO:0045165 | 3e-04 | 3.4986 | 3.691 | 12 | 220 | cell fate commitment |
| GO:0030198 | 4e-04 | 2.9858 | 5.3916 | 15 | 318 | extracellular matrix organization |
| GO:0050911 | 4e-04 | 6.9599 | 0.9664 | 6 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0032501 | 5e-04 | 1.6064 | 73.2952 | 97 | 4673 | multicellular organismal process |
| GO:0071626 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | mastication |
| GO:0098583 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | learned vocalization behavior |
| GO:1905747 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | negative regulation of saliva secretion |
| GO:1905748 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | hard palate morphogenesis |
| GO:0050482 | 0.001 | 10.2266 | 0.4578 | 4 | 27 | arachidonic acid secretion |
| GO:0008284 | 0.0012 | 2.0511 | 13.5807 | 26 | 801 | positive regulation of cell proliferation |
| GO:0050906 | 0.0016 | 3.9241 | 2.1872 | 8 | 129 | detection of stimulus involved in sensory perception |
| GO:0050900 | 0.0016 | 2.5467 | 6.2563 | 15 | 369 | leukocyte migration |
| GO:0034653 | 0.0017 | 58.4258 | 0.0678 | 2 | 4 | retinoic acid catabolic process |
| GO:0019372 | 0.0019 | 14.6539 | 0.2543 | 3 | 15 | lipoxygenase pathway |
| GO:0060429 | 0.0019 | 1.8398 | 18.6671 | 32 | 1101 | epithelium development |
| GO:0048333 | 0.0022 | 8.1075 | 0.5595 | 4 | 33 | mesodermal cell differentiation |
| GO:0048665 | 0.0022 | 8.1075 | 0.5595 | 4 | 33 | neuron fate specification |
| GO:0042246 | 0.0025 | 5.777 | 0.9495 | 5 | 56 | tissue regeneration |
| GO:0036148 | 0.0027 | 12.5588 | 0.2882 | 3 | 17 | phosphatidylglycerol acyl-chain remodeling |
| GO:0000467 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0007356 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | thorax and anterior abdomen determination |
| GO:0021650 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | vestibulocochlear nerve formation |
| GO:0043305 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | negative regulation of mast cell degranulation |
| GO:0071038 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | nuclear polyadenylation-dependent tRNA catabolic process |
| GO:0097070 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | ductus arteriosus closure |
| GO:1901078 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | negative regulation of relaxation of muscle |
| GO:0048856 | 0.0029 | 1.9347 | 14.6994 | 26 | 965 | anatomical structure development |
| GO:0042693 | 0.0033 | 11.7208 | 0.3052 | 3 | 18 | muscle cell fate commitment |
| GO:0009593 | 0.0036 | 3.7995 | 1.9667 | 7 | 116 | detection of chemical stimulus |
| GO:0007218 | 0.0038 | 4.3197 | 1.492 | 6 | 88 | neuropeptide signaling pathway |
| GO:0048557 | 0.0038 | 10.9875 | 0.3221 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:0001957 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | intramembranous ossification |
| GO:0016115 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | terpenoid catabolic process |
| GO:0060426 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | lung vasculature development |
| GO:0060842 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | arterial endothelial cell differentiation |
| GO:0061074 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | regulation of neural retina development |
| GO:0071029 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | nuclear ncRNA surveillance |
| GO:0071035 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | nuclear polyadenylation-dependent rRNA catabolic process |
| GO:1902302 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | regulation of potassium ion export |
| GO:0048568 | 0.0041 | 2.2939 | 6.9006 | 15 | 407 | embryonic organ development |
| GO:0001756 | 0.0043 | 5.0773 | 1.0681 | 5 | 63 | somitogenesis |
| GO:0070268 | 0.0053 | 4.0235 | 1.5937 | 6 | 94 | cornification |
| GO:0045927 | 0.0053 | 2.7522 | 3.8318 | 10 | 226 | positive regulation of growth |
| GO:0048731 | 0.0054 | 1.4198 | 71.0064 | 90 | 4188 | system development |
| GO:0071715 | 0.0055 | 6.1836 | 0.7121 | 4 | 42 | icosanoid transport |
| GO:0032429 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | regulation of phospholipase A2 activity |
| GO:0043634 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | polyadenylation-dependent ncRNA catabolic process |
| GO:0097623 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | potassium ion export across plasma membrane |
| GO:0098700 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
| GO:0045944 | 0.006 | 1.7397 | 17.7007 | 29 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0045686 | 0.0066 | 8.7876 | 0.39 | 3 | 23 | negative regulation of glial cell differentiation |
| GO:0048729 | 0.0067 | 1.9709 | 10.1559 | 19 | 599 | tissue morphogenesis |
| GO:0055007 | 0.0068 | 3.8059 | 1.6785 | 6 | 99 | cardiac muscle cell differentiation |
| GO:0006955 | 0.0069 | 1.5738 | 28.6026 | 42 | 1687 | immune response |
| GO:0003008 | 0.007 | 1.5967 | 26.1103 | 39 | 1540 | system process |
| GO:0010927 | 0.0071 | 3.7652 | 1.6955 | 6 | 100 | cellular component assembly involved in morphogenesis |
| GO:0007606 | 0.0073 | 3.3096 | 2.238 | 7 | 132 | sensory perception of chemical stimulus |
| GO:0072202 | 0.0075 | 8.3686 | 0.4069 | 3 | 24 | cell differentiation involved in metanephros development |
| GO:0031017 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | exocrine pancreas development |
| GO:0034475 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | U4 snRNA 3'-end processing |
| GO:0035881 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | amacrine cell differentiation |
| GO:0048743 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | positive regulation of skeletal muscle fiber development |
| GO:0045661 | 0.0075 | 5.5932 | 0.7799 | 4 | 46 | regulation of myoblast differentiation |
| GO:0060042 | 0.0075 | 5.5932 | 0.7799 | 4 | 46 | retina morphogenesis in camera-type eye |
| GO:0044236 | 0.0082 | 3.2314 | 2.2889 | 7 | 135 | multicellular organism metabolic process |
| GO:0036152 | 0.0084 | 7.9877 | 0.4239 | 3 | 25 | phosphatidylethanolamine acyl-chain remodeling |
| GO:1902253 | 0.0084 | 7.9877 | 0.4239 | 3 | 25 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0009605 | 0.0084 | 1.5253 | 32.3666 | 46 | 1909 | response to external stimulus |
| GO:0003002 | 0.0088 | 2.3127 | 5.4425 | 12 | 321 | regionalization |
| GO:0040011 | 0.0089 | 1.5699 | 26.5002 | 39 | 1563 | locomotion |
| GO:0072009 | 0.0089 | 3.5738 | 1.7802 | 6 | 105 | nephron epithelium development |
| GO:0070207 | 0.0094 | 7.6399 | 0.4408 | 3 | 26 | protein homotrimerization |
| GO:0050885 | 0.0094 | 5.2192 | 0.8308 | 4 | 49 | neuromuscular process controlling balance |
| GO:0015816 | 0.0095 | 16.6875 | 0.1526 | 2 | 9 | glycine transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006355 | 0 | 1.8523 | 99.5843 | 153 | 3375 | regulation of transcription, DNA-templated |
| GO:0009792 | 0 | 2.9975 | 16.14 | 43 | 547 | embryo development ending in birth or egg hatching |
| GO:2001141 | 0 | 1.8333 | 100.3515 | 153 | 3401 | regulation of RNA biosynthetic process |
| GO:0007389 | 0 | 4.3814 | 6.5168 | 25 | 229 | pattern specification process |
| GO:1903507 | 0 | 2.2985 | 32.8702 | 67 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0023019 | 0 | 24.3364 | 0.5606 | 8 | 19 | signal transduction involved in regulation of gene expression |
| GO:0051253 | 0 | 2.217 | 35.0242 | 69 | 1187 | negative regulation of RNA metabolic process |
| GO:0007423 | 0 | 2.9129 | 14.9303 | 39 | 506 | sensory organ development |
| GO:0048562 | 0 | 6.7812 | 2.6416 | 15 | 93 | embryonic organ morphogenesis |
| GO:0019219 | 0 | 1.6967 | 116.0195 | 165 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0000122 | 0 | 2.4436 | 22.2479 | 49 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0034654 | 0 | 1.6805 | 117.6423 | 166 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0010454 | 0 | 39.9901 | 0.3246 | 6 | 11 | negative regulation of cell fate commitment |
| GO:0009952 | 0 | 4.2247 | 5.3434 | 20 | 183 | anterior/posterior pattern specification |
| GO:0010648 | 0 | 2.0503 | 35.7323 | 66 | 1211 | negative regulation of cell communication |
| GO:0023057 | 0 | 2.0425 | 35.8504 | 66 | 1215 | negative regulation of signaling |
| GO:0045944 | 0 | 2.0734 | 30.8048 | 58 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048585 | 0 | 1.9329 | 40.6894 | 71 | 1379 | negative regulation of response to stimulus |
| GO:0009890 | 0 | 1.8917 | 44.6138 | 76 | 1512 | negative regulation of biosynthetic process |
| GO:0022008 | 0 | 2.0123 | 34.0266 | 62 | 1172 | neurogenesis |
| GO:0048704 | 0 | 5.544 | 2.7146 | 13 | 92 | embryonic skeletal system morphogenesis |
| GO:0048729 | 0 | 2.4953 | 15.3174 | 35 | 526 | tissue morphogenesis |
| GO:2000113 | 0 | 1.9004 | 40.0403 | 69 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0072175 | 0 | 4.4824 | 3.7768 | 15 | 128 | epithelial tube formation |
| GO:0001947 | 0 | 7.1347 | 1.6819 | 10 | 57 | heart looping |
| GO:1903508 | 0 | 1.8904 | 39.5977 | 68 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0051172 | 0 | 1.6927 | 66.0355 | 100 | 2238 | negative regulation of nitrogen compound metabolic process |
| GO:0003151 | 0 | 5.862 | 2.1835 | 11 | 74 | outflow tract morphogenesis |
| GO:0060255 | 0 | 1.5122 | 164.4691 | 208 | 5574 | regulation of macromolecule metabolic process |
| GO:0060485 | 0 | 3.2163 | 6.816 | 20 | 231 | mesenchyme development |
| GO:0070848 | 0 | 2.2297 | 18.4711 | 38 | 626 | response to growth factor |
| GO:0048839 | 0 | 3.5703 | 5.2522 | 17 | 178 | inner ear development |
| GO:0060322 | 0 | 2.1696 | 19.9759 | 40 | 677 | head development |
| GO:0003357 | 0 | 44.2397 | 0.2065 | 4 | 7 | noradrenergic neuron differentiation |
| GO:0061303 | 0 | 44.2397 | 0.2065 | 4 | 7 | cornea development in camera-type eye |
| GO:0014033 | 0 | 5.879 | 1.9769 | 10 | 67 | neural crest cell differentiation |
| GO:0016331 | 0 | 3.8917 | 4.2784 | 15 | 145 | morphogenesis of embryonic epithelium |
| GO:0035107 | 0 | 3.8917 | 4.2784 | 15 | 145 | appendage morphogenesis |
| GO:0009954 | 0 | 9.7293 | 0.9147 | 7 | 31 | proximal/distal pattern formation |
| GO:0031324 | 0 | 1.6288 | 70.3729 | 103 | 2385 | negative regulation of cellular metabolic process |
| GO:0010628 | 0 | 1.7281 | 50.2495 | 79 | 1703 | positive regulation of gene expression |
| GO:0051254 | 0 | 1.7841 | 41.6336 | 68 | 1411 | positive regulation of RNA metabolic process |
| GO:0030901 | 0 | 5.0555 | 2.4785 | 11 | 84 | midbrain development |
| GO:0001764 | 0 | 3.9619 | 3.9244 | 14 | 133 | neuron migration |
| GO:0048665 | 0 | 8.9796 | 0.9737 | 7 | 33 | neuron fate specification |
| GO:0035050 | 0 | 5.403 | 2.1245 | 10 | 72 | embryonic heart tube development |
| GO:0021915 | 1e-04 | 3.6375 | 4.544 | 15 | 154 | neural tube development |
| GO:0071901 | 1e-04 | 4.0854 | 3.5408 | 13 | 120 | negative regulation of protein serine/threonine kinase activity |
| GO:0031328 | 1e-04 | 1.6905 | 49.8069 | 77 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0009799 | 1e-04 | 4.0099 | 3.5998 | 13 | 122 | specification of symmetry |
| GO:0090287 | 1e-04 | 2.9768 | 6.934 | 19 | 235 | regulation of cellular response to growth factor stimulus |
| GO:0071542 | 1e-04 | 8.0491 | 1.0622 | 7 | 36 | dopaminergic neuron differentiation |
| GO:0043433 | 1e-04 | 3.9017 | 3.6883 | 13 | 125 | negative regulation of DNA binding transcription factor activity |
| GO:0030326 | 1e-04 | 3.8669 | 3.7178 | 13 | 126 | embryonic limb morphogenesis |
| GO:0014031 | 1e-04 | 5.5735 | 1.8589 | 9 | 63 | mesenchymal cell development |
| GO:0042662 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0070836 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | caveola assembly |
| GO:1902746 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | regulation of lens fiber cell differentiation |
| GO:1905903 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | negative regulation of mesoderm formation |
| GO:0048486 | 1e-04 | 13.8476 | 0.5016 | 5 | 17 | parasympathetic nervous system development |
| GO:0007368 | 1e-04 | 4.0278 | 3.3047 | 12 | 112 | determination of left/right symmetry |
| GO:0010629 | 1e-04 | 1.6537 | 50.043 | 76 | 1696 | negative regulation of gene expression |
| GO:0010470 | 1e-04 | 7.293 | 1.1508 | 7 | 39 | regulation of gastrulation |
| GO:0032502 | 1e-04 | 1.5004 | 110.9959 | 144 | 4066 | developmental process |
| GO:0010557 | 1e-04 | 1.6751 | 46.0301 | 71 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:2000678 | 1e-04 | 12.7815 | 0.5311 | 5 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0060173 | 2e-04 | 3.2584 | 5.0161 | 15 | 170 | limb development |
| GO:1901576 | 2e-04 | 1.4221 | 173.5571 | 211 | 5882 | organic substance biosynthetic process |
| GO:0001706 | 2e-04 | 5.8058 | 1.5933 | 8 | 54 | endoderm formation |
| GO:0009953 | 2e-04 | 4.492 | 2.4924 | 10 | 85 | dorsal/ventral pattern formation |
| GO:0044857 | 2e-04 | 49.6614 | 0.1475 | 3 | 5 | plasma membrane raft organization |
| GO:0046533 | 2e-04 | 49.6614 | 0.1475 | 3 | 5 | negative regulation of photoreceptor cell differentiation |
| GO:0048731 | 3e-04 | 1.5588 | 68.9197 | 96 | 2657 | system development |
| GO:1901861 | 3e-04 | 3.6592 | 3.5998 | 12 | 122 | regulation of muscle tissue development |
| GO:0048592 | 3e-04 | 3.4103 | 4.1604 | 13 | 141 | eye morphogenesis |
| GO:0007267 | 3e-04 | 1.6546 | 43.0499 | 66 | 1459 | cell-cell signaling |
| GO:0048485 | 3e-04 | 10.3829 | 0.6196 | 5 | 21 | sympathetic nervous system development |
| GO:0030900 | 3e-04 | 2.3843 | 10.3273 | 23 | 350 | forebrain development |
| GO:0045746 | 3e-04 | 7.6795 | 0.9442 | 6 | 32 | negative regulation of Notch signaling pathway |
| GO:0003207 | 3e-04 | 16.5843 | 0.3541 | 4 | 12 | cardiac chamber formation |
| GO:0097154 | 3e-04 | 16.5843 | 0.3541 | 4 | 12 | GABAergic neuron differentiation |
| GO:0048634 | 3e-04 | 3.5613 | 3.6883 | 12 | 125 | regulation of muscle organ development |
| GO:0007517 | 4e-04 | 2.7708 | 6.6019 | 17 | 228 | muscle organ development |
| GO:0042127 | 4e-04 | 1.639 | 43.404 | 66 | 1471 | regulation of cell proliferation |
| GO:0042471 | 4e-04 | 3.6837 | 3.2752 | 11 | 111 | ear morphogenesis |
| GO:0045597 | 4e-04 | 1.864 | 22.9113 | 40 | 784 | positive regulation of cell differentiation |
| GO:0045936 | 4e-04 | 2.0361 | 16.2286 | 31 | 550 | negative regulation of phosphate metabolic process |
| GO:0021544 | 5e-04 | 33.3824 | 0.1756 | 3 | 6 | subpallium development |
| GO:0045686 | 5e-04 | 9.228 | 0.6786 | 5 | 23 | negative regulation of glial cell differentiation |
| GO:0060022 | 5e-04 | 33.1054 | 0.177 | 3 | 6 | hard palate development |
| GO:0061074 | 5e-04 | 33.1054 | 0.177 | 3 | 6 | regulation of neural retina development |
| GO:0048646 | 5e-04 | 1.7864 | 26.9189 | 45 | 931 | anatomical structure formation involved in morphogenesis |
| GO:2000826 | 5e-04 | 6.8836 | 1.0327 | 6 | 35 | regulation of heart morphogenesis |
| GO:0048864 | 5e-04 | 4.8528 | 1.8589 | 8 | 63 | stem cell development |
| GO:1903524 | 5e-04 | 4.8528 | 1.8589 | 8 | 63 | positive regulation of blood circulation |
| GO:0021510 | 5e-04 | 3.8889 | 2.8326 | 10 | 96 | spinal cord development |
| GO:0071560 | 5e-04 | 2.7615 | 6.2259 | 16 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0009888 | 6e-04 | 1.816 | 24.7711 | 42 | 898 | tissue development |
| GO:0002088 | 6e-04 | 4.7658 | 1.8884 | 8 | 64 | lens development in camera-type eye |
| GO:0060914 | 6e-04 | 8.7417 | 0.7082 | 5 | 24 | heart formation |
| GO:0021756 | 6e-04 | 13.2656 | 0.4131 | 4 | 14 | striatum development |
| GO:0090304 | 6e-04 | 1.3867 | 141.6606 | 174 | 4801 | nucleic acid metabolic process |
| GO:0009798 | 6e-04 | 4.175 | 2.39 | 9 | 81 | axis specification |
| GO:0061138 | 6e-04 | 2.9571 | 5.1046 | 14 | 173 | morphogenesis of a branching epithelium |
| GO:0030182 | 7e-04 | 1.6911 | 32.8905 | 52 | 1144 | neuron differentiation |
| GO:0061053 | 7e-04 | 4.1175 | 2.4195 | 9 | 82 | somite development |
| GO:0045744 | 7e-04 | 6.4387 | 1.0917 | 6 | 37 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0051100 | 7e-04 | 3.2429 | 4.0129 | 12 | 136 | negative regulation of binding |
| GO:0045992 | 7e-04 | 8.3041 | 0.7377 | 5 | 25 | negative regulation of embryonic development |
| GO:0048596 | 7e-04 | 8.3041 | 0.7377 | 5 | 25 | embryonic camera-type eye morphogenesis |
| GO:0060562 | 7e-04 | 3.4437 | 3.4755 | 11 | 121 | epithelial tube morphogenesis |
| GO:0071773 | 8e-04 | 3.028 | 4.6325 | 13 | 157 | cellular response to BMP stimulus |
| GO:0060026 | 8e-04 | 12.0588 | 0.4426 | 4 | 15 | convergent extension |
| GO:0051093 | 8e-04 | 1.815 | 22.8562 | 39 | 782 | negative regulation of developmental process |
| GO:0021798 | 8e-04 | 24.8274 | 0.2065 | 3 | 7 | forebrain dorsal/ventral pattern formation |
| GO:2000096 | 8e-04 | 24.8274 | 0.2065 | 3 | 7 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0061458 | 8e-04 | 2.1615 | 11.8026 | 24 | 400 | reproductive system development |
| GO:0042221 | 9e-04 | 1.4027 | 108.7904 | 138 | 3687 | response to chemical |
| GO:0021903 | 9e-04 | Inf | 0.0587 | 2 | 2 | rostrocaudal neural tube patterning |
| GO:0014036 | 9e-04 | Inf | 0.059 | 2 | 2 | neural crest cell fate specification |
| GO:0021882 | 9e-04 | Inf | 0.059 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
| GO:0021893 | 9e-04 | Inf | 0.059 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
| GO:0071228 | 9e-04 | Inf | 0.059 | 2 | 2 | cellular response to tumor cell |
| GO:1902868 | 9e-04 | Inf | 0.059 | 2 | 2 | positive regulation of retina development in camera-type eye |
| GO:1902871 | 9e-04 | Inf | 0.059 | 2 | 2 | positive regulation of amacrine cell differentiation |
| GO:2001111 | 9e-04 | Inf | 0.059 | 2 | 2 | positive regulation of lens epithelial cell proliferation |
| GO:0048732 | 9e-04 | 2.1498 | 11.8616 | 24 | 402 | gland development |
| GO:0097746 | 0.001 | 3.3162 | 3.5998 | 11 | 122 | regulation of blood vessel diameter |
| GO:0061311 | 0.001 | 7.5481 | 0.7967 | 5 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0035270 | 0.001 | 3.2864 | 3.6293 | 11 | 123 | endocrine system development |
| GO:0071310 | 0.0011 | 1.5407 | 49.612 | 71 | 1731 | cellular response to organic substance |
| GO:0055024 | 0.0011 | 4.2342 | 2.095 | 8 | 71 | regulation of cardiac muscle tissue development |
| GO:0051101 | 0.0012 | 3.4814 | 3.1277 | 10 | 106 | regulation of DNA binding |
| GO:2000026 | 0.0012 | 1.5945 | 39.6033 | 59 | 1397 | regulation of multicellular organismal development |
| GO:0042659 | 0.0013 | 19.9473 | 0.2351 | 3 | 8 | regulation of cell fate specification |
| GO:0003310 | 0.0013 | 19.8605 | 0.2361 | 3 | 8 | pancreatic A cell differentiation |
| GO:1903251 | 0.0013 | 19.8605 | 0.2361 | 3 | 8 | multi-ciliated epithelial cell differentiation |
| GO:1905770 | 0.0013 | 19.8605 | 0.2361 | 3 | 8 | regulation of mesodermal cell differentiation |
| GO:0048332 | 0.0014 | 4.1034 | 2.154 | 8 | 73 | mesoderm morphogenesis |
| GO:0003203 | 0.0014 | 6.9182 | 0.8557 | 5 | 29 | endocardial cushion morphogenesis |
| GO:0031128 | 0.0014 | 6.9182 | 0.8557 | 5 | 29 | developmental induction |
| GO:0007519 | 0.0015 | 2.9544 | 4.367 | 12 | 148 | skeletal muscle tissue development |
| GO:0033673 | 0.0015 | 2.4024 | 7.5242 | 17 | 255 | negative regulation of kinase activity |
| GO:1905207 | 0.0015 | 5.3923 | 1.2688 | 6 | 43 | regulation of cardiocyte differentiation |
| GO:0009889 | 0.0016 | 1.4541 | 71.6334 | 95 | 2632 | regulation of biosynthetic process |
| GO:0031016 | 0.0016 | 3.9804 | 2.213 | 8 | 75 | pancreas development |
| GO:0048598 | 0.0016 | 2.6525 | 5.629 | 14 | 206 | embryonic morphogenesis |
| GO:0035150 | 0.0016 | 3.0916 | 3.8358 | 11 | 130 | regulation of tube size |
| GO:0051962 | 0.0017 | 2.0093 | 13.1599 | 25 | 446 | positive regulation of nervous system development |
| GO:0051148 | 0.0017 | 4.4819 | 1.7409 | 7 | 59 | negative regulation of muscle cell differentiation |
| GO:0051173 | 0.0017 | 1.4159 | 80.3756 | 105 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0051241 | 0.0018 | 1.6746 | 27.8541 | 44 | 953 | negative regulation of multicellular organismal process |
| GO:0009719 | 0.0018 | 1.5533 | 41.132 | 60 | 1394 | response to endogenous stimulus |
| GO:0030917 | 0.0019 | 16.5493 | 0.2656 | 3 | 9 | midbrain-hindbrain boundary development |
| GO:0048865 | 0.0019 | 16.5493 | 0.2656 | 3 | 9 | stem cell fate commitment |
| GO:0051240 | 0.002 | 1.6973 | 25.6235 | 41 | 906 | positive regulation of multicellular organismal process |
| GO:0006725 | 0.002 | 1.3303 | 165.2067 | 195 | 5599 | cellular aromatic compound metabolic process |
| GO:0001502 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | cartilage condensation |
| GO:0001710 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | mesodermal cell fate commitment |
| GO:0072079 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | nephron tubule formation |
| GO:2000050 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | regulation of non-canonical Wnt signaling pathway |
| GO:0071396 | 0.0021 | 1.8979 | 15.5794 | 28 | 528 | cellular response to lipid |
| GO:0030514 | 0.0025 | 4.8649 | 1.3868 | 6 | 47 | negative regulation of BMP signaling pathway |
| GO:0042476 | 0.0025 | 6.0071 | 0.9615 | 5 | 33 | odontogenesis |
| GO:0048468 | 0.0025 | 1.4796 | 51.9868 | 72 | 1790 | cell development |
| GO:0043576 | 0.0025 | 8.2876 | 0.5901 | 4 | 20 | regulation of respiratory gaseous exchange |
| GO:0019065 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | receptor-mediated endocytosis of virus by host cell |
| GO:0021558 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | trochlear nerve development |
| GO:0021912 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0033693 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | neurofilament bundle assembly |
| GO:0035880 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0001765 | 0.0026 | 14.1842 | 0.2951 | 3 | 10 | membrane raft assembly |
| GO:0021877 | 0.0026 | 14.1842 | 0.2951 | 3 | 10 | forebrain neuron fate commitment |
| GO:0050966 | 0.0026 | 14.1842 | 0.2951 | 3 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0003156 | 0.0026 | 5.9282 | 0.9737 | 5 | 33 | regulation of animal organ formation |
| GO:0042475 | 0.0026 | 3.6517 | 2.39 | 8 | 81 | odontogenesis of dentin-containing tooth |
| GO:0009966 | 0.0028 | 1.3871 | 83.3558 | 107 | 2825 | regulation of signal transduction |
| GO:0055123 | 0.0029 | 2.85 | 4.1309 | 11 | 140 | digestive system development |
| GO:0060411 | 0.003 | 4.0166 | 1.9179 | 7 | 65 | cardiac septum morphogenesis |
| GO:0017015 | 0.003 | 3.2629 | 2.9802 | 9 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0031116 | 0.003 | 7.7996 | 0.6196 | 4 | 21 | positive regulation of microtubule polymerization |
| GO:0050951 | 0.003 | 7.7996 | 0.6196 | 4 | 21 | sensory perception of temperature stimulus |
| GO:0003008 | 0.003 | 1.497 | 45.44 | 64 | 1540 | system process |
| GO:0065007 | 0.0032 | 1.3518 | 310.6146 | 337 | 10527 | biological regulation |
| GO:0002011 | 0.0034 | 4.5323 | 1.4753 | 6 | 50 | morphogenesis of an epithelial sheet |
| GO:0010665 | 0.0034 | 5.5323 | 1.0327 | 5 | 35 | regulation of cardiac muscle cell apoptotic process |
| GO:0030857 | 0.0034 | 5.5323 | 1.0327 | 5 | 35 | negative regulation of epithelial cell differentiation |
| GO:0001708 | 0.0035 | 5.4898 | 1.0369 | 5 | 36 | cell fate specification |
| GO:0046483 | 0.0035 | 1.3067 | 164.174 | 192 | 5564 | heterocycle metabolic process |
| GO:0060573 | 0.0035 | 12.4103 | 0.3246 | 3 | 11 | cell fate specification involved in pattern specification |
| GO:0090009 | 0.0035 | 12.4103 | 0.3246 | 3 | 11 | primitive streak formation |
| GO:0001892 | 0.0036 | 3.4611 | 2.5081 | 8 | 85 | embryonic placenta development |
| GO:0007417 | 0.0036 | 1.7629 | 18.5182 | 31 | 645 | central nervous system development |
| GO:1901360 | 0.0038 | 1.302 | 171.1966 | 199 | 5802 | organic cyclic compound metabolic process |
| GO:0043500 | 0.0038 | 3.4165 | 2.5376 | 8 | 86 | muscle adaptation |
| GO:0060606 | 0.0038 | 3.4165 | 2.5376 | 8 | 86 | tube closure |
| GO:0060993 | 0.0038 | 3.4165 | 2.5376 | 8 | 86 | kidney morphogenesis |
| GO:0003407 | 0.004 | 4.3633 | 1.5247 | 6 | 52 | neural retina development |
| GO:0032355 | 0.0041 | 2.8772 | 3.7178 | 10 | 126 | response to estradiol |
| GO:0050794 | 0.0041 | 1.3382 | 211.7988 | 237 | 7754 | regulation of cellular process |
| GO:0090103 | 0.0042 | 6.9776 | 0.6786 | 4 | 23 | cochlea morphogenesis |
| GO:0090175 | 0.0044 | 3.0619 | 3.1572 | 9 | 107 | regulation of establishment of planar polarity |
| GO:0001755 | 0.0044 | 5.1858 | 1.0917 | 5 | 37 | neural crest cell migration |
| GO:0014029 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | neural crest formation |
| GO:0033605 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | positive regulation of catecholamine secretion |
| GO:0060766 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | negative regulation of androgen receptor signaling pathway |
| GO:2000726 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | negative regulation of cardiac muscle cell differentiation |
| GO:0043409 | 0.0047 | 2.6625 | 4.3965 | 11 | 149 | negative regulation of MAPK cascade |
| GO:0042310 | 0.0049 | 3.6386 | 2.095 | 7 | 71 | vasoconstriction |
| GO:0072088 | 0.0049 | 3.6386 | 2.095 | 7 | 71 | nephron epithelium morphogenesis |
| GO:0034641 | 0.0049 | 1.289 | 178.9568 | 206 | 6065 | cellular nitrogen compound metabolic process |
| GO:0000188 | 0.005 | 6.6283 | 0.7082 | 4 | 24 | inactivation of MAPK activity |
| GO:0050927 | 0.005 | 6.6283 | 0.7082 | 4 | 24 | positive regulation of positive chemotaxis |
| GO:0001705 | 0.005 | 33.0336 | 0.118 | 2 | 4 | ectoderm formation |
| GO:0003199 | 0.005 | 33.0336 | 0.118 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0003219 | 0.005 | 33.0336 | 0.118 | 2 | 4 | cardiac right ventricle formation |
| GO:0003308 | 0.005 | 33.0336 | 0.118 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0008078 | 0.005 | 33.0336 | 0.118 | 2 | 4 | mesodermal cell migration |
| GO:0021557 | 0.005 | 33.0336 | 0.118 | 2 | 4 | oculomotor nerve development |
| GO:0021913 | 0.005 | 33.0336 | 0.118 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0042663 | 0.005 | 33.0336 | 0.118 | 2 | 4 | regulation of endodermal cell fate specification |
| GO:0060406 | 0.005 | 33.0336 | 0.118 | 2 | 4 | positive regulation of penile erection |
| GO:0060729 | 0.005 | 33.0336 | 0.118 | 2 | 4 | intestinal epithelial structure maintenance |
| GO:0090244 | 0.005 | 33.0336 | 0.118 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
| GO:0097476 | 0.005 | 33.0336 | 0.118 | 2 | 4 | spinal cord motor neuron migration |
| GO:1902412 | 0.005 | 33.0336 | 0.118 | 2 | 4 | regulation of mitotic cytokinesis |
| GO:0001501 | 0.0051 | 2.0234 | 9.8728 | 19 | 345 | skeletal system development |
| GO:0003018 | 0.0052 | 2.6241 | 4.4555 | 11 | 151 | vascular process in circulatory system |
| GO:0021766 | 0.0053 | 3.5824 | 2.1245 | 7 | 72 | hippocampus development |
| GO:0021879 | 0.0054 | 4.911 | 1.1438 | 5 | 39 | forebrain neuron differentiation |
| GO:0007050 | 0.0054 | 2.2239 | 7.1111 | 15 | 241 | cell cycle arrest |
| GO:0001658 | 0.0055 | 4.0685 | 1.6229 | 6 | 55 | branching involved in ureteric bud morphogenesis |
| GO:0031110 | 0.0055 | 4.0685 | 1.6229 | 6 | 55 | regulation of microtubule polymerization or depolymerization |
| GO:0048857 | 0.0055 | 4.0685 | 1.6229 | 6 | 55 | neural nucleus development |
| GO:0008406 | 0.0055 | 2.3764 | 5.7833 | 13 | 196 | gonad development |
| GO:0050680 | 0.0056 | 2.941 | 3.2752 | 9 | 111 | negative regulation of epithelial cell proliferation |
| GO:0061333 | 0.0057 | 3.5278 | 2.154 | 7 | 73 | renal tubule morphogenesis |
| GO:0014020 | 0.0058 | 3.1711 | 2.7146 | 8 | 92 | primary neural tube formation |
| GO:0042074 | 0.0059 | 9.9269 | 0.3836 | 3 | 13 | cell migration involved in gastrulation |
| GO:0048935 | 0.0059 | 9.9269 | 0.3836 | 3 | 13 | peripheral nervous system neuron development |
| GO:0061029 | 0.0059 | 9.9269 | 0.3836 | 3 | 13 | eyelid development in camera-type eye |
| GO:0010660 | 0.006 | 3.9868 | 1.6524 | 6 | 56 | regulation of muscle cell apoptotic process |
| GO:0001709 | 0.0061 | 4.7403 | 1.1803 | 5 | 40 | cell fate determination |
| GO:0010658 | 0.0061 | 4.7403 | 1.1803 | 5 | 40 | striated muscle cell apoptotic process |
| GO:0061448 | 0.0065 | 2.2419 | 6.5799 | 14 | 223 | connective tissue development |
| GO:0030855 | 0.0065 | 1.7319 | 16.9437 | 28 | 583 | epithelial cell differentiation |
| GO:0008344 | 0.0066 | 3.4236 | 2.213 | 7 | 75 | adult locomotory behavior |
| GO:0021522 | 0.0066 | 6.0509 | 0.764 | 4 | 26 | spinal cord motor neuron differentiation |
| GO:1904030 | 0.0067 | 6.0249 | 0.7672 | 4 | 26 | negative regulation of cyclin-dependent protein kinase activity |
| GO:0003300 | 0.0071 | 3.3738 | 2.2425 | 7 | 76 | cardiac muscle hypertrophy |
| GO:0045669 | 0.0071 | 3.833 | 1.7114 | 6 | 58 | positive regulation of osteoblast differentiation |
| GO:0051937 | 0.0071 | 3.833 | 1.7114 | 6 | 58 | catecholamine transport |
| GO:0007507 | 0.0073 | 1.8803 | 11.702 | 21 | 406 | heart development |
| GO:0003214 | 0.0073 | 9.0238 | 0.4131 | 3 | 14 | cardiac left ventricle morphogenesis |
| GO:1900116 | 0.0073 | 9.0238 | 0.4131 | 3 | 14 | extracellular negative regulation of signal transduction |
| GO:2001212 | 0.0073 | 9.0238 | 0.4131 | 3 | 14 | regulation of vasculogenesis |
| GO:0003231 | 0.0074 | 2.8027 | 3.4228 | 9 | 116 | cardiac ventricle development |
| GO:0007164 | 0.0074 | 2.8027 | 3.4228 | 9 | 116 | establishment of tissue polarity |
| GO:0015837 | 0.0076 | 3.3253 | 2.272 | 7 | 77 | amine transport |
| GO:0045843 | 0.0076 | 4.4835 | 1.2393 | 5 | 42 | negative regulation of striated muscle tissue development |
| GO:0048870 | 0.0077 | 1.4635 | 39.5682 | 55 | 1341 | cell motility |
| GO:0016055 | 0.0079 | 1.8085 | 13.3104 | 23 | 453 | Wnt signaling pathway |
| GO:0090101 | 0.0079 | 3.7307 | 1.7521 | 6 | 60 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:2000027 | 0.0081 | 3.2763 | 2.3 | 7 | 80 | regulation of organ morphogenesis |
| GO:0003150 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | muscular septum morphogenesis |
| GO:0021523 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | somatic motor neuron differentiation |
| GO:0060023 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | soft palate development |
| GO:0061009 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | common bile duct development |
| GO:0061043 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | regulation of vascular wound healing |
| GO:0061743 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | motor learning |
| GO:1904956 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | regulation of midbrain dopaminergic neuron differentiation |
| GO:2000823 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | regulation of androgen receptor activity |
| GO:0050982 | 0.0084 | 4.3652 | 1.2688 | 5 | 43 | detection of mechanical stimulus |
| GO:0090090 | 0.0087 | 2.4311 | 4.78 | 11 | 162 | negative regulation of canonical Wnt signaling pathway |
| GO:0014896 | 0.0087 | 3.2325 | 2.331 | 7 | 79 | muscle hypertrophy |
| GO:0003215 | 0.0088 | 8.3074 | 0.4407 | 3 | 15 | cardiac right ventricle morphogenesis |
| GO:0071229 | 0.0089 | 2.3166 | 5.4587 | 12 | 185 | cellular response to acid chemical |
| GO:0050965 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | detection of temperature stimulus involved in sensory perception of pain |
| GO:0060579 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | ventral spinal cord interneuron fate commitment |
| GO:0090177 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | establishment of planar polarity involved in neural tube closure |
| GO:2000380 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | regulation of mesoderm development |
| GO:0072171 | 0.009 | 3.6231 | 1.7999 | 6 | 61 | mesonephric tubule morphogenesis |
| GO:0048706 | 0.0091 | 5.4311 | 0.836 | 4 | 29 | embryonic skeletal system development |
| GO:0097659 | 0.0097 | 1.4478 | 41.1023 | 56 | 1558 | nucleic acid-templated transcription |
| GO:0048708 | 0.0097 | 3.5582 | 1.8294 | 6 | 62 | astrocyte differentiation |
| GO:1901701 | 0.0098 | 1.5267 | 28.1197 | 41 | 953 | cellular response to oxygen-containing compound |
| GO:0050768 | 0.0098 | 2.1282 | 6.9045 | 14 | 234 | negative regulation of neurogenesis |
| GO:0007187 | 0.0099 | 2.3832 | 4.8686 | 11 | 165 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0048709 | 0.0099 | 3.1447 | 2.39 | 7 | 81 | oligodendrocyte differentiation |
| GO:0010092 | 0.0099 | 5.3009 | 0.8557 | 4 | 29 | specification of animal organ identity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009913 | 0 | 7.5184 | 3.4777 | 22 | 252 | epidermal cell differentiation |
| GO:0070268 | 0 | 13.3277 | 1.2972 | 14 | 94 | cornification |
| GO:0043588 | 0 | 5.9386 | 4.3057 | 22 | 312 | skin development |
| GO:0050911 | 0 | 15.9149 | 0.7866 | 10 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0031424 | 0 | 15.32 | 0.5573 | 7 | 43 | keratinization |
| GO:0050906 | 0 | 6.9747 | 1.7802 | 11 | 129 | detection of stimulus involved in sensory perception |
| GO:0009593 | 0 | 7.0288 | 1.6008 | 10 | 116 | detection of chemical stimulus |
| GO:0007606 | 0 | 6.1004 | 1.8216 | 10 | 132 | sensory perception of chemical stimulus |
| GO:0007186 | 1e-04 | 2.467 | 11.5785 | 26 | 839 | G-protein coupled receptor signaling pathway |
| GO:0060429 | 3e-04 | 2.1687 | 15.1942 | 30 | 1101 | epithelium development |
| GO:0007320 | 5e-04 | 24.1514 | 0.1656 | 3 | 12 | insemination |
| GO:0003095 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | pressure natriuresis |
| GO:0042109 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | lymphotoxin A biosynthetic process |
| GO:0061760 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | antifungal innate immune response |
| GO:0032645 | 8e-04 | 19.7576 | 0.1932 | 3 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0036101 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | leukotriene B4 catabolic process |
| GO:0007618 | 0.0013 | 9.3805 | 0.483 | 4 | 35 | mating |
| GO:0050829 | 0.0018 | 6.2864 | 0.8694 | 5 | 63 | defense response to Gram-negative bacterium |
| GO:1901523 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | icosanoid catabolic process |
| GO:0033559 | 0.0019 | 4.9863 | 1.2972 | 6 | 94 | unsaturated fatty acid metabolic process |
| GO:0009620 | 0.002 | 8.3062 | 0.5382 | 4 | 39 | response to fungus |
| GO:0006501 | 0.0025 | 5.7855 | 0.9384 | 5 | 68 | C-terminal protein lipidation |
| GO:0015939 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | pantothenate metabolic process |
| GO:0045087 | 0.0029 | 2.1108 | 10.117 | 20 | 740 | innate immune response |
| GO:0019373 | 0.0029 | 12.0684 | 0.2898 | 3 | 21 | epoxygenase P450 pathway |
| GO:0030825 | 0.0029 | 12.0684 | 0.2898 | 3 | 21 | positive regulation of cGMP metabolic process |
| GO:0030826 | 0.0033 | 11.4325 | 0.3036 | 3 | 22 | regulation of cGMP biosynthetic process |
| GO:0050830 | 0.0038 | 5.2045 | 1.035 | 5 | 75 | defense response to Gram-positive bacterium |
| GO:0050877 | 0.0041 | 1.9711 | 11.9097 | 22 | 863 | nervous system process |
| GO:0007586 | 0.0042 | 3.6884 | 2.0149 | 7 | 146 | digestion |
| GO:0032501 | 0.0051 | 1.4852 | 73.4508 | 91 | 6027 | multicellular organismal process |
| GO:0071346 | 0.0052 | 4.02 | 1.587 | 6 | 115 | cellular response to interferon-gamma |
| GO:0032621 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | interleukin-18 production |
| GO:0048262 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | determination of dorsal/ventral asymmetry |
| GO:0070098 | 0.0079 | 5.4787 | 0.7866 | 4 | 57 | chemokine-mediated signaling pathway |
| GO:0006691 | 0.008 | 8.0408 | 0.414 | 3 | 30 | leukotriene metabolic process |
| GO:0001676 | 0.0085 | 4.2317 | 1.2558 | 5 | 91 | long-chain fatty acid metabolic process |
| GO:0031284 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | positive regulation of guanylate cyclase activity |
| GO:0031295 | 0.01 | 5.0928 | 0.8418 | 4 | 61 | T cell costimulation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048663 | 2e-04 | 5.7555 | 1.5685 | 8 | 68 | neuron fate commitment |
| GO:0021527 | 2e-04 | 17.1251 | 0.3229 | 4 | 14 | spinal cord association neuron differentiation |
| GO:2000502 | 5e-04 | Inf | 0.0461 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0042756 | 6e-04 | 25.6224 | 0.1845 | 3 | 8 | drinking behavior |
| GO:0010469 | 0.001 | 2.1765 | 11.2333 | 23 | 487 | regulation of receptor activity |
| GO:0007186 | 0.001 | 1.8734 | 19.3526 | 34 | 839 | G-protein coupled receptor signaling pathway |
| GO:0006334 | 0.0011 | 3.7718 | 2.5834 | 9 | 112 | nucleosome assembly |
| GO:0016338 | 0.0015 | 9.5088 | 0.5075 | 4 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0021530 | 0.0016 | 85.1862 | 0.0692 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0060415 | 0.0017 | 4.4283 | 1.73 | 7 | 75 | muscle tissue morphogenesis |
| GO:0021517 | 0.003 | 5.6389 | 0.9919 | 5 | 43 | ventral spinal cord development |
| GO:0030321 | 0.0031 | 42.5903 | 0.0923 | 2 | 4 | transepithelial chloride transport |
| GO:1900037 | 0.0037 | 11.6418 | 0.3229 | 3 | 14 | regulation of cellular response to hypoxia |
| GO:2000291 | 0.0037 | 11.6418 | 0.3229 | 3 | 14 | regulation of myoblast proliferation |
| GO:0010744 | 0.0045 | 10.671 | 0.346 | 3 | 15 | positive regulation of macrophage derived foam cell differentiation |
| GO:0035914 | 0.0047 | 5.0203 | 1.0989 | 5 | 48 | skeletal muscle cell differentiation |
| GO:0042220 | 0.0048 | 4.9815 | 1.1072 | 5 | 48 | response to cocaine |
| GO:0070265 | 0.0048 | 4.9815 | 1.1072 | 5 | 48 | necrotic cell death |
| GO:0021779 | 0.0051 | 28.3916 | 0.1153 | 2 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0.0051 | 28.3916 | 0.1153 | 2 | 5 | glial cell fate specification |
| GO:0060455 | 0.0051 | 28.3916 | 0.1153 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0009953 | 0.0054 | 3.5385 | 2.1221 | 7 | 92 | dorsal/ventral pattern formation |
| GO:1902914 | 0.0055 | 9.8495 | 0.3691 | 3 | 16 | regulation of protein polyubiquitination |
| GO:2001014 | 0.0065 | 9.1453 | 0.3921 | 3 | 17 | regulation of skeletal muscle cell differentiation |
| GO:0090077 | 0.0067 | 5.8976 | 0.7612 | 4 | 33 | foam cell differentiation |
| GO:0033993 | 0.0069 | 1.6789 | 19.4218 | 31 | 842 | response to lipid |
| GO:0006578 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | amino-acid betaine biosynthetic process |
| GO:0022605 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | oogenesis stage |
| GO:2000766 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | negative regulation of cytoplasmic translation |
| GO:2001199 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | negative regulation of dendritic cell differentiation |
| GO:0051965 | 0.0086 | 4.2821 | 1.2686 | 5 | 55 | positive regulation of synapse assembly |
| GO:0003009 | 0.0092 | 5.3437 | 0.8304 | 4 | 36 | skeletal muscle contraction |
| GO:0030814 | 0.0092 | 2.8904 | 2.9294 | 8 | 127 | regulation of cAMP metabolic process |
| GO:0030801 | 0.0093 | 3.1639 | 2.3528 | 7 | 102 | positive regulation of cyclic nucleotide metabolic process |
| GO:0006333 | 0.0095 | 2.6717 | 3.5522 | 9 | 154 | chromatin assembly or disassembly |
| GO:0021515 | 0.0097 | 5.2383 | 0.8445 | 4 | 37 | cell differentiation in spinal cord |
| GO:0050911 | 0.01 | 4.1168 | 1.3148 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 8.6555 | 3.596 | 25 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007267 | 0 | 2.2802 | 34.1972 | 68 | 1453 | cell-cell signaling |
| GO:0098609 | 0 | 2.5647 | 17.7433 | 41 | 750 | cell-cell adhesion |
| GO:0007389 | 0 | 3.5428 | 7.5152 | 24 | 325 | pattern specification process |
| GO:0009952 | 0 | 4.3903 | 4.5896 | 18 | 194 | anterior/posterior pattern specification |
| GO:0007399 | 0 | 1.9104 | 47.7033 | 80 | 2041 | nervous system development |
| GO:0032502 | 0 | 1.6963 | 103.1786 | 142 | 4581 | developmental process |
| GO:0035108 | 0 | 4.5485 | 3.4304 | 14 | 145 | limb morphogenesis |
| GO:0035113 | 0 | 4.8882 | 2.9809 | 13 | 126 | embryonic appendage morphogenesis |
| GO:0003253 | 0 | 55.633 | 0.1656 | 4 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0048736 | 0 | 4.124 | 4.0218 | 15 | 170 | appendage development |
| GO:0009798 | 0 | 5.9501 | 1.9163 | 10 | 81 | axis specification |
| GO:0048568 | 0 | 2.6994 | 9.6287 | 24 | 407 | embryonic organ development |
| GO:0003008 | 1e-04 | 1.8077 | 36.4329 | 60 | 1540 | system process |
| GO:0022610 | 1e-04 | 1.8754 | 30.2583 | 52 | 1279 | biological adhesion |
| GO:0061308 | 1e-04 | 23.8363 | 0.2602 | 4 | 11 | cardiac neural crest cell development involved in heart development |
| GO:0014033 | 2e-04 | 5.7003 | 1.5851 | 8 | 67 | neural crest cell differentiation |
| GO:0032501 | 2e-04 | 1.5735 | 90.5648 | 119 | 4446 | multicellular organismal process |
| GO:0030855 | 2e-04 | 2.1753 | 14.8098 | 30 | 626 | epithelial cell differentiation |
| GO:0072109 | 3e-04 | 16.682 | 0.3312 | 4 | 14 | glomerular mesangium development |
| GO:1903508 | 3e-04 | 1.7756 | 31.7487 | 52 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0045944 | 3e-04 | 1.8776 | 24.6987 | 43 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001657 | 3e-04 | 4.5641 | 2.1765 | 9 | 92 | ureteric bud development |
| GO:0009953 | 3e-04 | 4.5641 | 2.1765 | 9 | 92 | dorsal/ventral pattern formation |
| GO:0048704 | 3e-04 | 4.5641 | 2.1765 | 9 | 92 | embryonic skeletal system morphogenesis |
| GO:0072163 | 4e-04 | 4.5095 | 2.2002 | 9 | 93 | mesonephric epithelium development |
| GO:0030216 | 4e-04 | 3.1235 | 4.8262 | 14 | 204 | keratinocyte differentiation |
| GO:0007186 | 4e-04 | 1.9447 | 19.8489 | 36 | 839 | G-protein coupled receptor signaling pathway |
| GO:0035116 | 5e-04 | 9.0839 | 0.6624 | 5 | 28 | embryonic hindlimb morphogenesis |
| GO:0048729 | 5e-04 | 2.1101 | 14.171 | 28 | 599 | tissue morphogenesis |
| GO:0060809 | 6e-04 | Inf | 0.0473 | 2 | 2 | mesodermal to mesenchymal transition involved in gastrulation |
| GO:0061032 | 6e-04 | Inf | 0.0473 | 2 | 2 | visceral serous pericardium development |
| GO:0072254 | 6e-04 | Inf | 0.0473 | 2 | 2 | metanephric glomerular mesangial cell differentiation |
| GO:0097402 | 6e-04 | Inf | 0.0473 | 2 | 2 | neuroblast migration |
| GO:1905772 | 6e-04 | Inf | 0.0473 | 2 | 2 | positive regulation of mesodermal cell differentiation |
| GO:2000054 | 6e-04 | Inf | 0.0473 | 2 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:2000079 | 6e-04 | Inf | 0.0473 | 2 | 2 | regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
| GO:2000738 | 6e-04 | 12.8297 | 0.4022 | 4 | 17 | positive regulation of stem cell differentiation |
| GO:0014031 | 7e-04 | 5.2411 | 1.4904 | 7 | 63 | mesenchymal cell development |
| GO:0048864 | 7e-04 | 5.2411 | 1.4904 | 7 | 63 | stem cell development |
| GO:0007530 | 7e-04 | 11.9125 | 0.4258 | 4 | 18 | sex determination |
| GO:0048646 | 7e-04 | 1.8278 | 22.8297 | 39 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0031328 | 8e-04 | 1.6252 | 39.9343 | 60 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0051254 | 9e-04 | 1.6769 | 33.3811 | 52 | 1411 | positive regulation of RNA metabolic process |
| GO:1902742 | 9e-04 | 7.736 | 0.757 | 5 | 32 | apoptotic process involved in development |
| GO:0061138 | 9e-04 | 3.1476 | 4.0928 | 12 | 173 | morphogenesis of a branching epithelium |
| GO:0090288 | 9e-04 | 3.5688 | 3.0282 | 10 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0046661 | 9e-04 | 3.3133 | 3.5723 | 11 | 151 | male sex differentiation |
| GO:0060993 | 0.001 | 4.3062 | 2.0346 | 8 | 86 | kidney morphogenesis |
| GO:0003156 | 0.001 | 7.4593 | 0.7807 | 5 | 33 | regulation of animal organ formation |
| GO:0060923 | 0.001 | 20.7997 | 0.2129 | 3 | 9 | cardiac muscle cell fate commitment |
| GO:0072239 | 0.001 | 20.7997 | 0.2129 | 3 | 9 | metanephric glomerulus vasculature development |
| GO:0035051 | 0.001 | 3.8511 | 2.5369 | 9 | 108 | cardiocyte differentiation |
| GO:0035239 | 0.001 | 2.4219 | 7.9017 | 18 | 334 | tube morphogenesis |
| GO:0048663 | 0.0011 | 4.8099 | 1.6087 | 7 | 68 | neuron fate commitment |
| GO:0060688 | 0.0011 | 5.7061 | 1.1829 | 6 | 50 | regulation of morphogenesis of a branching structure |
| GO:0072080 | 0.0011 | 4.198 | 2.0819 | 8 | 88 | nephron tubule development |
| GO:0060485 | 0.0012 | 2.7298 | 5.4649 | 14 | 231 | mesenchyme development |
| GO:0009792 | 0.0013 | 2.0494 | 12.9408 | 25 | 547 | embryo development ending in birth or egg hatching |
| GO:0032275 | 0.0014 | 17.8271 | 0.2366 | 3 | 10 | luteinizing hormone secretion |
| GO:0001707 | 0.0014 | 4.5835 | 1.6797 | 7 | 71 | mesoderm formation |
| GO:0072088 | 0.0014 | 4.5835 | 1.6797 | 7 | 71 | nephron epithelium morphogenesis |
| GO:0072125 | 0.0016 | 82.9944 | 0.071 | 2 | 3 | negative regulation of glomerular mesangial cell proliferation |
| GO:1904862 | 0.0016 | 82.9944 | 0.071 | 2 | 3 | inhibitory synapse assembly |
| GO:0010557 | 0.0017 | 1.5998 | 36.9061 | 55 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0061333 | 0.0017 | 4.444 | 1.727 | 7 | 73 | renal tubule morphogenesis |
| GO:0070268 | 0.0017 | 3.9035 | 2.2238 | 8 | 94 | cornification |
| GO:0048731 | 0.0017 | 1.6057 | 39.0307 | 57 | 1922 | system development |
| GO:0001658 | 0.0018 | 5.1221 | 1.3012 | 6 | 55 | branching involved in ureteric bud morphogenesis |
| GO:0008544 | 0.0019 | 2.2885 | 8.3275 | 18 | 352 | epidermis development |
| GO:0048484 | 0.0019 | 15.5977 | 0.2602 | 3 | 11 | enteric nervous system development |
| GO:0042481 | 0.0019 | 8.7747 | 0.5441 | 4 | 23 | regulation of odontogenesis |
| GO:0021510 | 0.002 | 3.8143 | 2.2711 | 8 | 96 | spinal cord development |
| GO:0007423 | 0.0022 | 2.0311 | 11.9708 | 23 | 506 | sensory organ development |
| GO:0050911 | 0.0022 | 4.9206 | 1.3485 | 6 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0061217 | 0.0023 | 8.3354 | 0.5678 | 4 | 24 | regulation of mesonephros development |
| GO:0072210 | 0.0024 | 5.9646 | 0.9463 | 5 | 40 | metanephric nephron development |
| GO:1901722 | 0.0025 | 13.8637 | 0.2839 | 3 | 12 | regulation of cell proliferation involved in kidney development |
| GO:0048596 | 0.0026 | 7.9379 | 0.5914 | 4 | 25 | embryonic camera-type eye morphogenesis |
| GO:0051705 | 0.0026 | 4.7343 | 1.3958 | 6 | 59 | multi-organism behavior |
| GO:0010628 | 0.0027 | 1.5425 | 40.2892 | 58 | 1703 | positive regulation of gene expression |
| GO:0055013 | 0.0029 | 4.6463 | 1.4195 | 6 | 60 | cardiac muscle cell development |
| GO:0042475 | 0.003 | 3.9615 | 1.9163 | 7 | 81 | odontogenesis of dentin-containing tooth |
| GO:0061440 | 0.0031 | 7.5766 | 0.6151 | 4 | 26 | kidney vasculature development |
| GO:0072171 | 0.0031 | 4.5615 | 1.4431 | 6 | 61 | mesonephric tubule morphogenesis |
| GO:0048935 | 0.0031 | 12.4765 | 0.3076 | 3 | 13 | peripheral nervous system neuron development |
| GO:0072216 | 0.0031 | 12.4765 | 0.3076 | 3 | 13 | positive regulation of metanephros development |
| GO:0034653 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | retinoic acid catabolic process |
| GO:0051464 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | positive regulation of cortisol secretion |
| GO:0060686 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | negative regulation of prostatic bud formation |
| GO:0061325 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0090245 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | axis elongation involved in somitogenesis |
| GO:0008584 | 0.0034 | 3.1756 | 3.0282 | 9 | 128 | male gonad development |
| GO:1901342 | 0.0034 | 2.4233 | 6.1037 | 14 | 258 | regulation of vasculature development |
| GO:0060986 | 0.0037 | 5.3514 | 1.0409 | 5 | 44 | endocrine hormone secretion |
| GO:0003281 | 0.0037 | 4.4008 | 1.4904 | 6 | 63 | ventricular septum development |
| GO:0042733 | 0.0037 | 4.4008 | 1.4904 | 6 | 63 | embryonic digit morphogenesis |
| GO:0090101 | 0.0039 | 3.388 | 2.5314 | 8 | 107 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0021527 | 0.0039 | 11.3415 | 0.3312 | 3 | 14 | spinal cord association neuron differentiation |
| GO:2000846 | 0.0039 | 11.3415 | 0.3312 | 3 | 14 | regulation of corticosteroid hormone secretion |
| GO:0007274 | 0.004 | 6.9443 | 0.6624 | 4 | 28 | neuromuscular synaptic transmission |
| GO:0007600 | 0.0043 | 1.9161 | 12.6332 | 23 | 534 | sensory perception |
| GO:0048706 | 0.0043 | 6.8007 | 0.673 | 4 | 29 | embryonic skeletal system development |
| GO:0060411 | 0.0043 | 4.2511 | 1.5378 | 6 | 65 | cardiac septum morphogenesis |
| GO:0061045 | 0.0043 | 4.2511 | 1.5378 | 6 | 65 | negative regulation of wound healing |
| GO:0035094 | 0.0045 | 5.0897 | 1.0883 | 5 | 46 | response to nicotine |
| GO:0046660 | 0.0046 | 3.2877 | 2.6024 | 8 | 110 | female sex differentiation |
| GO:0060537 | 0.0047 | 2.1355 | 8.3748 | 17 | 354 | muscle tissue development |
| GO:0001667 | 0.0047 | 2.1898 | 7.6888 | 16 | 325 | ameboidal-type cell migration |
| GO:0008595 | 0.0048 | 10.3957 | 0.3549 | 3 | 15 | anterior/posterior axis specification, embryo |
| GO:0071300 | 0.005 | 4.1111 | 1.5851 | 6 | 67 | cellular response to retinoic acid |
| GO:1901890 | 0.0052 | 6.4092 | 0.7097 | 4 | 30 | positive regulation of cell junction assembly |
| GO:0060157 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | urinary bladder development |
| GO:0060591 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | chondroblast differentiation |
| GO:0070172 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | positive regulation of tooth mineralization |
| GO:0072298 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | regulation of metanephric glomerulus development |
| GO:2000195 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | negative regulation of female gonad development |
| GO:0060429 | 0.0058 | 1.9576 | 10.7429 | 20 | 475 | epithelium development |
| GO:0043092 | 0.0058 | 9.5953 | 0.3785 | 3 | 16 | L-amino acid import |
| GO:0090185 | 0.0058 | 9.5953 | 0.3785 | 3 | 16 | negative regulation of kidney development |
| GO:0003209 | 0.0059 | 6.1715 | 0.7334 | 4 | 31 | cardiac atrium morphogenesis |
| GO:0009954 | 0.0059 | 6.1715 | 0.7334 | 4 | 31 | proximal/distal pattern formation |
| GO:0009887 | 0.0059 | 1.6849 | 20.0066 | 32 | 860 | animal organ morphogenesis |
| GO:0072006 | 0.0061 | 3.4467 | 2.1753 | 7 | 93 | nephron development |
| GO:0001568 | 0.0062 | 1.827 | 13.7925 | 24 | 583 | blood vessel development |
| GO:0009593 | 0.0063 | 3.1037 | 2.7443 | 8 | 116 | detection of chemical stimulus |
| GO:0048608 | 0.0066 | 2.0106 | 9.3921 | 18 | 397 | reproductive structure development |
| GO:0045165 | 0.0066 | 2.6669 | 3.9613 | 10 | 170 | cell fate commitment |
| GO:0021536 | 0.0066 | 3.8571 | 1.6797 | 6 | 71 | diencephalon development |
| GO:0021675 | 0.0066 | 3.8571 | 1.6797 | 6 | 71 | nerve development |
| GO:0060079 | 0.0069 | 3.3665 | 2.2238 | 7 | 94 | excitatory postsynaptic potential |
| GO:0009790 | 0.0069 | 2.3948 | 5.2754 | 12 | 233 | embryo development |
| GO:0051412 | 0.007 | 8.9094 | 0.4022 | 3 | 17 | response to corticosterone |
| GO:1904948 | 0.007 | 8.9094 | 0.4022 | 3 | 17 | midbrain dopaminergic neuron differentiation |
| GO:2001026 | 0.007 | 8.9094 | 0.4022 | 3 | 17 | regulation of endothelial cell chemotaxis |
| GO:0043388 | 0.0075 | 4.4381 | 1.2302 | 5 | 52 | positive regulation of DNA binding |
| GO:0001838 | 0.0077 | 2.9921 | 2.8389 | 8 | 120 | embryonic epithelial tube formation |
| GO:0003278 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0003402 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
| GO:0016115 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | terpenoid catabolic process |
| GO:0038001 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | paracrine signaling |
| GO:0038031 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0044340 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | canonical Wnt signaling pathway involved in regulation of cell proliferation |
| GO:0051964 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | negative regulation of synapse assembly |
| GO:2000382 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | positive regulation of mesoderm development |
| GO:2001023 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | regulation of response to drug |
| GO:0007271 | 0.0082 | 5.5532 | 0.8044 | 4 | 34 | synaptic transmission, cholinergic |
| GO:0007350 | 0.0082 | 8.3148 | 0.4258 | 3 | 18 | blastoderm segmentation |
| GO:0007519 | 0.0087 | 2.715 | 3.5013 | 9 | 148 | skeletal muscle tissue development |
| GO:0035270 | 0.0089 | 2.9134 | 2.9099 | 8 | 123 | endocrine system development |
| GO:0007618 | 0.009 | 5.3737 | 0.828 | 4 | 35 | mating |
| GO:2000826 | 0.009 | 5.3737 | 0.828 | 4 | 35 | regulation of heart morphogenesis |
| GO:0010002 | 0.0096 | 7.7946 | 0.4495 | 3 | 19 | cardioblast differentiation |
| GO:0016048 | 0.0096 | 7.7946 | 0.4495 | 3 | 19 | detection of temperature stimulus |
| GO:0060575 | 0.0096 | 7.7946 | 0.4495 | 3 | 19 | intestinal epithelial cell differentiation |
| GO:0072001 | 0.0099 | 2.1923 | 6.213 | 13 | 264 | renal system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 8.7419 | 1.2591 | 9 | 48 | embryonic skeletal system morphogenesis |
| GO:0043009 | 0 | 2.6991 | 12.5749 | 31 | 480 | chordate embryonic development |
| GO:0009887 | 0 | 2.5701 | 13.1658 | 31 | 515 | animal organ morphogenesis |
| GO:0022404 | 0 | 5.5146 | 2.2776 | 11 | 86 | molting cycle process |
| GO:0007416 | 0 | 4.5707 | 3.1836 | 13 | 121 | synapse assembly |
| GO:0007420 | 0 | 2.3038 | 16.9759 | 36 | 641 | brain development |
| GO:0014707 | 0 | Inf | 0.0795 | 3 | 3 | branchiomeric skeletal muscle development |
| GO:0043269 | 0 | 2.3621 | 15.1486 | 33 | 572 | regulation of ion transport |
| GO:0032502 | 0 | 1.6198 | 92.8912 | 127 | 3821 | developmental process |
| GO:0007267 | 0 | 1.9941 | 27.4219 | 50 | 1064 | cell-cell signaling |
| GO:0007399 | 0 | 1.7294 | 50.7293 | 79 | 1977 | nervous system development |
| GO:0048568 | 0 | 2.6125 | 10.7788 | 26 | 407 | embryonic organ development |
| GO:0021879 | 0 | 7.2976 | 1.2977 | 8 | 49 | forebrain neuron differentiation |
| GO:0009889 | 1e-04 | 1.5199 | 109.7478 | 145 | 4144 | regulation of biosynthetic process |
| GO:0010628 | 1e-04 | 1.7274 | 45.1015 | 71 | 1703 | positive regulation of gene expression |
| GO:0006355 | 1e-04 | 1.543 | 89.3819 | 122 | 3375 | regulation of transcription, DNA-templated |
| GO:0008284 | 1e-04 | 2.0349 | 21.2133 | 40 | 801 | positive regulation of cell proliferation |
| GO:0042633 | 1e-04 | 4.4904 | 2.7278 | 11 | 103 | hair cycle |
| GO:0048598 | 1e-04 | 2.7463 | 8.2575 | 21 | 322 | embryonic morphogenesis |
| GO:2001141 | 1e-04 | 1.5273 | 90.0705 | 122 | 3401 | regulation of RNA biosynthetic process |
| GO:0007268 | 1e-04 | 2.2113 | 15.0691 | 31 | 569 | chemical synaptic transmission |
| GO:0099537 | 1e-04 | 2.2028 | 15.1221 | 31 | 571 | trans-synaptic signaling |
| GO:0021544 | 1e-04 | 12.3945 | 0.5297 | 5 | 20 | subpallium development |
| GO:0002009 | 1e-04 | 2.5768 | 9.1835 | 22 | 354 | morphogenesis of an epithelium |
| GO:0001708 | 2e-04 | 5.1289 | 1.9772 | 9 | 75 | cell fate specification |
| GO:0007275 | 2e-04 | 1.6089 | 64.8588 | 92 | 2683 | multicellular organism development |
| GO:0030154 | 2e-04 | 1.7025 | 44.2556 | 68 | 1789 | cell differentiation |
| GO:0009952 | 2e-04 | 3.834 | 3.4319 | 12 | 131 | anterior/posterior pattern specification |
| GO:0048736 | 2e-04 | 3.3816 | 4.5022 | 14 | 170 | appendage development |
| GO:0097154 | 2e-04 | 18.5539 | 0.3178 | 4 | 12 | GABAergic neuron differentiation |
| GO:0048646 | 2e-04 | 1.9118 | 23.6303 | 42 | 902 | anatomical structure formation involved in morphogenesis |
| GO:0019219 | 2e-04 | 1.4784 | 104.1333 | 136 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0045944 | 2e-04 | 1.8296 | 27.6488 | 47 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0051924 | 3e-04 | 3.0739 | 5.2702 | 15 | 199 | regulation of calcium ion transport |
| GO:0048699 | 3e-04 | 1.7315 | 34.9318 | 56 | 1319 | generation of neurons |
| GO:0030857 | 3e-04 | 7.7052 | 0.9269 | 6 | 35 | negative regulation of epithelial cell differentiation |
| GO:0048663 | 3e-04 | 5.1789 | 1.7395 | 8 | 66 | neuron fate commitment |
| GO:0060022 | 3e-04 | 37.0275 | 0.1589 | 3 | 6 | hard palate development |
| GO:1903508 | 4e-04 | 1.6977 | 35.5409 | 56 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0031069 | 4e-04 | 9.2927 | 0.6621 | 5 | 25 | hair follicle morphogenesis |
| GO:0031328 | 4e-04 | 1.6229 | 44.7042 | 67 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0016331 | 5e-04 | 3.3877 | 3.8401 | 12 | 145 | morphogenesis of embryonic epithelium |
| GO:0035108 | 5e-04 | 3.3877 | 3.8401 | 12 | 145 | limb morphogenesis |
| GO:0051254 | 5e-04 | 1.6726 | 37.3683 | 58 | 1411 | positive regulation of RNA metabolic process |
| GO:0055024 | 6e-04 | 4.7421 | 1.8803 | 8 | 71 | regulation of cardiac muscle tissue development |
| GO:0034654 | 6e-04 | 1.4335 | 105.5899 | 135 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0051051 | 6e-04 | 2.2191 | 11.5203 | 24 | 435 | negative regulation of transport |
| GO:0003357 | 6e-04 | 27.7688 | 0.1854 | 3 | 7 | noradrenergic neuron differentiation |
| GO:2001012 | 6e-04 | 27.7688 | 0.1854 | 3 | 7 | mesenchymal cell differentiation involved in renal system development |
| GO:0043588 | 7e-04 | 2.4522 | 8.2629 | 19 | 312 | skin development |
| GO:0021882 | 7e-04 | Inf | 0.053 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
| GO:0021893 | 7e-04 | Inf | 0.053 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
| GO:1902868 | 7e-04 | Inf | 0.053 | 2 | 2 | positive regulation of retina development in camera-type eye |
| GO:1902871 | 7e-04 | Inf | 0.053 | 2 | 2 | positive regulation of amacrine cell differentiation |
| GO:0007156 | 7e-04 | 3.2168 | 4.0255 | 12 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0072359 | 7e-04 | 1.7977 | 24.3384 | 41 | 919 | circulatory system development |
| GO:0034762 | 7e-04 | 2.221 | 11.0172 | 23 | 416 | regulation of transmembrane transport |
| GO:0016339 | 8e-04 | 8.079 | 0.7415 | 5 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0035116 | 8e-04 | 8.079 | 0.7415 | 5 | 28 | embryonic hindlimb morphogenesis |
| GO:0006812 | 8e-04 | 1.755 | 26.7749 | 44 | 1011 | cation transport |
| GO:0045607 | 9e-04 | 22.2135 | 0.2119 | 3 | 8 | regulation of auditory receptor cell differentiation |
| GO:0045631 | 9e-04 | 22.2135 | 0.2119 | 3 | 8 | regulation of mechanoreceptor differentiation |
| GO:0097084 | 9e-04 | 22.2135 | 0.2119 | 3 | 8 | vascular smooth muscle cell development |
| GO:0044057 | 0.001 | 2.0967 | 12.6591 | 25 | 478 | regulation of system process |
| GO:2000678 | 0.0011 | 10.5979 | 0.4767 | 4 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0009954 | 0.0012 | 7.1453 | 0.821 | 5 | 31 | proximal/distal pattern formation |
| GO:0001841 | 0.0013 | 3.6957 | 2.6484 | 9 | 100 | neural tube formation |
| GO:0048468 | 0.0014 | 1.5324 | 49.1799 | 70 | 1857 | cell development |
| GO:0021895 | 0.0014 | 9.8907 | 0.5032 | 4 | 19 | cerebral cortex neuron differentiation |
| GO:0060231 | 0.0014 | 9.8907 | 0.5032 | 4 | 19 | mesenchymal to epithelial transition |
| GO:0042178 | 0.0014 | 18.51 | 0.2384 | 3 | 9 | xenobiotic catabolic process |
| GO:0070838 | 0.0015 | 2.1412 | 10.8847 | 22 | 411 | divalent metal ion transport |
| GO:0035239 | 0.0015 | 2.2775 | 8.8455 | 19 | 334 | tube morphogenesis |
| GO:0051047 | 0.0015 | 2.223 | 9.5341 | 20 | 360 | positive regulation of secretion |
| GO:0043266 | 0.0016 | 3.9802 | 2.1981 | 8 | 83 | regulation of potassium ion transport |
| GO:0021515 | 0.0018 | 6.4474 | 0.8947 | 5 | 34 | cell differentiation in spinal cord |
| GO:0001501 | 0.0019 | 2.3507 | 7.6662 | 17 | 295 | skeletal system development |
| GO:0035113 | 0.0019 | 3.2241 | 3.3369 | 10 | 126 | embryonic appendage morphogenesis |
| GO:0050966 | 0.0019 | 15.8646 | 0.2648 | 3 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0023061 | 0.002 | 2.1225 | 10.461 | 21 | 395 | signal release |
| GO:0051216 | 0.002 | 2.8287 | 4.5287 | 12 | 171 | cartilage development |
| GO:0007617 | 0.002 | 8.7259 | 0.5562 | 4 | 21 | mating behavior |
| GO:0021558 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | trochlear nerve development |
| GO:0038162 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | erythropoietin-mediated signaling pathway |
| GO:0060435 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | bronchiole development |
| GO:1905333 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | regulation of gastric motility |
| GO:0072175 | 0.0021 | 3.169 | 3.3899 | 10 | 128 | epithelial tube formation |
| GO:0003002 | 0.0023 | 3.3928 | 2.8582 | 9 | 112 | regionalization |
| GO:0021513 | 0.0024 | 8.2406 | 0.5826 | 4 | 22 | spinal cord dorsal/ventral patterning |
| GO:0051952 | 0.0025 | 4.1389 | 1.8538 | 7 | 70 | regulation of amine transport |
| GO:0021521 | 0.0026 | 13.8806 | 0.2913 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0007186 | 0.0026 | 1.7878 | 18.915 | 32 | 727 | G-protein coupled receptor signaling pathway |
| GO:0001964 | 0.0029 | 7.8064 | 0.6091 | 4 | 23 | startle response |
| GO:2000026 | 0.0029 | 1.5121 | 43.7823 | 62 | 1672 | regulation of multicellular organismal development |
| GO:0051384 | 0.003 | 3.0144 | 3.5488 | 10 | 134 | response to glucocorticoid |
| GO:1904062 | 0.003 | 2.3778 | 6.6739 | 15 | 252 | regulation of cation transmembrane transport |
| GO:0046887 | 0.0031 | 3.2309 | 2.9926 | 9 | 113 | positive regulation of hormone secretion |
| GO:0071773 | 0.0031 | 2.8192 | 4.1579 | 11 | 157 | cellular response to BMP stimulus |
| GO:0033993 | 0.0032 | 1.7048 | 22.2991 | 36 | 842 | response to lipid |
| GO:1904427 | 0.0032 | 4.5541 | 1.4566 | 6 | 55 | positive regulation of calcium ion transmembrane transport |
| GO:0000122 | 0.0033 | 1.7433 | 19.9686 | 33 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0030878 | 0.0034 | 7.4155 | 0.6356 | 4 | 24 | thyroid gland development |
| GO:0060487 | 0.0034 | 7.4155 | 0.6356 | 4 | 24 | lung epithelial cell differentiation |
| GO:0072182 | 0.0034 | 12.3375 | 0.3178 | 3 | 12 | regulation of nephron tubule epithelial cell differentiation |
| GO:2000726 | 0.0034 | 12.3375 | 0.3178 | 3 | 12 | negative regulation of cardiac muscle cell differentiation |
| GO:0010470 | 0.0035 | 5.4611 | 1.0329 | 5 | 39 | regulation of gastrulation |
| GO:0060043 | 0.0035 | 5.4611 | 1.0329 | 5 | 39 | regulation of cardiac muscle cell proliferation |
| GO:0060420 | 0.0035 | 4.4627 | 1.4831 | 6 | 56 | regulation of heart growth |
| GO:0060255 | 0.0036 | 1.3246 | 147.6192 | 174 | 5574 | regulation of macromolecule metabolic process |
| GO:0034767 | 0.0037 | 3.1397 | 3.0721 | 9 | 116 | positive regulation of ion transmembrane transport |
| GO:0060548 | 0.0038 | 1.6712 | 23.3585 | 37 | 882 | negative regulation of cell death |
| GO:0003013 | 0.0039 | 1.932 | 12.5267 | 23 | 473 | circulatory system process |
| GO:0007626 | 0.004 | 2.5822 | 4.9259 | 12 | 186 | locomotory behavior |
| GO:0007621 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | negative regulation of female receptivity |
| GO:0018916 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | nitrobenzene metabolic process |
| GO:0021557 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | oculomotor nerve development |
| GO:0021615 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0035910 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | ascending aorta morphogenesis |
| GO:0042663 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | regulation of endodermal cell fate specification |
| GO:0046952 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | ketone body catabolic process |
| GO:0060480 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | lung goblet cell differentiation |
| GO:0072137 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | condensed mesenchymal cell proliferation |
| GO:1904340 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
| GO:1905024 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | regulation of membrane repolarization during ventricular cardiac muscle cell action potential |
| GO:0060456 | 0.0043 | 11.103 | 0.3443 | 3 | 13 | positive regulation of digestive system process |
| GO:0001942 | 0.0043 | 4.2571 | 1.5457 | 6 | 59 | hair follicle development |
| GO:0021517 | 0.0045 | 6.7851 | 0.6842 | 4 | 26 | ventral spinal cord development |
| GO:0003016 | 0.0046 | 6.7405 | 0.6886 | 4 | 26 | respiratory system process |
| GO:0045745 | 0.0046 | 6.7405 | 0.6886 | 4 | 26 | positive regulation of G-protein coupled receptor protein signaling pathway |
| GO:0035295 | 0.0048 | 2.4193 | 5.6763 | 13 | 220 | tube development |
| GO:0071805 | 0.0048 | 2.5235 | 5.0319 | 12 | 190 | potassium ion transmembrane transport |
| GO:0045843 | 0.0048 | 5.0173 | 1.1123 | 5 | 42 | negative regulation of striated muscle tissue development |
| GO:0010557 | 0.0049 | 1.49 | 41.3143 | 58 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:1903507 | 0.005 | 1.5743 | 29.5027 | 44 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0060429 | 0.0051 | 1.8125 | 15.0929 | 26 | 602 | epithelium development |
| GO:0045923 | 0.0052 | 6.447 | 0.7151 | 4 | 27 | positive regulation of fatty acid metabolic process |
| GO:0090280 | 0.0054 | 10.093 | 0.3708 | 3 | 14 | positive regulation of calcium ion import |
| GO:0099054 | 0.0054 | 10.093 | 0.3708 | 3 | 14 | presynapse assembly |
| GO:2001212 | 0.0054 | 10.093 | 0.3708 | 3 | 14 | regulation of vasculogenesis |
| GO:0090596 | 0.0054 | 2.2922 | 6.4355 | 14 | 243 | sensory organ morphogenesis |
| GO:0010469 | 0.0055 | 1.8719 | 12.8975 | 23 | 487 | regulation of receptor activity |
| GO:0051094 | 0.0057 | 1.5545 | 30.5461 | 45 | 1159 | positive regulation of developmental process |
| GO:0051253 | 0.0058 | 1.5441 | 31.436 | 46 | 1187 | negative regulation of RNA metabolic process |
| GO:0048701 | 0.0059 | 4.7594 | 1.1653 | 5 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0010453 | 0.006 | 6.1779 | 0.7415 | 4 | 28 | regulation of cell fate commitment |
| GO:1903530 | 0.0061 | 1.7623 | 16.0755 | 27 | 607 | regulation of secretion by cell |
| GO:0043066 | 0.0063 | 1.6608 | 20.869 | 33 | 788 | negative regulation of apoptotic process |
| GO:0001756 | 0.0063 | 3.9128 | 1.6685 | 6 | 63 | somitogenesis |
| GO:0030510 | 0.0064 | 3.4279 | 2.1981 | 7 | 83 | regulation of BMP signaling pathway |
| GO:0045683 | 0.0066 | 9.2513 | 0.3973 | 3 | 15 | negative regulation of epidermis development |
| GO:0060581 | 0.0066 | 9.2513 | 0.3973 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0003150 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | muscular septum morphogenesis |
| GO:0010040 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | response to iron(II) ion |
| GO:0021523 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | somatic motor neuron differentiation |
| GO:0046533 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | negative regulation of photoreceptor cell differentiation |
| GO:0051970 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0060023 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | soft palate development |
| GO:0060336 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0072162 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | metanephric mesenchymal cell differentiation |
| GO:0090325 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | regulation of locomotion involved in locomotory behavior |
| GO:0061061 | 0.0068 | 1.7652 | 15.4399 | 26 | 583 | muscle structure development |
| GO:0042755 | 0.0068 | 5.9304 | 0.768 | 4 | 29 | eating behavior |
| GO:0009893 | 0.0069 | 1.3507 | 80.5364 | 101 | 3041 | positive regulation of metabolic process |
| GO:0001843 | 0.0073 | 3.3395 | 2.2511 | 7 | 85 | neural tube closure |
| GO:0032411 | 0.0073 | 3.3395 | 2.2511 | 7 | 85 | positive regulation of transporter activity |
| GO:0060411 | 0.0074 | 3.7796 | 1.7214 | 6 | 65 | cardiac septum morphogenesis |
| GO:0044706 | 0.0074 | 2.3749 | 5.3232 | 12 | 201 | multi-multicellular organism process |
| GO:0009913 | 0.0074 | 2.2041 | 6.6739 | 14 | 252 | epidermal cell differentiation |
| GO:0043114 | 0.0077 | 5.7019 | 0.7945 | 4 | 30 | regulation of vascular permeability |
| GO:0060563 | 0.0078 | 4.4185 | 1.2447 | 5 | 47 | neuroepithelial cell differentiation |
| GO:0003007 | 0.0084 | 2.2422 | 6.0912 | 13 | 230 | heart morphogenesis |
| GO:0036092 | 0.0085 | 4.3155 | 1.2712 | 5 | 48 | phosphatidylinositol-3-phosphate biosynthetic process |
| GO:0048713 | 0.0087 | 5.4904 | 0.821 | 4 | 31 | regulation of oligodendrocyte differentiation |
| GO:0007218 | 0.0088 | 3.2152 | 2.3306 | 7 | 88 | neuropeptide signaling pathway |
| GO:0032879 | 0.009 | 1.368 | 63.9048 | 82 | 2413 | regulation of localization |
| GO:0042742 | 0.0093 | 2.4029 | 4.82 | 11 | 182 | defense response to bacterium |
| GO:0021514 | 0.0095 | 7.9286 | 0.4502 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:0048486 | 0.0095 | 7.9286 | 0.4502 | 3 | 17 | parasympathetic nervous system development |
| GO:2000406 | 0.0095 | 7.9286 | 0.4502 | 3 | 17 | positive regulation of T cell migration |
| GO:0045823 | 0.0097 | 5.2939 | 0.8475 | 4 | 32 | positive regulation of heart contraction |
| GO:0009996 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | negative regulation of cell fate specification |
| GO:0038031 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0043987 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | histone H3-S10 phosphorylation |
| GO:0045617 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | negative regulation of keratinocyte differentiation |
| GO:0046958 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | nonassociative learning |
| GO:0060482 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | lobar bronchus development |
| GO:0060842 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | arterial endothelial cell differentiation |
| GO:0061074 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | regulation of neural retina development |
| GO:0097647 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | amylin receptor signaling pathway |
| GO:1901894 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | regulation of calcium-transporting ATPase activity |
| GO:0006334 | 0.0098 | 2.8647 | 2.9662 | 8 | 112 | nucleosome assembly |
| GO:0021953 | 0.0098 | 3.1375 | 2.3812 | 7 | 92 | central nervous system neuron differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 9.0197 | 1.717 | 13 | 92 | embryonic skeletal system morphogenesis |
| GO:0030878 | 0 | 22.1729 | 0.4479 | 7 | 24 | thyroid gland development |
| GO:0009887 | 0 | 2.6153 | 17.6555 | 41 | 946 | animal organ morphogenesis |
| GO:0007275 | 0 | 1.8303 | 87.7923 | 127 | 4704 | multicellular organism development |
| GO:0009952 | 0 | 5.8184 | 2.7218 | 14 | 148 | anterior/posterior pattern specification |
| GO:0001525 | 0 | 3.3886 | 7.8386 | 24 | 420 | angiogenesis |
| GO:0072358 | 0 | 2.7893 | 11.4593 | 29 | 614 | cardiovascular system development |
| GO:0048568 | 0 | 3.5229 | 5.9157 | 19 | 322 | embryonic organ development |
| GO:0048598 | 0 | 2.8338 | 10.0595 | 26 | 544 | embryonic morphogenesis |
| GO:0031424 | 0 | 5.2264 | 2.5569 | 12 | 137 | keratinization |
| GO:0045944 | 0 | 2.2743 | 19.4845 | 40 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001568 | 0 | 2.7506 | 10.3389 | 26 | 559 | blood vessel development |
| GO:0009888 | 0 | 2.2209 | 18.4172 | 37 | 1033 | tissue development |
| GO:0060037 | 1e-04 | 13.3629 | 0.4666 | 5 | 25 | pharyngeal system development |
| GO:0051216 | 1e-04 | 4.0993 | 3.1914 | 12 | 171 | cartilage development |
| GO:1903524 | 2e-04 | 6.7134 | 1.1758 | 7 | 63 | positive regulation of blood circulation |
| GO:0001656 | 2e-04 | 5.6663 | 1.5677 | 8 | 84 | metanephros development |
| GO:0050900 | 2e-04 | 2.8113 | 6.8868 | 18 | 369 | leukocyte migration |
| GO:0002791 | 2e-04 | 2.7021 | 7.5587 | 19 | 405 | regulation of peptide secretion |
| GO:0021545 | 2e-04 | 7.8393 | 0.8772 | 6 | 47 | cranial nerve development |
| GO:0009913 | 3e-04 | 3.2015 | 4.7032 | 14 | 252 | epidermal cell differentiation |
| GO:0048869 | 3e-04 | 1.5935 | 64.9141 | 90 | 3588 | cellular developmental process |
| GO:0003231 | 3e-04 | 4.5347 | 2.1649 | 9 | 116 | cardiac ventricle development |
| GO:0071657 | 3e-04 | Inf | 0.0373 | 2 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0003279 | 4e-04 | 4.8897 | 1.7917 | 8 | 96 | cardiac septum development |
| GO:0070555 | 5e-04 | 4.8344 | 1.8103 | 8 | 97 | response to interleukin-1 |
| GO:0032501 | 5e-04 | 2.1096 | 16.7277 | 31 | 1135 | multicellular organismal process |
| GO:0003266 | 5e-04 | 26.5605 | 0.168 | 3 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0010656 | 5e-04 | 8.6149 | 0.6719 | 5 | 36 | negative regulation of muscle cell apoptotic process |
| GO:0051241 | 6e-04 | 1.9744 | 18.0213 | 33 | 972 | negative regulation of multicellular organismal process |
| GO:0010662 | 6e-04 | 8.3451 | 0.6905 | 5 | 37 | regulation of striated muscle cell apoptotic process |
| GO:0022603 | 6e-04 | 2.0126 | 16.5794 | 31 | 897 | regulation of anatomical structure morphogenesis |
| GO:0002718 | 6e-04 | 6.4243 | 1.0451 | 6 | 56 | regulation of cytokine production involved in immune response |
| GO:0048870 | 6e-04 | 1.8216 | 25.0275 | 42 | 1341 | cell motility |
| GO:1903508 | 6e-04 | 1.82 | 25.0462 | 42 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0003002 | 6e-04 | 6.329 | 1.0551 | 6 | 60 | regionalization |
| GO:0003263 | 7e-04 | 22.7646 | 0.1866 | 3 | 10 | cardioblast proliferation |
| GO:0006935 | 8e-04 | 2.3145 | 9.6863 | 21 | 519 | chemotaxis |
| GO:0042481 | 8e-04 | 11.2135 | 0.4293 | 4 | 23 | regulation of odontogenesis |
| GO:0050714 | 8e-04 | 3.1696 | 4.0499 | 12 | 217 | positive regulation of protein secretion |
| GO:0043588 | 8e-04 | 2.7479 | 5.823 | 15 | 312 | skin development |
| GO:1903555 | 8e-04 | 4.3878 | 1.9783 | 8 | 106 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0010469 | 8e-04 | 2.3467 | 9.089 | 20 | 487 | regulation of receptor activity |
| GO:0048729 | 9e-04 | 2.1965 | 11.1793 | 23 | 599 | tissue morphogenesis |
| GO:0009111 | 9e-04 | 19.9177 | 0.2053 | 3 | 11 | vitamin catabolic process |
| GO:0051173 | 0.001 | 1.5727 | 50.8389 | 72 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0032264 | 0.001 | 105.9007 | 0.056 | 2 | 3 | IMP salvage |
| GO:2000297 | 0.001 | 105.9007 | 0.056 | 2 | 3 | negative regulation of synapse maturation |
| GO:0007507 | 0.0011 | 2.3009 | 9.257 | 20 | 496 | heart development |
| GO:0003148 | 0.0011 | 10.1442 | 0.4666 | 4 | 25 | outflow tract septum morphogenesis |
| GO:0051094 | 0.0012 | 1.8332 | 21.1319 | 36 | 1143 | positive regulation of developmental process |
| GO:0051047 | 0.0012 | 2.5319 | 6.7188 | 16 | 360 | positive regulation of secretion |
| GO:0003207 | 0.0012 | 17.7034 | 0.224 | 3 | 12 | cardiac chamber formation |
| GO:0090197 | 0.0012 | 17.7034 | 0.224 | 3 | 12 | positive regulation of chemokine secretion |
| GO:0030855 | 0.0013 | 2.5227 | 6.7477 | 16 | 374 | epithelial cell differentiation |
| GO:0070374 | 0.0014 | 3.3486 | 3.1914 | 10 | 171 | positive regulation of ERK1 and ERK2 cascade |
| GO:0035176 | 0.0015 | 6.6725 | 0.8399 | 5 | 45 | social behavior |
| GO:0009948 | 0.0016 | 6.5093 | 0.8585 | 5 | 46 | anterior/posterior axis specification |
| GO:0051254 | 0.0016 | 1.7196 | 26.334 | 42 | 1411 | positive regulation of RNA metabolic process |
| GO:0006959 | 0.0017 | 3.2665 | 3.2661 | 10 | 175 | humoral immune response |
| GO:0070741 | 0.0017 | 8.8744 | 0.5226 | 4 | 28 | response to interleukin-6 |
| GO:0043207 | 0.0017 | 2.0108 | 13.2323 | 25 | 709 | response to external biotic stimulus |
| GO:0050710 | 0.0018 | 6.3539 | 0.8772 | 5 | 47 | negative regulation of cytokine secretion |
| GO:2001212 | 0.002 | 14.4827 | 0.2613 | 3 | 14 | regulation of vasculogenesis |
| GO:0021615 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0034653 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | retinoic acid catabolic process |
| GO:0072040 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis |
| GO:0097029 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | mature conventional dendritic cell differentiation |
| GO:1900738 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:1901256 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:1904637 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | cellular response to ionomycin |
| GO:2001181 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | positive regulation of interleukin-10 secretion |
| GO:0008284 | 0.0022 | 1.9219 | 14.9493 | 27 | 801 | positive regulation of cell proliferation |
| GO:0048534 | 0.0022 | 1.9192 | 14.968 | 27 | 802 | hematopoietic or lymphoid organ development |
| GO:1903530 | 0.0023 | 2.0595 | 11.3286 | 22 | 607 | regulation of secretion by cell |
| GO:0072028 | 0.0024 | 4.7888 | 1.3624 | 6 | 73 | nephron morphogenesis |
| GO:0003156 | 0.0024 | 13.4047 | 0.2773 | 3 | 15 | regulation of animal organ formation |
| GO:0071599 | 0.0025 | 13.2749 | 0.28 | 3 | 15 | otic vesicle development |
| GO:2000484 | 0.0025 | 13.2749 | 0.28 | 3 | 15 | positive regulation of interleukin-8 secretion |
| GO:0030326 | 0.0025 | 3.6392 | 2.3516 | 8 | 126 | embryonic limb morphogenesis |
| GO:0032355 | 0.0025 | 3.6392 | 2.3516 | 8 | 126 | response to estradiol |
| GO:0051954 | 0.0025 | 7.8868 | 0.5786 | 4 | 31 | positive regulation of amine transport |
| GO:0002440 | 0.0025 | 3.3146 | 2.8928 | 9 | 155 | production of molecular mediator of immune response |
| GO:0002286 | 0.0026 | 4.718 | 1.3811 | 6 | 74 | T cell activation involved in immune response |
| GO:0065008 | 0.0027 | 1.4741 | 60.8798 | 81 | 3262 | regulation of biological quality |
| GO:0032729 | 0.0028 | 5.676 | 0.9705 | 5 | 52 | positive regulation of interferon-gamma production |
| GO:0007599 | 0.0029 | 2.4703 | 5.9909 | 14 | 321 | hemostasis |
| GO:0050896 | 0.0029 | 1.4043 | 140.5163 | 164 | 7529 | response to stimulus |
| GO:0032675 | 0.003 | 3.947 | 1.9037 | 7 | 102 | regulation of interleukin-6 production |
| GO:0007267 | 0.003 | 1.6554 | 27.2298 | 42 | 1459 | cell-cell signaling |
| GO:0001662 | 0.0032 | 7.3419 | 0.6159 | 4 | 33 | behavioral fear response |
| GO:0048665 | 0.0032 | 7.3419 | 0.6159 | 4 | 33 | neuron fate specification |
| GO:0031328 | 0.0033 | 1.6063 | 31.5037 | 47 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0019236 | 0.0033 | 35.2955 | 0.0933 | 2 | 5 | response to pheromone |
| GO:0046642 | 0.0033 | 35.2955 | 0.0933 | 2 | 5 | negative regulation of alpha-beta T cell proliferation |
| GO:0070945 | 0.0033 | 35.2955 | 0.0933 | 2 | 5 | neutrophil mediated killing of gram-negative bacterium |
| GO:0043009 | 0.0034 | 2.1109 | 9.513 | 19 | 518 | chordate embryonic development |
| GO:0003013 | 0.0035 | 2.1532 | 8.8278 | 18 | 473 | circulatory system process |
| GO:0072009 | 0.0035 | 3.8254 | 1.9597 | 7 | 105 | nephron epithelium development |
| GO:0035909 | 0.0035 | 7.0967 | 0.6346 | 4 | 34 | aorta morphogenesis |
| GO:0019229 | 0.0036 | 5.3344 | 1.0265 | 5 | 55 | regulation of vasoconstriction |
| GO:0032677 | 0.0036 | 5.3344 | 1.0265 | 5 | 55 | regulation of interleukin-8 production |
| GO:0071294 | 0.0036 | 11.377 | 0.3173 | 3 | 17 | cellular response to zinc ion |
| GO:2000136 | 0.0036 | 11.377 | 0.3173 | 3 | 17 | regulation of cell proliferation involved in heart morphogenesis |
| GO:2000738 | 0.0036 | 11.377 | 0.3173 | 3 | 17 | positive regulation of stem cell differentiation |
| GO:0003206 | 0.0037 | 3.7872 | 1.9774 | 7 | 107 | cardiac chamber morphogenesis |
| GO:0010628 | 0.0039 | 1.59 | 31.7837 | 47 | 1703 | positive regulation of gene expression |
| GO:0036293 | 0.0039 | 2.3831 | 6.1962 | 14 | 332 | response to decreased oxygen levels |
| GO:0060562 | 0.004 | 2.4655 | 5.5617 | 13 | 298 | epithelial tube morphogenesis |
| GO:0060485 | 0.0042 | 2.6947 | 4.3112 | 11 | 231 | mesenchyme development |
| GO:0001759 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | organ induction |
| GO:0032682 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | negative regulation of chemokine production |
| GO:0042693 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | muscle cell fate commitment |
| GO:0072643 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | interferon-gamma secretion |
| GO:1905331 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | negative regulation of morphogenesis of an epithelium |
| GO:0030193 | 0.0043 | 4.2191 | 1.5304 | 6 | 82 | regulation of blood coagulation |
| GO:0009615 | 0.0046 | 2.5294 | 5.0018 | 12 | 268 | response to virus |
| GO:0060173 | 0.0047 | 3.0028 | 3.1728 | 9 | 170 | limb development |
| GO:0019915 | 0.0048 | 4.9379 | 1.1011 | 5 | 59 | lipid storage |
| GO:0032653 | 0.0048 | 6.4502 | 0.6905 | 4 | 37 | regulation of interleukin-10 production |
| GO:0060561 | 0.0049 | 10.0222 | 0.3522 | 3 | 19 | apoptotic process involved in morphogenesis |
| GO:0003278 | 0.005 | 26.4699 | 0.112 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0016115 | 0.005 | 26.4699 | 0.112 | 2 | 6 | terpenoid catabolic process |
| GO:0021546 | 0.005 | 26.4699 | 0.112 | 2 | 6 | rhombomere development |
| GO:0097647 | 0.005 | 26.4699 | 0.112 | 2 | 6 | amylin receptor signaling pathway |
| GO:1904746 | 0.005 | 26.4699 | 0.112 | 2 | 6 | negative regulation of apoptotic process involved in development |
| GO:0003215 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0010002 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | cardioblast differentiation |
| GO:0072079 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | nephron tubule formation |
| GO:1900745 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | positive regulation of p38MAPK cascade |
| GO:0012501 | 0.005 | 1.5453 | 34.7885 | 50 | 1864 | programmed cell death |
| GO:0001892 | 0.0051 | 4.0581 | 1.5864 | 6 | 85 | embryonic placenta development |
| GO:0050702 | 0.0053 | 6.2601 | 0.7092 | 4 | 38 | interleukin-1 beta secretion |
| GO:0045995 | 0.0058 | 3.4689 | 2.1463 | 7 | 115 | regulation of embryonic development |
| GO:2000778 | 0.0058 | 9.3674 | 0.3733 | 3 | 20 | positive regulation of interleukin-6 secretion |
| GO:0051240 | 0.0059 | 1.6342 | 24.1307 | 37 | 1333 | positive regulation of multicellular organismal process |
| GO:0035107 | 0.0059 | 3.1304 | 2.7062 | 8 | 145 | appendage morphogenesis |
| GO:0010557 | 0.0059 | 1.5779 | 29.1148 | 43 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0007218 | 0.0061 | 3.9088 | 1.6424 | 6 | 88 | neuropeptide signaling pathway |
| GO:0006937 | 0.0061 | 3.1075 | 2.7248 | 8 | 146 | regulation of muscle contraction |
| GO:1901215 | 0.0063 | 2.8591 | 3.3221 | 9 | 178 | negative regulation of neuron death |
| GO:0021983 | 0.0064 | 5.9115 | 0.7465 | 4 | 40 | pituitary gland development |
| GO:0043586 | 0.0067 | 8.8464 | 0.3919 | 3 | 21 | tongue development |
| GO:0048520 | 0.0067 | 8.8464 | 0.3919 | 3 | 21 | positive regulation of behavior |
| GO:0060713 | 0.0067 | 8.8464 | 0.3919 | 3 | 21 | labyrinthine layer morphogenesis |
| GO:0003203 | 0.0067 | 21.3749 | 0.1295 | 2 | 7 | endocardial cushion morphogenesis |
| GO:0021700 | 0.0068 | 2.5093 | 4.6098 | 11 | 247 | developmental maturation |
| GO:0003253 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0070943 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | neutrophil mediated killing of symbiont cell |
| GO:0071863 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | regulation of cell proliferation in bone marrow |
| GO:1902455 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | negative regulation of stem cell population maintenance |
| GO:1904672 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | regulation of somatic stem cell population maintenance |
| GO:0042345 | 0.007 | 5.7514 | 0.7652 | 4 | 41 | regulation of NF-kappaB import into nucleus |
| GO:0051048 | 0.007 | 2.8086 | 3.3781 | 9 | 181 | negative regulation of secretion |
| GO:0061138 | 0.0071 | 3.0269 | 2.7924 | 8 | 151 | morphogenesis of a branching epithelium |
| GO:0042742 | 0.0072 | 2.7922 | 3.3967 | 9 | 182 | defense response to bacterium |
| GO:0032088 | 0.0073 | 4.4424 | 1.2131 | 5 | 65 | negative regulation of NF-kappaB transcription factor activity |
| GO:0050817 | 0.0073 | 2.2854 | 5.9723 | 13 | 320 | coagulation |
| GO:0045937 | 0.0075 | 1.689 | 18.7753 | 30 | 1006 | positive regulation of phosphate metabolic process |
| GO:0001657 | 0.0075 | 3.726 | 1.717 | 6 | 92 | ureteric bud development |
| GO:0009953 | 0.0075 | 3.726 | 1.717 | 6 | 92 | dorsal/ventral pattern formation |
| GO:0001501 | 0.0076 | 2.3633 | 5.333 | 12 | 295 | skeletal system development |
| GO:0009855 | 0.0076 | 3.285 | 2.2583 | 7 | 121 | determination of bilateral symmetry |
| GO:0003272 | 0.0076 | 8.3802 | 0.4106 | 3 | 22 | endocardial cushion formation |
| GO:0060445 | 0.0076 | 8.3802 | 0.4106 | 3 | 22 | branching involved in salivary gland morphogenesis |
| GO:0072163 | 0.0079 | 3.683 | 1.7357 | 6 | 93 | mesonephric epithelium development |
| GO:0045165 | 0.0079 | 2.5844 | 4.0674 | 10 | 220 | cell fate commitment |
| GO:0032502 | 0.0081 | 1.6249 | 24.9425 | 37 | 1576 | developmental process |
| GO:0002443 | 0.0081 | 1.8363 | 12.5978 | 22 | 675 | leukocyte mediated immunity |
| GO:0007411 | 0.0082 | 2.5712 | 4.0873 | 10 | 219 | axon guidance |
| GO:0032720 | 0.0083 | 5.4557 | 0.8025 | 4 | 43 | negative regulation of tumor necrosis factor production |
| GO:0010667 | 0.0086 | 7.9607 | 0.4293 | 3 | 23 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0002741 | 0.009 | 17.6442 | 0.1493 | 2 | 8 | positive regulation of cytokine secretion involved in immune response |
| GO:0033141 | 0.009 | 17.6442 | 0.1493 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0045188 | 0.009 | 17.6442 | 0.1493 | 2 | 8 | regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0001934 | 0.0097 | 1.7167 | 15.9385 | 26 | 854 | positive regulation of protein phosphorylation |
| GO:0009967 | 0.0097 | 1.5644 | 25.7554 | 38 | 1380 | positive regulation of signal transduction |
| GO:0072012 | 0.0097 | 7.5811 | 0.4479 | 3 | 24 | glomerulus vasculature development |
| GO:0030178 | 0.0098 | 2.6525 | 3.5647 | 9 | 191 | negative regulation of Wnt signaling pathway |
| GO:0032612 | 0.0099 | 4.0993 | 1.3064 | 5 | 70 | interleukin-1 production |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 0 | 4.1434 | 5.9765 | 22 | 406 | pattern specification process |
| GO:0021877 | 0 | 205.3151 | 0.0584 | 3 | 4 | forebrain neuron fate commitment |
| GO:0009790 | 0 | 2.5513 | 13.528 | 31 | 919 | embryo development |
| GO:0045165 | 1e-04 | 4.0439 | 3.5035 | 13 | 238 | cell fate commitment |
| GO:0045638 | 2e-04 | 6.685 | 1.1629 | 7 | 79 | negative regulation of myeloid cell differentiation |
| GO:0021882 | 2e-04 | Inf | 0.0294 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
| GO:0021893 | 2e-04 | Inf | 0.0294 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
| GO:1902868 | 2e-04 | Inf | 0.0294 | 2 | 2 | positive regulation of retina development in camera-type eye |
| GO:1902871 | 2e-04 | Inf | 0.0294 | 2 | 2 | positive regulation of amacrine cell differentiation |
| GO:0008544 | 2e-04 | 3.1213 | 5.1816 | 15 | 352 | epidermis development |
| GO:0043009 | 3e-04 | 2.6586 | 7.7179 | 19 | 531 | chordate embryonic development |
| GO:0090023 | 3e-04 | 14.3292 | 0.3386 | 4 | 23 | positive regulation of neutrophil chemotaxis |
| GO:0002690 | 3e-04 | 7.1499 | 0.9342 | 6 | 64 | positive regulation of leukocyte chemotaxis |
| GO:0048562 | 3e-04 | 4.0671 | 2.6542 | 10 | 185 | embryonic organ morphogenesis |
| GO:0048704 | 4e-04 | 5.6577 | 1.3543 | 7 | 92 | embryonic skeletal system morphogenesis |
| GO:0031644 | 4e-04 | 6.85 | 0.9715 | 6 | 66 | regulation of neurological system process |
| GO:0050920 | 5e-04 | 4.2276 | 2.2964 | 9 | 156 | regulation of chemotaxis |
| GO:0021761 | 5e-04 | 5.402 | 1.4132 | 7 | 96 | limbic system development |
| GO:0009952 | 6e-04 | 3.7609 | 2.8558 | 10 | 194 | anterior/posterior pattern specification |
| GO:0014029 | 6e-04 | 22.6003 | 0.1766 | 3 | 12 | neural crest formation |
| GO:0097154 | 6e-04 | 22.6003 | 0.1766 | 3 | 12 | GABAergic neuron differentiation |
| GO:0002501 | 6e-04 | 135.0631 | 0.0442 | 2 | 3 | peptide antigen assembly with MHC protein complex |
| GO:0099566 | 6e-04 | 135.0631 | 0.0442 | 2 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:1902732 | 6e-04 | 135.0631 | 0.0442 | 2 | 3 | positive regulation of chondrocyte proliferation |
| GO:0030216 | 9e-04 | 3.5646 | 3.003 | 10 | 204 | keratinocyte differentiation |
| GO:1902622 | 9e-04 | 10.4664 | 0.4416 | 4 | 30 | regulation of neutrophil migration |
| GO:0007610 | 0.001 | 2.432 | 7.9196 | 18 | 538 | behavior |
| GO:0048513 | 0.0011 | 1.7169 | 32.7402 | 50 | 2370 | animal organ development |
| GO:0055123 | 0.0011 | 4.1698 | 2.0609 | 8 | 140 | digestive system development |
| GO:0050706 | 0.0012 | 9.7175 | 0.4711 | 4 | 32 | regulation of interleukin-1 beta secretion |
| GO:0048870 | 0.0012 | 1.8738 | 19.74 | 34 | 1341 | cell motility |
| GO:0042475 | 0.0012 | 5.4745 | 1.1924 | 6 | 81 | odontogenesis of dentin-containing tooth |
| GO:0048866 | 0.0013 | 67.527 | 0.0589 | 2 | 4 | stem cell fate specification |
| GO:0048665 | 0.0013 | 9.3818 | 0.4858 | 4 | 33 | neuron fate specification |
| GO:0007186 | 0.0014 | 2.0876 | 12.3504 | 24 | 839 | G-protein coupled receptor signaling pathway |
| GO:0048646 | 0.0015 | 2.0219 | 13.8516 | 26 | 953 | anatomical structure formation involved in morphogenesis |
| GO:0070098 | 0.0015 | 6.56 | 0.8391 | 5 | 57 | chemokine-mediated signaling pathway |
| GO:0009953 | 0.0015 | 5.2423 | 1.2406 | 6 | 85 | dorsal/ventral pattern formation |
| GO:0021872 | 0.0017 | 6.3162 | 0.8685 | 5 | 59 | forebrain generation of neurons |
| GO:0060326 | 0.0018 | 3.2271 | 3.2974 | 10 | 224 | cell chemotaxis |
| GO:1903557 | 0.002 | 6.0898 | 0.8979 | 5 | 61 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0046533 | 0.0021 | 45.015 | 0.0736 | 2 | 5 | negative regulation of photoreceptor cell differentiation |
| GO:0042474 | 0.0022 | 13.5548 | 0.265 | 3 | 18 | middle ear morphogenesis |
| GO:0045765 | 0.0023 | 3.1234 | 3.4004 | 10 | 231 | regulation of angiogenesis |
| GO:0060485 | 0.0023 | 3.1234 | 3.4004 | 10 | 231 | mesenchyme development |
| GO:0030855 | 0.0023 | 2.1966 | 9.215 | 19 | 626 | epithelial cell differentiation |
| GO:1902105 | 0.0023 | 3.1092 | 3.4151 | 10 | 232 | regulation of leukocyte differentiation |
| GO:2000026 | 0.0024 | 1.7135 | 25.4368 | 40 | 1728 | regulation of multicellular organismal development |
| GO:0021543 | 0.0025 | 3.6404 | 2.3405 | 8 | 159 | pallium development |
| GO:0003215 | 0.0026 | 12.7067 | 0.2797 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0021895 | 0.0026 | 12.7067 | 0.2797 | 3 | 19 | cerebral cortex neuron differentiation |
| GO:0023019 | 0.0026 | 12.7067 | 0.2797 | 3 | 19 | signal transduction involved in regulation of gene expression |
| GO:0008284 | 0.0026 | 2.0492 | 11.4679 | 22 | 789 | positive regulation of cell proliferation |
| GO:0070268 | 0.0026 | 4.6617 | 1.3837 | 6 | 94 | cornification |
| GO:0071622 | 0.0028 | 7.554 | 0.5888 | 4 | 40 | regulation of granulocyte chemotaxis |
| GO:0006874 | 0.0028 | 2.5852 | 5.3288 | 13 | 362 | cellular calcium ion homeostasis |
| GO:0044706 | 0.003 | 3.227 | 2.9588 | 9 | 201 | multi-multicellular organism process |
| GO:0051482 | 0.003 | 11.9585 | 0.2944 | 3 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
| GO:0045944 | 0.003 | 1.8835 | 15.3681 | 27 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0021902 | 0.0031 | 33.759 | 0.0883 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0061074 | 0.0031 | 33.759 | 0.0883 | 2 | 6 | regulation of neural retina development |
| GO:0050701 | 0.0033 | 7.1555 | 0.6183 | 4 | 42 | interleukin-1 secretion |
| GO:0048514 | 0.0034 | 2.2816 | 7.4338 | 16 | 505 | blood vessel morphogenesis |
| GO:0097530 | 0.0034 | 4.4096 | 1.4573 | 6 | 99 | granulocyte migration |
| GO:0003008 | 0.0035 | 1.7174 | 22.6694 | 36 | 1540 | system process |
| GO:0048863 | 0.0036 | 2.9219 | 3.6212 | 10 | 246 | stem cell differentiation |
| GO:0021517 | 0.0036 | 6.9716 | 0.633 | 4 | 43 | ventral spinal cord development |
| GO:0030826 | 0.0039 | 10.6983 | 0.3238 | 3 | 22 | regulation of cGMP biosynthetic process |
| GO:0045589 | 0.0039 | 10.6983 | 0.3238 | 3 | 22 | regulation of regulatory T cell differentiation |
| GO:0051093 | 0.004 | 1.9686 | 11.8941 | 22 | 808 | negative regulation of developmental process |
| GO:0051272 | 0.0041 | 2.3772 | 6.2267 | 14 | 423 | positive regulation of cellular component movement |
| GO:0002573 | 0.0041 | 3.3284 | 2.5466 | 8 | 173 | myeloid leukocyte differentiation |
| GO:0035050 | 0.0042 | 5.0862 | 1.0599 | 5 | 72 | embryonic heart tube development |
| GO:0032501 | 0.0043 | 1.5678 | 47.1172 | 63 | 3751 | multicellular organismal process |
| GO:0001826 | 0.0043 | 27.0054 | 0.103 | 2 | 7 | inner cell mass cell differentiation |
| GO:0021798 | 0.0043 | 27.0054 | 0.103 | 2 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0060017 | 0.0043 | 27.0054 | 0.103 | 2 | 7 | parathyroid gland development |
| GO:0006952 | 0.0043 | 1.7438 | 19.7253 | 32 | 1340 | defense response |
| GO:0017148 | 0.0045 | 2.8246 | 3.739 | 10 | 254 | negative regulation of translation |
| GO:0032461 | 0.0045 | 10.1627 | 0.3386 | 3 | 23 | positive regulation of protein oligomerization |
| GO:0044030 | 0.0045 | 10.1627 | 0.3386 | 3 | 23 | regulation of DNA methylation |
| GO:0007215 | 0.0047 | 4.9381 | 1.0893 | 5 | 74 | glutamate receptor signaling pathway |
| GO:0060562 | 0.0047 | 2.6462 | 4.3867 | 11 | 298 | epithelial tube morphogenesis |
| GO:0030878 | 0.0051 | 9.6781 | 0.3533 | 3 | 24 | thyroid gland development |
| GO:0007492 | 0.0055 | 4.7314 | 1.1335 | 5 | 77 | endoderm development |
| GO:0030335 | 0.0057 | 2.3629 | 5.7998 | 13 | 394 | positive regulation of cell migration |
| GO:0060638 | 0.0057 | 22.503 | 0.1178 | 2 | 8 | mesenchymal-epithelial cell signaling |
| GO:2000510 | 0.0057 | 22.503 | 0.1178 | 2 | 8 | positive regulation of dendritic cell chemotaxis |
| GO:0010469 | 0.0058 | 2.208 | 7.1688 | 15 | 487 | regulation of receptor activity |
| GO:0007566 | 0.0058 | 6.0396 | 0.7213 | 4 | 49 | embryo implantation |
| GO:0040017 | 0.0059 | 2.2687 | 6.5064 | 14 | 442 | positive regulation of locomotion |
| GO:0048546 | 0.0062 | 5.9079 | 0.736 | 4 | 50 | digestive tract morphogenesis |
| GO:0060688 | 0.0062 | 5.9079 | 0.736 | 4 | 50 | regulation of morphogenesis of a branching structure |
| GO:0002685 | 0.0063 | 3.8575 | 1.6514 | 6 | 114 | regulation of leukocyte migration |
| GO:0021515 | 0.0067 | 5.7818 | 0.7507 | 4 | 51 | cell differentiation in spinal cord |
| GO:0072507 | 0.0068 | 2.307 | 5.9323 | 13 | 403 | divalent inorganic cation homeostasis |
| GO:0000003 | 0.0069 | 1.7091 | 18.7538 | 30 | 1274 | reproduction |
| GO:0002385 | 0.0071 | 8.4666 | 0.3975 | 3 | 27 | mucosal immune response |
| GO:0042104 | 0.0071 | 8.4666 | 0.3975 | 3 | 27 | positive regulation of activated T cell proliferation |
| GO:0060706 | 0.0071 | 8.4666 | 0.3975 | 3 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0002664 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | regulation of T cell tolerance induction |
| GO:0006069 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | ethanol oxidation |
| GO:0007196 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
| GO:0042747 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | circadian sleep/wake cycle, REM sleep |
| GO:0048617 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | embryonic foregut morphogenesis |
| GO:0007423 | 0.0081 | 2.1198 | 7.4485 | 15 | 506 | sensory organ development |
| GO:0051707 | 0.0084 | 1.9271 | 10.4073 | 19 | 707 | response to other organism |
| GO:0040029 | 0.0085 | 2.43 | 4.7547 | 11 | 323 | regulation of gene expression, epigenetic |
| GO:0001944 | 0.0085 | 2.0048 | 8.9353 | 17 | 607 | vasculature development |
| GO:0036230 | 0.0088 | 2.1595 | 6.8155 | 14 | 463 | granulocyte activation |
| GO:0033690 | 0.009 | 16.875 | 0.1472 | 2 | 10 | positive regulation of osteoblast proliferation |
| GO:0048715 | 0.009 | 16.875 | 0.1472 | 2 | 10 | negative regulation of oligodendrocyte differentiation |
| GO:0061140 | 0.009 | 16.875 | 0.1472 | 2 | 10 | lung secretory cell differentiation |
| GO:1904627 | 0.009 | 16.875 | 0.1472 | 2 | 10 | response to phorbol 13-acetate 12-myristate |
| GO:0050918 | 0.0092 | 5.2241 | 0.8243 | 4 | 56 | positive chemotaxis |
| GO:0001501 | 0.0093 | 2.1447 | 6.8597 | 14 | 466 | skeletal system development |
| GO:0051930 | 0.0095 | 7.5244 | 0.4416 | 3 | 30 | regulation of sensory perception of pain |
| GO:0051241 | 0.0097 | 1.7639 | 14.4113 | 24 | 979 | negative regulation of multicellular organismal process |
| GO:0032496 | 0.0097 | 2.5009 | 4.1953 | 10 | 285 | response to lipopolysaccharide |
| GO:0032103 | 0.0098 | 2.6518 | 3.5623 | 9 | 242 | positive regulation of response to external stimulus |
| GO:0001947 | 0.0098 | 5.1252 | 0.8391 | 4 | 57 | heart looping |
| GO:0034121 | 0.0098 | 5.1252 | 0.8391 | 4 | 57 | regulation of toll-like receptor signaling pathway |
| GO:0010951 | 0.0099 | 2.8401 | 2.9588 | 8 | 201 | negative regulation of endopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 17.9939 | 3.1165 | 38 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007267 | 0 | 2.9239 | 29.9144 | 72 | 1459 | cell-cell signaling |
| GO:0032502 | 0 | 3.0404 | 31.5582 | 72 | 1720 | developmental process |
| GO:0098609 | 0 | 3.4884 | 15.3775 | 46 | 750 | cell-cell adhesion |
| GO:0032501 | 0 | 2.1458 | 78.0707 | 121 | 4321 | multicellular organismal process |
| GO:0022610 | 0 | 2.4472 | 26.2238 | 56 | 1279 | biological adhesion |
| GO:0007416 | 0 | 6.2226 | 2.768 | 15 | 135 | synapse assembly |
| GO:0007399 | 0 | 2.2338 | 33.3217 | 64 | 1742 | nervous system development |
| GO:0007389 | 0 | 3.3206 | 8.3244 | 25 | 406 | pattern specification process |
| GO:0016339 | 0 | 16.2667 | 0.5741 | 7 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0009952 | 0 | 4.6334 | 3.8516 | 16 | 189 | anterior/posterior pattern specification |
| GO:0048704 | 0 | 6.6882 | 1.8863 | 11 | 92 | embryonic skeletal system morphogenesis |
| GO:0009887 | 0 | 2.2048 | 19.3962 | 39 | 946 | animal organ morphogenesis |
| GO:0009888 | 0 | 1.8959 | 35.3273 | 60 | 1723 | tissue development |
| GO:0048598 | 0 | 2.5299 | 11.5844 | 27 | 565 | embryonic morphogenesis |
| GO:0045944 | 0 | 2.097 | 21.4055 | 41 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0051891 | 1e-04 | 72.3447 | 0.1025 | 3 | 5 | positive regulation of cardioblast differentiation |
| GO:0001764 | 1e-04 | 4.4282 | 2.727 | 11 | 133 | neuron migration |
| GO:0048568 | 1e-04 | 2.7144 | 8.3449 | 21 | 407 | embryonic organ development |
| GO:0021520 | 1e-04 | 21.4949 | 0.2665 | 4 | 13 | spinal cord motor neuron cell fate specification |
| GO:0006355 | 2e-04 | 1.5758 | 69.1989 | 96 | 3375 | regulation of transcription, DNA-templated |
| GO:0007268 | 3e-04 | 2.2996 | 11.6664 | 25 | 569 | chemical synaptic transmission |
| GO:0099537 | 3e-04 | 2.2908 | 11.7074 | 25 | 571 | trans-synaptic signaling |
| GO:2001141 | 3e-04 | 1.5599 | 69.732 | 96 | 3401 | regulation of RNA biosynthetic process |
| GO:0021545 | 4e-04 | 7.1086 | 0.9637 | 6 | 47 | cranial nerve development |
| GO:0021570 | 4e-04 | Inf | 0.041 | 2 | 2 | rhombomere 4 development |
| GO:1901253 | 4e-04 | Inf | 0.041 | 2 | 2 | negative regulation of intracellular transport of viral material |
| GO:0003310 | 4e-04 | 28.932 | 0.164 | 3 | 8 | pancreatic A cell differentiation |
| GO:0019219 | 5e-04 | 1.512 | 80.6193 | 107 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0034654 | 5e-04 | 1.5048 | 81.747 | 108 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0045761 | 6e-04 | 5.4069 | 1.4352 | 7 | 70 | regulation of adenylate cyclase activity |
| GO:0035270 | 6e-04 | 4.1338 | 2.3642 | 9 | 116 | endocrine system development |
| GO:0001501 | 6e-04 | 2.345 | 9.5546 | 21 | 466 | skeletal system development |
| GO:0009889 | 7e-04 | 1.4887 | 84.966 | 111 | 4144 | regulation of biosynthetic process |
| GO:1903508 | 7e-04 | 1.7683 | 27.5155 | 45 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0051961 | 8e-04 | 2.8829 | 5.1874 | 14 | 253 | negative regulation of nervous system development |
| GO:0048857 | 9e-04 | 5.9448 | 1.1277 | 6 | 55 | neural nucleus development |
| GO:0045665 | 0.0014 | 3.1488 | 3.7316 | 11 | 182 | negative regulation of neuron differentiation |
| GO:0001708 | 0.0014 | 4.5998 | 1.6608 | 7 | 81 | cell fate specification |
| GO:0030802 | 0.0017 | 3.5406 | 2.727 | 9 | 133 | regulation of cyclic nucleotide biosynthetic process |
| GO:0031328 | 0.0018 | 1.6221 | 34.6097 | 52 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0021517 | 0.0018 | 6.3719 | 0.8816 | 5 | 43 | ventral spinal cord development |
| GO:0051254 | 0.0019 | 1.6705 | 28.9303 | 45 | 1411 | positive regulation of RNA metabolic process |
| GO:0021953 | 0.0021 | 3.1717 | 3.3626 | 10 | 164 | central nervous system neuron differentiation |
| GO:0003008 | 0.0021 | 1.6345 | 31.5752 | 48 | 1540 | system process |
| GO:0010628 | 0.0021 | 1.6056 | 34.9173 | 52 | 1703 | positive regulation of gene expression |
| GO:0007218 | 0.0022 | 4.2003 | 1.8043 | 7 | 88 | neuropeptide signaling pathway |
| GO:0006171 | 0.0024 | 3.674 | 2.3374 | 8 | 114 | cAMP biosynthetic process |
| GO:0002730 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | regulation of dendritic cell cytokine production |
| GO:0009786 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | regulation of asymmetric cell division |
| GO:0021615 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0021913 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0032811 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | negative regulation of epinephrine secretion |
| GO:0051464 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | positive regulation of cortisol secretion |
| GO:0110022 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | regulation of cardiac muscle myoblast proliferation |
| GO:1900371 | 0.0025 | 3.3243 | 2.891 | 9 | 141 | regulation of purine nucleotide biosynthetic process |
| GO:0048663 | 0.0027 | 4.6942 | 1.3942 | 6 | 68 | neuron fate commitment |
| GO:0030855 | 0.0037 | 2.2515 | 7.4975 | 16 | 374 | epithelial cell differentiation |
| GO:0021515 | 0.0038 | 5.2609 | 1.0457 | 5 | 51 | cell differentiation in spinal cord |
| GO:0006816 | 0.0038 | 2.2413 | 7.5247 | 16 | 367 | calcium ion transport |
| GO:0010721 | 0.0039 | 2.4781 | 5.5359 | 13 | 270 | negative regulation of cell development |
| GO:0030150 | 0.0039 | 11.1217 | 0.3281 | 3 | 16 | protein import into mitochondrial matrix |
| GO:0007356 | 0.004 | 32.0473 | 0.1025 | 2 | 5 | thorax and anterior abdomen determination |
| GO:0035634 | 0.004 | 32.0473 | 0.1025 | 2 | 5 | response to stilbenoid |
| GO:0043388 | 0.0041 | 5.1487 | 1.0662 | 5 | 52 | positive regulation of DNA binding |
| GO:0071383 | 0.0042 | 2.5635 | 4.9413 | 12 | 241 | cellular response to steroid hormone stimulus |
| GO:0001662 | 0.0044 | 6.6619 | 0.6766 | 4 | 33 | behavioral fear response |
| GO:0071385 | 0.0045 | 5.0411 | 1.0867 | 5 | 53 | cellular response to glucocorticoid stimulus |
| GO:0010557 | 0.0046 | 1.5699 | 31.9853 | 47 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0030814 | 0.0047 | 3.2698 | 2.6039 | 8 | 127 | regulation of cAMP metabolic process |
| GO:0048486 | 0.0047 | 10.3266 | 0.3486 | 3 | 17 | parasympathetic nervous system development |
| GO:0051412 | 0.0047 | 10.3266 | 0.3486 | 3 | 17 | response to corticosterone |
| GO:2000736 | 0.0051 | 3.2153 | 2.6449 | 8 | 129 | regulation of stem cell differentiation |
| GO:0051450 | 0.0055 | 9.6375 | 0.3691 | 3 | 18 | myoblast proliferation |
| GO:0071371 | 0.0055 | 9.6375 | 0.3691 | 3 | 18 | cellular response to gonadotropin stimulus |
| GO:0060541 | 0.0059 | 2.7088 | 3.8956 | 10 | 190 | respiratory system development |
| GO:0009913 | 0.0059 | 2.4442 | 5.1669 | 12 | 252 | epidermal cell differentiation |
| GO:0032277 | 0.006 | 24.0339 | 0.123 | 2 | 6 | negative regulation of gonadotropin secretion |
| GO:0048241 | 0.006 | 24.0339 | 0.123 | 2 | 6 | epinephrine transport |
| GO:0090324 | 0.006 | 24.0339 | 0.123 | 2 | 6 | negative regulation of oxidative phosphorylation |
| GO:0007517 | 0.0064 | 2.1766 | 7.2377 | 15 | 353 | muscle organ development |
| GO:0060575 | 0.0065 | 9.0346 | 0.3896 | 3 | 19 | intestinal epithelial cell differentiation |
| GO:0007420 | 0.0067 | 1.8399 | 13.1427 | 23 | 641 | brain development |
| GO:0031424 | 0.0073 | 3.0143 | 2.809 | 8 | 137 | keratinization |
| GO:0021854 | 0.0075 | 8.5026 | 0.4101 | 3 | 20 | hypothalamus development |
| GO:0048869 | 0.0081 | 1.3726 | 74.3157 | 93 | 3718 | cellular developmental process |
| GO:0010700 | 0.0082 | 19.2258 | 0.1435 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:0021612 | 0.0082 | 19.2258 | 0.1435 | 2 | 7 | facial nerve structural organization |
| GO:0032661 | 0.0082 | 19.2258 | 0.1435 | 2 | 7 | regulation of interleukin-18 production |
| GO:0060017 | 0.0082 | 19.2258 | 0.1435 | 2 | 7 | parathyroid gland development |
| GO:2000848 | 0.0082 | 19.2258 | 0.1435 | 2 | 7 | positive regulation of corticosteroid hormone secretion |
| GO:0048731 | 0.0084 | 1.583 | 27.4391 | 40 | 1714 | system development |
| GO:0060173 | 0.0085 | 2.7201 | 3.4856 | 9 | 170 | limb development |
| GO:0043009 | 0.0085 | 1.8835 | 11.1333 | 20 | 543 | chordate embryonic development |
| GO:0003181 | 0.0086 | 8.0297 | 0.4306 | 3 | 21 | atrioventricular valve morphogenesis |
| GO:0046887 | 0.0087 | 3.2042 | 2.3169 | 7 | 113 | positive regulation of hormone secretion |
| GO:0007189 | 0.0088 | 4.2425 | 1.2712 | 5 | 62 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
| GO:0001709 | 0.0089 | 5.364 | 0.8201 | 4 | 40 | cell fate determination |
| GO:0003170 | 0.0089 | 5.364 | 0.8201 | 4 | 40 | heart valve development |
| GO:0032757 | 0.0089 | 5.364 | 0.8201 | 4 | 40 | positive regulation of interleukin-8 production |
| GO:1900543 | 0.0094 | 4.1691 | 1.2917 | 5 | 63 | negative regulation of purine nucleotide metabolic process |
| GO:0019932 | 0.0097 | 2.2798 | 5.5154 | 12 | 269 | second-messenger-mediated signaling |
| GO:0009165 | 0.0099 | 2.1912 | 6.2125 | 13 | 303 | nucleotide biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 38.1735 | 0.8053 | 19 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 16.9857 | 1.639 | 21 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 14.9281 | 1.8226 | 21 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 14.5217 | 1.865 | 21 | 132 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 3.4337 | 11.8542 | 35 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 2.8694 | 12.1933 | 31 | 863 | nervous system process |
| GO:0045087 | 0 | 2.7821 | 10.3602 | 26 | 740 | innate immune response |
| GO:0070098 | 0 | 10.0638 | 0.8053 | 7 | 57 | chemokine-mediated signaling pathway |
| GO:0002933 | 0 | 106.1321 | 0.0706 | 3 | 5 | lipid hydroxylation |
| GO:0002548 | 0 | 11.305 | 0.6217 | 6 | 44 | monocyte chemotaxis |
| GO:0007565 | 2e-04 | 4.3864 | 2.4726 | 10 | 175 | female pregnancy |
| GO:0048247 | 2e-04 | 10.4818 | 0.551 | 5 | 39 | lymphocyte chemotaxis |
| GO:0050829 | 3e-04 | 7.5271 | 0.8901 | 6 | 63 | defense response to Gram-negative bacterium |
| GO:0030593 | 4e-04 | 6.9177 | 0.9608 | 6 | 68 | neutrophil chemotaxis |
| GO:0061760 | 6e-04 | 140.8545 | 0.0424 | 2 | 3 | antifungal innate immune response |
| GO:0050830 | 7e-04 | 6.213 | 1.0597 | 6 | 75 | defense response to Gram-positive bacterium |
| GO:0050776 | 8e-04 | 2.1902 | 11.84 | 24 | 838 | regulation of immune response |
| GO:0098542 | 0.001 | 2.7853 | 5.369 | 14 | 380 | defense response to other organism |
| GO:0042904 | 0.0012 | 70.4225 | 0.0565 | 2 | 4 | 9-cis-retinoic acid biosynthetic process |
| GO:0016579 | 0.0017 | 3.0574 | 3.8289 | 11 | 271 | protein deubiquitination |
| GO:0009617 | 0.0018 | 2.5175 | 6.3439 | 15 | 449 | response to bacterium |
| GO:0010951 | 0.0023 | 3.37 | 2.8399 | 9 | 201 | negative regulation of endopeptidase activity |
| GO:0097530 | 0.0028 | 4.6023 | 1.3988 | 6 | 99 | granulocyte migration |
| GO:0031640 | 0.0028 | 7.4652 | 0.5934 | 4 | 42 | killing of cells of other organism |
| GO:0001915 | 0.0029 | 35.2066 | 0.0848 | 2 | 6 | negative regulation of T cell mediated cytotoxicity |
| GO:0045861 | 0.0029 | 2.8351 | 4.1115 | 11 | 291 | negative regulation of proteolysis |
| GO:0002376 | 0.0031 | 1.6065 | 35.0963 | 51 | 2484 | immune system process |
| GO:0019730 | 0.0033 | 5.3882 | 1.0032 | 5 | 71 | antimicrobial humoral response |
| GO:0031424 | 0.0033 | 3.85 | 1.9357 | 7 | 137 | keratinization |
| GO:0016338 | 0.0035 | 11.1591 | 0.3108 | 3 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:2001185 | 0.004 | 28.1634 | 0.0989 | 2 | 7 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0071347 | 0.0042 | 5.0789 | 1.0597 | 5 | 75 | cellular response to interleukin-1 |
| GO:0001909 | 0.0044 | 5.007 | 1.0738 | 5 | 76 | leukocyte mediated cytotoxicity |
| GO:0035865 | 0.0053 | 23.4679 | 0.113 | 2 | 8 | cellular response to potassium ion |
| GO:2000252 | 0.0053 | 23.4679 | 0.113 | 2 | 8 | negative regulation of feeding behavior |
| GO:0043207 | 0.0057 | 2.0107 | 10.0174 | 19 | 709 | response to external biotic stimulus |
| GO:0071346 | 0.0058 | 3.9225 | 1.6248 | 6 | 115 | cellular response to interferon-gamma |
| GO:0008299 | 0.0063 | 8.8314 | 0.3815 | 3 | 27 | isoprenoid biosynthetic process |
| GO:0032342 | 0.0067 | 20.114 | 0.1272 | 2 | 9 | aldosterone biosynthetic process |
| GO:0034651 | 0.0067 | 20.114 | 0.1272 | 2 | 9 | cortisol biosynthetic process |
| GO:0042178 | 0.0067 | 20.114 | 0.1272 | 2 | 9 | xenobiotic catabolic process |
| GO:0097267 | 0.0067 | 20.114 | 0.1272 | 2 | 9 | omega-hydroxylase P450 pathway |
| GO:0008212 | 0.0083 | 17.5986 | 0.1413 | 2 | 10 | mineralocorticoid metabolic process |
| GO:0016102 | 0.0083 | 17.5986 | 0.1413 | 2 | 10 | diterpenoid biosynthetic process |
| GO:0034058 | 0.0083 | 17.5986 | 0.1413 | 2 | 10 | endosomal vesicle fusion |
| GO:0045919 | 0.0083 | 17.5986 | 0.1413 | 2 | 10 | positive regulation of cytolysis |
| GO:0051873 | 0.0083 | 17.5986 | 0.1413 | 2 | 10 | killing by host of symbiont cells |
| GO:0060484 | 0.0083 | 17.5986 | 0.1413 | 2 | 10 | lung-associated mesenchyme development |
| GO:0031341 | 0.0091 | 5.2477 | 0.8195 | 4 | 58 | regulation of cell killing |
| GO:0009913 | 0.0097 | 2.6535 | 3.5605 | 9 | 252 | epidermal cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 7.663 | 4.3951 | 27 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007275 | 0 | 2.2135 | 70.6046 | 123 | 2735 | multicellular organism development |
| GO:0032502 | 0 | 2.1171 | 89.7765 | 145 | 3456 | developmental process |
| GO:0098609 | 0 | 2.7033 | 21.6863 | 52 | 750 | cell-cell adhesion |
| GO:0007399 | 0 | 1.9912 | 56.1037 | 97 | 1977 | nervous system development |
| GO:0009952 | 0 | 4.3268 | 5.4988 | 21 | 191 | anterior/posterior pattern specification |
| GO:0048562 | 0 | 4.3392 | 5.2106 | 20 | 185 | embryonic organ morphogenesis |
| GO:0048729 | 0 | 2.6185 | 17.3201 | 41 | 599 | tissue morphogenesis |
| GO:0045944 | 0 | 2.1683 | 30.1873 | 59 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:2000026 | 0 | 1.914 | 49.9652 | 85 | 1728 | regulation of multicellular organismal development |
| GO:0060429 | 0 | 2.1547 | 29.2835 | 57 | 1029 | epithelium development |
| GO:0030878 | 0 | 14.0361 | 0.694 | 7 | 24 | thyroid gland development |
| GO:0001944 | 0 | 2.3604 | 17.5514 | 38 | 607 | vasculature development |
| GO:0048704 | 0 | 7.9626 | 1.3761 | 9 | 48 | embryonic skeletal system morphogenesis |
| GO:0007267 | 0 | 1.8561 | 42.187 | 71 | 1459 | cell-cell signaling |
| GO:0009792 | 0 | 2.4078 | 15.8165 | 35 | 547 | embryo development ending in birth or egg hatching |
| GO:0010628 | 0 | 1.7724 | 49.2423 | 79 | 1703 | positive regulation of gene expression |
| GO:0048644 | 0 | 5.4656 | 2.3132 | 11 | 80 | muscle organ morphogenesis |
| GO:0022610 | 0 | 1.8636 | 36.9823 | 63 | 1279 | biological adhesion |
| GO:0048646 | 0 | 2.0313 | 25.7013 | 48 | 906 | anatomical structure formation involved in morphogenesis |
| GO:0051241 | 0 | 1.987 | 27.3522 | 50 | 953 | negative regulation of multicellular organismal process |
| GO:0006355 | 0 | 1.5414 | 97.5882 | 133 | 3375 | regulation of transcription, DNA-templated |
| GO:0060485 | 0 | 3.1006 | 6.6794 | 19 | 231 | mesenchyme development |
| GO:1903508 | 0 | 1.7979 | 38.804 | 64 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0003008 | 0 | 1.7431 | 44.5291 | 71 | 1540 | system process |
| GO:0030858 | 1e-04 | 6.0295 | 1.7349 | 9 | 60 | positive regulation of epithelial cell differentiation |
| GO:0048514 | 1e-04 | 2.4363 | 12.4074 | 28 | 434 | blood vessel morphogenesis |
| GO:0051254 | 1e-04 | 1.7623 | 40.7991 | 66 | 1411 | positive regulation of RNA metabolic process |
| GO:2001141 | 1e-04 | 1.5257 | 98.34 | 133 | 3401 | regulation of RNA biosynthetic process |
| GO:0030326 | 1e-04 | 3.9508 | 3.6433 | 13 | 126 | embryonic limb morphogenesis |
| GO:0048468 | 1e-04 | 1.8657 | 30.2649 | 52 | 1079 | cell development |
| GO:0051094 | 1e-04 | 1.8044 | 33.5703 | 56 | 1161 | positive regulation of developmental process |
| GO:0051216 | 1e-04 | 3.3079 | 4.9445 | 15 | 171 | cartilage development |
| GO:0019219 | 1e-04 | 1.4725 | 113.6939 | 148 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0060562 | 2e-04 | 2.6236 | 8.6167 | 21 | 298 | epithelial tube morphogenesis |
| GO:0051240 | 2e-04 | 1.7106 | 39.1987 | 62 | 1367 | positive regulation of multicellular organismal process |
| GO:0010454 | 2e-04 | 19.3578 | 0.3181 | 4 | 11 | negative regulation of cell fate commitment |
| GO:0035050 | 2e-04 | 4.877 | 2.0819 | 9 | 72 | embryonic heart tube development |
| GO:0090596 | 3e-04 | 2.7587 | 7.0264 | 18 | 243 | sensory organ morphogenesis |
| GO:0008284 | 3e-04 | 1.9362 | 21.5713 | 39 | 754 | positive regulation of cell proliferation |
| GO:0035107 | 3e-04 | 3.3778 | 4.1927 | 13 | 145 | appendage morphogenesis |
| GO:0048665 | 3e-04 | 7.5525 | 0.9542 | 6 | 33 | neuron fate specification |
| GO:0045446 | 3e-04 | 4.1171 | 2.6891 | 10 | 93 | endothelial cell differentiation |
| GO:0030154 | 4e-04 | 1.6634 | 42.169 | 64 | 1630 | cell differentiation |
| GO:0007368 | 4e-04 | 3.7258 | 3.2385 | 11 | 112 | determination of left/right symmetry |
| GO:0009890 | 4e-04 | 1.6269 | 43.7195 | 66 | 1512 | negative regulation of biosynthetic process |
| GO:0030049 | 4e-04 | 7.0307 | 1.012 | 6 | 35 | muscle filament sliding |
| GO:0030240 | 4e-04 | 33.8078 | 0.1735 | 3 | 6 | skeletal muscle thin filament assembly |
| GO:0042713 | 4e-04 | 33.8078 | 0.1735 | 3 | 6 | sperm ejaculation |
| GO:0007416 | 5e-04 | 3.3403 | 3.9035 | 12 | 135 | synapse assembly |
| GO:0001709 | 6e-04 | 6.6062 | 1.0652 | 6 | 37 | cell fate determination |
| GO:0071772 | 6e-04 | 3.0938 | 4.5397 | 13 | 157 | response to BMP |
| GO:0003206 | 7e-04 | 3.4827 | 3.4409 | 11 | 119 | cardiac chamber morphogenesis |
| GO:0031328 | 7e-04 | 1.5659 | 48.8086 | 71 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0009799 | 8e-04 | 3.3878 | 3.5276 | 11 | 122 | specification of symmetry |
| GO:0043134 | 8e-04 | Inf | 0.0578 | 2 | 2 | regulation of hindgut contraction |
| GO:0060465 | 8e-04 | Inf | 0.0578 | 2 | 2 | pharynx development |
| GO:1901207 | 8e-04 | Inf | 0.0578 | 2 | 2 | regulation of heart looping |
| GO:1901246 | 8e-04 | Inf | 0.0578 | 2 | 2 | regulation of lung ciliated cell differentiation |
| GO:2000824 | 8e-04 | Inf | 0.0578 | 2 | 2 | negative regulation of androgen receptor activity |
| GO:0010469 | 0.001 | 2.0347 | 14.0816 | 27 | 487 | regulation of receptor activity |
| GO:0048771 | 0.001 | 3.1107 | 4.1638 | 12 | 144 | tissue remodeling |
| GO:0007218 | 0.001 | 3.885 | 2.5445 | 9 | 88 | neuropeptide signaling pathway |
| GO:0010557 | 0.001 | 1.569 | 45.1074 | 66 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0014706 | 0.001 | 2.7884 | 5.3806 | 14 | 189 | striated muscle tissue development |
| GO:0048706 | 0.0012 | 7.262 | 0.8168 | 5 | 29 | embryonic skeletal system development |
| GO:0010940 | 0.0012 | 20.2819 | 0.2313 | 3 | 8 | positive regulation of necrotic cell death |
| GO:0071294 | 0.0012 | 10.4192 | 0.4916 | 4 | 17 | cellular response to zinc ion |
| GO:0010092 | 0.0013 | 7.0656 | 0.8385 | 5 | 29 | specification of animal organ identity |
| GO:0031128 | 0.0013 | 7.0656 | 0.8385 | 5 | 29 | developmental induction |
| GO:0042755 | 0.0013 | 7.0656 | 0.8385 | 5 | 29 | eating behavior |
| GO:0035295 | 0.0013 | 2.0161 | 13.6618 | 26 | 480 | tube development |
| GO:0060173 | 0.0013 | 2.8351 | 4.9156 | 13 | 170 | limb development |
| GO:0050433 | 0.0014 | 5.5075 | 1.2433 | 6 | 43 | regulation of catecholamine secretion |
| GO:0007530 | 0.0015 | 9.6743 | 0.5205 | 4 | 18 | sex determination |
| GO:0055008 | 0.0016 | 4.5117 | 1.7274 | 7 | 60 | cardiac muscle tissue morphogenesis |
| GO:0072359 | 0.0017 | 2.0779 | 11.7237 | 23 | 423 | circulatory system development |
| GO:0021522 | 0.0018 | 6.5212 | 0.8964 | 5 | 31 | spinal cord motor neuron differentiation |
| GO:0051954 | 0.0018 | 6.5212 | 0.8964 | 5 | 31 | positive regulation of amine transport |
| GO:0048645 | 0.0018 | 9.1336 | 0.5433 | 4 | 19 | animal organ formation |
| GO:0003215 | 0.0019 | 9.0287 | 0.5494 | 4 | 19 | cardiac right ventricle morphogenesis |
| GO:0023019 | 0.0019 | 9.0287 | 0.5494 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0060231 | 0.0019 | 9.0287 | 0.5494 | 4 | 19 | mesenchymal to epithelial transition |
| GO:0003231 | 0.002 | 3.2187 | 3.3541 | 10 | 116 | cardiac ventricle development |
| GO:0051093 | 0.002 | 1.7439 | 22.4443 | 37 | 782 | negative regulation of developmental process |
| GO:1903507 | 0.0021 | 1.6135 | 32.2113 | 49 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0000122 | 0.0022 | 1.7448 | 21.8019 | 36 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:2000179 | 0.0022 | 4.9689 | 1.359 | 6 | 47 | positive regulation of neural precursor cell proliferation |
| GO:0048699 | 0.0023 | 1.5604 | 38.1389 | 56 | 1319 | generation of neurons |
| GO:0048663 | 0.0023 | 6.1272 | 0.9434 | 5 | 33 | neuron fate commitment |
| GO:0034654 | 0.0023 | 1.3548 | 115.2842 | 142 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0048598 | 0.0023 | 2.3001 | 7.8265 | 17 | 288 | embryonic morphogenesis |
| GO:0002125 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | maternal aggressive behavior |
| GO:0003245 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | cardiac muscle tissue growth involved in heart morphogenesis |
| GO:0003285 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | septum secundum development |
| GO:0021912 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035054 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0060913 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | cardiac cell fate determination |
| GO:0061010 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | gall bladder development |
| GO:0061737 | 0.0025 | 67.4703 | 0.0867 | 2 | 3 | leukotriene signaling pathway |
| GO:0003211 | 0.0025 | 14.4851 | 0.2892 | 3 | 10 | cardiac ventricle formation |
| GO:0033993 | 0.0025 | 1.6925 | 24.3465 | 39 | 842 | response to lipid |
| GO:0009889 | 0.0025 | 1.4276 | 71.8255 | 94 | 2632 | regulation of biosynthetic process |
| GO:0007507 | 0.0026 | 2.2762 | 7.905 | 17 | 279 | heart development |
| GO:0008015 | 0.0026 | 1.9402 | 13.5901 | 25 | 470 | blood circulation |
| GO:0009893 | 0.0027 | 1.3812 | 87.9306 | 112 | 3041 | positive regulation of metabolic process |
| GO:0021879 | 0.0028 | 4.7371 | 1.4168 | 6 | 49 | forebrain neuron differentiation |
| GO:0051253 | 0.0028 | 1.5743 | 34.3221 | 51 | 1187 | negative regulation of RNA metabolic process |
| GO:0010665 | 0.0031 | 5.6502 | 1.012 | 5 | 35 | regulation of cardiac muscle cell apoptotic process |
| GO:0009111 | 0.0033 | 12.6736 | 0.3181 | 3 | 11 | vitamin catabolic process |
| GO:0048484 | 0.0033 | 12.6736 | 0.3181 | 3 | 11 | enteric nervous system development |
| GO:0060573 | 0.0033 | 12.6736 | 0.3181 | 3 | 11 | cell fate specification involved in pattern specification |
| GO:0016338 | 0.0033 | 7.5224 | 0.6361 | 4 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0072009 | 0.0034 | 3.1934 | 3.0361 | 9 | 105 | nephron epithelium development |
| GO:0030509 | 0.0035 | 2.781 | 4.2216 | 11 | 146 | BMP signaling pathway |
| GO:0060541 | 0.0036 | 2.5113 | 5.4939 | 13 | 190 | respiratory system development |
| GO:0035051 | 0.0038 | 2.9139 | 3.6722 | 10 | 127 | cardiocyte differentiation |
| GO:0007519 | 0.0038 | 2.74 | 4.2794 | 11 | 148 | skeletal muscle tissue development |
| GO:0007610 | 0.004 | 1.8251 | 15.5563 | 27 | 538 | behavior |
| GO:0003002 | 0.004 | 3.0964 | 3.1169 | 9 | 113 | regionalization |
| GO:0042659 | 0.0043 | 11.2647 | 0.347 | 3 | 12 | regulation of cell fate specification |
| GO:0043249 | 0.0043 | 11.2647 | 0.347 | 3 | 12 | erythrocyte maturation |
| GO:0001570 | 0.0044 | 3.7165 | 2.053 | 7 | 71 | vasculogenesis |
| GO:0050794 | 0.0044 | 1.3124 | 270.4134 | 297 | 9352 | regulation of cellular process |
| GO:0048513 | 0.0045 | 1.5036 | 41.2717 | 58 | 1623 | animal organ development |
| GO:0060487 | 0.0046 | 6.7693 | 0.694 | 4 | 24 | lung epithelial cell differentiation |
| GO:0060914 | 0.0046 | 6.7693 | 0.694 | 4 | 24 | heart formation |
| GO:0061217 | 0.0046 | 6.7693 | 0.694 | 4 | 24 | regulation of mesonephros development |
| GO:0070887 | 0.0047 | 1.3678 | 79.3428 | 101 | 2744 | cellular response to chemical stimulus |
| GO:0045766 | 0.0047 | 2.8168 | 3.7879 | 10 | 131 | positive regulation of angiogenesis |
| GO:0001992 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0003308 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0007198 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0010701 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | positive regulation of norepinephrine secretion |
| GO:0021615 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0021764 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | amygdala development |
| GO:0021913 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0034653 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | retinoic acid catabolic process |
| GO:0042662 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0060406 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | positive regulation of penile erection |
| GO:0060480 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | lung goblet cell differentiation |
| GO:0060920 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | cardiac pacemaker cell differentiation |
| GO:0061055 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | myotome development |
| GO:0072107 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0090191 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905205 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:1905903 | 0.0048 | 33.7329 | 0.1157 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0001947 | 0.0048 | 4.1746 | 1.5833 | 6 | 55 | heart looping |
| GO:0007517 | 0.005 | 2.1784 | 7.7371 | 16 | 273 | muscle organ development |
| GO:0042692 | 0.005 | 1.9861 | 10.5829 | 20 | 366 | muscle cell differentiation |
| GO:0010470 | 0.0051 | 4.9841 | 1.1277 | 5 | 39 | regulation of gastrulation |
| GO:0006334 | 0.0052 | 2.9749 | 3.2385 | 9 | 112 | nucleosome assembly |
| GO:0045992 | 0.0054 | 6.4465 | 0.7229 | 4 | 25 | negative regulation of embryonic development |
| GO:0010660 | 0.0054 | 4.072 | 1.6192 | 6 | 56 | regulation of muscle cell apoptotic process |
| GO:0042472 | 0.0055 | 3.2009 | 2.6891 | 8 | 93 | inner ear morphogenesis |
| GO:0003151 | 0.0055 | 3.5493 | 2.1397 | 7 | 74 | outflow tract morphogenesis |
| GO:0048935 | 0.0055 | 10.1375 | 0.3759 | 3 | 13 | peripheral nervous system neuron development |
| GO:0090196 | 0.0055 | 10.1375 | 0.3759 | 3 | 13 | regulation of chemokine secretion |
| GO:0010658 | 0.0056 | 4.8414 | 1.1566 | 5 | 40 | striated muscle cell apoptotic process |
| GO:0043583 | 0.0057 | 2.3626 | 5.8119 | 13 | 201 | ear development |
| GO:0060255 | 0.0058 | 1.2884 | 161.1724 | 187 | 5574 | regulation of macromolecule metabolic process |
| GO:0051937 | 0.0064 | 3.9148 | 1.6771 | 6 | 58 | catecholamine transport |
| GO:0060284 | 0.0064 | 1.6323 | 22.4959 | 35 | 778 | regulation of cell development |
| GO:2000113 | 0.0065 | 1.4785 | 39.2377 | 55 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0001667 | 0.0066 | 2.0104 | 9.3974 | 18 | 325 | ameboidal-type cell migration |
| GO:0042711 | 0.0069 | 9.2153 | 0.4048 | 3 | 14 | maternal behavior |
| GO:2000291 | 0.0069 | 9.2153 | 0.4048 | 3 | 14 | regulation of myoblast proliferation |
| GO:0035850 | 0.007 | 4.5791 | 1.2144 | 5 | 42 | epithelial cell differentiation involved in kidney development |
| GO:0060706 | 0.0071 | 5.8851 | 0.7807 | 4 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0007498 | 0.0073 | 2.81 | 3.412 | 9 | 118 | mesoderm development |
| GO:0090257 | 0.0073 | 2.2886 | 5.9854 | 13 | 207 | regulation of muscle system process |
| GO:0070252 | 0.0075 | 3.022 | 2.8337 | 8 | 98 | actin-mediated cell contraction |
| GO:0055123 | 0.0075 | 2.6202 | 4.0481 | 10 | 140 | digestive system development |
| GO:1901700 | 0.0077 | 1.4541 | 41.3196 | 57 | 1429 | response to oxygen-containing compound |
| GO:0045765 | 0.0077 | 3.001 | 2.8503 | 8 | 100 | regulation of angiogenesis |
| GO:0021778 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0045409 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
| GO:0051122 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0051891 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0051970 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0060455 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0061009 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | common bile duct development |
| GO:0071502 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | cellular response to temperature stimulus |
| GO:0090131 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | mesenchyme migration |
| GO:2000195 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | negative regulation of female gonad development |
| GO:2001188 | 0.0079 | 22.4871 | 0.1446 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0009887 | 0.0079 | 1.809 | 13.3205 | 23 | 502 | animal organ morphogenesis |
| GO:0060441 | 0.0081 | 5.6395 | 0.8096 | 4 | 28 | epithelial tube branching involved in lung morphogenesis |
| GO:0060419 | 0.0083 | 3.2563 | 2.3132 | 7 | 80 | heart growth |
| GO:0045664 | 0.0084 | 1.7322 | 15.7009 | 26 | 543 | regulation of neuron differentiation |
| GO:0051546 | 0.0084 | 8.4468 | 0.4337 | 3 | 15 | keratinocyte migration |
| GO:0060579 | 0.0084 | 8.4468 | 0.4337 | 3 | 15 | ventral spinal cord interneuron fate commitment |
| GO:2000484 | 0.0084 | 8.4468 | 0.4337 | 3 | 15 | positive regulation of interleukin-8 secretion |
| GO:0048701 | 0.0085 | 4.3436 | 1.2723 | 5 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0040007 | 0.0086 | 1.5664 | 25.4163 | 38 | 879 | growth |
| GO:0009798 | 0.0089 | 3.2121 | 2.3421 | 7 | 81 | axis specification |
| GO:0070661 | 0.0092 | 2.1448 | 6.8529 | 14 | 237 | leukocyte proliferation |
| GO:0021772 | 0.0092 | 5.4136 | 0.8385 | 4 | 29 | olfactory bulb development |
| GO:0071276 | 0.0092 | 5.4136 | 0.8385 | 4 | 29 | cellular response to cadmium ion |
| GO:0032330 | 0.0093 | 4.2348 | 1.3012 | 5 | 45 | regulation of chondrocyte differentiation |
| GO:0045933 | 0.0093 | 4.2348 | 1.3012 | 5 | 45 | positive regulation of muscle contraction |
| GO:0032675 | 0.0094 | 2.8926 | 2.9493 | 8 | 102 | regulation of interleukin-6 production |
| GO:0065007 | 0.0095 | 1.2985 | 304.3885 | 327 | 10527 | biological regulation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045944 | 0 | 2.5164 | 30.3931 | 67 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048562 | 0 | 4.1029 | 8.0641 | 29 | 277 | embryonic organ morphogenesis |
| GO:0048706 | 0 | 5.6291 | 3.5226 | 17 | 121 | embryonic skeletal system development |
| GO:0009792 | 0 | 2.7931 | 15.9244 | 40 | 547 | embryo development ending in birth or egg hatching |
| GO:0072358 | 0 | 2.6005 | 17.8749 | 42 | 614 | cardiovascular system development |
| GO:0051094 | 0 | 2.081 | 33.0138 | 62 | 1143 | positive regulation of developmental process |
| GO:1903508 | 0 | 1.992 | 39.0685 | 70 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0060485 | 0 | 3.6417 | 6.7249 | 22 | 231 | mesenchyme development |
| GO:0010628 | 0 | 1.8721 | 49.578 | 83 | 1703 | positive regulation of gene expression |
| GO:0051254 | 0 | 1.9472 | 41.0773 | 72 | 1411 | positive regulation of RNA metabolic process |
| GO:0048513 | 0 | 1.6922 | 78.386 | 116 | 2803 | animal organ development |
| GO:0051240 | 0 | 1.9041 | 40.0332 | 69 | 1392 | positive regulation of multicellular organismal process |
| GO:0048536 | 0 | 9.6854 | 1.048 | 8 | 36 | spleen development |
| GO:0030858 | 0 | 6.8009 | 1.7467 | 10 | 60 | positive regulation of epithelial cell differentiation |
| GO:0003151 | 0 | 5.9458 | 2.1543 | 11 | 74 | outflow tract morphogenesis |
| GO:0001568 | 0 | 2.4794 | 14.4882 | 33 | 503 | blood vessel development |
| GO:0023019 | 0 | 15.5899 | 0.5531 | 6 | 19 | signal transduction involved in regulation of gene expression |
| GO:0051241 | 0 | 2.0956 | 24.4453 | 47 | 854 | negative regulation of multicellular organismal process |
| GO:0031328 | 0 | 1.7473 | 49.1414 | 78 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0010557 | 0 | 1.7629 | 45.415 | 73 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0090596 | 0 | 4.609 | 2.9296 | 12 | 102 | sensory organ morphogenesis |
| GO:0030154 | 0 | 1.6152 | 73.4539 | 105 | 2741 | cell differentiation |
| GO:0009889 | 0 | 1.5004 | 120.6409 | 158 | 4144 | regulation of biosynthetic process |
| GO:0030878 | 1e-04 | 11.2555 | 0.6987 | 6 | 24 | thyroid gland development |
| GO:0006355 | 1e-04 | 1.5092 | 98.2536 | 132 | 3375 | regulation of transcription, DNA-templated |
| GO:0007368 | 1e-04 | 4.0856 | 3.2606 | 12 | 112 | determination of left/right symmetry |
| GO:0048863 | 1e-04 | 2.8717 | 7.1616 | 19 | 246 | stem cell differentiation |
| GO:2001141 | 1e-04 | 1.4938 | 99.0105 | 132 | 3401 | regulation of RNA biosynthetic process |
| GO:0009653 | 2e-04 | 2.0369 | 19.642 | 37 | 747 | anatomical structure morphogenesis |
| GO:0022603 | 2e-04 | 1.8631 | 26.5212 | 46 | 911 | regulation of anatomical structure morphogenesis |
| GO:0009799 | 2e-04 | 3.7116 | 3.5517 | 12 | 122 | specification of symmetry |
| GO:0035050 | 2e-04 | 4.8423 | 2.0961 | 9 | 72 | embryonic heart tube development |
| GO:0060455 | 2e-04 | 50.3591 | 0.1456 | 3 | 5 | negative regulation of gastric acid secretion |
| GO:0003002 | 3e-04 | 3.6684 | 3.5844 | 12 | 127 | regionalization |
| GO:0042221 | 3e-04 | 1.4467 | 107.3366 | 139 | 3687 | response to chemical |
| GO:0048665 | 3e-04 | 7.4991 | 0.9607 | 6 | 33 | neuron fate specification |
| GO:0048699 | 3e-04 | 1.6817 | 38.399 | 60 | 1319 | generation of neurons |
| GO:0048729 | 3e-04 | 2.0204 | 17.4382 | 33 | 599 | tissue morphogenesis |
| GO:0035909 | 4e-04 | 7.2308 | 0.9898 | 6 | 34 | aorta morphogenesis |
| GO:0008284 | 4e-04 | 1.8638 | 22.9143 | 40 | 792 | positive regulation of cell proliferation |
| GO:0045766 | 4e-04 | 3.4288 | 3.8137 | 12 | 131 | positive regulation of angiogenesis |
| GO:0021902 | 5e-04 | 33.5705 | 0.1747 | 3 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:2001199 | 5e-04 | 33.5705 | 0.1747 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0021879 | 5e-04 | 5.6315 | 1.4265 | 7 | 49 | forebrain neuron differentiation |
| GO:0048644 | 5e-04 | 4.2944 | 2.329 | 9 | 80 | muscle organ morphogenesis |
| GO:0071542 | 5e-04 | 6.7478 | 1.048 | 6 | 36 | dopaminergic neuron differentiation |
| GO:0060411 | 6e-04 | 4.7484 | 1.8923 | 8 | 65 | cardiac septum morphogenesis |
| GO:1901342 | 6e-04 | 2.5648 | 7.5109 | 18 | 258 | regulation of vasculature development |
| GO:0007399 | 6e-04 | 1.6476 | 38.5566 | 59 | 1364 | nervous system development |
| GO:0060041 | 6e-04 | 3.2894 | 3.9593 | 12 | 136 | retina development in camera-type eye |
| GO:0060037 | 7e-04 | 8.4212 | 0.7278 | 5 | 25 | pharyngeal system development |
| GO:0035295 | 7e-04 | 2.0877 | 13.7569 | 27 | 480 | tube development |
| GO:0071772 | 7e-04 | 3.0715 | 4.5706 | 13 | 157 | response to BMP |
| GO:0051173 | 7e-04 | 1.4605 | 79.3016 | 106 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0009952 | 7e-04 | 2.9039 | 5.1858 | 14 | 180 | anterior/posterior pattern specification |
| GO:0050789 | 8e-04 | 1.4618 | 170.3127 | 198 | 6364 | regulation of biological process |
| GO:0034127 | 8e-04 | 25.1761 | 0.2038 | 3 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0034654 | 8e-04 | 1.3992 | 116.0703 | 146 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0048486 | 8e-04 | Inf | 0.0579 | 2 | 2 | parasympathetic nervous system development |
| GO:0002930 | 8e-04 | Inf | 0.0582 | 2 | 2 | trabecular meshwork development |
| GO:1901246 | 8e-04 | Inf | 0.0582 | 2 | 2 | regulation of lung ciliated cell differentiation |
| GO:2000824 | 8e-04 | Inf | 0.0582 | 2 | 2 | negative regulation of androgen receptor activity |
| GO:0071363 | 9e-04 | 1.9261 | 17.642 | 32 | 606 | cellular response to growth factor stimulus |
| GO:0060429 | 0.001 | 1.6979 | 29.4874 | 47 | 1029 | epithelium development |
| GO:0048771 | 0.001 | 3.0884 | 4.1922 | 12 | 144 | tissue remodeling |
| GO:0016101 | 0.001 | 3.8574 | 2.5619 | 9 | 88 | diterpenoid metabolic process |
| GO:0030198 | 0.0011 | 2.2968 | 9.2577 | 20 | 318 | extracellular matrix organization |
| GO:2000026 | 0.0011 | 1.8606 | 19.4549 | 34 | 714 | regulation of multicellular organismal development |
| GO:0001667 | 0.0011 | 2.2839 | 9.3053 | 20 | 321 | ameboidal-type cell migration |
| GO:0019219 | 0.0012 | 1.4624 | 72.7221 | 97 | 2603 | regulation of nucleobase-containing compound metabolic process |
| GO:0010940 | 0.0012 | 20.1395 | 0.2329 | 3 | 8 | positive regulation of necrotic cell death |
| GO:0001947 | 0.0013 | 4.7279 | 1.6594 | 7 | 57 | heart looping |
| GO:0048583 | 0.0015 | 1.3858 | 104.6874 | 132 | 3596 | regulation of response to stimulus |
| GO:0045446 | 0.0015 | 3.6266 | 2.7074 | 9 | 93 | endothelial cell differentiation |
| GO:0001759 | 0.0016 | 9.6062 | 0.524 | 4 | 18 | organ induction |
| GO:0042474 | 0.0016 | 9.6062 | 0.524 | 4 | 18 | middle ear morphogenesis |
| GO:0048701 | 0.0016 | 5.3243 | 1.2809 | 6 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0002520 | 0.0017 | 1.7246 | 24.5707 | 40 | 844 | immune system development |
| GO:0001525 | 0.0017 | 2.3133 | 8.2566 | 18 | 289 | angiogenesis |
| GO:0009605 | 0.0017 | 1.4862 | 55.5751 | 77 | 1909 | response to external stimulus |
| GO:0048646 | 0.0017 | 1.9762 | 13.928 | 26 | 505 | anatomical structure formation involved in morphogenesis |
| GO:0071774 | 0.0018 | 3.0581 | 3.8719 | 11 | 133 | response to fibroblast growth factor |
| GO:2000288 | 0.0018 | 16.7818 | 0.262 | 3 | 9 | positive regulation of myoblast proliferation |
| GO:0051954 | 0.0019 | 6.4752 | 0.9025 | 5 | 31 | positive regulation of amine transport |
| GO:0003215 | 0.0019 | 8.9652 | 0.5531 | 4 | 19 | cardiac right ventricle morphogenesis |
| GO:0060216 | 0.0019 | 8.9652 | 0.5531 | 4 | 19 | definitive hemopoiesis |
| GO:0043069 | 0.0022 | 1.7206 | 23.348 | 38 | 802 | negative regulation of programmed cell death |
| GO:0072593 | 0.0022 | 2.4663 | 6.4629 | 15 | 222 | reactive oxygen species metabolic process |
| GO:0055008 | 0.0023 | 4.2196 | 1.8341 | 7 | 63 | cardiac muscle tissue morphogenesis |
| GO:0010951 | 0.0023 | 2.5456 | 5.8515 | 14 | 201 | negative regulation of endopeptidase activity |
| GO:0043583 | 0.0023 | 2.5456 | 5.8515 | 14 | 201 | ear development |
| GO:0007498 | 0.0023 | 3.1362 | 3.4352 | 10 | 118 | mesoderm development |
| GO:0042475 | 0.0024 | 3.7036 | 2.3581 | 8 | 81 | odontogenesis of dentin-containing tooth |
| GO:0003285 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | septum secundum development |
| GO:0003350 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | pulmonary myocardium development |
| GO:0014717 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0021912 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035054 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0055014 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0060741 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0060913 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | cardiac cell fate determination |
| GO:0061010 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | gall bladder development |
| GO:0061031 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:2000297 | 0.0025 | 66.9977 | 0.0873 | 2 | 3 | negative regulation of synapse maturation |
| GO:0003211 | 0.0025 | 14.3834 | 0.2911 | 3 | 10 | cardiac ventricle formation |
| GO:0061072 | 0.0025 | 14.3834 | 0.2911 | 3 | 10 | iris morphogenesis |
| GO:0008630 | 0.0025 | 3.346 | 2.9112 | 9 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0060255 | 0.0026 | 1.3223 | 162.2713 | 191 | 5574 | regulation of macromolecule metabolic process |
| GO:0042220 | 0.0026 | 4.816 | 1.3974 | 6 | 48 | response to cocaine |
| GO:0043154 | 0.0026 | 3.6533 | 2.3872 | 8 | 82 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0008543 | 0.0027 | 3.3094 | 2.9403 | 9 | 101 | fibroblast growth factor receptor signaling pathway |
| GO:0007263 | 0.0029 | 7.9094 | 0.6114 | 4 | 21 | nitric oxide mediated signal transduction |
| GO:0043586 | 0.0029 | 7.9094 | 0.6114 | 4 | 21 | tongue development |
| GO:0048485 | 0.0029 | 7.9094 | 0.6114 | 4 | 21 | sympathetic nervous system development |
| GO:0007601 | 0.0029 | 2.5818 | 5.3566 | 13 | 184 | visual perception |
| GO:0060562 | 0.0029 | 2.1924 | 8.6754 | 18 | 298 | epithelial tube morphogenesis |
| GO:0048705 | 0.0029 | 2.4785 | 5.9971 | 14 | 206 | skeletal system morphogenesis |
| GO:0048663 | 0.0031 | 5.6779 | 1.0073 | 5 | 35 | neuron fate commitment |
| GO:0048645 | 0.0031 | 5.6544 | 1.0113 | 5 | 35 | animal organ formation |
| GO:0010665 | 0.0032 | 5.6104 | 1.0189 | 5 | 35 | regulation of cardiac muscle cell apoptotic process |
| GO:0010454 | 0.0034 | 12.5847 | 0.3202 | 3 | 11 | negative regulation of cell fate commitment |
| GO:0021903 | 0.0034 | 12.5847 | 0.3202 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0048484 | 0.0034 | 12.5847 | 0.3202 | 3 | 11 | enteric nervous system development |
| GO:0003008 | 0.0034 | 1.4926 | 44.8328 | 63 | 1540 | system process |
| GO:0021515 | 0.0035 | 4.494 | 1.4847 | 6 | 51 | cell differentiation in spinal cord |
| GO:0030509 | 0.0036 | 2.7611 | 4.2504 | 11 | 146 | BMP signaling pathway |
| GO:0007275 | 0.0038 | 1.4291 | 65.7913 | 86 | 2608 | multicellular organism development |
| GO:0060541 | 0.0038 | 2.4932 | 5.5313 | 13 | 190 | respiratory system development |
| GO:0048522 | 0.0039 | 1.3494 | 104.9945 | 129 | 3784 | positive regulation of cellular process |
| GO:0030814 | 0.004 | 2.8932 | 3.6972 | 10 | 127 | regulation of cAMP metabolic process |
| GO:0042472 | 0.004 | 3.7788 | 2.0225 | 7 | 70 | inner ear morphogenesis |
| GO:0045686 | 0.004 | 7.0759 | 0.6696 | 4 | 23 | negative regulation of glial cell differentiation |
| GO:0090103 | 0.004 | 7.0759 | 0.6696 | 4 | 23 | cochlea morphogenesis |
| GO:0001709 | 0.0041 | 5.2828 | 1.0725 | 5 | 37 | cell fate determination |
| GO:0030818 | 0.0041 | 5.259 | 1.0772 | 5 | 37 | negative regulation of cAMP biosynthetic process |
| GO:0045596 | 0.0042 | 1.7768 | 17.159 | 29 | 593 | negative regulation of cell differentiation |
| GO:0043306 | 0.0044 | 11.1856 | 0.3493 | 3 | 12 | positive regulation of mast cell degranulation |
| GO:0055015 | 0.0044 | 11.1856 | 0.3493 | 3 | 12 | ventricular cardiac muscle cell development |
| GO:0010469 | 0.0045 | 1.8528 | 14.1776 | 25 | 487 | regulation of receptor activity |
| GO:0002886 | 0.0046 | 5.0993 | 1.1063 | 5 | 38 | regulation of myeloid leukocyte mediated immunity |
| GO:0001975 | 0.0047 | 6.7216 | 0.6987 | 4 | 24 | response to amphetamine |
| GO:0060487 | 0.0047 | 6.7216 | 0.6987 | 4 | 24 | lung epithelial cell differentiation |
| GO:0060914 | 0.0047 | 6.7216 | 0.6987 | 4 | 24 | heart formation |
| GO:0048666 | 0.0048 | 1.5938 | 27.7439 | 42 | 953 | neuron development |
| GO:0002580 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0003308 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0008078 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | mesodermal cell migration |
| GO:0010701 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | positive regulation of norepinephrine secretion |
| GO:0021764 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | amygdala development |
| GO:0021913 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0042662 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0060406 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | positive regulation of penile erection |
| GO:0060920 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | cardiac pacemaker cell differentiation |
| GO:0061055 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | myotome development |
| GO:0072107 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0090191 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905205 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:1905903 | 0.0049 | 33.4966 | 0.1164 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0033993 | 0.0049 | 1.6303 | 24.5125 | 38 | 842 | response to lipid |
| GO:0045934 | 0.0049 | 1.5021 | 38.6901 | 55 | 1329 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0060322 | 0.0049 | 1.7055 | 19.7089 | 32 | 677 | head development |
| GO:0090132 | 0.0049 | 2.2459 | 7.0451 | 15 | 242 | epithelium migration |
| GO:0006334 | 0.0054 | 2.9538 | 3.2606 | 9 | 112 | nucleosome assembly |
| GO:0039528 | 0.0055 | 6.4011 | 0.7278 | 4 | 25 | cytoplasmic pattern recognition receptor signaling pathway in response to virus |
| GO:0030802 | 0.0055 | 2.7509 | 3.8719 | 10 | 133 | regulation of cyclic nucleotide biosynthetic process |
| GO:0010660 | 0.0056 | 4.0432 | 1.6303 | 6 | 56 | regulation of muscle cell apoptotic process |
| GO:0045165 | 0.0056 | 2.7429 | 3.8791 | 10 | 137 | cell fate commitment |
| GO:0090196 | 0.0056 | 10.0664 | 0.3785 | 3 | 13 | regulation of chemokine secretion |
| GO:0010658 | 0.0058 | 4.8072 | 1.1645 | 5 | 40 | striated muscle cell apoptotic process |
| GO:0043300 | 0.0058 | 4.8072 | 1.1645 | 5 | 40 | regulation of leukocyte degranulation |
| GO:0048870 | 0.0059 | 1.4867 | 39.0394 | 55 | 1341 | cell motility |
| GO:0021700 | 0.006 | 2.1968 | 7.1907 | 15 | 247 | developmental maturation |
| GO:0007611 | 0.0061 | 2.2632 | 6.5211 | 14 | 224 | learning or memory |
| GO:0050830 | 0.0061 | 3.4721 | 2.1834 | 7 | 75 | defense response to Gram-positive bacterium |
| GO:0042445 | 0.0062 | 2.4353 | 5.2111 | 12 | 179 | hormone metabolic process |
| GO:0045995 | 0.0064 | 2.8696 | 3.3479 | 9 | 115 | regulation of embryonic development |
| GO:0051937 | 0.0066 | 3.8872 | 1.6885 | 6 | 58 | catecholamine transport |
| GO:0061061 | 0.0067 | 1.7286 | 16.9724 | 28 | 583 | muscle structure development |
| GO:0003231 | 0.0068 | 2.8426 | 3.377 | 9 | 116 | cardiac ventricle development |
| GO:0051960 | 0.0068 | 1.637 | 21.7759 | 34 | 748 | regulation of nervous system development |
| GO:0030900 | 0.007 | 1.9553 | 10.1893 | 19 | 350 | forebrain development |
| GO:0060284 | 0.0071 | 1.62 | 22.6493 | 35 | 778 | regulation of cell development |
| GO:0030809 | 0.0072 | 4.5468 | 1.2227 | 5 | 42 | negative regulation of nucleotide biosynthetic process |
| GO:0021602 | 0.0073 | 5.8437 | 0.786 | 4 | 27 | cranial nerve morphogenesis |
| GO:0033006 | 0.0073 | 5.8437 | 0.786 | 4 | 27 | regulation of mast cell activation involved in immune response |
| GO:0042572 | 0.0073 | 5.8437 | 0.786 | 4 | 27 | retinol metabolic process |
| GO:0060706 | 0.0073 | 5.8437 | 0.786 | 4 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0006720 | 0.0076 | 2.79 | 3.4352 | 9 | 118 | isoprenoid metabolic process |
| GO:0021517 | 0.0079 | 4.4268 | 1.2518 | 5 | 43 | ventral spinal cord development |
| GO:0030800 | 0.0079 | 4.4268 | 1.2518 | 5 | 43 | negative regulation of cyclic nucleotide metabolic process |
| GO:0050433 | 0.0079 | 4.4268 | 1.2518 | 5 | 43 | regulation of catecholamine secretion |
| GO:0003241 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0021523 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | somatic motor neuron differentiation |
| GO:0051122 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0051891 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0061009 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | common bile duct development |
| GO:0071502 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | cellular response to temperature stimulus |
| GO:1903232 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | melanosome assembly |
| GO:2000609 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | regulation of thyroid hormone generation |
| GO:2001188 | 0.008 | 22.3296 | 0.1456 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0007224 | 0.008 | 2.7645 | 3.4643 | 9 | 119 | smoothened signaling pathway |
| GO:0007409 | 0.0081 | 1.8598 | 11.8195 | 21 | 406 | axonogenesis |
| GO:0048592 | 0.0082 | 2.5815 | 4.1048 | 10 | 141 | eye morphogenesis |
| GO:1900371 | 0.0082 | 2.5815 | 4.1048 | 10 | 141 | regulation of purine nucleotide biosynthetic process |
| GO:2000116 | 0.0083 | 2.2486 | 6.0844 | 13 | 209 | regulation of cysteine-type endopeptidase activity |
| GO:0009950 | 0.0086 | 8.3875 | 0.4367 | 3 | 15 | dorsal/ventral axis specification |
| GO:0021783 | 0.0086 | 8.3875 | 0.4367 | 3 | 15 | preganglionic parasympathetic fiber development |
| GO:0033005 | 0.0086 | 8.3875 | 0.4367 | 3 | 15 | positive regulation of mast cell activation |
| GO:2000484 | 0.0086 | 8.3875 | 0.4367 | 3 | 15 | positive regulation of interleukin-8 secretion |
| GO:0060840 | 0.0086 | 3.2332 | 2.329 | 7 | 80 | artery development |
| GO:0002448 | 0.0087 | 4.313 | 1.2809 | 5 | 44 | mast cell mediated immunity |
| GO:0007389 | 0.0088 | 5.4724 | 0.8268 | 4 | 30 | pattern specification process |
| GO:0014706 | 0.0088 | 1.9468 | 9.6815 | 18 | 334 | striated muscle tissue development |
| GO:1903707 | 0.0089 | 2.7147 | 3.5226 | 9 | 121 | negative regulation of hemopoiesis |
| GO:0052652 | 0.0091 | 2.5423 | 4.163 | 10 | 143 | cyclic purine nucleotide metabolic process |
| GO:0043542 | 0.0094 | 2.4016 | 4.8326 | 11 | 166 | endothelial cell migration |
| GO:0042755 | 0.0095 | 5.3755 | 0.8443 | 4 | 29 | eating behavior |
| GO:0035176 | 0.0096 | 4.2049 | 1.31 | 5 | 45 | social behavior |
| GO:0099024 | 0.0096 | 4.2049 | 1.31 | 5 | 45 | plasma membrane invagination |
| GO:0032675 | 0.0098 | 2.8721 | 2.9694 | 8 | 102 | regulation of interleukin-6 production |
| GO:0050865 | 0.0098 | 1.7716 | 13.5657 | 23 | 468 | regulation of cell activation |
| GO:0014031 | 0.0099 | 3.545 | 1.8341 | 6 | 63 | mesenchymal cell development |
| GO:0052547 | 0.0099 | 1.8853 | 10.5386 | 19 | 362 | regulation of peptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 6.7787 | 2.727 | 16 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0032501 | 0 | 2.0922 | 86.9923 | 129 | 5200 | multicellular organismal process |
| GO:0098609 | 0 | 3.0273 | 13.4553 | 36 | 750 | cell-cell adhesion |
| GO:0001501 | 0 | 3.0115 | 8.3603 | 23 | 466 | skeletal system development |
| GO:0007399 | 0 | 1.888 | 37.8903 | 63 | 2112 | nervous system development |
| GO:0060429 | 2e-04 | 2.0452 | 19.7524 | 37 | 1101 | epithelium development |
| GO:0042060 | 3e-04 | 2.5274 | 8.9343 | 21 | 498 | wound healing |
| GO:0018003 | 3e-04 | Inf | 0.0359 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0060415 | 4e-04 | 5.757 | 1.3455 | 7 | 75 | muscle tissue morphogenesis |
| GO:0032924 | 6e-04 | 8.43 | 0.6817 | 5 | 38 | activin receptor signaling pathway |
| GO:0060840 | 6e-04 | 5.3609 | 1.4352 | 7 | 80 | artery development |
| GO:0033690 | 6e-04 | 23.7095 | 0.1794 | 3 | 10 | positive regulation of osteoblast proliferation |
| GO:0008544 | 6e-04 | 2.7067 | 6.315 | 16 | 352 | epidermis development |
| GO:0007267 | 8e-04 | 1.7861 | 26.1751 | 43 | 1459 | cell-cell signaling |
| GO:0007588 | 8e-04 | 5.9743 | 1.1123 | 6 | 62 | excretion |
| GO:0001558 | 8e-04 | 2.6345 | 6.4765 | 16 | 361 | regulation of cell growth |
| GO:0006068 | 8e-04 | 20.7444 | 0.1973 | 3 | 11 | ethanol catabolic process |
| GO:0034155 | 0.001 | 110.2804 | 0.0538 | 2 | 3 | regulation of toll-like receptor 7 signaling pathway |
| GO:0042335 | 0.001 | 110.2804 | 0.0538 | 2 | 3 | cuticle development |
| GO:0007155 | 0.001 | 2.3687 | 8.5842 | 19 | 524 | cell adhesion |
| GO:0060707 | 0.0011 | 18.4383 | 0.2153 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0001657 | 0.0013 | 4.6003 | 1.6505 | 7 | 92 | ureteric bud development |
| GO:0010518 | 0.0013 | 6.7815 | 0.8253 | 5 | 46 | positive regulation of phospholipase activity |
| GO:0009887 | 0.0014 | 1.9465 | 15.9581 | 29 | 900 | animal organ morphogenesis |
| GO:0072163 | 0.0014 | 4.5465 | 1.6685 | 7 | 93 | mesonephric epithelium development |
| GO:0001775 | 0.0015 | 1.8067 | 21.4389 | 36 | 1195 | cell activation |
| GO:0043588 | 0.0016 | 2.6566 | 5.5974 | 14 | 312 | skin development |
| GO:0048762 | 0.0017 | 3.2655 | 3.2652 | 10 | 182 | mesenchymal cell differentiation |
| GO:0061036 | 0.0017 | 8.8738 | 0.5203 | 4 | 29 | positive regulation of cartilage development |
| GO:0010611 | 0.0018 | 6.3178 | 0.8791 | 5 | 49 | regulation of cardiac muscle hypertrophy |
| GO:0001994 | 0.0019 | 55.1365 | 0.0718 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0060708 | 0.0019 | 55.1365 | 0.0718 | 2 | 4 | spongiotrophoblast differentiation |
| GO:0071260 | 0.002 | 4.9898 | 1.3097 | 6 | 73 | cellular response to mechanical stimulus |
| GO:0007423 | 0.002 | 2.2206 | 9.0779 | 19 | 506 | sensory organ development |
| GO:0070848 | 0.0021 | 2.0809 | 11.2307 | 22 | 626 | response to growth factor |
| GO:0071773 | 0.0021 | 3.4082 | 2.8167 | 9 | 157 | cellular response to BMP stimulus |
| GO:0048731 | 0.0022 | 1.8199 | 20.5811 | 34 | 1389 | system development |
| GO:0090288 | 0.0022 | 3.7293 | 2.2964 | 8 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0060973 | 0.0022 | 13.8259 | 0.2691 | 3 | 15 | cell migration involved in heart development |
| GO:0040007 | 0.0023 | 1.8926 | 15.7697 | 28 | 879 | growth |
| GO:0061448 | 0.0024 | 2.9175 | 4.0007 | 11 | 223 | connective tissue development |
| GO:0060191 | 0.0024 | 4.775 | 1.3635 | 6 | 76 | regulation of lipase activity |
| GO:0032965 | 0.0028 | 7.6477 | 0.592 | 4 | 33 | regulation of collagen biosynthetic process |
| GO:0014897 | 0.0028 | 4.6417 | 1.3994 | 6 | 78 | striated muscle hypertrophy |
| GO:0050896 | 0.0031 | 1.4163 | 131.3384 | 154 | 7443 | response to stimulus |
| GO:0035909 | 0.0031 | 7.3923 | 0.61 | 4 | 34 | aorta morphogenesis |
| GO:0014706 | 0.0032 | 2.4468 | 6.0459 | 14 | 337 | striated muscle tissue development |
| GO:0003198 | 0.0032 | 11.8492 | 0.305 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0031424 | 0.0033 | 3.467 | 2.4578 | 8 | 137 | keratinization |
| GO:0001655 | 0.0033 | 2.5266 | 5.436 | 13 | 303 | urogenital system development |
| GO:0072358 | 0.0036 | 2.0167 | 11.0154 | 21 | 614 | cardiovascular system development |
| GO:0030510 | 0.0038 | 4.3388 | 1.4891 | 6 | 83 | regulation of BMP signaling pathway |
| GO:0030278 | 0.0038 | 3.1107 | 3.0678 | 9 | 171 | regulation of ossification |
| GO:0032963 | 0.0041 | 3.719 | 2.0093 | 7 | 112 | collagen metabolic process |
| GO:0030154 | 0.0042 | 1.5549 | 38.1464 | 54 | 2273 | cell differentiation |
| GO:0090257 | 0.0043 | 2.8463 | 3.7137 | 10 | 207 | regulation of muscle system process |
| GO:0060216 | 0.0045 | 10.3667 | 0.3409 | 3 | 19 | definitive hemopoiesis |
| GO:0043500 | 0.0045 | 4.1753 | 1.5429 | 6 | 86 | muscle adaptation |
| GO:0003278 | 0.0046 | 27.5646 | 0.1076 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0070278 | 0.0046 | 27.5646 | 0.1076 | 2 | 6 | extracellular matrix constituent secretion |
| GO:2000489 | 0.0046 | 27.5646 | 0.1076 | 2 | 6 | regulation of hepatic stellate cell activation |
| GO:0045777 | 0.0046 | 6.5209 | 0.6817 | 4 | 38 | positive regulation of blood pressure |
| GO:0009792 | 0.0047 | 2.0424 | 9.8134 | 19 | 547 | embryo development ending in birth or egg hatching |
| GO:0008285 | 0.0048 | 1.9615 | 11.3025 | 21 | 630 | negative regulation of cell proliferation |
| GO:0044246 | 0.0051 | 6.3341 | 0.6997 | 4 | 39 | regulation of multicellular organismal metabolic process |
| GO:0051241 | 0.0054 | 1.7508 | 17.5637 | 29 | 979 | negative regulation of multicellular organismal process |
| GO:0008016 | 0.0057 | 2.7203 | 3.8751 | 10 | 216 | regulation of heart contraction |
| GO:0060713 | 0.006 | 9.2136 | 0.3767 | 3 | 21 | labyrinthine layer morphogenesis |
| GO:0090189 | 0.006 | 9.2136 | 0.3767 | 3 | 21 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0001822 | 0.0061 | 2.5507 | 4.5389 | 11 | 253 | kidney development |
| GO:0035914 | 0.0062 | 4.6281 | 1.1661 | 5 | 65 | skeletal muscle cell differentiation |
| GO:0008202 | 0.0063 | 2.4255 | 5.2027 | 12 | 290 | steroid metabolic process |
| GO:0045596 | 0.0063 | 1.9438 | 10.836 | 20 | 604 | negative regulation of cell differentiation |
| GO:0045650 | 0.0063 | 22.0502 | 0.1256 | 2 | 7 | negative regulation of macrophage differentiation |
| GO:0060976 | 0.0066 | 5.8329 | 0.7535 | 4 | 42 | coronary vasculature development |
| GO:0055001 | 0.0067 | 3.0598 | 2.7628 | 8 | 154 | muscle cell development |
| GO:0060538 | 0.0069 | 3.0388 | 2.7808 | 8 | 155 | skeletal muscle organ development |
| GO:1901342 | 0.007 | 2.4982 | 4.6286 | 11 | 258 | regulation of vasculature development |
| GO:0007200 | 0.0072 | 3.7508 | 1.7043 | 6 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0055074 | 0.0076 | 2.196 | 6.6918 | 14 | 373 | calcium ion homeostasis |
| GO:0030512 | 0.0079 | 4.3377 | 1.2379 | 5 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0001701 | 0.0081 | 2.3397 | 5.3821 | 12 | 300 | in utero embryonic development |
| GO:0010533 | 0.0084 | 18.3739 | 0.1435 | 2 | 8 | regulation of activation of Janus kinase activity |
| GO:0048743 | 0.0084 | 18.3739 | 0.1435 | 2 | 8 | positive regulation of skeletal muscle fiber development |
| GO:0051133 | 0.0084 | 18.3739 | 0.1435 | 2 | 8 | regulation of NK T cell activation |
| GO:0060020 | 0.0084 | 18.3739 | 0.1435 | 2 | 8 | Bergmann glial cell differentiation |
| GO:1905065 | 0.0084 | 18.3739 | 0.1435 | 2 | 8 | positive regulation of vascular smooth muscle cell differentiation |
| GO:0046427 | 0.0084 | 4.2707 | 1.2558 | 5 | 70 | positive regulation of JAK-STAT cascade |
| GO:0002682 | 0.0085 | 1.6111 | 23.0535 | 35 | 1285 | regulation of immune system process |
| GO:0048856 | 0.0087 | 1.8843 | 12.0621 | 21 | 893 | anatomical structure development |
| GO:0030878 | 0.0087 | 7.8958 | 0.4306 | 3 | 24 | thyroid gland development |
| GO:0051894 | 0.0087 | 7.8958 | 0.4306 | 3 | 24 | positive regulation of focal adhesion assembly |
| GO:0001707 | 0.0089 | 4.2057 | 1.2738 | 5 | 71 | mesoderm formation |
| GO:0035019 | 0.0089 | 4.2057 | 1.2738 | 5 | 71 | somatic stem cell population maintenance |
| GO:0001525 | 0.009 | 2.0871 | 7.535 | 15 | 420 | angiogenesis |
| GO:0061061 | 0.0091 | 1.9072 | 10.4593 | 19 | 583 | muscle structure development |
| GO:0010862 | 0.0092 | 5.276 | 0.8253 | 4 | 46 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0072132 | 0.0092 | 5.276 | 0.8253 | 4 | 46 | mesenchyme morphogenesis |
| GO:0045597 | 0.0094 | 1.7431 | 15.1059 | 25 | 842 | positive regulation of cell differentiation |
| GO:0001649 | 0.0096 | 2.6614 | 3.5522 | 9 | 198 | osteoblast differentiation |
| GO:0006875 | 0.0096 | 2.0191 | 8.3064 | 16 | 463 | cellular metal ion homeostasis |
| GO:0010922 | 0.0098 | 7.5364 | 0.4485 | 3 | 25 | positive regulation of phosphatase activity |
| GO:0072273 | 0.0098 | 7.5364 | 0.4485 | 3 | 25 | metanephric nephron morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 52.5358 | 0.8653 | 24 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 20.9917 | 1.7609 | 26 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 18.3262 | 1.9583 | 26 | 129 | detection of stimulus involved in sensory perception |
| GO:0007186 | 0 | 3.4868 | 12.7363 | 38 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 3.2695 | 13.1007 | 37 | 863 | nervous system process |
| GO:0016579 | 0 | 4.4446 | 3.9895 | 16 | 265 | protein deubiquitination |
| GO:0003095 | 0 | Inf | 0.0455 | 3 | 3 | pressure natriuresis |
| GO:0045087 | 0 | 3.6916 | 5.3765 | 18 | 366 | innate immune response |
| GO:0070268 | 0 | 7.107 | 1.427 | 9 | 94 | cornification |
| GO:0036101 | 0 | 197.1711 | 0.0607 | 3 | 4 | leukotriene B4 catabolic process |
| GO:1901523 | 0 | 98.5789 | 0.0759 | 3 | 5 | icosanoid catabolic process |
| GO:0030216 | 1e-04 | 4.222 | 3.0968 | 12 | 204 | keratinocyte differentiation |
| GO:0050776 | 1e-04 | 4.8402 | 2.2609 | 10 | 155 | regulation of immune response |
| GO:0019730 | 1e-04 | 7.2861 | 1.0778 | 7 | 71 | antimicrobial humoral response |
| GO:0002376 | 1e-04 | 1.8184 | 37.7081 | 60 | 2484 | immune system process |
| GO:0019373 | 3e-04 | 15.5159 | 0.3188 | 4 | 21 | epoxygenase P450 pathway |
| GO:0097267 | 3e-04 | 32.8509 | 0.1366 | 3 | 9 | omega-hydroxylase P450 pathway |
| GO:0007565 | 3e-04 | 4.0644 | 2.6566 | 10 | 175 | female pregnancy |
| GO:0003071 | 4e-04 | 13.8808 | 0.3491 | 4 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0002221 | 9e-04 | 3.8791 | 2.4896 | 9 | 164 | pattern recognition receptor signaling pathway |
| GO:0008544 | 0.001 | 2.796 | 5.3435 | 14 | 352 | epidermis development |
| GO:0042360 | 0.0013 | 65.4323 | 0.0607 | 2 | 4 | vitamin E metabolic process |
| GO:0003091 | 0.0017 | 8.7847 | 0.5161 | 4 | 34 | renal water homeostasis |
| GO:0070098 | 0.0017 | 6.3538 | 0.8653 | 5 | 57 | chemokine-mediated signaling pathway |
| GO:0042742 | 0.0019 | 3.4713 | 2.7628 | 9 | 182 | defense response to bacterium |
| GO:0007635 | 0.002 | 14.0714 | 0.2581 | 3 | 17 | chemosensory behavior |
| GO:0002250 | 0.0028 | 2.7007 | 4.7059 | 12 | 310 | adaptive immune response |
| GO:0030104 | 0.0028 | 5.5973 | 0.9715 | 5 | 64 | water homeostasis |
| GO:0055078 | 0.0031 | 7.3177 | 0.6072 | 4 | 40 | sodium ion homeostasis |
| GO:0002218 | 0.0032 | 2.799 | 4.1594 | 11 | 274 | activation of innate immune response |
| GO:0071947 | 0.0033 | 32.7118 | 0.0911 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0006508 | 0.0033 | 1.6982 | 24.2127 | 38 | 1595 | proteolysis |
| GO:0031349 | 0.0038 | 2.3956 | 6.1784 | 14 | 407 | positive regulation of defense response |
| GO:0050778 | 0.0039 | 2.0872 | 9.6547 | 19 | 636 | positive regulation of immune response |
| GO:0007608 | 0.0041 | 10.4566 | 0.3277 | 3 | 24 | sensory perception of smell |
| GO:0002548 | 0.0044 | 6.5841 | 0.6679 | 4 | 44 | monocyte chemotaxis |
| GO:0032819 | 0.0046 | 26.1677 | 0.1063 | 2 | 7 | positive regulation of natural killer cell proliferation |
| GO:2001185 | 0.0046 | 26.1677 | 0.1063 | 2 | 7 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0002761 | 0.0048 | 4.0932 | 1.5636 | 6 | 103 | regulation of myeloid leukocyte differentiation |
| GO:0019941 | 0.005 | 2.1251 | 8.4555 | 17 | 557 | modification-dependent protein catabolic process |
| GO:0045088 | 0.0051 | 2.3955 | 5.723 | 13 | 377 | regulation of innate immune response |
| GO:0035865 | 0.006 | 21.8049 | 0.1214 | 2 | 8 | cellular response to potassium ion |
| GO:2000318 | 0.006 | 21.8049 | 0.1214 | 2 | 8 | positive regulation of T-helper 17 type immune response |
| GO:0045671 | 0.0062 | 8.9498 | 0.3795 | 3 | 25 | negative regulation of osteoclast differentiation |
| GO:0007194 | 0.0069 | 8.5601 | 0.3947 | 3 | 26 | negative regulation of adenylate cyclase activity |
| GO:0002757 | 0.0076 | 2.1997 | 6.6946 | 14 | 441 | immune response-activating signal transduction |
| GO:0032342 | 0.0077 | 18.6887 | 0.1366 | 2 | 9 | aldosterone biosynthetic process |
| GO:0034651 | 0.0077 | 18.6887 | 0.1366 | 2 | 9 | cortisol biosynthetic process |
| GO:0060158 | 0.0077 | 18.6887 | 0.1366 | 2 | 9 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0090279 | 0.0085 | 7.8742 | 0.4251 | 3 | 28 | regulation of calcium ion import |
| GO:0018149 | 0.0094 | 7.5709 | 0.4402 | 3 | 29 | peptide cross-linking |
| GO:0008212 | 0.0095 | 16.3515 | 0.1518 | 2 | 10 | mineralocorticoid metabolic process |
| GO:0045919 | 0.0095 | 16.3515 | 0.1518 | 2 | 10 | positive regulation of cytolysis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 8.3974 | 2.707 | 19 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0022610 | 0 | 2.6548 | 22.7777 | 52 | 1279 | biological adhesion |
| GO:0098609 | 0 | 4.287 | 6.3414 | 24 | 366 | cell-cell adhesion |
| GO:0032502 | 0 | 1.8859 | 98.7689 | 140 | 5546 | developmental process |
| GO:0031424 | 0 | 5.4935 | 2.4398 | 12 | 137 | keratinization |
| GO:0032501 | 0 | 1.7754 | 85.1492 | 117 | 5200 | multicellular organismal process |
| GO:0043588 | 2e-04 | 3.1055 | 5.5564 | 16 | 312 | skin development |
| GO:0001775 | 2e-04 | 2.0053 | 21.2818 | 39 | 1195 | cell activation |
| GO:0042403 | 3e-04 | 14.9124 | 0.3384 | 4 | 19 | thyroid hormone metabolic process |
| GO:0018003 | 3e-04 | Inf | 0.0356 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:2000502 | 3e-04 | Inf | 0.0356 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0048731 | 4e-04 | 1.7797 | 33.7419 | 53 | 2076 | system development |
| GO:0007399 | 4e-04 | 1.7091 | 37.6127 | 58 | 2112 | nervous system development |
| GO:0060840 | 6e-04 | 5.4022 | 1.4247 | 7 | 80 | artery development |
| GO:0060429 | 6e-04 | 1.931 | 19.6077 | 35 | 1101 | epithelium development |
| GO:0033690 | 6e-04 | 23.8897 | 0.1781 | 3 | 10 | positive regulation of osteoblast proliferation |
| GO:0050863 | 7e-04 | 2.9279 | 5.1112 | 14 | 287 | regulation of T cell activation |
| GO:0042335 | 9e-04 | 111.1152 | 0.0534 | 2 | 3 | cuticle development |
| GO:0001657 | 0.0013 | 4.6358 | 1.6384 | 7 | 92 | ureteric bud development |
| GO:0072163 | 0.0014 | 4.5816 | 1.6562 | 7 | 93 | mesonephric epithelium development |
| GO:0030154 | 0.0016 | 1.5017 | 65.2879 | 87 | 3666 | cell differentiation |
| GO:0010762 | 0.0016 | 8.9414 | 0.5165 | 4 | 29 | regulation of fibroblast migration |
| GO:0090183 | 0.0017 | 6.3662 | 0.8726 | 5 | 49 | regulation of kidney development |
| GO:0002699 | 0.0018 | 3.4822 | 2.7604 | 9 | 155 | positive regulation of immune effector process |
| GO:2001027 | 0.0019 | 55.5539 | 0.0712 | 2 | 4 | negative regulation of endothelial cell chemotaxis |
| GO:0045785 | 0.0019 | 2.5021 | 6.3578 | 15 | 357 | positive regulation of cell adhesion |
| GO:0009913 | 0.0019 | 2.839 | 4.4879 | 12 | 252 | epidermal cell differentiation |
| GO:0090288 | 0.0021 | 3.7582 | 2.2796 | 8 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0060415 | 0.0022 | 4.8817 | 1.3357 | 6 | 75 | muscle tissue morphogenesis |
| GO:0007267 | 0.0022 | 1.7006 | 25.9834 | 41 | 1459 | cell-cell signaling |
| GO:0032965 | 0.0027 | 7.7061 | 0.5877 | 4 | 33 | regulation of collagen biosynthetic process |
| GO:0032649 | 0.0028 | 4.613 | 1.4069 | 6 | 79 | regulation of interferon-gamma production |
| GO:0009636 | 0.0028 | 3.024 | 3.5084 | 10 | 197 | response to toxic substance |
| GO:0035909 | 0.003 | 7.4487 | 0.6055 | 4 | 34 | aorta morphogenesis |
| GO:0043305 | 0.003 | 37.0335 | 0.089 | 2 | 5 | negative regulation of mast cell degranulation |
| GO:2000609 | 0.003 | 37.0335 | 0.089 | 2 | 5 | regulation of thyroid hormone generation |
| GO:0003198 | 0.0032 | 11.9392 | 0.3028 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0043583 | 0.0033 | 2.9598 | 3.5796 | 10 | 201 | ear development |
| GO:0042060 | 0.0036 | 2.1442 | 8.8689 | 18 | 498 | wound healing |
| GO:0042035 | 0.0036 | 4.3722 | 1.4781 | 6 | 83 | regulation of cytokine biosynthetic process |
| GO:0060393 | 0.0037 | 5.282 | 1.0329 | 5 | 58 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0045954 | 0.0037 | 11.1425 | 0.3206 | 3 | 18 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0048145 | 0.0038 | 4.3158 | 1.496 | 6 | 84 | regulation of fibroblast proliferation |
| GO:0008285 | 0.0045 | 1.9775 | 11.2197 | 21 | 630 | negative regulation of cell proliferation |
| GO:0070278 | 0.0045 | 27.7732 | 0.1069 | 2 | 6 | extracellular matrix constituent secretion |
| GO:1903961 | 0.0045 | 27.7732 | 0.1069 | 2 | 6 | positive regulation of anion transmembrane transport |
| GO:2000489 | 0.0045 | 27.7732 | 0.1069 | 2 | 6 | regulation of hepatic stellate cell activation |
| GO:0031295 | 0.0046 | 4.998 | 1.0864 | 5 | 61 | T cell costimulation |
| GO:0071345 | 0.0048 | 1.8507 | 14.3007 | 25 | 803 | cellular response to cytokine stimulus |
| GO:0044246 | 0.005 | 6.3825 | 0.6946 | 4 | 39 | regulation of multicellular organismal metabolic process |
| GO:0061213 | 0.0051 | 9.8303 | 0.3562 | 3 | 20 | positive regulation of mesonephros development |
| GO:0033077 | 0.0052 | 4.825 | 1.122 | 5 | 63 | T cell differentiation in thymus |
| GO:0002688 | 0.0054 | 4.0059 | 1.6028 | 6 | 90 | regulation of leukocyte chemotaxis |
| GO:0008016 | 0.0054 | 2.7415 | 3.8468 | 10 | 216 | regulation of heart contraction |
| GO:0055078 | 0.0054 | 6.2047 | 0.7124 | 4 | 40 | sodium ion homeostasis |
| GO:0044057 | 0.0054 | 2.103 | 8.5127 | 17 | 478 | regulation of system process |
| GO:0090189 | 0.0059 | 9.2836 | 0.374 | 3 | 21 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0032102 | 0.0059 | 2.5599 | 4.5235 | 11 | 254 | negative regulation of response to external stimulus |
| GO:0050896 | 0.0061 | 1.3721 | 134.0842 | 155 | 7529 | response to stimulus |
| GO:2000402 | 0.0063 | 22.2171 | 0.1247 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0051591 | 0.0063 | 3.867 | 1.6562 | 6 | 93 | response to cAMP |
| GO:0046649 | 0.0063 | 1.981 | 10.0977 | 19 | 567 | lymphocyte activation |
| GO:0050900 | 0.0065 | 2.239 | 6.5715 | 14 | 369 | leukocyte migration |
| GO:0008284 | 0.0068 | 1.8174 | 13.9402 | 24 | 791 | positive regulation of cell proliferation |
| GO:0060326 | 0.007 | 2.6376 | 3.9892 | 10 | 224 | cell chemotaxis |
| GO:0071773 | 0.0071 | 3.0208 | 2.796 | 8 | 157 | cellular response to BMP stimulus |
| GO:0042107 | 0.0074 | 3.7374 | 1.7097 | 6 | 96 | cytokine metabolic process |
| GO:0045577 | 0.0076 | 8.3541 | 0.4096 | 3 | 23 | regulation of B cell differentiation |
| GO:0060986 | 0.0076 | 5.5828 | 0.7836 | 4 | 44 | endocrine hormone secretion |
| GO:0002694 | 0.0077 | 2.9761 | 2.8355 | 8 | 163 | regulation of leukocyte activation |
| GO:0008584 | 0.008 | 3.2487 | 2.2796 | 7 | 128 | male gonad development |
| GO:0046427 | 0.0082 | 4.3034 | 1.2466 | 5 | 70 | positive regulation of JAK-STAT cascade |
| GO:0010533 | 0.0082 | 18.513 | 0.1425 | 2 | 8 | regulation of activation of Janus kinase activity |
| GO:0042535 | 0.0082 | 18.513 | 0.1425 | 2 | 8 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0048743 | 0.0082 | 18.513 | 0.1425 | 2 | 8 | positive regulation of skeletal muscle fiber development |
| GO:0051133 | 0.0082 | 18.513 | 0.1425 | 2 | 8 | regulation of NK T cell activation |
| GO:0060020 | 0.0082 | 18.513 | 0.1425 | 2 | 8 | Bergmann glial cell differentiation |
| GO:1905065 | 0.0082 | 18.513 | 0.1425 | 2 | 8 | positive regulation of vascular smooth muscle cell differentiation |
| GO:1903039 | 0.0086 | 2.7112 | 3.4906 | 9 | 196 | positive regulation of leukocyte cell-cell adhesion |
| GO:1904892 | 0.0087 | 3.1954 | 2.3152 | 7 | 130 | regulation of STAT cascade |
| GO:0051241 | 0.009 | 1.6957 | 17.435 | 28 | 979 | negative regulation of multicellular organismal process |
| GO:0022407 | 0.0091 | 2.146 | 6.8387 | 14 | 384 | regulation of cell-cell adhesion |
| GO:0002696 | 0.0095 | 2.3897 | 4.8262 | 11 | 271 | positive regulation of leukocyte activation |
| GO:0010922 | 0.0096 | 7.5936 | 0.4452 | 3 | 25 | positive regulation of phosphatase activity |
| GO:0072273 | 0.0096 | 7.5936 | 0.4452 | 3 | 25 | metanephric nephron morphogenesis |
| GO:0071774 | 0.0098 | 3.1187 | 2.3686 | 7 | 133 | response to fibroblast growth factor |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007275 | 0 | 2.7167 | 50.5353 | 100 | 2732 | multicellular organism development |
| GO:0007156 | 0 | 6.6793 | 3.1465 | 18 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0022610 | 0 | 2.5847 | 26.476 | 59 | 1279 | biological adhesion |
| GO:0007399 | 0 | 2.7976 | 18.979 | 46 | 983 | nervous system development |
| GO:0098609 | 0 | 2.8203 | 15.5254 | 39 | 750 | cell-cell adhesion |
| GO:0045944 | 0 | 2.3195 | 21.6114 | 45 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0009888 | 0 | 1.9352 | 32.8493 | 57 | 1611 | tissue development |
| GO:0051254 | 0 | 1.9703 | 29.2085 | 52 | 1411 | positive regulation of RNA metabolic process |
| GO:1903508 | 0 | 1.9876 | 27.7801 | 50 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:2000026 | 0 | 1.8668 | 35.7705 | 60 | 1728 | regulation of multicellular organismal development |
| GO:0048699 | 0 | 1.9773 | 27.304 | 49 | 1319 | generation of neurons |
| GO:0070848 | 0 | 2.4297 | 12.9585 | 29 | 626 | response to growth factor |
| GO:0048513 | 0 | 1.7814 | 46.0457 | 72 | 2387 | animal organ development |
| GO:0009653 | 1e-04 | 1.9759 | 25.1763 | 45 | 1302 | anatomical structure morphogenesis |
| GO:0060538 | 1e-04 | 4.0875 | 3.2086 | 12 | 155 | skeletal muscle organ development |
| GO:0042476 | 1e-04 | 4.6652 | 2.3599 | 10 | 114 | odontogenesis |
| GO:0007267 | 1e-04 | 1.8514 | 30.2021 | 51 | 1459 | cell-cell signaling |
| GO:0042127 | 1e-04 | 2.1522 | 16.662 | 33 | 841 | regulation of cell proliferation |
| GO:0003278 | 2e-04 | 47.7532 | 0.1242 | 3 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0001558 | 2e-04 | 2.7327 | 7.4729 | 19 | 361 | regulation of cell growth |
| GO:0001568 | 2e-04 | 2.317 | 12.0684 | 26 | 583 | blood vessel development |
| GO:0061061 | 2e-04 | 2.317 | 12.0684 | 26 | 583 | muscle structure development |
| GO:0090288 | 3e-04 | 4.1078 | 2.6497 | 10 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0010557 | 4e-04 | 1.7561 | 32.2928 | 52 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0035914 | 4e-04 | 5.8166 | 1.3455 | 7 | 65 | skeletal muscle cell differentiation |
| GO:0031328 | 4e-04 | 1.7189 | 34.9425 | 55 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0072358 | 5e-04 | 2.1901 | 12.7101 | 26 | 614 | cardiovascular system development |
| GO:0009792 | 5e-04 | 2.2675 | 11.3232 | 24 | 547 | embryo development ending in birth or egg hatching |
| GO:0072073 | 5e-04 | 3.9075 | 2.7739 | 10 | 134 | kidney epithelium development |
| GO:0060216 | 5e-04 | 12.7648 | 0.3933 | 4 | 19 | definitive hemopoiesis |
| GO:0010720 | 6e-04 | 2.3699 | 9.4601 | 21 | 457 | positive regulation of cell development |
| GO:0055002 | 6e-04 | 3.7547 | 2.8774 | 10 | 139 | striated muscle cell development |
| GO:0008285 | 7e-04 | 2.1297 | 13.0413 | 26 | 630 | negative regulation of cell proliferation |
| GO:0070886 | 7e-04 | 23.8718 | 0.1863 | 3 | 9 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0042060 | 7e-04 | 2.2756 | 10.3089 | 22 | 498 | wound healing |
| GO:0045596 | 8e-04 | 2.1325 | 12.5031 | 25 | 604 | negative regulation of cell differentiation |
| GO:0023052 | 9e-04 | 1.5143 | 78.0026 | 102 | 4065 | signaling |
| GO:0001649 | 9e-04 | 3.1334 | 4.0987 | 12 | 198 | osteoblast differentiation |
| GO:0048146 | 9e-04 | 5.8859 | 1.1385 | 6 | 55 | positive regulation of fibroblast proliferation |
| GO:0033690 | 9e-04 | 20.4602 | 0.207 | 3 | 10 | positive regulation of osteoblast proliferation |
| GO:0050665 | 9e-04 | 20.4602 | 0.207 | 3 | 10 | hydrogen peroxide biosynthetic process |
| GO:0030198 | 0.001 | 2.587 | 6.5828 | 16 | 318 | extracellular matrix organization |
| GO:0009719 | 0.001 | 1.7194 | 28.8565 | 46 | 1394 | response to endogenous stimulus |
| GO:0051962 | 0.001 | 2.3038 | 9.2324 | 20 | 446 | positive regulation of nervous system development |
| GO:0032924 | 0.0011 | 7.2674 | 0.7866 | 5 | 38 | activin receptor signaling pathway |
| GO:0060348 | 0.0011 | 3.2318 | 3.6433 | 11 | 176 | bone development |
| GO:0035295 | 0.0013 | 2.1318 | 11.4681 | 23 | 554 | tube development |
| GO:0003350 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | pulmonary myocardium development |
| GO:0042335 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | cuticle development |
| GO:2000254 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | regulation of male germ cell proliferation |
| GO:0007512 | 0.0013 | 17.9014 | 0.2277 | 3 | 11 | adult heart development |
| GO:0032964 | 0.0013 | 6.8512 | 0.828 | 5 | 40 | collagen biosynthetic process |
| GO:0007166 | 0.0014 | 1.5361 | 52.1446 | 73 | 2519 | cell surface receptor signaling pathway |
| GO:0030878 | 0.0014 | 9.5704 | 0.4968 | 4 | 24 | thyroid gland development |
| GO:0048762 | 0.0015 | 3.1171 | 3.7675 | 11 | 182 | mesenchymal cell differentiation |
| GO:0014706 | 0.0016 | 2.4705 | 6.8714 | 16 | 334 | striated muscle tissue development |
| GO:0007154 | 0.0016 | 1.4791 | 78.3864 | 101 | 4085 | cell communication |
| GO:0071773 | 0.0016 | 3.291 | 3.25 | 10 | 157 | cellular response to BMP stimulus |
| GO:0010922 | 0.0016 | 9.1141 | 0.5175 | 4 | 25 | positive regulation of phosphatase activity |
| GO:0060415 | 0.0016 | 16.1075 | 0.2455 | 3 | 12 | muscle tissue morphogenesis |
| GO:0060707 | 0.0017 | 15.9113 | 0.2484 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0090596 | 0.0017 | 2.746 | 5.0302 | 13 | 243 | sensory organ morphogenesis |
| GO:0007588 | 0.0017 | 5.1477 | 1.2834 | 6 | 62 | excretion |
| GO:0010718 | 0.0021 | 6.1468 | 0.9108 | 5 | 44 | positive regulation of epithelial to mesenchymal transition |
| GO:0045666 | 0.0022 | 2.4672 | 6.4379 | 15 | 311 | positive regulation of neuron differentiation |
| GO:0043588 | 0.0022 | 2.4588 | 6.4586 | 15 | 312 | skin development |
| GO:0001954 | 0.0023 | 5.9927 | 0.9315 | 5 | 45 | positive regulation of cell-matrix adhesion |
| GO:0001994 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0048852 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | diencephalon morphogenesis |
| GO:0060018 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | astrocyte fate commitment |
| GO:0061325 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0010628 | 0.0026 | 1.5869 | 35.253 | 52 | 1703 | positive regulation of gene expression |
| GO:0003231 | 0.0028 | 3.5696 | 2.4013 | 8 | 116 | cardiac ventricle development |
| GO:0044259 | 0.0028 | 3.5696 | 2.4013 | 8 | 116 | multicellular organismal macromolecule metabolic process |
| GO:0051216 | 0.003 | 3.0019 | 3.5398 | 10 | 171 | cartilage development |
| GO:0030512 | 0.003 | 4.5736 | 1.4283 | 6 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0048869 | 0.0032 | 1.6195 | 31.6481 | 47 | 1722 | cellular developmental process |
| GO:1901890 | 0.0032 | 7.3589 | 0.621 | 4 | 30 | positive regulation of cell junction assembly |
| GO:0030516 | 0.0032 | 4.5018 | 1.449 | 6 | 70 | regulation of axon extension |
| GO:0001667 | 0.0033 | 2.3535 | 6.7277 | 15 | 325 | ameboidal-type cell migration |
| GO:0003206 | 0.0033 | 3.4724 | 2.4634 | 8 | 119 | cardiac chamber morphogenesis |
| GO:0031960 | 0.0034 | 3.1698 | 3.0223 | 9 | 146 | response to corticosteroid |
| GO:0050768 | 0.0036 | 2.6189 | 4.8439 | 12 | 234 | negative regulation of neurogenesis |
| GO:0048706 | 0.0037 | 3.4105 | 2.5048 | 8 | 121 | embryonic skeletal system development |
| GO:0003002 | 0.0037 | 2.3979 | 6.1595 | 14 | 300 | regionalization |
| GO:0048705 | 0.0038 | 2.729 | 4.2643 | 11 | 206 | skeletal system morphogenesis |
| GO:0010810 | 0.0038 | 2.8929 | 3.664 | 10 | 177 | regulation of cell-substrate adhesion |
| GO:0051241 | 0.0039 | 1.7264 | 20.2658 | 33 | 979 | negative regulation of multicellular organismal process |
| GO:0090257 | 0.004 | 2.7149 | 4.285 | 11 | 207 | regulation of muscle system process |
| GO:0021515 | 0.004 | 5.209 | 1.0557 | 5 | 51 | cell differentiation in spinal cord |
| GO:0071260 | 0.004 | 4.2994 | 1.5111 | 6 | 73 | cellular response to mechanical stimulus |
| GO:0006590 | 0.004 | 11.0126 | 0.3312 | 3 | 16 | thyroid hormone generation |
| GO:0045165 | 0.0041 | 2.5718 | 4.9267 | 12 | 238 | cell fate commitment |
| GO:0036093 | 0.0041 | 31.7338 | 0.1035 | 2 | 5 | germ cell proliferation |
| GO:0051270 | 0.0043 | 1.7979 | 16.4569 | 28 | 795 | regulation of cellular component movement |
| GO:0010001 | 0.0043 | 2.8413 | 3.7261 | 10 | 180 | glial cell differentiation |
| GO:0001655 | 0.0044 | 2.3518 | 6.2723 | 14 | 303 | urogenital system development |
| GO:0014902 | 0.0045 | 3.6586 | 2.0494 | 7 | 99 | myotube differentiation |
| GO:0071560 | 0.0046 | 2.6599 | 4.3678 | 11 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0071385 | 0.0047 | 4.9913 | 1.0971 | 5 | 53 | cellular response to glucocorticoid stimulus |
| GO:0048856 | 0.0047 | 24.8897 | 0.1072 | 2 | 8 | anatomical structure development |
| GO:0048666 | 0.0048 | 1.7165 | 19.7276 | 32 | 953 | neuron development |
| GO:0003198 | 0.0048 | 10.2253 | 0.3519 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0106056 | 0.0048 | 10.2253 | 0.3519 | 3 | 17 | regulation of calcineurin-mediated signaling |
| GO:0032526 | 0.005 | 3.5803 | 2.0908 | 7 | 101 | response to retinoic acid |
| GO:0048562 | 0.0052 | 2.3868 | 5.734 | 13 | 277 | embryonic organ morphogenesis |
| GO:0048468 | 0.0053 | 1.8361 | 14.4141 | 25 | 739 | cell development |
| GO:0008016 | 0.0054 | 2.5941 | 4.4713 | 11 | 216 | regulation of heart contraction |
| GO:0032989 | 0.0054 | 1.6988 | 19.9139 | 32 | 962 | cellular component morphogenesis |
| GO:0030220 | 0.0057 | 9.5429 | 0.3726 | 3 | 18 | platelet formation |
| GO:0007417 | 0.0057 | 1.7391 | 17.5955 | 29 | 850 | central nervous system development |
| GO:0045637 | 0.0058 | 2.5687 | 4.5127 | 11 | 218 | regulation of myeloid cell differentiation |
| GO:0046958 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | nonassociative learning |
| GO:0072014 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | proximal tubule development |
| GO:2000489 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | regulation of hepatic stellate cell activation |
| GO:0001501 | 0.0062 | 3.8905 | 1.6534 | 6 | 84 | skeletal system development |
| GO:0060412 | 0.0063 | 5.9767 | 0.7452 | 4 | 36 | ventricular septum morphogenesis |
| GO:0001525 | 0.0067 | 2.0524 | 8.6942 | 17 | 420 | angiogenesis |
| GO:0048593 | 0.0068 | 3.3641 | 2.215 | 7 | 107 | camera-type eye morphogenesis |
| GO:0003407 | 0.0069 | 4.5189 | 1.2006 | 5 | 58 | neural retina development |
| GO:0060193 | 0.0069 | 4.5189 | 1.2006 | 5 | 58 | positive regulation of lipase activity |
| GO:0007162 | 0.0071 | 2.4954 | 4.6369 | 11 | 224 | negative regulation of cell adhesion |
| GO:0030334 | 0.0074 | 1.7997 | 14.0143 | 24 | 677 | regulation of cell migration |
| GO:0030219 | 0.0075 | 3.7385 | 1.7181 | 6 | 83 | megakaryocyte differentiation |
| GO:0030510 | 0.0075 | 3.7385 | 1.7181 | 6 | 83 | regulation of BMP signaling pathway |
| GO:0040012 | 0.0076 | 1.7325 | 16.3948 | 27 | 792 | regulation of locomotion |
| GO:0045777 | 0.0076 | 5.6244 | 0.7866 | 4 | 38 | positive regulation of blood pressure |
| GO:0002695 | 0.0077 | 2.9842 | 2.836 | 8 | 137 | negative regulation of leukocyte activation |
| GO:0035929 | 0.0077 | 8.4191 | 0.414 | 3 | 20 | steroid hormone secretion |
| GO:0051716 | 0.0084 | 1.3231 | 129.7095 | 151 | 6266 | cellular response to stimulus |
| GO:0003253 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0045650 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | negative regulation of macrophage differentiation |
| GO:0060215 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | primitive hemopoiesis |
| GO:0040007 | 0.0084 | 2.1683 | 6.7744 | 14 | 337 | growth |
| GO:0031214 | 0.0087 | 3.2028 | 2.3185 | 7 | 112 | biomineral tissue development |
| GO:0097435 | 0.0087 | 1.8788 | 11.1576 | 20 | 539 | supramolecular fiber organization |
| GO:0003181 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | atrioventricular valve morphogenesis |
| GO:0021516 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | dorsal spinal cord development |
| GO:0060972 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | left/right pattern formation |
| GO:0001775 | 0.0089 | 1.5797 | 24.7371 | 37 | 1195 | cell activation |
| GO:0030003 | 0.0091 | 1.8714 | 11.199 | 20 | 541 | cellular cation homeostasis |
| GO:0048844 | 0.0091 | 4.2006 | 1.2834 | 5 | 62 | artery morphogenesis |
| GO:0003170 | 0.0092 | 5.3112 | 0.828 | 4 | 40 | heart valve development |
| GO:0072210 | 0.0092 | 5.3112 | 0.828 | 4 | 40 | metanephric nephron development |
| GO:0043583 | 0.0092 | 2.5253 | 4.1608 | 10 | 201 | ear development |
| GO:0048589 | 0.0092 | 1.8677 | 11.2197 | 20 | 542 | developmental growth |
| GO:0055008 | 0.0097 | 4.1279 | 1.3041 | 5 | 63 | cardiac muscle tissue morphogenesis |
| GO:0050868 | 0.0098 | 3.5094 | 1.8216 | 6 | 88 | negative regulation of T cell activation |
| GO:0010559 | 0.01 | 5.1673 | 0.8487 | 4 | 41 | regulation of glycoprotein biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 12.0897 | 0.7866 | 8 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0031424 | 0 | 6.5283 | 1.8906 | 11 | 137 | keratinization |
| GO:0002430 | 0 | 41.6089 | 0.1518 | 4 | 11 | complement receptor mediated signaling pathway |
| GO:0050900 | 1e-04 | 3.4237 | 5.0923 | 16 | 369 | leukocyte migration |
| GO:0007186 | 1e-04 | 2.467 | 11.5785 | 26 | 839 | G-protein coupled receptor signaling pathway |
| GO:0043588 | 1e-04 | 3.5256 | 4.3057 | 14 | 312 | skin development |
| GO:0071657 | 2e-04 | Inf | 0.0276 | 2 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0009913 | 2e-04 | 3.729 | 3.4777 | 12 | 252 | epidermal cell differentiation |
| GO:0009593 | 2e-04 | 5.4635 | 1.6008 | 8 | 116 | detection of chemical stimulus |
| GO:0043252 | 4e-04 | 13.2259 | 0.3588 | 4 | 26 | sodium-independent organic anion transport |
| GO:0050906 | 4e-04 | 4.8723 | 1.7802 | 8 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 5e-04 | 4.7534 | 1.8216 | 8 | 132 | sensory perception of chemical stimulus |
| GO:0031427 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | response to methotrexate |
| GO:1901256 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:0014824 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | artery smooth muscle contraction |
| GO:0002645 | 0.0038 | 28.85 | 0.0966 | 2 | 7 | positive regulation of tolerance induction |
| GO:0031069 | 0.0048 | 9.8715 | 0.345 | 3 | 25 | hair follicle morphogenesis |
| GO:0015698 | 0.0064 | 3.3926 | 2.1805 | 7 | 158 | inorganic anion transport |
| GO:0043516 | 0.0073 | 8.3506 | 0.4002 | 3 | 29 | regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0008284 | 0.0076 | 1.9174 | 11.0541 | 20 | 801 | positive regulation of cell proliferation |
| GO:0015747 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | urate transport |
| GO:0098656 | 0.008 | 2.7434 | 3.4501 | 9 | 250 | anion transmembrane transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007606 | 0 | 7.7656 | 2.2554 | 15 | 132 | sensory perception of chemical stimulus |
| GO:0050911 | 0 | 12.6894 | 0.9739 | 10 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 7.5902 | 1.982 | 13 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 6.1373 | 2.2041 | 12 | 129 | detection of stimulus involved in sensory perception |
| GO:0007157 | 1e-04 | 8.8093 | 0.786 | 6 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0032501 | 2e-04 | 1.5602 | 107.8136 | 136 | 6310 | multicellular organismal process |
| GO:0009620 | 5e-04 | 8.6061 | 0.6664 | 5 | 39 | response to fungus |
| GO:0007186 | 5e-04 | 2.1051 | 14.3353 | 28 | 839 | G-protein coupled receptor signaling pathway |
| GO:0002675 | 8e-04 | 11.1131 | 0.4272 | 4 | 25 | positive regulation of acute inflammatory response |
| GO:0032289 | 9e-04 | 115.938 | 0.0513 | 2 | 3 | central nervous system myelin formation |
| GO:0099010 | 9e-04 | 115.938 | 0.0513 | 2 | 3 | modification of postsynaptic structure |
| GO:0002684 | 0.0011 | 2.0055 | 14.9846 | 28 | 877 | positive regulation of immune system process |
| GO:0070268 | 0.0011 | 4.729 | 1.6061 | 7 | 94 | cornification |
| GO:0050727 | 0.0015 | 2.7791 | 4.9721 | 13 | 291 | regulation of inflammatory response |
| GO:0060397 | 0.0019 | 14.5379 | 0.2563 | 3 | 15 | JAK-STAT cascade involved in growth hormone signaling pathway |
| GO:0002718 | 0.0026 | 5.7309 | 0.9568 | 5 | 56 | regulation of cytokine production involved in immune response |
| GO:0032103 | 0.003 | 2.8162 | 4.1348 | 11 | 242 | positive regulation of response to external stimulus |
| GO:0051047 | 0.0037 | 2.4032 | 6.151 | 14 | 360 | positive regulation of secretion |
| GO:0050807 | 0.0037 | 6.9613 | 0.64 | 4 | 38 | regulation of synapse organization |
| GO:0050707 | 0.0038 | 3.3843 | 2.5117 | 8 | 147 | regulation of cytokine secretion |
| GO:0050714 | 0.0042 | 2.8502 | 3.7077 | 10 | 217 | positive regulation of protein secretion |
| GO:0002791 | 0.0042 | 2.2868 | 6.9199 | 15 | 405 | regulation of peptide secretion |
| GO:0097696 | 0.0043 | 3.3121 | 2.5629 | 8 | 150 | STAT cascade |
| GO:0045087 | 0.0044 | 1.919 | 12.695 | 23 | 743 | innate immune response |
| GO:0031349 | 0.0044 | 2.2748 | 6.9541 | 15 | 407 | positive regulation of defense response |
| GO:1902667 | 0.0045 | 10.2586 | 0.3417 | 3 | 20 | regulation of axon guidance |
| GO:0098609 | 0.0049 | 1.8995 | 12.8146 | 23 | 750 | cell-cell adhesion |
| GO:0048799 | 0.0052 | 9.6881 | 0.3588 | 3 | 21 | animal organ maturation |
| GO:0050913 | 0.006 | 9.1776 | 0.3759 | 3 | 22 | sensory perception of bitter taste |
| GO:0002253 | 0.0063 | 2.0699 | 8.6456 | 17 | 506 | activation of immune response |
| GO:0071378 | 0.0068 | 8.7181 | 0.393 | 3 | 23 | cellular response to growth hormone stimulus |
| GO:0050877 | 0.0069 | 1.7924 | 14.7454 | 25 | 863 | nervous system process |
| GO:0035881 | 0.0076 | 19.3165 | 0.1367 | 2 | 8 | amacrine cell differentiation |
| GO:0030449 | 0.0077 | 5.5487 | 0.786 | 4 | 46 | regulation of complement activation |
| GO:0030802 | 0.0079 | 3.2567 | 2.2725 | 7 | 133 | regulation of cyclic nucleotide biosynthetic process |
| GO:0030801 | 0.0081 | 3.6567 | 1.7428 | 6 | 102 | positive regulation of cyclic nucleotide metabolic process |
| GO:0030216 | 0.0085 | 2.7144 | 3.4856 | 9 | 204 | keratinocyte differentiation |
| GO:0051963 | 0.0097 | 4.111 | 1.2985 | 5 | 76 | regulation of synapse assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070268 | 0 | 11.1835 | 1.5258 | 14 | 94 | cornification |
| GO:0009913 | 0 | 5.9288 | 4.0904 | 21 | 252 | epidermal cell differentiation |
| GO:0043588 | 0 | 5.216 | 5.0643 | 23 | 312 | skin development |
| GO:0031424 | 0 | 12.78 | 0.6625 | 7 | 43 | keratinization |
| GO:0060429 | 0 | 2.3872 | 15.8093 | 34 | 991 | epithelium development |
| GO:0010469 | 1e-04 | 2.7362 | 7.9049 | 20 | 487 | regulation of receptor activity |
| GO:0030154 | 4e-04 | 1.6084 | 59.5059 | 83 | 3666 | cell differentiation |
| GO:0007586 | 6e-04 | 4.0942 | 2.3698 | 9 | 146 | digestion |
| GO:2000352 | 7e-04 | 11.7178 | 0.4058 | 4 | 25 | negative regulation of endothelial cell apoptotic process |
| GO:0061760 | 8e-04 | 122.1959 | 0.0487 | 2 | 3 | antifungal innate immune response |
| GO:0060674 | 0.0013 | 9.4612 | 0.487 | 4 | 30 | placenta blood vessel development |
| GO:0032645 | 0.0013 | 16.7202 | 0.2272 | 3 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:2001212 | 0.0013 | 16.7202 | 0.2272 | 3 | 14 | regulation of vasculogenesis |
| GO:0006954 | 0.0022 | 2.155 | 9.869 | 20 | 608 | inflammatory response |
| GO:0032502 | 0.0023 | 1.4559 | 90.0218 | 112 | 5546 | developmental process |
| GO:0014060 | 0.0025 | 40.7265 | 0.0812 | 2 | 5 | regulation of epinephrine secretion |
| GO:0043305 | 0.0025 | 40.7265 | 0.0812 | 2 | 5 | negative regulation of mast cell degranulation |
| GO:0007218 | 0.0031 | 4.5202 | 1.4284 | 6 | 88 | neuropeptide signaling pathway |
| GO:1903306 | 0.0034 | 11.4913 | 0.3084 | 3 | 19 | negative regulation of regulated secretory pathway |
| GO:0090276 | 0.0036 | 3.1247 | 3.0516 | 9 | 188 | regulation of peptide hormone secretion |
| GO:0015939 | 0.0038 | 30.5429 | 0.0974 | 2 | 6 | pantothenate metabolic process |
| GO:0048241 | 0.0038 | 30.5429 | 0.0974 | 2 | 6 | epinephrine transport |
| GO:0003416 | 0.0039 | 10.8146 | 0.3246 | 3 | 20 | endochondral bone growth |
| GO:0006346 | 0.0039 | 10.8146 | 0.3246 | 3 | 20 | methylation-dependent chromatin silencing |
| GO:0045087 | 0.0042 | 1.9581 | 11.9167 | 22 | 740 | innate immune response |
| GO:0009888 | 0.0047 | 2.0979 | 9.1211 | 18 | 622 | tissue development |
| GO:0030593 | 0.0049 | 4.8888 | 1.1038 | 5 | 68 | neutrophil chemotaxis |
| GO:0030800 | 0.0051 | 6.302 | 0.698 | 4 | 43 | negative regulation of cyclic nucleotide metabolic process |
| GO:0030826 | 0.0052 | 9.6749 | 0.3571 | 3 | 22 | regulation of cGMP biosynthetic process |
| GO:0007187 | 0.0056 | 3.1582 | 2.6783 | 8 | 165 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0010817 | 0.0067 | 2.1655 | 7.2881 | 15 | 449 | regulation of hormone levels |
| GO:0008343 | 0.0069 | 20.3592 | 0.1299 | 2 | 8 | adult feeding behavior |
| GO:0018158 | 0.0069 | 20.3592 | 0.1299 | 2 | 8 | protein oxidation |
| GO:0071347 | 0.0074 | 4.3979 | 1.2174 | 5 | 75 | cellular response to interleukin-1 |
| GO:0009790 | 0.0079 | 1.7731 | 14.9171 | 25 | 919 | embryo development |
| GO:0019935 | 0.008 | 3.6652 | 1.7368 | 6 | 107 | cyclic-nucleotide-mediated signaling |
| GO:0034115 | 0.0088 | 17.4496 | 0.1461 | 2 | 9 | negative regulation of heterotypic cell-cell adhesion |
| GO:0003158 | 0.0091 | 3.5587 | 1.7855 | 6 | 110 | endothelium development |
| GO:0002385 | 0.0093 | 7.6568 | 0.4383 | 3 | 27 | mucosal immune response |
| GO:0050708 | 0.0095 | 2.2044 | 6.1843 | 13 | 381 | regulation of protein secretion |
| GO:0048731 | 0.0099 | 1.3897 | 67.979 | 85 | 4188 | system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048598 | 0 | 2.5502 | 11.0646 | 26 | 565 | embryonic morphogenesis |
| GO:0048704 | 1e-04 | 5.5665 | 1.8017 | 9 | 92 | embryonic skeletal system morphogenesis |
| GO:0050830 | 1e-04 | 6.1151 | 1.4688 | 8 | 75 | defense response to Gram-positive bacterium |
| GO:0060842 | 1e-04 | 50.5627 | 0.1175 | 3 | 6 | arterial endothelial cell differentiation |
| GO:0007389 | 2e-04 | 2.7087 | 7.9508 | 20 | 406 | pattern specification process |
| GO:0009887 | 2e-04 | 2.0463 | 18.5259 | 35 | 946 | animal organ morphogenesis |
| GO:0009954 | 3e-04 | 9.7749 | 0.6071 | 5 | 31 | proximal/distal pattern formation |
| GO:0044657 | 4e-04 | Inf | 0.0392 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 4e-04 | Inf | 0.0392 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 4e-04 | Inf | 0.0392 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 4e-04 | Inf | 0.0392 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0002227 | 4e-04 | 13.5184 | 0.3721 | 4 | 19 | innate immune response in mucosa |
| GO:0019373 | 7e-04 | 11.9264 | 0.4113 | 4 | 21 | epoxygenase P450 pathway |
| GO:0061844 | 7e-04 | 7.9389 | 0.7246 | 5 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0030154 | 8e-04 | 1.5108 | 71.7926 | 96 | 3666 | cell differentiation |
| GO:0060429 | 9e-04 | 1.846 | 21.5613 | 37 | 1101 | epithelium development |
| GO:0009620 | 9e-04 | 7.4709 | 0.7638 | 5 | 39 | response to fungus |
| GO:0048568 | 0.001 | 2.5124 | 7.2038 | 17 | 372 | embryonic organ development |
| GO:0014707 | 0.0011 | 100.7973 | 0.0588 | 2 | 3 | branchiomeric skeletal muscle development |
| GO:0060435 | 0.0011 | 100.7973 | 0.0588 | 2 | 3 | bronchiole development |
| GO:0061737 | 0.0011 | 100.7973 | 0.0588 | 2 | 3 | leukotriene signaling pathway |
| GO:0061760 | 0.0011 | 100.7973 | 0.0588 | 2 | 3 | antifungal innate immune response |
| GO:0060576 | 0.0014 | 16.8475 | 0.235 | 3 | 12 | intestinal epithelial cell development |
| GO:0051216 | 0.002 | 3.1828 | 3.3488 | 10 | 171 | cartilage development |
| GO:0014878 | 0.0022 | 50.3953 | 0.0783 | 2 | 4 | response to electrical stimulus involved in regulation of muscle adaptation |
| GO:0051673 | 0.0022 | 50.3953 | 0.0783 | 2 | 4 | membrane disruption in other organism |
| GO:0070235 | 0.0022 | 50.3953 | 0.0783 | 2 | 4 | regulation of activation-induced cell death of T cells |
| GO:0072268 | 0.0022 | 50.3953 | 0.0783 | 2 | 4 | pattern specification involved in metanephros development |
| GO:0002251 | 0.0023 | 8.1056 | 0.5679 | 4 | 29 | organ or tissue specific immune response |
| GO:0042755 | 0.0023 | 8.1056 | 0.5679 | 4 | 29 | eating behavior |
| GO:0019731 | 0.0026 | 7.7933 | 0.5875 | 4 | 30 | antibacterial humoral response |
| GO:0045746 | 0.0034 | 7.2357 | 0.6267 | 4 | 32 | negative regulation of Notch signaling pathway |
| GO:0002323 | 0.0034 | 11.6605 | 0.3133 | 3 | 16 | natural killer cell activation involved in immune response |
| GO:0098542 | 0.0034 | 2.2687 | 7.4417 | 16 | 380 | defense response to other organism |
| GO:0010469 | 0.0035 | 2.1028 | 9.5371 | 19 | 487 | regulation of receptor activity |
| GO:0048729 | 0.0036 | 1.9813 | 11.7304 | 22 | 599 | tissue morphogenesis |
| GO:0007386 | 0.0037 | 33.5946 | 0.0979 | 2 | 5 | compartment pattern specification |
| GO:0072081 | 0.0037 | 33.5946 | 0.0979 | 2 | 5 | specification of nephron tubule identity |
| GO:0072162 | 0.0037 | 33.5946 | 0.0979 | 2 | 5 | metanephric mesenchymal cell differentiation |
| GO:0009952 | 0.004 | 2.8787 | 3.6776 | 10 | 189 | anterior/posterior pattern specification |
| GO:0045143 | 0.004 | 5.1787 | 1.0575 | 5 | 54 | homologous chromosome segregation |
| GO:0003008 | 0.0041 | 1.5971 | 30.1584 | 45 | 1540 | system process |
| GO:0030857 | 0.0047 | 6.5341 | 0.6854 | 4 | 35 | negative regulation of epithelial cell differentiation |
| GO:0048566 | 0.0047 | 6.5341 | 0.6854 | 4 | 35 | embryonic digestive tract development |
| GO:0072678 | 0.0047 | 6.5341 | 0.6854 | 4 | 35 | T cell migration |
| GO:0007130 | 0.0049 | 10.1044 | 0.3525 | 3 | 18 | synaptonemal complex assembly |
| GO:0048286 | 0.0052 | 6.3295 | 0.705 | 4 | 36 | lung alveolus development |
| GO:0043009 | 0.0052 | 1.9803 | 10.6338 | 20 | 543 | chordate embryonic development |
| GO:0051902 | 0.0054 | 25.1943 | 0.1175 | 2 | 6 | negative regulation of mitochondrial depolarization |
| GO:0014850 | 0.0057 | 9.4722 | 0.3721 | 3 | 19 | response to muscle activity |
| GO:0010712 | 0.0063 | 5.9564 | 0.7442 | 4 | 38 | regulation of collagen metabolic process |
| GO:0055123 | 0.0063 | 3.0903 | 2.7417 | 8 | 140 | digestive system development |
| GO:0035295 | 0.0065 | 1.938 | 10.8492 | 20 | 554 | tube development |
| GO:0051339 | 0.0068 | 3.8114 | 1.6842 | 6 | 86 | regulation of lyase activity |
| GO:0051239 | 0.0075 | 1.4327 | 51.3084 | 68 | 2620 | regulation of multicellular organismal process |
| GO:0002069 | 0.0075 | 20.1541 | 0.1371 | 2 | 7 | columnar/cuboidal epithelial cell maturation |
| GO:0014732 | 0.0075 | 20.1541 | 0.1371 | 2 | 7 | skeletal muscle atrophy |
| GO:2001012 | 0.0075 | 20.1541 | 0.1371 | 2 | 7 | mesenchymal cell differentiation involved in renal system development |
| GO:0006959 | 0.0076 | 2.7677 | 3.4271 | 9 | 175 | humoral immune response |
| GO:0016338 | 0.0087 | 7.975 | 0.4308 | 3 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0031640 | 0.009 | 5.328 | 0.8225 | 4 | 42 | killing of cells of other organism |
| GO:0048856 | 0.0092 | 1.3568 | 87.1938 | 106 | 4599 | anatomical structure development |
| GO:0035282 | 0.0094 | 3.544 | 1.8017 | 6 | 92 | segmentation |
| GO:0008544 | 0.0097 | 2.1266 | 6.8933 | 14 | 352 | epidermis development |
| GO:0010738 | 0.0099 | 7.5758 | 0.4504 | 3 | 23 | regulation of protein kinase A signaling |
| GO:0002315 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | marginal zone B cell differentiation |
| GO:0010917 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | negative regulation of mitochondrial membrane potential |
| GO:0010940 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | positive regulation of necrotic cell death |
| GO:0033141 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0048743 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | positive regulation of skeletal muscle fiber development |
| GO:0051549 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | positive regulation of keratinocyte migration |
| GO:0055091 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | phospholipid homeostasis |
| GO:0060539 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | diaphragm development |
| GO:0060638 | 0.0099 | 16.7939 | 0.1567 | 2 | 8 | mesenchymal-epithelial cell signaling |
| GO:0032501 | 0.01 | 1.456 | 48.1657 | 63 | 2753 | multicellular organismal process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 7.8336 | 2.3095 | 15 | 92 | embryonic skeletal system morphogenesis |
| GO:0007389 | 0 | 3.5352 | 10.192 | 32 | 406 | pattern specification process |
| GO:0009952 | 0 | 4.6552 | 4.8701 | 20 | 194 | anterior/posterior pattern specification |
| GO:0032502 | 0 | 2.1956 | 38.8061 | 71 | 1720 | developmental process |
| GO:0048568 | 0 | 3.0169 | 10.2171 | 28 | 407 | embryonic organ development |
| GO:0048598 | 0 | 2.6319 | 14.1835 | 34 | 565 | embryonic morphogenesis |
| GO:0009887 | 0 | 2.2227 | 22.2481 | 45 | 895 | animal organ morphogenesis |
| GO:0001501 | 0 | 2.7067 | 11.6982 | 29 | 466 | skeletal system development |
| GO:0021545 | 0 | 8.1152 | 1.1799 | 8 | 47 | cranial nerve development |
| GO:0007275 | 0 | 1.5921 | 101.5664 | 137 | 4298 | multicellular organism development |
| GO:0021615 | 1e-04 | 117.4195 | 0.1004 | 3 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0008544 | 1e-04 | 2.6861 | 8.8364 | 22 | 352 | epidermis development |
| GO:0043009 | 3e-04 | 2.1993 | 13.6312 | 28 | 543 | chordate embryonic development |
| GO:0030878 | 3e-04 | 10.342 | 0.6025 | 5 | 24 | thyroid gland development |
| GO:0031960 | 3e-04 | 3.5581 | 3.6651 | 12 | 146 | response to corticosteroid |
| GO:0060173 | 4e-04 | 3.2937 | 4.2676 | 13 | 170 | limb development |
| GO:0007399 | 4e-04 | 1.5879 | 53.0186 | 77 | 2112 | nervous system development |
| GO:0030855 | 5e-04 | 2.0362 | 15.7148 | 30 | 626 | epithelial cell differentiation |
| GO:0098742 | 6e-04 | 4.7269 | 1.8767 | 8 | 76 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0035116 | 6e-04 | 8.5411 | 0.7029 | 5 | 28 | embryonic hindlimb morphogenesis |
| GO:0021570 | 6e-04 | Inf | 0.0502 | 2 | 2 | rhombomere 4 development |
| GO:0071657 | 6e-04 | Inf | 0.0502 | 2 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0007631 | 7e-04 | 4.0902 | 2.4099 | 9 | 96 | feeding behavior |
| GO:0006833 | 7e-04 | 12.0651 | 0.4268 | 4 | 17 | water transport |
| GO:0032691 | 7e-04 | 12.0651 | 0.4268 | 4 | 17 | negative regulation of interleukin-1 beta production |
| GO:0023019 | 0.0011 | 10.455 | 0.477 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0009889 | 0.0013 | 1.4075 | 104.0289 | 131 | 4144 | regulation of biosynthetic process |
| GO:0033993 | 0.0013 | 1.811 | 21.1371 | 36 | 842 | response to lipid |
| GO:0048665 | 0.0013 | 7.0135 | 0.8284 | 5 | 33 | neuron fate specification |
| GO:0009888 | 0.0013 | 1.6486 | 33.2028 | 51 | 1371 | tissue development |
| GO:1903555 | 0.0014 | 3.6661 | 2.661 | 9 | 106 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0045944 | 0.0017 | 1.7054 | 26.2081 | 42 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0014707 | 0.0019 | 78.0737 | 0.0753 | 2 | 3 | branchiomeric skeletal muscle development |
| GO:0014717 | 0.0019 | 78.0737 | 0.0753 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0060435 | 0.0019 | 78.0737 | 0.0753 | 2 | 3 | bronchiole development |
| GO:0030216 | 0.002 | 2.7011 | 5.1211 | 13 | 204 | keratinocyte differentiation |
| GO:0009953 | 0.0022 | 3.7563 | 2.3095 | 8 | 92 | dorsal/ventral pattern formation |
| GO:0048869 | 0.0026 | 1.3959 | 88.3885 | 112 | 3588 | cellular developmental process |
| GO:0033604 | 0.0029 | 13.0396 | 0.3012 | 3 | 12 | negative regulation of catecholamine secretion |
| GO:0043568 | 0.0029 | 13.0396 | 0.3012 | 3 | 12 | positive regulation of insulin-like growth factor receptor signaling pathway |
| GO:1903707 | 0.0034 | 3.1718 | 3.0375 | 9 | 121 | negative regulation of hemopoiesis |
| GO:0015840 | 0.0036 | 39.0342 | 0.1004 | 2 | 4 | urea transport |
| GO:0019732 | 0.0036 | 39.0342 | 0.1004 | 2 | 4 | antifungal humoral response |
| GO:0032100 | 0.0036 | 39.0342 | 0.1004 | 2 | 4 | positive regulation of appetite |
| GO:1901256 | 0.0036 | 39.0342 | 0.1004 | 2 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:1903998 | 0.0036 | 39.0342 | 0.1004 | 2 | 4 | regulation of eating behavior |
| GO:1905205 | 0.0036 | 39.0342 | 0.1004 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:0071880 | 0.0037 | 11.7348 | 0.3263 | 3 | 13 | adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0050794 | 0.0039 | 1.3461 | 234.768 | 260 | 9352 | regulation of cellular process |
| GO:0006355 | 0.004 | 1.3772 | 84.7243 | 107 | 3375 | regulation of transcription, DNA-templated |
| GO:1901568 | 0.004 | 2.884 | 3.6902 | 10 | 147 | fatty acid derivative metabolic process |
| GO:0032652 | 0.0042 | 4.2882 | 1.5313 | 6 | 61 | regulation of interleukin-1 production |
| GO:0032720 | 0.0043 | 5.1644 | 1.0795 | 5 | 43 | negative regulation of tumor necrosis factor production |
| GO:0007156 | 0.0051 | 2.7815 | 3.8157 | 10 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:2001141 | 0.0051 | 1.3632 | 85.377 | 107 | 3401 | regulation of RNA biosynthetic process |
| GO:0043588 | 0.0051 | 3.223 | 2.6545 | 8 | 108 | skin development |
| GO:0051240 | 0.0053 | 1.5229 | 35.4964 | 51 | 1414 | positive regulation of multicellular organismal process |
| GO:0019372 | 0.0057 | 9.7777 | 0.3766 | 3 | 15 | lipoxygenase pathway |
| GO:0045409 | 0.006 | 26.0211 | 0.1255 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
| GO:1902617 | 0.006 | 26.0211 | 0.1255 | 2 | 5 | response to fluoride |
| GO:0010628 | 0.0064 | 1.4656 | 42.7513 | 59 | 1703 | positive regulation of gene expression |
| GO:0008284 | 0.0065 | 1.6723 | 20.1079 | 32 | 801 | positive regulation of cell proliferation |
| GO:0006750 | 0.0069 | 9.025 | 0.4017 | 3 | 16 | glutathione biosynthetic process |
| GO:0045165 | 0.0073 | 2.2876 | 5.9746 | 13 | 238 | cell fate commitment |
| GO:0021879 | 0.0075 | 4.4583 | 1.2301 | 5 | 49 | forebrain neuron differentiation |
| GO:0035115 | 0.0081 | 5.596 | 0.8033 | 4 | 32 | embryonic forelimb morphogenesis |
| GO:0051952 | 0.0082 | 3.6829 | 1.7572 | 6 | 70 | regulation of amine transport |
| GO:0051412 | 0.0082 | 8.3798 | 0.4268 | 3 | 17 | response to corticosterone |
| GO:0070977 | 0.0082 | 8.3798 | 0.4268 | 3 | 17 | bone maturation |
| GO:0001957 | 0.0088 | 19.5145 | 0.1506 | 2 | 6 | intramembranous ossification |
| GO:0014719 | 0.0088 | 19.5145 | 0.1506 | 2 | 6 | skeletal muscle satellite cell activation |
| GO:0032109 | 0.0088 | 19.5145 | 0.1506 | 2 | 6 | positive regulation of response to nutrient levels |
| GO:0035900 | 0.0088 | 19.5145 | 0.1506 | 2 | 6 | response to isolation stress |
| GO:0051902 | 0.0088 | 19.5145 | 0.1506 | 2 | 6 | negative regulation of mitochondrial depolarization |
| GO:2001199 | 0.0088 | 19.5145 | 0.1506 | 2 | 6 | negative regulation of dendritic cell differentiation |
| GO:0060425 | 0.0089 | 4.2639 | 1.2803 | 5 | 51 | lung morphogenesis |
| GO:0009605 | 0.0092 | 1.417 | 47.9226 | 64 | 1909 | response to external stimulus |
| GO:0007267 | 0.0095 | 1.4693 | 36.626 | 51 | 1459 | cell-cell signaling |
| GO:0032095 | 0.0097 | 7.8206 | 0.4519 | 3 | 18 | regulation of response to food |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 21.6609 | 0.8128 | 13 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0050906 | 0 | 10.487 | 1.8396 | 16 | 129 | detection of stimulus involved in sensory perception |
| GO:0009593 | 0 | 10.9541 | 1.6542 | 15 | 116 | detection of chemical stimulus |
| GO:0007606 | 0 | 8.6978 | 1.8824 | 14 | 132 | sensory perception of chemical stimulus |
| GO:0008284 | 0 | 3.0801 | 11.4226 | 31 | 801 | positive regulation of cell proliferation |
| GO:0007186 | 0 | 2.9744 | 11.8008 | 31 | 835 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 2.7284 | 12.3067 | 30 | 863 | nervous system process |
| GO:0045596 | 0 | 2.9423 | 8.6133 | 23 | 604 | negative regulation of cell differentiation |
| GO:0048869 | 0 | 1.7899 | 54.5602 | 81 | 3826 | cellular developmental process |
| GO:0032501 | 1e-04 | 2.1874 | 20.1647 | 37 | 1606 | multicellular organismal process |
| GO:0006955 | 2e-04 | 1.9484 | 24.0572 | 42 | 1687 | immune response |
| GO:1902679 | 3e-04 | 2.1396 | 15.9003 | 31 | 1115 | negative regulation of RNA biosynthetic process |
| GO:0006952 | 3e-04 | 2.0181 | 19.1089 | 35 | 1340 | defense response |
| GO:0048704 | 3e-04 | 5.849 | 1.312 | 7 | 92 | embryonic skeletal system morphogenesis |
| GO:0001501 | 4e-04 | 2.7546 | 6.6453 | 17 | 466 | skeletal system development |
| GO:0030593 | 4e-04 | 6.8512 | 0.9697 | 6 | 68 | neutrophil chemotaxis |
| GO:0009952 | 5e-04 | 3.8899 | 2.7665 | 10 | 194 | anterior/posterior pattern specification |
| GO:0001545 | 6e-04 | 139.5256 | 0.0428 | 2 | 3 | primary ovarian follicle growth |
| GO:0034344 | 6e-04 | 139.5256 | 0.0428 | 2 | 3 | regulation of type III interferon production |
| GO:0050793 | 7e-04 | 1.7504 | 31.9575 | 50 | 2241 | regulation of developmental process |
| GO:0045892 | 7e-04 | 2.0473 | 15.4012 | 29 | 1080 | negative regulation of transcription, DNA-templated |
| GO:0043066 | 9e-04 | 2.2061 | 11.2372 | 23 | 788 | negative regulation of apoptotic process |
| GO:0043517 | 9e-04 | 19.1024 | 0.1996 | 3 | 14 | positive regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0045934 | 0.0012 | 1.8964 | 18.952 | 33 | 1329 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0019732 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | antifungal humoral response |
| GO:0032962 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | positive regulation of inositol trisphosphate biosynthetic process |
| GO:0042699 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | follicle-stimulating hormone signaling pathway |
| GO:0006935 | 0.0013 | 2.4548 | 7.4011 | 17 | 519 | chemotaxis |
| GO:0070098 | 0.0013 | 6.7798 | 0.8128 | 5 | 57 | chemokine-mediated signaling pathway |
| GO:0043651 | 0.0014 | 16.1614 | 0.2282 | 3 | 16 | linoleic acid metabolic process |
| GO:0043067 | 0.0014 | 1.8589 | 19.9217 | 34 | 1397 | regulation of programmed cell death |
| GO:0032760 | 0.0015 | 6.5278 | 0.8414 | 5 | 59 | positive regulation of tumor necrosis factor production |
| GO:0002074 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | extraocular skeletal muscle development |
| GO:0009597 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | detection of virus |
| GO:0007620 | 0.002 | 14.0047 | 0.2567 | 3 | 18 | copulation |
| GO:0051450 | 0.002 | 14.0047 | 0.2567 | 3 | 18 | myoblast proliferation |
| GO:0002275 | 0.0021 | 2.4028 | 7.0874 | 16 | 497 | myeloid cell activation involved in immune response |
| GO:0045321 | 0.0023 | 1.9294 | 15.0589 | 27 | 1056 | leukocyte activation |
| GO:0050729 | 0.0026 | 4.6588 | 1.3833 | 6 | 97 | positive regulation of inflammatory response |
| GO:0034123 | 0.0027 | 12.3554 | 0.2852 | 3 | 20 | positive regulation of toll-like receptor signaling pathway |
| GO:0030595 | 0.0027 | 3.5728 | 2.3815 | 8 | 167 | leukocyte chemotaxis |
| GO:0009890 | 0.0028 | 1.7607 | 21.5617 | 35 | 1512 | negative regulation of biosynthetic process |
| GO:0006501 | 0.0028 | 5.5919 | 0.9697 | 5 | 68 | C-terminal protein lipidation |
| GO:0048584 | 0.0029 | 1.678 | 27.3656 | 42 | 1919 | positive regulation of response to stimulus |
| GO:0021546 | 0.0029 | 34.8744 | 0.0856 | 2 | 6 | rhombomere development |
| GO:0043950 | 0.0029 | 34.8744 | 0.0856 | 2 | 6 | positive regulation of cAMP-mediated signaling |
| GO:0097530 | 0.0029 | 4.558 | 1.4118 | 6 | 99 | granulocyte migration |
| GO:0031640 | 0.0029 | 7.3941 | 0.5989 | 4 | 42 | killing of cells of other organism |
| GO:0031424 | 0.0035 | 3.8128 | 1.9537 | 7 | 137 | keratinization |
| GO:0002761 | 0.0036 | 4.3689 | 1.4688 | 6 | 103 | regulation of myeloid leukocyte differentiation |
| GO:0060548 | 0.0038 | 1.9517 | 12.5776 | 23 | 882 | negative regulation of cell death |
| GO:0030855 | 0.0038 | 2.1411 | 8.927 | 18 | 626 | epithelial cell differentiation |
| GO:1903555 | 0.0041 | 4.237 | 1.5116 | 6 | 106 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0009888 | 0.0041 | 1.6775 | 24.5706 | 38 | 1723 | tissue development |
| GO:0043299 | 0.0046 | 2.2707 | 6.9876 | 15 | 490 | leukocyte degranulation |
| GO:0045671 | 0.0052 | 9.5442 | 0.3565 | 3 | 25 | negative regulation of osteoclast differentiation |
| GO:0060693 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | regulation of branching involved in salivary gland morphogenesis |
| GO:0048513 | 0.0056 | 1.5545 | 36.2269 | 51 | 2630 | animal organ development |
| GO:0007275 | 0.0056 | 1.4472 | 67.0808 | 85 | 4704 | multicellular organism development |
| GO:0048568 | 0.0057 | 2.3624 | 5.804 | 13 | 407 | embryonic organ development |
| GO:1902533 | 0.006 | 1.8994 | 12.3112 | 22 | 871 | positive regulation of intracellular signal transduction |
| GO:0071346 | 0.0061 | 3.8848 | 1.6399 | 6 | 115 | cellular response to interferon-gamma |
| GO:0030816 | 0.0063 | 4.5709 | 1.1694 | 5 | 82 | positive regulation of cAMP metabolic process |
| GO:0032728 | 0.0065 | 8.7477 | 0.385 | 3 | 27 | positive regulation of interferon-beta production |
| GO:0002446 | 0.0066 | 2.2401 | 6.5883 | 14 | 462 | neutrophil mediated immunity |
| GO:0036230 | 0.0067 | 2.235 | 6.6025 | 14 | 463 | granulocyte activation |
| GO:0032957 | 0.0068 | 19.9243 | 0.1283 | 2 | 9 | inositol trisphosphate metabolic process |
| GO:0032735 | 0.0072 | 8.3972 | 0.3993 | 3 | 28 | positive regulation of interleukin-12 production |
| GO:0051873 | 0.0084 | 17.4326 | 0.1426 | 2 | 10 | killing by host of symbiont cells |
| GO:0034097 | 0.0086 | 1.8346 | 12.706 | 22 | 891 | response to cytokine |
| GO:0010647 | 0.0086 | 1.6421 | 21.5332 | 33 | 1510 | positive regulation of cell communication |
| GO:0002682 | 0.0091 | 1.688 | 18.3246 | 29 | 1285 | regulation of immune system process |
| GO:0023056 | 0.0091 | 1.6347 | 21.6187 | 33 | 1516 | positive regulation of signaling |
| GO:0002221 | 0.0092 | 3.1514 | 2.3387 | 7 | 164 | pattern recognition receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 0 | 4.0244 | 8.1808 | 29 | 325 | pattern specification process |
| GO:0003008 | 0 | 2.1858 | 39.2666 | 75 | 1540 | system process |
| GO:0048646 | 0 | 2.3589 | 24.6054 | 52 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0009653 | 0 | 3.1661 | 10.238 | 29 | 450 | anatomical structure morphogenesis |
| GO:0007600 | 0 | 2.7525 | 13.6158 | 34 | 534 | sensory perception |
| GO:0051241 | 0 | 2.2728 | 24.3902 | 50 | 963 | negative regulation of multicellular organismal process |
| GO:0007601 | 0 | 4.2972 | 4.6916 | 18 | 184 | visual perception |
| GO:0009790 | 0 | 3.161 | 9.0781 | 26 | 372 | embryo development |
| GO:0007275 | 0 | 1.7386 | 84.3218 | 122 | 3668 | multicellular organism development |
| GO:0006935 | 0 | 2.5518 | 13.2334 | 31 | 519 | chemotaxis |
| GO:0021517 | 0 | 8.8986 | 1.0964 | 8 | 43 | ventral spinal cord development |
| GO:0045944 | 0 | 2.059 | 26.6197 | 50 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0022008 | 0 | 1.9082 | 35.8499 | 62 | 1406 | neurogenesis |
| GO:0048562 | 0 | 3.8343 | 4.599 | 16 | 185 | embryonic organ morphogenesis |
| GO:0035113 | 0 | 4.5146 | 3.2127 | 13 | 126 | embryonic appendage morphogenesis |
| GO:0035108 | 0 | 4.1999 | 3.6972 | 14 | 145 | limb morphogenesis |
| GO:0060429 | 0 | 1.986 | 28.0731 | 51 | 1101 | epithelium development |
| GO:0048736 | 0 | 3.8071 | 4.3346 | 15 | 170 | appendage development |
| GO:0048667 | 0 | 2.4679 | 12.7234 | 29 | 499 | cell morphogenesis involved in neuron differentiation |
| GO:0021515 | 0 | 7.2392 | 1.3004 | 8 | 51 | cell differentiation in spinal cord |
| GO:0007411 | 0 | 3.5143 | 4.9785 | 16 | 197 | axon guidance |
| GO:2000543 | 0 | 30.8833 | 0.2295 | 4 | 9 | positive regulation of gastrulation |
| GO:0090596 | 0 | 4.8246 | 2.5507 | 11 | 102 | sensory organ morphogenesis |
| GO:0034653 | 1e-04 | 115.5429 | 0.102 | 3 | 4 | retinoic acid catabolic process |
| GO:0061564 | 1e-04 | 2.5008 | 11.219 | 26 | 440 | axon development |
| GO:0009792 | 1e-04 | 2.3198 | 13.9473 | 30 | 547 | embryo development ending in birth or egg hatching |
| GO:0002064 | 1e-04 | 3.4677 | 4.7171 | 15 | 185 | epithelial cell development |
| GO:0010628 | 1e-04 | 1.7148 | 43.4228 | 68 | 1703 | positive regulation of gene expression |
| GO:0048665 | 1e-04 | 13.0211 | 0.5051 | 5 | 20 | neuron fate specification |
| GO:0009952 | 1e-04 | 3.2913 | 4.9466 | 15 | 194 | anterior/posterior pattern specification |
| GO:0021545 | 2e-04 | 6.7928 | 1.1984 | 7 | 47 | cranial nerve development |
| GO:0048513 | 2e-04 | 1.6736 | 47.7388 | 72 | 2060 | animal organ development |
| GO:0048704 | 2e-04 | 6.6971 | 1.2116 | 7 | 48 | embryonic skeletal system morphogenesis |
| GO:0048812 | 2e-04 | 2.2009 | 14.1258 | 29 | 554 | neuron projection morphogenesis |
| GO:0021520 | 2e-04 | 17.1528 | 0.3315 | 4 | 13 | spinal cord motor neuron cell fate specification |
| GO:0021978 | 2e-04 | 17.1528 | 0.3315 | 4 | 13 | telencephalon regionalization |
| GO:0048468 | 3e-04 | 1.681 | 41.4886 | 64 | 1672 | cell development |
| GO:0016115 | 3e-04 | 38.5091 | 0.153 | 3 | 6 | terpenoid catabolic process |
| GO:0051240 | 3e-04 | 1.7096 | 36.0539 | 57 | 1414 | positive regulation of multicellular organismal process |
| GO:0048858 | 3e-04 | 2.1293 | 14.5592 | 29 | 571 | cell projection morphogenesis |
| GO:0050926 | 4e-04 | 9.6664 | 0.6374 | 5 | 25 | regulation of positive chemotaxis |
| GO:0001709 | 5e-04 | 6.8348 | 1.0199 | 6 | 40 | cell fate determination |
| GO:0021983 | 5e-04 | 6.8348 | 1.0199 | 6 | 40 | pituitary gland development |
| GO:1903508 | 5e-04 | 1.6997 | 34.218 | 54 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0072358 | 5e-04 | 2.044 | 15.6556 | 30 | 614 | cardiovascular system development |
| GO:0045766 | 5e-04 | 3.5765 | 3.3402 | 11 | 131 | positive regulation of angiogenesis |
| GO:0021798 | 5e-04 | 28.8799 | 0.1785 | 3 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0048514 | 6e-04 | 2.1517 | 12.8764 | 26 | 505 | blood vessel morphogenesis |
| GO:0060348 | 6e-04 | 3.1191 | 4.4876 | 13 | 176 | bone development |
| GO:0042472 | 6e-04 | 4.1684 | 2.3713 | 9 | 93 | inner ear morphogenesis |
| GO:0035116 | 6e-04 | 8.4039 | 0.7139 | 5 | 28 | embryonic hindlimb morphogenesis |
| GO:1902692 | 6e-04 | 8.4039 | 0.7139 | 5 | 28 | regulation of neuroblast proliferation |
| GO:0048729 | 6e-04 | 2.0395 | 15.1457 | 29 | 597 | tissue morphogenesis |
| GO:0002930 | 6e-04 | Inf | 0.051 | 2 | 2 | trabecular meshwork development |
| GO:0003404 | 6e-04 | Inf | 0.051 | 2 | 2 | optic vesicle morphogenesis |
| GO:0030900 | 7e-04 | 2.3878 | 8.9242 | 20 | 350 | forebrain development |
| GO:0010469 | 7e-04 | 2.1417 | 12.4174 | 25 | 487 | regulation of receptor activity |
| GO:0007517 | 8e-04 | 2.3658 | 9.0007 | 20 | 353 | muscle organ development |
| GO:0060537 | 8e-04 | 2.3586 | 9.0262 | 20 | 354 | muscle tissue development |
| GO:0045596 | 8e-04 | 2.0025 | 15.4007 | 29 | 604 | negative regulation of cell differentiation |
| GO:0050891 | 9e-04 | 5.027 | 1.5554 | 7 | 61 | multicellular organismal water homeostasis |
| GO:0048869 | 9e-04 | 1.6345 | 39.5273 | 59 | 1722 | cellular developmental process |
| GO:0050794 | 9e-04 | 1.4124 | 238.4554 | 268 | 9352 | regulation of cellular process |
| GO:1901881 | 0.001 | 11.0231 | 0.459 | 4 | 18 | positive regulation of protein depolymerization |
| GO:0051254 | 0.001 | 1.6411 | 35.9774 | 55 | 1411 | positive regulation of RNA metabolic process |
| GO:0048592 | 0.001 | 3.2991 | 3.5952 | 11 | 141 | eye morphogenesis |
| GO:0009890 | 0.001 | 1.6168 | 38.5527 | 58 | 1512 | negative regulation of biosynthetic process |
| GO:0009954 | 0.001 | 7.4327 | 0.7904 | 5 | 31 | proximal/distal pattern formation |
| GO:0065007 | 0.001 | 1.446 | 268.4153 | 296 | 10527 | biological regulation |
| GO:0051094 | 0.0011 | 1.6969 | 29.6029 | 47 | 1161 | positive regulation of developmental process |
| GO:2000179 | 0.0012 | 5.6652 | 1.1984 | 6 | 47 | positive regulation of neural precursor cell proliferation |
| GO:1901700 | 0.0013 | 1.6174 | 36.4364 | 55 | 1429 | response to oxygen-containing compound |
| GO:0045892 | 0.0014 | 1.7029 | 27.5376 | 44 | 1080 | negative regulation of transcription, DNA-templated |
| GO:0009953 | 0.0014 | 4.0643 | 2.1515 | 8 | 85 | dorsal/ventral pattern formation |
| GO:0007519 | 0.0015 | 3.129 | 3.7737 | 11 | 148 | skeletal muscle tissue development |
| GO:1902679 | 0.0015 | 1.687 | 28.43 | 45 | 1115 | negative regulation of RNA biosynthetic process |
| GO:0008284 | 0.0015 | 1.8448 | 18.9867 | 33 | 754 | positive regulation of cell proliferation |
| GO:0061436 | 0.0015 | 9.6439 | 0.51 | 4 | 20 | establishment of skin barrier |
| GO:0021879 | 0.0015 | 5.4009 | 1.2494 | 6 | 49 | forebrain neuron differentiation |
| GO:0032989 | 0.0016 | 1.7337 | 24.5289 | 40 | 962 | cellular component morphogenesis |
| GO:0043010 | 0.0016 | 3.9517 | 2.2047 | 8 | 89 | camera-type eye development |
| GO:2000112 | 0.0016 | 1.4026 | 97.1466 | 123 | 3810 | regulation of cellular macromolecule biosynthetic process |
| GO:0007423 | 0.0016 | 2.9053 | 4.4121 | 12 | 180 | sensory organ development |
| GO:0061072 | 0.0017 | 16.4994 | 0.255 | 3 | 10 | iris morphogenesis |
| GO:0051290 | 0.0018 | 6.4399 | 0.8924 | 5 | 35 | protein heterotetramerization |
| GO:0003099 | 0.0019 | 76.829 | 0.0765 | 2 | 3 | positive regulation of the force of heart contraction by chemical signal |
| GO:0007231 | 0.0019 | 76.829 | 0.0765 | 2 | 3 | osmosensory signaling pathway |
| GO:0060743 | 0.0019 | 76.829 | 0.0765 | 2 | 3 | epithelial cell maturation involved in prostate gland development |
| GO:2000254 | 0.0019 | 76.829 | 0.0765 | 2 | 3 | regulation of male germ cell proliferation |
| GO:0071542 | 0.0021 | 6.2318 | 0.9179 | 5 | 36 | dopaminergic neuron differentiation |
| GO:0010557 | 0.0021 | 1.5595 | 39.7766 | 58 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0008045 | 0.0021 | 8.5712 | 0.561 | 4 | 22 | motor neuron axon guidance |
| GO:0001764 | 0.0022 | 3.163 | 3.3912 | 10 | 133 | neuron migration |
| GO:0072088 | 0.0022 | 4.2386 | 1.8103 | 7 | 71 | nephron epithelium morphogenesis |
| GO:0009111 | 0.0023 | 14.436 | 0.2805 | 3 | 11 | vitamin catabolic process |
| GO:2000774 | 0.0023 | 14.436 | 0.2805 | 3 | 11 | positive regulation of cellular senescence |
| GO:0002690 | 0.0024 | 4.1731 | 1.8358 | 7 | 72 | positive regulation of leukocyte chemotaxis |
| GO:0060322 | 0.0024 | 1.8368 | 17.262 | 30 | 677 | head development |
| GO:0035239 | 0.0024 | 2.2343 | 8.5163 | 18 | 334 | tube morphogenesis |
| GO:0021953 | 0.0025 | 3.3416 | 2.8962 | 9 | 115 | central nervous system neuron differentiation |
| GO:0061333 | 0.0025 | 4.1096 | 1.8613 | 7 | 73 | renal tubule morphogenesis |
| GO:0060041 | 0.0025 | 3.087 | 3.4677 | 10 | 136 | retina development in camera-type eye |
| GO:0042476 | 0.0026 | 3.33 | 2.9067 | 9 | 114 | odontogenesis |
| GO:0010660 | 0.0029 | 4.6426 | 1.4279 | 6 | 56 | regulation of muscle cell apoptotic process |
| GO:0006335 | 0.003 | 7.713 | 0.6119 | 4 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0035195 | 0.003 | 2.8362 | 4.1306 | 11 | 162 | gene silencing by miRNA |
| GO:0051173 | 0.0031 | 1.4192 | 69.456 | 91 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0031328 | 0.0031 | 1.5137 | 43.0403 | 61 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0045165 | 0.0031 | 2.6692 | 4.7722 | 12 | 190 | cell fate commitment |
| GO:0040011 | 0.0031 | 2.551 | 5.4076 | 13 | 222 | locomotion |
| GO:0007498 | 0.0032 | 3.2069 | 3.0087 | 9 | 118 | mesoderm development |
| GO:0009581 | 0.0034 | 3.1775 | 3.0342 | 9 | 119 | detection of external stimulus |
| GO:0060037 | 0.0034 | 7.3452 | 0.6374 | 4 | 25 | pharyngeal system development |
| GO:0021764 | 0.0038 | 38.4119 | 0.102 | 2 | 4 | amygdala development |
| GO:0021913 | 0.0038 | 38.4119 | 0.102 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0090191 | 0.0038 | 38.4119 | 0.102 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:0097476 | 0.0038 | 38.4119 | 0.102 | 2 | 4 | spinal cord motor neuron migration |
| GO:1905205 | 0.0038 | 38.4119 | 0.102 | 2 | 4 | positive regulation of connective tissue replacement |
| GO:0031047 | 0.0038 | 2.5973 | 4.8956 | 12 | 192 | gene silencing by RNA |
| GO:0021781 | 0.0039 | 11.5473 | 0.3315 | 3 | 13 | glial cell fate commitment |
| GO:0045653 | 0.0039 | 11.5473 | 0.3315 | 3 | 13 | negative regulation of megakaryocyte differentiation |
| GO:0048935 | 0.0039 | 11.5473 | 0.3315 | 3 | 13 | peripheral nervous system neuron development |
| GO:0050930 | 0.0039 | 11.5473 | 0.3315 | 3 | 13 | induction of positive chemotaxis |
| GO:0061029 | 0.0039 | 11.5473 | 0.3315 | 3 | 13 | eyelid development in camera-type eye |
| GO:0000183 | 0.004 | 7.0109 | 0.6629 | 4 | 26 | chromatin silencing at rDNA |
| GO:0009582 | 0.004 | 3.0925 | 3.1107 | 9 | 122 | detection of abiotic stimulus |
| GO:0048870 | 0.0041 | 1.5512 | 34.1925 | 50 | 1341 | cell motility |
| GO:0016441 | 0.0041 | 2.7093 | 4.3091 | 11 | 169 | posttranscriptional gene silencing |
| GO:0008544 | 0.0041 | 2.1113 | 8.9752 | 18 | 352 | epidermis development |
| GO:0030858 | 0.0041 | 4.2976 | 1.5299 | 6 | 60 | positive regulation of epithelial cell differentiation |
| GO:0048863 | 0.0044 | 2.3552 | 6.2725 | 14 | 246 | stem cell differentiation |
| GO:0051216 | 0.0045 | 2.675 | 4.3601 | 11 | 171 | cartilage development |
| GO:0072171 | 0.0045 | 4.2191 | 1.5554 | 6 | 61 | mesonephric tubule morphogenesis |
| GO:0001523 | 0.0046 | 3.6634 | 2.0653 | 7 | 81 | retinoid metabolic process |
| GO:0009798 | 0.0046 | 3.6634 | 2.0653 | 7 | 81 | axis specification |
| GO:0060706 | 0.0046 | 6.7056 | 0.6884 | 4 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0042501 | 0.0049 | 10.4968 | 0.357 | 3 | 14 | serine phosphorylation of STAT protein |
| GO:0001655 | 0.0049 | 2.1793 | 7.7258 | 16 | 303 | urogenital system development |
| GO:0048701 | 0.005 | 4.9508 | 1.1219 | 5 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0048706 | 0.0055 | 6.3329 | 0.7209 | 4 | 29 | embryonic skeletal system development |
| GO:0043583 | 0.0055 | 2.4721 | 5.1251 | 12 | 201 | ear development |
| GO:0002088 | 0.0057 | 4.0001 | 1.6319 | 6 | 64 | lens development in camera-type eye |
| GO:0032502 | 0.0057 | 1.6762 | 22.6178 | 35 | 1155 | developmental process |
| GO:0051101 | 0.0057 | 3.1646 | 2.7028 | 8 | 106 | regulation of DNA binding |
| GO:0014874 | 0.006 | 9.6214 | 0.3825 | 3 | 15 | response to stimulus involved in regulation of muscle adaptation |
| GO:0031114 | 0.006 | 9.6214 | 0.3825 | 3 | 15 | regulation of microtubule depolymerization |
| GO:0060579 | 0.006 | 9.6214 | 0.3825 | 3 | 15 | ventral spinal cord interneuron fate commitment |
| GO:0010092 | 0.006 | 6.1683 | 0.7394 | 4 | 29 | specification of animal organ identity |
| GO:1904892 | 0.0061 | 2.8865 | 3.3147 | 9 | 130 | regulation of STAT cascade |
| GO:0021778 | 0.0062 | 25.6062 | 0.1275 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0036093 | 0.0062 | 25.6062 | 0.1275 | 2 | 5 | germ cell proliferation |
| GO:0051122 | 0.0062 | 25.6062 | 0.1275 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0072081 | 0.0062 | 25.6062 | 0.1275 | 2 | 5 | specification of nephron tubule identity |
| GO:0060993 | 0.0063 | 3.4303 | 2.1928 | 7 | 86 | kidney morphogenesis |
| GO:0090277 | 0.0063 | 3.4303 | 2.1928 | 7 | 86 | positive regulation of peptide hormone secretion |
| GO:0021987 | 0.0064 | 3.1008 | 2.7538 | 8 | 108 | cerebral cortex development |
| GO:1901342 | 0.0066 | 2.2376 | 6.5784 | 14 | 258 | regulation of vasculature development |
| GO:0002067 | 0.0067 | 4.5962 | 1.1984 | 5 | 47 | glandular epithelial cell differentiation |
| GO:0072604 | 0.0068 | 5.9307 | 0.7649 | 4 | 30 | interleukin-6 secretion |
| GO:0090257 | 0.0069 | 2.3951 | 5.278 | 12 | 207 | regulation of muscle system process |
| GO:0045665 | 0.0071 | 2.5011 | 4.6406 | 11 | 182 | negative regulation of neuron differentiation |
| GO:0007610 | 0.0072 | 1.8266 | 13.1964 | 23 | 521 | behavior |
| GO:0072080 | 0.0072 | 3.3452 | 2.2438 | 7 | 88 | nephron tubule development |
| GO:0002323 | 0.0072 | 8.8807 | 0.408 | 3 | 16 | natural killer cell activation involved in immune response |
| GO:0006004 | 0.0072 | 8.8807 | 0.408 | 3 | 16 | fucose metabolic process |
| GO:0035855 | 0.0072 | 8.8807 | 0.408 | 3 | 16 | megakaryocyte development |
| GO:0048385 | 0.0072 | 8.8807 | 0.408 | 3 | 16 | regulation of retinoic acid receptor signaling pathway |
| GO:0090185 | 0.0072 | 8.8807 | 0.408 | 3 | 16 | negative regulation of kidney development |
| GO:0070206 | 0.0073 | 4.489 | 1.2239 | 5 | 48 | protein trimerization |
| GO:0048705 | 0.0076 | 3.0031 | 2.834 | 8 | 114 | skeletal system morphogenesis |
| GO:0030198 | 0.0077 | 2.0689 | 8.1083 | 16 | 318 | extracellular matrix organization |
| GO:0030182 | 0.0084 | 1.6268 | 21.3126 | 33 | 872 | neuron differentiation |
| GO:0035115 | 0.0085 | 5.5063 | 0.8159 | 4 | 32 | embryonic forelimb morphogenesis |
| GO:0007635 | 0.0086 | 8.2458 | 0.4335 | 3 | 17 | chemosensory behavior |
| GO:0060004 | 0.0086 | 8.2458 | 0.4335 | 3 | 17 | reflex |
| GO:0061323 | 0.0086 | 8.2458 | 0.4335 | 3 | 17 | cell proliferation involved in heart morphogenesis |
| GO:0060021 | 0.0086 | 3.2251 | 2.3203 | 7 | 91 | palate development |
| GO:0060688 | 0.0087 | 4.2889 | 1.2749 | 5 | 50 | regulation of morphogenesis of a branching structure |
| GO:0034249 | 0.009 | 2.148 | 6.8334 | 14 | 268 | negative regulation of cellular amide metabolic process |
| GO:0021902 | 0.0091 | 19.2034 | 0.153 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0048541 | 0.0091 | 19.2034 | 0.153 | 2 | 6 | Peyer's patch development |
| GO:1901894 | 0.0091 | 19.2034 | 0.153 | 2 | 6 | regulation of calcium-transporting ATPase activity |
| GO:2000535 | 0.0091 | 19.2034 | 0.153 | 2 | 6 | regulation of entry of bacterium into host cell |
| GO:0001657 | 0.0091 | 3.1869 | 2.3458 | 7 | 92 | ureteric bud development |
| GO:0048583 | 0.0093 | 1.3214 | 91.6901 | 112 | 3596 | regulation of response to stimulus |
| GO:0007605 | 0.0093 | 2.685 | 3.5442 | 9 | 139 | sensory perception of sound |
| GO:0033993 | 0.0094 | 1.611 | 21.4691 | 33 | 842 | response to lipid |
| GO:0072163 | 0.0096 | 3.1496 | 2.3713 | 7 | 93 | mesonephric epithelium development |
| GO:0051960 | 0.0096 | 1.6469 | 19.0724 | 30 | 748 | regulation of nervous system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003008 | 0 | 1.9818 | 29.2476 | 52 | 1540 | system process |
| GO:0007389 | 1e-04 | 2.801 | 7.7107 | 20 | 406 | pattern specification process |
| GO:0002724 | 2e-04 | 17.4456 | 0.3039 | 4 | 16 | regulation of T cell cytokine production |
| GO:0007186 | 3e-04 | 2.0997 | 15.9342 | 31 | 839 | G-protein coupled receptor signaling pathway |
| GO:0060638 | 4e-04 | 31.307 | 0.1519 | 3 | 8 | mesenchymal-epithelial cell signaling |
| GO:0048665 | 4e-04 | 9.3687 | 0.6267 | 5 | 33 | neuron fate specification |
| GO:0003231 | 4e-04 | 4.4522 | 2.2031 | 9 | 116 | cardiac ventricle development |
| GO:0035809 | 4e-04 | 13.9537 | 0.3608 | 4 | 19 | regulation of urine volume |
| GO:0060173 | 4e-04 | 3.6754 | 3.2286 | 11 | 170 | limb development |
| GO:0003206 | 4e-04 | 4.3299 | 2.26 | 9 | 119 | cardiac chamber morphogenesis |
| GO:0003279 | 5e-04 | 4.801 | 1.8232 | 8 | 96 | cardiac septum development |
| GO:0003151 | 5e-04 | 5.5058 | 1.4054 | 7 | 74 | outflow tract morphogenesis |
| GO:0007267 | 5e-04 | 1.7951 | 27.2856 | 45 | 1451 | cell-cell signaling |
| GO:0030879 | 6e-04 | 4.1769 | 2.336 | 9 | 123 | mammary gland development |
| GO:0042531 | 6e-04 | 6.4379 | 1.0446 | 6 | 55 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0008284 | 7e-04 | 2.0453 | 15.2125 | 29 | 801 | positive regulation of cell proliferation |
| GO:0035113 | 7e-04 | 4.069 | 2.393 | 9 | 126 | embryonic appendage morphogenesis |
| GO:0043372 | 7e-04 | 11.6257 | 0.4178 | 4 | 22 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0002704 | 7e-04 | 7.9465 | 0.7217 | 5 | 38 | negative regulation of leukocyte mediated immunity |
| GO:0050911 | 7e-04 | 6.1846 | 1.0825 | 6 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0010960 | 7e-04 | 22.3591 | 0.1899 | 3 | 10 | magnesium ion homeostasis |
| GO:0050906 | 8e-04 | 3.9664 | 2.45 | 9 | 129 | detection of stimulus involved in sensory perception |
| GO:0001964 | 8e-04 | 11.0131 | 0.4368 | 4 | 23 | startle response |
| GO:0045766 | 9e-04 | 3.9009 | 2.4879 | 9 | 131 | positive regulation of angiogenesis |
| GO:0021983 | 9e-04 | 7.4914 | 0.7597 | 5 | 40 | pituitary gland development |
| GO:2000514 | 0.001 | 7.2829 | 0.7787 | 5 | 41 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:0010159 | 0.0011 | 104.0209 | 0.057 | 2 | 3 | specification of animal organ position |
| GO:1904862 | 0.0011 | 104.0209 | 0.057 | 2 | 3 | inhibitory synapse assembly |
| GO:0042733 | 0.0012 | 5.5313 | 1.1965 | 6 | 63 | embryonic digit morphogenesis |
| GO:0009952 | 0.0012 | 3.1882 | 3.6844 | 11 | 194 | anterior/posterior pattern specification |
| GO:0045836 | 0.0013 | 17.3881 | 0.2279 | 3 | 12 | positive regulation of meiotic nuclear division |
| GO:0033598 | 0.0014 | 9.5094 | 0.4938 | 4 | 26 | mammary gland epithelial cell proliferation |
| GO:0035148 | 0.0015 | 3.6029 | 2.6779 | 9 | 141 | tube formation |
| GO:0030154 | 0.0016 | 1.4836 | 69.6244 | 92 | 3666 | cell differentiation |
| GO:0051216 | 0.0016 | 3.2875 | 3.2476 | 10 | 171 | cartilage development |
| GO:0009593 | 0.0017 | 3.9067 | 2.2031 | 8 | 116 | detection of chemical stimulus |
| GO:0043009 | 0.0017 | 2.1625 | 10.3126 | 21 | 543 | chordate embryonic development |
| GO:0048771 | 0.0017 | 3.5221 | 2.7348 | 9 | 144 | tissue remodeling |
| GO:0002294 | 0.0017 | 6.3926 | 0.8736 | 5 | 46 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
| GO:0035116 | 0.0018 | 8.7158 | 0.5318 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0002287 | 0.0019 | 6.2399 | 0.8926 | 5 | 47 | alpha-beta T cell activation involved in immune response |
| GO:0030203 | 0.002 | 3.4449 | 2.7918 | 9 | 147 | glycosaminoglycan metabolic process |
| GO:0048568 | 0.0021 | 2.3298 | 7.7297 | 17 | 407 | embryonic organ development |
| GO:0001838 | 0.0021 | 3.7661 | 2.279 | 8 | 120 | embryonic epithelial tube formation |
| GO:0021772 | 0.0021 | 8.3666 | 0.5508 | 4 | 29 | olfactory bulb development |
| GO:0046637 | 0.0021 | 6.0944 | 0.9116 | 5 | 48 | regulation of alpha-beta T cell differentiation |
| GO:0002249 | 0.0021 | 52.007 | 0.076 | 2 | 4 | lymphocyte anergy |
| GO:0002667 | 0.0021 | 52.007 | 0.076 | 2 | 4 | regulation of T cell anergy |
| GO:0003164 | 0.0021 | 52.007 | 0.076 | 2 | 4 | His-Purkinje system development |
| GO:2000660 | 0.0021 | 52.007 | 0.076 | 2 | 4 | negative regulation of interleukin-1-mediated signaling pathway |
| GO:1904894 | 0.0021 | 4.924 | 1.3294 | 6 | 70 | positive regulation of STAT cascade |
| GO:0032645 | 0.0021 | 14.2247 | 0.2659 | 3 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0086069 | 0.0021 | 14.2247 | 0.2659 | 3 | 14 | bundle of His cell to Purkinje myocyte communication |
| GO:0021879 | 0.0023 | 5.9555 | 0.9306 | 5 | 49 | forebrain neuron differentiation |
| GO:0008595 | 0.0026 | 13.0385 | 0.2849 | 3 | 15 | anterior/posterior axis specification, embryo |
| GO:0035743 | 0.0026 | 13.0385 | 0.2849 | 3 | 15 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0051546 | 0.0026 | 13.0385 | 0.2849 | 3 | 15 | keratinocyte migration |
| GO:0055075 | 0.0026 | 13.0385 | 0.2849 | 3 | 15 | potassium ion homeostasis |
| GO:0015672 | 0.0028 | 2.1505 | 9.344 | 19 | 492 | monovalent inorganic cation transport |
| GO:0050730 | 0.0029 | 2.8418 | 4.1023 | 11 | 216 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0030814 | 0.0029 | 3.5429 | 2.412 | 8 | 127 | regulation of cAMP metabolic process |
| GO:0032753 | 0.0032 | 12.0347 | 0.3039 | 3 | 16 | positive regulation of interleukin-4 production |
| GO:0036035 | 0.0032 | 12.0347 | 0.3039 | 3 | 16 | osteoclast development |
| GO:0002367 | 0.0032 | 4.5002 | 1.4434 | 6 | 76 | cytokine production involved in immune response |
| GO:0002292 | 0.0033 | 5.4577 | 1.0066 | 5 | 53 | T cell differentiation involved in immune response |
| GO:0043305 | 0.0035 | 34.669 | 0.095 | 2 | 5 | negative regulation of mast cell degranulation |
| GO:0060157 | 0.0035 | 34.669 | 0.095 | 2 | 5 | urinary bladder development |
| GO:1903232 | 0.0035 | 34.669 | 0.095 | 2 | 5 | melanosome assembly |
| GO:2000553 | 0.0035 | 34.669 | 0.095 | 2 | 5 | positive regulation of T-helper 2 cell cytokine production |
| GO:0048738 | 0.0035 | 2.9367 | 3.6085 | 10 | 190 | cardiac muscle tissue development |
| GO:0071804 | 0.0035 | 2.9367 | 3.6085 | 10 | 190 | cellular potassium ion transport |
| GO:0051239 | 0.0036 | 1.4956 | 48.9151 | 67 | 2599 | regulation of multicellular organismal process |
| GO:0007275 | 0.0036 | 1.4471 | 70.099 | 90 | 3943 | multicellular organism development |
| GO:0002687 | 0.0037 | 3.7953 | 1.9752 | 7 | 104 | positive regulation of leukocyte migration |
| GO:0007606 | 0.0037 | 3.3989 | 2.5069 | 8 | 132 | sensory perception of chemical stimulus |
| GO:0002029 | 0.0038 | 11.1743 | 0.3229 | 3 | 17 | desensitization of G-protein coupled receptor protein signaling pathway |
| GO:0023058 | 0.0038 | 11.1743 | 0.3229 | 3 | 17 | adaptation of signaling pathway |
| GO:0030802 | 0.0039 | 3.3715 | 2.5259 | 8 | 133 | regulation of cyclic nucleotide biosynthetic process |
| GO:1901342 | 0.0039 | 2.5855 | 4.8999 | 12 | 258 | regulation of vasculature development |
| GO:0051384 | 0.0041 | 3.3445 | 2.5449 | 8 | 134 | response to glucocorticoid |
| GO:0002706 | 0.0041 | 3.7181 | 2.0131 | 7 | 106 | regulation of lymphocyte mediated immunity |
| GO:0030857 | 0.0042 | 6.7445 | 0.6647 | 4 | 35 | negative regulation of epithelial cell differentiation |
| GO:0086091 | 0.0042 | 6.7445 | 0.6647 | 4 | 35 | regulation of heart rate by cardiac conduction |
| GO:0002822 | 0.0043 | 3.6807 | 2.0321 | 7 | 107 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0022409 | 0.0043 | 2.6824 | 4.3302 | 11 | 228 | positive regulation of cell-cell adhesion |
| GO:0007350 | 0.0045 | 10.4287 | 0.3419 | 3 | 18 | blastoderm segmentation |
| GO:1905276 | 0.0045 | 10.4287 | 0.3419 | 3 | 18 | regulation of epithelial tube formation |
| GO:1905331 | 0.0045 | 10.4287 | 0.3419 | 3 | 18 | negative regulation of morphogenesis of an epithelium |
| GO:0043207 | 0.0045 | 1.8831 | 13.4653 | 24 | 709 | response to external biotic stimulus |
| GO:0060412 | 0.0047 | 6.5333 | 0.6837 | 4 | 36 | ventricular septum morphogenesis |
| GO:0030510 | 0.005 | 4.0891 | 1.5763 | 6 | 83 | regulation of BMP signaling pathway |
| GO:0042035 | 0.005 | 4.0891 | 1.5763 | 6 | 83 | regulation of cytokine biosynthetic process |
| GO:0046879 | 0.005 | 2.6281 | 4.4141 | 11 | 235 | hormone secretion |
| GO:0072359 | 0.005 | 1.7593 | 17.4536 | 29 | 919 | circulatory system development |
| GO:0001878 | 0.0051 | 26 | 0.114 | 2 | 6 | response to yeast |
| GO:0003105 | 0.0051 | 26 | 0.114 | 2 | 6 | negative regulation of glomerular filtration |
| GO:0038031 | 0.0051 | 26 | 0.114 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:2000667 | 0.0051 | 26 | 0.114 | 2 | 6 | positive regulation of interleukin-13 secretion |
| GO:0030818 | 0.0051 | 6.3349 | 0.7027 | 4 | 37 | negative regulation of cAMP biosynthetic process |
| GO:0002793 | 0.0052 | 2.6092 | 4.4441 | 11 | 234 | positive regulation of peptide secretion |
| GO:0042102 | 0.0053 | 4.0364 | 1.5953 | 6 | 84 | positive regulation of T cell proliferation |
| GO:0007420 | 0.0055 | 1.9047 | 12.1738 | 22 | 641 | brain development |
| GO:0009653 | 0.0055 | 1.5019 | 41.0241 | 57 | 2209 | anatomical structure morphogenesis |
| GO:0007188 | 0.0055 | 3.167 | 2.6779 | 8 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:1900371 | 0.0055 | 3.167 | 2.6779 | 8 | 141 | regulation of purine nucleotide biosynthetic process |
| GO:0009617 | 0.0055 | 2.0972 | 8.5274 | 17 | 449 | response to bacterium |
| GO:0010817 | 0.0055 | 2.0972 | 8.5274 | 17 | 449 | regulation of hormone levels |
| GO:0001843 | 0.0056 | 3.9851 | 1.6143 | 6 | 85 | neural tube closure |
| GO:0043268 | 0.0057 | 6.1482 | 0.7217 | 4 | 38 | positive regulation of potassium ion transport |
| GO:0046006 | 0.0057 | 6.1482 | 0.7217 | 4 | 38 | regulation of activated T cell proliferation |
| GO:0060428 | 0.0057 | 6.1482 | 0.7217 | 4 | 38 | lung epithelium development |
| GO:0050921 | 0.0058 | 3.471 | 2.1461 | 7 | 113 | positive regulation of chemotaxis |
| GO:0052652 | 0.006 | 3.1197 | 2.7158 | 8 | 143 | cyclic purine nucleotide metabolic process |
| GO:1903530 | 0.0061 | 1.9178 | 11.5281 | 21 | 607 | regulation of secretion by cell |
| GO:0035136 | 0.0062 | 5.9721 | 0.7407 | 4 | 39 | forelimb morphogenesis |
| GO:0045995 | 0.0064 | 3.4062 | 2.1841 | 7 | 115 | regulation of embryonic development |
| GO:0048513 | 0.0064 | 1.5712 | 30.2221 | 44 | 1730 | animal organ development |
| GO:0001709 | 0.0068 | 5.8058 | 0.7597 | 4 | 40 | cell fate determination |
| GO:0043588 | 0.0068 | 2.3045 | 5.9255 | 13 | 312 | skin development |
| GO:0051146 | 0.0069 | 2.5065 | 4.615 | 11 | 243 | striated muscle cell differentiation |
| GO:0042749 | 0.007 | 8.6888 | 0.3988 | 3 | 21 | regulation of circadian sleep/wake cycle |
| GO:0060713 | 0.007 | 8.6888 | 0.3988 | 3 | 21 | labyrinthine layer morphogenesis |
| GO:0099623 | 0.007 | 8.6888 | 0.3988 | 3 | 21 | regulation of cardiac muscle cell membrane repolarization |
| GO:0002158 | 0.0071 | 20.7986 | 0.1329 | 2 | 7 | osteoclast proliferation |
| GO:0045630 | 0.0071 | 20.7986 | 0.1329 | 2 | 7 | positive regulation of T-helper 2 cell differentiation |
| GO:0045938 | 0.0071 | 20.7986 | 0.1329 | 2 | 7 | positive regulation of circadian sleep/wake cycle, sleep |
| GO:0060017 | 0.0071 | 20.7986 | 0.1329 | 2 | 7 | parathyroid gland development |
| GO:0060028 | 0.0071 | 20.7986 | 0.1329 | 2 | 7 | convergent extension involved in axis elongation |
| GO:0086043 | 0.0071 | 20.7986 | 0.1329 | 2 | 7 | bundle of His cell action potential |
| GO:0098700 | 0.0071 | 20.7986 | 0.1329 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
| GO:2000027 | 0.0072 | 2.6246 | 4.0093 | 10 | 213 | regulation of organ morphogenesis |
| GO:0002688 | 0.0073 | 3.7466 | 1.7093 | 6 | 90 | regulation of leukocyte chemotaxis |
| GO:0071887 | 0.0073 | 3.7466 | 1.7093 | 6 | 90 | leukocyte apoptotic process |
| GO:0060021 | 0.0077 | 3.7023 | 1.7283 | 6 | 91 | palate development |
| GO:0032755 | 0.0078 | 4.3627 | 1.2345 | 5 | 65 | positive regulation of interleukin-6 production |
| GO:0050793 | 0.0078 | 1.4659 | 42.5609 | 58 | 2241 | regulation of developmental process |
| GO:0060537 | 0.0079 | 2.1843 | 6.7231 | 14 | 354 | muscle tissue development |
| GO:0045087 | 0.0079 | 1.7898 | 14.111 | 24 | 743 | innate immune response |
| GO:0046633 | 0.008 | 8.231 | 0.4178 | 3 | 22 | alpha-beta T cell proliferation |
| GO:0030809 | 0.0081 | 5.4995 | 0.7977 | 4 | 42 | negative regulation of nucleotide biosynthetic process |
| GO:0048704 | 0.0081 | 3.659 | 1.7473 | 6 | 92 | embryonic skeletal system morphogenesis |
| GO:1902107 | 0.0083 | 3.2256 | 2.298 | 7 | 121 | positive regulation of leukocyte differentiation |
| GO:0032496 | 0.0085 | 2.3255 | 5.4127 | 12 | 285 | response to lipopolysaccharide |
| GO:0097746 | 0.0087 | 3.1974 | 2.317 | 7 | 122 | regulation of blood vessel diameter |
| GO:0030800 | 0.0088 | 5.3582 | 0.8167 | 4 | 43 | negative regulation of cyclic nucleotide metabolic process |
| GO:0046635 | 0.0088 | 5.3582 | 0.8167 | 4 | 43 | positive regulation of alpha-beta T cell activation |
| GO:0070231 | 0.0088 | 5.3582 | 0.8167 | 4 | 43 | T cell apoptotic process |
| GO:0045582 | 0.0088 | 4.2214 | 1.2725 | 5 | 67 | positive regulation of T cell differentiation |
| GO:0050863 | 0.0089 | 2.3083 | 5.4507 | 12 | 287 | regulation of T cell activation |
| GO:0002828 | 0.0091 | 7.8189 | 0.4368 | 3 | 23 | regulation of type 2 immune response |
| GO:0032461 | 0.0091 | 7.8189 | 0.4368 | 3 | 23 | positive regulation of protein oligomerization |
| GO:0042481 | 0.0091 | 7.8189 | 0.4368 | 3 | 23 | regulation of odontogenesis |
| GO:0001501 | 0.0092 | 2.3002 | 5.4702 | 12 | 295 | skeletal system development |
| GO:0045188 | 0.0093 | 17.331 | 0.1519 | 2 | 8 | regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:1902715 | 0.0093 | 17.331 | 0.1519 | 2 | 8 | positive regulation of interferon-gamma secretion |
| GO:2000510 | 0.0093 | 17.331 | 0.1519 | 2 | 8 | positive regulation of dendritic cell chemotaxis |
| GO:1901379 | 0.0094 | 4.1541 | 1.2915 | 5 | 68 | regulation of potassium ion transmembrane transport |
| GO:0031018 | 0.0095 | 5.2239 | 0.8356 | 4 | 44 | endocrine pancreas development |
| GO:0051445 | 0.0095 | 5.2239 | 0.8356 | 4 | 44 | regulation of meiotic cell cycle |
| GO:0060986 | 0.0095 | 5.2239 | 0.8356 | 4 | 44 | endocrine hormone secretion |
| GO:0002699 | 0.0096 | 2.8627 | 2.9437 | 8 | 155 | positive regulation of immune effector process |
| GO:0035295 | 0.0097 | 1.8932 | 10.5215 | 19 | 554 | tube development |
| GO:0009891 | 0.0098 | 1.5049 | 32.5521 | 46 | 1714 | positive regulation of biosynthetic process |
| GO:0090276 | 0.0099 | 2.6485 | 3.5705 | 9 | 188 | regulation of peptide hormone secretion |
| GO:0019933 | 0.0099 | 3.4954 | 1.8232 | 6 | 96 | cAMP-mediated signaling |
| GO:0021510 | 0.0099 | 3.4954 | 1.8232 | 6 | 96 | spinal cord development |
| GO:0021761 | 0.0099 | 3.4954 | 1.8232 | 6 | 96 | limbic system development |
| GO:0042107 | 0.0099 | 3.4954 | 1.8232 | 6 | 96 | cytokine metabolic process |
| GO:0019226 | 0.01 | 4.0889 | 1.3104 | 5 | 69 | transmission of nerve impulse |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 5.4845 | 2.0495 | 10 | 92 | embryonic skeletal system morphogenesis |
| GO:0003057 | 2e-04 | 44.2708 | 0.1337 | 3 | 6 | regulation of the force of heart contraction by chemical signal |
| GO:0050909 | 4e-04 | 7.0365 | 0.9802 | 6 | 44 | sensory perception of taste |
| GO:0050877 | 9e-04 | 1.8892 | 19.2257 | 34 | 863 | nervous system process |
| GO:0060546 | 0.0012 | 18.9681 | 0.2228 | 3 | 10 | negative regulation of necroptotic process |
| GO:0061146 | 0.0015 | 88.2908 | 0.0668 | 2 | 3 | Peyer's patch morphogenesis |
| GO:0061760 | 0.0015 | 88.2908 | 0.0668 | 2 | 3 | antifungal innate immune response |
| GO:2000286 | 0.0015 | 88.2908 | 0.0668 | 2 | 3 | receptor internalization involved in canonical Wnt signaling pathway |
| GO:0007512 | 0.0016 | 16.596 | 0.2451 | 3 | 11 | adult heart development |
| GO:0097300 | 0.0016 | 6.5358 | 0.8688 | 5 | 39 | programmed necrotic cell death |
| GO:0003207 | 0.0021 | 14.751 | 0.2673 | 3 | 12 | cardiac chamber formation |
| GO:0007186 | 0.0021 | 1.8175 | 18.691 | 32 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050906 | 0.0024 | 3.3541 | 2.8738 | 9 | 129 | detection of stimulus involved in sensory perception |
| GO:0009650 | 0.0027 | 13.275 | 0.2896 | 3 | 13 | UV protection |
| GO:0048513 | 0.0027 | 1.4407 | 67.6574 | 89 | 3037 | animal organ development |
| GO:0060547 | 0.0028 | 44.518 | 0.0884 | 2 | 4 | negative regulation of necrotic cell death |
| GO:0045776 | 0.0028 | 5.6959 | 0.9802 | 5 | 44 | negative regulation of blood pressure |
| GO:0035633 | 0.0029 | 44.1424 | 0.0891 | 2 | 4 | maintenance of permeability of blood-brain barrier |
| GO:0042853 | 0.0029 | 44.1424 | 0.0891 | 2 | 4 | L-alanine catabolic process |
| GO:0009653 | 0.0038 | 1.4653 | 52.3304 | 71 | 2349 | anatomical structure morphogenesis |
| GO:0009416 | 0.004 | 2.3754 | 6.2155 | 14 | 279 | response to light stimulus |
| GO:0007340 | 0.0042 | 6.8207 | 0.6683 | 4 | 30 | acrosome reaction |
| GO:0008306 | 0.0043 | 4.2371 | 1.5372 | 6 | 69 | associative learning |
| GO:0007188 | 0.0043 | 3.0467 | 3.1412 | 9 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0009593 | 0.0044 | 3.3054 | 2.5842 | 8 | 116 | detection of chemical stimulus |
| GO:0072359 | 0.0046 | 1.7031 | 20.4732 | 33 | 919 | circulatory system development |
| GO:0051928 | 0.0047 | 3.6265 | 2.0718 | 7 | 93 | positive regulation of calcium ion transport |
| GO:0006522 | 0.0047 | 29.4263 | 0.1114 | 2 | 5 | alanine metabolic process |
| GO:0009080 | 0.0047 | 29.4263 | 0.1114 | 2 | 5 | pyruvate family amino acid catabolic process |
| GO:0070838 | 0.0051 | 2.0668 | 9.1561 | 18 | 411 | divalent metal ion transport |
| GO:0002224 | 0.0052 | 3.2154 | 2.651 | 8 | 119 | toll-like receptor signaling pathway |
| GO:0010737 | 0.0053 | 6.3326 | 0.7129 | 4 | 32 | protein kinase A signaling |
| GO:0051926 | 0.0054 | 4.8269 | 1.1362 | 5 | 51 | negative regulation of calcium ion transport |
| GO:0007275 | 0.0055 | 1.3482 | 104.7944 | 127 | 4704 | multicellular organism development |
| GO:0007631 | 0.0056 | 3.5036 | 2.1387 | 7 | 96 | feeding behavior |
| GO:0007597 | 0.0059 | 9.4796 | 0.3787 | 3 | 17 | blood coagulation, intrinsic pathway |
| GO:0051412 | 0.0059 | 9.4796 | 0.3787 | 3 | 17 | response to corticosterone |
| GO:0007519 | 0.0059 | 2.8919 | 3.2971 | 9 | 148 | skeletal muscle tissue development |
| GO:0002606 | 0.007 | 22.0682 | 0.1337 | 2 | 6 | positive regulation of dendritic cell antigen processing and presentation |
| GO:0042421 | 0.007 | 22.0682 | 0.1337 | 2 | 6 | norepinephrine biosynthetic process |
| GO:0048537 | 0.007 | 22.0682 | 0.1337 | 2 | 6 | mucosal-associated lymphoid tissue development |
| GO:0030326 | 0.0072 | 3.0232 | 2.807 | 8 | 126 | embryonic limb morphogenesis |
| GO:0048562 | 0.0073 | 2.6191 | 4.0241 | 10 | 185 | embryonic organ morphogenesis |
| GO:0006457 | 0.0076 | 2.4738 | 4.6783 | 11 | 210 | protein folding |
| GO:0008584 | 0.0079 | 2.9724 | 2.8515 | 8 | 128 | male gonad development |
| GO:0061041 | 0.0079 | 2.9724 | 2.8515 | 8 | 128 | regulation of wound healing |
| GO:0048536 | 0.0081 | 5.5396 | 0.802 | 4 | 36 | spleen development |
| GO:0050911 | 0.0087 | 4.2682 | 1.2698 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0043207 | 0.0089 | 1.7264 | 15.7949 | 26 | 709 | response to external biotic stimulus |
| GO:0007589 | 0.0094 | 3.5563 | 1.8045 | 6 | 81 | body fluid secretion |
| GO:0061053 | 0.0099 | 3.5092 | 1.8268 | 6 | 82 | somite development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 15.2041 | 4.2353 | 43 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0098609 | 0 | 3.5113 | 20.8977 | 62 | 750 | cell-cell adhesion |
| GO:0032502 | 0 | 3.2181 | 25.6319 | 65 | 1130 | developmental process |
| GO:0007275 | 0 | 2.3842 | 66.8692 | 122 | 2734 | multicellular organism development |
| GO:0007267 | 0 | 2.4488 | 40.653 | 85 | 1459 | cell-cell signaling |
| GO:0007389 | 0 | 3.8589 | 11.3126 | 38 | 406 | pattern specification process |
| GO:0022610 | 0 | 2.4671 | 35.6375 | 76 | 1279 | biological adhesion |
| GO:0007399 | 0 | 2.2112 | 51.7899 | 97 | 1938 | nervous system development |
| GO:0009952 | 0 | 4.4037 | 5.4055 | 21 | 194 | anterior/posterior pattern specification |
| GO:0009792 | 0 | 2.7627 | 15.2414 | 38 | 547 | embryo development ending in birth or egg hatching |
| GO:0009653 | 0 | 2.5403 | 18.9214 | 43 | 731 | anatomical structure morphogenesis |
| GO:0048646 | 0 | 2.1251 | 26.8883 | 52 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0007416 | 0 | 7.3585 | 1.6249 | 10 | 59 | synapse assembly |
| GO:0048704 | 0 | 8.3032 | 1.3223 | 9 | 48 | embryonic skeletal system morphogenesis |
| GO:0051094 | 0 | 3.0776 | 8.5658 | 24 | 319 | positive regulation of developmental process |
| GO:0016339 | 0 | 11.8082 | 0.7802 | 7 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0051241 | 0 | 2.063 | 27.0459 | 51 | 975 | negative regulation of multicellular organismal process |
| GO:0048562 | 0 | 3.5044 | 5.0026 | 16 | 185 | embryonic organ morphogenesis |
| GO:0045944 | 1e-04 | 1.9002 | 29.0896 | 51 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001708 | 1e-04 | 5.0085 | 2.2569 | 10 | 81 | cell fate specification |
| GO:0008284 | 1e-04 | 1.9766 | 22.3187 | 41 | 801 | positive regulation of cell proliferation |
| GO:0023019 | 1e-04 | 12.5972 | 0.5294 | 5 | 19 | signal transduction involved in regulation of gene expression |
| GO:0048729 | 2e-04 | 2.1215 | 16.6903 | 33 | 599 | tissue morphogenesis |
| GO:0009953 | 2e-04 | 4.3334 | 2.5634 | 10 | 92 | dorsal/ventral pattern formation |
| GO:0045766 | 3e-04 | 3.5916 | 3.6501 | 12 | 131 | positive regulation of angiogenesis |
| GO:0051216 | 3e-04 | 3.1832 | 4.7647 | 14 | 171 | cartilage development |
| GO:1903524 | 3e-04 | 5.1531 | 1.7554 | 8 | 63 | positive regulation of blood circulation |
| GO:0030855 | 3e-04 | 2.021 | 17.4426 | 33 | 626 | epithelial cell differentiation |
| GO:2001199 | 4e-04 | 35.1306 | 0.1672 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0051240 | 4e-04 | 1.6846 | 37.087 | 58 | 1351 | positive regulation of multicellular organismal process |
| GO:0060914 | 4e-04 | 9.279 | 0.6687 | 5 | 24 | heart formation |
| GO:0051093 | 5e-04 | 1.867 | 22.3025 | 39 | 804 | negative regulation of developmental process |
| GO:0072358 | 5e-04 | 1.9933 | 17.1082 | 32 | 614 | cardiovascular system development |
| GO:0010628 | 5e-04 | 1.5935 | 47.4517 | 70 | 1703 | positive regulation of gene expression |
| GO:2000026 | 6e-04 | 1.6396 | 40.0936 | 61 | 1470 | regulation of multicellular organismal development |
| GO:0048663 | 6e-04 | 4.7221 | 1.8947 | 8 | 68 | neuron fate commitment |
| GO:0021570 | 8e-04 | Inf | 0.0557 | 2 | 2 | rhombomere 4 development |
| GO:0043134 | 8e-04 | Inf | 0.0557 | 2 | 2 | regulation of hindgut contraction |
| GO:0070366 | 8e-04 | Inf | 0.0557 | 2 | 2 | regulation of hepatocyte differentiation |
| GO:2000818 | 8e-04 | Inf | 0.0557 | 2 | 2 | negative regulation of myoblast proliferation |
| GO:2000824 | 8e-04 | Inf | 0.0557 | 2 | 2 | negative regulation of androgen receptor activity |
| GO:0060485 | 8e-04 | 2.659 | 6.4365 | 16 | 231 | mesenchyme development |
| GO:0060706 | 8e-04 | 8.012 | 0.7523 | 5 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0043651 | 8e-04 | 11.731 | 0.4458 | 4 | 16 | linoleic acid metabolic process |
| GO:1903508 | 9e-04 | 1.6327 | 37.3929 | 57 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0048483 | 9e-04 | 6.0525 | 1.1424 | 6 | 41 | autonomic nervous system development |
| GO:0048514 | 0.001 | 2.0367 | 14.0711 | 27 | 505 | blood vessel morphogenesis |
| GO:0048706 | 0.001 | 7.5763 | 0.7842 | 5 | 29 | embryonic skeletal system development |
| GO:0042472 | 0.0011 | 3.7975 | 2.5913 | 9 | 93 | inner ear morphogenesis |
| GO:0048513 | 0.0012 | 1.4889 | 62.9794 | 86 | 2397 | animal organ development |
| GO:0010469 | 0.0012 | 2.0309 | 13.5696 | 26 | 487 | regulation of receptor activity |
| GO:0048701 | 0.0013 | 5.5735 | 1.226 | 6 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0019932 | 0.0015 | 2.4102 | 7.4953 | 17 | 269 | second-messenger-mediated signaling |
| GO:0043583 | 0.0015 | 2.6671 | 5.6006 | 14 | 201 | ear development |
| GO:0001993 | 0.0016 | 17.5618 | 0.2508 | 3 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
| GO:0021610 | 0.0016 | 17.5618 | 0.2508 | 3 | 9 | facial nerve morphogenesis |
| GO:0043587 | 0.0016 | 17.5618 | 0.2508 | 3 | 9 | tongue morphogenesis |
| GO:0051254 | 0.0017 | 1.5742 | 39.3155 | 58 | 1411 | positive regulation of RNA metabolic process |
| GO:0045987 | 0.0018 | 6.5261 | 0.8916 | 5 | 32 | positive regulation of smooth muscle contraction |
| GO:0003073 | 0.0019 | 3.8778 | 2.2569 | 8 | 81 | regulation of systemic arterial blood pressure |
| GO:0035914 | 0.0021 | 4.2647 | 1.8111 | 7 | 65 | skeletal muscle cell differentiation |
| GO:0021953 | 0.0022 | 2.8055 | 4.5696 | 12 | 164 | central nervous system neuron differentiation |
| GO:0035296 | 0.0022 | 3.1662 | 3.3994 | 10 | 122 | regulation of tube diameter |
| GO:0002125 | 0.0023 | 70.1043 | 0.0836 | 2 | 3 | maternal aggressive behavior |
| GO:0060741 | 0.0023 | 70.1043 | 0.0836 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0060913 | 0.0023 | 70.1043 | 0.0836 | 2 | 3 | cardiac cell fate determination |
| GO:0061737 | 0.0023 | 70.1043 | 0.0836 | 2 | 3 | leukotriene signaling pathway |
| GO:0045597 | 0.0023 | 1.7129 | 23.4611 | 38 | 842 | positive regulation of cell differentiation |
| GO:1901342 | 0.0024 | 2.358 | 7.1888 | 16 | 258 | regulation of vasculature development |
| GO:0035113 | 0.0028 | 3.0562 | 3.5108 | 10 | 126 | embryonic appendage morphogenesis |
| GO:0010460 | 0.0029 | 7.8175 | 0.613 | 4 | 22 | positive regulation of heart rate |
| GO:0044062 | 0.0029 | 7.8175 | 0.613 | 4 | 22 | regulation of excretion |
| GO:0048736 | 0.0029 | 2.6979 | 4.7368 | 12 | 170 | appendage development |
| GO:0043588 | 0.003 | 2.1864 | 8.6934 | 18 | 312 | skin development |
| GO:0007512 | 0.003 | 13.1695 | 0.3065 | 3 | 11 | adult heart development |
| GO:0010454 | 0.003 | 13.1695 | 0.3065 | 3 | 11 | negative regulation of cell fate commitment |
| GO:2000774 | 0.003 | 13.1695 | 0.3065 | 3 | 11 | positive regulation of cellular senescence |
| GO:0071542 | 0.003 | 5.6825 | 1.0031 | 5 | 36 | dopaminergic neuron differentiation |
| GO:2001141 | 0.003 | 1.3684 | 94.764 | 119 | 3401 | regulation of RNA biosynthetic process |
| GO:0007218 | 0.0031 | 3.5368 | 2.452 | 8 | 88 | neuropeptide signaling pathway |
| GO:0050880 | 0.0033 | 2.9785 | 3.5944 | 10 | 129 | regulation of blood vessel size |
| GO:0045686 | 0.0035 | 7.4055 | 0.6409 | 4 | 23 | negative regulation of glial cell differentiation |
| GO:0010721 | 0.0038 | 2.2447 | 7.5232 | 16 | 270 | negative regulation of cell development |
| GO:0045777 | 0.0039 | 5.3374 | 1.0588 | 5 | 38 | positive regulation of blood pressure |
| GO:0060670 | 0.0039 | 11.7055 | 0.3344 | 3 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0048643 | 0.0041 | 7.0348 | 0.6687 | 4 | 24 | positive regulation of skeletal muscle tissue development |
| GO:0019229 | 0.0041 | 4.3191 | 1.5325 | 6 | 55 | regulation of vasoconstriction |
| GO:0060562 | 0.0043 | 2.1571 | 8.3033 | 17 | 298 | epithelial tube morphogenesis |
| GO:0001994 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0002580 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0003308 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0008078 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | mesodermal cell migration |
| GO:0035811 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | negative regulation of urine volume |
| GO:0042662 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0090191 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905903 | 0.0045 | 35.0498 | 0.1115 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0003151 | 0.0045 | 3.6895 | 2.0619 | 7 | 74 | outflow tract morphogenesis |
| GO:0010660 | 0.0045 | 4.2324 | 1.5604 | 6 | 56 | regulation of muscle cell apoptotic process |
| GO:0001947 | 0.0049 | 4.1492 | 1.5882 | 6 | 57 | heart looping |
| GO:0071880 | 0.005 | 10.5342 | 0.3622 | 3 | 13 | adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0090196 | 0.005 | 10.5342 | 0.3622 | 3 | 13 | regulation of chemokine secretion |
| GO:0007200 | 0.005 | 3.2507 | 2.647 | 8 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0022603 | 0.005 | 1.6172 | 25.3837 | 39 | 911 | regulation of anatomical structure morphogenesis |
| GO:0051963 | 0.0052 | 3.5821 | 2.1176 | 7 | 76 | regulation of synapse assembly |
| GO:0019933 | 0.0053 | 3.2135 | 2.6749 | 8 | 96 | cAMP-mediated signaling |
| GO:0048869 | 0.0056 | 1.4474 | 50.4848 | 68 | 1946 | cellular developmental process |
| GO:0090596 | 0.0057 | 2.2776 | 6.4778 | 14 | 234 | sensory organ morphogenesis |
| GO:0031327 | 0.0058 | 1.4752 | 41.6003 | 58 | 1493 | negative regulation of cellular biosynthetic process |
| GO:0021872 | 0.0059 | 3.9921 | 1.644 | 6 | 59 | forebrain generation of neurons |
| GO:0010557 | 0.0062 | 1.4608 | 43.4672 | 60 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0061311 | 0.0063 | 6.1159 | 0.7523 | 4 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0031328 | 0.0064 | 1.4416 | 47.0337 | 64 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0006357 | 0.0071 | 1.649 | 21.0576 | 33 | 802 | regulation of transcription from RNA polymerase II promoter |
| GO:0035116 | 0.0072 | 5.8607 | 0.7802 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0048625 | 0.0073 | 23.3649 | 0.1393 | 2 | 5 | myoblast fate commitment |
| GO:0051122 | 0.0073 | 23.3649 | 0.1393 | 2 | 5 | hepoxilin biosynthetic process |
| GO:0035108 | 0.0074 | 2.6227 | 4.0402 | 10 | 145 | limb morphogenesis |
| GO:0035270 | 0.0075 | 2.7925 | 3.4272 | 9 | 123 | endocrine system development |
| GO:0048545 | 0.0075 | 1.9416 | 10.2538 | 19 | 368 | response to steroid hormone |
| GO:0021783 | 0.0076 | 8.7773 | 0.418 | 3 | 15 | preganglionic parasympathetic fiber development |
| GO:0071599 | 0.0076 | 8.7773 | 0.418 | 3 | 15 | otic vesicle development |
| GO:2000484 | 0.0076 | 8.7773 | 0.418 | 3 | 15 | positive regulation of interleukin-8 secretion |
| GO:0061053 | 0.0078 | 3.2942 | 2.2848 | 7 | 82 | somite development |
| GO:0090132 | 0.0081 | 2.1813 | 6.743 | 14 | 242 | epithelium migration |
| GO:0003203 | 0.0081 | 5.6259 | 0.808 | 4 | 29 | endocardial cushion morphogenesis |
| GO:0010092 | 0.0081 | 5.6259 | 0.808 | 4 | 29 | specification of animal organ identity |
| GO:0031128 | 0.0081 | 5.6259 | 0.808 | 4 | 29 | developmental induction |
| GO:0072359 | 0.0084 | 2.0499 | 8.1874 | 16 | 305 | circulatory system development |
| GO:0048468 | 0.0085 | 1.4395 | 43.3195 | 59 | 1587 | cell development |
| GO:0060429 | 0.0086 | 1.8821 | 11.133 | 20 | 417 | epithelium development |
| GO:0048699 | 0.0089 | 1.4835 | 34.746 | 49 | 1260 | generation of neurons |
| GO:0072009 | 0.009 | 2.9136 | 2.9257 | 8 | 105 | nephron epithelium development |
| GO:0034142 | 0.0092 | 5.4092 | 0.8359 | 4 | 30 | toll-like receptor 4 signaling pathway |
| GO:0007625 | 0.0092 | 8.1016 | 0.4458 | 3 | 16 | grooming behavior |
| GO:0060850 | 0.0092 | 8.1016 | 0.4458 | 3 | 16 | regulation of transcription involved in cell fate commitment |
| GO:0043535 | 0.0093 | 3.5846 | 1.8111 | 6 | 65 | regulation of blood vessel endothelial cell migration |
| GO:0070848 | 0.0095 | 1.6784 | 17.4426 | 28 | 626 | response to growth factor |
| GO:0044344 | 0.0096 | 2.6742 | 3.5665 | 9 | 128 | cellular response to fibroblast growth factor stimulus |
| GO:0021545 | 0.0096 | 4.1911 | 1.3096 | 5 | 47 | cranial nerve development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 41.3282 | 0.869 | 21 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 17.6219 | 1.7685 | 23 | 116 | detection of chemical stimulus |
| GO:0007606 | 0 | 15.8942 | 2.0125 | 24 | 132 | sensory perception of chemical stimulus |
| GO:0050906 | 0 | 15.4472 | 1.9667 | 23 | 129 | detection of stimulus involved in sensory perception |
| GO:0007186 | 0 | 3.0248 | 12.7915 | 34 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 2.8281 | 13.1574 | 33 | 863 | nervous system process |
| GO:0070268 | 0 | 7.9907 | 1.4331 | 10 | 94 | cornification |
| GO:0050829 | 0 | 9.6948 | 0.9605 | 8 | 63 | defense response to Gram-negative bacterium |
| GO:0030216 | 0 | 4.5978 | 3.1102 | 13 | 204 | keratinocyte differentiation |
| GO:0045087 | 0 | 2.6622 | 11.1871 | 27 | 740 | innate immune response |
| GO:0016579 | 1e-04 | 3.8037 | 4.007 | 14 | 265 | protein deubiquitination |
| GO:0006508 | 1e-04 | 2.0272 | 24.3175 | 44 | 1595 | proteolysis |
| GO:0019730 | 1e-04 | 7.2533 | 1.0825 | 7 | 71 | antimicrobial humoral response |
| GO:0043207 | 2e-04 | 2.4088 | 10.8095 | 24 | 709 | response to external biotic stimulus |
| GO:0070098 | 2e-04 | 7.7741 | 0.869 | 6 | 57 | chemokine-mediated signaling pathway |
| GO:0050776 | 5e-04 | 2.203 | 12.7762 | 26 | 838 | regulation of immune response |
| GO:0003095 | 7e-04 | 130.2957 | 0.0457 | 2 | 3 | pressure natriuresis |
| GO:0009624 | 7e-04 | 130.2957 | 0.0457 | 2 | 3 | response to nematode |
| GO:0061760 | 7e-04 | 130.2957 | 0.0457 | 2 | 3 | antifungal innate immune response |
| GO:0050830 | 0.001 | 5.7391 | 1.1435 | 6 | 75 | defense response to Gram-positive bacterium |
| GO:0008544 | 0.001 | 2.7829 | 5.3666 | 14 | 352 | epidermis development |
| GO:0036101 | 0.0014 | 65.1435 | 0.061 | 2 | 4 | leukotriene B4 catabolic process |
| GO:0007565 | 0.0015 | 3.6029 | 2.6681 | 9 | 175 | female pregnancy |
| GO:0002933 | 0.0022 | 43.4261 | 0.0762 | 2 | 5 | lipid hydroxylation |
| GO:1901523 | 0.0022 | 43.4261 | 0.0762 | 2 | 5 | icosanoid catabolic process |
| GO:0009620 | 0.0028 | 7.4937 | 0.5946 | 4 | 39 | response to fungus |
| GO:0048247 | 0.0028 | 7.4937 | 0.5946 | 4 | 39 | lymphocyte chemotaxis |
| GO:0071947 | 0.0033 | 32.5674 | 0.0915 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0045104 | 0.0034 | 7.0877 | 0.6251 | 4 | 41 | intermediate filament cytoskeleton organization |
| GO:0030855 | 0.0034 | 2.1129 | 9.5441 | 19 | 626 | epithelial cell differentiation |
| GO:0019373 | 0.0038 | 10.893 | 0.3202 | 3 | 21 | epoxygenase P450 pathway |
| GO:0002548 | 0.0044 | 6.5548 | 0.6708 | 4 | 44 | monocyte chemotaxis |
| GO:0003071 | 0.0049 | 9.8024 | 0.3507 | 3 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0019941 | 0.0052 | 2.1151 | 8.4921 | 17 | 557 | modification-dependent protein catabolic process |
| GO:0042742 | 0.0056 | 4.72 | 1.1362 | 5 | 77 | defense response to bacterium |
| GO:0002376 | 0.0058 | 1.529 | 37.8713 | 53 | 2484 | immune system process |
| GO:0035865 | 0.0061 | 21.7087 | 0.122 | 2 | 8 | cellular response to potassium ion |
| GO:0032342 | 0.0078 | 18.6062 | 0.1372 | 2 | 9 | aldosterone biosynthetic process |
| GO:0034651 | 0.0078 | 18.6062 | 0.1372 | 2 | 9 | cortisol biosynthetic process |
| GO:0097267 | 0.0078 | 18.6062 | 0.1372 | 2 | 9 | omega-hydroxylase P450 pathway |
| GO:0018149 | 0.0095 | 7.5373 | 0.4421 | 3 | 29 | peptide cross-linking |
| GO:0002003 | 0.0096 | 16.2793 | 0.1525 | 2 | 10 | angiotensin maturation |
| GO:0008212 | 0.0096 | 16.2793 | 0.1525 | 2 | 10 | mineralocorticoid metabolic process |
| GO:0045919 | 0.0096 | 16.2793 | 0.1525 | 2 | 10 | positive regulation of cytolysis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 62.2667 | 0.9102 | 27 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 23.1885 | 1.8524 | 29 | 116 | detection of chemical stimulus |
| GO:0050906 | 0 | 20.1564 | 2.06 | 29 | 129 | detection of stimulus involved in sensory perception |
| GO:0050877 | 0 | 3.4944 | 13.7812 | 41 | 863 | nervous system process |
| GO:0007186 | 0 | 3.4957 | 13.398 | 40 | 839 | G-protein coupled receptor signaling pathway |
| GO:0070268 | 0 | 7.6078 | 1.5011 | 10 | 94 | cornification |
| GO:0016579 | 0 | 4.2041 | 4.1986 | 16 | 265 | protein deubiquitination |
| GO:0045087 | 0 | 3.4797 | 5.6725 | 18 | 366 | innate immune response |
| GO:0019730 | 0 | 8.0573 | 1.1338 | 8 | 71 | antimicrobial humoral response |
| GO:0030216 | 0 | 4.3747 | 3.2577 | 13 | 204 | keratinocyte differentiation |
| GO:0050776 | 1e-04 | 3.7096 | 4.1078 | 14 | 265 | regulation of immune response |
| GO:0002376 | 1e-04 | 1.8148 | 39.667 | 63 | 2484 | immune system process |
| GO:0097267 | 3e-04 | 31.1833 | 0.1437 | 3 | 9 | omega-hydroxylase P450 pathway |
| GO:0007565 | 5e-04 | 3.852 | 2.7946 | 10 | 175 | female pregnancy |
| GO:0008544 | 6e-04 | 2.8574 | 5.6211 | 15 | 352 | epidermis development |
| GO:0003095 | 8e-04 | 124.2573 | 0.0479 | 2 | 3 | pressure natriuresis |
| GO:0018149 | 0.0011 | 10.0077 | 0.4631 | 4 | 29 | peptide cross-linking |
| GO:0002221 | 0.0013 | 3.6772 | 2.6189 | 9 | 164 | pattern recognition receptor signaling pathway |
| GO:0036101 | 0.0015 | 62.1245 | 0.0639 | 2 | 4 | leukotriene B4 catabolic process |
| GO:0007635 | 0.0023 | 13.3571 | 0.2715 | 3 | 17 | chemosensory behavior |
| GO:1901523 | 0.0025 | 41.4136 | 0.0798 | 2 | 5 | icosanoid catabolic process |
| GO:0050829 | 0.0033 | 5.4028 | 1.006 | 5 | 63 | defense response to Gram-negative bacterium |
| GO:0071947 | 0.0037 | 31.0581 | 0.0958 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0045104 | 0.004 | 6.7565 | 0.6547 | 4 | 41 | intermediate filament cytoskeleton organization |
| GO:0019373 | 0.0043 | 10.3861 | 0.3353 | 3 | 21 | epoxygenase P450 pathway |
| GO:0007608 | 0.0046 | 10.0087 | 0.342 | 3 | 24 | sensory perception of smell |
| GO:0002218 | 0.0047 | 2.6521 | 4.3755 | 11 | 274 | activation of innate immune response |
| GO:0032819 | 0.0051 | 24.8448 | 0.1118 | 2 | 7 | positive regulation of natural killer cell proliferation |
| GO:2001185 | 0.0051 | 24.8448 | 0.1118 | 2 | 7 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0002548 | 0.0052 | 6.2485 | 0.7026 | 4 | 44 | monocyte chemotaxis |
| GO:0003071 | 0.0056 | 9.3462 | 0.3673 | 3 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0002761 | 0.0061 | 3.8828 | 1.6448 | 6 | 103 | regulation of myeloid leukocyte differentiation |
| GO:0035865 | 0.0067 | 20.7026 | 0.1278 | 2 | 8 | cellular response to potassium ion |
| GO:0045671 | 0.0071 | 8.4955 | 0.3992 | 3 | 25 | negative regulation of osteoclast differentiation |
| GO:0045088 | 0.0077 | 2.2686 | 6.0203 | 13 | 377 | regulation of innate immune response |
| GO:0006508 | 0.0078 | 1.5973 | 25.4705 | 38 | 1595 | proteolysis |
| GO:0007194 | 0.008 | 8.1255 | 0.4152 | 3 | 26 | negative regulation of adenylate cyclase activity |
| GO:0019941 | 0.0082 | 2.0106 | 8.8947 | 17 | 557 | modification-dependent protein catabolic process |
| GO:0032342 | 0.0085 | 17.7439 | 0.1437 | 2 | 9 | aldosterone biosynthetic process |
| GO:0034651 | 0.0085 | 17.7439 | 0.1437 | 2 | 9 | cortisol biosynthetic process |
| GO:0060158 | 0.0085 | 17.7439 | 0.1437 | 2 | 9 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0002764 | 0.0087 | 2.0993 | 7.5054 | 15 | 470 | immune response-regulating signaling pathway |
| GO:0090279 | 0.0098 | 7.4745 | 0.4471 | 3 | 28 | regulation of calcium ion import |
| GO:0043207 | 0.0099 | 1.8595 | 11.322 | 20 | 709 | response to external biotic stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 3.4194 | 28.0236 | 79 | 989 | sequence-specific DNA binding |
| GO:0000981 | 0 | 3.2038 | 20.6281 | 57 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0001077 | 0 | 3.9388 | 7.4522 | 26 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0001012 | 0 | 2.8142 | 16.6612 | 42 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0140110 | 0 | 1.9981 | 42.673 | 76 | 1506 | transcription regulator activity |
| GO:0000976 | 0 | 2.4531 | 18.843 | 42 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0000978 | 0 | 3.01 | 9.8607 | 27 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0000975 | 0 | 2.2419 | 23.0083 | 47 | 812 | regulatory region DNA binding |
| GO:0001159 | 0 | 2.8639 | 10.314 | 27 | 364 | core promoter proximal region DNA binding |
| GO:0003690 | 0 | 2.1753 | 22.0449 | 44 | 778 | double-stranded DNA binding |
| GO:0001653 | 1e-04 | 4.0807 | 3.2586 | 12 | 115 | peptide receptor activity |
| GO:0071837 | 1e-04 | 13.3318 | 0.51 | 5 | 18 | HMG box domain binding |
| GO:0005506 | 3e-04 | 3.3486 | 4.222 | 13 | 149 | iron ion binding |
| GO:0048018 | 5e-04 | 2.3037 | 10.6541 | 23 | 376 | receptor ligand activity |
| GO:0016165 | 8e-04 | Inf | 0.0567 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0036461 | 8e-04 | Inf | 0.0567 | 2 | 2 | BLOC-2 complex binding |
| GO:0000979 | 9e-04 | 5.0668 | 1.5584 | 7 | 55 | RNA polymerase II core promoter sequence-specific DNA binding |
| GO:0004930 | 0.001 | 2.1362 | 11.9292 | 24 | 421 | G-protein coupled receptor activity |
| GO:0046982 | 0.0011 | 2.0796 | 12.7509 | 25 | 450 | protein heterodimerization activity |
| GO:0102991 | 0.0011 | 20.7119 | 0.2267 | 3 | 8 | myristoyl-CoA hydrolase activity |
| GO:0008190 | 0.0017 | 17.2587 | 0.255 | 3 | 9 | eukaryotic initiation factor 4E binding |
| GO:0070410 | 0.0017 | 17.2587 | 0.255 | 3 | 9 | co-SMAD binding |
| GO:0017046 | 0.0019 | 6.413 | 0.9067 | 5 | 32 | peptide hormone binding |
| GO:0035651 | 0.0024 | 68.8977 | 0.085 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0016290 | 0.0031 | 12.9423 | 0.3117 | 3 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0001078 | 0.0039 | 2.9017 | 3.6836 | 10 | 130 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0035650 | 0.0046 | 34.4465 | 0.1133 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0001191 | 0.0046 | 5.0902 | 1.1051 | 5 | 39 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
| GO:0008188 | 0.0052 | 4.9445 | 1.1334 | 5 | 40 | neuropeptide receptor activity |
| GO:0019841 | 0.0052 | 10.3524 | 0.3684 | 3 | 13 | retinol binding |
| GO:0005184 | 0.0058 | 6.2838 | 0.7367 | 4 | 26 | neuropeptide hormone activity |
| GO:0016918 | 0.0065 | 9.4107 | 0.3967 | 3 | 14 | retinal binding |
| GO:0005499 | 0.0076 | 22.9628 | 0.1417 | 2 | 5 | vitamin D binding |
| GO:0015057 | 0.0076 | 22.9628 | 0.1417 | 2 | 5 | thrombin-activated receptor activity |
| GO:0016019 | 0.0076 | 22.9628 | 0.1417 | 2 | 5 | peptidoglycan receptor activity |
| GO:1901338 | 0.008 | 8.6259 | 0.425 | 3 | 15 | catecholamine binding |
| GO:0035326 | 0.0084 | 2.9546 | 2.8902 | 8 | 102 | enhancer binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 37.432 | 0.759 | 18 | 57 | olfactory receptor activity |
| GO:0036459 | 0 | 15.1852 | 1.4247 | 17 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 9.7907 | 2.3434 | 19 | 176 | cysteine-type peptidase activity |
| GO:0060089 | 0 | 3.1768 | 15.3255 | 41 | 1151 | molecular transducer activity |
| GO:0038023 | 0 | 3.3939 | 12.05 | 35 | 905 | signaling receptor activity |
| GO:0004867 | 0 | 12.3201 | 0.972 | 10 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0004930 | 0 | 4.461 | 5.6056 | 22 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 3.2754 | 11.2511 | 32 | 845 | transmembrane receptor activity |
| GO:0008233 | 0 | 3.4612 | 7.7893 | 24 | 585 | peptidase activity |
| GO:0030414 | 0 | 6.6758 | 1.8508 | 11 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0 | 6.6758 | 1.8508 | 11 | 139 | endopeptidase regulator activity |
| GO:0020037 | 0 | 6.2407 | 1.5978 | 9 | 120 | heme binding |
| GO:0008392 | 1e-04 | 23.2393 | 0.2264 | 4 | 17 | arachidonic acid epoxygenase activity |
| GO:0003823 | 3e-04 | 9.4716 | 0.5992 | 5 | 45 | antigen binding |
| GO:0008201 | 8e-04 | 4.3989 | 1.9573 | 8 | 147 | heparin binding |
| GO:0004468 | 0.0026 | 37.4104 | 0.0799 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0004321 | 0.0035 | 29.9264 | 0.0932 | 2 | 7 | fatty-acyl-CoA synthase activity |
| GO:0005506 | 0.0038 | 3.7477 | 1.9839 | 7 | 149 | iron ion binding |
| GO:0016712 | 0.0038 | 10.73 | 0.3196 | 3 | 24 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
| GO:0003996 | 0.0047 | 24.937 | 0.1065 | 2 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0.0047 | 24.937 | 0.1065 | 2 | 8 | butyrate-CoA ligase activity |
| GO:0033691 | 0.006 | 21.3731 | 0.1198 | 2 | 9 | sialic acid binding |
| GO:0070492 | 0.006 | 21.3731 | 0.1198 | 2 | 9 | oligosaccharide binding |
| GO:0030280 | 0.0074 | 18.7002 | 0.1331 | 2 | 10 | structural constituent of epidermis |
| GO:0008395 | 0.0087 | 7.7659 | 0.4261 | 3 | 32 | steroid hydroxylase activity |
| GO:0005549 | 0.009 | 16.6213 | 0.1465 | 2 | 11 | odorant binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001664 | 0 | 3.87 | 4.536 | 16 | 226 | G-protein coupled receptor binding |
| GO:0008009 | 3e-04 | 9.9103 | 0.6021 | 5 | 30 | chemokine activity |
| GO:0031727 | 4e-04 | Inf | 0.0401 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0004939 | 0.0012 | 98.2829 | 0.0602 | 2 | 3 | beta-adrenergic receptor activity |
| GO:0004252 | 0.0019 | 3.2017 | 3.3318 | 10 | 166 | serine-type endopeptidase activity |
| GO:0017171 | 0.0022 | 2.9418 | 3.974 | 11 | 198 | serine hydrolase activity |
| GO:0051380 | 0.0023 | 49.1382 | 0.0803 | 2 | 4 | norepinephrine binding |
| GO:0004527 | 0.0037 | 4.3741 | 1.4852 | 6 | 74 | exonuclease activity |
| GO:0005132 | 0.0039 | 32.7566 | 0.1004 | 2 | 5 | type I interferon receptor binding |
| GO:0004930 | 0.0051 | 2.1165 | 8.4498 | 17 | 421 | G-protein coupled receptor activity |
| GO:0055131 | 0.0057 | 24.5658 | 0.1204 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0051379 | 0.0079 | 19.6513 | 0.1405 | 2 | 7 | epinephrine binding |
| GO:0070330 | 0.0081 | 8.2079 | 0.4215 | 3 | 21 | aromatase activity |
| GO:0004872 | 0.0087 | 1.6154 | 22.2184 | 34 | 1107 | receptor activity |
| GO:0003735 | 0.009 | 2.9007 | 2.9103 | 8 | 145 | structural constituent of ribosome |
| GO:0008201 | 0.0097 | 2.8586 | 2.9504 | 8 | 147 | heparin binding |
| GO:0005126 | 0.0099 | 2.4937 | 4.2086 | 10 | 211 | cytokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 16.3601 | 0.7664 | 10 | 57 | olfactory receptor activity |
| GO:0017159 | 2e-04 | Inf | 0.0269 | 2 | 2 | pantetheine hydrolase activity |
| GO:0031727 | 2e-04 | Inf | 0.0269 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0048020 | 2e-04 | 16.7761 | 0.293 | 4 | 22 | CCR chemokine receptor binding |
| GO:0060089 | 4e-04 | 2.1287 | 15.4765 | 30 | 1151 | molecular transducer activity |
| GO:0099600 | 4e-04 | 2.2966 | 11.362 | 24 | 845 | transmembrane receptor activity |
| GO:0038023 | 5e-04 | 2.235 | 12.1688 | 25 | 905 | signaling receptor activity |
| GO:0004930 | 6e-04 | 2.8458 | 5.6608 | 15 | 421 | G-protein coupled receptor activity |
| GO:0018685 | 0.0011 | 74.0837 | 0.0538 | 2 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 0.0011 | 74.0837 | 0.0538 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0020037 | 0.0012 | 4.6704 | 1.6135 | 7 | 120 | heme binding |
| GO:0008392 | 0.0014 | 15.9409 | 0.2286 | 3 | 17 | arachidonic acid epoxygenase activity |
| GO:0008048 | 0.0018 | 49.3859 | 0.0672 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
| GO:0019825 | 0.0022 | 8.0699 | 0.5513 | 4 | 41 | oxygen binding |
| GO:0005126 | 0.0026 | 3.2906 | 2.9044 | 9 | 216 | cytokine receptor binding |
| GO:0001664 | 0.0035 | 3.1368 | 3.0388 | 9 | 226 | G-protein coupled receptor binding |
| GO:0010853 | 0.0036 | 29.6276 | 0.0941 | 2 | 7 | cyclase activator activity |
| GO:0001530 | 0.0039 | 10.6223 | 0.3227 | 3 | 24 | lipopolysaccharide binding |
| GO:0004175 | 0.0048 | 2.5212 | 5.0289 | 12 | 374 | endopeptidase activity |
| GO:0004465 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | lipoprotein lipase activity |
| GO:0030249 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | guanylate cyclase regulator activity |
| GO:0102991 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0048018 | 0.005 | 2.507 | 5.0558 | 12 | 376 | receptor ligand activity |
| GO:0008233 | 0.0057 | 2.1532 | 7.866 | 16 | 585 | peptidase activity |
| GO:0016709 | 0.006 | 9.0084 | 0.3729 | 3 | 28 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
| GO:0008009 | 0.0074 | 8.2585 | 0.4034 | 3 | 30 | chemokine activity |
| GO:1990841 | 0.0082 | 7.963 | 0.4168 | 3 | 31 | promoter-specific chromatin binding |
| GO:0008237 | 0.0087 | 3.1874 | 2.3127 | 7 | 172 | metallopeptidase activity |
| GO:0016290 | 0.0091 | 16.4554 | 0.1479 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 5e-04 | Inf | 0.0437 | 2 | 2 | MHC class Ib receptor activity |
| GO:0005212 | 5e-04 | 12.9388 | 0.3932 | 4 | 18 | structural constituent of eye lens |
| GO:0004930 | 0.001 | 2.3124 | 9.1954 | 20 | 421 | G-protein coupled receptor activity |
| GO:0048018 | 0.0016 | 2.3232 | 8.2125 | 18 | 376 | receptor ligand activity |
| GO:0031432 | 0.0031 | 12.3157 | 0.3058 | 3 | 14 | titin binding |
| GO:0032407 | 0.0046 | 30.0302 | 0.1092 | 2 | 5 | MutSalpha complex binding |
| GO:0004984 | 0.008 | 4.3565 | 1.245 | 5 | 57 | olfactory receptor activity |
| GO:0005126 | 0.008 | 2.451 | 4.7178 | 11 | 216 | cytokine receptor binding |
| GO:0004871 | 0.0087 | 1.5625 | 26.3412 | 39 | 1206 | signal transducer activity |
| GO:0031418 | 0.0089 | 7.9658 | 0.4368 | 3 | 20 | L-ascorbic acid binding |
| GO:0000981 | 0.0096 | 1.7144 | 15.9008 | 26 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 11.1138 | 0.9758 | 9 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 3.5419 | 7.2072 | 23 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 1e-04 | 2.3464 | 14.4658 | 31 | 845 | transmembrane receptor activity |
| GO:0038023 | 1e-04 | 2.2589 | 15.4929 | 32 | 905 | signaling receptor activity |
| GO:0008294 | 3e-04 | Inf | 0.0342 | 2 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
| GO:0031727 | 3e-04 | Inf | 0.0342 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0036459 | 5e-04 | 4.7546 | 1.8318 | 8 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0005539 | 5e-04 | 3.5394 | 3.3383 | 11 | 195 | glycosaminoglycan binding |
| GO:0042379 | 6e-04 | 8.3426 | 0.6848 | 5 | 40 | chemokine receptor binding |
| GO:0060089 | 6e-04 | 1.9246 | 19.7043 | 35 | 1151 | molecular transducer activity |
| GO:0005549 | 7e-04 | 21.7689 | 0.1883 | 3 | 11 | odorant binding |
| GO:0016709 | 0.0021 | 8.3141 | 0.5478 | 4 | 32 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
| GO:0008233 | 0.0026 | 2.118 | 10.0148 | 20 | 585 | peptidase activity |
| GO:0008234 | 0.0033 | 3.1689 | 3.013 | 9 | 176 | cysteine-type peptidase activity |
| GO:0042923 | 0.0039 | 10.8786 | 0.3253 | 3 | 19 | neuropeptide binding |
| GO:0019825 | 0.0052 | 6.2879 | 0.7019 | 4 | 41 | oxygen binding |
| GO:0030250 | 0.0058 | 23.1351 | 0.1198 | 2 | 7 | guanylate cyclase activator activity |
| GO:0032393 | 0.0058 | 23.1351 | 0.1198 | 2 | 7 | MHC class I receptor activity |
| GO:0032395 | 0.0058 | 23.1351 | 0.1198 | 2 | 7 | MHC class II receptor activity |
| GO:0031995 | 0.0076 | 19.278 | 0.137 | 2 | 8 | insulin-like growth factor II binding |
| GO:0035240 | 0.0076 | 19.278 | 0.137 | 2 | 8 | dopamine binding |
| GO:0001530 | 0.0077 | 8.2857 | 0.4109 | 3 | 24 | lipopolysaccharide binding |
| GO:0010851 | 0.0097 | 16.5229 | 0.1541 | 2 | 9 | cyclase regulator activity |
| GO:0015279 | 0.0097 | 16.5229 | 0.1541 | 2 | 9 | store-operated calcium channel activity |
| GO:0033691 | 0.0097 | 16.5229 | 0.1541 | 2 | 9 | sialic acid binding |
| GO:0070679 | 0.0097 | 16.5229 | 0.1541 | 2 | 9 | inositol 1,4,5 trisphosphate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 2.3237 | 19.0716 | 40 | 989 | sequence-specific DNA binding |
| GO:0000981 | 1e-04 | 2.3206 | 14.0386 | 30 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0001632 | 4e-04 | Inf | 0.0386 | 2 | 2 | leukotriene B4 receptor activity |
| GO:0016165 | 4e-04 | Inf | 0.0386 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0038100 | 4e-04 | Inf | 0.0386 | 2 | 2 | nodal binding |
| GO:0047025 | 4e-04 | Inf | 0.0386 | 2 | 2 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity |
| GO:0004861 | 0.0014 | 17.1168 | 0.2314 | 3 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0043236 | 0.0019 | 8.5793 | 0.5399 | 4 | 28 | laminin binding |
| GO:0034513 | 0.0022 | 51.1986 | 0.0771 | 2 | 4 | box H/ACA snoRNA binding |
| GO:0004953 | 0.0022 | 14.0028 | 0.27 | 3 | 14 | icosanoid receptor activity |
| GO:1903231 | 0.0032 | 7.3517 | 0.6171 | 4 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004602 | 0.0039 | 11 | 0.3278 | 3 | 17 | glutathione peroxidase activity |
| GO:0140110 | 0.0057 | 1.5795 | 29.0413 | 43 | 1506 | transcription regulator activity |
| GO:0004871 | 0.0058 | 1.6436 | 23.2562 | 36 | 1206 | signal transducer activity |
| GO:0004888 | 0.0066 | 1.7747 | 15.4463 | 26 | 801 | transmembrane signaling receptor activity |
| GO:0019955 | 0.0083 | 3.6439 | 1.7548 | 6 | 91 | cytokine binding |
| GO:0004872 | 0.0083 | 1.6338 | 21.3471 | 33 | 1107 | receptor activity |
| GO:0015280 | 0.0096 | 17.0616 | 0.1543 | 2 | 8 | ligand-gated sodium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001077 | 1e-04 | 3.7118 | 3.7951 | 13 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0000981 | 1e-04 | 2.4911 | 10.5051 | 24 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0008502 | 2e-04 | Inf | 0.0289 | 2 | 2 | melatonin receptor activity |
| GO:1990837 | 2e-04 | 2.4669 | 10.1299 | 23 | 702 | sequence-specific double-stranded DNA binding |
| GO:0099600 | 2e-04 | 2.3248 | 12.1934 | 26 | 845 | transmembrane receptor activity |
| GO:0048018 | 4e-04 | 2.9724 | 5.4257 | 15 | 376 | receptor ligand activity |
| GO:0008066 | 5e-04 | 12.6296 | 0.3752 | 4 | 26 | glutamate receptor activity |
| GO:0004024 | 6e-04 | 137.844 | 0.0433 | 2 | 3 | alcohol dehydrogenase activity, zinc-dependent |
| GO:0099583 | 6e-04 | 137.844 | 0.0433 | 2 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0000975 | 7e-04 | 2.2125 | 11.7172 | 24 | 812 | regulatory region DNA binding |
| GO:0004930 | 0.001 | 2.6744 | 5.992 | 15 | 419 | G-protein coupled receptor activity |
| GO:0038023 | 0.0016 | 2.1029 | 11.7492 | 23 | 829 | signaling receptor activity |
| GO:0000978 | 0.0017 | 2.7541 | 5.0216 | 13 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0020037 | 0.0018 | 4.3372 | 1.7316 | 7 | 120 | heme binding |
| GO:0000977 | 0.0019 | 3.2057 | 3.3208 | 10 | 239 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0001159 | 0.0025 | 2.6257 | 5.2525 | 13 | 364 | core promoter proximal region DNA binding |
| GO:0019825 | 0.0028 | 7.502 | 0.5916 | 4 | 41 | oxygen binding |
| GO:0070330 | 0.0033 | 11.5269 | 0.303 | 3 | 21 | aromatase activity |
| GO:0060089 | 0.0045 | 1.8055 | 16.6089 | 28 | 1151 | molecular transducer activity |
| GO:0030594 | 0.0048 | 4.8985 | 1.0967 | 5 | 76 | neurotransmitter receptor activity |
| GO:0030249 | 0.0055 | 22.9664 | 0.1154 | 2 | 8 | guanylate cyclase regulator activity |
| GO:0043565 | 0.0058 | 2.7163 | 3.8874 | 10 | 287 | sequence-specific DNA binding |
| GO:0005506 | 0.0059 | 3.4447 | 2.1501 | 7 | 149 | iron ion binding |
| GO:0070410 | 0.007 | 19.6841 | 0.1299 | 2 | 9 | co-SMAD binding |
| GO:0003700 | 0.0072 | 2.295 | 5.9807 | 13 | 443 | DNA binding transcription factor activity |
| GO:0008009 | 0.009 | 7.68 | 0.4329 | 3 | 30 | chemokine activity |
| GO:0004497 | 0.0093 | 4.1368 | 1.2843 | 5 | 89 | monooxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 4.2866 | 13.0988 | 47 | 636 | calcium ion binding |
| GO:0043565 | 0 | 3.4835 | 20.369 | 59 | 989 | sequence-specific DNA binding |
| GO:0140110 | 0 | 2.2031 | 31.0169 | 60 | 1506 | transcription regulator activity |
| GO:0000975 | 0 | 2.2853 | 16.7236 | 35 | 812 | regulatory region DNA binding |
| GO:0001077 | 0 | 3.4171 | 5.4166 | 17 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0003690 | 1e-04 | 2.2364 | 16.0234 | 33 | 778 | double-stranded DNA binding |
| GO:0001012 | 1e-04 | 2.4099 | 12.1102 | 27 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0000976 | 1e-04 | 2.2872 | 13.6961 | 29 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0001228 | 3e-04 | 4.1595 | 2.6166 | 10 | 132 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0000978 | 3e-04 | 2.6908 | 7.1673 | 18 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0071837 | 4e-04 | 13.7493 | 0.3707 | 4 | 18 | HMG box domain binding |
| GO:0001159 | 6e-04 | 2.5635 | 7.4968 | 18 | 364 | core promoter proximal region DNA binding |
| GO:0022884 | 7e-04 | 12.029 | 0.4119 | 4 | 20 | macromolecule transmembrane transporter activity |
| GO:0000981 | 8e-04 | 2.6535 | 6.4353 | 16 | 333 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0070405 | 0.0012 | 5.5744 | 1.1945 | 6 | 58 | ammonium ion binding |
| GO:0015266 | 0.0013 | 17.9952 | 0.2266 | 3 | 11 | protein channel activity |
| GO:0060089 | 0.0014 | 1.7625 | 23.7055 | 39 | 1151 | molecular transducer activity |
| GO:0005184 | 0.0018 | 8.7449 | 0.5355 | 4 | 26 | neuropeptide hormone activity |
| GO:0099600 | 0.0026 | 1.8297 | 17.4033 | 30 | 845 | transmembrane receptor activity |
| GO:0003676 | 0.0035 | 1.4136 | 76.7391 | 98 | 3726 | nucleic acid binding |
| GO:0005132 | 0.0041 | 31.8996 | 0.103 | 2 | 5 | type I interferon receptor binding |
| GO:0038023 | 0.0057 | 1.777 | 16.0287 | 27 | 790 | signaling receptor activity |
| GO:0004930 | 0.0065 | 2.0583 | 8.6707 | 17 | 421 | G-protein coupled receptor activity |
| GO:0031628 | 0.0083 | 19.1372 | 0.1442 | 2 | 7 | opioid receptor binding |
| GO:0043169 | 0.0086 | 1.361 | 78.1559 | 97 | 3854 | cation binding |
| GO:0008188 | 0.009 | 5.3391 | 0.8238 | 4 | 40 | neuropeptide receptor activity |
| GO:0001653 | 0.0097 | 3.1297 | 2.3685 | 7 | 115 | peptide receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 41.9274 | 0.7403 | 19 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 5.0902 | 5.4675 | 24 | 421 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 3.3744 | 11.7532 | 34 | 905 | signaling receptor activity |
| GO:0099600 | 0 | 3.3753 | 10.974 | 32 | 845 | transmembrane receptor activity |
| GO:0036459 | 0 | 8.1986 | 1.3896 | 10 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008009 | 0 | 19.5625 | 0.3896 | 6 | 30 | chemokine activity |
| GO:0048020 | 0 | 23.146 | 0.2829 | 5 | 22 | CCR chemokine receptor binding |
| GO:0004252 | 0 | 5.652 | 2.1558 | 11 | 166 | serine-type endopeptidase activity |
| GO:0008234 | 0 | 5.3059 | 2.2857 | 11 | 176 | cysteine-type peptidase activity |
| GO:0017171 | 1e-04 | 4.6747 | 2.5714 | 11 | 198 | serine hydrolase activity |
| GO:0004321 | 1e-04 | 57.8615 | 0.0909 | 3 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 1e-04 | 46.2862 | 0.1039 | 3 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 1e-04 | 46.2862 | 0.1039 | 3 | 8 | butyrate-CoA ligase activity |
| GO:0004507 | 2e-04 | Inf | 0.026 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0030109 | 2e-04 | Inf | 0.026 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0031727 | 2e-04 | Inf | 0.026 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0047783 | 2e-04 | Inf | 0.026 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0003823 | 3e-04 | 9.7202 | 0.5844 | 5 | 45 | antigen binding |
| GO:0004867 | 4e-04 | 6.9874 | 0.9481 | 6 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0030414 | 5e-04 | 4.7945 | 1.8052 | 8 | 139 | peptidase inhibitor activity |
| GO:0061135 | 5e-04 | 4.7945 | 1.8052 | 8 | 139 | endopeptidase regulator activity |
| GO:0016709 | 7e-04 | 11.0604 | 0.4156 | 4 | 32 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
| GO:0004497 | 8e-04 | 7.615 | 0.7268 | 5 | 57 | monooxygenase activity |
| GO:0020037 | 0.001 | 4.8439 | 1.5584 | 7 | 120 | heme binding |
| GO:0101020 | 0.001 | 76.7653 | 0.0519 | 2 | 4 | estrogen 16-alpha-hydroxylase activity |
| GO:0061783 | 0.0011 | 17.7929 | 0.2078 | 3 | 16 | peptidoglycan muralytic activity |
| GO:0070011 | 0.0012 | 2.8826 | 4.827 | 13 | 389 | peptidase activity, acting on L-amino acid peptides |
| GO:0015645 | 0.0021 | 13.6027 | 0.2597 | 3 | 20 | fatty acid ligase activity |
| GO:0070330 | 0.0024 | 12.8462 | 0.2727 | 3 | 21 | aromatase activity |
| GO:0005506 | 0.0033 | 3.8471 | 1.9351 | 7 | 149 | iron ion binding |
| GO:0032393 | 0.0034 | 30.7 | 0.0909 | 2 | 7 | MHC class I receptor activity |
| GO:0048018 | 0.0038 | 2.6026 | 4.8831 | 12 | 376 | receptor ligand activity |
| GO:0005539 | 0.004 | 3.3461 | 2.5325 | 8 | 195 | glycosaminoglycan binding |
| GO:0004364 | 0.0045 | 10.0502 | 0.3377 | 3 | 26 | glutathione transferase activity |
| GO:0042287 | 0.0061 | 8.8888 | 0.3766 | 3 | 29 | MHC protein binding |
| GO:0005126 | 0.0073 | 3.004 | 2.8052 | 8 | 216 | cytokine receptor binding |
| GO:0005549 | 0.0085 | 17.051 | 0.1429 | 2 | 11 | odorant binding |
| GO:0001664 | 0.0095 | 2.8643 | 2.9351 | 8 | 226 | G-protein coupled receptor binding |
| GO:0004872 | 0.0098 | 3.4924 | 1.8126 | 6 | 159 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001664 | 0 | 3.87 | 4.536 | 16 | 226 | G-protein coupled receptor binding |
| GO:0008009 | 3e-04 | 9.9103 | 0.6021 | 5 | 30 | chemokine activity |
| GO:0031727 | 4e-04 | Inf | 0.0401 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0004939 | 0.0012 | 98.2829 | 0.0602 | 2 | 3 | beta-adrenergic receptor activity |
| GO:0004252 | 0.0019 | 3.2017 | 3.3318 | 10 | 166 | serine-type endopeptidase activity |
| GO:0017171 | 0.0022 | 2.9418 | 3.974 | 11 | 198 | serine hydrolase activity |
| GO:0051380 | 0.0023 | 49.1382 | 0.0803 | 2 | 4 | norepinephrine binding |
| GO:0004527 | 0.0037 | 4.3741 | 1.4852 | 6 | 74 | exonuclease activity |
| GO:0005132 | 0.0039 | 32.7566 | 0.1004 | 2 | 5 | type I interferon receptor binding |
| GO:0004930 | 0.0051 | 2.1165 | 8.4498 | 17 | 421 | G-protein coupled receptor activity |
| GO:0055131 | 0.0057 | 24.5658 | 0.1204 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0051379 | 0.0079 | 19.6513 | 0.1405 | 2 | 7 | epinephrine binding |
| GO:0070330 | 0.0081 | 8.2079 | 0.4215 | 3 | 21 | aromatase activity |
| GO:0004872 | 0.0087 | 1.6154 | 22.2184 | 34 | 1107 | receptor activity |
| GO:0003735 | 0.009 | 2.9007 | 2.9103 | 8 | 145 | structural constituent of ribosome |
| GO:0008201 | 0.0097 | 2.8586 | 2.9504 | 8 | 147 | heparin binding |
| GO:0005126 | 0.0099 | 2.4937 | 4.2086 | 10 | 211 | cytokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 57.4124 | 0.8001 | 24 | 57 | olfactory receptor activity |
| GO:0099600 | 0 | 4.8775 | 11.8608 | 46 | 845 | transmembrane receptor activity |
| GO:0060089 | 0 | 4.2872 | 16.156 | 54 | 1151 | molecular transducer activity |
| GO:0036459 | 0 | 15.4193 | 1.5019 | 18 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0004930 | 0 | 6.5657 | 5.7459 | 31 | 413 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 4.5529 | 12.3164 | 45 | 889 | signaling receptor activity |
| GO:0008234 | 0 | 9.2316 | 2.4704 | 19 | 176 | cysteine-type peptidase activity |
| GO:0018685 | 0 | 213.7109 | 0.0561 | 3 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 0 | 213.7109 | 0.0561 | 3 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0005549 | 0 | 40.8844 | 0.1544 | 4 | 11 | odorant binding |
| GO:0004497 | 0 | 7.1682 | 1.2492 | 8 | 89 | monooxygenase activity |
| GO:0008392 | 1e-04 | 22.0059 | 0.2386 | 4 | 17 | arachidonic acid epoxygenase activity |
| GO:0004321 | 1e-04 | 53.4171 | 0.0983 | 3 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 1e-04 | 42.7308 | 0.1123 | 3 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 1e-04 | 42.7308 | 0.1123 | 3 | 8 | butyrate-CoA ligase activity |
| GO:0030246 | 2e-04 | 3.8572 | 3.3688 | 12 | 240 | carbohydrate binding |
| GO:0004507 | 2e-04 | Inf | 0.0281 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0030109 | 2e-04 | Inf | 0.0281 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0047783 | 2e-04 | Inf | 0.0281 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0016705 | 2e-04 | 4.7039 | 2.0774 | 9 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0020037 | 3e-04 | 5.1734 | 1.6844 | 8 | 120 | heme binding |
| GO:0003823 | 4e-04 | 8.9665 | 0.6316 | 5 | 45 | antigen binding |
| GO:0004867 | 6e-04 | 6.443 | 1.0247 | 6 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0004252 | 6e-04 | 4.1595 | 2.3301 | 9 | 166 | serine-type endopeptidase activity |
| GO:0030414 | 8e-04 | 4.4174 | 1.9511 | 8 | 139 | peptidase inhibitor activity |
| GO:0061135 | 8e-04 | 4.4174 | 1.9511 | 8 | 139 | endopeptidase regulator activity |
| GO:0005506 | 0.0012 | 4.1014 | 2.0914 | 8 | 149 | iron ion binding |
| GO:0008329 | 0.0013 | 16.4262 | 0.2246 | 3 | 16 | signaling pattern recognition receptor activity |
| GO:0061783 | 0.0013 | 16.4262 | 0.2246 | 3 | 16 | peptidoglycan muralytic activity |
| GO:0017171 | 0.002 | 3.4479 | 2.7792 | 9 | 198 | serine hydrolase activity |
| GO:0015645 | 0.0026 | 12.5578 | 0.2807 | 3 | 20 | fatty acid ligase activity |
| GO:0032393 | 0.0039 | 28.3528 | 0.0983 | 2 | 7 | MHC class I receptor activity |
| GO:0048020 | 0.0044 | 10.1632 | 0.3369 | 3 | 24 | CCR chemokine receptor binding |
| GO:0070011 | 0.0048 | 2.5217 | 5.0335 | 12 | 389 | peptidase activity, acting on L-amino acid peptides |
| GO:0004952 | 0.0052 | 23.6258 | 0.1123 | 2 | 8 | dopamine neurotransmitter receptor activity |
| GO:0035240 | 0.0052 | 23.6258 | 0.1123 | 2 | 8 | dopamine binding |
| GO:0045295 | 0.0082 | 17.717 | 0.1404 | 2 | 10 | gamma-catenin binding |
| GO:0008009 | 0.0084 | 7.9015 | 0.4211 | 3 | 30 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 0 | 3.5628 | 9.7862 | 31 | 400 | receptor regulator activity |
| GO:0005125 | 0 | 4.0047 | 4.1347 | 15 | 169 | cytokine activity |
| GO:0005179 | 0 | 4.882 | 2.5199 | 11 | 103 | hormone activity |
| GO:0043565 | 1e-04 | 1.9711 | 24.1963 | 44 | 989 | sequence-specific DNA binding |
| GO:0001664 | 1e-04 | 3.1294 | 5.5292 | 16 | 226 | G-protein coupled receptor binding |
| GO:0051379 | 5e-04 | 30.1399 | 0.1713 | 3 | 7 | epinephrine binding |
| GO:0005185 | 6e-04 | Inf | 0.0489 | 2 | 2 | neurohypophyseal hormone activity |
| GO:0016165 | 6e-04 | Inf | 0.0489 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0001205 | 6e-04 | 8.4064 | 0.7095 | 5 | 29 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
| GO:0102991 | 7e-04 | 24.1103 | 0.1957 | 3 | 8 | myristoyl-CoA hydrolase activity |
| GO:0004939 | 0.0018 | 80.1725 | 0.0734 | 2 | 3 | beta-adrenergic receptor activity |
| GO:0043027 | 0.0018 | 8.9461 | 0.5382 | 4 | 22 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
| GO:0016290 | 0.0021 | 15.0659 | 0.2691 | 3 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0051380 | 0.0035 | 40.0836 | 0.0979 | 2 | 4 | norepinephrine binding |
| GO:0000977 | 0.0052 | 1.8293 | 14.3612 | 25 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0005126 | 0.0056 | 2.4643 | 5.1362 | 12 | 211 | cytokine receptor binding |
| GO:0005132 | 0.0057 | 26.7206 | 0.1223 | 2 | 5 | type I interferon receptor binding |
| GO:0016019 | 0.0057 | 26.7206 | 0.1223 | 2 | 5 | peptidoglycan receptor activity |
| GO:0031694 | 0.0057 | 26.7206 | 0.1223 | 2 | 5 | alpha-2A adrenergic receptor binding |
| GO:1903231 | 0.0074 | 5.7472 | 0.7829 | 4 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0003700 | 0.0079 | 1.5447 | 28.649 | 42 | 1171 | DNA binding transcription factor activity |
| GO:0043546 | 0.0084 | 20.0391 | 0.1468 | 2 | 6 | molybdopterin cofactor binding |
| GO:0055131 | 0.0084 | 20.0391 | 0.1468 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0071837 | 0.009 | 8.0314 | 0.4404 | 3 | 18 | HMG box domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 3.4065 | 11.013 | 33 | 636 | calcium ion binding |
| GO:0008430 | 2e-04 | 43.0402 | 0.1212 | 3 | 7 | selenium binding |
| GO:0030617 | 3e-04 | Inf | 0.0346 | 2 | 2 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity |
| GO:0032394 | 3e-04 | Inf | 0.0346 | 2 | 2 | MHC class Ib receptor activity |
| GO:0034713 | 4e-04 | 28.6897 | 0.1558 | 3 | 9 | type I transforming growth factor beta receptor binding |
| GO:0004950 | 4e-04 | 13.543 | 0.3636 | 4 | 21 | chemokine receptor activity |
| GO:0005134 | 0.0018 | 57.1756 | 0.0693 | 2 | 4 | interleukin-2 receptor binding |
| GO:0070697 | 0.0018 | 57.1756 | 0.0693 | 2 | 4 | activin receptor binding |
| GO:0016174 | 0.0029 | 38.1145 | 0.0866 | 2 | 5 | NAD(P)H oxidase activity |
| GO:0004872 | 0.003 | 1.7844 | 19.1688 | 32 | 1107 | receptor activity |
| GO:0042288 | 0.0035 | 11.469 | 0.3117 | 3 | 18 | MHC class I protein binding |
| GO:0050431 | 0.0041 | 10.7514 | 0.329 | 3 | 19 | transforming growth factor beta binding |
| GO:0004601 | 0.0041 | 6.7638 | 0.658 | 4 | 38 | peroxidase activity |
| GO:0004468 | 0.0043 | 28.584 | 0.1039 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0008172 | 0.0043 | 28.584 | 0.1039 | 2 | 6 | S-methyltransferase activity |
| GO:0017134 | 0.007 | 8.5989 | 0.3983 | 3 | 23 | fibroblast growth factor binding |
| GO:0001968 | 0.0099 | 7.4758 | 0.4502 | 3 | 26 | fibronectin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0 | 4.4464 | 5.3571 | 21 | 421 | G-protein coupled receptor activity |
| GO:0004984 | 0 | 13.1692 | 0.7253 | 8 | 57 | olfactory receptor activity |
| GO:0004875 | 0 | 52.793 | 0.1272 | 4 | 10 | complement receptor activity |
| GO:0004982 | 0 | 236.4031 | 0.0509 | 3 | 4 | N-formyl peptide receptor activity |
| GO:0060089 | 0 | 2.5546 | 14.6461 | 33 | 1151 | molecular transducer activity |
| GO:0099600 | 0 | 2.8133 | 10.7523 | 27 | 845 | transmembrane receptor activity |
| GO:0015347 | 2e-04 | 16.6571 | 0.2927 | 4 | 23 | sodium-independent organic anion transmembrane transporter activity |
| GO:0005549 | 3e-04 | 29.5366 | 0.14 | 3 | 11 | odorant binding |
| GO:0005124 | 5e-04 | 156.7812 | 0.0382 | 2 | 3 | scavenger receptor binding |
| GO:0001653 | 7e-04 | 5.1796 | 1.4633 | 7 | 115 | peptide receptor activity |
| GO:0038023 | 0.0019 | 2.2045 | 9.7634 | 20 | 790 | signaling receptor activity |
| GO:0005452 | 0.003 | 11.8052 | 0.2927 | 3 | 23 | inorganic anion exchanger activity |
| GO:0031404 | 0.0032 | 31.3479 | 0.0891 | 2 | 7 | chloride ion binding |
| GO:0015301 | 0.0053 | 9.441 | 0.3563 | 3 | 28 | anion:anion antiporter activity |
| GO:0015143 | 0.0055 | 22.3884 | 0.1145 | 2 | 9 | urate transmembrane transporter activity |
| GO:0008509 | 0.0056 | 2.9111 | 3.2632 | 9 | 260 | anion transmembrane transporter activity |
| GO:0061135 | 0.0087 | 3.58 | 1.7687 | 6 | 139 | endopeptidase regulator activity |
| GO:0005283 | 0.0098 | 15.6687 | 0.1527 | 2 | 12 | sodium:amino acid symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 12.714 | 0.9721 | 10 | 57 | olfactory receptor activity |
| GO:0038023 | 0 | 2.438 | 15.4336 | 34 | 905 | signaling receptor activity |
| GO:0060089 | 0 | 2.2707 | 19.6288 | 40 | 1151 | molecular transducer activity |
| GO:0099600 | 0 | 2.4467 | 14.4103 | 32 | 845 | transmembrane receptor activity |
| GO:0004930 | 1e-04 | 2.8601 | 7.1796 | 19 | 421 | G-protein coupled receptor activity |
| GO:0061629 | 3e-04 | Inf | 0.0341 | 2 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
| GO:0005125 | 0.0025 | 3.3226 | 2.8821 | 9 | 169 | cytokine activity |
| GO:0008048 | 0.0028 | 38.7158 | 0.0853 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
| GO:0030545 | 0.0037 | 2.3219 | 6.8215 | 15 | 400 | receptor regulator activity |
| GO:0010853 | 0.0057 | 23.2264 | 0.1194 | 2 | 7 | cyclase activator activity |
| GO:0016308 | 0.0057 | 23.2264 | 0.1194 | 2 | 7 | 1-phosphatidylinositol-4-phosphate 5-kinase activity |
| GO:0030249 | 0.0076 | 19.354 | 0.1364 | 2 | 8 | guanylate cyclase regulator activity |
| GO:0015143 | 0.0096 | 16.588 | 0.1535 | 2 | 9 | urate transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 0 | 3.2553 | 6.3754 | 19 | 400 | receptor regulator activity |
| GO:0005179 | 0 | 6.1002 | 1.6417 | 9 | 103 | hormone activity |
| GO:0005126 | 2e-04 | 3.7685 | 3.4427 | 12 | 216 | cytokine receptor binding |
| GO:0017159 | 3e-04 | Inf | 0.0319 | 2 | 2 | pantetheine hydrolase activity |
| GO:0031727 | 3e-04 | Inf | 0.0319 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0048020 | 4e-04 | 14.0506 | 0.3478 | 4 | 22 | CCR chemokine receptor binding |
| GO:0008009 | 0.0012 | 9.6408 | 0.4782 | 4 | 30 | chemokine activity |
| GO:0001664 | 0.0013 | 3.3667 | 3.1693 | 10 | 201 | G-protein coupled receptor binding |
| GO:0005198 | 0.0022 | 2.1604 | 9.8501 | 20 | 618 | structural molecule activity |
| GO:0008327 | 0.0032 | 11.7086 | 0.3028 | 3 | 19 | methyl-CpG binding |
| GO:0046906 | 0.0044 | 3.6481 | 2.0401 | 7 | 128 | tetrapyrrole binding |
| GO:0001228 | 0.0045 | 2.3463 | 6.2957 | 14 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0004966 | 0.005 | 24.8929 | 0.1116 | 2 | 7 | galanin receptor activity |
| GO:0032395 | 0.005 | 24.8929 | 0.1116 | 2 | 7 | MHC class II receptor activity |
| GO:0060089 | 0.0052 | 1.7442 | 18.3453 | 30 | 1151 | molecular transducer activity |
| GO:0004415 | 0.0066 | 20.7427 | 0.1275 | 2 | 8 | hyalurononglucosaminidase activity |
| GO:0071855 | 0.0071 | 8.5119 | 0.3985 | 3 | 25 | neuropeptide receptor binding |
| GO:0004930 | 0.0077 | 2.1925 | 6.7102 | 14 | 421 | G-protein coupled receptor activity |
| GO:0008201 | 0.0093 | 3.1489 | 2.343 | 7 | 147 | heparin binding |
| GO:0038023 | 0.01 | 1.7567 | 14.4244 | 24 | 905 | signaling receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008392 | 2e-04 | 16.3088 | 0.3189 | 4 | 17 | arachidonic acid epoxygenase activity |
| GO:0000981 | 3e-04 | 2.2109 | 13.6566 | 28 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0001632 | 4e-04 | Inf | 0.0375 | 2 | 2 | leukotriene B4 receptor activity |
| GO:0031727 | 4e-04 | Inf | 0.0375 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0048018 | 8e-04 | 2.5703 | 7.0534 | 17 | 376 | receptor ligand activity |
| GO:0019825 | 0.001 | 7.3764 | 0.7691 | 5 | 41 | oxygen binding |
| GO:0005132 | 0.0034 | 35.1103 | 0.0938 | 2 | 5 | type I interferon receptor binding |
| GO:0015272 | 0.0034 | 35.1103 | 0.0938 | 2 | 5 | ATP-activated inward rectifier potassium channel activity |
| GO:0000977 | 0.0036 | 2.0153 | 11.0115 | 21 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0070888 | 0.0049 | 6.4161 | 0.6941 | 4 | 37 | E-box binding |
| GO:0001848 | 0.0051 | 9.9011 | 0.3564 | 3 | 19 | complement binding |
| GO:0004497 | 0.0065 | 3.8409 | 1.6696 | 6 | 89 | monooxygenase activity |
| GO:1990837 | 0.0068 | 1.8393 | 13.1688 | 23 | 702 | sequence-specific double-stranded DNA binding |
| GO:0098634 | 0.0069 | 21.0634 | 0.1313 | 2 | 7 | cell-matrix adhesion mediator activity |
| GO:0008199 | 0.0091 | 17.5516 | 0.1501 | 2 | 8 | ferric iron binding |
| GO:0035240 | 0.0091 | 17.5516 | 0.1501 | 2 | 8 | dopamine binding |
| GO:0008374 | 0.0091 | 5.2908 | 0.8254 | 4 | 44 | O-acyltransferase activity |
| GO:0004872 | 0.0097 | 1.6272 | 20.7662 | 32 | 1107 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038023 | 2e-04 | 2.0731 | 18.2828 | 35 | 905 | signaling receptor activity |
| GO:0099600 | 2e-04 | 2.0876 | 17.0707 | 33 | 845 | transmembrane receptor activity |
| GO:0004930 | 4e-04 | 2.8051 | 6.1067 | 16 | 307 | G-protein coupled receptor activity |
| GO:0047961 | 0.0024 | 48.8105 | 0.0808 | 2 | 4 | glycine N-acyltransferase activity |
| GO:0060089 | 0.0033 | 1.6943 | 23.2525 | 37 | 1151 | molecular transducer activity |
| GO:0002151 | 0.0039 | 32.5381 | 0.101 | 2 | 5 | G-quadruplex RNA binding |
| GO:0043565 | 0.0057 | 1.6938 | 19.9798 | 32 | 989 | sequence-specific DNA binding |
| GO:0030250 | 0.008 | 19.5203 | 0.1414 | 2 | 7 | guanylate cyclase activator activity |
| GO:0042813 | 0.0083 | 8.153 | 0.4242 | 3 | 21 | Wnt-activated receptor activity |
| GO:0008528 | 0.0084 | 3.2234 | 2.303 | 7 | 114 | G-protein coupled peptide receptor activity |
| GO:0004175 | 0.0093 | 2.079 | 7.5556 | 15 | 374 | endopeptidase activity |
| GO:0008138 | 0.01 | 5.1593 | 0.8485 | 4 | 42 | protein tyrosine/serine/threonine phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 2.9602 | 24.4558 | 62 | 989 | sequence-specific DNA binding |
| GO:0000981 | 0 | 2.6658 | 18.0018 | 43 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0140110 | 0 | 1.9791 | 37.2401 | 66 | 1506 | transcription regulator activity |
| GO:1903231 | 0 | 11.2333 | 0.7913 | 7 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0001077 | 0 | 3.1811 | 6.5034 | 19 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0030545 | 1e-04 | 2.6206 | 9.8911 | 24 | 400 | receptor regulator activity |
| GO:0001012 | 3e-04 | 2.1333 | 14.5399 | 29 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0001785 | 6e-04 | Inf | 0.0495 | 2 | 2 | prostaglandin J receptor activity |
| GO:0004956 | 6e-04 | Inf | 0.0495 | 2 | 2 | prostaglandin D receptor activity |
| GO:0016165 | 6e-04 | Inf | 0.0495 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0071837 | 9e-04 | 11.3788 | 0.4451 | 4 | 18 | HMG box domain binding |
| GO:0000975 | 0.001 | 1.8561 | 20.079 | 35 | 812 | regulatory region DNA binding |
| GO:0000976 | 0.0011 | 1.938 | 16.444 | 30 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0019840 | 0.0012 | 7.1241 | 0.816 | 5 | 33 | isoprenoid binding |
| GO:0031490 | 0.0023 | 3.7267 | 2.3244 | 8 | 94 | chromatin DNA binding |
| GO:0008401 | 0.0035 | 39.6453 | 0.0989 | 2 | 4 | retinoic acid 4-hydroxylase activity |
| GO:0008191 | 0.0036 | 11.919 | 0.3215 | 3 | 13 | metalloendopeptidase inhibitor activity |
| GO:0004872 | 0.0037 | 1.625 | 27.3737 | 42 | 1107 | receptor activity |
| GO:0001159 | 0.0043 | 2.1045 | 9.0009 | 18 | 364 | core promoter proximal region DNA binding |
| GO:0019838 | 0.0043 | 3.0573 | 3.1404 | 9 | 127 | growth factor binding |
| GO:0016918 | 0.0045 | 10.8347 | 0.3462 | 3 | 14 | retinal binding |
| GO:0005132 | 0.0058 | 26.4284 | 0.1236 | 2 | 5 | type I interferon receptor binding |
| GO:0016019 | 0.0058 | 26.4284 | 0.1236 | 2 | 5 | peptidoglycan receptor activity |
| GO:0000978 | 0.0061 | 2.0741 | 8.6053 | 17 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0008528 | 0.0074 | 3.0195 | 2.819 | 8 | 114 | G-protein coupled peptide receptor activity |
| GO:0004888 | 0.0091 | 1.6405 | 19.807 | 31 | 801 | transmembrane signaling receptor activity |
| GO:0001972 | 0.0093 | 7.9433 | 0.4451 | 3 | 18 | retinoic acid binding |
| GO:0005212 | 0.0093 | 7.9433 | 0.4451 | 3 | 18 | structural constituent of eye lens |
| GO:0005125 | 0.0094 | 2.5209 | 4.179 | 10 | 169 | cytokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 1e-04 | 2.8409 | 8.008 | 21 | 421 | G-protein coupled receptor activity |
| GO:0033872 | 4e-04 | Inf | 0.038 | 2 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
| GO:0036461 | 4e-04 | Inf | 0.038 | 2 | 2 | BLOC-2 complex binding |
| GO:0004984 | 7e-04 | 6.1744 | 1.0842 | 6 | 57 | olfactory receptor activity |
| GO:0005549 | 0.001 | 19.5314 | 0.2092 | 3 | 11 | odorant binding |
| GO:0017153 | 0.0011 | 103.8542 | 0.0571 | 2 | 3 | sodium:dicarboxylate symporter activity |
| GO:0035651 | 0.0011 | 103.8542 | 0.0571 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 0.0021 | 51.9236 | 0.0761 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0043565 | 0.0023 | 1.8143 | 18.8121 | 32 | 989 | sequence-specific DNA binding |
| GO:0048018 | 0.0023 | 2.3676 | 7.152 | 16 | 376 | receptor ligand activity |
| GO:0005267 | 0.0028 | 3.5673 | 2.3967 | 8 | 126 | potassium channel activity |
| GO:0022843 | 0.0033 | 3.4781 | 2.4538 | 8 | 129 | voltage-gated cation channel activity |
| GO:0071837 | 0.0045 | 10.4118 | 0.3424 | 3 | 18 | HMG box domain binding |
| GO:0099600 | 0.0059 | 1.7744 | 16.0731 | 27 | 845 | transmembrane receptor activity |
| GO:0005251 | 0.0061 | 9.1857 | 0.3804 | 3 | 20 | delayed rectifier potassium channel activity |
| GO:0099106 | 0.007 | 3.7858 | 1.6929 | 6 | 89 | ion channel regulator activity |
| GO:0008467 | 0.0071 | 20.7653 | 0.1331 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
| GO:0031433 | 0.0071 | 20.7653 | 0.1331 | 2 | 7 | telethonin binding |
| GO:0038023 | 0.0077 | 1.7157 | 17.2144 | 28 | 905 | signaling receptor activity |
| GO:0001228 | 0.0088 | 2.0922 | 7.5134 | 15 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 5e-04 | Inf | 0.0449 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0019841 | 0.0027 | 13.1805 | 0.2916 | 3 | 13 | retinol binding |
| GO:0034617 | 0.0029 | 43.8294 | 0.0897 | 2 | 4 | tetrahydrobiopterin binding |
| GO:0015301 | 0.0033 | 7.3373 | 0.6281 | 4 | 28 | anion:anion antiporter activity |
| GO:0046870 | 0.0071 | 21.9118 | 0.1346 | 2 | 6 | cadmium ion binding |
| GO:0005179 | 0.0085 | 3.2231 | 2.3105 | 7 | 103 | hormone activity |
| GO:0015276 | 0.0086 | 2.9263 | 2.8937 | 8 | 129 | ligand-gated ion channel activity |
| GO:0043565 | 0.0087 | 1.6124 | 22.1854 | 34 | 989 | sequence-specific DNA binding |
| GO:0004984 | 0.0089 | 4.2376 | 1.2786 | 5 | 57 | olfactory receptor activity |
| GO:0004966 | 0.0098 | 17.5282 | 0.157 | 2 | 7 | galanin receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 46.5457 | 0.7814 | 21 | 57 | olfactory receptor activity |
| GO:0036459 | 0 | 13.6159 | 1.4668 | 16 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0099600 | 0 | 4.1845 | 11.5837 | 40 | 845 | transmembrane receptor activity |
| GO:0004930 | 0 | 5.7643 | 5.7713 | 28 | 421 | G-protein coupled receptor activity |
| GO:0060089 | 0 | 3.5581 | 15.7785 | 46 | 1151 | molecular transducer activity |
| GO:0008234 | 0 | 8.8747 | 2.4127 | 18 | 176 | cysteine-type peptidase activity |
| GO:0038023 | 0 | 3.7671 | 12.0246 | 38 | 889 | signaling receptor activity |
| GO:0004252 | 0 | 7.0307 | 2.2756 | 14 | 166 | serine-type endopeptidase activity |
| GO:0017171 | 0 | 5.7955 | 2.7143 | 14 | 198 | serine hydrolase activity |
| GO:0004497 | 0 | 7.3489 | 1.2201 | 8 | 89 | monooxygenase activity |
| GO:0070011 | 0 | 3.5557 | 4.9303 | 16 | 389 | peptidase activity, acting on L-amino acid peptides |
| GO:0004321 | 1e-04 | 54.7318 | 0.096 | 3 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 1e-04 | 43.7825 | 0.1097 | 3 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 1e-04 | 43.7825 | 0.1097 | 3 | 8 | butyrate-CoA ligase activity |
| GO:0004507 | 2e-04 | Inf | 0.0274 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0030109 | 2e-04 | Inf | 0.0274 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0031727 | 2e-04 | Inf | 0.0274 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0047783 | 2e-04 | Inf | 0.0274 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0048020 | 2e-04 | 16.4412 | 0.2987 | 4 | 22 | CCR chemokine receptor binding |
| GO:0016705 | 2e-04 | 4.8231 | 2.0289 | 9 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0001530 | 3e-04 | 14.6507 | 0.329 | 4 | 24 | lipopolysaccharide binding |
| GO:0008009 | 7e-04 | 11.2653 | 0.4113 | 4 | 30 | chemokine activity |
| GO:0018685 | 0.0011 | 72.6329 | 0.0548 | 2 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 0.0011 | 72.6329 | 0.0548 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0008329 | 0.0012 | 16.8305 | 0.2193 | 3 | 16 | signaling pattern recognition receptor activity |
| GO:0020037 | 0.0013 | 4.5767 | 1.645 | 7 | 120 | heme binding |
| GO:0004866 | 0.0024 | 4.1009 | 1.8232 | 7 | 133 | endopeptidase inhibitor activity |
| GO:0015645 | 0.0024 | 12.8669 | 0.2742 | 3 | 20 | fatty acid ligase activity |
| GO:0003823 | 0.0033 | 7.1367 | 0.6169 | 4 | 45 | antigen binding |
| GO:0032393 | 0.0038 | 29.0473 | 0.096 | 2 | 7 | MHC class I receptor activity |
| GO:0005506 | 0.0045 | 3.635 | 2.0426 | 7 | 149 | iron ion binding |
| GO:0005539 | 0.0055 | 3.1607 | 2.6732 | 8 | 195 | glycosaminoglycan binding |
| GO:0070492 | 0.0063 | 20.7453 | 0.1234 | 2 | 9 | oligosaccharide binding |
| GO:0042056 | 0.0065 | 8.7449 | 0.3838 | 3 | 28 | chemoattractant activity |
| GO:0005549 | 0.0095 | 16.1331 | 0.1508 | 2 | 11 | odorant binding |
| GO:0061134 | 0.0099 | 3.1044 | 2.3716 | 7 | 173 | peptidase regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 69.2031 | 0.83 | 27 | 57 | olfactory receptor activity |
| GO:0004872 | 0 | 4.8271 | 16.1192 | 59 | 1107 | receptor activity |
| GO:0004930 | 0 | 7.0605 | 5.9627 | 34 | 413 | G-protein coupled receptor activity |
| GO:0036459 | 0 | 14.8067 | 1.558 | 18 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0004871 | 0 | 3.5813 | 17.5608 | 51 | 1206 | signal transducer activity |
| GO:0008234 | 0 | 8.863 | 2.5628 | 19 | 176 | cysteine-type peptidase activity |
| GO:0004321 | 0 | 91.8716 | 0.1019 | 4 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 0 | 68.8991 | 0.1165 | 4 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0 | 68.8991 | 0.1165 | 4 | 8 | butyrate-CoA ligase activity |
| GO:0005549 | 0 | 39.363 | 0.1602 | 4 | 11 | odorant binding |
| GO:0030246 | 0 | 4.2633 | 3.3353 | 13 | 231 | carbohydrate binding |
| GO:0004252 | 2e-04 | 4.4956 | 2.4172 | 10 | 166 | serine-type endopeptidase activity |
| GO:0015645 | 2e-04 | 17.211 | 0.2912 | 4 | 20 | fatty acid ligase activity |
| GO:0004507 | 2e-04 | Inf | 0.0291 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0030109 | 2e-04 | Inf | 0.0291 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0047783 | 2e-04 | Inf | 0.0291 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0004497 | 3e-04 | 5.9327 | 1.2959 | 7 | 89 | monooxygenase activity |
| GO:0003823 | 5e-04 | 8.6313 | 0.6553 | 5 | 45 | antigen binding |
| GO:0017171 | 7e-04 | 3.7224 | 2.8831 | 10 | 198 | serine hydrolase activity |
| GO:0004867 | 7e-04 | 6.2011 | 1.063 | 6 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0030414 | 0.001 | 4.25 | 2.024 | 8 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0.001 | 4.25 | 2.024 | 8 | 139 | endopeptidase regulator activity |
| GO:0018685 | 0.0012 | 68.2818 | 0.0582 | 2 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 0.0012 | 68.2818 | 0.0582 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0016705 | 0.0015 | 3.9744 | 2.1551 | 8 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0008329 | 0.0015 | 15.8177 | 0.233 | 3 | 16 | signaling pattern recognition receptor activity |
| GO:0061783 | 0.0015 | 15.8177 | 0.233 | 3 | 16 | peptidoglycan muralytic activity |
| GO:0008392 | 0.0018 | 14.6869 | 0.2475 | 3 | 17 | arachidonic acid epoxygenase activity |
| GO:0020037 | 0.0019 | 4.2962 | 1.7473 | 7 | 120 | heme binding |
| GO:0070011 | 0.0024 | 2.6369 | 5.24 | 13 | 389 | peptidase activity, acting on L-amino acid peptides |
| GO:0032393 | 0.0042 | 27.3073 | 0.1019 | 2 | 7 | MHC class I receptor activity |
| GO:0048020 | 0.0049 | 9.7867 | 0.3495 | 3 | 24 | CCR chemokine receptor binding |
| GO:0004952 | 0.0056 | 22.7545 | 0.1165 | 2 | 8 | dopamine neurotransmitter receptor activity |
| GO:0035240 | 0.0056 | 22.7545 | 0.1165 | 2 | 8 | dopamine binding |
| GO:0005506 | 0.0062 | 3.4122 | 2.1696 | 7 | 149 | iron ion binding |
| GO:0004888 | 0.007 | 2.5068 | 4.6317 | 11 | 373 | transmembrane signaling receptor activity |
| GO:0070492 | 0.0071 | 19.5026 | 0.1311 | 2 | 9 | oligosaccharide binding |
| GO:0030280 | 0.0088 | 17.0636 | 0.1456 | 2 | 10 | structural constituent of epidermis |
| GO:0045295 | 0.0088 | 17.0636 | 0.1456 | 2 | 10 | gamma-catenin binding |
| GO:0008009 | 0.0093 | 7.6088 | 0.4368 | 3 | 30 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 3e-04 | 1.9153 | 22.5097 | 40 | 989 | sequence-specific DNA binding |
| GO:0031727 | 5e-04 | Inf | 0.0455 | 2 | 2 | CCR2 chemokine receptor binding |
| GO:0004939 | 0.0015 | 86.3652 | 0.0683 | 2 | 3 | beta-adrenergic receptor activity |
| GO:0008201 | 0.002 | 3.1974 | 3.3457 | 10 | 147 | heparin binding |
| GO:0042379 | 0.002 | 6.2089 | 0.9104 | 5 | 40 | chemokine receptor binding |
| GO:0000981 | 0.0025 | 1.8526 | 16.5693 | 29 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0051380 | 0.003 | 43.1797 | 0.091 | 2 | 4 | norepinephrine binding |
| GO:0000975 | 0.0034 | 1.7734 | 18.4812 | 31 | 812 | regulatory region DNA binding |
| GO:0004930 | 0.0037 | 2.089 | 9.582 | 19 | 421 | G-protein coupled receptor activity |
| GO:0030545 | 0.0048 | 2.0792 | 9.104 | 18 | 400 | receptor regulator activity |
| GO:0005132 | 0.0049 | 28.7845 | 0.1138 | 2 | 5 | type I interferon receptor binding |
| GO:0031694 | 0.0049 | 28.7845 | 0.1138 | 2 | 5 | alpha-2A adrenergic receptor binding |
| GO:0005125 | 0.0054 | 2.7509 | 3.8465 | 10 | 169 | cytokine activity |
| GO:0003735 | 0.006 | 2.8904 | 3.3002 | 9 | 145 | structural constituent of ribosome |
| GO:0099600 | 0.006 | 1.6975 | 19.2323 | 31 | 845 | transmembrane receptor activity |
| GO:0008301 | 0.0063 | 9.2722 | 0.3869 | 3 | 17 | DNA binding, bending |
| GO:0003690 | 0.0063 | 1.7228 | 17.7073 | 29 | 778 | double-stranded DNA binding |
| GO:0055131 | 0.0073 | 21.587 | 0.1366 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0071837 | 0.0074 | 8.6535 | 0.4097 | 3 | 18 | HMG box domain binding |
| GO:0038023 | 0.0089 | 1.6321 | 20.5979 | 32 | 905 | signaling receptor activity |
| GO:0001664 | 0.0095 | 2.5137 | 4.1833 | 10 | 186 | G-protein coupled receptor binding |
| GO:0000976 | 0.0098 | 1.7298 | 15.1354 | 25 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0004806 | 0.01 | 7.6344 | 0.4552 | 3 | 20 | triglyceride lipase activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048514 | 0 | 2.5558 | 16.8898 | 39 | 440 | blood vessel morphogenesis |
| GO:0072359 | 0 | 1.9755 | 30.9775 | 56 | 807 | circulatory system development |
| GO:2000026 | 0 | 1.6941 | 58.5386 | 90 | 1525 | regulation of multicellular organismal development |
| GO:0001944 | 0 | 2.1887 | 19.3787 | 39 | 508 | vasculature development |
| GO:0048568 | 0 | 2.3675 | 14.2412 | 31 | 371 | embryonic organ development |
| GO:0051674 | 1e-04 | 1.7147 | 44.3358 | 70 | 1155 | localization of cell |
| GO:0048706 | 1e-04 | 3.6518 | 4.2992 | 14 | 112 | embryonic skeletal system development |
| GO:0048646 | 1e-04 | 1.8223 | 31.3931 | 53 | 828 | anatomical structure formation involved in morphogenesis |
| GO:0003199 | 2e-04 | 75.5941 | 0.1535 | 3 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0042126 | 2e-04 | 75.5941 | 0.1535 | 3 | 4 | nitrate metabolic process |
| GO:0097176 | 2e-04 | 75.5941 | 0.1535 | 3 | 4 | epoxide metabolic process |
| GO:2000145 | 3e-04 | 1.8772 | 23.9912 | 42 | 625 | regulation of cell motility |
| GO:0034103 | 3e-04 | 4.6662 | 2.2264 | 9 | 58 | regulation of tissue remodeling |
| GO:0008217 | 3e-04 | 3.1918 | 4.8366 | 14 | 126 | regulation of blood pressure |
| GO:0045766 | 4e-04 | 3.3497 | 4.2992 | 13 | 112 | positive regulation of angiogenesis |
| GO:0010755 | 4e-04 | 16.8254 | 0.3839 | 4 | 10 | regulation of plasminogen activation |
| GO:0021877 | 4e-04 | 16.8254 | 0.3839 | 4 | 10 | forebrain neuron fate commitment |
| GO:0007389 | 4e-04 | 2.151 | 13.9725 | 28 | 364 | pattern specification process |
| GO:0042445 | 4e-04 | 3.1078 | 4.9518 | 14 | 129 | hormone metabolic process |
| GO:0006954 | 5e-04 | 1.9866 | 17.7727 | 33 | 463 | inflammatory response |
| GO:0030198 | 6e-04 | 2.3743 | 9.5197 | 21 | 248 | extracellular matrix organization |
| GO:0009887 | 7e-04 | 1.7022 | 31.3613 | 50 | 817 | animal organ morphogenesis |
| GO:0030194 | 8e-04 | 8.4235 | 0.7677 | 5 | 20 | positive regulation of blood coagulation |
| GO:0043433 | 0.001 | 3.1499 | 4.1841 | 12 | 109 | negative regulation of DNA binding transcription factor activity |
| GO:0022610 | 0.001 | 1.5999 | 40.0366 | 60 | 1043 | biological adhesion |
| GO:0046394 | 0.001 | 2.2626 | 9.942 | 21 | 259 | carboxylic acid biosynthetic process |
| GO:0035360 | 0.001 | 25.1941 | 0.2303 | 3 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0006590 | 0.0012 | 11.2143 | 0.499 | 4 | 13 | thyroid hormone generation |
| GO:0072148 | 0.0012 | 11.2143 | 0.499 | 4 | 13 | epithelial cell fate commitment |
| GO:0038111 | 0.0014 | 5.6215 | 1.2667 | 6 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0014 | 5.6215 | 1.2667 | 6 | 33 | response to interleukin-7 |
| GO:0045597 | 0.0014 | 1.685 | 28.3672 | 45 | 739 | positive regulation of cell differentiation |
| GO:0003342 | 0.0015 | Inf | 0.0768 | 2 | 2 | proepicardium development |
| GO:0060838 | 0.0015 | Inf | 0.0768 | 2 | 2 | lymphatic endothelial cell fate commitment |
| GO:1901731 | 0.0015 | Inf | 0.0768 | 2 | 2 | positive regulation of platelet aggregation |
| GO:0042471 | 0.0015 | 3.1426 | 3.8386 | 11 | 100 | ear morphogenesis |
| GO:0040017 | 0.0016 | 1.9618 | 14.6251 | 27 | 381 | positive regulation of locomotion |
| GO:0048856 | 0.0017 | 1.3285 | 161.2302 | 192 | 4293 | anatomical structure development |
| GO:0050678 | 0.0017 | 2.261 | 8.9823 | 19 | 234 | regulation of epithelial cell proliferation |
| GO:0006805 | 0.0018 | 3.9765 | 2.2648 | 8 | 59 | xenobiotic metabolic process |
| GO:0045596 | 0.0018 | 1.7988 | 20.0375 | 34 | 522 | negative regulation of cell differentiation |
| GO:0060562 | 0.0019 | 2.1432 | 10.441 | 21 | 272 | epithelial tube morphogenesis |
| GO:0060706 | 0.0019 | 6.648 | 0.9213 | 5 | 24 | cell differentiation involved in embryonic placenta development |
| GO:0051272 | 0.0019 | 1.9651 | 14.0493 | 26 | 366 | positive regulation of cellular component movement |
| GO:0009792 | 0.002 | 1.8037 | 19.3849 | 33 | 505 | embryo development ending in birth or egg hatching |
| GO:0048598 | 0.0022 | 1.8138 | 18.6879 | 32 | 490 | embryonic morphogenesis |
| GO:0051240 | 0.0022 | 1.5149 | 45.6383 | 65 | 1195 | positive regulation of multicellular organismal process |
| GO:0043535 | 0.0022 | 3.8258 | 2.3415 | 8 | 61 | regulation of blood vessel endothelial cell migration |
| GO:0072593 | 0.0023 | 2.3216 | 7.8307 | 17 | 204 | reactive oxygen species metabolic process |
| GO:0050867 | 0.0025 | 2.2326 | 8.5985 | 18 | 224 | positive regulation of cell activation |
| GO:0001667 | 0.0026 | 2.0839 | 10.7097 | 21 | 279 | ameboidal-type cell migration |
| GO:0008206 | 0.0026 | 4.8946 | 1.4203 | 6 | 37 | bile acid metabolic process |
| GO:0050829 | 0.0026 | 4.8946 | 1.4203 | 6 | 37 | defense response to Gram-negative bacterium |
| GO:0009651 | 0.0027 | 8.4087 | 0.6142 | 4 | 16 | response to salt stress |
| GO:0060982 | 0.0027 | 15.1141 | 0.3071 | 3 | 8 | coronary artery morphogenesis |
| GO:1905205 | 0.0027 | 15.1141 | 0.3071 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0030335 | 0.0032 | 1.9411 | 13.0896 | 24 | 341 | positive regulation of cell migration |
| GO:0003158 | 0.0032 | 3.0221 | 3.6083 | 10 | 94 | endothelium development |
| GO:0070286 | 0.0033 | 5.7401 | 1.0364 | 5 | 27 | axonemal dynein complex assembly |
| GO:0006631 | 0.0033 | 2.0355 | 10.94 | 21 | 285 | fatty acid metabolic process |
| GO:0043542 | 0.0034 | 2.5446 | 5.4892 | 13 | 143 | endothelial cell migration |
| GO:0010632 | 0.0034 | 2.4419 | 6.1418 | 14 | 160 | regulation of epithelial cell migration |
| GO:0048701 | 0.0034 | 4.5972 | 1.4971 | 6 | 39 | embryonic cranial skeleton morphogenesis |
| GO:0031638 | 0.0039 | 5.4901 | 1.0748 | 5 | 28 | zymogen activation |
| GO:0003207 | 0.004 | 12.5941 | 0.3455 | 3 | 9 | cardiac chamber formation |
| GO:0060900 | 0.004 | 12.5941 | 0.3455 | 3 | 9 | embryonic camera-type eye formation |
| GO:0061029 | 0.004 | 12.5941 | 0.3455 | 3 | 9 | eyelid development in camera-type eye |
| GO:1903244 | 0.004 | 12.5941 | 0.3455 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0009410 | 0.004 | 3.4351 | 2.5719 | 8 | 67 | response to xenobiotic stimulus |
| GO:0009611 | 0.0042 | 1.7263 | 19.5385 | 32 | 509 | response to wounding |
| GO:0034112 | 0.0043 | 50.496 | 0.1147 | 2 | 3 | positive regulation of homotypic cell-cell adhesion |
| GO:2000778 | 0.0043 | 7.2063 | 0.6909 | 4 | 18 | positive regulation of interleukin-6 secretion |
| GO:0003219 | 0.0043 | 50.2964 | 0.1152 | 2 | 3 | cardiac right ventricle formation |
| GO:0033128 | 0.0043 | 50.2964 | 0.1152 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0051410 | 0.0043 | 50.2964 | 0.1152 | 2 | 3 | detoxification of nitrogen compound |
| GO:0055005 | 0.0043 | 50.2964 | 0.1152 | 2 | 3 | ventricular cardiac myofibril assembly |
| GO:0061044 | 0.0043 | 50.2964 | 0.1152 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0070634 | 0.0043 | 50.2964 | 0.1152 | 2 | 3 | transepithelial ammonium transport |
| GO:2001199 | 0.0043 | 50.2964 | 0.1152 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0010810 | 0.0043 | 2.4679 | 5.6427 | 13 | 147 | regulation of cell-substrate adhesion |
| GO:0045785 | 0.0044 | 1.9818 | 11.2087 | 21 | 292 | positive regulation of cell adhesion |
| GO:0032309 | 0.0045 | 5.2609 | 1.1132 | 5 | 29 | icosanoid secretion |
| GO:0006575 | 0.0048 | 2.5415 | 5.0669 | 12 | 132 | cellular modified amino acid metabolic process |
| GO:0051893 | 0.005 | 4.2131 | 1.6122 | 6 | 42 | regulation of focal adhesion assembly |
| GO:0007162 | 0.0051 | 2.2472 | 7.1014 | 15 | 185 | negative regulation of cell adhesion |
| GO:0018958 | 0.0052 | 3.2681 | 2.687 | 8 | 70 | phenol-containing compound metabolic process |
| GO:0090103 | 0.0053 | 6.7254 | 0.7293 | 4 | 19 | cochlea morphogenesis |
| GO:1901571 | 0.0053 | 5.0501 | 1.1516 | 5 | 30 | fatty acid derivative transport |
| GO:0006334 | 0.0053 | 2.6351 | 4.4912 | 11 | 117 | nucleosome assembly |
| GO:0009605 | 0.0055 | 1.4014 | 59.767 | 79 | 1557 | response to external stimulus |
| GO:0003157 | 0.0055 | 10.7941 | 0.3839 | 3 | 10 | endocardium development |
| GO:0071941 | 0.0055 | 10.7941 | 0.3839 | 3 | 10 | nitrogen cycle metabolic process |
| GO:0097154 | 0.0055 | 10.7941 | 0.3839 | 3 | 10 | GABAergic neuron differentiation |
| GO:0006928 | 0.0055 | 1.4591 | 44.9487 | 62 | 1200 | movement of cell or subcellular component |
| GO:0090132 | 0.0057 | 2.1572 | 7.8691 | 16 | 205 | epithelium migration |
| GO:0048839 | 0.006 | 2.361 | 5.8731 | 13 | 153 | inner ear development |
| GO:0048583 | 0.0063 | 1.2983 | 117.8449 | 142 | 3070 | regulation of response to stimulus |
| GO:0031341 | 0.0063 | 3.9908 | 1.689 | 6 | 44 | regulation of cell killing |
| GO:0051241 | 0.0064 | 1.526 | 32.3978 | 47 | 844 | negative regulation of multicellular organismal process |
| GO:0070887 | 0.0064 | 1.3304 | 89.0938 | 111 | 2321 | cellular response to chemical stimulus |
| GO:0045765 | 0.0068 | 2.8683 | 3.3951 | 9 | 90 | regulation of angiogenesis |
| GO:0001890 | 0.0068 | 2.5384 | 4.6447 | 11 | 121 | placenta development |
| GO:0030168 | 0.0072 | 2.5154 | 4.6831 | 11 | 122 | platelet activation |
| GO:0014744 | 0.0074 | 9.4441 | 0.4222 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0021783 | 0.0074 | 9.4441 | 0.4222 | 3 | 11 | preganglionic parasympathetic fiber development |
| GO:1900025 | 0.0074 | 9.4441 | 0.4222 | 3 | 11 | negative regulation of substrate adhesion-dependent cell spreading |
| GO:0021761 | 0.0076 | 2.8156 | 3.4547 | 9 | 90 | limbic system development |
| GO:0060037 | 0.0076 | 5.9332 | 0.8061 | 4 | 21 | pharyngeal system development |
| GO:0060055 | 0.0076 | 5.9332 | 0.8061 | 4 | 21 | angiogenesis involved in wound healing |
| GO:0003208 | 0.0078 | 3.3409 | 2.3032 | 7 | 60 | cardiac ventricle morphogenesis |
| GO:0007599 | 0.0079 | 1.939 | 10.3258 | 19 | 269 | hemostasis |
| GO:0050817 | 0.0079 | 1.939 | 10.3258 | 19 | 269 | coagulation |
| GO:0006082 | 0.0082 | 1.4841 | 35.3919 | 50 | 922 | organic acid metabolic process |
| GO:0006629 | 0.0082 | 1.4437 | 42.263 | 58 | 1101 | lipid metabolic process |
| GO:0002003 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | angiotensin maturation |
| GO:0002583 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | regulation of antigen processing and presentation of peptide antigen |
| GO:0003253 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0021648 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0033353 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | S-adenosylmethionine cycle |
| GO:0043622 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | cortical microtubule organization |
| GO:0051122 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060214 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | endocardium formation |
| GO:0060455 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | negative regulation of gastric acid secretion |
| GO:0071502 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | cellular response to temperature stimulus |
| GO:2000977 | 0.0084 | 25.1462 | 0.1535 | 2 | 4 | regulation of forebrain neuron differentiation |
| GO:0001945 | 0.0091 | 5.6032 | 0.8445 | 4 | 22 | lymph vessel development |
| GO:0050900 | 0.0093 | 1.8695 | 11.2471 | 20 | 293 | leukocyte migration |
| GO:0006690 | 0.0099 | 2.8928 | 2.9941 | 8 | 78 | icosanoid metabolic process |
| GO:0050671 | 0.01 | 2.6823 | 3.6083 | 9 | 94 | positive regulation of lymphocyte proliferation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 20.9895 | 0.7712 | 12 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 10.1514 | 1.6566 | 14 | 116 | sensory perception of chemical stimulus |
| GO:0009593 | 0 | 11.397 | 1.3853 | 13 | 97 | detection of chemical stimulus |
| GO:0050906 | 0 | 9.0498 | 1.5567 | 12 | 109 | detection of stimulus involved in sensory perception |
| GO:0031338 | 0 | 12.2566 | 0.8854 | 9 | 62 | regulation of vesicle fusion |
| GO:0002227 | 0 | 32.1986 | 0.2285 | 5 | 16 | innate immune response in mucosa |
| GO:0090630 | 0 | 9.009 | 1.1568 | 9 | 81 | activation of GTPase activity |
| GO:0006968 | 0 | 17.0754 | 0.4427 | 6 | 31 | cellular defense response |
| GO:0002251 | 0 | 20.8248 | 0.3142 | 5 | 22 | organ or tissue specific immune response |
| GO:0007186 | 0 | 3.0151 | 8.5289 | 23 | 610 | G-protein coupled receptor signaling pathway |
| GO:0050830 | 1e-04 | 9.2651 | 0.7426 | 6 | 52 | defense response to Gram-positive bacterium |
| GO:0097530 | 1e-04 | 7.1291 | 1.0997 | 7 | 77 | granulocyte migration |
| GO:0050832 | 1e-04 | 18.782 | 0.2713 | 4 | 19 | defense response to fungus |
| GO:0090174 | 2e-04 | 4.8913 | 2.0137 | 9 | 141 | organelle membrane fusion |
| GO:0044657 | 2e-04 | Inf | 0.0286 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 2e-04 | Inf | 0.0286 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 2e-04 | Inf | 0.0286 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 2e-04 | Inf | 0.0286 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0019731 | 2e-04 | 15.648 | 0.3142 | 4 | 22 | antibacterial humoral response |
| GO:0050877 | 3e-04 | 2.4361 | 10.354 | 23 | 725 | nervous system process |
| GO:0051673 | 6e-04 | 139.508 | 0.0428 | 2 | 3 | membrane disruption in other organism |
| GO:0061844 | 7e-04 | 11.2605 | 0.4142 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0031640 | 8e-04 | 10.8266 | 0.4284 | 4 | 30 | killing of cells of other organism |
| GO:0031424 | 8e-04 | 4.9788 | 1.5281 | 7 | 107 | keratinization |
| GO:0003009 | 0.0011 | 10.0517 | 0.457 | 4 | 32 | skeletal muscle contraction |
| GO:0043207 | 0.0011 | 2.4236 | 8.0119 | 18 | 561 | response to external biotic stimulus |
| GO:0014721 | 0.0012 | 69.7487 | 0.0571 | 2 | 4 | twitch skeletal muscle contraction |
| GO:2000416 | 0.0012 | 69.7487 | 0.0571 | 2 | 4 | regulation of eosinophil migration |
| GO:0009617 | 0.0013 | 2.8549 | 4.8842 | 13 | 342 | response to bacterium |
| GO:0042832 | 0.0014 | 16.1687 | 0.2285 | 3 | 16 | defense response to protozoan |
| GO:0048245 | 0.002 | 46.4955 | 0.0714 | 2 | 5 | eosinophil chemotaxis |
| GO:0098542 | 0.0027 | 4.6567 | 1.3878 | 6 | 100 | defense response to other organism |
| GO:0071624 | 0.0027 | 12.3605 | 0.2856 | 3 | 20 | positive regulation of granulocyte chemotaxis |
| GO:0002664 | 0.0029 | 34.869 | 0.0857 | 2 | 6 | regulation of T cell tolerance induction |
| GO:0050879 | 0.003 | 7.4009 | 0.5998 | 4 | 42 | multicellular organismal movement |
| GO:0050672 | 0.0038 | 6.8577 | 0.6427 | 4 | 45 | negative regulation of lymphocyte proliferation |
| GO:0007200 | 0.0041 | 5.1103 | 1.0568 | 5 | 74 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0030520 | 0.0048 | 6.3887 | 0.6855 | 4 | 48 | intracellular estrogen receptor signaling pathway |
| GO:0070664 | 0.0048 | 6.3887 | 0.6855 | 4 | 48 | negative regulation of leukocyte proliferation |
| GO:0031284 | 0.0054 | 23.2424 | 0.1143 | 2 | 8 | positive regulation of guanylate cyclase activity |
| GO:0006953 | 0.0065 | 8.7507 | 0.3856 | 3 | 27 | acute-phase response |
| GO:0051852 | 0.0068 | 19.9206 | 0.1285 | 2 | 9 | disruption by host of symbiont cells |
| GO:0007588 | 0.0073 | 5.6195 | 0.7712 | 4 | 54 | excretion |
| GO:0048247 | 0.008 | 8.0763 | 0.4142 | 3 | 29 | lymphocyte chemotaxis |
| GO:0001659 | 0.0088 | 7.7766 | 0.4284 | 3 | 30 | temperature homeostasis |
| GO:0003008 | 0.0091 | 2.1627 | 6.8826 | 14 | 530 | system process |
| GO:0050900 | 0.0095 | 2.5193 | 4.1844 | 10 | 293 | leukocyte migration |
| GO:0014902 | 0.0097 | 4.0947 | 1.2996 | 5 | 91 | myotube differentiation |
| GO:0051607 | 0.0098 | 3.1171 | 2.3707 | 7 | 166 | defense response to virus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002690 | 1e-04 | 6.6353 | 1.3874 | 8 | 61 | positive regulation of leukocyte chemotaxis |
| GO:0050865 | 1e-04 | 2.6728 | 8.5064 | 21 | 374 | regulation of cell activation |
| GO:0050863 | 2e-04 | 3.193 | 5.0948 | 15 | 224 | regulation of T cell activation |
| GO:2001190 | 5e-04 | Inf | 0.0455 | 2 | 2 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0071622 | 6e-04 | 8.3855 | 0.7051 | 5 | 31 | regulation of granulocyte chemotaxis |
| GO:0050920 | 7e-04 | 3.7004 | 2.934 | 10 | 129 | regulation of chemotaxis |
| GO:0090023 | 8e-04 | 11.5987 | 0.4321 | 4 | 19 | positive regulation of neutrophil chemotaxis |
| GO:0022407 | 8e-04 | 2.5733 | 7.0735 | 17 | 311 | regulation of cell-cell adhesion |
| GO:0046394 | 9e-04 | 2.7275 | 5.8908 | 15 | 259 | carboxylic acid biosynthetic process |
| GO:0002696 | 0.0012 | 2.8592 | 4.8673 | 13 | 214 | positive regulation of leukocyte activation |
| GO:0014741 | 0.0014 | 9.6633 | 0.5004 | 4 | 22 | negative regulation of muscle hypertrophy |
| GO:1902622 | 0.0014 | 9.6633 | 0.5004 | 4 | 22 | regulation of neutrophil migration |
| GO:0032103 | 0.0017 | 2.893 | 4.4352 | 12 | 195 | positive regulation of response to external stimulus |
| GO:0097530 | 0.0018 | 4.3752 | 1.7513 | 7 | 77 | granulocyte migration |
| GO:0006633 | 0.002 | 3.811 | 2.2744 | 8 | 100 | fatty acid biosynthetic process |
| GO:0006955 | 0.0022 | 1.8386 | 18.0482 | 31 | 821 | immune response |
| GO:0032940 | 0.0025 | 1.694 | 25.3146 | 40 | 1113 | secretion by cell |
| GO:0032930 | 0.0028 | 13.0097 | 0.2957 | 3 | 13 | positive regulation of superoxide anion generation |
| GO:0086023 | 0.003 | 43.2475 | 0.091 | 2 | 4 | adrenergic receptor signaling pathway involved in heart process |
| GO:1902715 | 0.003 | 43.2475 | 0.091 | 2 | 4 | positive regulation of interferon-gamma secretion |
| GO:0007159 | 0.0032 | 3.5035 | 2.4557 | 8 | 110 | leukocyte cell-cell adhesion |
| GO:0032689 | 0.0035 | 11.8261 | 0.3184 | 3 | 14 | negative regulation of interferon-gamma production |
| GO:0007626 | 0.0045 | 2.8329 | 3.7528 | 10 | 165 | locomotory behavior |
| GO:0002263 | 0.0048 | 1.9628 | 11.304 | 21 | 497 | cell activation involved in immune response |
| GO:0033239 | 0.0049 | 28.8294 | 0.1137 | 2 | 5 | negative regulation of cellular amine metabolic process |
| GO:0033299 | 0.0049 | 28.8294 | 0.1137 | 2 | 5 | secretion of lysosomal enzymes |
| GO:0019932 | 0.0054 | 2.4797 | 5.1175 | 12 | 225 | second-messenger-mediated signaling |
| GO:0050671 | 0.0056 | 3.5156 | 2.138 | 7 | 94 | positive regulation of lymphocyte proliferation |
| GO:0002275 | 0.0056 | 2.051 | 9.257 | 18 | 407 | myeloid cell activation involved in immune response |
| GO:0030833 | 0.0058 | 3.154 | 2.7066 | 8 | 119 | regulation of actin filament polymerization |
| GO:0010611 | 0.0059 | 4.7323 | 1.16 | 5 | 51 | regulation of cardiac muscle hypertrophy |
| GO:0045055 | 0.0061 | 1.8592 | 13.0553 | 23 | 574 | regulated exocytosis |
| GO:0042346 | 0.0063 | 9.2898 | 0.3867 | 3 | 17 | positive regulation of NF-kappaB import into nucleus |
| GO:0070665 | 0.0066 | 3.3976 | 2.2062 | 7 | 97 | positive regulation of leukocyte proliferation |
| GO:0045785 | 0.0071 | 2.2206 | 6.6414 | 14 | 292 | positive regulation of cell adhesion |
| GO:0003360 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | brainstem development |
| GO:0044341 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | sodium-dependent phosphate transport |
| GO:1903243 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | negative regulation of cardiac muscle hypertrophy in response to stress |
| GO:2001300 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | lipoxin metabolic process |
| GO:1901017 | 0.0074 | 8.6698 | 0.4094 | 3 | 18 | negative regulation of potassium ion transmembrane transporter activity |
| GO:0060291 | 0.0075 | 4.4415 | 1.2282 | 5 | 54 | long-term synaptic potentiation |
| GO:0044283 | 0.0078 | 1.9404 | 10.3032 | 19 | 453 | small molecule biosynthetic process |
| GO:0060326 | 0.0079 | 2.5954 | 4.0713 | 10 | 179 | cell chemotaxis |
| GO:0014897 | 0.0081 | 3.6845 | 1.7513 | 6 | 77 | striated muscle hypertrophy |
| GO:0046649 | 0.0083 | 1.9266 | 10.3715 | 19 | 456 | lymphocyte activation |
| GO:0002683 | 0.0084 | 2.1726 | 6.7778 | 14 | 298 | negative regulation of immune system process |
| GO:0007155 | 0.0085 | 1.7214 | 16.5654 | 27 | 747 | cell adhesion |
| GO:1903039 | 0.0087 | 2.7183 | 3.5026 | 9 | 154 | positive regulation of leukocyte cell-cell adhesion |
| GO:0032720 | 0.0087 | 5.4297 | 0.8188 | 4 | 36 | negative regulation of tumor necrosis factor production |
| GO:0002886 | 0.0096 | 5.2648 | 0.8415 | 4 | 37 | regulation of myeloid leukocyte mediated immunity |
| GO:0043303 | 0.0096 | 5.2648 | 0.8415 | 4 | 37 | mast cell degranulation |
| GO:0051899 | 0.0097 | 3.5343 | 1.8196 | 6 | 80 | membrane depolarization |
| GO:0002707 | 0.01 | 7.6486 | 0.4549 | 3 | 20 | negative regulation of lymphocyte mediated immunity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007399 | 0 | 1.7679 | 54.153 | 85 | 1881 | nervous system development |
| GO:0021515 | 1e-04 | 7.047 | 1.3531 | 8 | 47 | cell differentiation in spinal cord |
| GO:0021517 | 1e-04 | 7.2711 | 1.1516 | 7 | 40 | ventral spinal cord development |
| GO:0050832 | 2e-04 | 12.1951 | 0.547 | 5 | 19 | defense response to fungus |
| GO:0007218 | 2e-04 | 4.9913 | 2.0441 | 9 | 71 | neuropeptide signaling pathway |
| GO:0021953 | 3e-04 | 3.328 | 4.2608 | 13 | 148 | central nervous system neuron differentiation |
| GO:0007267 | 4e-04 | 1.7037 | 36.2747 | 57 | 1260 | cell-cell signaling |
| GO:0044003 | 8e-04 | 6.2158 | 1.1228 | 6 | 39 | modification by symbiont of host morphology or physiology |
| GO:0001906 | 8e-04 | 4.0142 | 2.4759 | 9 | 86 | cell killing |
| GO:0044657 | 8e-04 | Inf | 0.0576 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0051610 | 8e-04 | Inf | 0.0576 | 2 | 2 | serotonin uptake |
| GO:0052043 | 8e-04 | Inf | 0.0576 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 8e-04 | Inf | 0.0576 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 8e-04 | Inf | 0.0576 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0061379 | 8e-04 | Inf | 0.0576 | 2 | 2 | inferior colliculus development |
| GO:0048663 | 9e-04 | 5.0311 | 1.572 | 7 | 55 | neuron fate commitment |
| GO:0042136 | 9e-04 | 11.3537 | 0.4606 | 4 | 16 | neurotransmitter biosynthetic process |
| GO:0007156 | 0.001 | 3.3222 | 3.5987 | 11 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0099537 | 0.001 | 2.0365 | 14.1356 | 27 | 491 | trans-synaptic signaling |
| GO:0046189 | 0.0013 | 7.1083 | 0.8349 | 5 | 29 | phenol-containing compound biosynthetic process |
| GO:1902108 | 0.0015 | 4.6075 | 1.6986 | 7 | 59 | regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:0072678 | 0.0015 | 6.8234 | 0.8637 | 5 | 30 | T cell migration |
| GO:0048149 | 0.0017 | 16.9934 | 0.2591 | 3 | 9 | behavioral response to ethanol |
| GO:0048664 | 0.0017 | 16.9934 | 0.2591 | 3 | 9 | neuron fate determination |
| GO:0048536 | 0.0018 | 6.5605 | 0.8925 | 5 | 31 | spleen development |
| GO:0042221 | 0.0018 | 1.4089 | 90.1974 | 115 | 3133 | response to chemical |
| GO:0007389 | 0.002 | 2.1276 | 10.4794 | 21 | 364 | pattern specification process |
| GO:0050905 | 0.0021 | 3.8073 | 2.3032 | 8 | 80 | neuromuscular process |
| GO:0021885 | 0.0022 | 4.9998 | 1.3531 | 6 | 47 | forebrain cell migration |
| GO:0022610 | 0.0024 | 1.6329 | 30.0274 | 46 | 1043 | biological adhesion |
| GO:0032227 | 0.0024 | 67.8206 | 0.0864 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
| GO:0051673 | 0.0024 | 67.8206 | 0.0864 | 2 | 3 | membrane disruption in other organism |
| GO:0003008 | 0.0027 | 1.5723 | 36.0244 | 53 | 1262 | system process |
| GO:0019731 | 0.0033 | 7.5656 | 0.6334 | 4 | 22 | antibacterial humoral response |
| GO:0051894 | 0.0033 | 7.5656 | 0.6334 | 4 | 22 | positive regulation of focal adhesion assembly |
| GO:0060143 | 0.0033 | 7.5656 | 0.6334 | 4 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0002087 | 0.0033 | 12.7431 | 0.3167 | 3 | 11 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0008595 | 0.0033 | 12.7431 | 0.3167 | 3 | 11 | anterior/posterior axis specification, embryo |
| GO:0048870 | 0.0038 | 1.5676 | 33.2519 | 49 | 1155 | cell motility |
| GO:0007154 | 0.0043 | 3.7367 | 2.0473 | 7 | 81 | cell communication |
| GO:0048468 | 0.0043 | 1.474 | 47.186 | 65 | 1639 | cell development |
| GO:0051818 | 0.0043 | 11.3263 | 0.3455 | 3 | 12 | disruption of cells of other organism involved in symbiotic interaction |
| GO:1903818 | 0.0043 | 11.3263 | 0.3455 | 3 | 12 | positive regulation of voltage-gated potassium channel activity |
| GO:1904888 | 0.0044 | 4.2683 | 1.5546 | 6 | 54 | cranial skeletal system development |
| GO:0007274 | 0.0046 | 6.808 | 0.6909 | 4 | 24 | neuromuscular synaptic transmission |
| GO:0032502 | 0.0046 | 1.3248 | 138.1895 | 163 | 4800 | developmental process |
| GO:0008628 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0048625 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | myoblast fate commitment |
| GO:1904506 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | negative regulation of telomere maintenance in response to DNA damage |
| GO:2000354 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | regulation of ovarian follicle development |
| GO:0031589 | 0.0049 | 2.2493 | 7.0534 | 15 | 245 | cell-substrate adhesion |
| GO:0042127 | 0.0051 | 1.5209 | 36.3323 | 52 | 1262 | regulation of cell proliferation |
| GO:0009952 | 0.0052 | 2.5007 | 5.0957 | 12 | 177 | anterior/posterior pattern specification |
| GO:0008038 | 0.0053 | 6.4833 | 0.7197 | 4 | 25 | neuron recognition |
| GO:0007350 | 0.0055 | 10.1929 | 0.3743 | 3 | 13 | blastoderm segmentation |
| GO:0021520 | 0.0055 | 10.1929 | 0.3743 | 3 | 13 | spinal cord motor neuron cell fate specification |
| GO:0009719 | 0.0056 | 1.5241 | 34.8065 | 50 | 1209 | response to endogenous stimulus |
| GO:0035295 | 0.0057 | 1.8181 | 14.4811 | 25 | 503 | tube development |
| GO:0090559 | 0.0062 | 3.4677 | 2.188 | 7 | 76 | regulation of membrane permeability |
| GO:0007006 | 0.0063 | 2.882 | 3.3396 | 9 | 116 | mitochondrial membrane organization |
| GO:0007165 | 0.0068 | 1.3124 | 124.9464 | 148 | 4340 | signal transduction |
| GO:0006584 | 0.0068 | 4.6061 | 1.2092 | 5 | 42 | catecholamine metabolic process |
| GO:0043280 | 0.0068 | 3.0759 | 2.7926 | 8 | 97 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:1903749 | 0.0068 | 3.0759 | 2.7926 | 8 | 97 | positive regulation of establishment of protein localization to mitochondrion |
| GO:0003016 | 0.007 | 5.9186 | 0.7773 | 4 | 27 | respiratory system process |
| GO:0001708 | 0.0071 | 3.3695 | 2.2456 | 7 | 78 | cell fate specification |
| GO:0001764 | 0.0074 | 2.8027 | 3.4259 | 9 | 119 | neuron migration |
| GO:0007268 | 0.0077 | 1.8172 | 13.2992 | 23 | 466 | chemical synaptic transmission |
| GO:0001547 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | antral ovarian follicle growth |
| GO:0003105 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | negative regulation of glomerular filtration |
| GO:0016576 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | histone dephosphorylation |
| GO:0045617 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:0051459 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | regulation of corticotropin secretion |
| GO:0052150 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | modulation by symbiont of host apoptotic process |
| GO:0097211 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | cellular response to gonadotropin-releasing hormone |
| GO:0071392 | 0.008 | 5.6715 | 0.8061 | 4 | 28 | cellular response to estradiol stimulus |
| GO:0019372 | 0.0083 | 8.4927 | 0.4318 | 3 | 15 | lipoxygenase pathway |
| GO:0007266 | 0.0084 | 2.5779 | 4.1169 | 10 | 143 | Rho protein signal transduction |
| GO:0006734 | 0.0091 | 5.4442 | 0.8349 | 4 | 29 | NADH metabolic process |
| GO:0061844 | 0.0091 | 5.4442 | 0.8349 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:1901381 | 0.0091 | 5.4442 | 0.8349 | 4 | 29 | positive regulation of potassium ion transmembrane transport |
| GO:1903727 | 0.0091 | 5.4442 | 0.8349 | 4 | 29 | positive regulation of phospholipid metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 0 | 2.6545 | 11.1519 | 27 | 293 | pattern specification process |
| GO:1903507 | 0 | 1.8104 | 39.1154 | 65 | 1017 | negative regulation of nucleic acid-templated transcription |
| GO:0090102 | 1e-04 | 6.5387 | 1.5 | 8 | 39 | cochlea development |
| GO:0051253 | 1e-04 | 1.7078 | 41.8077 | 66 | 1087 | negative regulation of RNA metabolic process |
| GO:1902412 | 2e-04 | 75.4387 | 0.1538 | 3 | 4 | regulation of mitotic cytokinesis |
| GO:0007218 | 4e-04 | 4.1605 | 2.7308 | 10 | 71 | neuropeptide signaling pathway |
| GO:0006935 | 4e-04 | 2.0355 | 16.8462 | 32 | 438 | chemotaxis |
| GO:0021903 | 6e-04 | 14.3909 | 0.4231 | 4 | 11 | rostrocaudal neural tube patterning |
| GO:0045475 | 6e-04 | 14.3909 | 0.4231 | 4 | 11 | locomotor rhythm |
| GO:0019233 | 7e-04 | 3.7861 | 2.9615 | 10 | 77 | sensory perception of pain |
| GO:0071805 | 7e-04 | 2.7025 | 6.4231 | 16 | 167 | potassium ion transmembrane transport |
| GO:2000113 | 9e-04 | 1.5425 | 50 | 72 | 1300 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0001964 | 0.001 | 7.8801 | 0.8077 | 5 | 21 | startle response |
| GO:0021796 | 0.001 | 25.1423 | 0.2308 | 3 | 6 | cerebral cortex regionalization |
| GO:1903034 | 0.0011 | 2.9253 | 4.8462 | 13 | 126 | regulation of response to wounding |
| GO:0009653 | 0.0012 | 1.4318 | 79.2308 | 105 | 2060 | anatomical structure morphogenesis |
| GO:0000122 | 0.0012 | 1.7254 | 26.5 | 43 | 689 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0009890 | 0.0013 | 1.4994 | 54.9615 | 77 | 1429 | negative regulation of biosynthetic process |
| GO:0072272 | 0.0015 | Inf | 0.0769 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0033555 | 0.0016 | 4.0479 | 2.2308 | 8 | 58 | multicellular organismal response to stress |
| GO:0009953 | 0.0017 | 3.3354 | 3.3077 | 10 | 86 | dorsal/ventral pattern formation |
| GO:0003013 | 0.0017 | 1.933 | 15.3846 | 28 | 400 | circulatory system process |
| GO:0045773 | 0.0017 | 5.4091 | 1.3077 | 6 | 34 | positive regulation of axon extension |
| GO:0002692 | 0.0018 | 18.8552 | 0.2692 | 3 | 7 | negative regulation of cellular extravasation |
| GO:0007154 | 0.0019 | 1.3121 | 183.4231 | 215 | 4769 | cell communication |
| GO:0051240 | 0.0021 | 1.514 | 46.3846 | 66 | 1206 | positive regulation of multicellular organismal process |
| GO:0048513 | 0.0021 | 1.3659 | 100.6923 | 127 | 2618 | animal organ development |
| GO:0007399 | 0.0023 | 1.4149 | 71.9633 | 95 | 1878 | nervous system development |
| GO:0006333 | 0.0026 | 2.5242 | 5.9615 | 14 | 155 | chromatin assembly or disassembly |
| GO:0045663 | 0.0027 | 8.3914 | 0.6154 | 4 | 16 | positive regulation of myoblast differentiation |
| GO:0023052 | 0.0027 | 1.2978 | 182.7692 | 213 | 4752 | signaling |
| GO:0048699 | 0.0028 | 1.5005 | 45.2692 | 64 | 1177 | generation of neurons |
| GO:1903522 | 0.0031 | 2.1848 | 8.7692 | 18 | 228 | regulation of blood circulation |
| GO:0006813 | 0.0032 | 2.3008 | 7.4231 | 16 | 193 | potassium ion transport |
| GO:0061564 | 0.0032 | 1.8601 | 15.3462 | 27 | 399 | axon development |
| GO:0008217 | 0.0034 | 2.671 | 4.8462 | 12 | 126 | regulation of blood pressure |
| GO:0009790 | 0.0035 | 1.6081 | 28.8995 | 44 | 759 | embryo development |
| GO:0035295 | 0.0037 | 1.7454 | 19.3462 | 32 | 503 | tube development |
| GO:0007610 | 0.0037 | 2.0967 | 9.6162 | 19 | 256 | behavior |
| GO:0009954 | 0.0039 | 5.4788 | 1.0769 | 5 | 28 | proximal/distal pattern formation |
| GO:0021517 | 0.004 | 4.4525 | 1.5385 | 6 | 40 | ventral spinal cord development |
| GO:0003207 | 0.004 | 12.5682 | 0.3462 | 3 | 9 | cardiac chamber formation |
| GO:0048663 | 0.0043 | 3.7819 | 2.0662 | 7 | 54 | neuron fate commitment |
| GO:0043586 | 0.0043 | 7.1915 | 0.6923 | 4 | 18 | tongue development |
| GO:0003219 | 0.0043 | 50.1933 | 0.1154 | 2 | 3 | cardiac right ventricle formation |
| GO:0014028 | 0.0043 | 50.1933 | 0.1154 | 2 | 3 | notochord formation |
| GO:0021524 | 0.0043 | 50.1933 | 0.1154 | 2 | 3 | visceral motor neuron differentiation |
| GO:0070054 | 0.0043 | 50.1933 | 0.1154 | 2 | 3 | mRNA splicing, via endonucleolytic cleavage and ligation |
| GO:0070055 | 0.0043 | 50.1933 | 0.1154 | 2 | 3 | mRNA endonucleolytic cleavage involved in unfolded protein response |
| GO:0070837 | 0.0043 | 50.1933 | 0.1154 | 2 | 3 | dehydroascorbic acid transport |
| GO:0042593 | 0.0047 | 2.2696 | 7.0385 | 15 | 183 | glucose homeostasis |
| GO:0051705 | 0.0049 | 3.6827 | 2.1154 | 7 | 55 | multi-organism behavior |
| GO:0007411 | 0.005 | 2.1879 | 7.7692 | 16 | 202 | axon guidance |
| GO:0007631 | 0.0053 | 2.9958 | 3.2692 | 9 | 85 | feeding behavior |
| GO:0048562 | 0.0053 | 2.1172 | 8.512 | 17 | 223 | embryonic organ morphogenesis |
| GO:0051482 | 0.0053 | 6.7116 | 0.7308 | 4 | 19 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
| GO:0048048 | 0.0053 | 5.0397 | 1.1538 | 5 | 30 | embryonic eye morphogenesis |
| GO:0098815 | 0.0053 | 5.0397 | 1.1538 | 5 | 30 | modulation of excitatory postsynaptic potential |
| GO:0006334 | 0.0054 | 2.6296 | 4.5 | 11 | 117 | nucleosome assembly |
| GO:0098742 | 0.0055 | 2.2292 | 7.1538 | 15 | 186 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0021877 | 0.0055 | 10.7719 | 0.3846 | 3 | 10 | forebrain neuron fate commitment |
| GO:0060379 | 0.0055 | 10.7719 | 0.3846 | 3 | 10 | cardiac muscle cell myoblast differentiation |
| GO:0071888 | 0.0055 | 10.7719 | 0.3846 | 3 | 10 | macrophage apoptotic process |
| GO:0051094 | 0.0057 | 1.488 | 38.9615 | 55 | 1013 | positive regulation of developmental process |
| GO:0090303 | 0.0057 | 4.0905 | 1.6538 | 6 | 43 | positive regulation of wound healing |
| GO:0030534 | 0.0057 | 2.6048 | 4.5385 | 11 | 118 | adult behavior |
| GO:0009798 | 0.0057 | 3.2093 | 2.7308 | 8 | 71 | axis specification |
| GO:0007155 | 0.0061 | 1.4767 | 39.9615 | 56 | 1039 | cell adhesion |
| GO:0007492 | 0.0063 | 3.1589 | 2.7692 | 8 | 72 | endoderm development |
| GO:0048869 | 0.0068 | 1.2877 | 127.4615 | 152 | 3314 | cellular developmental process |
| GO:0044259 | 0.0071 | 2.8451 | 3.4231 | 9 | 89 | multicellular organismal macromolecule metabolic process |
| GO:0021521 | 0.0074 | 9.4247 | 0.4231 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:1900103 | 0.0074 | 9.4247 | 0.4231 | 3 | 11 | positive regulation of endoplasmic reticulum unfolded protein response |
| GO:0030198 | 0.0074 | 1.9916 | 9.5385 | 18 | 248 | extracellular matrix organization |
| GO:2001141 | 0.0075 | 1.2889 | 119.3462 | 143 | 3103 | regulation of RNA biosynthetic process |
| GO:0006355 | 0.0076 | 1.2895 | 118.4231 | 142 | 3079 | regulation of transcription, DNA-templated |
| GO:0021871 | 0.0077 | 5.921 | 0.8077 | 4 | 21 | forebrain regionalization |
| GO:0060037 | 0.0077 | 5.921 | 0.8077 | 4 | 21 | pharyngeal system development |
| GO:0090596 | 0.0079 | 2.0746 | 8.1538 | 16 | 212 | sensory organ morphogenesis |
| GO:0003208 | 0.0079 | 3.334 | 2.3077 | 7 | 60 | cardiac ventricle morphogenesis |
| GO:0003199 | 0.0084 | 25.0947 | 0.1538 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0007343 | 0.0084 | 25.0947 | 0.1538 | 2 | 4 | egg activation |
| GO:0021555 | 0.0084 | 25.0947 | 0.1538 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0072086 | 0.0084 | 25.0947 | 0.1538 | 2 | 4 | specification of loop of Henle identity |
| GO:0061053 | 0.0086 | 2.9722 | 2.9231 | 8 | 76 | somite development |
| GO:0021515 | 0.0089 | 3.6902 | 1.8077 | 6 | 47 | cell differentiation in spinal cord |
| GO:0021885 | 0.0089 | 3.6902 | 1.8077 | 6 | 47 | forebrain cell migration |
| GO:0090224 | 0.0091 | 4.3432 | 1.3077 | 5 | 34 | regulation of spindle organization |
| GO:0061436 | 0.0096 | 8.3768 | 0.4615 | 3 | 12 | establishment of skin barrier |
| GO:0071625 | 0.0096 | 8.3768 | 0.4615 | 3 | 12 | vocalization behavior |
| GO:0030574 | 0.0098 | 3.6021 | 1.8462 | 6 | 48 | collagen catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007186 | 1e-04 | 2.0001 | 21.6044 | 40 | 684 | G-protein coupled receptor signaling pathway |
| GO:0045617 | 3e-04 | 46.3157 | 0.1579 | 3 | 5 | negative regulation of keratinocyte differentiation |
| GO:0050877 | 4e-04 | 1.874 | 22.8994 | 40 | 725 | nervous system process |
| GO:0007156 | 6e-04 | 3.3226 | 3.9482 | 12 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0045683 | 8e-04 | 12.3729 | 0.4422 | 4 | 14 | negative regulation of epidermis development |
| GO:0060290 | 0.001 | 23.1542 | 0.2211 | 3 | 7 | transdifferentiation |
| GO:0048704 | 0.0014 | 3.6887 | 2.6848 | 9 | 85 | embryonic skeletal system morphogenesis |
| GO:0055082 | 0.0016 | 1.8716 | 17.593 | 31 | 557 | cellular chemical homeostasis |
| GO:0030728 | 0.0021 | 8.8351 | 0.5685 | 4 | 18 | ovulation |
| GO:0007267 | 0.0022 | 1.5567 | 39.7975 | 58 | 1260 | cell-cell signaling |
| GO:0032501 | 0.0026 | 1.3391 | 155.5919 | 183 | 5044 | multicellular organismal process |
| GO:0031427 | 0.0029 | 61.6106 | 0.0948 | 2 | 3 | response to methotrexate |
| GO:0050968 | 0.0029 | 61.6106 | 0.0948 | 2 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:0071314 | 0.0029 | 61.6106 | 0.0948 | 2 | 3 | cellular response to cocaine |
| GO:0006811 | 0.003 | 1.5474 | 37.8392 | 55 | 1198 | ion transport |
| GO:0048665 | 0.0031 | 5.7345 | 1.0107 | 5 | 32 | neuron fate specification |
| GO:0035136 | 0.0035 | 5.5292 | 1.0423 | 5 | 33 | forelimb morphogenesis |
| GO:0098659 | 0.0035 | 5.5292 | 1.0423 | 5 | 33 | inorganic cation import across plasma membrane |
| GO:0006816 | 0.0036 | 2.1013 | 9.5703 | 19 | 303 | calcium ion transport |
| GO:0007606 | 0.0037 | 2.9389 | 3.6639 | 10 | 116 | sensory perception of chemical stimulus |
| GO:0015711 | 0.0049 | 1.9943 | 10.5811 | 20 | 335 | organic anion transport |
| GO:0034122 | 0.0054 | 6.5075 | 0.7265 | 4 | 23 | negative regulation of toll-like receptor signaling pathway |
| GO:0043114 | 0.0054 | 6.5075 | 0.7265 | 4 | 23 | regulation of vascular permeability |
| GO:0007155 | 0.0054 | 1.8783 | 12.9143 | 23 | 421 | cell adhesion |
| GO:0070920 | 0.0056 | 10.2867 | 0.379 | 3 | 12 | regulation of production of small RNA involved in gene silencing by RNA |
| GO:0008628 | 0.0057 | 30.8029 | 0.1263 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0019482 | 0.0057 | 30.8029 | 0.1263 | 2 | 4 | beta-alanine metabolic process |
| GO:0060214 | 0.0057 | 30.8029 | 0.1263 | 2 | 4 | endocardium formation |
| GO:0009953 | 0.0057 | 3.1865 | 2.7163 | 8 | 86 | dorsal/ventral pattern formation |
| GO:0007389 | 0.0059 | 1.9236 | 11.4971 | 21 | 364 | pattern specification process |
| GO:0072511 | 0.006 | 1.956 | 10.7706 | 20 | 341 | divalent inorganic cation transport |
| GO:0048598 | 0.006 | 1.767 | 16.0769 | 27 | 509 | embryonic morphogenesis |
| GO:0042462 | 0.0063 | 6.1816 | 0.758 | 4 | 24 | eye photoreceptor cell development |
| GO:0010810 | 0.0069 | 2.5199 | 4.643 | 11 | 147 | regulation of cell-substrate adhesion |
| GO:0030003 | 0.0071 | 1.8067 | 13.9607 | 24 | 442 | cellular cation homeostasis |
| GO:0098609 | 0.0074 | 1.6688 | 19.5197 | 31 | 618 | cell-cell adhesion |
| GO:0050906 | 0.0076 | 2.7981 | 3.4428 | 9 | 109 | detection of stimulus involved in sensory perception |
| GO:0050856 | 0.0085 | 5.6188 | 0.8212 | 4 | 26 | regulation of T cell receptor signaling pathway |
| GO:0072488 | 0.0088 | 8.4151 | 0.4422 | 3 | 14 | ammonium transmembrane transport |
| GO:0097094 | 0.0088 | 8.4151 | 0.4422 | 3 | 14 | craniofacial suture morphogenesis |
| GO:0030001 | 0.009 | 1.6308 | 20.5936 | 32 | 652 | metal ion transport |
| GO:0098771 | 0.0091 | 1.7232 | 15.8242 | 26 | 501 | inorganic ion homeostasis |
| GO:0006836 | 0.0093 | 2.4123 | 4.8326 | 11 | 153 | neurotransmitter transport |
| GO:0016115 | 0.0093 | 20.5337 | 0.1579 | 2 | 5 | terpenoid catabolic process |
| GO:0021778 | 0.0093 | 20.5337 | 0.1579 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0033141 | 0.0093 | 20.5337 | 0.1579 | 2 | 5 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0050917 | 0.0093 | 20.5337 | 0.1579 | 2 | 5 | sensory perception of umami taste |
| GO:0051096 | 0.0093 | 20.5337 | 0.1579 | 2 | 5 | positive regulation of helicase activity |
| GO:0051459 | 0.0093 | 20.5337 | 0.1579 | 2 | 5 | regulation of corticotropin secretion |
| GO:2000822 | 0.0093 | 20.5337 | 0.1579 | 2 | 5 | regulation of behavioral fear response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007588 | 0 | 8.7356 | 1.2404 | 9 | 54 | excretion |
| GO:0033141 | 1e-04 | 64.4252 | 0.1149 | 3 | 5 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0071732 | 2e-04 | 17.2267 | 0.3216 | 4 | 14 | cellular response to nitric oxide |
| GO:0060602 | 3e-04 | 15.6594 | 0.3446 | 4 | 15 | branch elongation of an epithelium |
| GO:0045777 | 5e-04 | 8.9925 | 0.6662 | 5 | 29 | positive regulation of blood pressure |
| GO:0033076 | 5e-04 | Inf | 0.0459 | 2 | 2 | isoquinoline alkaloid metabolic process |
| GO:0038060 | 5e-04 | Inf | 0.0459 | 2 | 2 | nitric oxide-cGMP-mediated signaling pathway |
| GO:0019933 | 6e-04 | 4.6954 | 1.8836 | 8 | 82 | cAMP-mediated signaling |
| GO:1900544 | 6e-04 | 4.1219 | 2.389 | 9 | 104 | positive regulation of purine nucleotide metabolic process |
| GO:0000132 | 8e-04 | 11.48 | 0.4365 | 4 | 19 | establishment of mitotic spindle orientation |
| GO:0006955 | 9e-04 | 1.7215 | 30.276 | 48 | 1318 | immune response |
| GO:0006952 | 9e-04 | 1.8017 | 23.9589 | 40 | 1043 | defense response |
| GO:0060259 | 0.001 | 10.7617 | 0.4594 | 4 | 20 | regulation of feeding behavior |
| GO:0007586 | 0.0011 | 3.7993 | 2.5728 | 9 | 112 | digestion |
| GO:0045651 | 0.0013 | 18.4001 | 0.2297 | 3 | 10 | positive regulation of macrophage differentiation |
| GO:0007610 | 0.0013 | 2.1636 | 10.8424 | 22 | 472 | behavior |
| GO:0042110 | 0.0014 | 2.4194 | 7.4886 | 17 | 326 | T cell activation |
| GO:0032501 | 0.0015 | 1.4465 | 108.2965 | 133 | 4936 | multicellular organismal process |
| GO:0001878 | 0.0016 | 85.6225 | 0.0689 | 2 | 3 | response to yeast |
| GO:0033861 | 0.0016 | 85.6225 | 0.0689 | 2 | 3 | negative regulation of NAD(P)H oxidase activity |
| GO:0035814 | 0.0016 | 85.6225 | 0.0689 | 2 | 3 | negative regulation of renal sodium excretion |
| GO:0045347 | 0.0016 | 85.6225 | 0.0689 | 2 | 3 | negative regulation of MHC class II biosynthetic process |
| GO:0070384 | 0.0016 | 85.6225 | 0.0689 | 2 | 3 | Harderian gland development |
| GO:0008595 | 0.0017 | 16.0988 | 0.2527 | 3 | 11 | anterior/posterior axis specification, embryo |
| GO:0031342 | 0.0017 | 16.0988 | 0.2527 | 3 | 11 | negative regulation of cell killing |
| GO:1903530 | 0.0019 | 2.0649 | 11.8531 | 23 | 516 | regulation of secretion by cell |
| GO:0002682 | 0.0021 | 1.882 | 16.4549 | 29 | 734 | regulation of immune system process |
| GO:0030801 | 0.0022 | 4.209 | 1.8147 | 7 | 79 | positive regulation of cyclic nucleotide metabolic process |
| GO:1903818 | 0.0023 | 14.309 | 0.2757 | 3 | 12 | positive regulation of voltage-gated potassium channel activity |
| GO:0045471 | 0.0024 | 3.6906 | 2.3431 | 8 | 102 | response to ethanol |
| GO:0009617 | 0.0024 | 2.2973 | 7.8561 | 17 | 342 | response to bacterium |
| GO:0000083 | 0.0027 | 7.823 | 0.5972 | 4 | 26 | regulation of transcription involved in G1/S transition of mitotic cell cycle |
| GO:0007350 | 0.0029 | 12.8771 | 0.2986 | 3 | 13 | blastoderm segmentation |
| GO:0030540 | 0.0029 | 12.8771 | 0.2986 | 3 | 13 | female genitalia development |
| GO:0060788 | 0.0029 | 12.8771 | 0.2986 | 3 | 13 | ectodermal placode formation |
| GO:0038028 | 0.0031 | 42.8079 | 0.0919 | 2 | 4 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase |
| GO:0060638 | 0.0031 | 42.8079 | 0.0919 | 2 | 4 | mesenchymal-epithelial cell signaling |
| GO:0003014 | 0.0036 | 3.834 | 1.9755 | 7 | 86 | renal system process |
| GO:0071696 | 0.0036 | 11.7055 | 0.3216 | 3 | 14 | ectodermal placode development |
| GO:1901701 | 0.0037 | 1.7688 | 18.6296 | 31 | 811 | cellular response to oxygen-containing compound |
| GO:0002696 | 0.004 | 2.5894 | 4.9158 | 12 | 214 | positive regulation of leukocyte activation |
| GO:0061844 | 0.0041 | 6.8827 | 0.6662 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0071346 | 0.0044 | 3.6929 | 2.0444 | 7 | 89 | cellular response to interferon-gamma |
| GO:0019827 | 0.0044 | 3.0513 | 3.147 | 9 | 137 | stem cell population maintenance |
| GO:0003094 | 0.0044 | 10.7292 | 0.3446 | 3 | 15 | glomerular filtration |
| GO:0010817 | 0.0045 | 2.1479 | 8.3615 | 17 | 364 | regulation of hormone levels |
| GO:0046879 | 0.0046 | 2.4344 | 5.6509 | 13 | 246 | hormone secretion |
| GO:0051341 | 0.0046 | 4.1788 | 1.562 | 6 | 68 | regulation of oxidoreductase activity |
| GO:0031640 | 0.0047 | 6.6174 | 0.6891 | 4 | 30 | killing of cells of other organism |
| GO:0051349 | 0.0047 | 5.0117 | 1.1026 | 5 | 48 | positive regulation of lyase activity |
| GO:0007188 | 0.0047 | 3.2698 | 2.6187 | 8 | 114 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0008015 | 0.0048 | 2.0842 | 9.1195 | 18 | 397 | blood circulation |
| GO:0009190 | 0.005 | 3.2389 | 2.6417 | 8 | 115 | cyclic nucleotide biosynthetic process |
| GO:0032687 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | negative regulation of interferon-alpha production |
| GO:0034154 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | toll-like receptor 7 signaling pathway |
| GO:0045650 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | negative regulation of macrophage differentiation |
| GO:0090241 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | negative regulation of histone H4 acetylation |
| GO:0098528 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | skeletal muscle fiber differentiation |
| GO:0071805 | 0.0052 | 2.7672 | 3.8362 | 10 | 167 | potassium ion transmembrane transport |
| GO:0006182 | 0.0053 | 6.3719 | 0.7121 | 4 | 31 | cGMP biosynthetic process |
| GO:0051293 | 0.0053 | 6.3719 | 0.7121 | 4 | 31 | establishment of spindle localization |
| GO:0060338 | 0.0053 | 6.3719 | 0.7121 | 4 | 31 | regulation of type I interferon-mediated signaling pathway |
| GO:0030903 | 0.0054 | 9.9031 | 0.3675 | 3 | 16 | notochord development |
| GO:0032496 | 0.0055 | 2.4772 | 5.1226 | 12 | 223 | response to lipopolysaccharide |
| GO:0048593 | 0.0055 | 3.52 | 2.1363 | 7 | 93 | camera-type eye morphogenesis |
| GO:0072009 | 0.0055 | 3.52 | 2.1363 | 7 | 93 | nephron epithelium development |
| GO:0002703 | 0.0058 | 3.1499 | 2.7106 | 8 | 118 | regulation of leukocyte mediated immunity |
| GO:0019932 | 0.0059 | 2.4536 | 5.1685 | 12 | 225 | second-messenger-mediated signaling |
| GO:0050865 | 0.0059 | 2.0861 | 8.5912 | 17 | 374 | regulation of cell activation |
| GO:0048871 | 0.0059 | 2.3521 | 5.8347 | 13 | 254 | multicellular organismal homeostasis |
| GO:0050878 | 0.006 | 2.0821 | 8.607 | 17 | 377 | regulation of body fluid levels |
| GO:0032411 | 0.0061 | 3.9243 | 1.6539 | 6 | 72 | positive regulation of transporter activity |
| GO:0050995 | 0.0064 | 9.1951 | 0.3905 | 3 | 17 | negative regulation of lipid catabolic process |
| GO:0072234 | 0.0064 | 9.1951 | 0.3905 | 3 | 17 | metanephric nephron tubule development |
| GO:0046903 | 0.0064 | 1.5833 | 27.5654 | 41 | 1200 | secretion |
| GO:0090184 | 0.0066 | 5.9315 | 0.758 | 4 | 33 | positive regulation of kidney development |
| GO:0060560 | 0.0069 | 2.6477 | 3.997 | 10 | 174 | developmental growth involved in morphogenesis |
| GO:0001754 | 0.0074 | 5.7333 | 0.781 | 4 | 34 | eye photoreceptor cell differentiation |
| GO:0003402 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
| GO:0006570 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | tyrosine metabolic process |
| GO:0042538 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | hyperosmotic salinity response |
| GO:0046877 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | regulation of saliva secretion |
| GO:0060513 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | prostatic bud formation |
| GO:0060592 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | mammary gland formation |
| GO:0001892 | 0.008 | 3.6989 | 1.7458 | 6 | 76 | embryonic placenta development |
| GO:0043268 | 0.0082 | 5.548 | 0.804 | 4 | 35 | positive regulation of potassium ion transport |
| GO:0042060 | 0.0082 | 1.9664 | 9.6249 | 18 | 419 | wound healing |
| GO:0006970 | 0.0084 | 4.3077 | 1.2634 | 5 | 55 | response to osmotic stress |
| GO:0002761 | 0.0085 | 3.6466 | 1.7688 | 6 | 77 | regulation of myeloid leukocyte differentiation |
| GO:0097530 | 0.0085 | 3.6466 | 1.7688 | 6 | 77 | granulocyte migration |
| GO:0022898 | 0.0087 | 2.553 | 4.1348 | 10 | 180 | regulation of transmembrane transporter activity |
| GO:0072079 | 0.0089 | 8.0444 | 0.4365 | 3 | 19 | nephron tubule formation |
| GO:0060759 | 0.009 | 2.9096 | 2.9173 | 8 | 127 | regulation of response to cytokine stimulus |
| GO:0022409 | 0.0091 | 2.5379 | 4.1578 | 10 | 181 | positive regulation of cell-cell adhesion |
| GO:0035821 | 0.0091 | 3.1843 | 2.3431 | 7 | 102 | modification of morphology or physiology of other organism |
| GO:0002683 | 0.0091 | 2.1496 | 6.8454 | 14 | 298 | negative regulation of immune system process |
| GO:0050877 | 0.0092 | 1.7082 | 16.6541 | 27 | 725 | nervous system process |
| GO:1903037 | 0.0093 | 2.2997 | 5.4901 | 12 | 239 | regulation of leukocyte cell-cell adhesion |
| GO:0010646 | 0.0094 | 1.387 | 61.8153 | 79 | 2691 | regulation of cell communication |
| GO:0030010 | 0.0096 | 3.1509 | 2.366 | 7 | 103 | establishment of cell polarity |
| GO:0061326 | 0.0096 | 3.5461 | 1.8147 | 6 | 79 | renal tubule development |
| GO:0023051 | 0.0097 | 1.3828 | 62.8031 | 80 | 2734 | regulation of signaling |
| GO:0050920 | 0.0098 | 2.8611 | 2.9633 | 8 | 129 | regulation of chemotaxis |
| GO:0045776 | 0.0099 | 5.2109 | 0.8499 | 4 | 37 | negative regulation of blood pressure |
| GO:0050829 | 0.0099 | 5.2109 | 0.8499 | 4 | 37 | defense response to Gram-negative bacterium |
| GO:0070231 | 0.0099 | 5.2109 | 0.8499 | 4 | 37 | T cell apoptotic process |
| GO:0072210 | 0.0099 | 5.2109 | 0.8499 | 4 | 37 | metanephric nephron development |
| GO:0090596 | 0.01 | 2.3775 | 4.8699 | 11 | 212 | sensory organ morphogenesis |
| GO:0032535 | 0.01 | 2.1942 | 6.2252 | 13 | 271 | regulation of cellular component size |
| GO:0045088 | 0.01 | 2.194 | 6.2259 | 13 | 274 | regulation of innate immune response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003203 | 0 | 10.3352 | 0.9181 | 7 | 25 | endocardial cushion morphogenesis |
| GO:0007156 | 1e-04 | 3.6589 | 4.5904 | 15 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0032502 | 1e-04 | 1.4248 | 176.2732 | 216 | 4800 | developmental process |
| GO:0001764 | 1e-04 | 3.5715 | 4.3701 | 14 | 119 | neuron migration |
| GO:0031115 | 2e-04 | 21.1502 | 0.3305 | 4 | 9 | negative regulation of microtubule polymerization |
| GO:0035108 | 2e-04 | 3.3464 | 4.6272 | 14 | 126 | limb morphogenesis |
| GO:0008038 | 2e-04 | 8.3743 | 0.9181 | 6 | 25 | neuron recognition |
| GO:0060644 | 3e-04 | 11.0326 | 0.6243 | 5 | 17 | mammary gland epithelial cell differentiation |
| GO:0048736 | 4e-04 | 2.9979 | 5.4718 | 15 | 149 | appendage development |
| GO:0021903 | 5e-04 | 15.1049 | 0.404 | 4 | 11 | rostrocaudal neural tube patterning |
| GO:0060485 | 5e-04 | 2.6119 | 7.4549 | 18 | 203 | mesenchyme development |
| GO:0035113 | 6e-04 | 3.3018 | 4.0029 | 12 | 109 | embryonic appendage morphogenesis |
| GO:0007154 | 7e-04 | 1.3548 | 175.1348 | 209 | 4769 | cell communication |
| GO:0030857 | 8e-04 | 6.3615 | 1.1384 | 6 | 31 | negative regulation of epithelial cell differentiation |
| GO:0048468 | 9e-04 | 1.5041 | 60.19 | 84 | 1639 | cell development |
| GO:0022008 | 0.0012 | 1.5517 | 46.1983 | 67 | 1258 | neurogenesis |
| GO:0042733 | 0.0012 | 4.2504 | 2.13 | 8 | 58 | embryonic digit morphogenesis |
| GO:0007275 | 0.0012 | 1.3552 | 142.3979 | 173 | 3956 | multicellular organism development |
| GO:0003148 | 0.0013 | 7.3516 | 0.8446 | 5 | 23 | outflow tract septum morphogenesis |
| GO:0014059 | 0.0013 | 7.3516 | 0.8446 | 5 | 23 | regulation of dopamine secretion |
| GO:0003188 | 0.0013 | 10.571 | 0.5141 | 4 | 14 | heart valve formation |
| GO:0097094 | 0.0013 | 10.571 | 0.5141 | 4 | 14 | craniofacial suture morphogenesis |
| GO:1900155 | 0.0013 | Inf | 0.0734 | 2 | 2 | negative regulation of bone trabecula formation |
| GO:0007155 | 0.0014 | 1.592 | 38.1558 | 57 | 1039 | cell adhesion |
| GO:0023052 | 0.0016 | 1.3274 | 174.5105 | 206 | 4752 | signaling |
| GO:0007399 | 0.0019 | 1.7998 | 20.1067 | 34 | 581 | nervous system development |
| GO:0031110 | 0.0022 | 4.3179 | 1.8362 | 7 | 50 | regulation of microtubule polymerization or depolymerization |
| GO:0051952 | 0.0023 | 3.7932 | 2.3503 | 8 | 64 | regulation of amine transport |
| GO:0003002 | 0.0023 | 2.103 | 10.6131 | 21 | 289 | regionalization |
| GO:0048870 | 0.0024 | 1.529 | 42.4157 | 61 | 1155 | cell motility |
| GO:0007130 | 0.0029 | 8.1296 | 0.6243 | 4 | 17 | synaptonemal complex assembly |
| GO:0060487 | 0.0029 | 8.1296 | 0.6243 | 4 | 17 | lung epithelial cell differentiation |
| GO:0051290 | 0.0032 | 4.6743 | 1.4689 | 6 | 40 | protein heterotetramerization |
| GO:0007193 | 0.0034 | 3.9491 | 1.9831 | 7 | 54 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0014032 | 0.0034 | 3.9491 | 1.9831 | 7 | 54 | neural crest cell development |
| GO:0030502 | 0.0035 | 13.1905 | 0.3305 | 3 | 9 | negative regulation of bone mineralization |
| GO:1903244 | 0.0035 | 13.1905 | 0.3305 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0006335 | 0.0037 | 5.5111 | 1.065 | 5 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0046888 | 0.0038 | 3.8666 | 2.0198 | 7 | 55 | negative regulation of hormone secretion |
| GO:0048771 | 0.0038 | 2.7619 | 4.2967 | 11 | 117 | tissue remodeling |
| GO:0051239 | 0.0039 | 1.3666 | 83.2524 | 106 | 2267 | regulation of multicellular organismal process |
| GO:0031333 | 0.0039 | 2.922 | 3.7091 | 10 | 101 | negative regulation of protein complex assembly |
| GO:0007621 | 0.0039 | 52.6736 | 0.1102 | 2 | 3 | negative regulation of female receptivity |
| GO:0021524 | 0.0039 | 52.6736 | 0.1102 | 2 | 3 | visceral motor neuron differentiation |
| GO:0043152 | 0.0039 | 52.6736 | 0.1102 | 2 | 3 | induction of bacterial agglutination |
| GO:0070495 | 0.0039 | 52.6736 | 0.1102 | 2 | 3 | negative regulation of thrombin-activated receptor signaling pathway |
| GO:1905333 | 0.0039 | 52.6736 | 0.1102 | 2 | 3 | regulation of gastric motility |
| GO:0048863 | 0.0041 | 2.1747 | 8.2995 | 17 | 226 | stem cell differentiation |
| GO:0051259 | 0.0042 | 1.7989 | 16.4154 | 28 | 447 | protein oligomerization |
| GO:0010469 | 0.0042 | 1.8661 | 14.1386 | 25 | 385 | regulation of receptor activity |
| GO:0007268 | 0.0043 | 1.7574 | 17.9946 | 30 | 490 | chemical synaptic transmission |
| GO:0099537 | 0.0044 | 1.7535 | 18.0313 | 30 | 491 | trans-synaptic signaling |
| GO:0061035 | 0.0047 | 3.7113 | 2.0932 | 7 | 57 | regulation of cartilage development |
| GO:0030182 | 0.0048 | 1.4974 | 39.5146 | 56 | 1076 | neuron differentiation |
| GO:0043217 | 0.0049 | 11.3052 | 0.3672 | 3 | 10 | myelin maintenance |
| GO:0051895 | 0.0049 | 11.3052 | 0.3672 | 3 | 10 | negative regulation of focal adhesion assembly |
| GO:0014742 | 0.005 | 5.0864 | 1.1384 | 5 | 31 | positive regulation of muscle hypertrophy |
| GO:0015844 | 0.0051 | 3.6383 | 2.13 | 7 | 58 | monoamine transport |
| GO:0021510 | 0.0053 | 2.9877 | 3.2684 | 9 | 89 | spinal cord development |
| GO:0045956 | 0.0054 | 6.6037 | 0.7345 | 4 | 20 | positive regulation of calcium ion-dependent exocytosis |
| GO:0043583 | 0.0054 | 2.3044 | 6.4634 | 14 | 176 | ear development |
| GO:0023061 | 0.0055 | 1.8752 | 12.9267 | 23 | 352 | signal release |
| GO:0000183 | 0.0058 | 4.8976 | 1.1752 | 5 | 32 | chromatin silencing at rDNA |
| GO:0030072 | 0.0064 | 2.1867 | 7.2713 | 15 | 198 | peptide hormone secretion |
| GO:0060429 | 0.0065 | 1.5061 | 34.9609 | 50 | 952 | epithelium development |
| GO:0014744 | 0.0065 | 9.8913 | 0.404 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0033604 | 0.0065 | 9.8913 | 0.404 | 3 | 11 | negative regulation of catecholamine secretion |
| GO:0061430 | 0.0065 | 9.8913 | 0.404 | 3 | 11 | bone trabecula morphogenesis |
| GO:0015872 | 0.0066 | 4.7223 | 1.2119 | 5 | 33 | dopamine transport |
| GO:0003253 | 0.0077 | 26.3347 | 0.1469 | 2 | 4 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0021555 | 0.0077 | 26.3347 | 0.1469 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0032610 | 0.0077 | 26.3347 | 0.1469 | 2 | 4 | interleukin-1 alpha production |
| GO:0051461 | 0.0077 | 26.3347 | 0.1469 | 2 | 4 | positive regulation of corticotropin secretion |
| GO:0021884 | 0.0078 | 5.8691 | 0.8079 | 4 | 22 | forebrain neuron development |
| GO:0071695 | 0.0079 | 2.4787 | 4.7373 | 11 | 129 | anatomical structure maturation |
| GO:0048705 | 0.0084 | 2.1816 | 6.7939 | 14 | 185 | skeletal system morphogenesis |
| GO:0002115 | 0.0085 | 8.7916 | 0.4407 | 3 | 12 | store-operated calcium entry |
| GO:0051969 | 0.0085 | 8.7916 | 0.4407 | 3 | 12 | regulation of transmission of nerve impulse |
| GO:0061323 | 0.0085 | 8.7916 | 0.4407 | 3 | 12 | cell proliferation involved in heart morphogenesis |
| GO:0001709 | 0.0085 | 4.4068 | 1.2853 | 5 | 35 | cell fate determination |
| GO:0071805 | 0.0086 | 2.2476 | 6.1328 | 13 | 167 | potassium ion transmembrane transport |
| GO:0007610 | 0.0087 | 1.6942 | 17.3335 | 28 | 472 | behavior |
| GO:0051960 | 0.009 | 1.5719 | 24.6783 | 37 | 672 | regulation of nervous system development |
| GO:0046320 | 0.0091 | 5.5597 | 0.8446 | 4 | 23 | regulation of fatty acid oxidation |
| GO:0090504 | 0.0091 | 5.5597 | 0.8446 | 4 | 23 | epiboly |
| GO:0042472 | 0.0096 | 2.9059 | 2.9746 | 8 | 81 | inner ear morphogenesis |
| GO:0002685 | 0.0097 | 2.5296 | 4.2232 | 10 | 115 | regulation of leukocyte migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 13.0212 | 1.2515 | 12 | 46 | embryonic skeletal system morphogenesis |
| GO:0048568 | 0 | 3.0435 | 10.2043 | 28 | 371 | embryonic organ development |
| GO:0048598 | 0 | 2.7318 | 13.3747 | 33 | 491 | embryonic morphogenesis |
| GO:0009887 | 0 | 2.2106 | 22.4715 | 45 | 817 | animal organ morphogenesis |
| GO:0009888 | 0 | 1.8612 | 40.7623 | 68 | 1482 | tissue development |
| GO:0043009 | 0 | 2.4561 | 13.78 | 31 | 501 | chordate embryonic development |
| GO:0001501 | 0 | 2.6192 | 11.2495 | 27 | 409 | skeletal system development |
| GO:0030878 | 0 | 12.6714 | 0.6326 | 6 | 23 | thyroid gland development |
| GO:0021602 | 1e-04 | 16.37 | 0.4378 | 5 | 16 | cranial nerve morphogenesis |
| GO:0009952 | 1e-04 | 3.3715 | 4.8684 | 15 | 177 | anterior/posterior pattern specification |
| GO:0001568 | 2e-04 | 2.2345 | 14 | 29 | 509 | blood vessel development |
| GO:0072358 | 2e-04 | 2.1993 | 14.7151 | 30 | 535 | cardiovascular system development |
| GO:0048532 | 2e-04 | 17.8639 | 0.3301 | 4 | 12 | anatomical structure arrangement |
| GO:0060795 | 2e-04 | 7.9721 | 0.9077 | 6 | 33 | cell fate commitment involved in formation of primary germ layer |
| GO:0021675 | 3e-04 | 5.3333 | 1.7053 | 8 | 62 | nerve development |
| GO:0021781 | 3e-04 | 15.8778 | 0.3576 | 4 | 13 | glial cell fate commitment |
| GO:0048486 | 3e-04 | 15.8778 | 0.3576 | 4 | 13 | parasympathetic nervous system development |
| GO:0021561 | 4e-04 | 35.6427 | 0.165 | 3 | 6 | facial nerve development |
| GO:0019229 | 4e-04 | 5.8491 | 1.3752 | 7 | 50 | regulation of vasoconstriction |
| GO:0001525 | 5e-04 | 2.3564 | 10.0118 | 22 | 364 | angiogenesis |
| GO:0048646 | 5e-04 | 2.1683 | 12.8615 | 26 | 484 | anatomical structure formation involved in morphogenesis |
| GO:0007631 | 5e-04 | 4.2678 | 2.3379 | 9 | 85 | feeding behavior |
| GO:0007275 | 6e-04 | 1.4376 | 112.9077 | 142 | 4105 | multicellular organism development |
| GO:0003342 | 8e-04 | Inf | 0.055 | 2 | 2 | proepicardium development |
| GO:0021633 | 8e-04 | Inf | 0.055 | 2 | 2 | optic nerve structural organization |
| GO:0072009 | 0.001 | 3.859 | 2.558 | 9 | 93 | nephron epithelium development |
| GO:0031102 | 0.0011 | 5.8129 | 1.1827 | 6 | 43 | neuron projection regeneration |
| GO:0042474 | 0.0013 | 10.2032 | 0.4951 | 4 | 18 | middle ear morphogenesis |
| GO:0061326 | 0.0014 | 4.051 | 2.1729 | 8 | 79 | renal tubule development |
| GO:0051674 | 0.0015 | 1.6546 | 31.7682 | 49 | 1155 | localization of cell |
| GO:0072078 | 0.0015 | 4.5686 | 1.7053 | 7 | 62 | nephron tubule morphogenesis |
| GO:0072028 | 0.0018 | 4.4076 | 1.7603 | 7 | 64 | nephron morphogenesis |
| GO:0051093 | 0.0021 | 1.8012 | 19.4735 | 33 | 708 | negative regulation of developmental process |
| GO:0006703 | 0.0021 | 15.2707 | 0.275 | 3 | 10 | estrogen biosynthetic process |
| GO:0021554 | 0.0021 | 15.2707 | 0.275 | 3 | 10 | optic nerve development |
| GO:0002277 | 0.0022 | 71.0994 | 0.0825 | 2 | 3 | myeloid dendritic cell activation involved in immune response |
| GO:0003166 | 0.0022 | 71.0994 | 0.0825 | 2 | 3 | bundle of His development |
| GO:0061551 | 0.0022 | 71.0994 | 0.0825 | 2 | 3 | trigeminal ganglion development |
| GO:0072513 | 0.0022 | 71.0994 | 0.0825 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
| GO:0097647 | 0.0022 | 71.0994 | 0.0825 | 2 | 3 | amylin receptor signaling pathway |
| GO:2000366 | 0.0022 | 71.0994 | 0.0825 | 2 | 3 | positive regulation of STAT protein import into nucleus |
| GO:0061217 | 0.0023 | 8.4007 | 0.5776 | 4 | 21 | regulation of mesonephros development |
| GO:0007186 | 0.0023 | 1.8062 | 18.8134 | 32 | 684 | G-protein coupled receptor signaling pathway |
| GO:0097756 | 0.0028 | 4.0506 | 1.8978 | 7 | 69 | negative regulation of blood vessel diameter |
| GO:0003161 | 0.0029 | 13.3608 | 0.3026 | 3 | 11 | cardiac conduction system development |
| GO:0043523 | 0.0032 | 2.6742 | 4.7859 | 12 | 174 | regulation of neuron apoptotic process |
| GO:0035850 | 0.0032 | 5.5876 | 1.0177 | 5 | 37 | epithelial cell differentiation involved in kidney development |
| GO:0060675 | 0.0035 | 4.477 | 1.4853 | 6 | 54 | ureteric bud morphogenesis |
| GO:0097709 | 0.0038 | 11.8753 | 0.3301 | 3 | 12 | connective tissue replacement |
| GO:0042745 | 0.0039 | 7.1389 | 0.6601 | 4 | 24 | circadian sleep/wake cycle |
| GO:0048701 | 0.0041 | 5.2581 | 1.0727 | 5 | 39 | embryonic cranial skeleton morphogenesis |
| GO:0051057 | 0.0041 | 5.2581 | 1.0727 | 5 | 39 | positive regulation of small GTPase mediated signal transduction |
| GO:0003199 | 0.0044 | 35.547 | 0.11 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0021612 | 0.0044 | 35.547 | 0.11 | 2 | 4 | facial nerve structural organization |
| GO:0021648 | 0.0044 | 35.547 | 0.11 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0098706 | 0.0044 | 35.547 | 0.11 | 2 | 4 | ferric iron import across plasma membrane |
| GO:0007501 | 0.0048 | 10.687 | 0.3576 | 3 | 13 | mesodermal cell fate specification |
| GO:0051241 | 0.0049 | 1.6591 | 22.9585 | 36 | 839 | negative regulation of multicellular organismal process |
| GO:0034103 | 0.005 | 4.1313 | 1.5953 | 6 | 58 | regulation of tissue remodeling |
| GO:0040011 | 0.0051 | 1.5167 | 37.2141 | 53 | 1353 | locomotion |
| GO:0050877 | 0.0056 | 1.6936 | 19.9411 | 32 | 725 | nervous system process |
| GO:0035176 | 0.0056 | 4.8306 | 1.1552 | 5 | 42 | social behavior |
| GO:0045935 | 0.0058 | 1.4853 | 40.8998 | 57 | 1487 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0043616 | 0.006 | 6.2063 | 0.7426 | 4 | 27 | keratinocyte proliferation |
| GO:0035025 | 0.006 | 9.7147 | 0.3851 | 3 | 14 | positive regulation of Rho protein signal transduction |
| GO:0060977 | 0.006 | 9.7147 | 0.3851 | 3 | 14 | coronary vasculature morphogenesis |
| GO:0032768 | 0.0069 | 4.5822 | 1.2102 | 5 | 44 | regulation of monooxygenase activity |
| GO:0030855 | 0.007 | 1.8337 | 13.1935 | 23 | 485 | epithelial cell differentiation |
| GO:0003406 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | retinal pigment epithelium development |
| GO:0006526 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | arginine biosynthetic process |
| GO:0006545 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | glycine biosynthetic process |
| GO:0015677 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | copper ion import |
| GO:0021546 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | rhombomere development |
| GO:0042636 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | negative regulation of hair cycle |
| GO:0051891 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0072161 | 0.0071 | 23.6961 | 0.1375 | 2 | 5 | mesenchymal cell differentiation involved in kidney development |
| GO:0001822 | 0.0079 | 2.2657 | 6.0511 | 13 | 220 | kidney development |
| GO:0016477 | 0.008 | 1.5466 | 28.6876 | 42 | 1043 | cell migration |
| GO:0008217 | 0.008 | 2.7634 | 3.4656 | 9 | 126 | regulation of blood pressure |
| GO:0046903 | 0.0084 | 1.5067 | 33.0059 | 47 | 1200 | secretion |
| GO:0001708 | 0.0085 | 3.667 | 1.7748 | 6 | 65 | cell fate specification |
| GO:0048333 | 0.0088 | 5.4889 | 0.8251 | 4 | 30 | mesodermal cell differentiation |
| GO:0003018 | 0.0088 | 2.7165 | 3.5206 | 9 | 128 | vascular process in circulatory system |
| GO:0090190 | 0.0089 | 8.2188 | 0.4401 | 3 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0003002 | 0.0093 | 4.2257 | 1.2972 | 5 | 49 | regionalization |
| GO:0045893 | 0.0094 | 1.4953 | 33.2259 | 47 | 1208 | positive regulation of transcription, DNA-templated |
| GO:0009953 | 0.0094 | 3.1747 | 2.3654 | 7 | 86 | dorsal/ventral pattern formation |
| GO:0043583 | 0.0095 | 2.3994 | 4.8409 | 11 | 176 | ear development |
| GO:1902680 | 0.0095 | 1.4939 | 33.2534 | 47 | 1209 | positive regulation of RNA biosynthetic process |
| GO:0045823 | 0.0099 | 5.2852 | 0.8527 | 4 | 31 | positive regulation of heart contraction |
| GO:0045987 | 0.0099 | 5.2852 | 0.8527 | 4 | 31 | positive regulation of smooth muscle contraction |
| GO:0032526 | 0.01 | 3.1348 | 2.3929 | 7 | 87 | response to retinoic acid |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018149 | 0 | 16.6156 | 0.4135 | 5 | 18 | peptide cross-linking |
| GO:0050911 | 2e-04 | 6.4604 | 1.2404 | 7 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 3e-04 | 4.115 | 2.6647 | 10 | 116 | sensory perception of chemical stimulus |
| GO:0050877 | 0.0013 | 1.9275 | 16.6541 | 30 | 725 | nervous system process |
| GO:0048850 | 0.0016 | 85.6225 | 0.0689 | 2 | 3 | hypophysis morphogenesis |
| GO:0007156 | 0.0024 | 3.3701 | 2.8714 | 9 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0035609 | 0.0031 | 42.8079 | 0.0919 | 2 | 4 | C-terminal protein deglutamylation |
| GO:0050906 | 0.0036 | 3.433 | 2.5039 | 8 | 109 | detection of stimulus involved in sensory perception |
| GO:0018200 | 0.0036 | 7.17 | 0.6432 | 4 | 28 | peptidyl-glutamic acid modification |
| GO:0071346 | 0.0044 | 3.6929 | 2.0444 | 7 | 89 | cellular response to interferon-gamma |
| GO:0033141 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0051964 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | negative regulation of synapse assembly |
| GO:1900020 | 0.005 | 28.5364 | 0.1149 | 2 | 5 | positive regulation of protein kinase C activity |
| GO:0006958 | 0.0064 | 9.1951 | 0.3905 | 3 | 17 | complement activation, classical pathway |
| GO:0009792 | 0.0064 | 1.9082 | 11.6004 | 21 | 505 | embryo development ending in birth or egg hatching |
| GO:0009593 | 0.007 | 3.3625 | 2.2282 | 7 | 97 | detection of chemical stimulus |
| GO:0003360 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | brainstem development |
| GO:1900040 | 0.0074 | 21.4007 | 0.1378 | 2 | 6 | regulation of interleukin-2 secretion |
| GO:0050808 | 0.009 | 2.4141 | 4.801 | 11 | 209 | synapse organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 5.6617 | 2.46 | 12 | 85 | embryonic skeletal system morphogenesis |
| GO:0009952 | 0 | 3.6842 | 5.1225 | 17 | 177 | anterior/posterior pattern specification |
| GO:0030168 | 2e-04 | 3.7464 | 3.5308 | 12 | 122 | platelet activation |
| GO:0032946 | 4e-04 | 4.0747 | 2.7204 | 10 | 94 | positive regulation of mononuclear cell proliferation |
| GO:0060142 | 4e-04 | 9.4305 | 0.6656 | 5 | 23 | regulation of syncytium formation by plasma membrane fusion |
| GO:0045446 | 5e-04 | 4.2711 | 2.3442 | 9 | 81 | endothelial cell differentiation |
| GO:0042428 | 8e-04 | 25.3559 | 0.2026 | 3 | 7 | serotonin metabolic process |
| GO:0007389 | 9e-04 | 2.229 | 10.5344 | 22 | 364 | pattern specification process |
| GO:1901741 | 0.0015 | 9.6773 | 0.5209 | 4 | 18 | positive regulation of myoblast fusion |
| GO:0046513 | 0.0018 | 5.2283 | 1.3023 | 6 | 45 | ceramide biosynthetic process |
| GO:0015780 | 0.0018 | 16.9013 | 0.2605 | 3 | 9 | nucleotide-sugar transport |
| GO:0022408 | 0.0018 | 3.2544 | 3.3282 | 10 | 115 | negative regulation of cell-cell adhesion |
| GO:0006949 | 0.002 | 5.0972 | 1.3313 | 6 | 46 | syncytium formation |
| GO:0016064 | 0.0022 | 4.2537 | 1.8233 | 7 | 63 | immunoglobulin mediated immune response |
| GO:0021602 | 0.0023 | 8.4664 | 0.5788 | 4 | 20 | cranial nerve morphogenesis |
| GO:0002376 | 0.0024 | 1.5199 | 46.1132 | 65 | 1636 | immune system process |
| GO:0006682 | 0.0025 | 67.4541 | 0.0868 | 2 | 3 | galactosylceramide biosynthetic process |
| GO:0061044 | 0.0025 | 67.4541 | 0.0868 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0006954 | 0.0033 | 2.3557 | 6.7603 | 15 | 239 | inflammatory response |
| GO:0035723 | 0.0033 | 12.674 | 0.3183 | 3 | 11 | interleukin-15-mediated signaling pathway |
| GO:0070672 | 0.0033 | 12.674 | 0.3183 | 3 | 11 | response to interleukin-15 |
| GO:0009605 | 0.0035 | 1.4966 | 45.0605 | 63 | 1557 | response to external stimulus |
| GO:0061041 | 0.0036 | 3.1641 | 3.0677 | 9 | 106 | regulation of wound healing |
| GO:0031424 | 0.0038 | 3.1315 | 3.0966 | 9 | 107 | keratinization |
| GO:0010092 | 0.004 | 7.1279 | 0.6656 | 4 | 23 | specification of animal organ identity |
| GO:0002791 | 0.0041 | 2.0706 | 9.6951 | 19 | 335 | regulation of peptide secretion |
| GO:0050727 | 0.0043 | 2.3639 | 6.2801 | 14 | 217 | regulation of inflammatory response |
| GO:0090036 | 0.0044 | 11.2649 | 0.3473 | 3 | 12 | regulation of protein kinase C signaling |
| GO:1901623 | 0.0044 | 11.2649 | 0.3473 | 3 | 12 | regulation of lymphocyte chemotaxis |
| GO:0002583 | 0.0048 | 33.7244 | 0.1158 | 2 | 4 | regulation of antigen processing and presentation of peptide antigen |
| GO:0042663 | 0.0048 | 33.7244 | 0.1158 | 2 | 4 | regulation of endodermal cell fate specification |
| GO:0043308 | 0.0048 | 33.7244 | 0.1158 | 2 | 4 | eosinophil degranulation |
| GO:0051122 | 0.0048 | 33.7244 | 0.1158 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0070100 | 0.0048 | 33.7244 | 0.1158 | 2 | 4 | negative regulation of chemokine-mediated signaling pathway |
| GO:0002253 | 0.0049 | 1.9569 | 11.3158 | 21 | 391 | activation of immune response |
| GO:0030595 | 0.005 | 2.7972 | 3.8202 | 10 | 132 | leukocyte chemotaxis |
| GO:0008284 | 0.0051 | 1.7058 | 19.7954 | 32 | 684 | positive regulation of cell proliferation |
| GO:0007599 | 0.0052 | 2.1709 | 7.785 | 16 | 269 | hemostasis |
| GO:0050817 | 0.0052 | 2.1709 | 7.785 | 16 | 269 | coagulation |
| GO:0002263 | 0.0053 | 1.8315 | 14.3835 | 25 | 497 | cell activation involved in immune response |
| GO:0003298 | 0.0054 | 6.448 | 0.7235 | 4 | 25 | physiological muscle hypertrophy |
| GO:0045581 | 0.0054 | 6.448 | 0.7235 | 4 | 25 | negative regulation of T cell differentiation |
| GO:0061049 | 0.0054 | 6.448 | 0.7235 | 4 | 25 | cell growth involved in cardiac muscle cell development |
| GO:0006677 | 0.0055 | 10.1376 | 0.3762 | 3 | 13 | glycosylceramide metabolic process |
| GO:0002460 | 0.0059 | 2.7294 | 3.907 | 10 | 135 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0009653 | 0.0059 | 1.4121 | 58.5107 | 77 | 2040 | anatomical structure morphogenesis |
| GO:0002685 | 0.0062 | 2.8934 | 3.3282 | 9 | 115 | regulation of leukocyte migration |
| GO:0002532 | 0.0063 | 4.7086 | 1.1866 | 5 | 41 | production of molecular mediator involved in inflammatory response |
| GO:0097529 | 0.0069 | 2.8393 | 3.3861 | 9 | 117 | myeloid leukocyte migration |
| GO:0009611 | 0.0071 | 1.7843 | 14.7308 | 25 | 509 | response to wounding |
| GO:0050670 | 0.0075 | 2.6234 | 4.0517 | 10 | 140 | regulation of lymphocyte proliferation |
| GO:0043069 | 0.0077 | 1.6523 | 20.3742 | 32 | 704 | negative regulation of programmed cell death |
| GO:0002275 | 0.0077 | 1.8733 | 11.7788 | 21 | 407 | myeloid cell activation involved in immune response |
| GO:0002579 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | positive regulation of antigen processing and presentation |
| GO:0003241 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0006828 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | manganese ion transport |
| GO:0016576 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | histone dephosphorylation |
| GO:0021546 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | rhombomere development |
| GO:0043307 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | eosinophil activation |
| GO:0070669 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | response to interleukin-2 |
| GO:0050776 | 0.0079 | 1.6766 | 18.8114 | 30 | 650 | regulation of immune response |
| GO:0009954 | 0.0082 | 5.6407 | 0.8103 | 4 | 28 | proximal/distal pattern formation |
| GO:0035335 | 0.0084 | 3.2587 | 2.3152 | 7 | 80 | peptidyl-tyrosine dephosphorylation |
| GO:0090330 | 0.0084 | 8.4467 | 0.4341 | 3 | 15 | regulation of platelet aggregation |
| GO:0032940 | 0.0087 | 1.5075 | 32.2109 | 46 | 1113 | secretion by cell |
| GO:0002444 | 0.0088 | 1.8486 | 11.9235 | 21 | 412 | myeloid leukocyte mediated immunity |
| GO:0030890 | 0.0093 | 5.4147 | 0.8393 | 4 | 29 | positive regulation of B cell proliferation |
| GO:0002696 | 0.0095 | 2.2112 | 6.1933 | 13 | 214 | positive regulation of leukocyte activation |
| GO:0050870 | 0.0095 | 2.5253 | 4.1964 | 10 | 145 | positive regulation of T cell activation |
| GO:0070663 | 0.0095 | 2.5253 | 4.1964 | 10 | 145 | regulation of leukocyte proliferation |
| GO:0002443 | 0.0099 | 2.6667 | 3.5856 | 9 | 127 | leukocyte mediated immunity |
| GO:0042098 | 0.0099 | 2.6651 | 3.5886 | 9 | 124 | T cell proliferation |
| GO:0055002 | 0.0099 | 2.6651 | 3.5886 | 9 | 124 | striated muscle cell development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030878 | 2e-04 | 11.2986 | 0.5596 | 5 | 23 | thyroid gland development |
| GO:0042403 | 2e-04 | 18.0335 | 0.3163 | 4 | 13 | thyroid hormone metabolic process |
| GO:0009617 | 3e-04 | 2.5894 | 8.3213 | 20 | 342 | response to bacterium |
| GO:1903555 | 3e-04 | 4.6709 | 2.1412 | 9 | 88 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:2000363 | 6e-04 | Inf | 0.0487 | 2 | 2 | positive regulation of prostaglandin-E synthase activity |
| GO:0048598 | 7e-04 | 2.1614 | 12.3846 | 25 | 509 | embryonic morphogenesis |
| GO:0048568 | 8e-04 | 2.37 | 9.0269 | 20 | 371 | embryonic organ development |
| GO:0006954 | 0.001 | 2.1804 | 11.2654 | 23 | 463 | inflammatory response |
| GO:1901615 | 0.001 | 2.3091 | 9.2459 | 20 | 380 | organic hydroxy compound metabolic process |
| GO:0060536 | 0.0011 | 20.2288 | 0.219 | 3 | 9 | cartilage morphogenesis |
| GO:0043207 | 0.0013 | 2.0321 | 13.6498 | 26 | 561 | response to external biotic stimulus |
| GO:1902563 | 0.0015 | 17.3377 | 0.2433 | 3 | 10 | regulation of neutrophil activation |
| GO:0032720 | 0.0017 | 6.5539 | 0.8759 | 5 | 36 | negative regulation of tumor necrosis factor production |
| GO:0003219 | 0.0017 | 80.6937 | 0.073 | 2 | 3 | cardiac right ventricle formation |
| GO:0050968 | 0.0017 | 80.6937 | 0.073 | 2 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:0061044 | 0.0017 | 80.6937 | 0.073 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0071314 | 0.0017 | 80.6937 | 0.073 | 2 | 3 | cellular response to cocaine |
| GO:0046596 | 0.0021 | 8.5356 | 0.5596 | 4 | 23 | regulation of viral entry into host cell |
| GO:0010035 | 0.0025 | 2.1263 | 9.9758 | 20 | 410 | response to inorganic substance |
| GO:0034103 | 0.0028 | 4.6957 | 1.4112 | 6 | 58 | regulation of tissue remodeling |
| GO:2000026 | 0.0029 | 1.5671 | 37.1052 | 54 | 1525 | regulation of multicellular organismal development |
| GO:0060285 | 0.0029 | 7.7215 | 0.6083 | 4 | 25 | cilium-dependent cell motility |
| GO:0032496 | 0.0032 | 2.5447 | 5.4259 | 13 | 223 | response to lipopolysaccharide |
| GO:0072604 | 0.0034 | 7.3699 | 0.6326 | 4 | 26 | interleukin-6 secretion |
| GO:0034380 | 0.0034 | 12.1335 | 0.3163 | 3 | 13 | high-density lipoprotein particle assembly |
| GO:0043315 | 0.0034 | 40.3438 | 0.0973 | 2 | 4 | positive regulation of neutrophil degranulation |
| GO:1902715 | 0.0034 | 40.3438 | 0.0973 | 2 | 4 | positive regulation of interferon-gamma secretion |
| GO:0048731 | 0.0035 | 1.3955 | 88.7118 | 111 | 3646 | system development |
| GO:0007389 | 0.0035 | 2.1504 | 8.8566 | 18 | 364 | pattern specification process |
| GO:0002718 | 0.0037 | 5.3437 | 1.0462 | 5 | 43 | regulation of cytokine production involved in immune response |
| GO:0071294 | 0.0043 | 11.0296 | 0.3406 | 3 | 14 | cellular response to zinc ion |
| GO:0032715 | 0.0044 | 6.7547 | 0.6813 | 4 | 28 | negative regulation of interleukin-6 production |
| GO:0048704 | 0.0046 | 3.6564 | 2.0682 | 7 | 85 | embryonic skeletal system morphogenesis |
| GO:0098609 | 0.0047 | 1.828 | 15.0367 | 26 | 618 | cell-cell adhesion |
| GO:0010756 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | positive regulation of plasminogen activation |
| GO:0038203 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | TORC2 signaling |
| GO:0045410 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | positive regulation of interleukin-6 biosynthetic process |
| GO:0051459 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | regulation of corticotropin secretion |
| GO:2000609 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | regulation of thyroid hormone generation |
| GO:0016054 | 0.006 | 2.448 | 5.1826 | 12 | 213 | organic acid catabolic process |
| GO:0002227 | 0.0063 | 9.3313 | 0.3893 | 3 | 16 | innate immune response in mucosa |
| GO:0080154 | 0.0075 | 8.6641 | 0.4136 | 3 | 17 | regulation of fertilization |
| GO:0045597 | 0.0076 | 1.701 | 17.9808 | 29 | 739 | positive regulation of cell differentiation |
| GO:0032760 | 0.0078 | 4.4116 | 1.2409 | 5 | 51 | positive regulation of tumor necrosis factor production |
| GO:0022610 | 0.0079 | 1.5853 | 25.3775 | 38 | 1043 | biological adhesion |
| GO:0009063 | 0.008 | 3.2759 | 2.2871 | 7 | 94 | cellular amino acid catabolic process |
| GO:0032502 | 0.008 | 1.3272 | 116.7901 | 138 | 4800 | developmental process |
| GO:0015711 | 0.008 | 2.0641 | 8.151 | 16 | 335 | organic anion transport |
| GO:0009636 | 0.0081 | 2.5872 | 4.0877 | 10 | 168 | response to toxic substance |
| GO:0032675 | 0.0081 | 4.3644 | 1.2522 | 5 | 52 | regulation of interleukin-6 production |
| GO:0006527 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | arginine catabolic process |
| GO:0034372 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | very-low-density lipoprotein particle remodeling |
| GO:0042482 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | positive regulation of odontogenesis |
| GO:0060017 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | parathyroid gland development |
| GO:2000343 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:0031644 | 0.0084 | 4.3174 | 1.2652 | 5 | 52 | regulation of neurological system process |
| GO:0002440 | 0.0086 | 2.9382 | 2.8954 | 8 | 119 | production of molecular mediator of immune response |
| GO:0018149 | 0.0089 | 8.0859 | 0.438 | 3 | 18 | peptide cross-linking |
| GO:1904752 | 0.0089 | 8.0859 | 0.438 | 3 | 18 | regulation of vascular associated smooth muscle cell migration |
| GO:0071347 | 0.0091 | 4.2271 | 1.2896 | 5 | 53 | cellular response to interleukin-1 |
| GO:0051240 | 0.0094 | 1.533 | 29.0293 | 42 | 1200 | positive regulation of multicellular organismal process |
| GO:0044243 | 0.0099 | 4.1405 | 1.3139 | 5 | 54 | multicellular organismal catabolic process |
| GO:0032655 | 0.0099 | 5.2266 | 0.8516 | 4 | 35 | regulation of interleukin-12 production |
| GO:0050798 | 0.0099 | 5.2266 | 0.8516 | 4 | 35 | activated T cell proliferation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 6.8234 | 3.5515 | 20 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0042472 | 0 | 5.5056 | 2.3013 | 11 | 81 | inner ear morphogenesis |
| GO:0060435 | 0 | Inf | 0.0852 | 3 | 3 | bronchiole development |
| GO:0048791 | 0 | 11.5676 | 0.6819 | 6 | 24 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0051295 | 1e-04 | 103.4075 | 0.1136 | 3 | 4 | establishment of meiotic spindle localization |
| GO:0017158 | 1e-04 | 5.9255 | 1.5626 | 8 | 55 | regulation of calcium ion-dependent exocytosis |
| GO:0048704 | 3e-04 | 6.3042 | 1.2934 | 7 | 46 | embryonic skeletal system morphogenesis |
| GO:0030878 | 4e-04 | 9.6137 | 0.6535 | 5 | 23 | thyroid gland development |
| GO:0060677 | 4e-04 | 34.4638 | 0.1705 | 3 | 6 | ureteric bud elongation |
| GO:0007399 | 5e-04 | 1.578 | 53.4423 | 77 | 1881 | nervous system development |
| GO:0022610 | 6e-04 | 1.7448 | 29.6334 | 48 | 1043 | biological adhesion |
| GO:0098609 | 8e-04 | 1.9481 | 17.5584 | 32 | 618 | cell-cell adhesion |
| GO:0070649 | 8e-04 | Inf | 0.0568 | 2 | 2 | formin-nucleated actin cable assembly |
| GO:0090596 | 0.0011 | 2.6705 | 6.0233 | 15 | 212 | sensory organ morphogenesis |
| GO:0007338 | 0.0016 | 3.5998 | 2.7275 | 9 | 96 | single fertilization |
| GO:0060914 | 0.0018 | 9.2065 | 0.5398 | 4 | 19 | heart formation |
| GO:0007267 | 0.002 | 1.5993 | 35.506 | 53 | 1256 | cell-cell signaling |
| GO:0030855 | 0.002 | 1.9322 | 14.8309 | 27 | 522 | epithelial cell differentiation |
| GO:0060485 | 0.002 | 2.5924 | 5.7676 | 14 | 203 | mesenchyme development |
| GO:0017157 | 0.0022 | 2.9737 | 3.9776 | 11 | 140 | regulation of exocytosis |
| GO:0021602 | 0.0022 | 8.6304 | 0.5682 | 4 | 20 | cranial nerve morphogenesis |
| GO:0003264 | 0.0024 | 14.7656 | 0.2841 | 3 | 10 | regulation of cardioblast proliferation |
| GO:0070341 | 0.0024 | 14.7656 | 0.2841 | 3 | 10 | fat cell proliferation |
| GO:0008582 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | regulation of synaptic growth at neuromuscular junction |
| GO:0009946 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | proximal/distal axis specification |
| GO:0031296 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | B cell costimulation |
| GO:0060478 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | acrosomal vesicle exocytosis |
| GO:0061551 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | trigeminal ganglion development |
| GO:0072095 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:0072513 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
| GO:0060037 | 0.0026 | 8.1221 | 0.5966 | 4 | 21 | pharyngeal system development |
| GO:0021783 | 0.0032 | 12.9189 | 0.3125 | 3 | 11 | preganglionic parasympathetic fiber development |
| GO:0032536 | 0.0032 | 12.9189 | 0.3125 | 3 | 11 | regulation of cell projection size |
| GO:0042074 | 0.0032 | 12.9189 | 0.3125 | 3 | 11 | cell migration involved in gastrulation |
| GO:0050872 | 0.0032 | 12.9189 | 0.3125 | 3 | 11 | white fat cell differentiation |
| GO:0051653 | 0.0033 | 5.5765 | 1.0228 | 5 | 36 | spindle localization |
| GO:0051093 | 0.0036 | 1.7365 | 20.1155 | 33 | 708 | negative regulation of developmental process |
| GO:0060993 | 0.0036 | 3.8528 | 1.9888 | 7 | 70 | kidney morphogenesis |
| GO:0048935 | 0.0041 | 11.4826 | 0.3409 | 3 | 12 | peripheral nervous system neuron development |
| GO:0061323 | 0.0041 | 11.4826 | 0.3409 | 3 | 12 | cell proliferation involved in heart morphogenesis |
| GO:0072075 | 0.0041 | 11.4826 | 0.3409 | 3 | 12 | metanephric mesenchyme development |
| GO:0001974 | 0.0042 | 5.2377 | 1.0796 | 5 | 38 | blood vessel remodeling |
| GO:0043583 | 0.0045 | 2.5517 | 5.0005 | 12 | 176 | ear development |
| GO:0072171 | 0.0045 | 4.2391 | 1.5626 | 6 | 55 | mesonephric tubule morphogenesis |
| GO:0030910 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | olfactory placode formation |
| GO:0040038 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | polar body extrusion after meiotic divisions |
| GO:0048382 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | mesendoderm development |
| GO:0048866 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | stem cell fate specification |
| GO:0060638 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | mesenchymal-epithelial cell signaling |
| GO:0061055 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | myotome development |
| GO:0061197 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | fungiform papilla morphogenesis |
| GO:0070350 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | regulation of white fat cell proliferation |
| GO:0071698 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | olfactory placode development |
| GO:0072107 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0097167 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | circadian regulation of translation |
| GO:1904970 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | brush border assembly |
| GO:2000354 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | regulation of ovarian follicle development |
| GO:0048701 | 0.0047 | 5.0832 | 1.1081 | 5 | 39 | embryonic cranial skeleton morphogenesis |
| GO:0070098 | 0.0047 | 5.0832 | 1.1081 | 5 | 39 | chemokine-mediated signaling pathway |
| GO:0001708 | 0.0048 | 3.6408 | 2.0919 | 7 | 74 | cell fate specification |
| GO:0071697 | 0.0053 | 10.3335 | 0.3694 | 3 | 13 | ectodermal placode morphogenesis |
| GO:0072080 | 0.0062 | 3.4656 | 2.1877 | 7 | 77 | nephron tubule development |
| GO:0031639 | 0.0066 | 9.3934 | 0.3978 | 3 | 14 | plasminogen activation |
| GO:0042481 | 0.0066 | 9.3934 | 0.3978 | 3 | 14 | regulation of odontogenesis |
| GO:0071599 | 0.0066 | 9.3934 | 0.3978 | 3 | 14 | otic vesicle development |
| GO:0071677 | 0.0066 | 9.3934 | 0.3978 | 3 | 14 | positive regulation of mononuclear cell migration |
| GO:0001501 | 0.0066 | 1.9012 | 11.6204 | 21 | 409 | skeletal system development |
| GO:0050808 | 0.0068 | 2.3136 | 5.938 | 13 | 209 | synapse organization |
| GO:0048562 | 0.0071 | 2.5064 | 4.6507 | 11 | 168 | embryonic organ morphogenesis |
| GO:0002690 | 0.0075 | 3.7748 | 1.7331 | 6 | 61 | positive regulation of leukocyte chemotaxis |
| GO:0010891 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | negative regulation of sequestering of triglyceride |
| GO:0021546 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | rhombomere development |
| GO:0036089 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | cleavage furrow formation |
| GO:0051891 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0071205 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | protein localization to juxtaparanode region of axon |
| GO:2000818 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | negative regulation of myoblast proliferation |
| GO:0021879 | 0.0079 | 4.4298 | 1.2501 | 5 | 44 | forebrain neuron differentiation |
| GO:0060425 | 0.0079 | 4.4298 | 1.2501 | 5 | 44 | lung morphogenesis |
| GO:0001759 | 0.008 | 8.6099 | 0.4262 | 3 | 15 | organ induction |
| GO:0048714 | 0.008 | 8.6099 | 0.4262 | 3 | 15 | positive regulation of oligodendrocyte differentiation |
| GO:0060602 | 0.008 | 8.6099 | 0.4262 | 3 | 15 | branch elongation of an epithelium |
| GO:0003002 | 0.0086 | 2.0488 | 8.211 | 16 | 289 | regionalization |
| GO:0001655 | 0.0086 | 2.1041 | 7.5007 | 15 | 264 | urogenital system development |
| GO:0048546 | 0.0087 | 4.3187 | 1.2785 | 5 | 45 | digestive tract morphogenesis |
| GO:0097306 | 0.0087 | 4.3187 | 1.2785 | 5 | 45 | cellular response to alcohol |
| GO:1905207 | 0.0087 | 4.3187 | 1.2785 | 5 | 45 | regulation of cardiocyte differentiation |
| GO:0072088 | 0.0088 | 3.6418 | 1.7899 | 6 | 63 | nephron epithelium morphogenesis |
| GO:0048663 | 0.0095 | 3.5788 | 1.8183 | 6 | 64 | neuron fate commitment |
| GO:0014015 | 0.0095 | 4.2131 | 1.3069 | 5 | 46 | positive regulation of gliogenesis |
| GO:0061005 | 0.0095 | 4.2131 | 1.3069 | 5 | 46 | cell differentiation involved in kidney development |
| GO:0051241 | 0.0095 | 1.5791 | 23.9794 | 36 | 844 | negative regulation of multicellular organismal process |
| GO:0070723 | 0.0097 | 7.947 | 0.4546 | 3 | 16 | response to cholesterol |
| GO:0035108 | 0.0098 | 2.6705 | 3.5799 | 9 | 126 | limb morphogenesis |
| GO:0030336 | 0.0099 | 2.2834 | 5.5403 | 12 | 195 | negative regulation of cell migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 13.2306 | 0.7304 | 8 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 7.801 | 1.312 | 9 | 97 | detection of chemical stimulus |
| GO:0031424 | 0 | 6.9996 | 1.4473 | 9 | 107 | keratinization |
| GO:0050704 | 0 | 18.7284 | 0.3381 | 5 | 25 | regulation of interleukin-1 secretion |
| GO:0032732 | 0 | 17.8352 | 0.3517 | 5 | 26 | positive regulation of interleukin-1 production |
| GO:0050718 | 1e-04 | 24.8438 | 0.2164 | 4 | 16 | positive regulation of interleukin-1 beta secretion |
| GO:0050906 | 1e-04 | 6.0003 | 1.4743 | 8 | 109 | detection of stimulus involved in sensory perception |
| GO:0016045 | 1e-04 | 44.4886 | 0.1082 | 3 | 8 | detection of bacterium |
| GO:0009913 | 4e-04 | 4.0498 | 2.6781 | 10 | 198 | epidermal cell differentiation |
| GO:0098581 | 4e-04 | 27.799 | 0.1488 | 3 | 11 | detection of external biotic stimulus |
| GO:0048247 | 6e-04 | 11.9131 | 0.3922 | 4 | 29 | lymphocyte chemotaxis |
| GO:0050900 | 6e-04 | 3.2665 | 3.963 | 12 | 293 | leukocyte migration |
| GO:0018298 | 0.0011 | 73.7458 | 0.0541 | 2 | 4 | protein-chromophore linkage |
| GO:0071346 | 0.0013 | 5.4204 | 1.2038 | 6 | 89 | cellular response to interferon-gamma |
| GO:0001562 | 0.0017 | 14.8182 | 0.2435 | 3 | 18 | response to protozoan |
| GO:0018149 | 0.0017 | 14.8182 | 0.2435 | 3 | 18 | peptide cross-linking |
| GO:0022610 | 0.0017 | 2.0115 | 14.1074 | 26 | 1043 | biological adhesion |
| GO:0010898 | 0.0018 | 49.1601 | 0.0676 | 2 | 5 | positive regulation of triglyceride catabolic process |
| GO:0045345 | 0.0018 | 49.1601 | 0.0676 | 2 | 5 | positive regulation of MHC class I biosynthetic process |
| GO:0050748 | 0.0018 | 49.1601 | 0.0676 | 2 | 5 | negative regulation of lipoprotein metabolic process |
| GO:0034220 | 0.0019 | 2.1211 | 11.2399 | 22 | 831 | ion transmembrane transport |
| GO:0050877 | 0.0019 | 2.2035 | 9.8062 | 20 | 725 | nervous system process |
| GO:0045087 | 0.0021 | 2.3502 | 7.7773 | 17 | 575 | innate immune response |
| GO:0060135 | 0.0022 | 8.042 | 0.5546 | 4 | 41 | maternal process involved in female pregnancy |
| GO:0043588 | 0.0025 | 3.081 | 3.4626 | 10 | 256 | skin development |
| GO:0045046 | 0.0026 | 36.8672 | 0.0812 | 2 | 6 | protein import into peroxisome membrane |
| GO:0032651 | 0.0026 | 7.6284 | 0.5816 | 4 | 43 | regulation of interleukin-1 beta production |
| GO:0006952 | 0.0027 | 2.5093 | 5.9891 | 14 | 468 | defense response |
| GO:0007608 | 0.0031 | 11.5973 | 0.2984 | 3 | 23 | sensory perception of smell |
| GO:0030823 | 0.0035 | 11.1094 | 0.3111 | 3 | 23 | regulation of cGMP metabolic process |
| GO:0010713 | 0.0037 | 29.4915 | 0.0947 | 2 | 7 | negative regulation of collagen metabolic process |
| GO:0007586 | 0.0041 | 4.2368 | 1.5149 | 6 | 112 | digestion |
| GO:0052548 | 0.0042 | 2.8559 | 3.7196 | 10 | 275 | regulation of endopeptidase activity |
| GO:0045591 | 0.0048 | 24.5744 | 0.1082 | 2 | 8 | positive regulation of regulatory T cell differentiation |
| GO:2000484 | 0.0048 | 24.5744 | 0.1082 | 2 | 8 | positive regulation of interleukin-8 secretion |
| GO:0006953 | 0.0056 | 9.255 | 0.3652 | 3 | 27 | acute-phase response |
| GO:0010466 | 0.0059 | 3.4548 | 2.1506 | 7 | 159 | negative regulation of peptidase activity |
| GO:0070234 | 0.0062 | 21.0621 | 0.1217 | 2 | 9 | positive regulation of T cell apoptotic process |
| GO:0090026 | 0.0062 | 21.0621 | 0.1217 | 2 | 9 | positive regulation of monocyte chemotaxis |
| GO:0044706 | 0.0074 | 3.3009 | 2.2453 | 7 | 166 | multi-multicellular organism process |
| GO:0021554 | 0.0076 | 18.428 | 0.1353 | 2 | 10 | optic nerve development |
| GO:0031282 | 0.0076 | 18.428 | 0.1353 | 2 | 10 | regulation of guanylate cyclase activity |
| GO:0072643 | 0.0076 | 18.428 | 0.1353 | 2 | 10 | interferon-gamma secretion |
| GO:0032940 | 0.0081 | 1.7856 | 15.0542 | 25 | 1113 | secretion by cell |
| GO:0043299 | 0.0087 | 2.3273 | 5.4509 | 12 | 403 | leukocyte degranulation |
| GO:0019934 | 0.0092 | 16.3792 | 0.1488 | 2 | 11 | cGMP-mediated signaling |
| GO:0042074 | 0.0092 | 16.3792 | 0.1488 | 2 | 11 | cell migration involved in gastrulation |
| GO:0090009 | 0.0092 | 16.3792 | 0.1488 | 2 | 11 | primitive streak formation |
| GO:0002275 | 0.0094 | 2.303 | 5.505 | 12 | 407 | myeloid cell activation involved in immune response |
| GO:0098609 | 0.0097 | 2.0305 | 8.3589 | 16 | 618 | cell-cell adhesion |
| GO:0070374 | 0.0097 | 3.5026 | 1.8125 | 6 | 134 | positive regulation of ERK1 and ERK2 cascade |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 4.5641 | 4.5716 | 18 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0001944 | 0 | 2.3876 | 19.3834 | 42 | 530 | vasculature development |
| GO:0072359 | 0 | 2.0905 | 29.514 | 56 | 807 | circulatory system development |
| GO:0048646 | 0 | 2.0211 | 26.428 | 49 | 733 | anatomical structure formation involved in morphogenesis |
| GO:0007389 | 0 | 2.4564 | 13.3124 | 30 | 364 | pattern specification process |
| GO:0048568 | 0 | 2.4046 | 13.5684 | 30 | 371 | embryonic organ development |
| GO:0090103 | 0 | 12.2984 | 0.6949 | 6 | 19 | cochlea morphogenesis |
| GO:0048514 | 0 | 2.433 | 12.9647 | 29 | 359 | blood vessel morphogenesis |
| GO:2001199 | 0 | Inf | 0.1097 | 3 | 3 | negative regulation of dendritic cell differentiation |
| GO:0021602 | 1e-04 | 11.419 | 0.7314 | 6 | 20 | cranial nerve morphogenesis |
| GO:0060055 | 1e-04 | 10.6569 | 0.768 | 6 | 21 | angiogenesis involved in wound healing |
| GO:0045765 | 1e-04 | 4.1858 | 3.251 | 12 | 90 | regulation of angiogenesis |
| GO:0001708 | 1e-04 | 4.4023 | 2.8527 | 11 | 78 | cell fate specification |
| GO:0022610 | 2e-04 | 1.7281 | 38.1451 | 61 | 1043 | biological adhesion |
| GO:0042126 | 2e-04 | 79.5156 | 0.1463 | 3 | 4 | nitrate metabolic process |
| GO:0007200 | 3e-04 | 4.1818 | 2.7064 | 10 | 74 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0051094 | 4e-04 | 1.6816 | 37.0479 | 58 | 1013 | positive regulation of developmental process |
| GO:0021783 | 5e-04 | 15.1702 | 0.4023 | 4 | 11 | preganglionic parasympathetic fiber development |
| GO:0048839 | 5e-04 | 2.923 | 5.5956 | 15 | 153 | inner ear development |
| GO:0021562 | 9e-04 | 26.501 | 0.2194 | 3 | 6 | vestibulocochlear nerve development |
| GO:0048598 | 9e-04 | 1.9236 | 17.7238 | 32 | 490 | embryonic morphogenesis |
| GO:0006590 | 0.001 | 11.7972 | 0.4754 | 4 | 13 | thyroid hormone generation |
| GO:0048704 | 0.001 | 3.5654 | 3.1087 | 10 | 85 | embryonic skeletal system morphogenesis |
| GO:0042471 | 0.001 | 3.3083 | 3.6572 | 11 | 100 | ear morphogenesis |
| GO:0040011 | 0.0011 | 1.5378 | 49.4825 | 71 | 1353 | locomotion |
| GO:0006575 | 0.0011 | 2.9296 | 4.8276 | 13 | 132 | cellular modified amino acid metabolic process |
| GO:0001501 | 0.0011 | 1.9934 | 14.9581 | 28 | 409 | skeletal system development |
| GO:0034103 | 0.0012 | 4.2689 | 2.1212 | 8 | 58 | regulation of tissue remodeling |
| GO:0010092 | 0.0012 | 7.3834 | 0.8412 | 5 | 23 | specification of animal organ identity |
| GO:2000026 | 0.0013 | 1.5564 | 44.7246 | 65 | 1255 | regulation of multicellular organismal development |
| GO:0071294 | 0.0013 | 10.6167 | 0.512 | 4 | 14 | cellular response to zinc ion |
| GO:0051674 | 0.0013 | 1.5669 | 42.2412 | 62 | 1155 | localization of cell |
| GO:0003342 | 0.0013 | Inf | 0.0731 | 2 | 2 | proepicardium development |
| GO:0043134 | 0.0013 | Inf | 0.0731 | 2 | 2 | regulation of hindgut contraction |
| GO:0070366 | 0.0013 | Inf | 0.0731 | 2 | 2 | regulation of hepatocyte differentiation |
| GO:0003211 | 0.0015 | 19.8742 | 0.256 | 3 | 7 | cardiac ventricle formation |
| GO:0044650 | 0.0015 | 19.8742 | 0.256 | 3 | 7 | adhesion of symbiont to host cell |
| GO:0006928 | 0.0017 | 1.4775 | 57.2725 | 79 | 1566 | movement of cell or subcellular component |
| GO:0019372 | 0.0017 | 9.6508 | 0.5486 | 4 | 15 | lipoxygenase pathway |
| GO:0030198 | 0.0019 | 2.2341 | 9.07 | 19 | 248 | extracellular matrix organization |
| GO:0009651 | 0.0023 | 8.8458 | 0.5852 | 4 | 16 | response to salt stress |
| GO:0016477 | 0.0023 | 1.5594 | 38.1451 | 56 | 1043 | cell migration |
| GO:0060982 | 0.0024 | 15.8981 | 0.2926 | 3 | 8 | coronary artery morphogenesis |
| GO:1905205 | 0.0024 | 15.8981 | 0.2926 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0042445 | 0.0027 | 2.7451 | 4.7178 | 12 | 129 | hormone metabolic process |
| GO:2000181 | 0.0027 | 3.3363 | 2.9624 | 9 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0001710 | 0.0029 | 8.1647 | 0.6217 | 4 | 17 | mesodermal cell fate commitment |
| GO:0001704 | 0.0032 | 2.8278 | 4.2058 | 11 | 115 | formation of primary germ layer |
| GO:0006954 | 0.0034 | 1.8087 | 16.9331 | 29 | 463 | inflammatory response |
| GO:0009888 | 0.0034 | 1.4529 | 53.4768 | 73 | 1470 | tissue development |
| GO:1903244 | 0.0035 | 13.2474 | 0.3292 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0048332 | 0.0036 | 3.4961 | 2.5235 | 8 | 69 | mesoderm morphogenesis |
| GO:2000027 | 0.0037 | 2.26 | 7.5339 | 16 | 206 | regulation of organ morphogenesis |
| GO:0050878 | 0.0038 | 1.8853 | 14.0073 | 25 | 383 | regulation of body fluid levels |
| GO:0018958 | 0.0039 | 3.4394 | 2.5601 | 8 | 70 | phenol-containing compound metabolic process |
| GO:0021650 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | vestibulocochlear nerve formation |
| GO:0051410 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | detoxification of nitrogen compound |
| GO:0060913 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | cardiac cell fate determination |
| GO:0061044 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0061551 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | trigeminal ganglion development |
| GO:0070634 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | transepithelial ammonium transport |
| GO:1901166 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | neural crest cell migration involved in autonomic nervous system development |
| GO:0098609 | 0.0039 | 1.68 | 22.6018 | 36 | 618 | cell-cell adhesion |
| GO:0035023 | 0.0041 | 2.9027 | 3.7304 | 10 | 102 | regulation of Rho protein signal transduction |
| GO:0003206 | 0.0044 | 2.8712 | 3.767 | 10 | 103 | cardiac chamber morphogenesis |
| GO:0023019 | 0.0044 | 7.075 | 0.6949 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0060914 | 0.0044 | 7.075 | 0.6949 | 4 | 19 | heart formation |
| GO:0007154 | 0.0048 | 1.2835 | 174.4141 | 202 | 4769 | cell communication |
| GO:0010755 | 0.0048 | 11.354 | 0.3657 | 3 | 10 | regulation of plasminogen activation |
| GO:0071941 | 0.0048 | 11.354 | 0.3657 | 3 | 10 | nitrogen cycle metabolic process |
| GO:0021879 | 0.005 | 4.1991 | 1.6092 | 6 | 44 | forebrain neuron differentiation |
| GO:0045995 | 0.005 | 2.8103 | 3.8401 | 10 | 105 | regulation of embryonic development |
| GO:0023052 | 0.0053 | 1.2796 | 173.7924 | 201 | 4752 | signaling |
| GO:0060562 | 0.0054 | 2.0183 | 9.9477 | 19 | 272 | epithelial tube morphogenesis |
| GO:1900048 | 0.0054 | 6.6323 | 0.7314 | 4 | 20 | positive regulation of hemostasis |
| GO:0030855 | 0.0055 | 1.7086 | 19.0908 | 31 | 522 | epithelial cell differentiation |
| GO:0006805 | 0.0055 | 3.5835 | 2.1578 | 7 | 59 | xenobiotic metabolic process |
| GO:0051240 | 0.0057 | 1.4697 | 42.4177 | 59 | 1174 | positive regulation of multicellular organismal process |
| GO:0051093 | 0.0059 | 1.5996 | 25.6484 | 39 | 704 | negative regulation of developmental process |
| GO:0009792 | 0.0062 | 1.7076 | 18.4691 | 30 | 505 | embryo development ending in birth or egg hatching |
| GO:0006071 | 0.0064 | 9.934 | 0.4023 | 3 | 11 | glycerol metabolic process |
| GO:0014744 | 0.0064 | 9.934 | 0.4023 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0042573 | 0.0064 | 9.934 | 0.4023 | 3 | 11 | retinoic acid metabolic process |
| GO:0050820 | 0.0064 | 6.2417 | 0.768 | 4 | 21 | positive regulation of coagulation |
| GO:0060037 | 0.0064 | 6.2417 | 0.768 | 4 | 21 | pharyngeal system development |
| GO:0038111 | 0.0065 | 4.7428 | 1.2069 | 5 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0065 | 4.7428 | 1.2069 | 5 | 33 | response to interleukin-7 |
| GO:0030326 | 0.0066 | 2.6959 | 3.9864 | 10 | 109 | embryonic limb morphogenesis |
| GO:0043535 | 0.0066 | 3.4503 | 2.2309 | 7 | 61 | regulation of blood vessel endothelial cell migration |
| GO:0048731 | 0.0067 | 1.3429 | 86.9296 | 108 | 2564 | system development |
| GO:0046394 | 0.007 | 2.0049 | 9.4723 | 18 | 259 | carboxylic acid biosynthetic process |
| GO:0021675 | 0.0073 | 3.3873 | 2.2675 | 7 | 62 | nerve development |
| GO:0003308 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0010572 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | positive regulation of platelet activation |
| GO:0033353 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | S-adenosylmethionine cycle |
| GO:0035989 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | tendon development |
| GO:0042662 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0042663 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | regulation of endodermal cell fate specification |
| GO:0046813 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | receptor-mediated virion attachment to host cell |
| GO:0051122 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060920 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | cardiac pacemaker cell differentiation |
| GO:0061055 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | myotome development |
| GO:0097176 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | epoxide metabolic process |
| GO:1901842 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | negative regulation of high voltage-gated calcium channel activity |
| GO:1905903 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0045766 | 0.0079 | 2.616 | 4.0961 | 10 | 112 | positive regulation of angiogenesis |
| GO:0032502 | 0.008 | 1.3215 | 100.753 | 122 | 2979 | developmental process |
| GO:0072593 | 0.0081 | 2.1256 | 7.4608 | 15 | 204 | reactive oxygen species metabolic process |
| GO:0048532 | 0.0084 | 8.8295 | 0.4389 | 3 | 12 | anatomical structure arrangement |
| GO:0061548 | 0.0084 | 8.8295 | 0.4389 | 3 | 12 | ganglion development |
| GO:0045595 | 0.0087 | 1.4024 | 51.1649 | 68 | 1399 | regulation of cell differentiation |
| GO:0003148 | 0.009 | 5.5838 | 0.8412 | 4 | 23 | outflow tract septum morphogenesis |
| GO:0030878 | 0.009 | 5.5838 | 0.8412 | 4 | 23 | thyroid gland development |
| GO:0060561 | 0.009 | 5.5838 | 0.8412 | 4 | 23 | apoptotic process involved in morphogenesis |
| GO:0061756 | 0.009 | 5.5838 | 0.8412 | 4 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0006342 | 0.009 | 2.7263 | 3.5475 | 9 | 97 | chromatin silencing |
| GO:0022600 | 0.0094 | 3.2113 | 2.3772 | 7 | 65 | digestive system process |
| GO:0003012 | 0.0094 | 1.8091 | 12.7638 | 22 | 349 | muscle system process |
| GO:0051241 | 0.0095 | 1.5084 | 30.6032 | 44 | 840 | negative regulation of multicellular organismal process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048514 | 0 | 2.5168 | 17.1226 | 39 | 440 | blood vessel morphogenesis |
| GO:0072359 | 0 | 2.0707 | 31.4043 | 59 | 807 | circulatory system development |
| GO:0048646 | 0 | 1.9979 | 31.8317 | 58 | 828 | anatomical structure formation involved in morphogenesis |
| GO:0034103 | 0 | 5.8845 | 2.2571 | 11 | 58 | regulation of tissue remodeling |
| GO:0001944 | 0 | 2.155 | 19.6479 | 39 | 508 | vasculature development |
| GO:0006928 | 0 | 1.6361 | 60.9408 | 91 | 1566 | movement of cell or subcellular component |
| GO:0051674 | 1e-04 | 1.7164 | 44.9467 | 71 | 1155 | localization of cell |
| GO:2000026 | 1e-04 | 1.618 | 59.3452 | 88 | 1525 | regulation of multicellular organismal development |
| GO:1905205 | 1e-04 | 24.8826 | 0.3113 | 4 | 8 | positive regulation of connective tissue replacement |
| GO:0003199 | 2e-04 | 74.5195 | 0.1557 | 3 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0042126 | 2e-04 | 74.5195 | 0.1557 | 3 | 4 | nitrate metabolic process |
| GO:0097176 | 2e-04 | 74.5195 | 0.1557 | 3 | 4 | epoxide metabolic process |
| GO:0040011 | 2e-04 | 1.6021 | 52.6519 | 78 | 1353 | locomotion |
| GO:0006954 | 3e-04 | 2.025 | 18.0176 | 34 | 463 | inflammatory response |
| GO:0048856 | 3e-04 | 1.3825 | 170.3028 | 207 | 4441 | anatomical structure development |
| GO:0008217 | 4e-04 | 3.1455 | 4.9033 | 14 | 126 | regulation of blood pressure |
| GO:2000145 | 4e-04 | 1.8484 | 24.3218 | 42 | 625 | regulation of cell motility |
| GO:0021877 | 4e-04 | 16.5858 | 0.3891 | 4 | 10 | forebrain neuron fate commitment |
| GO:0048706 | 4e-04 | 3.3011 | 4.3585 | 13 | 112 | embryonic skeletal system development |
| GO:0030194 | 8e-04 | 8.3033 | 0.7783 | 5 | 20 | positive regulation of blood coagulation |
| GO:0022610 | 8e-04 | 1.6059 | 40.5883 | 61 | 1043 | biological adhesion |
| GO:0048562 | 9e-04 | 2.288 | 9.8455 | 21 | 253 | embryonic organ morphogenesis |
| GO:0030168 | 9e-04 | 2.9959 | 4.7476 | 13 | 122 | platelet activation |
| GO:0035360 | 0.0011 | 24.8359 | 0.2335 | 3 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0046394 | 0.0012 | 2.2293 | 10.079 | 21 | 259 | carboxylic acid biosynthetic process |
| GO:0072148 | 0.0012 | 11.0546 | 0.5059 | 4 | 13 | epithelial cell fate commitment |
| GO:0045766 | 0.0014 | 3.0105 | 4.3585 | 12 | 112 | positive regulation of angiogenesis |
| GO:0003342 | 0.0015 | Inf | 0.0778 | 2 | 2 | proepicardium development |
| GO:0060838 | 0.0015 | Inf | 0.0778 | 2 | 2 | lymphatic endothelial cell fate commitment |
| GO:1901731 | 0.0015 | Inf | 0.0778 | 2 | 2 | positive regulation of platelet aggregation |
| GO:0042445 | 0.0015 | 2.8136 | 5.02 | 13 | 129 | hormone metabolic process |
| GO:0035239 | 0.0018 | 2.0692 | 11.8301 | 23 | 304 | tube morphogenesis |
| GO:0006805 | 0.0019 | 3.9194 | 2.296 | 8 | 59 | xenobiotic metabolic process |
| GO:0007599 | 0.0019 | 2.1377 | 10.4681 | 21 | 269 | hemostasis |
| GO:0050817 | 0.0019 | 2.1377 | 10.4681 | 21 | 269 | coagulation |
| GO:0045214 | 0.0021 | 5.1582 | 1.362 | 6 | 35 | sarcomere organization |
| GO:0009792 | 0.0025 | 1.7765 | 19.652 | 33 | 505 | embryo development ending in birth or egg hatching |
| GO:0072593 | 0.0026 | 2.2877 | 7.9386 | 17 | 204 | reactive oxygen species metabolic process |
| GO:0008206 | 0.0028 | 4.8246 | 1.4399 | 6 | 37 | bile acid metabolic process |
| GO:0050829 | 0.0028 | 4.8246 | 1.4399 | 6 | 37 | defense response to Gram-negative bacterium |
| GO:0060982 | 0.0028 | 14.8992 | 0.3113 | 3 | 8 | coronary artery morphogenesis |
| GO:0072604 | 0.0029 | 5.9281 | 1.0118 | 5 | 26 | interleukin-6 secretion |
| GO:0001667 | 0.003 | 2.0532 | 10.8573 | 21 | 279 | ameboidal-type cell migration |
| GO:0043433 | 0.0034 | 2.8108 | 4.2417 | 11 | 109 | negative regulation of DNA binding transcription factor activity |
| GO:0070286 | 0.0035 | 5.6582 | 1.0507 | 5 | 27 | axonemal dynein complex assembly |
| GO:0003158 | 0.0035 | 2.9785 | 3.658 | 10 | 94 | endothelium development |
| GO:0050671 | 0.0035 | 2.9785 | 3.658 | 10 | 94 | positive regulation of lymphocyte proliferation |
| GO:0048701 | 0.0037 | 4.5315 | 1.5177 | 6 | 39 | embryonic cranial skeleton morphogenesis |
| GO:0030198 | 0.0039 | 2.0893 | 9.6509 | 19 | 248 | extracellular matrix organization |
| GO:0016477 | 0.004 | 1.5945 | 29.1328 | 44 | 764 | cell migration |
| GO:0003207 | 0.0041 | 12.415 | 0.3502 | 3 | 9 | cardiac chamber formation |
| GO:0016264 | 0.0041 | 12.415 | 0.3502 | 3 | 9 | gap junction assembly |
| GO:0060900 | 0.0041 | 12.415 | 0.3502 | 3 | 9 | embryonic camera-type eye formation |
| GO:0061029 | 0.0041 | 12.415 | 0.3502 | 3 | 9 | eyelid development in camera-type eye |
| GO:1903244 | 0.0041 | 12.415 | 0.3502 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:2001044 | 0.0041 | 12.415 | 0.3502 | 3 | 9 | regulation of integrin-mediated signaling pathway |
| GO:0042472 | 0.0041 | 3.1243 | 3.1521 | 9 | 81 | inner ear morphogenesis |
| GO:0045596 | 0.0042 | 1.7123 | 20.3136 | 33 | 522 | negative regulation of cell differentiation |
| GO:0009410 | 0.0043 | 3.3858 | 2.6073 | 8 | 67 | response to xenobiotic stimulus |
| GO:0007389 | 0.0043 | 1.8632 | 14.165 | 25 | 364 | pattern specification process |
| GO:0034112 | 0.0044 | 49.7769 | 0.1163 | 2 | 3 | positive regulation of homotypic cell-cell adhesion |
| GO:0003219 | 0.0044 | 49.5828 | 0.1167 | 2 | 3 | cardiac right ventricle formation |
| GO:0033128 | 0.0044 | 49.5828 | 0.1167 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0051410 | 0.0044 | 49.5828 | 0.1167 | 2 | 3 | detoxification of nitrogen compound |
| GO:0055005 | 0.0044 | 49.5828 | 0.1167 | 2 | 3 | ventricular cardiac myofibril assembly |
| GO:0061044 | 0.0044 | 49.5828 | 0.1167 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0070634 | 0.0044 | 49.5828 | 0.1167 | 2 | 3 | transepithelial ammonium transport |
| GO:2001199 | 0.0044 | 49.5828 | 0.1167 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0070665 | 0.0044 | 2.8752 | 3.7747 | 10 | 97 | positive regulation of leukocyte proliferation |
| GO:0032309 | 0.0048 | 5.1859 | 1.1285 | 5 | 29 | icosanoid secretion |
| GO:0010810 | 0.0048 | 2.4321 | 5.7205 | 13 | 147 | regulation of cell-substrate adhesion |
| GO:0045785 | 0.0051 | 1.9526 | 11.3632 | 21 | 292 | positive regulation of cell adhesion |
| GO:0048729 | 0.0051 | 1.6872 | 20.586 | 33 | 529 | tissue morphogenesis |
| GO:0045597 | 0.0053 | 1.5737 | 28.7581 | 43 | 739 | positive regulation of cell differentiation |
| GO:0051893 | 0.0054 | 4.1529 | 1.6344 | 6 | 42 | regulation of focal adhesion assembly |
| GO:0050867 | 0.0055 | 10.8128 | 0.3833 | 3 | 10 | positive regulation of cell activation |
| GO:1901571 | 0.0056 | 4.978 | 1.1674 | 5 | 30 | fatty acid derivative transport |
| GO:0003007 | 0.0056 | 2.1605 | 7.8608 | 16 | 202 | heart morphogenesis |
| GO:0050673 | 0.0057 | 1.967 | 10.7405 | 20 | 276 | epithelial cell proliferation |
| GO:0003157 | 0.0057 | 10.6406 | 0.3891 | 3 | 10 | endocardium development |
| GO:0010755 | 0.0057 | 10.6406 | 0.3891 | 3 | 10 | regulation of plasminogen activation |
| GO:0071941 | 0.0057 | 10.6406 | 0.3891 | 3 | 10 | nitrogen cycle metabolic process |
| GO:0097154 | 0.0057 | 10.6406 | 0.3891 | 3 | 10 | GABAergic neuron differentiation |
| GO:0006334 | 0.0059 | 2.597 | 4.553 | 11 | 117 | nucleosome assembly |
| GO:0097435 | 0.0059 | 1.7141 | 18.4068 | 30 | 473 | supramolecular fiber organization |
| GO:0042060 | 0.0064 | 1.7769 | 15.3923 | 26 | 398 | wound healing |
| GO:0050896 | 0.0067 | 1.2541 | 250.0283 | 278 | 6425 | response to stimulus |
| GO:0031341 | 0.0068 | 3.9337 | 1.7123 | 6 | 44 | regulation of cell killing |
| GO:0033555 | 0.007 | 3.4227 | 2.2571 | 7 | 58 | multicellular organismal response to stress |
| GO:0045765 | 0.0075 | 2.8201 | 3.4499 | 9 | 90 | regulation of angiogenesis |
| GO:0014744 | 0.0077 | 9.3098 | 0.4281 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0021783 | 0.0077 | 9.3098 | 0.4281 | 3 | 11 | preganglionic parasympathetic fiber development |
| GO:1900025 | 0.0077 | 9.3098 | 0.4281 | 3 | 11 | negative regulation of substrate adhesion-dependent cell spreading |
| GO:0042127 | 0.0077 | 1.4162 | 49.1106 | 66 | 1262 | regulation of cell proliferation |
| GO:0072175 | 0.008 | 2.4791 | 4.7476 | 11 | 122 | epithelial tube formation |
| GO:0060037 | 0.008 | 5.8487 | 0.8172 | 4 | 21 | pharyngeal system development |
| GO:0060055 | 0.008 | 5.8487 | 0.8172 | 4 | 21 | angiogenesis involved in wound healing |
| GO:0006631 | 0.0081 | 1.8988 | 11.0908 | 20 | 285 | fatty acid metabolic process |
| GO:0021761 | 0.0082 | 2.7751 | 3.5023 | 9 | 90 | limbic system development |
| GO:0003208 | 0.0084 | 3.293 | 2.3349 | 7 | 60 | cardiac ventricle morphogenesis |
| GO:0038111 | 0.0084 | 4.4436 | 1.2842 | 5 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0084 | 4.4436 | 1.2842 | 5 | 33 | response to interleukin-7 |
| GO:0032944 | 0.0085 | 2.3467 | 5.4481 | 12 | 140 | regulation of mononuclear cell proliferation |
| GO:0002003 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | angiotensin maturation |
| GO:0002138 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | retinoic acid biosynthetic process |
| GO:0002583 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | regulation of antigen processing and presentation of peptide antigen |
| GO:0003253 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0021648 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0033353 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | S-adenosylmethionine cycle |
| GO:0051122 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060214 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | endocardium formation |
| GO:0060455 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | negative regulation of gastric acid secretion |
| GO:0071502 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | cellular response to temperature stimulus |
| GO:2000977 | 0.0086 | 24.7895 | 0.1557 | 2 | 4 | regulation of forebrain neuron differentiation |
| GO:0043535 | 0.0092 | 3.2318 | 2.3738 | 7 | 61 | regulation of blood vessel endothelial cell migration |
| GO:0001945 | 0.0095 | 5.5234 | 0.8561 | 4 | 22 | lymph vessel development |
| GO:0002696 | 0.0096 | 2.0277 | 8.3278 | 16 | 214 | positive regulation of leukocyte activation |
| GO:0010632 | 0.0097 | 2.2148 | 6.2264 | 13 | 160 | regulation of epithelial cell migration |
| GO:0048878 | 0.0097 | 1.4982 | 31.4822 | 45 | 809 | chemical homeostasis |
| GO:0030326 | 0.0099 | 2.5243 | 4.2417 | 10 | 109 | embryonic limb morphogenesis |
| GO:0043542 | 0.01 | 2.2924 | 5.5648 | 12 | 143 | endothelial cell migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002690 | 1e-04 | 6.6353 | 1.3874 | 8 | 61 | positive regulation of leukocyte chemotaxis |
| GO:0050865 | 1e-04 | 2.6728 | 8.5064 | 21 | 374 | regulation of cell activation |
| GO:0050863 | 2e-04 | 3.193 | 5.0948 | 15 | 224 | regulation of T cell activation |
| GO:2001190 | 5e-04 | Inf | 0.0455 | 2 | 2 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0071622 | 6e-04 | 8.3855 | 0.7051 | 5 | 31 | regulation of granulocyte chemotaxis |
| GO:0050920 | 7e-04 | 3.7004 | 2.934 | 10 | 129 | regulation of chemotaxis |
| GO:0090023 | 8e-04 | 11.5987 | 0.4321 | 4 | 19 | positive regulation of neutrophil chemotaxis |
| GO:0022407 | 8e-04 | 2.5733 | 7.0735 | 17 | 311 | regulation of cell-cell adhesion |
| GO:0046394 | 9e-04 | 2.7275 | 5.8908 | 15 | 259 | carboxylic acid biosynthetic process |
| GO:0002696 | 0.0012 | 2.8592 | 4.8673 | 13 | 214 | positive regulation of leukocyte activation |
| GO:0014741 | 0.0014 | 9.6633 | 0.5004 | 4 | 22 | negative regulation of muscle hypertrophy |
| GO:1902622 | 0.0014 | 9.6633 | 0.5004 | 4 | 22 | regulation of neutrophil migration |
| GO:0032103 | 0.0017 | 2.893 | 4.4352 | 12 | 195 | positive regulation of response to external stimulus |
| GO:0097530 | 0.0018 | 4.3752 | 1.7513 | 7 | 77 | granulocyte migration |
| GO:0006633 | 0.002 | 3.811 | 2.2744 | 8 | 100 | fatty acid biosynthetic process |
| GO:0006955 | 0.0022 | 1.8386 | 18.0482 | 31 | 821 | immune response |
| GO:0032940 | 0.0025 | 1.694 | 25.3146 | 40 | 1113 | secretion by cell |
| GO:0032930 | 0.0028 | 13.0097 | 0.2957 | 3 | 13 | positive regulation of superoxide anion generation |
| GO:0086023 | 0.003 | 43.2475 | 0.091 | 2 | 4 | adrenergic receptor signaling pathway involved in heart process |
| GO:1902715 | 0.003 | 43.2475 | 0.091 | 2 | 4 | positive regulation of interferon-gamma secretion |
| GO:0007159 | 0.0032 | 3.5035 | 2.4557 | 8 | 110 | leukocyte cell-cell adhesion |
| GO:0032689 | 0.0035 | 11.8261 | 0.3184 | 3 | 14 | negative regulation of interferon-gamma production |
| GO:0007626 | 0.0045 | 2.8329 | 3.7528 | 10 | 165 | locomotory behavior |
| GO:0002263 | 0.0048 | 1.9628 | 11.304 | 21 | 497 | cell activation involved in immune response |
| GO:0033239 | 0.0049 | 28.8294 | 0.1137 | 2 | 5 | negative regulation of cellular amine metabolic process |
| GO:0033299 | 0.0049 | 28.8294 | 0.1137 | 2 | 5 | secretion of lysosomal enzymes |
| GO:0019932 | 0.0054 | 2.4797 | 5.1175 | 12 | 225 | second-messenger-mediated signaling |
| GO:0050671 | 0.0056 | 3.5156 | 2.138 | 7 | 94 | positive regulation of lymphocyte proliferation |
| GO:0002275 | 0.0056 | 2.051 | 9.257 | 18 | 407 | myeloid cell activation involved in immune response |
| GO:0030833 | 0.0058 | 3.154 | 2.7066 | 8 | 119 | regulation of actin filament polymerization |
| GO:0010611 | 0.0059 | 4.7323 | 1.16 | 5 | 51 | regulation of cardiac muscle hypertrophy |
| GO:0045055 | 0.0061 | 1.8592 | 13.0553 | 23 | 574 | regulated exocytosis |
| GO:0042346 | 0.0063 | 9.2898 | 0.3867 | 3 | 17 | positive regulation of NF-kappaB import into nucleus |
| GO:0070665 | 0.0066 | 3.3976 | 2.2062 | 7 | 97 | positive regulation of leukocyte proliferation |
| GO:0045785 | 0.0071 | 2.2206 | 6.6414 | 14 | 292 | positive regulation of cell adhesion |
| GO:0003360 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | brainstem development |
| GO:0044341 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | sodium-dependent phosphate transport |
| GO:1903243 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | negative regulation of cardiac muscle hypertrophy in response to stress |
| GO:2001300 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | lipoxin metabolic process |
| GO:1901017 | 0.0074 | 8.6698 | 0.4094 | 3 | 18 | negative regulation of potassium ion transmembrane transporter activity |
| GO:0060291 | 0.0075 | 4.4415 | 1.2282 | 5 | 54 | long-term synaptic potentiation |
| GO:0044283 | 0.0078 | 1.9404 | 10.3032 | 19 | 453 | small molecule biosynthetic process |
| GO:0060326 | 0.0079 | 2.5954 | 4.0713 | 10 | 179 | cell chemotaxis |
| GO:0014897 | 0.0081 | 3.6845 | 1.7513 | 6 | 77 | striated muscle hypertrophy |
| GO:0046649 | 0.0083 | 1.9266 | 10.3715 | 19 | 456 | lymphocyte activation |
| GO:0002683 | 0.0084 | 2.1726 | 6.7778 | 14 | 298 | negative regulation of immune system process |
| GO:0007155 | 0.0085 | 1.7214 | 16.5654 | 27 | 747 | cell adhesion |
| GO:1903039 | 0.0087 | 2.7183 | 3.5026 | 9 | 154 | positive regulation of leukocyte cell-cell adhesion |
| GO:0032720 | 0.0087 | 5.4297 | 0.8188 | 4 | 36 | negative regulation of tumor necrosis factor production |
| GO:0002886 | 0.0096 | 5.2648 | 0.8415 | 4 | 37 | regulation of myeloid leukocyte mediated immunity |
| GO:0043303 | 0.0096 | 5.2648 | 0.8415 | 4 | 37 | mast cell degranulation |
| GO:0051899 | 0.0097 | 3.5343 | 1.8196 | 6 | 80 | membrane depolarization |
| GO:0002707 | 0.01 | 7.6486 | 0.4549 | 3 | 20 | negative regulation of lymphocyte mediated immunity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048646 | 0 | 2.1055 | 28.8348 | 55 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0048514 | 0 | 2.4066 | 14.9615 | 33 | 440 | blood vessel morphogenesis |
| GO:0072358 | 1e-04 | 2.1408 | 18.1918 | 36 | 535 | cardiovascular system development |
| GO:1905205 | 1e-04 | 28.6547 | 0.272 | 4 | 8 | positive regulation of connective tissue replacement |
| GO:0010612 | 1e-04 | 14.3528 | 0.51 | 5 | 15 | regulation of cardiac muscle adaptation |
| GO:0042126 | 2e-04 | 85.7919 | 0.136 | 3 | 4 | nitrate metabolic process |
| GO:0007275 | 2e-04 | 1.4337 | 139.5836 | 175 | 4105 | multicellular organism development |
| GO:0046394 | 2e-04 | 2.5804 | 8.8069 | 21 | 259 | carboxylic acid biosynthetic process |
| GO:0072175 | 3e-04 | 3.4593 | 4.1484 | 13 | 122 | epithelial tube formation |
| GO:0002700 | 3e-04 | 4.1881 | 2.6863 | 10 | 79 | regulation of production of molecular mediator of immune response |
| GO:0045766 | 4e-04 | 3.4751 | 3.8084 | 12 | 112 | positive regulation of angiogenesis |
| GO:0022409 | 5e-04 | 2.8195 | 6.1546 | 16 | 181 | positive regulation of cell-cell adhesion |
| GO:0051270 | 6e-04 | 1.8301 | 23.3603 | 40 | 687 | regulation of cellular component movement |
| GO:0035239 | 7e-04 | 2.2788 | 10.337 | 22 | 304 | tube morphogenesis |
| GO:1901342 | 8e-04 | 3.0499 | 4.6392 | 13 | 138 | regulation of vasculature development |
| GO:0006629 | 9e-04 | 1.631 | 37.4377 | 57 | 1101 | lipid metabolic process |
| GO:0040012 | 0.001 | 1.7946 | 23.1563 | 39 | 681 | regulation of locomotion |
| GO:0034754 | 0.0011 | 3.8736 | 2.5843 | 9 | 76 | cellular hormone metabolic process |
| GO:0001698 | 0.0012 | Inf | 0.068 | 2 | 2 | gastrin-induced gastric acid secretion |
| GO:0002730 | 0.0012 | Inf | 0.068 | 2 | 2 | regulation of dendritic cell cytokine production |
| GO:0006954 | 0.0012 | 1.9602 | 15.7435 | 29 | 463 | inflammatory response |
| GO:0001841 | 0.0013 | 3.4361 | 3.1963 | 10 | 94 | neural tube formation |
| GO:0050671 | 0.0013 | 3.4361 | 3.1963 | 10 | 94 | positive regulation of lymphocyte proliferation |
| GO:0050870 | 0.0013 | 2.8513 | 4.9305 | 13 | 145 | positive regulation of T cell activation |
| GO:0003299 | 0.0013 | 7.1708 | 0.8501 | 5 | 25 | muscle hypertrophy in response to stress |
| GO:0001843 | 0.0017 | 3.6032 | 2.7543 | 9 | 81 | neural tube closure |
| GO:0045446 | 0.0017 | 3.6032 | 2.7543 | 9 | 81 | endothelial cell differentiation |
| GO:0070665 | 0.0017 | 3.3169 | 3.2983 | 10 | 97 | positive regulation of leukocyte proliferation |
| GO:0016331 | 0.0019 | 2.8672 | 4.5224 | 12 | 133 | morphogenesis of embryonic epithelium |
| GO:0045091 | 0.0019 | 17.153 | 0.272 | 3 | 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0014888 | 0.0024 | 4.9224 | 1.3941 | 6 | 41 | striated muscle adaptation |
| GO:0002696 | 0.0027 | 2.3434 | 7.2767 | 16 | 214 | positive regulation of leukocyte activation |
| GO:1903244 | 0.0028 | 14.2931 | 0.306 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0002367 | 0.0031 | 4.0243 | 1.9382 | 7 | 57 | cytokine production involved in immune response |
| GO:0002277 | 0.0034 | 57.067 | 0.102 | 2 | 3 | myeloid dendritic cell activation involved in immune response |
| GO:0033128 | 0.0034 | 57.067 | 0.102 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0051410 | 0.0034 | 57.067 | 0.102 | 2 | 3 | detoxification of nitrogen compound |
| GO:0070634 | 0.0034 | 57.067 | 0.102 | 2 | 3 | transepithelial ammonium transport |
| GO:0001501 | 0.0034 | 1.8995 | 13.9074 | 25 | 409 | skeletal system development |
| GO:0048568 | 0.0041 | 1.9249 | 12.6152 | 23 | 371 | embryonic organ development |
| GO:0002230 | 0.0041 | 7.157 | 0.6801 | 4 | 20 | positive regulation of defense response to virus by host |
| GO:0051674 | 0.0042 | 1.5112 | 39.2738 | 56 | 1155 | localization of cell |
| GO:0042127 | 0.0047 | 1.4824 | 42.9122 | 60 | 1262 | regulation of cell proliferation |
| GO:0042104 | 0.005 | 6.7354 | 0.7141 | 4 | 21 | positive regulation of activated T cell proliferation |
| GO:0014744 | 0.0053 | 10.7181 | 0.374 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0060415 | 0.0054 | 3.5914 | 2.1422 | 7 | 63 | muscle tissue morphogenesis |
| GO:0022603 | 0.0056 | 1.5882 | 27.2027 | 41 | 800 | regulation of anatomical structure morphogenesis |
| GO:0050679 | 0.0057 | 2.6006 | 4.5224 | 11 | 133 | positive regulation of epithelial cell proliferation |
| GO:0016525 | 0.0057 | 3.1956 | 2.7203 | 8 | 80 | negative regulation of angiogenesis |
| GO:0050878 | 0.006 | 1.8589 | 13.0233 | 23 | 383 | regulation of body fluid levels |
| GO:0042472 | 0.0062 | 3.1516 | 2.7543 | 8 | 81 | inner ear morphogenesis |
| GO:0050896 | 0.0062 | 1.2771 | 218.4714 | 245 | 6425 | response to stimulus |
| GO:0042475 | 0.0064 | 3.467 | 2.2102 | 7 | 65 | odontogenesis of dentin-containing tooth |
| GO:0002138 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | retinoic acid biosynthetic process |
| GO:0009972 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | cytidine deamination |
| GO:0033353 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | S-adenosylmethionine cycle |
| GO:0046087 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | cytidine metabolic process |
| GO:0051122 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0055009 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | atrial cardiac muscle tissue morphogenesis |
| GO:0070221 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | sulfide oxidation, using sulfide:quinone oxidoreductase |
| GO:0070383 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | DNA cytosine deamination |
| GO:0097176 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | epoxide metabolic process |
| GO:2000354 | 0.0066 | 28.5312 | 0.136 | 2 | 4 | regulation of ovarian follicle development |
| GO:0006833 | 0.0068 | 9.5265 | 0.408 | 3 | 12 | water transport |
| GO:0010666 | 0.0068 | 9.5265 | 0.408 | 3 | 12 | positive regulation of cardiac muscle cell apoptotic process |
| GO:0032695 | 0.0068 | 9.5265 | 0.408 | 3 | 12 | negative regulation of interleukin-12 production |
| GO:0042454 | 0.0068 | 9.5265 | 0.408 | 3 | 12 | ribonucleoside catabolic process |
| GO:2000651 | 0.0068 | 9.5265 | 0.408 | 3 | 12 | positive regulation of sodium ion transmembrane transporter activity |
| GO:0050706 | 0.007 | 6.0255 | 0.7821 | 4 | 23 | regulation of interleukin-1 beta secretion |
| GO:0061756 | 0.007 | 6.0255 | 0.7821 | 4 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0032720 | 0.007 | 4.6223 | 1.2241 | 5 | 36 | negative regulation of tumor necrosis factor production |
| GO:0001667 | 0.0071 | 1.9992 | 9.4869 | 18 | 279 | ameboidal-type cell migration |
| GO:0002376 | 0.008 | 1.3596 | 68.9247 | 88 | 2027 | immune system process |
| GO:0032649 | 0.0081 | 3.7421 | 1.7682 | 6 | 52 | regulation of interferon-gamma production |
| GO:0060706 | 0.0082 | 5.7238 | 0.8161 | 4 | 24 | cell differentiation involved in embryonic placenta development |
| GO:0009611 | 0.0085 | 1.6971 | 17.3077 | 28 | 509 | response to wounding |
| GO:0010632 | 0.0085 | 2.3391 | 5.4405 | 12 | 160 | regulation of epithelial cell migration |
| GO:0072148 | 0.0087 | 8.5732 | 0.442 | 3 | 13 | epithelial cell fate commitment |
| GO:0030168 | 0.0087 | 2.5714 | 4.1484 | 10 | 122 | platelet activation |
| GO:0002687 | 0.0088 | 2.9484 | 2.9243 | 8 | 86 | positive regulation of leukocyte migration |
| GO:1901343 | 0.0088 | 2.9484 | 2.9243 | 8 | 86 | negative regulation of vasculature development |
| GO:0043542 | 0.0096 | 2.4017 | 4.8625 | 11 | 143 | endothelial cell migration |
| GO:2000147 | 0.0097 | 1.8303 | 12.0372 | 21 | 354 | positive regulation of cell motility |
| GO:0042098 | 0.0097 | 2.5259 | 4.2164 | 10 | 124 | T cell proliferation |
| GO:2000242 | 0.0099 | 4.2135 | 1.3261 | 5 | 39 | negative regulation of reproductive process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007186 | 1e-04 | 2.3821 | 13.3347 | 29 | 684 | G-protein coupled receptor signaling pathway |
| GO:0031424 | 2e-04 | 4.7497 | 2.086 | 9 | 107 | keratinization |
| GO:0047484 | 4e-04 | 30.52 | 0.156 | 3 | 8 | regulation of response to osmotic stress |
| GO:0032642 | 6e-04 | 6.4127 | 1.0527 | 6 | 54 | regulation of chemokine production |
| GO:0043368 | 8e-04 | 11.3368 | 0.4289 | 4 | 22 | positive T cell selection |
| GO:1904892 | 0.0011 | 4.2051 | 2.0665 | 8 | 106 | regulation of STAT cascade |
| GO:0015747 | 0.0011 | 101.3672 | 0.0585 | 2 | 3 | urate transport |
| GO:0022408 | 0.0018 | 3.8487 | 2.242 | 8 | 115 | negative regulation of cell-cell adhesion |
| GO:0038170 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | somatostatin signaling pathway |
| GO:2000320 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | negative regulation of T-helper 17 cell differentiation |
| GO:2000416 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | regulation of eosinophil migration |
| GO:0030335 | 0.0029 | 2.3953 | 6.6479 | 15 | 341 | positive regulation of cell migration |
| GO:0006968 | 0.0029 | 7.5526 | 0.6044 | 4 | 31 | cellular defense response |
| GO:0010830 | 0.0036 | 5.3228 | 1.0332 | 5 | 53 | regulation of myotube differentiation |
| GO:0048245 | 0.0036 | 33.7839 | 0.0975 | 2 | 5 | eosinophil chemotaxis |
| GO:0097530 | 0.0039 | 4.3276 | 1.5011 | 6 | 77 | granulocyte migration |
| GO:0007263 | 0.0041 | 10.8924 | 0.3314 | 3 | 17 | nitric oxide mediated signal transduction |
| GO:0010632 | 0.0041 | 3.0699 | 3.1192 | 9 | 160 | regulation of epithelial cell migration |
| GO:0042127 | 0.0045 | 1.6584 | 24.603 | 38 | 1262 | regulation of cell proliferation |
| GO:0007259 | 0.0047 | 4.149 | 1.5597 | 6 | 81 | JAK-STAT cascade |
| GO:2000343 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:0051272 | 0.0055 | 2.2203 | 7.1353 | 15 | 366 | positive regulation of cellular component movement |
| GO:0034097 | 0.0062 | 1.8131 | 14.6214 | 25 | 750 | response to cytokine |
| GO:0051240 | 0.0065 | 1.6363 | 23.5113 | 36 | 1206 | positive regulation of multicellular organismal process |
| GO:0071624 | 0.0065 | 8.9682 | 0.3899 | 3 | 20 | positive regulation of granulocyte chemotaxis |
| GO:0010533 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | regulation of activation of Janus kinase activity |
| GO:0030948 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0043697 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | cell dedifferentiation |
| GO:0090197 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | positive regulation of chemokine secretion |
| GO:0040017 | 0.0079 | 2.1268 | 7.4277 | 15 | 381 | positive regulation of locomotion |
| GO:0007019 | 0.0086 | 8.0229 | 0.4289 | 3 | 22 | microtubule depolymerization |
| GO:0046636 | 0.0086 | 8.0229 | 0.4289 | 3 | 22 | negative regulation of alpha-beta T cell activation |
| GO:0051250 | 0.0087 | 3.6109 | 1.7741 | 6 | 91 | negative regulation of lymphocyte activation |
| GO:0048513 | 0.0088 | 1.4335 | 51.0385 | 67 | 2618 | animal organ development |
| GO:0045087 | 0.0089 | 1.8807 | 11.2098 | 20 | 575 | innate immune response |
| GO:0006954 | 0.0094 | 1.9817 | 9.0263 | 17 | 463 | inflammatory response |
| GO:0046426 | 0.0096 | 5.2239 | 0.8383 | 4 | 43 | negative regulation of JAK-STAT cascade |
| GO:0006600 | 0.0098 | 16.888 | 0.156 | 2 | 8 | creatine metabolic process |
| GO:0009629 | 0.0098 | 16.888 | 0.156 | 2 | 8 | response to gravity |
| GO:0017185 | 0.0098 | 16.888 | 0.156 | 2 | 8 | peptidyl-lysine hydroxylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 15.706 | 0.8079 | 10 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0051606 | 0 | 6.1976 | 3.3663 | 18 | 225 | detection of stimulus |
| GO:0007600 | 0 | 3.7364 | 6.6429 | 22 | 444 | sensory perception |
| GO:0003008 | 0 | 2.2374 | 19.2853 | 38 | 1289 | system process |
| GO:0034341 | 1e-04 | 5.7971 | 1.5261 | 8 | 102 | response to interferon-gamma |
| GO:0006955 | 3e-04 | 2.0374 | 19.7192 | 36 | 1318 | immune response |
| GO:0060333 | 3e-04 | 7.2433 | 0.9276 | 6 | 62 | interferon-gamma-mediated signaling pathway |
| GO:0006952 | 5e-04 | 2.3313 | 10.7932 | 23 | 751 | defense response |
| GO:0071345 | 5e-04 | 2.3628 | 10.1289 | 22 | 677 | cellular response to cytokine stimulus |
| GO:0002223 | 7e-04 | 5.1005 | 1.4961 | 7 | 100 | stimulatory C-type lectin receptor signaling pathway |
| GO:0001580 | 0.0011 | 18.2168 | 0.2095 | 3 | 14 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0031424 | 0.0011 | 4.7409 | 1.6009 | 7 | 107 | keratinization |
| GO:0007186 | 0.0014 | 2.2142 | 10.2336 | 21 | 684 | G-protein coupled receptor signaling pathway |
| GO:0098542 | 0.0015 | 2.9392 | 4.3687 | 12 | 292 | defense response to other organism |
| GO:0042373 | 0.0022 | 44.3299 | 0.0748 | 2 | 5 | vitamin K metabolic process |
| GO:0050829 | 0.0022 | 8.1243 | 0.5536 | 4 | 37 | defense response to Gram-negative bacterium |
| GO:2000403 | 0.0027 | 12.5192 | 0.2843 | 3 | 19 | positive regulation of lymphocyte migration |
| GO:0009913 | 0.003 | 3.2368 | 2.9624 | 9 | 198 | epidermal cell differentiation |
| GO:0050907 | 0.0031 | 11.6883 | 0.2995 | 3 | 21 | detection of chemical stimulus involved in sensory perception |
| GO:0009583 | 0.0038 | 6.8713 | 0.6433 | 4 | 43 | detection of light stimulus |
| GO:0002764 | 0.0039 | 2.4885 | 5.5507 | 13 | 371 | immune response-regulating signaling pathway |
| GO:0051704 | 0.0043 | 1.6525 | 27.2299 | 41 | 1820 | multi-organism process |
| GO:0010820 | 0.0045 | 26.5939 | 0.1047 | 2 | 7 | positive regulation of T cell chemotaxis |
| GO:0031295 | 0.0045 | 6.5351 | 0.6733 | 4 | 45 | T cell costimulation |
| GO:0002758 | 0.0046 | 3.0103 | 3.1718 | 9 | 212 | innate immune response-activating signal transduction |
| GO:2000404 | 0.0047 | 10.0123 | 0.3441 | 3 | 23 | regulation of T cell migration |
| GO:0043588 | 0.0052 | 2.7655 | 3.8301 | 10 | 256 | skin development |
| GO:0045089 | 0.0054 | 2.7541 | 3.8451 | 10 | 257 | positive regulation of innate immune response |
| GO:0019953 | 0.0054 | 2.0691 | 9.2611 | 18 | 619 | sexual reproduction |
| GO:0003374 | 0.0059 | 22.1599 | 0.1197 | 2 | 8 | dynamin family protein polymerization involved in mitochondrial fission |
| GO:0009109 | 0.0059 | 22.1599 | 0.1197 | 2 | 8 | coenzyme catabolic process |
| GO:1904871 | 0.0059 | 22.1599 | 0.1197 | 2 | 8 | positive regulation of protein localization to Cajal body |
| GO:0002253 | 0.006 | 2.3531 | 5.8499 | 13 | 391 | activation of immune response |
| GO:0050908 | 0.0075 | 18.9927 | 0.1347 | 2 | 9 | detection of light stimulus involved in visual perception |
| GO:1903405 | 0.0075 | 18.9927 | 0.1347 | 2 | 9 | protein localization to nuclear body |
| GO:0007173 | 0.0076 | 3.7061 | 1.7206 | 6 | 115 | epidermal growth factor receptor signaling pathway |
| GO:0051251 | 0.0083 | 2.941 | 2.8726 | 8 | 192 | positive regulation of lymphocyte activation |
| GO:0052548 | 0.0085 | 2.5634 | 4.1144 | 10 | 275 | regulation of endopeptidase activity |
| GO:0009605 | 0.0088 | 1.6244 | 23.295 | 35 | 1557 | response to external stimulus |
| GO:0007163 | 0.009 | 3.1698 | 2.334 | 7 | 156 | establishment or maintenance of cell polarity |
| GO:0002523 | 0.0093 | 16.6173 | 0.1496 | 2 | 10 | leukocyte migration involved in inflammatory response |
| GO:0050851 | 0.0093 | 3.1484 | 2.3489 | 7 | 157 | antigen receptor-mediated signaling pathway |
| GO:0038093 | 0.0097 | 3.1273 | 2.3639 | 7 | 158 | Fc receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1902742 | 6e-04 | 6.7734 | 1.079 | 6 | 30 | apoptotic process involved in development |
| GO:0014736 | 0.0013 | Inf | 0.0719 | 2 | 2 | negative regulation of muscle atrophy |
| GO:0021633 | 0.0013 | Inf | 0.0719 | 2 | 2 | optic nerve structural organization |
| GO:0035564 | 0.0013 | Inf | 0.0719 | 2 | 2 | regulation of kidney size |
| GO:0050976 | 0.0013 | Inf | 0.0719 | 2 | 2 | detection of mechanical stimulus involved in sensory perception of touch |
| GO:1903796 | 0.0013 | Inf | 0.0719 | 2 | 2 | negative regulation of inorganic anion transmembrane transport |
| GO:0002692 | 0.0015 | 20.223 | 0.2518 | 3 | 7 | negative regulation of cellular extravasation |
| GO:0036017 | 0.0015 | 20.223 | 0.2518 | 3 | 7 | response to erythropoietin |
| GO:0015698 | 0.0027 | 2.9065 | 4.1003 | 11 | 114 | inorganic anion transport |
| GO:0080154 | 0.0027 | 8.3083 | 0.6115 | 4 | 17 | regulation of fertilization |
| GO:0048565 | 0.0028 | 2.8783 | 4.1363 | 11 | 115 | digestive tract development |
| GO:0006749 | 0.0028 | 4.7775 | 1.4387 | 6 | 40 | glutathione metabolic process |
| GO:0048384 | 0.0029 | 5.8779 | 1.0071 | 5 | 28 | retinoic acid receptor signaling pathway |
| GO:0007389 | 0.0032 | 1.9393 | 13.0923 | 24 | 364 | pattern specification process |
| GO:1902337 | 0.0033 | 13.4799 | 0.3237 | 3 | 9 | regulation of apoptotic process involved in morphogenesis |
| GO:0035909 | 0.0034 | 5.6325 | 1.0431 | 5 | 29 | aorta morphogenesis |
| GO:0051674 | 0.0037 | 1.5055 | 41.543 | 59 | 1155 | localization of cell |
| GO:0007412 | 0.0038 | 53.827 | 0.1079 | 2 | 3 | axon target recognition |
| GO:0010836 | 0.0038 | 53.827 | 0.1079 | 2 | 3 | negative regulation of protein ADP-ribosylation |
| GO:0034442 | 0.0038 | 53.827 | 0.1079 | 2 | 3 | regulation of lipoprotein oxidation |
| GO:0038162 | 0.0038 | 53.827 | 0.1079 | 2 | 3 | erythropoietin-mediated signaling pathway |
| GO:0042160 | 0.0038 | 53.827 | 0.1079 | 2 | 3 | lipoprotein modification |
| GO:0072679 | 0.0038 | 53.827 | 0.1079 | 2 | 3 | thymocyte migration |
| GO:1900212 | 0.0038 | 53.827 | 0.1079 | 2 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
| GO:0050832 | 0.0042 | 7.1994 | 0.6834 | 4 | 19 | defense response to fungus |
| GO:0009303 | 0.0046 | 5.1984 | 1.115 | 5 | 31 | rRNA transcription |
| GO:0048562 | 0.0046 | 2.0943 | 9.0999 | 18 | 253 | embryonic organ morphogenesis |
| GO:0042531 | 0.0046 | 4.2732 | 1.5826 | 6 | 44 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0019953 | 0.0054 | 1.6544 | 22.2642 | 35 | 619 | sexual reproduction |
| GO:0001656 | 0.0058 | 3.19 | 2.7336 | 8 | 76 | metanephros development |
| GO:0060037 | 0.0061 | 6.3514 | 0.7553 | 4 | 21 | pharyngeal system development |
| GO:0050982 | 0.0061 | 4.8264 | 1.1869 | 5 | 33 | detection of mechanical stimulus |
| GO:0031099 | 0.0061 | 2.455 | 5.2154 | 12 | 145 | regeneration |
| GO:0045161 | 0.0061 | 10.1084 | 0.3956 | 3 | 11 | neuronal ion channel clustering |
| GO:2001053 | 0.0061 | 10.1084 | 0.3956 | 3 | 11 | regulation of mesenchymal cell apoptotic process |
| GO:0019233 | 0.0063 | 3.1436 | 2.7695 | 8 | 77 | sensory perception of pain |
| GO:0060415 | 0.0072 | 3.3854 | 2.266 | 7 | 63 | muscle tissue morphogenesis |
| GO:0007343 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | egg activation |
| GO:0030321 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | transepithelial chloride transport |
| GO:0034653 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | retinoic acid catabolic process |
| GO:0060971 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | embryonic heart tube left/right pattern formation |
| GO:0070221 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | sulfide oxidation, using sulfide:quinone oxidoreductase |
| GO:0072040 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis |
| GO:0072179 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | nephric duct formation |
| GO:1902412 | 0.0074 | 26.9114 | 0.1439 | 2 | 4 | regulation of mitotic cytokinesis |
| GO:0051606 | 0.0074 | 2.0885 | 8.0928 | 16 | 225 | detection of stimulus |
| GO:0001709 | 0.0078 | 4.5039 | 1.2589 | 5 | 35 | cell fate determination |
| GO:0051897 | 0.008 | 2.611 | 4.1003 | 10 | 114 | positive regulation of protein kinase B signaling |
| GO:1905063 | 0.008 | 8.9845 | 0.4316 | 3 | 12 | regulation of vascular smooth muscle cell differentiation |
| GO:0032504 | 0.0081 | 1.6054 | 22.8756 | 35 | 636 | multicellular organism reproduction |
| GO:0048638 | 0.0084 | 2.0085 | 8.9201 | 17 | 248 | regulation of developmental growth |
| GO:0003148 | 0.0085 | 5.682 | 0.8273 | 4 | 23 | outflow tract septum morphogenesis |
| GO:0043552 | 0.0085 | 5.682 | 0.8273 | 4 | 23 | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:2000404 | 0.0085 | 5.682 | 0.8273 | 4 | 23 | regulation of T cell migration |
| GO:0034637 | 0.0086 | 3.2681 | 2.3379 | 7 | 65 | cellular carbohydrate biosynthetic process |
| GO:0042475 | 0.0086 | 3.2681 | 2.3379 | 7 | 65 | odontogenesis of dentin-containing tooth |
| GO:0048771 | 0.0095 | 2.5372 | 4.2083 | 10 | 117 | tissue remodeling |
| GO:0008037 | 0.0098 | 2.6826 | 3.5968 | 9 | 100 | cell recognition |
| GO:1900015 | 0.0099 | 5.3975 | 0.8632 | 4 | 24 | regulation of cytokine production involved in inflammatory response |
| GO:0016477 | 0.0099 | 1.4562 | 37.5146 | 52 | 1043 | cell migration |
| GO:0010559 | 0.0099 | 4.2217 | 1.3308 | 5 | 37 | regulation of glycoprotein biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070268 | 1e-04 | 6.6799 | 1.3703 | 8 | 65 | cornification |
| GO:0009913 | 3e-04 | 3.3735 | 4.1742 | 13 | 198 | epidermal cell differentiation |
| GO:2000502 | 4e-04 | Inf | 0.0422 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0002689 | 7e-04 | 23.4583 | 0.1897 | 3 | 9 | negative regulation of leukocyte chemotaxis |
| GO:0001910 | 8e-04 | 7.8619 | 0.7379 | 5 | 35 | regulation of leukocyte mediated cytotoxicity |
| GO:0007588 | 9e-04 | 5.9098 | 1.1384 | 6 | 54 | excretion |
| GO:0043588 | 0.0011 | 2.7753 | 5.397 | 14 | 256 | skin development |
| GO:0002715 | 0.0012 | 9.9032 | 0.4849 | 4 | 23 | regulation of natural killer cell mediated immunity |
| GO:0006311 | 0.0013 | 93.5307 | 0.0632 | 2 | 3 | meiotic gene conversion |
| GO:0010841 | 0.0013 | 93.5307 | 0.0632 | 2 | 3 | positive regulation of circadian sleep/wake cycle, wakefulness |
| GO:0050877 | 0.0014 | 1.9619 | 15.2845 | 28 | 725 | nervous system process |
| GO:2000241 | 0.0016 | 3.9542 | 2.1925 | 8 | 104 | regulation of reproductive process |
| GO:0006812 | 0.0016 | 1.8817 | 17.6668 | 31 | 838 | cation transport |
| GO:0031424 | 0.0016 | 6.5337 | 0.8643 | 5 | 42 | keratinization |
| GO:0015669 | 0.0018 | 15.6353 | 0.253 | 3 | 12 | gas transport |
| GO:0097106 | 0.0018 | 15.6353 | 0.253 | 3 | 12 | postsynaptic density organization |
| GO:0030154 | 0.0022 | 1.4747 | 66.8723 | 88 | 3172 | cell differentiation |
| GO:0015793 | 0.0026 | 46.7617 | 0.0843 | 2 | 4 | glycerol transport |
| GO:0007339 | 0.0027 | 7.837 | 0.5903 | 4 | 28 | binding of sperm to zona pellucida |
| GO:0051146 | 0.0027 | 2.7277 | 4.6802 | 12 | 222 | striated muscle cell differentiation |
| GO:0051056 | 0.0027 | 2.6002 | 5.3127 | 13 | 252 | regulation of small GTPase mediated signal transduction |
| GO:0009988 | 0.0027 | 5.7477 | 0.9698 | 5 | 46 | cell-cell recognition |
| GO:0032502 | 0.0028 | 1.4164 | 101.1939 | 124 | 4800 | developmental process |
| GO:0032501 | 0.0028 | 1.4215 | 107.4172 | 130 | 5301 | multicellular organismal process |
| GO:0035025 | 0.0028 | 12.7905 | 0.2951 | 3 | 14 | positive regulation of Rho protein signal transduction |
| GO:0045954 | 0.0028 | 12.7905 | 0.2951 | 3 | 14 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0031343 | 0.003 | 7.5229 | 0.6114 | 4 | 29 | positive regulation of cell killing |
| GO:1903522 | 0.0033 | 2.6506 | 4.8067 | 12 | 228 | regulation of blood circulation |
| GO:0003094 | 0.0035 | 11.7237 | 0.3162 | 3 | 15 | glomerular filtration |
| GO:0061337 | 0.0039 | 3.3851 | 2.5298 | 8 | 120 | cardiac conduction |
| GO:0051446 | 0.0042 | 10.8211 | 0.3373 | 3 | 16 | positive regulation of meiotic cell cycle |
| GO:0042320 | 0.0042 | 31.1721 | 0.1054 | 2 | 5 | regulation of circadian sleep/wake cycle, REM sleep |
| GO:0050807 | 0.0052 | 3.5592 | 2.1082 | 7 | 100 | regulation of synapse organization |
| GO:0060047 | 0.0054 | 2.6044 | 4.4694 | 11 | 212 | heart contraction |
| GO:0070838 | 0.0057 | 2.208 | 7.1679 | 15 | 340 | divalent metal ion transport |
| GO:0035902 | 0.006 | 9.3768 | 0.3795 | 3 | 18 | response to immobilization stress |
| GO:2000727 | 0.006 | 9.3768 | 0.3795 | 3 | 18 | positive regulation of cardiac muscle cell differentiation |
| GO:0010959 | 0.0062 | 2.3403 | 5.8608 | 13 | 278 | regulation of metal ion transport |
| GO:0015889 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | cobalamin transport |
| GO:0021826 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | substrate-independent telencephalic tangential migration |
| GO:0021830 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | interneuron migration from the subpallium to the cortex |
| GO:0032489 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | regulation of Cdc42 protein signal transduction |
| GO:0042538 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | hyperosmotic salinity response |
| GO:0051599 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | response to hydrostatic pressure |
| GO:0060297 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | regulation of sarcomere organization |
| GO:0060373 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | regulation of ventricular cardiac muscle cell membrane depolarization |
| GO:2000402 | 0.0063 | 23.3773 | 0.1265 | 2 | 6 | negative regulation of lymphocyte migration |
| GO:0034308 | 0.0067 | 5.8741 | 0.759 | 4 | 36 | primary alcohol metabolic process |
| GO:0034765 | 0.0069 | 2.1603 | 7.3155 | 15 | 347 | regulation of ion transmembrane transport |
| GO:0051482 | 0.007 | 8.7901 | 0.4006 | 3 | 19 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
| GO:0000003 | 0.007 | 1.6348 | 22.7686 | 35 | 1080 | reproduction |
| GO:0035850 | 0.0074 | 5.6956 | 0.78 | 4 | 37 | epithelial cell differentiation involved in kidney development |
| GO:0072210 | 0.0074 | 5.6956 | 0.78 | 4 | 37 | metanephric nephron development |
| GO:0044703 | 0.0075 | 1.7593 | 15.6218 | 26 | 741 | multi-organism reproductive process |
| GO:0010469 | 0.0077 | 2.075 | 8.1166 | 16 | 385 | regulation of receptor activity |
| GO:0072243 | 0.0081 | 8.2724 | 0.4216 | 3 | 20 | metanephric nephron epithelium development |
| GO:0051458 | 0.0087 | 18.7004 | 0.1476 | 2 | 7 | corticotropin secretion |
| GO:0060631 | 0.0087 | 18.7004 | 0.1476 | 2 | 7 | regulation of meiosis I |
| GO:2001256 | 0.0087 | 18.7004 | 0.1476 | 2 | 7 | regulation of store-operated calcium entry |
| GO:0086010 | 0.0089 | 5.3694 | 0.8222 | 4 | 39 | membrane depolarization during action potential |
| GO:0046579 | 0.0091 | 7.8913 | 0.4384 | 3 | 21 | positive regulation of Ras protein signal transduction |
| GO:0016101 | 0.0091 | 4.2033 | 1.286 | 5 | 61 | diterpenoid metabolic process |
| GO:0070296 | 0.0093 | 7.8122 | 0.4427 | 3 | 21 | sarcoplasmic reticulum calcium ion transport |
| GO:0072202 | 0.0093 | 7.8122 | 0.4427 | 3 | 21 | cell differentiation involved in metanephros development |
| GO:0090279 | 0.0093 | 7.8122 | 0.4427 | 3 | 21 | regulation of calcium ion import |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030326 | 2e-04 | 4.4706 | 2.4709 | 10 | 109 | embryonic limb morphogenesis |
| GO:0003013 | 3e-04 | 2.4934 | 9.0676 | 21 | 400 | circulatory system process |
| GO:0044657 | 5e-04 | Inf | 0.0453 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 5e-04 | Inf | 0.0453 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 5e-04 | Inf | 0.0453 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 5e-04 | Inf | 0.0453 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0031640 | 5e-04 | 8.7519 | 0.6801 | 5 | 30 | killing of cells of other organism |
| GO:0035107 | 6e-04 | 3.8103 | 2.8563 | 10 | 126 | appendage morphogenesis |
| GO:0050830 | 0.0011 | 5.7178 | 1.1788 | 6 | 52 | defense response to Gram-positive bacterium |
| GO:0061180 | 0.0012 | 5.5957 | 1.2015 | 6 | 53 | mammary gland epithelium development |
| GO:2000482 | 0.0012 | 18.6537 | 0.2267 | 3 | 10 | regulation of interleukin-8 secretion |
| GO:0043152 | 0.0015 | 86.7987 | 0.068 | 2 | 3 | induction of bacterial agglutination |
| GO:0051673 | 0.0015 | 86.7987 | 0.068 | 2 | 3 | membrane disruption in other organism |
| GO:0061756 | 0.0016 | 9.1856 | 0.5214 | 4 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0009913 | 0.0019 | 2.8557 | 4.4884 | 12 | 198 | epidermal cell differentiation |
| GO:0003333 | 0.0019 | 5.0557 | 1.3148 | 6 | 58 | amino acid transmembrane transport |
| GO:0060173 | 0.0021 | 3.1742 | 3.3777 | 10 | 149 | limb development |
| GO:0006805 | 0.0021 | 4.96 | 1.3375 | 6 | 59 | xenobiotic metabolic process |
| GO:1903522 | 0.0021 | 2.6796 | 5.1685 | 13 | 228 | regulation of blood circulation |
| GO:0032412 | 0.0022 | 2.9638 | 3.9671 | 11 | 175 | regulation of ion transmembrane transporter activity |
| GO:0010818 | 0.0022 | 14.5062 | 0.272 | 3 | 12 | T cell chemotaxis |
| GO:0051818 | 0.0022 | 14.5062 | 0.272 | 3 | 12 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0098656 | 0.0022 | 2.7947 | 4.5791 | 12 | 202 | anion transmembrane transport |
| GO:0050879 | 0.0025 | 5.9079 | 0.9521 | 5 | 42 | multicellular organismal movement |
| GO:0032374 | 0.0028 | 5.752 | 0.9748 | 5 | 43 | regulation of cholesterol transport |
| GO:0031424 | 0.003 | 3.552 | 2.4256 | 8 | 107 | keratinization |
| GO:0014721 | 0.003 | 43.396 | 0.0907 | 2 | 4 | twitch skeletal muscle contraction |
| GO:0060638 | 0.003 | 43.396 | 0.0907 | 2 | 4 | mesenchymal-epithelial cell signaling |
| GO:0006094 | 0.0032 | 4.5306 | 1.4508 | 6 | 64 | gluconeogenesis |
| GO:0098739 | 0.0034 | 5.4636 | 1.0201 | 5 | 45 | import across plasma membrane |
| GO:0033599 | 0.0035 | 11.8669 | 0.3174 | 3 | 14 | regulation of mammary gland epithelial cell proliferation |
| GO:0006959 | 0.0035 | 3.4467 | 2.4936 | 8 | 110 | humoral immune response |
| GO:0032501 | 0.0037 | 1.3884 | 115.3483 | 138 | 5259 | multicellular organismal process |
| GO:0019953 | 0.0038 | 1.8886 | 14.032 | 25 | 619 | sexual reproduction |
| GO:1903825 | 0.0038 | 3.791 | 1.9949 | 7 | 88 | organic acid transmembrane transport |
| GO:0061844 | 0.0039 | 6.9778 | 0.6574 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0009410 | 0.004 | 4.3068 | 1.5188 | 6 | 67 | response to xenobiotic stimulus |
| GO:0006026 | 0.0041 | 5.2026 | 1.0654 | 5 | 47 | aminoglycan catabolic process |
| GO:0099622 | 0.0045 | 6.7089 | 0.6801 | 4 | 30 | cardiac muscle cell membrane repolarization |
| GO:0008343 | 0.0049 | 28.9284 | 0.1133 | 2 | 5 | adult feeding behavior |
| GO:0045650 | 0.0049 | 28.9284 | 0.1133 | 2 | 5 | negative regulation of macrophage differentiation |
| GO:0060762 | 0.0049 | 28.9284 | 0.1133 | 2 | 5 | regulation of branching involved in mammary gland duct morphogenesis |
| GO:1900020 | 0.0049 | 28.9284 | 0.1133 | 2 | 5 | positive regulation of protein kinase C activity |
| GO:0045638 | 0.005 | 4.104 | 1.5868 | 6 | 70 | negative regulation of myeloid cell differentiation |
| GO:0002227 | 0.0052 | 10.0396 | 0.3627 | 3 | 16 | innate immune response in mucosa |
| GO:0042832 | 0.0052 | 10.0396 | 0.3627 | 3 | 16 | defense response to protozoan |
| GO:0046364 | 0.0054 | 4.0405 | 1.6095 | 6 | 71 | monosaccharide biosynthetic process |
| GO:0003009 | 0.0056 | 6.2288 | 0.7254 | 4 | 32 | skeletal muscle contraction |
| GO:0019748 | 0.0056 | 6.2288 | 0.7254 | 4 | 32 | secondary metabolic process |
| GO:0032411 | 0.0058 | 3.979 | 1.6322 | 6 | 72 | positive regulation of transporter activity |
| GO:0006109 | 0.0072 | 2.8061 | 3.4003 | 9 | 150 | regulation of carbohydrate metabolic process |
| GO:0030853 | 0.0072 | 21.6946 | 0.136 | 2 | 6 | negative regulation of granulocyte differentiation |
| GO:1901387 | 0.0072 | 21.6946 | 0.136 | 2 | 6 | positive regulation of voltage-gated calcium channel activity |
| GO:1903236 | 0.0072 | 21.6946 | 0.136 | 2 | 6 | regulation of leukocyte tethering or rolling |
| GO:0060307 | 0.0073 | 8.6997 | 0.408 | 3 | 18 | regulation of ventricular cardiac muscle cell membrane repolarization |
| GO:1901017 | 0.0073 | 8.6997 | 0.408 | 3 | 18 | negative regulation of potassium ion transmembrane transporter activity |
| GO:0022414 | 0.0074 | 1.6056 | 24.4597 | 37 | 1079 | reproductive process |
| GO:0048731 | 0.0077 | 1.3649 | 82.6507 | 102 | 3646 | system development |
| GO:0006836 | 0.0081 | 2.747 | 3.4683 | 9 | 153 | neurotransmitter transport |
| GO:0034762 | 0.0083 | 2.0558 | 8.1835 | 16 | 361 | regulation of transmembrane transport |
| GO:0019731 | 0.0084 | 8.21 | 0.4279 | 3 | 19 | antibacterial humoral response |
| GO:0007568 | 0.0084 | 2.3324 | 5.4179 | 12 | 239 | aging |
| GO:0050832 | 0.0085 | 8.1553 | 0.4307 | 3 | 19 | defense response to fungus |
| GO:0055022 | 0.0085 | 8.1553 | 0.4307 | 3 | 19 | negative regulation of cardiac muscle tissue growth |
| GO:0051707 | 0.0087 | 1.8234 | 12.6946 | 22 | 560 | response to other organism |
| GO:0032787 | 0.0088 | 1.9155 | 10.4277 | 19 | 460 | monocarboxylic acid metabolic process |
| GO:0070252 | 0.009 | 3.5955 | 1.7908 | 6 | 79 | actin-mediated cell contraction |
| GO:0006936 | 0.0093 | 2.2167 | 6.1659 | 13 | 272 | muscle contraction |
| GO:0050829 | 0.0095 | 5.283 | 0.8387 | 4 | 37 | defense response to Gram-negative bacterium |
| GO:0044650 | 0.01 | 17.3544 | 0.1587 | 2 | 7 | adhesion of symbiont to host cell |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 10.3641 | 1.3875 | 11 | 46 | embryonic skeletal system morphogenesis |
| GO:0048568 | 0 | 3.1784 | 11.2976 | 32 | 371 | embryonic organ development |
| GO:0048598 | 0 | 2.9697 | 12.0076 | 32 | 400 | embryonic morphogenesis |
| GO:0022610 | 0 | 2.1522 | 31.7613 | 61 | 1043 | biological adhesion |
| GO:0007389 | 0 | 2.8924 | 11.0845 | 29 | 364 | pattern specification process |
| GO:0043009 | 0 | 2.5832 | 14.4948 | 34 | 480 | chordate embryonic development |
| GO:0009887 | 0 | 2.2131 | 22.3861 | 45 | 744 | animal organ morphogenesis |
| GO:0007156 | 0 | 4.1242 | 3.8065 | 14 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0003211 | 0 | 42.8672 | 0.2132 | 4 | 7 | cardiac ventricle formation |
| GO:0098609 | 0 | 2.199 | 18.8193 | 38 | 618 | cell-cell adhesion |
| GO:0001501 | 1e-04 | 2.3402 | 12.4548 | 27 | 409 | skeletal system development |
| GO:0045019 | 3e-04 | 16.0689 | 0.3654 | 4 | 12 | negative regulation of nitric oxide biosynthetic process |
| GO:0007423 | 4e-04 | 2.1645 | 13.3684 | 27 | 439 | sensory organ development |
| GO:0002690 | 5e-04 | 4.8829 | 1.8576 | 8 | 61 | positive regulation of leukocyte chemotaxis |
| GO:0009952 | 5e-04 | 3.0235 | 5.0216 | 14 | 166 | anterior/posterior pattern specification |
| GO:0021902 | 5e-04 | 32.07 | 0.1827 | 3 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0048856 | 5e-04 | 1.4428 | 113.4187 | 143 | 3900 | anatomical structure development |
| GO:2000404 | 5e-04 | 8.9426 | 0.7004 | 5 | 23 | regulation of T cell migration |
| GO:0043010 | 9e-04 | 2.5431 | 7.1682 | 17 | 237 | camera-type eye development |
| GO:0002887 | 9e-04 | 24.0506 | 0.2132 | 3 | 7 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0043301 | 9e-04 | 24.0506 | 0.2132 | 3 | 7 | negative regulation of leukocyte degranulation |
| GO:0055014 | 9e-04 | Inf | 0.0609 | 2 | 2 | atrial cardiac muscle cell development |
| GO:0071469 | 9e-04 | Inf | 0.0609 | 2 | 2 | cellular response to alkaline pH |
| GO:1902567 | 9e-04 | Inf | 0.0609 | 2 | 2 | negative regulation of eosinophil activation |
| GO:0072676 | 9e-04 | 5.0226 | 1.5835 | 7 | 52 | lymphocyte migration |
| GO:0035115 | 0.001 | 7.6633 | 0.7917 | 5 | 26 | embryonic forelimb morphogenesis |
| GO:0002828 | 0.0012 | 10.7093 | 0.4872 | 4 | 16 | regulation of type 2 immune response |
| GO:1905205 | 0.0014 | 19.239 | 0.2436 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0050728 | 0.0015 | 3.6408 | 2.7102 | 9 | 89 | negative regulation of inflammatory response |
| GO:0001525 | 0.0018 | 2.1086 | 11.0845 | 22 | 364 | angiogenesis |
| GO:0034103 | 0.0018 | 4.4296 | 1.7662 | 7 | 58 | regulation of tissue remodeling |
| GO:0008284 | 0.0018 | 1.7852 | 20.8291 | 35 | 684 | positive regulation of cell proliferation |
| GO:0002691 | 0.0018 | 9.1779 | 0.5481 | 4 | 18 | regulation of cellular extravasation |
| GO:0048771 | 0.0019 | 4.4046 | 1.7732 | 7 | 59 | tissue remodeling |
| GO:0006959 | 0.0019 | 3.2394 | 3.3497 | 10 | 110 | humoral immune response |
| GO:0050920 | 0.0019 | 3.0232 | 3.9283 | 11 | 129 | regulation of chemotaxis |
| GO:0051270 | 0.002 | 1.7766 | 20.9204 | 35 | 687 | regulation of cellular component movement |
| GO:0060173 | 0.002 | 2.8437 | 4.5373 | 12 | 149 | limb development |
| GO:0045064 | 0.0021 | 16.0312 | 0.2741 | 3 | 9 | T-helper 2 cell differentiation |
| GO:0061029 | 0.0021 | 16.0312 | 0.2741 | 3 | 9 | eyelid development in camera-type eye |
| GO:0071622 | 0.0023 | 6.1872 | 0.944 | 5 | 31 | regulation of granulocyte chemotaxis |
| GO:0023019 | 0.0023 | 8.5654 | 0.5786 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:2000378 | 0.0023 | 4.9572 | 1.3703 | 6 | 45 | negative regulation of reactive oxygen species metabolic process |
| GO:0097530 | 0.0023 | 3.746 | 2.3448 | 8 | 77 | granulocyte migration |
| GO:0035148 | 0.0026 | 2.8992 | 4.0806 | 11 | 134 | tube formation |
| GO:0048870 | 0.0027 | 1.5752 | 35.1719 | 52 | 1155 | cell motility |
| GO:0003166 | 0.0027 | 63.99 | 0.0914 | 2 | 3 | bundle of His development |
| GO:0021615 | 0.0027 | 63.99 | 0.0914 | 2 | 3 | glossopharyngeal nerve morphogenesis |
| GO:0071314 | 0.0027 | 63.99 | 0.0914 | 2 | 3 | cellular response to cocaine |
| GO:0072683 | 0.0027 | 63.99 | 0.0914 | 2 | 3 | T cell extravasation |
| GO:1902564 | 0.0027 | 63.99 | 0.0914 | 2 | 3 | negative regulation of neutrophil activation |
| GO:1904349 | 0.0027 | 63.99 | 0.0914 | 2 | 3 | positive regulation of small intestine smooth muscle contraction |
| GO:2000449 | 0.0027 | 63.99 | 0.0914 | 2 | 3 | regulation of CD8-positive, alpha-beta T cell extravasation |
| GO:0032736 | 0.0029 | 13.74 | 0.3045 | 3 | 10 | positive regulation of interleukin-13 production |
| GO:2000543 | 0.0029 | 13.74 | 0.3045 | 3 | 10 | positive regulation of gastrulation |
| GO:0031532 | 0.003 | 3.589 | 2.4361 | 8 | 80 | actin cytoskeleton reorganization |
| GO:0060326 | 0.0033 | 2.5432 | 5.4509 | 13 | 179 | cell chemotaxis |
| GO:0060037 | 0.0034 | 7.5565 | 0.6395 | 4 | 21 | pharyngeal system development |
| GO:0007399 | 0.0036 | 1.4438 | 57.28 | 77 | 1881 | nervous system development |
| GO:0045785 | 0.0037 | 2.1426 | 8.8919 | 18 | 292 | positive regulation of cell adhesion |
| GO:0001568 | 0.0037 | 1.8398 | 15.5 | 27 | 509 | blood vessel development |
| GO:0072358 | 0.0038 | 1.815 | 16.2917 | 28 | 535 | cardiovascular system development |
| GO:0003161 | 0.0039 | 12.0216 | 0.335 | 3 | 11 | cardiac conduction system development |
| GO:0021903 | 0.0039 | 12.0216 | 0.335 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0035358 | 0.0039 | 12.0216 | 0.335 | 3 | 11 | regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0003170 | 0.0039 | 5.3606 | 1.0658 | 5 | 35 | heart valve development |
| GO:0048596 | 0.004 | 7.1362 | 0.6699 | 4 | 22 | embryonic camera-type eye morphogenesis |
| GO:0042330 | 0.0041 | 1.8993 | 13.3379 | 24 | 438 | taxis |
| GO:0006952 | 0.0043 | 1.5688 | 31.7613 | 47 | 1043 | defense response |
| GO:0032720 | 0.0044 | 5.1872 | 1.0963 | 5 | 36 | negative regulation of tumor necrosis factor production |
| GO:0010810 | 0.0044 | 3.0603 | 3.1678 | 9 | 105 | regulation of cell-substrate adhesion |
| GO:2000026 | 0.0047 | 1.4692 | 46.4391 | 64 | 1525 | regulation of multicellular organismal development |
| GO:0003148 | 0.0047 | 6.7601 | 0.7004 | 4 | 23 | outflow tract septum morphogenesis |
| GO:0030878 | 0.0047 | 6.7601 | 0.7004 | 4 | 23 | thyroid gland development |
| GO:0060561 | 0.0047 | 6.7601 | 0.7004 | 4 | 23 | apoptotic process involved in morphogenesis |
| GO:0001867 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | complement activation, lectin pathway |
| GO:0003253 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0008078 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | mesodermal cell migration |
| GO:0014827 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | intestine smooth muscle contraction |
| GO:0050859 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | negative regulation of B cell receptor signaling pathway |
| GO:0051122 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060920 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | cardiac pacemaker cell differentiation |
| GO:1904304 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | regulation of gastro-intestinal system smooth muscle contraction |
| GO:2000416 | 0.0053 | 31.9925 | 0.1218 | 2 | 4 | regulation of eosinophil migration |
| GO:0048246 | 0.0056 | 6.4216 | 0.7308 | 4 | 24 | macrophage chemotaxis |
| GO:0035113 | 0.006 | 2.9081 | 3.3193 | 9 | 109 | embryonic appendage morphogenesis |
| GO:0048729 | 0.0061 | 1.7636 | 16.109 | 27 | 529 | tissue morphogenesis |
| GO:0030334 | 0.0062 | 1.7248 | 17.6925 | 29 | 581 | regulation of cell migration |
| GO:0048701 | 0.0063 | 4.7284 | 1.1876 | 5 | 39 | embryonic cranial skeleton morphogenesis |
| GO:0070098 | 0.0063 | 4.7284 | 1.1876 | 5 | 39 | chemokine-mediated signaling pathway |
| GO:0036159 | 0.0064 | 9.6158 | 0.3959 | 3 | 13 | inner dynein arm assembly |
| GO:0055012 | 0.0064 | 9.6158 | 0.3959 | 3 | 13 | ventricular cardiac muscle cell differentiation |
| GO:0003209 | 0.0065 | 6.1153 | 0.7613 | 4 | 25 | cardiac atrium morphogenesis |
| GO:0060349 | 0.0067 | 3.4188 | 2.223 | 7 | 73 | bone morphogenesis |
| GO:0048646 | 0.0068 | 1.9315 | 10.9034 | 20 | 374 | anatomical structure formation involved in morphogenesis |
| GO:0022603 | 0.0073 | 1.5989 | 24.3615 | 37 | 800 | regulation of anatomical structure morphogenesis |
| GO:0002686 | 0.0074 | 5.8369 | 0.7917 | 4 | 26 | negative regulation of leukocyte migration |
| GO:0046621 | 0.0074 | 5.8369 | 0.7917 | 4 | 26 | negative regulation of organ growth |
| GO:0072604 | 0.0074 | 5.8369 | 0.7917 | 4 | 26 | interleukin-6 secretion |
| GO:0003205 | 0.0075 | 2.6289 | 4.0501 | 10 | 133 | cardiac chamber development |
| GO:0048521 | 0.0079 | 8.7409 | 0.4263 | 3 | 14 | negative regulation of behavior |
| GO:0071294 | 0.0079 | 8.7409 | 0.4263 | 3 | 14 | cellular response to zinc ion |
| GO:0001838 | 0.008 | 2.7685 | 3.4715 | 9 | 114 | embryonic epithelial tube formation |
| GO:0010812 | 0.0086 | 4.344 | 1.279 | 5 | 42 | negative regulation of cell-substrate adhesion |
| GO:0048538 | 0.0086 | 4.344 | 1.279 | 5 | 42 | thymus development |
| GO:2000677 | 0.0086 | 4.344 | 1.279 | 5 | 42 | regulation of transcription regulatory region DNA binding |
| GO:0007160 | 0.0086 | 2.4381 | 4.7809 | 11 | 157 | cell-matrix adhesion |
| GO:0003180 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | aortic valve morphogenesis |
| GO:0003241 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0021546 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | rhombomere development |
| GO:0035701 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | hematopoietic stem cell migration |
| GO:0045617 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:0051459 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | regulation of corticotropin secretion |
| GO:0051891 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0060374 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | mast cell differentiation |
| GO:2000507 | 0.0087 | 21.3267 | 0.1523 | 2 | 5 | positive regulation of energy homeostasis |
| GO:0030198 | 0.0091 | 2.0903 | 7.5521 | 15 | 248 | extracellular matrix organization |
| GO:0060562 | 0.0092 | 2.0308 | 8.2829 | 16 | 272 | epithelial tube morphogenesis |
| GO:0071674 | 0.0095 | 4.2294 | 1.3094 | 5 | 43 | mononuclear cell migration |
| GO:0002407 | 0.0097 | 8.0119 | 0.4568 | 3 | 15 | dendritic cell chemotaxis |
| GO:0019372 | 0.0097 | 8.0119 | 0.4568 | 3 | 15 | lipoxygenase pathway |
| GO:0032691 | 0.0097 | 8.0119 | 0.4568 | 3 | 15 | negative regulation of interleukin-1 beta production |
| GO:0048243 | 0.0097 | 8.0119 | 0.4568 | 3 | 15 | norepinephrine secretion |
| GO:0003156 | 0.0097 | 5.3496 | 0.8527 | 4 | 28 | regulation of animal organ formation |
| GO:0051093 | 0.0099 | 1.6062 | 21.5599 | 33 | 708 | negative regulation of developmental process |
| GO:0007154 | 0.0099 | 1.2788 | 145.225 | 168 | 4769 | cell communication |
| GO:0035051 | 0.0099 | 2.6661 | 3.5933 | 9 | 118 | cardiocyte differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 7.2641 | 1.5864 | 10 | 85 | embryonic skeletal system morphogenesis |
| GO:0031424 | 1e-04 | 9.1433 | 0.7686 | 6 | 42 | keratinization |
| GO:0009952 | 1e-04 | 3.9681 | 3.3035 | 12 | 177 | anterior/posterior pattern specification |
| GO:0034163 | 1e-04 | 53.2131 | 0.112 | 3 | 6 | regulation of toll-like receptor 9 signaling pathway |
| GO:0009913 | 3e-04 | 3.5143 | 3.6955 | 12 | 198 | epidermal cell differentiation |
| GO:0007389 | 5e-04 | 2.6924 | 6.7937 | 17 | 364 | pattern specification process |
| GO:0002700 | 7e-04 | 5.2318 | 1.4745 | 7 | 79 | regulation of production of molecular mediator of immune response |
| GO:0019228 | 9e-04 | 10.6724 | 0.4479 | 4 | 24 | neuronal action potential |
| GO:0007186 | 0.001 | 2.1067 | 12.7662 | 25 | 684 | G-protein coupled receptor signaling pathway |
| GO:0010841 | 0.001 | 106.0082 | 0.056 | 2 | 3 | positive regulation of circadian sleep/wake cycle, wakefulness |
| GO:0061044 | 0.001 | 106.0082 | 0.056 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0072139 | 0.001 | 106.0082 | 0.056 | 2 | 3 | glomerular parietal epithelial cell differentiation |
| GO:0043588 | 0.0011 | 2.9136 | 4.778 | 13 | 256 | skin development |
| GO:0030049 | 0.0011 | 10.1634 | 0.4666 | 4 | 25 | muscle filament sliding |
| GO:0050776 | 0.0011 | 2.1251 | 12.1316 | 24 | 650 | regulation of immune response |
| GO:1903555 | 0.0013 | 4.6472 | 1.6424 | 7 | 88 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0070268 | 0.0013 | 5.4552 | 1.2132 | 6 | 65 | cornification |
| GO:0002639 | 0.0015 | 9.2782 | 0.5039 | 4 | 27 | positive regulation of immunoglobulin production |
| GO:0048568 | 0.0016 | 2.4646 | 6.9244 | 16 | 371 | embryonic organ development |
| GO:0001501 | 0.0018 | 2.3748 | 7.6336 | 17 | 409 | skeletal system development |
| GO:0030890 | 0.0019 | 8.5347 | 0.5413 | 4 | 29 | positive regulation of B cell proliferation |
| GO:0008628 | 0.002 | 53 | 0.0747 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0048856 | 0.0021 | 1.4747 | 81.3396 | 103 | 4432 | anatomical structure development |
| GO:0006954 | 0.0021 | 2.33 | 7.7728 | 17 | 422 | inflammatory response |
| GO:0050877 | 0.0023 | 1.9767 | 13.5314 | 25 | 725 | nervous system process |
| GO:0048869 | 0.0023 | 1.5 | 61.8527 | 82 | 3314 | cellular developmental process |
| GO:0051094 | 0.0023 | 1.8215 | 18.9067 | 32 | 1013 | positive regulation of developmental process |
| GO:0002699 | 0.0027 | 3.5891 | 2.389 | 8 | 128 | positive regulation of immune effector process |
| GO:0009887 | 0.0028 | 1.8948 | 15.2485 | 27 | 817 | animal organ morphogenesis |
| GO:0003009 | 0.0028 | 7.6185 | 0.5972 | 4 | 32 | skeletal muscle contraction |
| GO:0045824 | 0.0028 | 7.6185 | 0.5972 | 4 | 32 | negative regulation of innate immune response |
| GO:0048598 | 0.0032 | 2.1253 | 9.5 | 19 | 509 | embryonic morphogenesis |
| GO:0051251 | 0.0033 | 2.9687 | 3.5835 | 10 | 192 | positive regulation of lymphocyte activation |
| GO:0032088 | 0.0033 | 5.4554 | 1.0079 | 5 | 54 | negative regulation of NF-kappaB transcription factor activity |
| GO:0021546 | 0.0033 | 35.3306 | 0.0933 | 2 | 5 | rhombomere development |
| GO:0032687 | 0.0033 | 35.3306 | 0.0933 | 2 | 5 | negative regulation of interferon-alpha production |
| GO:0042320 | 0.0033 | 35.3306 | 0.0933 | 2 | 5 | regulation of circadian sleep/wake cycle, REM sleep |
| GO:0046642 | 0.0033 | 35.3306 | 0.0933 | 2 | 5 | negative regulation of alpha-beta T cell proliferation |
| GO:0050917 | 0.0033 | 35.3306 | 0.0933 | 2 | 5 | sensory perception of umami taste |
| GO:0031347 | 0.0034 | 2.1164 | 9.5373 | 19 | 511 | regulation of defense response |
| GO:0050900 | 0.0035 | 2.5212 | 5.4686 | 13 | 293 | leukocyte migration |
| GO:0050864 | 0.0035 | 4.4043 | 1.4745 | 6 | 79 | regulation of B cell activation |
| GO:0002376 | 0.0036 | 1.6174 | 31.033 | 46 | 1722 | immune system process |
| GO:2000026 | 0.0037 | 1.6364 | 28.4627 | 43 | 1525 | regulation of multicellular organismal development |
| GO:2000181 | 0.004 | 4.2861 | 1.5118 | 6 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0002507 | 0.0043 | 10.6328 | 0.336 | 3 | 18 | tolerance induction |
| GO:0018149 | 0.0043 | 10.6328 | 0.336 | 3 | 18 | peptide cross-linking |
| GO:0042749 | 0.0043 | 10.6328 | 0.336 | 3 | 18 | regulation of circadian sleep/wake cycle |
| GO:0032720 | 0.0044 | 6.6641 | 0.6719 | 4 | 36 | negative regulation of tumor necrosis factor production |
| GO:0048646 | 0.0046 | 1.8186 | 15.8271 | 27 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0008284 | 0.0046 | 1.9147 | 12.7662 | 23 | 684 | positive regulation of cell proliferation |
| GO:0045765 | 0.0047 | 2.8118 | 3.7701 | 10 | 202 | regulation of angiogenesis |
| GO:0050670 | 0.0047 | 3.2598 | 2.613 | 8 | 140 | regulation of lymphocyte proliferation |
| GO:0051240 | 0.0048 | 1.6864 | 22.2761 | 35 | 1203 | positive regulation of multicellular organismal process |
| GO:0002291 | 0.005 | 26.4959 | 0.112 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0021604 | 0.005 | 26.4959 | 0.112 | 2 | 6 | cranial nerve structural organization |
| GO:0043950 | 0.005 | 26.4959 | 0.112 | 2 | 6 | positive regulation of cAMP-mediated signaling |
| GO:0032878 | 0.005 | 9.9675 | 0.3546 | 3 | 19 | regulation of establishment or maintenance of cell polarity |
| GO:0072010 | 0.0058 | 9.3804 | 0.3733 | 3 | 20 | glomerular epithelium development |
| GO:0021545 | 0.0058 | 6.0915 | 0.7279 | 4 | 39 | cranial nerve development |
| GO:0070663 | 0.0058 | 3.1396 | 2.7063 | 8 | 145 | regulation of leukocyte proliferation |
| GO:0030855 | 0.006 | 2.3518 | 5.8407 | 13 | 324 | epithelial cell differentiation |
| GO:0010959 | 0.0061 | 2.442 | 5.1886 | 12 | 278 | regulation of metal ion transport |
| GO:0001818 | 0.0062 | 2.8681 | 3.3222 | 9 | 178 | negative regulation of cytokine production |
| GO:0002758 | 0.0065 | 2.6706 | 3.9568 | 10 | 212 | innate immune response-activating signal transduction |
| GO:0032733 | 0.0067 | 8.8586 | 0.3919 | 3 | 21 | positive regulation of interleukin-10 production |
| GO:0050802 | 0.0067 | 8.8586 | 0.3919 | 3 | 21 | circadian sleep/wake cycle, sleep |
| GO:0060055 | 0.0067 | 8.8586 | 0.3919 | 3 | 21 | angiogenesis involved in wound healing |
| GO:0090279 | 0.0067 | 8.8586 | 0.3919 | 3 | 21 | regulation of calcium ion import |
| GO:0001826 | 0.0068 | 21.1951 | 0.1306 | 2 | 7 | inner cell mass cell differentiation |
| GO:0060290 | 0.0068 | 21.1951 | 0.1306 | 2 | 7 | transdifferentiation |
| GO:0090336 | 0.0068 | 21.1951 | 0.1306 | 2 | 7 | positive regulation of brown fat cell differentiation |
| GO:0002532 | 0.007 | 5.7613 | 0.7652 | 4 | 41 | production of molecular mediator involved in inflammatory response |
| GO:0099565 | 0.0075 | 3.7347 | 1.7171 | 6 | 92 | chemical synaptic transmission, postsynaptic |
| GO:0019221 | 0.0076 | 2.0311 | 8.8281 | 17 | 473 | cytokine-mediated signaling pathway |
| GO:0050879 | 0.0076 | 5.6093 | 0.7839 | 4 | 42 | multicellular organismal movement |
| GO:0003158 | 0.0083 | 3.6493 | 1.7544 | 6 | 94 | endothelium development |
| GO:0032946 | 0.0083 | 3.6493 | 1.7544 | 6 | 94 | positive regulation of mononuclear cell proliferation |
| GO:0034122 | 0.0086 | 7.9715 | 0.4293 | 3 | 23 | negative regulation of toll-like receptor signaling pathway |
| GO:0060324 | 0.009 | 5.328 | 0.8212 | 4 | 44 | face development |
| GO:0045089 | 0.009 | 2.4141 | 4.7967 | 11 | 257 | positive regulation of innate immune response |
| GO:0001820 | 0.009 | 17.6612 | 0.1493 | 2 | 8 | serotonin secretion |
| GO:0035095 | 0.009 | 17.6612 | 0.1493 | 2 | 8 | behavioral response to nicotine |
| GO:0032496 | 0.0092 | 2.5305 | 4.1621 | 10 | 223 | response to lipopolysaccharide |
| GO:0050867 | 0.0094 | 2.5184 | 4.1807 | 10 | 224 | positive regulation of cell activation |
| GO:0060548 | 0.0097 | 1.7635 | 14.39 | 24 | 771 | negative regulation of cell death |
| GO:0007274 | 0.0097 | 7.5913 | 0.4479 | 3 | 24 | neuromuscular synaptic transmission |
| GO:0048791 | 0.0097 | 7.5913 | 0.4479 | 3 | 24 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0048534 | 0.0099 | 1.806 | 12.8595 | 22 | 689 | hematopoietic or lymphoid organ development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 4.7143 | 3.0981 | 13 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0050865 | 0 | 2.8322 | 9.2695 | 24 | 374 | regulation of cell activation |
| GO:0007186 | 1e-04 | 2.1806 | 16.9527 | 34 | 684 | G-protein coupled receptor signaling pathway |
| GO:0022610 | 1e-04 | 1.9484 | 25.8504 | 46 | 1043 | biological adhesion |
| GO:0032502 | 1e-04 | 1.5152 | 118.9663 | 151 | 4800 | developmental process |
| GO:0016339 | 2e-04 | 11.0836 | 0.57 | 5 | 23 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:2001275 | 2e-04 | 17.6914 | 0.3222 | 4 | 13 | positive regulation of glucose import in response to insulin stimulus |
| GO:0098609 | 3e-04 | 2.2845 | 12.2692 | 26 | 503 | cell-cell adhesion |
| GO:2000402 | 3e-04 | 39.7015 | 0.1487 | 3 | 6 | negative regulation of lymphocyte migration |
| GO:0008284 | 4e-04 | 2.0318 | 16.9527 | 32 | 684 | positive regulation of cell proliferation |
| GO:0086097 | 6e-04 | Inf | 0.0496 | 2 | 2 | phospholipase C-activating angiotensin-activated signaling pathway |
| GO:1902957 | 6e-04 | Inf | 0.0496 | 2 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:2000502 | 6e-04 | Inf | 0.0496 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0032101 | 9e-04 | 2.1131 | 12.6402 | 25 | 510 | regulation of response to external stimulus |
| GO:0002706 | 0.001 | 4.277 | 2.0571 | 8 | 83 | regulation of lymphocyte mediated immunity |
| GO:0002695 | 0.0013 | 3.7256 | 2.6272 | 9 | 106 | negative regulation of leukocyte activation |
| GO:0035296 | 0.0015 | 3.613 | 2.7015 | 9 | 109 | regulation of tube diameter |
| GO:0097756 | 0.0016 | 4.5175 | 1.7101 | 7 | 69 | negative regulation of blood vessel diameter |
| GO:1901856 | 0.0018 | 79.1718 | 0.0744 | 2 | 3 | negative regulation of cellular respiration |
| GO:0050880 | 0.002 | 3.4729 | 2.8007 | 9 | 113 | regulation of blood vessel size |
| GO:0055013 | 0.0021 | 4.9915 | 1.3384 | 6 | 54 | cardiac muscle cell development |
| GO:0007275 | 0.0024 | 1.3994 | 101.741 | 126 | 4105 | multicellular organism development |
| GO:0006835 | 0.0025 | 4.117 | 1.8588 | 7 | 75 | dicarboxylic acid transport |
| GO:0007399 | 0.003 | 1.5093 | 46.6199 | 65 | 1881 | nervous system development |
| GO:0051046 | 0.0032 | 1.9116 | 13.8546 | 25 | 559 | regulation of secretion |
| GO:0032890 | 0.0033 | 5.5341 | 1.0162 | 5 | 41 | regulation of organic acid transport |
| GO:0055074 | 0.0034 | 2.2792 | 7.4354 | 16 | 300 | calcium ion homeostasis |
| GO:1901701 | 0.0034 | 1.7438 | 20.1003 | 33 | 811 | cellular response to oxygen-containing compound |
| GO:0007198 | 0.0036 | 39.5828 | 0.0991 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0014048 | 0.0036 | 11.904 | 0.3222 | 3 | 13 | regulation of glutamate secretion |
| GO:0048488 | 0.0036 | 7.2301 | 0.6444 | 4 | 26 | synaptic vesicle endocytosis |
| GO:0097028 | 0.0036 | 7.2301 | 0.6444 | 4 | 26 | dendritic cell differentiation |
| GO:0051146 | 0.0036 | 2.5072 | 5.5022 | 13 | 222 | striated muscle cell differentiation |
| GO:0003008 | 0.0045 | 1.5708 | 31.9474 | 47 | 1289 | system process |
| GO:0010544 | 0.0045 | 10.821 | 0.347 | 3 | 14 | negative regulation of platelet activation |
| GO:0051900 | 0.0045 | 10.821 | 0.347 | 3 | 14 | regulation of mitochondrial depolarization |
| GO:0051957 | 0.0045 | 10.821 | 0.347 | 3 | 14 | positive regulation of amino acid transport |
| GO:0031295 | 0.0049 | 4.9791 | 1.1153 | 5 | 45 | T cell costimulation |
| GO:1903039 | 0.005 | 2.7869 | 3.8168 | 10 | 154 | positive regulation of leukocyte cell-cell adhesion |
| GO:0042102 | 0.0054 | 4.0574 | 1.611 | 6 | 65 | positive regulation of T cell proliferation |
| GO:0072503 | 0.0054 | 2.1623 | 7.8072 | 16 | 315 | cellular divalent inorganic cation homeostasis |
| GO:0002248 | 0.0058 | 26.3865 | 0.1239 | 2 | 5 | connective tissue replacement involved in inflammatory response wound healing |
| GO:0002578 | 0.0058 | 26.3865 | 0.1239 | 2 | 5 | negative regulation of antigen processing and presentation |
| GO:0006828 | 0.0058 | 26.3865 | 0.1239 | 2 | 5 | manganese ion transport |
| GO:0009744 | 0.0058 | 26.3865 | 0.1239 | 2 | 5 | response to sucrose |
| GO:0042297 | 0.0058 | 26.3865 | 0.1239 | 2 | 5 | vocal learning |
| GO:1902548 | 0.0058 | 26.3865 | 0.1239 | 2 | 5 | negative regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:1903909 | 0.0058 | 26.3865 | 0.1239 | 2 | 5 | regulation of receptor clustering |
| GO:0035065 | 0.0059 | 4.7413 | 1.1649 | 5 | 47 | regulation of histone acetylation |
| GO:0042391 | 0.0061 | 2.133 | 7.9063 | 16 | 319 | regulation of membrane potential |
| GO:0030154 | 0.0064 | 1.3821 | 74.5105 | 94 | 3054 | cell differentiation |
| GO:0046717 | 0.0065 | 3.4104 | 2.2058 | 7 | 89 | acid secretion |
| GO:0032331 | 0.0066 | 9.1548 | 0.3966 | 3 | 16 | negative regulation of chondrocyte differentiation |
| GO:0060294 | 0.0066 | 9.1548 | 0.3966 | 3 | 16 | cilium movement involved in cell motility |
| GO:0016049 | 0.0068 | 1.9681 | 10.1617 | 19 | 410 | cell growth |
| GO:0023061 | 0.0069 | 2.0512 | 8.7242 | 17 | 352 | signal release |
| GO:0006968 | 0.0069 | 5.8889 | 0.7683 | 4 | 31 | cellular defense response |
| GO:0061045 | 0.0071 | 4.525 | 1.2144 | 5 | 49 | negative regulation of wound healing |
| GO:0050868 | 0.0072 | 3.7986 | 1.7101 | 6 | 69 | negative regulation of T cell activation |
| GO:0033574 | 0.0077 | 5.6781 | 0.7931 | 4 | 32 | response to testosterone |
| GO:1900047 | 0.0077 | 5.6781 | 0.7931 | 4 | 32 | negative regulation of hemostasis |
| GO:0019229 | 0.0077 | 4.4241 | 1.2392 | 5 | 50 | regulation of vasoconstriction |
| GO:0050795 | 0.0077 | 4.4241 | 1.2392 | 5 | 50 | regulation of behavior |
| GO:0022408 | 0.0078 | 2.9904 | 2.8502 | 8 | 115 | negative regulation of cell-cell adhesion |
| GO:0021854 | 0.0079 | 8.5002 | 0.4213 | 3 | 17 | hypothalamus development |
| GO:0042053 | 0.0079 | 8.5002 | 0.4213 | 3 | 17 | regulation of dopamine metabolic process |
| GO:0045662 | 0.0079 | 8.5002 | 0.4213 | 3 | 17 | negative regulation of myoblast differentiation |
| GO:0050670 | 0.0081 | 2.7513 | 3.4699 | 9 | 140 | regulation of lymphocyte proliferation |
| GO:0051251 | 0.0084 | 2.4396 | 4.7587 | 11 | 192 | positive regulation of lymphocyte activation |
| GO:0002697 | 0.0085 | 2.2447 | 6.097 | 13 | 246 | regulation of immune effector process |
| GO:0051480 | 0.0085 | 2.3297 | 5.4278 | 12 | 219 | regulation of cytosolic calcium ion concentration |
| GO:0002664 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | regulation of T cell tolerance induction |
| GO:0010886 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | positive regulation of cholesterol storage |
| GO:0031340 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | positive regulation of vesicle fusion |
| GO:0051918 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | negative regulation of fibrinolysis |
| GO:0090324 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | negative regulation of oxidative phosphorylation |
| GO:0098597 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | observational learning |
| GO:1903800 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | positive regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:1905446 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | regulation of mitochondrial ATP synthesis coupled electron transport |
| GO:2000020 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | positive regulation of male gonad development |
| GO:2000794 | 0.0086 | 19.7883 | 0.1487 | 2 | 6 | regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0032946 | 0.0088 | 3.2131 | 2.3298 | 7 | 94 | positive regulation of mononuclear cell proliferation |
| GO:0009612 | 0.0088 | 2.5536 | 4.139 | 10 | 167 | response to mechanical stimulus |
| GO:0035051 | 0.0091 | 2.9082 | 2.9246 | 8 | 118 | cardiocyte differentiation |
| GO:0001562 | 0.0093 | 7.9329 | 0.4461 | 3 | 18 | response to protozoan |
| GO:0001773 | 0.0093 | 7.9329 | 0.4461 | 3 | 18 | myeloid dendritic cell activation |
| GO:0002507 | 0.0093 | 7.9329 | 0.4461 | 3 | 18 | tolerance induction |
| GO:0007530 | 0.0093 | 7.9329 | 0.4461 | 3 | 18 | sex determination |
| GO:0047497 | 0.0093 | 7.9329 | 0.4461 | 3 | 18 | mitochondrion transport along microtubule |
| GO:0061213 | 0.0093 | 7.9329 | 0.4461 | 3 | 18 | positive regulation of mesonephros development |
| GO:0051240 | 0.0095 | 1.5234 | 29.8903 | 43 | 1206 | positive regulation of multicellular organismal process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000026 | 0 | 1.789 | 47.8219 | 77 | 1525 | regulation of multicellular organismal development |
| GO:0048665 | 0 | 8.7802 | 1.0035 | 7 | 32 | neuron fate specification |
| GO:0048870 | 1e-04 | 1.8096 | 36.2192 | 60 | 1155 | cell motility |
| GO:0008628 | 1e-04 | 93.335 | 0.1254 | 3 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0035641 | 3e-04 | 17.813 | 0.3449 | 4 | 11 | locomotory exploration behavior |
| GO:0045595 | 4e-04 | 1.6295 | 43.8707 | 66 | 1399 | regulation of cell differentiation |
| GO:0072359 | 8e-04 | 1.7742 | 25.3064 | 42 | 807 | circulatory system development |
| GO:0001826 | 0.001 | 23.3283 | 0.2195 | 3 | 7 | inner cell mass cell differentiation |
| GO:2000854 | 0.001 | Inf | 0.0627 | 2 | 2 | positive regulation of corticosterone secretion |
| GO:0032501 | 0.001 | 1.4686 | 87.7428 | 113 | 3062 | multicellular organismal process |
| GO:0019372 | 0.001 | 11.332 | 0.4704 | 4 | 15 | lipoxygenase pathway |
| GO:0016045 | 0.0015 | 18.6612 | 0.2509 | 3 | 8 | detection of bacterium |
| GO:0032494 | 0.0015 | 18.6612 | 0.2509 | 3 | 8 | response to peptidoglycan |
| GO:0003341 | 0.0021 | 4.2953 | 1.8188 | 7 | 58 | cilium movement |
| GO:0048664 | 0.0022 | 15.5498 | 0.2822 | 3 | 9 | neuron fate determination |
| GO:0050878 | 0.0022 | 2.0306 | 12.0104 | 23 | 383 | regulation of body fluid levels |
| GO:0045604 | 0.0024 | 4.9341 | 1.3798 | 6 | 44 | regulation of epidermal cell differentiation |
| GO:0051094 | 0.0026 | 1.6066 | 31.7663 | 48 | 1013 | positive regulation of developmental process |
| GO:0009605 | 0.0028 | 1.4911 | 48.8254 | 68 | 1557 | response to external stimulus |
| GO:0040012 | 0.0028 | 1.7356 | 21.3552 | 35 | 681 | regulation of locomotion |
| GO:0061044 | 0.0029 | 62.0726 | 0.0941 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0072095 | 0.0029 | 62.0726 | 0.0941 | 2 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:0072513 | 0.0029 | 62.0726 | 0.0941 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
| GO:0090191 | 0.0029 | 62.0726 | 0.0941 | 2 | 3 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:0006935 | 0.0029 | 1.9256 | 13.7351 | 25 | 438 | chemotaxis |
| GO:0042127 | 0.003 | 1.5346 | 39.5746 | 57 | 1262 | regulation of cell proliferation |
| GO:0090280 | 0.0031 | 13.3273 | 0.3136 | 3 | 10 | positive regulation of calcium ion import |
| GO:0006954 | 0.0034 | 2.1103 | 9.533 | 19 | 311 | inflammatory response |
| GO:0048869 | 0.0039 | 1.3485 | 103.9225 | 128 | 3314 | cellular developmental process |
| GO:1905954 | 0.0041 | 3.7748 | 2.0383 | 7 | 65 | positive regulation of lipid localization |
| GO:0021903 | 0.0042 | 11.6605 | 0.3449 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0021978 | 0.0042 | 11.6605 | 0.3449 | 3 | 11 | telencephalon regionalization |
| GO:0098581 | 0.0042 | 11.6605 | 0.3449 | 3 | 11 | detection of external biotic stimulus |
| GO:0007155 | 0.0042 | 1.561 | 32.5816 | 48 | 1039 | cell adhesion |
| GO:0035295 | 0.0047 | 1.8045 | 15.7734 | 27 | 503 | tube development |
| GO:0051240 | 0.0047 | 1.5149 | 37.8185 | 54 | 1206 | positive regulation of multicellular organismal process |
| GO:0048583 | 0.005 | 1.3444 | 96.271 | 119 | 3070 | regulation of response to stimulus |
| GO:0010646 | 0.0053 | 1.3581 | 84.3861 | 106 | 2691 | regulation of cell communication |
| GO:0007517 | 0.0054 | 2.016 | 9.9407 | 19 | 317 | muscle organ development |
| GO:0007389 | 0.0054 | 1.9387 | 11.4145 | 21 | 364 | pattern specification process |
| GO:0032530 | 0.0055 | 10.3641 | 0.3763 | 3 | 12 | regulation of microvillus organization |
| GO:0003199 | 0.0056 | 31.0339 | 0.1254 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0033353 | 0.0056 | 31.0339 | 0.1254 | 2 | 4 | S-adenosylmethionine cycle |
| GO:0070221 | 0.0056 | 31.0339 | 0.1254 | 2 | 4 | sulfide oxidation, using sulfide:quinone oxidoreductase |
| GO:0051270 | 0.0057 | 1.6626 | 21.5434 | 34 | 687 | regulation of cellular component movement |
| GO:0048856 | 0.0061 | 1.441 | 53.5667 | 71 | 1865 | anatomical structure development |
| GO:0048246 | 0.0062 | 6.2282 | 0.7526 | 4 | 24 | macrophage chemotaxis |
| GO:0048562 | 0.0062 | 2.1289 | 7.9337 | 16 | 253 | embryonic organ morphogenesis |
| GO:0007218 | 0.0067 | 3.4193 | 2.2265 | 7 | 71 | neuropeptide signaling pathway |
| GO:0050728 | 0.0067 | 3.0911 | 2.7909 | 8 | 89 | negative regulation of inflammatory response |
| GO:0048265 | 0.0072 | 5.9312 | 0.784 | 4 | 25 | response to pain |
| GO:0060285 | 0.0072 | 5.9312 | 0.784 | 4 | 25 | cilium-dependent cell motility |
| GO:0050729 | 0.0072 | 3.3664 | 2.2578 | 7 | 72 | positive regulation of inflammatory response |
| GO:0009888 | 0.0072 | 1.4379 | 46.4735 | 63 | 1482 | tissue development |
| GO:0003008 | 0.0074 | 1.4658 | 40.4213 | 56 | 1289 | system process |
| GO:0007399 | 0.0076 | 1.391 | 58.9856 | 77 | 1881 | nervous system development |
| GO:0035115 | 0.0082 | 5.6611 | 0.8153 | 4 | 26 | embryonic forelimb morphogenesis |
| GO:0009653 | 0.0083 | 1.371 | 64.5988 | 83 | 2060 | anatomical structure morphogenesis |
| GO:0023051 | 0.0085 | 1.3303 | 85.7345 | 106 | 2734 | regulation of signaling |
| GO:0000097 | 0.0086 | 8.4784 | 0.439 | 3 | 14 | sulfur amino acid biosynthetic process |
| GO:0045683 | 0.0086 | 8.4784 | 0.439 | 3 | 14 | negative regulation of epidermis development |
| GO:0060850 | 0.0086 | 8.4784 | 0.439 | 3 | 14 | regulation of transcription involved in cell fate commitment |
| GO:0090185 | 0.0086 | 8.4784 | 0.439 | 3 | 14 | negative regulation of kidney development |
| GO:0030334 | 0.0092 | 1.6696 | 18.2194 | 29 | 581 | regulation of cell migration |
| GO:0010757 | 0.0092 | 20.6877 | 0.1568 | 2 | 5 | negative regulation of plasminogen activation |
| GO:0021778 | 0.0092 | 20.6877 | 0.1568 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0032224 | 0.0092 | 20.6877 | 0.1568 | 2 | 5 | positive regulation of synaptic transmission, cholinergic |
| GO:0045617 | 0.0092 | 20.6877 | 0.1568 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:2000609 | 0.0092 | 20.6877 | 0.1568 | 2 | 5 | regulation of thyroid hormone generation |
| GO:0035194 | 0.0093 | 2.1482 | 6.8675 | 14 | 219 | posttranscriptional gene silencing by RNA |
| GO:0034249 | 0.0094 | 1.9383 | 9.7525 | 18 | 311 | negative regulation of cellular amide metabolic process |
| GO:0010719 | 0.0094 | 5.4146 | 0.8467 | 4 | 27 | negative regulation of epithelial to mesenchymal transition |
| GO:0070374 | 0.0095 | 2.5279 | 4.2021 | 10 | 134 | positive regulation of ERK1 and ERK2 cascade |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097756 | 0 | 6.5668 | 1.5798 | 9 | 69 | negative regulation of blood vessel diameter |
| GO:0003044 | 1e-04 | 10.0272 | 0.7327 | 6 | 32 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0031644 | 2e-04 | 6.7719 | 1.1906 | 7 | 52 | regulation of neurological system process |
| GO:0035296 | 2e-04 | 4.4238 | 2.4956 | 10 | 109 | regulation of tube diameter |
| GO:0050880 | 3e-04 | 4.2506 | 2.5872 | 10 | 113 | regulation of blood vessel size |
| GO:0001963 | 3e-04 | 9.8452 | 0.6182 | 5 | 27 | synaptic transmission, dopaminergic |
| GO:0007399 | 4e-04 | 1.6716 | 43.0666 | 65 | 1881 | nervous system development |
| GO:0099537 | 4e-04 | 2.2959 | 11.2417 | 24 | 491 | trans-synaptic signaling |
| GO:0032502 | 5e-04 | 1.4835 | 109.8987 | 138 | 4800 | developmental process |
| GO:0007267 | 5e-04 | 1.7736 | 28.8484 | 47 | 1260 | cell-cell signaling |
| GO:0048704 | 7e-04 | 4.5271 | 1.9461 | 8 | 85 | embryonic skeletal system morphogenesis |
| GO:0050886 | 8e-04 | 5.1594 | 1.5111 | 7 | 66 | endocrine process |
| GO:0010460 | 0.0012 | 10.1625 | 0.4808 | 4 | 21 | positive regulation of heart rate |
| GO:0006874 | 0.0012 | 2.5374 | 6.7313 | 16 | 294 | cellular calcium ion homeostasis |
| GO:0072507 | 0.0015 | 2.412 | 7.5097 | 17 | 328 | divalent inorganic cation homeostasis |
| GO:0002277 | 0.0015 | 85.9136 | 0.0687 | 2 | 3 | myeloid dendritic cell activation involved in immune response |
| GO:1900133 | 0.0015 | 85.9136 | 0.0687 | 2 | 3 | regulation of renin secretion into blood stream |
| GO:0007275 | 0.0016 | 1.4883 | 71.7348 | 94 | 3270 | multicellular organism development |
| GO:0007338 | 0.0016 | 3.9578 | 2.198 | 8 | 96 | single fertilization |
| GO:0019229 | 0.0016 | 9.1982 | 0.5207 | 4 | 23 | regulation of vasoconstriction |
| GO:0051930 | 0.0017 | 9.0914 | 0.5266 | 4 | 23 | regulation of sensory perception of pain |
| GO:0060670 | 0.0017 | 16.1537 | 0.2519 | 3 | 11 | branching involved in labyrinthine layer morphogenesis |
| GO:0007204 | 0.0021 | 2.8103 | 4.5562 | 12 | 199 | positive regulation of cytosolic calcium ion concentration |
| GO:0007156 | 0.0023 | 3.3819 | 2.8619 | 9 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0010951 | 0.0026 | 3.0738 | 3.4801 | 10 | 152 | negative regulation of endopeptidase activity |
| GO:0007610 | 0.0029 | 2.0607 | 10.8067 | 21 | 472 | behavior |
| GO:0046425 | 0.003 | 3.5512 | 2.4269 | 8 | 106 | regulation of JAK-STAT cascade |
| GO:0001992 | 0.003 | 42.9535 | 0.0916 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0001999 | 0.003 | 42.9535 | 0.0916 | 2 | 4 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure |
| GO:0014826 | 0.003 | 42.9535 | 0.0916 | 2 | 4 | vein smooth muscle contraction |
| GO:0021555 | 0.003 | 42.9535 | 0.0916 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0038042 | 0.003 | 42.9535 | 0.0916 | 2 | 4 | dimeric G-protein coupled receptor signaling pathway |
| GO:0045907 | 0.0031 | 7.5079 | 0.6182 | 4 | 27 | positive regulation of vasoconstriction |
| GO:0031623 | 0.0046 | 4.1932 | 1.5569 | 6 | 68 | receptor internalization |
| GO:0052652 | 0.0047 | 3.2811 | 2.6101 | 8 | 114 | cyclic purine nucleotide metabolic process |
| GO:0003100 | 0.005 | 28.6334 | 0.1145 | 2 | 5 | regulation of systemic arterial blood pressure by endothelin |
| GO:0003105 | 0.005 | 28.6334 | 0.1145 | 2 | 5 | negative regulation of glomerular filtration |
| GO:0033141 | 0.005 | 28.6334 | 0.1145 | 2 | 5 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0045617 | 0.005 | 28.6334 | 0.1145 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:0045987 | 0.0052 | 6.3937 | 0.7098 | 4 | 31 | positive regulation of smooth muscle contraction |
| GO:0051354 | 0.0053 | 9.9369 | 0.3663 | 3 | 16 | negative regulation of oxidoreductase activity |
| GO:0051446 | 0.0053 | 9.9369 | 0.3663 | 3 | 16 | positive regulation of meiotic cell cycle |
| GO:0009790 | 0.0053 | 1.7191 | 19.1178 | 31 | 835 | embryo development |
| GO:0019935 | 0.0054 | 3.5322 | 2.1293 | 7 | 93 | cyclic-nucleotide-mediated signaling |
| GO:0045861 | 0.0059 | 2.4505 | 5.1744 | 12 | 226 | negative regulation of proteolysis |
| GO:0009187 | 0.0062 | 2.88 | 3.3199 | 9 | 145 | cyclic nucleotide metabolic process |
| GO:0048070 | 0.0064 | 9.2264 | 0.3892 | 3 | 17 | regulation of developmental pigmentation |
| GO:0030003 | 0.0065 | 1.9783 | 10.1198 | 19 | 442 | cellular cation homeostasis |
| GO:0019233 | 0.0073 | 4.4645 | 1.2222 | 5 | 54 | sensory perception of pain |
| GO:0021826 | 0.0074 | 21.4734 | 0.1374 | 2 | 6 | substrate-independent telencephalic tangential migration |
| GO:0021830 | 0.0074 | 21.4734 | 0.1374 | 2 | 6 | interneuron migration from the subpallium to the cortex |
| GO:0048312 | 0.0074 | 21.4734 | 0.1374 | 2 | 6 | intracellular distribution of mitochondria |
| GO:0097696 | 0.0077 | 2.9959 | 2.8391 | 8 | 124 | STAT cascade |
| GO:0050801 | 0.008 | 1.8391 | 12.5926 | 22 | 550 | ion homeostasis |
| GO:0007617 | 0.0088 | 8.0719 | 0.435 | 3 | 19 | mating behavior |
| GO:0031960 | 0.0088 | 2.9197 | 2.9077 | 8 | 127 | response to corticosteroid |
| GO:0031103 | 0.0089 | 5.3926 | 0.8242 | 4 | 36 | axon regeneration |
| GO:0007268 | 0.0089 | 1.9119 | 10.447 | 19 | 463 | chemical synaptic transmission |
| GO:0055082 | 0.0092 | 1.814 | 12.7528 | 22 | 557 | cellular chemical homeostasis |
| GO:0055065 | 0.0094 | 1.9385 | 9.7535 | 18 | 426 | metal ion homeostasis |
| GO:0050877 | 0.0094 | 1.7422 | 15.1121 | 25 | 673 | nervous system process |
| GO:2000241 | 0.0099 | 3.1289 | 2.3811 | 7 | 104 | regulation of reproductive process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031338 | 0 | 7.4642 | 1.4148 | 9 | 62 | regulation of vesicle fusion |
| GO:0090630 | 1e-04 | 5.4863 | 1.8484 | 9 | 81 | activation of GTPase activity |
| GO:0090174 | 4e-04 | 3.7225 | 3.2176 | 11 | 141 | organelle membrane fusion |
| GO:0002250 | 4e-04 | 3.0635 | 4.9291 | 14 | 216 | adaptive immune response |
| GO:0001692 | 5e-04 | Inf | 0.0456 | 2 | 2 | histamine metabolic process |
| GO:1904875 | 5e-04 | Inf | 0.0456 | 2 | 2 | regulation of DNA ligase activity |
| GO:0045321 | 5e-04 | 1.9413 | 19.4655 | 35 | 853 | leukocyte activation |
| GO:0072376 | 6e-04 | 6.5331 | 1.0497 | 6 | 46 | protein activation cascade |
| GO:0002682 | 7e-04 | 1.8376 | 23.5502 | 40 | 1032 | regulation of immune system process |
| GO:0032879 | 8e-04 | 1.596 | 47.7623 | 69 | 2093 | regulation of localization |
| GO:0031623 | 9e-04 | 5.0068 | 1.5518 | 7 | 68 | receptor internalization |
| GO:0002252 | 9e-04 | 1.9165 | 18.507 | 33 | 811 | immune effector process |
| GO:0006959 | 9e-04 | 3.9022 | 2.5102 | 9 | 110 | humoral immune response |
| GO:0035082 | 0.0011 | 5.6783 | 1.1866 | 6 | 52 | axoneme assembly |
| GO:0007189 | 0.0013 | 5.5571 | 1.2095 | 6 | 53 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
| GO:0019935 | 0.0013 | 4.1127 | 2.1223 | 8 | 93 | cyclic-nucleotide-mediated signaling |
| GO:0003008 | 0.0015 | 1.6898 | 29.415 | 46 | 1289 | system process |
| GO:0051050 | 0.0016 | 1.882 | 17.617 | 31 | 772 | positive regulation of transport |
| GO:0030819 | 0.0024 | 4.8341 | 1.3692 | 6 | 60 | positive regulation of cAMP biosynthetic process |
| GO:0034765 | 0.0026 | 2.2779 | 7.9185 | 17 | 347 | regulation of ion transmembrane transport |
| GO:0022610 | 0.0027 | 1.7082 | 23.8013 | 38 | 1043 | biological adhesion |
| GO:0006590 | 0.0028 | 12.9652 | 0.2967 | 3 | 13 | thyroid hormone generation |
| GO:0045981 | 0.0029 | 7.6462 | 0.6074 | 4 | 27 | positive regulation of nucleotide metabolic process |
| GO:0030816 | 0.0029 | 43.7959 | 0.0899 | 2 | 4 | positive regulation of cAMP metabolic process |
| GO:0008628 | 0.003 | 43.1 | 0.0913 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0014050 | 0.003 | 43.1 | 0.0913 | 2 | 4 | negative regulation of glutamate secretion |
| GO:0044854 | 0.003 | 43.1 | 0.0913 | 2 | 4 | plasma membrane raft assembly |
| GO:0097039 | 0.003 | 43.1 | 0.0913 | 2 | 4 | protein linear polyubiquitination |
| GO:0048640 | 0.0031 | 4.5786 | 1.4377 | 6 | 63 | negative regulation of developmental growth |
| GO:0031424 | 0.0031 | 3.5272 | 2.4417 | 8 | 107 | keratinization |
| GO:0030101 | 0.0035 | 5.4259 | 1.0269 | 5 | 45 | natural killer cell activation |
| GO:0001906 | 0.0035 | 3.8606 | 1.9625 | 7 | 86 | cell killing |
| GO:0055075 | 0.0036 | 11.7856 | 0.3195 | 3 | 14 | potassium ion homeostasis |
| GO:0071407 | 0.0036 | 2.0571 | 10.2918 | 20 | 451 | cellular response to organic cyclic compound |
| GO:0098609 | 0.004 | 1.878 | 14.1028 | 25 | 618 | cell-cell adhesion |
| GO:0007190 | 0.004 | 6.9299 | 0.6618 | 4 | 29 | activation of adenylate cyclase activity |
| GO:0002520 | 0.0045 | 1.7938 | 16.5445 | 28 | 725 | immune system development |
| GO:0097756 | 0.0048 | 4.1406 | 1.5746 | 6 | 69 | negative regulation of blood vessel diameter |
| GO:0051351 | 0.005 | 28.7311 | 0.1141 | 2 | 5 | positive regulation of ligase activity |
| GO:0055078 | 0.0051 | 6.4156 | 0.7074 | 4 | 31 | sodium ion homeostasis |
| GO:0002449 | 0.0053 | 2.956 | 3.2404 | 9 | 142 | lymphocyte mediated immunity |
| GO:0071417 | 0.0053 | 2.0199 | 9.9267 | 19 | 435 | cellular response to organonitrogen compound |
| GO:0034162 | 0.0053 | 9.9709 | 0.3651 | 3 | 16 | toll-like receptor 9 signaling pathway |
| GO:0097553 | 0.0053 | 3.5444 | 2.1223 | 7 | 93 | calcium ion transmembrane import into cytosol |
| GO:0006958 | 0.0063 | 9.258 | 0.3879 | 3 | 17 | complement activation, classical pathway |
| GO:0010880 | 0.0063 | 9.258 | 0.3879 | 3 | 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO:0034138 | 0.0063 | 9.258 | 0.3879 | 3 | 17 | toll-like receptor 3 signaling pathway |
| GO:1900542 | 0.0065 | 2.535 | 4.5868 | 11 | 201 | regulation of purine nucleotide metabolic process |
| GO:0002757 | 0.0067 | 2.1101 | 7.987 | 16 | 350 | immune response-activating signal transduction |
| GO:0002027 | 0.0068 | 3.8347 | 1.6887 | 6 | 74 | regulation of heart rate |
| GO:0010562 | 0.0071 | 1.6809 | 19.5111 | 31 | 855 | positive regulation of phosphorus metabolic process |
| GO:0030799 | 0.0072 | 3.0327 | 2.8069 | 8 | 123 | regulation of cyclic nucleotide metabolic process |
| GO:0006835 | 0.0072 | 3.7788 | 1.7115 | 6 | 75 | dicarboxylic acid transport |
| GO:0060297 | 0.0073 | 21.5467 | 0.1369 | 2 | 6 | regulation of sarcomere organization |
| GO:0060373 | 0.0073 | 21.5467 | 0.1369 | 2 | 6 | regulation of ventricular cardiac muscle cell membrane depolarization |
| GO:0061052 | 0.0073 | 21.5467 | 0.1369 | 2 | 6 | negative regulation of cell growth involved in cardiac muscle cell development |
| GO:0086103 | 0.0073 | 21.5467 | 0.1369 | 2 | 6 | G-protein coupled receptor signaling pathway involved in heart process |
| GO:2001179 | 0.0073 | 21.5467 | 0.1369 | 2 | 6 | regulation of interleukin-10 secretion |
| GO:0001773 | 0.0074 | 8.6401 | 0.4108 | 3 | 18 | myeloid dendritic cell activation |
| GO:0018149 | 0.0074 | 8.6401 | 0.4108 | 3 | 18 | peptide cross-linking |
| GO:0009605 | 0.0077 | 1.5042 | 35.5308 | 50 | 1557 | response to external stimulus |
| GO:0030097 | 0.008 | 1.7683 | 14.9015 | 25 | 653 | hemopoiesis |
| GO:0032501 | 0.0082 | 1.3825 | 84.5272 | 103 | 4022 | multicellular organismal process |
| GO:0030810 | 0.0082 | 3.6718 | 1.7571 | 6 | 77 | positive regulation of nucleotide biosynthetic process |
| GO:0048513 | 0.0085 | 1.3995 | 59.7428 | 77 | 2618 | animal organ development |
| GO:0035809 | 0.0087 | 8.0995 | 0.4336 | 3 | 19 | regulation of urine volume |
| GO:0045577 | 0.0087 | 8.0995 | 0.4336 | 3 | 19 | regulation of B cell differentiation |
| GO:0061117 | 0.0087 | 8.0995 | 0.4336 | 3 | 19 | negative regulation of heart growth |
| GO:1903514 | 0.0087 | 8.0995 | 0.4336 | 3 | 19 | release of sequestered calcium ion into cytosol by endoplasmic reticulum |
| GO:1903169 | 0.0088 | 3.2064 | 2.3276 | 7 | 102 | regulation of calcium ion transmembrane transport |
| GO:0042113 | 0.0092 | 2.69 | 3.5371 | 9 | 155 | B cell activation |
| GO:1903524 | 0.0095 | 4.1699 | 1.3007 | 5 | 57 | positive regulation of blood circulation |
| GO:0050829 | 0.0097 | 5.2467 | 0.8443 | 4 | 37 | defense response to Gram-negative bacterium |
| GO:0050778 | 0.0098 | 1.8599 | 11.2959 | 20 | 495 | positive regulation of immune response |
| GO:0007187 | 0.0099 | 2.8571 | 2.9666 | 8 | 130 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 4.675 | 4.1937 | 17 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0072359 | 0 | 2.1638 | 27.0748 | 53 | 807 | circulatory system development |
| GO:0051674 | 0 | 1.9471 | 38.7502 | 68 | 1155 | localization of cell |
| GO:0022610 | 0 | 1.9927 | 34.9926 | 63 | 1043 | biological adhesion |
| GO:0098609 | 0 | 2.278 | 20.7339 | 43 | 618 | cell-cell adhesion |
| GO:0048514 | 0 | 2.5295 | 14.762 | 34 | 440 | blood vessel morphogenesis |
| GO:0001944 | 0 | 2.3395 | 17.7815 | 38 | 530 | vasculature development |
| GO:0048646 | 0 | 2.0448 | 26.2037 | 49 | 792 | anatomical structure formation involved in morphogenesis |
| GO:0045446 | 1e-04 | 4.6163 | 2.7175 | 11 | 81 | endothelial cell differentiation |
| GO:1905205 | 1e-04 | 29.0591 | 0.2684 | 4 | 8 | positive regulation of connective tissue replacement |
| GO:0048520 | 1e-04 | 13.2315 | 0.5368 | 5 | 16 | positive regulation of behavior |
| GO:0048513 | 3e-04 | 1.4898 | 87.8338 | 118 | 2618 | animal organ development |
| GO:2000145 | 3e-04 | 1.9457 | 20.9687 | 38 | 625 | regulation of cell motility |
| GO:0003180 | 4e-04 | 43.4966 | 0.1677 | 3 | 5 | aortic valve morphogenesis |
| GO:0016477 | 4e-04 | 1.8679 | 22.9771 | 40 | 702 | cell migration |
| GO:0006954 | 4e-04 | 2.068 | 15.5336 | 30 | 463 | inflammatory response |
| GO:0003205 | 5e-04 | 3.1846 | 4.4621 | 13 | 133 | cardiac chamber development |
| GO:2000026 | 5e-04 | 1.6201 | 43.3322 | 65 | 1319 | regulation of multicellular organismal development |
| GO:0051241 | 6e-04 | 1.7547 | 28.0635 | 46 | 840 | negative regulation of multicellular organismal process |
| GO:0034103 | 7e-04 | 4.6752 | 1.9459 | 8 | 58 | regulation of tissue remodeling |
| GO:0035360 | 7e-04 | 28.9955 | 0.2013 | 3 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0060017 | 7e-04 | 28.9955 | 0.2013 | 3 | 6 | parathyroid gland development |
| GO:0045765 | 8e-04 | 3.717 | 2.9767 | 10 | 90 | regulation of angiogenesis |
| GO:0007283 | 8e-04 | 2.0996 | 13.2187 | 26 | 394 | spermatogenesis |
| GO:0040011 | 9e-04 | 1.6824 | 31.8379 | 50 | 972 | locomotion |
| GO:0002690 | 9e-04 | 4.4096 | 2.0465 | 8 | 61 | positive regulation of leukocyte chemotaxis |
| GO:0006928 | 0.001 | 1.615 | 39.2602 | 59 | 1200 | movement of cell or subcellular component |
| GO:0090132 | 0.0011 | Inf | 0.0658 | 2 | 2 | epithelium migration |
| GO:0070366 | 0.0011 | Inf | 0.0671 | 2 | 2 | regulation of hepatocyte differentiation |
| GO:0071469 | 0.0011 | Inf | 0.0671 | 2 | 2 | cellular response to alkaline pH |
| GO:0072272 | 0.0011 | Inf | 0.0671 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0001955 | 0.0012 | 21.7449 | 0.2348 | 3 | 7 | blood vessel maturation |
| GO:0061085 | 0.0012 | 21.7449 | 0.2348 | 3 | 7 | regulation of histone H3-K27 methylation |
| GO:2000252 | 0.0012 | 21.7449 | 0.2348 | 3 | 7 | negative regulation of feeding behavior |
| GO:0010594 | 0.0012 | 3.2238 | 3.724 | 11 | 111 | regulation of endothelial cell migration |
| GO:0001759 | 0.0013 | 10.5612 | 0.5032 | 4 | 15 | organ induction |
| GO:0019372 | 0.0013 | 10.5612 | 0.5032 | 4 | 15 | lipoxygenase pathway |
| GO:0007389 | 0.0013 | 2.0924 | 12.2122 | 24 | 364 | pattern specification process |
| GO:0003007 | 0.0013 | 2.5332 | 6.7771 | 16 | 202 | heart morphogenesis |
| GO:0048645 | 0.0013 | 4.7485 | 1.6775 | 7 | 50 | animal organ formation |
| GO:2000027 | 0.0016 | 2.4791 | 6.9113 | 16 | 206 | regulation of organ morphogenesis |
| GO:0035082 | 0.0017 | 4.5367 | 1.7446 | 7 | 52 | axoneme assembly |
| GO:0002685 | 0.0017 | 3.0988 | 3.8582 | 11 | 115 | regulation of leukocyte migration |
| GO:0045616 | 0.0018 | 6.6101 | 0.9058 | 5 | 27 | regulation of keratinocyte differentiation |
| GO:0007275 | 0.002 | 1.4444 | 73.2847 | 96 | 2409 | multicellular organism development |
| GO:0045061 | 0.0021 | 8.935 | 0.5703 | 4 | 17 | thymic T cell selection |
| GO:0050901 | 0.0021 | 8.935 | 0.5703 | 4 | 17 | leukocyte tethering or rolling |
| GO:0007399 | 0.0022 | 1.4494 | 63.1075 | 85 | 1881 | nervous system development |
| GO:0071345 | 0.0024 | 1.7259 | 22.7133 | 37 | 677 | cellular response to cytokine stimulus |
| GO:0007218 | 0.0025 | 3.7067 | 2.382 | 8 | 71 | neuropeptide signaling pathway |
| GO:0030335 | 0.0026 | 2.0381 | 11.4405 | 22 | 341 | positive regulation of cell migration |
| GO:0003207 | 0.0027 | 14.4943 | 0.3019 | 3 | 9 | cardiac chamber formation |
| GO:0032099 | 0.0027 | 14.4943 | 0.3019 | 3 | 9 | negative regulation of appetite |
| GO:1903244 | 0.0027 | 14.4943 | 0.3019 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0043537 | 0.003 | 5.8155 | 1.0065 | 5 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0051272 | 0.003 | 1.9825 | 12.2793 | 23 | 366 | positive regulation of cellular component movement |
| GO:0009991 | 0.0032 | 1.9707 | 12.3464 | 23 | 368 | response to extracellular stimulus |
| GO:0010884 | 0.0032 | 7.7424 | 0.6374 | 4 | 19 | positive regulation of lipid storage |
| GO:0023019 | 0.0032 | 7.7424 | 0.6374 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0031116 | 0.0032 | 7.7424 | 0.6374 | 4 | 19 | positive regulation of microtubule polymerization |
| GO:0046010 | 0.0033 | 57.8688 | 0.1006 | 2 | 3 | positive regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0060913 | 0.0033 | 57.8688 | 0.1006 | 2 | 3 | cardiac cell fate determination |
| GO:0072679 | 0.0033 | 57.8688 | 0.1006 | 2 | 3 | thymocyte migration |
| GO:0008217 | 0.0034 | 2.8 | 4.2273 | 11 | 126 | regulation of blood pressure |
| GO:0010831 | 0.0034 | 5.5914 | 1.04 | 5 | 31 | positive regulation of myotube differentiation |
| GO:0071622 | 0.0034 | 5.5914 | 1.04 | 5 | 31 | regulation of granulocyte chemotaxis |
| GO:0010631 | 0.0035 | 2.3438 | 6.8106 | 15 | 203 | epithelial cell migration |
| GO:0002577 | 0.0038 | 12.4227 | 0.3355 | 3 | 10 | regulation of antigen processing and presentation |
| GO:0042060 | 0.0039 | 1.8772 | 14.0574 | 25 | 419 | wound healing |
| GO:1902624 | 0.0039 | 7.258 | 0.671 | 4 | 20 | positive regulation of neutrophil migration |
| GO:0017015 | 0.004 | 3.1296 | 3.1201 | 9 | 93 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0045766 | 0.0044 | 2.8662 | 3.7576 | 10 | 112 | positive regulation of angiogenesis |
| GO:0003208 | 0.0045 | 4.2856 | 1.5677 | 6 | 47 | cardiac ventricle morphogenesis |
| GO:0038111 | 0.0045 | 5.1912 | 1.1071 | 5 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0045 | 5.1912 | 1.1071 | 5 | 33 | response to interleukin-7 |
| GO:2000107 | 0.0045 | 5.1912 | 1.1071 | 5 | 33 | negative regulation of leukocyte apoptotic process |
| GO:0072078 | 0.0046 | 3.709 | 2.0801 | 7 | 62 | nephron tubule morphogenesis |
| GO:0060037 | 0.0048 | 6.8305 | 0.7045 | 4 | 21 | pharyngeal system development |
| GO:0060562 | 0.0048 | 2.0854 | 9.1256 | 18 | 272 | epithelial tube morphogenesis |
| GO:0040017 | 0.0048 | 1.8972 | 12.7825 | 23 | 381 | positive regulation of locomotion |
| GO:0021700 | 0.0048 | 2.2584 | 7.0455 | 15 | 210 | developmental maturation |
| GO:0045807 | 0.0049 | 3.0209 | 3.2208 | 9 | 96 | positive regulation of endocytosis |
| GO:0003161 | 0.0051 | 10.869 | 0.369 | 3 | 11 | cardiac conduction system development |
| GO:0014744 | 0.0051 | 10.869 | 0.369 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0032108 | 0.0051 | 10.869 | 0.369 | 3 | 11 | negative regulation of response to nutrient levels |
| GO:0050710 | 0.0052 | 5.0118 | 1.1407 | 5 | 34 | negative regulation of cytokine secretion |
| GO:0072028 | 0.0054 | 3.5783 | 2.1472 | 7 | 64 | nephron morphogenesis |
| GO:0060143 | 0.0057 | 6.4505 | 0.7381 | 4 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0051094 | 0.0057 | 1.5388 | 32.2449 | 47 | 976 | positive regulation of developmental process |
| GO:0051240 | 0.0058 | 1.4905 | 39.0415 | 55 | 1180 | positive regulation of multicellular organismal process |
| GO:0006334 | 0.006 | 2.7312 | 3.9253 | 10 | 117 | nucleosome assembly |
| GO:0032103 | 0.0061 | 2.2681 | 6.5422 | 14 | 195 | positive regulation of response to external stimulus |
| GO:0002606 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | positive regulation of dendritic cell antigen processing and presentation |
| GO:0003308 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0008078 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | mesodermal cell migration |
| GO:0008628 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0009972 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | cytidine deamination |
| GO:0042662 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0046087 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | cytidine metabolic process |
| GO:0048382 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | mesendoderm development |
| GO:0051122 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0060232 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | delamination |
| GO:0070383 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | DNA cytosine deamination |
| GO:0071502 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | cellular response to temperature stimulus |
| GO:0072086 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | specification of loop of Henle identity |
| GO:0097176 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | epoxide metabolic process |
| GO:1905903 | 0.0064 | 28.9321 | 0.1342 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0048729 | 0.0065 | 1.7176 | 17.7479 | 29 | 529 | tissue morphogenesis |
| GO:0090083 | 0.0066 | 9.6606 | 0.4026 | 3 | 12 | regulation of inclusion body assembly |
| GO:1901836 | 0.0066 | 9.6606 | 0.4026 | 3 | 12 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter |
| GO:0016339 | 0.0067 | 6.1105 | 0.7716 | 4 | 23 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:1900027 | 0.0067 | 6.1105 | 0.7716 | 4 | 23 | regulation of ruffle assembly |
| GO:1903671 | 0.0067 | 6.1105 | 0.7716 | 4 | 23 | negative regulation of sprouting angiogenesis |
| GO:2000404 | 0.0067 | 6.1105 | 0.7716 | 4 | 23 | regulation of T cell migration |
| GO:0009952 | 0.0067 | 2.3221 | 5.9383 | 13 | 177 | anterior/posterior pattern specification |
| GO:0007276 | 0.0069 | 1.7262 | 17.0434 | 28 | 508 | gamete generation |
| GO:0003012 | 0.0072 | 1.8862 | 11.7089 | 21 | 349 | muscle system process |
| GO:0046456 | 0.0075 | 4.5409 | 1.2413 | 5 | 37 | icosanoid biosynthetic process |
| GO:0050829 | 0.0075 | 4.5409 | 1.2413 | 5 | 37 | defense response to Gram-negative bacterium |
| GO:0070887 | 0.0075 | 1.3464 | 77.8694 | 98 | 2321 | cellular response to chemical stimulus |
| GO:0048704 | 0.0076 | 3.0294 | 2.8517 | 8 | 85 | embryonic skeletal system morphogenesis |
| GO:1905039 | 0.0076 | 3.0294 | 2.8517 | 8 | 85 | carboxylic acid transmembrane transport |
| GO:0060429 | 0.0077 | 1.516 | 31.9395 | 46 | 952 | epithelium development |
| GO:0002720 | 0.0078 | 5.8045 | 0.8052 | 4 | 24 | positive regulation of cytokine production involved in immune response |
| GO:0008283 | 0.0083 | 1.4013 | 52.9083 | 70 | 1577 | cell proliferation |
| GO:0003214 | 0.0083 | 8.6939 | 0.4361 | 3 | 13 | cardiac left ventricle morphogenesis |
| GO:0006590 | 0.0083 | 8.6939 | 0.4361 | 3 | 13 | thyroid hormone generation |
| GO:0048486 | 0.0083 | 8.6939 | 0.4361 | 3 | 13 | parasympathetic nervous system development |
| GO:0072606 | 0.0083 | 8.6939 | 0.4361 | 3 | 13 | interleukin-8 secretion |
| GO:1904994 | 0.0083 | 8.6939 | 0.4361 | 3 | 13 | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0032504 | 0.0086 | 1.6227 | 21.3378 | 33 | 636 | multicellular organism reproduction |
| GO:0007266 | 0.0088 | 2.4361 | 4.7976 | 11 | 143 | Rho protein signal transduction |
| GO:0051896 | 0.0089 | 2.3251 | 5.4686 | 12 | 163 | regulation of protein kinase B signaling |
| GO:0060285 | 0.009 | 5.5277 | 0.8387 | 4 | 25 | cilium-dependent cell motility |
| GO:0030858 | 0.0091 | 3.6364 | 1.8117 | 6 | 54 | positive regulation of epithelial cell differentiation |
| GO:0032502 | 0.0092 | 1.3267 | 95.8326 | 116 | 3180 | developmental process |
| GO:0048863 | 0.0093 | 2.0845 | 7.5823 | 15 | 226 | stem cell differentiation |
| GO:0070098 | 0.0093 | 4.2731 | 1.3084 | 5 | 39 | chemokine-mediated signaling pathway |
| GO:0097435 | 0.0094 | 1.7176 | 15.8691 | 26 | 473 | supramolecular fiber organization |
| GO:0007162 | 0.0096 | 2.2127 | 6.2067 | 13 | 185 | negative regulation of cell adhesion |
| GO:0045596 | 0.0099 | 1.6753 | 17.5131 | 28 | 522 | negative regulation of cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004888 | 5e-04 | 2.0921 | 14.9087 | 29 | 637 | transmembrane signaling receptor activity |
| GO:1903231 | 5e-04 | 4.7993 | 1.849 | 8 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0030395 | 5e-04 | Inf | 0.0468 | 2 | 2 | lactose binding |
| GO:0004872 | 0.0012 | 1.8464 | 20.3386 | 35 | 869 | receptor activity |
| GO:0008528 | 0.0013 | 4.1016 | 2.1298 | 8 | 91 | G-protein coupled peptide receptor activity |
| GO:0015143 | 0.0016 | 83.9871 | 0.0702 | 2 | 3 | urate transmembrane transporter activity |
| GO:0005452 | 0.0031 | 12.6302 | 0.3043 | 3 | 13 | inorganic anion exchanger activity |
| GO:0004950 | 0.0038 | 11.4811 | 0.3277 | 3 | 14 | chemokine receptor activity |
| GO:0030170 | 0.0039 | 5.2847 | 1.0532 | 5 | 45 | pyridoxal phosphate binding |
| GO:0004966 | 0.0052 | 27.9914 | 0.117 | 2 | 5 | galanin receptor activity |
| GO:0016661 | 0.0052 | 27.9914 | 0.117 | 2 | 5 | oxidoreductase activity, acting on other nitrogenous compounds as donors |
| GO:0050308 | 0.0077 | 20.9919 | 0.1404 | 2 | 6 | sugar-phosphatase activity |
| GO:0004871 | 0.0091 | 1.6 | 23.1237 | 35 | 988 | signal transducer activity |
| GO:0008483 | 0.0093 | 7.8902 | 0.4447 | 3 | 19 | transaminase activity |
| GO:0030246 | 0.0099 | 2.5028 | 4.2128 | 10 | 180 | carbohydrate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 103.121 | 0.1881 | 4 | 5 | molybdopterin cofactor binding |
| GO:0005201 | 0 | 6.5041 | 1.8814 | 10 | 50 | extracellular matrix structural constituent |
| GO:0030151 | 2e-04 | 77.1851 | 0.1505 | 3 | 4 | molybdenum ion binding |
| GO:0016165 | 0.0014 | Inf | 0.0753 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0046982 | 0.0018 | 1.9214 | 15.4651 | 28 | 411 | protein heterodimerization activity |
| GO:0008374 | 0.0027 | 4.8416 | 1.4299 | 6 | 38 | O-acyltransferase activity |
| GO:0030414 | 0.0028 | 3.0865 | 3.537 | 10 | 94 | peptidase inhibitor activity |
| GO:0047617 | 0.0032 | 7.9249 | 0.6397 | 4 | 17 | acyl-CoA hydrolase activity |
| GO:0005509 | 0.0034 | 1.7533 | 19.2655 | 32 | 512 | calcium ion binding |
| GO:0016803 | 0.0038 | 12.8592 | 0.3387 | 3 | 9 | ether hydrolase activity |
| GO:0005184 | 0.004 | 7.3583 | 0.6773 | 4 | 18 | neuropeptide hormone activity |
| GO:0008940 | 0.0041 | 51.3534 | 0.1129 | 2 | 3 | nitrate reductase activity |
| GO:0070573 | 0.0041 | 51.3534 | 0.1129 | 2 | 3 | metallodipeptidase activity |
| GO:0004180 | 0.0042 | 5.3721 | 1.0912 | 5 | 29 | carboxypeptidase activity |
| GO:0005164 | 0.0059 | 6.4375 | 0.7526 | 4 | 20 | tumor necrosis factor receptor binding |
| GO:0004867 | 0.0072 | 3.8709 | 1.7309 | 6 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0005506 | 0.0075 | 2.6426 | 4.0638 | 10 | 108 | iron ion binding |
| GO:0070008 | 0.009 | 8.5708 | 0.4515 | 3 | 12 | serine-type exopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 21.6977 | 0.7477 | 12 | 54 | olfactory receptor activity |
| GO:0004930 | 0 | 6.7215 | 3.3231 | 19 | 245 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 3.6497 | 9.2498 | 29 | 668 | transmembrane receptor activity |
| GO:0038023 | 0 | 3.5048 | 9.9699 | 30 | 720 | signaling receptor activity |
| GO:0060089 | 0 | 2.8283 | 12.5593 | 31 | 907 | molecular transducer activity |
| GO:0017137 | 4e-04 | 4.3823 | 2.2294 | 9 | 161 | Rab GTPase binding |
| GO:0005452 | 7e-04 | 21.7028 | 0.18 | 3 | 13 | inorganic anion exchanger activity |
| GO:0071723 | 0.0011 | 71.989 | 0.0554 | 2 | 4 | lipopeptide binding |
| GO:0004966 | 0.0019 | 47.989 | 0.0692 | 2 | 5 | galanin receptor activity |
| GO:0005096 | 0.0043 | 3.0542 | 3.1294 | 9 | 226 | GTPase activator activity |
| GO:0004896 | 0.0061 | 5.9206 | 0.7339 | 4 | 53 | cytokine receptor activity |
| GO:0005149 | 0.0064 | 20.5604 | 0.1246 | 2 | 9 | interleukin-1 receptor binding |
| GO:0008528 | 0.0086 | 4.2283 | 1.2601 | 5 | 91 | G-protein coupled peptide receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003779 | 7e-04 | 2.4459 | 8.3149 | 19 | 313 | actin binding |
| GO:0004126 | 0.0021 | 73.698 | 0.0797 | 2 | 3 | cytidine deaminase activity |
| GO:0005094 | 0.0021 | 73.698 | 0.0797 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0008453 | 0.0021 | 73.698 | 0.0797 | 2 | 3 | alanine-glyoxylate transaminase activity |
| GO:0045182 | 0.0035 | 5.4517 | 1.036 | 5 | 39 | translation regulator activity |
| GO:0005249 | 0.004 | 3.7724 | 2.019 | 7 | 76 | voltage-gated potassium channel activity |
| GO:0099106 | 0.004 | 3.7724 | 2.019 | 7 | 76 | ion channel regulator activity |
| GO:0003839 | 0.0041 | 36.8462 | 0.1063 | 2 | 4 | gamma-glutamylcyclotransferase activity |
| GO:0043565 | 0.0061 | 1.6218 | 24.1213 | 37 | 908 | sequence-specific DNA binding |
| GO:0048027 | 0.0096 | 7.9108 | 0.4516 | 3 | 17 | mRNA 5'-UTR binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000248 | 5e-04 | Inf | 0.0441 | 2 | 2 | C-5 sterol desaturase activity |
| GO:0005094 | 0.0014 | 89.3058 | 0.0661 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0030246 | 0.0022 | 2.9604 | 3.969 | 11 | 180 | carbohydrate binding |
| GO:0022803 | 0.0024 | 2.2995 | 7.8498 | 17 | 356 | passive transmembrane transporter activity |
| GO:0042923 | 0.0026 | 13.4328 | 0.2866 | 3 | 13 | neuropeptide binding |
| GO:0005436 | 0.0046 | 29.764 | 0.1102 | 2 | 5 | sodium:phosphate symporter activity |
| GO:0005534 | 0.0046 | 29.764 | 0.1102 | 2 | 5 | galactose binding |
| GO:0015321 | 0.0046 | 29.764 | 0.1102 | 2 | 5 | sodium-dependent phosphate transmembrane transporter activity |
| GO:0004364 | 0.0048 | 10.3305 | 0.3528 | 3 | 16 | glutathione transferase activity |
| GO:0030346 | 0.0069 | 22.3213 | 0.1323 | 2 | 6 | protein phosphatase 2B binding |
| GO:0022838 | 0.0069 | 2.1579 | 7.3206 | 15 | 332 | substrate-specific channel activity |
| GO:0015276 | 0.0073 | 3.3235 | 2.2491 | 7 | 102 | ligand-gated ion channel activity |
| GO:0035591 | 0.0077 | 4.4063 | 1.2348 | 5 | 56 | signaling adaptor activity |
| GO:0008009 | 0.0079 | 8.3916 | 0.4189 | 3 | 19 | chemokine activity |
| GO:0030552 | 0.0079 | 8.3916 | 0.4189 | 3 | 19 | cAMP binding |
| GO:0005092 | 0.0093 | 17.9779 | 0.1533 | 2 | 7 | GDP-dissociation inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004888 | 0 | 2.2671 | 17.8329 | 37 | 637 | transmembrane signaling receptor activity |
| GO:0004872 | 0 | 2.0195 | 24.3278 | 45 | 869 | receptor activity |
| GO:0004871 | 1e-04 | 1.935 | 27.6592 | 49 | 988 | signal transducer activity |
| GO:0005088 | 4e-04 | 2.8146 | 6.1309 | 16 | 219 | Ras guanyl-nucleotide exchange factor activity |
| GO:0043565 | 5e-04 | 1.8209 | 25.4196 | 43 | 908 | sequence-specific DNA binding |
| GO:0008528 | 0.001 | 3.8805 | 2.5476 | 9 | 91 | G-protein coupled peptide receptor activity |
| GO:0005044 | 0.0016 | 6.7543 | 0.8679 | 5 | 31 | scavenger receptor activity |
| GO:0005509 | 0.0025 | 1.9219 | 14.3335 | 26 | 512 | calcium ion binding |
| GO:0031267 | 0.0026 | 1.9741 | 12.8778 | 24 | 460 | small GTPase binding |
| GO:0001106 | 0.0041 | 7.0087 | 0.6719 | 4 | 24 | RNA polymerase II transcription corepressor activity |
| GO:0005237 | 0.0045 | 34.9027 | 0.112 | 2 | 4 | inhibitory extracellular ligand-gated ion channel activity |
| GO:0050544 | 0.0045 | 34.9027 | 0.112 | 2 | 4 | arachidonic acid binding |
| GO:0099104 | 0.0045 | 34.9027 | 0.112 | 2 | 4 | potassium channel activator activity |
| GO:0042923 | 0.0051 | 10.4927 | 0.3639 | 3 | 13 | neuropeptide binding |
| GO:0001228 | 0.0051 | 2.0276 | 9.8823 | 19 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0008083 | 0.0059 | 2.9131 | 3.3034 | 9 | 118 | growth factor activity |
| GO:0030676 | 0.0063 | 9.5381 | 0.3919 | 3 | 14 | Rac guanyl-nucleotide exchange factor activity |
| GO:0003700 | 0.0065 | 1.5513 | 30.0108 | 44 | 1072 | DNA binding transcription factor activity |
| GO:0008443 | 0.0074 | 23.2667 | 0.14 | 2 | 5 | phosphofructokinase activity |
| GO:0000983 | 0.0093 | 8.0694 | 0.4479 | 3 | 16 | transcription factor activity, RNA polymerase II core promoter sequence-specific |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099600 | 0 | 2.0563 | 24.8841 | 47 | 668 | transmembrane receptor activity |
| GO:0043565 | 0 | 1.8648 | 33.8245 | 58 | 908 | sequence-specific DNA binding |
| GO:0038023 | 1e-04 | 1.9369 | 26.8212 | 48 | 720 | signaling receptor activity |
| GO:0000981 | 2e-04 | 1.9026 | 24.8841 | 44 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0001012 | 3e-04 | 1.978 | 20.0786 | 37 | 539 | RNA polymerase II regulatory region DNA binding |
| GO:0004930 | 4e-04 | 2.2323 | 12.5166 | 26 | 336 | G-protein coupled receptor activity |
| GO:0060089 | 4e-04 | 1.714 | 33.7873 | 54 | 907 | molecular transducer activity |
| GO:0030020 | 5e-04 | 38.997 | 0.1863 | 3 | 5 | extracellular matrix structural constituent conferring tensile strength |
| GO:0000976 | 7e-04 | 1.8307 | 22.7235 | 39 | 610 | transcription regulatory region sequence-specific DNA binding |
| GO:0140110 | 7e-04 | 1.5526 | 51.221 | 74 | 1375 | transcription regulator activity |
| GO:0015079 | 0.0011 | 2.9221 | 4.8427 | 13 | 130 | potassium ion transmembrane transporter activity |
| GO:0022836 | 0.0012 | 2.2797 | 9.3874 | 20 | 252 | gated channel activity |
| GO:0046982 | 0.0016 | 1.9427 | 15.3104 | 28 | 411 | protein heterodimerization activity |
| GO:0000978 | 0.0017 | 2.0862 | 11.7343 | 23 | 315 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0015370 | 0.0019 | 5.22 | 1.3411 | 6 | 36 | solute:sodium symporter activity |
| GO:0005249 | 0.002 | 3.5174 | 2.8311 | 9 | 76 | voltage-gated potassium channel activity |
| GO:0005244 | 0.0022 | 2.5748 | 5.8485 | 14 | 157 | voltage-gated ion channel activity |
| GO:0001159 | 0.003 | 1.9819 | 12.293 | 23 | 330 | core promoter proximal region DNA binding |
| GO:0033613 | 0.0033 | 3.9749 | 1.9743 | 7 | 53 | activating transcription factor binding |
| GO:0015293 | 0.0038 | 2.9431 | 3.6879 | 10 | 99 | symporter activity |
| GO:0031492 | 0.0038 | 4.4726 | 1.5273 | 6 | 41 | nucleosomal DNA binding |
| GO:0033300 | 0.0041 | 51.8945 | 0.1118 | 2 | 3 | dehydroascorbic acid transporter activity |
| GO:0097108 | 0.0041 | 51.8945 | 0.1118 | 2 | 3 | hedgehog family protein binding |
| GO:0001664 | 0.0048 | 2.2663 | 7.0406 | 15 | 189 | G-protein coupled receptor binding |
| GO:0000975 | 0.0049 | 1.5921 | 27.7897 | 42 | 746 | regulatory region DNA binding |
| GO:0051427 | 0.0057 | 2.4778 | 5.178 | 12 | 139 | hormone receptor binding |
| GO:0001047 | 0.0061 | 2.4583 | 5.2152 | 12 | 140 | core promoter binding |
| GO:0003690 | 0.0065 | 1.5807 | 26.5977 | 40 | 714 | double-stranded DNA binding |
| GO:0022838 | 0.0066 | 1.8729 | 12.3675 | 22 | 332 | substrate-specific channel activity |
| GO:0004890 | 0.0068 | 9.7447 | 0.4098 | 3 | 11 | GABA-A receptor activity |
| GO:0008324 | 0.0068 | 1.6953 | 18.5886 | 30 | 499 | cation transmembrane transporter activity |
| GO:0035258 | 0.009 | 2.9435 | 2.9429 | 8 | 79 | steroid hormone receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 8.9341 | 0.9103 | 7 | 54 | olfactory receptor activity |
| GO:0005223 | 3e-04 | Inf | 0.0337 | 2 | 2 | intracellular cGMP activated cation channel activity |
| GO:0022803 | 4e-04 | 2.8787 | 6.0012 | 16 | 356 | passive transmembrane transporter activity |
| GO:0005216 | 4e-04 | 2.9334 | 5.5123 | 15 | 327 | ion channel activity |
| GO:0099600 | 9e-04 | 2.2032 | 11.2607 | 23 | 668 | transmembrane receptor activity |
| GO:0004082 | 0.0017 | 58.8378 | 0.0674 | 2 | 4 | bisphosphoglycerate mutase activity |
| GO:0046538 | 0.0017 | 58.8378 | 0.0674 | 2 | 4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:0004930 | 0.0017 | 2.6381 | 5.6641 | 14 | 336 | G-protein coupled receptor activity |
| GO:0046873 | 0.002 | 2.5886 | 5.7652 | 14 | 342 | metal ion transmembrane transporter activity |
| GO:0060089 | 0.0028 | 1.8976 | 15.2896 | 27 | 907 | molecular transducer activity |
| GO:0022836 | 0.0037 | 2.7478 | 4.248 | 11 | 252 | gated channel activity |
| GO:0005262 | 0.0051 | 4.0584 | 1.5846 | 6 | 94 | calcium channel activity |
| GO:0008035 | 0.0056 | 23.5297 | 0.118 | 2 | 7 | high-density lipoprotein particle binding |
| GO:0043855 | 0.0056 | 23.5297 | 0.118 | 2 | 7 | cyclic nucleotide-gated ion channel activity |
| GO:0044183 | 0.0083 | 8.0473 | 0.4214 | 3 | 25 | protein binding involved in protein folding |
| GO:0022891 | 0.0086 | 1.8609 | 11.9518 | 21 | 709 | substrate-specific transmembrane transporter activity |
| GO:0072509 | 0.0099 | 3.1127 | 2.3769 | 7 | 141 | divalent inorganic cation transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030883 | 8e-04 | Inf | 0.0575 | 2 | 2 | endogenous lipid antigen binding |
| GO:0030884 | 8e-04 | Inf | 0.0575 | 2 | 2 | exogenous lipid antigen binding |
| GO:0004303 | 0.0017 | 17.0185 | 0.2587 | 3 | 9 | estradiol 17-beta-dehydrogenase activity |
| GO:1903231 | 0.0019 | 3.8668 | 2.2711 | 8 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0003823 | 0.002 | 6.3263 | 0.9199 | 5 | 32 | antigen binding |
| GO:0004464 | 0.0024 | 67.9211 | 0.0862 | 2 | 3 | leukotriene-C4 synthase activity |
| GO:0005509 | 0.0036 | 1.8664 | 14.7188 | 26 | 512 | calcium ion binding |
| GO:0004095 | 0.0048 | 33.9579 | 0.115 | 2 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0071723 | 0.0048 | 33.9579 | 0.115 | 2 | 4 | lipopeptide binding |
| GO:0016493 | 0.0078 | 22.6368 | 0.1437 | 2 | 5 | C-C chemokine receptor activity |
| GO:0035473 | 0.0078 | 22.6368 | 0.1437 | 2 | 5 | lipase binding |
| GO:0004364 | 0.01 | 7.8504 | 0.46 | 3 | 16 | glutathione transferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 0 | 2.1126 | 26.6167 | 51 | 869 | receptor activity |
| GO:0004930 | 1e-04 | 2.5244 | 10.2914 | 24 | 336 | G-protein coupled receptor activity |
| GO:0004871 | 2e-04 | 1.8261 | 30.2616 | 51 | 988 | signal transducer activity |
| GO:0005328 | 7e-04 | 12.7752 | 0.4288 | 4 | 14 | neurotransmitter:sodium symporter activity |
| GO:0030215 | 9e-04 | 23.9053 | 0.2144 | 3 | 7 | semaphorin receptor binding |
| GO:0005132 | 9e-04 | Inf | 0.0613 | 2 | 2 | type I interferon receptor binding |
| GO:0005179 | 0.0022 | 3.778 | 2.3278 | 8 | 76 | hormone activity |
| GO:0005509 | 0.0022 | 1.8923 | 15.6821 | 28 | 512 | calcium ion binding |
| GO:0019828 | 0.0028 | 63.6049 | 0.0919 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
| GO:0015291 | 0.0036 | 2.6317 | 4.87 | 12 | 159 | secondary active transmembrane transporter activity |
| GO:0017171 | 0.0041 | 2.7246 | 4.3187 | 11 | 141 | serine hydrolase activity |
| GO:0015301 | 0.0041 | 7.0929 | 0.6738 | 4 | 22 | anion:anion antiporter activity |
| GO:0004977 | 0.0054 | 31.8 | 0.1225 | 2 | 4 | melanocortin receptor activity |
| GO:0005329 | 0.0054 | 31.8 | 0.1225 | 2 | 4 | dopamine transmembrane transporter activity |
| GO:0015081 | 0.0055 | 2.9496 | 3.2773 | 9 | 107 | sodium ion transmembrane transporter activity |
| GO:0022890 | 0.0055 | 1.8737 | 12.9255 | 23 | 422 | inorganic cation transmembrane transporter activity |
| GO:0005216 | 0.0058 | 1.999 | 10.0157 | 19 | 327 | ion channel activity |
| GO:0022891 | 0.0064 | 1.6483 | 21.7161 | 34 | 709 | substrate-specific transmembrane transporter activity |
| GO:0000900 | 0.0065 | 9.5577 | 0.3982 | 3 | 13 | translation repressor activity, nucleic acid binding |
| GO:0005217 | 0.0066 | 6.0782 | 0.7657 | 4 | 25 | intracellular ligand-gated ion channel activity |
| GO:0015267 | 0.0066 | 1.9354 | 10.8733 | 20 | 355 | channel activity |
| GO:0001653 | 0.0072 | 3.0545 | 2.8179 | 8 | 92 | peptide receptor activity |
| GO:0004888 | 0.0083 | 2.0092 | 8.9008 | 17 | 301 | transmembrane signaling receptor activity |
| GO:0004957 | 0.0088 | 21.1984 | 0.1531 | 2 | 5 | prostaglandin E receptor activity |
| GO:0005000 | 0.0088 | 21.1984 | 0.1531 | 2 | 5 | vasopressin receptor activity |
| GO:0004252 | 0.0098 | 2.6744 | 3.5836 | 9 | 117 | serine-type endopeptidase activity |
| GO:0071837 | 0.0099 | 7.9635 | 0.4594 | 3 | 15 | HMG box domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | Inf | 0.0693 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0693 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0005216 | 1e-04 | 2.8769 | 7.5549 | 20 | 327 | ion channel activity |
| GO:0022803 | 2e-04 | 2.6226 | 8.2249 | 20 | 356 | passive transmembrane transporter activity |
| GO:0005132 | 5e-04 | Inf | 0.0462 | 2 | 2 | type I interferon receptor binding |
| GO:0035240 | 6e-04 | 25.6105 | 0.1848 | 3 | 8 | dopamine binding |
| GO:0005267 | 8e-04 | 4.0115 | 2.449 | 9 | 106 | potassium channel activity |
| GO:0005111 | 0.0016 | 85.1148 | 0.0693 | 2 | 3 | type 2 fibroblast growth factor receptor binding |
| GO:0022836 | 0.0022 | 2.5583 | 5.8221 | 14 | 252 | gated channel activity |
| GO:0008144 | 0.0025 | 4.1258 | 1.8483 | 7 | 80 | drug binding |
| GO:0099104 | 0.0031 | 42.5541 | 0.0924 | 2 | 4 | potassium channel activator activity |
| GO:0005159 | 0.0037 | 11.6358 | 0.3234 | 3 | 14 | insulin-like growth factor receptor binding |
| GO:0022890 | 0.0044 | 2.0591 | 9.7497 | 19 | 422 | inorganic cation transmembrane transporter activity |
| GO:0042834 | 0.0051 | 28.3672 | 0.1155 | 2 | 5 | peptidoglycan binding |
| GO:0048018 | 0.0062 | 2.258 | 6.5383 | 14 | 283 | receptor ligand activity |
| GO:0004970 | 0.0065 | 9.1403 | 0.3928 | 3 | 17 | ionotropic glutamate receptor activity |
| GO:0005234 | 0.0065 | 9.1403 | 0.3928 | 3 | 17 | extracellularly glutamate-gated ion channel activity |
| GO:0044325 | 0.0068 | 3.3799 | 2.2179 | 7 | 96 | ion channel binding |
| GO:0005230 | 0.008 | 4.3695 | 1.2476 | 5 | 54 | extracellular ligand-gated ion channel activity |
| GO:0022835 | 0.0092 | 5.342 | 0.8317 | 4 | 36 | transmitter-gated channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 2e-04 | 2.0285 | 18.5334 | 35 | 512 | calcium ion binding |
| GO:0004063 | 0.0013 | Inf | 0.0724 | 2 | 2 | aryldialkylphosphatase activity |
| GO:0005249 | 0.0016 | 3.6257 | 2.7511 | 9 | 76 | voltage-gated potassium channel activity |
| GO:0000981 | 0.0022 | 1.7083 | 24.1803 | 39 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0140110 | 0.0031 | 1.4748 | 49.7724 | 69 | 1375 | transcription regulator activity |
| GO:0048018 | 0.0034 | 2.0692 | 10.2441 | 20 | 283 | receptor ligand activity |
| GO:0102007 | 0.0038 | 53.4697 | 0.1086 | 2 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
| GO:0046982 | 0.0042 | 1.8437 | 14.8774 | 26 | 411 | protein heterodimerization activity |
| GO:0003677 | 0.0053 | 1.3623 | 77.6811 | 99 | 2146 | DNA binding |
| GO:0015370 | 0.0091 | 4.3291 | 1.3031 | 5 | 36 | solute:sodium symporter activity |
| GO:0015293 | 0.0096 | 2.6943 | 3.5836 | 9 | 99 | symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 2e-04 | 6.5099 | 1.2313 | 7 | 54 | olfactory receptor activity |
| GO:0005132 | 5e-04 | Inf | 0.0456 | 2 | 2 | type I interferon receptor binding |
| GO:0043199 | 0.0015 | 86.2724 | 0.0684 | 2 | 3 | sulfate binding |
| GO:0004930 | 0.0018 | 2.3601 | 7.6616 | 17 | 336 | G-protein coupled receptor activity |
| GO:0099600 | 0.0055 | 1.8046 | 15.2321 | 26 | 668 | transmembrane receptor activity |
| GO:0005509 | 0.0069 | 1.8949 | 11.6749 | 21 | 512 | calcium ion binding |
| GO:0005216 | 0.0082 | 2.1156 | 7.4564 | 15 | 327 | ion channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016165 | 8e-04 | Inf | 0.0576 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0005338 | 0.0012 | 20.3684 | 0.2306 | 3 | 8 | nucleotide-sugar transmembrane transporter activity |
| GO:0005509 | 0.0019 | 1.9422 | 14.7574 | 27 | 512 | calcium ion binding |
| GO:0042287 | 0.0039 | 7.1579 | 0.6629 | 4 | 23 | MHC protein binding |
| GO:0001733 | 0.0048 | 33.8661 | 0.1153 | 2 | 4 | galactosylceramide sulfotransferase activity |
| GO:0015440 | 0.0048 | 33.8661 | 0.1153 | 2 | 4 | peptide-transporting ATPase activity |
| GO:0030414 | 0.0057 | 3.1799 | 2.7094 | 8 | 94 | peptidase inhibitor activity |
| GO:0004715 | 0.0076 | 4.4789 | 1.2394 | 5 | 43 | non-membrane spanning protein tyrosine kinase activity |
| GO:0016493 | 0.0078 | 22.5757 | 0.1441 | 2 | 5 | C-C chemokine receptor activity |
| GO:0042043 | 0.0078 | 22.5757 | 0.1441 | 2 | 5 | neurexin family protein binding |
| GO:1904315 | 0.0084 | 8.4822 | 0.4323 | 3 | 15 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
| GO:0004725 | 0.0087 | 3.228 | 2.3347 | 7 | 81 | protein tyrosine phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001161 | 0.0014 | 17.6367 | 0.2393 | 3 | 10 | intronic transcription regulatory region sequence-specific DNA binding |
| GO:0048030 | 0.0017 | 82.0823 | 0.0718 | 2 | 3 | disaccharide binding |
| GO:0005416 | 0.0025 | 13.7153 | 0.2872 | 3 | 12 | cation:amino acid symporter activity |
| GO:0010181 | 0.0032 | 12.3429 | 0.3111 | 3 | 13 | FMN binding |
| GO:0050660 | 0.0033 | 4.5157 | 1.4598 | 6 | 61 | flavin adenine dinucleotide binding |
| GO:0031014 | 0.0033 | 41.038 | 0.0957 | 2 | 4 | troponin T binding |
| GO:0034597 | 0.0033 | 41.038 | 0.0957 | 2 | 4 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity |
| GO:0015081 | 0.0041 | 3.3551 | 2.5607 | 8 | 107 | sodium ion transmembrane transporter activity |
| GO:0001602 | 0.0054 | 27.3565 | 0.1197 | 2 | 5 | pancreatic polypeptide receptor activity |
| GO:0003958 | 0.0054 | 27.3565 | 0.1197 | 2 | 5 | NADPH-hemoprotein reductase activity |
| GO:0005534 | 0.0054 | 27.3565 | 0.1197 | 2 | 5 | galactose binding |
| GO:0042834 | 0.0054 | 27.3565 | 0.1197 | 2 | 5 | peptidoglycan binding |
| GO:0005343 | 0.0072 | 8.8136 | 0.4068 | 3 | 17 | organic acid:sodium symporter activity |
| GO:0003677 | 0.0079 | 1.4257 | 51.3567 | 68 | 2146 | DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 2.9106 | 14.2565 | 37 | 512 | calcium ion binding |
| GO:0043546 | 2e-04 | 52.7902 | 0.1392 | 3 | 5 | molybdopterin cofactor binding |
| GO:0030276 | 3e-04 | 6.0565 | 1.3365 | 7 | 48 | clathrin binding |
| GO:0030553 | 7e-04 | 26.391 | 0.1949 | 3 | 7 | cGMP binding |
| GO:0001228 | 9e-04 | 2.2811 | 9.8292 | 21 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0005544 | 0.0038 | 5.3487 | 1.0581 | 5 | 38 | calcium-dependent phospholipid binding |
| GO:0001653 | 0.0041 | 3.3765 | 2.5617 | 8 | 92 | peptide receptor activity |
| GO:0043565 | 0.0045 | 1.6337 | 25.283 | 39 | 908 | sequence-specific DNA binding |
| GO:0000975 | 0.0057 | 1.6762 | 20.7721 | 33 | 746 | regulatory region DNA binding |
| GO:0001637 | 0.0062 | 9.5915 | 0.3898 | 3 | 14 | G-protein coupled chemoattractant receptor activity |
| GO:0004888 | 0.0064 | 1.7219 | 17.7371 | 29 | 637 | transmembrane signaling receptor activity |
| GO:0000976 | 0.0066 | 1.7353 | 16.9852 | 28 | 610 | transcription regulatory region sequence-specific DNA binding |
| GO:0016493 | 0.0073 | 23.3967 | 0.1392 | 2 | 5 | C-C chemokine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 13.1299 | 0.7356 | 8 | 54 | olfactory receptor activity |
| GO:0004556 | 0 | Inf | 0.0409 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0409 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0005215 | 1e-04 | 2.3344 | 14.4113 | 30 | 1058 | transporter activity |
| GO:0030246 | 2e-04 | 4.4503 | 2.4518 | 10 | 180 | carbohydrate binding |
| GO:0060089 | 2e-04 | 2.3278 | 12.3545 | 26 | 907 | molecular transducer activity |
| GO:0061134 | 3e-04 | 5.2242 | 1.6754 | 8 | 123 | peptidase regulator activity |
| GO:0005216 | 5e-04 | 3.1527 | 4.4542 | 13 | 327 | ion channel activity |
| GO:0046873 | 8e-04 | 3.0054 | 4.6585 | 13 | 342 | metal ion transmembrane transporter activity |
| GO:0008020 | 0.0011 | 73.2123 | 0.0545 | 2 | 4 | G-protein coupled photoreceptor activity |
| GO:0015267 | 0.0012 | 2.8882 | 4.8356 | 13 | 355 | channel activity |
| GO:0008324 | 0.0013 | 2.5345 | 6.797 | 16 | 499 | cation transmembrane transporter activity |
| GO:0004866 | 0.0014 | 5.3155 | 1.2259 | 6 | 90 | endopeptidase inhibitor activity |
| GO:0042834 | 0.0018 | 48.8045 | 0.0681 | 2 | 5 | peptidoglycan binding |
| GO:0030249 | 0.0027 | 36.6006 | 0.0817 | 2 | 6 | guanylate cyclase regulator activity |
| GO:0038023 | 0.0033 | 2.1354 | 9.5587 | 19 | 709 | signaling receptor activity |
| GO:0022891 | 0.0037 | 2.1106 | 9.6575 | 19 | 709 | substrate-specific transmembrane transporter activity |
| GO:0031404 | 0.0037 | 29.2782 | 0.0953 | 2 | 7 | chloride ion binding |
| GO:0022843 | 0.0037 | 4.3287 | 1.4847 | 6 | 109 | voltage-gated cation channel activity |
| GO:0099600 | 0.0044 | 2.1163 | 9.099 | 18 | 668 | transmembrane receptor activity |
| GO:0004252 | 0.0053 | 4.0142 | 1.5937 | 6 | 117 | serine-type endopeptidase activity |
| GO:0004930 | 0.0054 | 2.6076 | 4.4737 | 11 | 332 | G-protein coupled receptor activity |
| GO:0015103 | 0.007 | 4.4578 | 1.1987 | 5 | 88 | inorganic anion transmembrane transporter activity |
| GO:0016405 | 0.0077 | 18.2947 | 0.1362 | 2 | 10 | CoA-ligase activity |
| GO:0003823 | 0.0092 | 7.6005 | 0.4359 | 3 | 32 | antigen binding |
| GO:0008329 | 0.0094 | 16.2607 | 0.1498 | 2 | 11 | signaling pattern recognition receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 110.0172 | 0.1769 | 4 | 5 | molybdopterin cofactor binding |
| GO:0005509 | 0 | 2.2907 | 18.1096 | 38 | 512 | calcium ion binding |
| GO:0030151 | 2e-04 | 82.3362 | 0.1415 | 3 | 4 | molybdenum ion binding |
| GO:0030020 | 4e-04 | 41.1649 | 0.1769 | 3 | 5 | extracellular matrix structural constituent conferring tensile strength |
| GO:0004063 | 0.0012 | Inf | 0.0707 | 2 | 2 | aryldialkylphosphatase activity |
| GO:0016165 | 0.0012 | Inf | 0.0707 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0004953 | 0.0031 | 13.7173 | 0.3183 | 3 | 9 | icosanoid receptor activity |
| GO:0003846 | 0.0037 | 54.7735 | 0.1061 | 2 | 3 | 2-acylglycerol O-acyltransferase activity |
| GO:0004144 | 0.0037 | 54.7735 | 0.1061 | 2 | 3 | diacylglycerol O-acyltransferase activity |
| GO:0008940 | 0.0037 | 54.7735 | 0.1061 | 2 | 3 | nitrate reductase activity |
| GO:0102007 | 0.0037 | 54.7735 | 0.1061 | 2 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
| GO:0016801 | 0.0044 | 11.7568 | 0.3537 | 3 | 10 | hydrolase activity, acting on ether bonds |
| GO:0005201 | 0.0047 | 4.264 | 1.5821 | 6 | 45 | extracellular matrix structural constituent |
| GO:0000977 | 0.0052 | 1.7147 | 19.0292 | 31 | 538 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0005179 | 0.0053 | 3.2468 | 2.6881 | 8 | 76 | hormone activity |
| GO:0015296 | 0.0065 | 4.7419 | 1.2026 | 5 | 34 | anion:cation symporter activity |
| GO:0001972 | 0.0076 | 9.1428 | 0.4244 | 3 | 12 | retinoic acid binding |
| GO:0031406 | 0.008 | 2.4735 | 4.7396 | 11 | 134 | carboxylic acid binding |
| GO:1990837 | 0.008 | 1.6075 | 22.8492 | 35 | 646 | sequence-specific double-stranded DNA binding |
| GO:0000975 | 0.0093 | 1.5501 | 26.3862 | 39 | 746 | regulatory region DNA binding |
| GO:0001077 | 0.0095 | 2.0275 | 8.312 | 16 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 102.0519 | 0.19 | 4 | 5 | molybdopterin cofactor binding |
| GO:0005201 | 0 | 6.4359 | 1.9002 | 10 | 50 | extracellular matrix structural constituent |
| GO:0030151 | 2e-04 | 76.3865 | 0.152 | 3 | 4 | molybdenum ion binding |
| GO:0016165 | 0.0014 | Inf | 0.076 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0046982 | 0.0021 | 1.9005 | 15.6197 | 28 | 411 | protein heterodimerization activity |
| GO:0008374 | 0.0029 | 4.7912 | 1.4442 | 6 | 38 | O-acyltransferase activity |
| GO:0030414 | 0.003 | 3.0541 | 3.5724 | 10 | 94 | peptidase inhibitor activity |
| GO:0047617 | 0.0033 | 7.8428 | 0.6461 | 4 | 17 | acyl-CoA hydrolase activity |
| GO:0016803 | 0.0039 | 12.7261 | 0.342 | 3 | 9 | ether hydrolase activity |
| GO:0005184 | 0.0041 | 7.282 | 0.6841 | 4 | 18 | neuropeptide hormone activity |
| GO:0008940 | 0.0042 | 50.8231 | 0.114 | 2 | 3 | nitrate reductase activity |
| GO:0070573 | 0.0042 | 50.8231 | 0.114 | 2 | 3 | metallodipeptidase activity |
| GO:0031492 | 0.0042 | 4.3795 | 1.5582 | 6 | 41 | nucleosomal DNA binding |
| GO:0004180 | 0.0043 | 5.3163 | 1.1021 | 5 | 29 | carboxypeptidase activity |
| GO:0005044 | 0.0058 | 4.9065 | 1.1781 | 5 | 31 | scavenger receptor activity |
| GO:0005164 | 0.0061 | 6.3708 | 0.7601 | 4 | 20 | tumor necrosis factor receptor binding |
| GO:0004867 | 0.0075 | 3.8306 | 1.7482 | 6 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0030674 | 0.0085 | 2.4529 | 4.7885 | 11 | 126 | protein binding, bridging |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030395 | 4e-04 | Inf | 0.0405 | 2 | 2 | lactose binding |
| GO:0099600 | 5e-04 | 2.1545 | 13.5229 | 27 | 668 | transmembrane receptor activity |
| GO:0038023 | 7e-04 | 2.0696 | 14.5756 | 28 | 720 | signaling receptor activity |
| GO:1903231 | 0.0011 | 4.8043 | 1.5993 | 7 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0015143 | 0.0012 | 97.5131 | 0.0607 | 2 | 3 | urate transmembrane transporter activity |
| GO:0030247 | 0.0016 | 16.3033 | 0.2429 | 3 | 12 | polysaccharide binding |
| GO:0008528 | 0.0025 | 4.1142 | 1.8422 | 7 | 91 | G-protein coupled peptide receptor activity |
| GO:0004950 | 0.0025 | 13.337 | 0.2834 | 3 | 14 | chemokine receptor activity |
| GO:0060089 | 0.0029 | 1.8055 | 18.3612 | 31 | 907 | molecular transducer activity |
| GO:0004930 | 0.0036 | 2.6167 | 4.864 | 12 | 245 | G-protein coupled receptor activity |
| GO:0004966 | 0.0039 | 32.4994 | 0.1012 | 2 | 5 | galanin receptor activity |
| GO:0019864 | 0.0039 | 32.4994 | 0.1012 | 2 | 5 | IgG binding |
| GO:0008483 | 0.0063 | 9.1656 | 0.3846 | 3 | 19 | transaminase activity |
| GO:0030246 | 0.0068 | 2.8304 | 3.3661 | 9 | 168 | carbohydrate binding |
| GO:0008307 | 0.0071 | 5.7647 | 0.7693 | 4 | 38 | structural constituent of muscle |
| GO:0004955 | 0.008 | 19.4966 | 0.1417 | 2 | 7 | prostaglandin receptor activity |
| GO:0050840 | 0.0085 | 5.4436 | 0.8098 | 4 | 40 | extracellular matrix binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000248 | 5e-04 | Inf | 0.0441 | 2 | 2 | C-5 sterol desaturase activity |
| GO:0005094 | 0.0014 | 89.3058 | 0.0661 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0030246 | 0.0022 | 2.9604 | 3.969 | 11 | 180 | carbohydrate binding |
| GO:0022803 | 0.0024 | 2.2995 | 7.8498 | 17 | 356 | passive transmembrane transporter activity |
| GO:0042923 | 0.0026 | 13.4328 | 0.2866 | 3 | 13 | neuropeptide binding |
| GO:0005436 | 0.0046 | 29.764 | 0.1102 | 2 | 5 | sodium:phosphate symporter activity |
| GO:0005534 | 0.0046 | 29.764 | 0.1102 | 2 | 5 | galactose binding |
| GO:0015321 | 0.0046 | 29.764 | 0.1102 | 2 | 5 | sodium-dependent phosphate transmembrane transporter activity |
| GO:0004364 | 0.0048 | 10.3305 | 0.3528 | 3 | 16 | glutathione transferase activity |
| GO:0030346 | 0.0069 | 22.3213 | 0.1323 | 2 | 6 | protein phosphatase 2B binding |
| GO:0022838 | 0.0069 | 2.1579 | 7.3206 | 15 | 332 | substrate-specific channel activity |
| GO:0015276 | 0.0073 | 3.3235 | 2.2491 | 7 | 102 | ligand-gated ion channel activity |
| GO:0035591 | 0.0077 | 4.4063 | 1.2348 | 5 | 56 | signaling adaptor activity |
| GO:0008009 | 0.0079 | 8.3916 | 0.4189 | 3 | 19 | chemokine activity |
| GO:0030552 | 0.0079 | 8.3916 | 0.4189 | 3 | 19 | cAMP binding |
| GO:0005092 | 0.0093 | 17.9779 | 0.1533 | 2 | 7 | GDP-dissociation inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 40.6249 | 0.6705 | 17 | 54 | olfactory receptor activity |
| GO:0036459 | 0 | 15.3388 | 1.2417 | 15 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0004930 | 0 | 6.6289 | 4.1722 | 23 | 336 | G-protein coupled receptor activity |
| GO:0008234 | 0 | 9.8868 | 1.9495 | 16 | 157 | cysteine-type peptidase activity |
| GO:0099600 | 0 | 3.8099 | 8.2947 | 27 | 668 | transmembrane receptor activity |
| GO:0008233 | 0 | 4.2931 | 5.9106 | 22 | 476 | peptidase activity |
| GO:0038023 | 0 | 3.6189 | 8.7043 | 27 | 709 | signaling receptor activity |
| GO:0060089 | 0 | 3.103 | 11.2624 | 30 | 907 | molecular transducer activity |
| GO:0004556 | 0 | Inf | 0.0373 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0373 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0017137 | 2e-04 | 4.9232 | 1.9992 | 9 | 161 | Rab GTPase binding |
| GO:0061134 | 9e-04 | 4.9678 | 1.5273 | 7 | 123 | peptidase regulator activity |
| GO:0004866 | 9e-04 | 5.8576 | 1.1175 | 6 | 90 | endopeptidase inhibitor activity |
| GO:0032190 | 9e-04 | 80.4969 | 0.0497 | 2 | 4 | acrosin binding |
| GO:0005539 | 0.0018 | 4.3271 | 1.7384 | 7 | 140 | glycosaminoglycan binding |
| GO:0005096 | 0.0021 | 3.4312 | 2.8063 | 9 | 226 | GTPase activator activity |
| GO:0004875 | 0.0022 | 40.2423 | 0.0745 | 2 | 6 | complement receptor activity |
| GO:0005198 | 0.0028 | 2.4188 | 6.6556 | 15 | 536 | structural molecule activity |
| GO:0031404 | 0.0031 | 32.1914 | 0.0869 | 2 | 7 | chloride ion binding |
| GO:0020037 | 0.0033 | 5.3647 | 1.0058 | 5 | 81 | heme binding |
| GO:0004497 | 0.0039 | 6.7676 | 0.6457 | 4 | 52 | monooxygenase activity |
| GO:0015103 | 0.0048 | 4.9096 | 1.0927 | 5 | 88 | inorganic anion transmembrane transporter activity |
| GO:0030246 | 0.0072 | 3.3164 | 2.2351 | 7 | 180 | carbohydrate binding |
| GO:0008329 | 0.0078 | 17.8787 | 0.1366 | 2 | 11 | signaling pattern recognition receptor activity |
| GO:0005549 | 0.0093 | 16.0896 | 0.149 | 2 | 12 | odorant binding |
| GO:0015347 | 0.0093 | 16.0896 | 0.149 | 2 | 12 | sodium-independent organic anion transmembrane transporter activity |
| GO:0060589 | 0.0095 | 2.6755 | 3.5513 | 9 | 286 | nucleoside-triphosphatase regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 117.8624 | 0.1656 | 4 | 5 | molybdopterin cofactor binding |
| GO:0005201 | 0 | 6.5227 | 1.6556 | 9 | 50 | extracellular matrix structural constituent |
| GO:0030151 | 1e-04 | 88.1945 | 0.1325 | 3 | 4 | molybdenum ion binding |
| GO:0016165 | 0.0011 | Inf | 0.0662 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0047844 | 0.0011 | Inf | 0.0662 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0004126 | 0.0032 | 58.6621 | 0.0993 | 2 | 3 | cytidine deaminase activity |
| GO:0005094 | 0.0032 | 58.6621 | 0.0993 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0008940 | 0.0032 | 58.6621 | 0.0993 | 2 | 3 | nitrate reductase activity |
| GO:0005044 | 0.0032 | 5.6684 | 1.0265 | 5 | 31 | scavenger receptor activity |
| GO:0016801 | 0.0036 | 12.5933 | 0.3311 | 3 | 10 | hydrolase activity, acting on ether bonds |
| GO:0005164 | 0.0038 | 7.3578 | 0.6623 | 4 | 20 | tumor necrosis factor receptor binding |
| GO:0038023 | 0.0053 | 1.6353 | 23.8411 | 37 | 720 | signaling receptor activity |
| GO:0001733 | 0.0063 | 29.3288 | 0.1325 | 2 | 4 | galactosylceramide sulfotransferase activity |
| GO:0005088 | 0.0063 | 2.1875 | 7.2517 | 15 | 219 | Ras guanyl-nucleotide exchange factor activity |
| GO:0005509 | 0.0065 | 1.7361 | 16.9536 | 28 | 512 | calcium ion binding |
| GO:0005544 | 0.0079 | 4.4636 | 1.2583 | 5 | 38 | calcium-dependent phospholipid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038023 | 0 | 2.7599 | 13.4377 | 33 | 720 | signaling receptor activity |
| GO:0099600 | 0 | 2.7816 | 12.4672 | 31 | 668 | transmembrane receptor activity |
| GO:0060089 | 0 | 2.3725 | 16.9278 | 36 | 907 | molecular transducer activity |
| GO:0004930 | 5e-04 | 3.1696 | 4.4184 | 13 | 245 | G-protein coupled receptor activity |
| GO:0008528 | 5e-04 | 5.445 | 1.4212 | 7 | 77 | G-protein coupled peptide receptor activity |
| GO:0005501 | 6e-04 | 12.5583 | 0.3919 | 4 | 21 | retinoid binding |
| GO:0015143 | 0.001 | 106.0081 | 0.056 | 2 | 3 | urate transmembrane transporter activity |
| GO:0001637 | 0.002 | 14.5035 | 0.2613 | 3 | 14 | G-protein coupled chemoattractant receptor activity |
| GO:0004994 | 0.002 | 53 | 0.0747 | 2 | 4 | somatostatin receptor activity |
| GO:0030246 | 0.002 | 3.1809 | 3.3594 | 10 | 180 | carbohydrate binding |
| GO:0004896 | 0.003 | 5.5693 | 0.9892 | 5 | 53 | cytokine receptor activity |
| GO:0004966 | 0.0033 | 35.3306 | 0.0933 | 2 | 5 | galanin receptor activity |
| GO:0016493 | 0.0033 | 35.3306 | 0.0933 | 2 | 5 | C-C chemokine receptor activity |
| GO:0019842 | 0.0037 | 3.7968 | 1.9783 | 7 | 106 | vitamin binding |
| GO:0004955 | 0.0068 | 21.1951 | 0.1306 | 2 | 7 | prostaglandin receptor activity |
| GO:0016491 | 0.0075 | 1.9507 | 10.2836 | 19 | 551 | oxidoreductase activity |
| GO:0016832 | 0.009 | 17.6612 | 0.1493 | 2 | 8 | aldehyde-lyase activity |
| GO:0030170 | 0.0097 | 5.1975 | 0.8399 | 4 | 45 | pyridoxal phosphate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004888 | 5e-04 | 2.0921 | 14.9087 | 29 | 637 | transmembrane signaling receptor activity |
| GO:1903231 | 5e-04 | 4.7993 | 1.849 | 8 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0030395 | 5e-04 | Inf | 0.0468 | 2 | 2 | lactose binding |
| GO:0004872 | 0.0012 | 1.8464 | 20.3386 | 35 | 869 | receptor activity |
| GO:0008528 | 0.0013 | 4.1016 | 2.1298 | 8 | 91 | G-protein coupled peptide receptor activity |
| GO:0015143 | 0.0016 | 83.9871 | 0.0702 | 2 | 3 | urate transmembrane transporter activity |
| GO:0005452 | 0.0031 | 12.6302 | 0.3043 | 3 | 13 | inorganic anion exchanger activity |
| GO:0004950 | 0.0038 | 11.4811 | 0.3277 | 3 | 14 | chemokine receptor activity |
| GO:0030170 | 0.0039 | 5.2847 | 1.0532 | 5 | 45 | pyridoxal phosphate binding |
| GO:0004966 | 0.0052 | 27.9914 | 0.117 | 2 | 5 | galanin receptor activity |
| GO:0016661 | 0.0052 | 27.9914 | 0.117 | 2 | 5 | oxidoreductase activity, acting on other nitrogenous compounds as donors |
| GO:0050308 | 0.0077 | 20.9919 | 0.1404 | 2 | 6 | sugar-phosphatase activity |
| GO:0004871 | 0.0091 | 1.6 | 23.1237 | 35 | 988 | signal transducer activity |
| GO:0008483 | 0.0093 | 7.8902 | 0.4447 | 3 | 19 | transaminase activity |
| GO:0030246 | 0.0099 | 2.5028 | 4.2128 | 10 | 180 | carbohydrate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003823 | 1e-04 | 12.8723 | 0.4648 | 5 | 32 | antigen binding |
| GO:0004984 | 1e-04 | 8.7213 | 0.7843 | 6 | 54 | olfactory receptor activity |
| GO:0030883 | 2e-04 | Inf | 0.029 | 2 | 2 | endogenous lipid antigen binding |
| GO:0030884 | 2e-04 | Inf | 0.029 | 2 | 2 | exogenous lipid antigen binding |
| GO:0005159 | 0.001 | 18.7809 | 0.2033 | 3 | 14 | insulin-like growth factor receptor binding |
| GO:0004035 | 0.0012 | 68.5497 | 0.0581 | 2 | 4 | alkaline phosphatase activity |
| GO:0071723 | 0.0012 | 68.5497 | 0.0581 | 2 | 4 | lipopeptide binding |
| GO:0008483 | 0.0025 | 12.9069 | 0.276 | 3 | 19 | transaminase activity |
| GO:0030881 | 0.003 | 34.2696 | 0.0871 | 2 | 6 | beta-2-microglobulin binding |
| GO:0004930 | 0.0037 | 2.6133 | 4.8802 | 12 | 336 | G-protein coupled receptor activity |
| GO:0030246 | 0.0048 | 3.249 | 2.6144 | 8 | 180 | carbohydrate binding |
| GO:0005179 | 0.0049 | 4.8786 | 1.1039 | 5 | 76 | hormone activity |
| GO:0038023 | 0.0086 | 1.9306 | 10.4576 | 19 | 720 | signaling receptor activity |
| GO:0050700 | 0.0087 | 17.1296 | 0.1452 | 2 | 10 | CARD domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 15.438 | 0.8209 | 10 | 54 | olfactory receptor activity |
| GO:0060089 | 0 | 2.6269 | 13.7879 | 32 | 907 | molecular transducer activity |
| GO:0099600 | 0 | 2.8634 | 10.1547 | 26 | 668 | transmembrane receptor activity |
| GO:0038023 | 0 | 2.6378 | 10.9452 | 26 | 720 | signaling receptor activity |
| GO:0004930 | 1e-04 | 3.4317 | 5.1078 | 16 | 336 | G-protein coupled receptor activity |
| GO:0010484 | 7e-04 | 130.85 | 0.0456 | 2 | 3 | H3 histone acetyltransferase activity |
| GO:0004866 | 0.0025 | 4.7383 | 1.3682 | 6 | 90 | endopeptidase inhibitor activity |
| GO:0061134 | 0.0027 | 4.0137 | 1.8698 | 7 | 123 | peptidase regulator activity |
| GO:0032395 | 0.0033 | 32.705 | 0.0912 | 2 | 6 | MHC class II receptor activity |
| GO:0102991 | 0.0061 | 21.8 | 0.1216 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004364 | 0.0019 | 9.305 | 0.5575 | 4 | 16 | glutathione transferase activity |
| GO:0046982 | 0.0025 | 1.9224 | 14.3207 | 26 | 411 | protein heterodimerization activity |
| GO:0048407 | 0.003 | 13.9337 | 0.3136 | 3 | 9 | platelet-derived growth factor binding |
| GO:0008235 | 0.0031 | 4.6641 | 1.4634 | 6 | 42 | metalloexopeptidase activity |
| GO:0035939 | 0.0036 | 55.6356 | 0.1045 | 2 | 3 | microsatellite binding |
| GO:0008270 | 0.0041 | 1.6738 | 22.6831 | 36 | 651 | zinc ion binding |
| GO:0004890 | 0.0056 | 10.4486 | 0.3833 | 3 | 11 | GABA-A receptor activity |
| GO:0008401 | 0.0069 | 27.8156 | 0.1394 | 2 | 4 | retinoic acid 4-hydroxylase activity |
| GO:0005509 | 0.007 | 1.7074 | 17.8399 | 29 | 512 | calcium ion binding |
| GO:0001972 | 0.0073 | 9.287 | 0.4181 | 3 | 12 | retinoic acid binding |
| GO:0005452 | 0.0093 | 8.3576 | 0.453 | 3 | 13 | inorganic anion exchanger activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060089 | 0 | 2.3102 | 18.2929 | 38 | 907 | molecular transducer activity |
| GO:0099600 | 0 | 2.4463 | 13.4726 | 30 | 668 | transmembrane receptor activity |
| GO:0005102 | 2e-04 | 1.9709 | 22.8712 | 41 | 1134 | receptor binding |
| GO:0038023 | 3e-04 | 2.165 | 14.5214 | 29 | 720 | signaling receptor activity |
| GO:0005223 | 4e-04 | Inf | 0.0403 | 2 | 2 | intracellular cGMP activated cation channel activity |
| GO:0032394 | 4e-04 | Inf | 0.0403 | 2 | 2 | MHC class Ib receptor activity |
| GO:0005245 | 6e-04 | 8.5165 | 0.6857 | 5 | 34 | voltage-gated calcium channel activity |
| GO:0022836 | 6e-04 | 2.9602 | 5.0825 | 14 | 252 | gated channel activity |
| GO:0022803 | 9e-04 | 2.5335 | 7.18 | 17 | 356 | passive transmembrane transporter activity |
| GO:0051431 | 0.0012 | 97.8872 | 0.0605 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
| GO:0005261 | 0.0015 | 2.7856 | 4.9816 | 13 | 247 | cation channel activity |
| GO:0022838 | 0.0023 | 2.4492 | 6.5093 | 15 | 325 | substrate-specific channel activity |
| GO:0004028 | 0.0024 | 48.9398 | 0.0807 | 2 | 4 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0015168 | 0.0024 | 48.9398 | 0.0807 | 2 | 4 | glycerol transmembrane transporter activity |
| GO:0042288 | 0.0025 | 13.3883 | 0.2824 | 3 | 14 | MHC class I protein binding |
| GO:0030545 | 0.0035 | 2.4195 | 6.1312 | 14 | 304 | receptor regulator activity |
| GO:0004030 | 0.0039 | 32.6241 | 0.1008 | 2 | 5 | aldehyde dehydrogenase [NAD(P)+] activity |
| GO:0016015 | 0.0039 | 32.6241 | 0.1008 | 2 | 5 | morphogen activity |
| GO:0005244 | 0.0046 | 3.0222 | 3.1665 | 9 | 157 | voltage-gated ion channel activity |
| GO:0030297 | 0.0058 | 24.4662 | 0.121 | 2 | 6 | transmembrane receptor protein tyrosine kinase activator activity |
| GO:0015085 | 0.0065 | 3.3967 | 2.1984 | 7 | 109 | calcium ion transmembrane transporter activity |
| GO:1901681 | 0.0079 | 2.758 | 3.4488 | 9 | 171 | sulfur compound binding |
| GO:0004865 | 0.008 | 19.5714 | 0.1412 | 2 | 7 | protein serine/threonine phosphatase inhibitor activity |
| GO:0015250 | 0.008 | 19.5714 | 0.1412 | 2 | 7 | water channel activity |
| GO:0015665 | 0.008 | 19.5714 | 0.1412 | 2 | 7 | alcohol transmembrane transporter activity |
| GO:0043855 | 0.008 | 19.5714 | 0.1412 | 2 | 7 | cyclic nucleotide-gated ion channel activity |
| GO:0004930 | 0.0084 | 2.1736 | 6.7766 | 14 | 336 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | Inf | 0.0641 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0641 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0008329 | 1e-04 | 26.5245 | 0.2351 | 4 | 11 | signaling pattern recognition receptor activity |
| GO:0030911 | 3e-04 | 34.6975 | 0.1496 | 3 | 7 | TPR domain binding |
| GO:0015459 | 0.0012 | 7.0441 | 0.8122 | 5 | 38 | potassium channel regulator activity |
| GO:0016247 | 0.0023 | 3.703 | 2.3296 | 8 | 109 | channel regulator activity |
| GO:0004033 | 0.0073 | 8.6664 | 0.4061 | 3 | 19 | aldo-keto reductase (NADP) activity |
| GO:0016413 | 0.0089 | 18.4383 | 0.1496 | 2 | 7 | O-acetyltransferase activity |
| GO:0015171 | 0.0097 | 4.1436 | 1.3037 | 5 | 61 | amino acid transmembrane transporter activity |
| GO:0032947 | 0.0097 | 4.1436 | 1.3037 | 5 | 61 | protein complex scaffold activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004888 | 0 | 2.973 | 11.7448 | 31 | 637 | transmembrane signaling receptor activity |
| GO:0004872 | 0 | 2.5248 | 16.0224 | 36 | 869 | receptor activity |
| GO:0004871 | 0 | 2.4127 | 18.2164 | 39 | 988 | signal transducer activity |
| GO:0022824 | 5e-04 | 8.7446 | 0.6638 | 5 | 36 | transmitter-gated ion channel activity |
| GO:0022848 | 0.0012 | 17.9532 | 0.2213 | 3 | 12 | acetylcholine-gated cation-selective channel activity |
| GO:0004252 | 0.0014 | 4.0054 | 2.1572 | 8 | 117 | serine-type endopeptidase activity |
| GO:0042166 | 0.0024 | 13.4618 | 0.2766 | 3 | 15 | acetylcholine binding |
| GO:0099529 | 0.0024 | 13.4618 | 0.2766 | 3 | 15 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential |
| GO:0005509 | 0.003 | 2.1401 | 9.4401 | 19 | 512 | calcium ion binding |
| GO:0030594 | 0.0046 | 5.0112 | 1.0878 | 5 | 59 | neurotransmitter receptor activity |
| GO:0017171 | 0.0046 | 3.2765 | 2.5997 | 8 | 141 | serine hydrolase activity |
| GO:0070011 | 0.0048 | 2.1357 | 8.426 | 17 | 457 | peptidase activity, acting on L-amino acid peptides |
| GO:0005544 | 0.0051 | 6.3505 | 0.7006 | 4 | 38 | calcium-dependent phospholipid binding |
| GO:0071813 | 0.0056 | 9.4988 | 0.3688 | 3 | 20 | lipoprotein particle binding |
| GO:0005031 | 0.0064 | 8.9704 | 0.3872 | 3 | 21 | tumor necrosis factor-activated receptor activity |
| GO:0008528 | 0.0067 | 3.8271 | 1.6778 | 6 | 91 | G-protein coupled peptide receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038023 | 0 | 2.486 | 17.4473 | 39 | 720 | signaling receptor activity |
| GO:0099600 | 0 | 2.5379 | 16.1872 | 37 | 668 | transmembrane receptor activity |
| GO:0060089 | 0 | 2.2812 | 21.9788 | 45 | 907 | molecular transducer activity |
| GO:0004930 | 2e-04 | 2.9771 | 5.8108 | 16 | 245 | G-protein coupled receptor activity |
| GO:0032394 | 6e-04 | Inf | 0.0485 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 0.0042 | 11.0758 | 0.3393 | 3 | 14 | MHC class I protein binding |
| GO:0008528 | 0.0047 | 3.6473 | 2.0718 | 7 | 86 | G-protein coupled peptide receptor activity |
| GO:0005000 | 0.0056 | 27.0063 | 0.1212 | 2 | 5 | vasopressin receptor activity |
| GO:0005044 | 0.0064 | 6.028 | 0.7512 | 4 | 31 | scavenger receptor activity |
| GO:0005509 | 0.0068 | 1.8672 | 12.407 | 22 | 512 | calcium ion binding |
| GO:0032395 | 0.0082 | 20.2531 | 0.1454 | 2 | 6 | MHC class II receptor activity |
| GO:0051378 | 0.0082 | 20.2531 | 0.1454 | 2 | 6 | serotonin binding |
| GO:0070679 | 0.0082 | 20.2531 | 0.1454 | 2 | 6 | inositol 1,4,5 trisphosphate binding |
| GO:0005251 | 0.0088 | 8.1197 | 0.4362 | 3 | 18 | delayed rectifier potassium channel activity |
| GO:0005326 | 0.0088 | 8.1197 | 0.4362 | 3 | 18 | neurotransmitter transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0102007 | 0 | Inf | 0.0919 | 3 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
| GO:0004064 | 3e-04 | 47.8181 | 0.1531 | 3 | 5 | arylesterase activity |
| GO:0004063 | 9e-04 | Inf | 0.0613 | 2 | 2 | aryldialkylphosphatase activity |
| GO:0005509 | 0.0011 | 1.9693 | 15.6821 | 29 | 512 | calcium ion binding |
| GO:0043565 | 0.0016 | 1.6859 | 27.8113 | 44 | 908 | sequence-specific DNA binding |
| GO:0042287 | 0.0048 | 6.7191 | 0.7045 | 4 | 23 | MHC protein binding |
| GO:0070008 | 0.0051 | 10.6205 | 0.3675 | 3 | 12 | serine-type exopeptidase activity |
| GO:0001228 | 0.0062 | 1.9474 | 10.8121 | 20 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0005516 | 0.0078 | 2.4744 | 4.7169 | 11 | 154 | calmodulin binding |
| GO:0038023 | 0.008 | 1.6204 | 22.053 | 34 | 720 | signaling receptor activity |
| GO:0031490 | 0.0081 | 2.983 | 2.8791 | 8 | 94 | chromatin DNA binding |
| GO:0015247 | 0.0088 | 21.1984 | 0.1531 | 2 | 5 | aminophospholipid transporter activity |
| GO:0042834 | 0.0088 | 21.1984 | 0.1531 | 2 | 5 | peptidoglycan binding |
| GO:0043546 | 0.0088 | 21.1984 | 0.1531 | 2 | 5 | molybdopterin cofactor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030414 | 0 | 5.3159 | 2.1151 | 10 | 94 | peptidase inhibitor activity |
| GO:0061135 | 1e-04 | 5.1915 | 2.1601 | 10 | 96 | endopeptidase regulator activity |
| GO:0005132 | 5e-04 | Inf | 0.045 | 2 | 2 | type I interferon receptor binding |
| GO:0004867 | 5e-04 | 6.6292 | 1.0351 | 6 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0071855 | 9e-04 | 10.9941 | 0.45 | 4 | 20 | neuropeptide receptor binding |
| GO:0001588 | 0.0015 | 87.4613 | 0.0675 | 2 | 3 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0031708 | 0.0015 | 87.4613 | 0.0675 | 2 | 3 | endothelin B receptor binding |
| GO:1990459 | 0.0071 | 21.8603 | 0.135 | 2 | 6 | transferrin receptor binding |
| GO:0004888 | 0.0094 | 1.762 | 14.3335 | 24 | 637 | transmembrane signaling receptor activity |
| GO:0008198 | 0.0097 | 7.7337 | 0.45 | 3 | 20 | ferrous iron binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031404 | 3e-04 | 33.9564 | 0.1528 | 3 | 7 | chloride ion binding |
| GO:0032403 | 7e-04 | 2.0957 | 13.8365 | 27 | 634 | protein complex binding |
| GO:0099600 | 7e-04 | 2.0636 | 14.5786 | 28 | 668 | transmembrane receptor activity |
| GO:0017137 | 8e-04 | 3.377 | 3.5137 | 11 | 161 | Rab GTPase binding |
| GO:0097153 | 0.0011 | 19.3992 | 0.2182 | 3 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0060089 | 0.0014 | 1.8446 | 19.7946 | 34 | 907 | molecular transducer activity |
| GO:0004871 | 0.0016 | 1.7934 | 21.5623 | 36 | 988 | signal transducer activity |
| GO:0099094 | 0.0025 | 4.7965 | 1.3749 | 6 | 63 | ligand-gated cation channel activity |
| GO:0098639 | 0.0028 | 45.125 | 0.0873 | 2 | 4 | collagen binding involved in cell-matrix adhesion |
| GO:0004930 | 0.0029 | 2.3135 | 7.3329 | 16 | 336 | G-protein coupled receptor activity |
| GO:0015026 | 0.003 | 7.5606 | 0.6111 | 4 | 28 | coreceptor activity |
| GO:0051020 | 0.0041 | 1.962 | 11.8724 | 22 | 544 | GTPase binding |
| GO:0016494 | 0.0045 | 30.081 | 0.1091 | 2 | 5 | C-X-C chemokine receptor activity |
| GO:0004364 | 0.0047 | 10.4409 | 0.3492 | 3 | 16 | glutathione transferase activity |
| GO:0001530 | 0.0056 | 9.6944 | 0.371 | 3 | 17 | lipopolysaccharide binding |
| GO:0005249 | 0.0063 | 3.9018 | 1.6586 | 6 | 76 | voltage-gated potassium channel activity |
| GO:0017075 | 0.0066 | 9.0474 | 0.3928 | 3 | 18 | syntaxin-1 binding |
| GO:0015370 | 0.0076 | 5.667 | 0.7857 | 4 | 36 | solute:sodium symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 2.3521 | 16.7225 | 36 | 512 | calcium ion binding |
| GO:0004063 | 0.0011 | Inf | 0.0653 | 2 | 2 | aryldialkylphosphatase activity |
| GO:0016165 | 0.0011 | Inf | 0.0653 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0001228 | 0.0013 | 2.1238 | 11.5293 | 23 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0004126 | 0.0031 | 59.5046 | 0.098 | 2 | 3 | cytidine deaminase activity |
| GO:0102007 | 0.0031 | 59.5046 | 0.098 | 2 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
| GO:0043565 | 0.0033 | 1.6073 | 29.6562 | 45 | 908 | sequence-specific DNA binding |
| GO:0005089 | 0.0056 | 3.5552 | 2.1556 | 7 | 66 | Rho guanyl-nucleotide exchange factor activity |
| GO:0016520 | 0.0061 | 29.75 | 0.1306 | 2 | 4 | growth hormone-releasing hormone receptor activity |
| GO:0008307 | 0.0075 | 4.5281 | 1.2411 | 5 | 38 | structural constituent of muscle |
| GO:0097493 | 0.0078 | 8.9401 | 0.4246 | 3 | 13 | structural molecule activity conferring elasticity |
| GO:0008201 | 0.0083 | 2.7564 | 3.4947 | 9 | 107 | heparin binding |
| GO:0004064 | 0.01 | 19.8318 | 0.1633 | 2 | 5 | arylesterase activity |
| GO:0009374 | 0.01 | 19.8318 | 0.1633 | 2 | 5 | biotin binding |
| GO:0015247 | 0.01 | 19.8318 | 0.1633 | 2 | 5 | aminophospholipid transporter activity |
| GO:0016493 | 0.01 | 19.8318 | 0.1633 | 2 | 5 | C-C chemokine receptor activity |
| GO:0035473 | 0.01 | 19.8318 | 0.1633 | 2 | 5 | lipase binding |
| GO:0042043 | 0.01 | 19.8318 | 0.1633 | 2 | 5 | neurexin family protein binding |
| GO:0043546 | 0.01 | 19.8318 | 0.1633 | 2 | 5 | molybdopterin cofactor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 16.2398 | 0.6908 | 9 | 54 | olfactory receptor activity |
| GO:0036459 | 0 | 9.0472 | 1.2793 | 10 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0004556 | 0 | Inf | 0.0384 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0384 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0008234 | 0 | 6.1468 | 2.0086 | 11 | 157 | cysteine-type peptidase activity |
| GO:0008233 | 0 | 3.486 | 6.0897 | 19 | 476 | peptidase activity |
| GO:0017137 | 0 | 5.3671 | 2.0598 | 10 | 161 | Rab GTPase binding |
| GO:0004497 | 1e-04 | 10.3966 | 0.6653 | 6 | 52 | monooxygenase activity |
| GO:0020037 | 1e-04 | 7.5699 | 1.0363 | 7 | 81 | heme binding |
| GO:0004517 | 2e-04 | Inf | 0.0256 | 2 | 2 | nitric-oxide synthase activity |
| GO:0051870 | 2e-04 | Inf | 0.0256 | 2 | 2 | methotrexate binding |
| GO:0005506 | 5e-04 | 5.5348 | 1.3817 | 7 | 108 | iron ion binding |
| GO:0004321 | 5e-04 | 156.1548 | 0.0384 | 2 | 3 | fatty-acyl-CoA synthase activity |
| GO:0034617 | 5e-04 | 156.1548 | 0.0384 | 2 | 3 | tetrahydrobiopterin binding |
| GO:0005096 | 7e-04 | 3.7332 | 2.8913 | 10 | 226 | GTPase activator activity |
| GO:0003996 | 0.001 | 78.0714 | 0.0512 | 2 | 4 | acyl-CoA ligase activity |
| GO:0047760 | 0.001 | 78.0714 | 0.0512 | 2 | 4 | butyrate-CoA ligase activity |
| GO:0004930 | 0.001 | 3.1051 | 4.1617 | 12 | 329 | G-protein coupled receptor activity |
| GO:0060089 | 0.0013 | 2.1653 | 11.6037 | 23 | 907 | molecular transducer activity |
| GO:0003958 | 0.0016 | 52.0437 | 0.064 | 2 | 5 | NADPH-hemoprotein reductase activity |
| GO:0034618 | 0.0016 | 52.0437 | 0.064 | 2 | 5 | arginine binding |
| GO:0043177 | 0.0017 | 4.3582 | 1.7271 | 7 | 135 | organic acid binding |
| GO:0016705 | 0.0021 | 4.9111 | 1.3177 | 6 | 103 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0099600 | 0.0023 | 2.2715 | 8.5461 | 18 | 668 | transmembrane receptor activity |
| GO:0004952 | 0.0033 | 31.2214 | 0.0896 | 2 | 7 | dopamine neurotransmitter receptor activity |
| GO:0005542 | 0.0033 | 31.2214 | 0.0896 | 2 | 7 | folic acid binding |
| GO:0060589 | 0.0038 | 2.9081 | 3.6589 | 10 | 286 | nucleoside-triphosphatase regulator activity |
| GO:0038023 | 0.0038 | 2.1565 | 8.9713 | 18 | 709 | signaling receptor activity |
| GO:0061134 | 0.005 | 4.0654 | 1.5736 | 6 | 123 | peptidase regulator activity |
| GO:0004866 | 0.0059 | 4.6463 | 1.1514 | 5 | 90 | endopeptidase inhibitor activity |
| GO:0015267 | 0.006 | 2.569 | 4.5417 | 11 | 355 | channel activity |
| GO:0031267 | 0.0062 | 2.3472 | 5.885 | 13 | 460 | small GTPase binding |
| GO:0004890 | 0.0083 | 17.3399 | 0.1407 | 2 | 11 | GABA-A receptor activity |
| GO:0008329 | 0.0083 | 17.3399 | 0.1407 | 2 | 11 | signaling pattern recognition receptor activity |
| GO:0016877 | 0.0085 | 7.8371 | 0.4222 | 3 | 33 | ligase activity, forming carbon-sulfur bonds |
| GO:0005216 | 0.0094 | 2.5239 | 4.1835 | 10 | 327 | ion channel activity |
| GO:0050661 | 0.01 | 7.3462 | 0.4478 | 3 | 35 | NADP binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 56.2344 | 0.638 | 20 | 54 | olfactory receptor activity |
| GO:0036459 | 0 | 16.2129 | 1.1815 | 15 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0004930 | 0 | 7.0291 | 3.9699 | 23 | 336 | G-protein coupled receptor activity |
| GO:0008234 | 0 | 10.4542 | 1.855 | 16 | 157 | cysteine-type peptidase activity |
| GO:0099600 | 0 | 3.861 | 7.8925 | 26 | 668 | transmembrane receptor activity |
| GO:0038023 | 0 | 3.7277 | 8.5069 | 27 | 720 | signaling receptor activity |
| GO:0008233 | 0 | 4.3018 | 5.624 | 21 | 476 | peptidase activity |
| GO:0004556 | 0 | Inf | 0.0354 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0354 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0060089 | 0 | 3.0254 | 10.7164 | 28 | 907 | molecular transducer activity |
| GO:0017137 | 1e-04 | 5.1925 | 1.9022 | 9 | 161 | Rab GTPase binding |
| GO:0005549 | 3e-04 | 28.4026 | 0.1418 | 3 | 12 | odorant binding |
| GO:0005198 | 6e-04 | 2.752 | 6.3329 | 16 | 536 | structural molecule activity |
| GO:0061134 | 6e-04 | 5.2359 | 1.4533 | 7 | 123 | peptidase regulator activity |
| GO:0004866 | 7e-04 | 6.1717 | 1.0634 | 6 | 90 | endopeptidase inhibitor activity |
| GO:0032190 | 8e-04 | 84.7032 | 0.0473 | 2 | 4 | acrosin binding |
| GO:0005096 | 0.0015 | 3.6189 | 2.6702 | 9 | 226 | GTPase activator activity |
| GO:0004875 | 0.002 | 42.3452 | 0.0709 | 2 | 6 | complement receptor activity |
| GO:0020037 | 0.0027 | 5.6505 | 0.957 | 5 | 81 | heme binding |
| GO:0004497 | 0.0033 | 7.1258 | 0.6144 | 4 | 52 | monooxygenase activity |
| GO:0060589 | 0.0069 | 2.8219 | 3.3791 | 9 | 286 | nucleoside-triphosphatase regulator activity |
| GO:0015347 | 0.0085 | 16.9303 | 0.1418 | 2 | 12 | sodium-independent organic anion transmembrane transporter activity |
| GO:0008201 | 0.0087 | 4.2018 | 1.2642 | 5 | 107 | heparin binding |
| GO:0005506 | 0.0091 | 4.1607 | 1.276 | 5 | 108 | iron ion binding |
| GO:0005452 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | inorganic anion exchanger activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000248 | 7e-04 | Inf | 0.0513 | 2 | 2 | C-5 sterol desaturase activity |
| GO:0030552 | 0.0012 | 10.233 | 0.4876 | 4 | 19 | cAMP binding |
| GO:0004871 | 0.0015 | 1.7318 | 25.3543 | 41 | 988 | signal transducer activity |
| GO:0004126 | 0.0019 | 76.3776 | 0.077 | 2 | 3 | cytidine deaminase activity |
| GO:0005094 | 0.0019 | 76.3776 | 0.077 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0008453 | 0.0019 | 76.3776 | 0.077 | 2 | 3 | alanine-glyoxylate transaminase activity |
| GO:0045182 | 0.003 | 5.6517 | 1.0008 | 5 | 39 | translation regulator activity |
| GO:0030169 | 0.0031 | 12.7594 | 0.3079 | 3 | 12 | low-density lipoprotein particle binding |
| GO:0004872 | 0.0054 | 1.6612 | 22.3005 | 35 | 869 | receptor activity |
| GO:0019871 | 0.0062 | 25.4553 | 0.1283 | 2 | 5 | sodium channel inhibitor activity |
| GO:0004364 | 0.0073 | 8.8307 | 0.4106 | 3 | 16 | glutathione transferase activity |
| GO:0004888 | 0.0073 | 1.7391 | 16.3469 | 27 | 637 | transmembrane signaling receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070848 | 0 | 4.8161 | 3.6613 | 15 | 626 | response to growth factor |
| GO:0001568 | 0 | 4.7762 | 3.4098 | 14 | 583 | blood vessel development |
| GO:0072358 | 0 | 4.5198 | 3.5911 | 14 | 614 | cardiovascular system development |
| GO:0051254 | 0 | 3.2479 | 8.2525 | 22 | 1411 | positive regulation of RNA metabolic process |
| GO:1903508 | 0 | 3.2278 | 7.849 | 21 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0048869 | 0 | 2.4455 | 22.3772 | 40 | 3826 | cellular developmental process |
| GO:0009719 | 0 | 3.0939 | 8.1531 | 21 | 1394 | response to endogenous stimulus |
| GO:2000026 | 1e-04 | 3.2173 | 7.1259 | 19 | 1319 | regulation of multicellular organismal development |
| GO:0060485 | 1e-04 | 6.6013 | 1.3511 | 8 | 231 | mesenchyme development |
| GO:0010557 | 1e-04 | 2.9014 | 9.124 | 22 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0045777 | 1e-04 | 20.8913 | 0.2223 | 4 | 38 | positive regulation of blood pressure |
| GO:0007178 | 1e-04 | 5.6178 | 1.7897 | 9 | 306 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0060191 | 1e-04 | 12.6232 | 0.4445 | 5 | 76 | regulation of lipase activity |
| GO:0045944 | 1e-04 | 3.291 | 6.0321 | 17 | 1043 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0003198 | 1e-04 | 37.6595 | 0.0994 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0051241 | 1e-04 | 3.2723 | 5.6562 | 16 | 978 | negative regulation of multicellular organismal process |
| GO:0010518 | 1e-04 | 16.9031 | 0.269 | 4 | 46 | positive regulation of phospholipase activity |
| GO:0009887 | 2e-04 | 3.5282 | 4.559 | 14 | 819 | animal organ morphogenesis |
| GO:0060216 | 2e-04 | 32.9477 | 0.1111 | 3 | 19 | definitive hemopoiesis |
| GO:0001994 | 2e-04 | 173.8621 | 0.0234 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0031328 | 2e-04 | 2.6533 | 9.8726 | 22 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0071560 | 2e-04 | 6.2451 | 1.2341 | 7 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0003181 | 2e-04 | 29.2829 | 0.1228 | 3 | 21 | atrioventricular valve morphogenesis |
| GO:0010628 | 3e-04 | 2.6267 | 9.9604 | 22 | 1703 | positive regulation of gene expression |
| GO:0060538 | 3e-04 | 7.2672 | 0.9066 | 6 | 155 | skeletal muscle organ development |
| GO:0071773 | 3e-04 | 7.17 | 0.9182 | 6 | 157 | cellular response to BMP stimulus |
| GO:0051240 | 4e-04 | 2.7129 | 8.1719 | 19 | 1413 | positive regulation of multicellular organismal process |
| GO:0050789 | 4e-04 | 2.4185 | 58.2533 | 73 | 9960 | regulation of biological process |
| GO:0023052 | 5e-04 | 2.0635 | 32.3083 | 48 | 5524 | signaling |
| GO:0003278 | 5e-04 | 86.9195 | 0.0351 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:2000489 | 5e-04 | 86.9195 | 0.0351 | 2 | 6 | regulation of hepatic stellate cell activation |
| GO:0042221 | 5e-04 | 2.1352 | 21.5642 | 36 | 3687 | response to chemical |
| GO:0035914 | 6e-04 | 11.6235 | 0.3802 | 4 | 65 | skeletal muscle cell differentiation |
| GO:0003203 | 6e-04 | 20.2621 | 0.1696 | 3 | 29 | endocardial cushion morphogenesis |
| GO:1903706 | 6e-04 | 4.1422 | 2.3921 | 9 | 409 | regulation of hemopoiesis |
| GO:0042060 | 6e-04 | 3.7975 | 2.9127 | 10 | 498 | wound healing |
| GO:0045650 | 7e-04 | 69.531 | 0.0409 | 2 | 7 | negative regulation of macrophage differentiation |
| GO:0070371 | 7e-04 | 5.101 | 1.4973 | 7 | 256 | ERK1 and ERK2 cascade |
| GO:0071345 | 8e-04 | 3.1045 | 4.6965 | 13 | 803 | cellular response to cytokine stimulus |
| GO:0045907 | 8e-04 | 18.8123 | 0.1813 | 3 | 31 | positive regulation of vasoconstriction |
| GO:1903522 | 8e-04 | 4.9989 | 1.5265 | 7 | 261 | regulation of blood circulation |
| GO:0071260 | 9e-04 | 10.2704 | 0.427 | 4 | 73 | cellular response to mechanical stimulus |
| GO:0032502 | 9e-04 | 3.013 | 6.3296 | 15 | 1469 | developmental process |
| GO:0090288 | 9e-04 | 7.2614 | 0.7486 | 5 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0001837 | 0.001 | 7.2024 | 0.7545 | 5 | 129 | epithelial to mesenchymal transition |
| GO:1900274 | 0.001 | 16.9884 | 0.1989 | 3 | 34 | regulation of phospholipase C activity |
| GO:0097756 | 0.0011 | 9.7051 | 0.4504 | 4 | 77 | negative regulation of blood vessel diameter |
| GO:0072073 | 0.0011 | 6.9209 | 0.7837 | 5 | 134 | kidney epithelium development |
| GO:0007154 | 0.0011 | 1.9606 | 32.4253 | 47 | 5544 | cell communication |
| GO:0001501 | 0.0012 | 4.7138 | 1.6196 | 7 | 290 | skeletal system development |
| GO:0045638 | 0.0012 | 9.445 | 0.462 | 4 | 79 | negative regulation of myeloid cell differentiation |
| GO:0001993 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
| GO:0043589 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | skin morphogenesis |
| GO:0072537 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | fibroblast activation |
| GO:2000304 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | positive regulation of ceramide biosynthetic process |
| GO:0045597 | 0.0012 | 4.1574 | 2.1128 | 8 | 385 | positive regulation of cell differentiation |
| GO:0043009 | 0.0012 | 3.4662 | 3.1759 | 10 | 543 | chordate embryonic development |
| GO:0055002 | 0.0013 | 6.6604 | 0.813 | 5 | 139 | striated muscle cell development |
| GO:0090257 | 0.0013 | 5.3685 | 1.2107 | 6 | 207 | regulation of muscle system process |
| GO:0045595 | 0.0014 | 3.2469 | 3.8189 | 11 | 752 | regulation of cell differentiation |
| GO:0030510 | 0.0014 | 8.9644 | 0.4854 | 4 | 83 | regulation of BMP signaling pathway |
| GO:0033690 | 0.0015 | 43.4483 | 0.0585 | 2 | 10 | positive regulation of osteoblast proliferation |
| GO:0001892 | 0.0015 | 8.7419 | 0.4971 | 4 | 85 | embryonic placenta development |
| GO:0009888 | 0.0016 | 2.5748 | 7.1284 | 16 | 1320 | tissue development |
| GO:0032964 | 0.0016 | 14.2278 | 0.2339 | 3 | 40 | collagen biosynthetic process |
| GO:0055078 | 0.0016 | 14.2278 | 0.2339 | 3 | 40 | sodium ion homeostasis |
| GO:0001976 | 0.0018 | 38.6181 | 0.0643 | 2 | 11 | neurological system process involved in regulation of systemic arterial blood pressure |
| GO:0007512 | 0.0018 | 38.6181 | 0.0643 | 2 | 11 | adult heart development |
| GO:0009968 | 0.0019 | 2.585 | 6.5213 | 15 | 1115 | negative regulation of signal transduction |
| GO:0060021 | 0.002 | 8.1358 | 0.5322 | 4 | 91 | palate development |
| GO:0003205 | 0.002 | 6.0248 | 0.8949 | 5 | 153 | cardiac chamber development |
| GO:0061061 | 0.0021 | 3.2154 | 3.4098 | 10 | 583 | muscle structure development |
| GO:0003184 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | pulmonary valve morphogenesis |
| GO:0060536 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | cartilage morphogenesis |
| GO:0060707 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | trophoblast giant cell differentiation |
| GO:0097154 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | GABAergic neuron differentiation |
| GO:0051093 | 0.0023 | 2.8467 | 4.6672 | 12 | 807 | negative regulation of developmental process |
| GO:0007200 | 0.0023 | 7.7761 | 0.5556 | 4 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0070208 | 0.0025 | 31.5925 | 0.076 | 2 | 13 | protein heterotrimerization |
| GO:0071880 | 0.0025 | 31.5925 | 0.076 | 2 | 13 | adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0009790 | 0.0026 | 2.6851 | 5.375 | 13 | 919 | embryo development |
| GO:0007219 | 0.0026 | 5.676 | 0.9475 | 5 | 162 | Notch signaling pathway |
| GO:0048646 | 0.0026 | 3.3537 | 2.9465 | 9 | 545 | anatomical structure formation involved in morphogenesis |
| GO:0003002 | 0.0027 | 4.0274 | 1.8774 | 7 | 321 | regionalization |
| GO:0051173 | 0.0029 | 2.0072 | 15.9319 | 27 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0001525 | 0.0029 | 3.5808 | 2.4232 | 8 | 419 | angiogenesis |
| GO:0090153 | 0.0029 | 28.9579 | 0.0819 | 2 | 14 | regulation of sphingolipid biosynthetic process |
| GO:0006936 | 0.003 | 3.9503 | 1.9125 | 7 | 327 | muscle contraction |
| GO:0019218 | 0.0031 | 7.1439 | 0.6024 | 4 | 103 | regulation of steroid metabolic process |
| GO:0035904 | 0.0033 | 10.9593 | 0.2983 | 3 | 51 | aorta development |
| GO:0007204 | 0.0033 | 4.4467 | 1.4505 | 6 | 248 | positive regulation of cytosolic calcium ion concentration |
| GO:0060977 | 0.0034 | 26.7286 | 0.0877 | 2 | 15 | coronary vasculature morphogenesis |
| GO:0008285 | 0.0037 | 2.962 | 3.6847 | 10 | 630 | negative regulation of cell proliferation |
| GO:0060348 | 0.0037 | 5.2064 | 1.0294 | 5 | 176 | bone development |
| GO:1905314 | 0.0038 | 24.8177 | 0.0936 | 2 | 16 | semi-lunar valve development |
| GO:0045834 | 0.0041 | 6.6063 | 0.6492 | 4 | 111 | positive regulation of lipid metabolic process |
| GO:0048146 | 0.0041 | 10.1136 | 0.3217 | 3 | 55 | positive regulation of fibroblast proliferation |
| GO:0007166 | 0.0042 | 2.0415 | 13.151 | 23 | 2357 | cell surface receptor signaling pathway |
| GO:0060004 | 0.0043 | 23.1617 | 0.0994 | 2 | 17 | reflex |
| GO:0042476 | 0.0045 | 6.4248 | 0.6668 | 4 | 114 | odontogenesis |
| GO:0044259 | 0.0048 | 6.3092 | 0.6785 | 4 | 116 | multicellular organismal macromolecule metabolic process |
| GO:0055093 | 0.0049 | 21.7126 | 0.1053 | 2 | 18 | response to hyperoxia |
| GO:0072001 | 0.0049 | 4.0858 | 1.5733 | 6 | 269 | renal system development |
| GO:0035295 | 0.005 | 3.0103 | 3.2402 | 9 | 554 | tube development |
| GO:0048738 | 0.0051 | 4.8079 | 1.1113 | 5 | 190 | cardiac muscle tissue development |
| GO:0010720 | 0.0053 | 3.2289 | 2.6729 | 8 | 457 | positive regulation of cell development |
| GO:0050767 | 0.0054 | 2.797 | 3.8894 | 10 | 665 | regulation of neurogenesis |
| GO:0035809 | 0.0054 | 20.4341 | 0.1111 | 2 | 19 | regulation of urine volume |
| GO:0035813 | 0.0054 | 20.4341 | 0.1111 | 2 | 19 | regulation of renal sodium excretion |
| GO:0051716 | 0.0056 | 1.7558 | 36.6481 | 49 | 6266 | cellular response to stimulus |
| GO:0035296 | 0.0057 | 5.986 | 0.7135 | 4 | 122 | regulation of tube diameter |
| GO:0007588 | 0.0057 | 8.9095 | 0.3626 | 3 | 62 | excretion |
| GO:0048844 | 0.0057 | 8.9095 | 0.3626 | 3 | 62 | artery morphogenesis |
| GO:0048545 | 0.0058 | 3.492 | 2.1523 | 7 | 368 | response to steroid hormone |
| GO:0001985 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure |
| GO:0002041 | 0.0058 | Inf | 0.0058 | 1 | 1 | intussusceptive angiogenesis |
| GO:0007199 | 0.0058 | Inf | 0.0058 | 1 | 1 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
| GO:0010725 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of primitive erythrocyte differentiation |
| GO:0010734 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of protein glutathionylation |
| GO:0010805 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of lysine import |
| GO:0010963 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of L-arginine import |
| GO:0035854 | 0.0058 | Inf | 0.0058 | 1 | 1 | eosinophil fate commitment |
| GO:0050894 | 0.0058 | Inf | 0.0058 | 1 | 1 | determination of affect |
| GO:0060806 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of cell differentiation involved in embryonic placenta development |
| GO:0060981 | 0.0058 | Inf | 0.0058 | 1 | 1 | cell migration involved in coronary angiogenesis |
| GO:0097275 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular ammonia homeostasis |
| GO:0097276 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular creatinine homeostasis |
| GO:0097277 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular urea homeostasis |
| GO:0140076 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of lipoprotein transport |
| GO:1902618 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular response to fluoride |
| GO:1902867 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:1905010 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of L-lysine import across plasma membrane |
| GO:1905589 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of L-arginine import across plasma membrane |
| GO:2000763 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process |
| GO:2000764 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis |
| GO:2001260 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of semaphorin-plexin signaling pathway |
| GO:0003281 | 0.006 | 8.7605 | 0.3685 | 3 | 63 | ventricular septum development |
| GO:0035929 | 0.006 | 19.2976 | 0.117 | 2 | 20 | steroid hormone secretion |
| GO:0001649 | 0.0061 | 4.6062 | 1.158 | 5 | 198 | osteoblast differentiation |
| GO:0055074 | 0.0062 | 3.4431 | 2.1816 | 7 | 373 | calcium ion homeostasis |
| GO:0032355 | 0.0064 | 5.7882 | 0.7369 | 4 | 126 | response to estradiol |
| GO:0003013 | 0.0064 | 3.1144 | 2.7664 | 8 | 473 | circulatory system process |
| GO:0060411 | 0.0065 | 8.4767 | 0.3802 | 3 | 65 | cardiac septum morphogenesis |
| GO:0007423 | 0.0066 | 3.1063 | 2.7767 | 8 | 485 | sensory organ development |
| GO:0043586 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | tongue development |
| GO:0048485 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | sympathetic nervous system development |
| GO:0060713 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | labyrinthine layer morphogenesis |
| GO:2000679 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | positive regulation of transcription regulatory region DNA binding |
| GO:0045652 | 0.0068 | 8.3416 | 0.386 | 3 | 66 | regulation of megakaryocyte differentiation |
| GO:0045444 | 0.0069 | 4.4655 | 1.1931 | 5 | 204 | fat cell differentiation |
| GO:0050880 | 0.0069 | 5.6482 | 0.7545 | 4 | 129 | regulation of blood vessel size |
| GO:0048534 | 0.007 | 2.5561 | 4.6907 | 11 | 802 | hematopoietic or lymphoid organ development |
| GO:1904892 | 0.0071 | 5.603 | 0.7603 | 4 | 130 | regulation of STAT cascade |
| GO:0001775 | 0.0072 | 2.2826 | 6.7847 | 14 | 1186 | cell activation |
| GO:0030512 | 0.0077 | 7.9609 | 0.4036 | 3 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0072006 | 0.0077 | 5.4716 | 0.7779 | 4 | 133 | nephron development |
| GO:0007275 | 0.0078 | 2.1641 | 10.1284 | 18 | 2373 | multicellular organism development |
| GO:0051384 | 0.0079 | 5.4291 | 0.7837 | 4 | 134 | response to glucocorticoid |
| GO:0003071 | 0.0079 | 16.5375 | 0.1345 | 2 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0007202 | 0.0079 | 16.5375 | 0.1345 | 2 | 23 | activation of phospholipase C activity |
| GO:0045577 | 0.0079 | 16.5375 | 0.1345 | 2 | 23 | regulation of B cell differentiation |
| GO:0046427 | 0.008 | 7.8415 | 0.4094 | 3 | 70 | positive regulation of JAK-STAT cascade |
| GO:0071310 | 0.0083 | 2.2008 | 7.677 | 15 | 1456 | cellular response to organic substance |
| GO:0003208 | 0.0083 | 7.7257 | 0.4153 | 3 | 71 | cardiac ventricle morphogenesis |
| GO:0042554 | 0.0086 | 15.7847 | 0.1404 | 2 | 24 | superoxide anion generation |
| GO:0045648 | 0.0086 | 15.7847 | 0.1404 | 2 | 24 | positive regulation of erythrocyte differentiation |
| GO:0048608 | 0.0086 | 3.226 | 2.3219 | 7 | 397 | reproductive structure development |
| GO:0010942 | 0.0091 | 2.7287 | 3.556 | 9 | 608 | positive regulation of cell death |
| GO:0014706 | 0.0093 | 5.1748 | 0.8217 | 4 | 147 | striated muscle tissue development |
| GO:0003151 | 0.0093 | 7.3978 | 0.4328 | 3 | 74 | outflow tract morphogenesis |
| GO:0002026 | 0.0093 | 15.0975 | 0.1462 | 2 | 25 | regulation of the force of heart contraction |
| GO:0035265 | 0.0094 | 5.1493 | 0.8247 | 4 | 141 | organ growth |
| GO:0060415 | 0.0096 | 7.2946 | 0.4387 | 3 | 75 | muscle tissue morphogenesis |
| GO:0045666 | 0.0098 | 3.5133 | 1.819 | 6 | 311 | positive regulation of neuron differentiation |
| GO:0061448 | 0.0099 | 4.0711 | 1.3043 | 5 | 223 | connective tissue development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032502 | 0 | 1.7153 | 168.7901 | 237 | 3821 | developmental process |
| GO:0045944 | 0 | 2.1202 | 50.3579 | 95 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0009792 | 0 | 2.5067 | 26.3848 | 59 | 547 | embryo development ending in birth or egg hatching |
| GO:0007423 | 0 | 2.5655 | 23.5778 | 54 | 491 | sensory organ development |
| GO:0007275 | 0 | 1.6725 | 108.0015 | 157 | 2512 | multicellular organism development |
| GO:0060485 | 0 | 3.2979 | 9.9995 | 29 | 209 | mesenchyme development |
| GO:1903508 | 0 | 1.7875 | 64.7321 | 105 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0010628 | 0 | 1.696 | 82.1451 | 126 | 1703 | positive regulation of gene expression |
| GO:0007156 | 0 | 3.5995 | 7.3318 | 23 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0051254 | 0 | 1.7247 | 68.0603 | 107 | 1411 | positive regulation of RNA metabolic process |
| GO:0023019 | 0 | 14.4974 | 0.9165 | 8 | 19 | signal transduction involved in regulation of gene expression |
| GO:0051241 | 0 | 1.9742 | 34.2041 | 62 | 726 | negative regulation of multicellular organismal process |
| GO:0048646 | 0 | 1.9447 | 35.2343 | 63 | 752 | anatomical structure formation involved in morphogenesis |
| GO:0007399 | 0 | 2.0444 | 29.3886 | 55 | 637 | nervous system development |
| GO:0007267 | 0 | 1.6574 | 70.3756 | 107 | 1459 | cell-cell signaling |
| GO:0003002 | 0 | 3.6553 | 5.943 | 19 | 127 | regionalization |
| GO:2000026 | 0 | 1.9108 | 35.8595 | 63 | 775 | regulation of multicellular organismal development |
| GO:0042474 | 0 | 12.6678 | 0.8682 | 7 | 18 | middle ear morphogenesis |
| GO:0048665 | 0 | 7.4788 | 1.5918 | 9 | 33 | neuron fate specification |
| GO:0007218 | 0 | 4.1182 | 4.2447 | 15 | 88 | neuropeptide signaling pathway |
| GO:0060562 | 0 | 2.4363 | 14.3742 | 32 | 298 | epithelial tube morphogenesis |
| GO:0021872 | 0 | 5.105 | 2.8459 | 12 | 59 | forebrain generation of neurons |
| GO:0051216 | 0 | 2.9725 | 8.2483 | 22 | 171 | cartilage development |
| GO:0048514 | 0 | 2.0428 | 24.3589 | 46 | 505 | blood vessel morphogenesis |
| GO:0048562 | 0 | 3.9716 | 4.3614 | 15 | 93 | embryonic organ morphogenesis |
| GO:0031328 | 0 | 1.5585 | 81.4216 | 117 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0051094 | 0 | 1.6848 | 53.1665 | 83 | 1114 | positive regulation of developmental process |
| GO:0010557 | 0 | 1.5664 | 75.2474 | 109 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0098609 | 0 | 1.8146 | 36.1766 | 61 | 750 | cell-cell adhesion |
| GO:0048706 | 0 | 7.7303 | 1.3747 | 8 | 29 | embryonic skeletal system development |
| GO:0006355 | 1e-04 | 1.3929 | 162.7949 | 206 | 3375 | regulation of transcription, DNA-templated |
| GO:0021902 | 1e-04 | 39.674 | 0.2894 | 4 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0021953 | 1e-04 | 2.9942 | 7.0599 | 19 | 147 | central nervous system neuron differentiation |
| GO:0045165 | 1e-04 | 3.352 | 5.3713 | 16 | 115 | cell fate commitment |
| GO:0010454 | 1e-04 | 16.5489 | 0.5306 | 5 | 11 | negative regulation of cell fate commitment |
| GO:0007517 | 1e-04 | 2.1566 | 17.0271 | 34 | 353 | muscle organ development |
| GO:0030878 | 1e-04 | 8.1934 | 1.1577 | 7 | 24 | thyroid gland development |
| GO:0060913 | 1e-04 | Inf | 0.1447 | 3 | 3 | cardiac cell fate determination |
| GO:2001141 | 1e-04 | 1.3784 | 164.049 | 206 | 3401 | regulation of RNA biosynthetic process |
| GO:0060037 | 1e-04 | 7.7377 | 1.2059 | 7 | 25 | pharyngeal system development |
| GO:0009889 | 1e-04 | 1.3513 | 199.888 | 244 | 4144 | regulation of biosynthetic process |
| GO:0030858 | 1e-04 | 5.4606 | 2.0172 | 9 | 42 | positive regulation of epithelial cell differentiation |
| GO:0042693 | 1e-04 | 9.9389 | 0.8682 | 6 | 18 | muscle cell fate commitment |
| GO:0022603 | 1e-04 | 1.6904 | 41.7673 | 66 | 872 | regulation of anatomical structure morphogenesis |
| GO:0097154 | 2e-04 | 14.1838 | 0.5788 | 5 | 12 | GABAergic neuron differentiation |
| GO:0035050 | 2e-04 | 3.9953 | 3.473 | 12 | 72 | embryonic heart tube development |
| GO:0008284 | 2e-04 | 1.7147 | 38.0168 | 61 | 792 | positive regulation of cell proliferation |
| GO:0051240 | 2e-04 | 1.544 | 65.2411 | 94 | 1367 | positive regulation of multicellular organismal process |
| GO:0048536 | 3e-04 | 5.6887 | 1.7365 | 8 | 36 | spleen development |
| GO:0071542 | 3e-04 | 5.6887 | 1.7365 | 8 | 36 | dopaminergic neuron differentiation |
| GO:0001709 | 3e-04 | 5.515 | 1.7778 | 8 | 37 | cell fate determination |
| GO:0007368 | 3e-04 | 3.0941 | 5.4024 | 15 | 112 | determination of left/right symmetry |
| GO:1901342 | 3e-04 | 2.2558 | 12.4448 | 26 | 258 | regulation of vasculature development |
| GO:0003203 | 4e-04 | 6.3291 | 1.3988 | 7 | 29 | endocardial cushion morphogenesis |
| GO:0072359 | 4e-04 | 1.9532 | 19.7118 | 36 | 423 | circulatory system development |
| GO:0048704 | 4e-04 | 4.6373 | 2.2967 | 9 | 48 | embryonic skeletal system morphogenesis |
| GO:0060021 | 4e-04 | 3.3299 | 4.3894 | 13 | 91 | palate development |
| GO:0021877 | 4e-04 | 59.7524 | 0.192 | 3 | 4 | forebrain neuron fate commitment |
| GO:0042662 | 4e-04 | 59.4337 | 0.1929 | 3 | 4 | negative regulation of mesodermal cell fate specification |
| GO:1905903 | 4e-04 | 59.4337 | 0.1929 | 3 | 4 | negative regulation of mesoderm formation |
| GO:0003151 | 5e-04 | 4.5138 | 2.3481 | 9 | 49 | outflow tract morphogenesis |
| GO:0035295 | 5e-04 | 1.8694 | 22.2386 | 39 | 468 | tube development |
| GO:0060537 | 5e-04 | 2.0047 | 17.0754 | 32 | 354 | muscle tissue development |
| GO:0009952 | 5e-04 | 3.2294 | 4.4993 | 13 | 95 | anterior/posterior pattern specification |
| GO:2000288 | 6e-04 | 15.8663 | 0.4341 | 4 | 9 | positive regulation of myoblast proliferation |
| GO:0060173 | 6e-04 | 2.5222 | 8.2 | 19 | 170 | limb development |
| GO:0045766 | 6e-04 | 2.7842 | 6.3189 | 16 | 131 | positive regulation of angiogenesis |
| GO:0003206 | 6e-04 | 3.0238 | 5.1371 | 14 | 107 | cardiac chamber morphogenesis |
| GO:0090103 | 6e-04 | 7.0133 | 1.1094 | 6 | 23 | cochlea morphogenesis |
| GO:0035107 | 6e-04 | 2.659 | 6.9942 | 17 | 145 | appendage morphogenesis |
| GO:0007631 | 7e-04 | 3.1282 | 4.6306 | 13 | 96 | feeding behavior |
| GO:0048332 | 7e-04 | 3.5388 | 3.5212 | 11 | 73 | mesoderm morphogenesis |
| GO:0045596 | 8e-04 | 1.7397 | 27.4477 | 45 | 575 | negative regulation of cell differentiation |
| GO:0009799 | 8e-04 | 2.803 | 5.8847 | 15 | 122 | specification of symmetry |
| GO:0060487 | 8e-04 | 6.6232 | 1.1577 | 6 | 24 | lung epithelial cell differentiation |
| GO:0003158 | 8e-04 | 2.914 | 5.3059 | 14 | 110 | endothelium development |
| GO:0060541 | 9e-04 | 2.3584 | 9.1647 | 20 | 190 | respiratory system development |
| GO:0043010 | 9e-04 | 2.152 | 11.9581 | 24 | 250 | camera-type eye development |
| GO:2000738 | 0.001 | 8.271 | 0.82 | 5 | 17 | positive regulation of stem cell differentiation |
| GO:0003148 | 0.001 | 6.2741 | 1.2059 | 6 | 25 | outflow tract septum morphogenesis |
| GO:0045992 | 0.001 | 6.2741 | 1.2059 | 6 | 25 | negative regulation of embryonic development |
| GO:0035909 | 0.001 | 5.1552 | 1.64 | 7 | 34 | aorta morphogenesis |
| GO:0046533 | 0.001 | 29.7148 | 0.2412 | 3 | 5 | negative regulation of photoreceptor cell differentiation |
| GO:0060455 | 0.001 | 29.7148 | 0.2412 | 3 | 5 | negative regulation of gastric acid secretion |
| GO:0061009 | 0.001 | 29.7148 | 0.2412 | 3 | 5 | common bile duct development |
| GO:0061056 | 0.001 | 29.7148 | 0.2412 | 3 | 5 | sclerotome development |
| GO:0042445 | 0.0011 | 2.3788 | 8.6342 | 19 | 179 | hormone metabolic process |
| GO:0048701 | 0.0011 | 4.4221 | 2.1224 | 8 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0030326 | 0.0011 | 2.7012 | 6.0777 | 15 | 126 | embryonic limb morphogenesis |
| GO:0048857 | 0.0012 | 3.896 | 2.653 | 9 | 55 | neural nucleus development |
| GO:0035051 | 0.0012 | 2.6769 | 6.1259 | 15 | 127 | cardiocyte differentiation |
| GO:0030154 | 0.0013 | 1.5844 | 39.6759 | 59 | 916 | cell differentiation |
| GO:0030198 | 0.0013 | 1.9972 | 14.4088 | 27 | 300 | extracellular matrix organization |
| GO:0014033 | 0.0013 | 3.4957 | 3.2318 | 10 | 67 | neural crest cell differentiation |
| GO:0071300 | 0.0013 | 3.4957 | 3.2318 | 10 | 67 | cellular response to retinoic acid |
| GO:0010469 | 0.0013 | 1.758 | 23.4907 | 39 | 487 | regulation of receptor activity |
| GO:0009948 | 0.0014 | 4.1888 | 2.2188 | 8 | 46 | anterior/posterior axis specification |
| GO:0030855 | 0.0014 | 1.712 | 25.9444 | 42 | 547 | epithelial cell differentiation |
| GO:0001657 | 0.0015 | 2.9923 | 4.4377 | 12 | 92 | ureteric bud development |
| GO:0071773 | 0.0015 | 2.4291 | 7.573 | 17 | 157 | cellular response to BMP stimulus |
| GO:0021602 | 0.0015 | 5.6758 | 1.3024 | 6 | 27 | cranial nerve morphogenesis |
| GO:0072163 | 0.0017 | 2.9552 | 4.4859 | 12 | 93 | mesonephric epithelium development |
| GO:0048608 | 0.0017 | 1.826 | 19.1495 | 33 | 397 | reproductive structure development |
| GO:0001710 | 0.0017 | 7.0885 | 0.9165 | 5 | 19 | mesodermal cell fate commitment |
| GO:0003215 | 0.0017 | 7.0885 | 0.9165 | 5 | 19 | cardiac right ventricle morphogenesis |
| GO:0060284 | 0.0017 | 1.5742 | 37.5272 | 56 | 778 | regulation of cell development |
| GO:0009888 | 0.0018 | 1.9745 | 14.0081 | 26 | 314 | tissue development |
| GO:0051173 | 0.0018 | 1.3178 | 131.3936 | 162 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0060441 | 0.0019 | 5.4175 | 1.3506 | 6 | 28 | epithelial tube branching involved in lung morphogenesis |
| GO:0060415 | 0.0019 | 10.0007 | 0.5741 | 4 | 12 | muscle tissue morphogenesis |
| GO:0003207 | 0.0019 | 9.9144 | 0.5788 | 4 | 12 | cardiac chamber formation |
| GO:0033605 | 0.0019 | 9.9144 | 0.5788 | 4 | 12 | positive regulation of catecholamine secretion |
| GO:0042659 | 0.0019 | 9.9144 | 0.5788 | 4 | 12 | regulation of cell fate specification |
| GO:0043249 | 0.0019 | 9.9144 | 0.5788 | 4 | 12 | erythrocyte maturation |
| GO:0032109 | 0.002 | 19.8085 | 0.2894 | 3 | 6 | positive regulation of response to nutrient levels |
| GO:0042713 | 0.002 | 19.8085 | 0.2894 | 3 | 6 | sperm ejaculation |
| GO:0061074 | 0.002 | 19.8085 | 0.2894 | 3 | 6 | regulation of neural retina development |
| GO:2001199 | 0.002 | 19.8085 | 0.2894 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0007200 | 0.002 | 2.8836 | 4.5824 | 12 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0048729 | 0.002 | 1.7538 | 21.6912 | 36 | 460 | tissue morphogenesis |
| GO:0030099 | 0.0021 | 1.8564 | 17.1236 | 30 | 355 | myeloid cell differentiation |
| GO:0007507 | 0.0021 | 1.9247 | 14.8907 | 27 | 314 | heart development |
| GO:0022008 | 0.0022 | 1.4172 | 67.8191 | 91 | 1406 | neurogenesis |
| GO:0021544 | 0.0022 | 6.6155 | 0.9647 | 5 | 20 | subpallium development |
| GO:0042221 | 0.0023 | 1.2775 | 177.8444 | 211 | 3687 | response to chemical |
| GO:0048486 | 0.0023 | Inf | 0.096 | 2 | 2 | parasympathetic nervous system development |
| GO:0002930 | 0.0023 | Inf | 0.0965 | 2 | 2 | trabecular meshwork development |
| GO:0014036 | 0.0023 | Inf | 0.0965 | 2 | 2 | neural crest cell fate specification |
| GO:0021882 | 0.0023 | Inf | 0.0965 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
| GO:0021893 | 0.0023 | Inf | 0.0965 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
| GO:0043134 | 0.0023 | Inf | 0.0965 | 2 | 2 | regulation of hindgut contraction |
| GO:0072166 | 0.0023 | Inf | 0.0965 | 2 | 2 | posterior mesonephric tubule development |
| GO:1901207 | 0.0023 | Inf | 0.0965 | 2 | 2 | regulation of heart looping |
| GO:1901246 | 0.0023 | Inf | 0.0965 | 2 | 2 | regulation of lung ciliated cell differentiation |
| GO:1902868 | 0.0023 | Inf | 0.0965 | 2 | 2 | positive regulation of retina development in camera-type eye |
| GO:1902871 | 0.0023 | Inf | 0.0965 | 2 | 2 | positive regulation of amacrine cell differentiation |
| GO:2000824 | 0.0023 | Inf | 0.0965 | 2 | 2 | negative regulation of androgen receptor activity |
| GO:2001037 | 0.0023 | Inf | 0.0965 | 2 | 2 | positive regulation of tongue muscle cell differentiation |
| GO:0010470 | 0.0024 | 4.3482 | 1.8812 | 7 | 39 | regulation of gastrulation |
| GO:0060429 | 0.0024 | 1.8002 | 18.798 | 32 | 410 | epithelium development |
| GO:0001944 | 0.0024 | 1.8593 | 16.5179 | 29 | 349 | vasculature development |
| GO:0046661 | 0.0026 | 2.3684 | 7.2836 | 16 | 151 | male sex differentiation |
| GO:0007389 | 0.0027 | 6.1979 | 1.0026 | 5 | 22 | pattern specification process |
| GO:0060255 | 0.0027 | 1.2433 | 268.8648 | 305 | 5574 | regulation of macromolecule metabolic process |
| GO:0090189 | 0.0027 | 6.2016 | 1.0129 | 5 | 21 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0007611 | 0.0028 | 2.0719 | 10.8048 | 21 | 224 | learning or memory |
| GO:0006334 | 0.0029 | 2.6197 | 5.4024 | 13 | 112 | nucleosome assembly |
| GO:0045934 | 0.0029 | 1.4136 | 64.105 | 86 | 1329 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0032355 | 0.003 | 2.495 | 6.0777 | 14 | 126 | response to estradiol |
| GO:0001756 | 0.0031 | 3.317 | 3.0388 | 9 | 63 | somitogenesis |
| GO:0014031 | 0.0031 | 3.317 | 3.0388 | 9 | 63 | mesenchymal cell development |
| GO:0055008 | 0.0031 | 3.317 | 3.0388 | 9 | 63 | cardiac muscle tissue morphogenesis |
| GO:0046330 | 0.0031 | 2.5933 | 5.4506 | 13 | 113 | positive regulation of JNK cascade |
| GO:0034654 | 0.0032 | 1.2597 | 192.315 | 225 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0010831 | 0.0032 | 4.7664 | 1.4953 | 6 | 31 | positive regulation of myotube differentiation |
| GO:0045926 | 0.0032 | 2.0849 | 10.2259 | 20 | 212 | negative regulation of growth |
| GO:0021798 | 0.0034 | 14.8553 | 0.3376 | 3 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0034127 | 0.0034 | 14.8553 | 0.3376 | 3 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0060017 | 0.0034 | 14.8553 | 0.3376 | 3 | 7 | parathyroid gland development |
| GO:0016338 | 0.0034 | 5.8364 | 1.0612 | 5 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0007601 | 0.0035 | 2.1682 | 8.8753 | 18 | 184 | visual perception |
| GO:0043066 | 0.0037 | 1.5195 | 38.0096 | 55 | 788 | negative regulation of apoptotic process |
| GO:0000122 | 0.0037 | 1.5301 | 36.3696 | 53 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0001837 | 0.0037 | 2.4294 | 6.2224 | 14 | 129 | epithelial to mesenchymal transition |
| GO:0035914 | 0.0038 | 3.1981 | 3.1353 | 9 | 65 | skeletal muscle cell differentiation |
| GO:0032680 | 0.004 | 2.6286 | 4.9683 | 12 | 103 | regulation of tumor necrosis factor production |
| GO:0010951 | 0.004 | 2.0881 | 9.6953 | 19 | 201 | negative regulation of endopeptidase activity |
| GO:0031327 | 0.0041 | 1.3736 | 72.0156 | 94 | 1493 | negative regulation of cellular biosynthetic process |
| GO:0045686 | 0.0042 | 5.5117 | 1.1094 | 5 | 23 | negative regulation of glial cell differentiation |
| GO:0061138 | 0.0042 | 2.1775 | 8.3447 | 17 | 173 | morphogenesis of a branching epithelium |
| GO:0042127 | 0.0045 | 1.6083 | 26.7936 | 41 | 578 | regulation of cell proliferation |
| GO:0009887 | 0.0045 | 1.6072 | 26.786 | 41 | 587 | animal organ morphogenesis |
| GO:0040019 | 0.0045 | 4.4127 | 1.5918 | 6 | 33 | positive regulation of embryonic development |
| GO:0001947 | 0.0045 | 3.3939 | 2.6461 | 8 | 55 | heart looping |
| GO:0032649 | 0.0046 | 2.8853 | 3.8106 | 10 | 79 | regulation of interferon-gamma production |
| GO:0042471 | 0.0048 | 2.696 | 4.4484 | 11 | 93 | ear morphogenesis |
| GO:0009950 | 0.0048 | 7.209 | 0.7235 | 4 | 15 | dorsal/ventral axis specification |
| GO:0021783 | 0.0048 | 7.209 | 0.7235 | 4 | 15 | preganglionic parasympathetic fiber development |
| GO:0033189 | 0.0048 | 7.209 | 0.7235 | 4 | 15 | response to vitamin A |
| GO:0071599 | 0.0048 | 7.209 | 0.7235 | 4 | 15 | otic vesicle development |
| GO:0043588 | 0.0048 | 1.8229 | 15.0495 | 26 | 312 | skin development |
| GO:0071774 | 0.0049 | 2.3471 | 6.4153 | 14 | 133 | response to fibroblast growth factor |
| GO:0050789 | 0.005 | 1.2374 | 480.4258 | 513 | 9960 | regulation of biological process |
| GO:0051960 | 0.005 | 1.5104 | 36.0802 | 52 | 748 | regulation of nervous system development |
| GO:0001975 | 0.0051 | 5.2213 | 1.1577 | 5 | 24 | response to amphetamine |
| GO:0048643 | 0.0051 | 5.2213 | 1.1577 | 5 | 24 | positive regulation of skeletal muscle tissue development |
| GO:0060914 | 0.0051 | 5.2213 | 1.1577 | 5 | 24 | heart formation |
| GO:0050808 | 0.0051 | 1.9546 | 11.3836 | 21 | 236 | synapse organization |
| GO:0016202 | 0.0052 | 2.4225 | 5.7883 | 13 | 120 | regulation of striated muscle tissue development |
| GO:0010940 | 0.0052 | 11.8834 | 0.3859 | 3 | 8 | positive regulation of necrotic cell death |
| GO:0030916 | 0.0052 | 11.8834 | 0.3859 | 3 | 8 | otic vesicle formation |
| GO:0045924 | 0.0052 | 11.8834 | 0.3859 | 3 | 8 | regulation of female receptivity |
| GO:1905770 | 0.0052 | 11.8834 | 0.3859 | 3 | 8 | regulation of mesodermal cell differentiation |
| GO:0035176 | 0.0054 | 3.6601 | 2.1706 | 7 | 45 | social behavior |
| GO:0001523 | 0.0054 | 2.8037 | 3.9071 | 10 | 81 | retinoid metabolic process |
| GO:0042475 | 0.0054 | 2.8037 | 3.9071 | 10 | 81 | odontogenesis of dentin-containing tooth |
| GO:0001704 | 0.0056 | 2.3999 | 5.8365 | 13 | 121 | formation of primary germ layer |
| GO:0070304 | 0.0056 | 2.3079 | 6.5118 | 14 | 135 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0048645 | 0.0059 | 4.1308 | 1.6794 | 6 | 35 | animal organ formation |
| GO:0010665 | 0.006 | 4.1078 | 1.6882 | 6 | 35 | regulation of cardiac muscle cell apoptotic process |
| GO:0006590 | 0.0061 | 6.6078 | 0.7718 | 4 | 16 | thyroid hormone generation |
| GO:0090185 | 0.0061 | 6.6078 | 0.7718 | 4 | 16 | negative regulation of kidney development |
| GO:0001501 | 0.0062 | 1.9918 | 10.1048 | 19 | 217 | skeletal system development |
| GO:0051291 | 0.0063 | 2.465 | 5.2577 | 12 | 109 | protein heterooligomerization |
| GO:0051952 | 0.0063 | 2.9349 | 3.3765 | 9 | 70 | regulation of amine transport |
| GO:0050877 | 0.0064 | 1.4578 | 41.6273 | 58 | 863 | nervous system process |
| GO:1903507 | 0.0064 | 1.4029 | 53.7344 | 72 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0003279 | 0.0064 | 2.5771 | 4.6306 | 11 | 96 | cardiac septum development |
| GO:0021761 | 0.0064 | 2.5771 | 4.6306 | 11 | 96 | limbic system development |
| GO:0001708 | 0.0065 | 4.0338 | 1.7108 | 6 | 36 | cell fate specification |
| GO:0060548 | 0.0066 | 1.4508 | 42.5437 | 59 | 882 | negative regulation of cell death |
| GO:0071706 | 0.0067 | 2.4397 | 5.3059 | 12 | 110 | tumor necrosis factor superfamily cytokine production |
| GO:0002125 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | maternal aggressive behavior |
| GO:0003285 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | septum secundum development |
| GO:0003350 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | pulmonary myocardium development |
| GO:0014717 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0021524 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | visceral motor neuron differentiation |
| GO:0021912 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035054 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0038162 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | erythropoietin-mediated signaling pathway |
| GO:0055014 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0060061 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | Spemann organizer formation |
| GO:0060741 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0061010 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | gall bladder development |
| GO:0061031 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:0061737 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | leukotriene signaling pathway |
| GO:0070634 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | transepithelial ammonium transport |
| GO:0072190 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | ureter urothelium development |
| GO:1902809 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | regulation of skeletal muscle fiber differentiation |
| GO:2000297 | 0.0067 | 39.5683 | 0.1447 | 2 | 3 | negative regulation of synapse maturation |
| GO:0021675 | 0.0069 | 2.8874 | 3.4247 | 9 | 71 | nerve development |
| GO:0035137 | 0.007 | 3.9706 | 1.7365 | 6 | 36 | hindlimb morphogenesis |
| GO:0051146 | 0.0071 | 1.892 | 11.7212 | 21 | 243 | striated muscle cell differentiation |
| GO:0007420 | 0.0074 | 1.5218 | 30.919 | 45 | 641 | brain development |
| GO:0019219 | 0.0075 | 1.2764 | 121.4533 | 146 | 2603 | regulation of nucleobase-containing compound metabolic process |
| GO:0055001 | 0.0075 | 2.1529 | 7.4283 | 15 | 154 | muscle cell development |
| GO:0003139 | 0.0075 | 9.9022 | 0.4341 | 3 | 9 | secondary heart field specification |
| GO:0042363 | 0.0075 | 9.9022 | 0.4341 | 3 | 9 | fat-soluble vitamin catabolic process |
| GO:0043084 | 0.0075 | 9.9022 | 0.4341 | 3 | 9 | penile erection |
| GO:0043587 | 0.0075 | 9.9022 | 0.4341 | 3 | 9 | tongue morphogenesis |
| GO:0048387 | 0.0075 | 9.9022 | 0.4341 | 3 | 9 | negative regulation of retinoic acid receptor signaling pathway |
| GO:0048865 | 0.0075 | 9.9022 | 0.4341 | 3 | 9 | stem cell fate commitment |
| GO:0072172 | 0.0075 | 9.9022 | 0.4341 | 3 | 9 | mesonephric tubule formation |
| GO:0048468 | 0.0076 | 1.4367 | 43.7343 | 60 | 942 | cell development |
| GO:0050678 | 0.0077 | 1.8195 | 13.313 | 23 | 276 | regulation of epithelial cell proliferation |
| GO:0021514 | 0.0077 | 6.0991 | 0.82 | 4 | 17 | ventral spinal cord interneuron differentiation |
| GO:0055012 | 0.0077 | 6.0991 | 0.82 | 4 | 17 | ventricular cardiac muscle cell differentiation |
| GO:0061323 | 0.0077 | 6.0991 | 0.82 | 4 | 17 | cell proliferation involved in heart morphogenesis |
| GO:0009880 | 0.0078 | 3.0581 | 2.8941 | 8 | 60 | embryonic pattern specification |
| GO:0003008 | 0.0079 | 1.5097 | 31.8832 | 46 | 677 | system process |
| GO:0001755 | 0.008 | 3.8423 | 1.7847 | 6 | 37 | neural crest cell migration |
| GO:0030818 | 0.008 | 3.8423 | 1.7847 | 6 | 37 | negative regulation of cAMP biosynthetic process |
| GO:0031076 | 0.008 | 3.8423 | 1.7847 | 6 | 37 | embryonic camera-type eye development |
| GO:0060323 | 0.008 | 3.8423 | 1.7847 | 6 | 37 | head morphogenesis |
| GO:0008630 | 0.008 | 2.8119 | 3.5034 | 9 | 73 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0048592 | 0.0082 | 2.198 | 6.8012 | 14 | 141 | eye morphogenesis |
| GO:0060349 | 0.0083 | 2.6183 | 4.1483 | 10 | 86 | bone morphogenesis |
| GO:0033993 | 0.0083 | 1.49 | 33.6562 | 48 | 708 | response to lipid |
| GO:0045664 | 0.0085 | 1.5564 | 26.1919 | 39 | 543 | regulation of neuron differentiation |
| GO:0060706 | 0.0086 | 4.5084 | 1.3024 | 5 | 27 | cell differentiation involved in embryonic placenta development |
| GO:1902230 | 0.0086 | 4.5084 | 1.3024 | 5 | 27 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0045137 | 0.0086 | 1.9645 | 9.6953 | 18 | 201 | development of primary sexual characteristics |
| GO:0060324 | 0.0087 | 3.3106 | 2.3635 | 7 | 49 | face development |
| GO:0008584 | 0.0089 | 2.2527 | 6.1741 | 13 | 128 | male gonad development |
| GO:0008543 | 0.0094 | 2.4331 | 4.8718 | 11 | 101 | fibroblast growth factor receptor signaling pathway |
| GO:0002520 | 0.0094 | 1.4355 | 40.7108 | 56 | 844 | immune system development |
| GO:0001759 | 0.0096 | 5.663 | 0.8682 | 4 | 18 | organ induction |
| GO:0007530 | 0.0096 | 5.663 | 0.8682 | 4 | 18 | sex determination |
| GO:0032331 | 0.0096 | 5.663 | 0.8682 | 4 | 18 | negative regulation of chondrocyte differentiation |
| GO:0045603 | 0.0096 | 5.663 | 0.8682 | 4 | 18 | positive regulation of endothelial cell differentiation |
| GO:0072074 | 0.0096 | 5.663 | 0.8682 | 4 | 18 | kidney mesenchyme development |
| GO:1903055 | 0.0096 | 5.663 | 0.8682 | 4 | 18 | positive regulation of extracellular matrix organization |
| GO:1905276 | 0.0096 | 5.663 | 0.8682 | 4 | 18 | regulation of epithelial tube formation |
| GO:0072080 | 0.0097 | 2.5508 | 4.2447 | 10 | 88 | nephron tubule development |
| GO:0001818 | 0.0098 | 1.8977 | 10.5636 | 19 | 219 | negative regulation of cytokine production |
| GO:0007411 | 0.0098 | 1.8977 | 10.5636 | 19 | 219 | axon guidance |
| GO:0048771 | 0.0098 | 2.1468 | 6.9459 | 14 | 144 | tissue remodeling |
| GO:0031016 | 0.0098 | 2.7117 | 3.6177 | 9 | 75 | pancreas development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045540 | 0.0027 | Inf | 0.0027 | 1 | 41 | regulation of cholesterol biosynthetic process |
| GO:1902653 | 0.0041 | Inf | 0.0041 | 1 | 63 | secondary alcohol biosynthetic process |
| GO:0016126 | 0.0044 | Inf | 0.0044 | 1 | 67 | sterol biosynthetic process |
| GO:0019218 | 0.0068 | Inf | 0.0068 | 1 | 103 | regulation of steroid metabolic process |
| GO:0008203 | 0.0083 | Inf | 0.0083 | 1 | 126 | cholesterol metabolic process |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048240 | 0.0018 | Inf | 0.0018 | 1 | 27 | sperm capacitation |
| GO:0048515 | 0.0089 | Inf | 0.0089 | 1 | 135 | spermatid differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051412 | 1e-04 | 202.5333 | 0.0134 | 2 | 17 | response to corticosterone |
| GO:0019098 | 2e-04 | 108.4071 | 0.0237 | 2 | 30 | reproductive behavior |
| GO:0007618 | 3e-04 | 91.9515 | 0.0276 | 2 | 35 | mating |
| GO:0035176 | 6e-04 | 70.5209 | 0.0355 | 2 | 45 | social behavior |
| GO:0045851 | 6e-04 | 65.9087 | 0.0379 | 2 | 48 | pH reduction |
| GO:0071444 | 8e-04 | Inf | 8e-04 | 1 | 1 | cellular response to pheromone |
| GO:0075733 | 9e-04 | 55.0909 | 0.0449 | 2 | 57 | intracellular transport of virus |
| GO:0051952 | 0.0013 | 44.5206 | 0.0552 | 2 | 70 | regulation of amine transport |
| GO:0044766 | 0.0014 | 43.8725 | 0.056 | 2 | 71 | multi-organism transport |
| GO:0050886 | 0.0015 | 42.0361 | 0.0584 | 2 | 74 | endocrine process |
| GO:0042322 | 0.0016 | 1382.1818 | 0.0016 | 1 | 2 | negative regulation of circadian sleep/wake cycle, REM sleep |
| GO:2000854 | 0.0016 | 1382.1818 | 0.0016 | 1 | 2 | positive regulation of corticosterone secretion |
| GO:0051453 | 0.0021 | 35.5765 | 0.0686 | 2 | 87 | regulation of intracellular pH |
| GO:0002125 | 0.0024 | 691.0455 | 0.0024 | 1 | 3 | maternal aggressive behavior |
| GO:0031394 | 0.0024 | 691.0455 | 0.0024 | 1 | 3 | positive regulation of prostaglandin biosynthetic process |
| GO:0033685 | 0.0024 | 691.0455 | 0.0024 | 1 | 3 | negative regulation of luteinizing hormone secretion |
| GO:0042631 | 0.0024 | 691.0455 | 0.0024 | 1 | 3 | cellular response to water deprivation |
| GO:0046968 | 0.0024 | 691.0455 | 0.0024 | 1 | 3 | peptide antigen transport |
| GO:0070093 | 0.0024 | 691.0455 | 0.0024 | 1 | 3 | negative regulation of glucagon secretion |
| GO:0071314 | 0.0024 | 691.0455 | 0.0024 | 1 | 3 | cellular response to cocaine |
| GO:0019725 | 0.0028 | 8.9558 | 0.6372 | 4 | 808 | cellular homeostasis |
| GO:0030004 | 0.0029 | 29.6137 | 0.082 | 2 | 104 | cellular monovalent inorganic cation homeostasis |
| GO:0001992 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0007621 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | negative regulation of female receptivity |
| GO:0008628 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | hormone-mediated apoptotic signaling pathway |
| GO:0010841 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | positive regulation of circadian sleep/wake cycle, wakefulness |
| GO:0032811 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | negative regulation of epinephrine secretion |
| GO:0032849 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | positive regulation of cellular pH reduction |
| GO:0051461 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | positive regulation of corticotropin secretion |
| GO:0051464 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | positive regulation of cortisol secretion |
| GO:1902527 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | positive regulation of protein monoubiquitination |
| GO:0006811 | 0.0035 | 6.7914 | 1.145 | 5 | 1452 | ion transport |
| GO:0006091 | 0.0039 | 11.7055 | 0.3344 | 3 | 424 | generation of precursor metabolites and energy |
| GO:0051970 | 0.0039 | 345.4773 | 0.0039 | 1 | 5 | negative regulation of transmission of nerve impulse |
| GO:1902255 | 0.0039 | 345.4773 | 0.0039 | 1 | 5 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:1903232 | 0.0039 | 345.4773 | 0.0039 | 1 | 5 | melanosome assembly |
| GO:2000987 | 0.0039 | 345.4773 | 0.0039 | 1 | 5 | positive regulation of behavioral fear response |
| GO:2001279 | 0.0039 | 345.4773 | 0.0039 | 1 | 5 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0030260 | 0.0044 | 23.9349 | 0.1009 | 2 | 128 | entry into host cell |
| GO:0051828 | 0.0044 | 23.9349 | 0.1009 | 2 | 128 | entry into other organism involved in symbiotic interaction |
| GO:0014062 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | regulation of serotonin secretion |
| GO:0042713 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | sperm ejaculation |
| GO:0048241 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | epinephrine transport |
| GO:0060179 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | male mating behavior |
| GO:0048878 | 0.0055 | 7.3215 | 0.7697 | 4 | 976 | chemical homeostasis |
| GO:0010700 | 0.0055 | 230.2879 | 0.0055 | 1 | 7 | negative regulation of norepinephrine secretion |
| GO:1903365 | 0.0055 | 230.2879 | 0.0055 | 1 | 7 | regulation of fear response |
| GO:2000848 | 0.0055 | 230.2879 | 0.0055 | 1 | 7 | positive regulation of corticosteroid hormone secretion |
| GO:0031960 | 0.0057 | 20.9181 | 0.1151 | 2 | 146 | response to corticosteroid |
| GO:0019062 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | virion attachment to host cell |
| GO:0060155 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | platelet dense granule organization |
| GO:0008217 | 0.0068 | 19.0468 | 0.1262 | 2 | 160 | regulation of blood pressure |
| GO:0014049 | 0.0071 | 172.6932 | 0.0071 | 1 | 9 | positive regulation of glutamate secretion |
| GO:0043084 | 0.0071 | 172.6932 | 0.0071 | 1 | 9 | penile erection |
| GO:0060180 | 0.0071 | 172.6932 | 0.0071 | 1 | 9 | female mating behavior |
| GO:2000849 | 0.0071 | 172.6932 | 0.0071 | 1 | 9 | regulation of glucocorticoid secretion |
| GO:0006694 | 0.0077 | 17.7941 | 0.1348 | 2 | 171 | steroid biosynthetic process |
| GO:0032276 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | regulation of gonadotropin secretion |
| GO:0035646 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | endosome to melanosome transport |
| GO:0048757 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | pigment granule maturation |
| GO:0006873 | 0.0083 | 8.8484 | 0.4377 | 3 | 555 | cellular ion homeostasis |
| GO:0003084 | 0.0086 | 138.1364 | 0.0087 | 1 | 11 | positive regulation of systemic arterial blood pressure |
| GO:0035815 | 0.0086 | 138.1364 | 0.0087 | 1 | 11 | positive regulation of renal sodium excretion |
| GO:0043476 | 0.0086 | 138.1364 | 0.0087 | 1 | 11 | pigment accumulation |
| GO:0044406 | 0.0086 | 138.1364 | 0.0087 | 1 | 11 | adhesion of symbiont to host |
| GO:0045472 | 0.0086 | 138.1364 | 0.0087 | 1 | 11 | response to ether |
| GO:0042754 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | negative regulation of circadian rhythm |
| GO:0045723 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | positive regulation of fatty acid biosynthetic process |
| GO:0060541 | 0.0094 | 15.9755 | 0.1498 | 2 | 190 | respiratory system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070098 | 2e-04 | 137.7818 | 0.0225 | 2 | 57 | chemokine-mediated signaling pathway |
| GO:1990266 | 4e-04 | 98.2727 | 0.0311 | 2 | 79 | neutrophil migration |
| GO:0071621 | 5e-04 | 91.1325 | 0.0335 | 2 | 85 | granulocyte chemotaxis |
| GO:0045918 | 0.0012 | 1520.9 | 0.0012 | 1 | 3 | negative regulation of cytolysis |
| GO:0097529 | 0.0014 | 51.5925 | 0.0584 | 2 | 148 | myeloid leukocyte migration |
| GO:0045347 | 0.002 | 760.35 | 0.002 | 1 | 5 | negative regulation of MHC class II biosynthetic process |
| GO:0043950 | 0.0024 | 608.24 | 0.0024 | 1 | 6 | positive regulation of cAMP-mediated signaling |
| GO:0007186 | 0.0029 | 17.195 | 0.3308 | 3 | 839 | G-protein coupled receptor signaling pathway |
| GO:0060326 | 0.0031 | 33.759 | 0.0883 | 2 | 224 | cell chemotaxis |
| GO:0051873 | 0.0039 | 337.8222 | 0.0039 | 1 | 10 | killing by host of symbiont cells |
| GO:0051103 | 0.0043 | 304.02 | 0.0043 | 1 | 11 | DNA ligation involved in DNA repair |
| GO:0045651 | 0.0047 | 276.3636 | 0.0047 | 1 | 12 | positive regulation of macrophage differentiation |
| GO:0045653 | 0.0051 | 253.3167 | 0.0051 | 1 | 13 | negative regulation of megakaryocyte differentiation |
| GO:0010744 | 0.0059 | 217.1 | 0.0059 | 1 | 15 | positive regulation of macrophage derived foam cell differentiation |
| GO:0051818 | 0.0063 | 202.6133 | 0.0063 | 1 | 16 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0042832 | 0.0083 | 151.91 | 0.0083 | 1 | 21 | defense response to protozoan |
| GO:0090023 | 0.009 | 138.0818 | 0.0091 | 1 | 23 | positive regulation of neutrophil chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006378 | 0.0053 | 389.1282 | 0.0053 | 1 | 40 | mRNA polyadenylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006805 | 0.0066 | Inf | 0.0066 | 1 | 101 | xenobiotic metabolic process |
| GO:0009410 | 0.0074 | Inf | 0.0074 | 1 | 112 | response to xenobiotic stimulus |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002125 | 2e-04 | Inf | 2e-04 | 1 | 3 | maternal aggressive behavior |
| GO:0031394 | 2e-04 | Inf | 2e-04 | 1 | 3 | positive regulation of prostaglandin biosynthetic process |
| GO:0042631 | 2e-04 | Inf | 2e-04 | 1 | 3 | cellular response to water deprivation |
| GO:0001992 | 3e-04 | Inf | 3e-04 | 1 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0007621 | 3e-04 | Inf | 3e-04 | 1 | 4 | negative regulation of female receptivity |
| GO:0032849 | 3e-04 | Inf | 3e-04 | 1 | 4 | positive regulation of cellular pH reduction |
| GO:0051970 | 3e-04 | Inf | 3e-04 | 1 | 5 | negative regulation of transmission of nerve impulse |
| GO:2001279 | 3e-04 | Inf | 3e-04 | 1 | 5 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0042713 | 4e-04 | Inf | 4e-04 | 1 | 6 | sperm ejaculation |
| GO:0014049 | 6e-04 | Inf | 6e-04 | 1 | 9 | positive regulation of glutamate secretion |
| GO:0043084 | 6e-04 | Inf | 6e-04 | 1 | 9 | penile erection |
| GO:0060180 | 6e-04 | Inf | 6e-04 | 1 | 9 | female mating behavior |
| GO:0003084 | 7e-04 | Inf | 7e-04 | 1 | 11 | positive regulation of systemic arterial blood pressure |
| GO:0035815 | 7e-04 | Inf | 7e-04 | 1 | 11 | positive regulation of renal sodium excretion |
| GO:0045723 | 8e-04 | Inf | 8e-04 | 1 | 12 | positive regulation of fatty acid biosynthetic process |
| GO:0009415 | 9e-04 | Inf | 9e-04 | 1 | 14 | response to water |
| GO:0042711 | 9e-04 | Inf | 9e-04 | 1 | 14 | maternal behavior |
| GO:0007625 | 0.0011 | Inf | 0.0011 | 1 | 16 | grooming behavior |
| GO:0051412 | 0.0011 | Inf | 0.0011 | 1 | 17 | response to corticosterone |
| GO:0046457 | 0.0014 | Inf | 0.0014 | 1 | 21 | prostanoid biosynthetic process |
| GO:0010460 | 0.0014 | Inf | 0.0014 | 1 | 22 | positive regulation of heart rate |
| GO:0044062 | 0.0014 | Inf | 0.0014 | 1 | 22 | regulation of excretion |
| GO:0007202 | 0.0015 | Inf | 0.0015 | 1 | 23 | activation of phospholipase C activity |
| GO:0051955 | 0.0018 | Inf | 0.0018 | 1 | 27 | regulation of amino acid transport |
| GO:0032892 | 0.0018 | Inf | 0.0018 | 1 | 28 | positive regulation of organic acid transport |
| GO:0019098 | 0.002 | Inf | 0.002 | 1 | 30 | reproductive behavior |
| GO:0045907 | 0.002 | Inf | 0.002 | 1 | 31 | positive regulation of vasoconstriction |
| GO:0051954 | 0.002 | Inf | 0.002 | 1 | 31 | positive regulation of amine transport |
| GO:0006693 | 0.0021 | Inf | 0.0021 | 1 | 32 | prostaglandin metabolic process |
| GO:0098801 | 0.0021 | Inf | 0.0021 | 1 | 32 | regulation of renal system process |
| GO:1900274 | 0.0022 | Inf | 0.0022 | 1 | 34 | regulation of phospholipase C activity |
| GO:0007618 | 0.0023 | Inf | 0.0023 | 1 | 35 | mating |
| GO:0055078 | 0.0026 | Inf | 0.0026 | 1 | 40 | sodium ion homeostasis |
| GO:1903793 | 0.0026 | Inf | 0.0026 | 1 | 40 | positive regulation of anion transport |
| GO:0003044 | 0.0028 | Inf | 0.0028 | 1 | 42 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0035176 | 0.003 | Inf | 0.003 | 1 | 45 | social behavior |
| GO:0010518 | 0.003 | Inf | 0.003 | 1 | 46 | positive regulation of phospholipase activity |
| GO:0045851 | 0.0032 | Inf | 0.0032 | 1 | 48 | pH reduction |
| GO:0031644 | 0.0043 | Inf | 0.0043 | 1 | 66 | regulation of neurological system process |
| GO:0050886 | 0.0049 | Inf | 0.0049 | 1 | 74 | endocrine process |
| GO:0019217 | 0.005 | Inf | 0.005 | 1 | 76 | regulation of fatty acid metabolic process |
| GO:0060191 | 0.005 | Inf | 0.005 | 1 | 76 | regulation of lipase activity |
| GO:0097756 | 0.0051 | Inf | 0.0051 | 1 | 77 | negative regulation of blood vessel diameter |
| GO:1901570 | 0.0054 | Inf | 0.0054 | 1 | 82 | fatty acid derivative biosynthetic process |
| GO:0006835 | 0.0056 | Inf | 0.0056 | 1 | 85 | dicarboxylic acid transport |
| GO:0051453 | 0.0057 | Inf | 0.0057 | 1 | 87 | regulation of intracellular pH |
| GO:0033559 | 0.0062 | Inf | 0.0062 | 1 | 94 | unsaturated fatty acid metabolic process |
| GO:0014902 | 0.0065 | Inf | 0.0065 | 1 | 99 | myotube differentiation |
| GO:0006690 | 0.0066 | Inf | 0.0066 | 1 | 101 | icosanoid metabolic process |
| GO:0030004 | 0.0068 | Inf | 0.0068 | 1 | 104 | cellular monovalent inorganic cation homeostasis |
| GO:0046717 | 0.0072 | Inf | 0.0072 | 1 | 110 | acid secretion |
| GO:0045834 | 0.0073 | Inf | 0.0073 | 1 | 111 | positive regulation of lipid metabolic process |
| GO:0035296 | 0.008 | Inf | 0.008 | 1 | 122 | regulation of tube diameter |
| GO:0050880 | 0.0085 | Inf | 0.0085 | 1 | 129 | regulation of blood vessel size |
| GO:0030307 | 0.0093 | Inf | 0.0093 | 1 | 142 | positive regulation of cell growth |
| GO:0019722 | 0.0095 | Inf | 0.0095 | 1 | 145 | calcium-mediated signaling |
| GO:0031960 | 0.0096 | Inf | 0.0096 | 1 | 146 | response to corticosteroid |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048562 | 0 | 3.8199 | 11.5591 | 38 | 277 | embryonic organ morphogenesis |
| GO:0045944 | 0 | 2.1312 | 43.5657 | 83 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048706 | 0 | 4.6626 | 5.0493 | 20 | 121 | embryonic skeletal system development |
| GO:0009790 | 0 | 2.0879 | 37.0146 | 70 | 894 | embryo development |
| GO:0010628 | 0 | 1.7486 | 71.0656 | 112 | 1703 | positive regulation of gene expression |
| GO:0045165 | 0 | 3.498 | 7.7504 | 24 | 189 | cell fate commitment |
| GO:1903508 | 0 | 1.7826 | 56.0012 | 91 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0072358 | 0 | 2.1745 | 25.622 | 51 | 614 | cardiovascular system development |
| GO:0001568 | 0 | 2.1997 | 24.3284 | 49 | 583 | blood vessel development |
| GO:0060485 | 0 | 6.869 | 2.0108 | 11 | 49 | mesenchyme development |
| GO:0032502 | 0 | 1.5376 | 144.7177 | 191 | 3821 | developmental process |
| GO:0051254 | 0 | 1.7268 | 58.8805 | 93 | 1411 | positive regulation of RNA metabolic process |
| GO:0009888 | 0 | 1.9907 | 31.2059 | 57 | 783 | tissue development |
| GO:0060562 | 0 | 2.6485 | 12.4354 | 30 | 298 | epithelial tube morphogenesis |
| GO:0051094 | 0 | 1.7883 | 47.4527 | 78 | 1143 | positive regulation of developmental process |
| GO:0051241 | 0 | 1.9911 | 29.9826 | 55 | 736 | negative regulation of multicellular organismal process |
| GO:0048705 | 0 | 2.957 | 8.5963 | 23 | 206 | skeletal system morphogenesis |
| GO:0009952 | 0 | 3.126 | 7.4591 | 21 | 180 | anterior/posterior pattern specification |
| GO:0003206 | 0 | 3.6335 | 4.9658 | 16 | 119 | cardiac chamber morphogenesis |
| GO:0035050 | 0 | 4.662 | 3.0045 | 12 | 72 | embryonic heart tube development |
| GO:0030154 | 0 | 1.8943 | 31.6675 | 55 | 852 | cell differentiation |
| GO:0030878 | 0 | 9.5499 | 1.0015 | 7 | 24 | thyroid gland development |
| GO:0031328 | 0 | 1.5876 | 70.4396 | 103 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0010454 | 0 | 19.2804 | 0.459 | 5 | 11 | negative regulation of cell fate commitment |
| GO:0048665 | 0 | 7.4294 | 1.3771 | 8 | 33 | neuron fate specification |
| GO:0042474 | 1e-04 | 11.5819 | 0.7511 | 6 | 18 | middle ear morphogenesis |
| GO:0007368 | 1e-04 | 3.6128 | 4.6737 | 15 | 112 | determination of left/right symmetry |
| GO:0007218 | 1e-04 | 4.0427 | 3.6722 | 13 | 88 | neuropeptide signaling pathway |
| GO:0048729 | 1e-04 | 2.0315 | 21.7083 | 41 | 526 | tissue morphogenesis |
| GO:0023019 | 1e-04 | 10.6902 | 0.7929 | 6 | 19 | signal transduction involved in regulation of gene expression |
| GO:0048536 | 1e-04 | 6.632 | 1.5023 | 8 | 36 | spleen development |
| GO:0071542 | 1e-04 | 6.632 | 1.5023 | 8 | 36 | dopaminergic neuron differentiation |
| GO:0010557 | 1e-04 | 1.5752 | 65.0982 | 95 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0048468 | 1e-04 | 1.6903 | 43.9402 | 69 | 1079 | cell development |
| GO:0001709 | 1e-04 | 6.423 | 1.5394 | 8 | 37 | cell fate determination |
| GO:0090596 | 1e-04 | 3.8052 | 3.8616 | 13 | 94 | sensory organ morphogenesis |
| GO:0048731 | 1e-04 | 1.4372 | 123.5688 | 160 | 3181 | system development |
| GO:0021872 | 1e-04 | 4.7455 | 2.462 | 10 | 59 | forebrain generation of neurons |
| GO:0003151 | 2e-04 | 5.2616 | 2.032 | 9 | 49 | outflow tract morphogenesis |
| GO:0051240 | 2e-04 | 1.5851 | 57.6221 | 85 | 1392 | positive regulation of multicellular organismal process |
| GO:0010469 | 2e-04 | 2.0035 | 20.3223 | 38 | 487 | regulation of receptor activity |
| GO:0009799 | 2e-04 | 3.2729 | 5.091 | 15 | 122 | specification of symmetry |
| GO:0003158 | 2e-04 | 3.4018 | 4.5903 | 14 | 110 | endothelium development |
| GO:0003002 | 2e-04 | 3.2247 | 5.1483 | 15 | 127 | regionalization |
| GO:0006355 | 2e-04 | 1.3871 | 140.8376 | 178 | 3375 | regulation of transcription, DNA-templated |
| GO:0042662 | 3e-04 | 69.2136 | 0.1669 | 3 | 4 | negative regulation of mesodermal cell fate specification |
| GO:1905903 | 3e-04 | 69.2136 | 0.1669 | 3 | 4 | negative regulation of mesoderm formation |
| GO:0030858 | 3e-04 | 5.4892 | 1.7437 | 8 | 42 | positive regulation of epithelial cell differentiation |
| GO:0043583 | 3e-04 | 2.5874 | 8.3877 | 20 | 201 | ear development |
| GO:2001141 | 4e-04 | 1.3727 | 141.9225 | 178 | 3401 | regulation of RNA biosynthetic process |
| GO:0060487 | 4e-04 | 7.7181 | 1.0015 | 6 | 24 | lung epithelial cell differentiation |
| GO:0045766 | 4e-04 | 3.0171 | 5.4666 | 15 | 131 | positive regulation of angiogenesis |
| GO:0048646 | 4e-04 | 2.026 | 16.8722 | 32 | 424 | anatomical structure formation involved in morphogenesis |
| GO:0035909 | 4e-04 | 6.0088 | 1.4188 | 7 | 34 | aorta morphogenesis |
| GO:0022008 | 5e-04 | 1.5291 | 58.6719 | 84 | 1406 | neurogenesis |
| GO:0045992 | 5e-04 | 7.3114 | 1.0432 | 6 | 25 | negative regulation of embryonic development |
| GO:2000738 | 5e-04 | 9.6362 | 0.7094 | 5 | 17 | positive regulation of stem cell differentiation |
| GO:1901342 | 5e-04 | 2.2944 | 10.7662 | 23 | 258 | regulation of vasculature development |
| GO:0048762 | 6e-04 | 2.5648 | 7.5948 | 18 | 182 | mesenchymal cell differentiation |
| GO:0060455 | 7e-04 | 34.6044 | 0.2086 | 3 | 5 | negative regulation of gastric acid secretion |
| GO:0061009 | 7e-04 | 34.6044 | 0.2086 | 3 | 5 | common bile duct development |
| GO:2000026 | 7e-04 | 1.8026 | 24.2065 | 41 | 614 | regulation of multicellular organismal development |
| GO:0048645 | 7e-04 | 4.1785 | 2.462 | 9 | 59 | animal organ formation |
| GO:0061458 | 7e-04 | 1.9769 | 16.6919 | 31 | 400 | reproductive system development |
| GO:0008284 | 7e-04 | 1.6763 | 32.9132 | 52 | 792 | positive regulation of cell proliferation |
| GO:0048736 | 8e-04 | 2.5942 | 7.094 | 17 | 170 | appendage development |
| GO:0061061 | 8e-04 | 1.788 | 24.3284 | 41 | 583 | muscle structure development |
| GO:0006334 | 8e-04 | 3.0576 | 4.6737 | 13 | 112 | nucleosome assembly |
| GO:0048332 | 9e-04 | 3.6874 | 3.0463 | 10 | 73 | mesoderm morphogenesis |
| GO:0001710 | 9e-04 | 8.2585 | 0.7929 | 5 | 19 | mesodermal cell fate commitment |
| GO:0008630 | 9e-04 | 3.1725 | 4.173 | 12 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0010470 | 0.001 | 5.0682 | 1.6275 | 7 | 39 | regulation of gastrulation |
| GO:0030855 | 0.0011 | 1.797 | 22.4032 | 38 | 547 | epithelial cell differentiation |
| GO:0035108 | 0.0011 | 2.6896 | 6.0508 | 15 | 145 | limb morphogenesis |
| GO:0009605 | 0.0011 | 1.4202 | 79.6619 | 106 | 1909 | response to external stimulus |
| GO:0042659 | 0.0011 | 11.5483 | 0.5008 | 4 | 12 | regulation of cell fate specification |
| GO:0097154 | 0.0011 | 11.5483 | 0.5008 | 4 | 12 | GABAergic neuron differentiation |
| GO:0022603 | 0.0012 | 1.7184 | 26.4846 | 43 | 646 | regulation of anatomical structure morphogenesis |
| GO:0021902 | 0.0013 | 23.068 | 0.2504 | 3 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0032109 | 0.0013 | 23.068 | 0.2504 | 3 | 6 | positive regulation of response to nutrient levels |
| GO:0042713 | 0.0013 | 23.068 | 0.2504 | 3 | 6 | sperm ejaculation |
| GO:2001199 | 0.0013 | 23.068 | 0.2504 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0048863 | 0.0014 | 2.2529 | 9.4914 | 20 | 229 | stem cell differentiation |
| GO:0051954 | 0.0016 | 5.5543 | 1.2936 | 6 | 31 | positive regulation of amine transport |
| GO:0060041 | 0.0016 | 2.6721 | 5.6752 | 14 | 136 | retina development in camera-type eye |
| GO:0045596 | 0.0017 | 1.7192 | 24.5686 | 40 | 593 | negative regulation of cell differentiation |
| GO:0048486 | 0.0017 | Inf | 0.083 | 2 | 2 | parasympathetic nervous system development |
| GO:0002930 | 0.0017 | Inf | 0.0835 | 2 | 2 | trabecular meshwork development |
| GO:0043134 | 0.0017 | Inf | 0.0835 | 2 | 2 | regulation of hindgut contraction |
| GO:1901207 | 0.0017 | Inf | 0.0835 | 2 | 2 | regulation of heart looping |
| GO:1901246 | 0.0017 | Inf | 0.0835 | 2 | 2 | regulation of lung ciliated cell differentiation |
| GO:2000824 | 0.0017 | Inf | 0.0835 | 2 | 2 | negative regulation of androgen receptor activity |
| GO:2001037 | 0.0017 | Inf | 0.0835 | 2 | 2 | positive regulation of tongue muscle cell differentiation |
| GO:0009887 | 0.0017 | 2.1151 | 11.0647 | 22 | 281 | animal organ morphogenesis |
| GO:0048644 | 0.0018 | 3.317 | 3.3384 | 10 | 80 | muscle organ morphogenesis |
| GO:0034754 | 0.0018 | 2.9065 | 4.5068 | 12 | 108 | cellular hormone metabolic process |
| GO:0016338 | 0.0018 | 6.7997 | 0.9181 | 5 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0007601 | 0.0018 | 2.3744 | 7.6783 | 17 | 184 | visual perception |
| GO:0001947 | 0.0019 | 3.9585 | 2.2882 | 8 | 55 | heart looping |
| GO:0048857 | 0.0019 | 3.9458 | 2.2951 | 8 | 55 | neural nucleus development |
| GO:0060537 | 0.0019 | 1.9359 | 14.7723 | 27 | 354 | muscle tissue development |
| GO:0010951 | 0.0019 | 2.2955 | 8.3877 | 18 | 201 | negative regulation of endopeptidase activity |
| GO:0043062 | 0.0019 | 1.9917 | 13.3118 | 25 | 319 | extracellular structure organization |
| GO:0001523 | 0.0019 | 3.2701 | 3.3801 | 10 | 81 | retinoid metabolic process |
| GO:0042475 | 0.0019 | 3.2701 | 3.3801 | 10 | 81 | odontogenesis of dentin-containing tooth |
| GO:0021953 | 0.002 | 2.7249 | 5.172 | 13 | 125 | central nervous system neuron differentiation |
| GO:0051173 | 0.002 | 1.3386 | 113.6716 | 142 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0001818 | 0.0021 | 2.218 | 9.1388 | 19 | 219 | negative regulation of cytokine production |
| GO:0048701 | 0.0021 | 4.3818 | 1.8361 | 7 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0051216 | 0.0022 | 2.4059 | 7.1358 | 16 | 171 | cartilage development |
| GO:0048583 | 0.0022 | 1.3037 | 150.0598 | 181 | 3596 | regulation of response to stimulus |
| GO:0021798 | 0.0022 | 17.2998 | 0.2921 | 3 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0034127 | 0.0022 | 17.2998 | 0.2921 | 3 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0090103 | 0.0022 | 6.4215 | 0.9598 | 5 | 23 | cochlea morphogenesis |
| GO:0007275 | 0.0023 | 2.0027 | 12.7814 | 24 | 361 | multicellular organism development |
| GO:0032355 | 0.0023 | 2.6762 | 5.2579 | 13 | 126 | response to estradiol |
| GO:0035113 | 0.0023 | 2.6762 | 5.2579 | 13 | 126 | embryonic appendage morphogenesis |
| GO:0060322 | 0.0024 | 1.6406 | 28.251 | 44 | 677 | head development |
| GO:0035176 | 0.0024 | 4.2662 | 1.8778 | 7 | 45 | social behavior |
| GO:0060541 | 0.0026 | 2.2911 | 7.9286 | 17 | 190 | respiratory system development |
| GO:0007423 | 0.0026 | 2.3516 | 7.2769 | 16 | 180 | sensory organ development |
| GO:0007565 | 0.0027 | 2.3447 | 7.3027 | 16 | 175 | female pregnancy |
| GO:0001975 | 0.0027 | 6.0831 | 1.0015 | 5 | 24 | response to amphetamine |
| GO:0061217 | 0.0027 | 6.0831 | 1.0015 | 5 | 24 | regulation of mesonephros development |
| GO:0048771 | 0.0028 | 2.5062 | 6.0091 | 14 | 144 | tissue remodeling |
| GO:0009950 | 0.0028 | 8.3971 | 0.6259 | 4 | 15 | dorsal/ventral axis specification |
| GO:0021783 | 0.0028 | 8.3971 | 0.6259 | 4 | 15 | preganglionic parasympathetic fiber development |
| GO:0033189 | 0.0028 | 8.3971 | 0.6259 | 4 | 15 | response to vitamin A |
| GO:0071599 | 0.0028 | 8.3971 | 0.6259 | 4 | 15 | otic vesicle development |
| GO:0070848 | 0.0029 | 1.6515 | 26.1228 | 41 | 626 | response to growth factor |
| GO:0010665 | 0.003 | 4.7869 | 1.4605 | 6 | 35 | regulation of cardiac muscle cell apoptotic process |
| GO:0030509 | 0.0032 | 2.4679 | 6.0925 | 14 | 146 | BMP signaling pathway |
| GO:0022414 | 0.0032 | 1.4485 | 53.1218 | 73 | 1273 | reproductive process |
| GO:0003148 | 0.0033 | 5.7786 | 1.0432 | 5 | 25 | outflow tract septum morphogenesis |
| GO:0060037 | 0.0033 | 5.7786 | 1.0432 | 5 | 25 | pharyngeal system development |
| GO:0045926 | 0.0034 | 2.1636 | 8.8467 | 18 | 212 | negative regulation of growth |
| GO:0010940 | 0.0035 | 13.8389 | 0.3338 | 3 | 8 | positive regulation of necrotic cell death |
| GO:0030916 | 0.0035 | 13.8389 | 0.3338 | 3 | 8 | otic vesicle formation |
| GO:1905770 | 0.0035 | 13.8389 | 0.3338 | 3 | 8 | regulation of mesodermal cell differentiation |
| GO:0008406 | 0.0035 | 2.2134 | 8.179 | 17 | 196 | gonad development |
| GO:0006590 | 0.0037 | 7.6968 | 0.6677 | 4 | 16 | thyroid hormone generation |
| GO:0060255 | 0.0038 | 1.251 | 232.601 | 265 | 5574 | regulation of macromolecule metabolic process |
| GO:0042221 | 0.0039 | 1.5274 | 37.4236 | 54 | 943 | response to chemical |
| GO:0030818 | 0.004 | 4.4775 | 1.544 | 6 | 37 | negative regulation of cAMP biosynthetic process |
| GO:0031076 | 0.004 | 4.4775 | 1.544 | 6 | 37 | embryonic camera-type eye development |
| GO:0030099 | 0.004 | 1.8496 | 14.814 | 26 | 355 | myeloid cell differentiation |
| GO:0034654 | 0.0041 | 1.2709 | 166.3761 | 196 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0001525 | 0.0041 | 1.9564 | 11.8772 | 22 | 289 | angiogenesis |
| GO:0046661 | 0.0043 | 2.377 | 6.3012 | 14 | 151 | male sex differentiation |
| GO:0009889 | 0.0044 | 1.322 | 106.2018 | 131 | 2632 | regulation of biosynthetic process |
| GO:0055008 | 0.0045 | 3.37 | 2.629 | 8 | 63 | cardiac muscle tissue morphogenesis |
| GO:0060021 | 0.0046 | 2.8644 | 3.7974 | 10 | 91 | palate development |
| GO:0021514 | 0.0046 | 7.1042 | 0.7094 | 4 | 17 | ventral spinal cord interneuron differentiation |
| GO:0055012 | 0.0046 | 7.1042 | 0.7094 | 4 | 17 | ventricular cardiac muscle cell differentiation |
| GO:0001704 | 0.0047 | 2.5576 | 5.0493 | 12 | 121 | formation of primary germ layer |
| GO:0007492 | 0.0047 | 3.0686 | 3.2132 | 9 | 77 | endoderm development |
| GO:0021602 | 0.0047 | 5.2525 | 1.1267 | 5 | 27 | cranial nerve morphogenesis |
| GO:1903555 | 0.0047 | 2.6882 | 4.4233 | 11 | 106 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0065007 | 0.0047 | 1.2708 | 439.288 | 469 | 10527 | biological regulation |
| GO:0043069 | 0.0047 | 1.5357 | 33.4672 | 49 | 802 | negative regulation of programmed cell death |
| GO:0035295 | 0.0048 | 1.8209 | 15.0232 | 26 | 369 | tube development |
| GO:2000027 | 0.0048 | 2.0418 | 9.8482 | 19 | 236 | regulation of organ morphogenesis |
| GO:0050877 | 0.0048 | 1.5145 | 36.0127 | 52 | 863 | nervous system process |
| GO:0070887 | 0.0049 | 1.301 | 114.5061 | 140 | 2744 | cellular response to chemical stimulus |
| GO:0001657 | 0.0049 | 2.8293 | 3.8391 | 10 | 92 | ureteric bud development |
| GO:0043587 | 0.005 | 11.5316 | 0.3756 | 3 | 9 | tongue morphogenesis |
| GO:0048387 | 0.005 | 11.5316 | 0.3756 | 3 | 9 | negative regulation of retinoic acid receptor signaling pathway |
| GO:0060180 | 0.005 | 11.5316 | 0.3756 | 3 | 9 | female mating behavior |
| GO:0072172 | 0.005 | 11.5316 | 0.3756 | 3 | 9 | mesonephric tubule formation |
| GO:2000288 | 0.005 | 11.5316 | 0.3756 | 3 | 9 | positive regulation of myoblast proliferation |
| GO:0002125 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | maternal aggressive behavior |
| GO:0003285 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | septum secundum development |
| GO:0003350 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | pulmonary myocardium development |
| GO:0014717 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0021912 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035054 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0038162 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | erythropoietin-mediated signaling pathway |
| GO:0055014 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0060061 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | Spemann organizer formation |
| GO:0060741 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0060913 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | cardiac cell fate determination |
| GO:0061010 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | gall bladder development |
| GO:0061031 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:0061737 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | leukotriene signaling pathway |
| GO:0070634 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | transepithelial ammonium transport |
| GO:0072190 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | ureter urothelium development |
| GO:1902809 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | regulation of skeletal muscle fiber differentiation |
| GO:1902869 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | regulation of amacrine cell differentiation |
| GO:2000297 | 0.0051 | 46.0695 | 0.1252 | 2 | 3 | negative regulation of synapse maturation |
| GO:0072163 | 0.0053 | 2.795 | 3.8809 | 10 | 93 | mesonephric epithelium development |
| GO:0007507 | 0.0053 | 1.8797 | 12.8858 | 23 | 314 | heart development |
| GO:0035116 | 0.0055 | 5.0238 | 1.1684 | 5 | 28 | embryonic hindlimb morphogenesis |
| GO:0060441 | 0.0055 | 5.0238 | 1.1684 | 5 | 28 | epithelial tube branching involved in lung morphogenesis |
| GO:0001759 | 0.0058 | 6.5963 | 0.7511 | 4 | 18 | organ induction |
| GO:0045603 | 0.0058 | 6.5963 | 0.7511 | 4 | 18 | positive regulation of endothelial cell differentiation |
| GO:1903055 | 0.0058 | 6.5963 | 0.7511 | 4 | 18 | positive regulation of extracellular matrix organization |
| GO:1905276 | 0.0058 | 6.5963 | 0.7511 | 4 | 18 | regulation of epithelial tube formation |
| GO:0019219 | 0.0058 | 1.31 | 105.1471 | 129 | 2603 | regulation of nucleobase-containing compound metabolic process |
| GO:0051291 | 0.0058 | 2.6054 | 4.5485 | 11 | 109 | protein heterooligomerization |
| GO:0010658 | 0.0059 | 4.0815 | 1.6692 | 6 | 40 | striated muscle cell apoptotic process |
| GO:0061138 | 0.006 | 2.2087 | 7.2192 | 15 | 173 | morphogenesis of a branching epithelium |
| GO:0050678 | 0.006 | 1.9216 | 11.5174 | 21 | 276 | regulation of epithelial cell proliferation |
| GO:0048592 | 0.0061 | 2.3601 | 5.8839 | 13 | 141 | eye morphogenesis |
| GO:0045934 | 0.0062 | 1.4007 | 55.4587 | 74 | 1329 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0007631 | 0.0063 | 3.1607 | 2.7792 | 8 | 67 | feeding behavior |
| GO:0003203 | 0.0064 | 4.8142 | 1.2102 | 5 | 29 | endocardial cushion morphogenesis |
| GO:0042755 | 0.0064 | 4.8142 | 1.2102 | 5 | 29 | eating behavior |
| GO:0071300 | 0.0066 | 3.1407 | 2.7959 | 8 | 67 | cellular response to retinoic acid |
| GO:0033993 | 0.0066 | 1.5491 | 29.056 | 43 | 708 | response to lipid |
| GO:0003279 | 0.0067 | 2.6969 | 4.006 | 10 | 96 | cardiac septum development |
| GO:0030814 | 0.0068 | 2.4231 | 5.2997 | 12 | 127 | regulation of cAMP metabolic process |
| GO:0035051 | 0.0068 | 2.4231 | 5.2997 | 12 | 127 | cardiocyte differentiation |
| GO:0048565 | 0.0068 | 2.4231 | 5.2997 | 12 | 127 | digestive tract development |
| GO:0052652 | 0.0069 | 2.3235 | 5.9673 | 13 | 143 | cyclic purine nucleotide metabolic process |
| GO:0060284 | 0.0069 | 1.5146 | 32.4657 | 47 | 778 | regulation of cell development |
| GO:0003008 | 0.0069 | 1.5623 | 27.4969 | 41 | 677 | system process |
| GO:0048534 | 0.0069 | 1.5212 | 31.637 | 46 | 766 | hematopoietic or lymphoid organ development |
| GO:0003211 | 0.007 | 9.8836 | 0.4173 | 3 | 10 | cardiac ventricle formation |
| GO:0061072 | 0.007 | 9.8836 | 0.4173 | 3 | 10 | iris morphogenesis |
| GO:0043154 | 0.007 | 2.8575 | 3.4218 | 9 | 82 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0002888 | 0.0071 | 6.1562 | 0.7929 | 4 | 19 | positive regulation of myeloid leukocyte mediated immunity |
| GO:0003215 | 0.0071 | 6.1562 | 0.7929 | 4 | 19 | cardiac right ventricle morphogenesis |
| GO:0060216 | 0.0071 | 6.1562 | 0.7929 | 4 | 19 | definitive hemopoiesis |
| GO:0072087 | 0.0071 | 6.1562 | 0.7929 | 4 | 19 | renal vesicle development |
| GO:0006721 | 0.0072 | 2.6657 | 4.0478 | 10 | 97 | terpenoid metabolic process |
| GO:0019098 | 0.0075 | 4.6213 | 1.2519 | 5 | 30 | reproductive behavior |
| GO:0030809 | 0.0075 | 3.8543 | 1.7526 | 6 | 42 | negative regulation of nucleotide biosynthetic process |
| GO:0016331 | 0.0077 | 2.288 | 6.0508 | 13 | 145 | morphogenesis of embryonic epithelium |
| GO:0009890 | 0.0078 | 1.3638 | 63.0952 | 82 | 1512 | negative regulation of biosynthetic process |
| GO:0043009 | 0.0081 | 1.7203 | 16.4374 | 27 | 405 | chordate embryonic development |
| GO:0090130 | 0.0081 | 1.9332 | 10.349 | 19 | 248 | tissue migration |
| GO:0001667 | 0.0081 | 1.8071 | 13.3565 | 23 | 321 | ameboidal-type cell migration |
| GO:0042472 | 0.0082 | 3.0084 | 2.9025 | 8 | 70 | inner ear morphogenesis |
| GO:0010660 | 0.0084 | 3.306 | 2.3369 | 7 | 56 | regulation of muscle cell apoptotic process |
| GO:0030800 | 0.0084 | 3.7498 | 1.7944 | 6 | 43 | negative regulation of cyclic nucleotide metabolic process |
| GO:0032720 | 0.0084 | 3.7498 | 1.7944 | 6 | 43 | negative regulation of tumor necrosis factor production |
| GO:0050433 | 0.0084 | 3.7498 | 1.7944 | 6 | 43 | regulation of catecholamine secretion |
| GO:0021544 | 0.0085 | 5.771 | 0.8346 | 4 | 20 | subpallium development |
| GO:0043032 | 0.0085 | 5.771 | 0.8346 | 4 | 20 | positive regulation of macrophage activation |
| GO:0043302 | 0.0085 | 5.771 | 0.8346 | 4 | 20 | positive regulation of leukocyte degranulation |
| GO:0021522 | 0.0086 | 4.4432 | 1.2936 | 5 | 31 | spinal cord motor neuron differentiation |
| GO:0043537 | 0.0086 | 4.4432 | 1.2936 | 5 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0051960 | 0.0087 | 1.5058 | 31.2138 | 45 | 748 | regulation of nervous system development |
| GO:0071773 | 0.009 | 8.7633 | 0.4533 | 3 | 11 | cellular response to BMP stimulus |
| GO:0009111 | 0.0093 | 8.6475 | 0.459 | 3 | 11 | vitamin catabolic process |
| GO:0021903 | 0.0093 | 8.6475 | 0.459 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0043116 | 0.0093 | 8.6475 | 0.459 | 3 | 11 | negative regulation of vascular permeability |
| GO:0048484 | 0.0093 | 8.6475 | 0.459 | 3 | 11 | enteric nervous system development |
| GO:0060573 | 0.0093 | 8.6475 | 0.459 | 3 | 11 | cell fate specification involved in pattern specification |
| GO:1903140 | 0.0093 | 8.6475 | 0.459 | 3 | 11 | regulation of establishment of endothelial barrier |
| GO:0030802 | 0.0097 | 2.302 | 5.55 | 12 | 133 | regulation of cyclic nucleotide biosynthetic process |
| GO:0021877 | 0.0098 | 23.1381 | 0.1662 | 2 | 4 | forebrain neuron fate commitment |
| GO:0001992 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0002580 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0003308 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0007621 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | negative regulation of female receptivity |
| GO:0008078 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | mesodermal cell migration |
| GO:0010701 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | positive regulation of norepinephrine secretion |
| GO:0021764 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | amygdala development |
| GO:0021913 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0032100 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | positive regulation of appetite |
| GO:0034653 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | retinoic acid catabolic process |
| GO:0048866 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | stem cell fate specification |
| GO:0060406 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | positive regulation of penile erection |
| GO:0060920 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | cardiac pacemaker cell differentiation |
| GO:0061055 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | myotome development |
| GO:0072107 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0072193 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | ureter smooth muscle cell differentiation |
| GO:0090191 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:1905205 | 0.0099 | 23.0332 | 0.1669 | 2 | 4 | positive regulation of connective tissue replacement |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070848 | 0 | 4.8161 | 3.6613 | 15 | 626 | response to growth factor |
| GO:0001568 | 0 | 4.7762 | 3.4098 | 14 | 583 | blood vessel development |
| GO:0072358 | 0 | 4.5198 | 3.5911 | 14 | 614 | cardiovascular system development |
| GO:0051254 | 0 | 3.2479 | 8.2525 | 22 | 1411 | positive regulation of RNA metabolic process |
| GO:1903508 | 0 | 3.2278 | 7.849 | 21 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0048869 | 0 | 2.4455 | 22.3772 | 40 | 3826 | cellular developmental process |
| GO:0009719 | 0 | 3.0939 | 8.1531 | 21 | 1394 | response to endogenous stimulus |
| GO:2000026 | 1e-04 | 3.2173 | 7.1259 | 19 | 1319 | regulation of multicellular organismal development |
| GO:0060485 | 1e-04 | 6.6013 | 1.3511 | 8 | 231 | mesenchyme development |
| GO:0010557 | 1e-04 | 2.9014 | 9.124 | 22 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:0045777 | 1e-04 | 20.8913 | 0.2223 | 4 | 38 | positive regulation of blood pressure |
| GO:0007178 | 1e-04 | 5.6178 | 1.7897 | 9 | 306 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0060191 | 1e-04 | 12.6232 | 0.4445 | 5 | 76 | regulation of lipase activity |
| GO:0045944 | 1e-04 | 3.291 | 6.0321 | 17 | 1043 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0003198 | 1e-04 | 37.6595 | 0.0994 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0051241 | 1e-04 | 3.2723 | 5.6562 | 16 | 978 | negative regulation of multicellular organismal process |
| GO:0010518 | 1e-04 | 16.9031 | 0.269 | 4 | 46 | positive regulation of phospholipase activity |
| GO:0009887 | 2e-04 | 3.5282 | 4.559 | 14 | 819 | animal organ morphogenesis |
| GO:0060216 | 2e-04 | 32.9477 | 0.1111 | 3 | 19 | definitive hemopoiesis |
| GO:0001994 | 2e-04 | 173.8621 | 0.0234 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0031328 | 2e-04 | 2.6533 | 9.8726 | 22 | 1688 | positive regulation of cellular biosynthetic process |
| GO:0071560 | 2e-04 | 6.2451 | 1.2341 | 7 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0003181 | 2e-04 | 29.2829 | 0.1228 | 3 | 21 | atrioventricular valve morphogenesis |
| GO:0010628 | 3e-04 | 2.6267 | 9.9604 | 22 | 1703 | positive regulation of gene expression |
| GO:0060538 | 3e-04 | 7.2672 | 0.9066 | 6 | 155 | skeletal muscle organ development |
| GO:0071773 | 3e-04 | 7.17 | 0.9182 | 6 | 157 | cellular response to BMP stimulus |
| GO:0051240 | 4e-04 | 2.7129 | 8.1719 | 19 | 1413 | positive regulation of multicellular organismal process |
| GO:0050789 | 4e-04 | 2.4185 | 58.2533 | 73 | 9960 | regulation of biological process |
| GO:0023052 | 5e-04 | 2.0635 | 32.3083 | 48 | 5524 | signaling |
| GO:0003278 | 5e-04 | 86.9195 | 0.0351 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:2000489 | 5e-04 | 86.9195 | 0.0351 | 2 | 6 | regulation of hepatic stellate cell activation |
| GO:0042221 | 5e-04 | 2.1352 | 21.5642 | 36 | 3687 | response to chemical |
| GO:0035914 | 6e-04 | 11.6235 | 0.3802 | 4 | 65 | skeletal muscle cell differentiation |
| GO:0003203 | 6e-04 | 20.2621 | 0.1696 | 3 | 29 | endocardial cushion morphogenesis |
| GO:1903706 | 6e-04 | 4.1422 | 2.3921 | 9 | 409 | regulation of hemopoiesis |
| GO:0042060 | 6e-04 | 3.7975 | 2.9127 | 10 | 498 | wound healing |
| GO:0045650 | 7e-04 | 69.531 | 0.0409 | 2 | 7 | negative regulation of macrophage differentiation |
| GO:0070371 | 7e-04 | 5.101 | 1.4973 | 7 | 256 | ERK1 and ERK2 cascade |
| GO:0071345 | 8e-04 | 3.1045 | 4.6965 | 13 | 803 | cellular response to cytokine stimulus |
| GO:0045907 | 8e-04 | 18.8123 | 0.1813 | 3 | 31 | positive regulation of vasoconstriction |
| GO:1903522 | 8e-04 | 4.9989 | 1.5265 | 7 | 261 | regulation of blood circulation |
| GO:0071260 | 9e-04 | 10.2704 | 0.427 | 4 | 73 | cellular response to mechanical stimulus |
| GO:0032502 | 9e-04 | 3.013 | 6.3296 | 15 | 1469 | developmental process |
| GO:0090288 | 9e-04 | 7.2614 | 0.7486 | 5 | 128 | negative regulation of cellular response to growth factor stimulus |
| GO:0001837 | 0.001 | 7.2024 | 0.7545 | 5 | 129 | epithelial to mesenchymal transition |
| GO:1900274 | 0.001 | 16.9884 | 0.1989 | 3 | 34 | regulation of phospholipase C activity |
| GO:0097756 | 0.0011 | 9.7051 | 0.4504 | 4 | 77 | negative regulation of blood vessel diameter |
| GO:0072073 | 0.0011 | 6.9209 | 0.7837 | 5 | 134 | kidney epithelium development |
| GO:0007154 | 0.0011 | 1.9606 | 32.4253 | 47 | 5544 | cell communication |
| GO:0001501 | 0.0012 | 4.7138 | 1.6196 | 7 | 290 | skeletal system development |
| GO:0045638 | 0.0012 | 9.445 | 0.462 | 4 | 79 | negative regulation of myeloid cell differentiation |
| GO:0001993 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
| GO:0043589 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | skin morphogenesis |
| GO:0072537 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | fibroblast activation |
| GO:2000304 | 0.0012 | 49.6585 | 0.0526 | 2 | 9 | positive regulation of ceramide biosynthetic process |
| GO:0045597 | 0.0012 | 4.1574 | 2.1128 | 8 | 385 | positive regulation of cell differentiation |
| GO:0043009 | 0.0012 | 3.4662 | 3.1759 | 10 | 543 | chordate embryonic development |
| GO:0055002 | 0.0013 | 6.6604 | 0.813 | 5 | 139 | striated muscle cell development |
| GO:0090257 | 0.0013 | 5.3685 | 1.2107 | 6 | 207 | regulation of muscle system process |
| GO:0045595 | 0.0014 | 3.2469 | 3.8189 | 11 | 752 | regulation of cell differentiation |
| GO:0030510 | 0.0014 | 8.9644 | 0.4854 | 4 | 83 | regulation of BMP signaling pathway |
| GO:0033690 | 0.0015 | 43.4483 | 0.0585 | 2 | 10 | positive regulation of osteoblast proliferation |
| GO:0001892 | 0.0015 | 8.7419 | 0.4971 | 4 | 85 | embryonic placenta development |
| GO:0009888 | 0.0016 | 2.5748 | 7.1284 | 16 | 1320 | tissue development |
| GO:0032964 | 0.0016 | 14.2278 | 0.2339 | 3 | 40 | collagen biosynthetic process |
| GO:0055078 | 0.0016 | 14.2278 | 0.2339 | 3 | 40 | sodium ion homeostasis |
| GO:0001976 | 0.0018 | 38.6181 | 0.0643 | 2 | 11 | neurological system process involved in regulation of systemic arterial blood pressure |
| GO:0007512 | 0.0018 | 38.6181 | 0.0643 | 2 | 11 | adult heart development |
| GO:0009968 | 0.0019 | 2.585 | 6.5213 | 15 | 1115 | negative regulation of signal transduction |
| GO:0060021 | 0.002 | 8.1358 | 0.5322 | 4 | 91 | palate development |
| GO:0003205 | 0.002 | 6.0248 | 0.8949 | 5 | 153 | cardiac chamber development |
| GO:0061061 | 0.0021 | 3.2154 | 3.4098 | 10 | 583 | muscle structure development |
| GO:0003184 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | pulmonary valve morphogenesis |
| GO:0060536 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | cartilage morphogenesis |
| GO:0060707 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | trophoblast giant cell differentiation |
| GO:0097154 | 0.0021 | 34.754 | 0.0702 | 2 | 12 | GABAergic neuron differentiation |
| GO:0051093 | 0.0023 | 2.8467 | 4.6672 | 12 | 807 | negative regulation of developmental process |
| GO:0007200 | 0.0023 | 7.7761 | 0.5556 | 4 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0070208 | 0.0025 | 31.5925 | 0.076 | 2 | 13 | protein heterotrimerization |
| GO:0071880 | 0.0025 | 31.5925 | 0.076 | 2 | 13 | adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0009790 | 0.0026 | 2.6851 | 5.375 | 13 | 919 | embryo development |
| GO:0007219 | 0.0026 | 5.676 | 0.9475 | 5 | 162 | Notch signaling pathway |
| GO:0048646 | 0.0026 | 3.3537 | 2.9465 | 9 | 545 | anatomical structure formation involved in morphogenesis |
| GO:0003002 | 0.0027 | 4.0274 | 1.8774 | 7 | 321 | regionalization |
| GO:0051173 | 0.0029 | 2.0072 | 15.9319 | 27 | 2724 | positive regulation of nitrogen compound metabolic process |
| GO:0001525 | 0.0029 | 3.5808 | 2.4232 | 8 | 419 | angiogenesis |
| GO:0090153 | 0.0029 | 28.9579 | 0.0819 | 2 | 14 | regulation of sphingolipid biosynthetic process |
| GO:0006936 | 0.003 | 3.9503 | 1.9125 | 7 | 327 | muscle contraction |
| GO:0019218 | 0.0031 | 7.1439 | 0.6024 | 4 | 103 | regulation of steroid metabolic process |
| GO:0035904 | 0.0033 | 10.9593 | 0.2983 | 3 | 51 | aorta development |
| GO:0007204 | 0.0033 | 4.4467 | 1.4505 | 6 | 248 | positive regulation of cytosolic calcium ion concentration |
| GO:0060977 | 0.0034 | 26.7286 | 0.0877 | 2 | 15 | coronary vasculature morphogenesis |
| GO:0008285 | 0.0037 | 2.962 | 3.6847 | 10 | 630 | negative regulation of cell proliferation |
| GO:0060348 | 0.0037 | 5.2064 | 1.0294 | 5 | 176 | bone development |
| GO:1905314 | 0.0038 | 24.8177 | 0.0936 | 2 | 16 | semi-lunar valve development |
| GO:0045834 | 0.0041 | 6.6063 | 0.6492 | 4 | 111 | positive regulation of lipid metabolic process |
| GO:0048146 | 0.0041 | 10.1136 | 0.3217 | 3 | 55 | positive regulation of fibroblast proliferation |
| GO:0007166 | 0.0042 | 2.0415 | 13.151 | 23 | 2357 | cell surface receptor signaling pathway |
| GO:0060004 | 0.0043 | 23.1617 | 0.0994 | 2 | 17 | reflex |
| GO:0042476 | 0.0045 | 6.4248 | 0.6668 | 4 | 114 | odontogenesis |
| GO:0044259 | 0.0048 | 6.3092 | 0.6785 | 4 | 116 | multicellular organismal macromolecule metabolic process |
| GO:0055093 | 0.0049 | 21.7126 | 0.1053 | 2 | 18 | response to hyperoxia |
| GO:0072001 | 0.0049 | 4.0858 | 1.5733 | 6 | 269 | renal system development |
| GO:0035295 | 0.005 | 3.0103 | 3.2402 | 9 | 554 | tube development |
| GO:0048738 | 0.0051 | 4.8079 | 1.1113 | 5 | 190 | cardiac muscle tissue development |
| GO:0010720 | 0.0053 | 3.2289 | 2.6729 | 8 | 457 | positive regulation of cell development |
| GO:0050767 | 0.0054 | 2.797 | 3.8894 | 10 | 665 | regulation of neurogenesis |
| GO:0035809 | 0.0054 | 20.4341 | 0.1111 | 2 | 19 | regulation of urine volume |
| GO:0035813 | 0.0054 | 20.4341 | 0.1111 | 2 | 19 | regulation of renal sodium excretion |
| GO:0051716 | 0.0056 | 1.7558 | 36.6481 | 49 | 6266 | cellular response to stimulus |
| GO:0035296 | 0.0057 | 5.986 | 0.7135 | 4 | 122 | regulation of tube diameter |
| GO:0007588 | 0.0057 | 8.9095 | 0.3626 | 3 | 62 | excretion |
| GO:0048844 | 0.0057 | 8.9095 | 0.3626 | 3 | 62 | artery morphogenesis |
| GO:0048545 | 0.0058 | 3.492 | 2.1523 | 7 | 368 | response to steroid hormone |
| GO:0001985 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure |
| GO:0002041 | 0.0058 | Inf | 0.0058 | 1 | 1 | intussusceptive angiogenesis |
| GO:0007199 | 0.0058 | Inf | 0.0058 | 1 | 1 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
| GO:0010725 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of primitive erythrocyte differentiation |
| GO:0010734 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of protein glutathionylation |
| GO:0010805 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of lysine import |
| GO:0010963 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of L-arginine import |
| GO:0035854 | 0.0058 | Inf | 0.0058 | 1 | 1 | eosinophil fate commitment |
| GO:0050894 | 0.0058 | Inf | 0.0058 | 1 | 1 | determination of affect |
| GO:0060806 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of cell differentiation involved in embryonic placenta development |
| GO:0060981 | 0.0058 | Inf | 0.0058 | 1 | 1 | cell migration involved in coronary angiogenesis |
| GO:0097275 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular ammonia homeostasis |
| GO:0097276 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular creatinine homeostasis |
| GO:0097277 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular urea homeostasis |
| GO:0140076 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of lipoprotein transport |
| GO:1902618 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular response to fluoride |
| GO:1902867 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:1905010 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of L-lysine import across plasma membrane |
| GO:1905589 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of L-arginine import across plasma membrane |
| GO:2000763 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process |
| GO:2000764 | 0.0058 | Inf | 0.0058 | 1 | 1 | positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis |
| GO:2001260 | 0.0058 | Inf | 0.0058 | 1 | 1 | regulation of semaphorin-plexin signaling pathway |
| GO:0003281 | 0.006 | 8.7605 | 0.3685 | 3 | 63 | ventricular septum development |
| GO:0035929 | 0.006 | 19.2976 | 0.117 | 2 | 20 | steroid hormone secretion |
| GO:0001649 | 0.0061 | 4.6062 | 1.158 | 5 | 198 | osteoblast differentiation |
| GO:0055074 | 0.0062 | 3.4431 | 2.1816 | 7 | 373 | calcium ion homeostasis |
| GO:0032355 | 0.0064 | 5.7882 | 0.7369 | 4 | 126 | response to estradiol |
| GO:0003013 | 0.0064 | 3.1144 | 2.7664 | 8 | 473 | circulatory system process |
| GO:0060411 | 0.0065 | 8.4767 | 0.3802 | 3 | 65 | cardiac septum morphogenesis |
| GO:0007423 | 0.0066 | 3.1063 | 2.7767 | 8 | 485 | sensory organ development |
| GO:0043586 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | tongue development |
| GO:0048485 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | sympathetic nervous system development |
| GO:0060713 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | labyrinthine layer morphogenesis |
| GO:2000679 | 0.0066 | 18.2807 | 0.1228 | 2 | 21 | positive regulation of transcription regulatory region DNA binding |
| GO:0045652 | 0.0068 | 8.3416 | 0.386 | 3 | 66 | regulation of megakaryocyte differentiation |
| GO:0045444 | 0.0069 | 4.4655 | 1.1931 | 5 | 204 | fat cell differentiation |
| GO:0050880 | 0.0069 | 5.6482 | 0.7545 | 4 | 129 | regulation of blood vessel size |
| GO:0048534 | 0.007 | 2.5561 | 4.6907 | 11 | 802 | hematopoietic or lymphoid organ development |
| GO:1904892 | 0.0071 | 5.603 | 0.7603 | 4 | 130 | regulation of STAT cascade |
| GO:0001775 | 0.0072 | 2.2826 | 6.7847 | 14 | 1186 | cell activation |
| GO:0030512 | 0.0077 | 7.9609 | 0.4036 | 3 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0072006 | 0.0077 | 5.4716 | 0.7779 | 4 | 133 | nephron development |
| GO:0007275 | 0.0078 | 2.1641 | 10.1284 | 18 | 2373 | multicellular organism development |
| GO:0051384 | 0.0079 | 5.4291 | 0.7837 | 4 | 134 | response to glucocorticoid |
| GO:0003071 | 0.0079 | 16.5375 | 0.1345 | 2 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0007202 | 0.0079 | 16.5375 | 0.1345 | 2 | 23 | activation of phospholipase C activity |
| GO:0045577 | 0.0079 | 16.5375 | 0.1345 | 2 | 23 | regulation of B cell differentiation |
| GO:0046427 | 0.008 | 7.8415 | 0.4094 | 3 | 70 | positive regulation of JAK-STAT cascade |
| GO:0071310 | 0.0083 | 2.2008 | 7.677 | 15 | 1456 | cellular response to organic substance |
| GO:0003208 | 0.0083 | 7.7257 | 0.4153 | 3 | 71 | cardiac ventricle morphogenesis |
| GO:0042554 | 0.0086 | 15.7847 | 0.1404 | 2 | 24 | superoxide anion generation |
| GO:0045648 | 0.0086 | 15.7847 | 0.1404 | 2 | 24 | positive regulation of erythrocyte differentiation |
| GO:0048608 | 0.0086 | 3.226 | 2.3219 | 7 | 397 | reproductive structure development |
| GO:0010942 | 0.0091 | 2.7287 | 3.556 | 9 | 608 | positive regulation of cell death |
| GO:0014706 | 0.0093 | 5.1748 | 0.8217 | 4 | 147 | striated muscle tissue development |
| GO:0003151 | 0.0093 | 7.3978 | 0.4328 | 3 | 74 | outflow tract morphogenesis |
| GO:0002026 | 0.0093 | 15.0975 | 0.1462 | 2 | 25 | regulation of the force of heart contraction |
| GO:0035265 | 0.0094 | 5.1493 | 0.8247 | 4 | 141 | organ growth |
| GO:0060415 | 0.0096 | 7.2946 | 0.4387 | 3 | 75 | muscle tissue morphogenesis |
| GO:0045666 | 0.0098 | 3.5133 | 1.819 | 6 | 311 | positive regulation of neuron differentiation |
| GO:0061448 | 0.0099 | 4.0711 | 1.3043 | 5 | 223 | connective tissue development |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016338 | 0.0014 | Inf | 0.0014 | 1 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0003382 | 0.0017 | Inf | 0.0017 | 1 | 26 | epithelial cell morphogenesis |
| GO:0070830 | 0.0034 | Inf | 0.0034 | 1 | 51 | bicellular tight junction assembly |
| GO:0051291 | 0.0072 | Inf | 0.0072 | 1 | 109 | protein heterooligomerization |
| GO:0045471 | 0.0076 | Inf | 0.0076 | 1 | 115 | response to ethanol |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002264 | 3e-04 | Inf | 3e-04 | 1 | 1 | endothelial cell activation involved in immune response |
| GO:1900020 | 0.0016 | 950.5 | 0.0016 | 1 | 5 | positive regulation of protein kinase C activity |
| GO:0048251 | 0.0023 | 633.5833 | 0.0023 | 1 | 7 | elastic fiber assembly |
| GO:0071493 | 0.0026 | 543.0357 | 0.0026 | 1 | 8 | cellular response to UV-B |
| GO:0010739 | 0.0033 | 422.3056 | 0.0033 | 1 | 10 | positive regulation of protein kinase A signaling |
| GO:0060033 | 0.0036 | 380.05 | 0.0036 | 1 | 11 | anatomical structure regression |
| GO:2000353 | 0.0039 | 345.4773 | 0.0039 | 1 | 12 | positive regulation of endothelial cell apoptotic process |
| GO:0009650 | 0.0043 | 316.6667 | 0.0043 | 1 | 13 | UV protection |
| GO:1902259 | 0.0046 | 292.2885 | 0.0046 | 1 | 14 | regulation of delayed rectifier potassium channel activity |
| GO:0048535 | 0.0056 | 237.4375 | 0.0056 | 1 | 17 | lymph node development |
| GO:0042346 | 0.0075 | 172.6136 | 0.0076 | 1 | 23 | positive regulation of NF-kappaB import into nucleus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007634 | 5e-04 | Inf | 5e-04 | 1 | 1 | optokinetic behavior |
| GO:0048704 | 7e-04 | 67.2 | 0.0423 | 2 | 92 | embryonic skeletal system morphogenesis |
| GO:0006711 | 9e-04 | 2534.8333 | 9e-04 | 1 | 2 | estrogen catabolic process |
| GO:0021560 | 9e-04 | 2534.8333 | 9e-04 | 1 | 2 | abducens nerve development |
| GO:0021599 | 9e-04 | 2534.8333 | 9e-04 | 1 | 2 | abducens nerve formation |
| GO:0030824 | 9e-04 | 2534.8333 | 9e-04 | 1 | 2 | negative regulation of cGMP metabolic process |
| GO:0031283 | 9e-04 | 2534.8333 | 9e-04 | 1 | 2 | negative regulation of guanylate cyclase activity |
| GO:0060876 | 9e-04 | 2534.8333 | 9e-04 | 1 | 2 | semicircular canal formation |
| GO:0048702 | 0.0028 | 506.8333 | 0.0028 | 1 | 6 | embryonic neurocranium morphogenesis |
| GO:0009952 | 0.0033 | 31.2875 | 0.0892 | 2 | 194 | anterior/posterior pattern specification |
| GO:0007168 | 0.0041 | 316.7083 | 0.0041 | 1 | 9 | receptor guanylyl cyclase signaling pathway |
| GO:0042473 | 0.0041 | 316.7083 | 0.0041 | 1 | 9 | outer ear morphogenesis |
| GO:0043587 | 0.0041 | 316.7083 | 0.0041 | 1 | 9 | tongue morphogenesis |
| GO:0060872 | 0.0041 | 316.7083 | 0.0041 | 1 | 9 | semicircular canal development |
| GO:0035878 | 0.0046 | 281.5 | 0.0046 | 1 | 10 | nail development |
| GO:0019934 | 0.0055 | 230.2879 | 0.0055 | 1 | 12 | cGMP-mediated signaling |
| GO:0009887 | 0.0069 | 11.347 | 0.4352 | 3 | 946 | animal organ morphogenesis |
| GO:0052695 | 0.0073 | 168.8333 | 0.0074 | 1 | 16 | cellular glucuronidation |
| GO:0006833 | 0.0078 | 158.2708 | 0.0078 | 1 | 17 | water transport |
| GO:0045944 | 0.0091 | 10.2082 | 0.4803 | 3 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0006063 | 0.0096 | 126.5833 | 0.0097 | 1 | 21 | uronic acid metabolic process |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006378 | 0.0026 | Inf | 0.0026 | 1 | 40 | mRNA polyadenylation |
| GO:0031123 | 0.0074 | Inf | 0.0074 | 1 | 113 | RNA 3'-end processing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060764 | 3e-04 | 15214 | 3e-04 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0060435 | 4e-04 | 7606.5 | 4e-04 | 1 | 3 | bronchiole development |
| GO:0060480 | 5e-04 | 5070.6667 | 5e-04 | 1 | 4 | lung goblet cell differentiation |
| GO:0060535 | 5e-04 | 5070.6667 | 5e-04 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 5e-04 | 5070.6667 | 5e-04 | 1 | 4 | intestinal epithelial cell maturation |
| GO:0060482 | 8e-04 | 3042 | 8e-04 | 1 | 6 | lobar bronchus development |
| GO:0045647 | 0.0011 | 2172.5714 | 0.0011 | 1 | 8 | negative regulation of erythrocyte differentiation |
| GO:0060638 | 0.0011 | 2172.5714 | 0.0011 | 1 | 8 | mesenchymal-epithelial cell signaling |
| GO:0010870 | 0.0012 | 1900.875 | 0.0012 | 1 | 9 | positive regulation of receptor biosynthetic process |
| GO:0060484 | 0.0013 | 1689.5556 | 0.0013 | 1 | 10 | lung-associated mesenchyme development |
| GO:0002070 | 0.002 | 1085.7857 | 0.002 | 1 | 15 | epithelial cell maturation |
| GO:0033599 | 0.0021 | 1013.3333 | 0.0021 | 1 | 16 | regulation of mammary gland epithelial cell proliferation |
| GO:0060644 | 0.0022 | 949.9375 | 0.0022 | 1 | 17 | mammary gland epithelial cell differentiation |
| GO:0060749 | 0.0022 | 949.9375 | 0.0022 | 1 | 17 | mammary gland alveolus development |
| GO:0060438 | 0.0024 | 894 | 0.0024 | 1 | 18 | trachea development |
| GO:0060575 | 0.0025 | 844.2778 | 0.0025 | 1 | 19 | intestinal epithelial cell differentiation |
| GO:0030878 | 0.0032 | 660.5217 | 0.0032 | 1 | 24 | thyroid gland development |
| GO:0060487 | 0.0032 | 660.5217 | 0.0032 | 1 | 24 | lung epithelial cell differentiation |
| GO:0003016 | 0.0034 | 607.6 | 0.0034 | 1 | 26 | respiratory system process |
| GO:0060441 | 0.0037 | 562.5185 | 0.0037 | 1 | 28 | epithelial tube branching involved in lung morphogenesis |
| GO:0048286 | 0.0047 | 433.7143 | 0.0047 | 1 | 36 | lung alveolus development |
| GO:0002066 | 0.0068 | 297.3333 | 0.0068 | 1 | 52 | columnar/cuboidal epithelial cell development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001580 | 0.0012 | Inf | 0.0012 | 1 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0050909 | 0.0029 | Inf | 0.0029 | 1 | 44 | sensory perception of taste |
| GO:0001895 | 0.0043 | Inf | 0.0043 | 1 | 65 | retina homeostasis |
| GO:0050907 | 0.0055 | Inf | 0.0055 | 1 | 84 | detection of chemical stimulus involved in sensory perception |
| GO:2000117 | 0.0061 | Inf | 0.0061 | 1 | 93 | negative regulation of cysteine-type endopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050877 | 0.0032 | Inf | 0.1134 | 2 | 863 | nervous system process |
| GO:0018149 | 0.0038 | 542.3929 | 0.0038 | 1 | 29 | peptide cross-linking |
| GO:0071277 | 0.0073 | 275.6364 | 0.0074 | 1 | 56 | cellular response to calcium ion |
| GO:0050911 | 0.0075 | 270.6964 | 0.0075 | 1 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 55.037 | 1.2361 | 30 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0051606 | 0 | 7.1201 | 6.0505 | 35 | 279 | detection of stimulus |
| GO:0007600 | 0 | 4.649 | 11.5805 | 45 | 534 | sensory perception |
| GO:0007186 | 0 | 3.1907 | 18.1948 | 50 | 839 | G-protein coupled receptor signaling pathway |
| GO:0070268 | 0 | 8.9259 | 2.0385 | 15 | 94 | cornification |
| GO:0003008 | 0 | 2.2749 | 33.3969 | 66 | 1540 | system process |
| GO:0030216 | 0 | 4.5599 | 4.424 | 18 | 204 | keratinocyte differentiation |
| GO:0003095 | 0 | Inf | 0.0651 | 3 | 3 | pressure natriuresis |
| GO:0019730 | 0 | 13.9887 | 0.5552 | 6 | 26 | antimicrobial humoral response |
| GO:0016579 | 0 | 3.4406 | 5.7143 | 18 | 265 | protein deubiquitination |
| GO:0036101 | 0 | 136.5688 | 0.0867 | 3 | 4 | leukotriene B4 catabolic process |
| GO:0045087 | 0 | 2.9733 | 7.2988 | 20 | 349 | innate immune response |
| GO:0008544 | 1e-04 | 2.8284 | 7.6336 | 20 | 352 | epidermis development |
| GO:1901523 | 1e-04 | 68.2798 | 0.1084 | 3 | 5 | icosanoid catabolic process |
| GO:0003071 | 1e-04 | 12.7085 | 0.4988 | 5 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0010951 | 1e-04 | 3.4827 | 4.3589 | 14 | 201 | negative regulation of endopeptidase activity |
| GO:0070098 | 2e-04 | 6.4309 | 1.2361 | 7 | 57 | chemokine-mediated signaling pathway |
| GO:0044657 | 5e-04 | Inf | 0.0434 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 5e-04 | Inf | 0.0434 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 5e-04 | Inf | 0.0434 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 5e-04 | Inf | 0.0434 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0001580 | 5e-04 | 13.0351 | 0.3904 | 4 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0002227 | 7e-04 | 12.1652 | 0.412 | 4 | 19 | innate immune response in mucosa |
| GO:0097267 | 8e-04 | 22.7538 | 0.1952 | 3 | 9 | omega-hydroxylase P450 pathway |
| GO:0019373 | 0.001 | 10.7326 | 0.4554 | 4 | 21 | epoxygenase P450 pathway |
| GO:0002218 | 0.001 | 2.6895 | 5.942 | 15 | 274 | activation of innate immune response |
| GO:0061844 | 0.0011 | 7.1418 | 0.8024 | 5 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0050830 | 0.0012 | 4.7229 | 1.6265 | 7 | 75 | defense response to Gram-positive bacterium |
| GO:0007565 | 0.0015 | 3.0957 | 3.7951 | 11 | 175 | female pregnancy |
| GO:0045861 | 0.0018 | 2.5209 | 6.3107 | 15 | 291 | negative regulation of proteolysis |
| GO:0050907 | 0.0018 | 8.7174 | 0.5343 | 4 | 27 | detection of chemical stimulus involved in sensory perception |
| GO:0050776 | 0.0019 | 2.1803 | 9.7232 | 20 | 461 | regulation of immune response |
| GO:0031640 | 0.002 | 6.1746 | 0.9108 | 5 | 42 | killing of cells of other organism |
| GO:0051346 | 0.0021 | 2.3238 | 7.742 | 17 | 357 | negative regulation of hydrolase activity |
| GO:0050829 | 0.0024 | 4.8181 | 1.3662 | 6 | 63 | defense response to Gram-negative bacterium |
| GO:0044036 | 0.0025 | 13.6486 | 0.2819 | 3 | 13 | cell wall macromolecule metabolic process |
| GO:0042360 | 0.0027 | 45.3811 | 0.0867 | 2 | 4 | vitamin E metabolic process |
| GO:0051673 | 0.0027 | 45.3811 | 0.0867 | 2 | 4 | membrane disruption in other organism |
| GO:0002684 | 0.0028 | 1.7845 | 19.0189 | 32 | 877 | positive regulation of immune system process |
| GO:0010818 | 0.0031 | 12.407 | 0.3036 | 3 | 14 | T cell chemotaxis |
| GO:0002221 | 0.0031 | 2.9897 | 3.5565 | 10 | 164 | pattern recognition receptor signaling pathway |
| GO:0002250 | 0.0032 | 2.3554 | 6.7227 | 15 | 310 | adaptive immune response |
| GO:0043207 | 0.0033 | 1.856 | 15.3756 | 27 | 709 | response to external biotic stimulus |
| GO:0002251 | 0.0034 | 7.2942 | 0.6289 | 4 | 29 | organ or tissue specific immune response |
| GO:0018149 | 0.0034 | 7.2942 | 0.6289 | 4 | 29 | peptide cross-linking |
| GO:0045088 | 0.0037 | 2.1917 | 8.1757 | 17 | 377 | regulation of innate immune response |
| GO:0006691 | 0.0038 | 7.0132 | 0.6506 | 4 | 30 | leukotriene metabolic process |
| GO:0019731 | 0.0038 | 7.0132 | 0.6506 | 4 | 30 | antibacterial humoral response |
| GO:0098542 | 0.004 | 2.1731 | 8.2408 | 17 | 380 | defense response to other organism |
| GO:0009617 | 0.0044 | 2.054 | 9.7371 | 19 | 449 | response to bacterium |
| GO:0001990 | 0.0048 | 6.5114 | 0.694 | 4 | 32 | regulation of systemic arterial blood pressure by hormone |
| GO:0006952 | 0.0049 | 2.1841 | 7.7246 | 16 | 388 | defense response |
| GO:0016266 | 0.0053 | 4.8576 | 1.1277 | 5 | 52 | O-glycan processing |
| GO:0007635 | 0.0055 | 9.7464 | 0.3687 | 3 | 17 | chemosensory behavior |
| GO:0052547 | 0.0058 | 2.1415 | 7.8504 | 16 | 362 | regulation of peptidase activity |
| GO:0003091 | 0.006 | 6.0765 | 0.7373 | 4 | 34 | renal water homeostasis |
| GO:0050691 | 0.006 | 6.0765 | 0.7373 | 4 | 34 | regulation of defense response to virus by host |
| GO:0001915 | 0.0066 | 22.6875 | 0.1301 | 2 | 6 | negative regulation of T cell mediated cytotoxicity |
| GO:0071947 | 0.0066 | 22.6875 | 0.1301 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0050900 | 0.0069 | 2.098 | 8.0022 | 16 | 369 | leukocyte migration |
| GO:0045670 | 0.0078 | 4.3891 | 1.2361 | 5 | 57 | regulation of osteoclast differentiation |
| GO:0031349 | 0.0078 | 2.0189 | 8.8263 | 17 | 407 | positive regulation of defense response |
| GO:0070509 | 0.0083 | 4.306 | 1.2578 | 5 | 58 | calcium ion import |
| GO:0002376 | 0.009 | 1.5407 | 28.996 | 42 | 1420 | immune system process |
| GO:0032819 | 0.0092 | 18.1488 | 0.1518 | 2 | 7 | positive regulation of natural killer cell proliferation |
| GO:2001185 | 0.0092 | 18.1488 | 0.1518 | 2 | 7 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0030855 | 0.0098 | 1.7747 | 13.5756 | 23 | 626 | epithelial cell differentiation |
| GO:0009620 | 0.0098 | 5.2067 | 0.8458 | 4 | 39 | response to fungus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 58.344 | 0.2729 | 11 | 57 | olfactory receptor activity |
| GO:0038023 | 0 | 4.5102 | 4.3333 | 16 | 905 | signaling receptor activity |
| GO:0004930 | 0 | 6.3884 | 2.0158 | 11 | 421 | G-protein coupled receptor activity |
| GO:0060089 | 0 | 4.0555 | 5.5112 | 18 | 1151 | molecular transducer activity |
| GO:0099600 | 0 | 4.4692 | 4.046 | 15 | 845 | transmembrane receptor activity |
| GO:0008234 | 0 | 9.4162 | 0.8427 | 7 | 176 | cysteine-type peptidase activity |
| GO:0036459 | 6e-04 | 20.4505 | 0.1661 | 3 | 36 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0030246 | 0.001 | 5.7172 | 1.1492 | 6 | 240 | carbohydrate binding |
| GO:0008233 | 0.0018 | 3.5637 | 2.8011 | 9 | 585 | peptidase activity |
| GO:0004843 | 0.0048 | 9.52 | 0.34 | 3 | 71 | thiol-dependent ubiquitin-specific protease activity |
| GO:0001567 | 0.0096 | 210.7222 | 0.0096 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0030109 | 0.0096 | 210.7222 | 0.0096 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0055131 | 3e-04 | 113.2313 | 0.0272 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0043565 | 4e-04 | 3.3777 | 4.476 | 13 | 989 | sequence-specific DNA binding |
| GO:0001664 | 5e-04 | 6.6098 | 1.0036 | 6 | 225 | G-protein coupled receptor binding |
| GO:0003690 | 7e-04 | 3.5631 | 3.5211 | 11 | 778 | double-stranded DNA binding |
| GO:0008301 | 0.0026 | 30.1731 | 0.0769 | 2 | 17 | DNA binding, bending |
| GO:0000976 | 0.003 | 3.3204 | 3.0096 | 9 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0000975 | 0.0034 | 3.038 | 3.6749 | 10 | 812 | regulatory region DNA binding |
| GO:0001618 | 0.0039 | 10.251 | 0.3168 | 3 | 70 | virus receptor activity |
| GO:0008311 | 0.0045 | Inf | 0.0045 | 1 | 1 | double-stranded DNA 3'-5' exodeoxyribonuclease activity |
| GO:0031249 | 0.0045 | Inf | 0.0045 | 1 | 1 | denatured protein binding |
| GO:0031700 | 0.0045 | Inf | 0.0045 | 1 | 1 | adrenomedullin receptor binding |
| GO:0031773 | 0.0045 | Inf | 0.0045 | 1 | 1 | kisspeptin receptor binding |
| GO:0033735 | 0.0045 | Inf | 0.0045 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0004527 | 0.0046 | 9.6709 | 0.3349 | 3 | 74 | exonuclease activity |
| GO:0000981 | 0.0053 | 3.0163 | 3.2948 | 9 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0043548 | 0.0066 | 18.0919 | 0.1222 | 2 | 27 | phosphatidylinositol 3-kinase binding |
| GO:0044183 | 0.0066 | 18.0919 | 0.1222 | 2 | 27 | protein binding involved in protein folding |
| GO:0001205 | 0.0076 | 16.7496 | 0.1312 | 2 | 29 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
| GO:0044877 | 0.0082 | 2.6542 | 4.1682 | 10 | 921 | macromolecular complex binding |
| GO:0000035 | 0.009 | 223.1765 | 0.0091 | 1 | 2 | acyl binding |
| GO:0008260 | 0.009 | 223.1765 | 0.0091 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0016890 | 0.009 | 223.1765 | 0.0091 | 1 | 2 | site-specific endodeoxyribonuclease activity, specific for altered base |
| GO:0031708 | 0.009 | 223.1765 | 0.0091 | 1 | 2 | endothelin B receptor binding |
| GO:0070653 | 0.009 | 223.1765 | 0.0091 | 1 | 2 | high-density lipoprotein particle receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0055131 | 3e-04 | 116.7308 | 0.0264 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0001664 | 0.0031 | 5.4583 | 0.9932 | 5 | 226 | G-protein coupled receptor binding |
| GO:0004631 | 0.0044 | Inf | 0.0044 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0005147 | 0.0044 | Inf | 0.0044 | 1 | 1 | oncostatin-M receptor binding |
| GO:0031249 | 0.0044 | Inf | 0.0044 | 1 | 1 | denatured protein binding |
| GO:0033735 | 0.0044 | Inf | 0.0044 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0034353 | 0.0044 | Inf | 0.0044 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0048018 | 0.0061 | 3.9368 | 1.6524 | 6 | 376 | receptor ligand activity |
| GO:1902936 | 0.0062 | 8.6301 | 0.3735 | 3 | 85 | phosphatidylinositol bisphosphate binding |
| GO:0044183 | 0.0062 | 18.6511 | 0.1187 | 2 | 27 | protein binding involved in protein folding |
| GO:0008009 | 0.0076 | 16.6495 | 0.1318 | 2 | 30 | chemokine activity |
| GO:1903231 | 0.0087 | 15.5374 | 0.1406 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005153 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | interleukin-8 receptor binding |
| GO:0008260 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0031708 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | endothelin B receptor binding |
| GO:0033041 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | sweet taste receptor activity |
| GO:0048248 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | CXCR3 chemokine receptor binding |
| GO:0042826 | 0.0097 | 7.2883 | 0.4395 | 3 | 100 | histone deacetylase binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 4e-04 | 7.0498 | 0.997 | 6 | 400 | receptor regulator activity |
| GO:0005179 | 0.0021 | 12.9497 | 0.2567 | 3 | 103 | hormone activity |
| GO:0001604 | 0.0025 | Inf | 0.0025 | 1 | 1 | urotensin II receptor activity |
| GO:0005130 | 0.0025 | Inf | 0.0025 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0008009 | 0.0025 | 30.119 | 0.0748 | 2 | 30 | chemokine activity |
| GO:0004458 | 0.005 | 411 | 0.005 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
| GO:0005148 | 0.005 | 411 | 0.005 | 1 | 2 | prolactin receptor binding |
| GO:0017098 | 0.005 | 411 | 0.005 | 1 | 2 | sulfonylurea receptor binding |
| GO:0030369 | 0.0075 | 205.4865 | 0.0075 | 1 | 3 | ICAM-3 receptor activity |
| GO:0070405 | 0.0092 | 15.0317 | 0.1446 | 2 | 58 | ammonium ion binding |
| GO:0001591 | 0.0099 | 136.982 | 0.01 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004506 | 1e-04 | Inf | 1e-04 | 1 | 1 | squalene monooxygenase activity |
| GO:0050660 | 0.0046 | Inf | 0.0046 | 1 | 70 | flavin adenine dinucleotide binding |
| GO:0004497 | 0.0058 | Inf | 0.0058 | 1 | 89 | monooxygenase activity |
| GO:0016705 | 0.0097 | Inf | 0.0097 | 1 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017045 | 9e-04 | Inf | 9e-04 | 1 | 1 | corticotropin-releasing hormone activity |
| GO:0003854 | 0.0017 | 1269.3333 | 0.0017 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GO:0031894 | 0.0017 | 1269.3333 | 0.0017 | 1 | 2 | V1A vasopressin receptor binding |
| GO:0036461 | 0.0017 | 1269.3333 | 0.0017 | 1 | 2 | BLOC-2 complex binding |
| GO:0030369 | 0.0026 | 634.625 | 0.0026 | 1 | 3 | ICAM-3 receptor activity |
| GO:0035651 | 0.0026 | 634.625 | 0.0026 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0051431 | 0.0026 | 634.625 | 0.0026 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
| GO:0035650 | 0.0034 | 423.0556 | 0.0034 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0051430 | 0.0034 | 423.0556 | 0.0034 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0005000 | 0.0051 | 253.8 | 0.0051 | 1 | 6 | vasopressin receptor activity |
| GO:0046790 | 0.006 | 211.4861 | 0.006 | 1 | 7 | virion binding |
| GO:0008525 | 0.0068 | 181.2619 | 0.0068 | 1 | 8 | phosphatidylcholine transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 0 | 543.3571 | 0.0079 | 2 | 30 | chemokine activity |
| GO:0008502 | 5e-04 | 5080.3333 | 5e-04 | 1 | 2 | melatonin receptor activity |
| GO:0048248 | 5e-04 | 5080.3333 | 5e-04 | 1 | 2 | CXCR3 chemokine receptor binding |
| GO:0005126 | 0.0012 | 70.2243 | 0.0567 | 2 | 216 | cytokine receptor binding |
| GO:0001664 | 0.0013 | 67.0446 | 0.0593 | 2 | 226 | G-protein coupled receptor binding |
| GO:0048018 | 0.0035 | 39.754 | 0.0986 | 2 | 376 | receptor ligand activity |
| GO:0048020 | 0.0063 | 220.5652 | 0.0063 | 1 | 24 | CCR chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004652 | 0.0012 | 1904.5 | 0.0012 | 1 | 9 | polynucleotide adenylyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0.0021 | Inf | 0.0021 | 1 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034899 | 1e-04 | Inf | 1e-04 | 1 | 1 | trimethylamine monooxygenase activity |
| GO:0004499 | 3e-04 | Inf | 3e-04 | 1 | 4 | N,N-dimethylaniline monooxygenase activity |
| GO:0050661 | 0.0028 | Inf | 0.0028 | 1 | 43 | NADP binding |
| GO:0050660 | 0.0046 | Inf | 0.0046 | 1 | 70 | flavin adenine dinucleotide binding |
| GO:0004497 | 0.0058 | Inf | 0.0058 | 1 | 89 | monooxygenase activity |
| GO:0016705 | 0.0097 | Inf | 0.0097 | 1 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016779 | 0.0082 | Inf | 0.0082 | 1 | 125 | nucleotidyltransferase activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031894 | 1e-04 | Inf | 1e-04 | 1 | 2 | V1A vasopressin receptor binding |
| GO:0005000 | 4e-04 | Inf | 4e-04 | 1 | 6 | vasopressin receptor activity |
| GO:0017046 | 0.0021 | Inf | 0.0021 | 1 | 32 | peptide hormone binding |
| GO:0005080 | 0.0031 | Inf | 0.0031 | 1 | 47 | protein kinase C binding |
| GO:0001653 | 0.0075 | Inf | 0.0075 | 1 | 115 | peptide receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0055131 | 3e-04 | 116.7308 | 0.0264 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0001664 | 0.0031 | 5.4583 | 0.9932 | 5 | 226 | G-protein coupled receptor binding |
| GO:0004631 | 0.0044 | Inf | 0.0044 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0005147 | 0.0044 | Inf | 0.0044 | 1 | 1 | oncostatin-M receptor binding |
| GO:0031249 | 0.0044 | Inf | 0.0044 | 1 | 1 | denatured protein binding |
| GO:0033735 | 0.0044 | Inf | 0.0044 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0034353 | 0.0044 | Inf | 0.0044 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0048018 | 0.0061 | 3.9368 | 1.6524 | 6 | 376 | receptor ligand activity |
| GO:1902936 | 0.0062 | 8.6301 | 0.3735 | 3 | 85 | phosphatidylinositol bisphosphate binding |
| GO:0044183 | 0.0062 | 18.6511 | 0.1187 | 2 | 27 | protein binding involved in protein folding |
| GO:0008009 | 0.0076 | 16.6495 | 0.1318 | 2 | 30 | chemokine activity |
| GO:1903231 | 0.0087 | 15.5374 | 0.1406 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005153 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | interleukin-8 receptor binding |
| GO:0008260 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0031708 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | endothelin B receptor binding |
| GO:0033041 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | sweet taste receptor activity |
| GO:0048248 | 0.0088 | 229.9697 | 0.0088 | 1 | 2 | CXCR3 chemokine receptor binding |
| GO:0042826 | 0.0097 | 7.2883 | 0.4395 | 3 | 100 | histone deacetylase binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 55.7344 | 1.3945 | 32 | 57 | olfactory receptor activity |
| GO:0004872 | 0 | 3.807 | 27.0832 | 82 | 1107 | receptor activity |
| GO:0004930 | 0 | 5.8953 | 10.2999 | 49 | 421 | G-protein coupled receptor activity |
| GO:0004871 | 0 | 2.9509 | 29.5053 | 73 | 1206 | signal transducer activity |
| GO:0036459 | 0 | 9.6291 | 2.6178 | 20 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 5.6649 | 4.3059 | 21 | 176 | cysteine-type peptidase activity |
| GO:0030414 | 0 | 4.9837 | 3.4007 | 15 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0 | 4.9837 | 3.4007 | 15 | 139 | endopeptidase regulator activity |
| GO:0005549 | 0 | 33.6662 | 0.2691 | 5 | 11 | odorant binding |
| GO:0030246 | 0 | 3.5584 | 5.8717 | 19 | 240 | carbohydrate binding |
| GO:0004497 | 0 | 5.7637 | 2.1774 | 11 | 89 | monooxygenase activity |
| GO:0004867 | 0 | 6.476 | 1.786 | 10 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0004321 | 0 | 53.7308 | 0.1713 | 4 | 7 | fatty-acyl-CoA synthase activity |
| GO:0003996 | 0 | 40.2954 | 0.1957 | 4 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0 | 40.2954 | 0.1957 | 4 | 8 | butyrate-CoA ligase activity |
| GO:0018685 | 1e-04 | 120.5838 | 0.0979 | 3 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 1e-04 | 120.5838 | 0.0979 | 3 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0016705 | 1e-04 | 3.9423 | 3.6209 | 13 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0017171 | 1e-04 | 3.3634 | 4.8442 | 15 | 198 | serine hydrolase activity |
| GO:0070011 | 1e-04 | 2.6069 | 9.0861 | 22 | 389 | peptidase activity, acting on L-amino acid peptides |
| GO:0020037 | 2e-04 | 4.1159 | 2.9359 | 11 | 120 | heme binding |
| GO:0004252 | 2e-04 | 3.4742 | 4.0613 | 13 | 166 | serine-type endopeptidase activity |
| GO:0005506 | 3e-04 | 3.5755 | 3.6453 | 12 | 149 | iron ion binding |
| GO:0032393 | 5e-04 | 30.1399 | 0.1713 | 3 | 7 | MHC class I receptor activity |
| GO:0004507 | 6e-04 | Inf | 0.0489 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0030109 | 6e-04 | Inf | 0.0489 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0047783 | 6e-04 | Inf | 0.0489 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0008392 | 7e-04 | 12.3911 | 0.4159 | 4 | 17 | arachidonic acid epoxygenase activity |
| GO:0035240 | 7e-04 | 24.1103 | 0.1957 | 3 | 8 | dopamine binding |
| GO:0003823 | 7e-04 | 6.2184 | 1.1009 | 6 | 45 | antigen binding |
| GO:0015645 | 0.0013 | 10.0657 | 0.4893 | 4 | 20 | fatty acid ligase activity |
| GO:0030280 | 0.0015 | 17.2193 | 0.2447 | 3 | 10 | structural constituent of epidermis |
| GO:0005124 | 0.0018 | 80.1725 | 0.0734 | 2 | 3 | scavenger receptor binding |
| GO:0003796 | 0.0027 | 13.391 | 0.2936 | 3 | 12 | lysozyme activity |
| GO:0019825 | 0.0031 | 5.5997 | 1.0031 | 5 | 41 | oxygen binding |
| GO:0004982 | 0.0035 | 40.0836 | 0.0979 | 2 | 4 | N-formyl peptide receptor activity |
| GO:0005332 | 0.0035 | 40.0836 | 0.0979 | 2 | 4 | gamma-aminobutyric acid:sodium symporter activity |
| GO:0032190 | 0.0035 | 40.0836 | 0.0979 | 2 | 4 | acrosin binding |
| GO:0042806 | 0.0035 | 40.0836 | 0.0979 | 2 | 4 | fucose binding |
| GO:0005537 | 0.0064 | 9.2682 | 0.3914 | 3 | 16 | mannose binding |
| GO:0008329 | 0.0064 | 9.2682 | 0.3914 | 3 | 16 | signaling pattern recognition receptor activity |
| GO:0004888 | 0.0075 | 2.0778 | 8.0802 | 16 | 373 | transmembrane signaling receptor activity |
| GO:0042288 | 0.009 | 8.0314 | 0.4404 | 3 | 18 | MHC class I protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005179 | 0.0015 | 6.4414 | 0.8377 | 5 | 103 | hormone activity |
| GO:0004953 | 0.0056 | 20.6421 | 0.1139 | 2 | 14 | icosanoid receptor activity |
| GO:0005523 | 0.0056 | 20.6421 | 0.1139 | 2 | 14 | tropomyosin binding |
| GO:0004042 | 0.0081 | Inf | 0.0081 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0004516 | 0.0081 | Inf | 0.0081 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
| GO:0004631 | 0.0081 | Inf | 0.0081 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0004946 | 0.0081 | Inf | 0.0081 | 1 | 1 | bombesin receptor activity |
| GO:0005147 | 0.0081 | Inf | 0.0081 | 1 | 1 | oncostatin-M receptor binding |
| GO:0015052 | 0.0081 | Inf | 0.0081 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0017024 | 0.0081 | Inf | 0.0081 | 1 | 1 | myosin I binding |
| GO:0031249 | 0.0081 | Inf | 0.0081 | 1 | 1 | denatured protein binding |
| GO:0031700 | 0.0081 | Inf | 0.0081 | 1 | 1 | adrenomedullin receptor binding |
| GO:0047730 | 0.0081 | Inf | 0.0081 | 1 | 1 | carnosine synthase activity |
| GO:0047915 | 0.0081 | Inf | 0.0081 | 1 | 1 | ganglioside galactosyltransferase activity |
| GO:0098633 | 0.0081 | Inf | 0.0081 | 1 | 1 | collagen fibril binding |
| GO:0102102 | 0.0081 | Inf | 0.0081 | 1 | 1 | homocarnosine synthase activity |
| GO:0103045 | 0.0081 | Inf | 0.0081 | 1 | 1 | methione N-acyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0071 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 0.0018 | 36.4808 | 0.0638 | 2 | 18 | MHC class I protein binding |
| GO:0001604 | 0.0035 | Inf | 0.0035 | 1 | 1 | urotensin II receptor activity |
| GO:0031703 | 0.0035 | Inf | 0.0035 | 1 | 1 | type 2 angiotensin receptor binding |
| GO:0004364 | 0.0038 | 24.3077 | 0.0921 | 2 | 26 | glutathione transferase activity |
| GO:0003854 | 0.0071 | 286.6226 | 0.0071 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GO:0004174 | 0.0071 | 286.6226 | 0.0071 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
| GO:0070699 | 0.0071 | 286.6226 | 0.0071 | 1 | 2 | type II activin receptor binding |
| GO:0099600 | 0.0093 | 2.9827 | 2.9929 | 8 | 845 | transmembrane receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0 | 11.2477 | 1.1598 | 10 | 421 | G-protein coupled receptor activity |
| GO:0004984 | 0 | 39.3763 | 0.157 | 5 | 57 | olfactory receptor activity |
| GO:0004875 | 0 | 167 | 0.0275 | 3 | 10 | complement receptor activity |
| GO:0060089 | 0 | 4.9394 | 3.1708 | 12 | 1151 | molecular transducer activity |
| GO:0004982 | 0 | 380.05 | 0.011 | 2 | 4 | N-formyl peptide receptor activity |
| GO:0099600 | 1e-04 | 5.3776 | 2.3278 | 10 | 845 | transmembrane receptor activity |
| GO:0005549 | 4e-04 | 84.4167 | 0.0303 | 2 | 11 | odorant binding |
| GO:0038023 | 8e-04 | 4.7224 | 2.0362 | 8 | 790 | signaling receptor activity |
| GO:0042056 | 0.0027 | 29.1885 | 0.0771 | 2 | 28 | chemoattractant activity |
| GO:0015327 | 0.0028 | Inf | 0.0028 | 1 | 1 | cystine:glutamate antiporter activity |
| GO:1901680 | 0.0028 | Inf | 0.0028 | 1 | 1 | sulfur-containing amino acid secondary active transmembrane transporter activity |
| GO:0001653 | 0.0039 | 10.3654 | 0.3168 | 3 | 115 | peptide receptor activity |
| GO:0005124 | 0.0082 | 185.3902 | 0.0083 | 1 | 3 | scavenger receptor binding |
| GO:0005294 | 0.0082 | 185.3902 | 0.0083 | 1 | 3 | neutral L-amino acid secondary active transmembrane transporter activity |
| GO:0031531 | 0.0082 | 185.3902 | 0.0083 | 1 | 3 | thyrotropin-releasing hormone receptor binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032393 | 0.0028 | 507.8 | 0.0028 | 1 | 7 | MHC class I receptor activity |
| GO:0030246 | 0.0036 | 31.5168 | 0.0945 | 2 | 240 | carbohydrate binding |
| GO:0005251 | 0.0078 | 160.2211 | 0.0079 | 1 | 20 | delayed rectifier potassium channel activity |
| GO:0005112 | 0.0082 | 152.2 | 0.0083 | 1 | 21 | Notch binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030251 | 5e-04 | Inf | 5e-04 | 1 | 1 | guanylate cyclase inhibitor activity |
| GO:0001228 | 9e-04 | 22.7235 | 0.2073 | 3 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0043565 | 0.001 | 14.4701 | 0.519 | 4 | 989 | sequence-specific DNA binding |
| GO:0003700 | 0.0019 | 12.0574 | 0.6145 | 4 | 1171 | DNA binding transcription factor activity |
| GO:0010851 | 0.0047 | 271.9643 | 0.0047 | 1 | 9 | cyclase regulator activity |
| GO:1990381 | 0.0084 | 144.981 | 0.0084 | 1 | 16 | ubiquitin-specific protease binding |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004652 | 6e-04 | Inf | 6e-04 | 1 | 9 | polynucleotide adenylyltransferase activity |
| GO:0016779 | 0.0082 | Inf | 0.0082 | 1 | 125 | nucleotidyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0.0042 | Inf | 0.1297 | 2 | 989 | sequence-specific DNA binding |
| GO:0003700 | 0.0059 | Inf | 0.1536 | 2 | 1171 | DNA binding transcription factor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004869 | 0.0028 | Inf | 0.0028 | 1 | 43 | cysteine-type endopeptidase inhibitor activity |
| GO:0002020 | 0.0078 | Inf | 0.0078 | 1 | 119 | protease binding |
| GO:0030414 | 0.0091 | Inf | 0.0091 | 1 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0.0091 | Inf | 0.0091 | 1 | 139 | endopeptidase regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0075 | 271.2143 | 0.0075 | 1 | 57 | olfactory receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 59.3787 | 1.1553 | 30 | 57 | olfactory receptor activity |
| GO:0004930 | 0 | 6.0423 | 8.5327 | 42 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 4.0614 | 17.1261 | 57 | 845 | transmembrane receptor activity |
| GO:0038023 | 0 | 3.7892 | 17.8617 | 56 | 889 | signaling receptor activity |
| GO:0036459 | 0 | 11.8124 | 2.1686 | 20 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 6.9539 | 3.5671 | 21 | 176 | cysteine-type peptidase activity |
| GO:0030414 | 0 | 5.1626 | 2.8172 | 13 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0 | 5.1626 | 2.8172 | 13 | 139 | endopeptidase regulator activity |
| GO:0004321 | 0 | 65.2852 | 0.1419 | 4 | 7 | fatty-acyl-CoA synthase activity |
| GO:0030246 | 0 | 3.8414 | 4.8642 | 17 | 240 | carbohydrate binding |
| GO:0003996 | 0 | 48.9607 | 0.1621 | 4 | 8 | acyl-CoA ligase activity |
| GO:0047760 | 0 | 48.9607 | 0.1621 | 4 | 8 | butyrate-CoA ligase activity |
| GO:0004497 | 0 | 6.2902 | 1.8038 | 10 | 89 | monooxygenase activity |
| GO:0004867 | 0 | 6.9717 | 1.4795 | 9 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0020037 | 0 | 5.0215 | 2.4321 | 11 | 120 | heme binding |
| GO:0018685 | 0 | 146.4314 | 0.0811 | 3 | 4 | alkane 1-monooxygenase activity |
| GO:0050051 | 0 | 146.4314 | 0.0811 | 3 | 4 | leukotriene-B4 20-monooxygenase activity |
| GO:0016705 | 0 | 4.3972 | 2.9996 | 12 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0005549 | 0 | 27.9719 | 0.2229 | 4 | 11 | odorant binding |
| GO:0004252 | 1e-04 | 3.8785 | 3.3644 | 12 | 166 | serine-type endopeptidase activity |
| GO:0017171 | 2e-04 | 3.5021 | 4.013 | 13 | 198 | serine hydrolase activity |
| GO:0005506 | 2e-04 | 3.9585 | 3.0199 | 11 | 149 | iron ion binding |
| GO:0003823 | 3e-04 | 7.5644 | 0.912 | 6 | 45 | antigen binding |
| GO:0008392 | 3e-04 | 15.0557 | 0.3445 | 4 | 17 | arachidonic acid epoxygenase activity |
| GO:0004507 | 4e-04 | Inf | 0.0405 | 2 | 2 | steroid 11-beta-monooxygenase activity |
| GO:0030109 | 4e-04 | Inf | 0.0405 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0047783 | 4e-04 | Inf | 0.0405 | 2 | 2 | corticosterone 18-monooxygenase activity |
| GO:0070011 | 5e-04 | 2.5896 | 7.4341 | 18 | 389 | peptidase activity, acting on L-amino acid peptides |
| GO:0015645 | 6e-04 | 12.2303 | 0.4054 | 4 | 20 | fatty acid ligase activity |
| GO:0030280 | 9e-04 | 20.9104 | 0.2027 | 3 | 10 | structural constituent of epidermis |
| GO:0003796 | 0.0016 | 16.2614 | 0.2432 | 3 | 12 | lysozyme activity |
| GO:0004872 | 0.0019 | 3.4747 | 2.769 | 9 | 159 | receptor activity |
| GO:0032190 | 0.0024 | 48.6482 | 0.0811 | 2 | 4 | acrosin binding |
| GO:0042806 | 0.0024 | 48.6482 | 0.0811 | 2 | 4 | fucose binding |
| GO:0005537 | 0.0038 | 11.2549 | 0.3243 | 3 | 16 | mannose binding |
| GO:0008329 | 0.0038 | 11.2549 | 0.3243 | 3 | 16 | signaling pattern recognition receptor activity |
| GO:0019865 | 0.0063 | 9.1428 | 0.3851 | 3 | 19 | immunoglobulin binding |
| GO:0032393 | 0.008 | 19.4554 | 0.1419 | 2 | 7 | MHC class I receptor activity |
| GO:0019825 | 0.0093 | 5.2813 | 0.831 | 4 | 41 | oxygen binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0055131 | 7e-04 | 70.715 | 0.0429 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0001664 | 0.0011 | 4.7431 | 1.594 | 7 | 225 | G-protein coupled receptor binding |
| GO:0004631 | 0.0071 | Inf | 0.0071 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0005147 | 0.0071 | Inf | 0.0071 | 1 | 1 | oncostatin-M receptor binding |
| GO:0015052 | 0.0071 | Inf | 0.0071 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0031249 | 0.0071 | Inf | 0.0071 | 1 | 1 | denatured protein binding |
| GO:0031700 | 0.0071 | Inf | 0.0071 | 1 | 1 | adrenomedullin receptor binding |
| GO:0031773 | 0.0071 | Inf | 0.0071 | 1 | 1 | kisspeptin receptor binding |
| GO:0033735 | 0.0071 | Inf | 0.0071 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0034353 | 0.0071 | Inf | 0.0071 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0047915 | 0.0071 | Inf | 0.0071 | 1 | 1 | ganglioside galactosyltransferase activity |
| GO:0003841 | 0.0072 | 17.6647 | 0.1287 | 2 | 18 | 1-acylglycerol-3-phosphate O-acyltransferase activity |
| GO:0071617 | 0.008 | 16.6245 | 0.1358 | 2 | 19 | lysophospholipid acyltransferase activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022610 | 0 | 1.692 | 68.5666 | 106 | 1043 | biological adhesion |
| GO:0006590 | 0 | 16.7065 | 0.8546 | 7 | 13 | thyroid hormone generation |
| GO:0006954 | 0 | 1.9343 | 30.4375 | 54 | 463 | inflammatory response |
| GO:0098609 | 0 | 1.7888 | 40.6272 | 67 | 618 | cell-cell adhesion |
| GO:0009653 | 0 | 1.5575 | 80.9667 | 116 | 1260 | anatomical structure morphogenesis |
| GO:0007156 | 1e-04 | 2.9159 | 8.2175 | 21 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0034103 | 1e-04 | 4.1527 | 3.8129 | 13 | 58 | regulation of tissue remodeling |
| GO:0051674 | 1e-04 | 1.532 | 75.9294 | 108 | 1155 | localization of cell |
| GO:0042445 | 1e-04 | 2.807 | 8.4804 | 21 | 129 | hormone metabolic process |
| GO:0035082 | 1e-04 | 4.3091 | 3.4185 | 12 | 52 | axoneme assembly |
| GO:0030198 | 2e-04 | 2.1476 | 16.3035 | 32 | 248 | extracellular matrix organization |
| GO:0006928 | 2e-04 | 1.4302 | 102.9485 | 137 | 1566 | movement of cell or subcellular component |
| GO:0040011 | 2e-04 | 1.4597 | 88.9459 | 121 | 1353 | locomotion |
| GO:0032502 | 3e-04 | 1.3829 | 144.0918 | 181 | 2374 | developmental process |
| GO:2001199 | 3e-04 | Inf | 0.1972 | 3 | 3 | negative regulation of dendritic cell differentiation |
| GO:0003341 | 3e-04 | 3.7452 | 3.8129 | 12 | 58 | cilium movement |
| GO:0048704 | 4e-04 | 3.0812 | 5.5879 | 15 | 85 | embryonic skeletal system morphogenesis |
| GO:0016477 | 4e-04 | 1.4953 | 68.5666 | 96 | 1043 | cell migration |
| GO:0018958 | 6e-04 | 3.2752 | 4.6018 | 13 | 70 | phenol-containing compound metabolic process |
| GO:0001568 | 6e-04 | 1.6941 | 33.4615 | 53 | 509 | blood vessel development |
| GO:0032501 | 6e-04 | 1.3078 | 218.5565 | 258 | 3538 | multicellular organismal process |
| GO:0072358 | 6e-04 | 1.6708 | 35.1708 | 55 | 535 | cardiovascular system development |
| GO:0051240 | 7e-04 | 1.4374 | 79.2822 | 107 | 1206 | positive regulation of multicellular organismal process |
| GO:0060285 | 9e-04 | 5.5634 | 1.6435 | 7 | 25 | cilium-dependent cell motility |
| GO:0009790 | 9e-04 | 1.5101 | 54.8927 | 78 | 835 | embryo development |
| GO:0006575 | 0.001 | 2.4206 | 8.6776 | 19 | 132 | cellular modified amino acid metabolic process |
| GO:1905205 | 0.001 | 14.2725 | 0.5259 | 4 | 8 | positive regulation of connective tissue replacement |
| GO:0038111 | 0.0011 | 4.5806 | 2.1694 | 8 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0011 | 4.5806 | 2.1694 | 8 | 33 | response to interleukin-7 |
| GO:0002138 | 0.0011 | 42.7785 | 0.263 | 3 | 4 | retinoic acid biosynthetic process |
| GO:0003199 | 0.0011 | 42.7785 | 0.263 | 3 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0021648 | 0.0011 | 42.7785 | 0.263 | 3 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0042126 | 0.0011 | 42.7785 | 0.263 | 3 | 4 | nitrate metabolic process |
| GO:0097176 | 0.0011 | 42.7785 | 0.263 | 3 | 4 | epoxide metabolic process |
| GO:0015698 | 0.0012 | 2.5204 | 7.4943 | 17 | 114 | inorganic anion transport |
| GO:2000026 | 0.0014 | 1.3967 | 84.4 | 111 | 1301 | regulation of multicellular organismal development |
| GO:0031579 | 0.0014 | 6.126 | 1.3148 | 6 | 20 | membrane raft organization |
| GO:0045596 | 0.0017 | 1.6087 | 34.3162 | 52 | 522 | negative regulation of cell differentiation |
| GO:0046394 | 0.0018 | 1.8925 | 17.0266 | 30 | 259 | carboxylic acid biosynthetic process |
| GO:0060900 | 0.0018 | 11.4171 | 0.5917 | 4 | 9 | embryonic camera-type eye formation |
| GO:0051094 | 0.0018 | 1.4302 | 66.5944 | 90 | 1013 | positive regulation of developmental process |
| GO:0048731 | 0.0019 | 1.4101 | 75.7567 | 100 | 1239 | system development |
| GO:0051241 | 0.0019 | 1.4681 | 55.4844 | 77 | 844 | negative regulation of multicellular organismal process |
| GO:0001525 | 0.002 | 1.8962 | 16.4198 | 29 | 252 | angiogenesis |
| GO:0006631 | 0.0021 | 1.828 | 18.7358 | 32 | 285 | fatty acid metabolic process |
| GO:0035295 | 0.0022 | 1.6033 | 33.0671 | 50 | 503 | tube development |
| GO:0006955 | 0.0024 | 1.3671 | 86.645 | 112 | 1318 | immune response |
| GO:0008343 | 0.0026 | 21.3875 | 0.3287 | 3 | 5 | adult feeding behavior |
| GO:0060023 | 0.0026 | 21.3875 | 0.3287 | 3 | 5 | soft palate development |
| GO:2001046 | 0.0026 | 21.3875 | 0.3287 | 3 | 5 | positive regulation of integrin-mediated signaling pathway |
| GO:0001501 | 0.0026 | 1.6582 | 26.8876 | 42 | 409 | skeletal system development |
| GO:0010755 | 0.0028 | 9.5135 | 0.6574 | 4 | 10 | regulation of plasminogen activation |
| GO:0035646 | 0.0028 | 9.5135 | 0.6574 | 4 | 10 | endosome to melanosome transport |
| GO:0043476 | 0.0028 | 9.5135 | 0.6574 | 4 | 10 | pigment accumulation |
| GO:0048757 | 0.0028 | 9.5135 | 0.6574 | 4 | 10 | pigment granule maturation |
| GO:0009651 | 0.0029 | 6.4913 | 1.0518 | 5 | 16 | response to salt stress |
| GO:2000145 | 0.003 | 1.5164 | 41.0874 | 59 | 625 | regulation of cell motility |
| GO:0030878 | 0.003 | 5.0437 | 1.512 | 6 | 23 | thyroid gland development |
| GO:0007389 | 0.0031 | 1.6865 | 23.9293 | 38 | 364 | pattern specification process |
| GO:0030154 | 0.0031 | 1.2692 | 168.4168 | 200 | 2629 | cell differentiation |
| GO:0043010 | 0.0032 | 1.8528 | 16.172 | 28 | 246 | camera-type eye development |
| GO:0043066 | 0.0032 | 1.4864 | 45.4262 | 64 | 691 | negative regulation of apoptotic process |
| GO:0050671 | 0.0032 | 2.5113 | 6.1795 | 14 | 94 | positive regulation of lymphocyte proliferation |
| GO:1901342 | 0.0034 | 1.8928 | 14.7257 | 26 | 224 | regulation of vasculature development |
| GO:0060706 | 0.0038 | 4.7631 | 1.5778 | 6 | 24 | cell differentiation involved in embryonic placenta development |
| GO:0051290 | 0.0039 | 3.5766 | 2.6296 | 8 | 40 | protein heterotetramerization |
| GO:0072593 | 0.004 | 1.9203 | 13.4109 | 24 | 204 | reactive oxygen species metabolic process |
| GO:0001961 | 0.0041 | 4.0034 | 2.1037 | 7 | 32 | positive regulation of cytokine-mediated signaling pathway |
| GO:0006071 | 0.0042 | 8.1537 | 0.7231 | 4 | 11 | glycerol metabolic process |
| GO:0070665 | 0.0043 | 2.42 | 6.3768 | 14 | 97 | positive regulation of leukocyte proliferation |
| GO:0001698 | 0.0043 | Inf | 0.1315 | 2 | 2 | gastrin-induced gastric acid secretion |
| GO:0003342 | 0.0043 | Inf | 0.1315 | 2 | 2 | proepicardium development |
| GO:0043134 | 0.0043 | Inf | 0.1315 | 2 | 2 | regulation of hindgut contraction |
| GO:0055014 | 0.0043 | Inf | 0.1315 | 2 | 2 | atrial cardiac muscle cell development |
| GO:0060838 | 0.0043 | Inf | 0.1315 | 2 | 2 | lymphatic endothelial cell fate commitment |
| GO:1901731 | 0.0043 | Inf | 0.1315 | 2 | 2 | positive regulation of platelet aggregation |
| GO:1901994 | 0.0043 | Inf | 0.1315 | 2 | 2 | negative regulation of meiotic cell cycle phase transition |
| GO:2000410 | 0.0043 | Inf | 0.1315 | 2 | 2 | regulation of thymocyte migration |
| GO:0070887 | 0.0044 | 1.2645 | 152.582 | 182 | 2321 | cellular response to chemical stimulus |
| GO:0042127 | 0.0045 | 1.3452 | 82.9636 | 106 | 1262 | regulation of cell proliferation |
| GO:0009888 | 0.0046 | 1.3283 | 92.0217 | 116 | 1410 | tissue development |
| GO:0048534 | 0.0046 | 1.4638 | 45.2947 | 63 | 689 | hematopoietic or lymphoid organ development |
| GO:0006629 | 0.0047 | 1.3662 | 72.3795 | 94 | 1101 | lipid metabolic process |
| GO:0003407 | 0.0048 | 3.1418 | 3.287 | 9 | 50 | neural retina development |
| GO:0019062 | 0.0049 | 14.2572 | 0.3944 | 3 | 6 | virion attachment to host cell |
| GO:0021603 | 0.0049 | 14.2572 | 0.3944 | 3 | 6 | cranial nerve formation |
| GO:0021902 | 0.0049 | 14.2572 | 0.3944 | 3 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0035360 | 0.0049 | 14.2572 | 0.3944 | 3 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0060017 | 0.0049 | 14.2572 | 0.3944 | 3 | 6 | parathyroid gland development |
| GO:0019369 | 0.0049 | 3.8491 | 2.1694 | 7 | 33 | arachidonic acid metabolic process |
| GO:2000778 | 0.0051 | 5.4918 | 1.1833 | 5 | 18 | positive regulation of interleukin-6 secretion |
| GO:0043009 | 0.0054 | 1.5354 | 32.9356 | 48 | 501 | chordate embryonic development |
| GO:0048839 | 0.0055 | 2.0377 | 10.0582 | 19 | 153 | inner ear development |
| GO:0022603 | 0.0056 | 1.4182 | 52.5918 | 71 | 800 | regulation of anatomical structure morphogenesis |
| GO:0007423 | 0.0056 | 1.5714 | 28.8598 | 43 | 439 | sensory organ development |
| GO:0042471 | 0.0057 | 2.335 | 6.574 | 14 | 100 | ear morphogenesis |
| GO:0046500 | 0.006 | 7.1339 | 0.7889 | 4 | 12 | S-adenosylmethionine metabolic process |
| GO:0009617 | 0.0061 | 1.6462 | 22.483 | 35 | 342 | response to bacterium |
| GO:0072676 | 0.0063 | 2.9951 | 3.4185 | 9 | 52 | lymphocyte migration |
| GO:0045766 | 0.0065 | 2.2187 | 7.3629 | 15 | 112 | positive regulation of angiogenesis |
| GO:0090103 | 0.0065 | 5.0991 | 1.2491 | 5 | 19 | cochlea morphogenesis |
| GO:0007154 | 0.0068 | 1.1978 | 313.5129 | 348 | 4769 | cell communication |
| GO:0060562 | 0.0068 | 1.72 | 17.8812 | 29 | 272 | epithelial tube morphogenesis |
| GO:0001709 | 0.0069 | 3.5736 | 2.3009 | 7 | 35 | cell fate determination |
| GO:0048483 | 0.0069 | 3.5736 | 2.3009 | 7 | 35 | autonomic nervous system development |
| GO:0007492 | 0.007 | 2.5827 | 4.7333 | 11 | 72 | endoderm development |
| GO:0034446 | 0.007 | 2.5827 | 4.7333 | 11 | 72 | substrate adhesion-dependent cell spreading |
| GO:0045616 | 0.0071 | 4.0817 | 1.775 | 6 | 27 | regulation of keratinocyte differentiation |
| GO:0021879 | 0.0072 | 3.1781 | 2.8925 | 8 | 44 | forebrain neuron differentiation |
| GO:0050878 | 0.0072 | 1.5911 | 25.1783 | 38 | 383 | regulation of body fluid levels |
| GO:0043207 | 0.0074 | 1.4806 | 36.88 | 52 | 561 | response to external biotic stimulus |
| GO:0033993 | 0.0078 | 1.4268 | 45.5577 | 62 | 693 | response to lipid |
| GO:0030858 | 0.0081 | 2.8616 | 3.5499 | 9 | 54 | positive regulation of epithelial cell differentiation |
| GO:0001766 | 0.0081 | 10.692 | 0.4602 | 3 | 7 | membrane raft polarization |
| GO:0003211 | 0.0081 | 10.692 | 0.4602 | 3 | 7 | cardiac ventricle formation |
| GO:0016114 | 0.0081 | 10.692 | 0.4602 | 3 | 7 | terpenoid biosynthetic process |
| GO:0002230 | 0.0082 | 4.7588 | 1.3148 | 5 | 20 | positive regulation of defense response to virus by host |
| GO:0030194 | 0.0082 | 4.7588 | 1.3148 | 5 | 20 | positive regulation of blood coagulation |
| GO:0034110 | 0.0082 | 4.7588 | 1.3148 | 5 | 20 | regulation of homotypic cell-cell adhesion |
| GO:0036159 | 0.0082 | 6.3408 | 0.8546 | 4 | 13 | inner dynein arm assembly |
| GO:0045655 | 0.0082 | 6.3408 | 0.8546 | 4 | 13 | regulation of monocyte differentiation |
| GO:0072148 | 0.0082 | 6.3408 | 0.8546 | 4 | 13 | epithelial cell fate commitment |
| GO:0072606 | 0.0082 | 6.3408 | 0.8546 | 4 | 13 | interleukin-8 secretion |
| GO:0002685 | 0.0083 | 2.1516 | 7.5601 | 15 | 115 | regulation of leukocyte migration |
| GO:0050673 | 0.0083 | 1.6916 | 18.1442 | 29 | 276 | epithelial cell proliferation |
| GO:0035108 | 0.0084 | 2.0871 | 8.2832 | 16 | 126 | limb morphogenesis |
| GO:0002443 | 0.0084 | 1.4807 | 35.4337 | 50 | 539 | leukocyte mediated immunity |
| GO:0031638 | 0.0086 | 3.8958 | 1.8407 | 6 | 28 | zymogen activation |
| GO:0072529 | 0.0086 | 3.8958 | 1.8407 | 6 | 28 | pyrimidine-containing compound catabolic process |
| GO:0007399 | 0.0089 | 1.2626 | 120.6984 | 145 | 1846 | nervous system development |
| GO:0048562 | 0.0092 | 2.3619 | 5.5679 | 12 | 86 | embryonic organ morphogenesis |
| GO:0050829 | 0.0094 | 3.3348 | 2.4324 | 7 | 37 | defense response to Gram-negative bacterium |
| GO:0006334 | 0.0096 | 2.109 | 7.6916 | 15 | 117 | nucleosome assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022610 | 0.0011 | 2.5731 | 7.4872 | 17 | 1043 | biological adhesion |
| GO:0002697 | 0.0019 | 4.2935 | 1.7659 | 7 | 246 | regulation of immune effector process |
| GO:0032720 | 0.0022 | 12.9506 | 0.2584 | 3 | 36 | negative regulation of tumor necrosis factor production |
| GO:2001241 | 0.0022 | 35.2984 | 0.0718 | 2 | 10 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0006955 | 0.0023 | 2.2787 | 9.4612 | 19 | 1318 | immune response |
| GO:0032689 | 0.0044 | 23.5251 | 0.1005 | 2 | 14 | negative regulation of interferon-gamma production |
| GO:0002696 | 0.0044 | 4.1911 | 1.5362 | 6 | 214 | positive regulation of leukocyte activation |
| GO:0050671 | 0.0046 | 6.3731 | 0.6748 | 4 | 94 | positive regulation of lymphocyte proliferation |
| GO:0045785 | 0.005 | 3.5876 | 2.0961 | 7 | 292 | positive regulation of cell adhesion |
| GO:0070665 | 0.0052 | 6.1661 | 0.6963 | 4 | 97 | positive regulation of leukocyte proliferation |
| GO:0051249 | 0.0053 | 3.5494 | 2.1177 | 7 | 295 | regulation of lymphocyte activation |
| GO:0050865 | 0.0054 | 3.2091 | 2.6848 | 8 | 374 | regulation of cell activation |
| GO:0042346 | 0.0065 | 18.8158 | 0.122 | 2 | 17 | positive regulation of NF-kappaB import into nucleus |
| GO:0060291 | 0.0068 | 8.3683 | 0.3876 | 3 | 54 | long-term synaptic potentiation |
| GO:0006952 | 0.0072 | 2.209 | 7.4872 | 15 | 1043 | defense response |
| GO:0001207 | 0.0072 | Inf | 0.0072 | 1 | 1 | histone displacement |
| GO:0002264 | 0.0072 | Inf | 0.0072 | 1 | 1 | endothelial cell activation involved in immune response |
| GO:0010070 | 0.0072 | Inf | 0.0072 | 1 | 1 | zygote asymmetric cell division |
| GO:0030813 | 0.0072 | Inf | 0.0072 | 1 | 1 | positive regulation of nucleotide catabolic process |
| GO:0030822 | 0.0072 | Inf | 0.0072 | 1 | 1 | positive regulation of cAMP catabolic process |
| GO:0031048 | 0.0072 | Inf | 0.0072 | 1 | 1 | chromatin silencing by small RNA |
| GO:0032972 | 0.0072 | Inf | 0.0072 | 1 | 1 | regulation of muscle filament sliding speed |
| GO:0042361 | 0.0072 | Inf | 0.0072 | 1 | 1 | menaquinone catabolic process |
| GO:0042377 | 0.0072 | Inf | 0.0072 | 1 | 1 | vitamin K catabolic process |
| GO:0046092 | 0.0072 | Inf | 0.0072 | 1 | 1 | deoxycytidine metabolic process |
| GO:0051039 | 0.0072 | Inf | 0.0072 | 1 | 1 | positive regulation of transcription involved in meiotic cell cycle |
| GO:0060010 | 0.0072 | Inf | 0.0072 | 1 | 1 | Sertoli cell fate commitment |
| GO:0061847 | 0.0072 | Inf | 0.0072 | 1 | 1 | response to cholecystokinin |
| GO:0071538 | 0.0072 | Inf | 0.0072 | 1 | 1 | SH2 domain-mediated complex assembly |
| GO:1990349 | 0.0072 | Inf | 0.0072 | 1 | 1 | gap junction-mediated intercellular transport |
| GO:1990859 | 0.0072 | Inf | 0.0072 | 1 | 1 | cellular response to endothelin |
| GO:0032956 | 0.0082 | 3.6543 | 1.7515 | 6 | 244 | regulation of actin cytoskeleton organization |
| GO:0007422 | 0.0087 | 7.6182 | 0.4235 | 3 | 59 | peripheral nervous system development |
| GO:0002366 | 0.0088 | 2.7363 | 3.539 | 9 | 493 | leukocyte activation involved in immune response |
| GO:0002707 | 0.0089 | 15.6762 | 0.1436 | 2 | 20 | negative regulation of lymphocyte mediated immunity |
| GO:0042110 | 0.009 | 3.1968 | 2.3402 | 7 | 326 | T cell activation |
| GO:0006909 | 0.0095 | 4.1156 | 1.2921 | 5 | 180 | phagocytosis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 1e-04 | 21.4864 | 0.2383 | 4 | 19 | defense response to fungus |
| GO:0007399 | 1e-04 | 2.0682 | 23.5942 | 42 | 1881 | nervous system development |
| GO:0044657 | 2e-04 | Inf | 0.0251 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0051610 | 2e-04 | Inf | 0.0251 | 2 | 2 | serotonin uptake |
| GO:0052043 | 2e-04 | Inf | 0.0251 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 2e-04 | Inf | 0.0251 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 2e-04 | Inf | 0.0251 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0007268 | 4e-04 | 2.8341 | 6.1463 | 16 | 490 | chemical synaptic transmission |
| GO:0061844 | 4e-04 | 12.882 | 0.3638 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0099537 | 5e-04 | 2.8279 | 6.1588 | 16 | 491 | trans-synaptic signaling |
| GO:0032227 | 5e-04 | 159.3537 | 0.0376 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
| GO:0051673 | 5e-04 | 159.3537 | 0.0376 | 2 | 3 | membrane disruption in other organism |
| GO:0051897 | 6e-04 | 5.3328 | 1.43 | 7 | 114 | positive regulation of protein kinase B signaling |
| GO:0015872 | 7e-04 | 11.1017 | 0.4139 | 4 | 33 | dopamine transport |
| GO:0048625 | 9e-04 | 79.6707 | 0.0502 | 2 | 4 | myoblast fate commitment |
| GO:0007267 | 9e-04 | 2.0355 | 15.8047 | 29 | 1260 | cell-cell signaling |
| GO:0002227 | 0.001 | 18.4828 | 0.2007 | 3 | 16 | innate immune response in mucosa |
| GO:0010469 | 0.0011 | 2.8999 | 4.8292 | 13 | 385 | regulation of receptor activity |
| GO:0001547 | 0.0015 | 53.1098 | 0.0627 | 2 | 5 | antral ovarian follicle growth |
| GO:0003105 | 0.0015 | 53.1098 | 0.0627 | 2 | 5 | negative regulation of glomerular filtration |
| GO:0009605 | 0.002 | 1.8753 | 18.9486 | 32 | 1536 | response to external stimulus |
| GO:0001964 | 0.0022 | 13.3436 | 0.2634 | 3 | 21 | startle response |
| GO:0021826 | 0.0023 | 39.8293 | 0.0753 | 2 | 6 | substrate-independent telencephalic tangential migration |
| GO:0021830 | 0.0023 | 39.8293 | 0.0753 | 2 | 6 | interneuron migration from the subpallium to the cortex |
| GO:0043416 | 0.0023 | 39.8293 | 0.0753 | 2 | 6 | regulation of skeletal muscle tissue regeneration |
| GO:0045938 | 0.0023 | 39.8293 | 0.0753 | 2 | 6 | positive regulation of circadian sleep/wake cycle, sleep |
| GO:0007186 | 0.0023 | 2.2648 | 8.5797 | 18 | 684 | G-protein coupled receptor signaling pathway |
| GO:0002251 | 0.0025 | 12.6403 | 0.276 | 3 | 22 | organ or tissue specific immune response |
| GO:0019731 | 0.0025 | 12.6403 | 0.276 | 3 | 22 | antibacterial humoral response |
| GO:0060143 | 0.0025 | 12.6403 | 0.276 | 3 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0033993 | 0.0027 | 2.233 | 8.6926 | 18 | 693 | response to lipid |
| GO:0021885 | 0.0028 | 7.4792 | 0.5895 | 4 | 47 | forebrain cell migration |
| GO:0014059 | 0.0029 | 12.0074 | 0.2885 | 3 | 23 | regulation of dopamine secretion |
| GO:0042127 | 0.0041 | 1.8611 | 15.8298 | 27 | 1262 | regulation of cell proliferation |
| GO:2000344 | 0.0042 | 26.5488 | 0.1003 | 2 | 8 | positive regulation of acrosome reaction |
| GO:0003016 | 0.0045 | 10.0031 | 0.3387 | 3 | 27 | respiratory system process |
| GO:0048149 | 0.0053 | 22.7544 | 0.1129 | 2 | 9 | behavioral response to ethanol |
| GO:0051852 | 0.0053 | 22.7544 | 0.1129 | 2 | 9 | disruption by host of symbiont cells |
| GO:2000392 | 0.0053 | 22.7544 | 0.1129 | 2 | 9 | regulation of lamellipodium morphogenesis |
| GO:1903727 | 0.0056 | 9.2322 | 0.3638 | 3 | 29 | positive regulation of phospholipid metabolic process |
| GO:0042445 | 0.0057 | 3.9466 | 1.6181 | 6 | 129 | hormone metabolic process |
| GO:0014031 | 0.006 | 5.9506 | 0.7275 | 4 | 58 | mesenchymal cell development |
| GO:0015844 | 0.006 | 5.9506 | 0.7275 | 4 | 58 | monoamine transport |
| GO:0042221 | 0.0061 | 1.6067 | 32.4344 | 46 | 2695 | response to chemical |
| GO:0031640 | 0.0061 | 8.8896 | 0.3763 | 3 | 30 | killing of cells of other organism |
| GO:0030595 | 0.0064 | 3.8518 | 1.6557 | 6 | 132 | leukocyte chemotaxis |
| GO:0050793 | 0.0065 | 1.6573 | 24.6479 | 37 | 1965 | regulation of developmental process |
| GO:0006067 | 0.0066 | 19.9085 | 0.1254 | 2 | 10 | ethanol metabolic process |
| GO:0010960 | 0.0066 | 19.9085 | 0.1254 | 2 | 10 | magnesium ion homeostasis |
| GO:0070486 | 0.0066 | 19.9085 | 0.1254 | 2 | 10 | leukocyte aggregation |
| GO:0051716 | 0.0067 | 1.491 | 67.8099 | 84 | 5406 | cellular response to stimulus |
| GO:0032501 | 0.0067 | 1.49 | 67.835 | 84 | 5408 | multicellular organismal process |
| GO:0007264 | 0.0068 | 2.4118 | 5.2808 | 12 | 421 | small GTPase mediated signal transduction |
| GO:0048469 | 0.0068 | 3.791 | 1.6808 | 6 | 134 | cell maturation |
| GO:0001977 | 0.008 | 17.6951 | 0.138 | 2 | 11 | renal system process involved in regulation of blood volume |
| GO:0002087 | 0.008 | 17.6951 | 0.138 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0010310 | 0.008 | 17.6951 | 0.138 | 2 | 11 | regulation of hydrogen peroxide metabolic process |
| GO:0021978 | 0.008 | 17.6951 | 0.138 | 2 | 11 | telencephalon regionalization |
| GO:0032753 | 0.008 | 17.6951 | 0.138 | 2 | 11 | positive regulation of interleukin-4 production |
| GO:0008037 | 0.0085 | 4.2409 | 1.2543 | 5 | 100 | cell recognition |
| GO:0048663 | 0.0085 | 5.3531 | 0.8028 | 4 | 64 | neuron fate commitment |
| GO:0009719 | 0.0087 | 1.7796 | 15.165 | 25 | 1209 | response to endogenous stimulus |
| GO:0009755 | 0.0088 | 3.1881 | 2.3205 | 7 | 185 | hormone-mediated signaling pathway |
| GO:0006935 | 0.0092 | 2.3124 | 5.494 | 12 | 438 | chemotaxis |
| GO:0007266 | 0.0093 | 3.5395 | 1.7937 | 6 | 143 | Rho protein signal transduction |
| GO:0010818 | 0.0095 | 15.9244 | 0.1505 | 2 | 12 | T cell chemotaxis |
| GO:0051583 | 0.0095 | 15.9244 | 0.1505 | 2 | 12 | dopamine uptake involved in synaptic transmission |
| GO:0090493 | 0.0095 | 15.9244 | 0.1505 | 2 | 12 | catecholamine uptake |
| GO:1903818 | 0.0095 | 15.9244 | 0.1505 | 2 | 12 | positive regulation of voltage-gated potassium channel activity |
| GO:0048870 | 0.0096 | 1.7838 | 14.4877 | 24 | 1155 | cell motility |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048240 | 0.0026 | 826 | 0.0026 | 1 | 17 | sperm capacitation |
| GO:0006805 | 0.0089 | 227.1379 | 0.0089 | 1 | 59 | xenobiotic metabolic process |
| GO:0006081 | 0.0093 | 215.918 | 0.0094 | 1 | 62 | cellular aldehyde metabolic process |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0110023 | 2e-04 | Inf | 2e-04 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
| GO:1903769 | 2e-04 | Inf | 2e-04 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:0007568 | 0.001 | 109.654 | 0.0542 | 2 | 239 | aging |
| GO:0060837 | 0.0016 | 1102.0833 | 0.0016 | 1 | 7 | blood vessel endothelial cell differentiation |
| GO:0001833 | 0.0025 | 661.05 | 0.0025 | 1 | 11 | inner cell mass cell proliferation |
| GO:2000774 | 0.0025 | 661.05 | 0.0025 | 1 | 11 | positive regulation of cellular senescence |
| GO:2000291 | 0.0034 | 472.0357 | 0.0034 | 1 | 15 | regulation of myoblast proliferation |
| GO:0043537 | 0.0068 | 227.6207 | 0.0068 | 1 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0090342 | 0.009 | 169.1282 | 0.0091 | 1 | 40 | regulation of cell aging |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009645 | 1e-04 | Inf | 1e-04 | 1 | 1 | response to low light intensity stimulus |
| GO:0046690 | 1e-04 | Inf | 1e-04 | 1 | 1 | response to tellurium ion |
| GO:0055098 | 3e-04 | Inf | 3e-04 | 1 | 4 | response to low-density lipoprotein particle stimulus |
| GO:0071372 | 5e-04 | Inf | 5e-04 | 1 | 7 | cellular response to follicle-stimulating hormone stimulus |
| GO:0033197 | 8e-04 | Inf | 8e-04 | 1 | 11 | response to vitamin E |
| GO:0071397 | 8e-04 | Inf | 8e-04 | 1 | 11 | cellular response to cholesterol |
| GO:0036314 | 0.0013 | Inf | 0.0013 | 1 | 17 | response to sterol |
| GO:0008299 | 0.0016 | Inf | 0.0016 | 1 | 21 | isoprenoid biosynthetic process |
| GO:0034698 | 0.0018 | Inf | 0.0018 | 1 | 24 | response to gonadotropin |
| GO:0045540 | 0.0028 | Inf | 0.0028 | 1 | 37 | regulation of cholesterol biosynthetic process |
| GO:1902653 | 0.0042 | Inf | 0.0042 | 1 | 56 | secondary alcohol biosynthetic process |
| GO:0016126 | 0.0045 | Inf | 0.0045 | 1 | 59 | sterol biosynthetic process |
| GO:0019218 | 0.0066 | Inf | 0.0066 | 1 | 87 | regulation of steroid metabolic process |
| GO:0008203 | 0.0083 | Inf | 0.0083 | 1 | 110 | cholesterol metabolic process |
| GO:0008584 | 0.0083 | Inf | 0.0083 | 1 | 110 | male gonad development |
| GO:0014074 | 0.0085 | Inf | 0.0085 | 1 | 112 | response to purine-containing compound |
| GO:0001889 | 0.0086 | Inf | 0.0086 | 1 | 114 | liver development |
| GO:0046661 | 0.0098 | Inf | 0.0098 | 1 | 130 | male sex differentiation |
| GO:0007584 | 0.0099 | Inf | 0.0099 | 1 | 131 | response to nutrient |
| GO:0046890 | 0.01 | Inf | 0.01 | 1 | 132 | regulation of lipid biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0.0064 | Inf | 0.0064 | 1 | 85 | embryonic skeletal system morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0014049 | 0.0012 | 1889.2857 | 0.0012 | 1 | 8 | positive regulation of glutamate secretion |
| GO:0051901 | 0.0012 | 1889.2857 | 0.0012 | 1 | 8 | positive regulation of mitochondrial depolarization |
| GO:0032099 | 0.0014 | 1653 | 0.0014 | 1 | 9 | negative regulation of appetite |
| GO:0032108 | 0.0017 | 1322.2 | 0.0017 | 1 | 11 | negative regulation of response to nutrient levels |
| GO:0032095 | 0.0021 | 1016.8462 | 0.0021 | 1 | 14 | regulation of response to food |
| GO:0060294 | 0.0024 | 881.1333 | 0.0024 | 1 | 16 | cilium movement involved in cell motility |
| GO:0080154 | 0.0026 | 826 | 0.0026 | 1 | 17 | regulation of fertilization |
| GO:0032104 | 0.0029 | 734.1111 | 0.0029 | 1 | 19 | regulation of response to extracellular stimulus |
| GO:0032461 | 0.0029 | 734.1111 | 0.0029 | 1 | 19 | positive regulation of protein oligomerization |
| GO:0007205 | 0.0033 | 629.0952 | 0.0033 | 1 | 22 | protein kinase C-activating G-protein coupled receptor signaling pathway |
| GO:0051930 | 0.0035 | 600.4545 | 0.0035 | 1 | 23 | regulation of sensory perception of pain |
| GO:0001539 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | cilium or flagellum-dependent cell motility |
| GO:0032892 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | positive regulation of organic acid transport |
| GO:0051955 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | regulation of amino acid transport |
| GO:0042755 | 0.0039 | 528.28 | 0.0039 | 1 | 26 | eating behavior |
| GO:0001662 | 0.0044 | 471.5714 | 0.0044 | 1 | 29 | behavioral fear response |
| GO:0051954 | 0.0044 | 471.5714 | 0.0044 | 1 | 29 | positive regulation of amine transport |
| GO:1903793 | 0.0053 | 388.1765 | 0.0053 | 1 | 35 | positive regulation of anion transport |
| GO:0003254 | 0.0056 | 366.5556 | 0.0056 | 1 | 37 | regulation of membrane depolarization |
| GO:0051674 | 0.0076 | Inf | 0.1746 | 2 | 1155 | localization of cell |
| GO:0001836 | 0.0077 | 263.64 | 0.0077 | 1 | 51 | release of cytochrome c from mitochondria |
| GO:0031644 | 0.0078 | 258.451 | 0.0079 | 1 | 52 | regulation of neurological system process |
| GO:0120036 | 0.008 | Inf | 0.1785 | 2 | 1181 | plasma membrane bounded cell projection organization |
| GO:0051881 | 0.0083 | 244.037 | 0.0083 | 1 | 55 | regulation of mitochondrial membrane potential |
| GO:0033555 | 0.0087 | 231.1404 | 0.0088 | 1 | 58 | multicellular organismal response to stress |
| GO:0006919 | 0.0096 | 209.0317 | 0.0097 | 1 | 64 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0030317 | 0.0096 | 209.0317 | 0.0097 | 1 | 64 | flagellated sperm motility |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046597 | 0.0011 | Inf | 0.0011 | 1 | 14 | negative regulation of viral entry into host cell |
| GO:0032897 | 0.0015 | Inf | 0.0015 | 1 | 20 | negative regulation of viral transcription |
| GO:1902186 | 0.002 | Inf | 0.002 | 1 | 27 | regulation of viral release from host cell |
| GO:0035891 | 0.0023 | Inf | 0.0023 | 1 | 30 | exit from host cell |
| GO:0052126 | 0.0023 | Inf | 0.0023 | 1 | 30 | movement in host environment |
| GO:0060333 | 0.0047 | Inf | 0.0047 | 1 | 62 | interferon-gamma-mediated signaling pathway |
| GO:0034341 | 0.0077 | Inf | 0.0077 | 1 | 102 | response to interferon-gamma |
| GO:0030260 | 0.0083 | Inf | 0.0083 | 1 | 110 | entry into host cell |
| GO:0051828 | 0.0083 | Inf | 0.0083 | 1 | 110 | entry into other organism involved in symbiotic interaction |
| GO:0043901 | 0.009 | Inf | 0.009 | 1 | 119 | negative regulation of multi-organism process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036158 | 0.0011 | Inf | 0.0011 | 1 | 15 | outer dynein arm assembly |
| GO:0035082 | 0.0039 | Inf | 0.0039 | 1 | 52 | axoneme assembly |
| GO:0003341 | 0.0044 | Inf | 0.0044 | 1 | 58 | cilium movement |
| GO:0007286 | 0.0086 | Inf | 0.0086 | 1 | 114 | spermatid development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048646 | 0 | 1.8187 | 43.1313 | 72 | 831 | anatomical structure formation involved in morphogenesis |
| GO:0048856 | 0 | 1.4189 | 203.1529 | 252 | 3971 | anatomical structure development |
| GO:0006590 | 0 | 15.6622 | 0.6798 | 6 | 13 | thyroid hormone generation |
| GO:0034103 | 0 | 4.7939 | 3.0328 | 12 | 58 | regulation of tissue remodeling |
| GO:0030198 | 0 | 2.4613 | 12.9678 | 29 | 248 | extracellular matrix organization |
| GO:0051674 | 0 | 1.6334 | 60.3944 | 91 | 1155 | localization of cell |
| GO:0048514 | 1e-04 | 2.0269 | 23.0074 | 43 | 440 | blood vessel morphogenesis |
| GO:0048568 | 1e-04 | 2.0647 | 19.3994 | 37 | 371 | embryonic organ development |
| GO:2000026 | 2e-04 | 1.5035 | 79.7416 | 111 | 1525 | regulation of multicellular organismal development |
| GO:0072359 | 2e-04 | 1.6791 | 42.1977 | 66 | 807 | circulatory system development |
| GO:0022610 | 2e-04 | 1.5958 | 54.538 | 81 | 1043 | biological adhesion |
| GO:0048598 | 2e-04 | 1.9403 | 22.1924 | 40 | 428 | embryonic morphogenesis |
| GO:0001944 | 3e-04 | 1.8193 | 27.7135 | 47 | 530 | vasculature development |
| GO:0040011 | 3e-04 | 1.5028 | 70.7478 | 99 | 1353 | locomotion |
| GO:0048869 | 4e-04 | 1.3441 | 173.2876 | 212 | 3314 | cellular developmental process |
| GO:0042445 | 4e-04 | 2.7951 | 6.7454 | 17 | 129 | hormone metabolic process |
| GO:1905205 | 4e-04 | 18.2238 | 0.4183 | 4 | 8 | positive regulation of connective tissue replacement |
| GO:0003199 | 5e-04 | 54.6052 | 0.2092 | 3 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0042126 | 5e-04 | 54.6052 | 0.2092 | 3 | 4 | nitrate metabolic process |
| GO:0097176 | 5e-04 | 54.6052 | 0.2092 | 3 | 4 | epoxide metabolic process |
| GO:0018958 | 0.001 | 3.4175 | 3.6603 | 11 | 70 | phenol-containing compound metabolic process |
| GO:2000145 | 0.001 | 1.6589 | 32.681 | 51 | 625 | regulation of cell motility |
| GO:0010755 | 0.0012 | 12.1473 | 0.5229 | 4 | 10 | regulation of plasminogen activation |
| GO:0021877 | 0.0012 | 12.1473 | 0.5229 | 4 | 10 | forebrain neuron fate commitment |
| GO:0051094 | 0.0013 | 1.5038 | 52.9693 | 75 | 1013 | positive regulation of developmental process |
| GO:0060023 | 0.0013 | 27.3004 | 0.2614 | 3 | 5 | soft palate development |
| GO:0048704 | 0.0015 | 3.0143 | 4.4446 | 12 | 85 | embryonic skeletal system morphogenesis |
| GO:0001667 | 0.0015 | 1.9801 | 14.5888 | 27 | 279 | ameboidal-type cell migration |
| GO:0043433 | 0.0016 | 2.7054 | 5.6996 | 14 | 109 | negative regulation of DNA binding transcription factor activity |
| GO:2000778 | 0.0019 | 7.0143 | 0.9412 | 5 | 18 | positive regulation of interleukin-6 secretion |
| GO:0006928 | 0.002 | 1.4442 | 61.7345 | 84 | 1200 | movement of cell or subcellular component |
| GO:0098609 | 0.0023 | 1.6035 | 32.3149 | 49 | 618 | cell-cell adhesion |
| GO:0008217 | 0.0024 | 2.4813 | 6.5885 | 15 | 126 | regulation of blood pressure |
| GO:0035360 | 0.0025 | 18.1988 | 0.3137 | 3 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0046500 | 0.0026 | 9.109 | 0.6275 | 4 | 12 | S-adenosylmethionine metabolic process |
| GO:0003342 | 0.0027 | Inf | 0.1046 | 2 | 2 | proepicardium development |
| GO:0055014 | 0.0027 | Inf | 0.1046 | 2 | 2 | atrial cardiac muscle cell development |
| GO:0060838 | 0.0027 | Inf | 0.1046 | 2 | 2 | lymphatic endothelial cell fate commitment |
| GO:1901731 | 0.0027 | Inf | 0.1046 | 2 | 2 | positive regulation of platelet aggregation |
| GO:0007389 | 0.0028 | 1.7831 | 19.0334 | 32 | 364 | pattern specification process |
| GO:0031638 | 0.0028 | 4.9775 | 1.4641 | 6 | 28 | zymogen activation |
| GO:0001501 | 0.0028 | 1.7332 | 21.3864 | 35 | 409 | skeletal system development |
| GO:0002230 | 0.0031 | 6.0781 | 1.0458 | 5 | 20 | positive regulation of defense response to virus by host |
| GO:0030194 | 0.0031 | 6.0781 | 1.0458 | 5 | 20 | positive regulation of blood coagulation |
| GO:0050878 | 0.0033 | 1.7444 | 20.0269 | 33 | 383 | regulation of body fluid levels |
| GO:0009792 | 0.0034 | 1.6394 | 26.4062 | 41 | 505 | embryo development ending in birth or egg hatching |
| GO:0045596 | 0.0036 | 1.6237 | 27.2951 | 42 | 522 | negative regulation of cell differentiation |
| GO:0072148 | 0.0036 | 8.0963 | 0.6798 | 4 | 13 | epithelial cell fate commitment |
| GO:0072606 | 0.0036 | 8.0963 | 0.6798 | 4 | 13 | interleukin-8 secretion |
| GO:0006575 | 0.0037 | 2.353 | 6.9022 | 15 | 132 | cellular modified amino acid metabolic process |
| GO:0042476 | 0.0039 | 2.649 | 4.9675 | 12 | 95 | odontogenesis |
| GO:0060037 | 0.0039 | 5.6978 | 1.0981 | 5 | 21 | pharyngeal system development |
| GO:0060055 | 0.0039 | 5.6978 | 1.0981 | 5 | 21 | angiogenesis involved in wound healing |
| GO:0051241 | 0.0039 | 1.48 | 44.1324 | 62 | 844 | negative regulation of multicellular organismal process |
| GO:0006954 | 0.004 | 1.7217 | 20.26 | 33 | 391 | inflammatory response |
| GO:0007492 | 0.0041 | 2.9515 | 3.7648 | 10 | 72 | endoderm development |
| GO:0050729 | 0.0041 | 2.9515 | 3.7648 | 10 | 72 | positive regulation of inflammatory response |
| GO:0043535 | 0.0042 | 3.1651 | 3.1897 | 9 | 61 | regulation of blood vessel endothelial cell migration |
| GO:0016477 | 0.0043 | 1.5043 | 39.2173 | 56 | 764 | cell migration |
| GO:0060562 | 0.0044 | 1.8657 | 14.2228 | 25 | 272 | epithelial tube morphogenesis |
| GO:0009605 | 0.0046 | 1.3498 | 81.4148 | 104 | 1557 | response to external stimulus |
| GO:0035082 | 0.0052 | 3.3222 | 2.7191 | 8 | 52 | axoneme assembly |
| GO:0050673 | 0.0053 | 1.8354 | 14.4319 | 25 | 276 | epithelial cell proliferation |
| GO:0051240 | 0.0054 | 1.3858 | 63.0612 | 83 | 1206 | positive regulation of multicellular organismal process |
| GO:0045766 | 0.0056 | 2.4064 | 5.8564 | 13 | 112 | positive regulation of angiogenesis |
| GO:0061756 | 0.0059 | 5.0639 | 1.2027 | 5 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0042127 | 0.006 | 1.3716 | 65.9894 | 86 | 1262 | regulation of cell proliferation |
| GO:0032787 | 0.0061 | 1.6184 | 24.0532 | 37 | 460 | monocarboxylic acid metabolic process |
| GO:0042759 | 0.0065 | 10.9176 | 0.4183 | 3 | 8 | long-chain fatty acid biosynthetic process |
| GO:0060982 | 0.0065 | 10.9176 | 0.4183 | 3 | 8 | coronary artery morphogenesis |
| GO:0045765 | 0.0066 | 2.5772 | 4.6571 | 11 | 90 | regulation of angiogenesis |
| GO:0038111 | 0.0066 | 4.0541 | 1.7256 | 6 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0066 | 4.0541 | 1.7256 | 6 | 33 | response to interleukin-7 |
| GO:0044243 | 0.0066 | 3.1772 | 2.8236 | 8 | 54 | multicellular organismal catabolic process |
| GO:0050867 | 0.0069 | 1.9023 | 11.7129 | 21 | 224 | positive regulation of cell activation |
| GO:0021761 | 0.0071 | 2.5482 | 4.7061 | 11 | 90 | limbic system development |
| GO:0043171 | 0.0071 | 4.797 | 1.2549 | 5 | 24 | peptide catabolic process |
| GO:0060706 | 0.0071 | 4.797 | 1.2549 | 5 | 24 | cell differentiation involved in embryonic placenta development |
| GO:0031341 | 0.0073 | 3.4537 | 2.3007 | 7 | 44 | regulation of cell killing |
| GO:0048729 | 0.0075 | 1.5557 | 27.6612 | 41 | 529 | tissue morphogenesis |
| GO:0034112 | 0.0079 | 36.4564 | 0.1564 | 2 | 3 | positive regulation of homotypic cell-cell adhesion |
| GO:0002317 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | plasma cell differentiation |
| GO:0003219 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | cardiac right ventricle formation |
| GO:0033128 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0051410 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | detoxification of nitrogen compound |
| GO:0055005 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | ventricular cardiac myofibril assembly |
| GO:0061044 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0070634 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | transepithelial ammonium transport |
| GO:2001199 | 0.0079 | 36.3507 | 0.1569 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0006555 | 0.0081 | 6.0707 | 0.8366 | 4 | 16 | methionine metabolic process |
| GO:0009651 | 0.0081 | 6.0707 | 0.8366 | 4 | 16 | response to salt stress |
| GO:2001238 | 0.0083 | 3.3626 | 2.353 | 7 | 45 | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0045214 | 0.0089 | 3.7739 | 1.8301 | 6 | 35 | sarcomere organization |
| GO:0048483 | 0.0089 | 3.7739 | 1.8301 | 6 | 35 | autonomic nervous system development |
| GO:0035295 | 0.0089 | 1.5546 | 26.3016 | 39 | 503 | tube development |
| GO:0002252 | 0.009 | 1.4323 | 42.4068 | 58 | 811 | immune effector process |
| GO:0046394 | 0.0092 | 1.7927 | 13.543 | 23 | 259 | carboxylic acid biosynthetic process |
| GO:0006955 | 0.0092 | 1.3399 | 68.9176 | 88 | 1318 | immune response |
| GO:0042472 | 0.0094 | 2.5755 | 4.2355 | 10 | 81 | inner ear morphogenesis |
| GO:0003207 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | cardiac chamber formation |
| GO:0010889 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | regulation of sequestering of triglyceride |
| GO:0016264 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | gap junction assembly |
| GO:0016553 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | base conversion or substitution editing |
| GO:0060900 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | embryonic camera-type eye formation |
| GO:0061029 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | eyelid development in camera-type eye |
| GO:0097286 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | iron ion import |
| GO:0099133 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | ATP hydrolysis coupled anion transmembrane transport |
| GO:1903244 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:2001044 | 0.0094 | 9.0972 | 0.4706 | 3 | 9 | regulation of integrin-mediated signaling pathway |
| GO:0009887 | 0.0095 | 1.457 | 37.3666 | 52 | 722 | animal organ morphogenesis |
| GO:0010632 | 0.0096 | 2.0378 | 8.3663 | 16 | 160 | regulation of epithelial cell migration |
| GO:0003158 | 0.0098 | 2.4247 | 4.9152 | 11 | 94 | endothelium development |
| GO:0050671 | 0.0098 | 2.4247 | 4.9152 | 11 | 94 | positive regulation of lymphocyte proliferation |
| GO:0051272 | 0.0099 | 1.6463 | 19.138 | 30 | 366 | positive regulation of cellular component movement |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022610 | 0.0011 | 2.5731 | 7.4872 | 17 | 1043 | biological adhesion |
| GO:0002697 | 0.0019 | 4.2935 | 1.7659 | 7 | 246 | regulation of immune effector process |
| GO:0032720 | 0.0022 | 12.9506 | 0.2584 | 3 | 36 | negative regulation of tumor necrosis factor production |
| GO:2001241 | 0.0022 | 35.2984 | 0.0718 | 2 | 10 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0006955 | 0.0023 | 2.2787 | 9.4612 | 19 | 1318 | immune response |
| GO:0032689 | 0.0044 | 23.5251 | 0.1005 | 2 | 14 | negative regulation of interferon-gamma production |
| GO:0002696 | 0.0044 | 4.1911 | 1.5362 | 6 | 214 | positive regulation of leukocyte activation |
| GO:0050671 | 0.0046 | 6.3731 | 0.6748 | 4 | 94 | positive regulation of lymphocyte proliferation |
| GO:0045785 | 0.005 | 3.5876 | 2.0961 | 7 | 292 | positive regulation of cell adhesion |
| GO:0070665 | 0.0052 | 6.1661 | 0.6963 | 4 | 97 | positive regulation of leukocyte proliferation |
| GO:0051249 | 0.0053 | 3.5494 | 2.1177 | 7 | 295 | regulation of lymphocyte activation |
| GO:0050865 | 0.0054 | 3.2091 | 2.6848 | 8 | 374 | regulation of cell activation |
| GO:0042346 | 0.0065 | 18.8158 | 0.122 | 2 | 17 | positive regulation of NF-kappaB import into nucleus |
| GO:0060291 | 0.0068 | 8.3683 | 0.3876 | 3 | 54 | long-term synaptic potentiation |
| GO:0006952 | 0.0072 | 2.209 | 7.4872 | 15 | 1043 | defense response |
| GO:0001207 | 0.0072 | Inf | 0.0072 | 1 | 1 | histone displacement |
| GO:0002264 | 0.0072 | Inf | 0.0072 | 1 | 1 | endothelial cell activation involved in immune response |
| GO:0010070 | 0.0072 | Inf | 0.0072 | 1 | 1 | zygote asymmetric cell division |
| GO:0030813 | 0.0072 | Inf | 0.0072 | 1 | 1 | positive regulation of nucleotide catabolic process |
| GO:0030822 | 0.0072 | Inf | 0.0072 | 1 | 1 | positive regulation of cAMP catabolic process |
| GO:0031048 | 0.0072 | Inf | 0.0072 | 1 | 1 | chromatin silencing by small RNA |
| GO:0032972 | 0.0072 | Inf | 0.0072 | 1 | 1 | regulation of muscle filament sliding speed |
| GO:0042361 | 0.0072 | Inf | 0.0072 | 1 | 1 | menaquinone catabolic process |
| GO:0042377 | 0.0072 | Inf | 0.0072 | 1 | 1 | vitamin K catabolic process |
| GO:0046092 | 0.0072 | Inf | 0.0072 | 1 | 1 | deoxycytidine metabolic process |
| GO:0051039 | 0.0072 | Inf | 0.0072 | 1 | 1 | positive regulation of transcription involved in meiotic cell cycle |
| GO:0060010 | 0.0072 | Inf | 0.0072 | 1 | 1 | Sertoli cell fate commitment |
| GO:0061847 | 0.0072 | Inf | 0.0072 | 1 | 1 | response to cholecystokinin |
| GO:0071538 | 0.0072 | Inf | 0.0072 | 1 | 1 | SH2 domain-mediated complex assembly |
| GO:1990349 | 0.0072 | Inf | 0.0072 | 1 | 1 | gap junction-mediated intercellular transport |
| GO:1990859 | 0.0072 | Inf | 0.0072 | 1 | 1 | cellular response to endothelin |
| GO:0032956 | 0.0082 | 3.6543 | 1.7515 | 6 | 244 | regulation of actin cytoskeleton organization |
| GO:0007422 | 0.0087 | 7.6182 | 0.4235 | 3 | 59 | peripheral nervous system development |
| GO:0002366 | 0.0088 | 2.7363 | 3.539 | 9 | 493 | leukocyte activation involved in immune response |
| GO:0002707 | 0.0089 | 15.6762 | 0.1436 | 2 | 20 | negative regulation of lymphocyte mediated immunity |
| GO:0042110 | 0.009 | 3.1968 | 2.3402 | 7 | 326 | T cell activation |
| GO:0006909 | 0.0095 | 4.1156 | 1.2921 | 5 | 180 | phagocytosis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048646 | 0 | 2.433 | 18.3902 | 40 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0048514 | 0 | 2.8814 | 9.5421 | 25 | 440 | blood vessel morphogenesis |
| GO:0072358 | 0 | 2.6526 | 11.6023 | 28 | 535 | cardiovascular system development |
| GO:0051270 | 0 | 2.4421 | 14.8987 | 33 | 687 | regulation of cellular component movement |
| GO:1901342 | 0 | 3.616 | 4.8578 | 16 | 224 | regulation of vasculature development |
| GO:0040012 | 0 | 2.3779 | 14.7686 | 32 | 681 | regulation of locomotion |
| GO:0002700 | 1e-04 | 5.9554 | 1.7132 | 9 | 79 | regulation of production of molecular mediator of immune response |
| GO:0030334 | 1e-04 | 2.423 | 12.5999 | 28 | 581 | regulation of cell migration |
| GO:0001841 | 2e-04 | 4.8988 | 2.0385 | 9 | 94 | neural tube formation |
| GO:0022603 | 3e-04 | 2.0632 | 17.3493 | 33 | 800 | regulation of anatomical structure morphogenesis |
| GO:0051251 | 3e-04 | 3.3843 | 4.1638 | 13 | 192 | positive regulation of lymphocyte activation |
| GO:0051674 | 3e-04 | 1.8756 | 25.048 | 43 | 1155 | localization of cell |
| GO:0001843 | 4e-04 | 5.0568 | 1.7566 | 8 | 81 | neural tube closure |
| GO:0050867 | 4e-04 | 3.1104 | 4.8578 | 14 | 224 | positive regulation of cell activation |
| GO:0001698 | 5e-04 | Inf | 0.0434 | 2 | 2 | gastrin-induced gastric acid secretion |
| GO:0006954 | 5e-04 | 2.3543 | 10.0409 | 22 | 463 | inflammatory response |
| GO:1905205 | 5e-04 | 27.3423 | 0.1735 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:1903039 | 5e-04 | 3.5686 | 3.3397 | 11 | 154 | positive regulation of leukocyte cell-cell adhesion |
| GO:0045766 | 7e-04 | 4.037 | 2.4289 | 9 | 112 | positive regulation of angiogenesis |
| GO:1903244 | 8e-04 | 22.7835 | 0.1952 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0006955 | 8e-04 | 1.7519 | 28.5829 | 46 | 1318 | immune response |
| GO:0032946 | 0.001 | 4.2881 | 2.0385 | 8 | 94 | positive regulation of mononuclear cell proliferation |
| GO:0032720 | 0.001 | 7.3873 | 0.7807 | 5 | 36 | negative regulation of tumor necrosis factor production |
| GO:0042476 | 0.0011 | 4.2385 | 2.0602 | 8 | 95 | odontogenesis |
| GO:0001667 | 0.0011 | 2.6494 | 6.0506 | 15 | 279 | ameboidal-type cell migration |
| GO:0072175 | 0.0013 | 3.6769 | 2.6458 | 9 | 122 | epithelial tube formation |
| GO:0061756 | 0.0014 | 9.6173 | 0.4988 | 4 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0033128 | 0.0014 | 90.8491 | 0.0651 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0007275 | 0.0014 | 1.5096 | 68.0426 | 90 | 3270 | multicellular organism development |
| GO:0010633 | 0.0014 | 5.3992 | 1.2361 | 6 | 57 | negative regulation of epithelial cell migration |
| GO:0014744 | 0.0015 | 17.0849 | 0.2386 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0019221 | 0.0015 | 2.1824 | 10.2577 | 21 | 473 | cytokine-mediated signaling pathway |
| GO:0090132 | 0.0017 | 2.8836 | 4.4457 | 12 | 205 | epithelium migration |
| GO:0002699 | 0.0019 | 3.4899 | 2.7759 | 9 | 128 | positive regulation of immune effector process |
| GO:2000147 | 0.0019 | 2.356 | 7.677 | 17 | 354 | positive regulation of cell motility |
| GO:2000241 | 0.0019 | 3.8384 | 2.2554 | 8 | 104 | regulation of reproductive process |
| GO:0032695 | 0.0019 | 15.1854 | 0.2602 | 3 | 12 | negative regulation of interleukin-12 production |
| GO:0016331 | 0.0024 | 3.3478 | 2.8843 | 9 | 133 | morphogenesis of embryonic epithelium |
| GO:0002687 | 0.0026 | 4.0722 | 1.865 | 7 | 86 | positive regulation of leukocyte migration |
| GO:0035239 | 0.0027 | 2.4154 | 6.5927 | 15 | 304 | tube morphogenesis |
| GO:0009972 | 0.0027 | 45.4211 | 0.0867 | 2 | 4 | cytidine deamination |
| GO:0042126 | 0.0027 | 45.4211 | 0.0867 | 2 | 4 | nitrate metabolic process |
| GO:0046087 | 0.0027 | 45.4211 | 0.0867 | 2 | 4 | cytidine metabolic process |
| GO:0051122 | 0.0027 | 45.4211 | 0.0867 | 2 | 4 | hepoxilin biosynthetic process |
| GO:0070383 | 0.0027 | 45.4211 | 0.0867 | 2 | 4 | DNA cytosine deamination |
| GO:0097176 | 0.0027 | 45.4211 | 0.0867 | 2 | 4 | epoxide metabolic process |
| GO:2000354 | 0.0027 | 45.4211 | 0.0867 | 2 | 4 | regulation of ovarian follicle development |
| GO:0042102 | 0.0028 | 4.6642 | 1.4096 | 6 | 65 | positive regulation of T cell proliferation |
| GO:0032715 | 0.0029 | 7.6107 | 0.6072 | 4 | 28 | negative regulation of interleukin-6 production |
| GO:0002719 | 0.0031 | 12.4225 | 0.3036 | 3 | 14 | negative regulation of cytokine production involved in immune response |
| GO:0032101 | 0.0038 | 2.0113 | 11.0601 | 21 | 510 | regulation of response to external stimulus |
| GO:0010612 | 0.0038 | 11.3864 | 0.3253 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0019372 | 0.0038 | 11.3864 | 0.3253 | 3 | 15 | lipoxygenase pathway |
| GO:0051447 | 0.0038 | 11.3864 | 0.3253 | 3 | 15 | negative regulation of meiotic cell cycle |
| GO:0051497 | 0.0038 | 11.3864 | 0.3253 | 3 | 15 | negative regulation of stress fiber assembly |
| GO:0043537 | 0.0038 | 7.0242 | 0.6506 | 4 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0043542 | 0.004 | 3.0956 | 3.1012 | 9 | 143 | endothelial cell migration |
| GO:0051239 | 0.004 | 1.4877 | 49.1634 | 67 | 2267 | regulation of multicellular organismal process |
| GO:0051094 | 0.0041 | 1.6998 | 21.9685 | 35 | 1013 | positive regulation of developmental process |
| GO:0002703 | 0.0041 | 3.3462 | 2.559 | 8 | 118 | regulation of leukocyte mediated immunity |
| GO:0060023 | 0.0045 | 30.2784 | 0.1084 | 2 | 5 | soft palate development |
| GO:0070669 | 0.0045 | 30.2784 | 0.1084 | 2 | 5 | response to interleukin-2 |
| GO:0042060 | 0.0046 | 2.0935 | 9.0867 | 18 | 419 | wound healing |
| GO:0045785 | 0.0047 | 2.337 | 6.3325 | 14 | 292 | positive regulation of cell adhesion |
| GO:0030168 | 0.0051 | 3.2278 | 2.6458 | 8 | 122 | platelet activation |
| GO:2000146 | 0.0054 | 2.6063 | 4.4674 | 11 | 206 | negative regulation of cell motility |
| GO:0002285 | 0.0057 | 3.4932 | 2.147 | 7 | 99 | lymphocyte activation involved in immune response |
| GO:0016486 | 0.0065 | 9.107 | 0.3904 | 3 | 18 | peptide hormone processing |
| GO:0051129 | 0.0066 | 1.9372 | 10.8867 | 20 | 502 | negative regulation of cellular component organization |
| GO:0002291 | 0.0066 | 22.707 | 0.1301 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0045869 | 0.0066 | 22.707 | 0.1301 | 2 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 0.0066 | 22.707 | 0.1301 | 2 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0002708 | 0.0067 | 4.5734 | 1.1928 | 5 | 55 | positive regulation of lymphocyte mediated immunity |
| GO:0001910 | 0.0067 | 5.889 | 0.759 | 4 | 35 | regulation of leukocyte mediated cytotoxicity |
| GO:0008284 | 0.0075 | 1.7792 | 14.8336 | 25 | 684 | positive regulation of cell proliferation |
| GO:0039694 | 0.0076 | 8.5372 | 0.412 | 3 | 19 | viral RNA genome replication |
| GO:0016525 | 0.0078 | 3.7144 | 1.7349 | 6 | 80 | negative regulation of angiogenesis |
| GO:0051336 | 0.0078 | 1.6707 | 19.648 | 31 | 906 | regulation of hydrolase activity |
| GO:0009617 | 0.0078 | 2.1283 | 7.4168 | 15 | 342 | response to bacterium |
| GO:0009790 | 0.0082 | 1.6932 | 18.1083 | 29 | 835 | embryo development |
| GO:0042472 | 0.0082 | 3.6646 | 1.7566 | 6 | 81 | inner ear morphogenesis |
| GO:0045446 | 0.0082 | 3.6646 | 1.7566 | 6 | 81 | endothelial cell differentiation |
| GO:0006629 | 0.0085 | 1.6002 | 23.8769 | 36 | 1101 | lipid metabolic process |
| GO:0002822 | 0.0087 | 3.6161 | 1.7783 | 6 | 82 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0002230 | 0.0088 | 8.0344 | 0.4337 | 3 | 20 | positive regulation of defense response to virus by host |
| GO:0001955 | 0.0092 | 18.1642 | 0.1518 | 2 | 7 | blood vessel maturation |
| GO:0032496 | 0.0095 | 2.3941 | 4.8361 | 11 | 223 | response to lipopolysaccharide |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035296 | 1e-04 | 9.2657 | 0.7248 | 6 | 109 | regulation of tube diameter |
| GO:0050880 | 1e-04 | 8.9166 | 0.7514 | 6 | 113 | regulation of blood vessel size |
| GO:0010876 | 6e-04 | 4.663 | 1.8885 | 8 | 284 | lipid localization |
| GO:0045907 | 7e-04 | 19.2971 | 0.1795 | 3 | 27 | positive regulation of vasoconstriction |
| GO:0043697 | 9e-04 | 61.1209 | 0.0465 | 2 | 7 | cell dedifferentiation |
| GO:0008285 | 0.001 | 3.3609 | 3.6373 | 11 | 547 | negative regulation of cell proliferation |
| GO:0006954 | 0.001 | 3.5923 | 3.0787 | 10 | 463 | inflammatory response |
| GO:0097756 | 0.0011 | 9.5832 | 0.4588 | 4 | 69 | negative regulation of blood vessel diameter |
| GO:0045087 | 0.0015 | 3.1869 | 3.8235 | 11 | 575 | innate immune response |
| GO:0072677 | 0.0015 | 43.6512 | 0.0598 | 2 | 9 | eosinophil migration |
| GO:0007186 | 0.0018 | 2.9309 | 4.5483 | 12 | 684 | G-protein coupled receptor signaling pathway |
| GO:0006531 | 0.0023 | 33.9457 | 0.0731 | 2 | 11 | aspartate metabolic process |
| GO:0034433 | 0.0023 | 33.9457 | 0.0731 | 2 | 11 | steroid esterification |
| GO:0034435 | 0.0023 | 33.9457 | 0.0731 | 2 | 11 | cholesterol esterification |
| GO:2000846 | 0.0028 | 30.5488 | 0.0798 | 2 | 12 | regulation of corticosteroid hormone secretion |
| GO:0032368 | 0.003 | 7.2315 | 0.5985 | 4 | 90 | regulation of lipid transport |
| GO:1903522 | 0.0041 | 4.2597 | 1.5161 | 6 | 228 | regulation of blood circulation |
| GO:0097755 | 0.0044 | 9.8365 | 0.3325 | 3 | 50 | positive regulation of blood vessel diameter |
| GO:0003013 | 0.0051 | 3.2536 | 2.6598 | 8 | 400 | circulatory system process |
| GO:0010830 | 0.0052 | 9.2442 | 0.3524 | 3 | 53 | regulation of myotube differentiation |
| GO:0046849 | 0.0055 | 9.0623 | 0.3591 | 3 | 54 | bone remodeling |
| GO:0007263 | 0.0056 | 20.3581 | 0.113 | 2 | 17 | nitric oxide mediated signal transduction |
| GO:0009309 | 0.0056 | 20.3581 | 0.113 | 2 | 17 | amine biosynthetic process |
| GO:0035929 | 0.0056 | 20.3581 | 0.113 | 2 | 17 | steroid hormone secretion |
| GO:0046427 | 0.0058 | 8.8873 | 0.3657 | 3 | 55 | positive regulation of JAK-STAT cascade |
| GO:0009605 | 0.006 | 2.0783 | 10.3533 | 19 | 1557 | response to external stimulus |
| GO:0015850 | 0.0062 | 4.5982 | 1.1637 | 5 | 175 | organic hydroxy compound transport |
| GO:0034367 | 0.0062 | 19.0843 | 0.1197 | 2 | 18 | macromolecular complex remodeling |
| GO:0034369 | 0.0062 | 19.0843 | 0.1197 | 2 | 18 | plasma lipoprotein particle remodeling |
| GO:0007199 | 0.0066 | Inf | 0.0066 | 1 | 1 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
| GO:0010053 | 0.0066 | Inf | 0.0066 | 1 | 1 | root epidermal cell differentiation |
| GO:0010805 | 0.0066 | Inf | 0.0066 | 1 | 1 | regulation of lysine import |
| GO:0010963 | 0.0066 | Inf | 0.0066 | 1 | 1 | regulation of L-arginine import |
| GO:0014853 | 0.0066 | Inf | 0.0066 | 1 | 1 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction |
| GO:0014905 | 0.0066 | Inf | 0.0066 | 1 | 1 | myoblast fusion involved in skeletal muscle regeneration |
| GO:0034125 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
| GO:0034337 | 0.0066 | Inf | 0.0066 | 1 | 1 | RNA folding |
| GO:0034769 | 0.0066 | Inf | 0.0066 | 1 | 1 | basement membrane disassembly |
| GO:0048364 | 0.0066 | Inf | 0.0066 | 1 | 1 | root development |
| GO:0048764 | 0.0066 | Inf | 0.0066 | 1 | 1 | trichoblast maturation |
| GO:0048792 | 0.0066 | Inf | 0.0066 | 1 | 1 | spontaneous exocytosis of neurotransmitter |
| GO:0051134 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of NK T cell activation |
| GO:0060101 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of phagocytosis, engulfment |
| GO:0071799 | 0.0066 | Inf | 0.0066 | 1 | 1 | cellular response to prostaglandin D stimulus |
| GO:0080147 | 0.0066 | Inf | 0.0066 | 1 | 1 | root hair cell development |
| GO:0085032 | 0.0066 | Inf | 0.0066 | 1 | 1 | modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade |
| GO:1902569 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of activation of Janus kinase activity |
| GO:1902891 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of root hair elongation |
| GO:1903888 | 0.0066 | Inf | 0.0066 | 1 | 1 | regulation of plant epidermal cell differentiation |
| GO:1904676 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of somatic stem cell division |
| GO:1905010 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of L-lysine import across plasma membrane |
| GO:1905175 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of vascular smooth muscle cell dedifferentiation |
| GO:1905392 | 0.0066 | Inf | 0.0066 | 1 | 1 | plant organ morphogenesis |
| GO:1905589 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of L-arginine import across plasma membrane |
| GO:2000067 | 0.0066 | Inf | 0.0066 | 1 | 1 | regulation of root morphogenesis |
| GO:0034103 | 0.0067 | 8.4006 | 0.3857 | 3 | 58 | regulation of tissue remodeling |
| GO:1904385 | 0.0069 | 17.9603 | 0.1263 | 2 | 19 | cellular response to angiotensin |
| GO:0001909 | 0.0071 | 8.25 | 0.3923 | 3 | 59 | leukocyte mediated cytotoxicity |
| GO:1903779 | 0.0077 | 7.9643 | 0.4056 | 3 | 61 | regulation of cardiac conduction |
| GO:0032350 | 0.0085 | 16.0673 | 0.1396 | 2 | 21 | regulation of hormone metabolic process |
| GO:0010657 | 0.0085 | 7.6976 | 0.4189 | 3 | 63 | muscle cell apoptotic process |
| GO:0046470 | 0.0088 | 7.5709 | 0.4256 | 3 | 64 | phosphatidylcholine metabolic process |
| GO:0050663 | 0.0093 | 5.169 | 0.8245 | 4 | 124 | cytokine secretion |
| GO:0042221 | 0.0095 | 1.761 | 20.833 | 31 | 3133 | response to chemical |
| GO:0006936 | 0.0095 | 3.543 | 1.8087 | 6 | 272 | muscle contraction |
| GO:0050886 | 0.0096 | 7.3294 | 0.4389 | 3 | 66 | endocrine process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0.0041 | Inf | 0.0041 | 1 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0.0073 | Inf | 0.0073 | 1 | 97 | detection of chemical stimulus |
| GO:0050906 | 0.0082 | Inf | 0.0082 | 1 | 109 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0.0088 | Inf | 0.0088 | 1 | 116 | sensory perception of chemical stimulus |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 49.8993 | 0.1092 | 4 | 85 | embryonic skeletal system morphogenesis |
| GO:0045617 | 0 | 587.2889 | 0.0064 | 2 | 5 | negative regulation of keratinocyte differentiation |
| GO:0045683 | 1e-04 | 146.7222 | 0.018 | 2 | 14 | negative regulation of epidermis development |
| GO:0030857 | 7e-04 | 60.6345 | 0.0398 | 2 | 31 | negative regulation of epithelial cell differentiation |
| GO:0032502 | 9e-04 | 5.7233 | 6.1659 | 13 | 4800 | developmental process |
| GO:0007389 | 0.001 | 10.9889 | 0.4676 | 4 | 364 | pattern specification process |
| GO:0048568 | 0.0011 | 10.7734 | 0.4766 | 4 | 371 | embryonic organ development |
| GO:0060474 | 0.0013 | Inf | 0.0013 | 1 | 1 | positive regulation of flagellated sperm motility involved in capacitation |
| GO:1904155 | 0.0013 | Inf | 0.0013 | 1 | 1 | DN2 thymocyte differentiation |
| GO:1904156 | 0.0013 | Inf | 0.0013 | 1 | 1 | DN3 thymocyte differentiation |
| GO:0009952 | 0.0014 | 16.0628 | 0.2274 | 3 | 177 | anterior/posterior pattern specification |
| GO:0045604 | 0.0014 | 41.8254 | 0.0565 | 2 | 44 | regulation of epidermal cell differentiation |
| GO:0060324 | 0.0014 | 41.8254 | 0.0565 | 2 | 44 | face development |
| GO:0009888 | 0.0015 | 5.5725 | 1.9037 | 7 | 1482 | tissue development |
| GO:0001501 | 0.0016 | 9.7337 | 0.5254 | 4 | 409 | skeletal system development |
| GO:2000026 | 0.0018 | 5.3948 | 1.959 | 7 | 1525 | regulation of multicellular organismal development |
| GO:0009887 | 0.0029 | 6.3655 | 1.0495 | 5 | 817 | animal organ morphogenesis |
| GO:0043009 | 0.0033 | 7.8749 | 0.6436 | 4 | 501 | chordate embryonic development |
| GO:0014717 | 0.0038 | 412.9688 | 0.0039 | 1 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:0021615 | 0.0038 | 412.9688 | 0.0039 | 1 | 3 | glossopharyngeal nerve morphogenesis |
| GO:0060672 | 0.0038 | 412.9688 | 0.0039 | 1 | 3 | epithelial cell morphogenesis involved in placental branching |
| GO:0072679 | 0.0038 | 412.9688 | 0.0039 | 1 | 3 | thymocyte migration |
| GO:0043588 | 0.004 | 10.9802 | 0.3288 | 3 | 256 | skin development |
| GO:0050859 | 0.0051 | 275.2917 | 0.0051 | 1 | 4 | negative regulation of B cell receptor signaling pathway |
| GO:0048731 | 0.006 | 4.7485 | 3.2812 | 8 | 3237 | system development |
| GO:0014719 | 0.0064 | 206.4531 | 0.0064 | 1 | 5 | skeletal muscle satellite cell activation |
| GO:0021546 | 0.0064 | 206.4531 | 0.0064 | 1 | 5 | rhombomere development |
| GO:0031642 | 0.0064 | 206.4531 | 0.0064 | 1 | 5 | negative regulation of myelination |
| GO:0045656 | 0.0064 | 206.4531 | 0.0064 | 1 | 5 | negative regulation of monocyte differentiation |
| GO:0002638 | 0.0077 | 165.15 | 0.0077 | 1 | 6 | negative regulation of immunoglobulin production |
| GO:0034163 | 0.0077 | 165.15 | 0.0077 | 1 | 6 | regulation of toll-like receptor 9 signaling pathway |
| GO:0002521 | 0.0087 | 8.1899 | 0.4368 | 3 | 340 | leukocyte differentiation |
| GO:0048290 | 0.009 | 137.6146 | 0.009 | 1 | 7 | isotype switching to IgA isotypes |
| GO:0060463 | 0.009 | 137.6146 | 0.009 | 1 | 7 | lung lobe morphogenesis |
| GO:2000510 | 0.009 | 137.6146 | 0.009 | 1 | 7 | positive regulation of dendritic cell chemotaxis |
| GO:0002685 | 0.0093 | 15.4619 | 0.1477 | 2 | 115 | regulation of leukocyte migration |
| GO:0002440 | 0.01 | 14.9288 | 0.1529 | 2 | 119 | production of molecular mediator of immune response |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046597 | 0.0021 | 1016.8462 | 0.0021 | 1 | 14 | negative regulation of viral entry into host cell |
| GO:0032897 | 0.003 | 695.4211 | 0.003 | 1 | 20 | negative regulation of viral transcription |
| GO:0003298 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | physiological muscle hypertrophy |
| GO:0061049 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | cell growth involved in cardiac muscle cell development |
| GO:1902186 | 0.0041 | 507.9231 | 0.0041 | 1 | 27 | regulation of viral release from host cell |
| GO:0035891 | 0.0045 | 455.2759 | 0.0045 | 1 | 30 | exit from host cell |
| GO:0052126 | 0.0045 | 455.2759 | 0.0045 | 1 | 30 | movement in host environment |
| GO:0055006 | 0.009 | 223.2712 | 0.0091 | 1 | 60 | cardiac cell development |
| GO:0060333 | 0.0093 | 215.918 | 0.0094 | 1 | 62 | interferon-gamma-mediated signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030855 | 0.0045 | 48.8885 | 0.1183 | 2 | 522 | epithelial cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042930 | 2e-04 | Inf | 2e-04 | 1 | 1 | enterobactin transport |
| GO:0050915 | 3e-04 | 13231 | 3e-04 | 1 | 2 | sensory perception of sour taste |
| GO:0015688 | 5e-04 | 6615 | 5e-04 | 1 | 3 | iron chelate transport |
| GO:0050968 | 5e-04 | 6615 | 5e-04 | 1 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:0050966 | 0.0014 | 1653 | 0.0014 | 1 | 9 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0010447 | 0.0021 | 1016.8462 | 0.0021 | 1 | 14 | response to acidic pH |
| GO:0050965 | 0.0021 | 1016.8462 | 0.0021 | 1 | 14 | detection of temperature stimulus involved in sensory perception of pain |
| GO:0016048 | 0.0024 | 881.1333 | 0.0024 | 1 | 16 | detection of temperature stimulus |
| GO:0018149 | 0.0027 | 777.3529 | 0.0027 | 1 | 18 | peptide cross-linking |
| GO:0050951 | 0.0029 | 734.1111 | 0.0029 | 1 | 19 | sensory perception of temperature stimulus |
| GO:0050877 | 0.003 | Inf | 0.1096 | 2 | 725 | nervous system process |
| GO:0050982 | 0.005 | 412.5 | 0.005 | 1 | 33 | detection of mechanical stimulus |
| GO:0071277 | 0.008 | 253.4615 | 0.008 | 1 | 53 | cellular response to calcium ion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007600 | 0.0011 | Inf | 0.0671 | 2 | 444 | sensory perception |
| GO:0007042 | 0.0012 | 1889.2857 | 0.0012 | 1 | 8 | lysosomal lumen acidification |
| GO:0031987 | 0.0017 | 1322.2 | 0.0017 | 1 | 11 | locomotion involved in locomotory behavior |
| GO:0001573 | 0.0024 | 881.1333 | 0.0024 | 1 | 16 | ganglioside metabolic process |
| GO:0045880 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | positive regulation of smoothened signaling pathway |
| GO:0006968 | 0.0047 | 440.0667 | 0.0047 | 1 | 31 | cellular defense response |
| GO:1902017 | 0.0057 | 356.6216 | 0.0057 | 1 | 38 | regulation of cilium assembly |
| GO:0051452 | 0.0062 | 329.8 | 0.0062 | 1 | 41 | intracellular pH reduction |
| GO:0007040 | 0.0072 | 280.5319 | 0.0073 | 1 | 48 | lysosome organization |
| GO:0003008 | 0.0095 | Inf | 0.1948 | 2 | 1289 | system process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032720 | 8e-04 | 18.3678 | 0.185 | 3 | 36 | negative regulation of tumor necrosis factor production |
| GO:0001775 | 0.0012 | 3.0188 | 4.979 | 13 | 969 | cell activation |
| GO:2000026 | 0.0015 | 2.5769 | 7.8359 | 17 | 1525 | regulation of multicellular organismal development |
| GO:0032689 | 0.0023 | 33.2172 | 0.0719 | 2 | 14 | negative regulation of interferon-gamma production |
| GO:0006955 | 0.0024 | 2.5767 | 6.7723 | 15 | 1318 | immune response |
| GO:0048523 | 0.0039 | 2.0009 | 19.2942 | 30 | 3755 | negative regulation of cellular process |
| GO:0017148 | 0.0042 | 4.2667 | 1.5312 | 6 | 298 | negative regulation of translation |
| GO:0048856 | 0.0042 | 1.9613 | 23.0195 | 34 | 4480 | anatomical structure development |
| GO:0048167 | 0.0045 | 6.4683 | 0.668 | 4 | 130 | regulation of synaptic plasticity |
| GO:0071621 | 0.0045 | 9.7548 | 0.334 | 3 | 65 | granulocyte chemotaxis |
| GO:0002696 | 0.0048 | 4.9203 | 1.0996 | 5 | 214 | positive regulation of leukocyte activation |
| GO:0002264 | 0.0051 | Inf | 0.0051 | 1 | 1 | endothelial cell activation involved in immune response |
| GO:0002644 | 0.0051 | Inf | 0.0051 | 1 | 1 | negative regulation of tolerance induction |
| GO:0010070 | 0.0051 | Inf | 0.0051 | 1 | 1 | zygote asymmetric cell division |
| GO:0019265 | 0.0051 | Inf | 0.0051 | 1 | 1 | glycine biosynthetic process, by transamination of glyoxylate |
| GO:0019481 | 0.0051 | Inf | 0.0051 | 1 | 1 | L-alanine catabolic process, by transamination |
| GO:0030813 | 0.0051 | Inf | 0.0051 | 1 | 1 | positive regulation of nucleotide catabolic process |
| GO:0030822 | 0.0051 | Inf | 0.0051 | 1 | 1 | positive regulation of cAMP catabolic process |
| GO:0046092 | 0.0051 | Inf | 0.0051 | 1 | 1 | deoxycytidine metabolic process |
| GO:0060010 | 0.0051 | Inf | 0.0051 | 1 | 1 | Sertoli cell fate commitment |
| GO:1990349 | 0.0051 | Inf | 0.0051 | 1 | 1 | gap junction-mediated intercellular transport |
| GO:0043547 | 0.0055 | 4.0266 | 1.6186 | 6 | 315 | positive regulation of GTPase activity |
| GO:0007155 | 0.0062 | 2.5328 | 5.3387 | 12 | 1039 | cell adhesion |
| GO:0007266 | 0.0062 | 5.8575 | 0.7348 | 4 | 143 | Rho protein signal transduction |
| GO:0050870 | 0.0065 | 5.7735 | 0.7451 | 4 | 145 | positive regulation of T cell activation |
| GO:0031532 | 0.008 | 7.8456 | 0.4111 | 3 | 80 | actin cytoskeleton reorganization |
| GO:0032956 | 0.0083 | 4.2927 | 1.2537 | 5 | 244 | regulation of actin cytoskeleton organization |
| GO:0051093 | 0.009 | 2.7718 | 3.5796 | 9 | 707 | negative regulation of developmental process |
| GO:0032715 | 0.009 | 15.3147 | 0.1439 | 2 | 28 | negative regulation of interleukin-6 production |
| GO:0051241 | 0.0095 | 2.5975 | 4.2682 | 10 | 843 | negative regulation of multicellular organismal process |
| GO:0042698 | 0.0098 | 7.2751 | 0.4419 | 3 | 86 | ovulation cycle |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 2.0792 | 32.9825 | 62 | 512 | calcium ion binding |
| GO:0005201 | 0 | 5.3603 | 2.8898 | 12 | 45 | extracellular matrix structural constituent |
| GO:0043546 | 1e-04 | 58.3615 | 0.3221 | 4 | 5 | molybdopterin cofactor binding |
| GO:0051959 | 8e-04 | 5.6863 | 1.6105 | 7 | 25 | dynein light intermediate chain binding |
| GO:0004111 | 0.001 | 43.7198 | 0.2577 | 3 | 4 | creatine kinase activity |
| GO:0030151 | 0.001 | 43.7198 | 0.2577 | 3 | 4 | molybdenum ion binding |
| GO:0008235 | 0.0012 | 3.9924 | 2.7056 | 9 | 42 | metalloexopeptidase activity |
| GO:0008569 | 0.0013 | 8.1101 | 0.9019 | 5 | 14 | ATP-dependent microtubule motor activity, minus-end-directed |
| GO:0016416 | 0.0024 | 21.8581 | 0.3221 | 3 | 5 | O-palmitoyltransferase activity |
| GO:0030020 | 0.0024 | 21.8581 | 0.3221 | 3 | 5 | extracellular matrix structural constituent conferring tensile strength |
| GO:0016801 | 0.0026 | 9.723 | 0.6442 | 4 | 10 | hydrolase activity, acting on ether bonds |
| GO:0045505 | 0.0027 | 5.155 | 1.4816 | 6 | 23 | dynein intermediate chain binding |
| GO:0031492 | 0.0041 | 3.5446 | 2.6412 | 8 | 41 | nucleosomal DNA binding |
| GO:0004063 | 0.0041 | Inf | 0.1288 | 2 | 2 | aryldialkylphosphatase activity |
| GO:0016165 | 0.0041 | Inf | 0.1288 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0036461 | 0.0041 | Inf | 0.1288 | 2 | 2 | BLOC-2 complex binding |
| GO:0047844 | 0.0041 | Inf | 0.1288 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0008374 | 0.0043 | 3.9474 | 2.1192 | 7 | 33 | O-acyltransferase activity |
| GO:0005184 | 0.0046 | 5.6129 | 1.1595 | 5 | 18 | neuropeptide hormone activity |
| GO:0000979 | 0.0048 | 3.1346 | 3.2854 | 9 | 51 | RNA polymerase II core promoter sequence-specific DNA binding |
| GO:0030414 | 0.0071 | 2.3514 | 6.0554 | 13 | 94 | peptidase inhibitor activity |
| GO:0043565 | 0.0074 | 1.3799 | 58.4925 | 77 | 908 | sequence-specific DNA binding |
| GO:0045503 | 0.0075 | 4.8637 | 1.2884 | 5 | 20 | dynein light chain binding |
| GO:0097493 | 0.0076 | 6.4804 | 0.8374 | 4 | 13 | structural molecule activity conferring elasticity |
| GO:0004867 | 0.0084 | 3.077 | 2.9633 | 8 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0004180 | 0.0093 | 3.8084 | 1.8682 | 6 | 29 | carboxypeptidase activity |
| GO:0005031 | 0.0094 | 4.5593 | 1.3528 | 5 | 21 | tumor necrosis factor-activated receptor activity |
| GO:0046982 | 0.0097 | 1.5476 | 26.4762 | 39 | 411 | protein heterodimerization activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0 | 6.3439 | 2.7734 | 15 | 335 | G-protein coupled receptor activity |
| GO:0004984 | 0 | 18.8032 | 0.4511 | 7 | 54 | olfactory receptor activity |
| GO:0038023 | 0 | 3.9174 | 6.0144 | 20 | 720 | signaling receptor activity |
| GO:0099600 | 0 | 3.9866 | 5.5801 | 19 | 668 | transmembrane receptor activity |
| GO:0060089 | 0 | 3.2369 | 7.5765 | 21 | 907 | molecular transducer activity |
| GO:0071723 | 4e-04 | 120.8716 | 0.0334 | 2 | 4 | lipopeptide binding |
| GO:0015347 | 0.0043 | 24.1596 | 0.1002 | 2 | 12 | sodium-independent organic anion transmembrane transporter activity |
| GO:0005452 | 0.0051 | 21.9616 | 0.1086 | 2 | 13 | inorganic anion exchanger activity |
| GO:0097493 | 0.0051 | 21.9616 | 0.1086 | 2 | 13 | structural molecule activity conferring elasticity |
| GO:0001856 | 0.0084 | Inf | 0.0084 | 1 | 1 | complement component C5a binding |
| GO:0003858 | 0.0084 | Inf | 0.0084 | 1 | 1 | 3-hydroxybutyrate dehydrogenase activity |
| GO:0004878 | 0.0084 | Inf | 0.0084 | 1 | 1 | complement component C5a receptor activity |
| GO:0005550 | 0.0084 | Inf | 0.0084 | 1 | 1 | pheromone binding |
| GO:0016501 | 0.0084 | Inf | 0.0084 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.0084 | Inf | 0.0084 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0033791 | 0.0084 | Inf | 0.0084 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0038182 | 0.0084 | Inf | 0.0084 | 1 | 1 | G-protein coupled bile acid receptor activity |
| GO:0001530 | 0.0087 | 16.1003 | 0.142 | 2 | 17 | lipopolysaccharide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0.0019 | 8.2347 | 0.5291 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005092 | 0.0019 | 37.9052 | 0.067 | 2 | 10 | GDP-dissociation inhibitor activity |
| GO:0005070 | 0.0021 | 13.1203 | 0.2545 | 3 | 38 | SH3/SH2 adaptor activity |
| GO:0051020 | 0.0034 | 3.0022 | 3.6436 | 10 | 544 | GTPase binding |
| GO:0005088 | 0.0035 | 4.4073 | 1.4668 | 6 | 219 | Ras guanyl-nucleotide exchange factor activity |
| GO:0001604 | 0.0067 | Inf | 0.0067 | 1 | 1 | urotensin II receptor activity |
| GO:0004137 | 0.0067 | Inf | 0.0067 | 1 | 1 | deoxycytidine kinase activity |
| GO:0005147 | 0.0067 | Inf | 0.0067 | 1 | 1 | oncostatin-M receptor binding |
| GO:0008579 | 0.0067 | Inf | 0.0067 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0035755 | 0.0067 | Inf | 0.0067 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0039552 | 0.0067 | Inf | 0.0067 | 1 | 1 | RIG-I binding |
| GO:0045485 | 0.0067 | Inf | 0.0067 | 1 | 1 | omega-6 fatty acid desaturase activity |
| GO:0047747 | 0.0067 | Inf | 0.0067 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0067 | Inf | 0.0067 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0008092 | 0.0074 | 2.5334 | 4.7353 | 11 | 707 | cytoskeletal protein binding |
| GO:0005504 | 0.0078 | 16.834 | 0.134 | 2 | 20 | fatty acid binding |
| GO:0098772 | 0.0085 | 2.0758 | 9.1425 | 17 | 1365 | molecular function regulator |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 4e-04 | 3.4694 | 3.752 | 12 | 304 | receptor regulator activity |
| GO:0005088 | 5e-04 | 4.6886 | 1.8515 | 8 | 153 | Ras guanyl-nucleotide exchange factor activity |
| GO:0005509 | 6e-04 | 2.7524 | 6.3191 | 16 | 512 | calcium ion binding |
| GO:0008083 | 6e-04 | 5.227 | 1.4564 | 7 | 118 | growth factor activity |
| GO:0031267 | 0.0017 | 2.6531 | 5.6773 | 14 | 460 | small GTPase binding |
| GO:0001106 | 0.0031 | 11.6264 | 0.2962 | 3 | 24 | RNA polymerase II transcription corepressor activity |
| GO:0031406 | 0.0063 | 3.8556 | 1.6538 | 6 | 134 | carboxylic acid binding |
| GO:0005089 | 0.0089 | 5.2669 | 0.8146 | 4 | 66 | Rho guanyl-nucleotide exchange factor activity |
| GO:0016594 | 0.0092 | 16.1901 | 0.1481 | 2 | 12 | glycine binding |
| GO:0030247 | 0.0092 | 16.1901 | 0.1481 | 2 | 12 | polysaccharide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031716 | 5e-04 | Inf | 5e-04 | 1 | 1 | calcitonin receptor binding |
| GO:0031628 | 0.0032 | 442.5333 | 0.0032 | 1 | 6 | opioid receptor binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004033 | 0.0029 | 737.1111 | 0.0029 | 1 | 19 | aldo-keto reductase (NADP) activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033560 | 0.0025 | Inf | 0.0025 | 1 | 1 | folate reductase activity |
| GO:0000406 | 0.005 | 414.1875 | 0.005 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004119 | 0.005 | 414.1875 | 0.005 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GO:0004146 | 0.005 | 414.1875 | 0.005 | 1 | 2 | dihydrofolate reductase activity |
| GO:0005223 | 0.005 | 414.1875 | 0.005 | 1 | 2 | intracellular cGMP activated cation channel activity |
| GO:0032142 | 0.005 | 414.1875 | 0.005 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.005 | 414.1875 | 0.005 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0036461 | 0.005 | 414.1875 | 0.005 | 1 | 2 | BLOC-2 complex binding |
| GO:0051870 | 0.005 | 414.1875 | 0.005 | 1 | 2 | methotrexate binding |
| GO:0070735 | 0.005 | 414.1875 | 0.005 | 1 | 2 | protein-glycine ligase activity |
| GO:0000404 | 0.0074 | 207.0781 | 0.0075 | 1 | 3 | heteroduplex DNA loop binding |
| GO:0003854 | 0.0074 | 207.0781 | 0.0075 | 1 | 3 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GO:0035651 | 0.0074 | 207.0781 | 0.0075 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0043199 | 0.0074 | 207.0781 | 0.0075 | 1 | 3 | sulfate binding |
| GO:0016286 | 0.0099 | 138.0417 | 0.0099 | 1 | 4 | small conductance calcium-activated potassium channel activity |
| GO:0035650 | 0.0099 | 138.0417 | 0.0099 | 1 | 4 | AP-1 adaptor complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005115 | 0.0014 | Inf | 0.0014 | 1 | 1 | receptor tyrosine kinase-like orphan receptor binding |
| GO:0032500 | 0.0014 | Inf | 0.0014 | 1 | 1 | muramyl dipeptide binding |
| GO:0048248 | 0.0014 | Inf | 0.0014 | 1 | 1 | CXCR3 chemokine receptor binding |
| GO:1902379 | 0.0014 | Inf | 0.0014 | 1 | 1 | chemoattractant activity involved in axon guidance |
| GO:0005110 | 0.0027 | 780.5294 | 0.0027 | 1 | 2 | frizzled-2 binding |
| GO:0008502 | 0.0027 | 780.5294 | 0.0027 | 1 | 2 | melatonin receptor activity |
| GO:0032393 | 0.0054 | 260.1373 | 0.0054 | 1 | 4 | MHC class I receptor activity |
| GO:0016616 | 0.0058 | 19.8599 | 0.1151 | 2 | 85 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0042834 | 0.0068 | 195.0882 | 0.0068 | 1 | 5 | peptidoglycan binding |
| GO:0042608 | 0.0081 | 156.0588 | 0.0081 | 1 | 6 | T cell receptor binding |
| GO:0070679 | 0.0081 | 156.0588 | 0.0081 | 1 | 6 | inositol 1,4,5 trisphosphate binding |
| GO:0003779 | 0.0081 | 8.3613 | 0.424 | 3 | 313 | actin binding |
| GO:0004679 | 0.0094 | 130.0392 | 0.0095 | 1 | 7 | AMP-activated protein kinase activity |
| GO:0015279 | 0.0094 | 130.0392 | 0.0095 | 1 | 7 | store-operated calcium channel activity |
| GO:0031419 | 0.0094 | 130.0392 | 0.0095 | 1 | 7 | cobalamin binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018479 | 5e-04 | 6642 | 5e-04 | 1 | 2 | benzaldehyde dehydrogenase (NAD+) activity |
| GO:0004028 | 9e-04 | 2213.6667 | 9e-04 | 1 | 4 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0004030 | 0.0011 | 1660.125 | 0.0011 | 1 | 5 | aldehyde dehydrogenase [NAD(P)+] activity |
| GO:0008106 | 0.0027 | 603.3636 | 0.0027 | 1 | 12 | alcohol dehydrogenase (NADP+) activity |
| GO:0016903 | 0.0077 | 200.7879 | 0.0077 | 1 | 34 | oxidoreductase activity, acting on the aldehyde or oxo group of donors |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004421 | 2e-04 | Inf | 2e-04 | 1 | 1 | hydroxymethylglutaryl-CoA synthase activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005184 | 0.0041 | 390.2353 | 0.0041 | 1 | 18 | neuropeptide hormone activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 74.7141 | 0.2555 | 4 | 5 | molybdopterin cofactor binding |
| GO:0005201 | 1e-04 | 5.3934 | 2.2901 | 10 | 45 | extracellular matrix structural constituent |
| GO:0030151 | 5e-04 | 55.9527 | 0.2044 | 3 | 4 | molybdenum ion binding |
| GO:0008238 | 7e-04 | 3.318 | 4.0879 | 12 | 80 | exopeptidase activity |
| GO:0030020 | 0.0012 | 27.9741 | 0.2555 | 3 | 5 | extracellular matrix structural constituent conferring tensile strength |
| GO:0005509 | 0.0016 | 1.7029 | 26.1626 | 42 | 512 | calcium ion binding |
| GO:0016165 | 0.0026 | Inf | 0.1022 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0036461 | 0.0026 | Inf | 0.1022 | 2 | 2 | BLOC-2 complex binding |
| GO:0047844 | 0.0026 | Inf | 0.1022 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0005044 | 0.0043 | 4.4876 | 1.5841 | 6 | 31 | scavenger receptor activity |
| GO:0005179 | 0.0051 | 2.8407 | 3.8835 | 10 | 76 | hormone activity |
| GO:0016723 | 0.0061 | 11.187 | 0.4088 | 3 | 8 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
| GO:0070006 | 0.0075 | 6.2207 | 0.8176 | 4 | 16 | metalloaminopeptidase activity |
| GO:0004126 | 0.0076 | 37.2467 | 0.1533 | 2 | 3 | cytidine deaminase activity |
| GO:0008940 | 0.0076 | 37.2467 | 0.1533 | 2 | 3 | nitrate reductase activity |
| GO:0015111 | 0.0076 | 37.2467 | 0.1533 | 2 | 3 | iodide transmembrane transporter activity |
| GO:0035651 | 0.0076 | 37.2467 | 0.1533 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0070573 | 0.0076 | 37.2467 | 0.1533 | 2 | 3 | metallodipeptidase activity |
| GO:0004867 | 0.0083 | 3.3574 | 2.3505 | 7 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0030414 | 0.0083 | 2.4851 | 4.8033 | 11 | 94 | peptidase inhibitor activity |
| GO:0004953 | 0.0089 | 9.3217 | 0.4599 | 3 | 9 | icosanoid receptor activity |
| GO:0016803 | 0.0089 | 9.3217 | 0.4599 | 3 | 9 | ether hydrolase activity |
| GO:0043225 | 0.0089 | 9.3217 | 0.4599 | 3 | 9 | ATPase-coupled anion transmembrane transporter activity |
| GO:0005506 | 0.009 | 2.345 | 5.5187 | 12 | 108 | iron ion binding |
| GO:0047617 | 0.0094 | 5.7418 | 0.8687 | 4 | 17 | acyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 5e-04 | 4.8504 | 1.8405 | 8 | 335 | G-protein coupled receptor activity |
| GO:0038023 | 6e-04 | 3.4188 | 4.0096 | 12 | 720 | signaling receptor activity |
| GO:0099600 | 0.0011 | 3.3371 | 3.72 | 11 | 668 | transmembrane receptor activity |
| GO:0004950 | 0.0027 | 30.5602 | 0.078 | 2 | 14 | chemokine receptor activity |
| GO:0060089 | 0.0041 | 2.664 | 5.051 | 12 | 907 | molecular transducer activity |
| GO:0003858 | 0.0056 | Inf | 0.0056 | 1 | 1 | 3-hydroxybutyrate dehydrogenase activity |
| GO:0004607 | 0.0056 | Inf | 0.0056 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0004667 | 0.0056 | Inf | 0.0056 | 1 | 1 | prostaglandin-D synthase activity |
| GO:0016501 | 0.0056 | Inf | 0.0056 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.0056 | Inf | 0.0056 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0033791 | 0.0056 | Inf | 0.0056 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GO:0038182 | 0.0056 | Inf | 0.0056 | 1 | 1 | G-protein coupled bile acid receptor activity |
| GO:0005501 | 0.006 | 19.2909 | 0.1169 | 2 | 21 | retinoid binding |
| GO:1903231 | 0.0097 | 7.3043 | 0.4399 | 3 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0.0019 | 8.2347 | 0.5291 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005092 | 0.0019 | 37.9052 | 0.067 | 2 | 10 | GDP-dissociation inhibitor activity |
| GO:0005070 | 0.0021 | 13.1203 | 0.2545 | 3 | 38 | SH3/SH2 adaptor activity |
| GO:0051020 | 0.0034 | 3.0022 | 3.6436 | 10 | 544 | GTPase binding |
| GO:0005088 | 0.0035 | 4.4073 | 1.4668 | 6 | 219 | Ras guanyl-nucleotide exchange factor activity |
| GO:0001604 | 0.0067 | Inf | 0.0067 | 1 | 1 | urotensin II receptor activity |
| GO:0004137 | 0.0067 | Inf | 0.0067 | 1 | 1 | deoxycytidine kinase activity |
| GO:0005147 | 0.0067 | Inf | 0.0067 | 1 | 1 | oncostatin-M receptor binding |
| GO:0008579 | 0.0067 | Inf | 0.0067 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0035755 | 0.0067 | Inf | 0.0067 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0039552 | 0.0067 | Inf | 0.0067 | 1 | 1 | RIG-I binding |
| GO:0045485 | 0.0067 | Inf | 0.0067 | 1 | 1 | omega-6 fatty acid desaturase activity |
| GO:0047747 | 0.0067 | Inf | 0.0067 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0067 | Inf | 0.0067 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0008092 | 0.0074 | 2.5334 | 4.7353 | 11 | 707 | cytoskeletal protein binding |
| GO:0005504 | 0.0078 | 16.834 | 0.134 | 2 | 20 | fatty acid binding |
| GO:0098772 | 0.0085 | 2.0758 | 9.1425 | 17 | 1365 | molecular function regulator |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 47.1236 | 1.2273 | 27 | 54 | olfactory receptor activity |
| GO:0004930 | 0 | 5.723 | 7.6364 | 36 | 336 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 3.1935 | 16.3636 | 45 | 720 | signaling receptor activity |
| GO:0099600 | 0 | 3.1895 | 15.1818 | 42 | 668 | transmembrane receptor activity |
| GO:0060089 | 0 | 2.8081 | 20.6136 | 50 | 907 | molecular transducer activity |
| GO:0036459 | 0 | 7.9326 | 2.2727 | 15 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008234 | 0 | 5.0965 | 3.5682 | 16 | 157 | cysteine-type peptidase activity |
| GO:0005549 | 0 | 31.2145 | 0.2727 | 5 | 12 | odorant binding |
| GO:0008233 | 0 | 2.8599 | 10.8182 | 28 | 476 | peptidase activity |
| GO:0004556 | 0 | Inf | 0.0682 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0682 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0061134 | 1e-04 | 4.3451 | 2.7955 | 11 | 123 | peptidase regulator activity |
| GO:0002020 | 1e-04 | 4.6969 | 2.3636 | 10 | 104 | protease binding |
| GO:0004866 | 2e-04 | 4.8938 | 2.0455 | 9 | 90 | endopeptidase inhibitor activity |
| GO:0004252 | 3e-04 | 4.1221 | 2.6591 | 10 | 117 | serine-type endopeptidase activity |
| GO:0004517 | 5e-04 | Inf | 0.0455 | 2 | 2 | nitric-oxide synthase activity |
| GO:0008988 | 5e-04 | Inf | 0.0455 | 2 | 2 | rRNA (adenine-N6-)-methyltransferase activity |
| GO:0030883 | 5e-04 | Inf | 0.0455 | 2 | 2 | endogenous lipid antigen binding |
| GO:0030884 | 5e-04 | Inf | 0.0455 | 2 | 2 | exogenous lipid antigen binding |
| GO:0005198 | 5e-04 | 2.2033 | 12.1818 | 25 | 536 | structural molecule activity |
| GO:0017171 | 0.0014 | 3.3606 | 3.2045 | 10 | 141 | serine hydrolase activity |
| GO:0004321 | 0.0015 | 86.5667 | 0.0682 | 2 | 3 | fatty-acyl-CoA synthase activity |
| GO:0034617 | 0.0015 | 86.5667 | 0.0682 | 2 | 3 | tetrahydrobiopterin binding |
| GO:0030246 | 0.0027 | 2.8668 | 4.0909 | 11 | 180 | carbohydrate binding |
| GO:0003996 | 0.003 | 43.28 | 0.0909 | 2 | 4 | acyl-CoA ligase activity |
| GO:0004082 | 0.003 | 43.28 | 0.0909 | 2 | 4 | bisphosphoglycerate mutase activity |
| GO:0032190 | 0.003 | 43.28 | 0.0909 | 2 | 4 | acrosin binding |
| GO:0046538 | 0.003 | 43.28 | 0.0909 | 2 | 4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:0047760 | 0.003 | 43.28 | 0.0909 | 2 | 4 | butyrate-CoA ligase activity |
| GO:0071723 | 0.003 | 43.28 | 0.0909 | 2 | 4 | lipopeptide binding |
| GO:0046906 | 0.0039 | 3.7805 | 2 | 7 | 88 | tetrapyrrole binding |
| GO:0003796 | 0.0049 | 28.8511 | 0.1136 | 2 | 5 | lysozyme activity |
| GO:0003958 | 0.0049 | 28.8511 | 0.1136 | 2 | 5 | NADPH-hemoprotein reductase activity |
| GO:0034618 | 0.0049 | 28.8511 | 0.1136 | 2 | 5 | arginine binding |
| GO:0005096 | 0.0056 | 2.4696 | 5.1364 | 12 | 226 | GTPase activator activity |
| GO:0004497 | 0.0064 | 4.6346 | 1.1818 | 5 | 52 | monooxygenase activity |
| GO:0004875 | 0.0073 | 21.6367 | 0.1364 | 2 | 6 | complement receptor activity |
| GO:0030881 | 0.0073 | 21.6367 | 0.1364 | 2 | 6 | beta-2-microglobulin binding |
| GO:0042056 | 0.0074 | 8.6763 | 0.4091 | 3 | 18 | chemoattractant activity |
| GO:0016705 | 0.009 | 3.1861 | 2.3409 | 7 | 103 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005201 | 1e-04 | 7.7311 | 1.0536 | 7 | 50 | extracellular matrix structural constituent |
| GO:0043546 | 1e-04 | 70.4296 | 0.1054 | 3 | 5 | molybdopterin cofactor binding |
| GO:0016165 | 4e-04 | Inf | 0.0421 | 2 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0005164 | 7e-04 | 11.7681 | 0.4214 | 4 | 20 | tumor necrosis factor receptor binding |
| GO:0016801 | 0.001 | 20.115 | 0.2107 | 3 | 10 | hydrolase activity, acting on ether bonds |
| GO:0004126 | 0.0013 | 93.5755 | 0.0632 | 2 | 3 | cytidine deaminase activity |
| GO:0030151 | 0.0026 | 46.7842 | 0.0843 | 2 | 4 | molybdenum ion binding |
| GO:0030414 | 0.0037 | 3.8081 | 1.9807 | 7 | 94 | peptidase inhibitor activity |
| GO:0016701 | 0.0051 | 10.0521 | 0.3582 | 3 | 17 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
| GO:0033691 | 0.0087 | 18.7094 | 0.1475 | 2 | 7 | sialic acid binding |
| GO:0005031 | 0.0093 | 7.8159 | 0.4425 | 3 | 21 | tumor necrosis factor-activated receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 1e-04 | 4.9984 | 2.2505 | 10 | 336 | G-protein coupled receptor activity |
| GO:0060089 | 9e-04 | 2.7967 | 6.0749 | 15 | 907 | molecular transducer activity |
| GO:0038023 | 0.001 | 3.0223 | 4.8224 | 13 | 720 | signaling receptor activity |
| GO:0004954 | 0.0012 | 50.5479 | 0.0536 | 2 | 8 | prostanoid receptor activity |
| GO:0099600 | 0.0016 | 2.9798 | 4.4741 | 12 | 668 | transmembrane receptor activity |
| GO:0016491 | 0.0037 | 2.9617 | 3.6905 | 10 | 551 | oxidoreductase activity |
| GO:0071949 | 0.0063 | 18.9411 | 0.1206 | 2 | 18 | FAD binding |
| GO:0001785 | 0.0067 | Inf | 0.0067 | 1 | 1 | prostaglandin J receptor activity |
| GO:0004607 | 0.0067 | Inf | 0.0067 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0004956 | 0.0067 | Inf | 0.0067 | 1 | 1 | prostaglandin D receptor activity |
| GO:0008147 | 0.0067 | Inf | 0.0067 | 1 | 1 | structural constituent of bone |
| GO:0008445 | 0.0067 | Inf | 0.0067 | 1 | 1 | D-aspartate oxidase activity |
| GO:0008843 | 0.0067 | Inf | 0.0067 | 1 | 1 | endochitinase activity |
| GO:0016501 | 0.0067 | Inf | 0.0067 | 1 | 1 | prostacyclin receptor activity |
| GO:0017020 | 0.0067 | Inf | 0.0067 | 1 | 1 | myosin phosphatase regulator activity |
| GO:0031703 | 0.0067 | Inf | 0.0067 | 1 | 1 | type 2 angiotensin receptor binding |
| GO:0031764 | 0.0067 | Inf | 0.0067 | 1 | 1 | type 1 galanin receptor binding |
| GO:0031765 | 0.0067 | Inf | 0.0067 | 1 | 1 | type 2 galanin receptor binding |
| GO:0031766 | 0.0067 | Inf | 0.0067 | 1 | 1 | type 3 galanin receptor binding |
| GO:0033791 | 0.0067 | Inf | 0.0067 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030883 | 0 | Inf | 0.014 | 2 | 2 | endogenous lipid antigen binding |
| GO:0030884 | 0 | Inf | 0.014 | 2 | 2 | exogenous lipid antigen binding |
| GO:0005159 | 1e-04 | 39.9515 | 0.098 | 3 | 14 | insulin-like growth factor receptor binding |
| GO:0071723 | 3e-04 | 144.978 | 0.028 | 2 | 4 | lipopeptide binding |
| GO:0004984 | 5e-04 | 11.8157 | 0.3779 | 4 | 54 | olfactory receptor activity |
| GO:0030881 | 7e-04 | 72.478 | 0.042 | 2 | 6 | beta-2-microglobulin binding |
| GO:0003823 | 0.0014 | 15.1333 | 0.224 | 3 | 32 | antigen binding |
| GO:0008483 | 0.0068 | 18.3042 | 0.1246 | 2 | 18 | transaminase activity |
| GO:0033204 | 0.007 | Inf | 0.007 | 1 | 1 | ribonuclease P RNA binding |
| GO:0047305 | 0.007 | Inf | 0.007 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0004930 | 0.0092 | 3.1831 | 2.3516 | 7 | 336 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0041 | Inf | 0.0041 | 1 | 54 | olfactory receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008389 | 0.0012 | Inf | 0.0012 | 1 | 1 | coumarin 7-hydroxylase activity |
| GO:0052593 | 0.0012 | Inf | 0.0012 | 1 | 1 | tryptamine:oxygen oxidoreductase (deaminating) activity |
| GO:0052594 | 0.0012 | Inf | 0.0012 | 1 | 1 | aminoacetone:oxygen oxidoreductase(deaminating) activity |
| GO:0052595 | 0.0012 | Inf | 0.0012 | 1 | 1 | aliphatic-amine oxidase activity |
| GO:0052596 | 0.0012 | Inf | 0.0012 | 1 | 1 | phenethylamine:oxygen oxidoreductase (deaminating) activity |
| GO:0004047 | 0.0024 | 884.7333 | 0.0024 | 1 | 2 | aminomethyltransferase activity |
| GO:0008131 | 0.0024 | 884.7333 | 0.0024 | 1 | 2 | primary amine oxidase activity |
| GO:0071987 | 0.0036 | 442.3333 | 0.0036 | 1 | 3 | WD40-repeat domain binding |
| GO:0008392 | 0.0072 | 176.8933 | 0.0072 | 1 | 6 | arachidonic acid epoxygenase activity |
| GO:0055056 | 0.0084 | 147.4 | 0.0084 | 1 | 7 | D-glucose transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001077 | 0.0026 | 12.9708 | 0.283 | 3 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0043565 | 0.0034 | 6.2262 | 1.0933 | 5 | 908 | sequence-specific DNA binding |
| GO:0030550 | 0.0036 | 442.3333 | 0.0036 | 1 | 3 | acetylcholine receptor inhibitor activity |
| GO:0000978 | 0.0059 | 9.5858 | 0.3793 | 3 | 315 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0016493 | 0.006 | 221.1333 | 0.006 | 1 | 5 | C-C chemokine receptor activity |
| GO:0019957 | 0.006 | 221.1333 | 0.006 | 1 | 5 | C-C chemokine binding |
| GO:0001159 | 0.0067 | 9.1355 | 0.3974 | 3 | 330 | core promoter proximal region DNA binding |
| GO:0000981 | 0.0071 | 6.3293 | 0.8043 | 4 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0099602 | 0.0084 | 147.4 | 0.0084 | 1 | 7 | neurotransmitter receptor regulator activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008093 | 0.0017 | 1327.6 | 0.0017 | 1 | 11 | cytoskeletal adaptor activity |
| GO:0008307 | 0.0057 | 358.0811 | 0.0057 | 1 | 38 | structural constituent of muscle |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070008 | 9e-04 | Inf | 9e-04 | 1 | 12 | serine-type exopeptidase activity |
| GO:0015269 | 0.0011 | Inf | 0.0011 | 1 | 14 | calcium-activated potassium channel activity |
| GO:0022839 | 0.0024 | Inf | 0.0024 | 1 | 32 | ion gated channel activity |
| GO:0004252 | 0.0088 | Inf | 0.0088 | 1 | 117 | serine-type endopeptidase activity |
| GO:0015079 | 0.0098 | Inf | 0.0098 | 1 | 130 | potassium ion transmembrane transporter activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015603 | 2e-04 | Inf | 2e-04 | 1 | 1 | iron chelate transmembrane transporter activity |
| GO:0042931 | 2e-04 | Inf | 2e-04 | 1 | 1 | enterobactin transmembrane transporter activity |
| GO:0044736 | 3e-04 | 13285 | 3e-04 | 1 | 2 | acid-sensing ion channel activity |
| GO:0005381 | 0.0012 | 1897 | 0.0012 | 1 | 8 | iron ion transmembrane transporter activity |
| GO:0005272 | 0.0053 | 389.7647 | 0.0053 | 1 | 35 | sodium channel activity |
| GO:0099094 | 0.0095 | 213.2903 | 0.0095 | 1 | 63 | ligand-gated cation channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019894 | 0.0083 | 184.0139 | 0.0084 | 1 | 37 | kinesin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097153 | 8e-04 | Inf | 8e-04 | 1 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 53.7732 | 0.8859 | 24 | 54 | olfactory receptor activity |
| GO:0004930 | 0 | 6.9381 | 5.5123 | 31 | 336 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 3.9637 | 11.8122 | 39 | 720 | signaling receptor activity |
| GO:0036459 | 0 | 11.288 | 1.6406 | 15 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0099600 | 0 | 3.8928 | 10.9591 | 36 | 668 | transmembrane receptor activity |
| GO:0060089 | 0 | 3.2643 | 14.88 | 41 | 907 | molecular transducer activity |
| GO:0008234 | 0 | 7.263 | 2.5757 | 16 | 157 | cysteine-type peptidase activity |
| GO:0008233 | 0 | 3.2851 | 7.8092 | 23 | 476 | peptidase activity |
| GO:0004556 | 0 | Inf | 0.0492 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0492 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0004517 | 3e-04 | Inf | 0.0328 | 2 | 2 | nitric-oxide synthase activity |
| GO:0005198 | 5e-04 | 2.4575 | 8.7935 | 20 | 536 | structural molecule activity |
| GO:0004866 | 7e-04 | 5.1909 | 1.4765 | 7 | 90 | endopeptidase inhibitor activity |
| GO:0030246 | 8e-04 | 3.6482 | 2.953 | 10 | 180 | carbohydrate binding |
| GO:0034617 | 8e-04 | 121.0093 | 0.0492 | 2 | 3 | tetrahydrobiopterin binding |
| GO:0005549 | 9e-04 | 20.2496 | 0.1969 | 3 | 12 | odorant binding |
| GO:0061134 | 9e-04 | 4.2915 | 2.0179 | 8 | 123 | peptidase regulator activity |
| GO:0017137 | 0.0014 | 3.6597 | 2.6413 | 9 | 161 | Rab GTPase binding |
| GO:0004082 | 0.0016 | 60.5 | 0.0656 | 2 | 4 | bisphosphoglycerate mutase activity |
| GO:0032190 | 0.0016 | 60.5 | 0.0656 | 2 | 4 | acrosin binding |
| GO:0046538 | 0.0016 | 60.5 | 0.0656 | 2 | 4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:0004497 | 0.0016 | 6.5043 | 0.8531 | 5 | 52 | monooxygenase activity |
| GO:0002020 | 0.0016 | 4.4369 | 1.7062 | 7 | 104 | protease binding |
| GO:0020037 | 0.0021 | 4.9038 | 1.3289 | 6 | 81 | heme binding |
| GO:0003796 | 0.0026 | 40.3302 | 0.082 | 2 | 5 | lysozyme activity |
| GO:0003958 | 0.0026 | 40.3302 | 0.082 | 2 | 5 | NADPH-hemoprotein reductase activity |
| GO:0034618 | 0.0026 | 40.3302 | 0.082 | 2 | 5 | arginine binding |
| GO:0004875 | 0.0038 | 30.2454 | 0.0984 | 2 | 6 | complement receptor activity |
| GO:0005096 | 0.0042 | 2.861 | 3.7077 | 10 | 226 | GTPase activator activity |
| GO:0031404 | 0.0053 | 24.1944 | 0.1148 | 2 | 7 | chloride ion binding |
| GO:0016705 | 0.007 | 3.7852 | 1.6898 | 6 | 103 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0005539 | 0.0083 | 3.227 | 2.2968 | 7 | 140 | glycosaminoglycan binding |
| GO:0005506 | 0.0087 | 3.5982 | 1.7718 | 6 | 108 | iron ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 6e-04 | 11.4955 | 0.3864 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005092 | 0.001 | 52.4405 | 0.0489 | 2 | 10 | GDP-dissociation inhibitor activity |
| GO:0017048 | 0.0043 | 6.5534 | 0.6604 | 4 | 135 | Rho GTPase binding |
| GO:0005088 | 0.0043 | 5.0658 | 1.0713 | 5 | 219 | Ras guanyl-nucleotide exchange factor activity |
| GO:0005031 | 0.0047 | 22.0618 | 0.1027 | 2 | 21 | tumor necrosis factor-activated receptor activity |
| GO:0004137 | 0.0049 | Inf | 0.0049 | 1 | 1 | deoxycytidine kinase activity |
| GO:0005147 | 0.0049 | Inf | 0.0049 | 1 | 1 | oncostatin-M receptor binding |
| GO:0045485 | 0.0049 | Inf | 0.0049 | 1 | 1 | omega-6 fatty acid desaturase activity |
| GO:0047305 | 0.0049 | Inf | 0.0049 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
| GO:0047747 | 0.0049 | Inf | 0.0049 | 1 | 1 | cholate-CoA ligase activity |
| GO:0050429 | 0.0049 | Inf | 0.0049 | 1 | 1 | calcium-dependent phospholipase C activity |
| GO:0030371 | 0.0056 | 19.9577 | 0.1125 | 2 | 23 | translation repressor activity |
| GO:0031267 | 0.007 | 3.4022 | 2.2502 | 7 | 460 | small GTPase binding |
| GO:0042805 | 0.0082 | 16.1136 | 0.137 | 2 | 28 | actinin binding |
| GO:0000248 | 0.0098 | 206.5938 | 0.0098 | 1 | 2 | C-5 sterol desaturase activity |
| GO:0004797 | 0.0098 | 206.5938 | 0.0098 | 1 | 2 | thymidine kinase activity |
| GO:0005153 | 0.0098 | 206.5938 | 0.0098 | 1 | 2 | interleukin-8 receptor binding |
| GO:0030622 | 0.0098 | 206.5938 | 0.0098 | 1 | 2 | U4atac snRNA binding |
| GO:0047045 | 0.0098 | 206.5938 | 0.0098 | 1 | 2 | testosterone 17-beta-dehydrogenase (NADP+) activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
GO enrichment analysis was also performed for differentially variable regions.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
Workclouds for GO enrichment terms (Differential Variability)
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031497 | 4e-04 | 12.8104 | 0.353 | 4 | 131 | chromatin assembly |
| GO:0046459 | 5e-04 | 77.7744 | 0.0323 | 2 | 12 | short-chain fatty acid metabolic process |
| GO:0034728 | 5e-04 | 12.0448 | 0.3745 | 4 | 139 | nucleosome organization |
| GO:0006335 | 0.0019 | 35.324 | 0.0647 | 2 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0065004 | 0.002 | 8.2625 | 0.5389 | 4 | 200 | protein-DNA complex assembly |
| GO:0000183 | 0.0022 | 32.3761 | 0.0701 | 2 | 26 | chromatin silencing at rDNA |
| GO:0016077 | 0.0027 | Inf | 0.0027 | 1 | 1 | snoRNA catabolic process |
| GO:0032788 | 0.0027 | Inf | 0.0027 | 1 | 1 | saturated monocarboxylic acid metabolic process |
| GO:0032789 | 0.0027 | Inf | 0.0027 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
| GO:0035863 | 0.0027 | Inf | 0.0027 | 1 | 1 | dITP catabolic process |
| GO:0043105 | 0.0027 | Inf | 0.0027 | 1 | 1 | negative regulation of GTP cyclohydrolase I activity |
| GO:0046360 | 0.0027 | Inf | 0.0027 | 1 | 1 | 2-oxobutyrate biosynthetic process |
| GO:1901639 | 0.0027 | Inf | 0.0027 | 1 | 1 | XDP catabolic process |
| GO:1904977 | 0.0027 | Inf | 0.0027 | 1 | 1 | lymphatic endothelial cell migration |
| GO:0045814 | 0.003 | 11.3316 | 0.291 | 3 | 108 | negative regulation of gene expression, epigenetic |
| GO:0009261 | 0.0031 | 26.7851 | 0.0835 | 2 | 31 | ribonucleotide catabolic process |
| GO:0038111 | 0.0035 | 25.0538 | 0.0889 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0035 | 25.0538 | 0.0889 | 2 | 33 | response to interleukin-7 |
| GO:0051290 | 0.004 | 23.5322 | 0.0943 | 2 | 35 | protein heterotetramerization |
| GO:0016311 | 0.004 | 5.2657 | 1.0643 | 5 | 395 | dephosphorylation |
| GO:0071103 | 0.0041 | 6.7279 | 0.6574 | 4 | 244 | DNA conformation change |
| GO:0006196 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | AMP catabolic process |
| GO:0046086 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | adenosine biosynthetic process |
| GO:0046709 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | IDP catabolic process |
| GO:1901475 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | pyruvate transmembrane transport |
| GO:2000054 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:2000233 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | negative regulation of rRNA processing |
| GO:0006195 | 0.006 | 18.9306 | 0.1159 | 2 | 43 | purine nucleotide catabolic process |
| GO:0021759 | 0.0081 | 189.675 | 0.0081 | 1 | 3 | globus pallidus development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061033 | 0.0011 | 2172.5714 | 0.0011 | 1 | 2 | secretion by lung epithelial cell involved in lung growth |
| GO:0060665 | 0.0021 | 724.0952 | 0.0021 | 1 | 4 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling |
| GO:0060501 | 0.0032 | 434.4 | 0.0032 | 1 | 6 | positive regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0010838 | 0.0042 | 310.2449 | 0.0042 | 1 | 8 | positive regulation of keratinocyte proliferation |
| GO:0051549 | 0.0042 | 310.2449 | 0.0042 | 1 | 8 | positive regulation of keratinocyte migration |
| GO:0018298 | 0.0052 | 241.2698 | 0.0053 | 1 | 10 | protein-chromophore linkage |
| GO:0034472 | 0.0068 | 180.9167 | 0.0068 | 1 | 13 | snRNA 3'-end processing |
| GO:1903830 | 0.0073 | 166.989 | 0.0074 | 1 | 14 | magnesium ion transmembrane transport |
| GO:0033617 | 0.0079 | 155.051 | 0.0079 | 1 | 15 | mitochondrial respiratory chain complex IV assembly |
| GO:0030150 | 0.0084 | 144.7048 | 0.0084 | 1 | 16 | protein import into mitochondrial matrix |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 0 | Inf | 0.0022 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0006475 | 5e-04 | 23.9127 | 0.1542 | 3 | 138 | internal protein amino acid acetylation |
| GO:0050435 | 6e-04 | 67.4222 | 0.0357 | 2 | 32 | amyloid-beta metabolic process |
| GO:0046327 | 0.0011 | Inf | 0.0011 | 1 | 1 | glycerol biosynthetic process from pyruvate |
| GO:0060183 | 0.0011 | Inf | 0.0011 | 1 | 1 | apelin receptor signaling pathway |
| GO:1904022 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of G-protein coupled receptor internalization |
| GO:0043543 | 0.0012 | 16.9286 | 0.2156 | 3 | 193 | protein acylation |
| GO:0042255 | 0.0019 | 36.0571 | 0.0648 | 2 | 58 | ribosome assembly |
| GO:0030103 | 0.0022 | 949.9375 | 0.0022 | 1 | 2 | vasopressin secretion |
| GO:0061402 | 0.0022 | 949.9375 | 0.0022 | 1 | 2 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH |
| GO:0090134 | 0.0022 | 949.9375 | 0.0022 | 1 | 2 | cell migration involved in mesendoderm migration |
| GO:0034109 | 0.0028 | 29.2386 | 0.0793 | 2 | 71 | homotypic cell-cell adhesion |
| GO:0050830 | 0.0031 | 27.6292 | 0.0838 | 2 | 75 | defense response to Gram-positive bacterium |
| GO:0032431 | 0.0033 | 474.9375 | 0.0034 | 1 | 3 | activation of phospholipase A2 activity |
| GO:0044240 | 0.0033 | 474.9375 | 0.0034 | 1 | 3 | multicellular organismal lipid catabolic process |
| GO:0051365 | 0.0033 | 474.9375 | 0.0034 | 1 | 3 | cellular response to potassium ion starvation |
| GO:1904640 | 0.0033 | 474.9375 | 0.0034 | 1 | 3 | response to methionine |
| GO:0070253 | 0.0045 | 316.6042 | 0.0045 | 1 | 4 | somatostatin secretion |
| GO:0019233 | 0.0045 | 22.6382 | 0.1017 | 2 | 91 | sensory perception of pain |
| GO:0021510 | 0.005 | 21.427 | 0.1072 | 2 | 96 | spinal cord development |
| GO:0019401 | 0.0056 | 237.4375 | 0.0056 | 1 | 5 | alditol biosynthetic process |
| GO:0048382 | 0.0056 | 237.4375 | 0.0056 | 1 | 5 | mesendoderm development |
| GO:0071332 | 0.0056 | 237.4375 | 0.0056 | 1 | 5 | cellular response to fructose stimulus |
| GO:0030099 | 0.0067 | 9.039 | 0.3966 | 3 | 355 | myeloid cell differentiation |
| GO:0032429 | 0.0078 | 158.2708 | 0.0078 | 1 | 7 | regulation of phospholipase A2 activity |
| GO:0033601 | 0.0078 | 158.2708 | 0.0078 | 1 | 7 | positive regulation of mammary gland epithelial cell proliferation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018298 | 0 | 345.3636 | 0.0085 | 2 | 10 | protein-chromophore linkage |
| GO:0060011 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | Sertoli cell proliferation |
| GO:0072429 | 0.0034 | 422.25 | 0.0034 | 1 | 4 | response to intra-S DNA damage checkpoint signaling |
| GO:0055129 | 0.0043 | 316.6667 | 0.0043 | 1 | 5 | L-proline biosynthetic process |
| GO:0042713 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | sperm ejaculation |
| GO:0072402 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | response to DNA integrity checkpoint signaling |
| GO:0033015 | 0.006 | 211.0833 | 0.006 | 1 | 7 | tetrapyrrole catabolic process |
| GO:0042167 | 0.006 | 211.0833 | 0.006 | 1 | 7 | heme catabolic process |
| GO:0055002 | 0.006 | 19.996 | 0.1187 | 2 | 139 | striated muscle cell development |
| GO:0032927 | 0.0068 | 180.9167 | 0.0068 | 1 | 8 | positive regulation of activin receptor signaling pathway |
| GO:0006560 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | proline metabolic process |
| GO:0043084 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | penile erection |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071444 | 0.0014 | Inf | 0.0014 | 1 | 1 | cellular response to pheromone |
| GO:0072616 | 0.0014 | Inf | 0.0014 | 1 | 1 | interleukin-18 secretion |
| GO:2000663 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of interleukin-5 secretion |
| GO:0019878 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | lysine biosynthetic process via aminoadipic acid |
| GO:1990108 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | protein linear deubiquitination |
| GO:2000666 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | negative regulation of interleukin-13 secretion |
| GO:0001510 | 0.0032 | 27.0062 | 0.0842 | 2 | 61 | RNA methylation |
| GO:0033512 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | L-lysine catabolic process to acetyl-CoA via saccharopine |
| GO:0097252 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | oligodendrocyte apoptotic process |
| GO:2001180 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | negative regulation of interleukin-10 secretion |
| GO:0019477 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | L-lysine catabolic process |
| GO:1900227 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | positive regulation of NLRP3 inflammasome complex assembly |
| GO:1901026 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | ripoptosome assembly involved in necroptotic process |
| GO:1905907 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | negative regulation of amyloid fibril formation |
| GO:0050877 | 0.0055 | 5.2222 | 1.191 | 5 | 863 | nervous system process |
| GO:0034097 | 0.0063 | 5.0473 | 1.2296 | 5 | 891 | response to cytokine |
| GO:0050868 | 0.0065 | 18.4945 | 0.1214 | 2 | 88 | negative regulation of T cell activation |
| GO:0001661 | 0.0069 | 189.9 | 0.0069 | 1 | 5 | conditioned taste aversion |
| GO:0046604 | 0.0069 | 189.9 | 0.0069 | 1 | 5 | positive regulation of mitotic centrosome separation |
| GO:1903232 | 0.0069 | 189.9 | 0.0069 | 1 | 5 | melanosome assembly |
| GO:0010536 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | positive regulation of activation of Janus kinase activity |
| GO:0031642 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | negative regulation of myelination |
| GO:0097647 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | amylin receptor signaling pathway |
| GO:0050864 | 0.0086 | 15.8905 | 0.1408 | 2 | 102 | regulation of B cell activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001233 | 2e-04 | 8.4997 | 0.8399 | 6 | 355 | regulation of apoptotic signaling pathway |
| GO:0090083 | 6e-04 | 63.7269 | 0.0379 | 2 | 16 | regulation of inclusion body assembly |
| GO:0046620 | 9e-04 | 17.3786 | 0.194 | 3 | 82 | regulation of organ growth |
| GO:2001243 | 0.0012 | 15.7722 | 0.2129 | 3 | 90 | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0048705 | 0.0014 | 9.2692 | 0.4873 | 4 | 206 | skeletal system morphogenesis |
| GO:0006713 | 0.0024 | Inf | 0.0024 | 1 | 1 | glucocorticoid catabolic process |
| GO:0007634 | 0.0024 | Inf | 0.0024 | 1 | 1 | optokinetic behavior |
| GO:0015862 | 0.0024 | Inf | 0.0024 | 1 | 1 | uridine transport |
| GO:0048255 | 0.0027 | 28.7476 | 0.0781 | 2 | 33 | mRNA stabilization |
| GO:0048706 | 0.0029 | 11.6048 | 0.2863 | 3 | 121 | embryonic skeletal system development |
| GO:0032757 | 0.004 | 23.4412 | 0.0946 | 2 | 40 | positive regulation of interleukin-8 production |
| GO:0045843 | 0.0044 | 22.2662 | 0.0994 | 2 | 42 | negative regulation of striated muscle tissue development |
| GO:0021560 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | abducens nerve development |
| GO:0021599 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | abducens nerve formation |
| GO:0034633 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | retinol transport |
| GO:0035470 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | positive regulation of vascular wound healing |
| GO:0042351 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | 'de novo' GDP-L-fucose biosynthetic process |
| GO:0046864 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | isoprenoid transport |
| GO:0048343 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | paraxial mesodermal cell fate commitment |
| GO:0060876 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | semicircular canal formation |
| GO:0070370 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | cellular heat acclimation |
| GO:0070434 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:1902257 | 0.0047 | 433.7143 | 0.0047 | 1 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
| GO:0048701 | 0.0048 | 21.2031 | 0.1041 | 2 | 44 | embryonic cranial skeleton morphogenesis |
| GO:1902369 | 0.0048 | 21.2031 | 0.1041 | 2 | 44 | negative regulation of RNA catabolic process |
| GO:0060038 | 0.006 | 18.9412 | 0.1159 | 2 | 49 | cardiac muscle cell proliferation |
| GO:0019087 | 0.0071 | 216.8429 | 0.0071 | 1 | 3 | transformation of host cell by virus |
| GO:0032423 | 0.0071 | 216.8429 | 0.0071 | 1 | 3 | regulation of mismatch repair |
| GO:0048807 | 0.0071 | 216.8429 | 0.0071 | 1 | 3 | female genitalia morphogenesis |
| GO:0050717 | 0.0071 | 216.8429 | 0.0071 | 1 | 3 | positive regulation of interleukin-1 alpha secretion |
| GO:0070602 | 0.0071 | 216.8429 | 0.0071 | 1 | 3 | regulation of centromeric sister chromatid cohesion |
| GO:0072011 | 0.0071 | 216.8429 | 0.0071 | 1 | 3 | glomerular endothelium development |
| GO:0090063 | 0.0071 | 216.8429 | 0.0071 | 1 | 3 | positive regulation of microtubule nucleation |
| GO:0009792 | 0.0088 | 4.3563 | 1.2941 | 5 | 547 | embryo development ending in birth or egg hatching |
| GO:0010033 | 0.0093 | 2.5059 | 6.6407 | 13 | 2807 | response to organic substance |
| GO:0048844 | 0.0094 | 14.8245 | 0.1467 | 2 | 62 | artery morphogenesis |
| GO:0043570 | 0.0094 | 144.5524 | 0.0095 | 1 | 4 | maintenance of DNA repeat elements |
| GO:0046368 | 0.0094 | 144.5524 | 0.0095 | 1 | 4 | GDP-L-fucose metabolic process |
| GO:0061084 | 0.0094 | 144.5524 | 0.0095 | 1 | 4 | negative regulation of protein refolding |
| GO:0061181 | 0.0094 | 144.5524 | 0.0095 | 1 | 4 | regulation of chondrocyte development |
| GO:0070295 | 0.0094 | 144.5524 | 0.0095 | 1 | 4 | renal water absorption |
| GO:0001756 | 0.0097 | 14.5805 | 0.149 | 2 | 63 | somitogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 4e-04 | 23.5565 | 0.1525 | 3 | 116 | detection of chemical stimulus |
| GO:0050906 | 6e-04 | 21.1078 | 0.1695 | 3 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 7e-04 | 20.6129 | 0.1735 | 3 | 132 | sensory perception of chemical stimulus |
| GO:0042930 | 0.0013 | Inf | 0.0013 | 1 | 1 | enterobactin transport |
| GO:0030216 | 0.0023 | 13.1659 | 0.2681 | 3 | 204 | keratinocyte differentiation |
| GO:0050911 | 0.0025 | 30.5899 | 0.0749 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0046960 | 0.0026 | 799.7895 | 0.0026 | 1 | 2 | sensitization |
| GO:0015688 | 0.0039 | 399.8684 | 0.0039 | 1 | 3 | iron chelate transport |
| GO:0035106 | 0.0039 | 399.8684 | 0.0039 | 1 | 3 | operant conditioning |
| GO:0050968 | 0.0039 | 399.8684 | 0.0039 | 1 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:0060298 | 0.0039 | 399.8684 | 0.0039 | 1 | 3 | positive regulation of sarcomere organization |
| GO:0021853 | 0.0052 | 266.5614 | 0.0053 | 1 | 4 | cerebral cortex GABAergic interneuron migration |
| GO:0046959 | 0.0052 | 266.5614 | 0.0053 | 1 | 4 | habituation |
| GO:0001661 | 0.0066 | 199.9079 | 0.0066 | 1 | 5 | conditioned taste aversion |
| GO:0006824 | 0.0066 | 199.9079 | 0.0066 | 1 | 5 | cobalt ion transport |
| GO:0050915 | 0.0066 | 199.9079 | 0.0066 | 1 | 5 | sensory perception of sour taste |
| GO:0070268 | 0.0067 | 18.2428 | 0.1235 | 2 | 94 | cornification |
| GO:0043987 | 0.0079 | 159.9158 | 0.0079 | 1 | 6 | histone H3-S10 phosphorylation |
| GO:2000138 | 0.0079 | 159.9158 | 0.0079 | 1 | 6 | positive regulation of cell proliferation involved in heart morphogenesis |
| GO:0010898 | 0.0092 | 133.2544 | 0.0092 | 1 | 7 | positive regulation of triglyceride catabolic process |
| GO:0021843 | 0.0092 | 133.2544 | 0.0092 | 1 | 7 | substrate-independent telencephalic tangential interneuron migration |
| GO:0055009 | 0.0092 | 133.2544 | 0.0092 | 1 | 7 | atrial cardiac muscle tissue morphogenesis |
| GO:0090385 | 0.0092 | 133.2544 | 0.0092 | 1 | 7 | phagosome-lysosome fusion |
| GO:0006334 | 0.0094 | 15.2394 | 0.1472 | 2 | 112 | nucleosome assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006982 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | response to lipid hydroperoxide |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071444 | 5e-04 | Inf | 5e-04 | 1 | 1 | cellular response to pheromone |
| GO:1902559 | 9e-04 | 2534.8333 | 9e-04 | 1 | 2 | 3'-phospho-5'-adenylyl sulfate transmembrane transport |
| GO:0050428 | 0.0028 | 506.8333 | 0.0028 | 1 | 6 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process |
| GO:0042048 | 0.0037 | 361.9762 | 0.0037 | 1 | 8 | olfactory behavior |
| GO:0015868 | 0.0051 | 253.3333 | 0.0051 | 1 | 11 | purine ribonucleotide transport |
| GO:0051503 | 0.0051 | 253.3333 | 0.0051 | 1 | 11 | adenine nucleotide transport |
| GO:0015671 | 0.0055 | 230.2879 | 0.0055 | 1 | 12 | oxygen transport |
| GO:0034030 | 0.0073 | 168.8333 | 0.0074 | 1 | 16 | ribonucleoside bisphosphate biosynthetic process |
| GO:0034033 | 0.0073 | 168.8333 | 0.0074 | 1 | 16 | purine nucleoside bisphosphate biosynthetic process |
| GO:0043584 | 0.0073 | 168.8333 | 0.0074 | 1 | 16 | nose development |
| GO:0006862 | 0.0078 | 158.2708 | 0.0078 | 1 | 17 | nucleotide transport |
| GO:0042744 | 0.0087 | 140.6667 | 0.0087 | 1 | 19 | hydrogen peroxide catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000872 | 6e-04 | Inf | 6e-04 | 1 | 1 | positive regulation of progesterone secretion |
| GO:0003326 | 0.0012 | 1900.875 | 0.0012 | 1 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 0.0012 | 1900.875 | 0.0012 | 1 | 2 | pancreatic PP cell fate commitment |
| GO:0060730 | 0.0012 | 1900.875 | 0.0012 | 1 | 2 | regulation of intestinal epithelial structure maintenance |
| GO:0008065 | 0.0018 | 950.375 | 0.0018 | 1 | 3 | establishment of blood-nerve barrier |
| GO:0070458 | 0.0018 | 950.375 | 0.0018 | 1 | 3 | cellular detoxification of nitrogen compound |
| GO:0018916 | 0.0024 | 633.5417 | 0.0024 | 1 | 4 | nitrobenzene metabolic process |
| GO:0032020 | 0.0035 | 380.075 | 0.0035 | 1 | 6 | ISG15-protein conjugation |
| GO:2000675 | 0.0035 | 380.075 | 0.0035 | 1 | 6 | negative regulation of type B pancreatic cell apoptotic process |
| GO:0035881 | 0.0047 | 271.4464 | 0.0047 | 1 | 8 | amacrine cell differentiation |
| GO:2000252 | 0.0047 | 271.4464 | 0.0047 | 1 | 8 | negative regulation of feeding behavior |
| GO:0030855 | 0.0048 | 11.7055 | 0.3702 | 3 | 626 | epithelial cell differentiation |
| GO:0042178 | 0.0053 | 237.5 | 0.0053 | 1 | 9 | xenobiotic catabolic process |
| GO:0001553 | 0.0059 | 211.0972 | 0.0059 | 1 | 10 | luteinization |
| GO:0006853 | 0.0059 | 211.0972 | 0.0059 | 1 | 10 | carnitine shuttle |
| GO:1905941 | 0.0059 | 211.0972 | 0.0059 | 1 | 10 | positive regulation of gonad development |
| GO:0043568 | 0.0071 | 172.6932 | 0.0071 | 1 | 12 | positive regulation of insulin-like growth factor receptor signaling pathway |
| GO:2000194 | 0.0071 | 172.6932 | 0.0071 | 1 | 12 | regulation of female gonad development |
| GO:0046883 | 0.008 | 18.2833 | 0.1396 | 2 | 236 | regulation of hormone secretion |
| GO:0021542 | 0.0083 | 146.1058 | 0.0083 | 1 | 14 | dentate gyrus development |
| GO:0030277 | 0.0083 | 146.1058 | 0.0083 | 1 | 14 | maintenance of gastrointestinal epithelium |
| GO:0010866 | 0.0088 | 135.6607 | 0.0089 | 1 | 15 | regulation of triglyceride biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006334 | 0 | 29.551 | 0.3018 | 7 | 112 | nucleosome assembly |
| GO:0061844 | 0 | 65.7292 | 0.0997 | 5 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0006333 | 0 | 21.049 | 0.4149 | 7 | 154 | chromatin assembly or disassembly |
| GO:0002227 | 0 | 109.2685 | 0.0512 | 4 | 19 | innate immune response in mucosa |
| GO:0006323 | 0 | 19.081 | 0.4553 | 7 | 169 | DNA packaging |
| GO:0002251 | 0 | 65.5178 | 0.0781 | 4 | 29 | organ or tissue specific immune response |
| GO:0019731 | 0 | 62.9938 | 0.0808 | 4 | 30 | antibacterial humoral response |
| GO:0071824 | 0 | 13.8683 | 0.617 | 7 | 229 | protein-DNA complex subunit organization |
| GO:0006959 | 0 | 15.2227 | 0.4715 | 6 | 175 | humoral immune response |
| GO:0050830 | 0 | 22.9996 | 0.2021 | 4 | 75 | defense response to Gram-positive bacterium |
| GO:0009617 | 2e-04 | 6.8631 | 1.2098 | 7 | 449 | response to bacterium |
| GO:0008544 | 3e-04 | 7.3476 | 0.9484 | 6 | 352 | epidermis development |
| GO:0098542 | 5e-04 | 6.7847 | 1.0239 | 6 | 380 | defense response to other organism |
| GO:0043207 | 0.0026 | 4.2449 | 1.9103 | 7 | 709 | response to external biotic stimulus |
| GO:0032788 | 0.0027 | Inf | 0.0027 | 1 | 1 | saturated monocarboxylic acid metabolic process |
| GO:0032789 | 0.0027 | Inf | 0.0027 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
| GO:0051704 | 0.0032 | 2.8282 | 5.8009 | 13 | 2153 | multi-organism process |
| GO:0021784 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | postganglionic parasympathetic fiber development |
| GO:1901475 | 0.0054 | 379.375 | 0.0054 | 1 | 2 | pyruvate transmembrane transport |
| GO:0031424 | 0.0059 | 8.8621 | 0.3691 | 3 | 137 | keratinization |
| GO:0010043 | 0.0065 | 18.0477 | 0.1212 | 2 | 45 | response to zinc ion |
| GO:0051276 | 0.0078 | 3.1515 | 2.9422 | 8 | 1092 | chromosome organization |
| GO:0060741 | 0.0081 | 189.675 | 0.0081 | 1 | 3 | prostate gland stromal morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031497 | 4e-04 | 13.1671 | 0.3444 | 4 | 131 | chromatin assembly |
| GO:0046459 | 4e-04 | 79.8263 | 0.0315 | 2 | 12 | short-chain fatty acid metabolic process |
| GO:0034728 | 5e-04 | 12.3802 | 0.3654 | 4 | 139 | nucleosome organization |
| GO:0006335 | 0.0018 | 36.256 | 0.0631 | 2 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0065004 | 0.0018 | 8.4926 | 0.5257 | 4 | 200 | protein-DNA complex assembly |
| GO:0007200 | 0.002 | 13.2947 | 0.2497 | 3 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0000183 | 0.0021 | 33.2303 | 0.0683 | 2 | 26 | chromatin silencing at rDNA |
| GO:0016077 | 0.0026 | Inf | 0.0026 | 1 | 1 | snoRNA catabolic process |
| GO:0032788 | 0.0026 | Inf | 0.0026 | 1 | 1 | saturated monocarboxylic acid metabolic process |
| GO:0032789 | 0.0026 | Inf | 0.0026 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
| GO:0035863 | 0.0026 | Inf | 0.0026 | 1 | 1 | dITP catabolic process |
| GO:0043105 | 0.0026 | Inf | 0.0026 | 1 | 1 | negative regulation of GTP cyclohydrolase I activity |
| GO:0046360 | 0.0026 | Inf | 0.0026 | 1 | 1 | 2-oxobutyrate biosynthetic process |
| GO:1901639 | 0.0026 | Inf | 0.0026 | 1 | 1 | XDP catabolic process |
| GO:1904977 | 0.0026 | Inf | 0.0026 | 1 | 1 | lymphatic endothelial cell migration |
| GO:0045814 | 0.0028 | 11.6386 | 0.2839 | 3 | 108 | negative regulation of gene expression, epigenetic |
| GO:0009261 | 0.003 | 27.4918 | 0.0815 | 2 | 31 | ribonucleotide catabolic process |
| GO:0038111 | 0.0034 | 25.7148 | 0.0867 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0034 | 25.7148 | 0.0867 | 2 | 33 | response to interleukin-7 |
| GO:0016311 | 0.0036 | 5.4165 | 1.0383 | 5 | 395 | dephosphorylation |
| GO:0071103 | 0.0037 | 6.9153 | 0.6414 | 4 | 244 | DNA conformation change |
| GO:0051290 | 0.0038 | 24.1531 | 0.092 | 2 | 35 | protein heterotetramerization |
| GO:0006196 | 0.0053 | 389.1282 | 0.0053 | 1 | 2 | AMP catabolic process |
| GO:0046086 | 0.0053 | 389.1282 | 0.0053 | 1 | 2 | adenosine biosynthetic process |
| GO:0046709 | 0.0053 | 389.1282 | 0.0053 | 1 | 2 | IDP catabolic process |
| GO:1901475 | 0.0053 | 389.1282 | 0.0053 | 1 | 2 | pyruvate transmembrane transport |
| GO:2000054 | 0.0053 | 389.1282 | 0.0053 | 1 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:2000233 | 0.0053 | 389.1282 | 0.0053 | 1 | 2 | negative regulation of rRNA processing |
| GO:0006195 | 0.0057 | 19.43 | 0.113 | 2 | 43 | purine nucleotide catabolic process |
| GO:0021759 | 0.0079 | 194.5513 | 0.0079 | 1 | 3 | globus pallidus development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 0 | Inf | 0.0024 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0050911 | 0 | 56.0926 | 0.0674 | 3 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 3e-04 | 26.7009 | 0.1372 | 3 | 116 | detection of chemical stimulus |
| GO:0050906 | 4e-04 | 23.9254 | 0.1526 | 3 | 129 | detection of stimulus involved in sensory perception |
| GO:0007606 | 5e-04 | 23.3643 | 0.1561 | 3 | 132 | sensory perception of chemical stimulus |
| GO:0050435 | 6e-04 | 63.2042 | 0.0379 | 2 | 32 | amyloid-beta metabolic process |
| GO:0045660 | 0.0012 | Inf | 0.0012 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0050877 | 0.0027 | 6.4286 | 1.0208 | 5 | 863 | nervous system process |
| GO:0045085 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | negative regulation of interleukin-2 biosynthetic process |
| GO:0090107 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | regulation of high-density lipoprotein particle assembly |
| GO:0007218 | 0.0048 | 21.9666 | 0.1041 | 2 | 88 | neuropeptide signaling pathway |
| GO:2000035 | 0.0094 | 127.6639 | 0.0095 | 1 | 8 | regulation of stem cell division |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006742 | 0.0017 | Inf | 0.0017 | 1 | 1 | NADP catabolic process |
| GO:0007165 | 0.0028 | 3.2245 | 8.6353 | 16 | 5054 | signal transduction |
| GO:0002587 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II |
| GO:0050911 | 0.0042 | 22.9333 | 0.0974 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0002580 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0034653 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | retinoic acid catabolic process |
| GO:0072526 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | pyridine-containing compound catabolic process |
| GO:0002583 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | regulation of antigen processing and presentation of peptide antigen |
| GO:0051122 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | hepoxilin biosynthetic process |
| GO:1903232 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | melanosome assembly |
| GO:0051453 | 0.0096 | 14.8098 | 0.1486 | 2 | 87 | regulation of intracellular pH |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018191 | 0.0015 | Inf | 0.0015 | 1 | 1 | peptidyl-serine octanoylation |
| GO:0080134 | 0.002 | 4.834 | 1.9165 | 7 | 1268 | regulation of response to stress |
| GO:0002752 | 0.003 | 690.5909 | 0.003 | 1 | 2 | cell surface pattern recognition receptor signaling pathway |
| GO:0006127 | 0.003 | 690.5909 | 0.003 | 1 | 2 | glycerophosphate shuttle |
| GO:0046168 | 0.003 | 690.5909 | 0.003 | 1 | 2 | glycerol-3-phosphate catabolic process |
| GO:0006956 | 0.0035 | 25.2916 | 0.0892 | 2 | 59 | complement activation |
| GO:0043299 | 0.0058 | 6.3712 | 0.7406 | 4 | 490 | leukocyte degranulation |
| GO:0002275 | 0.0061 | 6.2778 | 0.7512 | 4 | 497 | myeloid cell activation involved in immune response |
| GO:0002444 | 0.0063 | 6.2126 | 0.7588 | 4 | 502 | myeloid leukocyte mediated immunity |
| GO:0002758 | 0.0067 | 8.7527 | 0.3915 | 3 | 259 | innate immune response-activating signal transduction |
| GO:0052646 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | alditol phosphate metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008207 | 6e-04 | 65.6623 | 0.0368 | 2 | 35 | C21-steroid hormone metabolic process |
| GO:0043207 | 6e-04 | 9.3601 | 0.7455 | 5 | 709 | response to external biotic stimulus |
| GO:0006979 | 6e-04 | 12.6257 | 0.4153 | 4 | 395 | response to oxidative stress |
| GO:0009617 | 0.001 | 11.0532 | 0.4721 | 4 | 449 | response to bacterium |
| GO:0045660 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0070377 | 0.0011 | Inf | 0.0011 | 1 | 1 | negative regulation of ERK5 cascade |
| GO:0042446 | 0.002 | 35.4567 | 0.0662 | 2 | 63 | hormone biosynthetic process |
| GO:0017143 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | insecticide metabolic process |
| GO:0030812 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | negative regulation of nucleotide catabolic process |
| GO:0030821 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | negative regulation of cAMP catabolic process |
| GO:0019730 | 0.0025 | 31.3292 | 0.0747 | 2 | 71 | antimicrobial humoral response |
| GO:0050830 | 0.0028 | 29.6047 | 0.0789 | 2 | 75 | defense response to Gram-positive bacterium |
| GO:0018963 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | phthalate metabolic process |
| GO:0050689 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | negative regulation of defense response to virus by host |
| GO:0070859 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | positive regulation of bile acid biosynthetic process |
| GO:0071373 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | cellular response to luteinizing hormone stimulus |
| GO:0072249 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | metanephric glomerular visceral epithelial cell development |
| GO:0072312 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | metanephric glomerular epithelial cell differentiation |
| GO:0018879 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | biphenyl metabolic process |
| GO:0018894 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | dibenzo-p-dioxin metabolic process |
| GO:0030805 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | regulation of cyclic nucleotide catabolic process |
| GO:0033121 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | regulation of purine nucleotide catabolic process |
| GO:0051344 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | negative regulation of cyclic-nucleotide phosphodiesterase activity |
| GO:0019933 | 0.0045 | 22.959 | 0.1009 | 2 | 96 | cAMP-mediated signaling |
| GO:0048518 | 0.0045 | 4.3253 | 5.4003 | 11 | 5136 | positive regulation of biological process |
| GO:0051534 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:1904753 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | negative regulation of vascular associated smooth muscle cell migration |
| GO:0001906 | 0.006 | 19.5987 | 0.1178 | 2 | 112 | cell killing |
| GO:0048545 | 0.0062 | 9.38 | 0.3869 | 3 | 368 | response to steroid hormone |
| GO:0006701 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | progesterone biosynthetic process |
| GO:0009635 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | response to herbicide |
| GO:0045906 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | negative regulation of vasoconstriction |
| GO:0060992 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | response to fungicide |
| GO:0097647 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | amylin receptor signaling pathway |
| GO:0098542 | 0.0068 | 9.0741 | 0.3996 | 3 | 380 | defense response to other organism |
| GO:0042542 | 0.0071 | 17.9536 | 0.1283 | 2 | 122 | response to hydrogen peroxide |
| GO:0051694 | 0.0073 | 168.8333 | 0.0074 | 1 | 7 | pointed-end actin filament capping |
| GO:0061370 | 0.0073 | 168.8333 | 0.0074 | 1 | 7 | testosterone biosynthetic process |
| GO:0071499 | 0.0073 | 168.8333 | 0.0074 | 1 | 7 | cellular response to laminar fluid shear stress |
| GO:0030814 | 0.0077 | 17.2297 | 0.1335 | 2 | 127 | regulation of cAMP metabolic process |
| GO:0097084 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | vascular smooth muscle cell development |
| GO:1904469 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | positive regulation of tumor necrosis factor secretion |
| GO:2000035 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | regulation of stem cell division |
| GO:0051384 | 0.0085 | 16.3084 | 0.1409 | 2 | 134 | response to glucocorticoid |
| GO:0048468 | 0.0088 | 4.3274 | 1.9526 | 6 | 1857 | cell development |
| GO:0034115 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | negative regulation of heterotypic cell-cell adhesion |
| GO:0035457 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | cellular response to interferon-alpha |
| GO:0042747 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | circadian sleep/wake cycle, REM sleep |
| GO:0045597 | 0.0099 | 5.7132 | 0.8853 | 4 | 842 | positive regulation of cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0055003 | 1e-04 | 144.6286 | 0.0179 | 2 | 16 | cardiac myofibril assembly |
| GO:0060668 | 0.0011 | Inf | 0.0011 | 1 | 1 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling |
| GO:0071444 | 0.0011 | Inf | 0.0011 | 1 | 1 | cellular response to pheromone |
| GO:0003015 | 0.0024 | 13.1896 | 0.2748 | 3 | 246 | heart process |
| GO:0055006 | 0.0024 | 31.5333 | 0.0737 | 2 | 66 | cardiac cell development |
| GO:2000297 | 0.0033 | 474.9375 | 0.0034 | 1 | 3 | negative regulation of synapse maturation |
| GO:0035995 | 0.0045 | 316.6042 | 0.0045 | 1 | 4 | detection of muscle stretch |
| GO:0055007 | 0.0053 | 20.7601 | 0.1106 | 2 | 99 | cardiac muscle cell differentiation |
| GO:0010927 | 0.0055 | 20.5469 | 0.1117 | 2 | 100 | cellular component assembly involved in morphogenesis |
| GO:0090131 | 0.0056 | 237.4375 | 0.0056 | 1 | 5 | mesenchyme migration |
| GO:0030240 | 0.0067 | 189.9375 | 0.0067 | 1 | 6 | skeletal muscle thin filament assembly |
| GO:0060179 | 0.0067 | 189.9375 | 0.0067 | 1 | 6 | male mating behavior |
| GO:0060048 | 0.007 | 17.9619 | 0.1274 | 2 | 114 | cardiac muscle contraction |
| GO:0035754 | 0.0078 | 158.2708 | 0.0078 | 1 | 7 | B cell chemotaxis |
| GO:1901387 | 0.0089 | 135.6518 | 0.0089 | 1 | 8 | positive regulation of voltage-gated calcium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001675 | 0.0073 | 166.989 | 0.0074 | 1 | 14 | acrosome assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002227 | 0 | 123.7092 | 0.0325 | 3 | 19 | innate immune response in mucosa |
| GO:0002251 | 0 | 76.0786 | 0.0495 | 3 | 29 | organ or tissue specific immune response |
| GO:0019731 | 0 | 73.256 | 0.0513 | 3 | 30 | antibacterial humoral response |
| GO:0061844 | 0 | 58.1471 | 0.0632 | 3 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0021892 | 1e-04 | 180.7619 | 0.0154 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0050830 | 3e-04 | 27.3895 | 0.1281 | 3 | 75 | defense response to Gram-positive bacterium |
| GO:0006334 | 9e-04 | 18.0479 | 0.1914 | 3 | 112 | nucleosome assembly |
| GO:0015872 | 0.0017 | 37.1495 | 0.0615 | 2 | 36 | dopamine transport |
| GO:0006333 | 0.0022 | 12.9916 | 0.2631 | 3 | 154 | chromatin assembly or disassembly |
| GO:0006323 | 0.0029 | 11.8059 | 0.2888 | 3 | 169 | DNA packaging |
| GO:0042220 | 0.003 | 27.4366 | 0.082 | 2 | 48 | response to cocaine |
| GO:0006959 | 0.0032 | 11.3895 | 0.299 | 3 | 175 | humoral immune response |
| GO:0051966 | 0.0034 | 25.7517 | 0.0871 | 2 | 51 | regulation of synaptic transmission, glutamatergic |
| GO:0046960 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | sensitization |
| GO:0022029 | 0.0037 | 24.7386 | 0.0906 | 2 | 53 | telencephalon cell migration |
| GO:0021872 | 0.0045 | 22.1257 | 0.1008 | 2 | 59 | forebrain generation of neurons |
| GO:0014063 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | negative regulation of serotonin secretion |
| GO:0021759 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | globus pallidus development |
| GO:0035106 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | operant conditioning |
| GO:0050805 | 0.0051 | 20.6694 | 0.1076 | 2 | 63 | negative regulation of synaptic transmission |
| GO:0015844 | 0.0058 | 19.3923 | 0.1145 | 2 | 67 | monoamine transport |
| GO:0006952 | 0.006 | 3.8301 | 2.2895 | 7 | 1340 | defense response |
| GO:0051952 | 0.0063 | 18.5331 | 0.1196 | 2 | 70 | regulation of amine transport |
| GO:0021766 | 0.0067 | 18.0012 | 0.123 | 2 | 72 | hippocampus development |
| GO:0071824 | 0.0068 | 8.637 | 0.3913 | 3 | 229 | protein-DNA complex subunit organization |
| GO:0007198 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0021853 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | cerebral cortex GABAergic interneuron migration |
| GO:0046952 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | ketone body catabolic process |
| GO:0046959 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | habituation |
| GO:0060486 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | Clara cell differentiation |
| GO:0001661 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | conditioned taste aversion |
| GO:0060510 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | Type II pneumocyte differentiation |
| GO:0071502 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | cellular response to temperature stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070268 | 0 | 25.8068 | 0.1853 | 4 | 94 | cornification |
| GO:0030216 | 7e-04 | 11.5285 | 0.4022 | 4 | 204 | keratinocyte differentiation |
| GO:0030855 | 0.0012 | 5.8738 | 1.2341 | 6 | 626 | epithelial cell differentiation |
| GO:0003210 | 0.002 | Inf | 0.002 | 1 | 1 | cardiac atrium formation |
| GO:0003236 | 0.002 | Inf | 0.002 | 1 | 1 | sinus venosus morphogenesis |
| GO:0003259 | 0.002 | Inf | 0.002 | 1 | 1 | cardioblast anterior-lateral migration |
| GO:0034760 | 0.002 | Inf | 0.002 | 1 | 1 | negative regulation of iron ion transmembrane transport |
| GO:0035481 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of Notch signaling pathway involved in heart induction |
| GO:0042404 | 0.002 | Inf | 0.002 | 1 | 1 | thyroid hormone catabolic process |
| GO:0042664 | 0.002 | Inf | 0.002 | 1 | 1 | negative regulation of endodermal cell fate specification |
| GO:0045660 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0060975 | 0.002 | Inf | 0.002 | 1 | 1 | cardioblast migration to the midline involved in heart field formation |
| GO:0070368 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of hepatocyte differentiation |
| GO:0048869 | 0.0029 | 2.985 | 7.5429 | 15 | 3826 | cellular developmental process |
| GO:0048513 | 0.003 | 3.0758 | 5.9874 | 13 | 3037 | animal organ development |
| GO:0010043 | 0.0035 | 25.1561 | 0.0887 | 2 | 45 | response to zinc ion |
| GO:0034756 | 0.0039 | 523.6552 | 0.0039 | 1 | 2 | regulation of iron ion transport |
| GO:0046960 | 0.0039 | 523.6552 | 0.0039 | 1 | 2 | sensitization |
| GO:0060921 | 0.0039 | 523.6552 | 0.0039 | 1 | 2 | sinoatrial node cell differentiation |
| GO:0060974 | 0.0039 | 523.6552 | 0.0039 | 1 | 2 | cell migration involved in heart formation |
| GO:0090082 | 0.0039 | 523.6552 | 0.0039 | 1 | 2 | positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway |
| GO:1990641 | 0.0039 | 523.6552 | 0.0039 | 1 | 2 | response to iron ion starvation |
| GO:0008544 | 0.0048 | 6.5601 | 0.694 | 4 | 352 | epidermis development |
| GO:0051155 | 0.0052 | 20.3962 | 0.1084 | 2 | 55 | positive regulation of striated muscle cell differentiation |
| GO:0035106 | 0.0059 | 261.8103 | 0.0059 | 1 | 3 | operant conditioning |
| GO:0060741 | 0.0059 | 261.8103 | 0.0059 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0060913 | 0.0059 | 261.8103 | 0.0059 | 1 | 3 | cardiac cell fate determination |
| GO:0100012 | 0.0059 | 261.8103 | 0.0059 | 1 | 3 | regulation of heart induction by canonical Wnt signaling pathway |
| GO:1903413 | 0.0059 | 261.8103 | 0.0059 | 1 | 3 | cellular response to bile acid |
| GO:0008078 | 0.0079 | 174.5287 | 0.0079 | 1 | 4 | mesodermal cell migration |
| GO:0021853 | 0.0079 | 174.5287 | 0.0079 | 1 | 4 | cerebral cortex GABAergic interneuron migration |
| GO:0042662 | 0.0079 | 174.5287 | 0.0079 | 1 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0046959 | 0.0079 | 174.5287 | 0.0079 | 1 | 4 | habituation |
| GO:1904479 | 0.0079 | 174.5287 | 0.0079 | 1 | 4 | negative regulation of intestinal absorption |
| GO:1905903 | 0.0079 | 174.5287 | 0.0079 | 1 | 4 | negative regulation of mesoderm formation |
| GO:0001661 | 0.0098 | 130.8879 | 0.0099 | 1 | 5 | conditioned taste aversion |
| GO:0003129 | 0.0098 | 130.8879 | 0.0099 | 1 | 5 | heart induction |
| GO:0003241 | 0.0098 | 130.8879 | 0.0099 | 1 | 5 | growth involved in heart morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007606 | 0 | 39.2526 | 0.1388 | 4 | 132 | sensory perception of chemical stimulus |
| GO:0050911 | 0 | 64.7308 | 0.0599 | 3 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 2e-04 | 30.8128 | 0.122 | 3 | 116 | detection of chemical stimulus |
| GO:0050906 | 3e-04 | 27.6099 | 0.1356 | 3 | 129 | detection of stimulus involved in sensory perception |
| GO:0045660 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0007186 | 0.0013 | 7.8303 | 0.8822 | 5 | 839 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0.0015 | 7.5985 | 0.9074 | 5 | 863 | nervous system process |
| GO:0045085 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | negative regulation of interleukin-2 biosynthetic process |
| GO:0033594 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | response to hydroxyisoflavone |
| GO:0002761 | 0.0051 | 21.3579 | 0.1083 | 2 | 103 | regulation of myeloid leukocyte differentiation |
| GO:0032571 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | response to vitamin K |
| GO:0048743 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | positive regulation of skeletal muscle fiber development |
| GO:2000035 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | regulation of stem cell division |
| GO:0009629 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | response to gravity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033735 | 0.0017 | Inf | 0.0017 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0036461 | 0.0034 | 608.76 | 0.0034 | 1 | 2 | BLOC-2 complex binding |
| GO:0004984 | 0.0042 | 22.9773 | 0.0972 | 2 | 57 | olfactory receptor activity |
| GO:0035651 | 0.0051 | 304.36 | 0.0051 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0046848 | 0.0051 | 304.36 | 0.0051 | 1 | 3 | hydroxyapatite binding |
| GO:0035650 | 0.0068 | 202.8933 | 0.0068 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0035727 | 0.0068 | 202.8933 | 0.0068 | 1 | 4 | lysophosphatidic acid binding |
| GO:0004872 | 0.0094 | 3.8471 | 1.8878 | 6 | 1107 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004778 | 0.0029 | Inf | 0.0029 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0044549 | 0.0029 | Inf | 0.0029 | 1 | 1 | GTP cyclohydrolase binding |
| GO:0050897 | 0.0029 | Inf | 0.0029 | 1 | 1 | cobalt ion binding |
| GO:0097383 | 0.0029 | Inf | 0.0029 | 1 | 1 | dIDP diphosphatase activity |
| GO:1901640 | 0.0029 | Inf | 0.0029 | 1 | 1 | XTP binding |
| GO:1901641 | 0.0029 | Inf | 0.0029 | 1 | 1 | ITP binding |
| GO:1990003 | 0.0029 | Inf | 0.0029 | 1 | 1 | IDP phosphatase activity |
| GO:0031492 | 0.0056 | 19.5174 | 0.1126 | 2 | 39 | nucleosomal DNA binding |
| GO:0035870 | 0.0058 | 353.5116 | 0.0058 | 1 | 2 | dITP diphosphatase activity |
| GO:0019834 | 0.0086 | 176.7442 | 0.0087 | 1 | 3 | phospholipase A2 inhibitor activity |
| GO:0070905 | 0.0086 | 176.7442 | 0.0087 | 1 | 3 | serine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008020 | 0.0053 | 237.9531 | 0.0053 | 1 | 9 | G-protein coupled photoreceptor activity |
| GO:0004535 | 0.0077 | 158.5938 | 0.0077 | 1 | 13 | poly(A)-specific ribonuclease activity |
| GO:0015095 | 0.0088 | 135.9196 | 0.0089 | 1 | 15 | magnesium ion transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004468 | 0 | 447.7353 | 0.0075 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0031704 | 0.0012 | Inf | 0.0012 | 1 | 1 | apelin receptor binding |
| GO:0047198 | 0.0012 | Inf | 0.0012 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0004613 | 0.0025 | 845.8889 | 0.0025 | 1 | 2 | phosphoenolpyruvate carboxykinase (GTP) activity |
| GO:0016407 | 0.0053 | 20.7127 | 0.1097 | 2 | 88 | acetyltransferase activity |
| GO:0016410 | 0.0053 | 20.7127 | 0.1097 | 2 | 88 | N-acyltransferase activity |
| GO:0015057 | 0.0062 | 211.4306 | 0.0062 | 1 | 5 | thrombin-activated receptor activity |
| GO:0005179 | 0.0072 | 17.6191 | 0.1284 | 2 | 103 | hormone activity |
| GO:0032052 | 0.0099 | 120.7937 | 0.01 | 1 | 8 | bile acid binding |
| GO:0070181 | 0.0099 | 120.7937 | 0.01 | 1 | 8 | small ribosomal subunit rRNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004468 | 0 | 447.7353 | 0.0075 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0048018 | 0.0011 | 10.6487 | 0.4686 | 4 | 376 | receptor ligand activity |
| GO:0004418 | 0.0012 | Inf | 0.0012 | 1 | 1 | hydroxymethylbilane synthase activity |
| GO:0019782 | 0.0012 | Inf | 0.0012 | 1 | 1 | ISG15 activating enzyme activity |
| GO:0047198 | 0.0012 | Inf | 0.0012 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0005153 | 0.0025 | 845.8889 | 0.0025 | 1 | 2 | interleukin-8 receptor binding |
| GO:0005094 | 0.0037 | 422.9167 | 0.0037 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0004839 | 0.005 | 281.9259 | 0.005 | 1 | 4 | ubiquitin activating enzyme activity |
| GO:0016407 | 0.0053 | 20.7127 | 0.1097 | 2 | 88 | acetyltransferase activity |
| GO:0016410 | 0.0053 | 20.7127 | 0.1097 | 2 | 88 | N-acyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046904 | 0.001 | Inf | 0.001 | 1 | 1 | calcium oxalate binding |
| GO:0004735 | 0.0029 | 543.8929 | 0.003 | 1 | 3 | pyrroline-5-carboxylate reductase activity |
| GO:0019862 | 0.0029 | 543.8929 | 0.003 | 1 | 3 | IgA binding |
| GO:0034711 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | inhibin binding |
| GO:0098821 | 0.0059 | 217.5143 | 0.0059 | 1 | 6 | BMP receptor activity |
| GO:0017002 | 0.0069 | 181.25 | 0.0069 | 1 | 7 | activin-activated receptor activity |
| GO:0008020 | 0.0088 | 135.9196 | 0.0089 | 1 | 9 | G-protein coupled photoreceptor activity |
| GO:0008821 | 0.0088 | 135.9196 | 0.0089 | 1 | 9 | crossover junction endodeoxyribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015035 | 7e-04 | 60.796 | 0.039 | 2 | 22 | protein disulfide oxidoreductase activity |
| GO:0000257 | 0.0018 | Inf | 0.0018 | 1 | 1 | nitrilase activity |
| GO:0004506 | 0.0018 | Inf | 0.0018 | 1 | 1 | squalene monooxygenase activity |
| GO:0016667 | 0.0044 | 22.4667 | 0.0992 | 2 | 56 | oxidoreductase activity, acting on a sulfur group of donors |
| GO:0035939 | 0.0053 | 292.6346 | 0.0053 | 1 | 3 | microsatellite binding |
| GO:0050220 | 0.0053 | 292.6346 | 0.0053 | 1 | 3 | prostaglandin-E synthase activity |
| GO:0043565 | 0.0067 | 4.1378 | 1.7515 | 6 | 989 | sequence-specific DNA binding |
| GO:0043237 | 0.0088 | 146.2981 | 0.0089 | 1 | 5 | laminin-1 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051787 | 0.0065 | 190.3375 | 0.0065 | 1 | 11 | misfolded protein binding |
| GO:0005523 | 0.0082 | 146.3846 | 0.0083 | 1 | 14 | tropomyosin binding |
| GO:0017127 | 0.01 | 118.9141 | 0.01 | 1 | 17 | cholesterol transporter activity |
| GO:0097602 | 0.01 | 118.9141 | 0.01 | 1 | 17 | cullin family protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 5e-04 | 9.2247 | 0.6789 | 5 | 450 | protein heterodimerization activity |
| GO:0009400 | 0.0015 | Inf | 0.0015 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
| GO:0015052 | 0.0015 | Inf | 0.0015 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0005153 | 0.003 | 691.9091 | 0.003 | 1 | 2 | interleukin-8 receptor binding |
| GO:0031699 | 0.003 | 691.9091 | 0.003 | 1 | 2 | beta-3 adrenergic receptor binding |
| GO:0047025 | 0.003 | 691.9091 | 0.003 | 1 | 2 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity |
| GO:0070404 | 0.0045 | 345.9318 | 0.0045 | 1 | 3 | NADH binding |
| GO:0051380 | 0.006 | 230.6061 | 0.006 | 1 | 4 | norepinephrine binding |
| GO:0047035 | 0.009 | 138.3455 | 0.0091 | 1 | 6 | testosterone dehydrogenase (NAD+) activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003924 | 7e-04 | 11.6459 | 0.4109 | 4 | 261 | GTPase activity |
| GO:0047130 | 0.0016 | Inf | 0.0016 | 1 | 1 | saccharopine dehydrogenase (NADP+, L-lysine-forming) activity |
| GO:0047131 | 0.0016 | Inf | 0.0016 | 1 | 1 | saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity |
| GO:0005148 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | prolactin receptor binding |
| GO:0036461 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | BLOC-2 complex binding |
| GO:0035651 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0005131 | 0.0078 | 165.413 | 0.0079 | 1 | 5 | growth hormone receptor binding |
| GO:0030620 | 0.0094 | 132.3217 | 0.0094 | 1 | 6 | U2 snRNA binding |
| GO:0034511 | 0.0094 | 132.3217 | 0.0094 | 1 | 6 | U3 snoRNA binding |
| GO:0061578 | 0.0094 | 132.3217 | 0.0094 | 1 | 6 | Lys63-specific deubiquitinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002083 | 0.0024 | Inf | 0.0024 | 1 | 1 | 4-hydroxybenzoate decaprenyltransferase activity |
| GO:0008111 | 0.0024 | Inf | 0.0024 | 1 | 1 | alpha-methylacyl-CoA racemase activity |
| GO:0030294 | 0.0024 | Inf | 0.0024 | 1 | 1 | receptor signaling protein tyrosine kinase inhibitor activity |
| GO:0042356 | 0.0024 | Inf | 0.0024 | 1 | 1 | GDP-4-dehydro-D-rhamnose reductase activity |
| GO:0047293 | 0.0024 | Inf | 0.0024 | 1 | 1 | 4-hydroxybenzoate nonaprenyltransferase activity |
| GO:0050577 | 0.0024 | Inf | 0.0024 | 1 | 1 | GDP-L-fucose synthase activity |
| GO:0016853 | 0.0035 | 10.7967 | 0.307 | 3 | 130 | isomerase activity |
| GO:0033906 | 0.0047 | 434.5429 | 0.0047 | 1 | 2 | hyaluronoglucuronidase activity |
| GO:0034632 | 0.0047 | 434.5429 | 0.0047 | 1 | 2 | retinol transporter activity |
| GO:0055077 | 0.0094 | 144.8286 | 0.0094 | 1 | 4 | gap junction hemi-channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008397 | 0.0012 | Inf | 0.0012 | 1 | 1 | sterol 12-alpha-hydroxylase activity |
| GO:0009400 | 0.0012 | Inf | 0.0012 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
| GO:0015603 | 0.0012 | Inf | 0.0012 | 1 | 1 | iron chelate transmembrane transporter activity |
| GO:0033778 | 0.0012 | Inf | 0.0012 | 1 | 1 | 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity |
| GO:0042931 | 0.0012 | Inf | 0.0012 | 1 | 1 | enterobactin transmembrane transporter activity |
| GO:0004984 | 0.0023 | 32.4535 | 0.071 | 2 | 57 | olfactory receptor activity |
| GO:0001588 | 0.005 | 281.9259 | 0.005 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0044736 | 0.005 | 281.9259 | 0.005 | 1 | 4 | acid-sensing ion channel activity |
| GO:0031433 | 0.0087 | 140.9352 | 0.0087 | 1 | 7 | telethonin binding |
| GO:0031419 | 0.0099 | 120.7937 | 0.01 | 1 | 8 | cobalamin binding |
| GO:0035240 | 0.0099 | 120.7937 | 0.01 | 1 | 8 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016412 | 0.0014 | Inf | 0.0014 | 1 | 1 | serine O-acyltransferase activity |
| GO:0017024 | 0.0014 | Inf | 0.0014 | 1 | 1 | myosin I binding |
| GO:0044549 | 0.0014 | Inf | 0.0014 | 1 | 1 | GTP cyclohydrolase binding |
| GO:0050897 | 0.0014 | Inf | 0.0014 | 1 | 1 | cobalt ion binding |
| GO:0097383 | 0.0014 | Inf | 0.0014 | 1 | 1 | dIDP diphosphatase activity |
| GO:1901640 | 0.0014 | Inf | 0.0014 | 1 | 1 | XTP binding |
| GO:1901641 | 0.0014 | Inf | 0.0014 | 1 | 1 | ITP binding |
| GO:1990003 | 0.0014 | Inf | 0.0014 | 1 | 1 | IDP phosphatase activity |
| GO:0001567 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0032090 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | Pyrin domain binding |
| GO:0035870 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | dITP diphosphatase activity |
| GO:0008823 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | cupric reductase activity |
| GO:0052851 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0050072 | 0.0072 | 181.1905 | 0.0072 | 1 | 5 | m7G(5')pppN diphosphatase activity |
| GO:0005138 | 0.0086 | 144.9429 | 0.0087 | 1 | 6 | interleukin-6 receptor binding |
| GO:0005179 | 0.0096 | 14.9733 | 0.1486 | 2 | 103 | hormone activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005334 | 0.002 | Inf | 0.002 | 1 | 1 | norepinephrine:sodium symporter activity |
| GO:0034899 | 0.002 | Inf | 0.002 | 1 | 1 | trimethylamine monooxygenase activity |
| GO:0050661 | 0.0032 | 26.4373 | 0.0846 | 2 | 43 | NADP binding |
| GO:0080019 | 0.0039 | 524.6552 | 0.0039 | 1 | 2 | fatty-acyl-CoA reductase (alcohol-forming) activity |
| GO:0102965 | 0.0039 | 524.6552 | 0.0039 | 1 | 2 | alcohol-forming fatty acyl-CoA reductase activity |
| GO:0004096 | 0.0059 | 262.3103 | 0.0059 | 1 | 3 | catalase activity |
| GO:0004689 | 0.0059 | 262.3103 | 0.0059 | 1 | 3 | phosphorylase kinase activity |
| GO:0051033 | 0.0059 | 262.3103 | 0.0059 | 1 | 3 | RNA transmembrane transporter activity |
| GO:0004499 | 0.0078 | 174.8621 | 0.0079 | 1 | 4 | N,N-dimethylaniline monooxygenase activity |
| GO:0004046 | 0.0098 | 131.1379 | 0.0098 | 1 | 5 | aminoacylase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031531 | 0.0029 | 543.8929 | 0.003 | 1 | 3 | thyrotropin-releasing hormone receptor binding |
| GO:0099104 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | potassium channel activator activity |
| GO:0008430 | 0.0069 | 181.25 | 0.0069 | 1 | 7 | selenium binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 3e-04 | 7.6767 | 0.9445 | 6 | 450 | protein heterodimerization activity |
| GO:0042802 | 0.003 | 3.5935 | 3.1547 | 9 | 1503 | identical protein binding |
| GO:0001105 | 0.003 | 27.3459 | 0.0819 | 2 | 39 | RNA polymerase II transcription coactivator activity |
| GO:0004342 | 0.0042 | 490.7419 | 0.0042 | 1 | 2 | glucosamine-6-phosphate deaminase activity |
| GO:0004821 | 0.0042 | 490.7419 | 0.0042 | 1 | 2 | histidine-tRNA ligase activity |
| GO:0004748 | 0.0063 | 245.3548 | 0.0063 | 1 | 3 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor |
| GO:0008426 | 0.0063 | 245.3548 | 0.0063 | 1 | 3 | protein kinase C inhibitor activity |
| GO:0016728 | 0.0063 | 245.3548 | 0.0063 | 1 | 3 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor |
| GO:0032450 | 0.0063 | 245.3548 | 0.0063 | 1 | 3 | maltose alpha-glucosidase activity |
| GO:0004558 | 0.0084 | 163.5591 | 0.0084 | 1 | 4 | alpha-1,4-glucosidase activity |
| GO:0052794 | 0.0084 | 163.5591 | 0.0084 | 1 | 4 | exo-alpha-(2->3)-sialidase activity |
| GO:0052795 | 0.0084 | 163.5591 | 0.0084 | 1 | 4 | exo-alpha-(2->6)-sialidase activity |
| GO:0052796 | 0.0084 | 163.5591 | 0.0084 | 1 | 4 | exo-alpha-(2->8)-sialidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031720 | 0.0012 | 1904.5 | 0.0012 | 1 | 2 | haptoglobin binding |
| GO:0046964 | 0.0012 | 1904.5 | 0.0012 | 1 | 2 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity |
| GO:0019863 | 0.0024 | 634.75 | 0.0024 | 1 | 4 | IgE binding |
| GO:0015216 | 0.0059 | 211.5 | 0.0059 | 1 | 10 | purine nucleotide transmembrane transporter activity |
| GO:0005344 | 0.0065 | 190.3375 | 0.0065 | 1 | 11 | oxygen carrier activity |
| GO:0015605 | 0.01 | 118.9141 | 0.01 | 1 | 17 | organophosphate ester transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019782 | 7e-04 | Inf | 7e-04 | 1 | 1 | ISG15 activating enzyme activity |
| GO:0004839 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | ubiquitin activating enzyme activity |
| GO:0043295 | 0.0072 | 169.1778 | 0.0072 | 1 | 11 | glutathione binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 9.1299 | 1.2397 | 9 | 450 | protein heterodimerization activity |
| GO:0019841 | 6e-04 | 69.0591 | 0.0358 | 2 | 13 | retinol binding |
| GO:0016918 | 7e-04 | 63.3 | 0.0386 | 2 | 14 | retinal binding |
| GO:0004778 | 0.0028 | Inf | 0.0028 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0019840 | 0.0037 | 24.4726 | 0.0909 | 2 | 33 | isoprenoid binding |
| GO:0004869 | 0.0062 | 18.4915 | 0.1185 | 2 | 43 | cysteine-type endopeptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004778 | 0.0028 | Inf | 0.0028 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0031771 | 0.0028 | Inf | 0.0028 | 1 | 1 | type 1 hypocretin receptor binding |
| GO:0031772 | 0.0028 | Inf | 0.0028 | 1 | 1 | type 2 hypocretin receptor binding |
| GO:0044549 | 0.0028 | Inf | 0.0028 | 1 | 1 | GTP cyclohydrolase binding |
| GO:0050897 | 0.0028 | Inf | 0.0028 | 1 | 1 | cobalt ion binding |
| GO:0097383 | 0.0028 | Inf | 0.0028 | 1 | 1 | dIDP diphosphatase activity |
| GO:1901640 | 0.0028 | Inf | 0.0028 | 1 | 1 | XTP binding |
| GO:1901641 | 0.0028 | Inf | 0.0028 | 1 | 1 | ITP binding |
| GO:1990003 | 0.0028 | Inf | 0.0028 | 1 | 1 | IDP phosphatase activity |
| GO:0031492 | 0.0054 | 19.9947 | 0.11 | 2 | 39 | nucleosomal DNA binding |
| GO:0035870 | 0.0056 | 361.9524 | 0.0056 | 1 | 2 | dITP diphosphatase activity |
| GO:0019834 | 0.0084 | 180.9643 | 0.0085 | 1 | 3 | phospholipase A2 inhibitor activity |
| GO:0070905 | 0.0084 | 180.9643 | 0.0085 | 1 | 3 | serine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033735 | 0.001 | Inf | 0.001 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0036403 | 0.001 | Inf | 0.001 | 1 | 1 | arachidonate 8(S)-lipoxygenase activity |
| GO:0016165 | 0.0021 | 1015.2667 | 0.0021 | 1 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0005496 | 0.0031 | 27.7509 | 0.084 | 2 | 80 | steroid binding |
| GO:0050473 | 0.0031 | 507.6 | 0.0031 | 1 | 3 | arachidonate 15-lipoxygenase activity |
| GO:0005198 | 0.0033 | 7.9349 | 0.6486 | 4 | 618 | structural molecule activity |
| GO:0101020 | 0.0042 | 338.3778 | 0.0042 | 1 | 4 | estrogen 16-alpha-hydroxylase activity |
| GO:0032395 | 0.0073 | 169.1556 | 0.0073 | 1 | 7 | MHC class II receptor activity |
| GO:0008510 | 0.0094 | 126.85 | 0.0094 | 1 | 9 | sodium:bicarbonate symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004468 | 0 | 447.7353 | 0.0075 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0048018 | 0.0011 | 10.6487 | 0.4686 | 4 | 376 | receptor ligand activity |
| GO:0004418 | 0.0012 | Inf | 0.0012 | 1 | 1 | hydroxymethylbilane synthase activity |
| GO:0019782 | 0.0012 | Inf | 0.0012 | 1 | 1 | ISG15 activating enzyme activity |
| GO:0047198 | 0.0012 | Inf | 0.0012 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0005153 | 0.0025 | 845.8889 | 0.0025 | 1 | 2 | interleukin-8 receptor binding |
| GO:0005094 | 0.0037 | 422.9167 | 0.0037 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0004839 | 0.005 | 281.9259 | 0.005 | 1 | 4 | ubiquitin activating enzyme activity |
| GO:0016407 | 0.0053 | 20.7127 | 0.1097 | 2 | 88 | acetyltransferase activity |
| GO:0016410 | 0.0053 | 20.7127 | 0.1097 | 2 | 88 | N-acyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004468 | 0 | 543.7857 | 0.0063 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0004984 | 0 | 64.8547 | 0.0598 | 3 | 57 | olfactory receptor activity |
| GO:0004607 | 0.001 | Inf | 0.001 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0047198 | 0.001 | Inf | 0.001 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0099600 | 0.0014 | 7.7868 | 0.8868 | 5 | 845 | transmembrane receptor activity |
| GO:0016746 | 0.0017 | 15.1842 | 0.2424 | 3 | 231 | transferase activity, transferring acyl groups |
| GO:0038023 | 0.0018 | 7.2374 | 0.9498 | 5 | 905 | signaling receptor activity |
| GO:0016407 | 0.0038 | 25.1561 | 0.0924 | 2 | 88 | acetyltransferase activity |
| GO:0016410 | 0.0038 | 25.1561 | 0.0924 | 2 | 88 | N-acyltransferase activity |
| GO:0034186 | 0.0042 | 338.3778 | 0.0042 | 1 | 4 | apolipoprotein A-I binding |
| GO:0060089 | 0.0053 | 5.5862 | 1.2079 | 5 | 1151 | molecular transducer activity |
| GO:0042289 | 0.0063 | 203 | 0.0063 | 1 | 6 | MHC class II protein binding |
| GO:0004930 | 0.009 | 8.1774 | 0.4418 | 3 | 421 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 0.0014 | 6.897 | 0.8385 | 5 | 376 | receptor ligand activity |
| GO:0004778 | 0.0022 | Inf | 0.0022 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0031704 | 0.0022 | Inf | 0.0022 | 1 | 1 | apelin receptor binding |
| GO:0047273 | 0.0022 | Inf | 0.0022 | 1 | 1 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity |
| GO:0003875 | 0.0045 | 460.9394 | 0.0045 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GO:0005146 | 0.0045 | 460.9394 | 0.0045 | 1 | 2 | leukemia inhibitory factor receptor binding |
| GO:0005153 | 0.0045 | 460.9394 | 0.0045 | 1 | 2 | interleukin-8 receptor binding |
| GO:0048306 | 0.0067 | 17.8762 | 0.1227 | 2 | 55 | calcium-dependent protein binding |
| GO:0019834 | 0.0067 | 230.4545 | 0.0067 | 1 | 3 | phospholipase A2 inhibitor activity |
| GO:0050833 | 0.0089 | 153.6263 | 0.0089 | 1 | 4 | pyruvate transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0024 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 2e-04 | 118.8438 | 0.0213 | 2 | 18 | MHC class I protein binding |
| GO:0004042 | 0.0012 | Inf | 0.0012 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0031764 | 0.0012 | Inf | 0.0012 | 1 | 1 | type 1 galanin receptor binding |
| GO:0031765 | 0.0012 | Inf | 0.0012 | 1 | 1 | type 2 galanin receptor binding |
| GO:0031766 | 0.0012 | Inf | 0.0012 | 1 | 1 | type 3 galanin receptor binding |
| GO:0103045 | 0.0012 | Inf | 0.0012 | 1 | 1 | methione N-acyltransferase activity |
| GO:0036461 | 0.0024 | 895.7059 | 0.0024 | 1 | 2 | BLOC-2 complex binding |
| GO:0035651 | 0.0035 | 447.8235 | 0.0035 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 0.0047 | 298.5294 | 0.0047 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0004966 | 0.0082 | 149.2353 | 0.0083 | 1 | 7 | galanin receptor activity |
| GO:0034618 | 0.0082 | 149.2353 | 0.0083 | 1 | 7 | arginine binding |
| GO:0042803 | 0.0091 | 5.7488 | 0.856 | 4 | 725 | protein homodimerization activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033735 | 0.0018 | Inf | 0.0018 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0036403 | 0.0018 | Inf | 0.0018 | 1 | 1 | arachidonate 8(S)-lipoxygenase activity |
| GO:0016165 | 0.0035 | 585.3077 | 0.0035 | 1 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0036461 | 0.0035 | 585.3077 | 0.0035 | 1 | 2 | BLOC-2 complex binding |
| GO:0004984 | 0.0045 | 22.0567 | 0.1009 | 2 | 57 | olfactory receptor activity |
| GO:0035651 | 0.0053 | 292.6346 | 0.0053 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0046848 | 0.0053 | 292.6346 | 0.0053 | 1 | 3 | hydroxyapatite binding |
| GO:0050473 | 0.0053 | 292.6346 | 0.0053 | 1 | 3 | arachidonate 15-lipoxygenase activity |
| GO:0035650 | 0.0071 | 195.0769 | 0.0071 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0035727 | 0.0071 | 195.0769 | 0.0071 | 1 | 4 | lysophosphatidic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001594 | 9e-04 | Inf | 9e-04 | 1 | 1 | trace-amine receptor activity |
| GO:0004398 | 9e-04 | Inf | 9e-04 | 1 | 1 | histidine decarboxylase activity |
| GO:0031731 | 9e-04 | Inf | 9e-04 | 1 | 1 | CCR6 chemokine receptor binding |
| GO:0005178 | 0.0042 | 24.0111 | 0.0983 | 2 | 107 | integrin binding |
| GO:0004865 | 0.0073 | 167.3077 | 0.0073 | 1 | 8 | protein serine/threonine phosphatase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008579 | 0.0016 | Inf | 0.0016 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0016412 | 0.0016 | Inf | 0.0016 | 1 | 1 | serine O-acyltransferase activity |
| GO:0004367 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | glycerol-3-phosphate dehydrogenase [NAD+] activity |
| GO:0004368 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | glycerol-3-phosphate dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015052 | 8e-04 | Inf | 8e-04 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0004613 | 0.0016 | 1384.8182 | 0.0016 | 1 | 2 | phosphoenolpyruvate carboxykinase (GTP) activity |
| GO:0015382 | 0.0016 | 1384.8182 | 0.0016 | 1 | 2 | sodium:sulfate symporter activity |
| GO:0031699 | 0.0016 | 1384.8182 | 0.0016 | 1 | 2 | beta-3 adrenergic receptor binding |
| GO:0051380 | 0.0031 | 461.5455 | 0.0031 | 1 | 4 | norepinephrine binding |
| GO:0051379 | 0.0055 | 230.7273 | 0.0055 | 1 | 7 | epinephrine binding |
| GO:0050786 | 0.0063 | 197.7532 | 0.0063 | 1 | 8 | RAGE receptor binding |
| GO:0004935 | 0.0071 | 173.0227 | 0.0071 | 1 | 9 | adrenergic receptor activity |
| GO:0008020 | 0.0071 | 173.0227 | 0.0071 | 1 | 9 | G-protein coupled photoreceptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031700 | 0.001 | Inf | 0.001 | 1 | 1 | adrenomedullin receptor binding |
| GO:0046703 | 0.0094 | 126.85 | 0.0094 | 1 | 9 | natural killer cell lectin-like receptor binding |
| GO:0047498 | 0.0094 | 126.85 | 0.0094 | 1 | 9 | calcium-dependent phospholipase A2 activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017147 | 0.0011 | 47.1832 | 0.0492 | 2 | 30 | Wnt-protein binding |
| GO:0004042 | 0.0016 | Inf | 0.0016 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0004498 | 0.0016 | Inf | 0.0016 | 1 | 1 | calcidiol 1-monooxygenase activity |
| GO:0103045 | 0.0016 | Inf | 0.0016 | 1 | 1 | methione N-acyltransferase activity |
| GO:0004560 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | alpha-L-fucosidase activity |
| GO:0035939 | 0.0049 | 317.0625 | 0.0049 | 1 | 3 | microsatellite binding |
| GO:0005025 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | transforming growth factor beta receptor activity, type I |
| GO:0016361 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | activin receptor activity, type I |
| GO:0098821 | 0.0098 | 126.8 | 0.0098 | 1 | 6 | BMP receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001594 | 0.0016 | Inf | 0.0016 | 1 | 1 | trace-amine receptor activity |
| GO:0004398 | 0.0016 | Inf | 0.0016 | 1 | 1 | histidine decarboxylase activity |
| GO:0004560 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | alpha-L-fucosidase activity |
| GO:0031720 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | haptoglobin binding |
| GO:0047710 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | bis(5'-adenosyl)-triphosphatase activity |
| GO:0008853 | 0.0049 | 317.0625 | 0.0049 | 1 | 3 | exodeoxyribonuclease III activity |
| GO:0032405 | 0.0082 | 158.5104 | 0.0082 | 1 | 5 | MutLalpha complex binding |
| GO:0032407 | 0.0082 | 158.5104 | 0.0082 | 1 | 5 | MutSalpha complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047220 | 0.0012 | Inf | 0.0012 | 1 | 1 | galactosylxylosylprotein 3-beta-galactosyltransferase activity |
| GO:0050840 | 0.0015 | 40.375 | 0.0579 | 2 | 49 | extracellular matrix binding |
| GO:0001567 | 0.0024 | 895.7059 | 0.0024 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0070052 | 0.0024 | 895.7059 | 0.0024 | 1 | 2 | collagen V binding |
| GO:0043237 | 0.0059 | 223.8824 | 0.0059 | 1 | 5 | laminin-1 binding |
| GO:0031433 | 0.0082 | 149.2353 | 0.0083 | 1 | 7 | telethonin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009400 | 6e-04 | Inf | 6e-04 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
| GO:0042975 | 0.0053 | 237.9531 | 0.0053 | 1 | 9 | peroxisome proliferator activated receptor binding |
| GO:0046965 | 0.0094 | 126.85 | 0.0094 | 1 | 16 | retinoid X receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004607 | 0.0012 | Inf | 0.0012 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0031849 | 0.005 | 281.9259 | 0.005 | 1 | 4 | olfactory receptor binding |
| GO:0034186 | 0.005 | 281.9259 | 0.005 | 1 | 4 | apolipoprotein A-I binding |
| GO:0016907 | 0.0062 | 211.4306 | 0.0062 | 1 | 5 | G-protein coupled acetylcholine receptor activity |
| GO:1990763 | 0.0075 | 169.1333 | 0.0075 | 1 | 6 | arrestin family protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 4e-04 | 9.3661 | 0.6627 | 5 | 421 | G-protein coupled receptor activity |
| GO:0001594 | 0.0016 | Inf | 0.0016 | 1 | 1 | trace-amine receptor activity |
| GO:0099600 | 0.0016 | 5.7143 | 1.3302 | 6 | 845 | transmembrane receptor activity |
| GO:0008260 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0070405 | 0.0037 | 24.6201 | 0.0913 | 2 | 58 | ammonium ion binding |
| GO:0046982 | 0.005 | 6.626 | 0.7084 | 4 | 450 | protein heterodimerization activity |
| GO:0001588 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0030594 | 0.0063 | 18.6093 | 0.1196 | 2 | 76 | neurotransmitter receptor activity |
| GO:0060089 | 0.0075 | 4.0981 | 1.8119 | 6 | 1151 | molecular transducer activity |
| GO:0004871 | 0.0094 | 3.895 | 1.8985 | 6 | 1206 | signal transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033798 | 0.0019 | Inf | 0.0019 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:1904768 | 0.0038 | 543.4286 | 0.0038 | 1 | 2 | all-trans-retinol binding |
| GO:0004800 | 0.0057 | 271.6964 | 0.0057 | 1 | 3 | thyroxine 5'-deiodinase activity |
| GO:0017171 | 0.0061 | 8.8888 | 0.3766 | 3 | 198 | serine hydrolase activity |
| GO:0001588 | 0.0076 | 181.119 | 0.0076 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008458 | 0.0012 | Inf | 0.0012 | 1 | 1 | carnitine O-octanoyltransferase activity |
| GO:0016415 | 0.0012 | Inf | 0.0012 | 1 | 1 | octanoyltransferase activity |
| GO:0001632 | 0.0025 | 845.8889 | 0.0025 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0004024 | 0.0037 | 422.9167 | 0.0037 | 1 | 3 | alcohol dehydrogenase activity, zinc-dependent |
| GO:0001591 | 0.005 | 281.9259 | 0.005 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0031849 | 0.005 | 281.9259 | 0.005 | 1 | 4 | olfactory receptor binding |
| GO:0047961 | 0.005 | 281.9259 | 0.005 | 1 | 4 | glycine N-acyltransferase activity |
| GO:0035240 | 0.0099 | 120.7937 | 0.01 | 1 | 8 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004031 | 0.0023 | Inf | 0.0023 | 1 | 1 | aldehyde oxidase activity |
| GO:0009400 | 0.0023 | Inf | 0.0023 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
| GO:0015052 | 0.0023 | Inf | 0.0023 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0031700 | 0.0023 | Inf | 0.0023 | 1 | 1 | adrenomedullin receptor binding |
| GO:0102797 | 0.0023 | Inf | 0.0023 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0023 | Inf | 0.0023 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0008289 | 0.0026 | 4.9438 | 1.4164 | 6 | 617 | lipid binding |
| GO:0046982 | 0.0034 | 5.5303 | 1.0331 | 5 | 450 | protein heterodimerization activity |
| GO:0031699 | 0.0046 | 447.3529 | 0.0046 | 1 | 2 | beta-3 adrenergic receptor binding |
| GO:0051380 | 0.0092 | 149.098 | 0.0092 | 1 | 4 | norepinephrine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 6e-04 | 13.261 | 0.4132 | 4 | 450 | protein heterodimerization activity |
| GO:0061714 | 9e-04 | Inf | 9e-04 | 1 | 1 | folic acid receptor activity |
| GO:0051870 | 0.0018 | 1171.6154 | 0.0018 | 1 | 2 | methotrexate binding |
| GO:0000064 | 0.0028 | 585.7692 | 0.0028 | 1 | 3 | L-ornithine transmembrane transporter activity |
| GO:0031531 | 0.0028 | 585.7692 | 0.0028 | 1 | 3 | thyrotropin-releasing hormone receptor binding |
| GO:0008517 | 0.0046 | 292.8462 | 0.0046 | 1 | 5 | folic acid transporter activity |
| GO:0005542 | 0.0082 | 146.3846 | 0.0083 | 1 | 9 | folic acid binding |
| GO:0015643 | 0.0091 | 130.1111 | 0.0092 | 1 | 10 | toxic substance binding |
| GO:0045295 | 0.0091 | 130.1111 | 0.0092 | 1 | 10 | gamma-catenin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 76.6566 | 0.0523 | 3 | 57 | olfactory receptor activity |
| GO:0099600 | 1e-04 | 12.8662 | 0.7759 | 6 | 845 | transmembrane receptor activity |
| GO:0038023 | 1e-04 | 11.9575 | 0.831 | 6 | 905 | signaling receptor activity |
| GO:0060089 | 3e-04 | 9.2273 | 1.0569 | 6 | 1151 | molecular transducer activity |
| GO:0004930 | 5e-04 | 14.211 | 0.3866 | 4 | 421 | G-protein coupled receptor activity |
| GO:0001594 | 9e-04 | Inf | 9e-04 | 1 | 1 | trace-amine receptor activity |
| GO:0008147 | 9e-04 | Inf | 9e-04 | 1 | 1 | structural constituent of bone |
| GO:0046848 | 0.0028 | 585.7692 | 0.0028 | 1 | 3 | hydroxyapatite binding |
| GO:0042289 | 0.0055 | 234.2615 | 0.0055 | 1 | 6 | MHC class II protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004468 | 0 | 692.2273 | 0.0051 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0030545 | 3e-04 | 16.6521 | 0.3411 | 4 | 400 | receptor regulator activity |
| GO:0031704 | 9e-04 | Inf | 9e-04 | 1 | 1 | apelin receptor binding |
| GO:0047198 | 9e-04 | Inf | 9e-04 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0004613 | 0.0017 | 1269.3333 | 0.0017 | 1 | 2 | phosphoenolpyruvate carboxykinase (GTP) activity |
| GO:0005153 | 0.0017 | 1269.3333 | 0.0017 | 1 | 2 | interleukin-8 receptor binding |
| GO:0016407 | 0.0025 | 32.0233 | 0.075 | 2 | 88 | acetyltransferase activity |
| GO:0016410 | 0.0025 | 32.0233 | 0.075 | 2 | 88 | N-acyltransferase activity |
| GO:0008083 | 0.0064 | 19.461 | 0.1219 | 2 | 143 | growth factor activity |
| GO:0005125 | 0.0088 | 16.4028 | 0.1441 | 2 | 169 | cytokine activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007155 | 0 | 5.4264 | 2.7478 | 11 | 1039 | cell adhesion |
| GO:0007160 | 7e-04 | 11.0023 | 0.4152 | 4 | 157 | cell-matrix adhesion |
| GO:2000352 | 0.0015 | 39.9364 | 0.0582 | 2 | 22 | negative regulation of endothelial cell apoptotic process |
| GO:0035491 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of leukotriene production involved in inflammatory response |
| GO:0042128 | 0.0026 | Inf | 0.0026 | 1 | 1 | nitrate assimilation |
| GO:0060857 | 0.0026 | Inf | 0.0026 | 1 | 1 | establishment of glial blood-brain barrier |
| GO:1990256 | 0.0026 | Inf | 0.0026 | 1 | 1 | signal clustering |
| GO:2000098 | 0.0026 | Inf | 0.0026 | 1 | 1 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000494 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
| GO:0071222 | 0.0035 | 10.8567 | 0.3068 | 3 | 116 | cellular response to lipopolysaccharide |
| GO:0030168 | 0.004 | 10.3046 | 0.3227 | 3 | 122 | platelet activation |
| GO:0030199 | 0.004 | 23.467 | 0.0952 | 2 | 36 | collagen fibril organization |
| GO:0048260 | 0.004 | 23.467 | 0.0952 | 2 | 36 | positive regulation of receptor-mediated endocytosis |
| GO:0060760 | 0.004 | 23.467 | 0.0952 | 2 | 36 | positive regulation of response to cytokine stimulus |
| GO:0043062 | 0.0041 | 6.8224 | 0.6585 | 4 | 249 | extracellular structure organization |
| GO:0001974 | 0.0045 | 22.1599 | 0.1005 | 2 | 38 | blood vessel remodeling |
| GO:0042060 | 0.0046 | 5.1469 | 1.1081 | 5 | 419 | wound healing |
| GO:0070206 | 0.0047 | 21.5594 | 0.1031 | 2 | 39 | protein trimerization |
| GO:0001300 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | chronological cell aging |
| GO:0002538 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0035669 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
| GO:2000111 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | positive regulation of macrophage apoptotic process |
| GO:2000669 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | negative regulation of dendritic cell apoptotic process |
| GO:0007599 | 0.0053 | 6.2977 | 0.7114 | 4 | 269 | hemostasis |
| GO:0050817 | 0.0053 | 6.2977 | 0.7114 | 4 | 269 | coagulation |
| GO:0010812 | 0.0055 | 19.9379 | 0.1111 | 2 | 42 | negative regulation of cell-substrate adhesion |
| GO:0071216 | 0.0057 | 9.0722 | 0.365 | 3 | 138 | cellular response to biotic stimulus |
| GO:0034128 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0035986 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | senescence-associated heterochromatin focus assembly |
| GO:0061044 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | negative regulation of vascular wound healing |
| GO:0071351 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | cellular response to interleukin-18 |
| GO:0097350 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | neutrophil clearance |
| GO:1904035 | 0.008 | 16.2647 | 0.1349 | 2 | 51 | regulation of epithelial cell apoptotic process |
| GO:0035082 | 0.0083 | 15.9382 | 0.1375 | 2 | 52 | axoneme assembly |
| GO:0048870 | 0.0092 | 3.1133 | 3.0546 | 8 | 1155 | cell motility |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035754 | 3e-04 | 117.6071 | 0.0263 | 2 | 6 | B cell chemotaxis |
| GO:0071824 | 5e-04 | 6.7638 | 0.9949 | 6 | 227 | protein-DNA complex subunit organization |
| GO:0006333 | 6e-04 | 8.1925 | 0.6793 | 5 | 155 | chromatin assembly or disassembly |
| GO:0006323 | 0.001 | 7.2608 | 0.7626 | 5 | 174 | DNA packaging |
| GO:0006590 | 0.0014 | 42.7435 | 0.057 | 2 | 13 | thyroid hormone generation |
| GO:0003341 | 0.0021 | 13.0126 | 0.2542 | 3 | 58 | cilium movement |
| GO:0035993 | 0.0044 | Inf | 0.0044 | 1 | 1 | deltoid tuberosity development |
| GO:0048855 | 0.0044 | Inf | 0.0044 | 1 | 1 | adenohypophysis morphogenesis |
| GO:0070367 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0090038 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of protein kinase C signaling |
| GO:0090386 | 0.0044 | Inf | 0.0044 | 1 | 1 | phagosome maturation involved in apoptotic cell clearance |
| GO:0090389 | 0.0044 | Inf | 0.0044 | 1 | 1 | phagosome-lysosome fusion involved in apoptotic cell clearance |
| GO:0097231 | 0.0044 | Inf | 0.0044 | 1 | 1 | cell motility in response to calcium ion |
| GO:0060285 | 0.0053 | 20.4239 | 0.1096 | 2 | 25 | cilium-dependent cell motility |
| GO:0006334 | 0.0061 | 8.6997 | 0.3732 | 3 | 88 | nucleosome assembly |
| GO:0006699 | 0.0066 | 18.0632 | 0.1227 | 2 | 28 | bile acid biosynthetic process |
| GO:0006335 | 0.0071 | 17.3929 | 0.1271 | 2 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0.0086 | 15.65 | 0.1402 | 2 | 32 | chromatin silencing at rDNA |
| GO:0016031 | 0.0087 | 231.1404 | 0.0088 | 1 | 2 | tRNA import into mitochondrion |
| GO:0035990 | 0.0087 | 231.1404 | 0.0088 | 1 | 2 | tendon cell differentiation |
| GO:0051012 | 0.0087 | 231.1404 | 0.0088 | 1 | 2 | microtubule sliding |
| GO:0070096 | 0.0087 | 231.1404 | 0.0088 | 1 | 2 | mitochondrial outer membrane translocase complex assembly |
| GO:0038111 | 0.0091 | 15.144 | 0.1446 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0091 | 15.144 | 0.1446 | 2 | 33 | response to interleukin-7 |
| GO:0042743 | 0.0097 | 14.6696 | 0.149 | 2 | 34 | hydrogen peroxide metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070475 | 2e-04 | 145.044 | 0.019 | 2 | 9 | rRNA base methylation |
| GO:0006193 | 0.0021 | Inf | 0.0021 | 1 | 1 | ITP catabolic process |
| GO:0009203 | 0.0021 | Inf | 0.0021 | 1 | 1 | ribonucleoside triphosphate catabolic process |
| GO:0060010 | 0.0021 | Inf | 0.0021 | 1 | 1 | Sertoli cell fate commitment |
| GO:0000154 | 0.0026 | 29.8009 | 0.0762 | 2 | 36 | rRNA modification |
| GO:0042309 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | homoiothermy |
| GO:0034465 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | response to carbon monoxide |
| GO:0045630 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | positive regulation of T-helper 2 cell differentiation |
| GO:0045794 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | negative regulation of cell volume |
| GO:0060083 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | smooth muscle contraction involved in micturition |
| GO:0001510 | 0.0066 | 18.0632 | 0.1227 | 2 | 58 | RNA methylation |
| GO:0008016 | 0.0072 | 8.4 | 0.3999 | 3 | 189 | regulation of heart contraction |
| GO:1901019 | 0.0075 | 16.8538 | 0.1312 | 2 | 62 | regulation of calcium ion transmembrane transporter activity |
| GO:0019918 | 0.0084 | 163 | 0.0085 | 1 | 4 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine |
| GO:0030951 | 0.0084 | 163 | 0.0085 | 1 | 4 | establishment or maintenance of microtubule cytoskeleton polarity |
| GO:0032237 | 0.0084 | 163 | 0.0085 | 1 | 4 | activation of store-operated calcium channel activity |
| GO:0033227 | 0.0084 | 163 | 0.0085 | 1 | 4 | dsRNA transport |
| GO:0044854 | 0.0084 | 163 | 0.0085 | 1 | 4 | plasma membrane raft assembly |
| GO:0060355 | 0.0084 | 163 | 0.0085 | 1 | 4 | positive regulation of cell adhesion molecule production |
| GO:0045638 | 0.0095 | 14.862 | 0.1481 | 2 | 70 | negative regulation of myeloid cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070475 | 1e-04 | 179.6463 | 0.0156 | 2 | 9 | rRNA base methylation |
| GO:0001510 | 1e-04 | 35.88 | 0.1008 | 3 | 58 | RNA methylation |
| GO:2000279 | 0.0011 | 46.5044 | 0.0504 | 2 | 29 | negative regulation of DNA biosynthetic process |
| GO:0032259 | 0.0017 | 9.0604 | 0.5283 | 4 | 304 | methylation |
| GO:0010070 | 0.0017 | Inf | 0.0017 | 1 | 1 | zygote asymmetric cell division |
| GO:0000154 | 0.0018 | 36.9104 | 0.0626 | 2 | 36 | rRNA modification |
| GO:0006879 | 0.0029 | 28.5 | 0.0799 | 2 | 46 | cellular iron ion homeostasis |
| GO:0071461 | 0.0035 | 600.4545 | 0.0035 | 1 | 2 | cellular response to redox state |
| GO:0002074 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | extraocular skeletal muscle development |
| GO:0031914 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | negative regulation of synaptic plasticity |
| GO:0006572 | 0.0069 | 200.1212 | 0.007 | 1 | 4 | tyrosine catabolic process |
| GO:1901164 | 0.0069 | 200.1212 | 0.007 | 1 | 4 | negative regulation of trophoblast cell migration |
| GO:0001554 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | luteolysis |
| GO:0050917 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | sensory perception of umami taste |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035752 | 0.002 | Inf | 0.002 | 1 | 1 | lysosomal lumen pH elevation |
| GO:0060010 | 0.002 | Inf | 0.002 | 1 | 1 | Sertoli cell fate commitment |
| GO:0001575 | 0.0041 | 507.9231 | 0.0041 | 1 | 2 | globoside metabolic process |
| GO:0045630 | 0.0061 | 253.9423 | 0.0061 | 1 | 3 | positive regulation of T-helper 2 cell differentiation |
| GO:0045852 | 0.0081 | 169.2821 | 0.0082 | 1 | 4 | pH elevation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000921 | 0.0019 | Inf | 0.0019 | 1 | 1 | septin ring assembly |
| GO:0032185 | 0.0038 | 550.3333 | 0.0038 | 1 | 2 | septin cytoskeleton organization |
| GO:0042309 | 0.0038 | 550.3333 | 0.0038 | 1 | 2 | homoiothermy |
| GO:1904172 | 0.0038 | 550.3333 | 0.0038 | 1 | 2 | positive regulation of bleb assembly |
| GO:0048678 | 0.0045 | 22.4348 | 0.1001 | 2 | 53 | response to axon injury |
| GO:0032100 | 0.0057 | 275.1458 | 0.0057 | 1 | 3 | positive regulation of appetite |
| GO:0090080 | 0.0057 | 275.1458 | 0.0057 | 1 | 3 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway |
| GO:0090521 | 0.0057 | 275.1458 | 0.0057 | 1 | 3 | glomerular visceral epithelial cell migration |
| GO:0032109 | 0.0075 | 183.4167 | 0.0076 | 1 | 4 | positive regulation of response to nutrient levels |
| GO:0090168 | 0.0075 | 183.4167 | 0.0076 | 1 | 4 | Golgi reassembly |
| GO:0008343 | 0.0094 | 137.5521 | 0.0094 | 1 | 5 | adult feeding behavior |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006616 | 0.0057 | 244.6667 | 0.0057 | 1 | 4 | SRP-dependent cotranslational protein targeting to membrane, translocation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017126 | 0.0036 | Inf | 0.0036 | 1 | 1 | nucleologenesis |
| GO:0070409 | 0.0036 | Inf | 0.0036 | 1 | 1 | carbamoyl phosphate biosynthetic process |
| GO:0071400 | 0.0036 | Inf | 0.0036 | 1 | 1 | cellular response to oleic acid |
| GO:0097510 | 0.0036 | Inf | 0.0036 | 1 | 1 | base-excision repair, AP site formation via deaminated base removal |
| GO:1903718 | 0.0036 | Inf | 0.0036 | 1 | 1 | cellular response to ammonia |
| GO:0048536 | 0.0056 | 19.7256 | 0.1124 | 2 | 31 | spleen development |
| GO:0061028 | 0.0063 | 18.4502 | 0.1197 | 2 | 33 | establishment of endothelial barrier |
| GO:0002268 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | follicular dendritic cell differentiation |
| GO:0014036 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | neural crest cell fate specification |
| GO:0016598 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | protein arginylation |
| GO:0045082 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | positive regulation of interleukin-10 biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009972 | 0 | 399.9091 | 0.0106 | 2 | 4 | cytidine deamination |
| GO:0046087 | 0 | 399.9091 | 0.0106 | 2 | 4 | cytidine metabolic process |
| GO:0070383 | 0 | 399.9091 | 0.0106 | 2 | 4 | DNA cytosine deamination |
| GO:0045869 | 1e-04 | 199.9242 | 0.0159 | 2 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 1e-04 | 199.9242 | 0.0159 | 2 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0016553 | 2e-04 | 114.2165 | 0.0238 | 2 | 9 | base conversion or substitution editing |
| GO:0040015 | 2e-04 | 114.2165 | 0.0238 | 2 | 9 | negative regulation of multicellular organism growth |
| GO:0006950 | 4e-04 | 3.3749 | 7.6776 | 17 | 2903 | response to stress |
| GO:1903901 | 4e-04 | 22.8212 | 0.1507 | 3 | 57 | negative regulation of viral life cycle |
| GO:0045069 | 7e-04 | 19.8644 | 0.1719 | 3 | 65 | regulation of viral genome replication |
| GO:0010529 | 7e-04 | 61.4732 | 0.0397 | 2 | 15 | negative regulation of transposition |
| GO:0039694 | 0.0011 | 46.9947 | 0.0502 | 2 | 19 | viral RNA genome replication |
| GO:0002230 | 0.0013 | 44.3805 | 0.0529 | 2 | 20 | positive regulation of defense response to virus by host |
| GO:0009164 | 0.0017 | 38.0317 | 0.0608 | 2 | 23 | nucleoside catabolic process |
| GO:0072529 | 0.0025 | 30.7063 | 0.0741 | 2 | 28 | pyrimidine-containing compound catabolic process |
| GO:0038129 | 0.0026 | Inf | 0.0026 | 1 | 1 | ERBB3 signaling pathway |
| GO:0048855 | 0.0026 | Inf | 0.0026 | 1 | 1 | adenohypophysis morphogenesis |
| GO:0009615 | 0.0031 | 7.3407 | 0.6136 | 4 | 232 | response to virus |
| GO:0043901 | 0.0038 | 10.5735 | 0.3147 | 3 | 119 | negative regulation of multi-organism process |
| GO:0048638 | 0.004 | 6.8509 | 0.6559 | 4 | 248 | regulation of developmental growth |
| GO:0006213 | 0.0043 | 22.7948 | 0.0979 | 2 | 37 | pyrimidine nucleoside metabolic process |
| GO:0009607 | 0.0044 | 4.4138 | 1.5789 | 6 | 597 | response to biotic stimulus |
| GO:0006624 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | vacuolar protein processing |
| GO:0021842 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
| GO:0046452 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | dihydrofolate metabolic process |
| GO:0009988 | 0.0065 | 18.1198 | 0.1217 | 2 | 46 | cell-cell recognition |
| GO:0034394 | 0.0068 | 17.7158 | 0.1243 | 2 | 47 | protein localization to cell surface |
| GO:0050792 | 0.0078 | 8.0471 | 0.4099 | 3 | 155 | regulation of viral process |
| GO:0002277 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | myeloid dendritic cell activation involved in immune response |
| GO:0002357 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | defense response to tumor cell |
| GO:0031427 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | response to methotrexate |
| GO:0036343 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | psychomotor behavior |
| GO:0042335 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | cuticle development |
| GO:0045213 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | neurotransmitter receptor metabolic process |
| GO:1900738 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0042446 | 0.0083 | 15.9382 | 0.1375 | 2 | 52 | hormone biosynthetic process |
| GO:1901185 | 0.0083 | 15.9382 | 0.1375 | 2 | 52 | negative regulation of ERBB signaling pathway |
| GO:0048678 | 0.0086 | 15.6245 | 0.1402 | 2 | 53 | response to axon injury |
| GO:0009636 | 0.0098 | 7.4057 | 0.4443 | 3 | 168 | response to toxic substance |
| GO:0002367 | 0.0099 | 14.4837 | 0.1507 | 2 | 57 | cytokine production involved in immune response |
| GO:0050688 | 0.0099 | 14.4837 | 0.1507 | 2 | 57 | regulation of defense response to virus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0090659 | 0.002 | 34.3125 | 0.0668 | 2 | 26 | walking behavior |
| GO:0051650 | 0.0021 | 8.2877 | 0.5472 | 4 | 213 | establishment of vesicle localization |
| GO:0006683 | 0.0026 | Inf | 0.0026 | 1 | 1 | galactosylceramide catabolic process |
| GO:0090386 | 0.0026 | Inf | 0.0026 | 1 | 1 | phagosome maturation involved in apoptotic cell clearance |
| GO:0090389 | 0.0026 | Inf | 0.0026 | 1 | 1 | phagosome-lysosome fusion involved in apoptotic cell clearance |
| GO:1903775 | 0.0026 | Inf | 0.0026 | 1 | 1 | regulation of DNA double-strand break processing |
| GO:0048489 | 0.0028 | 11.8417 | 0.2826 | 3 | 110 | synaptic vesicle transport |
| GO:0006906 | 0.0051 | 9.4362 | 0.352 | 3 | 137 | vesicle fusion |
| GO:1901136 | 0.0052 | 9.3656 | 0.3545 | 3 | 138 | carbohydrate derivative catabolic process |
| GO:0008088 | 0.0062 | 18.6875 | 0.1182 | 2 | 46 | axo-dendritic transport |
| GO:0006269 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | DNA replication, synthesis of RNA primer |
| GO:0007412 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | axon target recognition |
| GO:0045226 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | extracellular polysaccharide biosynthetic process |
| GO:0061357 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | positive regulation of Wnt protein secretion |
| GO:1900106 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | positive regulation of hyaluranon cable assembly |
| GO:0048284 | 0.0087 | 7.7402 | 0.4265 | 3 | 166 | organelle fusion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 11.8489 | 0.691 | 7 | 155 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 10.4855 | 0.7757 | 7 | 174 | DNA packaging |
| GO:0071824 | 1e-04 | 7.927 | 1.012 | 7 | 227 | protein-DNA complex subunit organization |
| GO:0045814 | 1e-04 | 11.416 | 0.4949 | 5 | 111 | negative regulation of gene expression, epigenetic |
| GO:0006335 | 3e-04 | 27.0927 | 0.1293 | 3 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 4e-04 | 24.2845 | 0.1427 | 3 | 32 | chromatin silencing at rDNA |
| GO:0038111 | 4e-04 | 23.4732 | 0.1471 | 3 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 4e-04 | 23.4732 | 0.1471 | 3 | 33 | response to interleukin-7 |
| GO:0006334 | 5e-04 | 11.9643 | 0.3732 | 4 | 88 | nucleosome assembly |
| GO:1905205 | 5e-04 | 77.0117 | 0.0357 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:1903244 | 7e-04 | 66.005 | 0.0401 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0051290 | 7e-04 | 19.0222 | 0.1783 | 3 | 40 | protein heterotetramerization |
| GO:0014744 | 0.001 | 51.3294 | 0.049 | 2 | 11 | positive regulation of muscle adaptation |
| GO:0010612 | 0.002 | 35.525 | 0.0669 | 2 | 15 | regulation of cardiac muscle adaptation |
| GO:0019221 | 0.0025 | 4.194 | 1.8665 | 7 | 440 | cytokine-mediated signaling pathway |
| GO:0042060 | 0.0025 | 4.1701 | 1.868 | 7 | 419 | wound healing |
| GO:0016458 | 0.0028 | 4.6826 | 1.4133 | 6 | 317 | gene silencing |
| GO:0045652 | 0.0032 | 11.1497 | 0.2942 | 3 | 66 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0.004 | 10.1755 | 0.321 | 3 | 72 | positive regulation of gene expression, epigenetic |
| GO:0032200 | 0.0043 | 6.5354 | 0.6643 | 4 | 149 | telomere organization |
| GO:0009115 | 0.0045 | Inf | 0.0045 | 1 | 1 | xanthine catabolic process |
| GO:0010477 | 0.0045 | Inf | 0.0045 | 1 | 1 | response to sulfur dioxide |
| GO:0070367 | 0.0045 | Inf | 0.0045 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:1903671 | 0.0047 | 21.9783 | 0.1025 | 2 | 23 | negative regulation of sprouting angiogenesis |
| GO:0003299 | 0.0055 | 20.0641 | 0.1115 | 2 | 25 | muscle hypertrophy in response to stress |
| GO:0043616 | 0.0064 | 18.4561 | 0.1204 | 2 | 27 | keratinocyte proliferation |
| GO:0061844 | 0.0073 | 17.0864 | 0.1293 | 2 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0014742 | 0.0084 | 15.9056 | 0.1382 | 2 | 31 | positive regulation of muscle hypertrophy |
| GO:0060964 | 0.0085 | 7.7025 | 0.4191 | 3 | 94 | regulation of gene silencing by miRNA |
| GO:0042418 | 0.0089 | 227.1379 | 0.0089 | 1 | 2 | epinephrine biosynthetic process |
| GO:1900155 | 0.0089 | 227.1379 | 0.0089 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:0071310 | 0.009 | 2.1825 | 8.6266 | 16 | 1935 | cellular response to organic substance |
| GO:1902036 | 0.009 | 7.5357 | 0.428 | 3 | 96 | regulation of hematopoietic stem cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010529 | 0 | 92.0769 | 0.0635 | 4 | 15 | negative regulation of transposition |
| GO:0009972 | 1e-04 | 244 | 0.0169 | 2 | 4 | cytidine deamination |
| GO:0046087 | 1e-04 | 244 | 0.0169 | 2 | 4 | cytidine metabolic process |
| GO:0070383 | 1e-04 | 244 | 0.0169 | 2 | 4 | DNA cytosine deamination |
| GO:0035754 | 3e-04 | 121.9815 | 0.0254 | 2 | 6 | B cell chemotaxis |
| GO:0045869 | 3e-04 | 121.9815 | 0.0254 | 2 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 3e-04 | 121.9815 | 0.0254 | 2 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0071824 | 4e-04 | 7.0355 | 0.9606 | 6 | 227 | protein-DNA complex subunit organization |
| GO:0006333 | 5e-04 | 8.515 | 0.6559 | 5 | 155 | chromatin assembly or disassembly |
| GO:0016553 | 6e-04 | 69.6878 | 0.0381 | 2 | 9 | base conversion or substitution editing |
| GO:0006323 | 8e-04 | 7.5467 | 0.7363 | 5 | 174 | DNA packaging |
| GO:0006590 | 0.0013 | 44.3333 | 0.055 | 2 | 13 | thyroid hormone generation |
| GO:0098542 | 0.0014 | 5.4092 | 1.2356 | 6 | 292 | defense response to other organism |
| GO:0039694 | 0.0029 | 28.6732 | 0.0804 | 2 | 19 | viral RNA genome replication |
| GO:0002230 | 0.0032 | 27.0782 | 0.0846 | 2 | 20 | positive regulation of defense response to virus by host |
| GO:0061053 | 0.0041 | 10.1615 | 0.3216 | 3 | 76 | somite development |
| GO:0009164 | 0.0042 | 23.2046 | 0.0973 | 2 | 23 | nucleoside catabolic process |
| GO:0035993 | 0.0042 | Inf | 0.0042 | 1 | 1 | deltoid tuberosity development |
| GO:0048855 | 0.0042 | Inf | 0.0042 | 1 | 1 | adenohypophysis morphogenesis |
| GO:0070367 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0090038 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of protein kinase C signaling |
| GO:0090386 | 0.0042 | Inf | 0.0042 | 1 | 1 | phagosome maturation involved in apoptotic cell clearance |
| GO:0090389 | 0.0042 | Inf | 0.0042 | 1 | 1 | phagosome-lysosome fusion involved in apoptotic cell clearance |
| GO:0006334 | 0.0056 | 9.0422 | 0.3599 | 3 | 88 | nucleosome assembly |
| GO:0006304 | 0.0061 | 8.719 | 0.3724 | 3 | 88 | DNA modification |
| GO:0006699 | 0.0062 | 18.735 | 0.1185 | 2 | 28 | bile acid biosynthetic process |
| GO:0072529 | 0.0062 | 18.735 | 0.1185 | 2 | 28 | pyrimidine-containing compound catabolic process |
| GO:0006335 | 0.0066 | 18.0398 | 0.1227 | 2 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0.008 | 16.2321 | 0.1354 | 2 | 32 | chromatin silencing at rDNA |
| GO:0018916 | 0.0084 | 239.5818 | 0.0085 | 1 | 2 | nitrobenzene metabolic process |
| GO:0035990 | 0.0084 | 239.5818 | 0.0085 | 1 | 2 | tendon cell differentiation |
| GO:0038111 | 0.0085 | 15.7073 | 0.1396 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0085 | 15.7073 | 0.1396 | 2 | 33 | response to interleukin-7 |
| GO:0042743 | 0.009 | 15.2153 | 0.1439 | 2 | 34 | hydrogen peroxide metabolic process |
| GO:0043207 | 0.0091 | 3.2553 | 2.3739 | 7 | 561 | response to external biotic stimulus |
| GO:0010470 | 0.0096 | 14.7531 | 0.1481 | 2 | 35 | regulation of gastrulation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030317 | 5e-04 | 21.541 | 0.1596 | 3 | 64 | flagellated sperm motility |
| GO:0007155 | 0.0033 | 3.7773 | 2.5908 | 8 | 1039 | cell adhesion |
| GO:0001974 | 0.004 | 23.5932 | 0.0948 | 2 | 38 | blood vessel remodeling |
| GO:0006431 | 0.005 | 412.5 | 0.005 | 1 | 2 | methionyl-tRNA aminoacylation |
| GO:0010159 | 0.005 | 412.5 | 0.005 | 1 | 2 | specification of animal organ position |
| GO:0017186 | 0.005 | 412.5 | 0.005 | 1 | 2 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase |
| GO:2000111 | 0.005 | 412.5 | 0.005 | 1 | 2 | positive regulation of macrophage apoptotic process |
| GO:0007160 | 0.0069 | 8.4721 | 0.3915 | 3 | 157 | cell-matrix adhesion |
| GO:0035082 | 0.0074 | 16.969 | 0.1297 | 2 | 52 | axoneme assembly |
| GO:0021615 | 0.0075 | 206.2344 | 0.0075 | 1 | 3 | glossopharyngeal nerve morphogenesis |
| GO:0033693 | 0.0075 | 206.2344 | 0.0075 | 1 | 3 | neurofilament bundle assembly |
| GO:0035986 | 0.0075 | 206.2344 | 0.0075 | 1 | 3 | senescence-associated heterochromatin focus assembly |
| GO:0003199 | 0.0099 | 137.4792 | 0.01 | 1 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:1904491 | 0.0099 | 137.4792 | 0.01 | 1 | 4 | protein localization to ciliary transition zone |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070475 | 1e-04 | 171.4675 | 0.0163 | 2 | 9 | rRNA base methylation |
| GO:0001510 | 2e-04 | 34.1688 | 0.1052 | 3 | 58 | RNA methylation |
| GO:2000279 | 0.0012 | 44.3872 | 0.0526 | 2 | 29 | negative regulation of DNA biosynthetic process |
| GO:0010070 | 0.0018 | Inf | 0.0018 | 1 | 1 | zygote asymmetric cell division |
| GO:0000154 | 0.0019 | 35.2299 | 0.0653 | 2 | 36 | rRNA modification |
| GO:0032259 | 0.002 | 8.6067 | 0.5513 | 4 | 304 | methylation |
| GO:0006879 | 0.0031 | 27.2025 | 0.0834 | 2 | 46 | cellular iron ion homeostasis |
| GO:0071461 | 0.0036 | 574.3043 | 0.0036 | 1 | 2 | cellular response to redox state |
| GO:0002074 | 0.0054 | 287.1304 | 0.0054 | 1 | 3 | extraocular skeletal muscle development |
| GO:0031914 | 0.0054 | 287.1304 | 0.0054 | 1 | 3 | negative regulation of synaptic plasticity |
| GO:0006572 | 0.0072 | 191.4058 | 0.0073 | 1 | 4 | tyrosine catabolic process |
| GO:1901164 | 0.0072 | 191.4058 | 0.0073 | 1 | 4 | negative regulation of trophoblast cell migration |
| GO:0001554 | 0.009 | 143.5435 | 0.0091 | 1 | 5 | luteolysis |
| GO:0050917 | 0.009 | 143.5435 | 0.0091 | 1 | 5 | sensory perception of umami taste |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0055002 | 8e-04 | 19.0953 | 0.1874 | 3 | 124 | striated muscle cell development |
| GO:0006408 | 0.003 | 695.4211 | 0.003 | 1 | 2 | snRNA export from nucleus |
| GO:1905461 | 0.003 | 695.4211 | 0.003 | 1 | 2 | positive regulation of vascular associated smooth muscle cell apoptotic process |
| GO:0035195 | 0.0038 | 10.9277 | 0.3219 | 3 | 213 | gene silencing by miRNA |
| GO:0016441 | 0.0042 | 10.5695 | 0.3325 | 3 | 220 | posttranscriptional gene silencing |
| GO:0002074 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | extraocular skeletal muscle development |
| GO:1905563 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | negative regulation of vascular endothelial cell proliferation |
| GO:0031047 | 0.0053 | 9.6627 | 0.3627 | 3 | 240 | gene silencing by RNA |
| GO:0006616 | 0.006 | 231.7719 | 0.006 | 1 | 4 | SRP-dependent cotranslational protein targeting to membrane, translocation |
| GO:0016525 | 0.0064 | 18.7123 | 0.1209 | 2 | 80 | negative regulation of angiogenesis |
| GO:1901343 | 0.0074 | 17.3677 | 0.13 | 2 | 86 | negative regulation of vasculature development |
| GO:1905522 | 0.0075 | 173.8158 | 0.0076 | 1 | 5 | negative regulation of macrophage migration |
| GO:0009249 | 0.009 | 139.0421 | 0.0091 | 1 | 6 | protein lipoylation |
| GO:0014706 | 0.01 | 7.6486 | 0.4549 | 3 | 301 | striated muscle tissue development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035646 | 4e-04 | 89.1014 | 0.0295 | 2 | 10 | endosome to melanosome transport |
| GO:0043476 | 4e-04 | 89.1014 | 0.0295 | 2 | 10 | pigment accumulation |
| GO:0048757 | 4e-04 | 89.1014 | 0.0295 | 2 | 10 | pigment granule maturation |
| GO:1900746 | 4e-04 | 89.1014 | 0.0295 | 2 | 10 | regulation of vascular endothelial growth factor signaling pathway |
| GO:0048846 | 0.001 | 50.8919 | 0.0472 | 2 | 16 | axon extension involved in axon guidance |
| GO:0006972 | 0.0011 | 47.4955 | 0.0501 | 2 | 17 | hyperosmotic response |
| GO:0018149 | 0.0013 | 44.5236 | 0.053 | 2 | 18 | peptide cross-linking |
| GO:0060055 | 0.0017 | 37.4851 | 0.0619 | 2 | 21 | angiogenesis involved in wound healing |
| GO:2000181 | 0.0017 | 14.0139 | 0.2387 | 3 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0008038 | 0.0024 | 30.9565 | 0.0737 | 2 | 25 | neuron recognition |
| GO:0050919 | 0.0026 | 29.6644 | 0.0766 | 2 | 26 | negative chemotaxis |
| GO:0072604 | 0.0026 | 29.6644 | 0.0766 | 2 | 26 | interleukin-6 secretion |
| GO:0007155 | 0.0027 | 3.5432 | 3.0619 | 9 | 1039 | cell adhesion |
| GO:0034105 | 0.0028 | 28.4757 | 0.0796 | 2 | 27 | positive regulation of tissue remodeling |
| GO:0045765 | 0.0029 | 7.5019 | 0.5953 | 4 | 202 | regulation of angiogenesis |
| GO:0010070 | 0.0029 | Inf | 0.0029 | 1 | 1 | zygote asymmetric cell division |
| GO:1903461 | 0.0029 | Inf | 0.0029 | 1 | 1 | Okazaki fragment processing involved in mitotic DNA replication |
| GO:1905243 | 0.0029 | Inf | 0.0029 | 1 | 1 | cellular response to 3,3',5-triiodo-L-thyronine |
| GO:1990256 | 0.0029 | Inf | 0.0029 | 1 | 1 | signal clustering |
| GO:0048869 | 0.0033 | 2.5743 | 9.7662 | 18 | 3314 | cellular developmental process |
| GO:0001822 | 0.0039 | 6.8672 | 0.6483 | 4 | 220 | kidney development |
| GO:0035924 | 0.0045 | 22.2348 | 0.1002 | 2 | 34 | cellular response to vascular endothelial growth factor stimulus |
| GO:0007416 | 0.0052 | 9.3148 | 0.3536 | 3 | 120 | synapse assembly |
| GO:0048066 | 0.0059 | 19.2228 | 0.1149 | 2 | 39 | developmental pigmentation |
| GO:0034344 | 0.0059 | 347.2105 | 0.0059 | 1 | 2 | regulation of type III interferon production |
| GO:0035582 | 0.0059 | 347.2105 | 0.0059 | 1 | 2 | sequestering of BMP in extracellular matrix |
| GO:0035583 | 0.0059 | 347.2105 | 0.0059 | 1 | 2 | sequestering of TGFbeta in extracellular matrix |
| GO:0060354 | 0.0059 | 347.2105 | 0.0059 | 1 | 2 | negative regulation of cell adhesion molecule production |
| GO:2000111 | 0.0059 | 347.2105 | 0.0059 | 1 | 2 | positive regulation of macrophage apoptotic process |
| GO:2000729 | 0.0059 | 347.2105 | 0.0059 | 1 | 2 | positive regulation of mesenchymal cell proliferation involved in ureter development |
| GO:0030308 | 0.0063 | 8.7133 | 0.3772 | 3 | 128 | negative regulation of cell growth |
| GO:0010596 | 0.0065 | 18.2342 | 0.1208 | 2 | 41 | negative regulation of endothelial cell migration |
| GO:0033059 | 0.0068 | 17.777 | 0.1238 | 2 | 42 | cellular pigmentation |
| GO:0001655 | 0.0074 | 5.6857 | 0.778 | 4 | 264 | urogenital system development |
| GO:0072359 | 0.0085 | 3.3893 | 2.3782 | 7 | 807 | circulatory system development |
| GO:0008582 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | regulation of synaptic growth at neuromuscular junction |
| GO:0031914 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | negative regulation of synaptic plasticity |
| GO:0033693 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | neurofilament bundle assembly |
| GO:0035986 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | senescence-associated heterochromatin focus assembly |
| GO:0045590 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | negative regulation of regulatory T cell differentiation |
| GO:0048808 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | male genitalia morphogenesis |
| GO:0051414 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | response to cortisol |
| GO:0061044 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | negative regulation of vascular wound healing |
| GO:0061364 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | apoptotic process involved in luteolysis |
| GO:0061551 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | trigeminal ganglion development |
| GO:0071692 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | protein localization to extracellular region |
| GO:0072095 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:0072193 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | ureter smooth muscle cell differentiation |
| GO:0072513 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | positive regulation of secondary heart field cardioblast proliferation |
| GO:0090191 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:2001205 | 0.0088 | 173.5921 | 0.0088 | 1 | 3 | negative regulation of osteoclast development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007155 | 0 | 5.4264 | 2.7478 | 11 | 1039 | cell adhesion |
| GO:0007160 | 7e-04 | 11.0023 | 0.4152 | 4 | 157 | cell-matrix adhesion |
| GO:2000352 | 0.0015 | 39.9364 | 0.0582 | 2 | 22 | negative regulation of endothelial cell apoptotic process |
| GO:0035491 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of leukotriene production involved in inflammatory response |
| GO:0042128 | 0.0026 | Inf | 0.0026 | 1 | 1 | nitrate assimilation |
| GO:0060857 | 0.0026 | Inf | 0.0026 | 1 | 1 | establishment of glial blood-brain barrier |
| GO:1990256 | 0.0026 | Inf | 0.0026 | 1 | 1 | signal clustering |
| GO:2000098 | 0.0026 | Inf | 0.0026 | 1 | 1 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000494 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
| GO:0071222 | 0.0035 | 10.8567 | 0.3068 | 3 | 116 | cellular response to lipopolysaccharide |
| GO:0030168 | 0.004 | 10.3046 | 0.3227 | 3 | 122 | platelet activation |
| GO:0030199 | 0.004 | 23.467 | 0.0952 | 2 | 36 | collagen fibril organization |
| GO:0048260 | 0.004 | 23.467 | 0.0952 | 2 | 36 | positive regulation of receptor-mediated endocytosis |
| GO:0060760 | 0.004 | 23.467 | 0.0952 | 2 | 36 | positive regulation of response to cytokine stimulus |
| GO:0043062 | 0.0041 | 6.8224 | 0.6585 | 4 | 249 | extracellular structure organization |
| GO:0001974 | 0.0045 | 22.1599 | 0.1005 | 2 | 38 | blood vessel remodeling |
| GO:0042060 | 0.0046 | 5.1469 | 1.1081 | 5 | 419 | wound healing |
| GO:0070206 | 0.0047 | 21.5594 | 0.1031 | 2 | 39 | protein trimerization |
| GO:0001300 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | chronological cell aging |
| GO:0002538 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0035669 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
| GO:2000111 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | positive regulation of macrophage apoptotic process |
| GO:2000669 | 0.0053 | 388.1765 | 0.0053 | 1 | 2 | negative regulation of dendritic cell apoptotic process |
| GO:0007599 | 0.0053 | 6.2977 | 0.7114 | 4 | 269 | hemostasis |
| GO:0050817 | 0.0053 | 6.2977 | 0.7114 | 4 | 269 | coagulation |
| GO:0010812 | 0.0055 | 19.9379 | 0.1111 | 2 | 42 | negative regulation of cell-substrate adhesion |
| GO:0071216 | 0.0057 | 9.0722 | 0.365 | 3 | 138 | cellular response to biotic stimulus |
| GO:0034128 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0035986 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | senescence-associated heterochromatin focus assembly |
| GO:0061044 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | negative regulation of vascular wound healing |
| GO:0071351 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | cellular response to interleukin-18 |
| GO:0097350 | 0.0079 | 194.0735 | 0.0079 | 1 | 3 | neutrophil clearance |
| GO:1904035 | 0.008 | 16.2647 | 0.1349 | 2 | 51 | regulation of epithelial cell apoptotic process |
| GO:0035082 | 0.0083 | 15.9382 | 0.1375 | 2 | 52 | axoneme assembly |
| GO:0048870 | 0.0092 | 3.1133 | 3.0546 | 8 | 1155 | cell motility |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006949 | 0 | 61.2698 | 0.0626 | 3 | 46 | syncytium formation |
| GO:0060143 | 4e-04 | 82.475 | 0.0299 | 2 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0043029 | 8e-04 | 54.9417 | 0.0435 | 2 | 32 | T cell homeostasis |
| GO:0002791 | 9e-04 | 11.1221 | 0.4556 | 4 | 335 | regulation of peptide secretion |
| GO:0007520 | 0.001 | 49.9356 | 0.0476 | 2 | 35 | myoblast fusion |
| GO:0051223 | 0.0011 | 7.9075 | 0.8406 | 5 | 618 | regulation of protein transport |
| GO:0003365 | 0.0014 | Inf | 0.0014 | 1 | 1 | establishment of cell polarity involved in ameboidal cell migration |
| GO:0006649 | 0.0014 | Inf | 0.0014 | 1 | 1 | phospholipid transfer to membrane |
| GO:0018032 | 0.0014 | Inf | 0.0014 | 1 | 1 | protein amidation |
| GO:1900035 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of cellular response to heat |
| GO:0050714 | 0.0016 | 15.1674 | 0.238 | 3 | 175 | positive regulation of protein secretion |
| GO:1904951 | 0.002 | 8.9692 | 0.5604 | 4 | 412 | positive regulation of establishment of protein localization |
| GO:0001519 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | peptide amidation |
| GO:0002415 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor |
| GO:0035759 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | mesangial cell-matrix adhesion |
| GO:0043132 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | NAD transport |
| GO:0044254 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | multicellular organismal protein catabolic process |
| GO:0050717 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | positive regulation of interleukin-1 alpha secretion |
| GO:0071657 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0072254 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | metanephric glomerular mesangial cell differentiation |
| GO:1900168 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | positive regulation of glial cell-derived neurotrophic factor secretion |
| GO:1904172 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | positive regulation of bleb assembly |
| GO:0051146 | 0.0032 | 11.8694 | 0.3019 | 3 | 222 | striated muscle cell differentiation |
| GO:0001776 | 0.0032 | 26.957 | 0.0857 | 2 | 63 | leukocyte homeostasis |
| GO:0045445 | 0.0034 | 26.5202 | 0.087 | 2 | 64 | myoblast differentiation |
| GO:0071260 | 0.0037 | 25.2904 | 0.0911 | 2 | 67 | cellular response to mechanical stimulus |
| GO:0032880 | 0.0039 | 5.8523 | 1.1153 | 5 | 820 | regulation of protein localization |
| GO:0008588 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | release of cytoplasmic sequestered NF-kappaB |
| GO:0032650 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | regulation of interleukin-1 alpha production |
| GO:0038001 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | paracrine signaling |
| GO:0045794 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | negative regulation of cell volume |
| GO:0072011 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | glomerular endothelium development |
| GO:1900041 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | negative regulation of interleukin-2 secretion |
| GO:1903530 | 0.0045 | 7.0893 | 0.7018 | 4 | 516 | regulation of secretion by cell |
| GO:0015833 | 0.0049 | 4.346 | 2.3054 | 7 | 1695 | peptide transport |
| GO:0006616 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | SRP-dependent cotranslational protein targeting to membrane, translocation |
| GO:0014054 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | positive regulation of gamma-aminobutyric acid secretion |
| GO:0060018 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | astrocyte fate commitment |
| GO:0060800 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | regulation of cell differentiation involved in embryonic placenta development |
| GO:1901256 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:0001666 | 0.0066 | 9.042 | 0.3931 | 3 | 289 | response to hypoxia |
| GO:2001214 | 0.0068 | 194.2941 | 0.0068 | 1 | 5 | positive regulation of vasculogenesis |
| GO:0042482 | 0.0081 | 155.4235 | 0.0082 | 1 | 6 | positive regulation of odontogenesis |
| GO:0070482 | 0.0083 | 8.299 | 0.4271 | 3 | 314 | response to oxygen levels |
| GO:0050707 | 0.0089 | 15.7596 | 0.1442 | 2 | 106 | regulation of cytokine secretion |
| GO:0042493 | 0.0092 | 7.9833 | 0.4434 | 3 | 326 | response to drug |
| GO:0010820 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | positive regulation of T cell chemotaxis |
| GO:0045919 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | positive regulation of cytolysis |
| GO:0060290 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | transdifferentiation |
| GO:0071971 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | extracellular exosome assembly |
| GO:0072007 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | mesangial cell differentiation |
| GO:1900038 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | negative regulation of cellular response to hypoxia |
| GO:0071705 | 0.0097 | 3.7669 | 2.6074 | 7 | 1917 | nitrogen compound transport |
| GO:0007586 | 0.0099 | 14.8932 | 0.1523 | 2 | 112 | digestion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061036 | 0.0016 | 38.2 | 0.0605 | 2 | 25 | positive regulation of cartilage development |
| GO:0000053 | 0.0024 | Inf | 0.0024 | 1 | 1 | argininosuccinate metabolic process |
| GO:0019732 | 0.0024 | Inf | 0.0024 | 1 | 1 | antifungal humoral response |
| GO:0030221 | 0.0024 | Inf | 0.0024 | 1 | 1 | basophil differentiation |
| GO:0046168 | 0.0024 | Inf | 0.0024 | 1 | 1 | glycerol-3-phosphate catabolic process |
| GO:0060217 | 0.0024 | Inf | 0.0024 | 1 | 1 | hemangioblast cell differentiation |
| GO:0060668 | 0.0024 | Inf | 0.0024 | 1 | 1 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling |
| GO:0061760 | 0.0024 | Inf | 0.0024 | 1 | 1 | antifungal innate immune response |
| GO:1990134 | 0.0024 | Inf | 0.0024 | 1 | 1 | epithelial cell apoptotic process involved in palatal shelf morphogenesis |
| GO:0001501 | 0.0028 | 5.8663 | 0.989 | 5 | 409 | skeletal system development |
| GO:0071695 | 0.0037 | 10.7356 | 0.3119 | 3 | 129 | anatomical structure maturation |
| GO:0048469 | 0.0041 | 10.3219 | 0.324 | 3 | 134 | cell maturation |
| GO:0001701 | 0.0041 | 6.8423 | 0.6625 | 4 | 274 | in utero embryonic development |
| GO:0006127 | 0.0048 | 425.8387 | 0.0048 | 1 | 2 | glycerophosphate shuttle |
| GO:0060375 | 0.0048 | 425.8387 | 0.0048 | 1 | 2 | regulation of mast cell differentiation |
| GO:0006733 | 0.0061 | 8.8816 | 0.3748 | 3 | 155 | oxidoreduction coenzyme metabolic process |
| GO:0045600 | 0.007 | 17.536 | 0.1257 | 2 | 52 | positive regulation of fat cell differentiation |
| GO:0019674 | 0.0072 | 17.1908 | 0.1282 | 2 | 53 | NAD metabolic process |
| GO:0045799 | 0.0072 | 212.9032 | 0.0073 | 1 | 3 | positive regulation of chromatin assembly or disassembly |
| GO:0030321 | 0.0096 | 141.9247 | 0.0097 | 1 | 4 | transepithelial chloride transport |
| GO:0042492 | 0.0096 | 141.9247 | 0.0097 | 1 | 4 | gamma-delta T cell differentiation |
| GO:0052646 | 0.0096 | 141.9247 | 0.0097 | 1 | 4 | alditol phosphate metabolic process |
| GO:0060018 | 0.0096 | 141.9247 | 0.0097 | 1 | 4 | astrocyte fate commitment |
| GO:1903012 | 0.0096 | 141.9247 | 0.0097 | 1 | 4 | positive regulation of bone development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001572 | 0.0016 | Inf | 0.0016 | 1 | 1 | lactosylceramide biosynthetic process |
| GO:0017198 | 0.0016 | Inf | 0.0016 | 1 | 1 | N-terminal peptidyl-serine acetylation |
| GO:0018002 | 0.0016 | Inf | 0.0016 | 1 | 1 | N-terminal peptidyl-glutamic acid acetylation |
| GO:0099566 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0006003 | 0.0048 | 330.275 | 0.0048 | 1 | 3 | fructose 2,6-bisphosphate metabolic process |
| GO:0070634 | 0.0048 | 330.275 | 0.0048 | 1 | 3 | transepithelial ammonium transport |
| GO:0072249 | 0.0048 | 330.275 | 0.0048 | 1 | 3 | metanephric glomerular visceral epithelial cell development |
| GO:0072312 | 0.0048 | 330.275 | 0.0048 | 1 | 3 | metanephric glomerular epithelial cell differentiation |
| GO:0038042 | 0.0063 | 220.1667 | 0.0063 | 1 | 4 | dimeric G-protein coupled receptor signaling pathway |
| GO:0019233 | 0.0065 | 18.4393 | 0.1222 | 2 | 77 | sensory perception of pain |
| GO:0007196 | 0.0095 | 132.08 | 0.0095 | 1 | 6 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0086069 | 1e-04 | 155.3529 | 0.0172 | 2 | 12 | bundle of His cell to Purkinje myocyte communication |
| GO:0086019 | 7e-04 | 62.0706 | 0.0388 | 2 | 27 | cell-cell signaling involved in cardiac conduction |
| GO:0086010 | 0.0014 | 41.9014 | 0.056 | 2 | 39 | membrane depolarization during action potential |
| GO:0048137 | 0.0014 | Inf | 0.0014 | 1 | 1 | spermatocyte division |
| GO:1901995 | 0.0014 | Inf | 0.0014 | 1 | 1 | positive regulation of meiotic cell cycle phase transition |
| GO:0000711 | 0.0043 | 367.0278 | 0.0043 | 1 | 3 | meiotic DNA repair synthesis |
| GO:0086048 | 0.0043 | 367.0278 | 0.0043 | 1 | 3 | membrane depolarization during bundle of His cell action potential |
| GO:1901843 | 0.0043 | 367.0278 | 0.0043 | 1 | 3 | positive regulation of high voltage-gated calcium channel activity |
| GO:0002027 | 0.005 | 21.4755 | 0.1062 | 2 | 74 | regulation of heart rate |
| GO:0007276 | 0.0053 | 6.7254 | 0.7293 | 4 | 508 | gamete generation |
| GO:0086043 | 0.0054 | 259.0196 | 0.0054 | 1 | 4 | bundle of His cell action potential |
| GO:0060048 | 0.0077 | 16.967 | 0.1335 | 2 | 93 | cardiac muscle contraction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001809 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of type IV hypersensitivity |
| GO:0002005 | 0.0026 | Inf | 0.0026 | 1 | 1 | angiotensin catabolic process in blood |
| GO:0006049 | 0.0026 | Inf | 0.0026 | 1 | 1 | UDP-N-acetylglucosamine catabolic process |
| GO:0016077 | 0.0026 | Inf | 0.0026 | 1 | 1 | snoRNA catabolic process |
| GO:0035863 | 0.0026 | Inf | 0.0026 | 1 | 1 | dITP catabolic process |
| GO:0046168 | 0.0026 | Inf | 0.0026 | 1 | 1 | glycerol-3-phosphate catabolic process |
| GO:1901639 | 0.0026 | Inf | 0.0026 | 1 | 1 | XDP catabolic process |
| GO:1903597 | 0.0026 | Inf | 0.0026 | 1 | 1 | negative regulation of gap junction assembly |
| GO:2000388 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of antral ovarian follicle growth |
| GO:0006654 | 0.0027 | 29.4018 | 0.0771 | 2 | 30 | phosphatidic acid biosynthetic process |
| GO:0006334 | 0.0033 | 11.1087 | 0.3006 | 3 | 117 | nucleosome assembly |
| GO:0035036 | 0.0036 | 24.9375 | 0.0899 | 2 | 35 | sperm-egg recognition |
| GO:0006127 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | glycerophosphate shuttle |
| GO:0010513 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | positive regulation of phosphatidylinositol biosynthetic process |
| GO:0044256 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | protein digestion |
| GO:0044266 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | multicellular organismal macromolecule catabolic process |
| GO:0046452 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | dihydrofolate metabolic process |
| GO:0046709 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | IDP catabolic process |
| GO:1900155 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:2000170 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | positive regulation of peptidyl-cysteine S-nitrosylation |
| GO:2000196 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | positive regulation of female gonad development |
| GO:2000233 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | negative regulation of rRNA processing |
| GO:2000360 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | negative regulation of binding of sperm to zona pellucida |
| GO:2000368 | 0.0051 | 399.9697 | 0.0051 | 1 | 2 | positive regulation of acrosomal vesicle exocytosis |
| GO:0006333 | 0.0072 | 8.3073 | 0.3982 | 3 | 155 | chromatin assembly or disassembly |
| GO:0002019 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | regulation of renal output by angiotensin |
| GO:0031427 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | response to methotrexate |
| GO:0035803 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | egg coat formation |
| GO:0044268 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | multicellular organismal protein metabolic process |
| GO:0050689 | 0.0077 | 199.9697 | 0.0077 | 1 | 3 | negative regulation of defense response to virus by host |
| GO:0002456 | 0.0084 | 15.8029 | 0.1387 | 2 | 54 | T cell mediated immunity |
| GO:0006323 | 0.0099 | 7.3735 | 0.447 | 3 | 174 | DNA packaging |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035993 | 0.0014 | Inf | 0.0014 | 1 | 1 | deltoid tuberosity development |
| GO:0043438 | 0.0014 | Inf | 0.0014 | 1 | 1 | acetoacetic acid metabolic process |
| GO:0071799 | 0.0014 | Inf | 0.0014 | 1 | 1 | cellular response to prostaglandin D stimulus |
| GO:0035990 | 0.0027 | 777.3529 | 0.0027 | 1 | 2 | tendon cell differentiation |
| GO:0006954 | 0.0031 | 7.9409 | 0.6297 | 4 | 463 | inflammatory response |
| GO:0031338 | 0.0031 | 27.4083 | 0.0843 | 2 | 62 | regulation of vesicle fusion |
| GO:0048023 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | positive regulation of melanin biosynthetic process |
| GO:0090630 | 0.0053 | 20.7864 | 0.1102 | 2 | 81 | activation of GTPase activity |
| GO:0035989 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | tendon development |
| GO:0061056 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | sclerotome development |
| GO:0030219 | 0.0056 | 20.2701 | 0.1129 | 2 | 83 | megakaryocyte differentiation |
| GO:1900376 | 0.0068 | 194.2941 | 0.0068 | 1 | 5 | regulation of secondary metabolite biosynthetic process |
| GO:0050900 | 0.0069 | 8.9145 | 0.3985 | 3 | 293 | leukocyte migration |
| GO:0008228 | 0.0081 | 155.4235 | 0.0082 | 1 | 6 | opsonization |
| GO:0002430 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | complement receptor mediated signaling pathway |
| GO:0035093 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | spermatogenesis, exchange of chromosomal proteins |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 2e-04 | 10.1054 | 0.5622 | 5 | 155 | chromatin assembly or disassembly |
| GO:1905205 | 4e-04 | 95.5072 | 0.029 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:0006323 | 4e-04 | 8.9562 | 0.6311 | 5 | 174 | DNA packaging |
| GO:1903244 | 5e-04 | 81.8571 | 0.0326 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0014744 | 7e-04 | 63.657 | 0.0399 | 2 | 11 | positive regulation of muscle adaptation |
| GO:0010612 | 0.0013 | 44.0569 | 0.0544 | 2 | 15 | regulation of cardiac muscle adaptation |
| GO:0071824 | 0.0013 | 6.7903 | 0.8233 | 5 | 227 | protein-DNA complex subunit organization |
| GO:1903671 | 0.0031 | 27.2567 | 0.0834 | 2 | 23 | negative regulation of sprouting angiogenesis |
| GO:0030219 | 0.0034 | 10.9217 | 0.301 | 3 | 83 | megakaryocyte differentiation |
| GO:0006334 | 0.0035 | 10.7311 | 0.3066 | 3 | 88 | nucleosome assembly |
| GO:0009115 | 0.0036 | Inf | 0.0036 | 1 | 1 | xanthine catabolic process |
| GO:0042128 | 0.0036 | Inf | 0.0036 | 1 | 1 | nitrate assimilation |
| GO:0060668 | 0.0036 | Inf | 0.0036 | 1 | 1 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling |
| GO:0070367 | 0.0036 | Inf | 0.0036 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:1904877 | 0.0036 | Inf | 0.0036 | 1 | 1 | positive regulation of DNA ligase activity |
| GO:0003299 | 0.0037 | 24.8828 | 0.0907 | 2 | 25 | muscle hypertrophy in response to stress |
| GO:0070286 | 0.0043 | 22.8887 | 0.0979 | 2 | 27 | axonemal dynein complex assembly |
| GO:0006335 | 0.0049 | 21.19 | 0.1052 | 2 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0014742 | 0.0056 | 19.7256 | 0.1124 | 2 | 31 | positive regulation of muscle hypertrophy |
| GO:0000183 | 0.006 | 19.0667 | 0.1161 | 2 | 32 | chromatin silencing at rDNA |
| GO:0038111 | 0.0063 | 18.4502 | 0.1197 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0063 | 18.4502 | 0.1197 | 2 | 33 | response to interleukin-7 |
| GO:0010916 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | negative regulation of very-low-density lipoprotein particle clearance |
| GO:0015840 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | urea transport |
| GO:0097327 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | response to antineoplastic agent |
| GO:1902957 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:1903518 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | positive regulation of single strand break repair |
| GO:0045814 | 0.0076 | 8.0728 | 0.4026 | 3 | 111 | negative regulation of gene expression, epigenetic |
| GO:0048771 | 0.0087 | 7.6444 | 0.4244 | 3 | 117 | tissue remodeling |
| GO:0051290 | 0.0092 | 15.0435 | 0.1451 | 2 | 40 | protein heterotetramerization |
| GO:0014888 | 0.0097 | 14.6566 | 0.1487 | 2 | 41 | striated muscle adaptation |
| GO:0001568 | 0.0098 | 3.6021 | 1.8462 | 6 | 509 | blood vessel development |
| GO:0001525 | 0.0099 | 4.1546 | 1.3202 | 5 | 364 | angiogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005201 | 3e-04 | 26.3418 | 0.1317 | 3 | 50 | extracellular matrix structural constituent |
| GO:0004861 | 4e-04 | 89.1852 | 0.029 | 2 | 11 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0008482 | 0.0026 | Inf | 0.0026 | 1 | 1 | sulfite oxidase activity |
| GO:0035373 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | chondroitin sulfate proteoglycan binding |
| GO:0098640 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
| GO:0004857 | 0.0054 | 6.2757 | 0.7138 | 4 | 271 | enzyme inhibitor activity |
| GO:0004867 | 0.0065 | 18.1942 | 0.1212 | 2 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0070573 | 0.0079 | 194.8676 | 0.0079 | 1 | 3 | metallodipeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004497 | 0.0014 | 15.2287 | 0.2191 | 3 | 52 | monooxygenase activity |
| GO:0046982 | 0.0016 | 4.5361 | 1.7321 | 7 | 411 | protein heterodimerization activity |
| GO:0001567 | 0.0042 | Inf | 0.0042 | 1 | 1 | cholesterol 25-hydroxylase activity |
| GO:0004042 | 0.0042 | Inf | 0.0042 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0017064 | 0.0042 | Inf | 0.0042 | 1 | 1 | fatty acid amide hydrolase activity |
| GO:0102077 | 0.0042 | Inf | 0.0042 | 1 | 1 | oleamide hydrolase activity |
| GO:0103045 | 0.0042 | Inf | 0.0042 | 1 | 1 | methione N-acyltransferase activity |
| GO:0103073 | 0.0042 | Inf | 0.0042 | 1 | 1 | anandamide amidohydrolase activity |
| GO:0020037 | 0.0048 | 9.5457 | 0.3414 | 3 | 81 | heme binding |
| GO:0003998 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | acylphosphatase activity |
| GO:0004040 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | amidase activity |
| GO:0008396 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | oxysterol 7-alpha-hydroxylase activity |
| GO:0019834 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | phospholipase A2 inhibitor activity |
| GO:0047844 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | deoxycytidine deaminase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001594 | 0.0013 | Inf | 0.0013 | 1 | 1 | trace-amine receptor activity |
| GO:0005157 | 0.0013 | Inf | 0.0013 | 1 | 1 | macrophage colony-stimulating factor receptor binding |
| GO:0004857 | 0.0046 | 10.3969 | 0.3467 | 3 | 271 | enzyme inhibitor activity |
| GO:0003839 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | gamma-glutamylcyclotransferase activity |
| GO:0004028 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0004030 | 0.0064 | 207.2969 | 0.0064 | 1 | 5 | aldehyde dehydrogenase [NAD(P)+] activity |
| GO:0036402 | 0.0077 | 165.825 | 0.0077 | 1 | 6 | proteasome-activating ATPase activity |
| GO:0033691 | 0.0089 | 138.1771 | 0.009 | 1 | 7 | sialic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051010 | 3e-04 | 94.6286 | 0.0271 | 2 | 12 | microtubule plus-end binding |
| GO:0002020 | 0.0016 | 14.4741 | 0.2348 | 3 | 104 | protease binding |
| GO:0031682 | 0.0023 | Inf | 0.0023 | 1 | 1 | G-protein gamma-subunit binding |
| GO:0036220 | 0.0023 | Inf | 0.0023 | 1 | 1 | ITP diphosphatase activity |
| GO:0036222 | 0.0023 | Inf | 0.0023 | 1 | 1 | XTP diphosphatase activity |
| GO:0060072 | 0.0023 | Inf | 0.0023 | 1 | 1 | large conductance calcium-activated potassium channel activity |
| GO:0008757 | 0.0035 | 10.9649 | 0.307 | 3 | 136 | S-adenosylmethionine-dependent methyltransferase activity |
| GO:0004980 | 0.0045 | 457.1379 | 0.0045 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
| GO:0035373 | 0.0045 | 457.1379 | 0.0045 | 1 | 2 | chondroitin sulfate proteoglycan binding |
| GO:0035870 | 0.0045 | 457.1379 | 0.0045 | 1 | 2 | dITP diphosphatase activity |
| GO:0008173 | 0.0063 | 18.4972 | 0.1197 | 2 | 53 | RNA methyltransferase activity |
| GO:0035243 | 0.009 | 152.3563 | 0.009 | 1 | 4 | protein-arginine omega-N symmetric methyltransferase activity |
| GO:0035529 | 0.009 | 152.3563 | 0.009 | 1 | 4 | NADH pyrophosphatase activity |
| GO:0044323 | 0.009 | 152.3563 | 0.009 | 1 | 4 | retinoic acid-responsive element binding |
| GO:0016741 | 0.0094 | 7.5613 | 0.4402 | 3 | 195 | transferase activity, transferring one-carbon groups |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008173 | 1e-04 | 37.7543 | 0.0957 | 3 | 53 | RNA methyltransferase activity |
| GO:0004411 | 0.0018 | Inf | 0.0018 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
| GO:0033682 | 0.0018 | Inf | 0.0018 | 1 | 1 | ATP-dependent 5'-3' DNA/RNA helicase activity |
| GO:0050290 | 0.0018 | Inf | 0.0018 | 1 | 1 | sphingomyelin phosphodiesterase D activity |
| GO:0005153 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | interleukin-8 receptor binding |
| GO:0016300 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | tRNA (uracil) methyltransferase activity |
| GO:1990269 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | RNA polymerase II C-terminal domain phosphoserine binding |
| GO:0016741 | 0.005 | 9.7262 | 0.3522 | 3 | 195 | transferase activity, transferring one-carbon groups |
| GO:0000293 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | ferric-chelate reductase activity |
| GO:0005094 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0010521 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | telomerase inhibitor activity |
| GO:0017116 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | single-stranded DNA-dependent ATP-dependent DNA helicase activity |
| GO:0033677 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | DNA/RNA helicase activity |
| GO:0043141 | 0.0072 | 192.1884 | 0.0072 | 1 | 4 | ATP-dependent 5'-3' DNA helicase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004004 | 2e-04 | 29.6942 | 0.1194 | 3 | 61 | ATP-dependent RNA helicase activity |
| GO:0070035 | 6e-04 | 20.4627 | 0.1702 | 3 | 87 | purine NTP-dependent helicase activity |
| GO:0051393 | 8e-04 | 58.0833 | 0.0411 | 2 | 21 | alpha-actinin binding |
| GO:0042623 | 0.0026 | 7.9369 | 0.589 | 4 | 301 | ATPase activity, coupled |
| GO:0034597 | 0.0078 | 176.7867 | 0.0078 | 1 | 4 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity |
| GO:0044323 | 0.0078 | 176.7867 | 0.0078 | 1 | 4 | retinoic acid-responsive element binding |
| GO:0070290 | 0.0078 | 176.7867 | 0.0078 | 1 | 4 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO:0017111 | 0.009 | 4.4818 | 1.3188 | 5 | 674 | nucleoside-triphosphatase activity |
| GO:0004630 | 0.0097 | 132.58 | 0.0098 | 1 | 5 | phospholipase D activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004102 | 0.002 | Inf | 0.002 | 1 | 1 | choline O-acetyltransferase activity |
| GO:0004980 | 0.0039 | 530.44 | 0.0039 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
| GO:0005499 | 0.0039 | 530.44 | 0.0039 | 1 | 2 | vitamin D binding |
| GO:0004566 | 0.0059 | 265.2 | 0.0059 | 1 | 3 | beta-glucuronidase activity |
| GO:0008422 | 0.0059 | 265.2 | 0.0059 | 1 | 3 | beta-glucosidase activity |
| GO:0045322 | 0.0059 | 265.2 | 0.0059 | 1 | 3 | unmethylated CpG binding |
| GO:0005179 | 0.0096 | 14.8514 | 0.1487 | 2 | 76 | hormone activity |
| GO:0019957 | 0.0097 | 132.58 | 0.0098 | 1 | 5 | C-C chemokine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030550 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | acetylcholine receptor inhibitor activity |
| GO:0004857 | 0.0046 | 10.3969 | 0.3467 | 3 | 271 | enzyme inhibitor activity |
| GO:0004866 | 0.0058 | 19.9742 | 0.1151 | 2 | 90 | endopeptidase inhibitor activity |
| GO:0008201 | 0.0081 | 16.7187 | 0.1369 | 2 | 107 | heparin binding |
| GO:0099602 | 0.0089 | 138.1771 | 0.009 | 1 | 7 | neurotransmitter receptor regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004991 | 0.0025 | Inf | 0.0025 | 1 | 1 | parathyroid hormone receptor activity |
| GO:0009400 | 0.0025 | Inf | 0.0025 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
| GO:0050613 | 0.0025 | Inf | 0.0025 | 1 | 1 | delta14-sterol reductase activity |
| GO:1903924 | 0.0025 | Inf | 0.0025 | 1 | 1 | estradiol binding |
| GO:0008235 | 0.0048 | 21.3145 | 0.1043 | 2 | 42 | metalloexopeptidase activity |
| GO:0005153 | 0.005 | 414.1875 | 0.005 | 1 | 2 | interleukin-8 receptor binding |
| GO:0019144 | 0.005 | 414.1875 | 0.005 | 1 | 2 | ADP-sugar diphosphatase activity |
| GO:0070401 | 0.005 | 414.1875 | 0.005 | 1 | 2 | NADP+ binding |
| GO:0043262 | 0.0074 | 207.0781 | 0.0075 | 1 | 3 | adenosine-diphosphatase activity |
| GO:0047631 | 0.0074 | 207.0781 | 0.0075 | 1 | 3 | ADP-ribose diphosphatase activity |
| GO:0004095 | 0.0099 | 138.0417 | 0.0099 | 1 | 4 | carnitine O-palmitoyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004057 | 0.0037 | Inf | 0.0037 | 1 | 1 | arginyltransferase activity |
| GO:0004087 | 0.0074 | 275.7917 | 0.0074 | 1 | 2 | carbamoyl-phosphate synthase (ammonia) activity |
| GO:0004088 | 0.0074 | 275.7917 | 0.0074 | 1 | 2 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003785 | 0.0011 | 48.6654 | 0.0486 | 2 | 19 | actin monomer binding |
| GO:0004043 | 0.0026 | Inf | 0.0026 | 1 | 1 | L-aminoadipate-semialdehyde dehydrogenase activity |
| GO:0004991 | 0.0026 | Inf | 0.0026 | 1 | 1 | parathyroid hormone receptor activity |
| GO:0008802 | 0.0026 | Inf | 0.0026 | 1 | 1 | betaine-aldehyde dehydrogenase activity |
| GO:0009400 | 0.0026 | Inf | 0.0026 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
| GO:0070888 | 0.0036 | 25.0398 | 0.0896 | 2 | 35 | E-box binding |
| GO:0008260 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0017077 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | oxidative phosphorylation uncoupler activity |
| GO:0070506 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | high-density lipoprotein particle receptor activity |
| GO:0017022 | 0.0056 | 19.6607 | 0.1126 | 2 | 44 | myosin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004126 | 0 | 779.4706 | 0.0081 | 2 | 3 | cytidine deaminase activity |
| GO:0008829 | 0.0027 | Inf | 0.0027 | 1 | 1 | dCTP deaminase activity |
| GO:0033560 | 0.0027 | Inf | 0.0027 | 1 | 1 | folate reductase activity |
| GO:0000406 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004146 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | dihydrofolate reductase activity |
| GO:0032142 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0047844 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | deoxycytidine deaminase activity |
| GO:0051870 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | methotrexate binding |
| GO:0005085 | 0.007 | 5.7911 | 0.7694 | 4 | 284 | guanyl-nucleotide exchange factor activity |
| GO:0017112 | 0.0077 | 16.5269 | 0.1328 | 2 | 49 | Rab guanyl-nucleotide exchange factor activity |
| GO:0000404 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | heteroduplex DNA loop binding |
| GO:0016174 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | NAD(P)H oxidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043394 | 0.0018 | 35.9484 | 0.064 | 2 | 25 | proteoglycan binding |
| GO:0000149 | 0.0024 | 12.4564 | 0.2687 | 3 | 102 | SNARE binding |
| GO:0004336 | 0.0026 | Inf | 0.0026 | 1 | 1 | galactosylceramidase activity |
| GO:0005157 | 0.0026 | Inf | 0.0026 | 1 | 1 | macrophage colony-stimulating factor receptor binding |
| GO:0045485 | 0.0026 | Inf | 0.0026 | 1 | 1 | omega-6 fatty acid desaturase activity |
| GO:0000248 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | C-5 sterol desaturase activity |
| GO:0008396 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | oxysterol 7-alpha-hydroxylase activity |
| GO:0030305 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | heparanase activity |
| GO:0035373 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | chondroitin sulfate proteoglycan binding |
| GO:0017116 | 0.0079 | 194.8676 | 0.0079 | 1 | 3 | single-stranded DNA-dependent ATP-dependent DNA helicase activity |
| GO:0031852 | 0.0079 | 194.8676 | 0.0079 | 1 | 3 | mu-type opioid receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050661 | 8e-04 | 57.3117 | 0.0421 | 2 | 35 | NADP binding |
| GO:0003957 | 0.0012 | Inf | 0.0012 | 1 | 1 | NAD(P)+ transhydrogenase (B-specific) activity |
| GO:0005018 | 0.0012 | Inf | 0.0012 | 1 | 1 | platelet-derived growth factor alpha-receptor activity |
| GO:0008750 | 0.0012 | Inf | 0.0012 | 1 | 1 | NAD(P)+ transhydrogenase (AB-specific) activity |
| GO:0016652 | 0.0012 | Inf | 0.0012 | 1 | 1 | oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor |
| GO:0018455 | 0.0012 | Inf | 0.0012 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0050613 | 0.0012 | Inf | 0.0012 | 1 | 1 | delta14-sterol reductase activity |
| GO:0050683 | 0.0012 | Inf | 0.0012 | 1 | 1 | AF-1 domain binding |
| GO:0038085 | 0.0024 | 884.7333 | 0.0024 | 1 | 2 | vascular endothelial growth factor binding |
| GO:0016491 | 0.0036 | 7.7544 | 0.6635 | 4 | 551 | oxidoreductase activity |
| GO:0004090 | 0.0036 | 442.3333 | 0.0036 | 1 | 3 | carbonyl reductase (NADPH) activity |
| GO:0019863 | 0.0036 | 442.3333 | 0.0036 | 1 | 3 | IgE binding |
| GO:0035939 | 0.0036 | 442.3333 | 0.0036 | 1 | 3 | microsatellite binding |
| GO:0000253 | 0.0048 | 294.8667 | 0.0048 | 1 | 4 | 3-keto sterol reductase activity |
| GO:0050733 | 0.006 | 221.1333 | 0.006 | 1 | 5 | RS domain binding |
| GO:0005021 | 0.0084 | 147.4 | 0.0084 | 1 | 7 | vascular endothelial growth factor-activated receptor activity |
| GO:0052650 | 0.0096 | 126.3333 | 0.0096 | 1 | 8 | NADP-retinol dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 7.6707 | 1.763 | 11 | 411 | protein heterodimerization activity |
| GO:0031492 | 7e-04 | 19.288 | 0.1759 | 3 | 41 | nucleosomal DNA binding |
| GO:0004031 | 0.0043 | Inf | 0.0043 | 1 | 1 | aldehyde oxidase activity |
| GO:0004603 | 0.0043 | Inf | 0.0043 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
| GO:0102797 | 0.0043 | Inf | 0.0043 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0043 | Inf | 0.0043 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0003875 | 0.0086 | 236.25 | 0.0086 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GO:0070506 | 0.0086 | 236.25 | 0.0086 | 1 | 2 | high-density lipoprotein particle receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047844 | 0 | Inf | 0.0084 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0004126 | 1e-04 | 490.037 | 0.0126 | 2 | 3 | cytidine deaminase activity |
| GO:0016810 | 0.0014 | 9.011 | 0.4889 | 4 | 116 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0001567 | 0.0042 | Inf | 0.0042 | 1 | 1 | cholesterol 25-hydroxylase activity |
| GO:0004042 | 0.0042 | Inf | 0.0042 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0008829 | 0.0042 | Inf | 0.0042 | 1 | 1 | dCTP deaminase activity |
| GO:0017064 | 0.0042 | Inf | 0.0042 | 1 | 1 | fatty acid amide hydrolase activity |
| GO:0102077 | 0.0042 | Inf | 0.0042 | 1 | 1 | oleamide hydrolase activity |
| GO:0103045 | 0.0042 | Inf | 0.0042 | 1 | 1 | methione N-acyltransferase activity |
| GO:0103073 | 0.0042 | Inf | 0.0042 | 1 | 1 | anandamide amidohydrolase activity |
| GO:0046982 | 0.0074 | 3.8006 | 1.7321 | 6 | 411 | protein heterodimerization activity |
| GO:0003998 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | acylphosphatase activity |
| GO:0004040 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | amidase activity |
| GO:0008396 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | oxysterol 7-alpha-hydroxylase activity |
| GO:0019834 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | phospholipase A2 inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004447 | 0.0023 | Inf | 0.0023 | 1 | 1 | iodide peroxidase activity |
| GO:0004825 | 0.0045 | 457.1379 | 0.0045 | 1 | 2 | methionine-tRNA ligase activity |
| GO:0016603 | 0.0045 | 457.1379 | 0.0045 | 1 | 2 | glutaminyl-peptide cyclotransferase activity |
| GO:0098640 | 0.0045 | 457.1379 | 0.0045 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
| GO:0004995 | 0.0068 | 228.5517 | 0.0068 | 1 | 3 | tachykinin receptor activity |
| GO:0004095 | 0.009 | 152.3563 | 0.009 | 1 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0030023 | 0.009 | 152.3563 | 0.009 | 1 | 4 | extracellular matrix constituent conferring elasticity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008173 | 1e-04 | 36.0355 | 0.0997 | 3 | 53 | RNA methyltransferase activity |
| GO:0004411 | 0.0019 | Inf | 0.0019 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
| GO:0033682 | 0.0019 | Inf | 0.0019 | 1 | 1 | ATP-dependent 5'-3' DNA/RNA helicase activity |
| GO:0050290 | 0.0019 | Inf | 0.0019 | 1 | 1 | sphingomyelin phosphodiesterase D activity |
| GO:0005153 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | interleukin-8 receptor binding |
| GO:0016300 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | tRNA (uracil) methyltransferase activity |
| GO:1990269 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | RNA polymerase II C-terminal domain phosphoserine binding |
| GO:0000293 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | ferric-chelate reductase activity |
| GO:0005094 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0010521 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | telomerase inhibitor activity |
| GO:0017116 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | single-stranded DNA-dependent ATP-dependent DNA helicase activity |
| GO:0033677 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | DNA/RNA helicase activity |
| GO:0016741 | 0.0056 | 9.2834 | 0.3669 | 3 | 195 | transferase activity, transferring one-carbon groups |
| GO:0043141 | 0.0075 | 184.1667 | 0.0075 | 1 | 4 | ATP-dependent 5'-3' DNA helicase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 2e-04 | 32.5485 | 0.113 | 3 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0070888 | 0.0011 | 47.1872 | 0.05 | 2 | 35 | E-box binding |
| GO:0045485 | 0.0014 | Inf | 0.0014 | 1 | 1 | omega-6 fatty acid desaturase activity |
| GO:0000248 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | C-5 sterol desaturase activity |
| GO:0008184 | 0.0043 | 368.5278 | 0.0043 | 1 | 3 | glycogen phosphorylase activity |
| GO:0102250 | 0.0043 | 368.5278 | 0.0043 | 1 | 3 | linear malto-oligosaccharide phosphorylase activity |
| GO:0102499 | 0.0043 | 368.5278 | 0.0043 | 1 | 3 | SHG alpha-glucan phosphorylase activity |
| GO:0015643 | 0.0086 | 147.3778 | 0.0086 | 1 | 6 | toxic substance binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 2e-04 | 163.321 | 0.0211 | 2 | 5 | molybdopterin cofactor binding |
| GO:0004031 | 0.0042 | Inf | 0.0042 | 1 | 1 | aldehyde oxidase activity |
| GO:0008482 | 0.0042 | Inf | 0.0042 | 1 | 1 | sulfite oxidase activity |
| GO:0047273 | 0.0042 | Inf | 0.0042 | 1 | 1 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity |
| GO:0102797 | 0.0042 | Inf | 0.0042 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0042 | Inf | 0.0042 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0020037 | 0.0048 | 9.5457 | 0.3414 | 3 | 81 | heme binding |
| GO:0003875 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GO:0005153 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | interleukin-8 receptor binding |
| GO:0019834 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | phospholipase A2 inhibitor activity |
| GO:0030305 | 0.0084 | 240.5636 | 0.0084 | 1 | 2 | heparanase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 6e-04 | 5.5203 | 1.5027 | 7 | 512 | calcium ion binding |
| GO:0005198 | 0.0044 | 4.3633 | 1.5731 | 6 | 536 | structural molecule activity |
| GO:0004794 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | L-threonine ammonia-lyase activity |
| GO:0035373 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | chondroitin sulfate proteoglycan binding |
| GO:0036461 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | BLOC-2 complex binding |
| GO:0048306 | 0.0083 | 15.8607 | 0.1379 | 2 | 47 | calcium-dependent protein binding |
| GO:0003941 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | L-serine ammonia-lyase activity |
| GO:0004465 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | lipoprotein lipase activity |
| GO:0004995 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | tachykinin receptor activity |
| GO:0033745 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | L-methionine-(R)-S-oxide reductase activity |
| GO:0035651 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | AP-3 adaptor complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005201 | 3e-04 | 26.3418 | 0.1317 | 3 | 50 | extracellular matrix structural constituent |
| GO:0004861 | 4e-04 | 89.1852 | 0.029 | 2 | 11 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0008482 | 0.0026 | Inf | 0.0026 | 1 | 1 | sulfite oxidase activity |
| GO:0035373 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | chondroitin sulfate proteoglycan binding |
| GO:0098640 | 0.0053 | 389.7647 | 0.0053 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
| GO:0004857 | 0.0054 | 6.2757 | 0.7138 | 4 | 271 | enzyme inhibitor activity |
| GO:0004867 | 0.0065 | 18.1942 | 0.1212 | 2 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0070573 | 0.0079 | 194.8676 | 0.0079 | 1 | 3 | metallodipeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004504 | 0.0013 | Inf | 0.0013 | 1 | 1 | peptidylglycine monooxygenase activity |
| GO:0004598 | 0.0013 | Inf | 0.0013 | 1 | 1 | peptidylamidoglycolate lyase activity |
| GO:0061629 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
| GO:0019958 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | C-X-C chemokine binding |
| GO:0043199 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | sulfate binding |
| GO:0016494 | 0.0064 | 207.2969 | 0.0064 | 1 | 5 | C-X-C chemokine receptor activity |
| GO:0042826 | 0.0064 | 18.8932 | 0.1215 | 2 | 95 | histone deacetylase binding |
| GO:0004931 | 0.0077 | 165.825 | 0.0077 | 1 | 6 | extracellularly ATP-gated cation channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003881 | 0.0025 | Inf | 0.0025 | 1 | 1 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity |
| GO:0004055 | 0.0025 | Inf | 0.0025 | 1 | 1 | argininosuccinate synthase activity |
| GO:0004367 | 0.0025 | Inf | 0.0025 | 1 | 1 | glycerol-3-phosphate dehydrogenase [NAD+] activity |
| GO:0005070 | 0.004 | 23.69 | 0.0944 | 2 | 38 | SH3/SH2 adaptor activity |
| GO:0004368 | 0.005 | 414.1875 | 0.005 | 1 | 2 | glycerol-3-phosphate dehydrogenase activity |
| GO:0004867 | 0.0058 | 19.371 | 0.1142 | 2 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0005025 | 0.0074 | 207.0781 | 0.0075 | 1 | 3 | transforming growth factor beta receptor activity, type I |
| GO:0015016 | 0.0099 | 138.0417 | 0.0099 | 1 | 4 | [heparan sulfate]-glucosamine N-sulfotransferase activity |
| GO:0016361 | 0.0099 | 138.0417 | 0.0099 | 1 | 4 | activin receptor activity, type I |
| GO:0016520 | 0.0099 | 138.0417 | 0.0099 | 1 | 4 | growth hormone-releasing hormone receptor activity |
| GO:0098821 | 0.0099 | 138.0417 | 0.0099 | 1 | 4 | BMP receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005018 | 0.0017 | Inf | 0.0017 | 1 | 1 | platelet-derived growth factor alpha-receptor activity |
| GO:0031732 | 0.0017 | Inf | 0.0017 | 1 | 1 | CCR7 chemokine receptor binding |
| GO:0004365 | 0.0035 | 602.9091 | 0.0035 | 1 | 2 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
| GO:0038085 | 0.0035 | 602.9091 | 0.0035 | 1 | 2 | vascular endothelial growth factor binding |
| GO:0004351 | 0.0052 | 301.4318 | 0.0052 | 1 | 3 | glutamate decarboxylase activity |
| GO:0050733 | 0.0086 | 150.6932 | 0.0087 | 1 | 5 | RS domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1990190 | 0.0014 | Inf | 0.0014 | 1 | 1 | peptide-glutamate-N-acetyltransferase activity |
| GO:0034212 | 0.0025 | 31.1035 | 0.0744 | 2 | 52 | peptide N-acetyltransferase activity |
| GO:0003873 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | 6-phosphofructo-2-kinase activity |
| GO:0099583 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
| GO:1990189 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | peptide-serine-N-acetyltransferase activity |
| GO:0004331 | 0.0043 | 368.5278 | 0.0043 | 1 | 3 | fructose-2,6-bisphosphate 2-phosphatase activity |
| GO:0016410 | 0.0052 | 20.9777 | 0.1087 | 2 | 76 | N-acyltransferase activity |
| GO:0016407 | 0.0056 | 20.1558 | 0.113 | 2 | 79 | acetyltransferase activity |
| GO:0050733 | 0.0071 | 184.2361 | 0.0071 | 1 | 5 | RS domain binding |
| GO:0019203 | 0.0086 | 147.3778 | 0.0086 | 1 | 6 | carbohydrate phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005164 | 4e-04 | 81.7901 | 0.0301 | 2 | 20 | tumor necrosis factor receptor binding |
| GO:0004991 | 0.0015 | Inf | 0.0015 | 1 | 1 | parathyroid hormone receptor activity |
| GO:0005175 | 0.0015 | Inf | 0.0015 | 1 | 1 | CD27 receptor binding |
| GO:0086057 | 0.0015 | Inf | 0.0015 | 1 | 1 | voltage-gated calcium channel activity involved in bundle of His cell action potential |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005164 | 6e-04 | 63.9855 | 0.0376 | 2 | 20 | tumor necrosis factor receptor binding |
| GO:0043394 | 0.0012 | 46.0452 | 0.0508 | 2 | 27 | proteoglycan binding |
| GO:0005125 | 0.0015 | 15.0619 | 0.2295 | 3 | 122 | cytokine activity |
| GO:0004769 | 0.0019 | Inf | 0.0019 | 1 | 1 | steroid delta-isomerase activity |
| GO:0005019 | 0.0019 | Inf | 0.0019 | 1 | 1 | platelet-derived growth factor beta-receptor activity |
| GO:0005157 | 0.0019 | Inf | 0.0019 | 1 | 1 | macrophage colony-stimulating factor receptor binding |
| GO:0005174 | 0.0019 | Inf | 0.0019 | 1 | 1 | CD40 receptor binding |
| GO:0102294 | 0.0019 | Inf | 0.0019 | 1 | 1 | cholesterol dehydrogenase activity |
| GO:0004687 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | myosin light chain kinase activity |
| GO:0004992 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | platelet activating factor receptor activity |
| GO:0019834 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | phospholipase A2 inhibitor activity |
| GO:0030305 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | heparanase activity |
| GO:0003854 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GO:0004464 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | leukotriene-C4 synthase activity |
| GO:0005127 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | ciliary neurotrophic factor receptor binding |
| GO:0043237 | 0.0094 | 138.1146 | 0.0094 | 1 | 5 | laminin-1 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008307 | 0.0015 | 40.8395 | 0.0572 | 2 | 38 | structural constituent of muscle |
| GO:0030977 | 0.0015 | Inf | 0.0015 | 1 | 1 | taurine binding |
| GO:1990190 | 0.0015 | Inf | 0.0015 | 1 | 1 | peptide-glutamate-N-acetyltransferase activity |
| GO:0008260 | 0.003 | 698.2632 | 0.003 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0070506 | 0.003 | 698.2632 | 0.003 | 1 | 2 | high-density lipoprotein particle receptor activity |
| GO:1990189 | 0.003 | 698.2632 | 0.003 | 1 | 2 | peptide-serine-N-acetyltransferase activity |
| GO:0016782 | 0.0036 | 25.3065 | 0.0903 | 2 | 60 | transferase activity, transferring sulfur-containing groups |
| GO:0046872 | 0.0043 | 3.6228 | 5.0542 | 11 | 3358 | metal ion binding |
| GO:0016934 | 0.0045 | 349.1053 | 0.0045 | 1 | 3 | extracellularly glycine-gated chloride channel activity |
| GO:0031433 | 0.0045 | 349.1053 | 0.0045 | 1 | 3 | telethonin binding |
| GO:0003810 | 0.006 | 232.7193 | 0.006 | 1 | 4 | protein-glutamine gamma-glutamyltransferase activity |
| GO:0047756 | 0.006 | 232.7193 | 0.006 | 1 | 4 | chondroitin 4-sulfotransferase activity |
| GO:0001537 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | N-acetylgalactosamine 4-O-sulfotransferase activity |
| GO:1903136 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | cuprous ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050840 | 0 | 54.4074 | 0.0933 | 4 | 40 | extracellular matrix binding |
| GO:0008482 | 0.0023 | Inf | 0.0023 | 1 | 1 | sulfite oxidase activity |
| GO:0031835 | 0.0023 | Inf | 0.0023 | 1 | 1 | substance P receptor binding |
| GO:0032440 | 0.0023 | Inf | 0.0023 | 1 | 1 | 2-alkenal reductase [NAD(P)] activity |
| GO:0004103 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | choline kinase activity |
| GO:0042806 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | fucose binding |
| GO:0047844 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | deoxycytidine deaminase activity |
| GO:0036132 | 0.007 | 220.9167 | 0.007 | 1 | 3 | 13-prostaglandin reductase activity |
| GO:0047522 | 0.007 | 220.9167 | 0.007 | 1 | 3 | 15-oxoprostaglandin 13-oxidase activity |
| GO:0030246 | 0.0083 | 7.9177 | 0.4199 | 3 | 180 | carbohydrate binding |
| GO:0004305 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | ethanolamine kinase activity |
| GO:0004634 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | phosphopyruvate hydratase activity |
| GO:0030151 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | molybdenum ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003827 | 0.0027 | Inf | 0.0027 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0003944 | 0.0027 | Inf | 0.0027 | 1 | 1 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity |
| GO:0004367 | 0.0027 | Inf | 0.0027 | 1 | 1 | glycerol-3-phosphate dehydrogenase [NAD+] activity |
| GO:0008241 | 0.0027 | Inf | 0.0027 | 1 | 1 | peptidyl-dipeptidase activity |
| GO:0033560 | 0.0027 | Inf | 0.0027 | 1 | 1 | folate reductase activity |
| GO:0050897 | 0.0027 | Inf | 0.0027 | 1 | 1 | cobalt ion binding |
| GO:0097383 | 0.0027 | Inf | 0.0027 | 1 | 1 | dIDP diphosphatase activity |
| GO:1901640 | 0.0027 | Inf | 0.0027 | 1 | 1 | XTP binding |
| GO:1901641 | 0.0027 | Inf | 0.0027 | 1 | 1 | ITP binding |
| GO:1990003 | 0.0027 | Inf | 0.0027 | 1 | 1 | IDP phosphatase activity |
| GO:0046983 | 0.0053 | 3.43 | 2.7824 | 8 | 1027 | protein dimerization activity |
| GO:0000406 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004146 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | dihydrofolate reductase activity |
| GO:0004368 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | glycerol-3-phosphate dehydrogenase activity |
| GO:0008240 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | tripeptidyl-peptidase activity |
| GO:0031711 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | bradykinin receptor binding |
| GO:0032142 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0035870 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | dITP diphosphatase activity |
| GO:0051870 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | methotrexate binding |
| GO:0000404 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | heteroduplex DNA loop binding |
| GO:0004165 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | dodecenoyl-CoA delta-isomerase activity |
| GO:0016508 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0070573 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | metallodipeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001785 | 0.0015 | Inf | 0.0015 | 1 | 1 | prostaglandin J receptor activity |
| GO:0004956 | 0.0015 | Inf | 0.0015 | 1 | 1 | prostaglandin D receptor activity |
| GO:0046982 | 0.0029 | 7.8999 | 0.6186 | 4 | 411 | protein heterodimerization activity |
| GO:0070053 | 0.0045 | 349.1053 | 0.0045 | 1 | 3 | thrombospondin receptor activity |
| GO:0003705 | 0.0075 | 17.2327 | 0.1309 | 2 | 87 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
| GO:0004957 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | prostaglandin E receptor activity |
| GO:0004875 | 0.009 | 139.6105 | 0.009 | 1 | 6 | complement receptor activity |
| GO:0050786 | 0.009 | 139.6105 | 0.009 | 1 | 6 | RAGE receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004509 | 0.002 | Inf | 0.002 | 1 | 1 | steroid 21-monooxygenase activity |
| GO:0017082 | 0.002 | Inf | 0.002 | 1 | 1 | mineralocorticoid receptor activity |
| GO:0001026 | 0.0041 | 510 | 0.0041 | 1 | 2 | TFIIIB-type transcription factor activity |
| GO:0004980 | 0.0041 | 510 | 0.0041 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
| GO:0008520 | 0.0041 | 510 | 0.0041 | 1 | 2 | L-ascorbate:sodium symporter activity |
| GO:0070890 | 0.0041 | 510 | 0.0041 | 1 | 2 | sodium-dependent L-ascorbate transmembrane transporter activity |
| GO:0042562 | 0.0046 | 22.0217 | 0.1016 | 2 | 50 | hormone binding |
| GO:0005496 | 0.0057 | 19.5659 | 0.1138 | 2 | 56 | steroid binding |
| GO:0001156 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | TFIIIC-class transcription factor binding |
| GO:0019797 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | procollagen-proline 3-dioxygenase activity |
| GO:0033300 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | dehydroascorbic acid transporter activity |
| GO:0015205 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | nucleobase transmembrane transporter activity |
| GO:0030284 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | estrogen receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 1e-04 | 210.1746 | 0.0166 | 2 | 5 | molybdopterin cofactor binding |
| GO:0004031 | 0.0033 | Inf | 0.0033 | 1 | 1 | aldehyde oxidase activity |
| GO:0004769 | 0.0033 | Inf | 0.0033 | 1 | 1 | steroid delta-isomerase activity |
| GO:0005157 | 0.0033 | Inf | 0.0033 | 1 | 1 | macrophage colony-stimulating factor receptor binding |
| GO:0008482 | 0.0033 | Inf | 0.0033 | 1 | 1 | sulfite oxidase activity |
| GO:0032440 | 0.0033 | Inf | 0.0033 | 1 | 1 | 2-alkenal reductase [NAD(P)] activity |
| GO:0102294 | 0.0033 | Inf | 0.0033 | 1 | 1 | cholesterol dehydrogenase activity |
| GO:0102797 | 0.0033 | Inf | 0.0033 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0033 | Inf | 0.0033 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0016614 | 0.0041 | 10.1276 | 0.3245 | 3 | 98 | oxidoreductase activity, acting on CH-OH group of donors |
| GO:0030305 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | heparanase activity |
| GO:0050840 | 0.0077 | 16.5489 | 0.1325 | 2 | 40 | extracellular matrix binding |
| GO:0031492 | 0.0081 | 16.1233 | 0.1358 | 2 | 41 | nucleosomal DNA binding |
| GO:0003854 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
| GO:0005025 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | transforming growth factor beta receptor activity, type I |
| GO:0036132 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 13-prostaglandin reductase activity |
| GO:0047522 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 15-oxoprostaglandin 13-oxidase activity |
| GO:1990599 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 3' overhang single-stranded DNA endodeoxyribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033560 | 0.0013 | Inf | 0.0013 | 1 | 1 | folate reductase activity |
| GO:0090409 | 0.0013 | Inf | 0.0013 | 1 | 1 | malonyl-CoA synthetase activity |
| GO:0000406 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004146 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | dihydrofolate reductase activity |
| GO:0032142 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0051870 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | methotrexate binding |
| GO:0000404 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | heteroduplex DNA loop binding |
| GO:0050501 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | hyaluronan synthase activity |
| GO:0003796 | 0.0064 | 207.2969 | 0.0064 | 1 | 5 | lysozyme activity |
| GO:1903136 | 0.0064 | 207.2969 | 0.0064 | 1 | 5 | cuprous ion binding |
| GO:0000403 | 0.0077 | 165.825 | 0.0077 | 1 | 6 | Y-form DNA binding |
| GO:0005542 | 0.0089 | 138.1771 | 0.009 | 1 | 7 | folic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0026 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 1e-04 | 147.3222 | 0.0179 | 2 | 14 | MHC class I protein binding |
| GO:0004180 | 6e-04 | 65.4025 | 0.0371 | 2 | 29 | carboxypeptidase activity |
| GO:0070888 | 9e-04 | 53.4869 | 0.0448 | 2 | 35 | E-box binding |
| GO:0001179 | 0.0013 | Inf | 0.0013 | 1 | 1 | RNA polymerase I transcription factor binding |
| GO:0003873 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | 6-phosphofructo-2-kinase activity |
| GO:0004331 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | fructose-2,6-bisphosphate 2-phosphatase activity |
| GO:0003839 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | gamma-glutamylcyclotransferase activity |
| GO:0042803 | 0.0071 | 6.2572 | 0.8009 | 4 | 626 | protein homodimerization activity |
| GO:0019203 | 0.0077 | 165.825 | 0.0077 | 1 | 6 | carbohydrate phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004411 | 0.0016 | Inf | 0.0016 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
| GO:0005153 | 0.0032 | 663.3 | 0.0032 | 1 | 2 | interleukin-8 receptor binding |
| GO:1990269 | 0.0032 | 663.3 | 0.0032 | 1 | 2 | RNA polymerase II C-terminal domain phosphoserine binding |
| GO:0098772 | 0.0038 | 4.3848 | 2.1572 | 7 | 1365 | molecular function regulator |
| GO:0005094 | 0.0047 | 331.625 | 0.0047 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0003810 | 0.0063 | 221.0667 | 0.0063 | 1 | 4 | protein-glutamine gamma-glutamyltransferase activity |
| GO:0015643 | 0.0094 | 132.62 | 0.0095 | 1 | 6 | toxic substance binding |
| GO:0048018 | 0.0096 | 7.7304 | 0.4472 | 3 | 283 | receptor ligand activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007275 | 6e-04 | 1.6761 | 55.0248 | 76 | 4704 | multicellular organism development |
| GO:0007588 | 8e-04 | 7.5966 | 0.7252 | 5 | 62 | excretion |
| GO:1903232 | 0.0013 | 56.9545 | 0.0585 | 2 | 5 | melanosome assembly |
| GO:0009888 | 0.0015 | 1.8662 | 20.1547 | 34 | 1723 | tissue development |
| GO:0002548 | 0.0017 | 8.6201 | 0.5147 | 4 | 44 | monocyte chemotaxis |
| GO:0032502 | 0.002 | 1.5669 | 64.874 | 84 | 5546 | developmental process |
| GO:0007156 | 0.0021 | 4.2048 | 1.778 | 7 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0048513 | 0.0033 | 1.621 | 35.5251 | 51 | 3037 | animal organ development |
| GO:0010917 | 0.0036 | 28.4716 | 0.0936 | 2 | 8 | negative regulation of mitochondrial membrane potential |
| GO:0010940 | 0.0036 | 28.4716 | 0.0936 | 2 | 8 | positive regulation of necrotic cell death |
| GO:0030856 | 0.0044 | 4.162 | 1.5324 | 6 | 131 | regulation of epithelial cell differentiation |
| GO:0050789 | 0.0048 | 1.5676 | 116.5065 | 133 | 9960 | regulation of biological process |
| GO:0007611 | 0.0049 | 3.2294 | 2.6202 | 8 | 224 | learning or memory |
| GO:0070268 | 0.0049 | 4.8548 | 1.0996 | 5 | 94 | cornification |
| GO:0006885 | 0.0054 | 4.7475 | 1.123 | 5 | 96 | regulation of pH |
| GO:0009583 | 0.0056 | 6.0423 | 0.7135 | 4 | 61 | detection of light stimulus |
| GO:0030432 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | peristalsis |
| GO:0035646 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | endosome to melanosome transport |
| GO:0035878 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | nail development |
| GO:0048757 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | pigment granule maturation |
| GO:0048598 | 0.0067 | 2.2446 | 6.6091 | 14 | 565 | embryonic morphogenesis |
| GO:0043476 | 0.007 | 18.9773 | 0.1287 | 2 | 11 | pigment accumulation |
| GO:0048484 | 0.007 | 18.9773 | 0.1287 | 2 | 11 | enteric nervous system development |
| GO:0030593 | 0.0082 | 5.379 | 0.7954 | 4 | 68 | neutrophil chemotaxis |
| GO:0072677 | 0.0083 | 17.0784 | 0.1404 | 2 | 12 | eosinophil migration |
| GO:0048584 | 0.0084 | 1.6476 | 22.4474 | 34 | 1919 | positive regulation of response to stimulus |
| GO:0008306 | 0.0087 | 5.2958 | 0.8071 | 4 | 69 | associative learning |
| GO:0001501 | 0.0088 | 2.3223 | 5.451 | 12 | 466 | skeletal system development |
| GO:0045616 | 0.0091 | 7.5655 | 0.4328 | 3 | 37 | regulation of keratinocyte differentiation |
| GO:0030154 | 0.0096 | 1.4919 | 42.8828 | 57 | 3666 | cell differentiation |
| GO:0009913 | 0.0097 | 2.8534 | 2.9478 | 8 | 252 | epidermal cell differentiation |
| GO:0050908 | 0.0098 | 15.5248 | 0.1521 | 2 | 13 | detection of light stimulus involved in visual perception |
| GO:0072216 | 0.0098 | 15.5248 | 0.1521 | 2 | 13 | positive regulation of metanephros development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 1e-04 | 4.6638 | 2.3378 | 10 | 154 | chromatin assembly or disassembly |
| GO:0051290 | 2e-04 | 11.0295 | 0.5313 | 5 | 35 | protein heterotetramerization |
| GO:0006323 | 3e-04 | 4.2195 | 2.5655 | 10 | 169 | DNA packaging |
| GO:0006335 | 4e-04 | 13.1859 | 0.3643 | 4 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0045637 | 5e-04 | 3.5698 | 3.3093 | 11 | 218 | regulation of myeloid cell differentiation |
| GO:0000183 | 6e-04 | 11.9856 | 0.3947 | 4 | 26 | chromatin silencing at rDNA |
| GO:0042531 | 0.0014 | 6.6088 | 0.8349 | 5 | 55 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0071294 | 0.002 | 14.0714 | 0.2581 | 3 | 17 | cellular response to zinc ion |
| GO:0006334 | 0.002 | 4.9279 | 1.3148 | 6 | 88 | nucleosome assembly |
| GO:0051970 | 0.0022 | 43.6186 | 0.0759 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0071824 | 0.0027 | 3.0511 | 3.4763 | 10 | 229 | protein-DNA complex subunit organization |
| GO:0070838 | 0.0041 | 2.3708 | 6.2391 | 14 | 411 | divalent metal ion transport |
| GO:0045815 | 0.0042 | 5.0786 | 1.0626 | 5 | 70 | positive regulation of gene expression, epigenetic |
| GO:1904894 | 0.0042 | 5.0786 | 1.0626 | 5 | 70 | positive regulation of STAT cascade |
| GO:0060218 | 0.0044 | 4.1799 | 1.5332 | 6 | 101 | hematopoietic stem cell differentiation |
| GO:1901532 | 0.0044 | 4.1799 | 1.5332 | 6 | 101 | regulation of hematopoietic progenitor cell differentiation |
| GO:0035754 | 0.0046 | 26.1677 | 0.1063 | 2 | 7 | B cell chemotaxis |
| GO:0007565 | 0.0053 | 3.1834 | 2.6566 | 8 | 175 | female pregnancy |
| GO:0002230 | 0.0055 | 9.3766 | 0.3643 | 3 | 24 | positive regulation of defense response to virus by host |
| GO:0045814 | 0.0061 | 3.8912 | 1.6395 | 6 | 108 | negative regulation of gene expression, epigenetic |
| GO:0009190 | 0.0064 | 3.3871 | 2.186 | 7 | 144 | cyclic nucleotide biosynthetic process |
| GO:0042742 | 0.0067 | 3.0539 | 2.7628 | 8 | 182 | defense response to bacterium |
| GO:0002682 | 0.0067 | 1.6973 | 19.5068 | 31 | 1285 | regulation of immune system process |
| GO:0051091 | 0.0073 | 2.7852 | 3.4004 | 9 | 224 | positive regulation of DNA binding transcription factor activity |
| GO:0010469 | 0.0076 | 2.1354 | 7.3929 | 15 | 487 | regulation of receptor activity |
| GO:0042363 | 0.0077 | 18.6887 | 0.1366 | 2 | 9 | fat-soluble vitamin catabolic process |
| GO:0042104 | 0.0077 | 8.2029 | 0.4099 | 3 | 27 | positive regulation of activated T cell proliferation |
| GO:0032735 | 0.0085 | 7.8742 | 0.4251 | 3 | 28 | positive regulation of interleukin-12 production |
| GO:0033028 | 0.0085 | 7.8742 | 0.4251 | 3 | 28 | myeloid cell apoptotic process |
| GO:0032946 | 0.0092 | 3.5414 | 1.7913 | 6 | 118 | positive regulation of mononuclear cell proliferation |
| GO:0045087 | 0.0095 | 1.8699 | 11.279 | 20 | 743 | innate immune response |
| GO:0009071 | 0.0095 | 16.3515 | 0.1518 | 2 | 10 | serine family amino acid catabolic process |
| GO:0061140 | 0.0095 | 16.3515 | 0.1518 | 2 | 10 | lung secretory cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018298 | 2e-04 | 32.9934 | 0.1301 | 3 | 10 | protein-chromophore linkage |
| GO:0007568 | 3e-04 | 3.6058 | 3.5912 | 12 | 276 | aging |
| GO:0014826 | 5e-04 | 153.2449 | 0.039 | 2 | 3 | vein smooth muscle contraction |
| GO:0019087 | 5e-04 | 153.2449 | 0.039 | 2 | 3 | transformation of host cell by virus |
| GO:0035633 | 0.001 | 76.6173 | 0.052 | 2 | 4 | maintenance of permeability of blood-brain barrier |
| GO:1902075 | 0.001 | 76.6173 | 0.052 | 2 | 4 | cellular response to salt |
| GO:0072223 | 0.0016 | 51.0748 | 0.0651 | 2 | 5 | metanephric glomerular mesangium development |
| GO:0006701 | 0.0024 | 38.3036 | 0.0781 | 2 | 6 | progesterone biosynthetic process |
| GO:0030953 | 0.0034 | 30.6408 | 0.0911 | 2 | 7 | astral microtubule organization |
| GO:0031620 | 0.0034 | 30.6408 | 0.0911 | 2 | 7 | regulation of fever generation |
| GO:0046887 | 0.0036 | 4.3551 | 1.4703 | 6 | 113 | positive regulation of hormone secretion |
| GO:0043921 | 0.004 | 10.4874 | 0.3253 | 3 | 25 | modulation by host of viral transcription |
| GO:1904029 | 0.0043 | 5.0273 | 1.067 | 5 | 82 | regulation of cyclin-dependent protein kinase activity |
| GO:1905820 | 0.0045 | 25.5323 | 0.1041 | 2 | 8 | positive regulation of chromosome separation |
| GO:0052312 | 0.0045 | 10.0308 | 0.3383 | 3 | 26 | modulation of transcription in other organism involved in symbiotic interaction |
| GO:0043084 | 0.0057 | 21.8834 | 0.1171 | 2 | 9 | penile erection |
| GO:0061042 | 0.0071 | 19.1467 | 0.1301 | 2 | 10 | vascular wound healing |
| GO:0046839 | 0.0075 | 8.2368 | 0.4034 | 3 | 31 | phospholipid dephosphorylation |
| GO:0051047 | 0.0076 | 2.4726 | 4.6842 | 11 | 360 | positive regulation of secretion |
| GO:0051851 | 0.0077 | 5.5092 | 0.7807 | 4 | 60 | modification by host of symbiont morphology or physiology |
| GO:0050931 | 0.0082 | 7.9523 | 0.4164 | 3 | 32 | pigment cell differentiation |
| GO:0051817 | 0.0092 | 7.5651 | 0.4352 | 3 | 34 | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0044057 | 0.0099 | 2.1994 | 6.2196 | 13 | 478 | regulation of system process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010469 | 0 | 3.7131 | 4.4805 | 15 | 487 | regulation of receptor activity |
| GO:0009888 | 1e-04 | 2.3455 | 15.852 | 32 | 1723 | tissue development |
| GO:0003326 | 1e-04 | Inf | 0.0184 | 2 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 1e-04 | Inf | 0.0184 | 2 | 2 | pancreatic PP cell fate commitment |
| GO:0070098 | 2e-04 | 10.7016 | 0.5244 | 5 | 57 | chemokine-mediated signaling pathway |
| GO:0021530 | 3e-04 | 218.4928 | 0.0276 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0009913 | 5e-04 | 4.1939 | 2.3185 | 9 | 252 | epidermal cell differentiation |
| GO:0031424 | 6e-04 | 11.7041 | 0.3839 | 4 | 43 | keratinization |
| GO:0043588 | 6e-04 | 3.7634 | 2.8705 | 10 | 312 | skin development |
| GO:0071347 | 6e-04 | 7.9402 | 0.69 | 5 | 75 | cellular response to interleukin-1 |
| GO:0021779 | 8e-04 | 72.8213 | 0.046 | 2 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 8e-04 | 72.8213 | 0.046 | 2 | 5 | glial cell fate specification |
| GO:0070268 | 0.0017 | 6.2372 | 0.8648 | 5 | 94 | cornification |
| GO:0033141 | 0.0023 | 36.4034 | 0.0736 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0097398 | 0.0023 | 36.4034 | 0.0736 | 2 | 8 | cellular response to interleukin-17 |
| GO:0008630 | 0.0023 | 5.8409 | 0.92 | 5 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0046463 | 0.0031 | 11.3627 | 0.2944 | 3 | 32 | acylglycerol biosynthetic process |
| GO:0010656 | 0.0044 | 9.9827 | 0.3312 | 3 | 36 | negative regulation of muscle cell apoptotic process |
| GO:0060326 | 0.0047 | 3.6042 | 2.0609 | 7 | 224 | cell chemotaxis |
| GO:0048731 | 0.0048 | 1.612 | 38.5306 | 53 | 4188 | system development |
| GO:0045161 | 0.0052 | 21.8362 | 0.1104 | 2 | 12 | neuronal ion channel clustering |
| GO:0048247 | 0.0055 | 9.149 | 0.3588 | 3 | 39 | lymphocyte chemotaxis |
| GO:0030855 | 0.0056 | 2.9243 | 3.2739 | 9 | 374 | epithelial cell differentiation |
| GO:0009746 | 0.0061 | 3.8802 | 1.6376 | 6 | 178 | response to hexose |
| GO:0021794 | 0.0061 | 19.8498 | 0.1196 | 2 | 13 | thalamus development |
| GO:0030502 | 0.0061 | 19.8498 | 0.1196 | 2 | 13 | negative regulation of bone mineralization |
| GO:0046425 | 0.007 | 4.4302 | 1.196 | 5 | 130 | regulation of JAK-STAT cascade |
| GO:0089711 | 0.0071 | 18.1944 | 0.1288 | 2 | 14 | L-glutamate transmembrane transport |
| GO:1900017 | 0.0071 | 18.1944 | 0.1288 | 2 | 14 | positive regulation of cytokine production involved in inflammatory response |
| GO:0043266 | 0.0072 | 5.5838 | 0.7636 | 4 | 83 | regulation of potassium ion transport |
| GO:0045766 | 0.0072 | 4.3948 | 1.2052 | 5 | 131 | positive regulation of angiogenesis |
| GO:0071356 | 0.0079 | 3.2537 | 2.2725 | 7 | 247 | cellular response to tumor necrosis factor |
| GO:0006641 | 0.0081 | 5.3784 | 0.7912 | 4 | 86 | triglyceride metabolic process |
| GO:0010866 | 0.0082 | 16.7938 | 0.138 | 2 | 15 | regulation of triglyceride biosynthetic process |
| GO:0035988 | 0.0082 | 16.7938 | 0.138 | 2 | 15 | chondrocyte proliferation |
| GO:0043508 | 0.0082 | 16.7938 | 0.138 | 2 | 15 | negative regulation of JUN kinase activity |
| GO:0002305 | 0.0092 | Inf | 0.0092 | 1 | 1 | CD8-positive, gamma-delta intraepithelial T cell differentiation |
| GO:0003327 | 0.0092 | Inf | 0.0092 | 1 | 1 | type B pancreatic cell fate commitment |
| GO:0003421 | 0.0092 | Inf | 0.0092 | 1 | 1 | growth plate cartilage axis specification |
| GO:0009956 | 0.0092 | Inf | 0.0092 | 1 | 1 | radial pattern formation |
| GO:0010053 | 0.0092 | Inf | 0.0092 | 1 | 1 | root epidermal cell differentiation |
| GO:0021568 | 0.0092 | Inf | 0.0092 | 1 | 1 | rhombomere 2 development |
| GO:0046327 | 0.0092 | Inf | 0.0092 | 1 | 1 | glycerol biosynthetic process from pyruvate |
| GO:0048364 | 0.0092 | Inf | 0.0092 | 1 | 1 | root development |
| GO:0048764 | 0.0092 | Inf | 0.0092 | 1 | 1 | trichoblast maturation |
| GO:0060580 | 0.0092 | Inf | 0.0092 | 1 | 1 | ventral spinal cord interneuron fate determination |
| GO:0061185 | 0.0092 | Inf | 0.0092 | 1 | 1 | negative regulation of dermatome development |
| GO:0080147 | 0.0092 | Inf | 0.0092 | 1 | 1 | root hair cell development |
| GO:1902891 | 0.0092 | Inf | 0.0092 | 1 | 1 | negative regulation of root hair elongation |
| GO:1903403 | 0.0092 | Inf | 0.0092 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:1903888 | 0.0092 | Inf | 0.0092 | 1 | 1 | regulation of plant epidermal cell differentiation |
| GO:1905392 | 0.0092 | Inf | 0.0092 | 1 | 1 | plant organ morphogenesis |
| GO:2000067 | 0.0092 | Inf | 0.0092 | 1 | 1 | regulation of root morphogenesis |
| GO:2000538 | 0.0092 | Inf | 0.0092 | 1 | 1 | positive regulation of B cell chemotaxis |
| GO:0002323 | 0.0093 | 15.5932 | 0.1472 | 2 | 16 | natural killer cell activation involved in immune response |
| GO:0032502 | 0.0094 | 1.5173 | 51.0245 | 65 | 5546 | developmental process |
| GO:0010596 | 0.0097 | 7.3148 | 0.4416 | 3 | 48 | negative regulation of endothelial cell migration |
| GO:1901342 | 0.0099 | 3.1088 | 2.3737 | 7 | 258 | regulation of vasculature development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033512 | 8e-04 | 118.2688 | 0.0503 | 2 | 3 | L-lysine catabolic process to acetyl-CoA via saccharopine |
| GO:0006536 | 0.0015 | 9.1548 | 0.5027 | 4 | 30 | glutamate metabolic process |
| GO:0019477 | 0.0016 | 59.1304 | 0.067 | 2 | 4 | L-lysine catabolic process |
| GO:0010592 | 0.0027 | 12.7109 | 0.2849 | 3 | 17 | positive regulation of lamellipodium assembly |
| GO:0001661 | 0.0027 | 39.4177 | 0.0838 | 2 | 5 | conditioned taste aversion |
| GO:0007610 | 0.0043 | 2.1093 | 9.0156 | 18 | 538 | behavior |
| GO:0045664 | 0.0047 | 2.0885 | 9.0994 | 18 | 543 | regulation of neuron differentiation |
| GO:1901701 | 0.0053 | 1.795 | 15.97 | 27 | 953 | cellular response to oxygen-containing compound |
| GO:0031620 | 0.0056 | 23.6474 | 0.1173 | 2 | 7 | regulation of fever generation |
| GO:0090091 | 0.0056 | 23.6474 | 0.1173 | 2 | 7 | positive regulation of extracellular matrix disassembly |
| GO:0009067 | 0.0057 | 9.3628 | 0.3687 | 3 | 22 | aspartate family amino acid biosynthetic process |
| GO:0009451 | 0.0066 | 3.3775 | 2.1952 | 7 | 131 | RNA modification |
| GO:0035303 | 0.0071 | 3.3235 | 2.2288 | 7 | 133 | regulation of dephosphorylation |
| GO:0009750 | 0.0073 | 19.7049 | 0.1341 | 2 | 8 | response to fructose |
| GO:0035562 | 0.0073 | 19.7049 | 0.1341 | 2 | 8 | negative regulation of chromatin binding |
| GO:1901565 | 0.0081 | 1.6819 | 18.9193 | 30 | 1129 | organonitrogen compound catabolic process |
| GO:1900027 | 0.0091 | 7.7324 | 0.4357 | 3 | 26 | regulation of ruffle assembly |
| GO:0001714 | 0.0093 | 16.8888 | 0.1508 | 2 | 9 | endodermal cell fate specification |
| GO:0006924 | 0.0093 | 16.8888 | 0.1508 | 2 | 9 | activation-induced cell death of T cells |
| GO:0009629 | 0.0093 | 16.8888 | 0.1508 | 2 | 9 | response to gravity |
| GO:1904153 | 0.0093 | 16.8888 | 0.1508 | 2 | 9 | negative regulation of retrograde protein transport, ER to cytosol |
| GO:0120035 | 0.0094 | 1.9798 | 9.0156 | 17 | 538 | regulation of plasma membrane bounded cell projection organization |
| GO:0006399 | 0.0097 | 2.8521 | 2.9493 | 8 | 176 | tRNA metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1990108 | 3e-04 | Inf | 0.0323 | 2 | 2 | protein linear deubiquitination |
| GO:0006066 | 0.001 | 2.9274 | 4.7367 | 13 | 293 | alcohol metabolic process |
| GO:0008286 | 0.0025 | 4.0687 | 1.8429 | 7 | 114 | insulin receptor signaling pathway |
| GO:0003097 | 0.0037 | 30.6701 | 0.097 | 2 | 6 | renal water transport |
| GO:0046600 | 0.0037 | 30.6701 | 0.097 | 2 | 6 | negative regulation of centriole replication |
| GO:1902600 | 0.0042 | 4.2281 | 1.5196 | 6 | 94 | hydrogen ion transmembrane transport |
| GO:0045869 | 0.0052 | 24.5344 | 0.1132 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:1901642 | 0.0052 | 24.5344 | 0.1132 | 2 | 7 | nucleoside transmembrane transport |
| GO:1901362 | 0.0054 | 1.4345 | 66.5767 | 85 | 4162 | organic cyclic compound biosynthetic process |
| GO:0060042 | 0.0064 | 5.8752 | 0.7436 | 4 | 46 | retina morphogenesis in camera-type eye |
| GO:0070072 | 0.0068 | 20.444 | 0.1293 | 2 | 8 | vacuolar proton-transporting V-type ATPase complex assembly |
| GO:0006818 | 0.0072 | 3.3179 | 2.2309 | 7 | 138 | hydrogen transport |
| GO:0015986 | 0.0074 | 8.3889 | 0.4042 | 3 | 25 | ATP synthesis coupled proton transport |
| GO:0006139 | 0.0082 | 1.3808 | 87.4264 | 106 | 5408 | nucleobase-containing compound metabolic process |
| GO:0033014 | 0.0082 | 8.0236 | 0.4203 | 3 | 26 | tetrapyrrole biosynthetic process |
| GO:0021603 | 0.0087 | 17.5222 | 0.1455 | 2 | 9 | cranial nerve formation |
| GO:0038003 | 0.0087 | 17.5222 | 0.1455 | 2 | 9 | opioid receptor signaling pathway |
| GO:0042572 | 0.0092 | 7.6888 | 0.4365 | 3 | 27 | retinol metabolic process |
| GO:0006826 | 0.0098 | 5.1388 | 0.8406 | 4 | 52 | iron ion transport |
| GO:0090181 | 0.0098 | 5.1388 | 0.8406 | 4 | 52 | regulation of cholesterol metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006334 | 1e-04 | 5.6511 | 1.7591 | 9 | 112 | nucleosome assembly |
| GO:0016070 | 3e-04 | 1.7073 | 48.6602 | 71 | 3263 | RNA metabolic process |
| GO:0060711 | 7e-04 | 7.9797 | 0.7068 | 5 | 45 | labyrinthine layer development |
| GO:0060669 | 7e-04 | 11.5714 | 0.4084 | 4 | 26 | embryonic placenta morphogenesis |
| GO:0035054 | 7e-04 | 126.3882 | 0.0471 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0060355 | 7e-04 | 126.3882 | 0.0471 | 2 | 3 | positive regulation of cell adhesion molecule production |
| GO:0006333 | 7e-04 | 4.0029 | 2.4187 | 9 | 154 | chromatin assembly or disassembly |
| GO:0060670 | 8e-04 | 21.1427 | 0.1885 | 3 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0045815 | 8e-04 | 6.0008 | 1.0994 | 6 | 70 | positive regulation of gene expression, epigenetic |
| GO:0006355 | 9e-04 | 1.5865 | 53.0081 | 74 | 3375 | regulation of transcription, DNA-templated |
| GO:0051099 | 0.001 | 3.8423 | 2.513 | 9 | 160 | positive regulation of binding |
| GO:0060674 | 0.0012 | 9.7885 | 0.4712 | 4 | 30 | placenta blood vessel development |
| GO:2001141 | 0.0012 | 1.5706 | 53.4165 | 74 | 3401 | regulation of RNA biosynthetic process |
| GO:0006469 | 0.0014 | 3.1351 | 3.7381 | 11 | 238 | negative regulation of protein kinase activity |
| GO:0006323 | 0.0014 | 3.624 | 2.6543 | 9 | 169 | DNA packaging |
| GO:0003308 | 0.0014 | 63.1899 | 0.0628 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0097659 | 0.0015 | 1.5463 | 55.6939 | 76 | 3546 | nucleic acid-templated transcription |
| GO:0044237 | 0.0017 | 1.5381 | 153.3074 | 175 | 9761 | cellular metabolic process |
| GO:0016071 | 0.0017 | 2.0843 | 11.7953 | 23 | 751 | mRNA metabolic process |
| GO:0006139 | 0.0018 | 1.97 | 15.7687 | 28 | 1103 | nucleobase-containing compound metabolic process |
| GO:0003129 | 0.0024 | 42.1238 | 0.0785 | 2 | 5 | heart induction |
| GO:0044854 | 0.0024 | 42.1238 | 0.0785 | 2 | 5 | plasma membrane raft assembly |
| GO:0045627 | 0.0024 | 42.1238 | 0.0785 | 2 | 5 | positive regulation of T-helper 1 cell differentiation |
| GO:0030521 | 0.0025 | 5.7976 | 0.9424 | 5 | 60 | androgen receptor signaling pathway |
| GO:0006807 | 0.0027 | 1.4823 | 143.8995 | 165 | 9162 | nitrogen compound metabolic process |
| GO:0010467 | 0.0032 | 1.528 | 53.1192 | 71 | 3621 | gene expression |
| GO:0071824 | 0.0034 | 2.9429 | 3.5967 | 10 | 229 | protein-DNA complex subunit organization |
| GO:0034645 | 0.0034 | 1.4913 | 61.27 | 80 | 4069 | cellular macromolecule biosynthetic process |
| GO:2000675 | 0.0035 | 31.5907 | 0.0942 | 2 | 6 | negative regulation of type B pancreatic cell apoptotic process |
| GO:0060255 | 0.0038 | 1.4347 | 87.5459 | 108 | 5574 | regulation of macromolecule metabolic process |
| GO:1901576 | 0.0038 | 1.4316 | 92.3834 | 113 | 5882 | organic substance biosynthetic process |
| GO:0007263 | 0.0041 | 10.565 | 0.3298 | 3 | 21 | nitric oxide mediated signal transduction |
| GO:0009889 | 0.0042 | 1.4574 | 65.0862 | 84 | 4144 | regulation of biosynthetic process |
| GO:0006412 | 0.0048 | 2.0034 | 10.5702 | 20 | 673 | translation |
| GO:0006681 | 0.0049 | 25.2709 | 0.1099 | 2 | 7 | galactosylceramide metabolic process |
| GO:0006782 | 0.0049 | 25.2709 | 0.1099 | 2 | 7 | protoporphyrinogen IX biosynthetic process |
| GO:0034141 | 0.0049 | 25.2709 | 0.1099 | 2 | 7 | positive regulation of toll-like receptor 3 signaling pathway |
| GO:0060290 | 0.0049 | 25.2709 | 0.1099 | 2 | 7 | transdifferentiation |
| GO:2000096 | 0.0049 | 25.2709 | 0.1099 | 2 | 7 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0140053 | 0.005 | 3.5565 | 2.0889 | 7 | 133 | mitochondrial gene expression |
| GO:0043604 | 0.0051 | 1.9233 | 12.1251 | 22 | 772 | amide biosynthetic process |
| GO:0006396 | 0.0053 | 1.8624 | 13.68 | 24 | 871 | RNA processing |
| GO:2000209 | 0.0054 | 9.5072 | 0.3612 | 3 | 23 | regulation of anoikis |
| GO:0070304 | 0.0055 | 3.5005 | 2.1203 | 7 | 135 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0034508 | 0.0058 | 6.0531 | 0.7225 | 4 | 46 | centromere complex assembly |
| GO:0048259 | 0.0058 | 4.6851 | 1.1465 | 5 | 73 | regulation of receptor-mediated endocytosis |
| GO:0000188 | 0.0061 | 9.0539 | 0.3769 | 3 | 24 | inactivation of MAPK activity |
| GO:0060548 | 0.0062 | 1.837 | 13.8528 | 24 | 882 | negative regulation of cell death |
| GO:0046426 | 0.0067 | 5.7772 | 0.7539 | 4 | 48 | negative regulation of JAK-STAT cascade |
| GO:0034654 | 0.0071 | 1.4257 | 62.6203 | 80 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0030307 | 0.0072 | 3.3174 | 2.2303 | 7 | 142 | positive regulation of cell growth |
| GO:0019219 | 0.0073 | 1.4256 | 61.7565 | 79 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0000398 | 0.0076 | 2.4696 | 4.6804 | 11 | 298 | mRNA splicing, via spliceosome |
| GO:0001958 | 0.0076 | 8.2655 | 0.4084 | 3 | 26 | endochondral ossification |
| GO:0000184 | 0.0081 | 3.6476 | 1.7434 | 6 | 111 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| GO:0045807 | 0.0081 | 3.6476 | 1.7434 | 6 | 111 | positive regulation of endocytosis |
| GO:0043241 | 0.0082 | 2.5726 | 4.0836 | 10 | 260 | protein complex disassembly |
| GO:0000375 | 0.0082 | 2.4436 | 4.7275 | 11 | 301 | RNA splicing, via transesterification reactions |
| GO:0042482 | 0.0082 | 18.0482 | 0.1414 | 2 | 9 | positive regulation of odontogenesis |
| GO:0048280 | 0.0082 | 18.0482 | 0.1414 | 2 | 9 | vesicle fusion with Golgi apparatus |
| GO:1903044 | 0.0082 | 18.0482 | 0.1414 | 2 | 9 | protein localization to membrane raft |
| GO:1903146 | 0.0083 | 5.4073 | 0.801 | 4 | 51 | regulation of autophagy of mitochondrion |
| GO:0031214 | 0.0085 | 3.6129 | 1.7591 | 6 | 112 | biomineral tissue development |
| GO:0060706 | 0.0085 | 7.9206 | 0.4241 | 3 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0061311 | 0.0085 | 7.9206 | 0.4241 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0046330 | 0.0088 | 3.5789 | 1.7748 | 6 | 113 | positive regulation of JNK cascade |
| GO:0007519 | 0.0089 | 3.175 | 2.3245 | 7 | 148 | skeletal muscle tissue development |
| GO:0042475 | 0.0089 | 4.1897 | 1.2722 | 5 | 81 | odontogenesis of dentin-containing tooth |
| GO:0001763 | 0.0089 | 2.896 | 2.9056 | 8 | 185 | morphogenesis of a branching structure |
| GO:0006338 | 0.0092 | 3.1524 | 2.3402 | 7 | 149 | chromatin remodeling |
| GO:0051348 | 0.0093 | 2.2967 | 5.4814 | 12 | 349 | negative regulation of transferase activity |
| GO:0044319 | 0.0094 | 7.6032 | 0.4398 | 3 | 28 | wound healing, spreading of cells |
| GO:0070125 | 0.0099 | 4.0817 | 1.3036 | 5 | 83 | mitochondrial translational elongation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 2e-04 | 15.8155 | 0.2847 | 4 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0006508 | 2e-04 | 2.8691 | 7.9661 | 19 | 1595 | proteolysis |
| GO:0007606 | 5e-04 | 8.3254 | 0.6593 | 5 | 132 | sensory perception of chemical stimulus |
| GO:0016579 | 0.0023 | 4.8116 | 1.3535 | 6 | 271 | protein deubiquitination |
| GO:0009593 | 0.0027 | 7.4549 | 0.5794 | 4 | 116 | detection of chemical stimulus |
| GO:0050906 | 0.0039 | 6.6738 | 0.6443 | 4 | 129 | detection of stimulus involved in sensory perception |
| GO:1900120 | 0.004 | 24.0445 | 0.0949 | 2 | 19 | regulation of receptor binding |
| GO:0003336 | 0.005 | Inf | 0.005 | 1 | 1 | corneocyte desquamation |
| GO:0007321 | 0.005 | Inf | 0.005 | 1 | 1 | sperm displacement |
| GO:0016077 | 0.005 | Inf | 0.005 | 1 | 1 | snoRNA catabolic process |
| GO:0034760 | 0.005 | Inf | 0.005 | 1 | 1 | negative regulation of iron ion transmembrane transport |
| GO:0035863 | 0.005 | Inf | 0.005 | 1 | 1 | dITP catabolic process |
| GO:0048877 | 0.005 | Inf | 0.005 | 1 | 1 | homeostasis of number of retina cells |
| GO:0071444 | 0.005 | Inf | 0.005 | 1 | 1 | cellular response to pheromone |
| GO:1901639 | 0.005 | Inf | 0.005 | 1 | 1 | XDP catabolic process |
| GO:1902072 | 0.005 | Inf | 0.005 | 1 | 1 | negative regulation of hypoxia-inducible factor-1alpha signaling pathway |
| GO:1904425 | 0.005 | Inf | 0.005 | 1 | 1 | negative regulation of GTP binding |
| GO:1905716 | 0.005 | Inf | 0.005 | 1 | 1 | negative regulation of cornification |
| GO:0001504 | 0.0053 | 20.4338 | 0.1099 | 2 | 22 | neurotransmitter uptake |
| GO:0071248 | 0.0063 | 5.8267 | 0.7342 | 4 | 147 | cellular response to metal ion |
| GO:0060292 | 0.0069 | 17.765 | 0.1249 | 2 | 25 | long term synaptic depression |
| GO:0007186 | 0.0087 | 2.6158 | 4.1903 | 10 | 839 | G-protein coupled receptor signaling pathway |
| GO:0018958 | 0.0091 | 7.4557 | 0.4295 | 3 | 86 | phenol-containing compound metabolic process |
| GO:0001694 | 0.01 | 201.8667 | 0.01 | 1 | 2 | histamine biosynthetic process |
| GO:0010609 | 0.01 | 201.8667 | 0.01 | 1 | 2 | mRNA localization resulting in posttranscriptional regulation of gene expression |
| GO:0033082 | 0.01 | 201.8667 | 0.01 | 1 | 2 | regulation of extrathymic T cell differentiation |
| GO:0034756 | 0.01 | 201.8667 | 0.01 | 1 | 2 | regulation of iron ion transport |
| GO:0036345 | 0.01 | 201.8667 | 0.01 | 1 | 2 | platelet maturation |
| GO:0038098 | 0.01 | 201.8667 | 0.01 | 1 | 2 | sequestering of BMP from receptor via BMP binding |
| GO:0046709 | 0.01 | 201.8667 | 0.01 | 1 | 2 | IDP catabolic process |
| GO:0046960 | 0.01 | 201.8667 | 0.01 | 1 | 2 | sensitization |
| GO:0051692 | 0.01 | 201.8667 | 0.01 | 1 | 2 | cellular oligosaccharide catabolic process |
| GO:0070889 | 0.01 | 201.8667 | 0.01 | 1 | 2 | platelet alpha granule organization |
| GO:1902559 | 0.01 | 201.8667 | 0.01 | 1 | 2 | 3'-phospho-5'-adenylyl sulfate transmembrane transport |
| GO:1904808 | 0.01 | 201.8667 | 0.01 | 1 | 2 | positive regulation of protein oxidation |
| GO:1990641 | 0.01 | 201.8667 | 0.01 | 1 | 2 | response to iron ion starvation |
| GO:2000233 | 0.01 | 201.8667 | 0.01 | 1 | 2 | negative regulation of rRNA processing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 5.9579 | 2.0544 | 11 | 154 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 5.3869 | 2.2545 | 11 | 169 | DNA packaging |
| GO:0006334 | 0 | 7.7672 | 1.1584 | 8 | 88 | nucleosome assembly |
| GO:0050830 | 1e-04 | 7.8498 | 1.0005 | 7 | 75 | defense response to Gram-positive bacterium |
| GO:0002227 | 1e-04 | 20.0992 | 0.2535 | 4 | 19 | innate immune response in mucosa |
| GO:0061844 | 1e-04 | 11.8229 | 0.4936 | 5 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0071824 | 3e-04 | 3.8885 | 3.0549 | 11 | 229 | protein-DNA complex subunit organization |
| GO:0008544 | 3e-04 | 3.2163 | 4.6958 | 14 | 352 | epidermis development |
| GO:0019730 | 3e-04 | 14.0131 | 0.3393 | 4 | 26 | antimicrobial humoral response |
| GO:0009624 | 5e-04 | 149.3831 | 0.04 | 2 | 3 | response to nematode |
| GO:0002251 | 6e-04 | 12.0515 | 0.3869 | 4 | 29 | organ or tissue specific immune response |
| GO:0098542 | 6e-04 | 2.9646 | 5.0693 | 14 | 380 | defense response to other organism |
| GO:0019731 | 6e-04 | 11.5872 | 0.4002 | 4 | 30 | antibacterial humoral response |
| GO:0007186 | 8e-04 | 2.2233 | 11.1925 | 23 | 839 | G-protein coupled receptor signaling pathway |
| GO:0009617 | 0.001 | 2.6804 | 5.9898 | 15 | 449 | response to bacterium |
| GO:0043207 | 0.0013 | 2.2722 | 9.4583 | 20 | 709 | response to external biotic stimulus |
| GO:0050829 | 0.0015 | 6.5117 | 0.8404 | 5 | 63 | defense response to Gram-negative bacterium |
| GO:0070268 | 0.0016 | 5.1659 | 1.254 | 6 | 94 | cornification |
| GO:0030216 | 0.0017 | 3.5255 | 2.7214 | 9 | 204 | keratinocyte differentiation |
| GO:0007565 | 0.0024 | 3.6474 | 2.3346 | 8 | 175 | female pregnancy |
| GO:0007617 | 0.0026 | 12.4967 | 0.2801 | 3 | 21 | mating behavior |
| GO:0010043 | 0.003 | 7.3406 | 0.6003 | 4 | 45 | response to zinc ion |
| GO:0016338 | 0.003 | 11.8382 | 0.2935 | 3 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0006335 | 0.0039 | 10.7093 | 0.3202 | 3 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0001906 | 0.0039 | 4.2835 | 1.4941 | 6 | 112 | cell killing |
| GO:0046688 | 0.0043 | 10.2218 | 0.3335 | 3 | 25 | response to copper ion |
| GO:0001523 | 0.0045 | 4.9635 | 1.0806 | 5 | 81 | retinoid metabolic process |
| GO:0042756 | 0.0047 | 24.8889 | 0.1067 | 2 | 8 | drinking behavior |
| GO:0051584 | 0.0047 | 24.8889 | 0.1067 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
| GO:2000698 | 0.0047 | 24.8889 | 0.1067 | 2 | 8 | positive regulation of epithelial cell differentiation involved in kidney development |
| GO:0000183 | 0.0049 | 9.7767 | 0.3468 | 3 | 26 | chromatin silencing at rDNA |
| GO:0010469 | 0.0058 | 2.2772 | 6.4967 | 14 | 487 | regulation of receptor activity |
| GO:0002138 | 0.006 | 21.3319 | 0.1201 | 2 | 9 | retinoic acid biosynthetic process |
| GO:0021892 | 0.006 | 21.3319 | 0.1201 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0042178 | 0.006 | 21.3319 | 0.1201 | 2 | 9 | xenobiotic catabolic process |
| GO:0042363 | 0.006 | 21.3319 | 0.1201 | 2 | 9 | fat-soluble vitamin catabolic process |
| GO:0042755 | 0.0066 | 8.6469 | 0.3869 | 3 | 29 | eating behavior |
| GO:0030432 | 0.0074 | 18.6642 | 0.1334 | 2 | 10 | peristalsis |
| GO:0046085 | 0.0074 | 18.6642 | 0.1334 | 2 | 10 | adenosine metabolic process |
| GO:0061140 | 0.0074 | 18.6642 | 0.1334 | 2 | 10 | lung secretory cell differentiation |
| GO:0051937 | 0.0074 | 5.5686 | 0.7737 | 4 | 58 | catecholamine transport |
| GO:0009953 | 0.0077 | 4.3327 | 1.2273 | 5 | 92 | dorsal/ventral pattern formation |
| GO:0051928 | 0.0081 | 4.2832 | 1.2407 | 5 | 93 | positive regulation of calcium ion transport |
| GO:0030804 | 0.0085 | 4.2348 | 1.254 | 5 | 94 | positive regulation of cyclic nucleotide biosynthetic process |
| GO:0048484 | 0.009 | 16.5893 | 0.1467 | 2 | 11 | enteric nervous system development |
| GO:0006721 | 0.0096 | 4.0958 | 1.294 | 5 | 97 | terpenoid metabolic process |
| GO:0030855 | 0.0098 | 2.0204 | 8.3511 | 16 | 626 | epithelial cell differentiation |
| GO:0006935 | 0.0099 | 2.1282 | 6.9236 | 14 | 519 | chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 1e-04 | Inf | 0.0218 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0006334 | 2e-04 | 6.2667 | 1.2218 | 7 | 112 | nucleosome assembly |
| GO:0045765 | 2e-04 | 4.3015 | 2.5199 | 10 | 231 | regulation of angiogenesis |
| GO:0072676 | 9e-04 | 7.3883 | 0.7418 | 5 | 68 | lymphocyte migration |
| GO:0002227 | 0.0011 | 17.2949 | 0.2073 | 3 | 19 | innate immune response in mucosa |
| GO:0036303 | 0.0011 | 17.2949 | 0.2073 | 3 | 19 | lymph vessel morphogenesis |
| GO:0006333 | 0.0015 | 4.4636 | 1.68 | 7 | 154 | chromatin assembly or disassembly |
| GO:0002579 | 0.0024 | 36.6976 | 0.0764 | 2 | 7 | positive regulation of antigen processing and presentation |
| GO:0035754 | 0.0024 | 36.6976 | 0.0764 | 2 | 7 | B cell chemotaxis |
| GO:0006323 | 0.0025 | 4.0462 | 1.8436 | 7 | 169 | DNA packaging |
| GO:0044351 | 0.0032 | 30.5793 | 0.0873 | 2 | 8 | macropinocytosis |
| GO:0060836 | 0.0032 | 30.5793 | 0.0873 | 2 | 8 | lymphatic endothelial cell differentiation |
| GO:0002251 | 0.0038 | 10.6359 | 0.3164 | 3 | 29 | organ or tissue specific immune response |
| GO:0061036 | 0.0038 | 10.6359 | 0.3164 | 3 | 29 | positive regulation of cartilage development |
| GO:0019731 | 0.0042 | 10.2413 | 0.3273 | 3 | 30 | antibacterial humoral response |
| GO:0048646 | 0.0043 | 2.0448 | 10.527 | 20 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0050706 | 0.005 | 9.5337 | 0.3491 | 3 | 32 | regulation of interleukin-1 beta secretion |
| GO:0061042 | 0.005 | 22.9314 | 0.1091 | 2 | 10 | vascular wound healing |
| GO:0006699 | 0.0065 | 8.6382 | 0.3818 | 3 | 35 | bile acid biosynthetic process |
| GO:0010469 | 0.0072 | 2.3911 | 5.3126 | 12 | 487 | regulation of receptor activity |
| GO:0046459 | 0.0073 | 18.3427 | 0.1309 | 2 | 12 | short-chain fatty acid metabolic process |
| GO:0061844 | 0.0075 | 8.129 | 0.4036 | 3 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0032688 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | negative regulation of interferon-beta production |
| GO:0050930 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | induction of positive chemotaxis |
| GO:0098542 | 0.0089 | 2.5435 | 4.1454 | 10 | 380 | defense response to other organism |
| GO:0050830 | 0.0091 | 5.2095 | 0.8182 | 4 | 75 | defense response to Gram-positive bacterium |
| GO:0071622 | 0.0094 | 7.4684 | 0.4364 | 3 | 40 | regulation of granulocyte chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051464 | 0 | 265.4647 | 0.0455 | 3 | 4 | positive regulation of cortisol secretion |
| GO:0032502 | 0 | 2.0353 | 41.381 | 64 | 4142 | developmental process |
| GO:2000848 | 0 | 66.3529 | 0.0796 | 3 | 7 | positive regulation of corticosteroid hormone secretion |
| GO:0007186 | 1e-04 | 2.6736 | 9.5385 | 23 | 839 | G-protein coupled receptor signaling pathway |
| GO:0035270 | 1e-04 | 6.2942 | 1.3984 | 8 | 123 | endocrine system development |
| GO:0008211 | 1e-04 | 20.9217 | 0.2387 | 4 | 21 | glucocorticoid metabolic process |
| GO:2000849 | 1e-04 | 44.2294 | 0.1023 | 3 | 9 | regulation of glucocorticoid secretion |
| GO:2000502 | 1e-04 | Inf | 0.0227 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0071549 | 3e-04 | 14.2192 | 0.3297 | 4 | 29 | cellular response to dexamethasone stimulus |
| GO:0051240 | 4e-04 | 2.1202 | 15.7571 | 30 | 1401 | positive regulation of multicellular organismal process |
| GO:0006952 | 5e-04 | 2.1096 | 15.2343 | 29 | 1340 | defense response |
| GO:0045429 | 6e-04 | 11.4625 | 0.3979 | 4 | 35 | positive regulation of nitric oxide biosynthetic process |
| GO:0048566 | 6e-04 | 11.4625 | 0.3979 | 4 | 35 | embryonic digestive tract development |
| GO:0007155 | 7e-04 | 2.6353 | 7.0239 | 17 | 653 | cell adhesion |
| GO:0046209 | 7e-04 | 7.8253 | 0.7049 | 5 | 62 | nitric oxide metabolic process |
| GO:0040011 | 7e-04 | 2.0031 | 17.7695 | 32 | 1563 | locomotion |
| GO:0002076 | 7e-04 | 20.4041 | 0.1819 | 3 | 16 | osteoblast development |
| GO:0010961 | 8e-04 | 87.9649 | 0.0455 | 2 | 4 | cellular magnesium ion homeostasis |
| GO:0050688 | 8e-04 | 7.559 | 0.7276 | 5 | 64 | regulation of defense response to virus |
| GO:2000831 | 9e-04 | 18.9454 | 0.1933 | 3 | 17 | regulation of steroid hormone secretion |
| GO:1903426 | 0.001 | 7.1918 | 0.7617 | 5 | 67 | regulation of reactive oxygen species biosynthetic process |
| GO:0001568 | 0.001 | 2.6021 | 6.628 | 16 | 583 | blood vessel development |
| GO:0001525 | 0.001 | 2.922 | 4.7749 | 13 | 420 | angiogenesis |
| GO:0055123 | 0.0011 | 4.7276 | 1.5916 | 7 | 140 | digestive system development |
| GO:0044057 | 0.0011 | 2.7668 | 5.4343 | 14 | 478 | regulation of system process |
| GO:0006526 | 0.0013 | 58.6394 | 0.0568 | 2 | 5 | arginine biosynthetic process |
| GO:0060718 | 0.0013 | 58.6394 | 0.0568 | 2 | 5 | chorionic trophoblast cell differentiation |
| GO:0021854 | 0.0014 | 15.599 | 0.2274 | 3 | 20 | hypothalamus development |
| GO:0098743 | 0.0014 | 15.599 | 0.2274 | 3 | 20 | cell aggregation |
| GO:0045165 | 0.0016 | 3.5503 | 2.7058 | 9 | 238 | cell fate commitment |
| GO:0032330 | 0.0017 | 8.661 | 0.5116 | 4 | 45 | regulation of chondrocyte differentiation |
| GO:0072358 | 0.0017 | 2.4619 | 6.9805 | 16 | 614 | cardiovascular system development |
| GO:0007368 | 0.0018 | 5.0632 | 1.2733 | 6 | 112 | determination of left/right symmetry |
| GO:0042476 | 0.0019 | 4.9687 | 1.2961 | 6 | 114 | odontogenesis |
| GO:0030155 | 0.0019 | 2.4322 | 7.0601 | 16 | 621 | regulation of cell adhesion |
| GO:0048732 | 0.0022 | 2.8006 | 4.5703 | 12 | 402 | gland development |
| GO:0009607 | 0.0022 | 2.2705 | 8.5266 | 18 | 750 | response to biotic stimulus |
| GO:0007517 | 0.0024 | 2.919 | 4.0132 | 11 | 353 | muscle organ development |
| GO:0007399 | 0.0024 | 1.7603 | 24.011 | 38 | 2112 | nervous system development |
| GO:2000379 | 0.0024 | 5.785 | 0.9322 | 5 | 82 | positive regulation of reactive oxygen species metabolic process |
| GO:0050927 | 0.0025 | 12.6244 | 0.2729 | 3 | 24 | positive regulation of positive chemotaxis |
| GO:0051385 | 0.0025 | 12.6244 | 0.2729 | 3 | 24 | response to mineralocorticoid |
| GO:0048546 | 0.0025 | 7.717 | 0.5684 | 4 | 50 | digestive tract morphogenesis |
| GO:0051674 | 0.0025 | 1.9324 | 15.2456 | 27 | 1341 | localization of cell |
| GO:2000402 | 0.0026 | 35.1789 | 0.0796 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0009799 | 0.0027 | 4.6236 | 1.387 | 6 | 122 | specification of symmetry |
| GO:0048596 | 0.0028 | 12.0497 | 0.2842 | 3 | 25 | embryonic camera-type eye morphogenesis |
| GO:0030154 | 0.0028 | 1.727 | 27.7921 | 42 | 2693 | cell differentiation |
| GO:0051707 | 0.0029 | 2.267 | 8.0378 | 17 | 707 | response to other organism |
| GO:0022617 | 0.0031 | 5.4305 | 0.9891 | 5 | 87 | extracellular matrix disassembly |
| GO:0009891 | 0.0032 | 1.8029 | 19.4862 | 32 | 1714 | positive regulation of biosynthetic process |
| GO:0071384 | 0.0035 | 6.9581 | 0.6253 | 4 | 55 | cellular response to corticosteroid stimulus |
| GO:0007275 | 0.0035 | 1.7239 | 27.4574 | 41 | 2735 | multicellular organism development |
| GO:0043062 | 0.0036 | 2.9255 | 3.6267 | 10 | 319 | extracellular structure organization |
| GO:2000026 | 0.0036 | 1.7862 | 19.6454 | 32 | 1728 | regulation of multicellular organismal development |
| GO:0045944 | 0.0037 | 1.999 | 11.8691 | 22 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0009792 | 0.0039 | 2.3972 | 6.2188 | 14 | 547 | embryo development ending in birth or egg hatching |
| GO:0048704 | 0.004 | 5.1167 | 1.0459 | 5 | 92 | embryonic skeletal system morphogenesis |
| GO:0001947 | 0.004 | 6.6947 | 0.648 | 4 | 57 | heart looping |
| GO:0050911 | 0.004 | 6.6947 | 0.648 | 4 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0042747 | 0.0044 | 25.1245 | 0.1023 | 2 | 9 | circadian sleep/wake cycle, REM sleep |
| GO:1903867 | 0.0044 | 25.1245 | 0.1023 | 2 | 9 | extraembryonic membrane development |
| GO:0008284 | 0.0045 | 2.1151 | 9.1065 | 18 | 801 | positive regulation of cell proliferation |
| GO:0032501 | 0.0045 | 2.077 | 11.6196 | 21 | 1355 | multicellular organismal process |
| GO:0048562 | 0.0046 | 3.6099 | 2.0549 | 7 | 185 | embryonic organ morphogenesis |
| GO:0002009 | 0.0046 | 2.4338 | 5.6731 | 13 | 499 | morphogenesis of an epithelium |
| GO:0048741 | 0.0047 | 9.815 | 0.3411 | 3 | 30 | skeletal muscle fiber development |
| GO:0050729 | 0.005 | 4.837 | 1.1028 | 5 | 97 | positive regulation of inflammatory response |
| GO:0001890 | 0.0051 | 4.028 | 1.5803 | 6 | 139 | placenta development |
| GO:0048646 | 0.0053 | 2.397 | 5.7734 | 13 | 537 | anatomical structure formation involved in morphogenesis |
| GO:0016477 | 0.0054 | 1.8769 | 13.7904 | 24 | 1213 | cell migration |
| GO:0000050 | 0.0054 | 21.9825 | 0.1137 | 2 | 10 | urea cycle |
| GO:0042127 | 0.0057 | 2.2256 | 7.2038 | 15 | 670 | regulation of cell proliferation |
| GO:0022414 | 0.006 | 2.2115 | 7.2377 | 15 | 665 | reproductive process |
| GO:0071805 | 0.0061 | 3.4244 | 2.1601 | 7 | 190 | potassium ion transmembrane transport |
| GO:0061458 | 0.0061 | 2.5581 | 4.5475 | 11 | 400 | reproductive system development |
| GO:0006937 | 0.0065 | 3.8248 | 1.6599 | 6 | 146 | regulation of muscle contraction |
| GO:0045472 | 0.0066 | 19.5387 | 0.1251 | 2 | 11 | response to ether |
| GO:0060033 | 0.0066 | 19.5387 | 0.1251 | 2 | 11 | anatomical structure regression |
| GO:0009605 | 0.0069 | 1.7295 | 18.9013 | 30 | 1710 | response to external stimulus |
| GO:0008544 | 0.0071 | 2.6373 | 4.0018 | 10 | 352 | epidermis development |
| GO:0060537 | 0.0073 | 2.6216 | 4.0246 | 10 | 354 | muscle tissue development |
| GO:0045597 | 0.0074 | 2.0041 | 9.5726 | 18 | 842 | positive regulation of cell differentiation |
| GO:0001701 | 0.0074 | 2.7822 | 3.4107 | 9 | 300 | in utero embryonic development |
| GO:0050728 | 0.0075 | 4.3598 | 1.2165 | 5 | 107 | negative regulation of inflammatory response |
| GO:0007267 | 0.0077 | 1.7579 | 16.5872 | 27 | 1459 | cell-cell signaling |
| GO:0009612 | 0.0077 | 3.2619 | 2.2624 | 7 | 199 | response to mechanical stimulus |
| GO:0003207 | 0.0079 | 17.5836 | 0.1364 | 2 | 12 | cardiac chamber formation |
| GO:0060536 | 0.0079 | 17.5836 | 0.1364 | 2 | 12 | cartilage morphogenesis |
| GO:0060707 | 0.0079 | 17.5836 | 0.1364 | 2 | 12 | trophoblast giant cell differentiation |
| GO:0035295 | 0.0079 | 2.359 | 5.3785 | 12 | 482 | tube development |
| GO:0043627 | 0.0083 | 5.3713 | 0.7958 | 4 | 70 | response to estrogen |
| GO:0001707 | 0.0087 | 5.2908 | 0.8072 | 4 | 71 | mesoderm formation |
| GO:0050920 | 0.0089 | 3.5674 | 1.7735 | 6 | 156 | regulation of chemotaxis |
| GO:0071219 | 0.0089 | 3.5674 | 1.7735 | 6 | 156 | cellular response to molecule of bacterial origin |
| GO:0035050 | 0.0091 | 5.2127 | 0.8186 | 4 | 72 | embryonic heart tube development |
| GO:1905954 | 0.0091 | 5.2127 | 0.8186 | 4 | 72 | positive regulation of lipid localization |
| GO:0060456 | 0.0092 | 15.9841 | 0.1478 | 2 | 13 | positive regulation of digestive system process |
| GO:0071941 | 0.0092 | 15.9841 | 0.1478 | 2 | 13 | nitrogen cycle metabolic process |
| GO:0046887 | 0.0094 | 4.116 | 1.2847 | 5 | 113 | positive regulation of hormone secretion |
| GO:0043588 | 0.0095 | 2.6698 | 3.5471 | 9 | 312 | skin development |
| GO:0003006 | 0.0096 | 2.142 | 6.9123 | 14 | 608 | developmental process involved in reproduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007275 | 6e-04 | 1.6761 | 55.0248 | 76 | 4704 | multicellular organism development |
| GO:0007588 | 8e-04 | 7.5966 | 0.7252 | 5 | 62 | excretion |
| GO:1903232 | 0.0013 | 56.9545 | 0.0585 | 2 | 5 | melanosome assembly |
| GO:0002548 | 0.0017 | 8.6201 | 0.5147 | 4 | 44 | monocyte chemotaxis |
| GO:0007156 | 0.0021 | 4.2048 | 1.778 | 7 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0048598 | 0.0027 | 2.4243 | 6.6091 | 15 | 565 | embryonic morphogenesis |
| GO:0032502 | 0.0032 | 1.5315 | 64.874 | 83 | 5546 | developmental process |
| GO:0048513 | 0.0033 | 1.621 | 35.5251 | 51 | 3037 | animal organ development |
| GO:0010917 | 0.0036 | 28.4716 | 0.0936 | 2 | 8 | negative regulation of mitochondrial membrane potential |
| GO:0010940 | 0.0036 | 28.4716 | 0.0936 | 2 | 8 | positive regulation of necrotic cell death |
| GO:1903715 | 0.0036 | 28.4716 | 0.0936 | 2 | 8 | regulation of aerobic respiration |
| GO:0030856 | 0.0044 | 4.162 | 1.5324 | 6 | 131 | regulation of epithelial cell differentiation |
| GO:0070268 | 0.0049 | 4.8548 | 1.0996 | 5 | 94 | cornification |
| GO:0006885 | 0.0054 | 4.7475 | 1.123 | 5 | 96 | regulation of pH |
| GO:0009583 | 0.0056 | 6.0423 | 0.7135 | 4 | 61 | detection of light stimulus |
| GO:0014894 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | response to denervation involved in regulation of muscle adaptation |
| GO:0030432 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | peristalsis |
| GO:0035646 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | endosome to melanosome transport |
| GO:0035878 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | nail development |
| GO:0048757 | 0.0058 | 21.3509 | 0.117 | 2 | 10 | pigment granule maturation |
| GO:0009109 | 0.007 | 18.9773 | 0.1287 | 2 | 11 | coenzyme catabolic process |
| GO:0014870 | 0.007 | 18.9773 | 0.1287 | 2 | 11 | response to muscle inactivity |
| GO:0043476 | 0.007 | 18.9773 | 0.1287 | 2 | 11 | pigment accumulation |
| GO:0048484 | 0.007 | 18.9773 | 0.1287 | 2 | 11 | enteric nervous system development |
| GO:0009952 | 0.0079 | 3.2512 | 2.2693 | 7 | 194 | anterior/posterior pattern specification |
| GO:0030593 | 0.0082 | 5.379 | 0.7954 | 4 | 68 | neutrophil chemotaxis |
| GO:0072677 | 0.0083 | 17.0784 | 0.1404 | 2 | 12 | eosinophil migration |
| GO:0008306 | 0.0087 | 5.2958 | 0.8071 | 4 | 69 | associative learning |
| GO:0001501 | 0.0088 | 2.3223 | 5.451 | 12 | 466 | skeletal system development |
| GO:0009888 | 0.0091 | 2.1651 | 6.8739 | 14 | 622 | tissue development |
| GO:0045616 | 0.0091 | 7.5655 | 0.4328 | 3 | 37 | regulation of keratinocyte differentiation |
| GO:0060429 | 0.0095 | 1.8246 | 12.8789 | 22 | 1101 | epithelium development |
| GO:0001707 | 0.0096 | 5.1371 | 0.8305 | 4 | 71 | mesoderm formation |
| GO:0009913 | 0.0097 | 2.8534 | 2.9478 | 8 | 252 | epidermal cell differentiation |
| GO:0050908 | 0.0098 | 15.5248 | 0.1521 | 2 | 13 | detection of light stimulus involved in visual perception |
| GO:0072216 | 0.0098 | 15.5248 | 0.1521 | 2 | 13 | positive regulation of metanephros development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050829 | 0 | 17.3322 | 0.3312 | 5 | 63 | defense response to Gram-negative bacterium |
| GO:0007606 | 1e-04 | 9.6596 | 0.694 | 6 | 132 | sensory perception of chemical stimulus |
| GO:0060474 | 2e-04 | 194.0385 | 0.021 | 2 | 4 | positive regulation of flagellated sperm motility involved in capacitation |
| GO:0050911 | 2e-04 | 14.9791 | 0.2997 | 4 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 4e-04 | 9.0246 | 0.6098 | 5 | 116 | detection of chemical stimulus |
| GO:0019731 | 5e-04 | 21.8038 | 0.1577 | 3 | 30 | antibacterial humoral response |
| GO:0050877 | 5e-04 | 3.2613 | 4.537 | 13 | 863 | nervous system process |
| GO:0050906 | 6e-04 | 8.0715 | 0.6782 | 5 | 129 | detection of stimulus involved in sensory perception |
| GO:0050830 | 6e-04 | 11.1683 | 0.3943 | 4 | 75 | defense response to Gram-positive bacterium |
| GO:0044597 | 7e-04 | 64.6624 | 0.0421 | 2 | 8 | daunorubicin metabolic process |
| GO:0044598 | 7e-04 | 64.6624 | 0.0421 | 2 | 8 | doxorubicin metabolic process |
| GO:0098542 | 8e-04 | 4.4101 | 1.9978 | 8 | 380 | defense response to other organism |
| GO:0061844 | 0.001 | 17.3067 | 0.1945 | 3 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:2000344 | 0.0012 | 48.4904 | 0.0526 | 2 | 10 | positive regulation of acrosome reaction |
| GO:0031640 | 0.0014 | 15.0829 | 0.2208 | 3 | 42 | killing of cells of other organism |
| GO:1901317 | 0.0021 | 35.2587 | 0.0683 | 2 | 13 | regulation of flagellated sperm motility |
| GO:0051155 | 0.003 | 11.3024 | 0.2892 | 3 | 55 | positive regulation of striated muscle cell differentiation |
| GO:0045600 | 0.0033 | 10.8824 | 0.2997 | 3 | 57 | positive regulation of fat cell differentiation |
| GO:0050896 | 0.0036 | 1.9026 | 39.582 | 52 | 7529 | response to stimulus |
| GO:0009611 | 0.0041 | 3.1309 | 3.1439 | 9 | 598 | response to wounding |
| GO:0010951 | 0.0041 | 5.082 | 1.0567 | 5 | 201 | negative regulation of endopeptidase activity |
| GO:0045861 | 0.0043 | 4.2253 | 1.5299 | 6 | 291 | negative regulation of proteolysis |
| GO:0002227 | 0.0044 | 22.8054 | 0.0999 | 2 | 19 | innate immune response in mucosa |
| GO:0045663 | 0.0044 | 22.8054 | 0.0999 | 2 | 19 | positive regulation of myoblast differentiation |
| GO:0002526 | 0.0051 | 6.1715 | 0.694 | 4 | 132 | acute inflammatory response |
| GO:0003147 | 0.0053 | Inf | 0.0053 | 1 | 1 | neural crest cell migration involved in heart formation |
| GO:0014737 | 0.0053 | Inf | 0.0053 | 1 | 1 | positive regulation of muscle atrophy |
| GO:0032023 | 0.0053 | Inf | 0.0053 | 1 | 1 | trypsinogen activation |
| GO:0045818 | 0.0053 | Inf | 0.0053 | 1 | 1 | negative regulation of glycogen catabolic process |
| GO:0060904 | 0.0053 | Inf | 0.0053 | 1 | 1 | regulation of protein folding in endoplasmic reticulum |
| GO:0061713 | 0.0053 | Inf | 0.0053 | 1 | 1 | anterior neural tube closure |
| GO:0071231 | 0.0053 | Inf | 0.0053 | 1 | 1 | cellular response to folic acid |
| GO:0072274 | 0.0053 | Inf | 0.0053 | 1 | 1 | metanephric glomerular basement membrane development |
| GO:1902867 | 0.0053 | Inf | 0.0053 | 1 | 1 | negative regulation of retina development in camera-type eye |
| GO:1902870 | 0.0053 | Inf | 0.0053 | 1 | 1 | negative regulation of amacrine cell differentiation |
| GO:0080154 | 0.0064 | 18.4567 | 0.1209 | 2 | 23 | regulation of fertilization |
| GO:0016485 | 0.0067 | 4.4995 | 1.1881 | 5 | 226 | protein processing |
| GO:0032101 | 0.007 | 2.8666 | 3.4172 | 9 | 650 | regulation of response to external stimulus |
| GO:0006706 | 0.0076 | 16.8495 | 0.1314 | 2 | 25 | steroid catabolic process |
| GO:0019730 | 0.0076 | 16.7456 | 0.132 | 2 | 26 | antimicrobial humoral response |
| GO:0033198 | 0.0082 | 16.1464 | 0.1367 | 2 | 26 | response to ATP |
| GO:0042730 | 0.0082 | 16.1464 | 0.1367 | 2 | 26 | fibrinolysis |
| GO:0071480 | 0.0082 | 16.1464 | 0.1367 | 2 | 26 | cellular response to gamma radiation |
| GO:0009617 | 0.0093 | 3.188 | 2.3605 | 7 | 449 | response to bacterium |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 1e-04 | Inf | 0.0206 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0032757 | 7e-04 | 10.9107 | 0.4127 | 4 | 40 | positive regulation of interleukin-8 production |
| GO:0001974 | 8e-04 | 10.6151 | 0.423 | 4 | 41 | blood vessel remodeling |
| GO:0046330 | 0.0011 | 5.5529 | 1.1659 | 6 | 113 | positive regulation of JNK cascade |
| GO:0007610 | 0.0014 | 2.7158 | 5.5508 | 14 | 538 | behavior |
| GO:0014062 | 0.0015 | 48.5677 | 0.0619 | 2 | 6 | regulation of serotonin secretion |
| GO:0051385 | 0.0019 | 13.9508 | 0.2476 | 3 | 24 | response to mineralocorticoid |
| GO:0032729 | 0.002 | 8.1765 | 0.5365 | 4 | 52 | positive regulation of interferon-gamma production |
| GO:2000402 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0070304 | 0.0028 | 4.5991 | 1.3929 | 6 | 135 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0042755 | 0.0032 | 11.2642 | 0.2992 | 3 | 29 | eating behavior |
| GO:0006721 | 0.0033 | 5.3518 | 1.0008 | 5 | 97 | terpenoid metabolic process |
| GO:0031349 | 0.0033 | 2.79 | 4.1992 | 11 | 407 | positive regulation of defense response |
| GO:0009967 | 0.0039 | 1.9156 | 14.238 | 25 | 1380 | positive regulation of signal transduction |
| GO:0009954 | 0.0039 | 10.4583 | 0.3198 | 3 | 31 | proximal/distal pattern formation |
| GO:0048583 | 0.0042 | 1.6092 | 37.1014 | 52 | 3596 | regulation of response to stimulus |
| GO:2001057 | 0.0045 | 6.4284 | 0.6706 | 4 | 65 | reactive nitrogen species metabolic process |
| GO:0051171 | 0.0046 | 1.5463 | 55.7346 | 72 | 5402 | regulation of nitrogen compound metabolic process |
| GO:0048522 | 0.0047 | 1.5619 | 47.3053 | 63 | 4585 | positive regulation of cellular process |
| GO:0051716 | 0.0052 | 1.5293 | 64.6489 | 81 | 6266 | cellular response to stimulus |
| GO:0045429 | 0.0055 | 9.1485 | 0.3611 | 3 | 35 | positive regulation of nitric oxide biosynthetic process |
| GO:0045088 | 0.0058 | 2.7235 | 3.8897 | 10 | 377 | regulation of innate immune response |
| GO:0007186 | 0.006 | 2.1033 | 8.6563 | 17 | 839 | G-protein coupled receptor signaling pathway |
| GO:0048286 | 0.006 | 8.8707 | 0.3714 | 3 | 36 | lung alveolus development |
| GO:0048469 | 0.0063 | 3.846 | 1.6508 | 6 | 160 | cell maturation |
| GO:0015671 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | oxygen transport |
| GO:0065007 | 0.0066 | 1.619 | 108.6114 | 123 | 10527 | biological regulation |
| GO:0031323 | 0.0066 | 1.5117 | 58.4068 | 74 | 5661 | regulation of cellular metabolic process |
| GO:0002218 | 0.0076 | 2.9861 | 2.827 | 8 | 274 | activation of innate immune response |
| GO:0010646 | 0.0076 | 1.5841 | 31.9014 | 45 | 3092 | regulation of cell communication |
| GO:0006837 | 0.0077 | 17.6528 | 0.1341 | 2 | 13 | serotonin transport |
| GO:0071901 | 0.0081 | 4.2749 | 1.2381 | 5 | 120 | negative regulation of protein serine/threonine kinase activity |
| GO:0002689 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | negative regulation of leukocyte chemotaxis |
| GO:1901623 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | regulation of lymphocyte chemotaxis |
| GO:0001523 | 0.0098 | 5.0872 | 0.8357 | 4 | 81 | retinoid metabolic process |
| GO:0023051 | 0.01 | 1.5545 | 32.376 | 45 | 3138 | regulation of signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007186 | 0 | 3.9011 | 6.3406 | 21 | 839 | G-protein coupled receptor signaling pathway |
| GO:0070098 | 0 | 16.245 | 0.4308 | 6 | 57 | chemokine-mediated signaling pathway |
| GO:0071347 | 3e-04 | 9.761 | 0.5668 | 5 | 75 | cellular response to interleukin-1 |
| GO:2000766 | 8e-04 | 66.8053 | 0.0453 | 2 | 6 | negative regulation of cytoplasmic translation |
| GO:0071310 | 0.0011 | 2.0383 | 17.072 | 30 | 2259 | cellular response to organic substance |
| GO:0010469 | 0.0011 | 3.25 | 3.6804 | 11 | 487 | regulation of receptor activity |
| GO:0051716 | 0.0012 | 1.8008 | 47.3543 | 64 | 6266 | cellular response to stimulus |
| GO:0007154 | 0.0014 | 1.7836 | 41.8979 | 58 | 5544 | cell communication |
| GO:0097398 | 0.0015 | 44.531 | 0.0605 | 2 | 8 | cellular response to interleukin-17 |
| GO:0030593 | 0.0017 | 8.4673 | 0.5139 | 4 | 68 | neutrophil chemotaxis |
| GO:0051216 | 0.0019 | 4.9832 | 1.2923 | 6 | 171 | cartilage development |
| GO:0046185 | 0.003 | 29.6814 | 0.0831 | 2 | 11 | aldehyde catabolic process |
| GO:0048247 | 0.0032 | 11.2098 | 0.2947 | 3 | 39 | lymphocyte chemotaxis |
| GO:0034341 | 0.0035 | 5.2759 | 1.0127 | 5 | 134 | response to interferon-gamma |
| GO:0071495 | 0.0035 | 2.2035 | 9.0008 | 18 | 1191 | cellular response to endogenous stimulus |
| GO:0023052 | 0.0042 | 1.6723 | 41.7467 | 56 | 5524 | signaling |
| GO:0032330 | 0.0047 | 9.6046 | 0.3401 | 3 | 45 | regulation of chondrocyte differentiation |
| GO:0006968 | 0.0054 | 9.1668 | 0.3552 | 3 | 47 | cellular defense response |
| GO:0090100 | 0.006 | 5.8794 | 0.7255 | 4 | 96 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0006954 | 0.0063 | 2.5698 | 4.5949 | 11 | 608 | inflammatory response |
| GO:0097530 | 0.0067 | 5.6926 | 0.7482 | 4 | 99 | granulocyte migration |
| GO:0050900 | 0.0069 | 3.053 | 2.7887 | 8 | 369 | leukocyte migration |
| GO:0042221 | 0.0069 | 1.6752 | 27.8639 | 40 | 3687 | response to chemical |
| GO:0060326 | 0.0071 | 3.7583 | 1.6928 | 6 | 224 | cell chemotaxis |
| GO:0002305 | 0.0076 | Inf | 0.0076 | 1 | 1 | CD8-positive, gamma-delta intraepithelial T cell differentiation |
| GO:0021858 | 0.0076 | Inf | 0.0076 | 1 | 1 | GABAergic neuron differentiation in basal ganglia |
| GO:0033609 | 0.0076 | Inf | 0.0076 | 1 | 1 | oxalate metabolic process |
| GO:0046327 | 0.0076 | Inf | 0.0076 | 1 | 1 | glycerol biosynthetic process from pyruvate |
| GO:0070782 | 0.0076 | Inf | 0.0076 | 1 | 1 | phosphatidylserine exposure on apoptotic cell surface |
| GO:1901194 | 0.0076 | Inf | 0.0076 | 1 | 1 | negative regulation of formation of translation preinitiation complex |
| GO:0072643 | 0.008 | 16.6881 | 0.136 | 2 | 18 | interferon-gamma secretion |
| GO:0045765 | 0.0082 | 3.6396 | 1.7457 | 6 | 231 | regulation of angiogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048729 | 0 | 3.7794 | 6.6131 | 22 | 599 | tissue morphogenesis |
| GO:0009952 | 0 | 5.6916 | 2.1418 | 11 | 194 | anterior/posterior pattern specification |
| GO:0060021 | 1e-04 | 7.7459 | 1.0047 | 7 | 91 | palate development |
| GO:2001055 | 1e-04 | Inf | 0.0221 | 2 | 2 | positive regulation of mesenchymal cell apoptotic process |
| GO:0072358 | 2e-04 | 2.91 | 6.7787 | 18 | 614 | cardiovascular system development |
| GO:0007389 | 2e-04 | 3.3991 | 4.4824 | 14 | 406 | pattern specification process |
| GO:0009790 | 2e-04 | 2.5055 | 10.146 | 23 | 919 | embryo development |
| GO:0035116 | 2e-04 | 15.2693 | 0.3091 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0060485 | 2e-04 | 4.2465 | 2.5503 | 10 | 231 | mesenchyme development |
| GO:0003203 | 3e-04 | 14.6576 | 0.3202 | 4 | 29 | endocardial cushion morphogenesis |
| GO:0060674 | 3e-04 | 14.0929 | 0.3312 | 4 | 30 | placenta blood vessel development |
| GO:0035880 | 4e-04 | 181.3012 | 0.0331 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0090427 | 4e-04 | 181.3012 | 0.0331 | 2 | 3 | activation of meiosis |
| GO:0048646 | 4e-04 | 2.3754 | 10.6539 | 23 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0001837 | 6e-04 | 5.3197 | 1.4242 | 7 | 129 | epithelial to mesenchymal transition |
| GO:0048844 | 6e-04 | 8.068 | 0.6845 | 5 | 62 | artery morphogenesis |
| GO:0003198 | 8e-04 | 19.526 | 0.1877 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:2000678 | 0.001 | 18.223 | 0.1987 | 3 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0048562 | 0.001 | 3.504 | 3.0582 | 10 | 277 | embryonic organ morphogenesis |
| GO:0043009 | 0.001 | 3.082 | 4.1836 | 12 | 389 | chordate embryonic development |
| GO:0051101 | 0.0011 | 5.5367 | 1.1703 | 6 | 106 | regulation of DNA binding |
| GO:2000026 | 0.0011 | 1.9258 | 19.0776 | 33 | 1728 | regulation of multicellular organismal development |
| GO:1904995 | 0.0012 | 60.4257 | 0.0552 | 2 | 5 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0003151 | 0.0013 | 6.6596 | 0.817 | 5 | 74 | outflow tract morphogenesis |
| GO:0006334 | 0.0015 | 5.2212 | 1.2365 | 6 | 112 | nucleosome assembly |
| GO:2000679 | 0.0015 | 15.1828 | 0.2318 | 3 | 21 | positive regulation of transcription regulatory region DNA binding |
| GO:0016338 | 0.0017 | 14.3828 | 0.2429 | 3 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0021546 | 0.0018 | 45.3163 | 0.0662 | 2 | 6 | rhombomere development |
| GO:0061312 | 0.0018 | 45.3163 | 0.0662 | 2 | 6 | BMP signaling pathway involved in heart development |
| GO:0060562 | 0.0018 | 3.2439 | 3.29 | 10 | 298 | epithelial tube morphogenesis |
| GO:1901888 | 0.0018 | 6.2075 | 0.8722 | 5 | 79 | regulation of cell junction assembly |
| GO:0061383 | 0.0021 | 8.1322 | 0.541 | 4 | 49 | trabecula morphogenesis |
| GO:0009890 | 0.0022 | 1.9085 | 16.6929 | 29 | 1512 | negative regulation of biosynthetic process |
| GO:0007186 | 0.0023 | 2.2127 | 9.2628 | 19 | 839 | G-protein coupled receptor signaling pathway |
| GO:0031077 | 0.0025 | 36.2506 | 0.0773 | 2 | 7 | post-embryonic camera-type eye development |
| GO:0044332 | 0.0025 | 36.2506 | 0.0773 | 2 | 7 | Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:0070570 | 0.0025 | 12.419 | 0.276 | 3 | 25 | regulation of neuron projection regeneration |
| GO:0048545 | 0.0026 | 2.8834 | 4.0628 | 11 | 368 | response to steroid hormone |
| GO:0043433 | 0.0026 | 4.6467 | 1.38 | 6 | 125 | negative regulation of DNA binding transcription factor activity |
| GO:1903507 | 0.0027 | 2.0294 | 12.2989 | 23 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0001568 | 0.0027 | 2.5081 | 5.9717 | 14 | 553 | blood vessel development |
| GO:0035113 | 0.0027 | 4.6077 | 1.3911 | 6 | 126 | embryonic appendage morphogenesis |
| GO:0051253 | 0.0028 | 1.99 | 13.1048 | 24 | 1187 | negative regulation of RNA metabolic process |
| GO:0048736 | 0.0028 | 3.9707 | 1.8768 | 7 | 170 | appendage development |
| GO:0045880 | 0.0032 | 11.3826 | 0.2981 | 3 | 27 | positive regulation of smoothened signaling pathway |
| GO:0071295 | 0.0032 | 11.3826 | 0.2981 | 3 | 27 | cellular response to vitamin |
| GO:0060429 | 0.0032 | 2.1966 | 8.8377 | 18 | 842 | epithelium development |
| GO:0033141 | 0.0032 | 30.2068 | 0.0883 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0035881 | 0.0032 | 30.2068 | 0.0883 | 2 | 8 | amacrine cell differentiation |
| GO:0035912 | 0.0032 | 30.2068 | 0.0883 | 2 | 8 | dorsal aorta morphogenesis |
| GO:1902669 | 0.0032 | 30.2068 | 0.0883 | 2 | 8 | positive regulation of axon guidance |
| GO:0009953 | 0.0035 | 5.2754 | 1.0157 | 5 | 92 | dorsal/ventral pattern formation |
| GO:0035282 | 0.0035 | 5.2754 | 1.0157 | 5 | 92 | segmentation |
| GO:2000113 | 0.0039 | 1.8871 | 14.9817 | 26 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0006776 | 0.0041 | 25.8898 | 0.0994 | 2 | 9 | vitamin A metabolic process |
| GO:0010459 | 0.0041 | 25.8898 | 0.0994 | 2 | 9 | negative regulation of heart rate |
| GO:0045765 | 0.0042 | 3.3242 | 2.5503 | 8 | 231 | regulation of angiogenesis |
| GO:0003279 | 0.0042 | 5.0421 | 1.0599 | 5 | 96 | cardiac septum development |
| GO:0008285 | 0.0042 | 2.301 | 6.9554 | 15 | 630 | negative regulation of cell proliferation |
| GO:0040020 | 0.0043 | 10.1158 | 0.3312 | 3 | 30 | regulation of meiotic nuclear division |
| GO:0045787 | 0.0044 | 2.8406 | 3.7316 | 10 | 338 | positive regulation of cell cycle |
| GO:0045595 | 0.0048 | 1.7976 | 17.5982 | 29 | 1594 | regulation of cell differentiation |
| GO:0051255 | 0.0051 | 22.6521 | 0.1104 | 2 | 10 | spindle midzone assembly |
| GO:0060346 | 0.0051 | 22.6521 | 0.1104 | 2 | 10 | bone trabecula formation |
| GO:0030513 | 0.0052 | 9.4169 | 0.3533 | 3 | 32 | positive regulation of BMP signaling pathway |
| GO:0035115 | 0.0052 | 9.4169 | 0.3533 | 3 | 32 | embryonic forelimb morphogenesis |
| GO:0035108 | 0.0055 | 3.9728 | 1.6008 | 6 | 145 | limb morphogenesis |
| GO:0002761 | 0.0057 | 4.6798 | 1.1371 | 5 | 103 | regulation of myeloid leukocyte differentiation |
| GO:0051241 | 0.0057 | 1.9855 | 10.8084 | 20 | 979 | negative regulation of multicellular organismal process |
| GO:0044848 | 0.0062 | 20.1339 | 0.1214 | 2 | 11 | biological phase |
| GO:0060525 | 0.0062 | 20.1339 | 0.1214 | 2 | 11 | prostate glandular acinus development |
| GO:0090084 | 0.0062 | 20.1339 | 0.1214 | 2 | 11 | negative regulation of inclusion body assembly |
| GO:0014033 | 0.0064 | 5.8018 | 0.7397 | 4 | 67 | neural crest cell differentiation |
| GO:0030857 | 0.0067 | 8.5324 | 0.3864 | 3 | 35 | negative regulation of epithelial cell differentiation |
| GO:0071392 | 0.0067 | 8.5324 | 0.3864 | 3 | 35 | cellular response to estradiol stimulus |
| GO:0044706 | 0.007 | 3.3292 | 2.2191 | 7 | 201 | multi-multicellular organism process |
| GO:0014070 | 0.0072 | 2.3936 | 5.3183 | 12 | 503 | response to organic cyclic compound |
| GO:0060412 | 0.0072 | 8.2733 | 0.3975 | 3 | 36 | ventricular septum morphogenesis |
| GO:0071542 | 0.0072 | 8.2733 | 0.3975 | 3 | 36 | dopaminergic neuron differentiation |
| GO:0006333 | 0.0073 | 3.729 | 1.7002 | 6 | 154 | chromatin assembly or disassembly |
| GO:0021915 | 0.0073 | 3.729 | 1.7002 | 6 | 154 | neural tube development |
| GO:0045651 | 0.0074 | 18.1193 | 0.1325 | 2 | 12 | positive regulation of macrophage differentiation |
| GO:0060670 | 0.0074 | 18.1193 | 0.1325 | 2 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0003158 | 0.0075 | 4.3658 | 1.2144 | 5 | 110 | endothelium development |
| GO:1901700 | 0.0076 | 1.7809 | 15.7766 | 26 | 1429 | response to oxygen-containing compound |
| GO:0001755 | 0.0078 | 8.0294 | 0.4085 | 3 | 37 | neural crest cell migration |
| GO:0061844 | 0.0078 | 8.0294 | 0.4085 | 3 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0022612 | 0.0083 | 4.2436 | 1.2476 | 5 | 113 | gland morphogenesis |
| GO:0061138 | 0.0085 | 3.601 | 1.7577 | 6 | 161 | morphogenesis of a branching epithelium |
| GO:0031643 | 0.0087 | 16.471 | 0.1435 | 2 | 13 | positive regulation of myelination |
| GO:0045653 | 0.0087 | 16.471 | 0.1435 | 2 | 13 | negative regulation of megakaryocyte differentiation |
| GO:0090179 | 0.0087 | 16.471 | 0.1435 | 2 | 13 | planar cell polarity pathway involved in neural tube closure |
| GO:0051094 | 0.0089 | 1.8402 | 12.8178 | 22 | 1161 | positive regulation of developmental process |
| GO:0000122 | 0.0093 | 2.0412 | 8.3244 | 16 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0009605 | 0.01 | 1.6512 | 21.0759 | 32 | 1909 | response to external stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060022 | 0 | 99.7351 | 0.0607 | 3 | 6 | hard palate development |
| GO:0009624 | 3e-04 | 198.1842 | 0.0304 | 2 | 3 | response to nematode |
| GO:0035880 | 3e-04 | 198.1842 | 0.0304 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0048513 | 3e-04 | 1.8859 | 30.7352 | 49 | 3037 | animal organ development |
| GO:0007601 | 6e-04 | 4.6348 | 1.8621 | 8 | 184 | visual perception |
| GO:0018894 | 6e-04 | 99.0855 | 0.0405 | 2 | 4 | dibenzo-p-dioxin metabolic process |
| GO:0007275 | 6e-04 | 1.7316 | 47.6057 | 67 | 4704 | multicellular organism development |
| GO:0061043 | 0.001 | 66.0526 | 0.0506 | 2 | 5 | regulation of vascular wound healing |
| GO:0060055 | 0.001 | 17.584 | 0.2024 | 3 | 20 | angiogenesis involved in wound healing |
| GO:0032502 | 0.0012 | 1.6645 | 56.127 | 75 | 5546 | developmental process |
| GO:0051045 | 0.0015 | 49.5362 | 0.0607 | 2 | 6 | negative regulation of membrane protein ectodomain proteolysis |
| GO:0016101 | 0.002 | 6.0564 | 0.8906 | 5 | 88 | diterpenoid metabolic process |
| GO:0048562 | 0.0021 | 3.4265 | 2.8033 | 9 | 277 | embryonic organ morphogenesis |
| GO:0001568 | 0.0024 | 2.5473 | 5.9001 | 14 | 583 | blood vessel development |
| GO:0045414 | 0.0027 | 33.0197 | 0.081 | 2 | 8 | regulation of interleukin-8 biosynthetic process |
| GO:0007600 | 0.003 | 2.5734 | 5.4042 | 13 | 534 | sensory perception |
| GO:0008544 | 0.0031 | 2.9892 | 3.5623 | 10 | 352 | epidermis development |
| GO:0006776 | 0.0035 | 28.3008 | 0.0911 | 2 | 9 | vitamin A metabolic process |
| GO:0072358 | 0.0038 | 2.4105 | 6.2138 | 14 | 614 | cardiovascular system development |
| GO:0003205 | 0.0046 | 4.1136 | 1.5484 | 6 | 153 | cardiac chamber development |
| GO:0042088 | 0.0052 | 9.3322 | 0.3542 | 3 | 35 | T-helper 1 type immune response |
| GO:0001525 | 0.0067 | 2.6652 | 3.9745 | 10 | 400 | angiogenesis |
| GO:1901615 | 0.0067 | 2.5269 | 4.6148 | 11 | 456 | organic hydroxy compound metabolic process |
| GO:0006720 | 0.007 | 4.4396 | 1.1942 | 5 | 118 | isoprenoid metabolic process |
| GO:0090179 | 0.0074 | 18.0048 | 0.1316 | 2 | 13 | planar cell polarity pathway involved in neural tube closure |
| GO:0001501 | 0.0078 | 2.4697 | 4.716 | 11 | 466 | skeletal system development |
| GO:0060443 | 0.0087 | 7.6536 | 0.4251 | 3 | 42 | mammary gland morphogenesis |
| GO:0043010 | 0.0092 | 2.8825 | 2.9248 | 8 | 289 | camera-type eye development |
| GO:0060347 | 0.0098 | 15.2328 | 0.1518 | 2 | 15 | heart trabecula formation |
| GO:0090177 | 0.0098 | 15.2328 | 0.1518 | 2 | 15 | establishment of planar polarity involved in neural tube closure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031424 | 1e-04 | 7.132 | 1.0804 | 7 | 137 | keratinization |
| GO:0051791 | 0.0013 | 51.1593 | 0.0552 | 2 | 7 | medium-chain fatty acid metabolic process |
| GO:0051256 | 0.0017 | 42.6299 | 0.0631 | 2 | 8 | mitotic spindle midzone assembly |
| GO:0051231 | 0.0032 | 28.4143 | 0.0867 | 2 | 11 | spindle elongation |
| GO:0051302 | 0.0035 | 5.25 | 1.0173 | 5 | 129 | regulation of cell division |
| GO:0009913 | 0.0038 | 3.7552 | 1.9873 | 7 | 252 | epidermal cell differentiation |
| GO:0060707 | 0.0039 | 25.5712 | 0.0946 | 2 | 12 | trophoblast giant cell differentiation |
| GO:0008285 | 0.0041 | 2.6032 | 4.9681 | 12 | 630 | negative regulation of cell proliferation |
| GO:0009650 | 0.0045 | 23.245 | 0.1025 | 2 | 13 | UV protection |
| GO:1902806 | 0.0073 | 4.3916 | 1.2065 | 5 | 153 | regulation of cell cycle G1/S phase transition |
| GO:2000134 | 0.0078 | 5.4454 | 0.7807 | 4 | 99 | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0003147 | 0.0079 | Inf | 0.0079 | 1 | 1 | neural crest cell migration involved in heart formation |
| GO:0034203 | 0.0079 | Inf | 0.0079 | 1 | 1 | glycolipid translocation |
| GO:0042694 | 0.0079 | Inf | 0.0079 | 1 | 1 | muscle cell fate specification |
| GO:0048264 | 0.0079 | Inf | 0.0079 | 1 | 1 | determination of ventral identity |
| GO:0050783 | 0.0079 | Inf | 0.0079 | 1 | 1 | cocaine metabolic process |
| GO:0061144 | 0.0079 | Inf | 0.0079 | 1 | 1 | alveolar secondary septum development |
| GO:0061713 | 0.0079 | Inf | 0.0079 | 1 | 1 | anterior neural tube closure |
| GO:0071231 | 0.0079 | Inf | 0.0079 | 1 | 1 | cellular response to folic acid |
| GO:0071412 | 0.0079 | Inf | 0.0079 | 1 | 1 | cellular response to genistein |
| GO:1902296 | 0.0079 | Inf | 0.0079 | 1 | 1 | DNA strand elongation involved in cell cycle DNA replication |
| GO:1902691 | 0.0079 | Inf | 0.0079 | 1 | 1 | respiratory basal cell differentiation |
| GO:1902983 | 0.0079 | Inf | 0.0079 | 1 | 1 | DNA strand elongation involved in mitotic DNA replication |
| GO:1903965 | 0.0079 | Inf | 0.0079 | 1 | 1 | monounsaturated fatty acid catabolic process |
| GO:1905322 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
| GO:1905546 | 0.0079 | Inf | 0.0079 | 1 | 1 | cellular response to phenylpropanoid |
| GO:2000761 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of N-terminal peptidyl-lysine acetylation |
| GO:0030154 | 0.008 | 1.6424 | 28.9098 | 41 | 3666 | cell differentiation |
| GO:0008630 | 0.0081 | 5.3883 | 0.7886 | 4 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0006067 | 0.0087 | 15.9756 | 0.1419 | 2 | 18 | ethanol metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009953 | 8e-04 | 5.9948 | 1.0883 | 6 | 92 | dorsal/ventral pattern formation |
| GO:0070268 | 9e-04 | 5.8578 | 1.1119 | 6 | 94 | cornification |
| GO:2000026 | 0.001 | 1.9025 | 20.4403 | 35 | 1728 | regulation of multicellular organismal development |
| GO:0060429 | 0.0012 | 2.0927 | 13.0236 | 25 | 1101 | epithelium development |
| GO:0019236 | 0.0014 | 56.3071 | 0.0591 | 2 | 5 | response to pheromone |
| GO:0016338 | 0.0021 | 13.397 | 0.2602 | 3 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0007186 | 0.0022 | 2.17 | 9.9244 | 20 | 839 | G-protein coupled receptor signaling pathway |
| GO:0034127 | 0.0028 | 33.7798 | 0.0828 | 2 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0002011 | 0.0029 | 7.4066 | 0.5914 | 4 | 50 | morphogenesis of an epithelial sheet |
| GO:0021515 | 0.0031 | 7.2485 | 0.6033 | 4 | 51 | cell differentiation in spinal cord |
| GO:0007389 | 0.0033 | 2.6546 | 4.8025 | 12 | 406 | pattern specification process |
| GO:0032411 | 0.0033 | 5.3418 | 1.0055 | 5 | 85 | positive regulation of transporter activity |
| GO:0032525 | 0.0037 | 28.1479 | 0.0946 | 2 | 8 | somite rostral/caudal axis specification |
| GO:0007179 | 0.0037 | 3.7622 | 1.9754 | 7 | 167 | transforming growth factor beta receptor signaling pathway |
| GO:0043587 | 0.0047 | 24.1252 | 0.1065 | 2 | 9 | tongue morphogenesis |
| GO:1903430 | 0.0047 | 24.1252 | 0.1065 | 2 | 9 | negative regulation of cell maturation |
| GO:2000543 | 0.0047 | 24.1252 | 0.1065 | 2 | 9 | positive regulation of gastrulation |
| GO:0048729 | 0.0051 | 2.2498 | 7.0855 | 15 | 599 | tissue morphogenesis |
| GO:0045601 | 0.0063 | 8.7715 | 0.3785 | 3 | 32 | regulation of endothelial cell differentiation |
| GO:0048731 | 0.007 | 1.4962 | 49.5393 | 65 | 4188 | system development |
| GO:0060712 | 0.0071 | 18.7615 | 0.1301 | 2 | 11 | spongiotrophoblast layer development |
| GO:0090084 | 0.0071 | 18.7615 | 0.1301 | 2 | 11 | negative regulation of inclusion body assembly |
| GO:1903140 | 0.0071 | 18.7615 | 0.1301 | 2 | 11 | regulation of establishment of endothelial barrier |
| GO:0071300 | 0.0081 | 5.4019 | 0.7925 | 4 | 67 | cellular response to retinoic acid |
| GO:0009887 | 0.0084 | 1.9048 | 11.1901 | 20 | 946 | animal organ morphogenesis |
| GO:0060670 | 0.0085 | 16.8843 | 0.1419 | 2 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0090101 | 0.0088 | 4.1835 | 1.2657 | 5 | 107 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0048568 | 0.0092 | 2.4065 | 4.8144 | 11 | 407 | embryonic organ development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 0 | Inf | 0.012 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0010469 | 2e-04 | 4.2319 | 2.9123 | 11 | 487 | regulation of receptor activity |
| GO:0042492 | 5e-04 | 84.9551 | 0.0359 | 2 | 6 | gamma-delta T cell differentiation |
| GO:0001937 | 9e-04 | 17.7473 | 0.1914 | 3 | 32 | negative regulation of endothelial cell proliferation |
| GO:0050678 | 0.0013 | 4.6025 | 1.6505 | 7 | 276 | regulation of epithelial cell proliferation |
| GO:0071559 | 0.0018 | 5.0627 | 1.2798 | 6 | 214 | response to transforming growth factor beta |
| GO:0030308 | 0.0018 | 6.1789 | 0.8731 | 5 | 146 | negative regulation of cell growth |
| GO:0043200 | 0.0029 | 7.2745 | 0.592 | 4 | 99 | response to amino acid |
| GO:0040008 | 0.0029 | 3.0632 | 3.5642 | 10 | 596 | regulation of growth |
| GO:0010033 | 0.003 | 1.9747 | 16.7863 | 28 | 2807 | response to organic substance |
| GO:0071363 | 0.0033 | 3.0098 | 3.624 | 10 | 606 | cellular response to growth factor stimulus |
| GO:0023051 | 0.0039 | 1.9017 | 18.7657 | 30 | 3138 | regulation of signaling |
| GO:0007565 | 0.004 | 5.1149 | 1.0465 | 5 | 175 | female pregnancy |
| GO:0090083 | 0.004 | 24.2568 | 0.0957 | 2 | 16 | regulation of inclusion body assembly |
| GO:0030888 | 0.0041 | 10.0769 | 0.3229 | 3 | 54 | regulation of B cell proliferation |
| GO:0060395 | 0.0041 | 10.0769 | 0.3229 | 3 | 54 | SMAD protein signal transduction |
| GO:0042100 | 0.0043 | 23.3488 | 0.0987 | 2 | 17 | B cell proliferation |
| GO:0032677 | 0.0043 | 9.8824 | 0.3289 | 3 | 55 | regulation of interleukin-8 production |
| GO:1901342 | 0.0045 | 4.1664 | 1.5429 | 6 | 258 | regulation of vasculature development |
| GO:2000136 | 0.0045 | 22.6382 | 0.1017 | 2 | 17 | regulation of cell proliferation involved in heart morphogenesis |
| GO:0070098 | 0.0048 | 9.5152 | 0.3409 | 3 | 57 | chemokine-mediated signaling pathway |
| GO:0014855 | 0.0053 | 9.1741 | 0.3528 | 3 | 59 | striated muscle cell proliferation |
| GO:0060359 | 0.0053 | 6.1084 | 0.6997 | 4 | 117 | response to ammonium ion |
| GO:0051241 | 0.0053 | 2.4431 | 5.8546 | 13 | 979 | negative regulation of multicellular organismal process |
| GO:0048870 | 0.0056 | 2.222 | 8.0194 | 16 | 1341 | cell motility |
| GO:0008277 | 0.006 | 5.898 | 0.7236 | 4 | 121 | regulation of G-protein coupled receptor protein signaling pathway |
| GO:0002305 | 0.006 | Inf | 0.006 | 1 | 1 | CD8-positive, gamma-delta intraepithelial T cell differentiation |
| GO:0007208 | 0.006 | Inf | 0.006 | 1 | 1 | phospholipase C-activating serotonin receptor signaling pathway |
| GO:0010232 | 0.006 | Inf | 0.006 | 1 | 1 | vascular transport |
| GO:0019244 | 0.006 | Inf | 0.006 | 1 | 1 | lactate biosynthetic process from pyruvate |
| GO:0034203 | 0.006 | Inf | 0.006 | 1 | 1 | glycolipid translocation |
| GO:0043378 | 0.006 | Inf | 0.006 | 1 | 1 | positive regulation of CD8-positive, alpha-beta T cell differentiation |
| GO:0046327 | 0.006 | Inf | 0.006 | 1 | 1 | glycerol biosynthetic process from pyruvate |
| GO:0060183 | 0.006 | Inf | 0.006 | 1 | 1 | apelin receptor signaling pathway |
| GO:0071045 | 0.006 | Inf | 0.006 | 1 | 1 | nuclear histone mRNA catabolic process |
| GO:1900758 | 0.006 | Inf | 0.006 | 1 | 1 | negative regulation of D-amino-acid oxidase activity |
| GO:1904022 | 0.006 | Inf | 0.006 | 1 | 1 | positive regulation of G-protein coupled receptor internalization |
| GO:1905243 | 0.006 | Inf | 0.006 | 1 | 1 | cellular response to 3,3',5-triiodo-L-thyronine |
| GO:0010646 | 0.0062 | 1.8421 | 18.4906 | 29 | 3092 | regulation of cell communication |
| GO:1903524 | 0.0063 | 8.5602 | 0.3767 | 3 | 63 | positive regulation of blood circulation |
| GO:0001501 | 0.0067 | 3.0869 | 2.7868 | 8 | 466 | skeletal system development |
| GO:0010594 | 0.0073 | 5.5625 | 0.7655 | 4 | 128 | regulation of endothelial cell migration |
| GO:0030260 | 0.0073 | 5.5625 | 0.7655 | 4 | 128 | entry into host cell |
| GO:0051828 | 0.0073 | 5.5625 | 0.7655 | 4 | 128 | entry into other organism involved in symbiotic interaction |
| GO:0043372 | 0.0076 | 16.973 | 0.1316 | 2 | 22 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0045766 | 0.0079 | 5.43 | 0.7834 | 4 | 131 | positive regulation of angiogenesis |
| GO:0001568 | 0.008 | 2.7825 | 3.4864 | 9 | 583 | blood vessel development |
| GO:0042026 | 0.0082 | 16.1637 | 0.1375 | 2 | 23 | protein refolding |
| GO:0090023 | 0.0082 | 16.1637 | 0.1375 | 2 | 23 | positive regulation of neutrophil chemotaxis |
| GO:0072359 | 0.0084 | 2.3813 | 5.4958 | 12 | 919 | circulatory system development |
| GO:0048583 | 0.0085 | 1.7595 | 21.5046 | 32 | 3596 | regulation of response to stimulus |
| GO:0031424 | 0.0092 | 5.183 | 0.8193 | 4 | 137 | keratinization |
| GO:0030335 | 0.0093 | 3.1738 | 2.3562 | 7 | 394 | positive regulation of cell migration |
| GO:0006475 | 0.0094 | 5.1439 | 0.8253 | 4 | 138 | internal protein amino acid acetylation |
| GO:0008016 | 0.0095 | 4.1097 | 1.2917 | 5 | 216 | regulation of heart contraction |
| GO:0001782 | 0.0097 | 14.7562 | 0.1495 | 2 | 25 | B cell homeostasis |
| GO:0007165 | 0.0097 | 1.6994 | 29.018 | 40 | 5000 | signal transduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036461 | 1e-04 | Inf | 0.0222 | 2 | 2 | BLOC-2 complex binding |
| GO:0048018 | 3e-04 | 3.3779 | 4.1679 | 13 | 376 | receptor ligand activity |
| GO:0035651 | 4e-04 | 180.5509 | 0.0333 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0043565 | 6e-04 | 2.3012 | 10.9629 | 23 | 989 | sequence-specific DNA binding |
| GO:0035650 | 7e-04 | 90.2695 | 0.0443 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0030280 | 0.0052 | 22.5584 | 0.1108 | 2 | 10 | structural constituent of epidermis |
| GO:1903231 | 0.0052 | 9.3776 | 0.3547 | 3 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004861 | 0.0075 | 18.0443 | 0.133 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0005243 | 0.0088 | 16.4028 | 0.1441 | 2 | 13 | gap junction channel activity |
| GO:0008253 | 0.0088 | 16.4028 | 0.1441 | 2 | 13 | 5'-nucleotidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 4e-04 | 2.8762 | 5.9819 | 16 | 400 | receptor regulator activity |
| GO:0005179 | 9e-04 | 4.9234 | 1.5403 | 7 | 103 | hormone activity |
| GO:0102991 | 0.0059 | 22.1416 | 0.1196 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0005506 | 0.0071 | 3.3182 | 2.2283 | 7 | 149 | iron ion binding |
| GO:0046983 | 0.0072 | 1.7356 | 17.183 | 28 | 1149 | protein dimerization activity |
| GO:0000977 | 0.0072 | 2.0422 | 8.7784 | 17 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 7e-04 | 3.2571 | 3.9706 | 12 | 376 | receptor ligand activity |
| GO:0004468 | 0.0016 | 47.4245 | 0.0634 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0055131 | 0.0016 | 47.4245 | 0.0634 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0005126 | 0.0021 | 3.7398 | 2.281 | 8 | 216 | cytokine receptor binding |
| GO:0003909 | 0.0022 | 37.9371 | 0.0739 | 2 | 7 | DNA ligase activity |
| GO:0008009 | 0.0038 | 10.5893 | 0.3168 | 3 | 30 | chemokine activity |
| GO:0042577 | 0.0057 | 21.0706 | 0.1162 | 2 | 11 | lipid phosphatase activity |
| GO:0060229 | 0.0068 | 18.9623 | 0.1267 | 2 | 12 | lipase activator activity |
| GO:0004197 | 0.0085 | 5.3125 | 0.8026 | 4 | 76 | cysteine-type endopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019864 | 1e-04 | 45.8102 | 0.1049 | 3 | 8 | IgG binding |
| GO:0034597 | 0.001 | 75.9798 | 0.0525 | 2 | 4 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity |
| GO:0004415 | 0.0046 | 25.3199 | 0.1049 | 2 | 8 | hyalurononglucosaminidase activity |
| GO:0008020 | 0.0058 | 21.7013 | 0.1181 | 2 | 9 | G-protein coupled photoreceptor activity |
| GO:1990825 | 0.0058 | 21.7013 | 0.1181 | 2 | 9 | sequence-specific mRNA binding |
| GO:0019838 | 0.0066 | 3.8149 | 1.666 | 6 | 127 | growth factor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 25.7924 | 0.3327 | 7 | 57 | olfactory receptor activity |
| GO:0038023 | 1e-04 | 3.5177 | 5.283 | 16 | 905 | signaling receptor activity |
| GO:0004930 | 2e-04 | 4.5416 | 2.4576 | 10 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 4e-04 | 3.218 | 4.9328 | 14 | 845 | transmembrane receptor activity |
| GO:0031433 | 7e-04 | 69.6644 | 0.0409 | 2 | 7 | telethonin binding |
| GO:0060089 | 9e-04 | 2.7078 | 6.7191 | 16 | 1151 | molecular transducer activity |
| GO:0002113 | 0.0058 | Inf | 0.0058 | 1 | 1 | interleukin-33 binding |
| GO:0005140 | 0.0058 | Inf | 0.0058 | 1 | 1 | interleukin-9 receptor binding |
| GO:0008111 | 0.0058 | Inf | 0.0058 | 1 | 1 | alpha-methylacyl-CoA racemase activity |
| GO:0050646 | 0.0058 | Inf | 0.0058 | 1 | 1 | 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding |
| GO:0050647 | 0.0058 | Inf | 0.0058 | 1 | 1 | 5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding |
| GO:0050648 | 0.0058 | Inf | 0.0058 | 1 | 1 | 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004300 | 0.0074 | 19.664 | 0.1343 | 2 | 8 | enoyl-CoA hydratase activity |
| GO:0004865 | 0.0074 | 19.664 | 0.1343 | 2 | 8 | protein serine/threonine phosphatase inhibitor activity |
| GO:0008525 | 0.0074 | 19.664 | 0.1343 | 2 | 8 | phosphatidylcholine transporter activity |
| GO:0031702 | 0.0094 | 16.8538 | 0.1511 | 2 | 9 | type 1 angiotensin receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042577 | 6e-04 | 23.0394 | 0.1782 | 3 | 11 | lipid phosphatase activity |
| GO:0061578 | 0.0038 | 30.602 | 0.0972 | 2 | 6 | Lys63-specific deubiquitinase activity |
| GO:0015078 | 0.0038 | 4.3172 | 1.4905 | 6 | 92 | hydrogen ion transmembrane transporter activity |
| GO:0005337 | 0.0087 | 17.4834 | 0.1458 | 2 | 9 | nucleoside transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 1e-04 | 4.1931 | 3.1568 | 12 | 376 | receptor ligand activity |
| GO:0098519 | 4e-04 | 120.928 | 0.0333 | 2 | 4 | nucleotide phosphatase activity, acting on free nucleotides |
| GO:0070700 | 0.0024 | 34.2653 | 0.0756 | 2 | 9 | BMP receptor binding |
| GO:0055102 | 0.0051 | 21.7994 | 0.1091 | 2 | 13 | lipase inhibitor activity |
| GO:0033612 | 0.0068 | 18.4432 | 0.1259 | 2 | 15 | receptor serine/threonine kinase binding |
| GO:0000121 | 0.0084 | Inf | 0.0084 | 1 | 1 | glycerol-1-phosphatase activity |
| GO:0001594 | 0.0084 | Inf | 0.0084 | 1 | 1 | trace-amine receptor activity |
| GO:0005144 | 0.0084 | Inf | 0.0084 | 1 | 1 | interleukin-13 receptor binding |
| GO:0015054 | 0.0084 | Inf | 0.0084 | 1 | 1 | gastrin receptor activity |
| GO:0016412 | 0.0084 | Inf | 0.0084 | 1 | 1 | serine O-acyltransferase activity |
| GO:0017024 | 0.0084 | Inf | 0.0084 | 1 | 1 | myosin I binding |
| GO:0031700 | 0.0084 | Inf | 0.0084 | 1 | 1 | adrenomedullin receptor binding |
| GO:0031741 | 0.0084 | Inf | 0.0084 | 1 | 1 | type B gastrin/cholecystokinin receptor binding |
| GO:0043136 | 0.0084 | Inf | 0.0084 | 1 | 1 | glycerol-3-phosphatase activity |
| GO:0044549 | 0.0084 | Inf | 0.0084 | 1 | 1 | GTP cyclohydrolase binding |
| GO:0050897 | 0.0084 | Inf | 0.0084 | 1 | 1 | cobalt ion binding |
| GO:0097383 | 0.0084 | Inf | 0.0084 | 1 | 1 | dIDP diphosphatase activity |
| GO:1901640 | 0.0084 | Inf | 0.0084 | 1 | 1 | XTP binding |
| GO:1901641 | 0.0084 | Inf | 0.0084 | 1 | 1 | ITP binding |
| GO:1990003 | 0.0084 | Inf | 0.0084 | 1 | 1 | IDP phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097602 | 1e-04 | 19.0553 | 0.2743 | 4 | 17 | cullin family protein binding |
| GO:0003723 | 0.0018 | 1.7398 | 24.9453 | 40 | 1546 | RNA binding |
| GO:0005109 | 0.0023 | 7.9813 | 0.5647 | 4 | 35 | frizzled binding |
| GO:0017108 | 0.0037 | 30.7295 | 0.0968 | 2 | 6 | 5'-flap endonuclease activity |
| GO:0061133 | 0.0037 | 30.7295 | 0.0968 | 2 | 6 | endopeptidase activator activity |
| GO:0140098 | 0.0098 | 2.2797 | 5.5183 | 12 | 342 | catalytic activity, acting on RNA |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004602 | 2e-04 | 29.7248 | 0.1249 | 3 | 17 | glutathione peroxidase activity |
| GO:0030332 | 0.0015 | 14.8486 | 0.2277 | 3 | 31 | cyclin binding |
| GO:0016684 | 0.0034 | 10.9338 | 0.3012 | 3 | 41 | oxidoreductase activity, acting on peroxide as acceptor |
| GO:0001054 | 0.0034 | 27.4982 | 0.0882 | 2 | 12 | RNA polymerase I activity |
| GO:0003796 | 0.0034 | 27.4982 | 0.0882 | 2 | 12 | lysozyme activity |
| GO:0004861 | 0.0034 | 27.4982 | 0.0882 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0008499 | 0.004 | 24.9967 | 0.0955 | 2 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GO:0070402 | 0.004 | 24.9967 | 0.0955 | 2 | 13 | NADPH binding |
| GO:0004489 | 0.0073 | Inf | 0.0073 | 1 | 1 | methylenetetrahydrofolate reductase (NAD(P)H) activity |
| GO:0004586 | 0.0073 | Inf | 0.0073 | 1 | 1 | ornithine decarboxylase activity |
| GO:0004799 | 0.0073 | Inf | 0.0073 | 1 | 1 | thymidylate synthase activity |
| GO:0008111 | 0.0073 | Inf | 0.0073 | 1 | 1 | alpha-methylacyl-CoA racemase activity |
| GO:0030586 | 0.0073 | Inf | 0.0073 | 1 | 1 | [methionine synthase] reductase activity |
| GO:0031732 | 0.0073 | Inf | 0.0073 | 1 | 1 | CCR7 chemokine receptor binding |
| GO:0047220 | 0.0073 | Inf | 0.0073 | 1 | 1 | galactosylxylosylprotein 3-beta-galactosyltransferase activity |
| GO:0047915 | 0.0073 | Inf | 0.0073 | 1 | 1 | ganglioside galactosyltransferase activity |
| GO:0050444 | 0.0073 | Inf | 0.0073 | 1 | 1 | aquacobalamin reductase (NADPH) activity |
| GO:0004984 | 0.0085 | 7.686 | 0.4187 | 3 | 57 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008426 | 8e-04 | 121.4251 | 0.049 | 2 | 3 | protein kinase C inhibitor activity |
| GO:0097177 | 8e-04 | 121.4251 | 0.049 | 2 | 3 | mitochondrial ribosome binding |
| GO:0003676 | 0.0023 | 1.7942 | 21.3988 | 35 | 1420 | nucleic acid binding |
| GO:0003735 | 0.0026 | 3.6006 | 2.3682 | 8 | 145 | structural constituent of ribosome |
| GO:0003677 | 0.0034 | 1.5672 | 37.6619 | 54 | 2306 | DNA binding |
| GO:0050681 | 0.0048 | 6.4271 | 0.686 | 4 | 42 | androgen receptor binding |
| GO:0016634 | 0.0089 | 17.3395 | 0.147 | 2 | 9 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036459 | 0 | 12.4315 | 0.5474 | 6 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0004984 | 2e-04 | 15.4156 | 0.2916 | 4 | 57 | olfactory receptor activity |
| GO:0008234 | 3e-04 | 7.352 | 0.9004 | 6 | 176 | cysteine-type peptidase activity |
| GO:0036122 | 9e-04 | 56.9962 | 0.046 | 2 | 9 | BMP binding |
| GO:0099600 | 0.0012 | 3.1289 | 4.3231 | 12 | 845 | transmembrane receptor activity |
| GO:0070011 | 0.0025 | 4.1205 | 1.8585 | 7 | 389 | peptidase activity, acting on L-amino acid peptides |
| GO:0004398 | 0.0051 | Inf | 0.0051 | 1 | 1 | histidine decarboxylase activity |
| GO:0034899 | 0.0051 | Inf | 0.0051 | 1 | 1 | trimethylamine monooxygenase activity |
| GO:0035717 | 0.0051 | Inf | 0.0051 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0047743 | 0.0051 | Inf | 0.0051 | 1 | 1 | chlordecone reductase activity |
| GO:0050897 | 0.0051 | Inf | 0.0051 | 1 | 1 | cobalt ion binding |
| GO:0052731 | 0.0051 | Inf | 0.0051 | 1 | 1 | phosphocholine phosphatase activity |
| GO:0052732 | 0.0051 | Inf | 0.0051 | 1 | 1 | phosphoethanolamine phosphatase activity |
| GO:0071791 | 0.0051 | Inf | 0.0051 | 1 | 1 | chemokine (C-C motif) ligand 5 binding |
| GO:0097383 | 0.0051 | Inf | 0.0051 | 1 | 1 | dIDP diphosphatase activity |
| GO:1901640 | 0.0051 | Inf | 0.0051 | 1 | 1 | XTP binding |
| GO:1901641 | 0.0051 | Inf | 0.0051 | 1 | 1 | ITP binding |
| GO:1990003 | 0.0051 | Inf | 0.0051 | 1 | 1 | IDP phosphatase activity |
| GO:0004930 | 0.0057 | 3.5136 | 2.1539 | 7 | 421 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 2e-04 | 3.1567 | 5.1423 | 15 | 400 | receptor regulator activity |
| GO:0019841 | 5e-04 | 23.3782 | 0.1671 | 3 | 13 | retinol binding |
| GO:0016918 | 7e-04 | 21.2515 | 0.18 | 3 | 14 | retinal binding |
| GO:0004930 | 0.0011 | 2.7675 | 5.4123 | 14 | 421 | G-protein coupled receptor activity |
| GO:0005179 | 0.0021 | 4.868 | 1.3242 | 6 | 103 | hormone activity |
| GO:0004957 | 0.0024 | 38.7784 | 0.0771 | 2 | 6 | prostaglandin E receptor activity |
| GO:0046982 | 0.0055 | 2.3755 | 5.7851 | 13 | 450 | protein heterodimerization activity |
| GO:0016493 | 0.0069 | 19.384 | 0.1286 | 2 | 10 | C-C chemokine receptor activity |
| GO:0008395 | 0.0079 | 8.0513 | 0.4114 | 3 | 32 | steroid hydroxylase activity |
| GO:0004954 | 0.0084 | 17.2291 | 0.1414 | 2 | 11 | prostanoid receptor activity |
| GO:0019840 | 0.0086 | 7.7824 | 0.4242 | 3 | 33 | isoprenoid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 1e-04 | 3.1545 | 5.8507 | 17 | 400 | receptor regulator activity |
| GO:0005179 | 1e-04 | 5.847 | 1.5066 | 8 | 103 | hormone activity |
| GO:0000978 | 0.0053 | 2.486 | 5.0901 | 12 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0102991 | 0.0056 | 22.6501 | 0.117 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0001159 | 0.0074 | 2.3704 | 5.3242 | 12 | 364 | core promoter proximal region DNA binding |
| GO:0005102 | 0.0083 | 1.6706 | 19.8193 | 31 | 1355 | receptor binding |
| GO:0046983 | 0.0098 | 1.7067 | 16.8062 | 27 | 1149 | protein dimerization activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051428 | 5e-04 | 23.5938 | 0.1547 | 3 | 18 | peptide hormone receptor binding |
| GO:0030414 | 0.0013 | 5.407 | 1.1943 | 6 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0.0013 | 5.407 | 1.1943 | 6 | 139 | endopeptidase regulator activity |
| GO:0004984 | 0.0014 | 8.9508 | 0.4898 | 4 | 57 | olfactory receptor activity |
| GO:0048018 | 0.0015 | 3.3304 | 3.2307 | 10 | 376 | receptor ligand activity |
| GO:0019864 | 0.002 | 39.0413 | 0.0687 | 2 | 8 | IgG binding |
| GO:0004867 | 0.0036 | 6.868 | 0.6272 | 4 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0005549 | 0.0038 | 26.0224 | 0.0945 | 2 | 11 | odorant binding |
| GO:0004055 | 0.0086 | Inf | 0.0086 | 1 | 1 | argininosuccinate synthase activity |
| GO:0008613 | 0.0086 | Inf | 0.0086 | 1 | 1 | diuretic hormone activity |
| GO:0019772 | 0.0086 | Inf | 0.0086 | 1 | 1 | low-affinity IgG receptor activity |
| GO:0030380 | 0.0086 | Inf | 0.0086 | 1 | 1 | interleukin-17E receptor binding |
| GO:0033735 | 0.0086 | Inf | 0.0086 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0036403 | 0.0086 | Inf | 0.0086 | 1 | 1 | arachidonate 8(S)-lipoxygenase activity |
| GO:0102116 | 0.0086 | Inf | 0.0086 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0086 | Inf | 0.0086 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 0.001 | 3.0895 | 4.1679 | 12 | 376 | receptor ligand activity |
| GO:0004468 | 0.0018 | 45.1287 | 0.0665 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0055131 | 0.0018 | 45.1287 | 0.0665 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0003909 | 0.0025 | 36.1006 | 0.0776 | 2 | 7 | DNA ligase activity |
| GO:0008234 | 0.0035 | 3.8117 | 1.9509 | 7 | 176 | cysteine-type peptidase activity |
| GO:0008009 | 0.0044 | 10.0736 | 0.3325 | 3 | 30 | chemokine activity |
| GO:0042577 | 0.0063 | 20.0506 | 0.1219 | 2 | 11 | lipid phosphatase activity |
| GO:0060229 | 0.0075 | 18.0443 | 0.133 | 2 | 12 | lipase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005506 | 9e-04 | 4.9122 | 1.5344 | 7 | 149 | iron ion binding |
| GO:0030545 | 9e-04 | 3.1357 | 4.1191 | 12 | 400 | receptor regulator activity |
| GO:0004468 | 0.0015 | 48.6613 | 0.0618 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0043546 | 0.0015 | 48.6613 | 0.0618 | 2 | 6 | molybdopterin cofactor binding |
| GO:0051379 | 0.0021 | 38.9265 | 0.0721 | 2 | 7 | epinephrine binding |
| GO:0102991 | 0.0028 | 32.4366 | 0.0824 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0008190 | 0.0036 | 27.8009 | 0.0927 | 2 | 9 | eukaryotic initiation factor 4E binding |
| GO:0005179 | 0.0042 | 5.0319 | 1.0607 | 5 | 103 | hormone activity |
| GO:0008395 | 0.0043 | 10.1164 | 0.3295 | 3 | 32 | steroid hydroxylase activity |
| GO:0016705 | 0.0043 | 4.1825 | 1.5241 | 6 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0016290 | 0.0055 | 21.6201 | 0.1133 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0046983 | 0.0072 | 1.9111 | 11.8322 | 21 | 1149 | protein dimerization activity |
| GO:0031406 | 0.0077 | 3.6843 | 1.7197 | 6 | 167 | carboxylic acid binding |
| GO:0020037 | 0.008 | 4.2832 | 1.2357 | 5 | 120 | heme binding |
| GO:0005523 | 0.0088 | 16.2118 | 0.1442 | 2 | 14 | tropomyosin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 1e-04 | Inf | 0.023 | 2 | 2 | MHC class Ib receptor activity |
| GO:0099600 | 3e-04 | 2.4893 | 9.6993 | 22 | 845 | transmembrane receptor activity |
| GO:0060089 | 3e-04 | 2.2637 | 13.2117 | 27 | 1151 | molecular transducer activity |
| GO:0004930 | 4e-04 | 3.133 | 4.8324 | 14 | 421 | G-protein coupled receptor activity |
| GO:0043565 | 4e-04 | 2.3233 | 11.3522 | 24 | 989 | sequence-specific DNA binding |
| GO:0004966 | 0.0026 | 34.8347 | 0.0803 | 2 | 7 | galanin receptor activity |
| GO:0071855 | 0.0028 | 11.931 | 0.287 | 3 | 25 | neuropeptide receptor binding |
| GO:0038023 | 0.0037 | 2.0683 | 10.388 | 20 | 905 | signaling receptor activity |
| GO:0004984 | 0.0041 | 6.6283 | 0.6543 | 4 | 57 | olfactory receptor activity |
| GO:0008510 | 0.0045 | 24.8786 | 0.1033 | 2 | 9 | sodium:bicarbonate symporter activity |
| GO:0005518 | 0.005 | 6.2719 | 0.6887 | 4 | 60 | collagen binding |
| GO:0030246 | 0.0066 | 3.064 | 2.7548 | 8 | 240 | carbohydrate binding |
| GO:0000977 | 0.0078 | 2.2002 | 6.7378 | 14 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0000987 | 0.0089 | 2.5417 | 4.1437 | 10 | 361 | core promoter proximal region sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036461 | 1e-04 | Inf | 0.022 | 2 | 2 | BLOC-2 complex binding |
| GO:0048018 | 3e-04 | 3.3999 | 4.1433 | 13 | 376 | receptor ligand activity |
| GO:0035651 | 4e-04 | 181.6506 | 0.0331 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 7e-04 | 90.8193 | 0.0441 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0043565 | 0.0013 | 2.1989 | 10.8981 | 22 | 989 | sequence-specific DNA binding |
| GO:0030280 | 0.0051 | 22.6958 | 0.1102 | 2 | 10 | structural constituent of epidermis |
| GO:1903231 | 0.0052 | 9.4351 | 0.3526 | 3 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004861 | 0.0074 | 18.1542 | 0.1322 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0005243 | 0.0087 | 16.5027 | 0.1433 | 2 | 13 | gap junction channel activity |
| GO:0008253 | 0.0087 | 16.5027 | 0.1433 | 2 | 13 | 5'-nucleotidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 2e-04 | 14.8121 | 0.3028 | 4 | 57 | olfactory receptor activity |
| GO:0004867 | 6e-04 | 11.3653 | 0.3878 | 4 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0030414 | 9e-04 | 7.3797 | 0.7385 | 5 | 139 | peptidase inhibitor activity |
| GO:0061135 | 9e-04 | 7.3797 | 0.7385 | 5 | 139 | endopeptidase regulator activity |
| GO:0005549 | 0.0015 | 42.6329 | 0.0584 | 2 | 11 | odorant binding |
| GO:0005179 | 0.0022 | 7.9055 | 0.5472 | 4 | 103 | hormone activity |
| GO:0022834 | 0.0049 | 6.2504 | 0.6854 | 4 | 129 | ligand-gated channel activity |
| GO:0001594 | 0.0053 | Inf | 0.0053 | 1 | 1 | trace-amine receptor activity |
| GO:0003912 | 0.0053 | Inf | 0.0053 | 1 | 1 | DNA nucleotidylexotransferase activity |
| GO:0004398 | 0.0053 | Inf | 0.0053 | 1 | 1 | histidine decarboxylase activity |
| GO:0008403 | 0.0053 | Inf | 0.0053 | 1 | 1 | 25-hydroxycholecalciferol-24-hydroxylase activity |
| GO:0008579 | 0.0053 | Inf | 0.0053 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0008753 | 0.0053 | Inf | 0.0053 | 1 | 1 | NADPH dehydrogenase (quinone) activity |
| GO:0030342 | 0.0053 | Inf | 0.0053 | 1 | 1 | 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity |
| GO:0031731 | 0.0053 | Inf | 0.0053 | 1 | 1 | CCR6 chemokine receptor binding |
| GO:0047743 | 0.0053 | Inf | 0.0053 | 1 | 1 | chlordecone reductase activity |
| GO:0061714 | 0.0053 | Inf | 0.0053 | 1 | 1 | folic acid receptor activity |
| GO:0005230 | 0.0056 | 8.9349 | 0.3613 | 3 | 68 | extracellular ligand-gated ion channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 1e-04 | Inf | 0.0216 | 2 | 2 | MHC class Ib receptor activity |
| GO:0030246 | 0.0012 | 3.7088 | 2.5974 | 9 | 240 | carbohydrate binding |
| GO:0004871 | 0.0012 | 2.1017 | 13.0519 | 25 | 1206 | signal transducer activity |
| GO:0004872 | 0.0019 | 2.0914 | 11.9805 | 23 | 1107 | receptor activity |
| GO:0005024 | 0.004 | 26.4224 | 0.0974 | 2 | 9 | transforming growth factor beta-activated receptor activity |
| GO:0033691 | 0.004 | 26.4224 | 0.0974 | 2 | 9 | sialic acid binding |
| GO:0004888 | 0.0053 | 2.1291 | 8.5435 | 17 | 799 | transmembrane signaling receptor activity |
| GO:0005344 | 0.006 | 20.5481 | 0.119 | 2 | 11 | oxygen carrier activity |
| GO:0005549 | 0.006 | 20.5481 | 0.119 | 2 | 11 | odorant binding |
| GO:0035591 | 0.0085 | 5.3278 | 0.8009 | 4 | 74 | signaling adaptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 20.5623 | 0.2302 | 4 | 30 | chemokine activity |
| GO:0004930 | 1e-04 | 4.1132 | 3.2308 | 12 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 2e-04 | 2.9362 | 6.4847 | 17 | 845 | transmembrane receptor activity |
| GO:0038023 | 5e-04 | 2.7263 | 6.9451 | 17 | 905 | signaling receptor activity |
| GO:0019864 | 0.0016 | 43.8348 | 0.0614 | 2 | 8 | IgG binding |
| GO:0001102 | 0.0028 | 11.6834 | 0.2839 | 3 | 37 | RNA polymerase II activating transcription factor binding |
| GO:0045236 | 0.0031 | 29.2174 | 0.0844 | 2 | 11 | CXCR chemokine receptor binding |
| GO:0048018 | 0.0044 | 3.6653 | 2.0372 | 7 | 273 | receptor ligand activity |
| GO:0005126 | 0.0064 | 3.8402 | 1.6576 | 6 | 216 | cytokine receptor binding |
| GO:0060089 | 0.0067 | 2.098 | 8.8329 | 17 | 1151 | molecular transducer activity |
| GO:0004042 | 0.0077 | Inf | 0.0077 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0008397 | 0.0077 | Inf | 0.0077 | 1 | 1 | sterol 12-alpha-hydroxylase activity |
| GO:0008404 | 0.0077 | Inf | 0.0077 | 1 | 1 | arachidonic acid 14,15-epoxygenase activity |
| GO:0008405 | 0.0077 | Inf | 0.0077 | 1 | 1 | arachidonic acid 11,12-epoxygenase activity |
| GO:0008700 | 0.0077 | Inf | 0.0077 | 1 | 1 | 4-hydroxy-2-oxoglutarate aldolase activity |
| GO:0015052 | 0.0077 | Inf | 0.0077 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0018467 | 0.0077 | Inf | 0.0077 | 1 | 1 | formaldehyde dehydrogenase activity |
| GO:0033778 | 0.0077 | Inf | 0.0077 | 1 | 1 | 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity |
| GO:0047016 | 0.0077 | Inf | 0.0077 | 1 | 1 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity |
| GO:0051903 | 0.0077 | Inf | 0.0077 | 1 | 1 | S-(hydroxymethyl)glutathione dehydrogenase activity |
| GO:0071614 | 0.0077 | Inf | 0.0077 | 1 | 1 | linoleic acid epoxygenase activity |
| GO:0103045 | 0.0077 | Inf | 0.0077 | 1 | 1 | methione N-acyltransferase activity |
| GO:0001664 | 0.0079 | 3.6631 | 1.7344 | 6 | 226 | G-protein coupled receptor binding |
| GO:0005179 | 0.0081 | 5.3741 | 0.7904 | 4 | 103 | hormone activity |
| GO:0031406 | 0.0093 | 4.1245 | 1.2816 | 5 | 167 | carboxylic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099600 | 0.0062 | 2.1521 | 7.9811 | 16 | 845 | transmembrane receptor activity |
| GO:0004930 | 0.0067 | 2.6675 | 3.9764 | 10 | 421 | G-protein coupled receptor activity |
| GO:0031005 | 0.0075 | 17.7113 | 0.1322 | 2 | 14 | filamin binding |
| GO:0048018 | 0.0094 | 2.6767 | 3.5514 | 9 | 376 | receptor ligand activity |
| GO:0008111 | 0.0094 | Inf | 0.0094 | 1 | 1 | alpha-methylacyl-CoA racemase activity |
| GO:0015410 | 0.0094 | Inf | 0.0094 | 1 | 1 | manganese-transporting ATPase activity |
| GO:0031700 | 0.0094 | Inf | 0.0094 | 1 | 1 | adrenomedullin receptor binding |
| GO:0034353 | 0.0094 | Inf | 0.0094 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0035757 | 0.0094 | Inf | 0.0094 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 0.0094 | Inf | 0.0094 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0036326 | 0.0094 | Inf | 0.0094 | 1 | 1 | VEGF-A-activated receptor activity |
| GO:0036327 | 0.0094 | Inf | 0.0094 | 1 | 1 | VEGF-B-activated receptor activity |
| GO:0036332 | 0.0094 | Inf | 0.0094 | 1 | 1 | placental growth factor-activated receptor activity |
| GO:0038117 | 0.0094 | Inf | 0.0094 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 0.0094 | Inf | 0.0094 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0042017 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-22 binding |
| GO:0042018 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-22 receptor activity |
| GO:0043739 | 0.0094 | Inf | 0.0094 | 1 | 1 | G/U mismatch-specific uracil-DNA glycosylase activity |
| GO:0047130 | 0.0094 | Inf | 0.0094 | 1 | 1 | saccharopine dehydrogenase (NADP+, L-lysine-forming) activity |
| GO:0047131 | 0.0094 | Inf | 0.0094 | 1 | 1 | saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity |
| GO:0031489 | 0.0097 | 15.1791 | 0.1511 | 2 | 16 | myosin V binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 8e-04 | 3.1922 | 4.0446 | 12 | 376 | receptor ligand activity |
| GO:0043027 | 0.0016 | 14.7725 | 0.2367 | 3 | 22 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
| GO:0005184 | 0.0026 | 12.2001 | 0.2797 | 3 | 26 | neuropeptide hormone activity |
| GO:0008296 | 0.0031 | 31.0206 | 0.0861 | 2 | 8 | 3'-5'-exodeoxyribonuclease activity |
| GO:0001228 | 0.0037 | 2.7519 | 4.249 | 11 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0051378 | 0.0039 | 26.5873 | 0.0968 | 2 | 9 | serotonin binding |
| GO:0043565 | 0.0048 | 2.0228 | 10.6386 | 20 | 989 | sequence-specific DNA binding |
| GO:0004993 | 0.0049 | 23.2623 | 0.1076 | 2 | 10 | G-protein coupled serotonin receptor activity |
| GO:0004930 | 0.0059 | 2.5728 | 4.5287 | 11 | 421 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019841 | 3e-04 | 30.166 | 0.1305 | 3 | 13 | retinol binding |
| GO:0019840 | 0.0043 | 10.042 | 0.3312 | 3 | 33 | isoprenoid binding |
| GO:0008191 | 0.0073 | 18.1601 | 0.1305 | 2 | 13 | metalloendopeptidase inhibitor activity |
| GO:0016918 | 0.0084 | 16.6457 | 0.1405 | 2 | 14 | retinal binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0.001 | 59.9762 | 0.0504 | 2 | 6 | molybdopterin cofactor binding |
| GO:0019840 | 0.0026 | 12.0704 | 0.2771 | 3 | 33 | isoprenoid binding |
| GO:0042301 | 0.003 | 29.9802 | 0.084 | 2 | 10 | phosphate ion binding |
| GO:0004861 | 0.0044 | 23.981 | 0.1007 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:1901338 | 0.0068 | 18.4432 | 0.1259 | 2 | 15 | catecholamine binding |
| GO:0008083 | 0.0071 | 4.4126 | 1.2006 | 5 | 143 | growth factor activity |
| GO:0001792 | 0.0084 | Inf | 0.0084 | 1 | 1 | polymeric immunoglobulin receptor activity |
| GO:0004031 | 0.0084 | Inf | 0.0084 | 1 | 1 | aldehyde oxidase activity |
| GO:0004336 | 0.0084 | Inf | 0.0084 | 1 | 1 | galactosylceramidase activity |
| GO:0004854 | 0.0084 | Inf | 0.0084 | 1 | 1 | xanthine dehydrogenase activity |
| GO:0004855 | 0.0084 | Inf | 0.0084 | 1 | 1 | xanthine oxidase activity |
| GO:0008419 | 0.0084 | Inf | 0.0084 | 1 | 1 | RNA lariat debranching enzyme activity |
| GO:0015052 | 0.0084 | Inf | 0.0084 | 1 | 1 | beta3-adrenergic receptor activity |
| GO:0015327 | 0.0084 | Inf | 0.0084 | 1 | 1 | cystine:glutamate antiporter activity |
| GO:0016497 | 0.0084 | Inf | 0.0084 | 1 | 1 | substance K receptor activity |
| GO:0033798 | 0.0084 | Inf | 0.0084 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0046904 | 0.0084 | Inf | 0.0084 | 1 | 1 | calcium oxalate binding |
| GO:0102797 | 0.0084 | Inf | 0.0084 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0084 | Inf | 0.0084 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:1901680 | 0.0084 | Inf | 0.0084 | 1 | 1 | sulfur-containing amino acid secondary active transmembrane transporter activity |
| GO:0004930 | 0.0091 | 2.6996 | 3.5346 | 9 | 421 | G-protein coupled receptor activity |
| GO:0001972 | 0.0098 | 14.9821 | 0.1511 | 2 | 18 | retinoic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004888 | 0.0034 | 2.1761 | 8.879 | 18 | 801 | transmembrane signaling receptor activity |
| GO:0004871 | 0.0036 | 1.9457 | 13.3684 | 24 | 1206 | signal transducer activity |
| GO:0005501 | 0.0048 | 9.7132 | 0.3436 | 3 | 31 | retinoid binding |
| GO:0005179 | 0.0058 | 4.66 | 1.1417 | 5 | 103 | hormone activity |
| GO:0008376 | 0.0062 | 8.7715 | 0.3769 | 3 | 34 | acetylgalactosaminyltransferase activity |
| GO:0004089 | 0.0063 | 20.0506 | 0.1219 | 2 | 11 | carbonate dehydratase activity |
| GO:0001102 | 0.0079 | 7.9959 | 0.4101 | 3 | 37 | RNA polymerase II activating transcription factor binding |
| GO:0008499 | 0.0088 | 16.4028 | 0.1441 | 2 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035174 | 7e-04 | 70.715 | 0.0429 | 2 | 6 | histone serine kinase activity |
| GO:0046982 | 0.005 | 2.9992 | 3.2172 | 9 | 450 | protein heterodimerization activity |
| GO:0001047 | 0.0057 | 4.6775 | 1.1368 | 5 | 159 | core promoter binding |
| GO:0004607 | 0.0071 | Inf | 0.0071 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0008068 | 0.0071 | Inf | 0.0071 | 1 | 1 | extracellularly glutamate-gated chloride channel activity |
| GO:0008458 | 0.0071 | Inf | 0.0071 | 1 | 1 | carnitine O-octanoyltransferase activity |
| GO:0016415 | 0.0071 | Inf | 0.0071 | 1 | 1 | octanoyltransferase activity |
| GO:0030387 | 0.0071 | Inf | 0.0071 | 1 | 1 | fructosamine-3-kinase activity |
| GO:0034353 | 0.0071 | Inf | 0.0071 | 1 | 1 | RNA pyrophosphohydrolase activity |
| GO:0034899 | 0.0071 | Inf | 0.0071 | 1 | 1 | trimethylamine monooxygenase activity |
| GO:0035299 | 0.0071 | Inf | 0.0071 | 1 | 1 | inositol pentakisphosphate 2-kinase activity |
| GO:0035755 | 0.0071 | Inf | 0.0071 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0050459 | 0.0071 | Inf | 0.0071 | 1 | 1 | ethanolamine-phosphate phospho-lyase activity |
| GO:0061714 | 0.0071 | Inf | 0.0071 | 1 | 1 | folic acid receptor activity |
| GO:0061750 | 0.0071 | Inf | 0.0071 | 1 | 1 | acid sphingomyelin phosphodiesterase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 0 | 5.2858 | 2.3613 | 11 | 400 | receptor regulator activity |
| GO:0005179 | 3e-04 | 9.2409 | 0.5955 | 5 | 102 | hormone activity |
| GO:0004468 | 5e-04 | 86.0909 | 0.0354 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0005126 | 0.0017 | 5.0837 | 1.2751 | 6 | 216 | cytokine receptor binding |
| GO:0005125 | 0.0032 | 5.3773 | 0.9976 | 5 | 169 | cytokine activity |
| GO:0004631 | 0.0059 | Inf | 0.0059 | 1 | 1 | phosphomevalonate kinase activity |
| GO:0004940 | 0.0059 | Inf | 0.0059 | 1 | 1 | beta1-adrenergic receptor activity |
| GO:0030354 | 0.0059 | Inf | 0.0059 | 1 | 1 | melanin-concentrating hormone activity |
| GO:0031704 | 0.0059 | Inf | 0.0059 | 1 | 1 | apelin receptor binding |
| GO:0047198 | 0.0059 | Inf | 0.0059 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0071886 | 0.0059 | Inf | 0.0059 | 1 | 1 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding |
| GO:0004950 | 0.0067 | 18.1065 | 0.124 | 2 | 21 | chemokine receptor activity |
| GO:0001618 | 0.0082 | 7.7658 | 0.4132 | 3 | 70 | virus receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022610 | 0 | 2.7799 | 16.3141 | 39 | 1043 | biological adhesion |
| GO:0048842 | 1e-04 | 47.8787 | 0.1095 | 3 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0035646 | 4e-04 | 27.3529 | 0.1564 | 3 | 10 | endosome to melanosome transport |
| GO:0043476 | 4e-04 | 27.3529 | 0.1564 | 3 | 10 | pigment accumulation |
| GO:0048757 | 4e-04 | 27.3529 | 0.1564 | 3 | 10 | pigment granule maturation |
| GO:0030198 | 5e-04 | 3.3353 | 3.8791 | 12 | 248 | extracellular matrix organization |
| GO:0061551 | 7e-04 | 127.0829 | 0.0469 | 2 | 3 | trigeminal ganglion development |
| GO:0036066 | 7e-04 | 21.2712 | 0.1877 | 3 | 12 | protein O-linked fucosylation |
| GO:0008037 | 0.001 | 4.8676 | 1.5642 | 7 | 100 | cell recognition |
| GO:0030155 | 0.0012 | 2.4061 | 8.0397 | 18 | 514 | regulation of cell adhesion |
| GO:0071651 | 0.0014 | 63.5366 | 0.0626 | 2 | 4 | positive regulation of chemokine (C-C motif) ligand 5 production |
| GO:0098706 | 0.0014 | 63.5366 | 0.0626 | 2 | 4 | ferric iron import across plasma membrane |
| GO:0003013 | 0.0016 | 2.5653 | 6.2566 | 15 | 400 | circulatory system process |
| GO:0031589 | 0.0017 | 3.0683 | 3.8322 | 11 | 245 | cell-substrate adhesion |
| GO:0007413 | 0.0018 | 14.7217 | 0.2503 | 3 | 16 | axonal fasciculation |
| GO:1902284 | 0.0018 | 14.7217 | 0.2503 | 3 | 16 | neuron projection extension involved in neuron projection guidance |
| GO:1902667 | 0.0018 | 14.7217 | 0.2503 | 3 | 16 | regulation of axon guidance |
| GO:0015677 | 0.0024 | 42.3545 | 0.0782 | 2 | 5 | copper ion import |
| GO:0048843 | 0.0024 | 42.3545 | 0.0782 | 2 | 5 | negative regulation of axon extension involved in axon guidance |
| GO:1903232 | 0.0024 | 42.3545 | 0.0782 | 2 | 5 | melanosome assembly |
| GO:2000507 | 0.0024 | 42.3545 | 0.0782 | 2 | 5 | positive regulation of energy homeostasis |
| GO:2001057 | 0.0026 | 5.7333 | 0.9541 | 5 | 61 | reactive nitrogen species metabolic process |
| GO:0001568 | 0.0027 | 2.2796 | 7.9615 | 17 | 509 | blood vessel development |
| GO:1902905 | 0.003 | 3.5224 | 2.4244 | 8 | 155 | positive regulation of supramolecular fiber organization |
| GO:0042538 | 0.0035 | 31.7634 | 0.0938 | 2 | 6 | hyperosmotic salinity response |
| GO:0071472 | 0.0035 | 31.7634 | 0.0938 | 2 | 6 | cellular response to salt stress |
| GO:0008217 | 0.0036 | 3.7965 | 1.9708 | 7 | 126 | regulation of blood pressure |
| GO:0050772 | 0.0037 | 5.2613 | 1.0323 | 5 | 66 | positive regulation of axonogenesis |
| GO:0048870 | 0.004 | 1.7931 | 18.066 | 30 | 1155 | cell motility |
| GO:0090049 | 0.0041 | 10.6283 | 0.3285 | 3 | 21 | regulation of cell migration involved in sprouting angiogenesis |
| GO:0072358 | 0.0044 | 2.1607 | 8.3682 | 17 | 535 | cardiovascular system development |
| GO:2000352 | 0.0047 | 10.0681 | 0.3441 | 3 | 22 | negative regulation of endothelial cell apoptotic process |
| GO:0001525 | 0.0048 | 2.42 | 5.6935 | 13 | 364 | angiogenesis |
| GO:0061387 | 0.0053 | 4.7879 | 1.1262 | 5 | 72 | regulation of extent of cell growth |
| GO:0051495 | 0.0057 | 3.1531 | 2.6903 | 8 | 172 | positive regulation of cytoskeleton organization |
| GO:0045428 | 0.0057 | 6.092 | 0.7195 | 4 | 46 | regulation of nitric oxide biosynthetic process |
| GO:0000038 | 0.006 | 9.1078 | 0.3754 | 3 | 24 | very long-chain fatty acid metabolic process |
| GO:0034661 | 0.006 | 9.1078 | 0.3754 | 3 | 24 | ncRNA catabolic process |
| GO:0043171 | 0.006 | 9.1078 | 0.3754 | 3 | 24 | peptide catabolic process |
| GO:0021859 | 0.0064 | 21.1724 | 0.1251 | 2 | 8 | pyramidal neuron differentiation |
| GO:0033629 | 0.0064 | 21.1724 | 0.1251 | 2 | 8 | negative regulation of cell adhesion mediated by integrin |
| GO:0047484 | 0.0064 | 21.1724 | 0.1251 | 2 | 8 | regulation of response to osmotic stress |
| GO:0019371 | 0.0082 | 18.1463 | 0.1408 | 2 | 9 | cyclooxygenase pathway |
| GO:0097286 | 0.0082 | 18.1463 | 0.1408 | 2 | 9 | iron ion import |
| GO:0099133 | 0.0082 | 18.1463 | 0.1408 | 2 | 9 | ATP hydrolysis coupled anion transmembrane transport |
| GO:1904035 | 0.0082 | 5.4418 | 0.7977 | 4 | 51 | regulation of epithelial cell apoptotic process |
| GO:0098609 | 0.0083 | 1.9725 | 9.6665 | 18 | 618 | cell-cell adhesion |
| GO:0002437 | 0.0084 | 7.9675 | 0.4223 | 3 | 27 | inflammatory response to antigenic stimulus |
| GO:0043001 | 0.0093 | 7.6482 | 0.438 | 3 | 28 | Golgi to plasma membrane protein transport |
| GO:0001952 | 0.0097 | 4.1092 | 1.2982 | 5 | 83 | regulation of cell-matrix adhesion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001286 | 8e-04 | 84.9091 | 0.0472 | 2 | 4 | regulation of caveolin-mediated endocytosis |
| GO:0051865 | 0.0032 | 7.1436 | 0.613 | 4 | 52 | protein autoubiquitination |
| GO:1901565 | 0.0036 | 2.0134 | 11.8821 | 22 | 1008 | organonitrogen compound catabolic process |
| GO:0070475 | 0.0047 | 24.2505 | 0.1061 | 2 | 9 | rRNA base methylation |
| GO:0032872 | 0.0051 | 3.546 | 2.0982 | 7 | 178 | regulation of stress-activated MAPK cascade |
| GO:0034612 | 0.0056 | 3.1592 | 2.6876 | 8 | 228 | response to tumor necrosis factor |
| GO:0055072 | 0.0061 | 5.9074 | 0.7308 | 4 | 62 | iron ion homeostasis |
| GO:0010498 | 0.007 | 2.5145 | 4.6444 | 11 | 394 | proteasomal protein catabolic process |
| GO:0071688 | 0.0071 | 18.8586 | 0.1297 | 2 | 11 | striated muscle myosin thick filament assembly |
| GO:0007520 | 0.008 | 7.9939 | 0.4126 | 3 | 35 | myoblast fusion |
| GO:0045214 | 0.008 | 7.9939 | 0.4126 | 3 | 35 | sarcomere organization |
| GO:0009410 | 0.008 | 5.4365 | 0.7898 | 4 | 67 | response to xenobiotic stimulus |
| GO:0006289 | 0.0083 | 4.2545 | 1.2495 | 5 | 106 | nucleotide-excision repair |
| GO:0002643 | 0.0084 | 16.9714 | 0.1415 | 2 | 12 | regulation of tolerance induction |
| GO:0042787 | 0.0088 | 3.1867 | 2.3222 | 7 | 197 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0019941 | 0.0091 | 2.2357 | 6.1768 | 13 | 524 | modification-dependent protein catabolic process |
| GO:0031033 | 0.0099 | 15.4274 | 0.1532 | 2 | 13 | myosin filament organization |
| GO:0050930 | 0.0099 | 15.4274 | 0.1532 | 2 | 13 | induction of positive chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045875 | 8e-04 | 122.2347 | 0.0487 | 2 | 3 | negative regulation of sister chromatid cohesion |
| GO:0014826 | 0.0015 | 61.1127 | 0.065 | 2 | 4 | vein smooth muscle contraction |
| GO:0072708 | 0.0015 | 61.1127 | 0.065 | 2 | 4 | response to sorbitol |
| GO:0006744 | 0.002 | 14.1575 | 0.2599 | 3 | 16 | ubiquinone biosynthetic process |
| GO:0071320 | 0.0032 | 7.24 | 0.6173 | 4 | 38 | cellular response to cAMP |
| GO:0015711 | 0.0033 | 2.5377 | 5.4424 | 13 | 335 | organic anion transport |
| GO:0010216 | 0.0038 | 30.5516 | 0.0975 | 2 | 6 | maintenance of DNA methylation |
| GO:0031620 | 0.0038 | 30.5516 | 0.0975 | 2 | 6 | regulation of fever generation |
| GO:0060051 | 0.0038 | 30.5516 | 0.0975 | 2 | 6 | negative regulation of protein glycosylation |
| GO:0015849 | 0.0044 | 2.8379 | 3.7366 | 10 | 230 | organic acid transport |
| GO:1901989 | 0.0049 | 4.8964 | 1.1047 | 5 | 68 | positive regulation of cell cycle phase transition |
| GO:0006678 | 0.0052 | 24.4394 | 0.1137 | 2 | 7 | glucosylceramide metabolic process |
| GO:0010896 | 0.0052 | 24.4394 | 0.1137 | 2 | 7 | regulation of triglyceride catabolic process |
| GO:0032754 | 0.0052 | 24.4394 | 0.1137 | 2 | 7 | positive regulation of interleukin-5 production |
| GO:0045842 | 0.0052 | 24.4394 | 0.1137 | 2 | 7 | positive regulation of mitotic metaphase/anaphase transition |
| GO:0046513 | 0.006 | 6.0007 | 0.7311 | 4 | 45 | ceramide biosynthetic process |
| GO:0045923 | 0.0067 | 8.7588 | 0.3899 | 3 | 24 | positive regulation of fatty acid metabolic process |
| GO:1901661 | 0.0067 | 8.7588 | 0.3899 | 3 | 24 | quinone metabolic process |
| GO:0032000 | 0.0069 | 20.3646 | 0.13 | 2 | 8 | positive regulation of fatty acid beta-oxidation |
| GO:0046512 | 0.0069 | 20.3646 | 0.13 | 2 | 8 | sphingosine biosynthetic process |
| GO:0090308 | 0.0069 | 20.3646 | 0.13 | 2 | 8 | regulation of methylation-dependent chromatin silencing |
| GO:1905820 | 0.0069 | 20.3646 | 0.13 | 2 | 8 | positive regulation of chromosome separation |
| GO:0045017 | 0.0088 | 2.7041 | 3.5091 | 9 | 216 | glycerolipid biosynthetic process |
| GO:0006865 | 0.0095 | 3.5308 | 1.8033 | 6 | 111 | amino acid transport |
| GO:0051046 | 0.0098 | 1.9765 | 9.0815 | 17 | 559 | regulation of secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060032 | 2e-04 | Inf | 0.028 | 2 | 2 | notochord regression |
| GO:0006003 | 6e-04 | 142.6011 | 0.0419 | 2 | 3 | fructose 2,6-bisphosphate metabolic process |
| GO:0045821 | 9e-04 | 19.5375 | 0.1957 | 3 | 14 | positive regulation of glycolytic process |
| GO:0051194 | 0.0011 | 17.908 | 0.2097 | 3 | 15 | positive regulation of cofactor metabolic process |
| GO:0007418 | 0.0011 | 71.2951 | 0.0559 | 2 | 4 | ventral midline development |
| GO:0021938 | 0.0011 | 71.2951 | 0.0559 | 2 | 4 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation |
| GO:0007165 | 0.0018 | 1.5719 | 60.6695 | 80 | 4340 | signal transduction |
| GO:0090103 | 0.0022 | 13.4269 | 0.2656 | 3 | 19 | cochlea morphogenesis |
| GO:0000281 | 0.0032 | 7.1873 | 0.6151 | 4 | 44 | mitotic cytokinesis |
| GO:0048546 | 0.0035 | 7.0115 | 0.6291 | 4 | 45 | digestive tract morphogenesis |
| GO:0007143 | 0.0039 | 10.7382 | 0.3215 | 3 | 23 | female meiotic nuclear division |
| GO:0071169 | 0.0039 | 28.5115 | 0.0979 | 2 | 7 | establishment of protein localization to chromatin |
| GO:0045619 | 0.0048 | 4.0929 | 1.5657 | 6 | 112 | regulation of lymphocyte differentiation |
| GO:0045880 | 0.0049 | 9.7605 | 0.3495 | 3 | 25 | positive regulation of smoothened signaling pathway |
| GO:0021940 | 0.0051 | 23.7577 | 0.1118 | 2 | 8 | positive regulation of cerebellar granule cell precursor proliferation |
| GO:0045616 | 0.0061 | 8.9457 | 0.3774 | 3 | 27 | regulation of keratinocyte differentiation |
| GO:0019371 | 0.0066 | 20.3622 | 0.1258 | 2 | 9 | cyclooxygenase pathway |
| GO:0070544 | 0.0066 | 20.3622 | 0.1258 | 2 | 9 | histone H3-K36 demethylation |
| GO:0090090 | 0.0068 | 3.3591 | 2.2087 | 7 | 158 | negative regulation of canonical Wnt signaling pathway |
| GO:0006693 | 0.0068 | 8.5873 | 0.3914 | 3 | 28 | prostaglandin metabolic process |
| GO:0032060 | 0.0081 | 17.8156 | 0.1398 | 2 | 10 | bleb assembly |
| GO:0071888 | 0.0081 | 17.8156 | 0.1398 | 2 | 10 | macrophage apoptotic process |
| GO:0007369 | 0.0085 | 3.2085 | 2.3066 | 7 | 165 | gastrulation |
| GO:0048562 | 0.0092 | 2.6836 | 3.5367 | 9 | 253 | embryonic organ morphogenesis |
| GO:0097067 | 0.0098 | 15.8349 | 0.1538 | 2 | 11 | cellular response to thyroid hormone stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071800 | 4e-04 | 24.7358 | 0.1483 | 3 | 18 | podosome assembly |
| GO:0042572 | 5e-04 | 23.1881 | 0.1565 | 3 | 19 | retinol metabolic process |
| GO:0006801 | 9e-04 | 10.3786 | 0.4283 | 4 | 52 | superoxide metabolic process |
| GO:0016101 | 0.0016 | 8.7338 | 0.5024 | 4 | 61 | diterpenoid metabolic process |
| GO:0055114 | 0.0016 | 2.6108 | 6.3502 | 15 | 771 | oxidation-reduction process |
| GO:0046330 | 0.0017 | 6.262 | 0.8648 | 5 | 105 | positive regulation of JNK cascade |
| GO:0006702 | 0.0029 | 30.6472 | 0.0824 | 2 | 10 | androgen biosynthetic process |
| GO:0070304 | 0.0038 | 5.1669 | 1.0378 | 5 | 126 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0042445 | 0.0042 | 5.0407 | 1.0625 | 5 | 129 | hormone metabolic process |
| GO:0006720 | 0.0057 | 5.986 | 0.7166 | 4 | 87 | isoprenoid metabolic process |
| GO:0001711 | 0.0075 | 17.5047 | 0.1318 | 2 | 16 | endodermal cell fate commitment |
| GO:0002380 | 0.0082 | Inf | 0.0082 | 1 | 1 | immunoglobulin secretion involved in immune response |
| GO:0019732 | 0.0082 | Inf | 0.0082 | 1 | 1 | antifungal humoral response |
| GO:0034247 | 0.0082 | Inf | 0.0082 | 1 | 1 | snoRNA splicing |
| GO:0036101 | 0.0082 | Inf | 0.0082 | 1 | 1 | leukotriene B4 catabolic process |
| GO:0061760 | 0.0082 | Inf | 0.0082 | 1 | 1 | antifungal innate immune response |
| GO:1903904 | 0.0082 | Inf | 0.0082 | 1 | 1 | negative regulation of establishment of T cell polarity |
| GO:1905872 | 0.0082 | Inf | 0.0082 | 1 | 1 | negative regulation of protein localization to cell leading edge |
| GO:2001107 | 0.0082 | Inf | 0.0082 | 1 | 1 | negative regulation of Rho guanyl-nucleotide exchange factor activity |
| GO:0009593 | 0.0084 | 5.3382 | 0.7989 | 4 | 97 | detection of chemical stimulus |
| GO:0051403 | 0.0089 | 3.5825 | 1.7791 | 6 | 216 | stress-activated MAPK cascade |
| GO:0050921 | 0.009 | 5.2251 | 0.8154 | 4 | 99 | positive regulation of chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030216 | 1e-04 | 5.067 | 1.9465 | 9 | 160 | keratinocyte differentiation |
| GO:0030855 | 0.0018 | 2.5464 | 6.3505 | 15 | 522 | epithelial cell differentiation |
| GO:0009128 | 0.0021 | 41.0975 | 0.073 | 2 | 6 | purine nucleoside monophosphate catabolic process |
| GO:0008544 | 0.0026 | 3.0706 | 3.4794 | 10 | 286 | epidermis development |
| GO:0043031 | 0.003 | 32.8755 | 0.0852 | 2 | 7 | negative regulation of macrophage activation |
| GO:0046085 | 0.0039 | 27.3941 | 0.0973 | 2 | 8 | adenosine metabolic process |
| GO:0006703 | 0.0062 | 20.5425 | 0.1217 | 2 | 10 | estrogen biosynthetic process |
| GO:0009313 | 0.0075 | 18.2586 | 0.1338 | 2 | 11 | oligosaccharide catabolic process |
| GO:0035728 | 0.0075 | 18.2586 | 0.1338 | 2 | 11 | response to hepatocyte growth factor |
| GO:0070268 | 0.008 | 5.4347 | 0.7908 | 4 | 65 | cornification |
| GO:0002643 | 0.009 | 16.4314 | 0.146 | 2 | 12 | regulation of tolerance induction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060444 | 1e-04 | 19.6939 | 0.2708 | 4 | 16 | branching involved in mammary gland duct morphogenesis |
| GO:0060443 | 2e-04 | 10.5855 | 0.5586 | 5 | 33 | mammary gland morphogenesis |
| GO:1902202 | 3e-04 | Inf | 0.0339 | 2 | 2 | regulation of hepatocyte growth factor receptor signaling pathway |
| GO:0045836 | 7e-04 | 22.0622 | 0.1862 | 3 | 11 | positive regulation of meiotic nuclear division |
| GO:0071847 | 8e-04 | 117.1982 | 0.0508 | 2 | 3 | TNFSF11-mediated signaling pathway |
| GO:0097094 | 0.0015 | 16.0415 | 0.237 | 3 | 14 | craniofacial suture morphogenesis |
| GO:0052572 | 0.0017 | 58.5946 | 0.0677 | 2 | 4 | response to host immune response |
| GO:0060364 | 0.0017 | 58.5946 | 0.0677 | 2 | 4 | frontal suture morphogenesis |
| GO:1903911 | 0.0017 | 58.5946 | 0.0677 | 2 | 4 | positive regulation of receptor clustering |
| GO:0045216 | 0.0019 | 3.2218 | 3.3175 | 10 | 196 | cell-cell junction organization |
| GO:0042060 | 0.0021 | 2.4064 | 7.092 | 16 | 419 | wound healing |
| GO:0002248 | 0.0028 | 39.0601 | 0.0846 | 2 | 5 | connective tissue replacement involved in inflammatory response wound healing |
| GO:0052173 | 0.0028 | 39.0601 | 0.0846 | 2 | 5 | response to defenses of other organism involved in symbiotic interaction |
| GO:0075136 | 0.0028 | 39.0601 | 0.0846 | 2 | 5 | response to host |
| GO:1903361 | 0.0028 | 39.0601 | 0.0846 | 2 | 5 | protein localization to basolateral plasma membrane |
| GO:0045596 | 0.0034 | 2.1682 | 8.8354 | 18 | 522 | negative regulation of cell differentiation |
| GO:0006284 | 0.0038 | 6.939 | 0.6432 | 4 | 38 | base-excision repair |
| GO:0010886 | 0.0041 | 29.2928 | 0.1016 | 2 | 6 | positive regulation of cholesterol storage |
| GO:0032700 | 0.0041 | 29.2928 | 0.1016 | 2 | 6 | negative regulation of interleukin-17 production |
| GO:1901888 | 0.0048 | 4.9277 | 1.1002 | 5 | 65 | regulation of cell junction assembly |
| GO:0006303 | 0.0051 | 4.8465 | 1.1171 | 5 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0046718 | 0.0055 | 3.9958 | 1.608 | 6 | 95 | viral entry into host cell |
| GO:0090594 | 0.0057 | 23.4324 | 0.1185 | 2 | 7 | inflammatory response to wounding |
| GO:2000018 | 0.0057 | 23.4324 | 0.1185 | 2 | 7 | regulation of male gonad development |
| GO:0010569 | 0.0058 | 9.2815 | 0.3724 | 3 | 22 | regulation of double-strand break repair via homologous recombination |
| GO:0044319 | 0.0058 | 9.2815 | 0.3724 | 3 | 22 | wound healing, spreading of cells |
| GO:0000186 | 0.0064 | 5.8955 | 0.7447 | 4 | 44 | activation of MAPKK activity |
| GO:0001942 | 0.0066 | 4.5469 | 1.1848 | 5 | 70 | hair follicle development |
| GO:2001022 | 0.0066 | 4.5469 | 1.1848 | 5 | 70 | positive regulation of response to DNA damage stimulus |
| GO:0035116 | 0.0066 | 8.8167 | 0.3893 | 3 | 23 | embryonic hindlimb morphogenesis |
| GO:0090504 | 0.0066 | 8.8167 | 0.3893 | 3 | 23 | epiboly |
| GO:0022404 | 0.0074 | 4.4105 | 1.2187 | 5 | 72 | molting cycle process |
| GO:0006348 | 0.0075 | 19.5255 | 0.1354 | 2 | 8 | chromatin silencing at telomere |
| GO:0008354 | 0.0075 | 19.5255 | 0.1354 | 2 | 8 | germ cell migration |
| GO:0030259 | 0.0075 | 19.5255 | 0.1354 | 2 | 8 | lipid glycosylation |
| GO:0045647 | 0.0075 | 19.5255 | 0.1354 | 2 | 8 | negative regulation of erythrocyte differentiation |
| GO:0072033 | 0.0075 | 19.5255 | 0.1354 | 2 | 8 | renal vesicle formation |
| GO:0061311 | 0.0084 | 8.014 | 0.4232 | 3 | 25 | cell surface receptor signaling pathway involved in heart development |
| GO:0033108 | 0.0088 | 4.2205 | 1.2695 | 5 | 75 | mitochondrial respiratory chain complex assembly |
| GO:1901136 | 0.0091 | 3.1714 | 2.3358 | 7 | 138 | carbohydrate derivative catabolic process |
| GO:0043405 | 0.0091 | 2.4094 | 4.807 | 11 | 284 | regulation of MAP kinase activity |
| GO:0044089 | 0.0099 | 2.1291 | 6.9228 | 14 | 409 | positive regulation of cellular component biogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045082 | 3e-04 | Inf | 0.0375 | 2 | 2 | positive regulation of interleukin-10 biosynthetic process |
| GO:0070124 | 3e-04 | Inf | 0.0375 | 2 | 2 | mitochondrial translational initiation |
| GO:0048866 | 0.002 | 52.7805 | 0.075 | 2 | 4 | stem cell fate specification |
| GO:0015936 | 0.0025 | 13.2388 | 0.2811 | 3 | 15 | coenzyme A metabolic process |
| GO:0061028 | 0.0032 | 7.3245 | 0.6184 | 4 | 33 | establishment of endothelial barrier |
| GO:0006552 | 0.0034 | 35.1843 | 0.0937 | 2 | 5 | leucine catabolic process |
| GO:0070278 | 0.0034 | 35.1843 | 0.0937 | 2 | 5 | extracellular matrix constituent secretion |
| GO:0031648 | 0.0044 | 6.6363 | 0.6746 | 4 | 36 | protein destabilization |
| GO:0007000 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | nucleolus organization |
| GO:0021578 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | hindbrain maturation |
| GO:0032790 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | ribosome disassembly |
| GO:0034182 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | regulation of maintenance of mitotic sister chromatid cohesion |
| GO:0019882 | 0.0055 | 2.9261 | 3.2607 | 9 | 174 | antigen processing and presentation |
| GO:0032740 | 0.0069 | 21.1073 | 0.1312 | 2 | 7 | positive regulation of interleukin-17 production |
| GO:0031146 | 0.0078 | 4.3598 | 1.2368 | 5 | 66 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| GO:0009109 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | coenzyme catabolic process |
| GO:0046629 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | gamma-delta T cell activation |
| GO:0050851 | 0.0095 | 2.8718 | 2.9421 | 8 | 157 | antigen receptor-mediated signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009972 | 0 | 207 | 0.058 | 3 | 4 | cytidine deamination |
| GO:0046087 | 0 | 207 | 0.058 | 3 | 4 | cytidine metabolic process |
| GO:0070383 | 0 | 207 | 0.058 | 3 | 4 | DNA cytosine deamination |
| GO:0010529 | 1e-04 | 25.205 | 0.2176 | 4 | 15 | negative regulation of transposition |
| GO:0045869 | 1e-04 | 68.9894 | 0.087 | 3 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 1e-04 | 68.9894 | 0.087 | 3 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0016553 | 2e-04 | 34.4868 | 0.1306 | 3 | 9 | base conversion or substitution editing |
| GO:0042403 | 8e-04 | 20.6857 | 0.1886 | 3 | 13 | thyroid hormone metabolic process |
| GO:0014032 | 0.0011 | 7.0899 | 0.7834 | 5 | 54 | neural crest cell development |
| GO:0021648 | 0.0012 | 68.6316 | 0.058 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0072289 | 0.0012 | 68.6316 | 0.058 | 2 | 4 | metanephric nephron tubule formation |
| GO:1901998 | 0.0013 | 9.5473 | 0.4788 | 4 | 33 | toxin transport |
| GO:1903901 | 0.0014 | 6.6794 | 0.827 | 5 | 57 | negative regulation of viral life cycle |
| GO:0072077 | 0.0015 | 15.9084 | 0.2321 | 3 | 16 | renal vesicle morphogenesis |
| GO:0072161 | 0.002 | 45.7509 | 0.0725 | 2 | 5 | mesenchymal cell differentiation involved in kidney development |
| GO:2000609 | 0.002 | 45.7509 | 0.0725 | 2 | 5 | regulation of thyroid hormone generation |
| GO:0048762 | 0.0022 | 3.7118 | 2.3068 | 8 | 159 | mesenchymal cell differentiation |
| GO:0039694 | 0.0025 | 12.9226 | 0.2757 | 3 | 19 | viral RNA genome replication |
| GO:0090189 | 0.0025 | 12.9226 | 0.2757 | 3 | 19 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0045069 | 0.0025 | 5.7852 | 0.943 | 5 | 65 | regulation of viral genome replication |
| GO:0010817 | 0.0025 | 2.6259 | 5.2809 | 13 | 364 | regulation of hormone levels |
| GO:0002230 | 0.0029 | 12.1615 | 0.2902 | 3 | 20 | positive regulation of defense response to virus by host |
| GO:0051607 | 0.0029 | 3.5454 | 2.4083 | 8 | 166 | defense response to virus |
| GO:0072593 | 0.0029 | 3.2401 | 2.9596 | 9 | 204 | reactive oxygen species metabolic process |
| GO:0021604 | 0.003 | 34.3105 | 0.087 | 2 | 6 | cranial nerve structural organization |
| GO:0072038 | 0.003 | 34.3105 | 0.087 | 2 | 6 | mesenchymal stem cell maintenance involved in nephron morphogenesis |
| GO:1902338 | 0.003 | 34.3105 | 0.087 | 2 | 6 | negative regulation of apoptotic process involved in morphogenesis |
| GO:0003151 | 0.003 | 5.5084 | 0.9865 | 5 | 68 | outflow tract morphogenesis |
| GO:0031102 | 0.0034 | 7.0938 | 0.6238 | 4 | 43 | neuron projection regeneration |
| GO:0090066 | 0.0035 | 2.5224 | 5.4841 | 13 | 378 | regulation of anatomical structure size |
| GO:0048596 | 0.0038 | 10.8797 | 0.3192 | 3 | 22 | embryonic camera-type eye morphogenesis |
| GO:0072273 | 0.0038 | 10.8797 | 0.3192 | 3 | 22 | metanephric nephron morphogenesis |
| GO:0003206 | 0.0039 | 4.305 | 1.4943 | 6 | 103 | cardiac chamber morphogenesis |
| GO:0030855 | 0.0039 | 2.2522 | 7.5732 | 16 | 522 | epithelial cell differentiation |
| GO:0060538 | 0.004 | 3.7292 | 2.0021 | 7 | 138 | skeletal muscle organ development |
| GO:0001766 | 0.0042 | 27.4463 | 0.1016 | 2 | 7 | membrane raft polarization |
| GO:0009164 | 0.0043 | 10.3349 | 0.3337 | 3 | 23 | nucleoside catabolic process |
| GO:0030878 | 0.0043 | 10.3349 | 0.3337 | 3 | 23 | thyroid gland development |
| GO:0014706 | 0.0045 | 2.6724 | 4.3669 | 11 | 301 | striated muscle tissue development |
| GO:0001708 | 0.0055 | 4.7502 | 1.1316 | 5 | 78 | cell fate specification |
| GO:0051665 | 0.0055 | 22.8702 | 0.1161 | 2 | 8 | membrane raft localization |
| GO:0060982 | 0.0055 | 22.8702 | 0.1161 | 2 | 8 | coronary artery morphogenesis |
| GO:0040015 | 0.007 | 19.6015 | 0.1306 | 2 | 9 | negative regulation of multicellular organism growth |
| GO:2001054 | 0.007 | 19.6015 | 0.1306 | 2 | 9 | negative regulation of mesenchymal cell apoptotic process |
| GO:0048678 | 0.0072 | 5.6418 | 0.7689 | 4 | 53 | response to axon injury |
| GO:0072529 | 0.0075 | 8.2648 | 0.4062 | 3 | 28 | pyrimidine-containing compound catabolic process |
| GO:0043901 | 0.0077 | 3.6908 | 1.7265 | 6 | 119 | negative regulation of multi-organism process |
| GO:0010811 | 0.0078 | 4.3322 | 1.2332 | 5 | 85 | positive regulation of cell-substrate adhesion |
| GO:0035914 | 0.0082 | 5.4197 | 0.7979 | 4 | 55 | skeletal muscle cell differentiation |
| GO:0048592 | 0.0084 | 3.6261 | 1.7555 | 6 | 121 | eye morphogenesis |
| GO:0050691 | 0.0085 | 17.4024 | 0.143 | 2 | 10 | regulation of defense response to virus by host |
| GO:0003337 | 0.0087 | 17.15 | 0.1451 | 2 | 10 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0072173 | 0.0087 | 17.15 | 0.1451 | 2 | 10 | metanephric tubule morphogenesis |
| GO:1904748 | 0.0087 | 17.15 | 0.1451 | 2 | 10 | regulation of apoptotic process involved in development |
| GO:2000232 | 0.0087 | 17.15 | 0.1451 | 2 | 10 | regulation of rRNA processing |
| GO:0006304 | 0.0091 | 4.1747 | 1.2767 | 5 | 88 | DNA modification |
| GO:0002376 | 0.0095 | 1.5597 | 29.4079 | 42 | 2027 | immune system process |
| GO:0003002 | 0.0096 | 2.5135 | 4.1928 | 10 | 289 | regionalization |
| GO:0043010 | 0.0098 | 2.6572 | 3.569 | 9 | 246 | camera-type eye development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002091 | 1e-04 | 49.8769 | 0.1192 | 3 | 6 | negative regulation of receptor internalization |
| GO:0000154 | 7e-04 | 8.0895 | 0.7154 | 5 | 36 | rRNA modification |
| GO:0050766 | 7e-04 | 8.0895 | 0.7154 | 5 | 36 | positive regulation of phagocytosis |
| GO:0034063 | 8e-04 | 21.3692 | 0.1987 | 3 | 10 | stress granule assembly |
| GO:0030100 | 0.0025 | 3.0866 | 3.4579 | 10 | 174 | regulation of endocytosis |
| GO:0006098 | 0.0051 | 9.9662 | 0.3577 | 3 | 18 | pentose-phosphate shunt |
| GO:0008228 | 0.0056 | 24.841 | 0.1192 | 2 | 6 | opsonization |
| GO:0016188 | 0.0056 | 24.841 | 0.1192 | 2 | 6 | synaptic vesicle maturation |
| GO:0090385 | 0.0056 | 24.841 | 0.1192 | 2 | 6 | phagosome-lysosome fusion |
| GO:2000020 | 0.0056 | 24.841 | 0.1192 | 2 | 6 | positive regulation of male gonad development |
| GO:0001510 | 0.0058 | 4.7236 | 1.1526 | 5 | 58 | RNA methylation |
| GO:0009083 | 0.0059 | 9.3425 | 0.3776 | 3 | 19 | branched-chain amino acid catabolic process |
| GO:0008203 | 0.0063 | 3.4161 | 2.186 | 7 | 110 | cholesterol metabolic process |
| GO:0043555 | 0.0069 | 8.7923 | 0.3975 | 3 | 20 | regulation of translation in response to stress |
| GO:0006396 | 0.0069 | 1.7546 | 16.3158 | 27 | 821 | RNA processing |
| GO:0016072 | 0.0072 | 2.3841 | 5.3061 | 12 | 267 | rRNA metabolic process |
| GO:0032057 | 0.0077 | 19.8713 | 0.1391 | 2 | 7 | negative regulation of translational initiation in response to stress |
| GO:0033598 | 0.0079 | 8.3032 | 0.4173 | 3 | 21 | mammary gland epithelial cell proliferation |
| GO:0090383 | 0.009 | 7.8656 | 0.4372 | 3 | 22 | phagosome acidification |
| GO:0044282 | 0.0094 | 2.2114 | 6.1805 | 13 | 311 | small molecule catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032727 | 0.0012 | 17.0524 | 0.2199 | 3 | 15 | positive regulation of interferon-alpha production |
| GO:0035426 | 0.0013 | 67.9062 | 0.0586 | 2 | 4 | extracellular matrix-cell signaling |
| GO:0061181 | 0.0013 | 67.9062 | 0.0586 | 2 | 4 | regulation of chondrocyte development |
| GO:0060762 | 0.0021 | 45.2674 | 0.0733 | 2 | 5 | regulation of branching involved in mammary gland duct morphogenesis |
| GO:0006054 | 0.0031 | 33.9479 | 0.088 | 2 | 6 | N-acetylneuraminate metabolic process |
| GO:0006681 | 0.0031 | 33.9479 | 0.088 | 2 | 6 | galactosylceramide metabolic process |
| GO:0042428 | 0.0043 | 27.1562 | 0.1026 | 2 | 7 | serotonin metabolic process |
| GO:0032728 | 0.005 | 9.7375 | 0.3518 | 3 | 24 | positive regulation of interferon-beta production |
| GO:0032494 | 0.0056 | 22.6285 | 0.1173 | 2 | 8 | response to peptidoglycan |
| GO:0035335 | 0.0064 | 4.5732 | 1.1727 | 5 | 80 | peptidyl-tyrosine dephosphorylation |
| GO:0039530 | 0.0072 | 19.3943 | 0.1319 | 2 | 9 | MDA-5 signaling pathway |
| GO:0006813 | 0.0076 | 2.9887 | 2.8292 | 8 | 193 | potassium ion transport |
| GO:0071359 | 0.0085 | 5.3618 | 0.8063 | 4 | 55 | cellular response to dsRNA |
| GO:0019896 | 0.0089 | 16.9688 | 0.1466 | 2 | 10 | axonal transport of mitochondrion |
| GO:0036444 | 0.0089 | 16.9688 | 0.1466 | 2 | 10 | mitochondrial calcium uptake |
| GO:0006361 | 0.0094 | 7.5701 | 0.4398 | 3 | 30 | transcription initiation from RNA polymerase I promoter |
| GO:0061035 | 0.0097 | 5.1587 | 0.8356 | 4 | 57 | regulation of cartilage development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006590 | 1e-04 | 20.101 | 0.2849 | 4 | 13 | thyroid hormone generation |
| GO:0006333 | 2e-04 | 3.8641 | 3.3966 | 12 | 155 | chromatin assembly or disassembly |
| GO:0001759 | 3e-04 | 16.4437 | 0.3287 | 4 | 15 | organ induction |
| GO:0050921 | 3e-04 | 4.5744 | 2.1694 | 9 | 99 | positive regulation of chemotaxis |
| GO:0048842 | 3e-04 | 33.8153 | 0.1534 | 3 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0006323 | 5e-04 | 3.4058 | 3.8129 | 12 | 174 | DNA packaging |
| GO:0006342 | 5e-04 | 5.5621 | 1.4081 | 7 | 65 | chromatin silencing |
| GO:1905205 | 5e-04 | 27.0502 | 0.1753 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0006334 | 6e-04 | 4.6183 | 1.9059 | 8 | 88 | nucleosome assembly |
| GO:1903244 | 8e-04 | 22.5401 | 0.1972 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0018958 | 8e-04 | 5.0573 | 1.5339 | 7 | 70 | phenol-containing compound metabolic process |
| GO:0007626 | 0.001 | 3.2744 | 3.6157 | 11 | 165 | locomotory behavior |
| GO:0070634 | 0.0014 | 89.8819 | 0.0657 | 2 | 3 | transepithelial ammonium transport |
| GO:1903660 | 0.0014 | 89.8819 | 0.0657 | 2 | 3 | negative regulation of complement-dependent cytotoxicity |
| GO:0014744 | 0.0015 | 16.9024 | 0.241 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0071824 | 0.0015 | 2.7918 | 4.9743 | 13 | 227 | protein-DNA complex subunit organization |
| GO:0032101 | 0.002 | 2.0953 | 11.1758 | 22 | 510 | regulation of response to external stimulus |
| GO:0070286 | 0.0027 | 7.8571 | 0.5917 | 4 | 27 | axonemal dynein complex assembly |
| GO:0014816 | 0.0028 | 44.9375 | 0.0877 | 2 | 4 | skeletal muscle satellite cell differentiation |
| GO:0001525 | 0.0028 | 2.2606 | 7.9764 | 17 | 364 | angiogenesis |
| GO:0001822 | 0.0034 | 2.6431 | 4.8209 | 12 | 220 | kidney development |
| GO:0006335 | 0.0035 | 7.2274 | 0.6355 | 4 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0042330 | 0.0037 | 2.0958 | 9.598 | 19 | 438 | taxis |
| GO:2000026 | 0.0037 | 1.5797 | 33.4177 | 49 | 1525 | regulation of multicellular organismal development |
| GO:0010612 | 0.0039 | 11.2648 | 0.3287 | 3 | 15 | regulation of cardiac muscle adaptation |
| GO:0006526 | 0.0046 | 29.956 | 0.1096 | 2 | 5 | arginine biosynthetic process |
| GO:0045650 | 0.0046 | 29.956 | 0.1096 | 2 | 5 | negative regulation of macrophage differentiation |
| GO:1902284 | 0.0047 | 10.3975 | 0.3506 | 3 | 16 | neuron projection extension involved in neuron projection guidance |
| GO:1902667 | 0.0047 | 10.3975 | 0.3506 | 3 | 16 | regulation of axon guidance |
| GO:0007492 | 0.0049 | 4.1223 | 1.5778 | 6 | 72 | endoderm development |
| GO:0010469 | 0.0049 | 2.128 | 8.4366 | 17 | 385 | regulation of receptor activity |
| GO:0000183 | 0.005 | 6.4515 | 0.7012 | 4 | 32 | chromatin silencing at rDNA |
| GO:0042446 | 0.0055 | 4.8141 | 1.1395 | 5 | 52 | hormone biosynthetic process |
| GO:0038111 | 0.0056 | 6.2286 | 0.7231 | 4 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0056 | 6.2286 | 0.7231 | 4 | 33 | response to interleukin-7 |
| GO:0071354 | 0.0056 | 9.6541 | 0.3725 | 3 | 17 | cellular response to interleukin-6 |
| GO:0042445 | 0.0064 | 3.8849 | 1.6648 | 6 | 77 | hormone metabolic process |
| GO:0007193 | 0.0064 | 4.6169 | 1.1833 | 5 | 54 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0019062 | 0.0068 | 22.4653 | 0.1315 | 2 | 6 | virion attachment to host cell |
| GO:0030853 | 0.0068 | 22.4653 | 0.1315 | 2 | 6 | negative regulation of granulocyte differentiation |
| GO:0033603 | 0.0068 | 22.4653 | 0.1315 | 2 | 6 | positive regulation of dopamine secretion |
| GO:0046439 | 0.0068 | 22.4653 | 0.1315 | 2 | 6 | L-cysteine metabolic process |
| GO:1901533 | 0.0068 | 22.4653 | 0.1315 | 2 | 6 | negative regulation of hematopoietic progenitor cell differentiation |
| GO:2000736 | 0.0068 | 3.0574 | 2.783 | 8 | 127 | regulation of stem cell differentiation |
| GO:1902373 | 0.0069 | 5.8259 | 0.767 | 4 | 35 | negative regulation of mRNA catabolic process |
| GO:0006809 | 0.0069 | 4.5242 | 1.2052 | 5 | 55 | nitric oxide biosynthetic process |
| GO:0090023 | 0.0078 | 8.446 | 0.4164 | 3 | 19 | positive regulation of neutrophil chemotaxis |
| GO:0030595 | 0.0086 | 2.933 | 2.8925 | 8 | 132 | leukocyte chemotaxis |
| GO:0034103 | 0.0087 | 4.2671 | 1.271 | 5 | 58 | regulation of tissue remodeling |
| GO:0071320 | 0.0093 | 5.3106 | 0.8327 | 4 | 38 | cellular response to cAMP |
| GO:0043652 | 0.0093 | 17.9708 | 0.1534 | 2 | 7 | engulfment of apoptotic cell |
| GO:0071635 | 0.0093 | 17.9708 | 0.1534 | 2 | 7 | negative regulation of transforming growth factor beta production |
| GO:0022603 | 0.0096 | 1.685 | 17.5306 | 28 | 800 | regulation of anatomical structure morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007416 | 1e-04 | 6.5719 | 1.3511 | 8 | 120 | synapse assembly |
| GO:0007155 | 1e-04 | 2.5191 | 11.698 | 26 | 1039 | cell adhesion |
| GO:0040011 | 2e-04 | 2.2413 | 15.2333 | 30 | 1353 | locomotion |
| GO:0008582 | 4e-04 | 178.0136 | 0.0338 | 2 | 3 | regulation of synaptic growth at neuromuscular junction |
| GO:0061551 | 4e-04 | 178.0136 | 0.0338 | 2 | 3 | trigeminal ganglion development |
| GO:0072095 | 4e-04 | 178.0136 | 0.0338 | 2 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:0006925 | 6e-04 | 22.3853 | 0.1689 | 3 | 15 | inflammatory cell apoptotic process |
| GO:0048260 | 7e-04 | 11.2526 | 0.4053 | 4 | 36 | positive regulation of receptor-mediated endocytosis |
| GO:0030910 | 7e-04 | 89 | 0.045 | 2 | 4 | olfactory placode formation |
| GO:0061055 | 7e-04 | 89 | 0.045 | 2 | 4 | myotome development |
| GO:0061197 | 7e-04 | 89 | 0.045 | 2 | 4 | fungiform papilla morphogenesis |
| GO:0071698 | 7e-04 | 89 | 0.045 | 2 | 4 | olfactory placode development |
| GO:0072107 | 7e-04 | 89 | 0.045 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0018149 | 0.001 | 17.9041 | 0.2027 | 3 | 18 | peptide cross-linking |
| GO:0051674 | 0.0011 | 2.133 | 13.004 | 25 | 1155 | localization of cell |
| GO:0034112 | 0.0012 | 59.3288 | 0.0563 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0090303 | 0.0014 | 9.2279 | 0.4841 | 4 | 43 | positive regulation of wound healing |
| GO:0060037 | 0.0016 | 14.9167 | 0.2364 | 3 | 21 | pharyngeal system development |
| GO:0033034 | 0.0018 | 44.4932 | 0.0676 | 2 | 6 | positive regulation of myeloid cell apoptotic process |
| GO:0042538 | 0.0018 | 44.4932 | 0.0676 | 2 | 6 | hyperosmotic salinity response |
| GO:0060677 | 0.0018 | 44.4932 | 0.0676 | 2 | 6 | ureteric bud elongation |
| GO:0030198 | 0.002 | 3.4553 | 2.7922 | 9 | 248 | extracellular matrix organization |
| GO:0006928 | 0.0023 | 1.8955 | 17.6314 | 30 | 1566 | movement of cell or subcellular component |
| GO:0008038 | 0.0027 | 12.2008 | 0.2815 | 3 | 25 | neuron recognition |
| GO:0021859 | 0.0034 | 29.6576 | 0.0901 | 2 | 8 | pyramidal neuron differentiation |
| GO:1990314 | 0.0034 | 29.6576 | 0.0901 | 2 | 8 | cellular response to insulin-like growth factor stimulus |
| GO:2000109 | 0.0034 | 29.6576 | 0.0901 | 2 | 8 | regulation of macrophage apoptotic process |
| GO:0051451 | 0.0043 | 25.4189 | 0.1013 | 2 | 9 | myoblast migration |
| GO:0072172 | 0.0043 | 25.4189 | 0.1013 | 2 | 9 | mesonephric tubule formation |
| GO:0098742 | 0.0051 | 3.5543 | 2.0942 | 7 | 186 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0001780 | 0.0053 | 22.2398 | 0.1126 | 2 | 10 | neutrophil homeostasis |
| GO:0035646 | 0.0053 | 22.2398 | 0.1126 | 2 | 10 | endosome to melanosome transport |
| GO:0043476 | 0.0053 | 22.2398 | 0.1126 | 2 | 10 | pigment accumulation |
| GO:0048757 | 0.0053 | 22.2398 | 0.1126 | 2 | 10 | pigment granule maturation |
| GO:1900746 | 0.0053 | 22.2398 | 0.1126 | 2 | 10 | regulation of vascular endothelial growth factor signaling pathway |
| GO:0030317 | 0.0058 | 5.9885 | 0.7206 | 4 | 64 | flagellated sperm motility |
| GO:0090184 | 0.006 | 8.9418 | 0.3715 | 3 | 33 | positive regulation of kidney development |
| GO:0010810 | 0.0064 | 3.8518 | 1.6551 | 6 | 147 | regulation of cell-substrate adhesion |
| GO:0016477 | 0.0065 | 1.9365 | 11.743 | 21 | 1043 | cell migration |
| GO:0044236 | 0.0066 | 4.5087 | 1.1822 | 5 | 105 | multicellular organism metabolic process |
| GO:2000147 | 0.0068 | 2.6646 | 3.9856 | 10 | 354 | positive regulation of cell motility |
| GO:0097435 | 0.0072 | 2.3986 | 5.3254 | 12 | 473 | supramolecular fiber organization |
| GO:0021692 | 0.0077 | 17.7891 | 0.1351 | 2 | 12 | cerebellar Purkinje cell layer morphogenesis |
| GO:0061548 | 0.0077 | 17.7891 | 0.1351 | 2 | 12 | ganglion development |
| GO:0072075 | 0.0077 | 17.7891 | 0.1351 | 2 | 12 | metanephric mesenchyme development |
| GO:2001014 | 0.0077 | 17.7891 | 0.1351 | 2 | 12 | regulation of skeletal muscle cell differentiation |
| GO:0007160 | 0.0087 | 3.5939 | 1.7676 | 6 | 157 | cell-matrix adhesion |
| GO:0001974 | 0.0088 | 7.6614 | 0.4278 | 3 | 38 | blood vessel remodeling |
| GO:0002313 | 0.0091 | 16.1707 | 0.1464 | 2 | 13 | mature B cell differentiation involved in immune response |
| GO:0006590 | 0.0091 | 16.1707 | 0.1464 | 2 | 13 | thyroid hormone generation |
| GO:0071697 | 0.0091 | 16.1707 | 0.1464 | 2 | 13 | ectodermal placode morphogenesis |
| GO:0010718 | 0.0095 | 7.4481 | 0.4391 | 3 | 39 | positive regulation of epithelial to mesenchymal transition |
| GO:0021545 | 0.0095 | 7.4481 | 0.4391 | 3 | 39 | cranial nerve development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001286 | 9e-04 | 82.2075 | 0.0487 | 2 | 4 | regulation of caveolin-mediated endocytosis |
| GO:0051865 | 0.0036 | 6.9135 | 0.6326 | 4 | 52 | protein autoubiquitination |
| GO:0070475 | 0.005 | 23.4789 | 0.1095 | 2 | 9 | rRNA base methylation |
| GO:1901565 | 0.0053 | 1.9402 | 12.263 | 22 | 1008 | organonitrogen compound catabolic process |
| GO:0032872 | 0.0061 | 3.4296 | 2.1655 | 7 | 178 | regulation of stress-activated MAPK cascade |
| GO:0034612 | 0.0068 | 3.0548 | 2.7738 | 8 | 228 | response to tumor necrosis factor |
| GO:0055072 | 0.0068 | 5.7171 | 0.7543 | 4 | 62 | iron ion homeostasis |
| GO:0071688 | 0.0075 | 18.2586 | 0.1338 | 2 | 11 | striated muscle myosin thick filament assembly |
| GO:0007520 | 0.0087 | 7.7379 | 0.4258 | 3 | 35 | myoblast fusion |
| GO:0045214 | 0.0087 | 7.7379 | 0.4258 | 3 | 35 | sarcomere organization |
| GO:0010498 | 0.0088 | 2.4298 | 4.7933 | 11 | 394 | proteasomal protein catabolic process |
| GO:0009410 | 0.0089 | 5.2613 | 0.8151 | 4 | 67 | response to xenobiotic stimulus |
| GO:0002643 | 0.009 | 16.4314 | 0.146 | 2 | 12 | regulation of tolerance induction |
| GO:0006289 | 0.0095 | 4.1165 | 1.2896 | 5 | 106 | nucleotide-excision repair |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 1e-04 | Inf | 0.019 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0070859 | 3e-04 | 211.4032 | 0.0286 | 2 | 3 | positive regulation of bile acid biosynthetic process |
| GO:0002155 | 5e-04 | 105.6935 | 0.0381 | 2 | 4 | regulation of thyroid hormone mediated signaling pathway |
| GO:0042692 | 0.0012 | 3.445 | 3.1419 | 10 | 330 | muscle cell differentiation |
| GO:2000402 | 0.0013 | 52.8387 | 0.0571 | 2 | 6 | negative regulation of lymphocyte migration |
| GO:0010830 | 0.0016 | 8.738 | 0.5046 | 4 | 53 | regulation of myotube differentiation |
| GO:0048743 | 0.0018 | 42.2677 | 0.0666 | 2 | 7 | positive regulation of skeletal muscle fiber development |
| GO:1904684 | 0.0018 | 42.2677 | 0.0666 | 2 | 7 | negative regulation of metalloendopeptidase activity |
| GO:0031047 | 0.0021 | 3.7627 | 2.285 | 8 | 240 | gene silencing by RNA |
| GO:0014904 | 0.0026 | 12.272 | 0.2761 | 3 | 29 | myotube cell development |
| GO:0002689 | 0.0031 | 30.1866 | 0.0857 | 2 | 9 | negative regulation of leukocyte chemotaxis |
| GO:0007597 | 0.0031 | 30.1866 | 0.0857 | 2 | 9 | blood coagulation, intrinsic pathway |
| GO:1904251 | 0.0031 | 30.1866 | 0.0857 | 2 | 9 | regulation of bile acid metabolic process |
| GO:0051775 | 0.0038 | 26.4113 | 0.0952 | 2 | 10 | response to redox state |
| GO:0045429 | 0.0041 | 10.2887 | 0.3237 | 3 | 34 | positive regulation of nitric oxide biosynthetic process |
| GO:0035195 | 0.0043 | 3.6842 | 2.028 | 7 | 213 | gene silencing by miRNA |
| GO:0071222 | 0.005 | 4.8384 | 1.1044 | 5 | 116 | cellular response to lipopolysaccharide |
| GO:0016441 | 0.0051 | 3.5612 | 2.0946 | 7 | 220 | posttranscriptional gene silencing |
| GO:0006000 | 0.0056 | 21.1258 | 0.1143 | 2 | 12 | fructose metabolic process |
| GO:0042537 | 0.0056 | 21.1258 | 0.1143 | 2 | 12 | benzene-containing compound metabolic process |
| GO:1901623 | 0.0056 | 21.1258 | 0.1143 | 2 | 12 | regulation of lymphocyte chemotaxis |
| GO:0019216 | 0.006 | 3.1289 | 2.723 | 8 | 286 | regulation of lipid metabolic process |
| GO:0055002 | 0.006 | 5.901 | 0.7275 | 4 | 78 | striated muscle cell development |
| GO:0051707 | 0.0071 | 2.4126 | 5.3317 | 12 | 560 | response to other organism |
| GO:0002228 | 0.0074 | 8.1732 | 0.3999 | 3 | 42 | natural killer cell mediated immunity |
| GO:0045954 | 0.0076 | 17.6022 | 0.1333 | 2 | 14 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0007566 | 0.0084 | 7.7733 | 0.4189 | 3 | 44 | embryo implantation |
| GO:0048747 | 0.0084 | 7.7733 | 0.4189 | 3 | 44 | muscle fiber development |
| GO:0007519 | 0.0088 | 4.1903 | 1.2663 | 5 | 133 | skeletal muscle tissue development |
| GO:0030101 | 0.0089 | 7.5877 | 0.4284 | 3 | 45 | natural killer cell activation |
| GO:0001906 | 0.0091 | 5.2083 | 0.8188 | 4 | 86 | cell killing |
| GO:0030334 | 0.0094 | 2.3197 | 5.5317 | 12 | 581 | regulation of cell migration |
| GO:0002432 | 0.0095 | Inf | 0.0095 | 1 | 1 | granuloma formation |
| GO:0034337 | 0.0095 | Inf | 0.0095 | 1 | 1 | RNA folding |
| GO:0043251 | 0.0095 | Inf | 0.0095 | 1 | 1 | sodium-dependent organic anion transport |
| GO:0046521 | 0.0095 | Inf | 0.0095 | 1 | 1 | sphingoid catabolic process |
| GO:0061767 | 0.0095 | Inf | 0.0095 | 1 | 1 | negative regulation of lung blood pressure |
| GO:0070458 | 0.0095 | Inf | 0.0095 | 1 | 1 | cellular detoxification of nitrogen compound |
| GO:0072382 | 0.0095 | Inf | 0.0095 | 1 | 1 | minus-end-directed vesicle transport along microtubule |
| GO:1901537 | 0.0095 | Inf | 0.0095 | 1 | 1 | positive regulation of DNA demethylation |
| GO:1990079 | 0.0095 | Inf | 0.0095 | 1 | 1 | cartilage homeostasis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010529 | 0 | 34.3042 | 0.2924 | 6 | 15 | negative regulation of transposition |
| GO:0009972 | 0 | 152.6471 | 0.078 | 3 | 4 | cytidine deamination |
| GO:0046087 | 0 | 152.6471 | 0.078 | 3 | 4 | cytidine metabolic process |
| GO:0070383 | 0 | 152.6471 | 0.078 | 3 | 4 | DNA cytosine deamination |
| GO:0045869 | 1e-04 | 50.8745 | 0.117 | 3 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 1e-04 | 50.8745 | 0.117 | 3 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0006333 | 2e-04 | 4.1755 | 2.8836 | 11 | 149 | chromatin assembly or disassembly |
| GO:0040012 | 2e-04 | 2.2974 | 13.2763 | 28 | 681 | regulation of locomotion |
| GO:0006323 | 2e-04 | 3.8585 | 3.3922 | 12 | 174 | DNA packaging |
| GO:0006699 | 2e-04 | 11.1299 | 0.5459 | 5 | 28 | bile acid biosynthetic process |
| GO:0000183 | 4e-04 | 9.4781 | 0.6238 | 5 | 32 | chromatin silencing at rDNA |
| GO:0071673 | 4e-04 | Inf | 0.039 | 2 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:0018958 | 4e-04 | 5.7162 | 1.3647 | 7 | 70 | phenol-containing compound metabolic process |
| GO:0030334 | 4e-04 | 2.2868 | 11.3267 | 24 | 581 | regulation of cell migration |
| GO:0039694 | 4e-04 | 13.6073 | 0.3704 | 4 | 19 | viral RNA genome replication |
| GO:0045815 | 5e-04 | 5.5395 | 1.4037 | 7 | 72 | positive regulation of gene expression, epigenetic |
| GO:0042060 | 6e-04 | 2.4994 | 8.1685 | 19 | 419 | wound healing |
| GO:0000038 | 0.0011 | 10.2016 | 0.4679 | 4 | 24 | very long-chain fatty acid metabolic process |
| GO:0002718 | 0.0014 | 6.7287 | 0.8383 | 5 | 43 | regulation of cytokine production involved in immune response |
| GO:0006334 | 0.0015 | 4.5029 | 1.6927 | 7 | 88 | nucleosome assembly |
| GO:0032103 | 0.0016 | 3.0961 | 3.8016 | 11 | 195 | positive regulation of response to external stimulus |
| GO:2000147 | 0.0016 | 2.4721 | 6.9013 | 16 | 354 | positive regulation of cell motility |
| GO:0045069 | 0.0016 | 5.2127 | 1.2672 | 6 | 65 | regulation of viral genome replication |
| GO:0072529 | 0.002 | 8.4987 | 0.5459 | 4 | 28 | pyrimidine-containing compound catabolic process |
| GO:0010572 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | positive regulation of platelet activation |
| GO:0030240 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | skeletal muscle thin filament assembly |
| GO:0035926 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | chemokine (C-C motif) ligand 2 secretion |
| GO:0042126 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | nitrate metabolic process |
| GO:0060157 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | urinary bladder development |
| GO:0006335 | 0.0023 | 8.1581 | 0.5654 | 4 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0051270 | 0.0027 | 1.9777 | 12.9448 | 24 | 671 | regulation of cellular component movement |
| GO:0050701 | 0.0029 | 7.5526 | 0.6044 | 4 | 31 | interleukin-1 secretion |
| GO:0055008 | 0.0031 | 5.5551 | 0.9943 | 5 | 51 | cardiac muscle tissue morphogenesis |
| GO:0043207 | 0.0033 | 2.0406 | 10.9368 | 21 | 561 | response to external biotic stimulus |
| GO:0072676 | 0.0033 | 5.4365 | 1.0138 | 5 | 52 | lymphocyte migration |
| GO:1902667 | 0.0034 | 11.7312 | 0.3119 | 3 | 16 | regulation of axon guidance |
| GO:0034112 | 0.0036 | 33.7839 | 0.0975 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0051823 | 0.0036 | 33.7839 | 0.0975 | 2 | 5 | regulation of synapse structural plasticity |
| GO:0038111 | 0.0037 | 7.0307 | 0.6433 | 4 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0037 | 7.0307 | 0.6433 | 4 | 33 | response to interleukin-7 |
| GO:1902903 | 0.0039 | 2.5886 | 4.9128 | 12 | 252 | regulation of supramolecular fiber organization |
| GO:0042743 | 0.0041 | 6.7958 | 0.6628 | 4 | 34 | hydrogen peroxide metabolic process |
| GO:0006954 | 0.0043 | 2.112 | 9.0263 | 18 | 463 | inflammatory response |
| GO:1901532 | 0.0044 | 3.6648 | 2.047 | 7 | 105 | regulation of hematopoietic progenitor cell differentiation |
| GO:0033993 | 0.0046 | 1.8868 | 13.5102 | 24 | 693 | response to lipid |
| GO:0046579 | 0.0046 | 6.5761 | 0.6823 | 4 | 35 | positive regulation of Ras protein signal transduction |
| GO:0002691 | 0.0048 | 10.1655 | 0.3509 | 3 | 18 | regulation of cellular extravasation |
| GO:0098542 | 0.0048 | 2.4148 | 5.6926 | 13 | 292 | defense response to other organism |
| GO:0046394 | 0.0049 | 2.5139 | 5.0493 | 12 | 259 | carboxylic acid biosynthetic process |
| GO:1903901 | 0.005 | 4.9118 | 1.1112 | 5 | 57 | negative regulation of viral life cycle |
| GO:0071824 | 0.005 | 2.6308 | 4.4254 | 11 | 227 | protein-DNA complex subunit organization |
| GO:0001672 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | regulation of chromatin assembly or disassembly |
| GO:0007168 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | receptor guanylyl cyclase signaling pathway |
| GO:0032534 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | regulation of microvillus assembly |
| GO:0035754 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | B cell chemotaxis |
| GO:0035900 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | response to isolation stress |
| GO:0060836 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | lymphatic endothelial cell differentiation |
| GO:0042330 | 0.0055 | 2.1036 | 8.5389 | 17 | 438 | taxis |
| GO:0045814 | 0.006 | 3.4517 | 2.164 | 7 | 111 | negative regulation of gene expression, epigenetic |
| GO:0002230 | 0.0065 | 8.9682 | 0.3899 | 3 | 20 | positive regulation of defense response to virus by host |
| GO:2000178 | 0.0065 | 8.9682 | 0.3899 | 3 | 20 | negative regulation of neural precursor cell proliferation |
| GO:0002687 | 0.0066 | 3.8381 | 1.6766 | 6 | 86 | positive regulation of leukocyte migration |
| GO:0050900 | 0.0068 | 2.8303 | 3.3649 | 9 | 178 | leukocyte migration |
| GO:0006304 | 0.0074 | 3.7439 | 1.7156 | 6 | 88 | DNA modification |
| GO:0051290 | 0.0074 | 5.6605 | 0.7798 | 4 | 40 | protein heterotetramerization |
| GO:0001955 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | blood vessel maturation |
| GO:0002741 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | positive regulation of cytokine secretion involved in immune response |
| GO:0043903 | 0.0076 | 2.7723 | 3.4312 | 9 | 176 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0032956 | 0.0085 | 2.4356 | 4.7568 | 11 | 244 | regulation of actin cytoskeleton organization |
| GO:0060326 | 0.0085 | 2.7227 | 3.4896 | 9 | 179 | cell chemotaxis |
| GO:0048870 | 0.0087 | 1.7611 | 15.0498 | 25 | 801 | cell motility |
| GO:0001959 | 0.0087 | 3.2032 | 2.3199 | 7 | 119 | regulation of cytokine-mediated signaling pathway |
| GO:0043901 | 0.0087 | 3.2032 | 2.3199 | 7 | 119 | negative regulation of multi-organism process |
| GO:0006584 | 0.0088 | 5.3618 | 0.8188 | 4 | 42 | catecholamine metabolic process |
| GO:0045087 | 0.0089 | 1.8807 | 11.2098 | 20 | 575 | innate immune response |
| GO:0000902 | 0.0091 | 1.7515 | 15.0893 | 25 | 774 | cell morphogenesis |
| GO:0045652 | 0.0092 | 4.1842 | 1.2867 | 5 | 66 | regulation of megakaryocyte differentiation |
| GO:0030198 | 0.0095 | 2.3938 | 4.8348 | 11 | 248 | extracellular matrix organization |
| GO:0009164 | 0.0097 | 7.6212 | 0.4484 | 3 | 23 | nucleoside catabolic process |
| GO:0034122 | 0.0097 | 7.6212 | 0.4484 | 3 | 23 | negative regulation of toll-like receptor signaling pathway |
| GO:0050706 | 0.0097 | 7.6212 | 0.4484 | 3 | 23 | regulation of interleukin-1 beta secretion |
| GO:0050927 | 0.0097 | 7.6212 | 0.4484 | 3 | 23 | positive regulation of positive chemotaxis |
| GO:0061756 | 0.0097 | 7.6212 | 0.4484 | 3 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0034145 | 0.0098 | 16.888 | 0.156 | 2 | 8 | positive regulation of toll-like receptor 4 signaling pathway |
| GO:2000484 | 0.0098 | 16.888 | 0.156 | 2 | 8 | positive regulation of interleukin-8 secretion |
| GO:0120032 | 0.0099 | 3.1156 | 2.3804 | 7 | 123 | regulation of plasma membrane bounded cell projection assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032502 | 1e-04 | 1.9023 | 48.2831 | 72 | 3581 | developmental process |
| GO:0007416 | 1e-04 | 5.5748 | 1.7863 | 9 | 120 | synapse assembly |
| GO:0007275 | 1e-04 | 1.7541 | 60.0749 | 85 | 4095 | multicellular organism development |
| GO:0090240 | 1e-04 | 50.3853 | 0.1042 | 3 | 7 | positive regulation of histone H4 acetylation |
| GO:0007155 | 2e-04 | 2.7891 | 7.4705 | 19 | 525 | cell adhesion |
| GO:0010596 | 3e-04 | 9.4047 | 0.6103 | 5 | 41 | negative regulation of endothelial cell migration |
| GO:0030238 | 4e-04 | 28.785 | 0.1489 | 3 | 10 | male sex determination |
| GO:0035646 | 4e-04 | 28.785 | 0.1489 | 3 | 10 | endosome to melanosome transport |
| GO:0043476 | 4e-04 | 28.785 | 0.1489 | 3 | 10 | pigment accumulation |
| GO:0048757 | 4e-04 | 28.785 | 0.1489 | 3 | 10 | pigment granule maturation |
| GO:0048538 | 4e-04 | 9.1498 | 0.6252 | 5 | 42 | thymus development |
| GO:1900116 | 5e-04 | 25.1849 | 0.1637 | 3 | 11 | extracellular negative regulation of signal transduction |
| GO:0090051 | 6e-04 | 22.3849 | 0.1786 | 3 | 12 | negative regulation of cell migration involved in sprouting angiogenesis |
| GO:0008582 | 7e-04 | 133.7026 | 0.0447 | 2 | 3 | regulation of synaptic growth at neuromuscular junction |
| GO:0061551 | 7e-04 | 133.7026 | 0.0447 | 2 | 3 | trigeminal ganglion development |
| GO:0072095 | 7e-04 | 133.7026 | 0.0447 | 2 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:0002090 | 7e-04 | 11.2375 | 0.4168 | 4 | 28 | regulation of receptor internalization |
| GO:0030326 | 0.0012 | 4.6721 | 1.6226 | 7 | 109 | embryonic limb morphogenesis |
| GO:0016525 | 0.0012 | 5.5029 | 1.1909 | 6 | 80 | negative regulation of angiogenesis |
| GO:1904888 | 0.0012 | 6.9026 | 0.8038 | 5 | 54 | cranial skeletal system development |
| GO:0048665 | 0.0012 | 9.6292 | 0.4763 | 4 | 32 | neuron fate specification |
| GO:0010572 | 0.0013 | 66.8462 | 0.0595 | 2 | 4 | positive regulation of platelet activation |
| GO:0030910 | 0.0013 | 66.8462 | 0.0595 | 2 | 4 | olfactory placode formation |
| GO:0061055 | 0.0013 | 66.8462 | 0.0595 | 2 | 4 | myotome development |
| GO:0061197 | 0.0013 | 66.8462 | 0.0595 | 2 | 4 | fungiform papilla morphogenesis |
| GO:0071698 | 0.0013 | 66.8462 | 0.0595 | 2 | 4 | olfactory placode development |
| GO:0072107 | 0.0013 | 66.8462 | 0.0595 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0090184 | 0.0014 | 9.2964 | 0.4912 | 4 | 33 | positive regulation of kidney development |
| GO:0051241 | 0.0015 | 2.1615 | 11.0114 | 22 | 758 | negative regulation of multicellular organismal process |
| GO:0090190 | 0.0016 | 15.4925 | 0.2382 | 3 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0048598 | 0.0016 | 2.4081 | 7.5769 | 17 | 509 | embryonic morphogenesis |
| GO:0016477 | 0.0016 | 1.9624 | 15.526 | 28 | 1043 | cell migration |
| GO:0048704 | 0.0017 | 5.1526 | 1.2653 | 6 | 85 | embryonic skeletal system morphogenesis |
| GO:1901343 | 0.0018 | 5.0878 | 1.2802 | 6 | 86 | negative regulation of vasculature development |
| GO:0048646 | 0.0018 | 2.0562 | 12.6232 | 24 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0051674 | 0.0019 | 1.9021 | 17.1932 | 30 | 1155 | localization of cell |
| GO:0042127 | 0.0019 | 1.8617 | 18.786 | 32 | 1262 | regulation of cell proliferation |
| GO:1902106 | 0.0021 | 6.0366 | 0.908 | 5 | 61 | negative regulation of leukocyte differentiation |
| GO:2001057 | 0.0021 | 6.0366 | 0.908 | 5 | 61 | reactive nitrogen species metabolic process |
| GO:1903232 | 0.0021 | 44.5607 | 0.0744 | 2 | 5 | melanosome assembly |
| GO:0018149 | 0.0022 | 13.4247 | 0.2679 | 3 | 18 | peptide cross-linking |
| GO:0043586 | 0.0022 | 13.4247 | 0.2679 | 3 | 18 | tongue development |
| GO:0021675 | 0.0023 | 5.9302 | 0.9229 | 5 | 62 | nerve development |
| GO:0060548 | 0.0025 | 2.0625 | 11.477 | 22 | 771 | negative regulation of cell death |
| GO:0048066 | 0.0026 | 7.6992 | 0.5806 | 4 | 39 | developmental pigmentation |
| GO:0072001 | 0.0027 | 3.045 | 3.4982 | 10 | 235 | renal system development |
| GO:0035107 | 0.0028 | 3.9994 | 1.8756 | 7 | 126 | appendage morphogenesis |
| GO:0006928 | 0.0028 | 1.7405 | 23.3113 | 37 | 1566 | movement of cell or subcellular component |
| GO:0021602 | 0.0031 | 11.8435 | 0.2977 | 3 | 20 | cranial nerve morphogenesis |
| GO:0040011 | 0.0032 | 2.1451 | 9.5289 | 19 | 672 | locomotion |
| GO:0042538 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | hyperosmotic salinity response |
| GO:0060677 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | ureteric bud elongation |
| GO:1904995 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0050896 | 0.0034 | 1.4951 | 95.6419 | 115 | 6425 | response to stimulus |
| GO:0043066 | 0.0034 | 2.0824 | 10.2862 | 20 | 691 | negative regulation of apoptotic process |
| GO:0060688 | 0.0034 | 7.0897 | 0.6252 | 4 | 42 | regulation of morphogenesis of a branching structure |
| GO:1903670 | 0.0034 | 7.0897 | 0.6252 | 4 | 42 | regulation of sprouting angiogenesis |
| GO:0060037 | 0.0035 | 11.1847 | 0.3126 | 3 | 21 | pharyngeal system development |
| GO:0061217 | 0.0035 | 11.1847 | 0.3126 | 3 | 21 | regulation of mesonephros development |
| GO:0048513 | 0.0039 | 1.6176 | 33.1335 | 48 | 2301 | animal organ development |
| GO:0030198 | 0.004 | 2.8758 | 3.6917 | 10 | 248 | extracellular matrix organization |
| GO:1903428 | 0.0041 | 6.7342 | 0.655 | 4 | 44 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0030155 | 0.0043 | 2.2257 | 7.6514 | 16 | 514 | regulation of cell adhesion |
| GO:0097306 | 0.0044 | 6.5694 | 0.6699 | 4 | 45 | cellular response to alcohol |
| GO:0045165 | 0.0045 | 3.0266 | 3.1558 | 9 | 212 | cell fate commitment |
| GO:0010092 | 0.0046 | 10.0647 | 0.3424 | 3 | 23 | specification of animal organ identity |
| GO:0030878 | 0.0046 | 10.0647 | 0.3424 | 3 | 23 | thyroid gland development |
| GO:0045428 | 0.0048 | 6.4125 | 0.6848 | 4 | 46 | regulation of nitric oxide biosynthetic process |
| GO:0003008 | 0.005 | 1.7486 | 19.1879 | 31 | 1289 | system process |
| GO:0003006 | 0.0052 | 2.1802 | 7.8002 | 16 | 524 | developmental process involved in reproduction |
| GO:0034661 | 0.0052 | 9.5847 | 0.3573 | 3 | 24 | ncRNA catabolic process |
| GO:0001656 | 0.0055 | 4.7557 | 1.1313 | 5 | 76 | metanephros development |
| GO:0002520 | 0.0058 | 1.9765 | 10.7923 | 20 | 725 | immune system development |
| GO:0042759 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | long-chain fatty acid biosynthetic process |
| GO:0047484 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | regulation of response to osmotic stress |
| GO:0071499 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | cellular response to laminar fluid shear stress |
| GO:1905205 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:1990314 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | cellular response to insulin-like growth factor stimulus |
| GO:2000109 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | regulation of macrophage apoptotic process |
| GO:0031128 | 0.0059 | 9.1483 | 0.3721 | 3 | 25 | developmental induction |
| GO:0045581 | 0.0059 | 9.1483 | 0.3721 | 3 | 25 | negative regulation of T cell differentiation |
| GO:2000758 | 0.0059 | 9.1483 | 0.3721 | 3 | 25 | positive regulation of peptidyl-lysine acetylation |
| GO:0040012 | 0.0063 | 1.9954 | 10.1373 | 19 | 681 | regulation of locomotion |
| GO:0072358 | 0.0063 | 2.1321 | 7.964 | 16 | 535 | cardiovascular system development |
| GO:0072604 | 0.0066 | 8.7499 | 0.387 | 3 | 26 | interleukin-6 secretion |
| GO:0098742 | 0.0067 | 3.0578 | 2.7688 | 8 | 186 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0009888 | 0.0067 | 1.6694 | 22.0609 | 34 | 1482 | tissue development |
| GO:0060173 | 0.0069 | 3.3456 | 2.218 | 7 | 149 | limb development |
| GO:0002009 | 0.0071 | 2.2269 | 6.654 | 14 | 447 | morphogenesis of an epithelium |
| GO:0034393 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | positive regulation of smooth muscle cell apoptotic process |
| GO:0045060 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | negative thymic T cell selection |
| GO:0048642 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | negative regulation of skeletal muscle tissue development |
| GO:0051451 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | myoblast migration |
| GO:0072172 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | mesonephric tubule formation |
| GO:1903244 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0022408 | 0.0074 | 3.7258 | 1.7119 | 6 | 115 | negative regulation of cell-cell adhesion |
| GO:0072006 | 0.0074 | 3.7258 | 1.7119 | 6 | 115 | nephron development |
| GO:0007517 | 0.0079 | 2.4605 | 4.7188 | 11 | 317 | muscle organ development |
| GO:0072330 | 0.008 | 3.253 | 2.2775 | 7 | 153 | monocarboxylic acid biosynthetic process |
| GO:0021522 | 0.0081 | 8.0487 | 0.4168 | 3 | 28 | spinal cord motor neuron differentiation |
| GO:0032715 | 0.0081 | 8.0487 | 0.4168 | 3 | 28 | negative regulation of interleukin-6 production |
| GO:0001501 | 0.0083 | 2.2553 | 6.0883 | 13 | 409 | skeletal system development |
| GO:0007165 | 0.0083 | 1.4392 | 64.6048 | 81 | 4340 | signal transduction |
| GO:0032103 | 0.0088 | 2.9086 | 2.9028 | 8 | 195 | positive regulation of response to external stimulus |
| GO:0021554 | 0.0092 | 16.7038 | 0.1489 | 2 | 10 | optic nerve development |
| GO:0071941 | 0.0092 | 16.7038 | 0.1489 | 2 | 10 | nitrogen cycle metabolic process |
| GO:1900746 | 0.0092 | 16.7038 | 0.1489 | 2 | 10 | regulation of vascular endothelial growth factor signaling pathway |
| GO:0032879 | 0.0097 | 1.5422 | 31.1562 | 44 | 2093 | regulation of localization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022610 | 0 | 2.7729 | 15.9201 | 38 | 1043 | biological adhesion |
| GO:0048842 | 1e-04 | 49.1005 | 0.1068 | 3 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0035646 | 4e-04 | 28.051 | 0.1526 | 3 | 10 | endosome to melanosome transport |
| GO:0043476 | 4e-04 | 28.051 | 0.1526 | 3 | 10 | pigment accumulation |
| GO:0048757 | 4e-04 | 28.051 | 0.1526 | 3 | 10 | pigment granule maturation |
| GO:0030198 | 4e-04 | 3.4244 | 3.7854 | 12 | 248 | extracellular matrix organization |
| GO:0061551 | 7e-04 | 130.31 | 0.0458 | 2 | 3 | trigeminal ganglion development |
| GO:0036066 | 7e-04 | 21.8141 | 0.1832 | 3 | 12 | protein O-linked fucosylation |
| GO:0008037 | 8e-04 | 4.9944 | 1.5264 | 7 | 100 | cell recognition |
| GO:0030155 | 9e-04 | 2.4725 | 7.8455 | 18 | 514 | regulation of cell adhesion |
| GO:0031589 | 0.0014 | 3.1498 | 3.7396 | 11 | 245 | cell-substrate adhesion |
| GO:0098706 | 0.0014 | 65.15 | 0.0611 | 2 | 4 | ferric iron import across plasma membrane |
| GO:0007413 | 0.0017 | 15.0974 | 0.2442 | 3 | 16 | axonal fasciculation |
| GO:1902284 | 0.0017 | 15.0974 | 0.2442 | 3 | 16 | neuron projection extension involved in neuron projection guidance |
| GO:1902667 | 0.0017 | 15.0974 | 0.2442 | 3 | 16 | regulation of axon guidance |
| GO:0001568 | 0.0021 | 2.3421 | 7.7692 | 17 | 509 | blood vessel development |
| GO:0015677 | 0.0022 | 43.43 | 0.0763 | 2 | 5 | copper ion import |
| GO:0048843 | 0.0022 | 43.43 | 0.0763 | 2 | 5 | negative regulation of axon extension involved in axon guidance |
| GO:1903232 | 0.0022 | 43.43 | 0.0763 | 2 | 5 | melanosome assembly |
| GO:2000507 | 0.0022 | 43.43 | 0.0763 | 2 | 5 | positive regulation of energy homeostasis |
| GO:2001057 | 0.0023 | 5.8811 | 0.9311 | 5 | 61 | reactive nitrogen species metabolic process |
| GO:1902905 | 0.0026 | 3.6146 | 2.3659 | 8 | 155 | positive regulation of supramolecular fiber organization |
| GO:0048870 | 0.0027 | 1.846 | 17.6296 | 30 | 1155 | cell motility |
| GO:0050772 | 0.0033 | 5.3969 | 1.0074 | 5 | 66 | positive regulation of axonogenesis |
| GO:0033034 | 0.0033 | 32.57 | 0.0916 | 2 | 6 | positive regulation of myeloid cell apoptotic process |
| GO:0042538 | 0.0033 | 32.57 | 0.0916 | 2 | 6 | hyperosmotic salinity response |
| GO:0071472 | 0.0033 | 32.57 | 0.0916 | 2 | 6 | cellular response to salt stress |
| GO:0072358 | 0.0035 | 2.22 | 8.1661 | 17 | 535 | cardiovascular system development |
| GO:0090049 | 0.0038 | 10.8995 | 0.3205 | 3 | 21 | regulation of cell migration involved in sprouting angiogenesis |
| GO:0001525 | 0.0039 | 2.485 | 5.556 | 13 | 364 | angiogenesis |
| GO:2000352 | 0.0044 | 10.325 | 0.3358 | 3 | 22 | negative regulation of endothelial cell apoptotic process |
| GO:0061387 | 0.0048 | 4.9114 | 1.099 | 5 | 72 | regulation of extent of cell growth |
| GO:0051495 | 0.0049 | 3.2356 | 2.6254 | 8 | 172 | positive regulation of cytoskeleton organization |
| GO:0045428 | 0.0052 | 6.2482 | 0.7021 | 4 | 46 | regulation of nitric oxide biosynthetic process |
| GO:0000038 | 0.0056 | 9.3403 | 0.3663 | 3 | 24 | very long-chain fatty acid metabolic process |
| GO:0034661 | 0.0056 | 9.3403 | 0.3663 | 3 | 24 | ncRNA catabolic process |
| GO:0021859 | 0.0061 | 21.71 | 0.1221 | 2 | 8 | pyramidal neuron differentiation |
| GO:0033629 | 0.0061 | 21.71 | 0.1221 | 2 | 8 | negative regulation of cell adhesion mediated by integrin |
| GO:0047484 | 0.0061 | 21.71 | 0.1221 | 2 | 8 | regulation of response to osmotic stress |
| GO:0098609 | 0.0065 | 2.027 | 9.433 | 18 | 618 | cell-cell adhesion |
| GO:0043067 | 0.0069 | 1.7166 | 18.8049 | 30 | 1232 | regulation of programmed cell death |
| GO:1904035 | 0.0075 | 5.5813 | 0.7784 | 4 | 51 | regulation of epithelial cell apoptotic process |
| GO:0019371 | 0.0078 | 18.6071 | 0.1374 | 2 | 9 | cyclooxygenase pathway |
| GO:0097286 | 0.0078 | 18.6071 | 0.1374 | 2 | 9 | iron ion import |
| GO:0099133 | 0.0078 | 18.6071 | 0.1374 | 2 | 9 | ATP hydrolysis coupled anion transmembrane transport |
| GO:0008015 | 0.008 | 2.2655 | 6.0597 | 13 | 397 | blood circulation |
| GO:0043001 | 0.0087 | 7.8434 | 0.4274 | 3 | 28 | Golgi to plasma membrane protein transport |
| GO:0001952 | 0.0088 | 4.2152 | 1.2669 | 5 | 83 | regulation of cell-matrix adhesion |
| GO:0032535 | 0.0088 | 2.5485 | 4.1365 | 10 | 271 | regulation of cellular component size |
| GO:0001780 | 0.0096 | 16.28 | 0.1526 | 2 | 10 | neutrophil homeostasis |
| GO:0002544 | 0.0096 | 16.28 | 0.1526 | 2 | 10 | chronic inflammatory response |
| GO:0071941 | 0.0096 | 16.28 | 0.1526 | 2 | 10 | nitrogen cycle metabolic process |
| GO:1900119 | 0.0096 | 16.28 | 0.1526 | 2 | 10 | positive regulation of execution phase of apoptosis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000768 | 3e-04 | 13.7383 | 0.3298 | 4 | 45 | syncytium formation by plasma membrane fusion |
| GO:0030449 | 9e-04 | 18.197 | 0.1906 | 3 | 26 | regulation of complement activation |
| GO:0030890 | 0.0012 | 16.0937 | 0.2126 | 3 | 29 | positive regulation of B cell proliferation |
| GO:0006952 | 0.0014 | 2.5084 | 7.6448 | 17 | 1043 | defense response |
| GO:0002684 | 0.0015 | 2.8617 | 5.0354 | 13 | 687 | positive regulation of immune system process |
| GO:0046651 | 0.0018 | 5.0594 | 1.2827 | 6 | 175 | lymphocyte proliferation |
| GO:0045214 | 0.0021 | 13.0701 | 0.2565 | 3 | 35 | sarcomere organization |
| GO:0070661 | 0.0024 | 4.773 | 1.356 | 6 | 185 | leukocyte proliferation |
| GO:0050776 | 0.0028 | 2.7658 | 4.7642 | 12 | 650 | regulation of immune response |
| GO:0071688 | 0.0028 | 30.7088 | 0.0806 | 2 | 11 | striated muscle myosin thick filament assembly |
| GO:0051251 | 0.0029 | 4.5909 | 1.4073 | 6 | 192 | positive regulation of lymphocyte activation |
| GO:0031033 | 0.0039 | 25.1215 | 0.0953 | 2 | 13 | myosin filament organization |
| GO:0002526 | 0.0041 | 6.6044 | 0.6523 | 4 | 89 | acute inflammatory response |
| GO:0045821 | 0.0046 | 23.0263 | 0.1026 | 2 | 14 | positive regulation of glycolytic process |
| GO:0072376 | 0.0046 | 9.7185 | 0.3372 | 3 | 46 | protein activation cascade |
| GO:0032946 | 0.005 | 6.2351 | 0.689 | 4 | 94 | positive regulation of mononuclear cell proliferation |
| GO:0010951 | 0.0052 | 4.8026 | 1.1141 | 5 | 152 | negative regulation of endopeptidase activity |
| GO:0001895 | 0.0052 | 9.2851 | 0.3518 | 3 | 48 | retina homeostasis |
| GO:0051194 | 0.0052 | 21.2534 | 0.1099 | 2 | 15 | positive regulation of cofactor metabolic process |
| GO:0051146 | 0.0058 | 3.9441 | 1.6272 | 6 | 222 | striated muscle cell differentiation |
| GO:0050867 | 0.006 | 3.9073 | 1.6418 | 6 | 224 | positive regulation of cell activation |
| GO:0051181 | 0.0067 | 18.4168 | 0.1246 | 2 | 17 | cofactor transport |
| GO:0003147 | 0.0073 | Inf | 0.0073 | 1 | 1 | neural crest cell migration involved in heart formation |
| GO:0003365 | 0.0073 | Inf | 0.0073 | 1 | 1 | establishment of cell polarity involved in ameboidal cell migration |
| GO:0006649 | 0.0073 | Inf | 0.0073 | 1 | 1 | phospholipid transfer to membrane |
| GO:0014905 | 0.0073 | Inf | 0.0073 | 1 | 1 | myoblast fusion involved in skeletal muscle regeneration |
| GO:0018032 | 0.0073 | Inf | 0.0073 | 1 | 1 | protein amidation |
| GO:0043128 | 0.0073 | Inf | 0.0073 | 1 | 1 | positive regulation of 1-phosphatidylinositol 4-kinase activity |
| GO:0061713 | 0.0073 | Inf | 0.0073 | 1 | 1 | anterior neural tube closure |
| GO:0071231 | 0.0073 | Inf | 0.0073 | 1 | 1 | cellular response to folic acid |
| GO:1900035 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of cellular response to heat |
| GO:0002253 | 0.0079 | 2.9933 | 2.8659 | 8 | 391 | activation of immune response |
| GO:0006959 | 0.0087 | 5.2875 | 0.8063 | 4 | 110 | humoral immune response |
| GO:0071496 | 0.0087 | 3.6043 | 1.7738 | 6 | 242 | cellular response to external stimulus |
| GO:0072010 | 0.0093 | 15.3439 | 0.1466 | 2 | 20 | glomerular epithelium development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042445 | 3e-04 | 5.0306 | 1.7351 | 8 | 129 | hormone metabolic process |
| GO:0032252 | 5e-04 | 148.3523 | 0.0404 | 2 | 3 | secretory granule localization |
| GO:0006590 | 6e-04 | 22.3646 | 0.1749 | 3 | 13 | thyroid hormone generation |
| GO:1903010 | 6e-04 | 22.3646 | 0.1749 | 3 | 13 | regulation of bone development |
| GO:0050853 | 7e-04 | 11.0932 | 0.417 | 4 | 31 | B cell receptor signaling pathway |
| GO:0021648 | 0.0011 | 74.1705 | 0.0538 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:1902667 | 0.0012 | 17.1996 | 0.2152 | 3 | 16 | regulation of axon guidance |
| GO:0009912 | 0.0018 | 49.4432 | 0.0673 | 2 | 5 | auditory receptor cell fate commitment |
| GO:0021631 | 0.0018 | 49.4432 | 0.0673 | 2 | 5 | optic nerve morphogenesis |
| GO:0021987 | 0.0021 | 4.9156 | 1.3181 | 6 | 98 | cerebral cortex development |
| GO:0048469 | 0.0022 | 4.1674 | 1.8023 | 7 | 134 | cell maturation |
| GO:0045165 | 0.0023 | 3.3718 | 2.8514 | 9 | 212 | cell fate commitment |
| GO:0021604 | 0.0026 | 37.0795 | 0.0807 | 2 | 6 | cranial nerve structural organization |
| GO:0097210 | 0.0026 | 37.0795 | 0.0807 | 2 | 6 | response to gonadotropin-releasing hormone |
| GO:0032814 | 0.0031 | 11.7627 | 0.2959 | 3 | 22 | regulation of natural killer cell activation |
| GO:0010092 | 0.0035 | 11.1737 | 0.3094 | 3 | 23 | specification of animal organ identity |
| GO:0032825 | 0.0036 | 29.6614 | 0.0942 | 2 | 7 | positive regulation of natural killer cell differentiation |
| GO:0048842 | 0.0036 | 29.6614 | 0.0942 | 2 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0019359 | 0.0039 | 10.6408 | 0.3228 | 3 | 24 | nicotinamide nucleotide biosynthetic process |
| GO:0065007 | 0.0039 | 1.6255 | 123.7284 | 140 | 9199 | biological regulation |
| GO:0061036 | 0.0044 | 10.1564 | 0.3363 | 3 | 25 | positive regulation of cartilage development |
| GO:0051251 | 0.0044 | 3.2921 | 2.5824 | 8 | 192 | positive regulation of lymphocyte activation |
| GO:0009888 | 0.0045 | 1.7543 | 19.9332 | 32 | 1482 | tissue development |
| GO:0048584 | 0.0054 | 1.7063 | 21.8028 | 34 | 1621 | positive regulation of response to stimulus |
| GO:0006955 | 0.0054 | 1.7767 | 17.7274 | 29 | 1318 | immune response |
| GO:0072525 | 0.0055 | 9.3086 | 0.3632 | 3 | 27 | pyridine-containing compound biosynthetic process |
| GO:0019674 | 0.0055 | 6.1023 | 0.7129 | 4 | 53 | NAD metabolic process |
| GO:0007154 | 0.0056 | 1.4906 | 64.144 | 81 | 4769 | cell communication |
| GO:0035729 | 0.0061 | 21.1834 | 0.1211 | 2 | 9 | cellular response to hepatocyte growth factor stimulus |
| GO:0097485 | 0.0064 | 3.0876 | 2.7438 | 8 | 204 | neuron projection guidance |
| GO:0002366 | 0.0068 | 2.2414 | 6.631 | 14 | 493 | leukocyte activation involved in immune response |
| GO:0023052 | 0.0077 | 1.4649 | 63.9154 | 80 | 4752 | signaling |
| GO:0071695 | 0.0079 | 3.6679 | 1.7351 | 6 | 129 | anatomical structure maturation |
| GO:0043299 | 0.0084 | 2.3415 | 5.4204 | 12 | 403 | leukocyte degranulation |
| GO:0048566 | 0.0089 | 7.7007 | 0.4304 | 3 | 32 | embryonic digestive tract development |
| GO:0021675 | 0.0096 | 5.1518 | 0.8339 | 4 | 62 | nerve development |
| GO:0009743 | 0.0097 | 3.1215 | 2.3672 | 7 | 176 | response to carbohydrate |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033600 | 4e-04 | 170.9542 | 0.0351 | 2 | 3 | negative regulation of mammary gland epithelial cell proliferation |
| GO:0038042 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | dimeric G-protein coupled receptor signaling pathway |
| GO:0008306 | 0.001 | 7.2328 | 0.7613 | 5 | 65 | associative learning |
| GO:0006473 | 0.0019 | 4.2786 | 1.7568 | 7 | 150 | protein acetylation |
| GO:0042487 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | regulation of odontogenesis of dentin-containing tooth |
| GO:0009792 | 0.0024 | 2.5456 | 5.9147 | 14 | 505 | embryo development ending in birth or egg hatching |
| GO:0001771 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | immunological synapse formation |
| GO:1903896 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | positive regulation of IRE1-mediated unfolded protein response |
| GO:0018393 | 0.0038 | 4.3124 | 1.4875 | 6 | 127 | internal peptidyl-lysine acetylation |
| GO:0003008 | 0.0041 | 1.8856 | 15.0971 | 26 | 1289 | system process |
| GO:0032352 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | positive regulation of hormone metabolic process |
| GO:0035729 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | cellular response to hepatocyte growth factor stimulus |
| GO:0048589 | 0.0048 | 2.4292 | 5.7156 | 13 | 488 | developmental growth |
| GO:0001701 | 0.005 | 2.9808 | 3.2092 | 9 | 274 | in utero embryonic development |
| GO:0048742 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | regulation of skeletal muscle fiber development |
| GO:0090280 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | positive regulation of calcium ion import |
| GO:1902969 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | mitotic DNA replication |
| GO:0008016 | 0.0068 | 3.3516 | 2.2136 | 7 | 189 | regulation of heart contraction |
| GO:0010225 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | response to UV-C |
| GO:1902547 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:0007611 | 0.0085 | 3.2085 | 2.3073 | 7 | 197 | learning or memory |
| GO:0035850 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | epithelial cell differentiation involved in kidney development |
| GO:0070231 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | T cell apoptotic process |
| GO:0021794 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | thalamus development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035148 | 3e-04 | 5.0707 | 1.7213 | 8 | 134 | tube formation |
| GO:0035023 | 3e-04 | 5.8626 | 1.3103 | 7 | 102 | regulation of Rho protein signal transduction |
| GO:0070208 | 4e-04 | 26.0579 | 0.1541 | 3 | 12 | protein heterotrimerization |
| GO:0071300 | 9e-04 | 7.4391 | 0.7451 | 5 | 58 | cellular response to retinoic acid |
| GO:0003008 | 0.001 | 2.0092 | 16.5581 | 30 | 1289 | system process |
| GO:0070245 | 0.001 | 77.75 | 0.0514 | 2 | 4 | positive regulation of thymocyte apoptotic process |
| GO:0050896 | 0.001 | 1.6394 | 82.5336 | 103 | 6425 | response to stimulus |
| GO:0042060 | 0.001 | 2.8051 | 5.3823 | 14 | 419 | wound healing |
| GO:0120035 | 0.0013 | 2.6338 | 6.1402 | 15 | 478 | regulation of plasma membrane bounded cell projection organization |
| GO:0048729 | 0.0013 | 2.5419 | 6.7954 | 16 | 529 | tissue morphogenesis |
| GO:0050900 | 0.0014 | 3.1358 | 3.7638 | 11 | 293 | leukocyte migration |
| GO:0009593 | 0.0015 | 5.2156 | 1.246 | 6 | 97 | detection of chemical stimulus |
| GO:2000739 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | regulation of mesenchymal stem cell differentiation |
| GO:0060562 | 0.0019 | 3.2286 | 3.316 | 10 | 261 | epithelial tube morphogenesis |
| GO:0021516 | 0.002 | 13.7869 | 0.2569 | 3 | 20 | dorsal spinal cord development |
| GO:0060740 | 0.002 | 13.7869 | 0.2569 | 3 | 20 | prostate gland epithelium morphogenesis |
| GO:0032534 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | regulation of microvillus assembly |
| GO:0060836 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | lymphatic endothelial cell differentiation |
| GO:0007599 | 0.0025 | 3.09 | 3.4555 | 10 | 269 | hemostasis |
| GO:0007200 | 0.0026 | 5.7071 | 0.9506 | 5 | 74 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0021915 | 0.0027 | 4.0225 | 1.8626 | 7 | 145 | neural tube development |
| GO:0034754 | 0.0029 | 5.5455 | 0.9763 | 5 | 76 | cellular hormone metabolic process |
| GO:1903671 | 0.0031 | 11.7162 | 0.2955 | 3 | 23 | negative regulation of sprouting angiogenesis |
| GO:0030574 | 0.0033 | 7.1303 | 0.6166 | 4 | 48 | collagen catabolic process |
| GO:0002741 | 0.0033 | 31.0929 | 0.0899 | 2 | 7 | positive regulation of cytokine secretion involved in immune response |
| GO:0046951 | 0.0033 | 31.0929 | 0.0899 | 2 | 7 | ketone body biosynthetic process |
| GO:1902474 | 0.0033 | 31.0929 | 0.0899 | 2 | 7 | positive regulation of protein localization to synapse |
| GO:2000049 | 0.0033 | 31.0929 | 0.0899 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:0001838 | 0.0035 | 4.3889 | 1.4644 | 6 | 114 | embryonic epithelial tube formation |
| GO:0031346 | 0.0036 | 2.9283 | 3.6353 | 10 | 283 | positive regulation of cell projection organization |
| GO:0040017 | 0.0038 | 2.6129 | 4.8942 | 12 | 381 | positive regulation of locomotion |
| GO:0061036 | 0.0039 | 10.6494 | 0.3211 | 3 | 25 | positive regulation of cartilage development |
| GO:0002791 | 0.004 | 2.7203 | 4.3033 | 11 | 335 | regulation of peptide secretion |
| GO:0061448 | 0.0041 | 3.3461 | 2.5434 | 8 | 198 | connective tissue development |
| GO:0002064 | 0.0043 | 3.6725 | 2.0296 | 7 | 158 | epithelial cell development |
| GO:0097028 | 0.0044 | 10.1856 | 0.334 | 3 | 26 | dendritic cell differentiation |
| GO:0030916 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | otic vesicle formation |
| GO:0043589 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | skin morphogenesis |
| GO:0060068 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | vagina development |
| GO:1905205 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:2000484 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | positive regulation of interleukin-8 secretion |
| GO:0010632 | 0.0046 | 3.6239 | 2.0553 | 7 | 160 | regulation of epithelial cell migration |
| GO:0030168 | 0.0049 | 4.0837 | 1.5672 | 6 | 122 | platelet activation |
| GO:0007193 | 0.005 | 6.2718 | 0.6937 | 4 | 54 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0051056 | 0.0053 | 2.9494 | 3.2371 | 9 | 252 | regulation of small GTPase mediated signal transduction |
| GO:0032879 | 0.0054 | 1.6503 | 26.8861 | 40 | 2093 | regulation of localization |
| GO:0050702 | 0.0054 | 9.3693 | 0.3597 | 3 | 28 | interleukin-1 beta secretion |
| GO:0007165 | 0.0054 | 1.5141 | 55.7503 | 72 | 4340 | signal transduction |
| GO:0048871 | 0.0056 | 2.9249 | 3.2628 | 9 | 254 | multicellular organismal homeostasis |
| GO:0006705 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | mineralocorticoid biosynthetic process |
| GO:0007342 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | fusion of sperm to egg plasma membrane involved in single fertilization |
| GO:0060900 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | embryonic camera-type eye formation |
| GO:1903244 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0001568 | 0.006 | 2.2788 | 6.5385 | 14 | 509 | blood vessel development |
| GO:0051223 | 0.006 | 2.1508 | 7.9386 | 16 | 618 | regulation of protein transport |
| GO:0072678 | 0.0066 | 8.674 | 0.3854 | 3 | 30 | T cell migration |
| GO:0060491 | 0.0066 | 3.8179 | 1.6699 | 6 | 130 | regulation of cell projection assembly |
| GO:0045597 | 0.0067 | 2.0273 | 9.493 | 18 | 739 | positive regulation of cell differentiation |
| GO:0003157 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | endocardium development |
| GO:0072643 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | interferon-gamma secretion |
| GO:1904951 | 0.0069 | 2.4046 | 5.2924 | 12 | 412 | positive regulation of establishment of protein localization |
| GO:0007155 | 0.0072 | 1.8554 | 13.3467 | 23 | 1039 | cell adhesion |
| GO:0007154 | 0.0074 | 2.5342 | 4.727 | 11 | 429 | cell communication |
| GO:0001525 | 0.0074 | 2.4912 | 4.6758 | 11 | 364 | angiogenesis |
| GO:0050714 | 0.0074 | 3.2965 | 2.248 | 7 | 175 | positive regulation of protein secretion |
| GO:0051272 | 0.0077 | 2.4767 | 4.7015 | 11 | 366 | positive regulation of cellular component movement |
| GO:0050817 | 0.008 | 2.7529 | 3.4555 | 9 | 269 | coagulation |
| GO:0014744 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | positive regulation of muscle adaptation |
| GO:0048841 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | regulation of axon extension involved in axon guidance |
| GO:0050872 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | white fat cell differentiation |
| GO:0061154 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | endothelial tube morphogenesis |
| GO:0050890 | 0.009 | 2.8964 | 2.916 | 8 | 227 | cognition |
| GO:0072358 | 0.0091 | 2.1606 | 6.8724 | 14 | 535 | cardiovascular system development |
| GO:0008306 | 0.0097 | 5.1365 | 0.835 | 4 | 65 | associative learning |
| GO:0070365 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | hepatocyte differentiation |
| GO:0098703 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | calcium ion import across plasma membrane |
| GO:1900029 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | positive regulation of ruffle assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042421 | 0 | 75.023 | 0.0802 | 3 | 6 | norepinephrine biosynthetic process |
| GO:0009713 | 1e-04 | 21.5409 | 0.2407 | 4 | 18 | catechol-containing compound biosynthetic process |
| GO:0043207 | 2e-04 | 2.7767 | 7.5032 | 19 | 561 | response to external biotic stimulus |
| GO:0009972 | 0.001 | 74.6 | 0.0535 | 2 | 4 | cytidine deamination |
| GO:0042126 | 0.001 | 74.6 | 0.0535 | 2 | 4 | nitrate metabolic process |
| GO:0046087 | 0.001 | 74.6 | 0.0535 | 2 | 4 | cytidine metabolic process |
| GO:0070383 | 0.001 | 74.6 | 0.0535 | 2 | 4 | DNA cytosine deamination |
| GO:0003215 | 0.0012 | 17.2997 | 0.214 | 3 | 16 | cardiac right ventricle morphogenesis |
| GO:0048485 | 0.0012 | 17.2997 | 0.214 | 3 | 16 | sympathetic nervous system development |
| GO:0003180 | 0.0017 | 49.7295 | 0.0669 | 2 | 5 | aortic valve morphogenesis |
| GO:0003357 | 0.0017 | 49.7295 | 0.0669 | 2 | 5 | noradrenergic neuron differentiation |
| GO:0050916 | 0.0017 | 49.7295 | 0.0669 | 2 | 5 | sensory perception of sweet taste |
| GO:0050917 | 0.0017 | 49.7295 | 0.0669 | 2 | 5 | sensory perception of umami taste |
| GO:0050886 | 0.0019 | 6.1933 | 0.8827 | 5 | 66 | endocrine process |
| GO:0006584 | 0.0023 | 7.9215 | 0.5617 | 4 | 42 | catecholamine metabolic process |
| GO:0019062 | 0.0026 | 37.2943 | 0.0802 | 2 | 6 | virion attachment to host cell |
| GO:0045869 | 0.0026 | 37.2943 | 0.0802 | 2 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 0.0026 | 37.2943 | 0.0802 | 2 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0071353 | 0.003 | 11.8312 | 0.2942 | 3 | 22 | cellular response to interleukin-4 |
| GO:0009164 | 0.0034 | 11.2388 | 0.3076 | 3 | 23 | nucleoside catabolic process |
| GO:0007262 | 0.0036 | 29.8331 | 0.0936 | 2 | 7 | STAT protein import into nucleus |
| GO:0086043 | 0.0036 | 29.8331 | 0.0936 | 2 | 7 | bundle of His cell action potential |
| GO:0003310 | 0.0047 | 24.859 | 0.107 | 2 | 8 | pancreatic A cell differentiation |
| GO:0044406 | 0.0047 | 24.859 | 0.107 | 2 | 8 | adhesion of symbiont to host |
| GO:0060155 | 0.0047 | 24.859 | 0.107 | 2 | 8 | platelet dense granule organization |
| GO:0019730 | 0.0047 | 6.4002 | 0.6821 | 4 | 51 | antimicrobial humoral response |
| GO:0002704 | 0.0054 | 9.3628 | 0.3611 | 3 | 27 | negative regulation of leukocyte mediated immunity |
| GO:0003207 | 0.006 | 21.3061 | 0.1204 | 2 | 9 | cardiac chamber formation |
| GO:0016553 | 0.006 | 21.3061 | 0.1204 | 2 | 9 | base conversion or substitution editing |
| GO:0009617 | 0.0063 | 2.5477 | 4.5741 | 11 | 342 | response to bacterium |
| GO:0006304 | 0.0065 | 4.544 | 1.177 | 5 | 88 | DNA modification |
| GO:0032693 | 0.0075 | 18.6414 | 0.1337 | 2 | 10 | negative regulation of interleukin-10 production |
| GO:0031342 | 0.009 | 16.5689 | 0.1471 | 2 | 11 | negative regulation of cell killing |
| GO:0072189 | 0.009 | 16.5689 | 0.1471 | 2 | 11 | ureter development |
| GO:0006954 | 0.0094 | 2.2207 | 6.1925 | 13 | 463 | inflammatory response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042309 | 1e-04 | Inf | 0.0219 | 2 | 2 | homoiothermy |
| GO:0061551 | 4e-04 | 183.049 | 0.0329 | 2 | 3 | trigeminal ganglion development |
| GO:0061055 | 7e-04 | 91.5175 | 0.0438 | 2 | 4 | myotome development |
| GO:0010469 | 0.0011 | 3.0759 | 4.2183 | 12 | 385 | regulation of receptor activity |
| GO:0007626 | 0.0014 | 4.5284 | 1.6654 | 7 | 154 | locomotory behavior |
| GO:0048706 | 0.0014 | 5.287 | 1.2271 | 6 | 112 | embryonic skeletal system development |
| GO:0002369 | 0.0015 | 15.3415 | 0.2301 | 3 | 21 | T cell cytokine production |
| GO:0050864 | 0.0017 | 6.2814 | 0.8656 | 5 | 79 | regulation of B cell activation |
| GO:0000187 | 0.0019 | 5.0014 | 1.2929 | 6 | 118 | activation of MAPK activity |
| GO:0043171 | 0.0022 | 13.1469 | 0.263 | 3 | 24 | peptide catabolic process |
| GO:0001771 | 0.0024 | 36.5986 | 0.0767 | 2 | 7 | immunological synapse formation |
| GO:1904469 | 0.0024 | 36.5986 | 0.0767 | 2 | 7 | positive regulation of tumor necrosis factor secretion |
| GO:0048265 | 0.0025 | 12.5483 | 0.2739 | 3 | 25 | response to pain |
| GO:0050830 | 0.0025 | 7.7074 | 0.5697 | 4 | 52 | defense response to Gram-positive bacterium |
| GO:0002702 | 0.0027 | 7.5496 | 0.5807 | 4 | 53 | positive regulation of production of molecular mediator of immune response |
| GO:0021761 | 0.0031 | 5.4639 | 0.9861 | 5 | 90 | limbic system development |
| GO:0032494 | 0.0032 | 30.4965 | 0.0877 | 2 | 8 | response to peptidoglycan |
| GO:0050679 | 0.0034 | 4.4056 | 1.4572 | 6 | 133 | positive regulation of epithelial cell proliferation |
| GO:0002460 | 0.0037 | 4.3366 | 1.4791 | 6 | 135 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0030890 | 0.0038 | 10.6146 | 0.3177 | 3 | 29 | positive regulation of B cell proliferation |
| GO:0042417 | 0.0038 | 10.6146 | 0.3177 | 3 | 29 | dopamine metabolic process |
| GO:0050731 | 0.0038 | 4.3029 | 1.4901 | 6 | 136 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0009790 | 0.0045 | 2.1289 | 9.1488 | 18 | 835 | embryo development |
| GO:0071902 | 0.0045 | 3.0273 | 3.1665 | 9 | 289 | positive regulation of protein serine/threonine kinase activity |
| GO:0002449 | 0.0047 | 4.1112 | 1.5558 | 6 | 142 | lymphocyte mediated immunity |
| GO:0006702 | 0.0051 | 22.8689 | 0.1096 | 2 | 10 | androgen biosynthetic process |
| GO:0051251 | 0.0052 | 3.5381 | 2.1037 | 7 | 192 | positive regulation of lymphocyte activation |
| GO:0003008 | 0.0054 | 2.4059 | 5.8163 | 13 | 564 | system process |
| GO:0002697 | 0.0057 | 3.153 | 2.6953 | 8 | 246 | regulation of immune effector process |
| GO:0008284 | 0.0057 | 2.3826 | 5.846 | 13 | 551 | positive regulation of cell proliferation |
| GO:0050877 | 0.0059 | 2.1657 | 7.9436 | 16 | 725 | nervous system process |
| GO:0051240 | 0.006 | 1.8974 | 13.2137 | 23 | 1206 | positive regulation of multicellular organismal process |
| GO:0045475 | 0.0061 | 20.3263 | 0.1205 | 2 | 11 | locomotor rhythm |
| GO:0061548 | 0.0073 | 18.2923 | 0.1315 | 2 | 12 | ganglion development |
| GO:1901224 | 0.0076 | 8.1121 | 0.4054 | 3 | 37 | positive regulation of NIK/NF-kappaB signaling |
| GO:0021537 | 0.008 | 3.2524 | 2.279 | 7 | 208 | telencephalon development |
| GO:0002705 | 0.008 | 5.4322 | 0.7889 | 4 | 72 | positive regulation of leukocyte mediated immunity |
| GO:0050865 | 0.0081 | 2.5895 | 4.0978 | 10 | 374 | regulation of cell activation |
| GO:0006750 | 0.0086 | 16.6281 | 0.1424 | 2 | 13 | glutathione biosynthetic process |
| GO:0021781 | 0.0086 | 16.6281 | 0.1424 | 2 | 13 | glial cell fate commitment |
| GO:0006955 | 0.0088 | 1.808 | 14.4408 | 24 | 1318 | immune response |
| GO:0051222 | 0.0092 | 2.5393 | 4.1745 | 10 | 381 | positive regulation of protein transport |
| GO:0002637 | 0.0095 | 7.4526 | 0.4383 | 3 | 40 | regulation of immunoglobulin production |
| GO:0010224 | 0.01 | 15.2413 | 0.1534 | 2 | 14 | response to UV-B |
| GO:0043584 | 0.01 | 15.2413 | 0.1534 | 2 | 14 | nose development |
| GO:0071696 | 0.01 | 15.2413 | 0.1534 | 2 | 14 | ectodermal placode development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071941 | 4e-04 | 28.9363 | 0.1481 | 3 | 10 | nitrogen cycle metabolic process |
| GO:0061107 | 6e-04 | 134.4021 | 0.0444 | 2 | 3 | seminal vesicle development |
| GO:0010529 | 0.0013 | 16.8731 | 0.2222 | 3 | 15 | negative regulation of transposition |
| GO:0009972 | 0.0013 | 67.1959 | 0.0592 | 2 | 4 | cytidine deamination |
| GO:0042126 | 0.0013 | 67.1959 | 0.0592 | 2 | 4 | nitrate metabolic process |
| GO:0046087 | 0.0013 | 67.1959 | 0.0592 | 2 | 4 | cytidine metabolic process |
| GO:0070383 | 0.0013 | 67.1959 | 0.0592 | 2 | 4 | DNA cytosine deamination |
| GO:0007157 | 0.0019 | 8.4674 | 0.5332 | 4 | 36 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0006526 | 0.0021 | 44.7938 | 0.0741 | 2 | 5 | arginine biosynthetic process |
| GO:0070257 | 0.0021 | 44.7938 | 0.0741 | 2 | 5 | positive regulation of mucus secretion |
| GO:0048729 | 0.0023 | 2.3235 | 7.8347 | 17 | 529 | tissue morphogenesis |
| GO:0001707 | 0.0031 | 5.4788 | 0.9923 | 5 | 67 | mesoderm formation |
| GO:0045869 | 0.0031 | 33.5928 | 0.0889 | 2 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 0.0031 | 33.5928 | 0.0889 | 2 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0051346 | 0.0043 | 2.6896 | 4.3394 | 11 | 293 | negative regulation of hydrolase activity |
| GO:0002692 | 0.0044 | 26.8722 | 0.1037 | 2 | 7 | negative regulation of cellular extravasation |
| GO:0045078 | 0.0044 | 26.8722 | 0.1037 | 2 | 7 | positive regulation of interferon-gamma biosynthetic process |
| GO:0009164 | 0.0046 | 10.1176 | 0.3406 | 3 | 23 | nucleoside catabolic process |
| GO:0061756 | 0.0046 | 10.1176 | 0.3406 | 3 | 23 | leukocyte adhesion to vascular endothelial cell |
| GO:0051240 | 0.0051 | 1.779 | 17.6124 | 29 | 1201 | positive regulation of multicellular organismal process |
| GO:0031424 | 0.0051 | 4.0449 | 1.5847 | 6 | 107 | keratinization |
| GO:0050926 | 0.0051 | 9.6351 | 0.3554 | 3 | 24 | regulation of positive chemotaxis |
| GO:0021683 | 0.0058 | 22.3918 | 0.1185 | 2 | 8 | cerebellar granular layer morphogenesis |
| GO:0050910 | 0.0058 | 22.3918 | 0.1185 | 2 | 8 | detection of mechanical stimulus involved in sensory perception of sound |
| GO:0048706 | 0.0064 | 3.8526 | 1.6588 | 6 | 112 | embryonic skeletal system development |
| GO:0009749 | 0.0067 | 3.3636 | 2.2067 | 7 | 149 | response to glucose |
| GO:0042472 | 0.007 | 4.4647 | 1.1996 | 5 | 81 | inner ear morphogenesis |
| GO:0000050 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | urea cycle |
| GO:0001714 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | endodermal cell fate specification |
| GO:0016553 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | base conversion or substitution editing |
| GO:1900452 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | regulation of long term synaptic depression |
| GO:0007517 | 0.0077 | 2.474 | 4.6949 | 11 | 317 | muscle organ development |
| GO:0072529 | 0.008 | 8.091 | 0.4147 | 3 | 28 | pyrimidine-containing compound catabolic process |
| GO:0007389 | 0.0081 | 2.3504 | 5.391 | 12 | 364 | pattern specification process |
| GO:0032103 | 0.0086 | 2.9243 | 2.888 | 8 | 195 | positive regulation of response to external stimulus |
| GO:0048247 | 0.0088 | 7.7792 | 0.4295 | 3 | 29 | lymphocyte chemotaxis |
| GO:0034284 | 0.0089 | 3.1822 | 2.3252 | 7 | 157 | response to monosaccharide |
| GO:0002687 | 0.009 | 4.1875 | 1.2737 | 5 | 86 | positive regulation of leukocyte migration |
| GO:0006954 | 0.0091 | 2.1568 | 6.8572 | 14 | 463 | inflammatory response |
| GO:0002577 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | regulation of antigen processing and presentation |
| GO:0090280 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | positive regulation of calcium ion import |
| GO:0032941 | 0.0097 | 7.4905 | 0.4443 | 3 | 30 | secretion by tissue |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001807 | 2e-04 | Inf | 0.0257 | 2 | 2 | regulation of type IV hypersensitivity |
| GO:0002865 | 0.001 | 77.75 | 0.0514 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
| GO:0090071 | 0.001 | 77.75 | 0.0514 | 2 | 4 | negative regulation of ribosome biogenesis |
| GO:0002861 | 0.001 | 18.0345 | 0.2055 | 3 | 16 | regulation of inflammatory response to antigenic stimulus |
| GO:1903020 | 0.001 | 18.0345 | 0.2055 | 3 | 16 | positive regulation of glycoprotein metabolic process |
| GO:0050999 | 0.0011 | 9.8133 | 0.4624 | 4 | 36 | regulation of nitric-oxide synthase activity |
| GO:0032102 | 0.0012 | 3.7477 | 2.582 | 9 | 201 | negative regulation of response to external stimulus |
| GO:0006575 | 0.0016 | 4.4453 | 1.6956 | 7 | 132 | cellular modified amino acid metabolic process |
| GO:0002524 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | hypersensitivity |
| GO:0042219 | 0.0023 | 13.02 | 0.2698 | 3 | 21 | cellular modified amino acid catabolic process |
| GO:0042026 | 0.0027 | 12.3338 | 0.2826 | 3 | 22 | protein refolding |
| GO:0034754 | 0.0029 | 5.5455 | 0.9763 | 5 | 76 | cellular hormone metabolic process |
| GO:0003084 | 0.0033 | 31.0929 | 0.0899 | 2 | 7 | positive regulation of systemic arterial blood pressure |
| GO:0045924 | 0.0033 | 31.0929 | 0.0899 | 2 | 7 | regulation of female receptivity |
| GO:0090084 | 0.0033 | 31.0929 | 0.0899 | 2 | 7 | negative regulation of inclusion body assembly |
| GO:0019229 | 0.0038 | 6.8193 | 0.6423 | 4 | 50 | regulation of vasoconstriction |
| GO:0001990 | 0.0039 | 10.6494 | 0.3211 | 3 | 25 | regulation of systemic arterial blood pressure by hormone |
| GO:0032835 | 0.0041 | 6.6737 | 0.6551 | 4 | 51 | glomerulus development |
| GO:0014049 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | positive regulation of glutamate secretion |
| GO:0048678 | 0.0047 | 6.4003 | 0.6808 | 4 | 53 | response to axon injury |
| GO:1903727 | 0.006 | 9.0083 | 0.3725 | 3 | 29 | positive regulation of phospholipid metabolic process |
| GO:0006702 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | androgen biosynthetic process |
| GO:0006703 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | estrogen biosynthetic process |
| GO:0010817 | 0.0074 | 2.4912 | 4.6758 | 11 | 364 | regulation of hormone levels |
| GO:0006342 | 0.0082 | 4.2727 | 1.246 | 5 | 97 | chromatin silencing |
| GO:0046434 | 0.0086 | 4.2265 | 1.2589 | 5 | 98 | organophosphate catabolic process |
| GO:0021983 | 0.0093 | 7.5524 | 0.4368 | 3 | 34 | pituitary gland development |
| GO:0046164 | 0.0093 | 7.5524 | 0.4368 | 3 | 34 | alcohol catabolic process |
| GO:0007162 | 0.0099 | 3.1089 | 2.3765 | 7 | 185 | negative regulation of cell adhesion |
| GO:0051969 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | regulation of transmission of nerve impulse |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006767 | 0.0024 | 7.7651 | 0.5617 | 4 | 63 | water-soluble vitamin metabolic process |
| GO:0030238 | 0.0034 | 28.25 | 0.0892 | 2 | 10 | male sex determination |
| GO:0050930 | 0.0058 | 20.5408 | 0.1159 | 2 | 13 | induction of positive chemotaxis |
| GO:0090630 | 0.0059 | 5.9417 | 0.7222 | 4 | 81 | activation of GTPase activity |
| GO:0035855 | 0.0087 | 16.1355 | 0.1427 | 2 | 16 | megakaryocyte development |
| GO:0002644 | 0.0089 | Inf | 0.0089 | 1 | 1 | negative regulation of tolerance induction |
| GO:0009115 | 0.0089 | Inf | 0.0089 | 1 | 1 | xanthine catabolic process |
| GO:0033037 | 0.0089 | Inf | 0.0089 | 1 | 1 | polysaccharide localization |
| GO:0035212 | 0.0089 | Inf | 0.0089 | 1 | 1 | cell competition in a multicellular organism |
| GO:0035874 | 0.0089 | Inf | 0.0089 | 1 | 1 | cellular response to copper ion starvation |
| GO:0035993 | 0.0089 | Inf | 0.0089 | 1 | 1 | deltoid tuberosity development |
| GO:0038098 | 0.0089 | Inf | 0.0089 | 1 | 1 | sequestering of BMP from receptor via BMP binding |
| GO:0043438 | 0.0089 | Inf | 0.0089 | 1 | 1 | acetoacetic acid metabolic process |
| GO:0046901 | 0.0089 | Inf | 0.0089 | 1 | 1 | tetrahydrofolylpolyglutamate biosynthetic process |
| GO:0060060 | 0.0089 | Inf | 0.0089 | 1 | 1 | post-embryonic retina morphogenesis in camera-type eye |
| GO:0070593 | 0.0089 | Inf | 0.0089 | 1 | 1 | dendrite self-avoidance |
| GO:0070902 | 0.0089 | Inf | 0.0089 | 1 | 1 | mitochondrial tRNA pseudouridine synthesis |
| GO:0071799 | 0.0089 | Inf | 0.0089 | 1 | 1 | cellular response to prostaglandin D stimulus |
| GO:0097185 | 0.0089 | Inf | 0.0089 | 1 | 1 | cellular response to azide |
| GO:0097749 | 0.0089 | Inf | 0.0089 | 1 | 1 | membrane tubulation |
| GO:1902216 | 0.0089 | Inf | 0.0089 | 1 | 1 | positive regulation of interleukin-4-mediated signaling pathway |
| GO:1990245 | 0.0089 | Inf | 0.0089 | 1 | 1 | histone H2A-T120 phosphorylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 1e-04 | Inf | 0.0183 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0051146 | 0.001 | 4.2673 | 2.0298 | 8 | 222 | striated muscle cell differentiation |
| GO:2000402 | 0.0012 | 55.0798 | 0.0549 | 2 | 6 | negative regulation of lymphocyte migration |
| GO:0010830 | 0.0014 | 9.1149 | 0.4846 | 4 | 53 | regulation of myotube differentiation |
| GO:0055001 | 0.0015 | 5.2106 | 1.2435 | 6 | 136 | muscle cell development |
| GO:0048743 | 0.0017 | 44.0605 | 0.064 | 2 | 7 | positive regulation of skeletal muscle fiber development |
| GO:0006699 | 0.0021 | 13.3098 | 0.256 | 3 | 28 | bile acid biosynthetic process |
| GO:0014904 | 0.0023 | 12.7969 | 0.2652 | 3 | 29 | myotube cell development |
| GO:0016052 | 0.0024 | 4.7321 | 1.3623 | 6 | 149 | carbohydrate catabolic process |
| GO:0002689 | 0.0029 | 31.467 | 0.0823 | 2 | 9 | negative regulation of leukocyte chemotaxis |
| GO:0007597 | 0.0029 | 31.467 | 0.0823 | 2 | 9 | blood coagulation, intrinsic pathway |
| GO:0006000 | 0.0052 | 22.0218 | 0.1097 | 2 | 12 | fructose metabolic process |
| GO:1901623 | 0.0052 | 22.0218 | 0.1097 | 2 | 12 | regulation of lymphocyte chemotaxis |
| GO:0006544 | 0.0061 | 20.0183 | 0.1189 | 2 | 13 | glycine metabolic process |
| GO:0045954 | 0.007 | 18.3487 | 0.128 | 2 | 14 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0007519 | 0.0075 | 4.3726 | 1.216 | 5 | 133 | skeletal muscle tissue development |
| GO:0048747 | 0.0075 | 8.1058 | 0.4023 | 3 | 44 | muscle fiber development |
| GO:0046653 | 0.0081 | 16.936 | 0.1371 | 2 | 15 | tetrahydrofolate metabolic process |
| GO:0002152 | 0.0091 | Inf | 0.0091 | 1 | 1 | bile acid conjugation |
| GO:0034337 | 0.0091 | Inf | 0.0091 | 1 | 1 | RNA folding |
| GO:0043251 | 0.0091 | Inf | 0.0091 | 1 | 1 | sodium-dependent organic anion transport |
| GO:0051692 | 0.0091 | Inf | 0.0091 | 1 | 1 | cellular oligosaccharide catabolic process |
| GO:0072382 | 0.0091 | Inf | 0.0091 | 1 | 1 | minus-end-directed vesicle transport along microtubule |
| GO:1901537 | 0.0091 | Inf | 0.0091 | 1 | 1 | positive regulation of DNA demethylation |
| GO:1990079 | 0.0091 | Inf | 0.0091 | 1 | 1 | cartilage homeostasis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036461 | 2e-04 | Inf | 0.0306 | 2 | 2 | BLOC-2 complex binding |
| GO:0008823 | 7e-04 | 130.1891 | 0.0458 | 2 | 3 | cupric reductase activity |
| GO:0035651 | 7e-04 | 130.1891 | 0.0458 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0052851 | 7e-04 | 130.1891 | 0.0458 | 2 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0002020 | 0.0011 | 4.782 | 1.5888 | 7 | 104 | protease binding |
| GO:0030023 | 0.0014 | 65.0896 | 0.0611 | 2 | 4 | extracellular matrix constituent conferring elasticity |
| GO:0035650 | 0.0014 | 65.0896 | 0.0611 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0005509 | 0.0022 | 2.3246 | 7.8218 | 17 | 512 | calcium ion binding |
| GO:0008235 | 0.0038 | 6.9013 | 0.6416 | 4 | 42 | metalloexopeptidase activity |
| GO:0030742 | 0.0044 | 10.3153 | 0.3361 | 3 | 22 | GTP-dependent protein binding |
| GO:0072341 | 0.007 | 5.6976 | 0.7638 | 4 | 50 | modified amino acid binding |
| GO:0043225 | 0.0078 | 18.5899 | 0.1375 | 2 | 9 | ATPase-coupled anion transmembrane transporter activity |
| GO:0044548 | 0.0078 | 18.5899 | 0.1375 | 2 | 9 | S100 protein binding |
| GO:0005198 | 0.0082 | 2.0675 | 8.1884 | 16 | 536 | structural molecule activity |
| GO:0005178 | 0.0092 | 4.1574 | 1.2833 | 5 | 84 | integrin binding |
| GO:0016918 | 0.0096 | 16.2649 | 0.1528 | 2 | 10 | retinal binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005520 | 2e-04 | 11.4093 | 0.5364 | 5 | 27 | insulin-like growth factor binding |
| GO:1901612 | 3e-04 | 37.4138 | 0.1391 | 3 | 7 | cardiolipin binding |
| GO:0047844 | 4e-04 | Inf | 0.0397 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0004126 | 0.0012 | 99.4122 | 0.0596 | 2 | 3 | cytidine deaminase activity |
| GO:0043177 | 0.0015 | 3.6129 | 2.6821 | 9 | 135 | organic acid binding |
| GO:0008028 | 0.0019 | 8.6963 | 0.5364 | 4 | 27 | monocarboxylic acid transmembrane transporter activity |
| GO:0008138 | 0.0054 | 6.2462 | 0.7152 | 4 | 36 | protein tyrosine/serine/threonine phosphatase activity |
| GO:0097677 | 0.0056 | 24.8473 | 0.1192 | 2 | 6 | STAT family protein binding |
| GO:0045503 | 0.0069 | 8.7945 | 0.3974 | 3 | 20 | dynein light chain binding |
| GO:0033293 | 0.0087 | 5.4 | 0.8146 | 4 | 41 | monocarboxylic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008144 | 0.0037 | 5.2378 | 1.0295 | 5 | 80 | drug binding |
| GO:0046703 | 0.0056 | 22.164 | 0.1158 | 2 | 9 | natural killer cell lectin-like receptor binding |
| GO:0008757 | 0.0083 | 3.6327 | 1.7502 | 6 | 136 | S-adenosylmethionine-dependent methyltransferase activity |
| GO:0016274 | 0.0084 | 17.236 | 0.1416 | 2 | 11 | protein-arginine N-methyltransferase activity |
| GO:0042162 | 0.0094 | 7.538 | 0.4375 | 3 | 34 | telomeric DNA binding |
| GO:0001972 | 0.01 | 15.5112 | 0.1544 | 2 | 12 | retinoic acid binding |
| GO:0004467 | 0.01 | 15.5112 | 0.1544 | 2 | 12 | long-chain fatty acid-CoA ligase activity |
| GO:0051010 | 0.01 | 15.5112 | 0.1544 | 2 | 12 | microtubule plus-end binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042805 | 0.004 | 10.4177 | 0.3245 | 3 | 28 | actinin binding |
| GO:0005092 | 0.0056 | 21.5888 | 0.1159 | 2 | 10 | GDP-dissociation inhibitor activity |
| GO:0051371 | 0.0069 | 19.1886 | 0.1275 | 2 | 11 | muscle alpha-actinin binding |
| GO:0097493 | 0.0096 | 15.6974 | 0.1507 | 2 | 13 | structural molecule activity conferring elasticity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017034 | 0.0016 | 60.5 | 0.0656 | 2 | 4 | Rap guanyl-nucleotide exchange factor activity |
| GO:0005516 | 0.0039 | 3.3722 | 2.5265 | 8 | 154 | calmodulin binding |
| GO:0051393 | 0.0047 | 10.1178 | 0.3445 | 3 | 21 | alpha-actinin binding |
| GO:0004683 | 0.0053 | 9.5846 | 0.3609 | 3 | 22 | calmodulin-dependent protein kinase activity |
| GO:0004185 | 0.0089 | 17.2791 | 0.1477 | 2 | 9 | serine-type carboxypeptidase activity |
| GO:0005310 | 0.0095 | 7.5849 | 0.443 | 3 | 27 | dicarboxylic acid transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003873 | 2e-04 | Inf | 0.0275 | 2 | 2 | 6-phosphofructo-2-kinase activity |
| GO:0004331 | 6e-04 | 144.7956 | 0.0413 | 2 | 3 | fructose-2,6-bisphosphate 2-phosphatase activity |
| GO:0004674 | 9e-04 | 2.8434 | 5.3022 | 14 | 385 | protein serine/threonine kinase activity |
| GO:0042392 | 0.0018 | 48.2578 | 0.0689 | 2 | 5 | sphingosine-1-phosphate phosphatase activity |
| GO:0019203 | 0.0027 | 36.1906 | 0.0826 | 2 | 6 | carbohydrate phosphatase activity |
| GO:0000976 | 0.0045 | 2.1608 | 8.4008 | 17 | 610 | transcription regulatory region sequence-specific DNA binding |
| GO:0046914 | 0.005 | 1.9754 | 11.4031 | 21 | 828 | transition metal ion binding |
| GO:0000981 | 0.005 | 2.0903 | 9.1996 | 18 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0008349 | 0.0064 | 20.6756 | 0.1239 | 2 | 9 | MAP kinase kinase kinase kinase activity |
| GO:0051864 | 0.0064 | 20.6756 | 0.1239 | 2 | 9 | histone demethylase activity (H3-K36 specific) |
| GO:0043565 | 0.0069 | 1.8845 | 12.5048 | 22 | 908 | sequence-specific DNA binding |
| GO:0000975 | 0.0071 | 1.9725 | 10.2738 | 19 | 746 | regulatory region DNA binding |
| GO:0046983 | 0.0074 | 1.8213 | 14.1437 | 24 | 1027 | protein dimerization activity |
| GO:0042577 | 0.0079 | 18.0898 | 0.1377 | 2 | 10 | lipid phosphatase activity |
| GO:0016773 | 0.009 | 2.0012 | 9.0205 | 17 | 655 | phosphotransferase activity, alcohol group as acceptor |
| GO:0004871 | 0.0091 | 1.8084 | 13.6066 | 23 | 988 | signal transducer activity |
| GO:0008195 | 0.0096 | 16.0786 | 0.1515 | 2 | 11 | phosphatidate phosphatase activity |
| GO:0003690 | 0.0097 | 1.945 | 9.8331 | 18 | 714 | double-stranded DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016175 | 0 | 127.9515 | 0.0479 | 3 | 6 | superoxide-generating NADPH oxidase activity |
| GO:0016176 | 0 | 63.9612 | 0.0718 | 3 | 9 | superoxide-generating NADPH oxidase activator activity |
| GO:0036459 | 0.0012 | 6.8197 | 0.7977 | 5 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0005179 | 0.0032 | 7.1405 | 0.6063 | 4 | 76 | hormone activity |
| GO:0030983 | 0.0033 | 28.1474 | 0.0877 | 2 | 11 | mismatched DNA binding |
| GO:0016651 | 0.004 | 6.6743 | 0.6461 | 4 | 81 | oxidoreductase activity, acting on NAD(P)H |
| GO:0008233 | 0.0047 | 2.8425 | 3.7971 | 10 | 476 | peptidase activity |
| GO:0098772 | 0.0052 | 2.0467 | 10.8888 | 20 | 1365 | molecular function regulator |
| GO:0030414 | 0.0067 | 5.7046 | 0.7498 | 4 | 94 | peptidase inhibitor activity |
| GO:0033764 | 0.007 | 18.0879 | 0.1276 | 2 | 16 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0016614 | 0.0073 | 5.5739 | 0.7665 | 4 | 97 | oxidoreductase activity, acting on CH-OH group of donors |
| GO:0072341 | 0.0074 | 8.1398 | 0.3989 | 3 | 50 | modified amino acid binding |
| GO:0004769 | 0.008 | Inf | 0.008 | 1 | 1 | steroid delta-isomerase activity |
| GO:0005148 | 0.008 | Inf | 0.008 | 1 | 1 | prolactin receptor binding |
| GO:0005174 | 0.008 | Inf | 0.008 | 1 | 1 | CD40 receptor binding |
| GO:0008389 | 0.008 | Inf | 0.008 | 1 | 1 | coumarin 7-hydroxylase activity |
| GO:0018455 | 0.008 | Inf | 0.008 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0031695 | 0.008 | Inf | 0.008 | 1 | 1 | alpha-2B adrenergic receptor binding |
| GO:0031721 | 0.008 | Inf | 0.008 | 1 | 1 | hemoglobin alpha binding |
| GO:0033560 | 0.008 | Inf | 0.008 | 1 | 1 | folate reductase activity |
| GO:0043739 | 0.008 | Inf | 0.008 | 1 | 1 | G/U mismatch-specific uracil-DNA glycosylase activity |
| GO:0050051 | 0.008 | Inf | 0.008 | 1 | 1 | leukotriene-B4 20-monooxygenase activity |
| GO:0052871 | 0.008 | Inf | 0.008 | 1 | 1 | alpha-tocopherol omega-hydroxylase activity |
| GO:0097258 | 0.008 | Inf | 0.008 | 1 | 1 | 20-hydroxy-leukotriene B4 omega oxidase activity |
| GO:0097259 | 0.008 | Inf | 0.008 | 1 | 1 | 20-aldehyde-leukotriene B4 20-monooxygenase activity |
| GO:0102294 | 0.008 | Inf | 0.008 | 1 | 1 | cholesterol dehydrogenase activity |
| GO:0008234 | 0.0084 | 4.2437 | 1.2524 | 5 | 157 | cysteine-type peptidase activity |
| GO:0019825 | 0.0099 | 14.8925 | 0.1516 | 2 | 19 | oxygen binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004095 | 9e-04 | 79.5091 | 0.0503 | 2 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0001013 | 0.0032 | 31.7964 | 0.088 | 2 | 7 | RNA polymerase I regulatory region DNA binding |
| GO:0001164 | 0.0032 | 31.7964 | 0.088 | 2 | 7 | RNA polymerase I CORE element sequence-specific DNA binding |
| GO:0004303 | 0.0053 | 22.7082 | 0.1131 | 2 | 9 | estradiol 17-beta-dehydrogenase activity |
| GO:0050661 | 0.0095 | 7.4823 | 0.4399 | 3 | 35 | NADP binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098631 | 2e-04 | 10.823 | 0.5491 | 5 | 32 | cell adhesion mediator activity |
| GO:0004165 | 9e-04 | 115.5664 | 0.0515 | 2 | 3 | dodecenoyl-CoA delta-isomerase activity |
| GO:0016248 | 0.0018 | 8.6197 | 0.5319 | 4 | 31 | channel inhibitor activity |
| GO:0098641 | 0.0019 | 14.4978 | 0.2574 | 3 | 15 | cadherin binding involved in cell-cell adhesion |
| GO:0005484 | 0.0036 | 7.0492 | 0.6349 | 4 | 37 | SNAP receptor activity |
| GO:0016835 | 0.0054 | 4.778 | 1.1325 | 5 | 66 | carbon-oxygen lyase activity |
| GO:0019869 | 0.0058 | 23.1062 | 0.1201 | 2 | 7 | chloride channel inhibitor activity |
| GO:0004300 | 0.0077 | 19.2537 | 0.1373 | 2 | 8 | enoyl-CoA hydratase activity |
| GO:0035250 | 0.0087 | 7.9018 | 0.429 | 3 | 25 | UDP-galactosyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043024 | 0.0017 | 15.63 | 0.2475 | 3 | 13 | ribosomal small subunit binding |
| GO:0016289 | 0.0053 | 9.7643 | 0.3618 | 3 | 19 | CoA hydrolase activity |
| GO:0003779 | 0.0071 | 2.2994 | 5.9594 | 13 | 313 | actin binding |
| GO:0070990 | 0.0071 | 20.7649 | 0.1333 | 2 | 7 | snRNP binding |
| GO:0019205 | 0.0088 | 5.3531 | 0.8187 | 4 | 43 | nucleobase-containing compound kinase activity |
| GO:0045505 | 0.0091 | 7.809 | 0.4379 | 3 | 23 | dynein intermediate chain binding |
| GO:0102991 | 0.0094 | 17.3028 | 0.1523 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 1e-04 | 3.4602 | 5.1035 | 16 | 411 | protein heterodimerization activity |
| GO:0004984 | 5e-04 | 8.338 | 0.6705 | 5 | 54 | olfactory receptor activity |
| GO:0016409 | 8e-04 | 10.8431 | 0.4222 | 4 | 34 | palmitoyltransferase activity |
| GO:0005249 | 0.0025 | 5.7447 | 0.9437 | 5 | 76 | voltage-gated potassium channel activity |
| GO:0005216 | 0.0026 | 2.8949 | 4.0604 | 11 | 327 | ion channel activity |
| GO:0004930 | 0.0032 | 2.8127 | 4.1722 | 11 | 336 | G-protein coupled receptor activity |
| GO:0015267 | 0.0048 | 2.6534 | 4.4081 | 11 | 355 | channel activity |
| GO:0015079 | 0.0056 | 3.9559 | 1.6142 | 6 | 130 | potassium ion transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070402 | 6e-04 | 23.3316 | 0.1716 | 3 | 12 | NADPH binding |
| GO:0004126 | 6e-04 | 139.3298 | 0.0429 | 2 | 3 | cytidine deaminase activity |
| GO:0008190 | 0.0041 | 27.8574 | 0.1001 | 2 | 7 | eukaryotic initiation factor 4E binding |
| GO:0005198 | 0.0044 | 2.2242 | 7.6641 | 16 | 536 | structural molecule activity |
| GO:0050664 | 0.0069 | 19.8951 | 0.1287 | 2 | 9 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor |
| GO:0019843 | 0.0073 | 5.612 | 0.7721 | 4 | 54 | rRNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003826 | 4e-04 | Inf | 0.0393 | 2 | 2 | alpha-ketoacid dehydrogenase activity |
| GO:0003863 | 4e-04 | Inf | 0.0393 | 2 | 2 | 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity |
| GO:0008649 | 0.0058 | 9.4557 | 0.3732 | 3 | 19 | rRNA methyltransferase activity |
| GO:0005225 | 0.0076 | 20.1112 | 0.1375 | 2 | 7 | volume-sensitive anion channel activity |
| GO:0043295 | 0.0076 | 20.1112 | 0.1375 | 2 | 7 | glutathione binding |
| GO:0097157 | 0.0076 | 20.1112 | 0.1375 | 2 | 7 | pre-mRNA intronic binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1901612 | 0.0042 | 27.4136 | 0.1017 | 2 | 7 | cardiolipin binding |
| GO:0004725 | 0.0065 | 4.5559 | 1.1765 | 5 | 81 | protein tyrosine phosphatase activity |
| GO:0043394 | 0.0068 | 8.5993 | 0.3922 | 3 | 27 | proteoglycan binding |
| GO:0004185 | 0.0071 | 19.5782 | 0.1307 | 2 | 9 | serine-type carboxypeptidase activity |
| GO:0031005 | 0.0071 | 19.5782 | 0.1307 | 2 | 9 | filamin binding |
| GO:0004089 | 0.0087 | 17.1296 | 0.1452 | 2 | 10 | carbonate dehydratase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001047 | 0.001 | 3.5095 | 3.0765 | 10 | 140 | core promoter binding |
| GO:0005315 | 0.0028 | 44.8069 | 0.0879 | 2 | 4 | inorganic phosphate transmembrane transporter activity |
| GO:0070290 | 0.0028 | 44.8069 | 0.0879 | 2 | 4 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO:0060090 | 0.0041 | 3.0757 | 3.1204 | 9 | 142 | molecular adaptor activity |
| GO:0004887 | 0.0068 | 22.4 | 0.1318 | 2 | 6 | thyroid hormone receptor activity |
| GO:0042802 | 0.0088 | 1.5431 | 28.9627 | 42 | 1318 | identical protein binding |
| GO:0005070 | 0.0094 | 5.2949 | 0.835 | 4 | 38 | SH3/SH2 adaptor activity |
| GO:0089720 | 0.0094 | 17.9186 | 0.1538 | 2 | 7 | caspase binding |
| GO:0097157 | 0.0094 | 17.9186 | 0.1538 | 2 | 7 | pre-mRNA intronic binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017137 | 0 | 9.7496 | 1.3207 | 11 | 161 | Rab GTPase binding |
| GO:0005096 | 0 | 6.062 | 1.8539 | 10 | 226 | GTPase activator activity |
| GO:0060589 | 1e-04 | 4.7222 | 2.346 | 10 | 286 | nucleoside-triphosphatase regulator activity |
| GO:0031267 | 4e-04 | 3.5156 | 3.7733 | 12 | 460 | small GTPase binding |
| GO:0043546 | 7e-04 | 82.0935 | 0.041 | 2 | 5 | molybdopterin cofactor binding |
| GO:0036459 | 0.0014 | 6.6215 | 0.8203 | 5 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0016903 | 0.0027 | 12.0037 | 0.2789 | 3 | 34 | oxidoreductase activity, acting on the aldehyde or oxo group of donors |
| GO:0008233 | 0.0057 | 2.7557 | 3.9046 | 10 | 476 | peptidase activity |
| GO:0035586 | 0.0065 | 18.9303 | 0.123 | 2 | 15 | purinergic receptor activity |
| GO:0004031 | 0.0082 | Inf | 0.0082 | 1 | 1 | aldehyde oxidase activity |
| GO:0004037 | 0.0082 | Inf | 0.0082 | 1 | 1 | allantoicase activity |
| GO:0004769 | 0.0082 | Inf | 0.0082 | 1 | 1 | steroid delta-isomerase activity |
| GO:0004991 | 0.0082 | Inf | 0.0082 | 1 | 1 | parathyroid hormone receptor activity |
| GO:0008482 | 0.0082 | Inf | 0.0082 | 1 | 1 | sulfite oxidase activity |
| GO:0008891 | 0.0082 | Inf | 0.0082 | 1 | 1 | glycolate oxidase activity |
| GO:0016151 | 0.0082 | Inf | 0.0082 | 1 | 1 | nickel cation binding |
| GO:0031716 | 0.0082 | Inf | 0.0082 | 1 | 1 | calcitonin receptor binding |
| GO:0031732 | 0.0082 | Inf | 0.0082 | 1 | 1 | CCR7 chemokine receptor binding |
| GO:0033885 | 0.0082 | Inf | 0.0082 | 1 | 1 | 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity |
| GO:0047969 | 0.0082 | Inf | 0.0082 | 1 | 1 | glyoxylate oxidase activity |
| GO:0050897 | 0.0082 | Inf | 0.0082 | 1 | 1 | cobalt ion binding |
| GO:0086076 | 0.0082 | Inf | 0.0082 | 1 | 1 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling |
| GO:0086078 | 0.0082 | Inf | 0.0082 | 1 | 1 | gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling |
| GO:0086079 | 0.0082 | Inf | 0.0082 | 1 | 1 | gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling |
| GO:0097383 | 0.0082 | Inf | 0.0082 | 1 | 1 | dIDP diphosphatase activity |
| GO:0102294 | 0.0082 | Inf | 0.0082 | 1 | 1 | cholesterol dehydrogenase activity |
| GO:0102797 | 0.0082 | Inf | 0.0082 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0082 | Inf | 0.0082 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:1901640 | 0.0082 | Inf | 0.0082 | 1 | 1 | XTP binding |
| GO:1901641 | 0.0082 | Inf | 0.0082 | 1 | 1 | ITP binding |
| GO:1990003 | 0.0082 | Inf | 0.0082 | 1 | 1 | IDP phosphatase activity |
| GO:0001530 | 0.0084 | 16.4037 | 0.1394 | 2 | 17 | lipopolysaccharide binding |
| GO:0031683 | 0.0084 | 16.4037 | 0.1394 | 2 | 17 | G-protein beta/gamma-subunit complex binding |
| GO:0008234 | 0.0094 | 4.1204 | 1.2879 | 5 | 157 | cysteine-type peptidase activity |
| GO:0004984 | 0.0098 | 7.2852 | 0.443 | 3 | 54 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 3.1184 | 8.877 | 25 | 411 | protein heterodimerization activity |
| GO:0030545 | 0.001 | 2.6062 | 6.5659 | 16 | 304 | receptor regulator activity |
| GO:0004435 | 0.0054 | 9.799 | 0.3672 | 3 | 17 | phosphatidylinositol phospholipase C activity |
| GO:0005179 | 0.0059 | 3.9444 | 1.6415 | 6 | 76 | hormone activity |
| GO:0020037 | 0.0081 | 3.68 | 1.7495 | 6 | 81 | heme binding |
| GO:0031406 | 0.0086 | 2.93 | 2.8942 | 8 | 134 | carboxylic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005520 | 2e-04 | 10.894 | 0.5608 | 5 | 27 | insulin-like growth factor binding |
| GO:0047844 | 4e-04 | Inf | 0.0415 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0004126 | 0.0013 | 94.9708 | 0.0623 | 2 | 3 | cytidine deaminase activity |
| GO:0031406 | 0.0019 | 3.4751 | 2.7833 | 9 | 134 | carboxylic acid binding |
| GO:0008028 | 0.0022 | 8.305 | 0.5608 | 4 | 27 | monocarboxylic acid transmembrane transporter activity |
| GO:0004867 | 0.0025 | 5.837 | 0.9554 | 5 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0047617 | 0.0049 | 10.2025 | 0.3531 | 3 | 17 | acyl-CoA hydrolase activity |
| GO:0097677 | 0.0061 | 23.7372 | 0.1246 | 2 | 6 | STAT family protein binding |
| GO:0045503 | 0.0078 | 8.4001 | 0.4154 | 3 | 20 | dynein light chain binding |
| GO:1901612 | 0.0084 | 18.9883 | 0.1454 | 2 | 7 | cardiolipin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030023 | 7e-04 | 91.25 | 0.0439 | 2 | 4 | extracellular matrix constituent conferring elasticity |
| GO:0070492 | 0.0032 | 30.4074 | 0.0879 | 2 | 8 | oligosaccharide binding |
| GO:0004861 | 0.0062 | 20.267 | 0.1209 | 2 | 11 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0004872 | 0.0069 | 2.031 | 9.548 | 18 | 869 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042805 | 0.0044 | 10.08 | 0.335 | 3 | 28 | actinin binding |
| GO:0005092 | 0.006 | 20.8933 | 0.1197 | 2 | 10 | GDP-dissociation inhibitor activity |
| GO:0051371 | 0.0073 | 18.5704 | 0.1316 | 2 | 11 | muscle alpha-actinin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 1e-04 | 79.166 | 0.0941 | 3 | 5 | molybdopterin cofactor binding |
| GO:0031492 | 1e-04 | 9.1356 | 0.7714 | 6 | 41 | nucleosomal DNA binding |
| GO:0047844 | 4e-04 | Inf | 0.0376 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0004126 | 0.001 | 105.1371 | 0.0564 | 2 | 3 | cytidine deaminase activity |
| GO:0001733 | 0.0021 | 52.5645 | 0.0753 | 2 | 4 | galactosylceramide sulfotransferase activity |
| GO:0030151 | 0.0021 | 52.5645 | 0.0753 | 2 | 4 | molybdenum ion binding |
| GO:0001965 | 0.0025 | 13.1842 | 0.2822 | 3 | 15 | G-protein alpha-subunit binding |
| GO:0016684 | 0.0029 | 7.5552 | 0.602 | 4 | 32 | oxidoreductase activity, acting on peroxide as acceptor |
| GO:0008395 | 0.0037 | 11.299 | 0.3198 | 3 | 17 | steroid hydroxylase activity |
| GO:0046982 | 0.0049 | 2.1886 | 7.7325 | 16 | 411 | protein heterodimerization activity |
| GO:0046914 | 0.0061 | 1.7961 | 15.3833 | 26 | 824 | transition metal ion binding |
| GO:0102991 | 0.0092 | 17.5161 | 0.1505 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036461 | 2e-04 | Inf | 0.0292 | 2 | 2 | BLOC-2 complex binding |
| GO:0035651 | 6e-04 | 136.3854 | 0.0438 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0005198 | 9e-04 | 2.483 | 7.8254 | 18 | 536 | structural molecule activity |
| GO:0016520 | 0.0012 | 68.1875 | 0.0584 | 2 | 4 | growth hormone-releasing hormone receptor activity |
| GO:0035650 | 0.0012 | 68.1875 | 0.0584 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0050840 | 0.0027 | 7.6363 | 0.584 | 4 | 40 | extracellular matrix binding |
| GO:0005539 | 0.0045 | 3.6479 | 2.0439 | 7 | 140 | glycosaminoglycan binding |
| GO:0048019 | 0.0056 | 22.7222 | 0.1168 | 2 | 8 | receptor antagonist activity |
| GO:0005546 | 0.0064 | 5.8441 | 0.7446 | 4 | 51 | phosphatidylinositol-4,5-bisphosphate binding |
| GO:0005509 | 0.0082 | 2.124 | 7.475 | 15 | 512 | calcium ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036461 | 2e-04 | Inf | 0.03 | 2 | 2 | BLOC-2 complex binding |
| GO:0008823 | 7e-04 | 132.8731 | 0.0449 | 2 | 3 | cupric reductase activity |
| GO:0035651 | 7e-04 | 132.8731 | 0.0449 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0052851 | 7e-04 | 132.8731 | 0.0449 | 2 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0002020 | 9e-04 | 4.8832 | 1.5575 | 7 | 104 | protease binding |
| GO:0030023 | 0.0013 | 66.4315 | 0.0599 | 2 | 4 | extracellular matrix constituent conferring elasticity |
| GO:0035650 | 0.0013 | 66.4315 | 0.0599 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0030742 | 0.0041 | 10.529 | 0.3295 | 3 | 22 | GTP-dependent protein binding |
| GO:0005509 | 0.0044 | 2.2198 | 7.6677 | 16 | 512 | calcium ion binding |
| GO:0043225 | 0.0075 | 18.9732 | 0.1348 | 2 | 9 | ATPase-coupled anion transmembrane transporter activity |
| GO:0044548 | 0.0075 | 18.9732 | 0.1348 | 2 | 9 | S100 protein binding |
| GO:0005178 | 0.0085 | 4.2444 | 1.258 | 5 | 84 | integrin binding |
| GO:0016918 | 0.0093 | 16.6003 | 0.1498 | 2 | 10 | retinal binding |
| GO:0001786 | 0.01 | 7.4048 | 0.4493 | 3 | 30 | phosphatidylserine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030414 | 4e-04 | 8.8744 | 0.6225 | 5 | 94 | peptidase inhibitor activity |
| GO:0061135 | 4e-04 | 8.678 | 0.6358 | 5 | 96 | endopeptidase regulator activity |
| GO:0042805 | 8e-04 | 18.6 | 0.1854 | 3 | 28 | actinin binding |
| GO:0051371 | 0.0023 | 34.0853 | 0.0728 | 2 | 11 | muscle alpha-actinin binding |
| GO:0031432 | 0.0027 | 30.6744 | 0.0795 | 2 | 12 | titin binding |
| GO:0097493 | 0.0032 | 27.8837 | 0.0861 | 2 | 13 | structural molecule activity conferring elasticity |
| GO:0004867 | 0.0035 | 10.7992 | 0.3046 | 3 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0016805 | 0.0043 | 23.5903 | 0.0993 | 2 | 15 | dipeptidase activity |
| GO:0019842 | 0.0053 | 6.1148 | 0.702 | 4 | 106 | vitamin binding |
| GO:0051183 | 0.0055 | 20.4419 | 0.1126 | 2 | 17 | vitamin transporter activity |
| GO:0003858 | 0.0066 | Inf | 0.0066 | 1 | 1 | 3-hydroxybutyrate dehydrogenase activity |
| GO:0004504 | 0.0066 | Inf | 0.0066 | 1 | 1 | peptidylglycine monooxygenase activity |
| GO:0004598 | 0.0066 | Inf | 0.0066 | 1 | 1 | peptidylamidoglycolate lyase activity |
| GO:0008389 | 0.0066 | Inf | 0.0066 | 1 | 1 | coumarin 7-hydroxylase activity |
| GO:0031835 | 0.0066 | Inf | 0.0066 | 1 | 1 | substance P receptor binding |
| GO:0043739 | 0.0066 | Inf | 0.0066 | 1 | 1 | G/U mismatch-specific uracil-DNA glycosylase activity |
| GO:0061714 | 0.0066 | Inf | 0.0066 | 1 | 1 | folic acid receptor activity |
| GO:0030246 | 0.0068 | 4.4836 | 1.1921 | 5 | 180 | carbohydrate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016175 | 0 | 74.0395 | 0.0813 | 3 | 6 | superoxide-generating NADPH oxidase activity |
| GO:0016651 | 8e-04 | 5.9922 | 1.0972 | 6 | 81 | oxidoreductase activity, acting on NAD(P)H |
| GO:1990837 | 0.0029 | 2.2081 | 8.7508 | 18 | 646 | sequence-specific double-stranded DNA binding |
| GO:0004791 | 0.0048 | 24.5356 | 0.1084 | 2 | 8 | thioredoxin-disulfide reductase activity |
| GO:0016176 | 0.0062 | 21.0289 | 0.1219 | 2 | 9 | superoxide-generating NADPH oxidase activator activity |
| GO:0000977 | 0.0065 | 2.1876 | 7.2878 | 15 | 538 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0035591 | 0.0069 | 5.7063 | 0.7586 | 4 | 56 | signaling adaptor activity |
| GO:0019992 | 0.0076 | 18.3989 | 0.1355 | 2 | 10 | diacylglycerol binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0022 | 7.9406 | 0.5527 | 4 | 54 | olfactory receptor activity |
| GO:0016903 | 0.005 | 9.5472 | 0.348 | 3 | 34 | oxidoreductase activity, acting on the aldehyde or oxo group of donors |
| GO:0017110 | 0.0064 | 19.6149 | 0.1228 | 2 | 12 | nucleoside-diphosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008233 | 0.0013 | 2.7429 | 5.5166 | 14 | 476 | peptidase activity |
| GO:0008201 | 0.0015 | 5.2313 | 1.2401 | 6 | 107 | heparin binding |
| GO:0016410 | 0.0019 | 6.174 | 0.8808 | 5 | 76 | N-acyltransferase activity |
| GO:0016407 | 0.0022 | 5.9224 | 0.9156 | 5 | 79 | acetyltransferase activity |
| GO:0034212 | 0.003 | 7.27 | 0.6026 | 4 | 52 | peptide N-acetyltransferase activity |
| GO:0036459 | 0.0061 | 4.6058 | 1.1589 | 5 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008081 | 0.008 | 5.4458 | 0.7881 | 4 | 68 | phosphoric diester hydrolase activity |
| GO:0008234 | 0.0099 | 3.4857 | 1.8195 | 6 | 157 | cysteine-type peptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004435 | 0.0012 | 17.0208 | 0.2149 | 3 | 17 | phosphatidylinositol phospholipase C activity |
| GO:0005089 | 0.0015 | 6.5669 | 0.8344 | 5 | 66 | Rho guanyl-nucleotide exchange factor activity |
| GO:0043169 | 0.0026 | 1.6118 | 43.2769 | 60 | 3423 | cation binding |
| GO:1901612 | 0.0032 | 31.6024 | 0.0885 | 2 | 7 | cardiolipin binding |
| GO:0004185 | 0.0054 | 22.5697 | 0.1138 | 2 | 9 | serine-type carboxypeptidase activity |
| GO:0048407 | 0.0054 | 22.5697 | 0.1138 | 2 | 9 | platelet-derived growth factor binding |
| GO:0097001 | 0.0054 | 22.5697 | 0.1138 | 2 | 9 | ceramide binding |
| GO:0043168 | 0.006 | 1.63 | 27.941 | 41 | 2210 | anion binding |
| GO:0008237 | 0.0073 | 3.7298 | 1.7068 | 6 | 135 | metallopeptidase activity |
| GO:0036094 | 0.0086 | 1.6218 | 25.071 | 37 | 1983 | small molecule binding |
| GO:0001047 | 0.0087 | 3.5893 | 1.77 | 6 | 140 | core promoter binding |
| GO:0004672 | 0.0093 | 2.1553 | 6.8904 | 14 | 545 | protein kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019785 | 2e-04 | Inf | 0.0263 | 2 | 2 | ISG15-specific protease activity |
| GO:0004126 | 5e-04 | 151.5838 | 0.0395 | 2 | 3 | cytidine deaminase activity |
| GO:0030151 | 0.001 | 75.7861 | 0.0527 | 2 | 4 | molybdenum ion binding |
| GO:0005184 | 0.0016 | 15.2302 | 0.2371 | 3 | 18 | neuropeptide hormone activity |
| GO:0043546 | 0.0017 | 50.5202 | 0.0658 | 2 | 5 | molybdopterin cofactor binding |
| GO:0015077 | 0.0034 | 2.9497 | 3.6085 | 10 | 274 | monovalent inorganic cation transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | Inf | 0.0339 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0339 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0016798 | 1e-04 | 7.1771 | 1.0837 | 7 | 96 | hydrolase activity, acting on glycosyl bonds |
| GO:0005125 | 5e-04 | 5.5434 | 1.3772 | 7 | 122 | cytokine activity |
| GO:0070006 | 7e-04 | 20.6044 | 0.1806 | 3 | 16 | metalloaminopeptidase activity |
| GO:0005164 | 0.0014 | 15.7515 | 0.2258 | 3 | 20 | tumor necrosis factor receptor binding |
| GO:0008083 | 0.0022 | 4.846 | 1.332 | 6 | 118 | growth factor activity |
| GO:0030545 | 0.0053 | 2.9493 | 3.2443 | 9 | 291 | receptor regulator activity |
| GO:0030546 | 0.0091 | 16.1265 | 0.1467 | 2 | 13 | receptor activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | Inf | 0.0275 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0275 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0046872 | 0.0051 | 1.677 | 30.8305 | 44 | 3358 | metal ion binding |
| GO:0001077 | 0.0059 | 3.4541 | 2.1576 | 7 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0008270 | 0.0067 | 2.342 | 5.977 | 13 | 651 | zinc ion binding |
| GO:0016755 | 0.0071 | 18.2694 | 0.1285 | 2 | 14 | transferase activity, transferring amino-acyl groups |
| GO:0046965 | 0.0071 | 18.2694 | 0.1285 | 2 | 14 | retinoid X receptor binding |
| GO:0003707 | 0.0081 | 7.8776 | 0.4132 | 3 | 45 | steroid hormone receptor activity |
| GO:0000978 | 0.0085 | 2.9394 | 2.8921 | 8 | 315 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0005142 | 0.0092 | Inf | 0.0092 | 1 | 1 | interleukin-11 receptor binding |
| GO:0005334 | 0.0092 | Inf | 0.0092 | 1 | 1 | norepinephrine:sodium symporter activity |
| GO:0030977 | 0.0092 | Inf | 0.0092 | 1 | 1 | taurine binding |
| GO:0031249 | 0.0092 | Inf | 0.0092 | 1 | 1 | denatured protein binding |
| GO:0031687 | 0.0092 | Inf | 0.0092 | 1 | 1 | A2A adenosine receptor binding |
| GO:0031894 | 0.0092 | Inf | 0.0092 | 1 | 1 | V1A vasopressin receptor binding |
| GO:1990190 | 0.0092 | Inf | 0.0092 | 1 | 1 | peptide-glutamate-N-acetyltransferase activity |
| GO:0030276 | 0.0097 | 7.3507 | 0.4407 | 3 | 48 | clathrin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047844 | 2e-04 | Inf | 0.0281 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0050840 | 2e-04 | 10.2559 | 0.5629 | 5 | 40 | extracellular matrix binding |
| GO:0004126 | 6e-04 | 141.6216 | 0.0422 | 2 | 3 | cytidine deaminase activity |
| GO:0043177 | 6e-04 | 4.5657 | 1.8998 | 8 | 135 | organic acid binding |
| GO:0016408 | 0.0011 | 17.784 | 0.2111 | 3 | 15 | C-acyltransferase activity |
| GO:0030151 | 0.0012 | 70.8054 | 0.0563 | 2 | 4 | molybdenum ion binding |
| GO:0032190 | 0.0012 | 70.8054 | 0.0563 | 2 | 4 | acrosin binding |
| GO:0043546 | 0.0019 | 47.2 | 0.0704 | 2 | 5 | molybdopterin cofactor binding |
| GO:0043565 | 0.0021 | 2.0349 | 12.7781 | 24 | 908 | sequence-specific DNA binding |
| GO:0016597 | 0.0031 | 7.3207 | 0.6051 | 4 | 43 | amino acid binding |
| GO:0004143 | 0.0066 | 20.2224 | 0.1267 | 2 | 9 | diacylglycerol kinase activity |
| GO:0001786 | 0.0084 | 7.8949 | 0.4222 | 3 | 30 | phosphatidylserine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0.0031 | 2.5637 | 5.4128 | 13 | 411 | protein heterodimerization activity |
| GO:0001106 | 0.0037 | 10.8738 | 0.3161 | 3 | 24 | RNA polymerase II transcription corepressor activity |
| GO:0008144 | 0.0041 | 5.1129 | 1.0536 | 5 | 80 | drug binding |
| GO:0072341 | 0.0042 | 6.6448 | 0.6585 | 4 | 50 | modified amino acid binding |
| GO:0016863 | 0.0058 | 21.6449 | 0.1185 | 2 | 9 | intramolecular oxidoreductase activity, transposing C=C bonds |
| GO:0031072 | 0.0064 | 4.562 | 1.1721 | 5 | 89 | heat shock protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008569 | 0.0072 | 18.1171 | 0.1296 | 2 | 14 | ATP-dependent microtubule motor activity, minus-end-directed |
| GO:0001785 | 0.0093 | Inf | 0.0093 | 1 | 1 | prostaglandin J receptor activity |
| GO:0004031 | 0.0093 | Inf | 0.0093 | 1 | 1 | aldehyde oxidase activity |
| GO:0004326 | 0.0093 | Inf | 0.0093 | 1 | 1 | tetrahydrofolylpolyglutamate synthase activity |
| GO:0004730 | 0.0093 | Inf | 0.0093 | 1 | 1 | pseudouridylate synthase activity |
| GO:0004956 | 0.0093 | Inf | 0.0093 | 1 | 1 | prostaglandin D receptor activity |
| GO:0017064 | 0.0093 | Inf | 0.0093 | 1 | 1 | fatty acid amide hydrolase activity |
| GO:0030109 | 0.0093 | Inf | 0.0093 | 1 | 1 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0031751 | 0.0093 | Inf | 0.0093 | 1 | 1 | D4 dopamine receptor binding |
| GO:0045523 | 0.0093 | Inf | 0.0093 | 1 | 1 | interleukin-27 receptor binding |
| GO:0052597 | 0.0093 | Inf | 0.0093 | 1 | 1 | diamine oxidase activity |
| GO:0052598 | 0.0093 | Inf | 0.0093 | 1 | 1 | histamine oxidase activity |
| GO:0052599 | 0.0093 | Inf | 0.0093 | 1 | 1 | methylputrescine oxidase activity |
| GO:0052600 | 0.0093 | Inf | 0.0093 | 1 | 1 | propane-1,3-diamine oxidase activity |
| GO:0102077 | 0.0093 | Inf | 0.0093 | 1 | 1 | oleamide hydrolase activity |
| GO:0102797 | 0.0093 | Inf | 0.0093 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0093 | Inf | 0.0093 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0103073 | 0.0093 | Inf | 0.0093 | 1 | 1 | anandamide amidohydrolase activity |
| GO:1990244 | 0.0093 | Inf | 0.0093 | 1 | 1 | histone kinase activity (H2A-T120 specific) |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048306 | 0.0025 | 7.7027 | 0.573 | 4 | 47 | calcium-dependent protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016623 | 3e-04 | Inf | 0.0328 | 2 | 2 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor |
| GO:0043546 | 0.0026 | 40.3302 | 0.082 | 2 | 5 | molybdopterin cofactor binding |
| GO:0048407 | 0.0089 | 17.2791 | 0.1477 | 2 | 9 | platelet-derived growth factor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005518 | 0.0054 | 9.1688 | 0.3566 | 3 | 46 | collagen binding |
| GO:0005201 | 0.0068 | 8.386 | 0.3876 | 3 | 50 | extracellular matrix structural constituent |
| GO:0001512 | 0.0078 | Inf | 0.0078 | 1 | 1 | dihydronicotinamide riboside quinone reductase activity |
| GO:0003868 | 0.0078 | Inf | 0.0078 | 1 | 1 | 4-hydroxyphenylpyruvate dioxygenase activity |
| GO:0004816 | 0.0078 | Inf | 0.0078 | 1 | 1 | asparagine-tRNA ligase activity |
| GO:0008419 | 0.0078 | Inf | 0.0078 | 1 | 1 | RNA lariat debranching enzyme activity |
| GO:0015603 | 0.0078 | Inf | 0.0078 | 1 | 1 | iron chelate transmembrane transporter activity |
| GO:0031870 | 0.0078 | Inf | 0.0078 | 1 | 1 | thromboxane A2 receptor binding |
| GO:0031962 | 0.0078 | Inf | 0.0078 | 1 | 1 | mineralocorticoid receptor binding |
| GO:0033560 | 0.0078 | Inf | 0.0078 | 1 | 1 | folate reductase activity |
| GO:0042931 | 0.0078 | Inf | 0.0078 | 1 | 1 | enterobactin transmembrane transporter activity |
| GO:0044730 | 0.0078 | Inf | 0.0078 | 1 | 1 | bone sialoprotein binding |
| GO:0047750 | 0.0078 | Inf | 0.0078 | 1 | 1 | cholestenol delta-isomerase activity |
| GO:0047915 | 0.0078 | Inf | 0.0078 | 1 | 1 | ganglioside galactosyltransferase activity |
| GO:0050613 | 0.0078 | Inf | 0.0078 | 1 | 1 | delta14-sterol reductase activity |
| GO:0071885 | 0.0078 | Inf | 0.0078 | 1 | 1 | N-terminal protein N-methyltransferase activity |
| GO:0090409 | 0.0078 | Inf | 0.0078 | 1 | 1 | malonyl-CoA synthetase activity |
| GO:1904408 | 0.0078 | Inf | 0.0078 | 1 | 1 | melatonin binding |
| GO:1905594 | 0.0078 | Inf | 0.0078 | 1 | 1 | resveratrol binding |
| GO:0003684 | 0.0089 | 7.5767 | 0.4263 | 3 | 55 | damaged DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000293 | 2e-04 | 258.4902 | 0.0235 | 2 | 3 | ferric-chelate reductase activity |
| GO:0004857 | 0.0013 | 4.0941 | 2.121 | 8 | 271 | enzyme inhibitor activity |
| GO:0032947 | 0.0013 | 9.2119 | 0.4774 | 4 | 61 | protein complex scaffold activity |
| GO:0005092 | 0.0026 | 32.2941 | 0.0783 | 2 | 10 | GDP-dissociation inhibitor activity |
| GO:0016722 | 0.0038 | 25.8314 | 0.0939 | 2 | 12 | oxidoreductase activity, oxidizing metal ions |
| GO:0098772 | 0.0042 | 2.0958 | 10.6833 | 20 | 1365 | molecular function regulator |
| GO:0004860 | 0.0044 | 6.4706 | 0.6653 | 4 | 85 | protein kinase inhibitor activity |
| GO:0048018 | 0.0068 | 3.375 | 2.2149 | 7 | 283 | receptor ligand activity |
| GO:0004364 | 0.0068 | 18.4454 | 0.1252 | 2 | 16 | glutathione transferase activity |
| GO:0004363 | 0.0078 | Inf | 0.0078 | 1 | 1 | glutathione synthase activity |
| GO:0004411 | 0.0078 | Inf | 0.0078 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
| GO:0004510 | 0.0078 | Inf | 0.0078 | 1 | 1 | tryptophan 5-monooxygenase activity |
| GO:0008579 | 0.0078 | Inf | 0.0078 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0019782 | 0.0078 | Inf | 0.0078 | 1 | 1 | ISG15 activating enzyme activity |
| GO:0030613 | 0.0078 | Inf | 0.0078 | 1 | 1 | oxidoreductase activity, acting on phosphorus or arsenic in donors |
| GO:0033682 | 0.0078 | Inf | 0.0078 | 1 | 1 | ATP-dependent 5'-3' DNA/RNA helicase activity |
| GO:0045174 | 0.0078 | Inf | 0.0078 | 1 | 1 | glutathione dehydrogenase (ascorbate) activity |
| GO:0050610 | 0.0078 | Inf | 0.0078 | 1 | 1 | methylarsonate reductase activity |
| GO:0051978 | 0.0078 | Inf | 0.0078 | 1 | 1 | lysophospholipid transporter activity |
| GO:0052597 | 0.0078 | Inf | 0.0078 | 1 | 1 | diamine oxidase activity |
| GO:0052598 | 0.0078 | Inf | 0.0078 | 1 | 1 | histamine oxidase activity |
| GO:0052599 | 0.0078 | Inf | 0.0078 | 1 | 1 | methylputrescine oxidase activity |
| GO:0052600 | 0.0078 | Inf | 0.0078 | 1 | 1 | propane-1,3-diamine oxidase activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 4.2912 | 4.1753 | 16 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0010469 | 0 | 2.6135 | 13.3775 | 32 | 487 | regulation of receptor activity |
| GO:0007267 | 0 | 1.8727 | 40.0777 | 68 | 1459 | cell-cell signaling |
| GO:0007275 | 0 | 1.5532 | 114.4355 | 152 | 4288 | multicellular organism development |
| GO:0001525 | 1e-04 | 2.425 | 11.5371 | 26 | 420 | angiogenesis |
| GO:0006952 | 1e-04 | 1.7701 | 36.8088 | 60 | 1340 | defense response |
| GO:0051716 | 1e-04 | 1.4433 | 172.1225 | 209 | 6266 | cellular response to stimulus |
| GO:0098609 | 2e-04 | 1.9785 | 20.602 | 38 | 750 | cell-cell adhesion |
| GO:0032502 | 2e-04 | 1.4644 | 125.9389 | 159 | 4738 | developmental process |
| GO:0007186 | 2e-04 | 1.9081 | 23.0467 | 41 | 839 | G-protein coupled receptor signaling pathway |
| GO:0043270 | 3e-04 | 2.935 | 5.8784 | 16 | 214 | positive regulation of ion transport |
| GO:0030154 | 4e-04 | 1.5756 | 58.2014 | 83 | 2235 | cell differentiation |
| GO:0019216 | 5e-04 | 2.4011 | 9.3396 | 21 | 340 | regulation of lipid metabolic process |
| GO:0001656 | 5e-04 | 4.32 | 2.3074 | 9 | 84 | metanephros development |
| GO:0023052 | 5e-04 | 1.6327 | 47.199 | 69 | 1932 | signaling |
| GO:0030335 | 6e-04 | 2.2645 | 10.8229 | 23 | 394 | positive regulation of cell migration |
| GO:0014874 | 6e-04 | 12.989 | 0.412 | 4 | 15 | response to stimulus involved in regulation of muscle adaptation |
| GO:0001707 | 7e-04 | 4.564 | 1.9503 | 8 | 71 | mesoderm formation |
| GO:0042221 | 7e-04 | 1.4266 | 101.2792 | 130 | 3687 | response to chemical |
| GO:0044060 | 7e-04 | 6.3242 | 1.0988 | 6 | 40 | regulation of endocrine process |
| GO:0002605 | 8e-04 | Inf | 0.0549 | 2 | 2 | negative regulation of dendritic cell antigen processing and presentation |
| GO:0048513 | 8e-04 | 1.4662 | 77.1454 | 103 | 2866 | animal organ development |
| GO:0003012 | 8e-04 | 2.2035 | 11.0976 | 23 | 404 | muscle system process |
| GO:0007154 | 8e-04 | 1.5937 | 48.8598 | 70 | 1993 | cell communication |
| GO:0010595 | 9e-04 | 4.423 | 2.0053 | 8 | 73 | positive regulation of endothelial cell migration |
| GO:0050880 | 9e-04 | 3.3626 | 3.5435 | 11 | 129 | regulation of blood vessel size |
| GO:0051216 | 9e-04 | 2.9744 | 4.6972 | 13 | 171 | cartilage development |
| GO:0048598 | 0.001 | 1.9838 | 15.5201 | 29 | 565 | embryonic morphogenesis |
| GO:0050801 | 0.001 | 1.8932 | 18.5143 | 33 | 674 | ion homeostasis |
| GO:0030856 | 0.001 | 3.3061 | 3.5985 | 11 | 131 | regulation of epithelial cell differentiation |
| GO:0090190 | 0.001 | 10.9892 | 0.467 | 4 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0070268 | 0.0011 | 3.8092 | 2.5821 | 9 | 94 | cornification |
| GO:0009967 | 0.0012 | 1.6083 | 37.9076 | 57 | 1380 | positive regulation of signal transduction |
| GO:0060986 | 0.0012 | 5.657 | 1.2086 | 6 | 44 | endocrine hormone secretion |
| GO:2000678 | 0.0013 | 10.2036 | 0.4944 | 4 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0072001 | 0.0013 | 2.4472 | 7.3892 | 17 | 269 | renal system development |
| GO:0014888 | 0.0014 | 5.5116 | 1.2361 | 6 | 45 | striated muscle adaptation |
| GO:0090303 | 0.0014 | 5.5116 | 1.2361 | 6 | 45 | positive regulation of wound healing |
| GO:0048608 | 0.0015 | 2.1369 | 10.9053 | 22 | 397 | reproductive structure development |
| GO:0051272 | 0.0015 | 2.0961 | 11.6195 | 23 | 423 | positive regulation of cellular component movement |
| GO:1901203 | 0.0015 | 17.8229 | 0.2472 | 3 | 9 | positive regulation of extracellular matrix assembly |
| GO:0007498 | 0.0015 | 3.334 | 3.2414 | 10 | 118 | mesoderm development |
| GO:0001568 | 0.0015 | 1.9169 | 16.0146 | 29 | 583 | blood vessel development |
| GO:0023019 | 0.0016 | 9.5227 | 0.5219 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0044321 | 0.0016 | 9.5227 | 0.5219 | 4 | 19 | response to leptin |
| GO:0072079 | 0.0016 | 9.5227 | 0.5219 | 4 | 19 | nephron tubule formation |
| GO:0072311 | 0.0016 | 9.5227 | 0.5219 | 4 | 19 | glomerular epithelial cell differentiation |
| GO:0022610 | 0.0017 | 1.6076 | 35.1332 | 53 | 1279 | biological adhesion |
| GO:0072358 | 0.0017 | 1.882 | 16.8661 | 30 | 614 | cardiovascular system development |
| GO:0060429 | 0.0017 | 1.6521 | 30.2437 | 47 | 1101 | epithelium development |
| GO:0031324 | 0.0019 | 1.4514 | 65.5142 | 88 | 2385 | negative regulation of cellular metabolic process |
| GO:1903053 | 0.0019 | 6.3866 | 0.9065 | 5 | 33 | regulation of extracellular matrix organization |
| GO:0035296 | 0.002 | 3.2141 | 3.3513 | 10 | 122 | regulation of tube diameter |
| GO:0032101 | 0.002 | 1.8591 | 17.0581 | 30 | 626 | regulation of response to external stimulus |
| GO:0030238 | 0.0021 | 15.2757 | 0.2747 | 3 | 10 | male sex determination |
| GO:0035878 | 0.0021 | 15.2757 | 0.2747 | 3 | 10 | nail development |
| GO:0002581 | 0.0022 | 71.1442 | 0.0824 | 2 | 3 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:1900673 | 0.0022 | 71.1442 | 0.0824 | 2 | 3 | olefin metabolic process |
| GO:1902164 | 0.0022 | 71.1442 | 0.0824 | 2 | 3 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:2000297 | 0.0022 | 71.1442 | 0.0824 | 2 | 3 | negative regulation of synapse maturation |
| GO:0051172 | 0.0022 | 1.4537 | 61.4762 | 83 | 2238 | negative regulation of nitrogen compound metabolic process |
| GO:0031960 | 0.0023 | 2.9357 | 4.0105 | 11 | 146 | response to corticosteroid |
| GO:0072009 | 0.0024 | 3.3702 | 2.8843 | 9 | 105 | nephron epithelium development |
| GO:0008285 | 0.0025 | 1.8298 | 17.3056 | 30 | 630 | negative regulation of cell proliferation |
| GO:0032355 | 0.0025 | 3.1024 | 3.4611 | 10 | 126 | response to estradiol |
| GO:0061005 | 0.0026 | 4.7748 | 1.4009 | 6 | 51 | cell differentiation involved in kidney development |
| GO:0040017 | 0.0026 | 1.9984 | 12.1414 | 23 | 442 | positive regulation of locomotion |
| GO:0071385 | 0.0032 | 4.571 | 1.4559 | 6 | 53 | cellular response to glucocorticoid stimulus |
| GO:0019932 | 0.0032 | 2.2883 | 7.3892 | 16 | 269 | second-messenger-mediated signaling |
| GO:0043062 | 0.0032 | 2.1675 | 8.7627 | 18 | 319 | extracellular structure organization |
| GO:0090184 | 0.0036 | 5.4171 | 1.0438 | 5 | 38 | positive regulation of kidney development |
| GO:0033993 | 0.0037 | 1.7418 | 19.3578 | 32 | 716 | response to lipid |
| GO:0014745 | 0.0038 | 11.8795 | 0.3296 | 3 | 12 | negative regulation of muscle adaptation |
| GO:0014889 | 0.0038 | 11.8795 | 0.3296 | 3 | 12 | muscle atrophy |
| GO:0032099 | 0.0038 | 11.8795 | 0.3296 | 3 | 12 | negative regulation of appetite |
| GO:0001657 | 0.0038 | 3.4181 | 2.5272 | 8 | 92 | ureteric bud development |
| GO:0023051 | 0.0038 | 1.3707 | 86.1986 | 109 | 3138 | regulation of signaling |
| GO:0071260 | 0.0038 | 3.8019 | 2.0053 | 7 | 73 | cellular response to mechanical stimulus |
| GO:0030511 | 0.0039 | 7.1396 | 0.6593 | 4 | 24 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032104 | 0.0039 | 7.1396 | 0.6593 | 4 | 24 | regulation of response to extracellular stimulus |
| GO:0061217 | 0.0039 | 7.1396 | 0.6593 | 4 | 24 | regulation of mesonephros development |
| GO:0072163 | 0.004 | 3.3777 | 2.5546 | 8 | 93 | mesonephric epithelium development |
| GO:0008544 | 0.0041 | 2.0686 | 9.6692 | 19 | 352 | epidermis development |
| GO:0043207 | 0.0041 | 1.7293 | 19.4757 | 32 | 709 | response to external biotic stimulus |
| GO:0097755 | 0.0042 | 4.2958 | 1.5383 | 6 | 56 | positive regulation of blood vessel diameter |
| GO:0033559 | 0.0043 | 3.3382 | 2.5821 | 8 | 94 | unsaturated fatty acid metabolic process |
| GO:0042161 | 0.0044 | 35.5697 | 0.1099 | 2 | 4 | lipoprotein oxidation |
| GO:0072107 | 0.0044 | 35.5697 | 0.1099 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:1902109 | 0.0044 | 35.5697 | 0.1099 | 2 | 4 | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:2000722 | 0.0044 | 35.5697 | 0.1099 | 2 | 4 | regulation of cardiac vascular smooth muscle cell differentiation |
| GO:0048870 | 0.0044 | 1.5232 | 36.8363 | 53 | 1341 | cell motility |
| GO:0055067 | 0.0046 | 2.8316 | 3.7633 | 10 | 137 | monovalent inorganic cation homeostasis |
| GO:0022008 | 0.0046 | 1.5082 | 38.6218 | 55 | 1406 | neurogenesis |
| GO:0010646 | 0.0047 | 1.3617 | 84.935 | 107 | 3092 | regulation of cell communication |
| GO:0034097 | 0.0047 | 1.6349 | 24.4751 | 38 | 891 | response to cytokine |
| GO:1903532 | 0.0047 | 2.0827 | 9.0923 | 18 | 331 | positive regulation of secretion by cell |
| GO:0001911 | 0.0048 | 10.6908 | 0.3571 | 3 | 13 | negative regulation of leukocyte mediated cytotoxicity |
| GO:0050908 | 0.0048 | 10.6908 | 0.3571 | 3 | 13 | detection of light stimulus involved in visual perception |
| GO:0070371 | 0.0049 | 2.2484 | 7.0321 | 15 | 256 | ERK1 and ERK2 cascade |
| GO:0045944 | 0.005 | 1.5806 | 28.6779 | 43 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001974 | 0.0051 | 4.9647 | 1.1262 | 5 | 41 | blood vessel remodeling |
| GO:0014898 | 0.0052 | 6.4897 | 0.7142 | 4 | 26 | cardiac muscle hypertrophy in response to stress |
| GO:0035411 | 0.0052 | 6.4897 | 0.7142 | 4 | 26 | catenin import into nucleus |
| GO:0060343 | 0.0052 | 6.4897 | 0.7142 | 4 | 26 | trabecula formation |
| GO:0050729 | 0.0052 | 3.225 | 2.6645 | 8 | 97 | positive regulation of inflammatory response |
| GO:0051093 | 0.0052 | 1.6581 | 22.1952 | 35 | 808 | negative regulation of developmental process |
| GO:0055065 | 0.0053 | 1.8268 | 14.3664 | 25 | 523 | metal ion homeostasis |
| GO:0014897 | 0.0056 | 3.533 | 2.1426 | 7 | 78 | striated muscle hypertrophy |
| GO:0007188 | 0.0056 | 2.7443 | 3.8732 | 10 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0042127 | 0.0058 | 1.6475 | 22.3698 | 35 | 841 | regulation of cell proliferation |
| GO:0044070 | 0.0059 | 3.1537 | 2.7195 | 8 | 99 | regulation of anion transport |
| GO:0002577 | 0.006 | 9.7183 | 0.3846 | 3 | 14 | regulation of antigen processing and presentation |
| GO:0021527 | 0.006 | 9.7183 | 0.3846 | 3 | 14 | spinal cord association neuron differentiation |
| GO:0032108 | 0.006 | 9.7183 | 0.3846 | 3 | 14 | negative regulation of response to nutrient levels |
| GO:0060547 | 0.006 | 9.7183 | 0.3846 | 3 | 14 | negative regulation of necrotic cell death |
| GO:0009166 | 0.0064 | 3.904 | 1.6756 | 6 | 61 | nucleotide catabolic process |
| GO:0009583 | 0.0064 | 3.904 | 1.6756 | 6 | 61 | detection of light stimulus |
| GO:0009617 | 0.0065 | 1.8699 | 12.3337 | 22 | 449 | response to bacterium |
| GO:0006690 | 0.0066 | 3.0854 | 2.7744 | 8 | 101 | icosanoid metabolic process |
| GO:0002683 | 0.0067 | 1.9659 | 10.1362 | 19 | 369 | negative regulation of immune system process |
| GO:0065008 | 0.0067 | 1.3366 | 89.6048 | 111 | 3262 | regulation of biological quality |
| GO:0030001 | 0.0067 | 1.6401 | 21.7557 | 34 | 792 | metal ion transport |
| GO:0016339 | 0.0068 | 5.9481 | 0.7691 | 4 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0032892 | 0.0068 | 5.9481 | 0.7691 | 4 | 28 | positive regulation of organic acid transport |
| GO:0002548 | 0.0069 | 4.5819 | 1.2086 | 5 | 44 | monocyte chemotaxis |
| GO:0007588 | 0.007 | 3.834 | 1.7031 | 6 | 62 | excretion |
| GO:1903508 | 0.0071 | 1.4878 | 36.8638 | 52 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0002933 | 0.0071 | 23.7115 | 0.1373 | 2 | 5 | lipid hydroxylation |
| GO:0030263 | 0.0071 | 23.7115 | 0.1373 | 2 | 5 | apoptotic chromosome condensation |
| GO:1903232 | 0.0071 | 23.7115 | 0.1373 | 2 | 5 | melanosome assembly |
| GO:0009952 | 0.0074 | 2.3738 | 5.329 | 12 | 194 | anterior/posterior pattern specification |
| GO:0051896 | 0.0074 | 2.3738 | 5.329 | 12 | 194 | regulation of protein kinase B signaling |
| GO:0014031 | 0.0075 | 3.7665 | 1.7306 | 6 | 63 | mesenchymal cell development |
| GO:0048864 | 0.0075 | 3.7665 | 1.7306 | 6 | 63 | stem cell development |
| GO:0032330 | 0.0076 | 4.467 | 1.2361 | 5 | 45 | regulation of chondrocyte differentiation |
| GO:0032501 | 0.008 | 1.5754 | 28.1291 | 41 | 1235 | multicellular organismal process |
| GO:1904888 | 0.0081 | 3.7013 | 1.758 | 6 | 64 | cranial skeletal system development |
| GO:0048729 | 0.0082 | 1.7175 | 16.4541 | 27 | 599 | tissue morphogenesis |
| GO:0050877 | 0.0083 | 1.5922 | 23.706 | 36 | 863 | nervous system process |
| GO:0008206 | 0.0083 | 4.3578 | 1.2636 | 5 | 46 | bile acid metabolic process |
| GO:0097696 | 0.0085 | 2.5664 | 4.1204 | 10 | 150 | STAT cascade |
| GO:0065007 | 0.0086 | 1.3462 | 186.5625 | 207 | 7265 | biological regulation |
| GO:0044057 | 0.0086 | 1.848 | 11.8901 | 21 | 438 | regulation of system process |
| GO:0002707 | 0.0087 | 5.4898 | 0.8241 | 4 | 30 | negative regulation of lymphocyte mediated immunity |
| GO:1901890 | 0.0087 | 5.4898 | 0.8241 | 4 | 30 | positive regulation of cell junction assembly |
| GO:0014068 | 0.0087 | 3.6383 | 1.7855 | 6 | 65 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0007389 | 0.0088 | 1.8764 | 11.1525 | 20 | 406 | pattern specification process |
| GO:0002076 | 0.0088 | 8.2221 | 0.4395 | 3 | 16 | osteoblast development |
| GO:0051046 | 0.0089 | 1.6711 | 18.1572 | 29 | 661 | regulation of secretion |
| GO:0045806 | 0.0091 | 4.2537 | 1.2911 | 5 | 47 | negative regulation of endocytosis |
| GO:0050906 | 0.0092 | 2.6917 | 3.5435 | 9 | 129 | detection of stimulus involved in sensory perception |
| GO:0050728 | 0.0093 | 2.8973 | 2.9392 | 8 | 107 | negative regulation of inflammatory response |
| GO:0051241 | 0.0094 | 1.5494 | 26.393 | 39 | 967 | negative regulation of multicellular organismal process |
| GO:0022600 | 0.0094 | 3.1735 | 2.3624 | 7 | 86 | digestive system process |
| GO:0051240 | 0.0094 | 1.4624 | 37.4391 | 52 | 1376 | positive regulation of multicellular organismal process |
| GO:0046425 | 0.0097 | 2.6693 | 3.571 | 9 | 130 | regulation of JAK-STAT cascade |
| GO:0010951 | 0.0097 | 2.2848 | 5.5213 | 12 | 201 | negative regulation of endopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010469 | 0 | 2.7278 | 14.9777 | 37 | 487 | regulation of receptor activity |
| GO:0048839 | 0 | 3.4154 | 5.4744 | 17 | 178 | inner ear development |
| GO:1901750 | 1e-04 | 25.4207 | 0.2768 | 4 | 9 | leukotriene D4 biosynthetic process |
| GO:2000026 | 1e-04 | 1.6391 | 53.1448 | 80 | 1728 | regulation of multicellular organismal development |
| GO:0006751 | 2e-04 | 21.1825 | 0.3076 | 4 | 10 | glutathione catabolic process |
| GO:0042531 | 3e-04 | 5.4401 | 1.6915 | 8 | 55 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:1904894 | 3e-04 | 4.7213 | 2.1529 | 9 | 70 | positive regulation of STAT cascade |
| GO:0007565 | 3e-04 | 3.0192 | 5.3821 | 15 | 175 | female pregnancy |
| GO:0009605 | 4e-04 | 1.5491 | 58.7114 | 84 | 1909 | response to external stimulus |
| GO:0007423 | 5e-04 | 2.0538 | 15.5621 | 30 | 506 | sensory organ development |
| GO:0090280 | 7e-04 | 12.706 | 0.4306 | 4 | 14 | positive regulation of calcium ion import |
| GO:0051384 | 9e-04 | 3.1551 | 4.1212 | 12 | 134 | response to glucocorticoid |
| GO:0045926 | 9e-04 | 2.6283 | 6.5201 | 16 | 212 | negative regulation of growth |
| GO:2000380 | 9e-04 | 11.5502 | 0.4613 | 4 | 15 | regulation of mesoderm development |
| GO:2000043 | 9e-04 | Inf | 0.0615 | 2 | 2 | regulation of cardiac cell fate specification |
| GO:0048562 | 0.001 | 2.3768 | 8.5192 | 19 | 277 | embryonic organ morphogenesis |
| GO:0033993 | 0.001 | 1.7536 | 25.4409 | 42 | 832 | response to lipid |
| GO:0072511 | 0.0011 | 2.0778 | 12.7634 | 25 | 415 | divalent inorganic cation transport |
| GO:0007405 | 0.0013 | 4.7498 | 1.6608 | 7 | 54 | neuroblast proliferation |
| GO:0045595 | 0.0014 | 1.5931 | 38.1454 | 57 | 1271 | regulation of cell differentiation |
| GO:1905770 | 0.0014 | 19.0245 | 0.246 | 3 | 8 | regulation of mesodermal cell differentiation |
| GO:0071294 | 0.0015 | 9.7719 | 0.5228 | 4 | 17 | cellular response to zinc ion |
| GO:0010092 | 0.0017 | 6.6257 | 0.8919 | 5 | 29 | specification of animal organ identity |
| GO:0007389 | 0.0018 | 2.033 | 12.4866 | 24 | 406 | pattern specification process |
| GO:0045944 | 0.002 | 1.6165 | 32.1083 | 49 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0006691 | 0.002 | 6.3603 | 0.9227 | 5 | 30 | leukotriene metabolic process |
| GO:0046456 | 0.0021 | 5.0277 | 1.3532 | 6 | 44 | icosanoid biosynthetic process |
| GO:0030819 | 0.0023 | 3.7547 | 2.3374 | 8 | 76 | positive regulation of cAMP biosynthetic process |
| GO:0072359 | 0.0023 | 1.6454 | 28.2639 | 44 | 919 | circulatory system development |
| GO:0030858 | 0.0024 | 4.2104 | 1.8453 | 7 | 60 | positive regulation of epithelial cell differentiation |
| GO:0001710 | 0.0024 | 8.4678 | 0.5843 | 4 | 19 | mesodermal cell fate commitment |
| GO:0023019 | 0.0024 | 8.4678 | 0.5843 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0072079 | 0.0024 | 8.4678 | 0.5843 | 4 | 19 | nephron tubule formation |
| GO:0007492 | 0.0025 | 3.7001 | 2.3681 | 8 | 77 | endoderm development |
| GO:0002125 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | maternal aggressive behavior |
| GO:0010956 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | negative regulation of calcidiol 1-monooxygenase activity |
| GO:0035564 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | regulation of kidney size |
| GO:0044691 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | tooth eruption |
| GO:0060913 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | cardiac cell fate determination |
| GO:0061010 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | gall bladder development |
| GO:0100012 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | regulation of heart induction by canonical Wnt signaling pathway |
| GO:2000297 | 0.0028 | 63.2961 | 0.0923 | 2 | 3 | negative regulation of synapse maturation |
| GO:1901362 | 0.0029 | 1.329 | 128.8023 | 156 | 4188 | organic cyclic compound biosynthetic process |
| GO:0006333 | 0.0029 | 2.707 | 4.7363 | 12 | 154 | chromatin assembly or disassembly |
| GO:0009651 | 0.0029 | 7.938 | 0.6151 | 4 | 20 | response to salt stress |
| GO:2000403 | 0.0029 | 7.938 | 0.6151 | 4 | 20 | positive regulation of lymphocyte migration |
| GO:1904627 | 0.003 | 13.5871 | 0.3076 | 3 | 10 | response to phorbol 13-acetate 12-myristate |
| GO:0001756 | 0.0031 | 3.984 | 1.9376 | 7 | 63 | somitogenesis |
| GO:0072091 | 0.0031 | 3.984 | 1.9376 | 7 | 63 | regulation of stem cell proliferation |
| GO:0006355 | 0.0031 | 1.3485 | 103.7984 | 129 | 3375 | regulation of transcription, DNA-templated |
| GO:0031326 | 0.0033 | 1.3251 | 125.4807 | 152 | 4080 | regulation of cellular biosynthetic process |
| GO:0042221 | 0.0035 | 1.3338 | 113.394 | 139 | 3687 | response to chemical |
| GO:0007263 | 0.0035 | 7.4706 | 0.6459 | 4 | 21 | nitric oxide mediated signal transduction |
| GO:0051354 | 0.0035 | 7.4706 | 0.6459 | 4 | 21 | negative regulation of oxidoreductase activity |
| GO:0010454 | 0.004 | 11.8879 | 0.3383 | 3 | 11 | negative regulation of cell fate commitment |
| GO:0051290 | 0.0041 | 5.2984 | 1.0764 | 5 | 35 | protein heterotetramerization |
| GO:0071675 | 0.0041 | 5.2984 | 1.0764 | 5 | 35 | regulation of mononuclear cell migration |
| GO:0071300 | 0.0044 | 3.7174 | 2.0606 | 7 | 67 | cellular response to retinoic acid |
| GO:0006816 | 0.0049 | 1.9556 | 11.2871 | 21 | 367 | calcium ion transport |
| GO:0009190 | 0.0049 | 2.6452 | 4.4287 | 11 | 144 | cyclic nucleotide biosynthetic process |
| GO:0060562 | 0.0051 | 2.067 | 9.165 | 18 | 298 | epithelial tube morphogenesis |
| GO:0001709 | 0.0051 | 4.9878 | 1.1333 | 5 | 37 | cell fate determination |
| GO:0033605 | 0.0052 | 10.5663 | 0.3691 | 3 | 12 | positive regulation of catecholamine secretion |
| GO:0001961 | 0.0052 | 4.9666 | 1.1379 | 5 | 37 | positive regulation of cytokine-mediated signaling pathway |
| GO:0045616 | 0.0052 | 4.9666 | 1.1379 | 5 | 37 | regulation of keratinocyte differentiation |
| GO:0060485 | 0.0053 | 2.2279 | 7.1044 | 15 | 231 | mesenchyme development |
| GO:0008284 | 0.0053 | 1.6199 | 24.6348 | 38 | 801 | positive regulation of cell proliferation |
| GO:0006334 | 0.0054 | 3.2125 | 2.6876 | 8 | 88 | nucleosome assembly |
| GO:0003308 | 0.0054 | 31.6459 | 0.123 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0008078 | 0.0054 | 31.6459 | 0.123 | 2 | 4 | mesodermal cell migration |
| GO:0032849 | 0.0054 | 31.6459 | 0.123 | 2 | 4 | positive regulation of cellular pH reduction |
| GO:0042662 | 0.0054 | 31.6459 | 0.123 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0072107 | 0.0054 | 31.6459 | 0.123 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0072108 | 0.0054 | 31.6459 | 0.123 | 2 | 4 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:1905903 | 0.0054 | 31.6459 | 0.123 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0031667 | 0.0055 | 1.9012 | 12.1483 | 22 | 395 | response to nutrient levels |
| GO:0060429 | 0.0057 | 1.5226 | 33.8613 | 49 | 1101 | epithelium development |
| GO:0002230 | 0.0058 | 6.3487 | 0.7381 | 4 | 24 | positive regulation of defense response to virus by host |
| GO:0006335 | 0.0058 | 6.3487 | 0.7381 | 4 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0060914 | 0.0058 | 6.3487 | 0.7381 | 4 | 24 | heart formation |
| GO:0090184 | 0.0059 | 4.8158 | 1.1687 | 5 | 38 | positive regulation of kidney development |
| GO:0006323 | 0.0061 | 2.4459 | 5.1976 | 12 | 169 | DNA packaging |
| GO:2000736 | 0.0065 | 2.6843 | 3.9674 | 10 | 129 | regulation of stem cell differentiation |
| GO:0002690 | 0.0066 | 3.4303 | 2.2144 | 7 | 72 | positive regulation of leukocyte chemotaxis |
| GO:0042074 | 0.0066 | 9.509 | 0.3998 | 3 | 13 | cell migration involved in gastrulation |
| GO:0050930 | 0.0066 | 9.509 | 0.3998 | 3 | 13 | induction of positive chemotaxis |
| GO:0009790 | 0.0066 | 1.5595 | 28.2639 | 42 | 919 | embryo development |
| GO:0050926 | 0.0067 | 6.046 | 0.7689 | 4 | 25 | regulation of positive chemotaxis |
| GO:0051171 | 0.0068 | 1.2737 | 166.1389 | 192 | 5402 | regulation of nitrogen compound metabolic process |
| GO:0046425 | 0.0069 | 2.6618 | 3.9982 | 10 | 130 | regulation of JAK-STAT cascade |
| GO:0042490 | 0.0073 | 3.8179 | 1.7223 | 6 | 56 | mechanoreceptor differentiation |
| GO:0002682 | 0.0076 | 1.4637 | 39.5203 | 55 | 1285 | regulation of immune system process |
| GO:0045637 | 0.0076 | 2.1986 | 6.7046 | 14 | 218 | regulation of myeloid cell differentiation |
| GO:0000183 | 0.0077 | 5.7708 | 0.7996 | 4 | 26 | chromatin silencing at rDNA |
| GO:1902680 | 0.0078 | 1.4519 | 41.3041 | 57 | 1343 | positive regulation of RNA biosynthetic process |
| GO:0009891 | 0.0079 | 1.402 | 52.7142 | 70 | 1714 | positive regulation of biosynthetic process |
| GO:0045935 | 0.0081 | 1.4069 | 50.9919 | 68 | 1658 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0051602 | 0.0081 | 4.4135 | 1.261 | 5 | 41 | response to electrical stimulus |
| GO:0043010 | 0.0082 | 2.0062 | 8.8882 | 17 | 289 | camera-type eye development |
| GO:0048513 | 0.0086 | 1.3564 | 69.1779 | 88 | 2368 | animal organ development |
| GO:0061311 | 0.0088 | 5.5195 | 0.8304 | 4 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0003129 | 0.0089 | 21.0959 | 0.1538 | 2 | 5 | heart induction |
| GO:0051970 | 0.0089 | 21.0959 | 0.1538 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0060455 | 0.0089 | 21.0959 | 0.1538 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0061009 | 0.0089 | 21.0959 | 0.1538 | 2 | 5 | common bile duct development |
| GO:2001034 | 0.0089 | 21.0959 | 0.1538 | 2 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
| GO:2001188 | 0.0089 | 21.0959 | 0.1538 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0051093 | 0.0089 | 1.572 | 24.6279 | 37 | 804 | negative regulation of developmental process |
| GO:1901215 | 0.0091 | 2.3118 | 5.4744 | 12 | 178 | negative regulation of neuron death |
| GO:0021761 | 0.0094 | 2.8974 | 2.9525 | 8 | 96 | limbic system development |
| GO:0051252 | 0.0096 | 1.2891 | 110.0109 | 132 | 3577 | regulation of RNA metabolic process |
| GO:0032648 | 0.0099 | 4.1807 | 1.3225 | 5 | 43 | regulation of interferon-beta production |
| GO:0072148 | 0.01 | 7.9231 | 0.4613 | 3 | 15 | epithelial cell fate commitment |
| GO:2000696 | 0.01 | 7.9231 | 0.4613 | 3 | 15 | regulation of epithelial cell differentiation involved in kidney development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051692 | 5e-04 | Inf | 0.0451 | 2 | 2 | cellular oligosaccharide catabolic process |
| GO:0072356 | 5e-04 | Inf | 0.0451 | 2 | 2 | chromosome passenger complex localization to kinetochore |
| GO:0017187 | 0.0012 | 18.7399 | 0.2254 | 3 | 10 | peptidyl-glutamic acid carboxylation |
| GO:0006396 | 0.0013 | 1.8453 | 19.6328 | 34 | 871 | RNA processing |
| GO:0038113 | 0.0015 | 87.2317 | 0.0676 | 2 | 3 | interleukin-9-mediated signaling pathway |
| GO:0071104 | 0.0015 | 87.2317 | 0.0676 | 2 | 3 | response to interleukin-9 |
| GO:0071626 | 0.0015 | 87.2317 | 0.0676 | 2 | 3 | mastication |
| GO:0098583 | 0.0015 | 87.2317 | 0.0676 | 2 | 3 | learned vocalization behavior |
| GO:1902263 | 0.0015 | 87.2317 | 0.0676 | 2 | 3 | apoptotic process involved in embryonic digit morphogenesis |
| GO:1905747 | 0.0015 | 87.2317 | 0.0676 | 2 | 3 | negative regulation of saliva secretion |
| GO:1905748 | 0.0015 | 87.2317 | 0.0676 | 2 | 3 | hard palate morphogenesis |
| GO:0032465 | 0.0023 | 4.8863 | 1.3524 | 6 | 60 | regulation of cytokinesis |
| GO:0035112 | 0.0027 | 13.1153 | 0.293 | 3 | 13 | genitalia morphogenesis |
| GO:0030222 | 0.0029 | 43.6129 | 0.0902 | 2 | 4 | eosinophil differentiation |
| GO:0007050 | 0.0033 | 2.5305 | 5.4323 | 13 | 241 | cell cycle arrest |
| GO:0003241 | 0.0048 | 29.0733 | 0.1127 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0007356 | 0.0048 | 29.0733 | 0.1127 | 2 | 5 | thorax and anterior abdomen determination |
| GO:0009240 | 0.0048 | 29.0733 | 0.1127 | 2 | 5 | isopentenyl diphosphate biosynthetic process |
| GO:0021650 | 0.0048 | 29.0733 | 0.1127 | 2 | 5 | vestibulocochlear nerve formation |
| GO:1901078 | 0.0048 | 29.0733 | 0.1127 | 2 | 5 | negative regulation of relaxation of muscle |
| GO:0002902 | 0.0051 | 10.0867 | 0.3606 | 3 | 16 | regulation of B cell apoptotic process |
| GO:0046716 | 0.0051 | 10.0867 | 0.3606 | 3 | 16 | muscle cell cellular homeostasis |
| GO:0090501 | 0.007 | 3.0382 | 2.795 | 8 | 124 | RNA phosphodiester bond hydrolysis |
| GO:0007000 | 0.0072 | 21.8035 | 0.1352 | 2 | 6 | nucleolus organization |
| GO:0071907 | 0.0072 | 21.8035 | 0.1352 | 2 | 6 | determination of digestive tract left/right asymmetry |
| GO:2000973 | 0.0072 | 21.8035 | 0.1352 | 2 | 6 | regulation of pro-B cell differentiation |
| GO:0097094 | 0.0072 | 8.7406 | 0.4057 | 3 | 18 | craniofacial suture morphogenesis |
| GO:0000462 | 0.0077 | 5.6496 | 0.7889 | 4 | 35 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0006364 | 0.0084 | 2.3288 | 5.4097 | 12 | 240 | rRNA processing |
| GO:0050810 | 0.0088 | 3.6099 | 1.7807 | 6 | 79 | regulation of steroid biosynthetic process |
| GO:0050906 | 0.0089 | 2.9117 | 2.9077 | 8 | 129 | detection of stimulus involved in sensory perception |
| GO:0007601 | 0.009 | 2.537 | 4.1475 | 10 | 184 | visual perception |
| GO:0050911 | 0.0091 | 4.2165 | 1.2848 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0014821 | 0.0097 | 7.7112 | 0.4508 | 3 | 20 | phasic smooth muscle contraction |
| GO:1903579 | 0.0097 | 7.7112 | 0.4508 | 3 | 20 | negative regulation of ATP metabolic process |
| GO:0022613 | 0.0098 | 1.9249 | 9.7826 | 18 | 434 | ribonucleoprotein complex biogenesis |
| GO:0001731 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | formation of translation preinitiation complex |
| GO:0015884 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | folic acid transport |
| GO:0032471 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | negative regulation of endoplasmic reticulum calcium ion concentration |
| GO:0032532 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | regulation of microvillus length |
| GO:0035234 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | ectopic germ cell programmed cell death |
| GO:0051791 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | medium-chain fatty acid metabolic process |
| GO:0090306 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | spindle assembly involved in meiosis |
| GO:2000210 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | positive regulation of anoikis |
| GO:2000767 | 0.0099 | 17.4416 | 0.1578 | 2 | 7 | positive regulation of cytoplasmic translation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 7e-04 | Inf | 0.052 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0070370 | 7e-04 | Inf | 0.052 | 2 | 2 | cellular heat acclimation |
| GO:0070434 | 7e-04 | Inf | 0.052 | 2 | 2 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0010165 | 0.0015 | 6.756 | 0.8588 | 5 | 33 | response to X-ray |
| GO:0071474 | 0.0018 | 16.1549 | 0.2602 | 3 | 10 | cellular hyperosmotic response |
| GO:0051490 | 0.002 | 75.2284 | 0.0781 | 2 | 3 | negative regulation of filopodium assembly |
| GO:0060596 | 0.002 | 75.2284 | 0.0781 | 2 | 3 | mammary placode formation |
| GO:0090063 | 0.002 | 75.2284 | 0.0781 | 2 | 3 | positive regulation of microtubule nucleation |
| GO:0006979 | 0.0036 | 2.0491 | 10.2793 | 20 | 395 | response to oxidative stress |
| GO:0055123 | 0.0036 | 2.9277 | 3.6433 | 10 | 140 | digestive system development |
| GO:0000303 | 0.0037 | 7.1914 | 0.6506 | 4 | 25 | response to superoxide |
| GO:0045992 | 0.0037 | 7.1914 | 0.6506 | 4 | 25 | negative regulation of embryonic development |
| GO:1900194 | 0.0039 | 37.6117 | 0.1041 | 2 | 4 | negative regulation of oocyte maturation |
| GO:1903564 | 0.0039 | 37.6117 | 0.1041 | 2 | 4 | regulation of protein localization to cilium |
| GO:1901135 | 0.0042 | 1.5684 | 31.7227 | 47 | 1219 | carbohydrate derivative metabolic process |
| GO:0043200 | 0.0043 | 3.3375 | 2.5763 | 8 | 99 | response to amino acid |
| GO:1904353 | 0.0043 | 6.8641 | 0.6766 | 4 | 26 | regulation of telomere capping |
| GO:0034111 | 0.0051 | 10.2776 | 0.3643 | 3 | 14 | negative regulation of homotypic cell-cell adhesion |
| GO:0071697 | 0.0051 | 10.2776 | 0.3643 | 3 | 14 | ectodermal placode morphogenesis |
| GO:0071732 | 0.0051 | 10.2776 | 0.3643 | 3 | 14 | cellular response to nitric oxide |
| GO:0010718 | 0.0055 | 4.8469 | 1.145 | 5 | 44 | positive regulation of epithelial to mesenchymal transition |
| GO:0120034 | 0.0062 | 3.4457 | 2.186 | 7 | 84 | positive regulation of plasma membrane bounded cell projection assembly |
| GO:0008595 | 0.0063 | 9.4205 | 0.3904 | 3 | 15 | anterior/posterior axis specification, embryo |
| GO:0006072 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | glycerol-3-phosphate metabolic process |
| GO:1905880 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | negative regulation of oogenesis |
| GO:0060348 | 0.0064 | 2.5378 | 4.5801 | 11 | 176 | bone development |
| GO:1901673 | 0.0091 | 8.0736 | 0.4424 | 3 | 17 | regulation of mitotic spindle assembly |
| GO:0001957 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | intramembranous ossification |
| GO:0006685 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | sphingomyelin catabolic process |
| GO:0031584 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | activation of phospholipase D activity |
| GO:0042045 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | epithelial fluid transport |
| GO:0048541 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | Peyer's patch development |
| GO:0060527 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
| GO:1903265 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | positive regulation of tumor necrosis factor-mediated signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035821 | 2e-04 | 3.6032 | 3.9838 | 13 | 121 | modification of morphology or physiology of other organism |
| GO:0044003 | 5e-04 | 5.7782 | 1.4157 | 7 | 43 | modification by symbiont of host morphology or physiology |
| GO:0052173 | 7e-04 | 29.5442 | 0.1975 | 3 | 6 | response to defenses of other organism involved in symbiotic interaction |
| GO:0075136 | 7e-04 | 29.5442 | 0.1975 | 3 | 6 | response to host |
| GO:0050730 | 8e-04 | 2.5623 | 7.1115 | 17 | 216 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0051306 | 0.001 | 4.9507 | 1.6133 | 7 | 49 | mitotic sister chromatid separation |
| GO:0072738 | 0.0011 | Inf | 0.0658 | 2 | 2 | cellular response to diamide |
| GO:1900453 | 0.0011 | Inf | 0.0658 | 2 | 2 | negative regulation of long term synaptic depression |
| GO:1904845 | 0.0011 | Inf | 0.0658 | 2 | 2 | cellular response to L-glutamine |
| GO:0031620 | 0.0011 | 22.1566 | 0.2305 | 3 | 7 | regulation of fever generation |
| GO:0050729 | 0.0013 | 3.4246 | 3.1936 | 10 | 97 | positive regulation of inflammatory response |
| GO:1905818 | 0.0013 | 4.7251 | 1.6791 | 7 | 51 | regulation of chromosome separation |
| GO:0051047 | 0.0019 | 2.053 | 11.8525 | 23 | 360 | positive regulation of secretion |
| GO:0007568 | 0.002 | 2.2177 | 9.0869 | 19 | 276 | aging |
| GO:0033047 | 0.0021 | 4.3301 | 1.8108 | 7 | 55 | regulation of mitotic sister chromatid segregation |
| GO:0032025 | 0.0026 | 14.7691 | 0.2963 | 3 | 9 | response to cobalt ion |
| GO:0044650 | 0.0026 | 14.7691 | 0.2963 | 3 | 9 | adhesion of symbiont to host cell |
| GO:1901203 | 0.0026 | 14.7691 | 0.2963 | 3 | 9 | positive regulation of extracellular matrix assembly |
| GO:0042176 | 0.0028 | 1.9866 | 12.2147 | 23 | 371 | regulation of protein catabolic process |
| GO:0014826 | 0.0032 | 58.978 | 0.0988 | 2 | 3 | vein smooth muscle contraction |
| GO:0019087 | 0.0032 | 58.978 | 0.0988 | 2 | 3 | transformation of host cell by virus |
| GO:0060689 | 0.0032 | 58.978 | 0.0988 | 2 | 3 | cell differentiation involved in salivary gland development |
| GO:0071284 | 0.0032 | 58.978 | 0.0988 | 2 | 3 | cellular response to lead ion |
| GO:1903936 | 0.0032 | 58.978 | 0.0988 | 2 | 3 | cellular response to sodium arsenite |
| GO:0030071 | 0.0034 | 4.5616 | 1.4816 | 6 | 45 | regulation of mitotic metaphase/anaphase transition |
| GO:0018298 | 0.0036 | 12.6583 | 0.3292 | 3 | 10 | protein-chromophore linkage |
| GO:0061042 | 0.0036 | 12.6583 | 0.3292 | 3 | 10 | vascular wound healing |
| GO:0034620 | 0.0042 | 2.7078 | 4.3459 | 11 | 132 | cellular response to unfolded protein |
| GO:0051188 | 0.0046 | 2.4389 | 5.6629 | 13 | 172 | cofactor biosynthetic process |
| GO:0044784 | 0.0047 | 4.2349 | 1.5803 | 6 | 48 | metaphase/anaphase transition of cell cycle |
| GO:0007039 | 0.0048 | 11.0753 | 0.3622 | 3 | 11 | protein catabolic process in the vacuole |
| GO:1904294 | 0.0048 | 11.0753 | 0.3622 | 3 | 11 | positive regulation of ERAD pathway |
| GO:0097190 | 0.0051 | 1.7319 | 18.1739 | 30 | 552 | apoptotic signaling pathway |
| GO:0035272 | 0.0052 | 4.1362 | 1.6133 | 6 | 49 | exocrine system development |
| GO:0032101 | 0.0053 | 1.6665 | 21.4004 | 34 | 650 | regulation of response to external stimulus |
| GO:1901215 | 0.0061 | 2.3493 | 5.8604 | 13 | 178 | negative regulation of neuron death |
| GO:0019049 | 0.0062 | 29.487 | 0.1317 | 2 | 4 | evasion or tolerance of host defenses by virus |
| GO:0032898 | 0.0062 | 29.487 | 0.1317 | 2 | 4 | neurotrophin production |
| GO:0035633 | 0.0062 | 29.487 | 0.1317 | 2 | 4 | maintenance of permeability of blood-brain barrier |
| GO:0044413 | 0.0062 | 29.487 | 0.1317 | 2 | 4 | avoidance of host defenses |
| GO:0051834 | 0.0062 | 29.487 | 0.1317 | 2 | 4 | evasion or tolerance of defenses of other organism involved in symbiotic interaction |
| GO:1902074 | 0.0063 | 9.844 | 0.3951 | 3 | 12 | response to salt |
| GO:0006672 | 0.0064 | 3.1259 | 2.7656 | 8 | 84 | ceramide metabolic process |
| GO:0032653 | 0.0069 | 4.6258 | 1.2182 | 5 | 37 | regulation of interleukin-10 production |
| GO:0035337 | 0.0069 | 4.6258 | 1.2182 | 5 | 37 | fatty-acyl-CoA metabolic process |
| GO:0071636 | 0.0079 | 8.859 | 0.428 | 3 | 13 | positive regulation of transforming growth factor beta production |
| GO:0072216 | 0.0079 | 8.859 | 0.428 | 3 | 13 | positive regulation of metanephros development |
| GO:0035966 | 0.0083 | 2.2526 | 6.0909 | 13 | 185 | response to topologically incorrect protein |
| GO:0043921 | 0.0085 | 5.6319 | 0.8231 | 4 | 25 | modulation by host of viral transcription |
| GO:0006487 | 0.0087 | 3.2441 | 2.3376 | 7 | 71 | protein N-linked glycosylation |
| GO:0090257 | 0.0087 | 2.1632 | 6.8152 | 14 | 207 | regulation of muscle system process |
| GO:0050801 | 0.009 | 1.6013 | 22.1906 | 34 | 674 | ion homeostasis |
| GO:0055082 | 0.0096 | 1.5934 | 22.2893 | 34 | 677 | cellular chemical homeostasis |
| GO:0052312 | 0.0098 | 5.3755 | 0.856 | 4 | 26 | modulation of transcription in other organism involved in symbiotic interaction |
| GO:0006684 | 0.0098 | 8.0531 | 0.4609 | 3 | 14 | sphingomyelin metabolic process |
| GO:0044065 | 0.0098 | 8.0531 | 0.4609 | 3 | 14 | regulation of respiratory system process |
| GO:1905038 | 0.0098 | 8.0531 | 0.4609 | 3 | 14 | regulation of membrane lipid metabolic process |
| GO:2000303 | 0.0098 | 8.0531 | 0.4609 | 3 | 14 | regulation of ceramide biosynthetic process |
| GO:1903364 | 0.0099 | 2.2008 | 6.2226 | 13 | 189 | positive regulation of cellular protein catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000027 | 0 | 3.4551 | 6.3742 | 20 | 236 | regulation of organ morphogenesis |
| GO:0001708 | 0 | 5.7891 | 2.1878 | 11 | 81 | cell fate specification |
| GO:0009952 | 0 | 3.5661 | 5.2398 | 17 | 194 | anterior/posterior pattern specification |
| GO:1905330 | 1e-04 | 3.6039 | 4.5646 | 15 | 169 | regulation of morphogenesis of an epithelium |
| GO:0007389 | 1e-04 | 2.5732 | 10.4939 | 25 | 391 | pattern specification process |
| GO:0009792 | 2e-04 | 2.1762 | 14.7741 | 30 | 547 | embryo development ending in birth or egg hatching |
| GO:0060707 | 2e-04 | 18.1794 | 0.3241 | 4 | 12 | trophoblast giant cell differentiation |
| GO:0060429 | 4e-04 | 1.7697 | 29.7372 | 49 | 1101 | epithelium development |
| GO:0001892 | 5e-04 | 4.3392 | 2.2958 | 9 | 85 | embryonic placenta development |
| GO:0048705 | 5e-04 | 2.8984 | 5.5639 | 15 | 206 | skeletal system morphogenesis |
| GO:0008544 | 6e-04 | 2.3548 | 9.5073 | 21 | 352 | epidermis development |
| GO:0018003 | 7e-04 | Inf | 0.054 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0060465 | 7e-04 | Inf | 0.054 | 2 | 2 | pharynx development |
| GO:0090190 | 9e-04 | 11.1835 | 0.4592 | 4 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:1905770 | 0.001 | 21.7662 | 0.2161 | 3 | 8 | regulation of mesodermal cell differentiation |
| GO:0048513 | 0.001 | 1.4453 | 82.0271 | 108 | 3037 | animal organ development |
| GO:0000122 | 0.0011 | 1.8466 | 20.1381 | 35 | 749 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0045995 | 0.0011 | 3.4915 | 3.1061 | 10 | 115 | regulation of embryonic development |
| GO:0048608 | 0.0012 | 2.1764 | 10.7227 | 22 | 397 | reproductive structure development |
| GO:0048562 | 0.0015 | 2.4139 | 7.4816 | 17 | 277 | embryonic organ morphogenesis |
| GO:2000543 | 0.0015 | 18.1373 | 0.2431 | 3 | 9 | positive regulation of gastrulation |
| GO:0048706 | 0.0016 | 3.3014 | 3.2681 | 10 | 121 | embryonic skeletal system development |
| GO:0060736 | 0.002 | 15.5452 | 0.2701 | 3 | 10 | prostate gland growth |
| GO:0035909 | 0.002 | 6.2753 | 0.9183 | 5 | 34 | aorta morphogenesis |
| GO:0043433 | 0.0021 | 3.1857 | 3.3762 | 10 | 125 | negative regulation of DNA binding transcription factor activity |
| GO:0015680 | 0.0021 | 72.3961 | 0.081 | 2 | 3 | intracellular copper ion transport |
| GO:0061357 | 0.0021 | 72.3961 | 0.081 | 2 | 3 | positive regulation of Wnt protein secretion |
| GO:0060688 | 0.0022 | 4.9704 | 1.3505 | 6 | 50 | regulation of morphogenesis of a branching structure |
| GO:0043586 | 0.0022 | 8.5498 | 0.5672 | 4 | 21 | tongue development |
| GO:0021521 | 0.0027 | 13.6011 | 0.2971 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0030856 | 0.0029 | 3.0265 | 3.5382 | 10 | 131 | regulation of epithelial cell differentiation |
| GO:0010667 | 0.0031 | 7.6488 | 0.6212 | 4 | 23 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0090103 | 0.0031 | 7.6488 | 0.6212 | 4 | 23 | cochlea morphogenesis |
| GO:0065004 | 0.0031 | 2.5535 | 5.4019 | 13 | 200 | protein-DNA complex assembly |
| GO:0048839 | 0.0033 | 2.6524 | 4.8076 | 12 | 178 | inner ear development |
| GO:0048729 | 0.0035 | 1.8226 | 16.1786 | 28 | 599 | tissue morphogenesis |
| GO:0003207 | 0.0036 | 12.0891 | 0.3241 | 3 | 12 | cardiac chamber formation |
| GO:0045779 | 0.0036 | 12.0891 | 0.3241 | 3 | 12 | negative regulation of bone resorption |
| GO:2000095 | 0.0036 | 12.0891 | 0.3241 | 3 | 12 | regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0061217 | 0.0036 | 7.2658 | 0.6482 | 4 | 24 | regulation of mesonephros development |
| GO:2001141 | 0.0039 | 1.362 | 91.8585 | 115 | 3401 | regulation of RNA biosynthetic process |
| GO:0002760 | 0.0042 | 36.1956 | 0.108 | 2 | 4 | positive regulation of antimicrobial humoral response |
| GO:0033594 | 0.0042 | 36.1956 | 0.108 | 2 | 4 | response to hydroxyisoflavone |
| GO:0042662 | 0.0042 | 36.1956 | 0.108 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0042663 | 0.0042 | 36.1956 | 0.108 | 2 | 4 | regulation of endodermal cell fate specification |
| GO:1902412 | 0.0042 | 36.1956 | 0.108 | 2 | 4 | regulation of mitotic cytokinesis |
| GO:1905903 | 0.0042 | 36.1956 | 0.108 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0006355 | 0.0043 | 1.3589 | 91.1563 | 114 | 3375 | regulation of transcription, DNA-templated |
| GO:0007275 | 0.0043 | 1.3423 | 111.1427 | 135 | 4298 | multicellular organism development |
| GO:0050793 | 0.005 | 1.4144 | 59.7427 | 79 | 2226 | regulation of developmental process |
| GO:0001838 | 0.0052 | 2.9639 | 3.2411 | 9 | 120 | embryonic epithelial tube formation |
| GO:0001704 | 0.0055 | 2.9372 | 3.2681 | 9 | 121 | formation of primary germ layer |
| GO:0003214 | 0.0057 | 9.8897 | 0.3781 | 3 | 14 | cardiac left ventricle morphogenesis |
| GO:0035067 | 0.0057 | 9.8897 | 0.3781 | 3 | 14 | negative regulation of histone acetylation |
| GO:0048699 | 0.0058 | 1.5125 | 35.6252 | 51 | 1319 | generation of neurons |
| GO:0035567 | 0.0063 | 2.69 | 3.9434 | 10 | 146 | non-canonical Wnt signaling pathway |
| GO:0002755 | 0.0064 | 6.0532 | 0.7563 | 4 | 28 | MyD88-dependent toll-like receptor signaling pathway |
| GO:0046620 | 0.0067 | 3.4032 | 2.2148 | 7 | 82 | regulation of organ growth |
| GO:0003150 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | muscular septum morphogenesis |
| GO:0035434 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | copper ion transmembrane transport |
| GO:0060023 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | soft palate development |
| GO:0060633 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | negative regulation of transcription initiation from RNA polymerase II promoter |
| GO:0061009 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | common bile duct development |
| GO:0090500 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | endocardial cushion to mesenchymal transition |
| GO:0098528 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | skeletal muscle fiber differentiation |
| GO:1990511 | 0.0069 | 24.1288 | 0.135 | 2 | 5 | piRNA biosynthetic process |
| GO:0060581 | 0.007 | 9.065 | 0.4051 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0090177 | 0.007 | 9.065 | 0.4051 | 3 | 15 | establishment of planar polarity involved in neural tube closure |
| GO:2000380 | 0.007 | 9.065 | 0.4051 | 3 | 15 | regulation of mesoderm development |
| GO:1903507 | 0.0071 | 1.5391 | 30.0883 | 44 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0022414 | 0.0073 | 1.502 | 34.3828 | 49 | 1273 | reproductive process |
| GO:0001942 | 0.0076 | 3.3144 | 2.2688 | 7 | 84 | hair follicle development |
| GO:0044344 | 0.0079 | 2.7631 | 3.4572 | 9 | 128 | cellular response to fibroblast growth factor stimulus |
| GO:1905208 | 0.0084 | 8.3671 | 0.4321 | 3 | 16 | negative regulation of cardiocyte differentiation |
| GO:0022404 | 0.0086 | 3.23 | 2.3228 | 7 | 86 | molting cycle process |
| GO:0022600 | 0.0086 | 3.23 | 2.3228 | 7 | 86 | digestive system process |
| GO:0003205 | 0.0087 | 2.5571 | 4.1324 | 10 | 153 | cardiac chamber development |
| GO:0010831 | 0.0093 | 5.3796 | 0.8373 | 4 | 31 | positive regulation of myotube differentiation |
| GO:0030154 | 0.0093 | 1.3094 | 99.016 | 120 | 3666 | cell differentiation |
| GO:0035239 | 0.0095 | 1.9721 | 9.0211 | 17 | 334 | tube morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 11.51 | 0.9439 | 9 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 6.1854 | 2.186 | 12 | 132 | sensory perception of chemical stimulus |
| GO:0009593 | 0 | 5.7925 | 1.921 | 10 | 116 | detection of chemical stimulus |
| GO:0050906 | 1e-04 | 5.1552 | 2.1363 | 10 | 129 | detection of stimulus involved in sensory perception |
| GO:0032914 | 8e-04 | 119.712 | 0.0497 | 2 | 3 | positive regulation of transforming growth factor beta1 production |
| GO:0009650 | 0.0011 | 18.0181 | 0.2153 | 3 | 13 | UV protection |
| GO:0071320 | 0.0011 | 7.0248 | 0.7949 | 5 | 48 | cellular response to cAMP |
| GO:0019732 | 0.0016 | 59.852 | 0.0662 | 2 | 4 | antifungal humoral response |
| GO:0051454 | 0.0026 | 39.8987 | 0.0828 | 2 | 5 | intracellular pH elevation |
| GO:0080184 | 0.0026 | 39.8987 | 0.0828 | 2 | 5 | response to phenylpropanoid |
| GO:0006508 | 0.0029 | 1.6769 | 26.4139 | 41 | 1595 | proteolysis |
| GO:0071345 | 0.0038 | 1.9169 | 13.298 | 24 | 803 | cellular response to cytokine stimulus |
| GO:0010757 | 0.0039 | 29.922 | 0.0994 | 2 | 6 | negative regulation of plasminogen activation |
| GO:0035672 | 0.0039 | 29.922 | 0.0994 | 2 | 6 | oligopeptide transmembrane transport |
| GO:0071674 | 0.0041 | 5.1143 | 1.0599 | 5 | 64 | mononuclear cell migration |
| GO:0032506 | 0.0042 | 10.5939 | 0.3312 | 3 | 20 | cytokinetic process |
| GO:0035025 | 0.0042 | 10.5939 | 0.3312 | 3 | 20 | positive regulation of Rho protein signal transduction |
| GO:0031638 | 0.0042 | 6.6886 | 0.6624 | 4 | 40 | zymogen activation |
| GO:0048251 | 0.0054 | 23.936 | 0.1159 | 2 | 7 | elastic fiber assembly |
| GO:0051302 | 0.0057 | 3.4761 | 2.1363 | 7 | 129 | regulation of cell division |
| GO:0006954 | 0.0061 | 1.9903 | 10.0687 | 19 | 608 | inflammatory response |
| GO:0007186 | 0.0065 | 1.8276 | 13.8942 | 24 | 839 | G-protein coupled receptor signaling pathway |
| GO:0006493 | 0.0067 | 3.8177 | 1.6726 | 6 | 101 | protein O-linked glycosylation |
| GO:0006952 | 0.0068 | 1.9038 | 11.6747 | 21 | 732 | defense response |
| GO:0048263 | 0.0072 | 19.9453 | 0.1325 | 2 | 8 | determination of dorsal identity |
| GO:0051256 | 0.0072 | 19.9453 | 0.1325 | 2 | 8 | mitotic spindle midzone assembly |
| GO:0055091 | 0.0072 | 19.9453 | 0.1325 | 2 | 8 | phospholipid homeostasis |
| GO:1904628 | 0.0072 | 19.9453 | 0.1325 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0006955 | 0.0076 | 1.5723 | 27.9374 | 41 | 1687 | immune response |
| GO:0031424 | 0.0078 | 3.2604 | 2.2688 | 7 | 137 | keratinization |
| GO:0010466 | 0.0087 | 2.7068 | 3.4942 | 9 | 211 | negative regulation of peptidase activity |
| GO:0042730 | 0.0088 | 7.8271 | 0.4306 | 3 | 26 | fibrinolysis |
| GO:0050877 | 0.009 | 1.7723 | 14.2916 | 24 | 863 | nervous system process |
| GO:0036500 | 0.0091 | 17.0949 | 0.149 | 2 | 9 | ATF6-mediated unfolded protein response |
| GO:0048240 | 0.0098 | 7.5005 | 0.4471 | 3 | 27 | sperm capacitation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 2e-04 | 19.3718 | 0.2947 | 4 | 13 | negative regulation of megakaryocyte differentiation |
| GO:0031069 | 2e-04 | 10.9206 | 0.5668 | 5 | 25 | hair follicle morphogenesis |
| GO:0070098 | 3e-04 | 6.1393 | 1.2923 | 7 | 57 | chemokine-mediated signaling pathway |
| GO:0010469 | 3e-04 | 2.3268 | 11.0413 | 24 | 487 | regulation of receptor activity |
| GO:0031424 | 4e-04 | 7.2035 | 0.9611 | 6 | 43 | keratinization |
| GO:0003326 | 5e-04 | Inf | 0.0453 | 2 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 5e-04 | Inf | 0.0453 | 2 | 2 | pancreatic PP cell fate commitment |
| GO:0009913 | 7e-04 | 2.8069 | 5.7133 | 15 | 252 | epidermal cell differentiation |
| GO:0045814 | 8e-04 | 3.997 | 2.4486 | 9 | 108 | negative regulation of gene expression, epigenetic |
| GO:0034080 | 9e-04 | 7.5269 | 0.7708 | 5 | 34 | CENP-A containing nucleosome assembly |
| GO:0051290 | 0.0011 | 7.2755 | 0.7935 | 5 | 35 | protein heterotetramerization |
| GO:0060429 | 0.0012 | 1.7574 | 24.9619 | 41 | 1101 | epithelium development |
| GO:0021530 | 0.0015 | 86.7114 | 0.068 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0060838 | 0.0015 | 86.7114 | 0.068 | 2 | 3 | lymphatic endothelial cell fate commitment |
| GO:0071347 | 0.0015 | 4.5087 | 1.7004 | 7 | 75 | cellular response to interleukin-1 |
| GO:1903707 | 0.0017 | 3.53 | 2.7433 | 9 | 121 | negative regulation of hemopoiesis |
| GO:0006335 | 0.0019 | 8.7109 | 0.5441 | 4 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0043588 | 0.0021 | 2.3948 | 7.0737 | 16 | 312 | skin development |
| GO:0000183 | 0.0026 | 7.9179 | 0.5895 | 4 | 26 | chromatin silencing at rDNA |
| GO:0048514 | 0.0027 | 2.0291 | 11.4494 | 22 | 505 | blood vessel morphogenesis |
| GO:0007186 | 0.0028 | 1.7819 | 19.0218 | 32 | 839 | G-protein coupled receptor signaling pathway |
| GO:0034724 | 0.0034 | 5.4529 | 1.0202 | 5 | 45 | DNA replication-independent nucleosome organization |
| GO:1900017 | 0.0035 | 11.8509 | 0.3174 | 3 | 14 | positive regulation of cytokine production involved in inflammatory response |
| GO:0006968 | 0.0041 | 5.1926 | 1.0656 | 5 | 47 | cellular defense response |
| GO:0010596 | 0.0045 | 5.0715 | 1.0883 | 5 | 48 | negative regulation of endothelial cell migration |
| GO:0021779 | 0.0049 | 28.8999 | 0.1134 | 2 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0.0049 | 28.8999 | 0.1134 | 2 | 5 | glial cell fate specification |
| GO:0061056 | 0.0049 | 28.8999 | 0.1134 | 2 | 5 | sclerotome development |
| GO:0070268 | 0.0055 | 3.5195 | 2.1312 | 7 | 94 | cornification |
| GO:0007631 | 0.0062 | 3.44 | 2.1765 | 7 | 96 | feeding behavior |
| GO:0036342 | 0.0062 | 9.3095 | 0.3854 | 3 | 17 | post-anal tail morphogenesis |
| GO:0045765 | 0.0066 | 2.4111 | 5.2372 | 12 | 231 | regulation of angiogenesis |
| GO:0008544 | 0.0066 | 3.3887 | 2.2051 | 7 | 100 | epidermis development |
| GO:0048646 | 0.0071 | 1.6371 | 21.8785 | 34 | 965 | anatomical structure formation involved in morphogenesis |
| GO:2000381 | 0.0072 | 21.6735 | 0.136 | 2 | 6 | negative regulation of mesoderm development |
| GO:0008630 | 0.0077 | 3.2911 | 2.2672 | 7 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0045429 | 0.0078 | 5.6157 | 0.7935 | 4 | 35 | positive regulation of nitric oxide biosynthetic process |
| GO:0071498 | 0.0085 | 8.1447 | 0.4308 | 3 | 19 | cellular response to fluid shear stress |
| GO:2000026 | 0.009 | 1.463 | 39.1772 | 54 | 1728 | regulation of multicellular organismal development |
| GO:1901617 | 0.0091 | 2.4039 | 4.8065 | 11 | 212 | organic hydroxy compound biosynthetic process |
| GO:0006346 | 0.0099 | 7.6651 | 0.4534 | 3 | 20 | methylation-dependent chromatin silencing |
| GO:0021796 | 0.01 | 17.3376 | 0.1587 | 2 | 7 | cerebral cortex regionalization |
| GO:2000210 | 0.01 | 17.3376 | 0.1587 | 2 | 7 | positive regulation of anoikis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048478 | 0.0016 | 19.7303 | 0.2576 | 3 | 7 | replication fork protection |
| GO:1900543 | 0.0021 | 3.8477 | 2.3185 | 8 | 63 | negative regulation of purine nucleotide metabolic process |
| GO:0071108 | 0.0023 | 6.2789 | 0.9568 | 5 | 26 | protein K48-linked deubiquitination |
| GO:0032259 | 0.0029 | 1.9822 | 12.2547 | 23 | 333 | methylation |
| GO:0031280 | 0.0032 | 5.7321 | 1.0304 | 5 | 28 | negative regulation of cyclase activity |
| GO:0042747 | 0.0035 | 13.1517 | 0.3312 | 3 | 9 | circadian sleep/wake cycle, REM sleep |
| GO:0044257 | 0.0038 | 1.6448 | 24.9142 | 39 | 677 | cellular protein catabolic process |
| GO:0033512 | 0.004 | 52.5305 | 0.1104 | 2 | 3 | L-lysine catabolic process to acetyl-CoA via saccharopine |
| GO:0060084 | 0.004 | 52.5305 | 0.1104 | 2 | 3 | synaptic transmission involved in micturition |
| GO:0019432 | 0.0044 | 5.2728 | 1.104 | 5 | 30 | triglyceride biosynthetic process |
| GO:0051350 | 0.0044 | 5.2728 | 1.104 | 5 | 30 | negative regulation of lyase activity |
| GO:0030433 | 0.0044 | 3.3573 | 2.6129 | 8 | 71 | ubiquitin-dependent ERAD pathway |
| GO:0030800 | 0.0046 | 4.2794 | 1.5824 | 6 | 43 | negative regulation of cyclic nucleotide metabolic process |
| GO:0006307 | 0.0049 | 11.2721 | 0.368 | 3 | 10 | DNA dealkylation involved in DNA repair |
| GO:0060284 | 0.0051 | 1.5754 | 28.6311 | 43 | 778 | regulation of cell development |
| GO:0007610 | 0.0053 | 1.6949 | 19.7989 | 32 | 538 | behavior |
| GO:0046460 | 0.0059 | 4.8815 | 1.1776 | 5 | 32 | neutral lipid biosynthetic process |
| GO:0006390 | 0.0066 | 9.8624 | 0.4048 | 3 | 11 | transcription from mitochondrial promoter |
| GO:0008211 | 0.0066 | 6.1955 | 0.7728 | 4 | 21 | glucocorticoid metabolic process |
| GO:0030814 | 0.0072 | 2.5116 | 4.6737 | 11 | 127 | regulation of cAMP metabolic process |
| GO:0019477 | 0.0077 | 26.2634 | 0.1472 | 2 | 4 | L-lysine catabolic process |
| GO:0030035 | 0.0077 | 26.2634 | 0.1472 | 2 | 4 | microspike assembly |
| GO:1905907 | 0.0077 | 26.2634 | 0.1472 | 2 | 4 | negative regulation of amyloid fibril formation |
| GO:2001137 | 0.0077 | 26.2634 | 0.1472 | 2 | 4 | positive regulation of endocytic recycling |
| GO:0035304 | 0.0082 | 3.3004 | 2.3185 | 7 | 63 | regulation of protein dephosphorylation |
| GO:0042254 | 0.0089 | 1.8744 | 11.1875 | 20 | 304 | ribosome biogenesis |
| GO:0009451 | 0.009 | 2.4272 | 4.8209 | 11 | 131 | RNA modification |
| GO:0008033 | 0.0093 | 2.5442 | 4.1953 | 10 | 114 | tRNA processing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009913 | 0 | 4.9665 | 4.8025 | 21 | 252 | epidermal cell differentiation |
| GO:0043588 | 0 | 4.3632 | 5.946 | 23 | 312 | skin development |
| GO:0070268 | 1e-04 | 5.5925 | 1.7914 | 9 | 94 | cornification |
| GO:0007186 | 1e-04 | 2.1983 | 15.8075 | 32 | 835 | G-protein coupled receptor signaling pathway |
| GO:0060429 | 3e-04 | 1.9667 | 20.9825 | 38 | 1101 | epithelium development |
| GO:0006334 | 3e-04 | 4.6096 | 2.1345 | 9 | 112 | nucleosome assembly |
| GO:0070370 | 4e-04 | Inf | 0.0381 | 2 | 2 | cellular heat acclimation |
| GO:0070434 | 4e-04 | Inf | 0.0381 | 2 | 2 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0010469 | 4e-04 | 2.4226 | 9.2811 | 21 | 487 | regulation of receptor activity |
| GO:0030819 | 6e-04 | 5.3263 | 1.4484 | 7 | 76 | positive regulation of cAMP biosynthetic process |
| GO:0045616 | 6e-04 | 8.1661 | 0.7051 | 5 | 37 | regulation of keratinocyte differentiation |
| GO:0045670 | 7e-04 | 6.1624 | 1.0863 | 6 | 57 | regulation of osteoclast differentiation |
| GO:0090084 | 0.001 | 19.4935 | 0.2096 | 3 | 11 | negative regulation of inclusion body assembly |
| GO:0001545 | 0.0011 | 103.6528 | 0.0572 | 2 | 3 | primary ovarian follicle growth |
| GO:0090063 | 0.0011 | 103.6528 | 0.0572 | 2 | 3 | positive regulation of microtubule nucleation |
| GO:0031424 | 0.0012 | 7.0576 | 0.799 | 5 | 43 | keratinization |
| GO:0042699 | 0.0021 | 51.8229 | 0.0762 | 2 | 4 | follicle-stimulating hormone signaling pathway |
| GO:0070293 | 0.0026 | 12.9922 | 0.2859 | 3 | 15 | renal absorption |
| GO:0006333 | 0.0028 | 3.2651 | 2.9349 | 9 | 154 | chromatin assembly or disassembly |
| GO:0044242 | 0.0028 | 3.0281 | 3.5066 | 10 | 184 | cellular lipid catabolic process |
| GO:0030810 | 0.003 | 3.9454 | 1.9058 | 7 | 100 | positive regulation of nucleotide biosynthetic process |
| GO:0048385 | 0.0032 | 11.992 | 0.3049 | 3 | 16 | regulation of retinoic acid receptor signaling pathway |
| GO:0030801 | 0.0034 | 3.8618 | 1.9439 | 7 | 102 | positive regulation of cyclic nucleotide metabolic process |
| GO:0045682 | 0.0035 | 4.4206 | 1.4674 | 6 | 77 | regulation of epidermis development |
| GO:0030856 | 0.0036 | 3.4144 | 2.4965 | 8 | 131 | regulation of epithelial cell differentiation |
| GO:0007606 | 0.0038 | 3.3866 | 2.5156 | 8 | 132 | sensory perception of chemical stimulus |
| GO:0006323 | 0.0052 | 2.956 | 3.2207 | 9 | 169 | DNA packaging |
| GO:0009838 | 0.0052 | 25.908 | 0.1143 | 2 | 6 | abscission |
| GO:0038001 | 0.0052 | 25.908 | 0.1143 | 2 | 6 | paracrine signaling |
| GO:1902172 | 0.0052 | 25.908 | 0.1143 | 2 | 6 | regulation of keratinocyte apoptotic process |
| GO:1903265 | 0.0052 | 25.908 | 0.1143 | 2 | 6 | positive regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0002227 | 0.0053 | 9.7415 | 0.3621 | 3 | 19 | innate immune response in mucosa |
| GO:0009190 | 0.0064 | 3.0853 | 2.7443 | 8 | 144 | cyclic nucleotide biosynthetic process |
| GO:0001516 | 0.0071 | 8.658 | 0.4002 | 3 | 21 | prostaglandin biosynthetic process |
| GO:0070424 | 0.0071 | 20.725 | 0.1334 | 2 | 7 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0021513 | 0.0081 | 8.2017 | 0.4193 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0031644 | 0.0084 | 4.2755 | 1.2578 | 5 | 66 | regulation of neurological system process |
| GO:0045637 | 0.0091 | 2.5273 | 4.1546 | 10 | 218 | regulation of myeloid cell differentiation |
| GO:0042026 | 0.0091 | 7.7911 | 0.4383 | 3 | 23 | protein refolding |
| GO:0048671 | 0.0094 | 17.2697 | 0.1525 | 2 | 8 | negative regulation of collateral sprouting |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 1e-04 | 2.6977 | 8.8046 | 22 | 406 | pattern specification process |
| GO:0009952 | 1e-04 | 3.6199 | 4.2071 | 14 | 194 | anterior/posterior pattern specification |
| GO:0060128 | 5e-04 | Inf | 0.0434 | 2 | 2 | corticotropin hormone secreting cell differentiation |
| GO:0042742 | 6e-04 | 3.2668 | 3.9469 | 12 | 182 | defense response to bacterium |
| GO:1900120 | 7e-04 | 12.1652 | 0.412 | 4 | 19 | regulation of receptor binding |
| GO:1904627 | 0.0011 | 19.502 | 0.2169 | 3 | 10 | response to phorbol 13-acetate 12-myristate |
| GO:0060129 | 0.0014 | 90.7683 | 0.0651 | 2 | 3 | thyroid-stimulating hormone-secreting cell differentiation |
| GO:2000297 | 0.0014 | 90.7683 | 0.0651 | 2 | 3 | negative regulation of synapse maturation |
| GO:1903555 | 0.0021 | 3.7493 | 2.2987 | 8 | 106 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0010469 | 0.0022 | 2.1032 | 10.5612 | 21 | 487 | regulation of receptor activity |
| GO:0014034 | 0.0027 | 45.3811 | 0.0867 | 2 | 4 | neural crest cell fate commitment |
| GO:0060979 | 0.0027 | 45.3811 | 0.0867 | 2 | 4 | vasculogenesis involved in coronary vascular morphogenesis |
| GO:0043067 | 0.0028 | 1.6228 | 30.2957 | 46 | 1397 | regulation of programmed cell death |
| GO:0048863 | 0.0028 | 2.5792 | 5.3348 | 13 | 246 | stem cell differentiation |
| GO:0002714 | 0.0029 | 7.5987 | 0.6072 | 4 | 28 | positive regulation of B cell mediated immunity |
| GO:0009607 | 0.0037 | 1.819 | 16.2647 | 28 | 750 | response to biotic stimulus |
| GO:0001569 | 0.0038 | 7.0132 | 0.6506 | 4 | 30 | branching involved in blood vessel morphogenesis |
| GO:0035282 | 0.0038 | 3.774 | 1.9951 | 7 | 92 | segmentation |
| GO:0009954 | 0.0043 | 6.753 | 0.6723 | 4 | 31 | proximal/distal pattern formation |
| GO:0072081 | 0.0045 | 30.252 | 0.1084 | 2 | 5 | specification of nephron tubule identity |
| GO:0043583 | 0.0045 | 2.6673 | 4.3589 | 11 | 201 | ear development |
| GO:0061138 | 0.0045 | 2.8229 | 3.7517 | 10 | 173 | morphogenesis of a branching epithelium |
| GO:0035295 | 0.0048 | 1.9274 | 12.0142 | 22 | 554 | tube development |
| GO:0051172 | 0.005 | 1.4635 | 48.5339 | 66 | 2238 | negative regulation of nitrogen compound metabolic process |
| GO:0060429 | 0.0052 | 1.6406 | 23.8766 | 37 | 1101 | epithelium development |
| GO:0032845 | 0.0053 | 2.7545 | 3.8385 | 10 | 177 | negative regulation of homeostatic process |
| GO:0006919 | 0.0053 | 4.0357 | 1.6048 | 6 | 74 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0080090 | 0.0055 | 1.3419 | 120.2938 | 143 | 5547 | regulation of primary metabolic process |
| GO:0051707 | 0.0061 | 1.7841 | 15.3322 | 26 | 707 | response to other organism |
| GO:0048646 | 0.0064 | 1.6637 | 20.9273 | 33 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0001759 | 0.0065 | 9.096 | 0.3904 | 3 | 18 | organ induction |
| GO:0031323 | 0.0065 | 1.3316 | 122.766 | 145 | 5661 | regulation of cellular metabolic process |
| GO:0002866 | 0.0066 | 22.6875 | 0.1301 | 2 | 6 | positive regulation of acute inflammatory response to antigenic stimulus |
| GO:0021546 | 0.0066 | 22.6875 | 0.1301 | 2 | 6 | rhombomere development |
| GO:0045687 | 0.0067 | 5.8801 | 0.759 | 4 | 35 | positive regulation of glial cell differentiation |
| GO:0048009 | 0.0067 | 5.8801 | 0.759 | 4 | 35 | insulin-like growth factor receptor signaling pathway |
| GO:0002700 | 0.0067 | 3.3744 | 2.212 | 7 | 102 | regulation of production of molecular mediator of immune response |
| GO:0050864 | 0.0067 | 3.3744 | 2.212 | 7 | 102 | regulation of B cell activation |
| GO:0097193 | 0.007 | 2.2981 | 5.942 | 13 | 274 | intrinsic apoptotic signaling pathway |
| GO:0043066 | 0.0071 | 1.7234 | 17.0888 | 28 | 788 | negative regulation of apoptotic process |
| GO:0050918 | 0.0072 | 4.4754 | 1.2144 | 5 | 56 | positive chemotaxis |
| GO:0007204 | 0.0081 | 2.3427 | 5.3782 | 12 | 248 | positive regulation of cytosolic calcium ion concentration |
| GO:0045830 | 0.0088 | 8.0248 | 0.4337 | 3 | 20 | positive regulation of isotype switching |
| GO:0008284 | 0.0088 | 1.6929 | 17.3707 | 28 | 801 | positive regulation of cell proliferation |
| GO:0006955 | 0.0089 | 1.4806 | 36.5847 | 51 | 1687 | immune response |
| GO:0032760 | 0.009 | 4.2259 | 1.2795 | 5 | 59 | positive regulation of tumor necrosis factor production |
| GO:0031119 | 0.0092 | 18.1488 | 0.1518 | 2 | 7 | tRNA pseudouridine synthesis |
| GO:0032226 | 0.0092 | 18.1488 | 0.1518 | 2 | 7 | positive regulation of synaptic transmission, dopaminergic |
| GO:0031327 | 0.0093 | 1.5044 | 32.3776 | 46 | 1493 | negative regulation of cellular biosynthetic process |
| GO:0006952 | 0.0097 | 1.5268 | 29.0596 | 42 | 1340 | defense response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003278 | 0 | 56.9574 | 0.205 | 4 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0000122 | 1e-04 | 1.9175 | 25.7659 | 46 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0048665 | 1e-04 | 7.6996 | 1.1277 | 7 | 33 | neuron fate specification |
| GO:0006334 | 1e-04 | 3.7809 | 3.8273 | 13 | 112 | nucleosome assembly |
| GO:0016070 | 1e-04 | 1.48 | 103.5557 | 137 | 3145 | RNA metabolic process |
| GO:0002076 | 1e-04 | 12.962 | 0.5468 | 5 | 16 | osteoblast development |
| GO:0033673 | 2e-04 | 2.6011 | 8.7139 | 21 | 255 | negative regulation of kinase activity |
| GO:0060548 | 3e-04 | 1.7728 | 30.14 | 50 | 882 | negative regulation of cell death |
| GO:0034654 | 3e-04 | 1.3971 | 136.245 | 171 | 3987 | nucleobase-containing compound biosynthetic process |
| GO:0045597 | 3e-04 | 1.7807 | 28.7731 | 48 | 842 | positive regulation of cell differentiation |
| GO:0044237 | 4e-04 | 1.4232 | 240.2718 | 274 | 7376 | cellular metabolic process |
| GO:0010467 | 4e-04 | 1.4365 | 108.0321 | 139 | 3305 | gene expression |
| GO:0042475 | 4e-04 | 4.0392 | 2.768 | 10 | 81 | odontogenesis of dentin-containing tooth |
| GO:0019219 | 5e-04 | 1.3863 | 134.3655 | 168 | 3932 | regulation of nucleobase-containing compound metabolic process |
| GO:0048762 | 5e-04 | 2.7789 | 6.2194 | 16 | 182 | mesenchymal cell differentiation |
| GO:2000679 | 6e-04 | 8.9084 | 0.7176 | 5 | 21 | positive regulation of transcription regulatory region DNA binding |
| GO:0006338 | 6e-04 | 2.9845 | 5.0917 | 14 | 149 | chromatin remodeling |
| GO:1901576 | 6e-04 | 1.3429 | 201.0015 | 237 | 5882 | organic substance biosynthetic process |
| GO:0006323 | 7e-04 | 2.805 | 5.7751 | 15 | 169 | DNA packaging |
| GO:0009650 | 8e-04 | 12.6512 | 0.4442 | 4 | 13 | UV protection |
| GO:0006355 | 8e-04 | 1.4862 | 67.1073 | 92 | 2033 | regulation of transcription, DNA-templated |
| GO:0006333 | 8e-04 | 2.8769 | 5.2625 | 14 | 154 | chromatin assembly or disassembly |
| GO:0009889 | 8e-04 | 1.3588 | 141.61 | 174 | 4144 | regulation of biosynthetic process |
| GO:0060255 | 9e-04 | 1.3329 | 190.4764 | 225 | 5574 | regulation of macromolecule metabolic process |
| GO:0043066 | 9e-04 | 1.7336 | 26.9278 | 44 | 788 | negative regulation of apoptotic process |
| GO:2000826 | 0.0011 | 5.9042 | 1.196 | 6 | 35 | regulation of heart morphogenesis |
| GO:1901255 | 0.0012 | Inf | 0.0683 | 2 | 2 | nucleotide-excision repair involved in interstrand cross-link repair |
| GO:1902257 | 0.0012 | Inf | 0.0683 | 2 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
| GO:2001141 | 0.0012 | 1.464 | 67.9374 | 92 | 2058 | regulation of RNA biosynthetic process |
| GO:0097659 | 0.0012 | 1.4312 | 80.387 | 106 | 2433 | nucleic acid-templated transcription |
| GO:0060290 | 0.0013 | 21.3148 | 0.2392 | 3 | 7 | transdifferentiation |
| GO:0060350 | 0.0013 | 4.7612 | 1.6744 | 7 | 49 | endochondral bone morphogenesis |
| GO:0009790 | 0.0013 | 1.6534 | 31.4044 | 49 | 919 | embryo development |
| GO:0045165 | 0.0014 | 2.3595 | 8.133 | 18 | 238 | cell fate commitment |
| GO:0040007 | 0.0015 | 1.6559 | 30.0375 | 47 | 879 | growth |
| GO:0060669 | 0.0017 | 6.785 | 0.8885 | 5 | 26 | embryonic placenta morphogenesis |
| GO:0006807 | 0.0017 | 1.3481 | 225.1274 | 255 | 6924 | nitrogen compound metabolic process |
| GO:0034645 | 0.0018 | 1.368 | 111.6164 | 139 | 3395 | cellular macromolecule biosynthetic process |
| GO:0030856 | 0.0018 | 2.8938 | 4.4766 | 12 | 131 | regulation of epithelial cell differentiation |
| GO:0001503 | 0.0022 | 2.0337 | 11.9603 | 23 | 350 | ossification |
| GO:0071824 | 0.0023 | 2.3092 | 7.8255 | 17 | 229 | protein-DNA complex subunit organization |
| GO:0001933 | 0.0024 | 1.9502 | 13.5322 | 25 | 396 | negative regulation of protein phosphorylation |
| GO:0010811 | 0.0025 | 3.1127 | 3.4856 | 10 | 102 | positive regulation of cell-substrate adhesion |
| GO:0071901 | 0.0027 | 2.8923 | 4.1007 | 11 | 120 | negative regulation of protein serine/threonine kinase activity |
| GO:0001707 | 0.0028 | 3.6295 | 2.4262 | 8 | 71 | mesoderm formation |
| GO:0016559 | 0.0029 | 14.2079 | 0.3076 | 3 | 9 | peroxisome fission |
| GO:0048010 | 0.0031 | 3.259 | 3.0072 | 9 | 88 | vascular endothelial growth factor receptor signaling pathway |
| GO:0035050 | 0.0031 | 3.5725 | 2.4604 | 8 | 72 | embryonic heart tube development |
| GO:0030199 | 0.0032 | 4.6251 | 1.4694 | 6 | 43 | collagen fibril organization |
| GO:0048729 | 0.0033 | 1.7395 | 19.9592 | 33 | 587 | tissue morphogenesis |
| GO:0051101 | 0.0034 | 2.9822 | 3.6223 | 10 | 106 | regulation of DNA binding |
| GO:0048259 | 0.0034 | 3.5173 | 2.4946 | 8 | 73 | regulation of receptor-mediated endocytosis |
| GO:0010482 | 0.0034 | 56.7413 | 0.1025 | 2 | 3 | regulation of epidermal cell division |
| GO:0035054 | 0.0034 | 56.7413 | 0.1025 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0060061 | 0.0034 | 56.7413 | 0.1025 | 2 | 3 | Spemann organizer formation |
| GO:0060355 | 0.0034 | 56.7413 | 0.1025 | 2 | 3 | positive regulation of cell adhesion molecule production |
| GO:0051253 | 0.0036 | 1.5087 | 40.5625 | 58 | 1187 | negative regulation of RNA metabolic process |
| GO:0006362 | 0.0037 | 5.4783 | 1.0593 | 5 | 31 | transcription elongation from RNA polymerase I promoter |
| GO:0010629 | 0.0038 | 1.4265 | 57.9562 | 78 | 1696 | negative regulation of gene expression |
| GO:0014032 | 0.0038 | 3.843 | 2.0162 | 7 | 59 | neural crest cell development |
| GO:0001765 | 0.004 | 12.1774 | 0.3417 | 3 | 10 | membrane raft assembly |
| GO:0035646 | 0.004 | 12.1774 | 0.3417 | 3 | 10 | endosome to melanosome transport |
| GO:0048340 | 0.004 | 12.1774 | 0.3417 | 3 | 10 | paraxial mesoderm morphogenesis |
| GO:0048757 | 0.004 | 12.1774 | 0.3417 | 3 | 10 | pigment granule maturation |
| GO:0060174 | 0.004 | 12.1774 | 0.3417 | 3 | 10 | limb bud formation |
| GO:0001657 | 0.0042 | 3.1011 | 3.1439 | 9 | 92 | ureteric bud development |
| GO:0030521 | 0.0042 | 3.7702 | 2.0503 | 7 | 60 | androgen receptor signaling pathway |
| GO:0061436 | 0.0042 | 7.1129 | 0.6834 | 4 | 20 | establishment of skin barrier |
| GO:1902742 | 0.0043 | 5.2751 | 1.0935 | 5 | 32 | apoptotic process involved in development |
| GO:0072163 | 0.0045 | 3.064 | 3.178 | 9 | 93 | mesonephric epithelium development |
| GO:0006139 | 0.0047 | 1.5476 | 34.5698 | 50 | 1103 | nucleobase-containing compound metabolic process |
| GO:2000113 | 0.005 | 1.455 | 46.3718 | 64 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0051172 | 0.005 | 1.3627 | 76.4776 | 98 | 2238 | negative regulation of nitrogen compound metabolic process |
| GO:0071459 | 0.0051 | 6.694 | 0.7176 | 4 | 21 | protein localization to chromosome, centromeric region |
| GO:0003413 | 0.0053 | 10.6545 | 0.3759 | 3 | 11 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0035413 | 0.0053 | 10.6545 | 0.3759 | 3 | 11 | positive regulation of catenin import into nucleus |
| GO:0043476 | 0.0053 | 10.6545 | 0.3759 | 3 | 11 | pigment accumulation |
| GO:1903507 | 0.0057 | 1.4908 | 38.068 | 54 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:0072006 | 0.0059 | 2.5818 | 4.5449 | 11 | 133 | nephron development |
| GO:0072010 | 0.006 | 6.3217 | 0.7518 | 4 | 22 | glomerular epithelium development |
| GO:0014706 | 0.0061 | 1.9152 | 11.5161 | 21 | 337 | striated muscle tissue development |
| GO:0007389 | 0.0067 | 1.8132 | 13.874 | 24 | 406 | pattern specification process |
| GO:0003219 | 0.0067 | 28.3687 | 0.1367 | 2 | 4 | cardiac right ventricle formation |
| GO:0003308 | 0.0067 | 28.3687 | 0.1367 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0060729 | 0.0067 | 28.3687 | 0.1367 | 2 | 4 | intestinal epithelial structure maintenance |
| GO:1904340 | 0.0067 | 28.3687 | 0.1367 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
| GO:0048546 | 0.0069 | 3.8874 | 1.7086 | 6 | 50 | digestive tract morphogenesis |
| GO:0030182 | 0.0069 | 1.5037 | 34.1934 | 49 | 1014 | neuron differentiation |
| GO:0014029 | 0.0069 | 9.47 | 0.4101 | 3 | 12 | neural crest formation |
| GO:0060536 | 0.0069 | 9.47 | 0.4101 | 3 | 12 | cartilage morphogenesis |
| GO:0060670 | 0.0069 | 9.47 | 0.4101 | 3 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0060707 | 0.0069 | 9.47 | 0.4101 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0097152 | 0.0069 | 9.47 | 0.4101 | 3 | 12 | mesenchymal cell apoptotic process |
| GO:2000095 | 0.0069 | 9.47 | 0.4101 | 3 | 12 | regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0070167 | 0.0071 | 3.3854 | 2.2554 | 7 | 66 | regulation of biomineral tissue development |
| GO:0045684 | 0.0072 | 4.5932 | 1.2302 | 5 | 36 | positive regulation of epidermis development |
| GO:0006665 | 0.0073 | 2.3873 | 5.3309 | 12 | 156 | sphingolipid metabolic process |
| GO:0050767 | 0.0076 | 1.6113 | 22.7246 | 35 | 665 | regulation of neurogenesis |
| GO:0032092 | 0.0079 | 3.006 | 2.8705 | 8 | 84 | positive regulation of protein binding |
| GO:0031324 | 0.0083 | 1.3269 | 81.501 | 102 | 2385 | negative regulation of cellular metabolic process |
| GO:0007369 | 0.0086 | 2.2445 | 6.1168 | 13 | 179 | gastrulation |
| GO:0021978 | 0.0088 | 8.5224 | 0.4442 | 3 | 13 | telencephalon regionalization |
| GO:0045893 | 0.0088 | 1.419 | 45.8592 | 62 | 1342 | positive regulation of transcription, DNA-templated |
| GO:0048469 | 0.0089 | 2.3221 | 5.4676 | 12 | 160 | cell maturation |
| GO:1902680 | 0.0089 | 1.4178 | 45.8934 | 62 | 1343 | positive regulation of RNA biosynthetic process |
| GO:0061138 | 0.009 | 2.3187 | 5.4743 | 12 | 161 | morphogenesis of a branching epithelium |
| GO:0071364 | 0.009 | 4.3142 | 1.2985 | 5 | 38 | cellular response to epidermal growth factor stimulus |
| GO:0046513 | 0.0091 | 3.6385 | 1.8111 | 6 | 53 | ceramide biosynthetic process |
| GO:0051276 | 0.0093 | 1.4591 | 37.3162 | 52 | 1092 | chromosome organization |
| GO:0035270 | 0.0095 | 2.5306 | 4.2032 | 10 | 123 | endocrine system development |
| GO:0045879 | 0.0096 | 5.4175 | 0.8543 | 4 | 25 | negative regulation of smoothened signaling pathway |
| GO:0045815 | 0.0098 | 3.1696 | 2.3921 | 7 | 70 | positive regulation of gene expression, epigenetic |
| GO:0045665 | 0.0098 | 2.2042 | 6.2194 | 13 | 182 | negative regulation of neuron differentiation |
| GO:0061448 | 0.0098 | 2.0691 | 7.6204 | 15 | 223 | connective tissue development |
| GO:0001706 | 0.01 | 3.5625 | 1.8453 | 6 | 54 | endoderm formation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030728 | 2e-04 | 16.5771 | 0.2964 | 4 | 22 | ovulation |
| GO:0007186 | 3e-04 | 2.3591 | 11.0917 | 24 | 831 | G-protein coupled receptor signaling pathway |
| GO:0035106 | 5e-04 | 147.8916 | 0.0404 | 2 | 3 | operant conditioning |
| GO:0033189 | 0.001 | 18.5644 | 0.2021 | 3 | 15 | response to vitamin A |
| GO:0043271 | 0.001 | 4.8337 | 1.5627 | 7 | 116 | negative regulation of ion transport |
| GO:0006953 | 0.0012 | 9.6171 | 0.4715 | 4 | 35 | acute-phase response |
| GO:0007620 | 0.0017 | 14.8485 | 0.2425 | 3 | 18 | copulation |
| GO:0051968 | 0.0017 | 14.8485 | 0.2425 | 3 | 18 | positive regulation of synaptic transmission, glutamatergic |
| GO:0006382 | 0.0018 | 49.2906 | 0.0674 | 2 | 5 | adenosine to inosine editing |
| GO:1902219 | 0.0018 | 49.2906 | 0.0674 | 2 | 5 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:0031424 | 0.0026 | 4.0472 | 1.8456 | 7 | 137 | keratinization |
| GO:0042713 | 0.0026 | 36.9655 | 0.0808 | 2 | 6 | sperm ejaculation |
| GO:0106049 | 0.0026 | 36.9655 | 0.0808 | 2 | 6 | regulation of cellular response to osmotic stress |
| GO:0006954 | 0.0036 | 2.2065 | 8.1908 | 17 | 608 | inflammatory response |
| GO:0036017 | 0.0036 | 29.5704 | 0.0943 | 2 | 7 | response to erythropoietin |
| GO:0097756 | 0.0038 | 5.1875 | 1.0373 | 5 | 77 | negative regulation of blood vessel diameter |
| GO:0007217 | 0.0048 | 24.6404 | 0.1078 | 2 | 8 | tachykinin receptor signaling pathway |
| GO:0048069 | 0.0048 | 24.6404 | 0.1078 | 2 | 8 | eye pigmentation |
| GO:0051549 | 0.0048 | 24.6404 | 0.1078 | 2 | 8 | positive regulation of keratinocyte migration |
| GO:0070474 | 0.0048 | 24.6404 | 0.1078 | 2 | 8 | positive regulation of uterine smooth muscle contraction |
| GO:0019953 | 0.0049 | 2.0426 | 9.8883 | 19 | 734 | sexual reproduction |
| GO:0050867 | 0.005 | 2.779 | 3.799 | 10 | 282 | positive regulation of cell activation |
| GO:0050671 | 0.005 | 4.0475 | 1.5762 | 6 | 117 | positive regulation of lymphocyte proliferation |
| GO:2001234 | 0.0051 | 3.2021 | 2.6405 | 8 | 196 | negative regulation of apoptotic signaling pathway |
| GO:0002673 | 0.0055 | 4.7256 | 1.1316 | 5 | 84 | regulation of acute inflammatory response |
| GO:0018958 | 0.0061 | 4.6083 | 1.1586 | 5 | 86 | phenol-containing compound metabolic process |
| GO:0046877 | 0.0061 | 21.1189 | 0.1212 | 2 | 9 | regulation of saliva secretion |
| GO:1900452 | 0.0061 | 21.1189 | 0.1212 | 2 | 9 | regulation of long term synaptic depression |
| GO:0070229 | 0.0062 | 8.9032 | 0.3772 | 3 | 28 | negative regulation of lymphocyte apoptotic process |
| GO:0035296 | 0.0062 | 3.8718 | 1.6436 | 6 | 122 | regulation of tube diameter |
| GO:0070665 | 0.0062 | 3.8718 | 1.6436 | 6 | 122 | positive regulation of leukocyte proliferation |
| GO:0022414 | 0.0068 | 1.7493 | 17.1496 | 28 | 1273 | reproductive process |
| GO:0018149 | 0.0068 | 8.5602 | 0.3907 | 3 | 29 | peptide cross-linking |
| GO:0009913 | 0.0072 | 2.7908 | 3.3949 | 9 | 252 | epidermal cell differentiation |
| GO:0050911 | 0.0072 | 5.6168 | 0.7679 | 4 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0051349 | 0.0072 | 5.6168 | 0.7679 | 4 | 57 | positive regulation of lyase activity |
| GO:0002684 | 0.0076 | 1.8874 | 11.8147 | 21 | 877 | positive regulation of immune system process |
| GO:0050880 | 0.008 | 3.6497 | 1.7379 | 6 | 129 | regulation of blood vessel size |
| GO:1901617 | 0.0081 | 2.9477 | 2.856 | 8 | 212 | organic hydroxy compound biosynthetic process |
| GO:0006940 | 0.0082 | 5.4118 | 0.7948 | 4 | 59 | regulation of smooth muscle contraction |
| GO:0006956 | 0.0082 | 5.4118 | 0.7948 | 4 | 59 | complement activation |
| GO:0006508 | 0.0082 | 1.6521 | 21.4875 | 33 | 1595 | proteolysis |
| GO:0032228 | 0.0082 | 7.9477 | 0.4176 | 3 | 31 | regulation of synaptic transmission, GABAergic |
| GO:0045907 | 0.0082 | 7.9477 | 0.4176 | 3 | 31 | positive regulation of vasoconstriction |
| GO:2001240 | 0.0082 | 7.9477 | 0.4176 | 3 | 31 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0031295 | 0.0092 | 5.2213 | 0.8218 | 4 | 61 | T cell costimulation |
| GO:1904035 | 0.0097 | 5.1309 | 0.8353 | 4 | 62 | regulation of epithelial cell apoptotic process |
| GO:0043243 | 0.0098 | 7.4168 | 0.4446 | 3 | 33 | positive regulation of protein complex disassembly |
| GO:0043588 | 0.0098 | 2.4979 | 4.2032 | 10 | 312 | skin development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009223 | 0 | 34.6626 | 0.246 | 5 | 12 | pyrimidine deoxyribonucleotide catabolic process |
| GO:0034655 | 0 | 2.9678 | 9.6161 | 26 | 469 | nucleobase-containing compound catabolic process |
| GO:2001034 | 1e-04 | 72.3447 | 0.1025 | 3 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
| GO:0009394 | 3e-04 | 10.0984 | 0.5946 | 5 | 29 | 2'-deoxyribonucleotide metabolic process |
| GO:0006402 | 4e-04 | 2.7585 | 6.6021 | 17 | 322 | mRNA catabolic process |
| GO:1902544 | 4e-04 | Inf | 0.041 | 2 | 2 | regulation of DNA N-glycosylase activity |
| GO:0072529 | 4e-04 | 8.9745 | 0.6561 | 5 | 32 | pyrimidine-containing compound catabolic process |
| GO:1901360 | 7e-04 | 1.4573 | 118.9606 | 147 | 5802 | organic cyclic compound metabolic process |
| GO:0009056 | 9e-04 | 1.584 | 47.1168 | 68 | 2298 | catabolic process |
| GO:0009166 | 0.0015 | 5.2941 | 1.2507 | 6 | 61 | nucleotide catabolic process |
| GO:0006220 | 0.0016 | 6.5446 | 0.8611 | 5 | 42 | pyrimidine nucleotide metabolic process |
| GO:0034433 | 0.0016 | 16.069 | 0.246 | 3 | 12 | steroid esterification |
| GO:0034435 | 0.0016 | 16.069 | 0.246 | 3 | 12 | cholesterol esterification |
| GO:0006725 | 0.0019 | 1.4084 | 114.7984 | 140 | 5599 | cellular aromatic compound metabolic process |
| GO:0046483 | 0.0021 | 1.404 | 114.0808 | 139 | 5564 | heterocycle metabolic process |
| GO:0051090 | 0.0027 | 2.3296 | 7.2582 | 16 | 354 | regulation of DNA binding transcription factor activity |
| GO:0046426 | 0.0029 | 5.6291 | 0.9842 | 5 | 48 | negative regulation of JAK-STAT cascade |
| GO:0090304 | 0.0037 | 1.3841 | 98.4367 | 121 | 4801 | nucleic acid metabolic process |
| GO:0035511 | 0.004 | 32.0473 | 0.1025 | 2 | 5 | oxidative DNA demethylation |
| GO:0007032 | 0.0044 | 4.216 | 1.5378 | 6 | 75 | endosome organization |
| GO:0006605 | 0.0046 | 2.1964 | 7.6683 | 16 | 374 | protein targeting |
| GO:0044241 | 0.0047 | 10.3266 | 0.3486 | 3 | 17 | lipid digestion |
| GO:1901673 | 0.0047 | 10.3266 | 0.3486 | 3 | 17 | regulation of mitotic spindle assembly |
| GO:0043162 | 0.0055 | 9.6375 | 0.3691 | 3 | 18 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
| GO:0010468 | 0.0057 | 1.3728 | 86.3808 | 107 | 4213 | regulation of gene expression |
| GO:0042045 | 0.006 | 24.0339 | 0.123 | 2 | 6 | epithelial fluid transport |
| GO:0044271 | 0.006 | 1.3615 | 94.9717 | 116 | 4632 | cellular nitrogen compound biosynthetic process |
| GO:0090090 | 0.0063 | 2.8639 | 3.3215 | 9 | 162 | negative regulation of canonical Wnt signaling pathway |
| GO:1904385 | 0.0065 | 9.0346 | 0.3896 | 3 | 19 | cellular response to angiotensin |
| GO:0019068 | 0.0067 | 5.8528 | 0.7586 | 4 | 37 | virion assembly |
| GO:0051252 | 0.0068 | 1.3984 | 66.4995 | 85 | 3315 | regulation of RNA metabolic process |
| GO:0071156 | 0.0068 | 3.364 | 2.2144 | 7 | 108 | regulation of cell cycle arrest |
| GO:0009116 | 0.0072 | 3.3308 | 2.2349 | 7 | 109 | nucleoside metabolic process |
| GO:0044058 | 0.0074 | 5.6803 | 0.7791 | 4 | 38 | regulation of digestive system process |
| GO:0046006 | 0.0074 | 5.6803 | 0.7791 | 4 | 38 | regulation of activated T cell proliferation |
| GO:1901136 | 0.0076 | 2.7723 | 3.4241 | 9 | 167 | carbohydrate derivative catabolic process |
| GO:0000184 | 0.0079 | 3.2663 | 2.2759 | 7 | 111 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| GO:0034641 | 0.0079 | 1.6029 | 26.5345 | 39 | 1433 | cellular nitrogen compound metabolic process |
| GO:1903311 | 0.008 | 2.3448 | 5.3719 | 12 | 262 | regulation of mRNA metabolic process |
| GO:1903506 | 0.0081 | 1.3778 | 69.609 | 88 | 3395 | regulation of nucleic acid-templated transcription |
| GO:1903321 | 0.0086 | 2.9228 | 2.891 | 8 | 141 | negative regulation of protein modification by small protein conjugation or removal |
| GO:0039702 | 0.0086 | 8.0297 | 0.4306 | 3 | 21 | viral budding via host ESCRT complex |
| GO:2000679 | 0.0086 | 8.0297 | 0.4306 | 3 | 21 | positive regulation of transcription regulatory region DNA binding |
| GO:0043488 | 0.0093 | 2.8791 | 2.932 | 8 | 143 | regulation of mRNA stability |
| GO:0044265 | 0.0097 | 1.6239 | 20.7494 | 32 | 1012 | cellular macromolecule catabolic process |
| GO:0006753 | 0.0099 | 1.7739 | 13.5937 | 23 | 663 | nucleoside phosphate metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007218 | 0 | 6.1609 | 2.4693 | 13 | 88 | neuropeptide signaling pathway |
| GO:0006334 | 0 | 5.082 | 3.1428 | 14 | 112 | nucleosome assembly |
| GO:0010469 | 0 | 2.5523 | 13.6656 | 32 | 487 | regulation of receptor activity |
| GO:0042445 | 0 | 3.744 | 5.0229 | 17 | 179 | hormone metabolic process |
| GO:0006775 | 1e-04 | 7.6865 | 1.0944 | 7 | 39 | fat-soluble vitamin metabolic process |
| GO:0006333 | 1e-04 | 3.5472 | 4.3214 | 14 | 154 | chromatin assembly or disassembly |
| GO:0001710 | 1e-04 | 12.5051 | 0.5332 | 5 | 19 | mesodermal cell fate commitment |
| GO:0010454 | 2e-04 | 19.9703 | 0.3087 | 4 | 11 | negative regulation of cell fate commitment |
| GO:0007186 | 2e-04 | 2.0413 | 18.3921 | 35 | 677 | G-protein coupled receptor signaling pathway |
| GO:0021953 | 2e-04 | 3.3085 | 4.602 | 14 | 164 | central nervous system neuron differentiation |
| GO:0030858 | 3e-04 | 5.4114 | 1.6836 | 8 | 60 | positive regulation of epithelial cell differentiation |
| GO:0006323 | 3e-04 | 3.2007 | 4.7423 | 14 | 169 | DNA packaging |
| GO:0016115 | 4e-04 | 34.875 | 0.1684 | 3 | 6 | terpenoid catabolic process |
| GO:0038001 | 4e-04 | 34.875 | 0.1684 | 3 | 6 | paracrine signaling |
| GO:0046137 | 4e-04 | 34.875 | 0.1684 | 3 | 6 | negative regulation of vitamin metabolic process |
| GO:0060137 | 4e-04 | 34.875 | 0.1684 | 3 | 6 | maternal process involved in parturition |
| GO:0006720 | 5e-04 | 3.6285 | 3.3112 | 11 | 118 | isoprenoid metabolic process |
| GO:0007631 | 5e-04 | 4.8168 | 1.8616 | 8 | 67 | feeding behavior |
| GO:0021515 | 5e-04 | 5.5856 | 1.4311 | 7 | 51 | cell differentiation in spinal cord |
| GO:0007188 | 6e-04 | 3.2863 | 3.9566 | 12 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0009953 | 7e-04 | 4.5736 | 1.9487 | 8 | 70 | dorsal/ventral pattern formation |
| GO:0052652 | 7e-04 | 3.2357 | 4.0127 | 12 | 143 | cyclic purine nucleotide metabolic process |
| GO:0002158 | 7e-04 | 26.1545 | 0.1964 | 3 | 7 | osteoclast proliferation |
| GO:0042572 | 8e-04 | 7.9535 | 0.7576 | 5 | 27 | retinol metabolic process |
| GO:0060135 | 8e-04 | 5.1188 | 1.5433 | 7 | 55 | maternal process involved in female pregnancy |
| GO:0035295 | 0.001 | 1.9798 | 15.5456 | 29 | 554 | tube development |
| GO:0070098 | 0.001 | 4.9133 | 1.5995 | 7 | 57 | chemokine-mediated signaling pathway |
| GO:0072507 | 0.0011 | 2.1589 | 11.3085 | 23 | 403 | divalent inorganic cation homeostasis |
| GO:0042755 | 0.0012 | 7.2897 | 0.8138 | 5 | 29 | eating behavior |
| GO:0021517 | 0.0012 | 5.6826 | 1.2066 | 6 | 43 | ventral spinal cord development |
| GO:0030799 | 0.0012 | 3.0258 | 4.2652 | 12 | 152 | regulation of cyclic nucleotide metabolic process |
| GO:0048513 | 0.0013 | 1.4243 | 85.2204 | 111 | 3037 | animal organ development |
| GO:0030817 | 0.0013 | 3.4195 | 3.1709 | 10 | 113 | regulation of cAMP biosynthetic process |
| GO:0009880 | 0.0014 | 4.6343 | 1.6836 | 7 | 60 | embryonic pattern specification |
| GO:0002138 | 0.0016 | 17.434 | 0.2525 | 3 | 9 | retinoic acid biosynthetic process |
| GO:2001256 | 0.0016 | 17.434 | 0.2525 | 3 | 9 | regulation of store-operated calcium entry |
| GO:0002227 | 0.0017 | 9.3144 | 0.5332 | 4 | 19 | innate immune response in mucosa |
| GO:0042127 | 0.002 | 1.5502 | 41.2773 | 60 | 1471 | regulation of cell proliferation |
| GO:0007267 | 0.002 | 1.553 | 40.5017 | 59 | 1453 | cell-cell signaling |
| GO:0007389 | 0.0021 | 2.2053 | 9.1155 | 19 | 331 | pattern specification process |
| GO:0030808 | 0.0022 | 2.9589 | 3.9846 | 11 | 142 | regulation of nucleotide biosynthetic process |
| GO:0009624 | 0.0023 | 69.5953 | 0.0842 | 2 | 3 | response to nematode |
| GO:0010956 | 0.0023 | 69.5953 | 0.0842 | 2 | 3 | negative regulation of calcidiol 1-monooxygenase activity |
| GO:1901994 | 0.0023 | 69.5953 | 0.0842 | 2 | 3 | negative regulation of meiotic cell cycle phase transition |
| GO:2000768 | 0.0023 | 69.5953 | 0.0842 | 2 | 3 | positive regulation of nephron tubule epithelial cell differentiation |
| GO:0001708 | 0.0023 | 4.1982 | 1.8365 | 7 | 66 | cell fate specification |
| GO:0007617 | 0.0025 | 8.2175 | 0.5893 | 4 | 21 | mating behavior |
| GO:0001707 | 0.0026 | 4.1107 | 1.8718 | 7 | 67 | mesoderm formation |
| GO:0014033 | 0.0027 | 4.0917 | 1.8801 | 7 | 67 | neural crest cell differentiation |
| GO:0031960 | 0.0028 | 2.8705 | 4.0969 | 11 | 146 | response to corticosteroid |
| GO:0001659 | 0.0028 | 5.8294 | 0.9821 | 5 | 35 | temperature homeostasis |
| GO:0048663 | 0.0029 | 4.0243 | 1.9081 | 7 | 68 | neuron fate commitment |
| GO:0016338 | 0.003 | 7.7604 | 0.6173 | 4 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0021513 | 0.003 | 7.7604 | 0.6173 | 4 | 22 | spinal cord dorsal/ventral patterning |
| GO:0009111 | 0.0031 | 13.0737 | 0.3087 | 3 | 11 | vitamin catabolic process |
| GO:0021521 | 0.0031 | 13.0737 | 0.3087 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0048484 | 0.0031 | 13.0737 | 0.3087 | 3 | 11 | enteric nervous system development |
| GO:0006874 | 0.0032 | 2.076 | 10.158 | 20 | 362 | cellular calcium ion homeostasis |
| GO:0009605 | 0.0034 | 1.455 | 53.5679 | 73 | 1909 | response to external stimulus |
| GO:0001755 | 0.0035 | 5.4643 | 1.0382 | 5 | 37 | neural crest cell migration |
| GO:0061844 | 0.0035 | 5.4643 | 1.0382 | 5 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0001523 | 0.0037 | 4.4231 | 1.5002 | 6 | 54 | retinoid metabolic process |
| GO:0002009 | 0.0038 | 1.8783 | 14.0023 | 25 | 499 | morphogenesis of an epithelium |
| GO:0016114 | 0.004 | 11.6203 | 0.3367 | 3 | 12 | terpenoid biosynthetic process |
| GO:0042659 | 0.004 | 11.6203 | 0.3367 | 3 | 12 | regulation of cell fate specification |
| GO:0001975 | 0.0042 | 6.9835 | 0.6735 | 4 | 24 | response to amphetamine |
| GO:0010470 | 0.0045 | 5.1422 | 1.0944 | 5 | 39 | regulation of gastrulation |
| GO:0001705 | 0.0045 | 34.7953 | 0.1122 | 2 | 4 | ectoderm formation |
| GO:0010701 | 0.0045 | 34.7953 | 0.1122 | 2 | 4 | positive regulation of norepinephrine secretion |
| GO:0034653 | 0.0045 | 34.7953 | 0.1122 | 2 | 4 | retinoic acid catabolic process |
| GO:0042662 | 0.0045 | 34.7953 | 0.1122 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0048866 | 0.0045 | 34.7953 | 0.1122 | 2 | 4 | stem cell fate specification |
| GO:0060406 | 0.0045 | 34.7953 | 0.1122 | 2 | 4 | positive regulation of penile erection |
| GO:1905903 | 0.0045 | 34.7953 | 0.1122 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0033993 | 0.0046 | 1.6482 | 23.6271 | 37 | 842 | response to lipid |
| GO:0070268 | 0.0049 | 3.2645 | 2.6377 | 8 | 94 | cornification |
| GO:0050830 | 0.005 | 3.6083 | 2.1046 | 7 | 75 | defense response to Gram-positive bacterium |
| GO:0008544 | 0.0051 | 2.0217 | 9.8774 | 19 | 352 | epidermis development |
| GO:0007200 | 0.0052 | 3.2267 | 2.6658 | 8 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0071824 | 0.0053 | 2.298 | 6.4259 | 14 | 229 | protein-DNA complex subunit organization |
| GO:0019730 | 0.0054 | 6.4063 | 0.7232 | 4 | 26 | antimicrobial humoral response |
| GO:0030815 | 0.0055 | 4.8558 | 1.1505 | 5 | 41 | negative regulation of cAMP metabolic process |
| GO:0051937 | 0.0056 | 4.0393 | 1.6275 | 6 | 58 | catecholamine transport |
| GO:0022414 | 0.0061 | 1.506 | 35.7213 | 51 | 1273 | reproductive process |
| GO:0003044 | 0.0062 | 4.7243 | 1.1786 | 5 | 42 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0007565 | 0.0062 | 2.8864 | 3.3241 | 9 | 120 | female pregnancy |
| GO:0006935 | 0.0063 | 1.7997 | 14.5635 | 25 | 519 | chemotaxis |
| GO:0007626 | 0.0063 | 2.4289 | 5.2193 | 12 | 186 | locomotory behavior |
| GO:0042711 | 0.0063 | 9.5062 | 0.3929 | 3 | 14 | maternal behavior |
| GO:0090280 | 0.0063 | 9.5062 | 0.3929 | 3 | 14 | positive regulation of calcium ion import |
| GO:0048754 | 0.0064 | 2.6835 | 3.9566 | 10 | 141 | branching morphogenesis of an epithelial tube |
| GO:0001824 | 0.0066 | 3.8892 | 1.6836 | 6 | 60 | blastocyst development |
| GO:0050433 | 0.0068 | 4.5997 | 1.2066 | 5 | 43 | regulation of catecholamine secretion |
| GO:0045926 | 0.007 | 2.3024 | 5.9489 | 13 | 212 | negative regulation of growth |
| GO:0038170 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | somatostatin signaling pathway |
| GO:0060023 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | soft palate development |
| GO:0060455 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0061056 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | sclerotome development |
| GO:0071502 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | cellular response to temperature stimulus |
| GO:0071799 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | cellular response to prostaglandin D stimulus |
| GO:1903142 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | positive regulation of establishment of endothelial barrier |
| GO:1904995 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2000609 | 0.0074 | 23.1953 | 0.1403 | 2 | 5 | regulation of thyroid hormone generation |
| GO:0097746 | 0.0074 | 2.7966 | 3.4234 | 9 | 122 | regulation of blood vessel diameter |
| GO:0001829 | 0.0078 | 8.7134 | 0.4209 | 3 | 15 | trophectodermal cell differentiation |
| GO:0060581 | 0.0078 | 8.7134 | 0.4209 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:2000380 | 0.0078 | 8.7134 | 0.4209 | 3 | 15 | regulation of mesoderm development |
| GO:2000696 | 0.0078 | 8.7134 | 0.4209 | 3 | 15 | regulation of epithelial cell differentiation involved in kidney development |
| GO:0032570 | 0.0083 | 4.3691 | 1.2627 | 5 | 45 | response to progesterone |
| GO:0001756 | 0.0083 | 3.6837 | 1.7678 | 6 | 63 | somitogenesis |
| GO:0014031 | 0.0083 | 3.6837 | 1.7678 | 6 | 63 | mesenchymal cell development |
| GO:0048864 | 0.0083 | 3.6837 | 1.7678 | 6 | 63 | stem cell development |
| GO:0002251 | 0.0083 | 5.5849 | 0.8138 | 4 | 29 | organ or tissue specific immune response |
| GO:0031128 | 0.0083 | 5.5849 | 0.8138 | 4 | 29 | developmental induction |
| GO:0002687 | 0.0089 | 2.9224 | 2.9183 | 8 | 104 | positive regulation of leukocyte migration |
| GO:0019932 | 0.0091 | 2.0836 | 7.5483 | 15 | 269 | second-messenger-mediated signaling |
| GO:0048385 | 0.0094 | 8.0426 | 0.449 | 3 | 16 | regulation of retinoic acid receptor signaling pathway |
| GO:0019731 | 0.0094 | 5.3697 | 0.8418 | 4 | 30 | antibacterial humoral response |
| GO:0048598 | 0.0094 | 1.7143 | 15.8543 | 26 | 565 | embryonic morphogenesis |
| GO:1901615 | 0.0098 | 1.7968 | 12.7957 | 22 | 456 | organic hydroxy compound metabolic process |
| GO:0031279 | 0.0098 | 3.1436 | 2.3852 | 7 | 85 | regulation of cyclase activity |
| GO:0051055 | 0.0099 | 4.1605 | 1.3189 | 5 | 47 | negative regulation of lipid biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010469 | 0 | 2.3003 | 15.0097 | 32 | 487 | regulation of receptor activity |
| GO:1901750 | 1e-04 | 25.3643 | 0.2774 | 4 | 9 | leukotriene D4 biosynthetic process |
| GO:0006751 | 2e-04 | 21.1355 | 0.3082 | 4 | 10 | glutathione catabolic process |
| GO:0007565 | 3e-04 | 3.0124 | 5.3936 | 15 | 175 | female pregnancy |
| GO:0030819 | 5e-04 | 4.2871 | 2.3424 | 9 | 76 | positive regulation of cAMP biosynthetic process |
| GO:0051384 | 9e-04 | 3.148 | 4.13 | 12 | 134 | response to glucocorticoid |
| GO:0003002 | 0.001 | 2.2575 | 9.8935 | 21 | 321 | regionalization |
| GO:0030810 | 0.001 | 3.5483 | 3.0821 | 10 | 100 | positive regulation of nucleotide biosynthetic process |
| GO:0030801 | 0.0012 | 3.4707 | 3.1437 | 10 | 102 | positive regulation of cyclic nucleotide metabolic process |
| GO:0009888 | 0.0012 | 1.5131 | 53.1042 | 75 | 1723 | tissue development |
| GO:0048839 | 0.0013 | 2.7362 | 5.4861 | 14 | 178 | inner ear development |
| GO:1904894 | 0.0014 | 4.1106 | 2.1575 | 8 | 70 | positive regulation of STAT cascade |
| GO:0042531 | 0.0014 | 4.6402 | 1.6951 | 7 | 55 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0071294 | 0.0015 | 9.7502 | 0.524 | 4 | 17 | cellular response to zinc ion |
| GO:0052652 | 0.0016 | 2.9299 | 4.4074 | 12 | 143 | cyclic purine nucleotide metabolic process |
| GO:0006691 | 0.0021 | 6.3461 | 0.9246 | 5 | 30 | leukotriene metabolic process |
| GO:0046456 | 0.0022 | 5.0165 | 1.3561 | 6 | 44 | icosanoid biosynthetic process |
| GO:0009605 | 0.0024 | 1.4526 | 58.8369 | 80 | 1909 | response to external stimulus |
| GO:0030856 | 0.0024 | 2.9277 | 4.0375 | 11 | 131 | regulation of epithelial cell differentiation |
| GO:0031497 | 0.0024 | 2.9277 | 4.0375 | 11 | 131 | chromatin assembly |
| GO:0072511 | 0.0024 | 1.9803 | 12.7906 | 24 | 415 | divalent inorganic cation transport |
| GO:0030802 | 0.0027 | 2.8793 | 4.0992 | 11 | 133 | regulation of cyclic nucleotide biosynthetic process |
| GO:0002025 | 0.0028 | 63.1563 | 0.0925 | 2 | 3 | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure |
| GO:0044691 | 0.0028 | 63.1563 | 0.0925 | 2 | 3 | tooth eruption |
| GO:1904627 | 0.003 | 13.557 | 0.3082 | 3 | 10 | response to phorbol 13-acetate 12-myristate |
| GO:0001756 | 0.0032 | 3.9751 | 1.9417 | 7 | 63 | somitogenesis |
| GO:0007263 | 0.0035 | 7.454 | 0.6472 | 4 | 21 | nitric oxide mediated signal transduction |
| GO:0034728 | 0.0038 | 2.7432 | 4.2841 | 11 | 139 | nucleosome organization |
| GO:0048568 | 0.0039 | 1.929 | 12.5441 | 23 | 407 | embryonic organ development |
| GO:0040015 | 0.004 | 11.8616 | 0.339 | 3 | 11 | negative regulation of multicellular organism growth |
| GO:0051290 | 0.0041 | 5.2866 | 1.0787 | 5 | 35 | protein heterotetramerization |
| GO:1901362 | 0.0043 | 1.3115 | 129.0775 | 155 | 4188 | organic cyclic compound biosynthetic process |
| GO:1900371 | 0.0043 | 2.7007 | 4.3457 | 11 | 141 | regulation of purine nucleotide biosynthetic process |
| GO:0071300 | 0.0045 | 3.7091 | 2.065 | 7 | 67 | cellular response to retinoic acid |
| GO:0006816 | 0.005 | 1.9511 | 11.3112 | 21 | 367 | calcium ion transport |
| GO:0045616 | 0.0053 | 4.9555 | 1.1404 | 5 | 37 | regulation of keratinocyte differentiation |
| GO:0032849 | 0.0055 | 31.576 | 0.1233 | 2 | 4 | positive regulation of cellular pH reduction |
| GO:0072107 | 0.0055 | 31.576 | 0.1233 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0006335 | 0.0058 | 6.3346 | 0.7397 | 4 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0030814 | 0.0059 | 2.7244 | 3.9142 | 10 | 127 | regulation of cAMP metabolic process |
| GO:0007405 | 0.0061 | 3.9687 | 1.6643 | 6 | 54 | neuroblast proliferation |
| GO:0045926 | 0.0061 | 2.2611 | 6.534 | 14 | 212 | negative regulation of growth |
| GO:0042074 | 0.0066 | 9.488 | 0.4007 | 3 | 13 | cell migration involved in gastrulation |
| GO:0045165 | 0.0071 | 2.152 | 7.3353 | 15 | 238 | cell fate commitment |
| GO:0042490 | 0.0073 | 3.8094 | 1.726 | 6 | 56 | mechanoreceptor differentiation |
| GO:1900544 | 0.0077 | 2.6119 | 4.0683 | 10 | 132 | positive regulation of purine nucleotide metabolic process |
| GO:0000183 | 0.0078 | 5.758 | 0.8013 | 4 | 26 | chromatin silencing at rDNA |
| GO:0090280 | 0.0082 | 8.6249 | 0.4315 | 3 | 14 | positive regulation of calcium ion import |
| GO:0050830 | 0.0083 | 3.2709 | 2.3116 | 7 | 75 | defense response to Gram-positive bacterium |
| GO:0031326 | 0.0088 | 1.2813 | 125.7488 | 149 | 4080 | regulation of cellular biosynthetic process |
| GO:0050793 | 0.0088 | 1.3512 | 69.0694 | 88 | 2241 | regulation of developmental process |
| GO:0007386 | 0.0089 | 21.0493 | 0.1541 | 2 | 5 | compartment pattern specification |
| GO:0048382 | 0.0089 | 21.0493 | 0.1541 | 2 | 5 | mesendoderm development |
| GO:0051970 | 0.0089 | 21.0493 | 0.1541 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:2001034 | 0.0089 | 21.0493 | 0.1541 | 2 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
| GO:2001188 | 0.0089 | 21.0493 | 0.1541 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0048645 | 0.0094 | 3.5931 | 1.8184 | 6 | 59 | animal organ formation |
| GO:0048863 | 0.0095 | 2.0763 | 7.5819 | 15 | 246 | stem cell differentiation |
| GO:0021761 | 0.0095 | 2.8909 | 2.9588 | 8 | 96 | limbic system development |
| GO:0032648 | 0.01 | 4.1714 | 1.3253 | 5 | 43 | regulation of interferon-beta production |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007267 | 1e-04 | 1.9187 | 29.9144 | 52 | 1459 | cell-cell signaling |
| GO:0098609 | 1e-04 | 2.2582 | 15.3775 | 32 | 750 | cell-cell adhesion |
| GO:0060455 | 1e-04 | 72.3447 | 0.1025 | 3 | 5 | negative regulation of gastric acid secretion |
| GO:0002922 | 1e-04 | 19.3442 | 0.287 | 4 | 14 | positive regulation of humoral immune response |
| GO:0032501 | 2e-04 | 1.6444 | 66.1112 | 91 | 3660 | multicellular organismal process |
| GO:0035360 | 3e-04 | 36.1675 | 0.1435 | 3 | 7 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0007156 | 3e-04 | 3.8266 | 3.1165 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0090187 | 4e-04 | Inf | 0.041 | 2 | 2 | positive regulation of pancreatic juice secretion |
| GO:0046717 | 4e-04 | 4.3537 | 2.2554 | 9 | 110 | acid secretion |
| GO:2000510 | 4e-04 | 28.932 | 0.164 | 3 | 8 | positive regulation of dendritic cell chemotaxis |
| GO:0032502 | 5e-04 | 1.5864 | 63.4348 | 87 | 3306 | developmental process |
| GO:0046887 | 5e-04 | 4.2272 | 2.3169 | 9 | 113 | positive regulation of hormone secretion |
| GO:2000288 | 7e-04 | 24.1084 | 0.1845 | 3 | 9 | positive regulation of myoblast proliferation |
| GO:0006954 | 8e-04 | 2.1399 | 12.4661 | 25 | 608 | inflammatory response |
| GO:0030154 | 8e-04 | 1.4999 | 75.1654 | 100 | 3666 | cell differentiation |
| GO:0022610 | 9e-04 | 1.7678 | 26.2238 | 43 | 1279 | biological adhesion |
| GO:0044058 | 0.001 | 7.3398 | 0.7791 | 5 | 38 | regulation of digestive system process |
| GO:0009620 | 0.0011 | 7.1235 | 0.7996 | 5 | 39 | response to fungus |
| GO:0003008 | 0.0012 | 1.6762 | 31.5752 | 49 | 1540 | system process |
| GO:0014717 | 0.0012 | 96.1548 | 0.0615 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
| GO:1902164 | 0.0012 | 96.1548 | 0.0615 | 2 | 3 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0007589 | 0.0014 | 4.5998 | 1.6608 | 7 | 81 | body fluid secretion |
| GO:0009888 | 0.0016 | 1.6217 | 35.3273 | 53 | 1723 | tissue development |
| GO:0009607 | 0.0016 | 1.9367 | 15.3775 | 28 | 750 | response to biotic stimulus |
| GO:0006955 | 0.0017 | 1.6232 | 34.5892 | 52 | 1687 | immune response |
| GO:0042730 | 0.0018 | 8.7857 | 0.5331 | 4 | 26 | fibrinolysis |
| GO:0071345 | 0.0022 | 1.8709 | 16.4642 | 29 | 803 | cellular response to cytokine stimulus |
| GO:0043403 | 0.0024 | 8.0525 | 0.5741 | 4 | 28 | skeletal muscle tissue regeneration |
| GO:0034653 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | retinoic acid catabolic process |
| GO:1902109 | 0.0024 | 48.0742 | 0.082 | 2 | 4 | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:0060547 | 0.0026 | 13.1456 | 0.287 | 3 | 14 | negative regulation of necrotic cell death |
| GO:0070268 | 0.0032 | 3.909 | 1.9273 | 7 | 94 | cornification |
| GO:0032303 | 0.0032 | 12.0494 | 0.3076 | 3 | 15 | regulation of icosanoid secretion |
| GO:0030217 | 0.0033 | 2.7857 | 4.1827 | 11 | 204 | T cell differentiation |
| GO:0035296 | 0.0036 | 3.4144 | 2.5014 | 8 | 122 | regulation of tube diameter |
| GO:0031342 | 0.0039 | 11.1217 | 0.3281 | 3 | 16 | negative regulation of cell killing |
| GO:0032101 | 0.004 | 1.9008 | 13.3272 | 24 | 650 | regulation of response to external stimulus |
| GO:0002933 | 0.004 | 32.0473 | 0.1025 | 2 | 5 | lipid hydroxylation |
| GO:0051412 | 0.0047 | 10.3266 | 0.3486 | 3 | 17 | response to corticosterone |
| GO:0050793 | 0.005 | 1.4785 | 45.9481 | 63 | 2241 | regulation of developmental process |
| GO:0050880 | 0.0051 | 3.2153 | 2.6449 | 8 | 129 | regulation of blood vessel size |
| GO:0050906 | 0.0051 | 3.2153 | 2.6449 | 8 | 129 | detection of stimulus involved in sensory perception |
| GO:0019229 | 0.0053 | 4.8388 | 1.1277 | 5 | 55 | regulation of vasoconstriction |
| GO:0048513 | 0.0055 | 1.4174 | 62.2688 | 81 | 3037 | animal organ development |
| GO:0010469 | 0.0057 | 2.0004 | 9.9851 | 19 | 487 | regulation of receptor activity |
| GO:0051240 | 0.0058 | 1.5928 | 27.3695 | 41 | 1351 | positive regulation of multicellular organismal process |
| GO:0071805 | 0.0059 | 2.7088 | 3.8956 | 10 | 190 | potassium ion transmembrane transport |
| GO:0001915 | 0.006 | 24.0339 | 0.123 | 2 | 6 | negative regulation of T cell mediated cytotoxicity |
| GO:0014719 | 0.006 | 24.0339 | 0.123 | 2 | 6 | skeletal muscle satellite cell activation |
| GO:0016115 | 0.006 | 24.0339 | 0.123 | 2 | 6 | terpenoid catabolic process |
| GO:1905709 | 0.006 | 24.0339 | 0.123 | 2 | 6 | negative regulation of membrane permeability |
| GO:1990144 | 0.006 | 24.0339 | 0.123 | 2 | 6 | intrinsic apoptotic signaling pathway in response to hypoxia |
| GO:2000766 | 0.006 | 24.0339 | 0.123 | 2 | 6 | negative regulation of cytoplasmic translation |
| GO:0048731 | 0.0061 | 1.6737 | 21.8293 | 34 | 1151 | system development |
| GO:0050911 | 0.0061 | 4.652 | 1.1687 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0044321 | 0.0065 | 9.0346 | 0.3896 | 3 | 19 | response to leptin |
| GO:0070304 | 0.0067 | 3.0622 | 2.768 | 8 | 135 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0042127 | 0.0069 | 1.5507 | 30.1605 | 44 | 1471 | regulation of cell proliferation |
| GO:0002886 | 0.0074 | 5.6803 | 0.7791 | 4 | 38 | regulation of myeloid leukocyte mediated immunity |
| GO:0031099 | 0.0076 | 2.7723 | 3.4241 | 9 | 167 | regeneration |
| GO:0002578 | 0.0082 | 19.2258 | 0.1435 | 2 | 7 | negative regulation of antigen processing and presentation |
| GO:0002883 | 0.0082 | 19.2258 | 0.1435 | 2 | 7 | regulation of hypersensitivity |
| GO:0010647 | 0.0085 | 1.5516 | 28.0251 | 41 | 1397 | positive regulation of cell communication |
| GO:0008211 | 0.0086 | 8.0297 | 0.4306 | 3 | 21 | glucocorticoid metabolic process |
| GO:1901687 | 0.0086 | 8.0297 | 0.4306 | 3 | 21 | glutathione derivative biosynthetic process |
| GO:0010951 | 0.0086 | 2.5509 | 4.1212 | 10 | 201 | negative regulation of endopeptidase activity |
| GO:0044706 | 0.0086 | 2.5509 | 4.1212 | 10 | 201 | multi-multicellular organism process |
| GO:0046330 | 0.0087 | 3.2042 | 2.3169 | 7 | 113 | positive regulation of JNK cascade |
| GO:0043300 | 0.0089 | 5.364 | 0.8201 | 4 | 40 | regulation of leukocyte degranulation |
| GO:0044060 | 0.0089 | 5.364 | 0.8201 | 4 | 40 | regulation of endocrine process |
| GO:0002793 | 0.0091 | 2.4061 | 4.7978 | 11 | 234 | positive regulation of peptide secretion |
| GO:0023056 | 0.0091 | 1.5441 | 28.1455 | 41 | 1403 | positive regulation of signaling |
| GO:0002237 | 0.0092 | 2.2145 | 6.151 | 13 | 300 | response to molecule of bacterial origin |
| GO:0051707 | 0.0092 | 1.7862 | 13.5114 | 23 | 668 | response to other organism |
| GO:0048584 | 0.0093 | 1.4634 | 39.346 | 54 | 1919 | positive regulation of response to stimulus |
| GO:1903524 | 0.0094 | 4.1691 | 1.2917 | 5 | 63 | positive regulation of blood circulation |
| GO:0046633 | 0.0098 | 7.6065 | 0.4511 | 3 | 22 | alpha-beta T cell proliferation |
| GO:0009593 | 0.0099 | 3.1154 | 2.3784 | 7 | 116 | detection of chemical stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 5e-04 | Inf | 0.0432 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0035630 | 5e-04 | 27.392 | 0.173 | 3 | 8 | bone mineralization involved in bone maturation |
| GO:0006656 | 8e-04 | 7.9071 | 0.7351 | 5 | 34 | phosphatidylcholine biosynthetic process |
| GO:0061754 | 0.0014 | 91.052 | 0.0649 | 2 | 3 | negative regulation of circulating fibrinogen levels |
| GO:0030500 | 0.0015 | 5.2998 | 1.254 | 6 | 58 | regulation of bone mineralization |
| GO:1904645 | 0.0019 | 8.7133 | 0.5405 | 4 | 25 | response to amyloid-beta |
| GO:0051775 | 0.0019 | 15.2137 | 0.2594 | 3 | 12 | response to redox state |
| GO:1902652 | 0.0021 | 3.4324 | 2.8107 | 9 | 130 | secondary alcohol metabolic process |
| GO:0031214 | 0.003 | 3.5428 | 2.4215 | 8 | 112 | biomineral tissue development |
| GO:0016125 | 0.0041 | 3.0735 | 3.1134 | 9 | 144 | sterol metabolic process |
| GO:0007519 | 0.0049 | 2.9843 | 3.1998 | 9 | 148 | skeletal muscle tissue development |
| GO:0031668 | 0.0049 | 2.6338 | 4.4106 | 11 | 204 | cellular response to extracellular stimulus |
| GO:0014904 | 0.0054 | 6.3062 | 0.7135 | 4 | 33 | myotube cell development |
| GO:0070977 | 0.0054 | 9.777 | 0.3675 | 3 | 17 | bone maturation |
| GO:0014065 | 0.0055 | 3.1737 | 2.6809 | 8 | 124 | phosphatidylinositol 3-kinase signaling |
| GO:0042060 | 0.006 | 1.9512 | 10.767 | 20 | 498 | wound healing |
| GO:1901991 | 0.0061 | 2.5533 | 4.5403 | 11 | 210 | negative regulation of mitotic cell cycle phase transition |
| GO:0036120 | 0.0064 | 9.1245 | 0.3892 | 3 | 18 | cellular response to platelet-derived growth factor stimulus |
| GO:0006545 | 0.0066 | 22.7584 | 0.1297 | 2 | 6 | glycine biosynthetic process |
| GO:0090205 | 0.0066 | 22.7584 | 0.1297 | 2 | 6 | positive regulation of cholesterol metabolic process |
| GO:1904417 | 0.0066 | 22.7584 | 0.1297 | 2 | 6 | positive regulation of xenophagy |
| GO:0050906 | 0.007 | 3.0415 | 2.7891 | 8 | 129 | detection of stimulus involved in sensory perception |
| GO:0071305 | 0.0075 | 8.5537 | 0.4108 | 3 | 19 | cellular response to vitamin D |
| GO:0050911 | 0.0077 | 4.4029 | 1.2324 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0.008 | 2.9673 | 2.8539 | 8 | 132 | sensory perception of chemical stimulus |
| GO:0045669 | 0.0082 | 4.3195 | 1.254 | 5 | 58 | positive regulation of osteoblast differentiation |
| GO:0051785 | 0.0082 | 4.3195 | 1.254 | 5 | 58 | positive regulation of nuclear division |
| GO:0021782 | 0.0086 | 3.6203 | 1.7729 | 6 | 82 | glial cell development |
| GO:1905048 | 0.0087 | 8.05 | 0.4324 | 3 | 20 | regulation of metallopeptidase activity |
| GO:0001503 | 0.0094 | 2.0752 | 7.5672 | 15 | 350 | ossification |
| GO:2000679 | 0.01 | 7.6022 | 0.454 | 3 | 21 | positive regulation of transcription regulatory region DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050830 | 0 | 6.1764 | 1.863 | 10 | 75 | defense response to Gram-positive bacterium |
| GO:0043207 | 0 | 2.2157 | 17.612 | 36 | 709 | response to external biotic stimulus |
| GO:0009617 | 1e-04 | 2.5173 | 11.1534 | 26 | 449 | response to bacterium |
| GO:0098542 | 1e-04 | 2.6282 | 9.4394 | 23 | 380 | defense response to other organism |
| GO:0051354 | 1e-04 | 12.4187 | 0.5217 | 5 | 21 | negative regulation of oxidoreductase activity |
| GO:0030595 | 3e-04 | 3.3963 | 4.1484 | 13 | 167 | leukocyte chemotaxis |
| GO:0046137 | 3e-04 | 39.5627 | 0.149 | 3 | 6 | negative regulation of vitamin metabolic process |
| GO:0060556 | 5e-04 | 29.67 | 0.1739 | 3 | 7 | regulation of vitamin D biosynthetic process |
| GO:0010469 | 5e-04 | 2.2039 | 12.0974 | 25 | 487 | regulation of receptor activity |
| GO:0018003 | 6e-04 | Inf | 0.0497 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:1901731 | 6e-04 | Inf | 0.0497 | 2 | 2 | positive regulation of platelet aggregation |
| GO:0016525 | 0.0011 | 4.2 | 2.0866 | 8 | 84 | negative regulation of angiogenesis |
| GO:0032768 | 0.0014 | 5.4234 | 1.242 | 6 | 50 | regulation of monooxygenase activity |
| GO:0072676 | 0.0015 | 4.571 | 1.6892 | 7 | 68 | lymphocyte migration |
| GO:2000147 | 0.0015 | 2.1736 | 10.2343 | 21 | 412 | positive regulation of cell motility |
| GO:1904627 | 0.0016 | 16.9509 | 0.2484 | 3 | 10 | response to phorbol 13-acetate 12-myristate |
| GO:0002408 | 0.0018 | 78.9255 | 0.0745 | 2 | 3 | myeloid dendritic cell chemotaxis |
| GO:0010956 | 0.0018 | 78.9255 | 0.0745 | 2 | 3 | negative regulation of calcidiol 1-monooxygenase activity |
| GO:0048646 | 0.0019 | 1.7285 | 23.9712 | 39 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0019730 | 0.0019 | 4.3558 | 1.7637 | 7 | 71 | antimicrobial humoral response |
| GO:0006334 | 0.0019 | 3.4895 | 2.7822 | 9 | 112 | nucleosome assembly |
| GO:0001676 | 0.0019 | 3.844 | 2.2605 | 8 | 91 | long-chain fatty acid metabolic process |
| GO:1901343 | 0.002 | 3.7979 | 2.2853 | 8 | 92 | negative regulation of vasculature development |
| GO:0042362 | 0.0022 | 14.831 | 0.2732 | 3 | 11 | fat-soluble vitamin biosynthetic process |
| GO:0002376 | 0.0023 | 1.4575 | 61.7041 | 83 | 2484 | immune system process |
| GO:0051674 | 0.0024 | 1.5997 | 33.3113 | 50 | 1341 | localization of cell |
| GO:0045926 | 0.0025 | 2.6202 | 5.2662 | 13 | 212 | negative regulation of growth |
| GO:0051239 | 0.0032 | 1.4302 | 65.0825 | 86 | 2620 | regulation of multicellular organismal process |
| GO:0002687 | 0.0044 | 3.3205 | 2.5834 | 8 | 104 | positive regulation of leukocyte migration |
| GO:0050829 | 0.0047 | 4.1828 | 1.565 | 6 | 63 | defense response to Gram-negative bacterium |
| GO:0051270 | 0.005 | 1.7062 | 19.7483 | 32 | 795 | regulation of cellular component movement |
| GO:0006333 | 0.0051 | 2.7731 | 3.8255 | 10 | 154 | chromatin assembly or disassembly |
| GO:0000038 | 0.0054 | 6.3375 | 0.7204 | 4 | 29 | very long-chain fatty acid metabolic process |
| GO:0042330 | 0.0055 | 1.8735 | 12.8923 | 23 | 519 | taxis |
| GO:0050920 | 0.0056 | 2.7347 | 3.8751 | 10 | 156 | regulation of chemotaxis |
| GO:0030334 | 0.0059 | 1.7492 | 16.8171 | 28 | 677 | regulation of cell migration |
| GO:0050868 | 0.0063 | 3.4377 | 2.186 | 7 | 88 | negative regulation of T cell activation |
| GO:0006590 | 0.0067 | 9.1237 | 0.3975 | 3 | 16 | thyroid hormone generation |
| GO:0001953 | 0.0069 | 5.8673 | 0.7701 | 4 | 31 | negative regulation of cell-matrix adhesion |
| GO:0002695 | 0.0072 | 2.8032 | 3.4032 | 9 | 137 | negative regulation of leukocyte activation |
| GO:0050865 | 0.0072 | 1.8809 | 11.6999 | 21 | 471 | regulation of cell activation |
| GO:0032103 | 0.0076 | 2.2723 | 6.0114 | 13 | 242 | positive regulation of response to external stimulus |
| GO:1901342 | 0.0078 | 2.5995 | 4.0608 | 10 | 166 | regulation of vasculature development |
| GO:0072359 | 0.0079 | 1.6108 | 22.8285 | 35 | 919 | circulatory system development |
| GO:0042359 | 0.008 | 8.4714 | 0.4223 | 3 | 17 | vitamin D metabolic process |
| GO:0071294 | 0.008 | 8.4714 | 0.4223 | 3 | 17 | cellular response to zinc ion |
| GO:0050793 | 0.0082 | 1.3989 | 55.6679 | 73 | 2241 | regulation of developmental process |
| GO:0006730 | 0.0087 | 5.4619 | 0.8197 | 4 | 33 | one-carbon metabolic process |
| GO:0006954 | 0.0096 | 1.7318 | 15.1031 | 25 | 608 | inflammatory response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001568 | 0 | 2.8059 | 16.7042 | 42 | 583 | blood vessel development |
| GO:0072358 | 0 | 2.648 | 17.5924 | 42 | 614 | cardiovascular system development |
| GO:0051674 | 0 | 1.9608 | 38.4226 | 68 | 1341 | localization of cell |
| GO:0007186 | 0 | 2.188 | 24.0392 | 48 | 839 | G-protein coupled receptor signaling pathway |
| GO:0007389 | 0 | 2.7224 | 11.6328 | 29 | 406 | pattern specification process |
| GO:0009952 | 0 | 3.5734 | 5.5585 | 18 | 194 | anterior/posterior pattern specification |
| GO:0032501 | 0 | 1.5989 | 119.1601 | 157 | 4638 | multicellular organismal process |
| GO:0040011 | 0 | 1.9642 | 31.259 | 56 | 1121 | locomotion |
| GO:0030155 | 0 | 2.2543 | 17.793 | 37 | 621 | regulation of cell adhesion |
| GO:0032502 | 0 | 1.5893 | 97.6873 | 132 | 3820 | developmental process |
| GO:0045765 | 0 | 3.1312 | 6.6187 | 19 | 231 | regulation of angiogenesis |
| GO:0043009 | 0 | 2.2914 | 15.5581 | 33 | 543 | chordate embryonic development |
| GO:0070268 | 1e-04 | 4.5834 | 2.6933 | 11 | 94 | cornification |
| GO:0033594 | 1e-04 | 102.4018 | 0.1146 | 3 | 4 | response to hydroxyisoflavone |
| GO:0051464 | 1e-04 | 102.4018 | 0.1146 | 3 | 4 | positive regulation of cortisol secretion |
| GO:0007267 | 1e-04 | 1.8525 | 29.7909 | 51 | 1064 | cell-cell signaling |
| GO:0007155 | 1e-04 | 2.6859 | 8.4435 | 21 | 316 | cell adhesion |
| GO:0045944 | 1e-04 | 1.8393 | 29.9129 | 51 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0071549 | 1e-04 | 8.9533 | 0.8309 | 6 | 29 | cellular response to dexamethasone stimulus |
| GO:0003184 | 3e-04 | 17.0984 | 0.3438 | 4 | 12 | pulmonary valve morphogenesis |
| GO:0040037 | 3e-04 | 17.0984 | 0.3438 | 4 | 12 | negative regulation of fibroblast growth factor receptor signaling pathway |
| GO:0048704 | 3e-04 | 4.2079 | 2.636 | 10 | 92 | embryonic skeletal system morphogenesis |
| GO:0008285 | 3e-04 | 2.013 | 18.0509 | 34 | 630 | negative regulation of cell proliferation |
| GO:0051240 | 3e-04 | 1.7015 | 36.7425 | 58 | 1313 | positive regulation of multicellular organismal process |
| GO:0061061 | 3e-04 | 2.0456 | 16.7042 | 32 | 583 | muscle structure development |
| GO:0022612 | 4e-04 | 3.7248 | 3.2377 | 11 | 113 | gland morphogenesis |
| GO:0007154 | 5e-04 | 1.5026 | 82.1461 | 109 | 3155 | cell communication |
| GO:0006935 | 5e-04 | 2.0781 | 14.8705 | 29 | 519 | chemotaxis |
| GO:2000145 | 5e-04 | 1.8937 | 20.8301 | 37 | 727 | regulation of cell motility |
| GO:0034616 | 5e-04 | 13.6769 | 0.4011 | 4 | 14 | response to laminar fluid shear stress |
| GO:0006928 | 6e-04 | 1.6539 | 38.4039 | 59 | 1379 | movement of cell or subcellular component |
| GO:0090132 | 6e-04 | 2.6248 | 6.9338 | 17 | 242 | epithelium migration |
| GO:1903426 | 6e-04 | 4.664 | 1.9197 | 8 | 67 | regulation of reactive oxygen species biosynthetic process |
| GO:0048729 | 7e-04 | 1.9717 | 16.7163 | 31 | 587 | tissue morphogenesis |
| GO:2000848 | 8e-04 | 25.5953 | 0.2006 | 3 | 7 | positive regulation of corticosteroid hormone secretion |
| GO:0007521 | 8e-04 | Inf | 0.0573 | 2 | 2 | muscle cell fate determination |
| GO:0014846 | 8e-04 | Inf | 0.0573 | 2 | 2 | esophagus smooth muscle contraction |
| GO:0046013 | 8e-04 | Inf | 0.0573 | 2 | 2 | regulation of T cell homeostatic proliferation |
| GO:2000502 | 8e-04 | Inf | 0.0573 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0001525 | 8e-04 | 2.8574 | 5.2591 | 14 | 189 | angiogenesis |
| GO:0043627 | 8e-04 | 4.4374 | 2.0057 | 8 | 70 | response to estrogen |
| GO:0030198 | 9e-04 | 2.3366 | 9.1114 | 20 | 318 | extracellular matrix organization |
| GO:0030154 | 9e-04 | 1.5711 | 48.5951 | 70 | 1844 | cell differentiation |
| GO:0046850 | 9e-04 | 6.0521 | 1.1461 | 6 | 40 | regulation of bone remodeling |
| GO:0002076 | 9e-04 | 11.3958 | 0.4584 | 4 | 16 | osteoblast development |
| GO:1905314 | 9e-04 | 11.3958 | 0.4584 | 4 | 16 | semi-lunar valve development |
| GO:0046649 | 9e-04 | 1.96 | 16.2458 | 30 | 567 | lymphocyte activation |
| GO:0019722 | 0.001 | 3.117 | 4.1546 | 12 | 145 | calcium-mediated signaling |
| GO:0001501 | 0.001 | 2.0669 | 13.3519 | 26 | 466 | skeletal system development |
| GO:0048593 | 0.001 | 3.5536 | 3.0658 | 10 | 107 | camera-type eye morphogenesis |
| GO:0030335 | 0.001 | 2.1631 | 11.289 | 23 | 394 | positive regulation of cell migration |
| GO:0030595 | 0.0011 | 2.919 | 4.7849 | 13 | 167 | leukocyte chemotaxis |
| GO:0001667 | 0.0011 | 2.2818 | 9.312 | 20 | 325 | ameboidal-type cell migration |
| GO:0050911 | 0.0012 | 4.8073 | 1.6332 | 7 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0010940 | 0.0012 | 20.4748 | 0.2292 | 3 | 8 | positive regulation of necrotic cell death |
| GO:0051272 | 0.0012 | 2.0997 | 12.1199 | 24 | 423 | positive regulation of cellular component movement |
| GO:0048872 | 0.0012 | 2.6377 | 6.0743 | 15 | 212 | homeostasis of number of cells |
| GO:0048167 | 0.0012 | 3.0252 | 4.2692 | 12 | 149 | regulation of synaptic plasticity |
| GO:0003151 | 0.0012 | 4.1674 | 2.1203 | 8 | 74 | outflow tract morphogenesis |
| GO:0023052 | 0.0013 | 1.4556 | 81.5073 | 106 | 3129 | signaling |
| GO:0008544 | 0.0013 | 2.2091 | 10.0856 | 21 | 352 | epidermis development |
| GO:0051094 | 0.0014 | 2.3043 | 8.7656 | 19 | 319 | positive regulation of developmental process |
| GO:0007159 | 0.0014 | 2.2443 | 9.4552 | 20 | 330 | leukocyte cell-cell adhesion |
| GO:0009966 | 0.0014 | 1.425 | 80.9424 | 106 | 2825 | regulation of signal transduction |
| GO:0010647 | 0.0015 | 1.5564 | 43.2648 | 63 | 1510 | positive regulation of cell communication |
| GO:0051963 | 0.0015 | 4.0443 | 2.1776 | 8 | 76 | regulation of synapse assembly |
| GO:0032331 | 0.0015 | 9.7665 | 0.5157 | 4 | 18 | negative regulation of chondrocyte differentiation |
| GO:1905331 | 0.0015 | 9.7665 | 0.5157 | 4 | 18 | negative regulation of morphogenesis of an epithelium |
| GO:0009605 | 0.0015 | 1.7943 | 21.3418 | 36 | 781 | response to external stimulus |
| GO:0001775 | 0.0016 | 1.6158 | 34.2393 | 52 | 1195 | cell activation |
| GO:0050863 | 0.0016 | 2.3231 | 8.2232 | 18 | 287 | regulation of T cell activation |
| GO:0002694 | 0.0017 | 2.0418 | 12.435 | 24 | 434 | regulation of leukocyte activation |
| GO:2000026 | 0.0017 | 1.6059 | 35.204 | 53 | 1267 | regulation of multicellular organismal development |
| GO:0090129 | 0.0017 | 17.0612 | 0.2579 | 3 | 9 | positive regulation of synapse maturation |
| GO:2000849 | 0.0017 | 17.0612 | 0.2579 | 3 | 9 | regulation of glucocorticoid secretion |
| GO:0045597 | 0.0018 | 1.7297 | 23.8797 | 39 | 837 | positive regulation of cell differentiation |
| GO:0022008 | 0.0018 | 1.5608 | 40.2849 | 59 | 1406 | neurogenesis |
| GO:0003094 | 0.0018 | 9.1148 | 0.5444 | 4 | 19 | glomerular filtration |
| GO:0071498 | 0.0018 | 9.1148 | 0.5444 | 4 | 19 | cellular response to fluid shear stress |
| GO:0046209 | 0.0019 | 4.3688 | 1.7764 | 7 | 62 | nitric oxide metabolic process |
| GO:0048584 | 0.002 | 1.482 | 54.9835 | 76 | 1919 | positive regulation of response to stimulus |
| GO:0031347 | 0.0021 | 1.8152 | 18.6239 | 32 | 650 | regulation of defense response |
| GO:0032101 | 0.0021 | 1.8152 | 18.6239 | 32 | 650 | regulation of response to external stimulus |
| GO:1903524 | 0.0021 | 4.2905 | 1.8051 | 7 | 63 | positive regulation of blood circulation |
| GO:0014902 | 0.0021 | 3.4405 | 2.8366 | 9 | 99 | myotube differentiation |
| GO:0040017 | 0.0021 | 2.0016 | 12.6643 | 24 | 442 | positive regulation of locomotion |
| GO:0098743 | 0.0022 | 8.5446 | 0.573 | 4 | 20 | cell aggregation |
| GO:0055123 | 0.0023 | 2.9398 | 4.0113 | 11 | 140 | digestive system development |
| GO:0061053 | 0.0024 | 3.7148 | 2.3495 | 8 | 82 | somite development |
| GO:2000379 | 0.0024 | 3.7148 | 2.3495 | 8 | 82 | positive regulation of reactive oxygen species metabolic process |
| GO:0010621 | 0.0024 | 68.1106 | 0.086 | 2 | 3 | negative regulation of transcription by transcription factor localization |
| GO:0034059 | 0.0024 | 68.1106 | 0.086 | 2 | 3 | response to anoxia |
| GO:0007219 | 0.0025 | 2.7606 | 4.6417 | 12 | 162 | Notch signaling pathway |
| GO:0023056 | 0.0026 | 1.5195 | 43.4367 | 62 | 1516 | positive regulation of signaling |
| GO:0090257 | 0.0026 | 2.5076 | 5.931 | 14 | 207 | regulation of muscle system process |
| GO:0060429 | 0.0026 | 1.7008 | 23.6269 | 38 | 850 | epithelium development |
| GO:0019932 | 0.0026 | 3.0795 | 3.4883 | 10 | 124 | second-messenger-mediated signaling |
| GO:0071229 | 0.0026 | 2.6103 | 5.3007 | 13 | 185 | cellular response to acid chemical |
| GO:0008211 | 0.0027 | 8.0414 | 0.6017 | 4 | 21 | glucocorticoid metabolic process |
| GO:0007166 | 0.0028 | 1.4269 | 66.3811 | 88 | 2357 | cell surface receptor signaling pathway |
| GO:0035270 | 0.0028 | 3.0471 | 3.5242 | 10 | 123 | endocrine system development |
| GO:0001655 | 0.0028 | 2.3195 | 7.3012 | 16 | 257 | urogenital system development |
| GO:0002685 | 0.0029 | 2.8506 | 4.1259 | 11 | 144 | regulation of leukocyte migration |
| GO:0019369 | 0.0029 | 4.6735 | 1.4326 | 6 | 50 | arachidonic acid metabolic process |
| GO:0048546 | 0.0029 | 4.6735 | 1.4326 | 6 | 50 | digestive tract morphogenesis |
| GO:0048534 | 0.0029 | 1.699 | 22.979 | 37 | 802 | hematopoietic or lymphoid organ development |
| GO:0043542 | 0.003 | 2.6881 | 4.7563 | 12 | 166 | endothelial cell migration |
| GO:0045429 | 0.003 | 5.7042 | 1.0028 | 5 | 35 | positive regulation of nitric oxide biosynthetic process |
| GO:0060537 | 0.0031 | 2.0795 | 10.1429 | 20 | 354 | muscle tissue development |
| GO:0045589 | 0.0032 | 7.5941 | 0.6303 | 4 | 22 | regulation of regulatory T cell differentiation |
| GO:0035413 | 0.0032 | 12.7942 | 0.3152 | 3 | 11 | positive regulation of catenin import into nucleus |
| GO:0048568 | 0.0033 | 2.1118 | 9.4893 | 19 | 335 | embryonic organ development |
| GO:0007399 | 0.0034 | 1.756 | 19.2717 | 32 | 706 | nervous system development |
| GO:0048598 | 0.0035 | 1.8204 | 16.1885 | 28 | 565 | embryonic morphogenesis |
| GO:0050728 | 0.0036 | 3.1579 | 3.0658 | 9 | 107 | negative regulation of inflammatory response |
| GO:0048736 | 0.0037 | 2.6194 | 4.8709 | 12 | 170 | appendage development |
| GO:0045165 | 0.0037 | 2.326 | 6.8192 | 15 | 238 | cell fate commitment |
| GO:0035902 | 0.0038 | 7.194 | 0.659 | 4 | 23 | response to immobilization stress |
| GO:0050906 | 0.004 | 2.8923 | 3.6961 | 10 | 129 | detection of stimulus involved in sensory perception |
| GO:0050807 | 0.0041 | 5.2583 | 1.0742 | 5 | 38 | regulation of synapse organization |
| GO:0003207 | 0.0042 | 11.3718 | 0.3438 | 3 | 12 | cardiac chamber formation |
| GO:0030157 | 0.0042 | 11.3718 | 0.3438 | 3 | 12 | pancreatic juice secretion |
| GO:0045780 | 0.0042 | 11.3718 | 0.3438 | 3 | 12 | positive regulation of bone resorption |
| GO:0060536 | 0.0042 | 11.3718 | 0.3438 | 3 | 12 | cartilage morphogenesis |
| GO:1903508 | 0.0043 | 1.5136 | 38.4512 | 55 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0030182 | 0.0044 | 1.5412 | 34.268 | 50 | 1196 | neuron differentiation |
| GO:0090596 | 0.0044 | 2.2742 | 6.9625 | 15 | 243 | sensory organ morphogenesis |
| GO:0035050 | 0.0045 | 3.6942 | 2.063 | 7 | 72 | embryonic heart tube development |
| GO:0050927 | 0.0045 | 6.8338 | 0.6877 | 4 | 24 | positive regulation of positive chemotaxis |
| GO:0010701 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | positive regulation of norepinephrine secretion |
| GO:0010961 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | cellular magnesium ion homeostasis |
| GO:0014034 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | neural crest cell fate commitment |
| GO:0015670 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | carbon dioxide transport |
| GO:0019482 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | beta-alanine metabolic process |
| GO:0048866 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | stem cell fate specification |
| GO:0051725 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | protein de-ADP-ribosylation |
| GO:0072193 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | ureter smooth muscle cell differentiation |
| GO:0090245 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | axis elongation involved in somitogenesis |
| GO:2001013 | 0.0047 | 34.053 | 0.1146 | 2 | 4 | epithelial cell proliferation involved in renal tubule morphogenesis |
| GO:0002260 | 0.0047 | 4.1952 | 1.5759 | 6 | 55 | lymphocyte homeostasis |
| GO:0071384 | 0.0047 | 4.1952 | 1.5759 | 6 | 55 | cellular response to corticosteroid stimulus |
| GO:0071216 | 0.0048 | 2.5225 | 5.0428 | 12 | 176 | cellular response to biotic stimulus |
| GO:0035282 | 0.0049 | 3.2704 | 2.636 | 8 | 92 | segmentation |
| GO:1901343 | 0.0049 | 3.2704 | 2.636 | 8 | 92 | negative regulation of vasculature development |
| GO:0009887 | 0.005 | 1.793 | 15.8287 | 27 | 576 | animal organ morphogenesis |
| GO:0051716 | 0.005 | 1.2974 | 171.6748 | 198 | 6090 | cellular response to stimulus |
| GO:0023061 | 0.005 | 1.9493 | 11.3176 | 21 | 395 | signal release |
| GO:0008284 | 0.0051 | 1.6489 | 22.9504 | 36 | 801 | positive regulation of cell proliferation |
| GO:0060538 | 0.0051 | 2.6308 | 4.4411 | 11 | 155 | skeletal muscle organ development |
| GO:0035295 | 0.0051 | 1.8576 | 13.5667 | 24 | 480 | tube development |
| GO:0050886 | 0.0052 | 3.5834 | 2.1203 | 7 | 74 | endocrine process |
| GO:0034110 | 0.0052 | 6.5079 | 0.7163 | 4 | 25 | regulation of homotypic cell-cell adhesion |
| GO:0060740 | 0.0052 | 6.5079 | 0.7163 | 4 | 25 | prostate gland epithelium morphogenesis |
| GO:0072073 | 0.0052 | 2.7747 | 3.8394 | 10 | 134 | kidney epithelium development |
| GO:0009617 | 0.0053 | 1.8766 | 12.8648 | 23 | 449 | response to bacterium |
| GO:0002790 | 0.0054 | 1.8241 | 14.3834 | 25 | 502 | peptide secretion |
| GO:0042127 | 0.0054 | 2.4855 | 5.1127 | 12 | 190 | regulation of cell proliferation |
| GO:0048731 | 0.0054 | 1.5498 | 33.1727 | 48 | 1341 | system development |
| GO:0007567 | 0.0054 | 10.2339 | 0.3725 | 3 | 13 | parturition |
| GO:0060456 | 0.0054 | 10.2339 | 0.3725 | 3 | 13 | positive regulation of digestive system process |
| GO:0070304 | 0.0055 | 2.7523 | 3.868 | 10 | 135 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0060562 | 0.0056 | 2.0936 | 8.5383 | 17 | 298 | epithelial tube morphogenesis |
| GO:0010001 | 0.0058 | 2.4618 | 5.1574 | 12 | 180 | glial cell differentiation |
| GO:0007420 | 0.0058 | 1.7137 | 18.366 | 30 | 641 | brain development |
| GO:0046328 | 0.0059 | 2.5766 | 4.527 | 11 | 158 | regulation of JNK cascade |
| GO:0016477 | 0.0059 | 1.7297 | 17.6127 | 29 | 640 | cell migration |
| GO:0030216 | 0.006 | 2.3476 | 5.845 | 13 | 204 | keratinocyte differentiation |
| GO:0030217 | 0.006 | 2.3476 | 5.845 | 13 | 204 | T cell differentiation |
| GO:0014898 | 0.006 | 6.2117 | 0.745 | 4 | 26 | cardiac muscle hypertrophy in response to stress |
| GO:0031328 | 0.0061 | 1.4445 | 46.9268 | 64 | 1653 | positive regulation of cellular biosynthetic process |
| GO:0003231 | 0.0061 | 2.8905 | 3.3237 | 9 | 116 | cardiac ventricle development |
| GO:0022409 | 0.0062 | 2.2582 | 6.5327 | 14 | 228 | positive regulation of cell-cell adhesion |
| GO:0003279 | 0.0063 | 3.1209 | 2.7506 | 8 | 96 | cardiac septum development |
| GO:0019933 | 0.0063 | 3.1209 | 2.7506 | 8 | 96 | cAMP-mediated signaling |
| GO:0072507 | 0.0063 | 1.9074 | 11.5468 | 21 | 403 | divalent inorganic cation homeostasis |
| GO:0010628 | 0.0065 | 1.4323 | 48.7946 | 66 | 1703 | positive regulation of gene expression |
| GO:0016055 | 0.0066 | 1.841 | 13.094 | 23 | 457 | Wnt signaling pathway |
| GO:0001822 | 0.0066 | 2.8542 | 3.361 | 9 | 119 | kidney development |
| GO:0006721 | 0.0067 | 3.0856 | 2.7793 | 8 | 97 | terpenoid metabolic process |
| GO:0050729 | 0.0067 | 3.0856 | 2.7793 | 8 | 97 | positive regulation of inflammatory response |
| GO:0014855 | 0.0067 | 3.8775 | 1.6905 | 6 | 59 | striated muscle cell proliferation |
| GO:0048645 | 0.0067 | 3.8775 | 1.6905 | 6 | 59 | animal organ formation |
| GO:0003044 | 0.0067 | 4.6228 | 1.2034 | 5 | 42 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0043303 | 0.0067 | 4.6228 | 1.2034 | 5 | 42 | mast cell degranulation |
| GO:0003188 | 0.0067 | 9.303 | 0.4011 | 3 | 14 | heart valve formation |
| GO:0098609 | 0.0068 | 1.9255 | 10.8947 | 20 | 391 | cell-cell adhesion |
| GO:0060706 | 0.0069 | 5.9412 | 0.7736 | 4 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0010557 | 0.0074 | 1.4413 | 44.6974 | 61 | 1560 | positive regulation of macromolecule biosynthetic process |
| GO:1903706 | 0.0074 | 1.8771 | 11.7187 | 21 | 409 | regulation of hemopoiesis |
| GO:0045619 | 0.0074 | 2.6252 | 4.04 | 10 | 141 | regulation of lymphocyte differentiation |
| GO:0048646 | 0.0074 | 1.8209 | 13.2403 | 23 | 493 | anatomical structure formation involved in morphogenesis |
| GO:0043200 | 0.0075 | 3.0174 | 2.8366 | 8 | 99 | response to amino acid |
| GO:0043207 | 0.0075 | 1.6501 | 20.3144 | 32 | 709 | response to external biotic stimulus |
| GO:0009611 | 0.0076 | 1.711 | 17.134 | 28 | 598 | response to wounding |
| GO:0051254 | 0.0076 | 1.4602 | 40.4282 | 56 | 1411 | positive regulation of RNA metabolic process |
| GO:0016202 | 0.0076 | 2.7856 | 3.4383 | 9 | 120 | regulation of striated muscle tissue development |
| GO:0002933 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | lipid hydroxylation |
| GO:0006526 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | arginine biosynthetic process |
| GO:0010991 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | negative regulation of SMAD protein complex assembly |
| GO:0032571 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | response to vitamin K |
| GO:0060455 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0060718 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | chorionic trophoblast cell differentiation |
| GO:0061009 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | common bile duct development |
| GO:0071504 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | cellular response to heparin |
| GO:2000987 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | positive regulation of behavioral fear response |
| GO:2001016 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | positive regulation of skeletal muscle cell differentiation |
| GO:2001046 | 0.0077 | 22.7005 | 0.1433 | 2 | 5 | positive regulation of integrin-mediated signaling pathway |
| GO:0006955 | 0.0079 | 1.4214 | 48.3362 | 65 | 1687 | immune response |
| GO:0050891 | 0.0079 | 3.736 | 1.7478 | 6 | 61 | multicellular organismal water homeostasis |
| GO:0034105 | 0.0079 | 5.6933 | 0.8023 | 4 | 28 | positive regulation of tissue remodeling |
| GO:0006942 | 0.008 | 3.2875 | 2.2922 | 7 | 80 | regulation of striated muscle contraction |
| GO:0010941 | 0.0081 | 1.4421 | 43.1502 | 59 | 1506 | regulation of cell death |
| GO:0090102 | 0.0082 | 4.3852 | 1.2607 | 5 | 44 | cochlea development |
| GO:0009950 | 0.0082 | 8.5271 | 0.4298 | 3 | 15 | dorsal/ventral axis specification |
| GO:0032303 | 0.0082 | 8.5271 | 0.4298 | 3 | 15 | regulation of icosanoid secretion |
| GO:1903798 | 0.0082 | 8.5271 | 0.4298 | 3 | 15 | regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:0032496 | 0.0082 | 2.0552 | 8.1659 | 16 | 285 | response to lipopolysaccharide |
| GO:0006874 | 0.0085 | 1.9179 | 10.3721 | 19 | 362 | cellular calcium ion homeostasis |
| GO:0048844 | 0.0085 | 3.669 | 1.7764 | 6 | 62 | artery morphogenesis |
| GO:0042475 | 0.0085 | 3.2429 | 2.3208 | 7 | 81 | odontogenesis of dentin-containing tooth |
| GO:0070301 | 0.0085 | 3.2429 | 2.3208 | 7 | 81 | cellular response to hydrogen peroxide |
| GO:0032879 | 0.0087 | 1.3547 | 69.1377 | 88 | 2413 | regulation of localization |
| GO:0071805 | 0.0087 | 2.3219 | 5.4439 | 12 | 190 | potassium ion transmembrane transport |
| GO:0010574 | 0.009 | 5.4652 | 0.8309 | 4 | 29 | regulation of vascular endothelial growth factor production |
| GO:0018149 | 0.009 | 5.4652 | 0.8309 | 4 | 29 | peptide cross-linking |
| GO:0030201 | 0.009 | 5.4652 | 0.8309 | 4 | 29 | heparan sulfate proteoglycan metabolic process |
| GO:0031128 | 0.009 | 5.4652 | 0.8309 | 4 | 29 | developmental induction |
| GO:0035108 | 0.009 | 2.5467 | 4.1546 | 10 | 145 | limb morphogenesis |
| GO:0014888 | 0.009 | 4.2752 | 1.2893 | 5 | 45 | striated muscle adaptation |
| GO:0009914 | 0.0091 | 2.0321 | 8.2518 | 16 | 288 | hormone transport |
| GO:1903530 | 0.0092 | 1.6833 | 17.3919 | 28 | 607 | regulation of secretion by cell |
| GO:0061035 | 0.0092 | 3.6044 | 1.8051 | 6 | 63 | regulation of cartilage development |
| GO:0050877 | 0.0094 | 1.5667 | 24.7268 | 37 | 863 | nervous system process |
| GO:0007507 | 0.0096 | 1.828 | 12.0103 | 21 | 424 | heart development |
| GO:0043331 | 0.0097 | 3.1571 | 2.3781 | 7 | 83 | response to dsRNA |
| GO:0003013 | 0.0097 | 1.7735 | 13.5525 | 23 | 473 | circulatory system process |
| GO:1901568 | 0.0098 | 2.5092 | 4.2119 | 10 | 147 | fatty acid derivative metabolic process |
| GO:0030850 | 0.0099 | 4.1707 | 1.318 | 5 | 46 | prostate gland development |
| GO:0030279 | 0.0099 | 3.542 | 1.8337 | 6 | 64 | negative regulation of ossification |
| GO:0140029 | 0.0099 | 3.542 | 1.8337 | 6 | 64 | exocytic process |
| GO:0000185 | 0.0099 | 7.8707 | 0.4584 | 3 | 16 | activation of MAPKKK activity |
| GO:0006910 | 0.0099 | 7.8707 | 0.4584 | 3 | 16 | phagocytosis, recognition |
| GO:0060572 | 0.0099 | 7.8707 | 0.4584 | 3 | 16 | morphogenesis of an epithelial bud |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010469 | 0 | 2.5263 | 13.3455 | 31 | 487 | regulation of receptor activity |
| GO:0007267 | 0 | 1.8439 | 39.9818 | 67 | 1459 | cell-cell signaling |
| GO:0007275 | 0 | 1.5426 | 114.1458 | 151 | 4288 | multicellular organism development |
| GO:0001525 | 0 | 2.5379 | 11.5095 | 27 | 420 | angiogenesis |
| GO:0007156 | 1e-04 | 3.6909 | 4.1653 | 14 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0051716 | 1e-04 | 1.4648 | 171.7107 | 210 | 6266 | cellular response to stimulus |
| GO:0030154 | 2e-04 | 1.6072 | 58.0393 | 84 | 2235 | cell differentiation |
| GO:0023052 | 2e-04 | 1.6819 | 47.5314 | 71 | 1932 | signaling |
| GO:0007186 | 2e-04 | 1.9133 | 22.9916 | 41 | 839 | G-protein coupled receptor signaling pathway |
| GO:0051216 | 3e-04 | 3.2401 | 4.686 | 14 | 171 | cartilage development |
| GO:0065007 | 3e-04 | 1.4845 | 288.4773 | 320 | 10527 | biological regulation |
| GO:0003012 | 3e-04 | 2.3174 | 11.071 | 24 | 404 | muscle system process |
| GO:0032502 | 3e-04 | 1.4454 | 125.2813 | 157 | 4738 | developmental process |
| GO:0007154 | 4e-04 | 1.641 | 49.2014 | 72 | 1993 | cell communication |
| GO:0048598 | 4e-04 | 2.0669 | 15.483 | 30 | 565 | embryonic morphogenesis |
| GO:0072001 | 5e-04 | 2.6149 | 7.3716 | 18 | 269 | renal system development |
| GO:0019216 | 5e-04 | 2.4073 | 9.3172 | 21 | 340 | regulation of lipid metabolic process |
| GO:0001656 | 5e-04 | 4.3309 | 2.3019 | 9 | 84 | metanephros development |
| GO:0043062 | 5e-04 | 2.4432 | 8.7417 | 20 | 319 | extracellular structure organization |
| GO:0014874 | 6e-04 | 13.0214 | 0.4111 | 4 | 15 | response to stimulus involved in regulation of muscle adaptation |
| GO:0048608 | 6e-04 | 2.2517 | 10.8792 | 23 | 397 | reproductive structure development |
| GO:0042221 | 6e-04 | 1.4317 | 101.0369 | 130 | 3687 | response to chemical |
| GO:0048513 | 7e-04 | 1.4762 | 76.7645 | 103 | 2866 | animal organ development |
| GO:0001707 | 7e-04 | 4.5755 | 1.9457 | 8 | 71 | mesoderm formation |
| GO:0044060 | 7e-04 | 6.3401 | 1.0961 | 6 | 40 | regulation of endocrine process |
| GO:0001568 | 7e-04 | 1.9971 | 15.9763 | 30 | 583 | blood vessel development |
| GO:0002605 | 7e-04 | Inf | 0.0548 | 2 | 2 | negative regulation of dendritic cell antigen processing and presentation |
| GO:0072358 | 8e-04 | 1.9585 | 16.8258 | 31 | 614 | cardiovascular system development |
| GO:0043270 | 8e-04 | 2.7378 | 5.8644 | 15 | 214 | positive regulation of ion transport |
| GO:0050880 | 8e-04 | 3.3711 | 3.5351 | 11 | 129 | regulation of blood vessel size |
| GO:0010595 | 8e-04 | 4.4341 | 2.0005 | 8 | 73 | positive regulation of endothelial cell migration |
| GO:0060429 | 9e-04 | 1.6982 | 30.1713 | 48 | 1101 | epithelium development |
| GO:0030856 | 0.001 | 3.3144 | 3.5899 | 11 | 131 | regulation of epithelial cell differentiation |
| GO:0090190 | 0.001 | 11.0166 | 0.4659 | 4 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0070268 | 0.0011 | 3.8188 | 2.5759 | 9 | 94 | cornification |
| GO:0009967 | 0.0011 | 1.6129 | 37.8169 | 57 | 1380 | positive regulation of signal transduction |
| GO:0060986 | 0.0012 | 5.6711 | 1.2058 | 6 | 44 | endocrine hormone secretion |
| GO:0008285 | 0.0012 | 1.904 | 17.2642 | 31 | 630 | negative regulation of cell proliferation |
| GO:2000678 | 0.0013 | 10.229 | 0.4933 | 4 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0014888 | 0.0013 | 5.5254 | 1.2332 | 6 | 45 | striated muscle adaptation |
| GO:0090303 | 0.0013 | 5.5254 | 1.2332 | 6 | 45 | positive regulation of wound healing |
| GO:0007498 | 0.0015 | 3.3424 | 3.2336 | 10 | 118 | mesoderm development |
| GO:0098609 | 0.0015 | 1.8049 | 20.5527 | 35 | 750 | cell-cell adhesion |
| GO:1901203 | 0.0015 | 17.8671 | 0.2466 | 3 | 9 | positive regulation of extracellular matrix assembly |
| GO:0023019 | 0.0016 | 9.5464 | 0.5207 | 4 | 19 | signal transduction involved in regulation of gene expression |
| GO:0044321 | 0.0016 | 9.5464 | 0.5207 | 4 | 19 | response to leptin |
| GO:0072079 | 0.0016 | 9.5464 | 0.5207 | 4 | 19 | nephron tubule formation |
| GO:0072311 | 0.0016 | 9.5464 | 0.5207 | 4 | 19 | glomerular epithelial cell differentiation |
| GO:0009605 | 0.0017 | 1.6958 | 27.0351 | 43 | 1031 | response to external stimulus |
| GO:0031324 | 0.0017 | 1.4559 | 65.3575 | 88 | 2385 | negative regulation of cellular metabolic process |
| GO:0050801 | 0.0018 | 1.833 | 18.47 | 32 | 674 | ion homeostasis |
| GO:1903053 | 0.0019 | 6.4026 | 0.9043 | 5 | 33 | regulation of extracellular matrix organization |
| GO:0035296 | 0.0019 | 3.2222 | 3.3432 | 10 | 122 | regulation of tube diameter |
| GO:0051172 | 0.0021 | 1.4582 | 61.3292 | 83 | 2238 | negative regulation of nitrogen compound metabolic process |
| GO:0030238 | 0.0021 | 15.3137 | 0.274 | 3 | 10 | male sex determination |
| GO:0035878 | 0.0021 | 15.3137 | 0.274 | 3 | 10 | nail development |
| GO:0002581 | 0.0022 | 71.3205 | 0.0822 | 2 | 3 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:1900673 | 0.0022 | 71.3205 | 0.0822 | 2 | 3 | olefin metabolic process |
| GO:1902164 | 0.0022 | 71.3205 | 0.0822 | 2 | 3 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:2000297 | 0.0022 | 71.3205 | 0.0822 | 2 | 3 | negative regulation of synapse maturation |
| GO:0031960 | 0.0023 | 2.9432 | 4.0009 | 11 | 146 | response to corticosteroid |
| GO:0060688 | 0.0023 | 4.8958 | 1.3702 | 6 | 50 | regulation of morphogenesis of a branching structure |
| GO:0072009 | 0.0024 | 3.3787 | 2.8774 | 9 | 105 | nephron epithelium development |
| GO:0032355 | 0.0024 | 3.1102 | 3.4528 | 10 | 126 | response to estradiol |
| GO:0061005 | 0.0026 | 4.7867 | 1.3976 | 6 | 51 | cell differentiation involved in kidney development |
| GO:0051093 | 0.0028 | 1.7169 | 22.1421 | 36 | 808 | negative regulation of developmental process |
| GO:0030335 | 0.0029 | 2.0511 | 10.797 | 21 | 394 | positive regulation of cell migration |
| GO:0019932 | 0.0031 | 2.2942 | 7.3716 | 16 | 269 | second-messenger-mediated signaling |
| GO:0071385 | 0.0032 | 4.5824 | 1.4524 | 6 | 53 | cellular response to glucocorticoid stimulus |
| GO:0006954 | 0.0032 | 1.9056 | 13.8227 | 25 | 511 | inflammatory response |
| GO:0033993 | 0.0036 | 1.7466 | 19.3103 | 32 | 716 | response to lipid |
| GO:0090184 | 0.0036 | 5.4306 | 1.0413 | 5 | 38 | positive regulation of kidney development |
| GO:0001657 | 0.0037 | 3.4267 | 2.5211 | 8 | 92 | ureteric bud development |
| GO:0014745 | 0.0037 | 11.909 | 0.3288 | 3 | 12 | negative regulation of muscle adaptation |
| GO:0014889 | 0.0037 | 11.909 | 0.3288 | 3 | 12 | muscle atrophy |
| GO:0032099 | 0.0037 | 11.909 | 0.3288 | 3 | 12 | negative regulation of appetite |
| GO:0071260 | 0.0038 | 3.8115 | 2.0005 | 7 | 73 | cellular response to mechanical stimulus |
| GO:0030511 | 0.0038 | 7.1574 | 0.6577 | 4 | 24 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032104 | 0.0038 | 7.1574 | 0.6577 | 4 | 24 | regulation of response to extracellular stimulus |
| GO:0061217 | 0.0038 | 7.1574 | 0.6577 | 4 | 24 | regulation of mesonephros development |
| GO:0009888 | 0.0039 | 1.8781 | 14.0445 | 25 | 540 | tissue development |
| GO:0043207 | 0.004 | 1.7339 | 19.4291 | 32 | 709 | response to external biotic stimulus |
| GO:0072163 | 0.004 | 3.3862 | 2.5485 | 8 | 93 | mesonephric epithelium development |
| GO:0097755 | 0.0042 | 4.3066 | 1.5346 | 6 | 56 | positive regulation of blood vessel diameter |
| GO:0033559 | 0.0042 | 3.3466 | 2.5759 | 8 | 94 | unsaturated fatty acid metabolic process |
| GO:0048729 | 0.0043 | 1.7937 | 16.4147 | 28 | 599 | tissue morphogenesis |
| GO:0042161 | 0.0043 | 35.6578 | 0.1096 | 2 | 4 | lipoprotein oxidation |
| GO:0072107 | 0.0043 | 35.6578 | 0.1096 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:1902109 | 0.0043 | 35.6578 | 0.1096 | 2 | 4 | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:2000722 | 0.0043 | 35.6578 | 0.1096 | 2 | 4 | regulation of cardiac vascular smooth muscle cell differentiation |
| GO:0022008 | 0.0044 | 1.5125 | 38.5294 | 55 | 1406 | neurogenesis |
| GO:0032102 | 0.0044 | 2.2733 | 6.9605 | 15 | 254 | negative regulation of response to external stimulus |
| GO:0055067 | 0.0045 | 2.8387 | 3.7543 | 10 | 137 | monovalent inorganic cation homeostasis |
| GO:1903532 | 0.0046 | 2.088 | 9.0706 | 18 | 331 | positive regulation of secretion by cell |
| GO:0001911 | 0.0048 | 10.7174 | 0.3562 | 3 | 13 | negative regulation of leukocyte mediated cytotoxicity |
| GO:0050908 | 0.0048 | 10.7174 | 0.3562 | 3 | 13 | detection of light stimulus involved in visual perception |
| GO:0032501 | 0.0048 | 1.6239 | 28.1291 | 42 | 1235 | multicellular organismal process |
| GO:0070371 | 0.0048 | 2.2541 | 7.0153 | 15 | 256 | ERK1 and ERK2 cascade |
| GO:0045944 | 0.0048 | 1.5849 | 28.6093 | 43 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0023051 | 0.0049 | 1.3577 | 85.9924 | 108 | 3138 | regulation of signaling |
| GO:0001974 | 0.005 | 4.9771 | 1.1235 | 5 | 41 | blood vessel remodeling |
| GO:0050729 | 0.0051 | 3.2331 | 2.6581 | 8 | 97 | positive regulation of inflammatory response |
| GO:0002063 | 0.0052 | 6.5058 | 0.7125 | 4 | 26 | chondrocyte development |
| GO:0014898 | 0.0052 | 6.5058 | 0.7125 | 4 | 26 | cardiac muscle hypertrophy in response to stress |
| GO:0035411 | 0.0052 | 6.5058 | 0.7125 | 4 | 26 | catenin import into nucleus |
| GO:0060343 | 0.0052 | 6.5058 | 0.7125 | 4 | 26 | trabecula formation |
| GO:0042127 | 0.0053 | 1.6572 | 22.2545 | 35 | 841 | regulation of cell proliferation |
| GO:0051241 | 0.0054 | 1.5995 | 26.3294 | 40 | 967 | negative regulation of multicellular organismal process |
| GO:0007188 | 0.0055 | 2.7513 | 3.8639 | 10 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0014897 | 0.0055 | 3.5418 | 2.1375 | 7 | 78 | striated muscle hypertrophy |
| GO:0044070 | 0.0058 | 3.1616 | 2.713 | 8 | 99 | regulation of anion transport |
| GO:0051240 | 0.0058 | 1.5002 | 37.3484 | 53 | 1376 | positive regulation of multicellular organismal process |
| GO:0048583 | 0.0059 | 1.3322 | 98.5432 | 121 | 3596 | regulation of response to stimulus |
| GO:0002577 | 0.0059 | 9.7424 | 0.3836 | 3 | 14 | regulation of antigen processing and presentation |
| GO:0021527 | 0.0059 | 9.7424 | 0.3836 | 3 | 14 | spinal cord association neuron differentiation |
| GO:0032108 | 0.0059 | 9.7424 | 0.3836 | 3 | 14 | negative regulation of response to nutrient levels |
| GO:0060547 | 0.0059 | 9.7424 | 0.3836 | 3 | 14 | negative regulation of necrotic cell death |
| GO:0048706 | 0.0061 | 2.8929 | 3.3158 | 9 | 121 | embryonic skeletal system development |
| GO:0010646 | 0.0061 | 1.3485 | 84.7318 | 106 | 3092 | regulation of cell communication |
| GO:0009617 | 0.0063 | 1.8748 | 12.3042 | 22 | 449 | response to bacterium |
| GO:0009583 | 0.0064 | 3.9137 | 1.6716 | 6 | 61 | detection of light stimulus |
| GO:0002683 | 0.0065 | 1.9709 | 10.1119 | 19 | 369 | negative regulation of immune system process |
| GO:0006690 | 0.0065 | 3.0932 | 2.7678 | 8 | 101 | icosanoid metabolic process |
| GO:0006939 | 0.0065 | 3.0932 | 2.7678 | 8 | 101 | smooth muscle contraction |
| GO:0051272 | 0.0066 | 1.8993 | 11.5917 | 21 | 423 | positive regulation of cellular component movement |
| GO:0048870 | 0.0067 | 1.4933 | 36.7482 | 52 | 1341 | cell motility |
| GO:0022610 | 0.0067 | 1.5044 | 35.0492 | 50 | 1279 | biological adhesion |
| GO:1903508 | 0.0068 | 1.492 | 36.7756 | 52 | 1342 | positive regulation of nucleic acid-templated transcription |
| GO:0032892 | 0.0068 | 5.9629 | 0.7673 | 4 | 28 | positive regulation of organic acid transport |
| GO:0002548 | 0.0068 | 4.5933 | 1.2058 | 5 | 44 | monocyte chemotaxis |
| GO:0045935 | 0.0068 | 1.4449 | 45.4351 | 62 | 1658 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0007588 | 0.0069 | 3.8436 | 1.699 | 6 | 62 | excretion |
| GO:0002933 | 0.0071 | 23.7703 | 0.137 | 2 | 5 | lipid hydroxylation |
| GO:0030263 | 0.0071 | 23.7703 | 0.137 | 2 | 5 | apoptotic chromosome condensation |
| GO:1903232 | 0.0071 | 23.7703 | 0.137 | 2 | 5 | melanosome assembly |
| GO:0009952 | 0.0073 | 2.3798 | 5.3163 | 12 | 194 | anterior/posterior pattern specification |
| GO:0051896 | 0.0073 | 2.3798 | 5.3163 | 12 | 194 | regulation of protein kinase B signaling |
| GO:0014031 | 0.0074 | 3.7759 | 1.7264 | 6 | 63 | mesenchymal cell development |
| GO:0048864 | 0.0074 | 3.7759 | 1.7264 | 6 | 63 | stem cell development |
| GO:0032330 | 0.0075 | 4.4782 | 1.2332 | 5 | 45 | regulation of chondrocyte differentiation |
| GO:0034097 | 0.0077 | 1.59 | 24.4166 | 37 | 891 | response to cytokine |
| GO:1904888 | 0.008 | 3.7105 | 1.7538 | 6 | 64 | cranial skeletal system development |
| GO:0061138 | 0.0082 | 2.4481 | 4.7408 | 11 | 173 | morphogenesis of a branching epithelium |
| GO:0008206 | 0.0082 | 4.3686 | 1.2606 | 5 | 46 | bile acid metabolic process |
| GO:0044057 | 0.0084 | 1.8529 | 11.8612 | 21 | 438 | regulation of system process |
| GO:0007389 | 0.0085 | 1.8812 | 11.1258 | 20 | 406 | pattern specification process |
| GO:0014068 | 0.0086 | 3.6474 | 1.7812 | 6 | 65 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0051046 | 0.0087 | 1.6756 | 18.1138 | 29 | 661 | regulation of secretion |
| GO:0002707 | 0.0087 | 5.5034 | 0.8221 | 4 | 30 | negative regulation of lymphocyte mediated immunity |
| GO:1901890 | 0.0087 | 5.5034 | 0.8221 | 4 | 30 | positive regulation of cell junction assembly |
| GO:0002076 | 0.0088 | 8.2425 | 0.4385 | 3 | 16 | osteoblast development |
| GO:0050906 | 0.0091 | 2.6985 | 3.5351 | 9 | 129 | detection of stimulus involved in sensory perception |
| GO:0022600 | 0.0093 | 3.1814 | 2.3567 | 7 | 86 | digestive system process |
| GO:0010951 | 0.0096 | 2.2906 | 5.5081 | 12 | 201 | negative regulation of endopeptidase activity |
| GO:0055065 | 0.0097 | 1.7502 | 14.3321 | 24 | 523 | metal ion homeostasis |
| GO:0009913 | 0.0098 | 2.1255 | 6.9057 | 14 | 252 | epidermal cell differentiation |
| GO:0010557 | 0.0099 | 1.4304 | 42.7496 | 58 | 1560 | positive regulation of macromolecule biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070268 | 1e-04 | 7.339 | 1.0563 | 7 | 94 | cornification |
| GO:0030216 | 1e-04 | 4.7551 | 2.2924 | 10 | 204 | keratinocyte differentiation |
| GO:0007606 | 1e-04 | 5.9062 | 1.4833 | 8 | 132 | sensory perception of chemical stimulus |
| GO:1904313 | 1e-04 | Inf | 0.0225 | 2 | 2 | response to methamphetamine hydrochloride |
| GO:0019730 | 2e-04 | 16.7128 | 0.2862 | 4 | 26 | antimicrobial humoral response |
| GO:0002252 | 4e-04 | 2.3434 | 11.2824 | 24 | 1004 | immune effector process |
| GO:0098542 | 4e-04 | 3.2909 | 4.2702 | 13 | 380 | defense response to other organism |
| GO:0050911 | 4e-04 | 8.6851 | 0.6405 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0008544 | 6e-04 | 3.2644 | 3.9556 | 12 | 352 | epidermis development |
| GO:0050829 | 7e-04 | 7.7835 | 0.708 | 5 | 63 | defense response to Gram-negative bacterium |
| GO:0060474 | 7e-04 | 89.0178 | 0.0449 | 2 | 4 | positive regulation of flagellated sperm motility involved in capacitation |
| GO:0061844 | 8e-04 | 10.8968 | 0.4158 | 4 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0009605 | 0.0011 | 1.8755 | 21.4523 | 36 | 1909 | response to external stimulus |
| GO:0031640 | 0.0012 | 9.4598 | 0.472 | 4 | 42 | killing of cells of other organism |
| GO:0009593 | 0.002 | 4.9375 | 1.3035 | 6 | 116 | detection of chemical stimulus |
| GO:0008015 | 0.0025 | 2.6266 | 5.2816 | 13 | 470 | blood circulation |
| GO:0007186 | 0.0028 | 2.1686 | 9.4282 | 19 | 839 | G-protein coupled receptor signaling pathway |
| GO:0033198 | 0.003 | 11.6638 | 0.2922 | 3 | 26 | response to ATP |
| GO:0042730 | 0.003 | 11.6638 | 0.2922 | 3 | 26 | fibrinolysis |
| GO:0006950 | 0.0032 | 1.6132 | 38.2185 | 54 | 3401 | response to stress |
| GO:0050906 | 0.0034 | 4.4118 | 1.4496 | 6 | 129 | detection of stimulus involved in sensory perception |
| GO:0044597 | 0.0034 | 29.6647 | 0.0899 | 2 | 8 | daunorubicin metabolic process |
| GO:0044598 | 0.0034 | 29.6647 | 0.0899 | 2 | 8 | doxorubicin metabolic process |
| GO:0045414 | 0.0034 | 29.6647 | 0.0899 | 2 | 8 | regulation of interleukin-8 biosynthetic process |
| GO:0006955 | 0.0039 | 1.7904 | 18.9575 | 31 | 1687 | immune response |
| GO:0019731 | 0.0045 | 9.9332 | 0.3371 | 3 | 30 | antibacterial humoral response |
| GO:1903580 | 0.0045 | 9.9332 | 0.3371 | 3 | 30 | positive regulation of ATP metabolic process |
| GO:0050896 | 0.0046 | 1.7296 | 30.1222 | 43 | 3052 | response to stimulus |
| GO:0043312 | 0.0048 | 2.529 | 5.0344 | 12 | 448 | neutrophil degranulation |
| GO:0014894 | 0.0053 | 22.2456 | 0.1124 | 2 | 10 | response to denervation involved in regulation of muscle adaptation |
| GO:2000344 | 0.0053 | 22.2456 | 0.1124 | 2 | 10 | positive regulation of acrosome reaction |
| GO:0045861 | 0.0057 | 2.9086 | 3.2701 | 9 | 291 | negative regulation of proteolysis |
| GO:0042119 | 0.0057 | 2.4649 | 5.158 | 12 | 459 | neutrophil activation |
| GO:0001771 | 0.0065 | 19.7725 | 0.1236 | 2 | 11 | immunological synapse formation |
| GO:0014870 | 0.0065 | 19.7725 | 0.1236 | 2 | 11 | response to muscle inactivity |
| GO:2000147 | 0.0069 | 2.5108 | 4.6298 | 11 | 412 | positive regulation of cell motility |
| GO:0006953 | 0.007 | 8.3783 | 0.3933 | 3 | 35 | acute-phase response |
| GO:0010951 | 0.0077 | 3.2677 | 2.2587 | 7 | 201 | negative regulation of endopeptidase activity |
| GO:0006264 | 0.0077 | 17.7941 | 0.1348 | 2 | 12 | mitochondrial DNA replication |
| GO:0033574 | 0.0082 | 7.8845 | 0.4158 | 3 | 37 | response to testosterone |
| GO:0050877 | 0.0084 | 1.9772 | 9.6979 | 18 | 863 | nervous system process |
| GO:0010469 | 0.009 | 2.3152 | 5.4726 | 12 | 487 | regulation of receptor activity |
| GO:0002031 | 0.009 | 16.1754 | 0.1461 | 2 | 13 | G-protein coupled receptor internalization |
| GO:1901317 | 0.009 | 16.1754 | 0.1461 | 2 | 13 | regulation of flagellated sperm motility |
| GO:0002366 | 0.0092 | 2.1544 | 6.8773 | 14 | 612 | leukocyte activation involved in immune response |
| GO:0031103 | 0.0095 | 7.4454 | 0.4383 | 3 | 39 | axon regeneration |
| GO:0048247 | 0.0095 | 7.4454 | 0.4383 | 3 | 39 | lymphocyte chemotaxis |
| GO:0070542 | 0.0096 | 5.1244 | 0.8316 | 4 | 74 | response to fatty acid |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007218 | 4e-04 | 4.4578 | 2.2322 | 9 | 88 | neuropeptide signaling pathway |
| GO:1903523 | 5e-04 | 8.8338 | 0.6849 | 5 | 27 | negative regulation of blood circulation |
| GO:0043279 | 0.0011 | 3.7832 | 2.5874 | 9 | 102 | response to alkaloid |
| GO:0001542 | 0.0012 | 19.3538 | 0.2283 | 3 | 9 | ovulation from ovarian follicle |
| GO:2000833 | 0.0012 | 19.3538 | 0.2283 | 3 | 9 | positive regulation of steroid hormone secretion |
| GO:0033993 | 0.0015 | 1.7898 | 21.3585 | 36 | 842 | response to lipid |
| GO:0051593 | 0.0017 | 16.5878 | 0.2537 | 3 | 10 | response to folic acid |
| GO:0006438 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | valyl-tRNA aminoacylation |
| GO:0014016 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | neuroblast differentiation |
| GO:0018197 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | peptidyl-aspartic acid modification |
| GO:0021510 | 0.003 | 3.5457 | 2.4352 | 8 | 96 | spinal cord development |
| GO:0044060 | 0.0032 | 5.5478 | 1.0147 | 5 | 40 | regulation of endocrine process |
| GO:0002675 | 0.0034 | 7.3847 | 0.6342 | 4 | 25 | positive regulation of acute inflammatory response |
| GO:0071805 | 0.0034 | 2.6413 | 4.8196 | 12 | 190 | potassium ion transmembrane transport |
| GO:0008016 | 0.0035 | 2.5114 | 5.4791 | 13 | 216 | regulation of heart contraction |
| GO:0019732 | 0.0037 | 38.6172 | 0.1015 | 2 | 4 | antifungal humoral response |
| GO:0030811 | 0.0037 | 38.6172 | 0.1015 | 2 | 4 | regulation of nucleotide catabolic process |
| GO:0030820 | 0.0037 | 38.6172 | 0.1015 | 2 | 4 | regulation of cAMP catabolic process |
| GO:2000172 | 0.0037 | 38.6172 | 0.1015 | 2 | 4 | regulation of branching morphogenesis of a nerve |
| GO:0021781 | 0.0038 | 11.6091 | 0.3298 | 3 | 13 | glial cell fate commitment |
| GO:0003015 | 0.0042 | 2.3682 | 6.2401 | 14 | 246 | heart process |
| GO:0021527 | 0.0048 | 10.5531 | 0.3551 | 3 | 14 | spinal cord association neuron differentiation |
| GO:0060986 | 0.0049 | 4.9775 | 1.1161 | 5 | 44 | endocrine hormone secretion |
| GO:0002920 | 0.0052 | 4.0925 | 1.5981 | 6 | 63 | regulation of humoral immune response |
| GO:0070848 | 0.0052 | 1.7869 | 15.8793 | 27 | 626 | response to growth factor |
| GO:0009617 | 0.0054 | 1.9361 | 11.3895 | 21 | 449 | response to bacterium |
| GO:0006952 | 0.0058 | 1.525 | 33.9909 | 49 | 1340 | defense response |
| GO:2000851 | 0.0061 | 25.7431 | 0.1268 | 2 | 5 | positive regulation of glucocorticoid secretion |
| GO:1901017 | 0.0071 | 8.9283 | 0.4059 | 3 | 16 | negative regulation of potassium ion transmembrane transporter activity |
| GO:0071320 | 0.0072 | 4.5132 | 1.2176 | 5 | 48 | cellular response to cAMP |
| GO:0007267 | 0.0075 | 1.4854 | 37.0095 | 52 | 1459 | cell-cell signaling |
| GO:0043278 | 0.0075 | 5.7413 | 0.7864 | 4 | 31 | response to morphine |
| GO:0050727 | 0.0076 | 2.1322 | 7.3816 | 15 | 291 | regulation of inflammatory response |
| GO:0006693 | 0.0084 | 5.5359 | 0.8117 | 4 | 32 | prostaglandin metabolic process |
| GO:0014074 | 0.0086 | 2.7207 | 3.5006 | 9 | 138 | response to purine-containing compound |
| GO:0055118 | 0.009 | 19.306 | 0.1522 | 2 | 6 | negative regulation of cardiac muscle contraction |
| GO:1902260 | 0.009 | 19.306 | 0.1522 | 2 | 6 | negative regulation of delayed rectifier potassium channel activity |
| GO:2000192 | 0.009 | 19.306 | 0.1522 | 2 | 6 | negative regulation of fatty acid transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 0 | 2.7761 | 9.7918 | 25 | 406 | pattern specification process |
| GO:0060021 | 1e-04 | 5.1074 | 2.1947 | 10 | 91 | palate development |
| GO:0060669 | 3e-04 | 9.7534 | 0.6271 | 5 | 26 | embryonic placenta morphogenesis |
| GO:0009950 | 4e-04 | 14.865 | 0.3618 | 4 | 15 | dorsal/ventral axis specification |
| GO:0009952 | 5e-04 | 3.1965 | 4.3806 | 13 | 183 | anterior/posterior pattern specification |
| GO:0002076 | 5e-04 | 13.6253 | 0.3859 | 4 | 16 | osteoblast development |
| GO:2001055 | 6e-04 | Inf | 0.0482 | 2 | 2 | positive regulation of mesenchymal cell apoptotic process |
| GO:0033993 | 6e-04 | 1.8951 | 20.3072 | 36 | 842 | response to lipid |
| GO:1904628 | 7e-04 | 24.4698 | 0.1929 | 3 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0002763 | 8e-04 | 6.1537 | 1.1094 | 6 | 46 | positive regulation of myeloid leukocyte differentiation |
| GO:0009790 | 8e-04 | 1.8314 | 22.1642 | 38 | 919 | embryo development |
| GO:0042330 | 8e-04 | 2.1243 | 12.5171 | 25 | 519 | taxis |
| GO:0072358 | 0.001 | 2.0105 | 14.8083 | 28 | 614 | cardiovascular system development |
| GO:1904886 | 0.0014 | 9.6146 | 0.5065 | 4 | 21 | beta-catenin destruction complex disassembly |
| GO:0051255 | 0.0015 | 17.4761 | 0.2412 | 3 | 10 | spindle midzone assembly |
| GO:0060485 | 0.0015 | 2.6744 | 5.5712 | 14 | 231 | mesenchyme development |
| GO:0035880 | 0.0017 | 81.3644 | 0.0724 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0090427 | 0.0017 | 81.3644 | 0.0724 | 2 | 3 | activation of meiosis |
| GO:0016338 | 0.0017 | 9.0799 | 0.5306 | 4 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0021903 | 0.002 | 15.2905 | 0.2653 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0001503 | 0.0022 | 2.2554 | 8.4412 | 18 | 350 | ossification |
| GO:0050918 | 0.0022 | 4.9197 | 1.3506 | 6 | 56 | positive chemotaxis |
| GO:0060670 | 0.0026 | 13.5907 | 0.2894 | 3 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0090026 | 0.0026 | 13.5907 | 0.2894 | 3 | 12 | positive regulation of monocyte chemotaxis |
| GO:0001709 | 0.0026 | 5.8465 | 0.9647 | 5 | 40 | cell fate determination |
| GO:0001974 | 0.0029 | 5.6837 | 0.9888 | 5 | 41 | blood vessel remodeling |
| GO:1901888 | 0.0029 | 3.991 | 1.9053 | 7 | 79 | regulation of cell junction assembly |
| GO:0030858 | 0.0032 | 4.554 | 1.4471 | 6 | 60 | positive regulation of epithelial cell differentiation |
| GO:0014034 | 0.0034 | 40.6795 | 0.0965 | 2 | 4 | neural crest cell fate commitment |
| GO:0021555 | 0.0034 | 40.6795 | 0.0965 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0060364 | 0.0034 | 40.6795 | 0.0965 | 2 | 4 | frontal suture morphogenesis |
| GO:0048646 | 0.0035 | 1.6821 | 23.2736 | 37 | 965 | anatomical structure formation involved in morphogenesis |
| GO:2000026 | 0.0036 | 1.5128 | 41.6755 | 59 | 1728 | regulation of multicellular organismal development |
| GO:0001568 | 0.0037 | 1.9131 | 13.2178 | 24 | 553 | blood vessel development |
| GO:0048844 | 0.0037 | 4.3908 | 1.4953 | 6 | 62 | artery morphogenesis |
| GO:0014070 | 0.0039 | 1.7094 | 21.0066 | 34 | 871 | response to organic cyclic compound |
| GO:0030216 | 0.004 | 2.5806 | 4.92 | 12 | 204 | keratinocyte differentiation |
| GO:0001837 | 0.0041 | 3.0859 | 3.1112 | 9 | 129 | epithelial to mesenchymal transition |
| GO:0021915 | 0.0042 | 2.8606 | 3.7141 | 10 | 154 | neural tube development |
| GO:0035116 | 0.0043 | 6.8072 | 0.6753 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0060711 | 0.0044 | 5.114 | 1.0853 | 5 | 45 | labyrinthine layer development |
| GO:0001501 | 0.0046 | 1.9647 | 11.2389 | 21 | 466 | skeletal system development |
| GO:0003203 | 0.0049 | 6.5344 | 0.6994 | 4 | 29 | endocardial cushion morphogenesis |
| GO:0002009 | 0.0049 | 1.9215 | 12.0348 | 22 | 499 | morphogenesis of an epithelium |
| GO:0000122 | 0.005 | 1.7369 | 18.1848 | 30 | 754 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0001763 | 0.0053 | 2.6062 | 4.4618 | 11 | 185 | morphogenesis of a branching structure |
| GO:0008544 | 0.0053 | 2.1045 | 8.4895 | 17 | 352 | epidermis development |
| GO:0007218 | 0.0053 | 3.5454 | 2.1224 | 7 | 88 | neuropeptide signaling pathway |
| GO:0051094 | 0.0054 | 1.5858 | 28.0007 | 42 | 1161 | positive regulation of developmental process |
| GO:0043009 | 0.0054 | 2.0516 | 9.2195 | 18 | 389 | chordate embryonic development |
| GO:0008589 | 0.0055 | 4.0295 | 1.6159 | 6 | 67 | regulation of smoothened signaling pathway |
| GO:1904995 | 0.0055 | 27.1178 | 0.1206 | 2 | 5 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0060674 | 0.0056 | 6.2827 | 0.7235 | 4 | 30 | placenta blood vessel development |
| GO:0022612 | 0.006 | 3.1293 | 2.7253 | 8 | 113 | gland morphogenesis |
| GO:0050921 | 0.006 | 3.1293 | 2.7253 | 8 | 113 | positive regulation of chemotaxis |
| GO:0045595 | 0.0063 | 1.4911 | 38.4437 | 54 | 1594 | regulation of cell differentiation |
| GO:0048863 | 0.0069 | 2.3038 | 5.933 | 13 | 246 | stem cell differentiation |
| GO:2000113 | 0.0073 | 1.5181 | 32.7278 | 47 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0003198 | 0.0074 | 8.7339 | 0.41 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:1903507 | 0.0074 | 1.569 | 26.8672 | 40 | 1114 | negative regulation of nucleic acid-templated transcription |
| GO:1901700 | 0.0074 | 1.504 | 34.4643 | 49 | 1429 | response to oxygen-containing compound |
| GO:0048562 | 0.0075 | 2.1997 | 6.6806 | 14 | 277 | embryonic organ morphogenesis |
| GO:0021546 | 0.0082 | 20.337 | 0.1447 | 2 | 6 | rhombomere development |
| GO:0021902 | 0.0082 | 20.337 | 0.1447 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0061312 | 0.0082 | 20.337 | 0.1447 | 2 | 6 | BMP signaling pathway involved in heart development |
| GO:0060326 | 0.0083 | 2.334 | 5.4024 | 12 | 224 | cell chemotaxis |
| GO:2000678 | 0.0087 | 8.1511 | 0.4341 | 3 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0031641 | 0.0087 | 5.4435 | 0.82 | 4 | 34 | regulation of myelination |
| GO:0003151 | 0.0088 | 3.613 | 1.7847 | 6 | 74 | outflow tract morphogenesis |
| GO:0071675 | 0.0097 | 5.2676 | 0.8441 | 4 | 35 | regulation of mononuclear cell migration |
| GO:0044706 | 0.0097 | 2.3841 | 4.8477 | 11 | 201 | multi-multicellular organism process |
| GO:0048015 | 0.0098 | 2.6606 | 3.5694 | 9 | 148 | phosphatidylinositol-mediated signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051094 | 0 | 1.9963 | 30.8237 | 56 | 1161 | positive regulation of developmental process |
| GO:0007186 | 0 | 2.0975 | 22.2748 | 43 | 839 | G-protein coupled receptor signaling pathway |
| GO:0051240 | 1e-04 | 1.7692 | 37.5406 | 61 | 1414 | positive regulation of multicellular organismal process |
| GO:0045766 | 2e-04 | 3.78 | 3.478 | 12 | 131 | positive regulation of angiogenesis |
| GO:0060429 | 2e-04 | 1.8055 | 29.2307 | 49 | 1101 | epithelium development |
| GO:0030182 | 3e-04 | 1.7651 | 31.7529 | 52 | 1196 | neuron differentiation |
| GO:2000026 | 5e-04 | 1.6726 | 38.1282 | 59 | 1470 | regulation of multicellular organismal development |
| GO:0021569 | 7e-04 | Inf | 0.0531 | 2 | 2 | rhombomere 3 development |
| GO:0009953 | 7e-04 | 4.0436 | 2.4425 | 9 | 92 | dorsal/ventral pattern formation |
| GO:0048731 | 8e-04 | 1.4202 | 109.0309 | 138 | 4147 | system development |
| GO:0007411 | 8e-04 | 2.7614 | 5.8143 | 15 | 219 | axon guidance |
| GO:0022008 | 8e-04 | 1.6395 | 37.3283 | 57 | 1406 | neurogenesis |
| GO:0070887 | 9e-04 | 1.4726 | 72.8512 | 98 | 2744 | cellular response to chemical stimulus |
| GO:0048563 | 9e-04 | 22.1566 | 0.2124 | 3 | 8 | post-embryonic animal organ morphogenesis |
| GO:0030858 | 0.001 | 4.9104 | 1.593 | 7 | 60 | positive regulation of epithelial cell differentiation |
| GO:0050729 | 0.0011 | 3.8126 | 2.5753 | 9 | 97 | positive regulation of inflammatory response |
| GO:0007188 | 0.0014 | 3.1613 | 3.7434 | 11 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:1901342 | 0.0015 | 2.4829 | 6.8497 | 16 | 258 | regulation of vasculature development |
| GO:0035295 | 0.0018 | 1.9414 | 14.7083 | 27 | 554 | tube development |
| GO:0007210 | 0.0019 | 15.824 | 0.2655 | 3 | 10 | serotonin receptor signaling pathway |
| GO:0048845 | 0.0019 | 15.824 | 0.2655 | 3 | 10 | venous blood vessel morphogenesis |
| GO:0051712 | 0.0019 | 15.824 | 0.2655 | 3 | 10 | positive regulation of killing of cells of other organism |
| GO:0061140 | 0.0019 | 15.824 | 0.2655 | 3 | 10 | lung secretory cell differentiation |
| GO:0007538 | 0.0021 | 73.6915 | 0.0796 | 2 | 3 | primary sex determination |
| GO:0021530 | 0.0021 | 73.6915 | 0.0796 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0050896 | 0.0026 | 1.3708 | 141.4713 | 167 | 5620 | response to stimulus |
| GO:0045944 | 0.0027 | 1.6436 | 27.7174 | 43 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001707 | 0.0027 | 4.0634 | 1.885 | 7 | 71 | mesoderm formation |
| GO:0021675 | 0.0027 | 4.0634 | 1.885 | 7 | 71 | nerve development |
| GO:0010469 | 0.0028 | 1.9575 | 12.9295 | 24 | 487 | regulation of receptor activity |
| GO:0007389 | 0.0029 | 2.0548 | 10.779 | 21 | 406 | pattern specification process |
| GO:0001764 | 0.0029 | 3.0312 | 3.5311 | 10 | 133 | neuron migration |
| GO:0035412 | 0.0029 | 7.7863 | 0.6106 | 4 | 23 | regulation of catenin import into nucleus |
| GO:0045595 | 0.0034 | 1.5098 | 42.3195 | 60 | 1594 | regulation of cell differentiation |
| GO:0014059 | 0.0034 | 7.3965 | 0.6372 | 4 | 24 | regulation of dopamine secretion |
| GO:0008219 | 0.0035 | 1.4598 | 52.7799 | 72 | 1988 | cell death |
| GO:0003008 | 0.0039 | 1.5079 | 40.8859 | 58 | 1540 | system process |
| GO:0001709 | 0.0039 | 5.2911 | 1.062 | 5 | 40 | cell fate determination |
| GO:0002357 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | defense response to tumor cell |
| GO:0007198 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0034627 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | 'de novo' NAD biosynthetic process |
| GO:0060164 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | regulation of timing of neuron differentiation |
| GO:0061113 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | pancreas morphogenesis |
| GO:0061183 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | regulation of dermatome development |
| GO:0071847 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | TNFSF11-mediated signaling pathway |
| GO:0090298 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | negative regulation of mitochondrial DNA replication |
| GO:1902109 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:1902527 | 0.0041 | 36.8433 | 0.1062 | 2 | 4 | positive regulation of protein monoubiquitination |
| GO:0048646 | 0.0041 | 1.6408 | 25.0839 | 39 | 951 | anatomical structure formation involved in morphogenesis |
| GO:0048483 | 0.0044 | 5.1438 | 1.0885 | 5 | 41 | autonomic nervous system development |
| GO:0009605 | 0.0045 | 1.4522 | 50.6825 | 69 | 1909 | response to external stimulus |
| GO:0002063 | 0.0046 | 6.7232 | 0.6903 | 4 | 26 | chondrocyte development |
| GO:0030324 | 0.0046 | 2.6643 | 4.3806 | 11 | 165 | lung development |
| GO:0043281 | 0.0047 | 2.5313 | 5.0178 | 12 | 189 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0048598 | 0.0047 | 1.8215 | 15.0003 | 26 | 565 | embryonic morphogenesis |
| GO:0071345 | 0.0049 | 1.6782 | 21.3191 | 34 | 803 | cellular response to cytokine stimulus |
| GO:1903707 | 0.005 | 2.9907 | 3.2125 | 9 | 121 | negative regulation of hemopoiesis |
| GO:0009611 | 0.0052 | 1.7863 | 15.8765 | 27 | 598 | response to wounding |
| GO:0042542 | 0.0052 | 2.964 | 3.239 | 9 | 122 | response to hydrogen peroxide |
| GO:0021602 | 0.0053 | 6.4304 | 0.7168 | 4 | 27 | cranial nerve morphogenesis |
| GO:0060487 | 0.0053 | 10.1382 | 0.3692 | 3 | 14 | lung epithelial cell differentiation |
| GO:0021517 | 0.0054 | 4.8724 | 1.1416 | 5 | 43 | ventral spinal cord development |
| GO:0006493 | 0.0054 | 3.1976 | 2.6815 | 8 | 101 | protein O-linked glycosylation |
| GO:0003188 | 0.0054 | 10.0671 | 0.3717 | 3 | 14 | heart valve formation |
| GO:0021527 | 0.0054 | 10.0671 | 0.3717 | 3 | 14 | spinal cord association neuron differentiation |
| GO:0099054 | 0.0054 | 10.0671 | 0.3717 | 3 | 14 | presynapse assembly |
| GO:2000291 | 0.0054 | 10.0671 | 0.3717 | 3 | 14 | regulation of myoblast proliferation |
| GO:0043009 | 0.0055 | 1.8204 | 14.4162 | 25 | 543 | chordate embryonic development |
| GO:0007154 | 0.0058 | 1.3029 | 147.1891 | 172 | 5544 | cell communication |
| GO:0033993 | 0.0058 | 1.6462 | 22.3545 | 35 | 842 | response to lipid |
| GO:0031623 | 0.0065 | 3.419 | 2.2036 | 7 | 83 | receptor internalization |
| GO:0014048 | 0.0067 | 9.2276 | 0.3982 | 3 | 15 | regulation of glutamate secretion |
| GO:0021783 | 0.0067 | 9.2276 | 0.3982 | 3 | 15 | preganglionic parasympathetic fiber development |
| GO:0007386 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | compartment pattern specification |
| GO:0021779 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | glial cell fate specification |
| GO:0035694 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | mitochondrial protein catabolic process |
| GO:0048382 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | mesendoderm development |
| GO:0052150 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | modulation by symbiont of host apoptotic process |
| GO:0071502 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | cellular response to temperature stimulus |
| GO:1903142 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | positive regulation of establishment of endothelial barrier |
| GO:1904995 | 0.0067 | 24.5605 | 0.1327 | 2 | 5 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0000038 | 0.0069 | 5.9152 | 0.7699 | 4 | 29 | very long-chain fatty acid metabolic process |
| GO:0010939 | 0.0069 | 5.9152 | 0.7699 | 4 | 29 | regulation of necrotic cell death |
| GO:0007420 | 0.0069 | 1.725 | 17.0181 | 28 | 641 | brain development |
| GO:0001568 | 0.007 | 1.7605 | 15.4782 | 26 | 583 | blood vessel development |
| GO:0060411 | 0.0075 | 3.7699 | 1.7257 | 6 | 65 | cardiac septum morphogenesis |
| GO:0043067 | 0.0079 | 1.4792 | 37.0893 | 52 | 1397 | regulation of programmed cell death |
| GO:0010823 | 0.0079 | 4.4071 | 1.2478 | 5 | 47 | negative regulation of mitochondrion organization |
| GO:2000179 | 0.0079 | 4.4071 | 1.2478 | 5 | 47 | positive regulation of neural precursor cell proliferation |
| GO:0031649 | 0.008 | 8.5172 | 0.4248 | 3 | 16 | heat generation |
| GO:0043278 | 0.0087 | 5.4763 | 0.823 | 4 | 31 | response to morphine |
| GO:0071773 | 0.0092 | 2.5322 | 4.1682 | 10 | 157 | cellular response to BMP stimulus |
| GO:0021879 | 0.0094 | 4.2063 | 1.3009 | 5 | 49 | forebrain neuron differentiation |
| GO:1903202 | 0.0094 | 4.2063 | 1.3009 | 5 | 49 | negative regulation of oxidative stress-induced cell death |
| GO:0036342 | 0.0096 | 7.9083 | 0.4513 | 3 | 17 | post-anal tail morphogenesis |
| GO:1904948 | 0.0096 | 7.9083 | 0.4513 | 3 | 17 | midbrain dopaminergic neuron differentiation |
| GO:2000406 | 0.0096 | 7.9083 | 0.4513 | 3 | 17 | positive regulation of T cell migration |
| GO:0090092 | 0.0098 | 2.283 | 5.5222 | 12 | 208 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0008038 | 0.0098 | 5.2804 | 0.8496 | 4 | 32 | neuron recognition |
| GO:0030513 | 0.0098 | 5.2804 | 0.8496 | 4 | 32 | positive regulation of BMP signaling pathway |
| GO:0048729 | 0.0098 | 1.7094 | 15.903 | 26 | 599 | tissue morphogenesis |
| GO:0009996 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | negative regulation of cell fate specification |
| GO:0014816 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | skeletal muscle satellite cell differentiation |
| GO:0021707 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | cerebellar granule cell differentiation |
| GO:0031622 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | positive regulation of fever generation |
| GO:0034112 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | positive regulation of homotypic cell-cell adhesion |
| GO:0038001 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | paracrine signaling |
| GO:0044339 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:0044532 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | modulation of apoptotic process in other organism |
| GO:0052248 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | modulation of programmed cell death in other organism involved in symbiotic interaction |
| GO:1905709 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | negative regulation of membrane permeability |
| GO:1990144 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | intrinsic apoptotic signaling pathway in response to hypoxia |
| GO:2001199 | 0.0098 | 18.4192 | 0.1593 | 2 | 6 | negative regulation of dendritic cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0 | 7.7551 | 1.8077 | 12 | 92 | embryonic skeletal system morphogenesis |
| GO:0048568 | 0 | 3.4719 | 7.9972 | 25 | 407 | embryonic organ development |
| GO:0001501 | 0 | 3.2739 | 9.1565 | 27 | 466 | skeletal system development |
| GO:0007389 | 0 | 3.0061 | 7.9775 | 22 | 406 | pattern specification process |
| GO:0009952 | 0 | 4.0221 | 3.8119 | 14 | 194 | anterior/posterior pattern specification |
| GO:0072498 | 2e-04 | 18.3753 | 0.2947 | 4 | 15 | embryonic skeletal joint development |
| GO:0051241 | 2e-04 | 2.0286 | 19.2364 | 36 | 979 | negative regulation of multicellular organismal process |
| GO:0035115 | 4e-04 | 9.3796 | 0.6288 | 5 | 32 | embryonic forelimb morphogenesis |
| GO:0003218 | 4e-04 | Inf | 0.0393 | 2 | 2 | cardiac left ventricle formation |
| GO:0035108 | 6e-04 | 3.7891 | 2.8491 | 10 | 145 | limb morphogenesis |
| GO:0060537 | 7e-04 | 2.6083 | 6.9558 | 17 | 354 | muscle tissue development |
| GO:0035113 | 9e-04 | 3.926 | 2.4758 | 9 | 126 | embryonic appendage morphogenesis |
| GO:0090596 | 0.0011 | 2.9028 | 4.7747 | 13 | 243 | sensory organ morphogenesis |
| GO:0060707 | 0.0014 | 16.7894 | 0.2358 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0060044 | 0.0019 | 15.1095 | 0.2554 | 3 | 13 | negative regulation of cardiac muscle cell proliferation |
| GO:0048736 | 0.002 | 3.1916 | 3.3403 | 10 | 170 | appendage development |
| GO:0035995 | 0.0022 | 50.2222 | 0.0786 | 2 | 4 | detection of muscle stretch |
| GO:0046541 | 0.0023 | 13.735 | 0.2751 | 3 | 14 | saliva secretion |
| GO:0007586 | 0.0024 | 3.3483 | 2.8688 | 9 | 146 | digestion |
| GO:0043009 | 0.0025 | 2.0833 | 10.6694 | 21 | 543 | chordate embryonic development |
| GO:0045165 | 0.0027 | 2.7181 | 4.6765 | 12 | 238 | cell fate commitment |
| GO:0001707 | 0.0027 | 4.6793 | 1.3951 | 6 | 71 | mesoderm formation |
| GO:0009954 | 0.003 | 7.4782 | 0.6091 | 4 | 31 | proximal/distal pattern formation |
| GO:0045601 | 0.0034 | 7.2107 | 0.6288 | 4 | 32 | regulation of endothelial cell differentiation |
| GO:0055003 | 0.0035 | 11.6203 | 0.3144 | 3 | 16 | cardiac myofibril assembly |
| GO:0060413 | 0.0035 | 11.6203 | 0.3144 | 3 | 16 | atrial septum morphogenesis |
| GO:0010989 | 0.0037 | 33.4792 | 0.0982 | 2 | 5 | negative regulation of low-density lipoprotein particle clearance |
| GO:0021650 | 0.0037 | 33.4792 | 0.0982 | 2 | 5 | vestibulocochlear nerve formation |
| GO:0051891 | 0.0037 | 33.4792 | 0.0982 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0072162 | 0.0037 | 33.4792 | 0.0982 | 2 | 5 | metanephric mesenchymal cell differentiation |
| GO:0098528 | 0.0037 | 33.4792 | 0.0982 | 2 | 5 | skeletal muscle fiber differentiation |
| GO:0048729 | 0.0037 | 1.974 | 11.7698 | 22 | 599 | tissue morphogenesis |
| GO:0048644 | 0.0049 | 4.1077 | 1.5719 | 6 | 80 | muscle organ morphogenesis |
| GO:0061117 | 0.0049 | 10.0696 | 0.3537 | 3 | 18 | negative regulation of heart growth |
| GO:0072074 | 0.0049 | 10.0696 | 0.3537 | 3 | 18 | kidney mesenchyme development |
| GO:0048608 | 0.0054 | 2.1572 | 7.8007 | 16 | 397 | reproductive structure development |
| GO:0003284 | 0.0055 | 25.1077 | 0.1179 | 2 | 6 | septum primum development |
| GO:0003406 | 0.0055 | 25.1077 | 0.1179 | 2 | 6 | retinal pigment epithelium development |
| GO:0030240 | 0.0055 | 25.1077 | 0.1179 | 2 | 6 | skeletal muscle thin filament assembly |
| GO:0060373 | 0.0055 | 25.1077 | 0.1179 | 2 | 6 | regulation of ventricular cardiac muscle cell membrane depolarization |
| GO:0070092 | 0.0055 | 25.1077 | 0.1179 | 2 | 6 | regulation of glucagon secretion |
| GO:0072143 | 0.0055 | 25.1077 | 0.1179 | 2 | 6 | mesangial cell development |
| GO:1902338 | 0.0055 | 25.1077 | 0.1179 | 2 | 6 | negative regulation of apoptotic process involved in morphogenesis |
| GO:0001710 | 0.0058 | 9.4396 | 0.3733 | 3 | 19 | mesodermal cell fate commitment |
| GO:0060575 | 0.0058 | 9.4396 | 0.3733 | 3 | 19 | intestinal epithelial cell differentiation |
| GO:0072079 | 0.0058 | 9.4396 | 0.3733 | 3 | 19 | nephron tubule formation |
| GO:0050877 | 0.0064 | 1.7426 | 16.9572 | 28 | 863 | nervous system process |
| GO:0035295 | 0.0067 | 1.9309 | 10.8856 | 20 | 554 | tube development |
| GO:0048844 | 0.0074 | 4.434 | 1.2182 | 5 | 62 | artery morphogenesis |
| GO:0010700 | 0.0076 | 20.0848 | 0.1375 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:2001012 | 0.0076 | 20.0848 | 0.1375 | 2 | 7 | mesenchymal cell differentiation involved in renal system development |
| GO:0045471 | 0.0076 | 3.2874 | 2.2596 | 7 | 115 | response to ethanol |
| GO:0016101 | 0.0077 | 3.705 | 1.7291 | 6 | 88 | diterpenoid metabolic process |
| GO:0003281 | 0.0079 | 4.3573 | 1.2379 | 5 | 63 | ventricular septum development |
| GO:0055008 | 0.0079 | 4.3573 | 1.2379 | 5 | 63 | cardiac muscle tissue morphogenesis |
| GO:2000026 | 0.0083 | 1.5069 | 33.9536 | 48 | 1728 | regulation of multicellular organismal development |
| GO:0060429 | 0.0085 | 1.6304 | 21.3803 | 33 | 1095 | epithelium development |
| GO:0007498 | 0.0087 | 3.1979 | 2.3186 | 7 | 118 | mesoderm development |
| GO:0051953 | 0.0088 | 7.9475 | 0.4323 | 3 | 22 | negative regulation of amine transport |
| GO:0007369 | 0.009 | 2.6923 | 3.5172 | 9 | 179 | gastrulation |
| GO:0002062 | 0.009 | 3.5735 | 1.7881 | 6 | 91 | chondrocyte differentiation |
| GO:0035850 | 0.0091 | 5.3095 | 0.8253 | 4 | 42 | epithelial cell differentiation involved in kidney development |
| GO:0045843 | 0.0091 | 5.3095 | 0.8253 | 4 | 42 | negative regulation of striated muscle tissue development |
| GO:0003206 | 0.0091 | 3.1691 | 2.3382 | 7 | 119 | cardiac chamber morphogenesis |
| GO:0051093 | 0.0093 | 1.7216 | 15.8765 | 26 | 808 | negative regulation of developmental process |
| GO:0001657 | 0.0095 | 3.5317 | 1.8077 | 6 | 92 | ureteric bud development |
| GO:0090103 | 0.0099 | 7.5497 | 0.4519 | 3 | 23 | cochlea morphogenesis |
| GO:0003056 | 0.01 | 16.7363 | 0.1572 | 2 | 8 | regulation of vascular smooth muscle contraction |
| GO:0008300 | 0.01 | 16.7363 | 0.1572 | 2 | 8 | isoprenoid catabolic process |
| GO:0019755 | 0.01 | 16.7363 | 0.1572 | 2 | 8 | one-carbon compound transport |
| GO:0021562 | 0.01 | 16.7363 | 0.1572 | 2 | 8 | vestibulocochlear nerve development |
| GO:0048793 | 0.01 | 16.7363 | 0.1572 | 2 | 8 | pronephros development |
| GO:0060693 | 0.01 | 16.7363 | 0.1572 | 2 | 8 | regulation of branching involved in salivary gland morphogenesis |
| GO:1904238 | 0.01 | 16.7363 | 0.1572 | 2 | 8 | pericyte cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050829 | 3e-04 | 6.1682 | 1.2752 | 7 | 63 | defense response to Gram-negative bacterium |
| GO:0009888 | 4e-04 | 1.7257 | 34.8744 | 55 | 1723 | tissue development |
| GO:2000334 | 4e-04 | Inf | 0.0405 | 2 | 2 | positive regulation of blood microparticle formation |
| GO:0050830 | 8e-04 | 5.0756 | 1.518 | 7 | 75 | defense response to Gram-positive bacterium |
| GO:0001503 | 8e-04 | 2.5571 | 7.0842 | 17 | 350 | ossification |
| GO:0090092 | 0.0011 | 3.0432 | 4.21 | 12 | 208 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0055096 | 0.0012 | 97.4379 | 0.0607 | 2 | 3 | low-density lipoprotein particle mediated signaling |
| GO:0060045 | 0.0013 | 9.7954 | 0.4858 | 4 | 24 | positive regulation of cardiac muscle cell proliferation |
| GO:0032103 | 0.0013 | 2.825 | 4.8982 | 13 | 242 | positive regulation of response to external stimulus |
| GO:0032502 | 0.0014 | 1.4261 | 112.2539 | 138 | 5546 | developmental process |
| GO:0044130 | 0.0016 | 16.2842 | 0.2429 | 3 | 12 | negative regulation of growth of symbiont in host |
| GO:0060343 | 0.0017 | 8.9037 | 0.5263 | 4 | 26 | trabecula formation |
| GO:0046467 | 0.002 | 3.4487 | 2.7932 | 9 | 138 | membrane lipid biosynthetic process |
| GO:0046321 | 0.002 | 14.6548 | 0.2631 | 3 | 13 | positive regulation of fatty acid oxidation |
| GO:0010469 | 0.0022 | 2.1476 | 9.8571 | 20 | 487 | regulation of receptor activity |
| GO:0010862 | 0.0023 | 5.9841 | 0.9311 | 5 | 46 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0019433 | 0.0023 | 8.1606 | 0.5667 | 4 | 28 | triglyceride catabolic process |
| GO:0030823 | 0.0023 | 8.1606 | 0.5667 | 4 | 28 | regulation of cGMP metabolic process |
| GO:0098754 | 0.0025 | 4.1044 | 1.8419 | 7 | 91 | detoxification |
| GO:0044144 | 0.0025 | 13.3216 | 0.2834 | 3 | 14 | modulation of growth of symbiont involved in interaction with host |
| GO:0045725 | 0.0025 | 13.3216 | 0.2834 | 3 | 14 | positive regulation of glycogen biosynthetic process |
| GO:0097237 | 0.0033 | 3.8725 | 1.9431 | 7 | 96 | cellular response to toxic substance |
| GO:0003209 | 0.0034 | 7.2524 | 0.6275 | 4 | 31 | cardiac atrium morphogenesis |
| GO:0055021 | 0.0036 | 5.3318 | 1.0323 | 5 | 51 | regulation of cardiac muscle tissue growth |
| GO:0003150 | 0.0039 | 32.4749 | 0.1012 | 2 | 5 | muscular septum morphogenesis |
| GO:0003241 | 0.0039 | 32.4749 | 0.1012 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0035609 | 0.0039 | 32.4749 | 0.1012 | 2 | 5 | C-terminal protein deglutamylation |
| GO:0060700 | 0.0039 | 32.4749 | 0.1012 | 2 | 5 | regulation of ribonuclease activity |
| GO:0003229 | 0.0039 | 5.218 | 1.0525 | 5 | 52 | ventricular cardiac muscle tissue development |
| GO:0046461 | 0.0042 | 6.7514 | 0.6679 | 4 | 33 | neutral lipid catabolic process |
| GO:0046513 | 0.0043 | 5.109 | 1.0727 | 5 | 53 | ceramide biosynthetic process |
| GO:0042249 | 0.0045 | 10.4649 | 0.3441 | 3 | 17 | establishment of planar polarity of embryonic epithelium |
| GO:0042359 | 0.0045 | 10.4649 | 0.3441 | 3 | 17 | vitamin D metabolic process |
| GO:0044110 | 0.0045 | 10.4649 | 0.3441 | 3 | 17 | growth involved in symbiotic interaction |
| GO:0050996 | 0.0045 | 10.4649 | 0.3441 | 3 | 17 | positive regulation of lipid catabolic process |
| GO:0060395 | 0.0046 | 5.0044 | 1.093 | 5 | 54 | SMAD protein signal transduction |
| GO:0060421 | 0.0053 | 6.3149 | 0.7084 | 4 | 35 | positive regulation of heart growth |
| GO:0002544 | 0.0053 | 9.7666 | 0.3643 | 3 | 18 | chronic inflammatory response |
| GO:2000311 | 0.0053 | 9.7666 | 0.3643 | 3 | 18 | regulation of AMPA receptor activity |
| GO:0050918 | 0.0054 | 4.8075 | 1.1335 | 5 | 56 | positive chemotaxis |
| GO:0071396 | 0.0055 | 1.9686 | 10.687 | 20 | 528 | cellular response to lipid |
| GO:0048644 | 0.0056 | 3.9829 | 1.6192 | 6 | 80 | muscle organ morphogenesis |
| GO:0015939 | 0.0058 | 24.3546 | 0.1214 | 2 | 6 | pantothenate metabolic process |
| GO:0031622 | 0.0058 | 24.3546 | 0.1214 | 2 | 6 | positive regulation of fever generation |
| GO:0034112 | 0.0058 | 24.3546 | 0.1214 | 2 | 6 | positive regulation of homotypic cell-cell adhesion |
| GO:0038001 | 0.0058 | 24.3546 | 0.1214 | 2 | 6 | paracrine signaling |
| GO:1900451 | 0.0058 | 24.3546 | 0.1214 | 2 | 6 | positive regulation of glutamate receptor signaling pathway |
| GO:0032501 | 0.0062 | 1.3562 | 116.6584 | 138 | 5960 | multicellular organismal process |
| GO:0030828 | 0.0063 | 9.1555 | 0.3846 | 3 | 19 | positive regulation of cGMP biosynthetic process |
| GO:0045785 | 0.0063 | 2.1806 | 7.2259 | 15 | 357 | positive regulation of cell adhesion |
| GO:0046676 | 0.0064 | 5.9314 | 0.7489 | 4 | 37 | negative regulation of insulin secretion |
| GO:1903039 | 0.0067 | 2.6562 | 3.9671 | 10 | 196 | positive regulation of leukocyte cell-cell adhesion |
| GO:0098869 | 0.0067 | 3.827 | 1.68 | 6 | 83 | cellular oxidant detoxification |
| GO:0030595 | 0.007 | 2.8102 | 3.3802 | 9 | 167 | leukocyte chemotaxis |
| GO:0003158 | 0.007 | 3.343 | 2.2265 | 7 | 110 | endothelium development |
| GO:0044264 | 0.0071 | 3.7776 | 1.7002 | 6 | 84 | cellular polysaccharide metabolic process |
| GO:0045668 | 0.0078 | 5.5917 | 0.7894 | 4 | 39 | negative regulation of osteoblast differentiation |
| GO:0016477 | 0.0079 | 1.5944 | 24.5518 | 37 | 1213 | cell migration |
| GO:0010886 | 0.008 | 19.4824 | 0.1417 | 2 | 7 | positive regulation of cholesterol storage |
| GO:0071447 | 0.008 | 19.4824 | 0.1417 | 2 | 7 | cellular response to hydroperoxide |
| GO:0097091 | 0.008 | 19.4824 | 0.1417 | 2 | 7 | synaptic vesicle clustering |
| GO:0045672 | 0.0083 | 8.1372 | 0.4251 | 3 | 21 | positive regulation of osteoclast differentiation |
| GO:0022617 | 0.0084 | 3.637 | 1.7609 | 6 | 87 | extracellular matrix disassembly |
| GO:0010883 | 0.0085 | 5.436 | 0.8096 | 4 | 40 | regulation of lipid storage |
| GO:0032757 | 0.0085 | 5.436 | 0.8096 | 4 | 40 | positive regulation of interleukin-8 production |
| GO:0046326 | 0.0085 | 5.436 | 0.8096 | 4 | 40 | positive regulation of glucose import |
| GO:0055008 | 0.0089 | 4.2253 | 1.2752 | 5 | 63 | cardiac muscle tissue morphogenesis |
| GO:0055025 | 0.0093 | 5.2888 | 0.8299 | 4 | 41 | positive regulation of cardiac muscle tissue development |
| GO:0003231 | 0.0093 | 3.1577 | 2.3479 | 7 | 116 | cardiac ventricle development |
| GO:0008645 | 0.0093 | 3.1577 | 2.3479 | 7 | 116 | hexose transport |
| GO:2001267 | 0.0095 | 7.7084 | 0.4453 | 3 | 22 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:0030308 | 0.0098 | 2.8543 | 2.9551 | 8 | 146 | negative regulation of cell growth |
| GO:2000147 | 0.01 | 2.0082 | 8.3391 | 16 | 412 | positive regulation of cell motility |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048513 | 0 | 1.5997 | 77.0377 | 109 | 3037 | animal organ development |
| GO:0051241 | 2e-04 | 1.9121 | 24.8337 | 44 | 979 | negative regulation of multicellular organismal process |
| GO:0035295 | 2e-04 | 2.2135 | 14.053 | 29 | 554 | tube development |
| GO:0032501 | 3e-04 | 1.4906 | 118.3319 | 149 | 5051 | multicellular organismal process |
| GO:0060022 | 3e-04 | 38.7154 | 0.1522 | 3 | 6 | hard palate development |
| GO:0007389 | 7e-04 | 2.2739 | 10.2987 | 22 | 406 | pattern specification process |
| GO:0090190 | 7e-04 | 11.9356 | 0.4312 | 4 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0032502 | 0.0011 | 1.6431 | 38.3376 | 57 | 1643 | developmental process |
| GO:0050707 | 0.0013 | 3.1695 | 3.7289 | 11 | 147 | regulation of cytokine secretion |
| GO:0051093 | 0.0014 | 1.8134 | 20.496 | 35 | 808 | negative regulation of developmental process |
| GO:0002408 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | myeloid dendritic cell chemotaxis |
| GO:0009624 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | response to nematode |
| GO:0035880 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0044691 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | tooth eruption |
| GO:2000768 | 0.0019 | 77.2396 | 0.0761 | 2 | 3 | positive regulation of nephron tubule epithelial cell differentiation |
| GO:0050807 | 0.0025 | 3.3481 | 2.8918 | 9 | 114 | regulation of synapse organization |
| GO:0001525 | 0.0025 | 2.081 | 10.6539 | 21 | 420 | angiogenesis |
| GO:0090184 | 0.0026 | 5.8848 | 0.9639 | 5 | 38 | positive regulation of kidney development |
| GO:0007186 | 0.0027 | 1.7397 | 21.2824 | 35 | 839 | G-protein coupled receptor signaling pathway |
| GO:0061217 | 0.0029 | 7.7545 | 0.6088 | 4 | 24 | regulation of mesonephros development |
| GO:0048754 | 0.0032 | 2.9844 | 3.5767 | 10 | 141 | branching morphogenesis of an epithelial tube |
| GO:2000026 | 0.0032 | 1.7076 | 22.3551 | 36 | 912 | regulation of multicellular organismal development |
| GO:0018894 | 0.0037 | 38.6172 | 0.1015 | 2 | 4 | dibenzo-p-dioxin metabolic process |
| GO:0070207 | 0.0039 | 7.0485 | 0.6595 | 4 | 26 | protein homotrimerization |
| GO:0045843 | 0.004 | 5.2472 | 1.0654 | 5 | 42 | negative regulation of striated muscle tissue development |
| GO:0050798 | 0.004 | 5.2472 | 1.0654 | 5 | 42 | activated T cell proliferation |
| GO:0030858 | 0.004 | 4.3208 | 1.522 | 6 | 60 | positive regulation of epithelial cell differentiation |
| GO:0017015 | 0.0041 | 3.3539 | 2.562 | 8 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0048562 | 0.0049 | 2.2483 | 7.0265 | 15 | 277 | embryonic organ morphogenesis |
| GO:0060429 | 0.0052 | 1.5878 | 27.9284 | 42 | 1101 | epithelium development |
| GO:0030901 | 0.0054 | 3.539 | 2.1308 | 7 | 84 | midbrain development |
| GO:0003205 | 0.0057 | 2.7317 | 3.8811 | 10 | 153 | cardiac chamber development |
| GO:0048532 | 0.0059 | 9.673 | 0.3805 | 3 | 15 | anatomical structure arrangement |
| GO:2000696 | 0.0059 | 9.673 | 0.3805 | 3 | 15 | regulation of epithelial cell differentiation involved in kidney development |
| GO:0043066 | 0.0059 | 1.683 | 19.9887 | 32 | 788 | negative regulation of apoptotic process |
| GO:0003007 | 0.006 | 2.3472 | 5.8343 | 13 | 230 | heart morphogenesis |
| GO:0060411 | 0.006 | 3.9533 | 1.6488 | 6 | 65 | cardiac septum morphogenesis |
| GO:0043009 | 0.0061 | 1.8283 | 13.7739 | 24 | 543 | chordate embryonic development |
| GO:0061043 | 0.0061 | 25.7431 | 0.1268 | 2 | 5 | regulation of vascular wound healing |
| GO:1902961 | 0.0061 | 25.7431 | 0.1268 | 2 | 5 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1904995 | 0.0061 | 25.7431 | 0.1268 | 2 | 5 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0043010 | 0.0071 | 2.148 | 7.3309 | 15 | 289 | camera-type eye development |
| GO:0007193 | 0.0075 | 3.7612 | 1.7249 | 6 | 68 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0030182 | 0.008 | 1.5277 | 30.3382 | 44 | 1196 | neuron differentiation |
| GO:0050706 | 0.0084 | 5.5359 | 0.8117 | 4 | 32 | regulation of interleukin-1 beta secretion |
| GO:0048869 | 0.0084 | 1.3208 | 97.0517 | 118 | 3826 | cellular developmental process |
| GO:0060688 | 0.0085 | 4.312 | 1.2683 | 5 | 50 | regulation of morphogenesis of a branching structure |
| GO:0008544 | 0.0087 | 1.9935 | 8.929 | 17 | 352 | epidermis development |
| GO:0045995 | 0.0089 | 2.9123 | 2.9171 | 8 | 115 | regulation of embryonic development |
| GO:0051960 | 0.009 | 1.6564 | 18.974 | 30 | 748 | regulation of nervous system development |
| GO:0014816 | 0.009 | 19.306 | 0.1522 | 2 | 6 | skeletal muscle satellite cell differentiation |
| GO:0051045 | 0.009 | 19.306 | 0.1522 | 2 | 6 | negative regulation of membrane protein ectodomain proteolysis |
| GO:0060137 | 0.009 | 19.306 | 0.1522 | 2 | 6 | maternal process involved in parturition |
| GO:0060613 | 0.009 | 19.306 | 0.1522 | 2 | 6 | fat pad development |
| GO:1902338 | 0.009 | 19.306 | 0.1522 | 2 | 6 | negative regulation of apoptotic process involved in morphogenesis |
| GO:0002790 | 0.0093 | 1.807 | 12.7339 | 22 | 502 | peptide secretion |
| GO:0050714 | 0.0095 | 2.2892 | 5.5045 | 12 | 217 | positive regulation of protein secretion |
| GO:0035148 | 0.0098 | 2.6584 | 3.5767 | 9 | 141 | tube formation |
| GO:0048592 | 0.0098 | 2.6584 | 3.5767 | 9 | 141 | eye morphogenesis |
| GO:0060548 | 0.0099 | 1.5927 | 22.3731 | 34 | 882 | negative regulation of cell death |
| GO:0001759 | 0.01 | 7.7368 | 0.4566 | 3 | 18 | organ induction |
| GO:0030540 | 0.01 | 7.7368 | 0.4566 | 3 | 18 | female genitalia development |
| GO:0051450 | 0.01 | 7.7368 | 0.4566 | 3 | 18 | myoblast proliferation |
| GO:0055022 | 0.01 | 7.7368 | 0.4566 | 3 | 18 | negative regulation of cardiac muscle tissue growth |
| GO:1905276 | 0.01 | 7.7368 | 0.4566 | 3 | 18 | regulation of epithelial tube formation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0021892 | 8e-04 | 22.8969 | 0.194 | 3 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0033327 | 8e-04 | 22.8969 | 0.194 | 3 | 9 | Leydig cell differentiation |
| GO:0010038 | 0.0011 | 2.5726 | 6.6173 | 16 | 307 | response to metal ion |
| GO:0060272 | 0.0019 | 15.2615 | 0.2587 | 3 | 12 | embryonic skeletal joint morphogenesis |
| GO:0021853 | 0.0027 | 45.6656 | 0.0862 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
| GO:0060486 | 0.0027 | 45.6656 | 0.0862 | 2 | 4 | Clara cell differentiation |
| GO:0071934 | 0.0027 | 45.6656 | 0.0862 | 2 | 4 | thiamine transmembrane transport |
| GO:0031424 | 0.0029 | 3.2536 | 2.953 | 9 | 137 | keratinization |
| GO:0042487 | 0.003 | 12.485 | 0.3018 | 3 | 14 | regulation of odontogenesis of dentin-containing tooth |
| GO:0035108 | 0.0042 | 3.0605 | 3.1255 | 9 | 145 | limb morphogenesis |
| GO:0043278 | 0.0042 | 6.7956 | 0.6682 | 4 | 31 | response to morphine |
| GO:0006552 | 0.0044 | 30.4417 | 0.1078 | 2 | 5 | leucine catabolic process |
| GO:0060510 | 0.0044 | 30.4417 | 0.1078 | 2 | 5 | Type II pneumocyte differentiation |
| GO:0080184 | 0.0044 | 30.4417 | 0.1078 | 2 | 5 | response to phenylpropanoid |
| GO:0010469 | 0.0046 | 2.0053 | 10.4972 | 20 | 487 | regulation of receptor activity |
| GO:0035115 | 0.0047 | 6.5525 | 0.6898 | 4 | 32 | embryonic forelimb morphogenesis |
| GO:0055093 | 0.0064 | 9.1532 | 0.388 | 3 | 18 | response to hyperoxia |
| GO:0043279 | 0.0065 | 3.3959 | 2.1986 | 7 | 102 | response to alkaloid |
| GO:0006701 | 0.0066 | 22.8298 | 0.1293 | 2 | 6 | progesterone biosynthetic process |
| GO:0009838 | 0.0066 | 22.8298 | 0.1293 | 2 | 6 | abscission |
| GO:0046546 | 0.0068 | 3.0512 | 2.7806 | 8 | 129 | development of primary male sexual characteristics |
| GO:0002227 | 0.0074 | 8.5806 | 0.4095 | 3 | 19 | innate immune response in mucosa |
| GO:0035809 | 0.0074 | 8.5806 | 0.4095 | 3 | 19 | regulation of urine volume |
| GO:0043588 | 0.0079 | 2.1831 | 6.7251 | 14 | 312 | skin development |
| GO:0007186 | 0.0083 | 1.6858 | 18.0845 | 29 | 839 | G-protein coupled receptor signaling pathway |
| GO:0032506 | 0.0086 | 8.0753 | 0.4311 | 3 | 20 | cytokinetic process |
| GO:0002158 | 0.0091 | 18.2626 | 0.1509 | 2 | 7 | osteoclast proliferation |
| GO:0021843 | 0.0091 | 18.2626 | 0.1509 | 2 | 7 | substrate-independent telencephalic tangential interneuron migration |
| GO:0033601 | 0.0091 | 18.2626 | 0.1509 | 2 | 7 | positive regulation of mammary gland epithelial cell proliferation |
| GO:0060430 | 0.0091 | 18.2626 | 0.1509 | 2 | 7 | lung saccule development |
| GO:0098700 | 0.0091 | 18.2626 | 0.1509 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
| GO:0030855 | 0.0091 | 1.7866 | 13.4933 | 23 | 626 | epithelial cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010705 | 4e-04 | Inf | 0.0406 | 2 | 2 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination |
| GO:0018003 | 4e-04 | Inf | 0.0406 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0001836 | 8e-04 | 6.0048 | 1.1168 | 6 | 55 | release of cytochrome c from mitochondria |
| GO:0051593 | 9e-04 | 20.8697 | 0.2031 | 3 | 10 | response to folic acid |
| GO:0014016 | 0.0012 | 97.114 | 0.0609 | 2 | 3 | neuroblast differentiation |
| GO:0061754 | 0.0012 | 97.114 | 0.0609 | 2 | 3 | negative regulation of circulating fibrinogen levels |
| GO:0043067 | 0.0013 | 1.7091 | 28.3678 | 45 | 1397 | regulation of programmed cell death |
| GO:0010942 | 0.0015 | 2.0655 | 12.3462 | 24 | 608 | positive regulation of cell death |
| GO:0060429 | 0.0017 | 1.7699 | 22.3572 | 37 | 1101 | epithelium development |
| GO:0009650 | 0.002 | 14.6059 | 0.264 | 3 | 13 | UV protection |
| GO:0010719 | 0.0023 | 8.1333 | 0.5686 | 4 | 28 | negative regulation of epithelial to mesenchymal transition |
| GO:0060478 | 0.0024 | 48.5537 | 0.0812 | 2 | 4 | acrosomal vesicle exocytosis |
| GO:0097107 | 0.0024 | 48.5537 | 0.0812 | 2 | 4 | postsynaptic density assembly |
| GO:0080184 | 0.0039 | 32.367 | 0.1015 | 2 | 5 | response to phenylpropanoid |
| GO:0097070 | 0.0039 | 32.367 | 0.1015 | 2 | 5 | ductus arteriosus closure |
| GO:0097105 | 0.0039 | 32.367 | 0.1015 | 2 | 5 | presynaptic membrane assembly |
| GO:0045786 | 0.004 | 1.9604 | 11.8385 | 22 | 583 | negative regulation of cell cycle |
| GO:2000134 | 0.004 | 3.7328 | 2.0103 | 7 | 99 | negative regulation of G1/S transition of mitotic cell cycle |
| GO:1902806 | 0.0041 | 3.0758 | 3.1069 | 9 | 153 | regulation of cell cycle G1/S phase transition |
| GO:0032355 | 0.0042 | 3.3313 | 2.5586 | 8 | 126 | response to estradiol |
| GO:0048665 | 0.0043 | 6.7288 | 0.6701 | 4 | 33 | neuron fate specification |
| GO:0060749 | 0.0046 | 10.43 | 0.3452 | 3 | 17 | mammary gland alveolus development |
| GO:0008285 | 0.0049 | 1.8947 | 12.7929 | 23 | 630 | negative regulation of cell proliferation |
| GO:0043065 | 0.0053 | 1.9401 | 11.3918 | 21 | 561 | positive regulation of apoptotic process |
| GO:0001580 | 0.0054 | 9.734 | 0.3655 | 3 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0043066 | 0.0056 | 1.7799 | 16.0013 | 27 | 788 | negative regulation of apoptotic process |
| GO:0060840 | 0.0057 | 3.9695 | 1.6245 | 6 | 80 | artery development |
| GO:2000807 | 0.0058 | 24.2736 | 0.1218 | 2 | 6 | regulation of synaptic vesicle clustering |
| GO:0031113 | 0.0065 | 5.9116 | 0.7513 | 4 | 37 | regulation of microtubule polymerization |
| GO:0031424 | 0.0069 | 3.0449 | 2.782 | 8 | 137 | keratinization |
| GO:0060548 | 0.0072 | 1.7066 | 17.9101 | 29 | 882 | negative regulation of cell death |
| GO:0003357 | 0.0081 | 19.4176 | 0.1421 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0051791 | 0.0081 | 19.4176 | 0.1421 | 2 | 7 | medium-chain fatty acid metabolic process |
| GO:0060430 | 0.0081 | 19.4176 | 0.1421 | 2 | 7 | lung saccule development |
| GO:0048485 | 0.0084 | 8.11 | 0.4264 | 3 | 21 | sympathetic nervous system development |
| GO:0033875 | 0.0086 | 5.4179 | 0.8122 | 4 | 40 | ribonucleoside bisphosphate metabolic process |
| GO:0034032 | 0.0086 | 5.4179 | 0.8122 | 4 | 40 | purine nucleoside bisphosphate metabolic process |
| GO:0006469 | 0.0095 | 2.3873 | 4.8329 | 11 | 238 | negative regulation of protein kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0021527 | 0 | 21.0458 | 0.3643 | 5 | 14 | spinal cord association neuron differentiation |
| GO:0030216 | 0 | 3.5102 | 5.3088 | 17 | 204 | keratinocyte differentiation |
| GO:0070268 | 0 | 5.0733 | 2.4462 | 11 | 94 | cornification |
| GO:0007186 | 1e-04 | 2.0295 | 21.8337 | 41 | 839 | G-protein coupled receptor signaling pathway |
| GO:0008544 | 1e-04 | 2.5831 | 9.1603 | 22 | 352 | epidermis development |
| GO:0060429 | 2e-04 | 1.8482 | 28.6519 | 49 | 1101 | epithelium development |
| GO:0021517 | 8e-04 | 6.1472 | 1.119 | 6 | 43 | ventral spinal cord development |
| GO:0042221 | 0.001 | 1.4231 | 95.9487 | 123 | 3687 | response to chemical |
| GO:0009266 | 0.0015 | 2.6657 | 5.5951 | 14 | 215 | response to temperature stimulus |
| GO:0009605 | 0.0018 | 1.5158 | 49.6789 | 70 | 1909 | response to external stimulus |
| GO:0048513 | 0.0018 | 1.4242 | 79.0334 | 103 | 3037 | animal organ development |
| GO:0072676 | 0.0019 | 4.3542 | 1.7696 | 7 | 68 | lymphocyte migration |
| GO:0050951 | 0.0019 | 8.886 | 0.5465 | 4 | 21 | sensory perception of temperature stimulus |
| GO:0100012 | 0.002 | 75.2284 | 0.0781 | 2 | 3 | regulation of heart induction by canonical Wnt signaling pathway |
| GO:0007389 | 0.0023 | 2.0998 | 10.5656 | 21 | 406 | pattern specification process |
| GO:0033993 | 0.0024 | 1.7388 | 21.9118 | 36 | 842 | response to lipid |
| GO:0060712 | 0.0025 | 14.1345 | 0.2863 | 3 | 11 | spongiotrophoblast layer development |
| GO:0010470 | 0.0032 | 5.5615 | 1.0149 | 5 | 39 | regulation of gastrulation |
| GO:0030154 | 0.0035 | 1.3655 | 95.4022 | 119 | 3666 | cell differentiation |
| GO:0050926 | 0.0037 | 7.1914 | 0.6506 | 4 | 25 | regulation of positive chemotaxis |
| GO:0018879 | 0.0039 | 37.6117 | 0.1041 | 2 | 4 | biphenyl metabolic process |
| GO:0032501 | 0.004 | 1.3298 | 149.4835 | 175 | 5904 | multicellular organismal process |
| GO:0071559 | 0.0041 | 2.4689 | 5.569 | 13 | 214 | response to transforming growth factor beta |
| GO:0050930 | 0.0041 | 11.3061 | 0.3383 | 3 | 13 | induction of positive chemotaxis |
| GO:0060669 | 0.0043 | 6.8641 | 0.6766 | 4 | 26 | embryonic placenta morphogenesis |
| GO:0007179 | 0.0044 | 2.6859 | 4.3459 | 11 | 167 | transforming growth factor beta receptor signaling pathway |
| GO:0007411 | 0.0049 | 2.4081 | 5.6992 | 13 | 219 | axon guidance |
| GO:0021602 | 0.0049 | 6.5652 | 0.7026 | 4 | 27 | cranial nerve morphogenesis |
| GO:0007501 | 0.0051 | 10.2776 | 0.3643 | 3 | 14 | mesodermal cell fate specification |
| GO:0010453 | 0.0056 | 6.2912 | 0.7287 | 4 | 28 | regulation of cell fate commitment |
| GO:0001756 | 0.0058 | 3.9849 | 1.6395 | 6 | 63 | somitogenesis |
| GO:0021783 | 0.0063 | 9.4205 | 0.3904 | 3 | 15 | preganglionic parasympathetic fiber development |
| GO:0048532 | 0.0063 | 9.4205 | 0.3904 | 3 | 15 | anatomical structure arrangement |
| GO:0048841 | 0.0063 | 9.4205 | 0.3904 | 3 | 15 | regulation of axon extension involved in axon guidance |
| GO:0050965 | 0.0063 | 9.4205 | 0.3904 | 3 | 15 | detection of temperature stimulus involved in sensory perception of pain |
| GO:2000484 | 0.0063 | 9.4205 | 0.3904 | 3 | 15 | positive regulation of interleukin-8 secretion |
| GO:0003129 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | heart induction |
| GO:0019236 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | response to pheromone |
| GO:0021523 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | somatic motor neuron differentiation |
| GO:0048382 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | mesendoderm development |
| GO:0060023 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | soft palate development |
| GO:0061317 | 0.0064 | 25.0728 | 0.1301 | 2 | 5 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
| GO:0030514 | 0.0073 | 4.4998 | 1.2231 | 5 | 47 | negative regulation of BMP signaling pathway |
| GO:0030856 | 0.0073 | 2.8019 | 3.4091 | 9 | 131 | regulation of epithelial cell differentiation |
| GO:0050670 | 0.0076 | 2.4771 | 4.6842 | 11 | 180 | regulation of lymphocyte proliferation |
| GO:0071300 | 0.0078 | 3.7226 | 1.7436 | 6 | 67 | cellular response to retinoic acid |
| GO:0050793 | 0.0083 | 1.3884 | 58.3187 | 76 | 2241 | regulation of developmental process |
| GO:0090092 | 0.0084 | 2.3318 | 5.4129 | 12 | 208 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0010469 | 0.0088 | 1.8161 | 12.6735 | 22 | 487 | regulation of receptor activity |
| GO:2000406 | 0.0091 | 8.0736 | 0.4424 | 3 | 17 | positive regulation of T cell migration |
| GO:0009996 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | negative regulation of cell fate specification |
| GO:0014816 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | skeletal muscle satellite cell differentiation |
| GO:0021546 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | rhombomere development |
| GO:2000382 | 0.0095 | 18.8033 | 0.1561 | 2 | 6 | positive regulation of mesoderm development |
| GO:0070663 | 0.0099 | 2.3774 | 4.8664 | 11 | 187 | regulation of leukocyte proliferation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071482 | 0.0013 | 4.1051 | 2.1115 | 8 | 102 | cellular response to light stimulus |
| GO:0071492 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | cellular response to UV-A |
| GO:0003431 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | growth plate cartilage chondrocyte development |
| GO:0042157 | 0.0042 | 2.8583 | 3.7054 | 10 | 179 | lipoprotein metabolic process |
| GO:0014065 | 0.0043 | 3.3216 | 2.5669 | 8 | 124 | phosphatidylinositol 3-kinase signaling |
| GO:0051302 | 0.0054 | 3.1832 | 2.6704 | 8 | 129 | regulation of cell division |
| GO:0051155 | 0.0055 | 4.791 | 1.1385 | 5 | 55 | positive regulation of striated muscle cell differentiation |
| GO:0030220 | 0.0057 | 9.5429 | 0.3726 | 3 | 18 | platelet formation |
| GO:0071305 | 0.0067 | 8.9459 | 0.3933 | 3 | 19 | cellular response to vitamin D |
| GO:0021782 | 0.007 | 3.7879 | 1.6974 | 6 | 82 | glial cell development |
| GO:0033273 | 0.0075 | 3.7385 | 1.7181 | 6 | 83 | response to vitamin |
| GO:0003416 | 0.0077 | 8.4191 | 0.414 | 3 | 20 | endochondral bone growth |
| GO:0050907 | 0.0079 | 3.6903 | 1.7388 | 6 | 84 | detection of chemical stimulus involved in sensory perception |
| GO:1901642 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | nucleoside transmembrane transport |
| GO:2000767 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | positive regulation of cytoplasmic translation |
| GO:1902653 | 0.0097 | 4.1279 | 1.3041 | 5 | 63 | secondary alcohol biosynthetic process |
| GO:0045540 | 0.01 | 5.1673 | 0.8487 | 4 | 41 | regulation of cholesterol biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 3e-04 | Inf | 0.0339 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0070370 | 3e-04 | Inf | 0.0339 | 2 | 2 | cellular heat acclimation |
| GO:0070434 | 3e-04 | Inf | 0.0339 | 2 | 2 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0097205 | 3e-04 | 14.7077 | 0.3391 | 4 | 20 | renal filtration |
| GO:0010469 | 7e-04 | 2.4615 | 8.2569 | 19 | 487 | regulation of receptor activity |
| GO:0090063 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | positive regulation of microtubule nucleation |
| GO:0003093 | 9e-04 | 19.5425 | 0.2035 | 3 | 12 | regulation of glomerular filtration |
| GO:0090083 | 0.0023 | 13.5258 | 0.2713 | 3 | 16 | regulation of inclusion body assembly |
| GO:0048146 | 0.0023 | 5.8929 | 0.9325 | 5 | 55 | positive regulation of fibroblast proliferation |
| GO:0042100 | 0.0024 | 7.9445 | 0.5689 | 4 | 34 | B cell proliferation |
| GO:0044241 | 0.0027 | 12.5588 | 0.2882 | 3 | 17 | lipid digestion |
| GO:0006072 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | glycerol-3-phosphate metabolic process |
| GO:0048293 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | regulation of isotype switching to IgE isotypes |
| GO:0060193 | 0.003 | 5.5582 | 0.9834 | 5 | 58 | positive regulation of lipase activity |
| GO:0030890 | 0.0034 | 7.1229 | 0.6273 | 4 | 37 | positive regulation of B cell proliferation |
| GO:0071559 | 0.0036 | 2.9165 | 3.6283 | 10 | 214 | response to transforming growth factor beta |
| GO:0051674 | 0.0039 | 1.6967 | 22.7363 | 36 | 1341 | localization of cell |
| GO:0002366 | 0.0039 | 2.0394 | 10.3763 | 20 | 612 | leukocyte activation involved in immune response |
| GO:0072358 | 0.0041 | 2.0322 | 10.4102 | 20 | 614 | cardiovascular system development |
| GO:0031584 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | activation of phospholipase D activity |
| GO:0032511 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | late endosome to vacuole transport via multivesicular body sorting pathway |
| GO:0042045 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | epithelial fluid transport |
| GO:0042492 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | gamma-delta T cell differentiation |
| GO:1903265 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | positive regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0050776 | 0.0044 | 1.8669 | 14.2081 | 25 | 838 | regulation of immune response |
| GO:0032757 | 0.0046 | 6.528 | 0.6782 | 4 | 40 | positive regulation of interleukin-8 production |
| GO:1901342 | 0.0046 | 2.6526 | 4.3743 | 11 | 258 | regulation of vasculature development |
| GO:0006782 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | protoporphyrinogen IX biosynthetic process |
| GO:0070424 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:1901029 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GO:1903546 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | protein localization to photoreceptor outer segment |
| GO:0048514 | 0.0057 | 2.0918 | 8.5621 | 17 | 505 | blood vessel morphogenesis |
| GO:0051272 | 0.0058 | 2.2015 | 7.1718 | 15 | 423 | positive regulation of cellular component movement |
| GO:0007178 | 0.0061 | 2.4332 | 5.1881 | 12 | 306 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0003071 | 0.0066 | 8.7876 | 0.39 | 3 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0042026 | 0.0066 | 8.7876 | 0.39 | 3 | 23 | protein refolding |
| GO:0001775 | 0.0067 | 1.6796 | 20.2609 | 32 | 1195 | cell activation |
| GO:0045766 | 0.007 | 3.3365 | 2.2211 | 7 | 131 | positive regulation of angiogenesis |
| GO:0048646 | 0.0072 | 1.7471 | 16.3613 | 27 | 965 | anatomical structure formation involved in morphogenesis |
| GO:0070661 | 0.0073 | 2.6169 | 4.0183 | 10 | 237 | leukocyte proliferation |
| GO:0060914 | 0.0075 | 8.3686 | 0.4069 | 3 | 24 | heart formation |
| GO:0002638 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | negative regulation of immunoglobulin production |
| GO:1903729 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | regulation of plasma membrane organization |
| GO:1904628 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0016477 | 0.0082 | 1.6519 | 20.5661 | 32 | 1213 | cell migration |
| GO:0001782 | 0.0084 | 7.9877 | 0.4239 | 3 | 25 | B cell homeostasis |
| GO:0001558 | 0.0088 | 2.2278 | 6.1207 | 13 | 361 | regulation of cell growth |
| GO:0002274 | 0.0089 | 1.9501 | 9.6981 | 18 | 572 | myeloid leukocyte activation |
| GO:0050896 | 0.0089 | 1.3593 | 127.6521 | 147 | 7529 | response to stimulus |
| GO:0040011 | 0.0089 | 1.5699 | 26.5002 | 39 | 1563 | locomotion |
| GO:0033014 | 0.0094 | 7.6399 | 0.4408 | 3 | 26 | tetrapyrrole biosynthetic process |
| GO:0007165 | 0.0095 | 1.3655 | 85.6892 | 104 | 5054 | signal transduction |
| GO:0010033 | 0.0095 | 1.4382 | 47.5919 | 63 | 2807 | response to organic substance |
| GO:0002634 | 0.0095 | 16.6875 | 0.1526 | 2 | 9 | regulation of germinal center formation |
| GO:0010459 | 0.0095 | 16.6875 | 0.1526 | 2 | 9 | negative regulation of heart rate |
| GO:0043587 | 0.0095 | 16.6875 | 0.1526 | 2 | 9 | tongue morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 0 | 3.0164 | 10.5995 | 29 | 400 | receptor regulator activity |
| GO:0005509 | 0 | 2.4731 | 16.8532 | 38 | 636 | calcium ion binding |
| GO:0001664 | 0 | 3.4891 | 5.9887 | 19 | 226 | G-protein coupled receptor binding |
| GO:0051428 | 1e-04 | 14.2944 | 0.477 | 5 | 18 | peptide hormone receptor binding |
| GO:0005184 | 5e-04 | 8.8441 | 0.689 | 5 | 26 | neuropeptide hormone activity |
| GO:0036461 | 7e-04 | Inf | 0.053 | 2 | 2 | BLOC-2 complex binding |
| GO:0004857 | 8e-04 | 2.3561 | 9.0361 | 20 | 341 | enzyme inhibitor activity |
| GO:0004872 | 9e-04 | 1.7117 | 29.3341 | 47 | 1107 | receptor activity |
| GO:0005179 | 9e-04 | 4.3744 | 2.0186 | 8 | 77 | hormone activity |
| GO:0008510 | 0.0014 | 18.4988 | 0.2385 | 3 | 9 | sodium:bicarbonate symporter activity |
| GO:0030280 | 0.0019 | 15.855 | 0.265 | 3 | 10 | structural constituent of epidermis |
| GO:0035651 | 0.0021 | 73.8358 | 0.0795 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0061134 | 0.0022 | 2.7914 | 4.5843 | 12 | 173 | peptidase regulator activity |
| GO:0004866 | 0.0029 | 3.0372 | 3.5243 | 10 | 133 | endopeptidase inhibitor activity |
| GO:0043565 | 0.0029 | 1.6554 | 26.2073 | 41 | 989 | sequence-specific DNA binding |
| GO:0035650 | 0.0041 | 36.9154 | 0.106 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0005243 | 0.0043 | 11.0963 | 0.3445 | 3 | 13 | gap junction channel activity |
| GO:0008253 | 0.0043 | 11.0963 | 0.3445 | 3 | 13 | 5'-nucleotidase activity |
| GO:0005125 | 0.0054 | 2.6013 | 4.4783 | 11 | 169 | cytokine activity |
| GO:0000981 | 0.0064 | 1.6866 | 19.2911 | 31 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0005102 | 0.0094 | 1.5262 | 28.9391 | 42 | 1129 | receptor binding |
| GO:0004957 | 0.0098 | 18.4552 | 0.159 | 2 | 6 | prostaglandin E receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 0 | 3.3478 | 12.1212 | 36 | 400 | receptor regulator activity |
| GO:0043565 | 0 | 1.9172 | 29.9697 | 53 | 989 | sequence-specific DNA binding |
| GO:0102991 | 1e-04 | 32.2707 | 0.2424 | 4 | 8 | myristoyl-CoA hydrolase activity |
| GO:0003700 | 1e-04 | 1.8 | 35.4848 | 59 | 1171 | DNA binding transcription factor activity |
| GO:0071837 | 2e-04 | 12.4314 | 0.5455 | 5 | 18 | HMG box domain binding |
| GO:0016290 | 2e-04 | 18.4367 | 0.3333 | 4 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0001159 | 3e-04 | 2.3278 | 11.0303 | 24 | 364 | core promoter proximal region DNA binding |
| GO:0008378 | 3e-04 | 7.4686 | 0.9697 | 6 | 32 | galactosyltransferase activity |
| GO:0003690 | 4e-04 | 1.8562 | 23.5758 | 41 | 778 | double-stranded DNA binding |
| GO:0000978 | 4e-04 | 2.3309 | 10.5455 | 23 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0008499 | 5e-04 | 14.3377 | 0.3939 | 4 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GO:0019841 | 5e-04 | 14.3377 | 0.3939 | 4 | 13 | retinol binding |
| GO:0000975 | 5e-04 | 1.82 | 24.6061 | 42 | 812 | regulatory region DNA binding |
| GO:0000976 | 6e-04 | 1.9017 | 20.1515 | 36 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0005125 | 6e-04 | 2.9494 | 5.1212 | 14 | 169 | cytokine activity |
| GO:0016918 | 7e-04 | 12.9031 | 0.4242 | 4 | 14 | retinal binding |
| GO:0000982 | 8e-04 | 2.1768 | 11.7273 | 24 | 387 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0036374 | 9e-04 | 24.1503 | 0.2121 | 3 | 7 | glutathione hydrolase activity |
| GO:0005185 | 9e-04 | Inf | 0.0606 | 2 | 2 | neurohypophyseal hormone activity |
| GO:0001012 | 0.001 | 1.9044 | 17.8182 | 32 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0005179 | 0.0011 | 3.4949 | 3.1212 | 10 | 103 | hormone activity |
| GO:0008083 | 0.0014 | 2.9828 | 4.3333 | 12 | 143 | growth factor activity |
| GO:0042056 | 0.0014 | 7.0217 | 0.8485 | 5 | 28 | chemoattractant activity |
| GO:0001972 | 0.0018 | 9.214 | 0.5455 | 4 | 18 | retinoic acid binding |
| GO:0001228 | 0.0022 | 2.0298 | 11.9697 | 23 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0016289 | 0.0022 | 8.5991 | 0.5758 | 4 | 19 | CoA hydrolase activity |
| GO:0005126 | 0.0025 | 2.4346 | 6.5455 | 15 | 216 | cytokine receptor binding |
| GO:0046982 | 0.0027 | 1.9328 | 13.6364 | 25 | 450 | protein heterodimerization activity |
| GO:0019840 | 0.0029 | 5.7659 | 1 | 5 | 33 | isoprenoid binding |
| GO:0004089 | 0.0038 | 12.0719 | 0.3333 | 3 | 11 | carbonate dehydratase activity |
| GO:0005102 | 0.0061 | 1.5683 | 28.166 | 42 | 957 | receptor binding |
| GO:0001664 | 0.0091 | 2.148 | 6.8485 | 14 | 226 | G-protein coupled receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003723 | 1e-04 | 1.8024 | 35.2885 | 58 | 1546 | RNA binding |
| GO:0001083 | 0.0015 | 86.1098 | 0.0685 | 2 | 3 | transcription factor activity, RNA polymerase II basal transcription factor binding |
| GO:0001093 | 0.0015 | 86.1098 | 0.0685 | 2 | 3 | TFIIB-class transcription factor binding |
| GO:0016972 | 0.003 | 43.052 | 0.0913 | 2 | 4 | thiol oxidase activity |
| GO:0035174 | 0.0073 | 21.5231 | 0.137 | 2 | 6 | histone serine kinase activity |
| GO:0061578 | 0.0073 | 21.5231 | 0.137 | 2 | 6 | Lys63-specific deubiquitinase activity |
| GO:0019865 | 0.0087 | 8.088 | 0.4337 | 3 | 19 | immunoglobulin binding |
| GO:0008173 | 0.0089 | 4.2437 | 1.2782 | 5 | 56 | RNA methyltransferase activity |
| GO:0004984 | 0.0096 | 4.1618 | 1.3011 | 5 | 57 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004939 | 0.0015 | 87.9292 | 0.0671 | 2 | 3 | beta-adrenergic receptor activity |
| GO:0015173 | 0.0015 | 87.9292 | 0.0671 | 2 | 3 | aromatic amino acid transmembrane transporter activity |
| GO:0003735 | 0.0016 | 3.3054 | 3.2431 | 10 | 145 | structural constituent of ribosome |
| GO:0005184 | 0.0025 | 8.0297 | 0.5815 | 4 | 26 | neuropeptide hormone activity |
| GO:0051380 | 0.0029 | 43.9617 | 0.0895 | 2 | 4 | norepinephrine binding |
| GO:0005521 | 0.0041 | 11.0155 | 0.3355 | 3 | 15 | lamin binding |
| GO:0031694 | 0.0048 | 29.3058 | 0.1118 | 2 | 5 | alpha-2A adrenergic receptor binding |
| GO:0004864 | 0.0067 | 5.8853 | 0.7605 | 4 | 34 | protein phosphatase inhibitor activity |
| GO:0004468 | 0.007 | 21.9779 | 0.1342 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0051379 | 0.0097 | 17.5811 | 0.1566 | 2 | 7 | epinephrine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004647 | 0.0021 | 74.0249 | 0.0793 | 2 | 3 | phosphoserine phosphatase activity |
| GO:0000179 | 0.004 | 37.01 | 0.1057 | 2 | 4 | rRNA (adenine-N6,N6-)-dimethyltransferase activity |
| GO:0004468 | 0.0097 | 18.5025 | 0.1586 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0055131 | 0.0097 | 18.5025 | 0.1586 | 2 | 6 | C3HC4-type RING finger domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019864 | 0.0019 | 17.292 | 0.2697 | 3 | 8 | IgG binding |
| GO:0004594 | 0.0065 | 28.7695 | 0.1349 | 2 | 4 | pantothenate kinase activity |
| GO:0030292 | 0.0065 | 28.7695 | 0.1349 | 2 | 4 | protein tyrosine kinase inhibitor activity |
| GO:0034597 | 0.0065 | 28.7695 | 0.1349 | 2 | 4 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity |
| GO:0034450 | 0.0085 | 8.6431 | 0.4383 | 3 | 13 | ubiquitin-ubiquitin ligase activity |
| GO:0043621 | 0.0086 | 3.6903 | 1.7868 | 6 | 53 | protein self-association |
| GO:0001618 | 0.0091 | 3.2148 | 2.36 | 7 | 70 | virus receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 11.6789 | 0.9309 | 9 | 57 | olfactory receptor activity |
| GO:0004930 | 6e-04 | 2.6468 | 6.8758 | 17 | 421 | G-protein coupled receptor activity |
| GO:0099600 | 0.003 | 1.9296 | 13.8007 | 25 | 845 | transmembrane receptor activity |
| GO:0038023 | 0.0037 | 1.8726 | 14.7806 | 26 | 905 | signaling receptor activity |
| GO:0004869 | 0.0052 | 6.2619 | 0.7023 | 4 | 43 | cysteine-type endopeptidase inhibitor activity |
| GO:0031433 | 0.0053 | 24.2785 | 0.1143 | 2 | 7 | telethonin binding |
| GO:0036041 | 0.0053 | 24.2785 | 0.1143 | 2 | 7 | long-chain fatty acid binding |
| GO:0070011 | 0.0054 | 2.0585 | 9.2277 | 18 | 565 | peptidase activity, acting on L-amino acid peptides |
| GO:0004252 | 0.006 | 3.1176 | 2.7111 | 8 | 166 | serine-type endopeptidase activity |
| GO:0005452 | 0.006 | 9.1323 | 0.3756 | 3 | 23 | inorganic anion exchanger activity |
| GO:0015106 | 0.006 | 9.1323 | 0.3756 | 3 | 23 | bicarbonate transmembrane transporter activity |
| GO:0030545 | 0.0062 | 2.255 | 6.5329 | 14 | 400 | receptor regulator activity |
| GO:0005125 | 0.0066 | 3.0589 | 2.7601 | 8 | 169 | cytokine activity |
| GO:1902282 | 0.007 | 20.2308 | 0.1307 | 2 | 8 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization |
| GO:0003735 | 0.0098 | 3.1145 | 2.3682 | 7 | 145 | structural constituent of ribosome |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047035 | 2e-04 | 44.2226 | 0.1338 | 3 | 6 | testosterone dehydrogenase (NAD+) activity |
| GO:0004303 | 0.0016 | 16.5779 | 0.2453 | 3 | 11 | estradiol 17-beta-dehydrogenase activity |
| GO:0005179 | 0.0021 | 3.7568 | 2.297 | 8 | 103 | hormone activity |
| GO:0048018 | 0.0029 | 2.4736 | 5.9853 | 14 | 273 | receptor ligand activity |
| GO:0004888 | 0.0039 | 1.7742 | 17.863 | 30 | 801 | transmembrane signaling receptor activity |
| GO:0008528 | 0.004 | 3.3644 | 2.5423 | 8 | 114 | G-protein coupled peptide receptor activity |
| GO:0008009 | 0.0042 | 6.8132 | 0.669 | 4 | 30 | chemokine activity |
| GO:0005132 | 0.0047 | 29.3945 | 0.1115 | 2 | 5 | type I interferon receptor binding |
| GO:0008327 | 0.0082 | 8.2845 | 0.4237 | 3 | 19 | methyl-CpG binding |
| GO:0016413 | 0.0097 | 17.6343 | 0.1561 | 2 | 7 | O-acetyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032557 | 0.0035 | 56.0686 | 0.1037 | 2 | 3 | pyrimidine ribonucleotide binding |
| GO:0050750 | 0.0044 | 7.0282 | 0.6913 | 4 | 20 | low-density lipoprotein particle receptor binding |
| GO:0042577 | 0.0055 | 10.5279 | 0.3802 | 3 | 11 | lipid phosphatase activity |
| GO:0008948 | 0.0068 | 28.0324 | 0.1383 | 2 | 4 | oxaloacetate decarboxylase activity |
| GO:0016520 | 0.0068 | 28.0324 | 0.1383 | 2 | 4 | growth hormone-releasing hormone receptor activity |
| GO:0002020 | 0.0082 | 2.5926 | 4.1134 | 10 | 119 | protease binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004963 | 4e-04 | Inf | 0.0384 | 2 | 2 | follicle-stimulating hormone receptor activity |
| GO:0005125 | 4e-04 | 3.6526 | 3.2479 | 11 | 169 | cytokine activity |
| GO:0001664 | 0.0015 | 2.9412 | 4.3433 | 12 | 226 | G-protein coupled receptor binding |
| GO:0055131 | 0.0052 | 25.6856 | 0.1153 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0048018 | 0.0057 | 2.7243 | 3.8717 | 10 | 207 | receptor ligand activity |
| GO:0032813 | 0.0065 | 5.8994 | 0.7495 | 4 | 39 | tumor necrosis factor receptor superfamily binding |
| GO:0038024 | 0.0082 | 4.3093 | 1.2492 | 5 | 65 | cargo receptor activity |
| GO:0004190 | 0.0083 | 8.131 | 0.4228 | 3 | 22 | aspartic-type endopeptidase activity |
| GO:0003680 | 0.0095 | 17.1214 | 0.1537 | 2 | 8 | AT DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098519 | 1e-04 | 67.3599 | 0.1099 | 3 | 5 | nucleotide phosphatase activity, acting on free nucleotides |
| GO:0050698 | 5e-04 | Inf | 0.0439 | 2 | 2 | proteoglycan sulfotransferase activity |
| GO:0004435 | 0.0023 | 8.1785 | 0.5713 | 4 | 26 | phosphatidylinositol phospholipase C activity |
| GO:0001733 | 0.0028 | 44.7718 | 0.0879 | 2 | 4 | galactosylceramide sulfotransferase activity |
| GO:0042056 | 0.0031 | 7.496 | 0.6152 | 4 | 28 | chemoattractant activity |
| GO:0008656 | 0.0032 | 12.2399 | 0.3076 | 3 | 14 | cysteine-type endopeptidase activator activity involved in apoptotic process |
| GO:0004175 | 0.0039 | 2.1794 | 8.2179 | 17 | 374 | endopeptidase activity |
| GO:0015057 | 0.0046 | 29.8458 | 0.1099 | 2 | 5 | thrombin-activated receptor activity |
| GO:0008233 | 0.0052 | 1.8822 | 12.8542 | 23 | 585 | peptidase activity |
| GO:0003700 | 0.006 | 1.6038 | 25.7304 | 39 | 1171 | DNA binding transcription factor activity |
| GO:0046935 | 0.0068 | 22.3829 | 0.1318 | 2 | 6 | 1-phosphatidylinositol-3-kinase regulator activity |
| GO:0050656 | 0.0068 | 22.3829 | 0.1318 | 2 | 6 | 3'-phosphoadenosine 5'-phosphosulfate binding |
| GO:0048018 | 0.0094 | 2.0746 | 7.5692 | 15 | 348 | receptor ligand activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005484 | 0.0015 | 5.5002 | 1.2693 | 6 | 37 | SNAP receptor activity |
| GO:0097027 | 0.002 | 16.9823 | 0.2744 | 3 | 8 | ubiquitin-protein transferase activator activity |
| GO:0097602 | 0.0023 | 8.7209 | 0.5832 | 4 | 17 | cullin family protein binding |
| GO:0034212 | 0.0026 | 4.1475 | 1.8867 | 7 | 55 | peptide N-acetyltransferase activity |
| GO:0003723 | 0.0029 | 1.4592 | 53.0341 | 73 | 1546 | RNA binding |
| GO:0004402 | 0.0046 | 4.2601 | 1.578 | 6 | 46 | histone acetyltransferase activity |
| GO:0000149 | 0.0055 | 2.7669 | 3.8764 | 10 | 113 | SNARE binding |
| GO:0140101 | 0.0066 | 2.688 | 3.9793 | 10 | 116 | catalytic activity, acting on a tRNA |
| GO:0031544 | 0.0067 | 28.2553 | 0.1372 | 2 | 4 | peptidyl-proline 3-dioxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060590 | 9e-04 | 7.4812 | 0.7698 | 5 | 36 | ATPase regulator activity |
| GO:0017017 | 0.0014 | 17.3127 | 0.2352 | 3 | 11 | MAP kinase tyrosine/serine/threonine phosphatase activity |
| GO:0051087 | 0.0021 | 4.23 | 1.7961 | 7 | 84 | chaperone binding |
| GO:0004857 | 0.0028 | 2.3178 | 7.2915 | 16 | 341 | enzyme inhibitor activity |
| GO:0004693 | 0.0036 | 7.1161 | 0.6415 | 4 | 30 | cyclin-dependent protein serine/threonine kinase activity |
| GO:0030332 | 0.0041 | 6.8521 | 0.6629 | 4 | 31 | cyclin binding |
| GO:0004602 | 0.0053 | 9.889 | 0.3635 | 3 | 17 | glutathione peroxidase activity |
| GO:0035254 | 0.0064 | 5.9663 | 0.7484 | 4 | 35 | glutamate receptor binding |
| GO:0042608 | 0.0065 | 23.0185 | 0.1283 | 2 | 6 | T cell receptor binding |
| GO:0050431 | 0.0073 | 8.6517 | 0.4063 | 3 | 19 | transforming growth factor beta binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003677 | 0 | 1.7857 | 81.0715 | 127 | 2306 | DNA binding |
| GO:0001077 | 4e-04 | 2.4378 | 9.2462 | 21 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0003682 | 5e-04 | 2.0097 | 16.4182 | 31 | 467 | chromatin binding |
| GO:0019207 | 7e-04 | 2.6002 | 7.0314 | 17 | 200 | kinase regulator activity |
| GO:0004860 | 0.0013 | 3.4336 | 3.1993 | 10 | 91 | protein kinase inhibitor activity |
| GO:0046625 | 0.002 | 9.2093 | 0.5625 | 4 | 16 | sphingolipid binding |
| GO:0043425 | 0.0022 | 6.2866 | 0.9492 | 5 | 27 | bHLH transcription factor binding |
| GO:1990837 | 0.0032 | 1.6626 | 24.68 | 39 | 702 | sequence-specific double-stranded DNA binding |
| GO:0008426 | 0.0036 | 55.0899 | 0.1055 | 2 | 3 | protein kinase C inhibitor activity |
| GO:0097177 | 0.0036 | 55.0899 | 0.1055 | 2 | 3 | mitochondrial ribosome binding |
| GO:0044212 | 0.0046 | 1.5856 | 28.477 | 43 | 810 | transcription regulatory region DNA binding |
| GO:0001067 | 0.0049 | 1.579 | 28.5824 | 43 | 813 | regulatory region nucleic acid binding |
| GO:1901363 | 0.005 | 1.2657 | 193.1513 | 222 | 5494 | heterocyclic compound binding |
| GO:0097159 | 0.0057 | 1.2598 | 195.6122 | 224 | 5564 | organic cyclic compound binding |
| GO:0035594 | 0.0071 | 27.5431 | 0.1406 | 2 | 4 | ganglioside binding |
| GO:0000981 | 0.0098 | 1.5504 | 25.5941 | 38 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008233 | 0 | 2.9296 | 7.866 | 21 | 585 | peptidase activity |
| GO:0008234 | 1e-04 | 4.5953 | 2.3665 | 10 | 176 | cysteine-type peptidase activity |
| GO:0099600 | 2e-04 | 2.4087 | 11.362 | 25 | 845 | transmembrane receptor activity |
| GO:0004930 | 2e-04 | 3.0593 | 5.6608 | 16 | 421 | G-protein coupled receptor activity |
| GO:0036459 | 6e-04 | 5.2822 | 1.4387 | 7 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0004499 | 0.0011 | 74.0837 | 0.0538 | 2 | 4 | N,N-dimethylaniline monooxygenase activity |
| GO:0005416 | 0.0017 | 14.8772 | 0.242 | 3 | 18 | cation:amino acid symporter activity |
| GO:0004322 | 0.0018 | 49.3859 | 0.0672 | 2 | 5 | ferroxidase activity |
| GO:0004252 | 0.0018 | 3.8252 | 2.2321 | 8 | 166 | serine-type endopeptidase activity |
| GO:0038023 | 0.0025 | 2.0287 | 12.1688 | 23 | 905 | signaling receptor activity |
| GO:0005343 | 0.0035 | 11.1542 | 0.3093 | 3 | 23 | organic acid:sodium symporter activity |
| GO:0102991 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0015179 | 0.0048 | 6.3487 | 0.6858 | 4 | 51 | L-amino acid transmembrane transporter activity |
| GO:0005539 | 0.0049 | 3.2257 | 2.622 | 8 | 195 | glycosaminoglycan binding |
| GO:0017171 | 0.0054 | 3.1741 | 2.6623 | 8 | 198 | serine hydrolase activity |
| GO:0036122 | 0.0061 | 21.1597 | 0.121 | 2 | 9 | BMP binding |
| GO:0042056 | 0.0061 | 8.9204 | 0.3765 | 3 | 28 | chemoattractant activity |
| GO:0004629 | 0.0068 | 8.5767 | 0.3899 | 3 | 29 | phospholipase C activity |
| GO:0004984 | 0.0072 | 5.6277 | 0.7664 | 4 | 57 | olfactory receptor activity |
| GO:0046943 | 0.008 | 3.6568 | 1.7346 | 6 | 129 | carboxylic acid transmembrane transporter activity |
| GO:0030545 | 0.008 | 2.3481 | 5.3785 | 12 | 400 | receptor regulator activity |
| GO:0016290 | 0.0091 | 16.4554 | 0.1479 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0051400 | 0.0091 | 16.4554 | 0.1479 | 2 | 11 | BH domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042800 | 4e-04 | 14.29 | 0.3624 | 4 | 17 | histone methyltransferase activity (H3-K4 specific) |
| GO:0001104 | 0.0035 | 3.8421 | 1.9612 | 7 | 92 | RNA polymerase II transcription cofactor activity |
| GO:0003735 | 0.0039 | 3.0963 | 3.091 | 9 | 145 | structural constituent of ribosome |
| GO:0019103 | 0.0043 | 30.7905 | 0.1066 | 2 | 5 | pyrimidine nucleotide binding |
| GO:0008565 | 0.0047 | 3.6274 | 2.0678 | 7 | 97 | protein transporter activity |
| GO:0005179 | 0.0065 | 3.3993 | 2.1957 | 7 | 103 | hormone activity |
| GO:0042054 | 0.0072 | 4.4678 | 1.2151 | 5 | 57 | histone methyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019841 | 0 | 30.9114 | 0.3556 | 6 | 13 | retinol binding |
| GO:0043565 | 0 | 2.2106 | 27.0506 | 54 | 989 | sequence-specific DNA binding |
| GO:0019840 | 0 | 11.5826 | 0.9026 | 8 | 33 | isoprenoid binding |
| GO:0001972 | 0 | 18.0255 | 0.4923 | 6 | 18 | retinoic acid binding |
| GO:0048018 | 0 | 3.5642 | 5.5605 | 18 | 207 | receptor ligand activity |
| GO:0016918 | 0 | 19.9838 | 0.3829 | 5 | 14 | retinal binding |
| GO:0005184 | 1e-04 | 10.8095 | 0.7111 | 6 | 26 | neuropeptide hormone activity |
| GO:0038023 | 1e-04 | 1.9137 | 24.753 | 44 | 905 | signaling receptor activity |
| GO:0099600 | 3e-04 | 1.9021 | 23.112 | 41 | 845 | transmembrane receptor activity |
| GO:0001012 | 4e-04 | 2.0578 | 16.0826 | 31 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0001664 | 4e-04 | 2.9628 | 5.4538 | 15 | 201 | G-protein coupled receptor binding |
| GO:0031406 | 7e-04 | 3.0663 | 4.5677 | 13 | 167 | carboxylic acid binding |
| GO:0000976 | 7e-04 | 1.9305 | 18.1887 | 33 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0008528 | 8e-04 | 4.4414 | 1.9953 | 8 | 74 | G-protein coupled peptide receptor activity |
| GO:0001159 | 0.0011 | 2.2396 | 9.9559 | 21 | 364 | core promoter proximal region DNA binding |
| GO:0000978 | 0.0015 | 2.2272 | 9.5183 | 20 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0000975 | 0.0016 | 1.7657 | 22.2094 | 37 | 812 | regulatory region DNA binding |
| GO:0016493 | 0.0021 | 15.3437 | 0.2735 | 3 | 10 | C-C chemokine receptor activity |
| GO:0005125 | 0.0024 | 2.769 | 4.6224 | 12 | 169 | cytokine activity |
| GO:0008188 | 0.0024 | 6.0146 | 0.953 | 5 | 35 | neuropeptide receptor activity |
| GO:0003690 | 0.0027 | 1.737 | 21.2794 | 35 | 778 | double-stranded DNA binding |
| GO:0045236 | 0.0028 | 13.4248 | 0.3009 | 3 | 11 | CXCR chemokine receptor binding |
| GO:0000981 | 0.0038 | 2.1318 | 8.9018 | 18 | 333 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0071855 | 0.0044 | 6.8295 | 0.6838 | 4 | 25 | neuropeptide receptor binding |
| GO:0001228 | 0.0063 | 1.9418 | 10.8038 | 20 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0004994 | 0.0071 | 23.8169 | 0.1368 | 2 | 5 | somatostatin receptor activity |
| GO:0004930 | 0.0082 | 2.0567 | 8.1558 | 16 | 307 | G-protein coupled receptor activity |
| GO:0008106 | 0.0087 | 8.2586 | 0.4376 | 3 | 16 | alcohol dehydrogenase (NADP+) activity |
| GO:0098772 | 0.0094 | 1.4265 | 44.3914 | 60 | 1623 | molecular function regulator |
| GO:0001078 | 0.0094 | 2.6813 | 3.5557 | 9 | 130 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0060089 | 0.0096 | 1.5009 | 31.4815 | 45 | 1151 | molecular transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 2e-04 | 2.6295 | 8.1848 | 20 | 273 | receptor ligand activity |
| GO:0003700 | 5e-04 | 1.6824 | 35.6385 | 56 | 1171 | DNA binding transcription factor activity |
| GO:0036374 | 9e-04 | 24.0423 | 0.213 | 3 | 7 | glutathione hydrolase activity |
| GO:0043565 | 9e-04 | 1.6972 | 30.0994 | 48 | 989 | sequence-specific DNA binding |
| GO:0000978 | 0.001 | 2.2071 | 10.5911 | 22 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0005179 | 0.0012 | 3.479 | 3.1347 | 10 | 103 | hormone activity |
| GO:0102991 | 0.0014 | 19.2325 | 0.2435 | 3 | 8 | myristoyl-CoA hydrolase activity |
| GO:0001159 | 0.0018 | 2.1016 | 11.0781 | 22 | 364 | core promoter proximal region DNA binding |
| GO:0001972 | 0.0018 | 9.1727 | 0.5478 | 4 | 18 | retinoic acid binding |
| GO:0071837 | 0.0018 | 9.1727 | 0.5478 | 4 | 18 | HMG box domain binding |
| GO:0004939 | 0.0027 | 63.987 | 0.0913 | 2 | 3 | beta-adrenergic receptor activity |
| GO:0000982 | 0.0038 | 1.966 | 11.778 | 22 | 387 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0016290 | 0.0039 | 12.0179 | 0.3348 | 3 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0000976 | 0.0041 | 1.7143 | 20.2388 | 33 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0001012 | 0.0041 | 1.7621 | 17.8953 | 30 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0003690 | 0.0048 | 1.6419 | 23.6778 | 37 | 778 | double-stranded DNA binding |
| GO:0051380 | 0.0053 | 31.9913 | 0.1217 | 2 | 4 | norepinephrine binding |
| GO:0098772 | 0.0059 | 1.4345 | 49.3947 | 67 | 1623 | molecular function regulator |
| GO:0008499 | 0.0064 | 9.613 | 0.3956 | 3 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GO:0019841 | 0.0064 | 9.613 | 0.3956 | 3 | 13 | retinol binding |
| GO:0016918 | 0.0079 | 8.7385 | 0.4261 | 3 | 14 | retinal binding |
| GO:0000975 | 0.0094 | 1.5661 | 24.7126 | 37 | 812 | regulatory region DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005179 | 2e-04 | 4.7371 | 2.0876 | 9 | 103 | hormone activity |
| GO:0005509 | 6e-04 | 2.1578 | 12.8902 | 26 | 636 | calcium ion binding |
| GO:0061134 | 8e-04 | 3.3666 | 3.5063 | 11 | 173 | peptidase regulator activity |
| GO:0004866 | 0.0016 | 3.5838 | 2.6956 | 9 | 133 | endopeptidase inhibitor activity |
| GO:0015077 | 0.0019 | 2.4246 | 6.9923 | 16 | 345 | monovalent inorganic cation transmembrane transporter activity |
| GO:0060089 | 0.002 | 1.7416 | 23.328 | 38 | 1151 | molecular transducer activity |
| GO:0005243 | 0.002 | 14.6343 | 0.2635 | 3 | 13 | gap junction channel activity |
| GO:0030545 | 0.0034 | 2.2123 | 8.107 | 17 | 400 | receptor regulator activity |
| GO:0015379 | 0.0039 | 32.43 | 0.1013 | 2 | 5 | potassium:chloride symporter activity |
| GO:0022820 | 0.0039 | 32.43 | 0.1013 | 2 | 5 | potassium ion symporter activity |
| GO:0051428 | 0.0054 | 9.7529 | 0.3648 | 3 | 18 | peptide hormone receptor binding |
| GO:0004984 | 0.0059 | 4.7081 | 1.1553 | 5 | 57 | olfactory receptor activity |
| GO:0005102 | 0.0061 | 1.5861 | 27.4626 | 41 | 1355 | receptor binding |
| GO:0019865 | 0.0063 | 9.1428 | 0.3851 | 3 | 19 | immunoglobulin binding |
| GO:0099600 | 0.0073 | 1.7221 | 17.1261 | 28 | 845 | transmembrane receptor activity |
| GO:0008289 | 0.0075 | 1.8477 | 12.5051 | 22 | 617 | lipid binding |
| GO:0032395 | 0.008 | 19.4554 | 0.1419 | 2 | 7 | MHC class II receptor activity |
| GO:0004950 | 0.0084 | 8.1258 | 0.4256 | 3 | 21 | chemokine receptor activity |
| GO:0005326 | 0.0095 | 7.6976 | 0.4459 | 3 | 22 | neurotransmitter transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004647 | 0.0021 | 73.4604 | 0.0799 | 2 | 3 | phosphoserine phosphatase activity |
| GO:0000179 | 0.0041 | 36.7277 | 0.1065 | 2 | 4 | rRNA (adenine-N6,N6-)-dimethyltransferase activity |
| GO:0004468 | 0.0099 | 18.3614 | 0.1598 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0055131 | 0.0099 | 18.3614 | 0.1598 | 2 | 6 | C3HC4-type RING finger domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004549 | 0.0039 | 11.2191 | 0.3296 | 3 | 15 | tRNA-specific ribonuclease activity |
| GO:1903231 | 0.0051 | 6.4234 | 0.7031 | 4 | 32 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004468 | 0.0068 | 22.3829 | 0.1318 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0004984 | 0.0082 | 4.3295 | 1.2525 | 5 | 57 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 1e-04 | 3.0166 | 6.4541 | 18 | 273 | receptor ligand activity |
| GO:0098772 | 4e-04 | 1.6706 | 38.9622 | 60 | 1623 | molecular function regulator |
| GO:0102991 | 7e-04 | 24.5868 | 0.1921 | 3 | 8 | myristoyl-CoA hydrolase activity |
| GO:0016835 | 0.0012 | 4.7369 | 1.6324 | 7 | 68 | carbon-oxygen lyase activity |
| GO:0070905 | 0.0017 | 81.7527 | 0.072 | 2 | 3 | serine binding |
| GO:0004867 | 0.0018 | 4.3766 | 1.7525 | 7 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0030414 | 0.0019 | 3.212 | 3.3369 | 10 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0.0019 | 3.212 | 3.3369 | 10 | 139 | endopeptidase regulator activity |
| GO:0004089 | 0.002 | 15.3636 | 0.2641 | 3 | 11 | carbonate dehydratase activity |
| GO:0016290 | 0.002 | 15.3636 | 0.2641 | 3 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0031406 | 0.0024 | 2.9246 | 4.0091 | 11 | 167 | carboxylic acid binding |
| GO:0020037 | 0.0024 | 3.3543 | 2.8808 | 9 | 120 | heme binding |
| GO:0044323 | 0.0033 | 40.8736 | 0.096 | 2 | 4 | retinoic acid-responsive element binding |
| GO:0005179 | 0.0034 | 3.4778 | 2.4726 | 8 | 103 | hormone activity |
| GO:0001640 | 0.0055 | 27.2473 | 0.12 | 2 | 5 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity |
| GO:0004468 | 0.0081 | 20.4341 | 0.144 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0043546 | 0.0081 | 20.4341 | 0.144 | 2 | 6 | molybdopterin cofactor binding |
| GO:0005506 | 0.0099 | 2.6543 | 3.5769 | 9 | 149 | iron ion binding |
| GO:0016289 | 0.01 | 7.6777 | 0.4561 | 3 | 19 | CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099600 | 0 | 2.3206 | 23.8325 | 50 | 845 | transmembrane receptor activity |
| GO:0004930 | 0 | 2.7669 | 11.8739 | 30 | 421 | G-protein coupled receptor activity |
| GO:0060089 | 0 | 1.9986 | 32.4629 | 59 | 1151 | molecular transducer activity |
| GO:0038023 | 0 | 1.9963 | 25.5247 | 47 | 905 | signaling receptor activity |
| GO:0043565 | 2e-04 | 1.8528 | 27.8939 | 48 | 989 | sequence-specific DNA binding |
| GO:0032394 | 8e-04 | Inf | 0.0564 | 2 | 2 | MHC class Ib receptor activity |
| GO:0043236 | 0.001 | 7.5668 | 0.7897 | 5 | 28 | laminin binding |
| GO:0004984 | 0.0011 | 4.8871 | 1.6076 | 7 | 57 | olfactory receptor activity |
| GO:0004065 | 0.0011 | 20.8117 | 0.2256 | 3 | 8 | arylsulfatase activity |
| GO:0005509 | 0.0011 | 1.8918 | 17.9378 | 32 | 636 | calcium ion binding |
| GO:0051428 | 0.0014 | 9.9276 | 0.5077 | 4 | 18 | peptide hormone receptor binding |
| GO:0071837 | 0.0014 | 9.9276 | 0.5077 | 4 | 18 | HMG box domain binding |
| GO:0004716 | 0.0016 | 17.3419 | 0.2538 | 3 | 9 | signal transducer, downstream of receptor, with protein tyrosine kinase activity |
| GO:0015250 | 0.0016 | 17.3419 | 0.2538 | 3 | 9 | water channel activity |
| GO:0008449 | 0.0023 | 69.229 | 0.0846 | 2 | 3 | N-acetylglucosamine-6-sulfatase activity |
| GO:0001159 | 0.0036 | 2.0522 | 10.2663 | 20 | 364 | core promoter proximal region DNA binding |
| GO:0005249 | 0.0041 | 3.365 | 2.5666 | 8 | 91 | voltage-gated potassium channel activity |
| GO:0019863 | 0.0046 | 34.6121 | 0.1128 | 2 | 4 | IgE binding |
| GO:0051430 | 0.0046 | 34.6121 | 0.1128 | 2 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0000978 | 0.0048 | 2.0356 | 9.815 | 19 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0008013 | 0.0048 | 3.6429 | 2.0871 | 7 | 74 | beta-catenin binding |
| GO:0000975 | 0.0049 | 1.6531 | 22.9017 | 36 | 812 | regulatory region DNA binding |
| GO:0001012 | 0.0049 | 1.7731 | 16.584 | 28 | 588 | RNA polymerase II regulatory region DNA binding |
| GO:0071855 | 0.0049 | 6.6152 | 0.7051 | 4 | 25 | neuropeptide receptor binding |
| GO:0005243 | 0.0052 | 10.4023 | 0.3667 | 3 | 13 | gap junction channel activity |
| GO:0015267 | 0.006 | 1.8852 | 12.2406 | 22 | 434 | channel activity |
| GO:0015272 | 0.0075 | 23.0732 | 0.141 | 2 | 5 | ATP-activated inward rectifier potassium channel activity |
| GO:0000976 | 0.0078 | 1.6749 | 18.7557 | 30 | 665 | transcription regulatory region sequence-specific DNA binding |
| GO:0001077 | 0.0079 | 2.1232 | 7.4177 | 15 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0046982 | 0.009 | 1.8127 | 12.6919 | 22 | 450 | protein heterodimerization activity |
| GO:0019838 | 0.0099 | 2.6628 | 3.5819 | 9 | 127 | growth factor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 0 | 2.9046 | 10.5733 | 28 | 400 | receptor regulator activity |
| GO:0005509 | 0 | 2.404 | 16.8115 | 37 | 636 | calcium ion binding |
| GO:0001664 | 0 | 3.4984 | 5.9739 | 19 | 226 | G-protein coupled receptor binding |
| GO:0051428 | 1e-04 | 14.3313 | 0.4758 | 5 | 18 | peptide hormone receptor binding |
| GO:0004872 | 5e-04 | 1.7599 | 29.2615 | 48 | 1107 | receptor activity |
| GO:0005184 | 5e-04 | 8.867 | 0.6873 | 5 | 26 | neuropeptide hormone activity |
| GO:0036461 | 7e-04 | Inf | 0.0529 | 2 | 2 | BLOC-2 complex binding |
| GO:0004857 | 8e-04 | 2.3624 | 9.0137 | 20 | 341 | enzyme inhibitor activity |
| GO:0008510 | 0.0014 | 18.5463 | 0.2379 | 3 | 9 | sodium:bicarbonate symporter activity |
| GO:0043565 | 0.0016 | 1.7072 | 26.1424 | 42 | 989 | sequence-specific DNA binding |
| GO:0030280 | 0.0019 | 15.8957 | 0.2643 | 3 | 10 | structural constituent of epidermis |
| GO:0035651 | 0.0021 | 74.0249 | 0.0793 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0061134 | 0.0022 | 2.7987 | 4.5729 | 12 | 173 | peptidase regulator activity |
| GO:0004866 | 0.0028 | 3.0452 | 3.5156 | 10 | 133 | endopeptidase inhibitor activity |
| GO:0005179 | 0.004 | 3.7729 | 2.0135 | 7 | 77 | hormone activity |
| GO:0035650 | 0.004 | 37.01 | 0.1057 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0005243 | 0.0043 | 11.1248 | 0.3436 | 3 | 13 | gap junction channel activity |
| GO:0005125 | 0.0053 | 2.6081 | 4.4672 | 11 | 169 | cytokine activity |
| GO:0000981 | 0.0062 | 1.6913 | 19.2433 | 31 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0005102 | 0.009 | 1.5307 | 28.8639 | 42 | 1129 | receptor binding |
| GO:0004957 | 0.0097 | 18.5025 | 0.1586 | 2 | 6 | prostaglandin E receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051870 | 1e-04 | Inf | 0.023 | 2 | 2 | methotrexate binding |
| GO:0048020 | 1e-04 | 17.6035 | 0.2755 | 4 | 24 | CCR chemokine receptor binding |
| GO:0004867 | 2e-04 | 7.9505 | 0.8379 | 6 | 73 | serine-type endopeptidase inhibitor activity |
| GO:0005549 | 2e-04 | 32.8408 | 0.1263 | 3 | 11 | odorant binding |
| GO:0004984 | 5e-04 | 8.4949 | 0.6543 | 5 | 57 | olfactory receptor activity |
| GO:0030414 | 0.0011 | 4.7156 | 1.5955 | 7 | 139 | peptidase inhibitor activity |
| GO:0061135 | 0.0011 | 4.7156 | 1.5955 | 7 | 139 | endopeptidase regulator activity |
| GO:0005179 | 0.0012 | 5.4806 | 1.1823 | 6 | 103 | hormone activity |
| GO:0015272 | 0.0013 | 58.0655 | 0.0574 | 2 | 5 | ATP-activated inward rectifier potassium channel activity |
| GO:0030545 | 0.0023 | 2.786 | 4.5914 | 12 | 400 | receptor regulator activity |
| GO:0031433 | 0.0026 | 34.8347 | 0.0803 | 2 | 7 | telethonin binding |
| GO:0004497 | 0.0036 | 5.2475 | 1.0216 | 5 | 89 | monooxygenase activity |
| GO:0099600 | 0.0039 | 2.1004 | 9.6993 | 19 | 845 | transmembrane receptor activity |
| GO:0005542 | 0.0045 | 24.8786 | 0.1033 | 2 | 9 | folic acid binding |
| GO:0001664 | 0.0046 | 3.2639 | 2.5941 | 8 | 226 | G-protein coupled receptor binding |
| GO:0070402 | 0.0094 | 15.8276 | 0.1492 | 2 | 13 | NADPH binding |
| GO:0004930 | 0.0094 | 2.3984 | 4.8324 | 11 | 421 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033691 | 1e-04 | 27.8141 | 0.2538 | 4 | 9 | sialic acid binding |
| GO:0032394 | 8e-04 | Inf | 0.0564 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042056 | 0.001 | 7.5668 | 0.7897 | 5 | 28 | chemoattractant activity |
| GO:0008138 | 0.0011 | 5.8097 | 1.1846 | 6 | 42 | protein tyrosine/serine/threonine phosphatase activity |
| GO:0004090 | 0.0046 | 34.6121 | 0.1128 | 2 | 4 | carbonyl reductase (NADPH) activity |
| GO:0005102 | 0.0047 | 1.5363 | 34.3992 | 50 | 1236 | receptor binding |
| GO:0030545 | 0.0048 | 1.9558 | 11.2816 | 21 | 400 | receptor regulator activity |
| GO:0016722 | 0.0064 | 9.456 | 0.3949 | 3 | 14 | oxidoreductase activity, oxidizing metal ions |
| GO:0070851 | 0.0065 | 2.858 | 3.3563 | 9 | 119 | growth factor receptor binding |
| GO:0043236 | 0.0075 | 5.7872 | 0.7897 | 4 | 28 | laminin binding |
| GO:0030246 | 0.0083 | 2.1726 | 6.769 | 14 | 240 | carbohydrate binding |
| GO:0043565 | 0.0085 | 1.5418 | 27.8939 | 41 | 989 | sequence-specific DNA binding |
| GO:0008227 | 0.0096 | 5.3413 | 0.8461 | 4 | 30 | G-protein coupled amine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0 | 3.1531 | 8.726 | 25 | 421 | G-protein coupled receptor activity |
| GO:0030545 | 0 | 2.8808 | 8.2907 | 22 | 400 | receptor regulator activity |
| GO:0005179 | 3e-04 | 4.6269 | 2.1349 | 9 | 103 | hormone activity |
| GO:0019865 | 5e-04 | 12.7479 | 0.3938 | 4 | 19 | immunoglobulin binding |
| GO:0099600 | 0.0015 | 1.8863 | 17.5141 | 31 | 845 | transmembrane receptor activity |
| GO:0038023 | 0.0022 | 1.8143 | 18.7577 | 32 | 905 | signaling receptor activity |
| GO:0008009 | 0.0032 | 7.3491 | 0.6218 | 4 | 30 | chemokine activity |
| GO:0033038 | 0.0061 | 23.7675 | 0.1244 | 2 | 6 | bitter taste receptor activity |
| GO:0004984 | 0.0064 | 4.5999 | 1.1814 | 5 | 57 | olfactory receptor activity |
| GO:0005539 | 0.0076 | 2.6047 | 4.0417 | 10 | 195 | glycosaminoglycan binding |
| GO:0001664 | 0.0076 | 2.4684 | 4.6842 | 11 | 226 | G-protein coupled receptor binding |
| GO:0005125 | 0.0079 | 2.9677 | 2.8502 | 8 | 139 | cytokine activity |
| GO:0016624 | 0.0084 | 19.0127 | 0.1451 | 2 | 7 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor |
| GO:0051379 | 0.0084 | 19.0127 | 0.1451 | 2 | 7 | epinephrine binding |
| GO:0060089 | 0.0087 | 1.593 | 23.8565 | 36 | 1151 | molecular transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004832 | 0.0019 | 78.0157 | 0.0754 | 2 | 3 | valine-tRNA ligase activity |
| GO:0018685 | 0.0037 | 39.0052 | 0.1005 | 2 | 4 | alkane 1-monooxygenase activity |
| GO:0031005 | 0.0047 | 10.6593 | 0.3517 | 3 | 14 | filamin binding |
| GO:0008528 | 0.008 | 2.97 | 2.8638 | 8 | 114 | G-protein coupled peptide receptor activity |
| GO:0097602 | 0.0082 | 8.3735 | 0.4271 | 3 | 17 | cullin family protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030545 | 1e-04 | 2.692 | 9.2352 | 23 | 400 | receptor regulator activity |
| GO:0003700 | 3e-04 | 1.8399 | 27.0361 | 46 | 1171 | DNA binding transcription factor activity |
| GO:0042056 | 4e-04 | 9.3165 | 0.6465 | 5 | 28 | chemoattractant activity |
| GO:0003990 | 5e-04 | Inf | 0.0462 | 2 | 2 | acetylcholinesterase activity |
| GO:0030943 | 0.0016 | 85.1029 | 0.0693 | 2 | 3 | mitochondrion targeting sequence binding |
| GO:0004089 | 0.0018 | 15.995 | 0.254 | 3 | 11 | carbonate dehydratase activity |
| GO:0045236 | 0.0018 | 15.995 | 0.254 | 3 | 11 | CXCR chemokine receptor binding |
| GO:0005102 | 0.0031 | 1.6006 | 31.2843 | 47 | 1355 | receptor binding |
| GO:0044212 | 0.004 | 1.7498 | 18.7013 | 31 | 810 | transcription regulatory region DNA binding |
| GO:0001067 | 0.0043 | 1.7428 | 18.7706 | 31 | 813 | regulatory region nucleic acid binding |
| GO:0004930 | 0.0043 | 2.0569 | 9.7201 | 19 | 421 | G-protein coupled receptor activity |
| GO:0017147 | 0.0048 | 6.5729 | 0.6926 | 4 | 30 | Wnt-protein binding |
| GO:0001227 | 0.005 | 2.5042 | 5.0563 | 12 | 219 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0005132 | 0.0051 | 28.3638 | 0.1154 | 2 | 5 | type I interferon receptor binding |
| GO:0043565 | 0.0053 | 2.2996 | 6.4133 | 14 | 287 | sequence-specific DNA binding |
| GO:1990841 | 0.0054 | 6.3291 | 0.7157 | 4 | 31 | promoter-specific chromatin binding |
| GO:0008083 | 0.006 | 2.8902 | 3.3016 | 9 | 143 | growth factor activity |
| GO:1990837 | 0.0067 | 1.75 | 16.2078 | 27 | 702 | sequence-specific double-stranded DNA binding |
| GO:0071837 | 0.0077 | 8.5266 | 0.4156 | 3 | 18 | HMG box domain binding |
| GO:0001077 | 0.0083 | 2.2463 | 6.0722 | 13 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0005109 | 0.0083 | 5.5109 | 0.8081 | 4 | 35 | frizzled binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003700 | 0.0018 | 1.7546 | 23.1957 | 38 | 1171 | DNA binding transcription factor activity |
| GO:0055077 | 0.0023 | 49.8067 | 0.0792 | 2 | 4 | gap junction hemi-channel activity |
| GO:0043565 | 0.0023 | 1.795 | 19.5906 | 33 | 989 | sequence-specific DNA binding |
| GO:0000062 | 0.0043 | 10.7 | 0.3367 | 3 | 17 | fatty-acyl-CoA binding |
| GO:0005168 | 0.0056 | 24.9 | 0.1189 | 2 | 6 | neurotrophin TRKA receptor binding |
| GO:0044212 | 0.0058 | 1.7757 | 16.0449 | 27 | 810 | transcription regulatory region DNA binding |
| GO:0001067 | 0.006 | 1.7685 | 16.1043 | 27 | 813 | regulatory region nucleic acid binding |
| GO:0004888 | 0.0093 | 1.7223 | 15.8666 | 26 | 801 | transmembrane signaling receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005125 | 0 | 4.4795 | 3.4585 | 14 | 169 | cytokine activity |
| GO:0017159 | 4e-04 | Inf | 0.0409 | 2 | 2 | pantetheine hydrolase activity |
| GO:0030545 | 6e-04 | 2.4769 | 8.1858 | 19 | 400 | receptor regulator activity |
| GO:0048030 | 0.0012 | 96.3419 | 0.0614 | 2 | 3 | disaccharide binding |
| GO:1900750 | 0.0016 | 16.1003 | 0.2456 | 3 | 12 | oligopeptide binding |
| GO:0005164 | 0.0018 | 8.8028 | 0.5321 | 4 | 26 | tumor necrosis factor receptor binding |
| GO:0008499 | 0.0021 | 14.4893 | 0.266 | 3 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GO:0005160 | 0.0026 | 5.7748 | 0.9618 | 5 | 47 | transforming growth factor beta receptor binding |
| GO:0033612 | 0.0032 | 12.0728 | 0.307 | 3 | 15 | receptor serine/threonine kinase binding |
| GO:0005499 | 0.004 | 32.1097 | 0.1023 | 2 | 5 | vitamin D binding |
| GO:0004864 | 0.0049 | 6.4519 | 0.6958 | 4 | 34 | protein phosphatase inhibitor activity |
| GO:0005484 | 0.0067 | 5.8642 | 0.7572 | 4 | 37 | SNAP receptor activity |
| GO:0004601 | 0.0073 | 5.6914 | 0.7776 | 4 | 38 | peroxidase activity |
| GO:0042813 | 0.0086 | 8.0453 | 0.4298 | 3 | 21 | Wnt-activated receptor activity |
| GO:0008083 | 0.0092 | 2.8848 | 2.9264 | 8 | 143 | growth factor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 2e-04 | 1.8948 | 24.4558 | 43 | 989 | sequence-specific DNA binding |
| GO:0001664 | 0.0015 | 2.6664 | 5.5885 | 14 | 226 | G-protein coupled receptor binding |
| GO:0004464 | 0.0018 | 79.296 | 0.0742 | 2 | 3 | leukotriene-C4 synthase activity |
| GO:0099600 | 0.002 | 1.7763 | 20.895 | 35 | 845 | transmembrane receptor activity |
| GO:0004930 | 0.0028 | 2.1017 | 10.0411 | 20 | 409 | G-protein coupled receptor activity |
| GO:0045125 | 0.0028 | 13.2442 | 0.2967 | 3 | 12 | bioactive lipid receptor activity |
| GO:0044547 | 0.0035 | 39.6453 | 0.0989 | 2 | 4 | DNA topoisomerase binding |
| GO:0008191 | 0.0036 | 11.919 | 0.3215 | 3 | 13 | metalloendopeptidase inhibitor activity |
| GO:0008499 | 0.0036 | 11.919 | 0.3215 | 3 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GO:0019841 | 0.0036 | 11.919 | 0.3215 | 3 | 13 | retinol binding |
| GO:0030547 | 0.0055 | 9.9311 | 0.3709 | 3 | 15 | receptor inhibitor activity |
| GO:0016661 | 0.0058 | 26.4284 | 0.1236 | 2 | 5 | oxidoreductase activity, acting on other nitrogenous compounds as donors |
| GO:0038023 | 0.0058 | 1.6467 | 22.3787 | 35 | 905 | signaling receptor activity |
| GO:0046625 | 0.0066 | 9.1666 | 0.3956 | 3 | 16 | sphingolipid binding |
| GO:0000981 | 0.0079 | 1.6893 | 18.0018 | 29 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0070300 | 0.0093 | 7.9433 | 0.4451 | 3 | 18 | phosphatidic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005179 | 1e-04 | 5.029 | 2.2092 | 10 | 103 | hormone activity |
| GO:0030545 | 0.0011 | 2.3539 | 8.5793 | 19 | 400 | receptor regulator activity |
| GO:0005125 | 0.0036 | 2.9284 | 3.6248 | 10 | 169 | cytokine activity |
| GO:0008252 | 0.0037 | 11.5023 | 0.3217 | 3 | 15 | nucleotidase activity |
| GO:0004046 | 0.0044 | 30.5969 | 0.1072 | 2 | 5 | aminoacylase activity |
| GO:0070064 | 0.0063 | 9.2 | 0.3861 | 3 | 18 | proline-rich region binding |
| GO:0004969 | 0.0065 | 22.9462 | 0.1287 | 2 | 6 | histamine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008574 | 0.0026 | 7.9572 | 0.5866 | 4 | 26 | ATP-dependent microtubule motor activity, plus-end-directed |
| GO:0030169 | 0.0028 | 13.1015 | 0.2933 | 3 | 13 | low-density lipoprotein particle binding |
| GO:0005134 | 0.003 | 43.5673 | 0.0903 | 2 | 4 | interleukin-2 receptor binding |
| GO:0043546 | 0.0072 | 21.7807 | 0.1354 | 2 | 6 | molybdopterin cofactor binding |
| GO:0099600 | 0.0095 | 1.6514 | 19.066 | 30 | 845 | transmembrane receptor activity |
| GO:0005525 | 0.0098 | 2.0644 | 7.6038 | 15 | 337 | GTP binding |
| GO:0004983 | 0.0099 | 17.4234 | 0.1579 | 2 | 7 | neuropeptide Y receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031849 | 0.0024 | 48.8105 | 0.0808 | 2 | 4 | olfactory receptor binding |
| GO:0070851 | 0.0029 | 3.562 | 2.404 | 8 | 119 | growth factor receptor binding |
| GO:0015026 | 0.0058 | 6.1291 | 0.7273 | 4 | 36 | coreceptor activity |
| GO:0004468 | 0.0058 | 24.402 | 0.1212 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0042043 | 0.0058 | 24.402 | 0.1212 | 2 | 6 | neurexin family protein binding |
| GO:0016746 | 0.0074 | 2.4778 | 4.6667 | 11 | 231 | transferase activity, transferring acyl groups |
| GO:0016410 | 0.0088 | 3.5994 | 1.7778 | 6 | 88 | N-acyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004888 | 2e-04 | 1.9897 | 19.9747 | 37 | 797 | transmembrane signaling receptor activity |
| GO:0048018 | 2e-04 | 2.4907 | 9.4703 | 22 | 376 | receptor ligand activity |
| GO:0004871 | 3e-04 | 1.7749 | 30.3754 | 50 | 1206 | signal transducer activity |
| GO:0004872 | 0.001 | 1.7249 | 27.8819 | 45 | 1107 | receptor activity |
| GO:0043565 | 0.0021 | 1.7047 | 24.9099 | 40 | 989 | sequence-specific DNA binding |
| GO:0001847 | 0.0037 | 38.9005 | 0.1007 | 2 | 4 | opsonin receptor activity |
| GO:0008499 | 0.0038 | 11.6945 | 0.3274 | 3 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GO:0005184 | 0.0038 | 7.1005 | 0.6549 | 4 | 26 | neuropeptide hormone activity |
| GO:0005506 | 0.0045 | 2.8321 | 3.7529 | 10 | 149 | iron ion binding |
| GO:0016641 | 0.0047 | 10.6306 | 0.3526 | 3 | 14 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
| GO:0001664 | 0.0049 | 2.4099 | 5.6922 | 13 | 226 | G-protein coupled receptor binding |
| GO:0008227 | 0.0065 | 6.0065 | 0.7556 | 4 | 30 | G-protein coupled amine receptor activity |
| GO:0005501 | 0.0073 | 5.7836 | 0.7808 | 4 | 31 | retinoid binding |
| GO:0005198 | 0.0075 | 1.7506 | 15.5655 | 26 | 618 | structural molecule activity |
| GO:0030020 | 0.0089 | 19.4476 | 0.1511 | 2 | 6 | extracellular matrix structural constituent conferring tensile strength |
| GO:0005416 | 0.0098 | 7.7937 | 0.4534 | 3 | 18 | cation:amino acid symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000062 | 0.0051 | 10.0478 | 0.3579 | 3 | 17 | fatty-acyl-CoA binding |
| GO:0035174 | 0.0063 | 23.3871 | 0.1263 | 2 | 6 | histone serine kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030621 | 0.0063 | 23.3125 | 0.1267 | 2 | 6 | U4 snRNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098772 | 0.0017 | 1.6905 | 28.8491 | 45 | 1623 | molecular function regulator |
| GO:0005179 | 0.0024 | 4.1096 | 1.8308 | 7 | 103 | hormone activity |
| GO:0048018 | 0.0031 | 2.667 | 4.7594 | 12 | 273 | receptor ligand activity |
| GO:0004468 | 0.0045 | 27.8271 | 0.1067 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0055131 | 0.0045 | 27.8271 | 0.1067 | 2 | 6 | C3HC4-type RING finger domain binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007155 | 0 | 2.7357 | 12.9477 | 32 | 421 | cell adhesion |
| GO:0030198 | 0 | 3.6456 | 5.8178 | 19 | 186 | extracellular matrix organization |
| GO:0036066 | 0 | 22.043 | 0.3808 | 5 | 12 | protein O-linked fucosylation |
| GO:0022617 | 7e-04 | 4.5883 | 1.9677 | 8 | 62 | extracellular matrix disassembly |
| GO:0048842 | 0.001 | 23.0396 | 0.2222 | 3 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0009651 | 0.0013 | 10.258 | 0.5078 | 4 | 16 | response to salt stress |
| GO:0010810 | 0.0018 | 3.2618 | 3.3343 | 10 | 106 | regulation of cell-substrate adhesion |
| GO:0051893 | 0.002 | 5.1441 | 1.3329 | 6 | 42 | regulation of focal adhesion assembly |
| GO:0019371 | 0.0023 | 15.3573 | 0.2856 | 3 | 9 | cyclooxygenase pathway |
| GO:0097286 | 0.0023 | 15.3573 | 0.2856 | 3 | 9 | iron ion import |
| GO:0048333 | 0.0023 | 6.1634 | 0.9521 | 5 | 30 | mesodermal cell differentiation |
| GO:0002040 | 0.0028 | 3.6396 | 2.412 | 8 | 76 | sprouting angiogenesis |
| GO:0033693 | 0.003 | 61.3062 | 0.0952 | 2 | 3 | neurofilament bundle assembly |
| GO:0044691 | 0.003 | 61.3062 | 0.0952 | 2 | 3 | tooth eruption |
| GO:0061551 | 0.003 | 61.3062 | 0.0952 | 2 | 3 | trigeminal ganglion development |
| GO:0070634 | 0.003 | 61.3062 | 0.0952 | 2 | 3 | transepithelial ammonium transport |
| GO:0007160 | 0.0032 | 2.8211 | 4.1883 | 11 | 133 | cell-matrix adhesion |
| GO:0002544 | 0.0032 | 13.1624 | 0.3174 | 3 | 10 | chronic inflammatory response |
| GO:0035646 | 0.0032 | 13.1624 | 0.3174 | 3 | 10 | endosome to melanosome transport |
| GO:0043476 | 0.0032 | 13.1624 | 0.3174 | 3 | 10 | pigment accumulation |
| GO:0048757 | 0.0032 | 13.1624 | 0.3174 | 3 | 10 | pigment granule maturation |
| GO:0009790 | 0.0035 | 1.6377 | 26.4999 | 41 | 835 | embryo development |
| GO:0001704 | 0.0036 | 2.9521 | 3.6497 | 10 | 115 | formation of primary germ layer |
| GO:0051216 | 0.0037 | 2.6247 | 4.8874 | 12 | 154 | cartilage development |
| GO:0098609 | 0.0045 | 1.721 | 19.6131 | 32 | 618 | cell-cell adhesion |
| GO:0048260 | 0.0053 | 4.9681 | 1.1425 | 5 | 36 | positive regulation of receptor-mediated endocytosis |
| GO:0030511 | 0.0055 | 6.4752 | 0.7299 | 4 | 23 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0034356 | 0.0056 | 10.2358 | 0.3808 | 3 | 12 | NAD biosynthesis via nicotinamide riboside salvage pathway |
| GO:0002138 | 0.0058 | 30.6507 | 0.1269 | 2 | 4 | retinoic acid biosynthetic process |
| GO:0042126 | 0.0058 | 30.6507 | 0.1269 | 2 | 4 | nitrate metabolic process |
| GO:0071651 | 0.0058 | 30.6507 | 0.1269 | 2 | 4 | positive regulation of chemokine (C-C motif) ligand 5 production |
| GO:0098706 | 0.0058 | 30.6507 | 0.1269 | 2 | 4 | ferric iron import across plasma membrane |
| GO:0048332 | 0.0061 | 3.4861 | 2.1898 | 7 | 69 | mesoderm morphogenesis |
| GO:0019674 | 0.0064 | 3.9368 | 1.682 | 6 | 53 | NAD metabolic process |
| GO:0001953 | 0.0064 | 6.151 | 0.7617 | 4 | 24 | negative regulation of cell-matrix adhesion |
| GO:0019359 | 0.0064 | 6.151 | 0.7617 | 4 | 24 | nicotinamide nucleotide biosynthetic process |
| GO:0034698 | 0.0064 | 6.151 | 0.7617 | 4 | 24 | response to gonadotropin |
| GO:0071560 | 0.0064 | 2.3339 | 5.903 | 13 | 186 | cellular response to transforming growth factor beta stimulus |
| GO:0009991 | 0.007 | 1.8909 | 11.679 | 21 | 368 | response to extracellular stimulus |
| GO:0006590 | 0.0072 | 9.2115 | 0.4126 | 3 | 13 | thyroid hormone generation |
| GO:0007501 | 0.0072 | 9.2115 | 0.4126 | 3 | 13 | mesodermal cell fate specification |
| GO:0021527 | 0.0072 | 9.2115 | 0.4126 | 3 | 13 | spinal cord association neuron differentiation |
| GO:0008038 | 0.0075 | 5.8576 | 0.7934 | 4 | 25 | neuron recognition |
| GO:0051495 | 0.0088 | 2.3261 | 5.4587 | 12 | 172 | positive regulation of cytoskeleton organization |
| GO:0042730 | 0.0089 | 8.3734 | 0.4443 | 3 | 14 | fibrinolysis |
| GO:0007044 | 0.0089 | 3.2246 | 2.3485 | 7 | 74 | cell-substrate junction assembly |
| GO:1900024 | 0.0092 | 4.2764 | 1.3012 | 5 | 41 | regulation of substrate adhesion-dependent cell spreading |
| GO:0048706 | 0.0093 | 2.7024 | 3.5545 | 9 | 112 | embryonic skeletal system development |
| GO:0010757 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | negative regulation of plasminogen activation |
| GO:0015677 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | copper ion import |
| GO:0034112 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0048843 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | negative regulation of axon extension involved in axon guidance |
| GO:0060839 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | endothelial cell fate commitment |
| GO:0090500 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | endocardial cushion to mesenchymal transition |
| GO:1903232 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | melanosome assembly |
| GO:2000507 | 0.0094 | 20.4322 | 0.1587 | 2 | 5 | positive regulation of energy homeostasis |
| GO:0072359 | 0.0095 | 1.5581 | 25.6113 | 38 | 807 | circulatory system development |
| GO:0072525 | 0.0098 | 5.3474 | 0.8569 | 4 | 27 | pyridine-containing compound biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043312 | 0.001 | 2.5128 | 7.2379 | 17 | 367 | neutrophil degranulation |
| GO:0042119 | 0.0012 | 2.4621 | 7.376 | 17 | 374 | neutrophil activation |
| GO:0006757 | 0.0014 | 4.5561 | 1.6764 | 7 | 85 | ATP generation from ADP |
| GO:0006000 | 0.0015 | 16.7494 | 0.2367 | 3 | 12 | fructose metabolic process |
| GO:0030150 | 0.0029 | 12.5591 | 0.2958 | 3 | 15 | protein import into mitochondrial matrix |
| GO:0002275 | 0.003 | 2.2479 | 8.0268 | 17 | 407 | myeloid cell activation involved in immune response |
| GO:1900034 | 0.0031 | 4.5324 | 1.4397 | 6 | 73 | regulation of cellular response to heat |
| GO:0002444 | 0.0034 | 2.2186 | 8.1254 | 17 | 412 | myeloid leukocyte mediated immunity |
| GO:0009179 | 0.0043 | 3.6966 | 2.0314 | 7 | 103 | purine ribonucleoside diphosphate metabolic process |
| GO:0046164 | 0.0043 | 6.7149 | 0.6705 | 4 | 34 | alcohol catabolic process |
| GO:0031663 | 0.0048 | 6.4978 | 0.6903 | 4 | 35 | lipopolysaccharide-mediated signaling pathway |
| GO:0009408 | 0.0048 | 3.2501 | 2.623 | 8 | 133 | response to heat |
| GO:0071800 | 0.005 | 10.045 | 0.355 | 3 | 18 | podosome assembly |
| GO:0046939 | 0.005 | 3.5838 | 2.0905 | 7 | 106 | nucleotide phosphorylation |
| GO:0031103 | 0.0053 | 6.2943 | 0.71 | 4 | 36 | axon regeneration |
| GO:0033034 | 0.0055 | 25.0367 | 0.1183 | 2 | 6 | positive regulation of myeloid cell apoptotic process |
| GO:0061621 | 0.0058 | 9.4164 | 0.3747 | 3 | 19 | canonical glycolysis |
| GO:0006378 | 0.0064 | 5.9231 | 0.7494 | 4 | 38 | mRNA polyadenylation |
| GO:0006090 | 0.0067 | 3.3774 | 2.2089 | 7 | 112 | pyruvate metabolic process |
| GO:0061615 | 0.0067 | 8.8618 | 0.3944 | 3 | 20 | glycolytic process through fructose-6-phosphate |
| GO:0060073 | 0.0076 | 20.0278 | 0.1381 | 2 | 7 | micturition |
| GO:0071223 | 0.0076 | 20.0278 | 0.1381 | 2 | 7 | cellular response to lipoteichoic acid |
| GO:0001704 | 0.0077 | 3.2828 | 2.268 | 7 | 115 | formation of primary germ layer |
| GO:0031099 | 0.0081 | 2.9626 | 2.8597 | 8 | 145 | regeneration |
| GO:0001701 | 0.0083 | 2.3381 | 5.4038 | 12 | 274 | in utero embryonic development |
| GO:0019320 | 0.0084 | 5.4416 | 0.8086 | 4 | 41 | hexose catabolic process |
| GO:0042267 | 0.0084 | 5.4416 | 0.8086 | 4 | 41 | natural killer cell mediated cytotoxicity |
| GO:0035987 | 0.0092 | 5.298 | 0.8283 | 4 | 42 | endodermal cell differentiation |
| GO:0016052 | 0.0094 | 2.8777 | 2.9386 | 8 | 149 | carbohydrate catabolic process |
| GO:0002263 | 0.0097 | 1.9321 | 9.8018 | 18 | 497 | cell activation involved in immune response |
| GO:0045055 | 0.0099 | 1.8603 | 11.3204 | 20 | 574 | regulated exocytosis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006884 | 4e-04 | 14.115 | 0.3808 | 4 | 15 | cell volume homeostasis |
| GO:0051974 | 5e-04 | 29.0405 | 0.1777 | 3 | 7 | negative regulation of telomerase activity |
| GO:0072163 | 0.0014 | 4.0611 | 2.1581 | 8 | 85 | mesonephric epithelium development |
| GO:0030513 | 0.0052 | 6.4629 | 0.7109 | 4 | 28 | positive regulation of BMP signaling pathway |
| GO:0001657 | 0.0054 | 3.5427 | 2.1327 | 7 | 84 | ureteric bud development |
| GO:0033539 | 0.0059 | 9.6742 | 0.3808 | 3 | 15 | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
| GO:0035269 | 0.0059 | 9.6742 | 0.3808 | 3 | 15 | protein O-linked mannosylation |
| GO:0009912 | 0.0061 | 25.7385 | 0.1269 | 2 | 5 | auditory receptor cell fate commitment |
| GO:0061009 | 0.0061 | 25.7385 | 0.1269 | 2 | 5 | common bile duct development |
| GO:1903371 | 0.0061 | 25.7385 | 0.1269 | 2 | 5 | regulation of endoplasmic reticulum tubular network organization |
| GO:0032211 | 0.0085 | 8.2909 | 0.4316 | 3 | 17 | negative regulation of telomere maintenance via telomerase |
| GO:0018103 | 0.009 | 19.3024 | 0.1523 | 2 | 6 | protein C-linked glycosylation |
| GO:0018211 | 0.009 | 19.3024 | 0.1523 | 2 | 6 | peptidyl-tryptophan modification |
| GO:0018406 | 0.009 | 19.3024 | 0.1523 | 2 | 6 | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan |
| GO:0051791 | 0.009 | 19.3024 | 0.1523 | 2 | 6 | medium-chain fatty acid metabolic process |
| GO:0097502 | 0.0093 | 5.3465 | 0.8378 | 4 | 33 | mannosylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051030 | 0.002 | 75.3743 | 0.078 | 2 | 3 | snRNA transport |
| GO:0006572 | 0.0039 | 37.6842 | 0.104 | 2 | 4 | tyrosine catabolic process |
| GO:0061056 | 0.0039 | 37.6842 | 0.104 | 2 | 4 | sclerotome development |
| GO:2001286 | 0.0039 | 37.6842 | 0.104 | 2 | 4 | regulation of caveolin-mediated endocytosis |
| GO:0070977 | 0.0051 | 10.3005 | 0.3639 | 3 | 14 | bone maturation |
| GO:0009410 | 0.0078 | 3.7333 | 1.7416 | 6 | 67 | response to xenobiotic stimulus |
| GO:0014823 | 0.0079 | 4.4066 | 1.2477 | 5 | 48 | response to activity |
| GO:0009072 | 0.009 | 8.0913 | 0.4419 | 3 | 17 | aromatic amino acid family metabolic process |
| GO:0046475 | 0.009 | 8.0913 | 0.4419 | 3 | 17 | glycerophospholipid catabolic process |
| GO:0030835 | 0.0091 | 5.4042 | 0.8318 | 4 | 32 | negative regulation of actin filament depolymerization |
| GO:0030239 | 0.0094 | 4.2101 | 1.2997 | 5 | 50 | myofibril assembly |
| GO:0006189 | 0.0094 | 18.8392 | 0.156 | 2 | 6 | 'de novo' IMP biosynthetic process |
| GO:0023041 | 0.0094 | 18.8392 | 0.156 | 2 | 6 | neuronal signal transduction |
| GO:0035630 | 0.0094 | 18.8392 | 0.156 | 2 | 6 | bone mineralization involved in bone maturation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010216 | 0 | 53.1167 | 0.2194 | 4 | 6 | maintenance of DNA methylation |
| GO:0014826 | 2e-04 | 79.5156 | 0.1463 | 3 | 4 | vein smooth muscle contraction |
| GO:0061061 | 7e-04 | 1.9107 | 18.9811 | 34 | 519 | muscle structure development |
| GO:0031340 | 9e-04 | 26.501 | 0.2194 | 3 | 6 | positive regulation of vesicle fusion |
| GO:0034651 | 0.0015 | 19.8742 | 0.256 | 3 | 7 | cortisol biosynthetic process |
| GO:0032000 | 0.0024 | 15.8981 | 0.2926 | 3 | 8 | positive regulation of fatty acid beta-oxidation |
| GO:0090308 | 0.0024 | 15.8981 | 0.2926 | 3 | 8 | regulation of methylation-dependent chromatin silencing |
| GO:0008211 | 0.0036 | 7.581 | 0.6583 | 4 | 18 | glucocorticoid metabolic process |
| GO:0006438 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | valyl-tRNA aminoacylation |
| GO:0045630 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | positive regulation of T-helper 2 cell differentiation |
| GO:0045875 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | negative regulation of sister chromatid cohesion |
| GO:0098908 | 0.0039 | 52.9004 | 0.1097 | 2 | 3 | regulation of neuronal action potential |
| GO:0030148 | 0.0041 | 3.1184 | 3.1452 | 9 | 86 | sphingolipid biosynthetic process |
| GO:0055085 | 0.0045 | 1.4983 | 40.2297 | 57 | 1100 | transmembrane transport |
| GO:0050892 | 0.0054 | 6.6323 | 0.7314 | 4 | 20 | intestinal absorption |
| GO:0060971 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | embryonic heart tube left/right pattern formation |
| GO:0072708 | 0.0076 | 26.4481 | 0.1463 | 2 | 4 | response to sorbitol |
| GO:0006643 | 0.0081 | 2.1912 | 6.7659 | 14 | 185 | membrane lipid metabolic process |
| GO:0018107 | 0.0096 | 2.6954 | 3.5841 | 9 | 98 | peptidyl-threonine phosphorylation |
| GO:0006820 | 0.0097 | 1.7129 | 15.909 | 26 | 435 | anion transport |
| GO:0046942 | 0.0097 | 2.0219 | 8.3385 | 16 | 228 | carboxylic acid transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035270 | 1e-04 | 4.3673 | 3.0805 | 12 | 107 | endocrine system development |
| GO:0007399 | 4e-04 | 1.5777 | 54.153 | 78 | 1881 | nervous system development |
| GO:0021532 | 6e-04 | 6.6178 | 1.0652 | 6 | 37 | neural tube patterning |
| GO:0008050 | 8e-04 | Inf | 0.0576 | 2 | 2 | female courtship behavior |
| GO:0016560 | 8e-04 | Inf | 0.0576 | 2 | 2 | protein import into peroxisome matrix, docking |
| GO:0060032 | 8e-04 | Inf | 0.0576 | 2 | 2 | notochord regression |
| GO:0071168 | 0.0015 | 9.7302 | 0.5182 | 4 | 18 | protein localization to chromatin |
| GO:0045604 | 0.0015 | 5.3958 | 1.2667 | 6 | 44 | regulation of epidermal cell differentiation |
| GO:0030917 | 0.0017 | 16.9934 | 0.2591 | 3 | 9 | midbrain-hindbrain boundary development |
| GO:0007275 | 0.0018 | 1.3798 | 118.1808 | 145 | 4105 | multicellular organism development |
| GO:0009952 | 0.0018 | 2.7332 | 5.0957 | 13 | 177 | anterior/posterior pattern specification |
| GO:0007165 | 0.0019 | 1.3733 | 124.9464 | 152 | 4340 | signal transduction |
| GO:0048699 | 0.002 | 1.6096 | 33.8852 | 51 | 1177 | generation of neurons |
| GO:0051239 | 0.0023 | 1.4488 | 65.2658 | 87 | 2267 | regulation of multicellular organismal process |
| GO:0006003 | 0.0024 | 67.8206 | 0.0864 | 2 | 3 | fructose 2,6-bisphosphate metabolic process |
| GO:0010621 | 0.0024 | 67.8206 | 0.0864 | 2 | 3 | negative regulation of transcription by transcription factor localization |
| GO:0090521 | 0.0024 | 67.8206 | 0.0864 | 2 | 3 | glomerular visceral epithelial cell migration |
| GO:0016973 | 0.0024 | 14.5646 | 0.2879 | 3 | 10 | poly(A)+ mRNA export from nucleus |
| GO:0072015 | 0.0024 | 14.5646 | 0.2879 | 3 | 10 | glomerular visceral epithelial cell development |
| GO:0048568 | 0.0025 | 2.0838 | 10.6809 | 21 | 371 | embryonic organ development |
| GO:0001649 | 0.0027 | 2.7356 | 4.6927 | 12 | 163 | osteoblast differentiation |
| GO:0018206 | 0.0033 | 12.7431 | 0.3167 | 3 | 11 | peptidyl-methionine modification |
| GO:0021521 | 0.0033 | 12.7431 | 0.3167 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0032755 | 0.0033 | 4.554 | 1.4683 | 6 | 51 | positive regulation of interleukin-6 production |
| GO:0048869 | 0.0033 | 1.373 | 95.4083 | 119 | 3314 | cellular developmental process |
| GO:0030279 | 0.004 | 4.3595 | 1.5258 | 6 | 53 | negative regulation of ossification |
| GO:0061640 | 0.004 | 4.3595 | 1.5258 | 6 | 53 | cytoskeleton-dependent cytokinesis |
| GO:0009798 | 0.0042 | 3.7401 | 2.0441 | 7 | 71 | axis specification |
| GO:0070571 | 0.0043 | 11.3263 | 0.3455 | 3 | 12 | negative regulation of neuron projection regeneration |
| GO:0050680 | 0.0047 | 3.2998 | 2.6198 | 8 | 91 | negative regulation of epithelial cell proliferation |
| GO:0030855 | 0.0047 | 1.8246 | 15.0281 | 26 | 522 | epithelial cell differentiation |
| GO:0003199 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0007418 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | ventral midline development |
| GO:0021938 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation |
| GO:0034127 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0060509 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | Type I pneumocyte differentiation |
| GO:1902412 | 0.0048 | 33.9077 | 0.1152 | 2 | 4 | regulation of mitotic cytokinesis |
| GO:0060322 | 0.0049 | 1.7592 | 17.3888 | 29 | 604 | head development |
| GO:0090102 | 0.005 | 5.0137 | 1.1228 | 5 | 39 | cochlea development |
| GO:0032785 | 0.0055 | 10.1929 | 0.3743 | 3 | 13 | negative regulation of DNA-templated transcription, elongation |
| GO:0061564 | 0.0058 | 1.9252 | 11.487 | 21 | 399 | axon development |
| GO:0007031 | 0.0061 | 6.1881 | 0.7485 | 4 | 26 | peroxisome organization |
| GO:0065007 | 0.0065 | 1.3502 | 264.8344 | 287 | 9199 | biological regulation |
| GO:0035025 | 0.0068 | 9.2655 | 0.4031 | 3 | 14 | positive regulation of Rho protein signal transduction |
| GO:0045821 | 0.0068 | 9.2655 | 0.4031 | 3 | 14 | positive regulation of glycolytic process |
| GO:1905314 | 0.0068 | 9.2655 | 0.4031 | 3 | 14 | semi-lunar valve development |
| GO:0019098 | 0.007 | 5.9186 | 0.7773 | 4 | 27 | reproductive behavior |
| GO:0043616 | 0.007 | 5.9186 | 0.7773 | 4 | 27 | keratinocyte proliferation |
| GO:0021549 | 0.0071 | 3.3695 | 2.2456 | 7 | 78 | cerebellum development |
| GO:0003180 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | aortic valve morphogenesis |
| GO:0060633 | 0.0078 | 22.6033 | 0.1439 | 2 | 5 | negative regulation of transcription initiation from RNA polymerase II promoter |
| GO:0010804 | 0.0083 | 8.4927 | 0.4318 | 3 | 15 | negative regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0034104 | 0.0083 | 8.4927 | 0.4318 | 3 | 15 | negative regulation of tissue remodeling |
| GO:0051194 | 0.0083 | 8.4927 | 0.4318 | 3 | 15 | positive regulation of cofactor metabolic process |
| GO:0060581 | 0.0083 | 8.4927 | 0.4318 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0048666 | 0.0086 | 1.5804 | 24.6438 | 37 | 856 | neuron development |
| GO:0042472 | 0.0087 | 3.2322 | 2.3319 | 7 | 81 | inner ear morphogenesis |
| GO:0045596 | 0.009 | 1.7459 | 15.0281 | 25 | 522 | negative regulation of cell differentiation |
| GO:0051150 | 0.0091 | 5.4442 | 0.8349 | 4 | 29 | regulation of smooth muscle cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038001 | 0.001 | 108.2583 | 0.0549 | 2 | 3 | paracrine signaling |
| GO:0050919 | 0.0012 | 9.9083 | 0.4754 | 4 | 26 | negative chemotaxis |
| GO:0048305 | 0.0023 | 13.5774 | 0.2743 | 3 | 15 | immunoglobulin secretion |
| GO:0030825 | 0.0028 | 12.532 | 0.2926 | 3 | 16 | positive regulation of cGMP metabolic process |
| GO:0046330 | 0.0031 | 3.9191 | 1.9201 | 7 | 105 | positive regulation of JNK cascade |
| GO:0071800 | 0.004 | 10.8594 | 0.3292 | 3 | 18 | podosome assembly |
| GO:0042572 | 0.0047 | 10.1799 | 0.3474 | 3 | 19 | retinol metabolic process |
| GO:0006720 | 0.0052 | 4.0524 | 1.5909 | 6 | 87 | isoprenoid metabolic process |
| GO:0002440 | 0.0062 | 3.4255 | 2.1761 | 7 | 119 | production of molecular mediator of immune response |
| GO:0033598 | 0.0063 | 9.0474 | 0.384 | 3 | 21 | mammary gland epithelial cell proliferation |
| GO:0003344 | 0.0066 | 21.645 | 0.128 | 2 | 7 | pericardium morphogenesis |
| GO:0030799 | 0.0074 | 3.3064 | 2.2492 | 7 | 123 | regulation of cyclic nucleotide metabolic process |
| GO:0002718 | 0.0077 | 5.582 | 0.7863 | 4 | 43 | regulation of cytokine production involved in immune response |
| GO:0070304 | 0.0084 | 3.2223 | 2.3041 | 7 | 126 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0002726 | 0.0087 | 18.0361 | 0.1463 | 2 | 8 | positive regulation of T cell cytokine production |
| GO:0031284 | 0.0087 | 18.0361 | 0.1463 | 2 | 8 | positive regulation of guanylate cyclase activity |
| GO:1904861 | 0.0087 | 18.0361 | 0.1463 | 2 | 8 | excitatory synapse assembly |
| GO:0009593 | 0.0087 | 3.6043 | 1.7738 | 6 | 97 | detection of chemical stimulus |
| GO:0050921 | 0.0096 | 3.5262 | 1.8103 | 6 | 99 | positive regulation of chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007257 | 6e-04 | 6.6336 | 1.0939 | 6 | 31 | activation of JUN kinase activity |
| GO:0010216 | 8e-04 | 27.5086 | 0.2117 | 3 | 6 | maintenance of DNA methylation |
| GO:0036265 | 8e-04 | 27.5086 | 0.2117 | 3 | 6 | RNA (guanine-N7)-methylation |
| GO:0000381 | 9e-04 | 6.1412 | 1.1645 | 6 | 33 | regulation of alternative mRNA splicing, via spliceosome |
| GO:0043506 | 0.001 | 3.9003 | 2.576 | 9 | 73 | regulation of JUN kinase activity |
| GO:1902202 | 0.0012 | Inf | 0.0706 | 2 | 2 | regulation of hepatocyte growth factor receptor signaling pathway |
| GO:1902732 | 0.0012 | Inf | 0.0706 | 2 | 2 | positive regulation of chondrocyte proliferation |
| GO:0060444 | 0.002 | 9.1829 | 0.5646 | 4 | 16 | branching involved in mammary gland duct morphogenesis |
| GO:0090308 | 0.0021 | 16.5026 | 0.2823 | 3 | 8 | regulation of methylation-dependent chromatin silencing |
| GO:0072087 | 0.0025 | 8.4758 | 0.5999 | 4 | 17 | renal vesicle development |
| GO:0050684 | 0.0026 | 3.1171 | 3.4935 | 10 | 99 | regulation of mRNA processing |
| GO:0042474 | 0.0032 | 7.8698 | 0.6352 | 4 | 18 | middle ear morphogenesis |
| GO:0033484 | 0.0036 | 54.9075 | 0.1059 | 2 | 3 | nitric oxide homeostasis |
| GO:0071847 | 0.0036 | 54.9075 | 0.1059 | 2 | 3 | TNFSF11-mediated signaling pathway |
| GO:0042060 | 0.0038 | 1.8563 | 14.7856 | 26 | 419 | wound healing |
| GO:0010884 | 0.0039 | 7.3446 | 0.6705 | 4 | 19 | positive regulation of lipid storage |
| GO:0006702 | 0.0044 | 11.7857 | 0.3529 | 3 | 10 | androgen biosynthetic process |
| GO:1901160 | 0.0044 | 11.7857 | 0.3529 | 3 | 10 | primary amino compound metabolic process |
| GO:0046467 | 0.0047 | 2.6774 | 4.411 | 11 | 125 | membrane lipid biosynthetic process |
| GO:0060443 | 0.0056 | 4.9239 | 1.1645 | 5 | 33 | mammary gland morphogenesis |
| GO:0045836 | 0.0058 | 10.3117 | 0.3882 | 3 | 11 | positive regulation of meiotic nuclear division |
| GO:0016477 | 0.0069 | 1.4889 | 36.8053 | 52 | 1043 | cell migration |
| GO:0040038 | 0.0071 | 27.4516 | 0.1412 | 2 | 4 | polar body extrusion after meiotic divisions |
| GO:0051295 | 0.0071 | 27.4516 | 0.1412 | 2 | 4 | establishment of meiotic spindle localization |
| GO:0052572 | 0.0071 | 27.4516 | 0.1412 | 2 | 4 | response to host immune response |
| GO:0060364 | 0.0071 | 27.4516 | 0.1412 | 2 | 4 | frontal suture morphogenesis |
| GO:0097056 | 0.0071 | 27.4516 | 0.1412 | 2 | 4 | selenocysteinyl-tRNA(Sec) biosynthetic process |
| GO:1903911 | 0.0071 | 27.4516 | 0.1412 | 2 | 4 | positive regulation of receptor clustering |
| GO:0070085 | 0.0075 | 2.0322 | 8.822 | 17 | 250 | glycosylation |
| GO:0035116 | 0.008 | 5.7965 | 0.8116 | 4 | 23 | embryonic hindlimb morphogenesis |
| GO:0060968 | 0.0084 | 2.589 | 4.1287 | 10 | 117 | regulation of gene silencing |
| GO:0006733 | 0.0088 | 2.3283 | 5.4696 | 12 | 155 | oxidoreduction coenzyme metabolic process |
| GO:0072283 | 0.0096 | 8.2481 | 0.4587 | 3 | 13 | metanephric renal vesicle morphogenesis |
| GO:0045216 | 0.0097 | 2.137 | 6.9164 | 14 | 196 | cell-cell junction organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007621 | 0 | Inf | 0.0771 | 3 | 3 | negative regulation of female receptivity |
| GO:0060180 | 0 | 38.3631 | 0.2055 | 4 | 8 | female mating behavior |
| GO:0031424 | 4e-04 | 3.9978 | 2.749 | 10 | 107 | keratinization |
| GO:0050432 | 6e-04 | 6.6 | 1.0533 | 6 | 41 | catecholamine secretion |
| GO:0002125 | 7e-04 | Inf | 0.0514 | 2 | 2 | maternal aggressive behavior |
| GO:1900155 | 7e-04 | Inf | 0.0514 | 2 | 2 | negative regulation of bone trabecula formation |
| GO:1902224 | 0.0018 | 16.3887 | 0.2569 | 3 | 10 | ketone body metabolic process |
| GO:0009913 | 0.0018 | 2.7311 | 5.0869 | 13 | 198 | epidermal cell differentiation |
| GO:0061430 | 0.0024 | 14.339 | 0.2826 | 3 | 11 | bone trabecula morphogenesis |
| GO:0050911 | 0.0025 | 4.8076 | 1.3873 | 6 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0014059 | 0.0026 | 8.067 | 0.5909 | 4 | 23 | regulation of dopamine secretion |
| GO:0007606 | 0.003 | 3.2494 | 2.9802 | 9 | 116 | sensory perception of chemical stimulus |
| GO:0035815 | 0.0031 | 12.7448 | 0.3083 | 3 | 12 | positive regulation of renal sodium excretion |
| GO:0051969 | 0.0031 | 12.7448 | 0.3083 | 3 | 12 | regulation of transmission of nerve impulse |
| GO:0048168 | 0.0034 | 5.4836 | 1.0277 | 5 | 40 | regulation of neuronal synaptic plasticity |
| GO:0051290 | 0.0034 | 5.4836 | 1.0277 | 5 | 40 | protein heterotetramerization |
| GO:0009593 | 0.0035 | 3.4669 | 2.4921 | 8 | 97 | detection of chemical stimulus |
| GO:0015844 | 0.0036 | 4.4364 | 1.4901 | 6 | 58 | monoamine transport |
| GO:0006811 | 0.0037 | 1.5948 | 30.7783 | 46 | 1198 | ion transport |
| GO:0010701 | 0.0038 | 38.142 | 0.1028 | 2 | 4 | positive regulation of norepinephrine secretion |
| GO:0010961 | 0.0038 | 38.142 | 0.1028 | 2 | 4 | cellular magnesium ion homeostasis |
| GO:0003352 | 0.004 | 11.4694 | 0.334 | 3 | 13 | regulation of cilium movement |
| GO:0007625 | 0.004 | 11.4694 | 0.334 | 3 | 13 | grooming behavior |
| GO:0098916 | 0.004 | 1.9307 | 12.5888 | 23 | 490 | anterograde trans-synaptic signaling |
| GO:0099536 | 0.0041 | 1.9264 | 12.6145 | 23 | 491 | synaptic signaling |
| GO:0019098 | 0.0047 | 6.662 | 0.6937 | 4 | 27 | reproductive behavior |
| GO:0009954 | 0.0054 | 6.3839 | 0.7194 | 4 | 28 | proximal/distal pattern formation |
| GO:0098660 | 0.0058 | 1.7737 | 16.0571 | 27 | 625 | inorganic ion transmembrane transport |
| GO:0050804 | 0.0059 | 2.2739 | 6.4999 | 14 | 253 | modulation of chemical synaptic transmission |
| GO:0048148 | 0.0061 | 9.5564 | 0.3854 | 3 | 15 | behavioral response to cocaine |
| GO:0006335 | 0.0061 | 6.1281 | 0.7451 | 4 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0051954 | 0.0061 | 6.1281 | 0.7451 | 4 | 29 | positive regulation of amine transport |
| GO:0006578 | 0.0063 | 25.426 | 0.1285 | 2 | 5 | amino-acid betaine biosynthetic process |
| GO:0043588 | 0.0065 | 2.2452 | 6.577 | 14 | 256 | skin development |
| GO:0050877 | 0.0068 | 1.6986 | 18.6263 | 30 | 725 | nervous system process |
| GO:0030326 | 0.007 | 3.0521 | 2.8004 | 8 | 109 | embryonic limb morphogenesis |
| GO:0007405 | 0.0075 | 4.4606 | 1.2332 | 5 | 48 | neuroblast proliferation |
| GO:0055078 | 0.0078 | 5.6733 | 0.7964 | 4 | 31 | sodium ion homeostasis |
| GO:0045814 | 0.0078 | 2.9924 | 2.8517 | 8 | 111 | negative regulation of gene expression, epigenetic |
| GO:0031623 | 0.0079 | 3.718 | 1.747 | 6 | 68 | receptor internalization |
| GO:0000183 | 0.0087 | 5.4702 | 0.8221 | 4 | 32 | chromatin silencing at rDNA |
| GO:0007618 | 0.0087 | 5.4702 | 0.8221 | 4 | 32 | mating |
| GO:0045744 | 0.0087 | 5.4702 | 0.8221 | 4 | 32 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0032020 | 0.0092 | 19.068 | 0.1541 | 2 | 6 | ISG15-protein conjugation |
| GO:0042713 | 0.0092 | 19.068 | 0.1541 | 2 | 6 | sperm ejaculation |
| GO:0015872 | 0.0097 | 5.2812 | 0.8478 | 4 | 33 | dopamine transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009972 | 1e-04 | 90.6085 | 0.1291 | 3 | 4 | cytidine deamination |
| GO:0046087 | 1e-04 | 90.6085 | 0.1291 | 3 | 4 | cytidine metabolic process |
| GO:0070383 | 1e-04 | 90.6085 | 0.1291 | 3 | 4 | DNA cytosine deamination |
| GO:0009605 | 2e-04 | 1.6282 | 50.2372 | 75 | 1557 | response to external stimulus |
| GO:0021781 | 6e-04 | 13.4468 | 0.4194 | 4 | 13 | glial cell fate commitment |
| GO:0045869 | 6e-04 | 30.1981 | 0.1936 | 3 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 6e-04 | 30.1981 | 0.1936 | 3 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0051224 | 7e-04 | 2.9194 | 5.1947 | 14 | 161 | negative regulation of protein transport |
| GO:0031099 | 8e-04 | 3.0152 | 4.6785 | 13 | 145 | regeneration |
| GO:0010817 | 0.001 | 3.2974 | 3.64 | 11 | 115 | regulation of hormone levels |
| GO:0021637 | 0.001 | Inf | 0.0645 | 2 | 2 | trigeminal nerve structural organization |
| GO:0035290 | 0.001 | Inf | 0.0645 | 2 | 2 | trunk segmentation |
| GO:0036486 | 0.001 | Inf | 0.0645 | 2 | 2 | ventral trunk neural crest cell migration |
| GO:1902287 | 0.001 | Inf | 0.0645 | 2 | 2 | semaphorin-plexin signaling pathway involved in axon guidance |
| GO:0090286 | 0.0011 | 22.6468 | 0.2259 | 3 | 7 | cytoskeletal anchoring at nuclear membrane |
| GO:0010529 | 0.0011 | 11.0002 | 0.484 | 4 | 15 | negative regulation of transposition |
| GO:0048585 | 0.0011 | 1.6055 | 38.7185 | 58 | 1200 | negative regulation of response to stimulus |
| GO:0009948 | 0.0014 | 5.5167 | 1.2583 | 6 | 39 | anterior/posterior axis specification |
| GO:0021545 | 0.0014 | 5.5167 | 1.2583 | 6 | 39 | cranial nerve development |
| GO:0006590 | 0.0016 | 18.1976 | 0.257 | 3 | 8 | thyroid hormone generation |
| GO:0023057 | 0.0021 | 1.5956 | 34.7175 | 52 | 1076 | negative regulation of signaling |
| GO:0090276 | 0.0024 | 2.6496 | 5.2593 | 13 | 163 | regulation of peptide hormone secretion |
| GO:0016553 | 0.0024 | 15.0955 | 0.2904 | 3 | 9 | base conversion or substitution editing |
| GO:0050691 | 0.0025 | 6.0578 | 0.968 | 5 | 30 | regulation of defense response to virus by host |
| GO:0003002 | 0.0027 | 2.1623 | 9.3247 | 19 | 289 | regionalization |
| GO:0039694 | 0.0028 | 8.0643 | 0.613 | 4 | 19 | viral RNA genome replication |
| GO:0021785 | 0.003 | 60.2635 | 0.0968 | 2 | 3 | branchiomotor neuron axon guidance |
| GO:0097490 | 0.003 | 60.2635 | 0.0968 | 2 | 3 | sympathetic neuron projection extension |
| GO:0097491 | 0.003 | 60.2635 | 0.0968 | 2 | 3 | sympathetic neuron projection guidance |
| GO:1901166 | 0.003 | 60.2635 | 0.0968 | 2 | 3 | neural crest cell migration involved in autonomic nervous system development |
| GO:0010648 | 0.0033 | 1.5641 | 34.6207 | 51 | 1073 | negative regulation of cell communication |
| GO:0060379 | 0.0034 | 12.938 | 0.3227 | 3 | 10 | cardiac muscle cell myoblast differentiation |
| GO:1900121 | 0.0034 | 12.938 | 0.3227 | 3 | 10 | negative regulation of receptor binding |
| GO:0001708 | 0.0036 | 3.4741 | 2.5167 | 8 | 78 | cell fate specification |
| GO:0060795 | 0.0038 | 5.4075 | 1.0648 | 5 | 33 | cell fate commitment involved in formation of primary germ layer |
| GO:0046676 | 0.0044 | 5.2206 | 1.097 | 5 | 34 | negative regulation of insulin secretion |
| GO:0021783 | 0.0045 | 11.3199 | 0.3549 | 3 | 11 | preganglionic parasympathetic fiber development |
| GO:0045069 | 0.0048 | 3.6635 | 2.0972 | 7 | 65 | regulation of viral genome replication |
| GO:0070536 | 0.0049 | 6.7187 | 0.7098 | 4 | 22 | protein K63-linked deubiquitination |
| GO:1901184 | 0.0056 | 3.1983 | 2.7103 | 8 | 84 | regulation of ERBB signaling pathway |
| GO:0048532 | 0.0059 | 10.0613 | 0.3872 | 3 | 12 | anatomical structure arrangement |
| GO:0021612 | 0.006 | 30.1294 | 0.1291 | 2 | 4 | facial nerve structural organization |
| GO:0021648 | 0.006 | 30.1294 | 0.1291 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0072289 | 0.006 | 30.1294 | 0.1291 | 2 | 4 | metanephric nephron tubule formation |
| GO:0042446 | 0.0063 | 3.9536 | 1.6778 | 6 | 52 | hormone biosynthetic process |
| GO:0009914 | 0.007 | 2.1009 | 8.0341 | 16 | 249 | hormone transport |
| GO:0018958 | 0.0072 | 3.3714 | 2.2586 | 7 | 70 | phenol-containing compound metabolic process |
| GO:0042221 | 0.0075 | 1.3169 | 101.0874 | 123 | 3133 | response to chemical |
| GO:0051607 | 0.0076 | 2.3758 | 5.3561 | 12 | 166 | defense response to virus |
| GO:0014032 | 0.0076 | 3.7883 | 1.7423 | 6 | 54 | neural crest cell development |
| GO:0009611 | 0.0079 | 1.726 | 16.4231 | 27 | 509 | response to wounding |
| GO:0001702 | 0.0079 | 5.7575 | 0.8066 | 4 | 25 | gastrulation with mouth forming second |
| GO:0002376 | 0.0081 | 1.3693 | 65.4019 | 84 | 2027 | immune system process |
| GO:0051716 | 0.0082 | 1.2739 | 174.4266 | 199 | 5406 | cellular response to stimulus |
| GO:0002792 | 0.0085 | 2.9629 | 2.9039 | 8 | 90 | negative regulation of peptide secretion |
| GO:0002578 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | negative regulation of antigen processing and presentation |
| GO:0019227 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | neuronal action potential propagation |
| GO:0021979 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | hypothalamus cell differentiation |
| GO:0030263 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | apoptotic chromosome condensation |
| GO:0030309 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | poly-N-acetyllactosamine metabolic process |
| GO:0048843 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | negative regulation of axon extension involved in axon guidance |
| GO:0072161 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | mesenchymal cell differentiation involved in kidney development |
| GO:2000609 | 0.0097 | 20.0847 | 0.1613 | 2 | 5 | regulation of thyroid hormone generation |
| GO:1903901 | 0.0099 | 3.5646 | 1.8391 | 6 | 57 | negative regulation of viral life cycle |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045851 | 0 | 6.7999 | 1.6513 | 9 | 41 | pH reduction |
| GO:0090383 | 2e-04 | 9.0263 | 0.8861 | 6 | 22 | phagosome acidification |
| GO:0032259 | 2e-04 | 2.2916 | 12.2436 | 26 | 304 | methylation |
| GO:0031062 | 9e-04 | 6.2757 | 1.168 | 6 | 29 | positive regulation of histone methylation |
| GO:0033572 | 0.0011 | 6.0138 | 1.2083 | 6 | 30 | transferrin transport |
| GO:0002091 | 0.0012 | 23.9585 | 0.2417 | 3 | 6 | negative regulation of receptor internalization |
| GO:0015991 | 0.0012 | 7.5077 | 0.8458 | 5 | 21 | ATP hydrolysis coupled proton transport |
| GO:0051569 | 0.0012 | 7.5077 | 0.8458 | 5 | 21 | regulation of histone H3-K4 methylation |
| GO:0006826 | 0.0015 | 4.6818 | 1.7318 | 7 | 43 | iron ion transport |
| GO:0072512 | 0.0015 | 5.5503 | 1.2888 | 6 | 32 | trivalent inorganic cation transport |
| GO:0014063 | 0.0016 | Inf | 0.0806 | 2 | 2 | negative regulation of serotonin secretion |
| GO:0048372 | 0.0016 | Inf | 0.0806 | 2 | 2 | lateral mesodermal cell fate commitment |
| GO:0048378 | 0.0016 | Inf | 0.0806 | 2 | 2 | regulation of lateral mesodermal cell fate specification |
| GO:0075732 | 0.0016 | Inf | 0.0806 | 2 | 2 | viral penetration into host nucleus |
| GO:0051453 | 0.0019 | 3.559 | 2.8193 | 9 | 70 | regulation of intracellular pH |
| GO:0032057 | 0.002 | 17.9675 | 0.2819 | 3 | 7 | negative regulation of translational initiation in response to stress |
| GO:0048304 | 0.002 | 17.9675 | 0.2819 | 3 | 7 | positive regulation of isotype switching to IgG isotypes |
| GO:0050766 | 0.0029 | 4.8087 | 1.4499 | 6 | 36 | positive regulation of phagocytosis |
| GO:1901576 | 0.0031 | 1.2804 | 215.9951 | 247 | 5363 | organic substance biosynthetic process |
| GO:0051052 | 0.004 | 1.9036 | 13.331 | 24 | 331 | regulation of DNA metabolic process |
| GO:0001708 | 0.004 | 3.1444 | 3.1415 | 9 | 78 | cell fate specification |
| GO:0060896 | 0.0045 | 11.9764 | 0.3625 | 3 | 9 | neural plate pattern specification |
| GO:1905049 | 0.0045 | 11.9764 | 0.3625 | 3 | 9 | negative regulation of metallopeptidase activity |
| GO:0061754 | 0.0047 | 47.8343 | 0.1208 | 2 | 3 | negative regulation of circulating fibrinogen levels |
| GO:0090116 | 0.0047 | 47.8343 | 0.1208 | 2 | 3 | C-5 methylation of cytosine |
| GO:1902583 | 0.0047 | 47.8343 | 0.1208 | 2 | 3 | multi-organism intracellular transport |
| GO:1905563 | 0.0047 | 47.8343 | 0.1208 | 2 | 3 | negative regulation of vascular endothelial cell proliferation |
| GO:1905832 | 0.0047 | 47.8343 | 0.1208 | 2 | 3 | positive regulation of spindle assembly |
| GO:0046794 | 0.0057 | 3.583 | 2.1749 | 7 | 54 | transport of virus |
| GO:1902652 | 0.0058 | 2.6029 | 4.5511 | 11 | 113 | secondary alcohol metabolic process |
| GO:0009083 | 0.0062 | 6.395 | 0.7652 | 4 | 19 | branched-chain amino acid catabolic process |
| GO:0034063 | 0.0063 | 10.2647 | 0.4028 | 3 | 10 | stress granule assembly |
| GO:0051972 | 0.0063 | 4.0054 | 1.6916 | 6 | 42 | regulation of telomerase activity |
| GO:0006888 | 0.0065 | 2.2571 | 6.6051 | 14 | 164 | ER to Golgi vesicle-mediated transport |
| GO:0030004 | 0.0066 | 2.8915 | 3.3831 | 9 | 84 | cellular monovalent inorganic cation homeostasis |
| GO:0072594 | 0.007 | 1.6235 | 22.6346 | 35 | 562 | establishment of protein localization to organelle |
| GO:0030857 | 0.0074 | 4.6165 | 1.2485 | 5 | 31 | negative regulation of epithelial cell differentiation |
| GO:0010226 | 0.0075 | 5.9948 | 0.8055 | 4 | 20 | response to lithium ion |
| GO:0043555 | 0.0075 | 5.9948 | 0.8055 | 4 | 20 | regulation of translation in response to stress |
| GO:0006139 | 0.0082 | 1.246 | 199.0796 | 226 | 4943 | nucleobase-containing compound metabolic process |
| GO:0001510 | 0.0084 | 3.3009 | 2.336 | 7 | 58 | RNA methylation |
| GO:0021521 | 0.0084 | 8.9809 | 0.443 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0044260 | 0.0088 | 1.2415 | 286.7986 | 314 | 7121 | cellular macromolecule metabolic process |
| GO:0006403 | 0.0088 | 2.0488 | 8.2564 | 16 | 205 | RNA localization |
| GO:0050658 | 0.0088 | 2.1692 | 6.8468 | 14 | 170 | RNA transport |
| GO:0045911 | 0.009 | 5.6417 | 0.8458 | 4 | 21 | positive regulation of DNA recombination |
| GO:0060037 | 0.009 | 5.6417 | 0.8458 | 4 | 21 | pharyngeal system development |
| GO:0032439 | 0.0092 | 23.9153 | 0.1611 | 2 | 4 | endosome localization |
| GO:0045415 | 0.0092 | 23.9153 | 0.1611 | 2 | 4 | negative regulation of interleukin-8 biosynthetic process |
| GO:0048370 | 0.0092 | 23.9153 | 0.1611 | 2 | 4 | lateral mesoderm formation |
| GO:0070350 | 0.0092 | 23.9153 | 0.1611 | 2 | 4 | regulation of white fat cell proliferation |
| GO:1904742 | 0.0092 | 23.9153 | 0.1611 | 2 | 4 | regulation of telomeric DNA binding |
| GO:0060795 | 0.0097 | 4.2861 | 1.3291 | 5 | 33 | cell fate commitment involved in formation of primary germ layer |
| GO:0044271 | 0.0099 | 1.2453 | 172.6189 | 198 | 4286 | cellular nitrogen compound biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031338 | 0 | 12.2449 | 1.1197 | 11 | 62 | regulation of vesicle fusion |
| GO:0090174 | 0 | 6.8394 | 2.5464 | 15 | 141 | organelle membrane fusion |
| GO:0090630 | 0 | 8.9082 | 1.4628 | 11 | 81 | activation of GTPase activity |
| GO:0009946 | 0 | Inf | 0.0542 | 3 | 3 | proximal/distal axis specification |
| GO:0016050 | 0 | 3.2365 | 6.0861 | 18 | 337 | vesicle organization |
| GO:0050906 | 2e-04 | 5.0459 | 1.9685 | 9 | 109 | detection of stimulus involved in sensory perception |
| GO:0097205 | 2e-04 | 18.4156 | 0.289 | 4 | 16 | renal filtration |
| GO:2000510 | 2e-04 | 41.285 | 0.1264 | 3 | 7 | positive regulation of dendritic cell chemotaxis |
| GO:0048771 | 3e-04 | 4.6692 | 2.113 | 9 | 117 | tissue remodeling |
| GO:0035759 | 3e-04 | Inf | 0.0361 | 2 | 2 | mesangial cell-matrix adhesion |
| GO:0030194 | 4e-04 | 13.8074 | 0.3612 | 4 | 20 | positive regulation of blood coagulation |
| GO:0043087 | 5e-04 | 2.6724 | 6.8446 | 17 | 379 | regulation of GTPase activity |
| GO:0001977 | 9e-04 | 20.6361 | 0.1987 | 3 | 11 | renal system process involved in regulation of blood volume |
| GO:0051345 | 9e-04 | 2.247 | 10.5287 | 22 | 583 | positive regulation of hydrolase activity |
| GO:0002687 | 9e-04 | 4.933 | 1.5531 | 7 | 86 | positive regulation of leukocyte migration |
| GO:0032101 | 0.001 | 2.3306 | 9.2104 | 20 | 510 | regulation of response to external stimulus |
| GO:1900133 | 0.001 | 109.654 | 0.0542 | 2 | 3 | regulation of renin secretion into blood stream |
| GO:0071674 | 0.001 | 7.2858 | 0.7766 | 5 | 43 | mononuclear cell migration |
| GO:0050877 | 0.0011 | 2.0955 | 12.8481 | 25 | 717 | nervous system process |
| GO:2000649 | 0.0011 | 7.0984 | 0.7946 | 5 | 44 | regulation of sodium ion transmembrane transporter activity |
| GO:0097529 | 0.0013 | 4.0942 | 2.113 | 8 | 117 | myeloid leukocyte migration |
| GO:0003081 | 0.0018 | 15.0046 | 0.2528 | 3 | 14 | regulation of systemic arterial blood pressure by renin-angiotensin |
| GO:0006954 | 0.0019 | 2.297 | 8.3616 | 18 | 463 | inflammatory response |
| GO:0001999 | 0.0019 | 54.8228 | 0.0722 | 2 | 4 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure |
| GO:0030070 | 0.0019 | 54.8228 | 0.0722 | 2 | 4 | insulin processing |
| GO:0097755 | 0.002 | 6.1491 | 0.903 | 5 | 50 | positive regulation of blood vessel diameter |
| GO:0071622 | 0.0022 | 8.1753 | 0.5598 | 4 | 31 | regulation of granulocyte chemotaxis |
| GO:0002028 | 0.0023 | 4.824 | 1.3545 | 6 | 75 | regulation of sodium ion transport |
| GO:0050921 | 0.0024 | 4.8093 | 1.3577 | 6 | 76 | positive regulation of chemotaxis |
| GO:0032496 | 0.0024 | 2.9091 | 4.0273 | 11 | 223 | response to lipopolysaccharide |
| GO:0019233 | 0.0027 | 4.6874 | 1.3906 | 6 | 77 | sensory perception of pain |
| GO:0006813 | 0.0027 | 3.0572 | 3.4855 | 10 | 193 | potassium ion transport |
| GO:0030595 | 0.0027 | 3.5947 | 2.3839 | 8 | 132 | leukocyte chemotaxis |
| GO:0002089 | 0.0027 | 12.6943 | 0.289 | 3 | 16 | lens morphogenesis in camera-type eye |
| GO:0007193 | 0.0028 | 5.6454 | 0.9752 | 5 | 54 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0070374 | 0.003 | 3.5371 | 2.42 | 8 | 134 | positive regulation of ERK1 and ERK2 cascade |
| GO:0003105 | 0.0031 | 36.5457 | 0.0903 | 2 | 5 | negative regulation of glomerular filtration |
| GO:2000348 | 0.0031 | 36.5457 | 0.0903 | 2 | 5 | regulation of CD40 signaling pathway |
| GO:0014706 | 0.0033 | 2.538 | 5.4359 | 13 | 301 | striated muscle tissue development |
| GO:0009888 | 0.0035 | 1.6603 | 26.7642 | 41 | 1482 | tissue development |
| GO:0035296 | 0.0036 | 3.8139 | 1.9685 | 7 | 109 | regulation of tube diameter |
| GO:0033555 | 0.0039 | 5.2177 | 1.0475 | 5 | 58 | multicellular organismal response to stress |
| GO:1905521 | 0.0039 | 11 | 0.3251 | 3 | 18 | regulation of macrophage migration |
| GO:0045776 | 0.0043 | 6.6858 | 0.6682 | 4 | 37 | negative regulation of blood pressure |
| GO:0035725 | 0.0044 | 3.6688 | 2.0407 | 7 | 113 | sodium ion transmembrane transport |
| GO:0050880 | 0.0044 | 3.6688 | 2.0407 | 7 | 113 | regulation of blood vessel size |
| GO:0036336 | 0.0046 | 10.3117 | 0.3431 | 3 | 19 | dendritic cell migration |
| GO:0050951 | 0.0046 | 10.3117 | 0.3431 | 3 | 19 | sensory perception of temperature stimulus |
| GO:0051482 | 0.0046 | 10.3117 | 0.3431 | 3 | 19 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
| GO:0090023 | 0.0046 | 10.3117 | 0.3431 | 3 | 19 | positive regulation of neutrophil chemotaxis |
| GO:0060677 | 0.0046 | 27.4072 | 0.1084 | 2 | 6 | ureteric bud elongation |
| GO:1900046 | 0.0048 | 4.937 | 1.1016 | 5 | 61 | regulation of hemostasis |
| GO:0090596 | 0.0052 | 2.7656 | 3.8286 | 10 | 212 | sensory organ morphogenesis |
| GO:0009581 | 0.0054 | 4.006 | 1.6073 | 6 | 89 | detection of external stimulus |
| GO:0071157 | 0.0061 | 9.1645 | 0.3793 | 3 | 21 | negative regulation of cell cycle arrest |
| GO:0009582 | 0.0064 | 3.8654 | 1.6615 | 6 | 92 | detection of abiotic stimulus |
| GO:0061635 | 0.0064 | 21.9241 | 0.1264 | 2 | 7 | regulation of protein complex stability |
| GO:1902931 | 0.0064 | 21.9241 | 0.1264 | 2 | 7 | negative regulation of alcohol biosynthetic process |
| GO:1904684 | 0.0064 | 21.9241 | 0.1264 | 2 | 7 | negative regulation of metalloendopeptidase activity |
| GO:0050818 | 0.0067 | 4.5306 | 1.1919 | 5 | 66 | regulation of coagulation |
| GO:1902622 | 0.007 | 8.6815 | 0.3973 | 3 | 22 | regulation of neutrophil migration |
| GO:0006874 | 0.0072 | 2.3832 | 5.3095 | 12 | 294 | cellular calcium ion homeostasis |
| GO:0051049 | 0.0074 | 1.5881 | 27.0893 | 40 | 1500 | regulation of transport |
| GO:0050927 | 0.0079 | 8.2468 | 0.4154 | 3 | 23 | positive regulation of positive chemotaxis |
| GO:0097756 | 0.0081 | 4.3172 | 1.2461 | 5 | 69 | negative regulation of blood vessel diameter |
| GO:0009593 | 0.0082 | 3.6516 | 1.7518 | 6 | 97 | detection of chemical stimulus |
| GO:2000021 | 0.0083 | 2.9458 | 2.8715 | 8 | 159 | regulation of ion homeostasis |
| GO:0036376 | 0.0085 | 18.2686 | 0.1445 | 2 | 8 | sodium ion export across plasma membrane |
| GO:0045779 | 0.0085 | 18.2686 | 0.1445 | 2 | 8 | negative regulation of bone resorption |
| GO:0050910 | 0.0085 | 18.2686 | 0.1445 | 2 | 8 | detection of mechanical stimulus involved in sensory perception of sound |
| GO:0007187 | 0.0093 | 3.1576 | 2.3477 | 7 | 130 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0009617 | 0.0094 | 2.2145 | 6.1764 | 13 | 342 | response to bacterium |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009653 | 0 | 1.5868 | 91.0609 | 130 | 2060 | anatomical structure morphogenesis |
| GO:0010469 | 2e-04 | 2.1144 | 16.8321 | 33 | 382 | regulation of receptor activity |
| GO:0006334 | 2e-04 | 3.2371 | 5.1719 | 15 | 117 | nucleosome assembly |
| GO:0042330 | 3e-04 | 1.9977 | 19.3615 | 36 | 438 | taxis |
| GO:0050921 | 0.0011 | 3.1064 | 4.2738 | 12 | 97 | positive regulation of chemotaxis |
| GO:0006342 | 0.0011 | 3.0955 | 4.2878 | 12 | 97 | chromatin silencing |
| GO:0006333 | 0.0014 | 2.5308 | 6.8517 | 16 | 155 | chromatin assembly or disassembly |
| GO:0014910 | 0.0014 | 4.1618 | 2.2102 | 8 | 50 | regulation of smooth muscle cell migration |
| GO:0048869 | 0.0015 | 1.3267 | 146.4931 | 178 | 3314 | cellular developmental process |
| GO:0032534 | 0.0016 | 21.7285 | 0.2652 | 3 | 6 | regulation of microvillus assembly |
| GO:0021941 | 0.002 | Inf | 0.0884 | 2 | 2 | negative regulation of cerebellar granule cell precursor proliferation |
| GO:0071673 | 0.002 | Inf | 0.0884 | 2 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:0006590 | 0.002 | 9.6692 | 0.5747 | 4 | 13 | thyroid hormone generation |
| GO:0014812 | 0.0026 | 3.392 | 2.9617 | 9 | 67 | muscle cell migration |
| GO:0048842 | 0.0026 | 16.2951 | 0.3094 | 3 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0050900 | 0.0027 | 1.9689 | 12.9519 | 24 | 293 | leukocyte migration |
| GO:1901998 | 0.0029 | 4.8444 | 1.4587 | 6 | 33 | toxin transport |
| GO:0035296 | 0.0031 | 2.71 | 4.8183 | 12 | 109 | regulation of tube diameter |
| GO:0042127 | 0.0032 | 1.4431 | 55.7859 | 76 | 1262 | regulation of cell proliferation |
| GO:0097756 | 0.0032 | 3.2784 | 3.0501 | 9 | 69 | negative regulation of blood vessel diameter |
| GO:0001655 | 0.0033 | 2.0034 | 11.6699 | 22 | 264 | urogenital system development |
| GO:0001759 | 0.0035 | 7.9099 | 0.6631 | 4 | 15 | organ induction |
| GO:0007218 | 0.0039 | 3.1721 | 3.1385 | 9 | 71 | neuropeptide signaling pathway |
| GO:0010940 | 0.0041 | 13.0351 | 0.3536 | 3 | 8 | positive regulation of necrotic cell death |
| GO:1905205 | 0.0041 | 13.0351 | 0.3536 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0001822 | 0.0041 | 2.0789 | 9.725 | 19 | 220 | kidney development |
| GO:0050880 | 0.0042 | 2.6018 | 4.9951 | 12 | 113 | regulation of blood vessel size |
| GO:0008038 | 0.0042 | 5.4435 | 1.1051 | 5 | 25 | neuron recognition |
| GO:0006323 | 0.0045 | 2.223 | 7.6916 | 16 | 174 | DNA packaging |
| GO:0046135 | 0.0045 | 7.2501 | 0.7073 | 4 | 16 | pyrimidine nucleoside catabolic process |
| GO:1902284 | 0.0045 | 7.2501 | 0.7073 | 4 | 16 | neuron projection extension involved in neuron projection guidance |
| GO:1902667 | 0.0045 | 7.2501 | 0.7073 | 4 | 16 | regulation of axon guidance |
| GO:0030216 | 0.0049 | 2.2693 | 7.0727 | 15 | 160 | keratinocyte differentiation |
| GO:0045596 | 0.0055 | 1.6411 | 23.0747 | 36 | 522 | negative regulation of cell differentiation |
| GO:0060300 | 0.0057 | 43.3894 | 0.1326 | 2 | 3 | regulation of cytokine activity |
| GO:0070634 | 0.0057 | 43.3894 | 0.1326 | 2 | 3 | transepithelial ammonium transport |
| GO:1903660 | 0.0057 | 43.3894 | 0.1326 | 2 | 3 | negative regulation of complement-dependent cytotoxicity |
| GO:1904862 | 0.0057 | 43.3894 | 0.1326 | 2 | 3 | inhibitory synapse assembly |
| GO:0060326 | 0.0059 | 2.154 | 7.9126 | 16 | 179 | cell chemotaxis |
| GO:0010839 | 0.0059 | 10.8617 | 0.3978 | 3 | 9 | negative regulation of keratinocyte proliferation |
| GO:0016264 | 0.0059 | 10.8617 | 0.3978 | 3 | 9 | gap junction assembly |
| GO:1903244 | 0.0059 | 10.8617 | 0.3978 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0071320 | 0.006 | 4.0858 | 1.6798 | 6 | 38 | cellular response to cAMP |
| GO:0001525 | 0.006 | 1.7678 | 16.0904 | 27 | 364 | angiogenesis |
| GO:0019229 | 0.0061 | 3.5504 | 2.2102 | 7 | 50 | regulation of vasoconstriction |
| GO:0007626 | 0.0064 | 2.1928 | 7.2937 | 15 | 165 | locomotory behavior |
| GO:0051272 | 0.0065 | 1.7571 | 16.1788 | 27 | 366 | positive regulation of cellular component movement |
| GO:0007611 | 0.0065 | 2.0733 | 8.7083 | 17 | 197 | learning or memory |
| GO:0032835 | 0.0068 | 3.4694 | 2.2544 | 7 | 51 | glomerulus development |
| GO:0055008 | 0.0068 | 3.4694 | 2.2544 | 7 | 51 | cardiac muscle tissue morphogenesis |
| GO:2000178 | 0.007 | 6.2349 | 0.7931 | 4 | 18 | negative regulation of neural precursor cell proliferation |
| GO:0016486 | 0.007 | 6.2134 | 0.7957 | 4 | 18 | peptide hormone processing |
| GO:0072015 | 0.0082 | 9.3093 | 0.442 | 3 | 10 | glomerular visceral epithelial cell development |
| GO:0008544 | 0.0083 | 1.8332 | 12.6424 | 22 | 286 | epidermis development |
| GO:0032196 | 0.0086 | 5.7987 | 0.8399 | 4 | 19 | transposition |
| GO:0051482 | 0.0086 | 5.7987 | 0.8399 | 4 | 19 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
| GO:0051241 | 0.0092 | 1.4606 | 37.3084 | 52 | 844 | negative regulation of multicellular organismal process |
| GO:0030855 | 0.0093 | 1.5892 | 23.0747 | 35 | 522 | epithelial cell differentiation |
| GO:0007193 | 0.0093 | 3.2472 | 2.387 | 7 | 54 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0042445 | 0.0096 | 2.419 | 4.8798 | 11 | 111 | hormone metabolic process |
| GO:0033993 | 0.0098 | 1.5038 | 30.6336 | 44 | 693 | response to lipid |
| GO:2000026 | 0.0099 | 1.3426 | 67.4116 | 86 | 1525 | regulation of multicellular organismal development |
| GO:0048644 | 0.0099 | 2.9091 | 3.0059 | 8 | 68 | muscle organ morphogenesis |
| GO:0007200 | 0.01 | 3.1977 | 2.4181 | 7 | 55 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061551 | 0 | Inf | 0.0746 | 3 | 3 | trigeminal ganglion development |
| GO:0072095 | 0 | Inf | 0.0746 | 3 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:0060677 | 3e-04 | 39.5767 | 0.1492 | 3 | 6 | ureteric bud elongation |
| GO:0071469 | 6e-04 | Inf | 0.0497 | 2 | 2 | cellular response to alkaline pH |
| GO:0050482 | 9e-04 | 11.3327 | 0.4475 | 4 | 18 | arachidonic acid secretion |
| GO:0015909 | 0.001 | 5.8283 | 1.1684 | 6 | 47 | long-chain fatty acid transport |
| GO:0019371 | 0.0011 | 19.7837 | 0.2237 | 3 | 9 | cyclooxygenase pathway |
| GO:0072172 | 0.0011 | 19.7837 | 0.2237 | 3 | 9 | mesonephric tubule formation |
| GO:0030198 | 0.0014 | 2.5981 | 6.1653 | 15 | 248 | extracellular matrix organization |
| GO:0008582 | 0.0018 | 78.9235 | 0.0746 | 2 | 3 | regulation of synaptic growth at neuromuscular junction |
| GO:2001205 | 0.0018 | 78.9235 | 0.0746 | 2 | 3 | negative regulation of osteoclast development |
| GO:0048484 | 0.0022 | 14.8355 | 0.2735 | 3 | 11 | enteric nervous system development |
| GO:0021692 | 0.0028 | 13.1861 | 0.2983 | 3 | 12 | cerebellar Purkinje cell layer morphogenesis |
| GO:0036066 | 0.0028 | 13.1861 | 0.2983 | 3 | 12 | protein O-linked fucosylation |
| GO:0061548 | 0.0028 | 13.1861 | 0.2983 | 3 | 12 | ganglion development |
| GO:0007416 | 0.003 | 3.2417 | 2.9832 | 9 | 120 | synapse assembly |
| GO:0008038 | 0.0031 | 7.5511 | 0.6215 | 4 | 25 | neuron recognition |
| GO:0031589 | 0.0033 | 2.4385 | 6.0908 | 14 | 245 | cell-substrate adhesion |
| GO:0030910 | 0.0036 | 39.4587 | 0.0994 | 2 | 4 | olfactory placode formation |
| GO:0061055 | 0.0036 | 39.4587 | 0.0994 | 2 | 4 | myotome development |
| GO:0061197 | 0.0036 | 39.4587 | 0.0994 | 2 | 4 | fungiform papilla morphogenesis |
| GO:0071698 | 0.0036 | 39.4587 | 0.0994 | 2 | 4 | olfactory placode development |
| GO:0072107 | 0.0036 | 39.4587 | 0.0994 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:0098706 | 0.0036 | 39.4587 | 0.0994 | 2 | 4 | ferric iron import across plasma membrane |
| GO:0006693 | 0.0048 | 6.6056 | 0.6961 | 4 | 28 | prostaglandin metabolic process |
| GO:0006925 | 0.0055 | 9.8873 | 0.3729 | 3 | 15 | inflammatory cell apoptotic process |
| GO:0060602 | 0.0055 | 9.8873 | 0.3729 | 3 | 15 | branch elongation of an epithelium |
| GO:0070633 | 0.0055 | 9.8873 | 0.3729 | 3 | 15 | transepithelial transport |
| GO:0015677 | 0.0059 | 26.3038 | 0.1243 | 2 | 5 | copper ion import |
| GO:0034112 | 0.0059 | 26.3038 | 0.1243 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0048843 | 0.0059 | 26.3038 | 0.1243 | 2 | 5 | negative regulation of axon extension involved in axon guidance |
| GO:0060839 | 0.0059 | 26.3038 | 0.1243 | 2 | 5 | endothelial cell fate commitment |
| GO:0061218 | 0.0059 | 26.3038 | 0.1243 | 2 | 5 | negative regulation of mesonephros development |
| GO:0090500 | 0.0059 | 26.3038 | 0.1243 | 2 | 5 | endocardial cushion to mesenchymal transition |
| GO:0071715 | 0.0062 | 6.0966 | 0.7458 | 4 | 30 | icosanoid transport |
| GO:0014812 | 0.0063 | 3.9113 | 1.6656 | 6 | 67 | muscle cell migration |
| GO:0048762 | 0.0064 | 2.6837 | 3.9528 | 10 | 159 | mesenchymal cell differentiation |
| GO:0022610 | 0.0067 | 1.5941 | 25.9292 | 39 | 1043 | biological adhesion |
| GO:0090190 | 0.0067 | 9.126 | 0.3978 | 3 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0098742 | 0.0069 | 2.5163 | 4.624 | 11 | 186 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0009887 | 0.0072 | 1.6635 | 20.3108 | 32 | 817 | animal organ morphogenesis |
| GO:0001838 | 0.0075 | 3.0092 | 2.8341 | 8 | 114 | embryonic epithelial tube formation |
| GO:0001755 | 0.0078 | 5.6602 | 0.7955 | 4 | 32 | neural crest cell migration |
| GO:0045662 | 0.008 | 8.4735 | 0.4226 | 3 | 17 | negative regulation of myoblast differentiation |
| GO:0021610 | 0.0087 | 19.7263 | 0.1492 | 2 | 6 | facial nerve morphogenesis |
| GO:0033034 | 0.0087 | 19.7263 | 0.1492 | 2 | 6 | positive regulation of myeloid cell apoptotic process |
| GO:0042538 | 0.0087 | 19.7263 | 0.1492 | 2 | 6 | hyperosmotic salinity response |
| GO:1903224 | 0.0087 | 19.7263 | 0.1492 | 2 | 6 | regulation of endodermal cell differentiation |
| GO:0090184 | 0.0087 | 5.4646 | 0.8204 | 4 | 33 | positive regulation of kidney development |
| GO:0048771 | 0.0088 | 2.9257 | 2.9086 | 8 | 117 | tissue remodeling |
| GO:0018149 | 0.0094 | 7.908 | 0.4475 | 3 | 18 | peptide cross-linking |
| GO:1905276 | 0.0094 | 7.908 | 0.4475 | 3 | 18 | regulation of epithelial tube formation |
| GO:0007338 | 0.0099 | 3.1304 | 2.3866 | 7 | 96 | single fertilization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051030 | 0.002 | 75.1487 | 0.0782 | 2 | 3 | snRNA transport |
| GO:0006572 | 0.0039 | 37.5714 | 0.1043 | 2 | 4 | tyrosine catabolic process |
| GO:0061056 | 0.0039 | 37.5714 | 0.1043 | 2 | 4 | sclerotome development |
| GO:2001286 | 0.0039 | 37.5714 | 0.1043 | 2 | 4 | regulation of caveolin-mediated endocytosis |
| GO:0070977 | 0.0052 | 10.2695 | 0.365 | 3 | 14 | bone maturation |
| GO:0042787 | 0.0056 | 2.4746 | 5.1356 | 12 | 197 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0009410 | 0.0079 | 3.722 | 1.7466 | 6 | 67 | response to xenobiotic stimulus |
| GO:0014823 | 0.008 | 4.3933 | 1.2513 | 5 | 48 | response to activity |
| GO:0009072 | 0.0091 | 8.067 | 0.4432 | 3 | 17 | aromatic amino acid family metabolic process |
| GO:0046475 | 0.0091 | 8.067 | 0.4432 | 3 | 17 | glycerophospholipid catabolic process |
| GO:0030835 | 0.0092 | 5.3879 | 0.8342 | 4 | 32 | negative regulation of actin filament depolymerization |
| GO:0006189 | 0.0095 | 18.7828 | 0.1564 | 2 | 6 | 'de novo' IMP biosynthetic process |
| GO:0023041 | 0.0095 | 18.7828 | 0.1564 | 2 | 6 | neuronal signal transduction |
| GO:0035630 | 0.0095 | 18.7828 | 0.1564 | 2 | 6 | bone mineralization involved in bone maturation |
| GO:0030239 | 0.0095 | 4.1974 | 1.3035 | 5 | 50 | myofibril assembly |
| GO:0006954 | 0.01 | 1.8252 | 12.07 | 21 | 463 | inflammatory response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051146 | 2e-04 | 3.5672 | 3.9589 | 13 | 222 | striated muscle cell differentiation |
| GO:0048743 | 2e-04 | 41.8262 | 0.1248 | 3 | 7 | positive regulation of skeletal muscle fiber development |
| GO:0009436 | 3e-04 | Inf | 0.0357 | 2 | 2 | glyoxylate catabolic process |
| GO:2000502 | 3e-04 | Inf | 0.0357 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0010830 | 3e-04 | 7.1883 | 0.9451 | 6 | 53 | regulation of myotube differentiation |
| GO:0055001 | 7e-04 | 4.0181 | 2.4253 | 9 | 136 | muscle cell development |
| GO:0070859 | 9e-04 | 111.0855 | 0.0535 | 2 | 3 | positive regulation of bile acid biosynthetic process |
| GO:0048747 | 0.0011 | 7.1923 | 0.7846 | 5 | 44 | muscle fiber development |
| GO:0014904 | 0.0016 | 8.9469 | 0.5172 | 4 | 29 | myotube cell development |
| GO:0002155 | 0.0019 | 55.5385 | 0.0713 | 2 | 4 | regulation of thyroid hormone mediated signaling pathway |
| GO:0006572 | 0.0019 | 55.5385 | 0.0713 | 2 | 4 | tyrosine catabolic process |
| GO:0070911 | 0.0019 | 8.6021 | 0.535 | 4 | 30 | global genome nucleotide-excision repair |
| GO:0001832 | 0.0022 | 13.9335 | 0.2675 | 3 | 15 | blastocyst growth |
| GO:2000379 | 0.0023 | 4.8179 | 1.3553 | 6 | 76 | positive regulation of reactive oxygen species metabolic process |
| GO:0045429 | 0.003 | 7.4529 | 0.6063 | 4 | 34 | positive regulation of nitric oxide biosynthetic process |
| GO:0006545 | 0.0031 | 37.0228 | 0.0892 | 2 | 5 | glycine biosynthetic process |
| GO:0001756 | 0.0037 | 5.2867 | 1.0343 | 5 | 58 | somitogenesis |
| GO:0008206 | 0.0041 | 6.7738 | 0.6598 | 4 | 37 | bile acid metabolic process |
| GO:2000402 | 0.0045 | 27.765 | 0.107 | 2 | 6 | negative regulation of lymphocyte migration |
| GO:0006081 | 0.0049 | 4.9142 | 1.1056 | 5 | 62 | cellular aldehyde metabolic process |
| GO:0060415 | 0.0052 | 4.8291 | 1.1235 | 5 | 63 | muscle tissue morphogenesis |
| GO:0001955 | 0.0063 | 22.2103 | 0.1248 | 2 | 7 | blood vessel maturation |
| GO:1904684 | 0.0063 | 22.2103 | 0.1248 | 2 | 7 | negative regulation of metalloendopeptidase activity |
| GO:1903426 | 0.0072 | 4.4441 | 1.2126 | 5 | 68 | regulation of reactive oxygen species biosynthetic process |
| GO:1903025 | 0.0083 | 18.5071 | 0.1427 | 2 | 8 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0032781 | 0.0083 | 5.4487 | 0.8025 | 4 | 45 | positive regulation of ATPase activity |
| GO:0007519 | 0.0098 | 3.1228 | 2.3718 | 7 | 133 | skeletal muscle tissue development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010529 | 0 | 17.9648 | 0.5429 | 6 | 15 | negative regulation of transposition |
| GO:0051270 | 0 | 2.0595 | 24.8657 | 47 | 687 | regulation of cellular component movement |
| GO:0009972 | 2e-04 | 80.3824 | 0.1448 | 3 | 4 | cytidine deamination |
| GO:0042126 | 2e-04 | 80.3824 | 0.1448 | 3 | 4 | nitrate metabolic process |
| GO:0046087 | 2e-04 | 80.3824 | 0.1448 | 3 | 4 | cytidine metabolic process |
| GO:0070383 | 2e-04 | 80.3824 | 0.1448 | 3 | 4 | DNA cytosine deamination |
| GO:0016477 | 2e-04 | 1.7149 | 37.751 | 60 | 1043 | cell migration |
| GO:0006334 | 3e-04 | 3.3935 | 4.2348 | 13 | 117 | nucleosome assembly |
| GO:0051674 | 4e-04 | 1.6487 | 41.8048 | 64 | 1155 | localization of cell |
| GO:0006699 | 4e-04 | 7.3417 | 1.0135 | 6 | 28 | bile acid biosynthetic process |
| GO:0051823 | 4e-04 | 40.188 | 0.181 | 3 | 5 | regulation of synapse structural plasticity |
| GO:0006333 | 5e-04 | 2.9129 | 5.6102 | 15 | 155 | chromatin assembly or disassembly |
| GO:1901342 | 5e-04 | 2.5286 | 8.1076 | 19 | 224 | regulation of vasculature development |
| GO:0051707 | 6e-04 | 1.8968 | 20.269 | 36 | 560 | response to other organism |
| GO:0050920 | 8e-04 | 3.0396 | 4.6691 | 13 | 129 | regulation of chemotaxis |
| GO:0045869 | 9e-04 | 26.7899 | 0.2172 | 3 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0046133 | 9e-04 | 26.7899 | 0.2172 | 3 | 6 | pyrimidine ribonucleoside catabolic process |
| GO:0018958 | 9e-04 | 3.9849 | 2.5336 | 9 | 70 | phenol-containing compound metabolic process |
| GO:0006590 | 9e-04 | 11.9261 | 0.4705 | 4 | 13 | thyroid hormone generation |
| GO:0071673 | 0.0013 | Inf | 0.0724 | 2 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:2000146 | 0.0013 | 2.4465 | 7.4561 | 17 | 206 | negative regulation of cell motility |
| GO:0032956 | 0.0014 | 2.3002 | 8.8315 | 19 | 244 | regulation of actin cytoskeleton organization |
| GO:0001525 | 0.0017 | 2.0168 | 13.1749 | 25 | 364 | angiogenesis |
| GO:0009607 | 0.0019 | 1.7664 | 21.6082 | 36 | 597 | response to biotic stimulus |
| GO:0032103 | 0.002 | 2.4279 | 7.058 | 16 | 195 | positive regulation of response to external stimulus |
| GO:0014910 | 0.002 | 4.3843 | 1.8097 | 7 | 50 | regulation of smooth muscle cell migration |
| GO:0045069 | 0.0023 | 3.7838 | 2.3527 | 8 | 65 | regulation of viral genome replication |
| GO:0042473 | 0.0023 | 16.0714 | 0.2896 | 3 | 8 | outer ear morphogenesis |
| GO:1902669 | 0.0023 | 16.0714 | 0.2896 | 3 | 8 | positive regulation of axon guidance |
| GO:1905205 | 0.0023 | 16.0714 | 0.2896 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0040012 | 0.0025 | 1.7798 | 19.6285 | 33 | 552 | regulation of locomotion |
| GO:0042445 | 0.0025 | 2.7756 | 4.6691 | 12 | 129 | hormone metabolic process |
| GO:2000181 | 0.0026 | 3.3731 | 2.9318 | 9 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0042330 | 0.0026 | 1.8693 | 15.8533 | 28 | 438 | taxis |
| GO:0002376 | 0.0028 | 1.405 | 73.3666 | 96 | 2027 | immune system process |
| GO:0051607 | 0.0028 | 2.4963 | 6.0083 | 14 | 166 | defense response to virus |
| GO:0002685 | 0.003 | 2.8592 | 4.1624 | 11 | 115 | regulation of leukocyte migration |
| GO:0072529 | 0.003 | 5.8393 | 1.0135 | 5 | 28 | pyrimidine-containing compound catabolic process |
| GO:0097485 | 0.0031 | 2.31 | 7.3837 | 16 | 204 | neuron projection guidance |
| GO:0060900 | 0.0034 | 13.3918 | 0.3258 | 3 | 9 | embryonic camera-type eye formation |
| GO:1903244 | 0.0034 | 13.3918 | 0.3258 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:1903670 | 0.0038 | 4.4817 | 1.5202 | 6 | 42 | regulation of sprouting angiogenesis |
| GO:0033128 | 0.0038 | 53.4759 | 0.1086 | 2 | 3 | negative regulation of histone phosphorylation |
| GO:0042335 | 0.0038 | 53.4759 | 0.1086 | 2 | 3 | cuticle development |
| GO:0048850 | 0.0038 | 53.4759 | 0.1086 | 2 | 3 | hypophysis morphogenesis |
| GO:0051410 | 0.0038 | 53.4759 | 0.1086 | 2 | 3 | detoxification of nitrogen compound |
| GO:0061044 | 0.0038 | 53.4759 | 0.1086 | 2 | 3 | negative regulation of vascular wound healing |
| GO:0039694 | 0.0043 | 7.1523 | 0.6877 | 4 | 19 | viral RNA genome replication |
| GO:0010633 | 0.0043 | 3.7684 | 2.0631 | 7 | 57 | negative regulation of epithelial cell migration |
| GO:1903901 | 0.0043 | 3.7684 | 2.0631 | 7 | 57 | negative regulation of viral life cycle |
| GO:0006323 | 0.0043 | 2.37 | 6.2979 | 14 | 174 | DNA packaging |
| GO:0045815 | 0.0044 | 3.3681 | 2.606 | 8 | 72 | positive regulation of gene expression, epigenetic |
| GO:1902903 | 0.0048 | 2.0893 | 9.1211 | 18 | 252 | regulation of supramolecular fiber organization |
| GO:0050793 | 0.0048 | 1.3812 | 71.1225 | 92 | 1965 | regulation of developmental process |
| GO:2000147 | 0.005 | 1.8932 | 12.8129 | 23 | 354 | positive regulation of cell motility |
| GO:0002230 | 0.0052 | 6.7047 | 0.7239 | 4 | 20 | positive regulation of defense response to virus by host |
| GO:0000183 | 0.0055 | 4.9727 | 1.1582 | 5 | 32 | chromatin silencing at rDNA |
| GO:0060512 | 0.0062 | 6.3098 | 0.7601 | 4 | 21 | prostate gland morphogenesis |
| GO:0038111 | 0.0062 | 4.7947 | 1.1944 | 5 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0062 | 4.7947 | 1.1944 | 5 | 33 | response to interleukin-7 |
| GO:0002739 | 0.0063 | 10.0423 | 0.3981 | 3 | 11 | regulation of cytokine secretion involved in immune response |
| GO:0014744 | 0.0063 | 10.0423 | 0.3981 | 3 | 11 | positive regulation of muscle adaptation |
| GO:0042074 | 0.0063 | 10.0423 | 0.3981 | 3 | 11 | cell migration involved in gastrulation |
| GO:0048841 | 0.0063 | 10.0423 | 0.3981 | 3 | 11 | regulation of axon extension involved in axon guidance |
| GO:0042743 | 0.0071 | 4.629 | 1.2306 | 5 | 34 | hydrogen peroxide metabolic process |
| GO:0120032 | 0.0071 | 2.5171 | 4.6691 | 11 | 129 | regulation of plasma membrane bounded cell projection assembly |
| GO:0035239 | 0.0074 | 1.9134 | 11.0032 | 20 | 304 | tube morphogenesis |
| GO:0010572 | 0.0075 | 26.7358 | 0.1448 | 2 | 4 | positive regulation of platelet activation |
| GO:0030240 | 0.0075 | 26.7358 | 0.1448 | 2 | 4 | skeletal muscle thin filament assembly |
| GO:0035926 | 0.0075 | 26.7358 | 0.1448 | 2 | 4 | chemokine (C-C motif) ligand 2 secretion |
| GO:0060157 | 0.0075 | 26.7358 | 0.1448 | 2 | 4 | urinary bladder development |
| GO:2000275 | 0.0075 | 26.7358 | 0.1448 | 2 | 4 | regulation of oxidative phosphorylation uncoupler activity |
| GO:0060415 | 0.0075 | 3.3631 | 2.2803 | 7 | 63 | muscle tissue morphogenesis |
| GO:0007409 | 0.0078 | 1.8143 | 13.3196 | 23 | 368 | axonogenesis |
| GO:0032530 | 0.0081 | 8.9258 | 0.4343 | 3 | 12 | regulation of microvillus organization |
| GO:0090051 | 0.0081 | 8.9258 | 0.4343 | 3 | 12 | negative regulation of cell migration involved in sprouting angiogenesis |
| GO:0009164 | 0.0087 | 5.6448 | 0.8325 | 4 | 23 | nucleoside catabolic process |
| GO:0000902 | 0.0091 | 1.5353 | 28.0147 | 41 | 774 | cell morphogenesis |
| GO:0032535 | 0.0098 | 1.9294 | 9.8088 | 18 | 271 | regulation of cellular component size |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030238 | 0 | 31.8955 | 0.3075 | 5 | 10 | male sex determination |
| GO:0007155 | 0 | 2.2018 | 22.5104 | 45 | 747 | cell adhesion |
| GO:0061551 | 0 | Inf | 0.0923 | 3 | 3 | trigeminal ganglion development |
| GO:0001655 | 1e-04 | 2.8174 | 8.1191 | 21 | 264 | urogenital system development |
| GO:0021675 | 1e-04 | 5.4502 | 1.9068 | 9 | 62 | nerve development |
| GO:0072079 | 2e-04 | 11.3833 | 0.5843 | 5 | 19 | nephron tubule formation |
| GO:0021602 | 3e-04 | 10.6235 | 0.6151 | 5 | 20 | cranial nerve morphogenesis |
| GO:0007416 | 3e-04 | 3.5778 | 3.6905 | 12 | 120 | synapse assembly |
| GO:0051241 | 4e-04 | 1.8223 | 25.9565 | 44 | 844 | negative regulation of multicellular organismal process |
| GO:0048870 | 4e-04 | 1.7026 | 35.521 | 56 | 1155 | cell motility |
| GO:0048483 | 6e-04 | 6.6031 | 1.0764 | 6 | 35 | autonomic nervous system development |
| GO:0042127 | 7e-04 | 1.6382 | 38.8117 | 59 | 1262 | regulation of cell proliferation |
| GO:0048856 | 9e-04 | 1.4175 | 115.4518 | 144 | 3909 | anatomical structure development |
| GO:0007389 | 9e-04 | 2.1931 | 11.1945 | 23 | 364 | pattern specification process |
| GO:0048535 | 9e-04 | 11.5642 | 0.4613 | 4 | 15 | lymph node development |
| GO:0090240 | 9e-04 | 23.8051 | 0.2153 | 3 | 7 | positive regulation of histone H4 acetylation |
| GO:0051240 | 0.001 | 1.6423 | 35.9761 | 55 | 1179 | positive regulation of multicellular organismal process |
| GO:0014812 | 0.001 | 4.339 | 2.0605 | 8 | 67 | muscle cell migration |
| GO:0014911 | 0.001 | 7.5847 | 0.7996 | 5 | 26 | positive regulation of smooth muscle cell migration |
| GO:0048704 | 0.0012 | 3.7939 | 2.6141 | 9 | 85 | embryonic skeletal system morphogenesis |
| GO:0048538 | 0.0017 | 5.3163 | 1.2917 | 6 | 42 | thymus development |
| GO:1903670 | 0.0017 | 5.3163 | 1.2917 | 6 | 42 | regulation of sprouting angiogenesis |
| GO:0035107 | 0.0017 | 3.0705 | 3.875 | 11 | 126 | appendage morphogenesis |
| GO:0007267 | 0.0019 | 1.5736 | 38.7502 | 57 | 1260 | cell-cell signaling |
| GO:0043586 | 0.0019 | 9.084 | 0.5536 | 4 | 18 | tongue development |
| GO:0030326 | 0.0019 | 3.2384 | 3.3522 | 10 | 109 | embryonic limb morphogenesis |
| GO:0051093 | 0.0021 | 1.7552 | 21.7739 | 36 | 708 | negative regulation of developmental process |
| GO:0009887 | 0.0024 | 1.6903 | 25.1261 | 40 | 817 | animal organ morphogenesis |
| GO:0097306 | 0.0024 | 4.9062 | 1.3839 | 6 | 45 | cellular response to alcohol |
| GO:0016331 | 0.0027 | 2.8928 | 4.0903 | 11 | 133 | morphogenesis of embryonic epithelium |
| GO:0007286 | 0.0027 | 3.0815 | 3.506 | 10 | 114 | spermatid development |
| GO:0002317 | 0.0028 | 63.3383 | 0.0923 | 2 | 3 | plasma cell differentiation |
| GO:0002584 | 0.0028 | 63.3383 | 0.0923 | 2 | 3 | negative regulation of antigen processing and presentation of peptide antigen |
| GO:0008582 | 0.0028 | 63.3383 | 0.0923 | 2 | 3 | regulation of synaptic growth at neuromuscular junction |
| GO:0014707 | 0.0028 | 63.3383 | 0.0923 | 2 | 3 | branchiomeric skeletal muscle development |
| GO:0044691 | 0.0028 | 63.3383 | 0.0923 | 2 | 3 | tooth eruption |
| GO:0072095 | 0.0028 | 63.3383 | 0.0923 | 2 | 3 | regulation of branch elongation involved in ureteric bud branching |
| GO:2001199 | 0.0028 | 63.3383 | 0.0923 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0022617 | 0.0028 | 4.0638 | 1.9068 | 7 | 62 | extracellular matrix disassembly |
| GO:0009886 | 0.0029 | 13.5997 | 0.3075 | 3 | 10 | post-embryonic animal morphogenesis |
| GO:0035646 | 0.0029 | 13.5997 | 0.3075 | 3 | 10 | endosome to melanosome transport |
| GO:0043476 | 0.0029 | 13.5997 | 0.3075 | 3 | 10 | pigment accumulation |
| GO:0048757 | 0.0029 | 13.5997 | 0.3075 | 3 | 10 | pigment granule maturation |
| GO:0071941 | 0.0029 | 13.5997 | 0.3075 | 3 | 10 | nitrogen cycle metabolic process |
| GO:0051094 | 0.003 | 1.603 | 31.1539 | 47 | 1013 | positive regulation of developmental process |
| GO:0003006 | 0.0032 | 1.8367 | 16.1152 | 28 | 524 | developmental process involved in reproduction |
| GO:0040017 | 0.0035 | 1.9846 | 11.7173 | 22 | 381 | positive regulation of locomotion |
| GO:0021783 | 0.004 | 11.8988 | 0.3383 | 3 | 11 | preganglionic parasympathetic fiber development |
| GO:1900116 | 0.004 | 11.8988 | 0.3383 | 3 | 11 | extracellular negative regulation of signal transduction |
| GO:1901342 | 0.004 | 2.3102 | 6.8889 | 15 | 224 | regulation of vasculature development |
| GO:0038084 | 0.0042 | 7.0631 | 0.6766 | 4 | 22 | vascular endothelial growth factor signaling pathway |
| GO:0072175 | 0.0044 | 2.8596 | 3.752 | 10 | 122 | epithelial tube formation |
| GO:0030198 | 0.0045 | 2.4464 | 5.6483 | 13 | 186 | extracellular matrix organization |
| GO:0001822 | 0.0045 | 2.6842 | 4.3776 | 11 | 144 | kidney development |
| GO:0003008 | 0.0049 | 1.5002 | 39.6421 | 56 | 1289 | system process |
| GO:0061548 | 0.0052 | 10.5759 | 0.369 | 3 | 12 | ganglion development |
| GO:0090051 | 0.0052 | 10.5759 | 0.369 | 3 | 12 | negative regulation of cell migration involved in sprouting angiogenesis |
| GO:0007198 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0010572 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | positive regulation of platelet activation |
| GO:0030910 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | olfactory placode formation |
| GO:0045415 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | negative regulation of interleukin-8 biosynthetic process |
| GO:0061055 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | myotome development |
| GO:0061197 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | fungiform papilla morphogenesis |
| GO:0071698 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | olfactory placode development |
| GO:0072086 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | specification of loop of Henle identity |
| GO:0072107 | 0.0054 | 31.6667 | 0.123 | 2 | 4 | positive regulation of ureteric bud formation |
| GO:1904888 | 0.0061 | 3.9835 | 1.6607 | 6 | 54 | cranial skeletal system development |
| GO:0060173 | 0.0063 | 2.5541 | 4.5824 | 11 | 149 | limb development |
| GO:0051153 | 0.0064 | 3.1163 | 2.7679 | 8 | 90 | regulation of striated muscle cell differentiation |
| GO:0006590 | 0.0066 | 9.5176 | 0.3998 | 3 | 13 | thyroid hormone generation |
| GO:1904994 | 0.0066 | 9.5176 | 0.3998 | 3 | 13 | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2000758 | 0.0067 | 6.0527 | 0.7689 | 4 | 25 | positive regulation of peptidyl-lysine acetylation |
| GO:0030154 | 0.0067 | 1.3486 | 85.2192 | 106 | 2832 | cell differentiation |
| GO:0035295 | 0.0069 | 1.7668 | 15.4693 | 26 | 503 | tube development |
| GO:0030334 | 0.0071 | 1.706 | 17.8681 | 29 | 581 | regulation of cell migration |
| GO:0009792 | 0.0072 | 1.7592 | 15.5308 | 26 | 505 | embryo development ending in birth or egg hatching |
| GO:0045766 | 0.0076 | 2.7935 | 3.4445 | 9 | 112 | positive regulation of angiogenesis |
| GO:0048646 | 0.0076 | 1.5743 | 26.0795 | 39 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0072604 | 0.0077 | 5.7771 | 0.7996 | 4 | 26 | interleukin-6 secretion |
| GO:0022407 | 0.0077 | 1.9795 | 9.5645 | 18 | 311 | regulation of cell-cell adhesion |
| GO:0051148 | 0.0079 | 3.7483 | 1.753 | 6 | 57 | negative regulation of muscle cell differentiation |
| GO:1903039 | 0.008 | 2.4639 | 4.7361 | 11 | 154 | positive regulation of leukocyte cell-cell adhesion |
| GO:0010596 | 0.0081 | 4.4192 | 1.2609 | 5 | 41 | negative regulation of endothelial cell migration |
| GO:0048569 | 0.0082 | 8.6517 | 0.4306 | 3 | 14 | post-embryonic animal organ development |
| GO:0048706 | 0.0084 | 5.6182 | 0.8172 | 4 | 27 | embryonic skeletal system development |
| GO:0001656 | 0.0087 | 3.2357 | 2.3373 | 7 | 76 | metanephros development |
| GO:0034105 | 0.0088 | 5.5255 | 0.8304 | 4 | 27 | positive regulation of tissue remodeling |
| GO:0006526 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | arginine biosynthetic process |
| GO:0014062 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | regulation of serotonin secretion |
| GO:0034112 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0048843 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | negative regulation of axon extension involved in axon guidance |
| GO:0060839 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | endothelial cell fate commitment |
| GO:0072047 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
| GO:0090500 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | endocardial cushion to mesenchymal transition |
| GO:1903232 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | melanosome assembly |
| GO:2000110 | 0.0089 | 21.1095 | 0.1538 | 2 | 5 | negative regulation of macrophage apoptotic process |
| GO:0045785 | 0.009 | 1.9896 | 8.9802 | 17 | 292 | positive regulation of cell adhesion |
| GO:0002521 | 0.009 | 1.9078 | 10.4564 | 19 | 340 | leukocyte differentiation |
| GO:0022412 | 0.0091 | 2.0337 | 8.2729 | 16 | 269 | cellular process involved in reproduction in multicellular organism |
| GO:0007268 | 0.0093 | 1.7399 | 15.0695 | 25 | 490 | chemical synaptic transmission |
| GO:0072080 | 0.0094 | 3.1892 | 2.3681 | 7 | 77 | nephron tubule development |
| GO:0099537 | 0.0095 | 1.736 | 15.1003 | 25 | 491 | trans-synaptic signaling |
| GO:0072359 | 0.0097 | 1.5658 | 24.8186 | 37 | 807 | circulatory system development |
| GO:0006925 | 0.01 | 7.9301 | 0.4613 | 3 | 15 | inflammatory cell apoptotic process |
| GO:0036120 | 0.01 | 7.9301 | 0.4613 | 3 | 15 | cellular response to platelet-derived growth factor stimulus |
| GO:2000726 | 0.01 | 7.9301 | 0.4613 | 3 | 15 | negative regulation of cardiac muscle cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007155 | 0 | 2.6901 | 12.7141 | 31 | 421 | cell adhesion |
| GO:0030198 | 0 | 3.7039 | 5.7331 | 19 | 186 | extracellular matrix organization |
| GO:0036066 | 0 | 22.3769 | 0.3754 | 5 | 12 | protein O-linked fucosylation |
| GO:0022617 | 7e-04 | 4.6583 | 1.9395 | 8 | 62 | extracellular matrix disassembly |
| GO:0048842 | 0.001 | 23.3869 | 0.219 | 3 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0009651 | 0.0013 | 10.413 | 0.5005 | 4 | 16 | response to salt stress |
| GO:0010810 | 0.0017 | 3.3124 | 3.2861 | 10 | 106 | regulation of cell-substrate adhesion |
| GO:0051893 | 0.0018 | 5.2222 | 1.3139 | 6 | 42 | regulation of focal adhesion assembly |
| GO:0098609 | 0.0019 | 1.8115 | 19.3329 | 33 | 618 | cell-cell adhesion |
| GO:0048333 | 0.0022 | 6.2567 | 0.9385 | 5 | 30 | mesodermal cell differentiation |
| GO:0019371 | 0.0022 | 15.5888 | 0.2815 | 3 | 9 | cyclooxygenase pathway |
| GO:0097286 | 0.0022 | 15.5888 | 0.2815 | 3 | 9 | iron ion import |
| GO:0007160 | 0.0029 | 2.8649 | 4.1279 | 11 | 133 | cell-matrix adhesion |
| GO:0033693 | 0.0029 | 62.2282 | 0.0938 | 2 | 3 | neurofilament bundle assembly |
| GO:0044691 | 0.0029 | 62.2282 | 0.0938 | 2 | 3 | tooth eruption |
| GO:0061551 | 0.0029 | 62.2282 | 0.0938 | 2 | 3 | trigeminal ganglion development |
| GO:0070634 | 0.0029 | 62.2282 | 0.0938 | 2 | 3 | transepithelial ammonium transport |
| GO:0002544 | 0.0031 | 13.3608 | 0.3128 | 3 | 10 | chronic inflammatory response |
| GO:0035646 | 0.0031 | 13.3608 | 0.3128 | 3 | 10 | endosome to melanosome transport |
| GO:0043476 | 0.0031 | 13.3608 | 0.3128 | 3 | 10 | pigment accumulation |
| GO:0048757 | 0.0031 | 13.3608 | 0.3128 | 3 | 10 | pigment granule maturation |
| GO:0001704 | 0.0032 | 2.9974 | 3.5976 | 10 | 115 | formation of primary germ layer |
| GO:0051216 | 0.0033 | 2.6651 | 4.8176 | 12 | 154 | cartilage development |
| GO:0009790 | 0.0047 | 1.6177 | 26.1214 | 40 | 835 | embryo development |
| GO:0048260 | 0.005 | 5.0434 | 1.1262 | 5 | 36 | positive regulation of receptor-mediated endocytosis |
| GO:0034356 | 0.0054 | 10.3901 | 0.3754 | 3 | 12 | NAD biosynthesis via nicotinamide riboside salvage pathway |
| GO:0002138 | 0.0056 | 31.1117 | 0.1251 | 2 | 4 | retinoic acid biosynthetic process |
| GO:0042126 | 0.0056 | 31.1117 | 0.1251 | 2 | 4 | nitrate metabolic process |
| GO:0071651 | 0.0056 | 31.1117 | 0.1251 | 2 | 4 | positive regulation of chemokine (C-C motif) ligand 5 production |
| GO:0098706 | 0.0056 | 31.1117 | 0.1251 | 2 | 4 | ferric iron import across plasma membrane |
| GO:0048332 | 0.0057 | 3.5391 | 2.1585 | 7 | 69 | mesoderm morphogenesis |
| GO:0001953 | 0.0061 | 6.2439 | 0.7508 | 4 | 24 | negative regulation of cell-matrix adhesion |
| GO:0007501 | 0.0069 | 9.3504 | 0.4067 | 3 | 13 | mesodermal cell fate specification |
| GO:0021527 | 0.0069 | 9.3504 | 0.4067 | 3 | 13 | spinal cord association neuron differentiation |
| GO:0008038 | 0.0071 | 5.9461 | 0.7821 | 4 | 25 | neuron recognition |
| GO:0007044 | 0.0083 | 3.2737 | 2.3149 | 7 | 74 | cell-substrate junction assembly |
| GO:0048706 | 0.0085 | 2.7437 | 3.5037 | 9 | 112 | embryonic skeletal system development |
| GO:0042730 | 0.0086 | 8.4997 | 0.438 | 3 | 14 | fibrinolysis |
| GO:1900024 | 0.0087 | 4.3412 | 1.2826 | 5 | 41 | regulation of substrate adhesion-dependent cell spreading |
| GO:0010757 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | negative regulation of plasminogen activation |
| GO:0015677 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | copper ion import |
| GO:0034112 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
| GO:0048843 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | negative regulation of axon extension involved in axon guidance |
| GO:0060839 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | endothelial cell fate commitment |
| GO:0090500 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | endocardial cushion to mesenchymal transition |
| GO:1903232 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | melanosome assembly |
| GO:2000507 | 0.0092 | 20.7395 | 0.1564 | 2 | 5 | positive regulation of energy homeostasis |
| GO:1902905 | 0.0095 | 2.4027 | 4.8489 | 11 | 155 | positive regulation of supramolecular fiber organization |
| GO:0002040 | 0.0095 | 3.1783 | 2.3775 | 7 | 76 | sprouting angiogenesis |
| GO:0048635 | 0.0096 | 4.2236 | 1.3139 | 5 | 42 | negative regulation of muscle organ development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045214 | 0 | 13.7259 | 0.5342 | 6 | 35 | sarcomere organization |
| GO:0032943 | 4e-04 | 4.0368 | 2.6864 | 10 | 176 | mononuclear cell proliferation |
| GO:0071688 | 5e-04 | 24.5427 | 0.1679 | 3 | 11 | striated muscle myosin thick filament assembly |
| GO:0006949 | 7e-04 | 8.042 | 0.7021 | 5 | 46 | syncytium formation |
| GO:0002074 | 7e-04 | 130.31 | 0.0458 | 2 | 3 | extraocular skeletal muscle development |
| GO:0001895 | 8e-04 | 7.6667 | 0.7327 | 5 | 48 | retina homeostasis |
| GO:0050878 | 8e-04 | 2.7604 | 5.846 | 15 | 383 | regulation of body fluid levels |
| GO:0031033 | 9e-04 | 19.6312 | 0.1984 | 3 | 13 | myosin filament organization |
| GO:0050776 | 0.001 | 2.2878 | 9.9214 | 21 | 650 | regulation of immune response |
| GO:0050670 | 0.0014 | 4.03 | 2.1369 | 8 | 140 | regulation of lymphocyte proliferation |
| GO:0070663 | 0.0017 | 3.8814 | 2.2132 | 8 | 145 | regulation of leukocyte proliferation |
| GO:0002684 | 0.0019 | 2.1542 | 10.4862 | 21 | 687 | positive regulation of immune system process |
| GO:0007520 | 0.0019 | 8.4725 | 0.5342 | 4 | 35 | myoblast fusion |
| GO:0032501 | 0.0021 | 1.5154 | 82.5462 | 103 | 5408 | multicellular organismal process |
| GO:0015884 | 0.0022 | 43.43 | 0.0763 | 2 | 5 | folic acid transport |
| GO:1905098 | 0.0022 | 43.43 | 0.0763 | 2 | 5 | negative regulation of guanyl-nucleotide exchange factor activity |
| GO:0009219 | 0.0024 | 13.0824 | 0.2747 | 3 | 18 | pyrimidine deoxyribonucleotide metabolic process |
| GO:0007596 | 0.0025 | 2.8973 | 4.0449 | 11 | 265 | blood coagulation |
| GO:0055002 | 0.0029 | 3.9625 | 1.8927 | 7 | 124 | striated muscle cell development |
| GO:0008228 | 0.0033 | 32.57 | 0.0916 | 2 | 6 | opsonization |
| GO:0015889 | 0.0033 | 32.57 | 0.0916 | 2 | 6 | cobalamin transport |
| GO:0051963 | 0.0035 | 5.3095 | 1.0227 | 5 | 67 | regulation of synapse assembly |
| GO:0046580 | 0.0037 | 6.908 | 0.6411 | 4 | 42 | negative regulation of Ras protein signal transduction |
| GO:0006760 | 0.0044 | 10.325 | 0.3358 | 3 | 22 | folic acid-containing compound metabolic process |
| GO:0060143 | 0.0044 | 10.325 | 0.3358 | 3 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0045078 | 0.0046 | 26.054 | 0.1068 | 2 | 7 | positive regulation of interferon-gamma biosynthetic process |
| GO:0051593 | 0.0046 | 26.054 | 0.1068 | 2 | 7 | response to folic acid |
| GO:0050808 | 0.0048 | 2.9919 | 3.1901 | 9 | 209 | synapse organization |
| GO:0009888 | 0.0057 | 1.678 | 22.6208 | 35 | 1482 | tissue development |
| GO:0002250 | 0.006 | 2.8892 | 3.297 | 9 | 216 | adaptive immune response |
| GO:0009404 | 0.0061 | 21.71 | 0.1221 | 2 | 8 | toxin metabolic process |
| GO:0045008 | 0.0061 | 21.71 | 0.1221 | 2 | 8 | depyrimidination |
| GO:0033209 | 0.0066 | 3.3788 | 2.198 | 7 | 144 | tumor necrosis factor-mediated signaling pathway |
| GO:0002694 | 0.0066 | 2.416 | 5.2507 | 12 | 344 | regulation of leukocyte activation |
| GO:0030036 | 0.007 | 2.1628 | 7.3453 | 15 | 488 | actin cytoskeleton organization |
| GO:0007271 | 0.007 | 8.5268 | 0.3969 | 3 | 26 | synaptic transmission, cholinergic |
| GO:0030449 | 0.007 | 8.5268 | 0.3969 | 3 | 26 | regulation of complement activation |
| GO:0002253 | 0.0071 | 2.3026 | 5.9681 | 13 | 391 | activation of immune response |
| GO:0006090 | 0.0074 | 3.733 | 1.7095 | 6 | 112 | pyruvate metabolic process |
| GO:0006002 | 0.0078 | 18.6071 | 0.1374 | 2 | 9 | fructose 6-phosphate metabolic process |
| GO:0010951 | 0.0088 | 3.1904 | 2.3201 | 7 | 152 | negative regulation of endopeptidase activity |
| GO:0044243 | 0.0092 | 5.2453 | 0.8242 | 4 | 54 | multicellular organismal catabolic process |
| GO:0051251 | 0.0093 | 2.8794 | 2.9306 | 8 | 192 | positive regulation of lymphocyte activation |
| GO:0030890 | 0.0096 | 7.5412 | 0.4426 | 3 | 29 | positive regulation of B cell proliferation |
| GO:0046541 | 0.0096 | 16.28 | 0.1526 | 2 | 10 | saliva secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042445 | 0 | 4.5541 | 3.7333 | 15 | 129 | hormone metabolic process |
| GO:0006590 | 4e-04 | 15.0595 | 0.3762 | 4 | 13 | thyroid hormone generation |
| GO:0032825 | 8e-04 | 25.3559 | 0.2026 | 3 | 7 | positive regulation of natural killer cell differentiation |
| GO:0060086 | 8e-04 | Inf | 0.0579 | 2 | 2 | circadian temperature homeostasis |
| GO:1905205 | 0.0012 | 20.2832 | 0.2315 | 3 | 8 | positive regulation of connective tissue replacement |
| GO:0034103 | 0.0014 | 4.6725 | 1.6786 | 7 | 58 | regulation of tissue remodeling |
| GO:0008045 | 0.0015 | 9.6773 | 0.5209 | 4 | 18 | motor neuron axon guidance |
| GO:0006955 | 0.0021 | 1.5726 | 38.1437 | 56 | 1318 | immune response |
| GO:0032252 | 0.0025 | 67.4541 | 0.0868 | 2 | 3 | secretory granule localization |
| GO:1902463 | 0.0025 | 67.4541 | 0.0868 | 2 | 3 | protein localization to cell leading edge |
| GO:0097485 | 0.0025 | 2.5282 | 5.9039 | 14 | 204 | neuron projection guidance |
| GO:0023052 | 0.0027 | 1.3487 | 137.5258 | 164 | 4752 | signaling |
| GO:0042573 | 0.0033 | 12.674 | 0.3183 | 3 | 11 | retinoic acid metabolic process |
| GO:0032814 | 0.0033 | 7.5245 | 0.6367 | 4 | 22 | regulation of natural killer cell activation |
| GO:0060143 | 0.0033 | 7.5245 | 0.6367 | 4 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:1903671 | 0.004 | 7.1279 | 0.6656 | 4 | 23 | negative regulation of sprouting angiogenesis |
| GO:0002043 | 0.0044 | 11.2649 | 0.3473 | 3 | 12 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0042330 | 0.0044 | 1.9145 | 12.676 | 23 | 438 | taxis |
| GO:0007154 | 0.0044 | 1.3263 | 138.0178 | 163 | 4769 | cell communication |
| GO:0021648 | 0.0048 | 33.7244 | 0.1158 | 2 | 4 | vestibulocochlear nerve morphogenesis |
| GO:0060385 | 0.0048 | 33.7244 | 0.1158 | 2 | 4 | axonogenesis involved in innervation |
| GO:1903010 | 0.0055 | 10.1376 | 0.3762 | 3 | 13 | regulation of bone development |
| GO:0048469 | 0.0056 | 2.7517 | 3.878 | 10 | 134 | cell maturation |
| GO:0031297 | 0.0062 | 6.1545 | 0.7525 | 4 | 26 | replication fork processing |
| GO:0021987 | 0.0075 | 3.0248 | 2.8362 | 8 | 98 | cerebral cortex development |
| GO:0007162 | 0.0076 | 2.3703 | 5.354 | 12 | 185 | negative regulation of cell adhesion |
| GO:0009912 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | auditory receptor cell fate commitment |
| GO:0021631 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | optic nerve morphogenesis |
| GO:0045110 | 0.0079 | 22.4812 | 0.1447 | 2 | 5 | intermediate filament bundle assembly |
| GO:0016101 | 0.0082 | 3.7027 | 1.7654 | 6 | 61 | diterpenoid metabolic process |
| GO:0021675 | 0.0089 | 3.6363 | 1.7943 | 6 | 62 | nerve development |
| GO:0045321 | 0.0089 | 1.5772 | 24.6863 | 37 | 853 | leukocyte activation |
| GO:2000181 | 0.0089 | 3.2145 | 2.3442 | 7 | 81 | negative regulation of blood vessel morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060135 | 4e-04 | 7.0543 | 0.9883 | 6 | 41 | maternal process involved in female pregnancy |
| GO:0034116 | 5e-04 | 30.6432 | 0.1687 | 3 | 7 | positive regulation of heterotypic cell-cell adhesion |
| GO:0046136 | 6e-04 | Inf | 0.0482 | 2 | 2 | positive regulation of vitamin metabolic process |
| GO:0060559 | 6e-04 | Inf | 0.0482 | 2 | 2 | positive regulation of calcidiol 1-monooxygenase activity |
| GO:0050995 | 6e-04 | 12.6027 | 0.4098 | 4 | 17 | negative regulation of lipid catabolic process |
| GO:0031424 | 0.0011 | 3.797 | 2.5792 | 9 | 107 | keratinization |
| GO:0035050 | 0.0013 | 4.6511 | 1.6632 | 7 | 69 | embryonic heart tube development |
| GO:0019730 | 0.0014 | 5.4824 | 1.2293 | 6 | 51 | antimicrobial humoral response |
| GO:0046469 | 0.0017 | 81.4763 | 0.0723 | 2 | 3 | platelet activating factor metabolic process |
| GO:1903140 | 0.002 | 15.3169 | 0.2652 | 3 | 11 | regulation of establishment of endothelial barrier |
| GO:0030730 | 0.0026 | 13.6139 | 0.2893 | 3 | 12 | sequestering of triglyceride |
| GO:0031649 | 0.0033 | 12.2516 | 0.3134 | 3 | 13 | heat generation |
| GO:0009181 | 0.0034 | 40.735 | 0.0964 | 2 | 4 | purine ribonucleoside diphosphate catabolic process |
| GO:0036515 | 0.0034 | 40.735 | 0.0964 | 2 | 4 | serotonergic neuron axon guidance |
| GO:0060355 | 0.0034 | 40.735 | 0.0964 | 2 | 4 | positive regulation of cell adhesion molecule production |
| GO:0043588 | 0.0037 | 2.4038 | 6.1708 | 14 | 256 | skin development |
| GO:0009954 | 0.0043 | 6.8206 | 0.6749 | 4 | 28 | proximal/distal pattern formation |
| GO:0031622 | 0.0055 | 27.1546 | 0.1205 | 2 | 5 | positive regulation of fever generation |
| GO:0036514 | 0.0055 | 27.1546 | 0.1205 | 2 | 5 | dopaminergic neuron axon guidance |
| GO:0071033 | 0.0055 | 27.1546 | 0.1205 | 2 | 5 | nuclear retention of pre-mRNA at the site of transcription |
| GO:1904938 | 0.0055 | 27.1546 | 0.1205 | 2 | 5 | planar cell polarity pathway involved in axon guidance |
| GO:0036342 | 0.0062 | 9.4221 | 0.3857 | 3 | 16 | post-anal tail morphogenesis |
| GO:0007606 | 0.007 | 3.0504 | 2.7961 | 8 | 116 | sensory perception of chemical stimulus |
| GO:0042346 | 0.0073 | 8.7484 | 0.4098 | 3 | 17 | positive regulation of NF-kappaB import into nucleus |
| GO:0050830 | 0.0081 | 4.3597 | 1.2534 | 5 | 52 | defense response to Gram-positive bacterium |
| GO:0060556 | 0.0081 | 20.3644 | 0.1446 | 2 | 6 | regulation of vitamin D biosynthetic process |
| GO:1902510 | 0.0081 | 20.3644 | 0.1446 | 2 | 6 | regulation of apoptotic DNA fragmentation |
| GO:0009913 | 0.0086 | 2.4309 | 4.7727 | 11 | 198 | epidermal cell differentiation |
| GO:0060716 | 0.0087 | 8.1646 | 0.4339 | 3 | 18 | labyrinthine layer blood vessel development |
| GO:0048871 | 0.0087 | 2.2342 | 6.1226 | 13 | 254 | multicellular organismal homeostasis |
| GO:0009593 | 0.0089 | 3.1971 | 2.3381 | 7 | 97 | detection of chemical stimulus |
| GO:0001947 | 0.0095 | 4.1811 | 1.3016 | 5 | 54 | heart looping |
| GO:0050911 | 0.0095 | 4.1811 | 1.3016 | 5 | 54 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0019216 | 0.0096 | 2.1336 | 6.8939 | 14 | 286 | regulation of lipid metabolic process |
| GO:0001892 | 0.01 | 3.5176 | 1.8319 | 6 | 76 | embryonic placenta development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048646 | 0 | 2.4977 | 24.029 | 53 | 848 | anatomical structure formation involved in morphogenesis |
| GO:0045765 | 2e-04 | 3.0366 | 5.7239 | 16 | 202 | regulation of angiogenesis |
| GO:1903671 | 4e-04 | 9.6404 | 0.6517 | 5 | 23 | negative regulation of sprouting angiogenesis |
| GO:2000181 | 5e-04 | 4.3671 | 2.2952 | 9 | 81 | negative regulation of blood vessel morphogenesis |
| GO:0032466 | 7e-04 | 25.9173 | 0.1984 | 3 | 7 | negative regulation of cytokinesis |
| GO:2000049 | 7e-04 | 25.9173 | 0.1984 | 3 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:0050890 | 8e-04 | 2.6716 | 6.4323 | 16 | 227 | cognition |
| GO:0060809 | 8e-04 | Inf | 0.0567 | 2 | 2 | mesodermal to mesenchymal transition involved in gastrulation |
| GO:1904933 | 8e-04 | Inf | 0.0567 | 2 | 2 | regulation of cell proliferation in midbrain |
| GO:0007610 | 0.001 | 2.0734 | 13.3746 | 26 | 472 | behavior |
| GO:0001568 | 0.0013 | 1.9923 | 14.4231 | 27 | 509 | blood vessel development |
| GO:0072358 | 0.0013 | 1.9659 | 15.1598 | 28 | 535 | cardiovascular system development |
| GO:0043537 | 0.0014 | 6.9373 | 0.8501 | 5 | 30 | negative regulation of blood vessel endothelial cell migration |
| GO:0021516 | 0.0021 | 8.6543 | 0.5667 | 4 | 20 | dorsal spinal cord development |
| GO:0030574 | 0.0022 | 4.9621 | 1.3601 | 6 | 48 | collagen catabolic process |
| GO:0048850 | 0.0024 | 68.9437 | 0.085 | 2 | 3 | hypophysis morphogenesis |
| GO:0031623 | 0.003 | 3.9908 | 1.9269 | 7 | 68 | receptor internalization |
| GO:0048841 | 0.0031 | 12.9546 | 0.3117 | 3 | 11 | regulation of axon extension involved in axon guidance |
| GO:0061154 | 0.0031 | 12.9546 | 0.3117 | 3 | 11 | endothelial tube morphogenesis |
| GO:2000026 | 0.0033 | 1.5121 | 43.2126 | 61 | 1525 | regulation of multicellular organismal development |
| GO:0045597 | 0.0036 | 1.7189 | 20.9404 | 34 | 739 | positive regulation of cell differentiation |
| GO:0030878 | 0.0037 | 7.2861 | 0.6517 | 4 | 23 | thyroid gland development |
| GO:0016055 | 0.0039 | 1.9666 | 11.8162 | 22 | 417 | Wnt signaling pathway |
| GO:0070208 | 0.0041 | 11.5143 | 0.34 | 3 | 12 | protein heterotrimerization |
| GO:0070365 | 0.0041 | 11.5143 | 0.34 | 3 | 12 | hepatocyte differentiation |
| GO:0098703 | 0.0041 | 11.5143 | 0.34 | 3 | 12 | calcium ion import across plasma membrane |
| GO:0050900 | 0.0042 | 2.1649 | 8.3025 | 17 | 293 | leukocyte migration |
| GO:0009888 | 0.0043 | 1.5005 | 41.9941 | 59 | 1482 | tissue development |
| GO:0060441 | 0.0043 | 6.9213 | 0.6801 | 4 | 24 | epithelial tube branching involved in lung morphogenesis |
| GO:0030240 | 0.0046 | 34.4692 | 0.1133 | 2 | 4 | skeletal muscle thin filament assembly |
| GO:0042663 | 0.0046 | 34.4692 | 0.1133 | 2 | 4 | regulation of endodermal cell fate specification |
| GO:0044878 | 0.0046 | 34.4692 | 0.1133 | 2 | 4 | mitotic cytokinesis checkpoint |
| GO:0070245 | 0.0046 | 34.4692 | 0.1133 | 2 | 4 | positive regulation of thymocyte apoptotic process |
| GO:0030198 | 0.0048 | 2.2579 | 7.0274 | 15 | 248 | extracellular matrix organization |
| GO:0007200 | 0.0049 | 3.6317 | 2.0969 | 7 | 74 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0034113 | 0.0052 | 4.9514 | 1.1334 | 5 | 40 | heterotypic cell-cell adhesion |
| GO:0060042 | 0.0052 | 4.9514 | 1.1334 | 5 | 40 | retina morphogenesis in camera-type eye |
| GO:0009887 | 0.0056 | 1.6423 | 23.1506 | 36 | 817 | animal organ morphogenesis |
| GO:0071300 | 0.0058 | 4.0047 | 1.6435 | 6 | 58 | cellular response to retinoic acid |
| GO:0007612 | 0.006 | 2.9032 | 3.3153 | 9 | 117 | learning |
| GO:0035239 | 0.0061 | 2.0801 | 8.6142 | 17 | 304 | tube morphogenesis |
| GO:0040017 | 0.0061 | 1.9505 | 10.7961 | 20 | 381 | positive regulation of locomotion |
| GO:0032609 | 0.0063 | 3.9288 | 1.6718 | 6 | 59 | interferon-gamma production |
| GO:0050878 | 0.0065 | 1.9394 | 10.8527 | 20 | 383 | regulation of body fluid levels |
| GO:0048853 | 0.0065 | 9.4194 | 0.3967 | 3 | 14 | forebrain morphogenesis |
| GO:0090130 | 0.0067 | 2.3201 | 5.9222 | 13 | 209 | tissue migration |
| GO:0048870 | 0.0073 | 1.5197 | 32.7282 | 47 | 1155 | cell motility |
| GO:0043542 | 0.0075 | 2.6215 | 4.0521 | 10 | 143 | endothelial cell migration |
| GO:0009838 | 0.0076 | 22.9777 | 0.1417 | 2 | 5 | abscission |
| GO:0060023 | 0.0076 | 22.9777 | 0.1417 | 2 | 5 | soft palate development |
| GO:0061009 | 0.0076 | 22.9777 | 0.1417 | 2 | 5 | common bile duct development |
| GO:0071415 | 0.0076 | 22.9777 | 0.1417 | 2 | 5 | cellular response to purine-containing compound |
| GO:0072201 | 0.0076 | 22.9777 | 0.1417 | 2 | 5 | negative regulation of mesenchymal cell proliferation |
| GO:2000739 | 0.0076 | 22.9777 | 0.1417 | 2 | 5 | regulation of mesenchymal stem cell differentiation |
| GO:0021879 | 0.0078 | 4.4421 | 1.2468 | 5 | 44 | forebrain neuron differentiation |
| GO:0007389 | 0.0079 | 1.9359 | 10.3143 | 19 | 364 | pattern specification process |
| GO:0003094 | 0.008 | 8.6337 | 0.425 | 3 | 15 | glomerular filtration |
| GO:0030334 | 0.0081 | 1.7233 | 16.4633 | 27 | 581 | regulation of cell migration |
| GO:0007169 | 0.0083 | 1.72 | 16.4916 | 27 | 582 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0035023 | 0.0084 | 2.9602 | 2.8903 | 8 | 102 | regulation of Rho protein signal transduction |
| GO:0019933 | 0.0085 | 3.2423 | 2.3236 | 7 | 82 | cAMP-mediated signaling |
| GO:0046189 | 0.0086 | 5.5349 | 0.8217 | 4 | 29 | phenol-containing compound biosynthetic process |
| GO:0002009 | 0.0086 | 1.8233 | 12.6662 | 22 | 447 | morphogenesis of an epithelium |
| GO:0007165 | 0.0087 | 1.302 | 122.9787 | 145 | 4340 | signal transduction |
| GO:0003008 | 0.0088 | 1.4776 | 36.5252 | 51 | 1289 | system process |
| GO:0050896 | 0.0093 | 1.2871 | 182.0595 | 205 | 6425 | response to stimulus |
| GO:0048663 | 0.0094 | 3.5887 | 1.8135 | 6 | 64 | neuron fate commitment |
| GO:0001711 | 0.0096 | 7.969 | 0.4534 | 3 | 16 | endodermal cell fate commitment |
| GO:1902284 | 0.0096 | 7.969 | 0.4534 | 3 | 16 | neuron projection extension involved in neuron projection guidance |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042421 | 4e-04 | 34.9457 | 0.1682 | 3 | 6 | norepinephrine biosynthetic process |
| GO:1900155 | 8e-04 | Inf | 0.0561 | 2 | 2 | negative regulation of bone trabecula formation |
| GO:0009713 | 0.0014 | 10.0031 | 0.5046 | 4 | 18 | catechol-containing compound biosynthetic process |
| GO:0043586 | 0.0014 | 10.0031 | 0.5046 | 4 | 18 | tongue development |
| GO:0003207 | 0.0016 | 17.4688 | 0.2523 | 3 | 9 | cardiac chamber formation |
| GO:0016553 | 0.0016 | 17.4688 | 0.2523 | 3 | 9 | base conversion or substitution editing |
| GO:0072079 | 0.0017 | 9.3355 | 0.5326 | 4 | 19 | nephron tubule formation |
| GO:0030194 | 0.0021 | 8.7514 | 0.5607 | 4 | 20 | positive regulation of blood coagulation |
| GO:0021554 | 0.0023 | 14.972 | 0.2803 | 3 | 10 | optic nerve development |
| GO:0003219 | 0.0023 | 69.7127 | 0.0841 | 2 | 3 | cardiac right ventricle formation |
| GO:0061430 | 0.003 | 13.0995 | 0.3084 | 3 | 11 | bone trabecula morphogenesis |
| GO:0018958 | 0.0034 | 3.9072 | 1.9624 | 7 | 70 | phenol-containing compound metabolic process |
| GO:0042454 | 0.004 | 11.6431 | 0.3364 | 3 | 12 | ribonucleoside catabolic process |
| GO:0097709 | 0.004 | 11.6431 | 0.3364 | 3 | 12 | connective tissue replacement |
| GO:0009972 | 0.0045 | 34.8537 | 0.1121 | 2 | 4 | cytidine deamination |
| GO:0035609 | 0.0045 | 34.8537 | 0.1121 | 2 | 4 | C-terminal protein deglutamylation |
| GO:0042126 | 0.0045 | 34.8537 | 0.1121 | 2 | 4 | nitrate metabolic process |
| GO:0046087 | 0.0045 | 34.8537 | 0.1121 | 2 | 4 | cytidine metabolic process |
| GO:0070383 | 0.0045 | 34.8537 | 0.1121 | 2 | 4 | DNA cytosine deamination |
| GO:0008038 | 0.0048 | 6.6651 | 0.7008 | 4 | 25 | neuron recognition |
| GO:0032101 | 0.0049 | 1.844 | 14.2973 | 25 | 510 | regulation of response to external stimulus |
| GO:0006584 | 0.0061 | 4.7356 | 1.1774 | 5 | 42 | catecholamine metabolic process |
| GO:0043616 | 0.0064 | 6.0846 | 0.7569 | 4 | 27 | keratinocyte proliferation |
| GO:2000179 | 0.0068 | 4.6107 | 1.2055 | 5 | 43 | positive regulation of neural precursor cell proliferation |
| GO:0003180 | 0.0074 | 23.234 | 0.1402 | 2 | 5 | aortic valve morphogenesis |
| GO:0003357 | 0.0074 | 23.234 | 0.1402 | 2 | 5 | noradrenergic neuron differentiation |
| GO:0030309 | 0.0074 | 23.234 | 0.1402 | 2 | 5 | poly-N-acetyllactosamine metabolic process |
| GO:0050916 | 0.0074 | 23.234 | 0.1402 | 2 | 5 | sensory perception of sweet taste |
| GO:0050917 | 0.0074 | 23.234 | 0.1402 | 2 | 5 | sensory perception of umami taste |
| GO:0061218 | 0.0074 | 23.234 | 0.1402 | 2 | 5 | negative regulation of mesonephros development |
| GO:2000609 | 0.0074 | 23.234 | 0.1402 | 2 | 5 | regulation of thyroid hormone generation |
| GO:0031099 | 0.0077 | 2.6117 | 4.0649 | 10 | 145 | regeneration |
| GO:1901658 | 0.0083 | 5.5969 | 0.813 | 4 | 29 | glycosyl compound catabolic process |
| GO:0046135 | 0.0093 | 8.0581 | 0.4485 | 3 | 16 | pyrimidine nucleoside catabolic process |
| GO:0048485 | 0.0093 | 8.0581 | 0.4485 | 3 | 16 | sympathetic nervous system development |
| GO:0080111 | 0.0093 | 8.0581 | 0.4485 | 3 | 16 | DNA demethylation |
| GO:0061041 | 0.0098 | 2.8706 | 2.9716 | 8 | 106 | regulation of wound healing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030890 | 1e-04 | 10.6403 | 0.7056 | 6 | 29 | positive regulation of B cell proliferation |
| GO:0008284 | 1e-04 | 2.2271 | 16.6426 | 34 | 684 | positive regulation of cell proliferation |
| GO:0003008 | 1e-04 | 1.8612 | 31.363 | 53 | 1289 | system process |
| GO:0007626 | 2e-04 | 3.5318 | 4.0147 | 13 | 165 | locomotory behavior |
| GO:0048265 | 3e-04 | 10.1672 | 0.6083 | 5 | 25 | response to pain |
| GO:0090218 | 3e-04 | 10.1672 | 0.6083 | 5 | 25 | positive regulation of lipid kinase activity |
| GO:0042309 | 6e-04 | Inf | 0.0487 | 2 | 2 | homoiothermy |
| GO:0050955 | 6e-04 | Inf | 0.0487 | 2 | 2 | thermoception |
| GO:0050864 | 7e-04 | 4.6079 | 1.9222 | 8 | 79 | regulation of B cell activation |
| GO:0045779 | 7e-04 | 24.2765 | 0.1947 | 3 | 8 | negative regulation of bone resorption |
| GO:1903792 | 0.001 | 10.8151 | 0.4623 | 4 | 19 | negative regulation of anion transport |
| GO:0006702 | 0.0015 | 17.3377 | 0.2433 | 3 | 10 | androgen biosynthetic process |
| GO:0051127 | 0.0015 | 17.3377 | 0.2433 | 3 | 10 | positive regulation of actin nucleation |
| GO:0050968 | 0.0017 | 80.6937 | 0.073 | 2 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:0061551 | 0.0017 | 80.6937 | 0.073 | 2 | 3 | trigeminal ganglion development |
| GO:0071655 | 0.0017 | 80.6937 | 0.073 | 2 | 3 | regulation of granulocyte colony-stimulating factor production |
| GO:0035640 | 0.0018 | 9.0105 | 0.5353 | 4 | 22 | exploration behavior |
| GO:0006835 | 0.0023 | 4.1974 | 1.8248 | 7 | 75 | dicarboxylic acid transport |
| GO:0001501 | 0.0025 | 2.132 | 9.9515 | 20 | 409 | skeletal system development |
| GO:0051240 | 0.0025 | 1.6443 | 29.3435 | 45 | 1206 | positive regulation of multicellular organismal process |
| GO:1901700 | 0.0025 | 1.6427 | 29.3678 | 45 | 1207 | response to oxygen-containing compound |
| GO:0010469 | 0.0028 | 2.1495 | 9.3675 | 19 | 385 | regulation of receptor activity |
| GO:0001539 | 0.0029 | 7.7215 | 0.6083 | 4 | 25 | cilium or flagellum-dependent cell motility |
| GO:0021781 | 0.0034 | 12.1335 | 0.3163 | 3 | 13 | glial cell fate commitment |
| GO:0030910 | 0.0034 | 40.3438 | 0.0973 | 2 | 4 | olfactory placode formation |
| GO:0036301 | 0.0034 | 40.3438 | 0.0973 | 2 | 4 | macrophage colony-stimulating factor production |
| GO:0060298 | 0.0034 | 40.3438 | 0.0973 | 2 | 4 | positive regulation of sarcomere organization |
| GO:0061055 | 0.0034 | 40.3438 | 0.0973 | 2 | 4 | myotome development |
| GO:0071698 | 0.0034 | 40.3438 | 0.0973 | 2 | 4 | olfactory placode development |
| GO:0009790 | 0.004 | 1.7242 | 20.3166 | 33 | 835 | embryo development |
| GO:0032891 | 0.0043 | 11.0296 | 0.3406 | 3 | 14 | negative regulation of organic acid transport |
| GO:0008306 | 0.0049 | 4.1363 | 1.5815 | 6 | 65 | associative learning |
| GO:0051094 | 0.005 | 1.6382 | 24.6476 | 38 | 1013 | positive regulation of developmental process |
| GO:0009988 | 0.005 | 4.9515 | 1.1192 | 5 | 46 | cell-cell recognition |
| GO:1903727 | 0.0051 | 6.484 | 0.7056 | 4 | 29 | positive regulation of phospholipid metabolic process |
| GO:0006978 | 0.0052 | 10.1097 | 0.365 | 3 | 15 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0034104 | 0.0052 | 10.1097 | 0.365 | 3 | 15 | negative regulation of tissue remodeling |
| GO:0051289 | 0.0053 | 4.0671 | 1.6059 | 6 | 66 | protein homotetramerization |
| GO:0014062 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | regulation of serotonin secretion |
| GO:0060839 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | endothelial cell fate commitment |
| GO:0061370 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | testosterone biosynthetic process |
| GO:1903789 | 0.0056 | 26.8938 | 0.1217 | 2 | 5 | regulation of amino acid transmembrane transport |
| GO:0051222 | 0.0057 | 2.0469 | 9.2702 | 18 | 381 | positive regulation of protein transport |
| GO:0071356 | 0.006 | 2.448 | 5.1826 | 12 | 213 | cellular response to tumor necrosis factor |
| GO:0007586 | 0.006 | 3.1377 | 2.7251 | 8 | 112 | digestion |
| GO:0045766 | 0.006 | 3.1377 | 2.7251 | 8 | 112 | positive regulation of angiogenesis |
| GO:0050731 | 0.006 | 2.8946 | 3.3091 | 9 | 136 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0030198 | 0.0061 | 2.3445 | 5.8542 | 13 | 242 | extracellular matrix organization |
| GO:0007600 | 0.0061 | 1.9505 | 10.8031 | 20 | 444 | sensory perception |
| GO:0010638 | 0.0062 | 1.8554 | 13.0659 | 23 | 537 | positive regulation of organelle organization |
| GO:0060294 | 0.0063 | 9.3313 | 0.3893 | 3 | 16 | cilium movement involved in cell motility |
| GO:0042596 | 0.0064 | 6.0028 | 0.7543 | 4 | 31 | fear response |
| GO:0002793 | 0.0068 | 2.516 | 4.6229 | 11 | 190 | positive regulation of peptide secretion |
| GO:0043406 | 0.0072 | 2.3876 | 5.3042 | 12 | 218 | positive regulation of MAP kinase activity |
| GO:0032663 | 0.0072 | 5.788 | 0.7786 | 4 | 32 | regulation of interleukin-2 production |
| GO:0048856 | 0.0073 | 1.3393 | 106.9782 | 128 | 4459 | anatomical structure development |
| GO:0051251 | 0.0074 | 2.4878 | 4.6716 | 11 | 192 | positive regulation of lymphocyte activation |
| GO:0072009 | 0.0075 | 3.3142 | 2.2628 | 7 | 93 | nephron epithelium development |
| GO:0021854 | 0.0075 | 8.6641 | 0.4136 | 3 | 17 | hypothalamus development |
| GO:0044283 | 0.0076 | 1.9086 | 11.0221 | 20 | 453 | small molecule biosynthetic process |
| GO:0032946 | 0.008 | 3.2759 | 2.2871 | 7 | 94 | positive regulation of mononuclear cell proliferation |
| GO:0042327 | 0.0081 | 1.6755 | 18.8811 | 30 | 776 | positive regulation of phosphorylation |
| GO:0014052 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | regulation of gamma-aminobutyric acid secretion |
| GO:0032534 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | regulation of microvillus assembly |
| GO:0060296 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | regulation of cilium beat frequency involved in ciliary motility |
| GO:0060677 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | ureteric bud elongation |
| GO:0071493 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | cellular response to UV-B |
| GO:1902019 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | regulation of cilium-dependent cell motility |
| GO:1903054 | 0.0083 | 20.1687 | 0.146 | 2 | 6 | negative regulation of extracellular matrix organization |
| GO:0014068 | 0.0084 | 4.3174 | 1.2652 | 5 | 52 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0050830 | 0.0084 | 4.3174 | 1.2652 | 5 | 52 | defense response to Gram-positive bacterium |
| GO:0035924 | 0.009 | 5.4013 | 0.8273 | 4 | 34 | cellular response to vascular endothelial growth factor stimulus |
| GO:0002702 | 0.0091 | 4.2271 | 1.2896 | 5 | 53 | positive regulation of production of molecular mediator of immune response |
| GO:0048871 | 0.0094 | 2.212 | 6.1801 | 13 | 254 | multicellular organismal homeostasis |
| GO:0012501 | 0.0096 | 1.4609 | 39.3923 | 54 | 1619 | programmed cell death |
| GO:0008202 | 0.0097 | 2.286 | 5.5232 | 12 | 227 | steroid metabolic process |
| GO:0050715 | 0.0098 | 3.5341 | 1.8248 | 6 | 75 | positive regulation of cytokine secretion |
| GO:0048545 | 0.0098 | 2.0682 | 7.6157 | 15 | 313 | response to steroid hormone |
| GO:0010243 | 0.0099 | 1.6638 | 18.3458 | 29 | 754 | response to organonitrogen compound |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060013 | 4e-04 | 32.9923 | 0.1571 | 3 | 7 | righting reflex |
| GO:1902957 | 5e-04 | Inf | 0.0449 | 2 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:0098664 | 6e-04 | 26.3918 | 0.1795 | 3 | 8 | G-protein coupled serotonin receptor signaling pathway |
| GO:0015696 | 0.001 | 4.9326 | 1.571 | 7 | 70 | ammonium transport |
| GO:0007588 | 0.0013 | 5.5365 | 1.2119 | 6 | 54 | excretion |
| GO:0042631 | 0.0015 | 87.7017 | 0.0673 | 2 | 3 | cellular response to water deprivation |
| GO:0051970 | 0.0015 | 87.7017 | 0.0673 | 2 | 3 | negative regulation of transmission of nerve impulse |
| GO:1901856 | 0.0015 | 87.7017 | 0.0673 | 2 | 3 | negative regulation of cellular respiration |
| GO:0008284 | 0.0016 | 1.9487 | 15.3505 | 28 | 684 | positive regulation of cell proliferation |
| GO:0014047 | 0.0019 | 6.3121 | 0.8977 | 5 | 40 | glutamate secretion |
| GO:0060911 | 0.0021 | 14.6576 | 0.2693 | 3 | 12 | cardiac cell fate commitment |
| GO:0003352 | 0.0027 | 13.1908 | 0.2917 | 3 | 13 | regulation of cilium movement |
| GO:0042310 | 0.0028 | 4.6591 | 1.4139 | 6 | 63 | vasoconstriction |
| GO:0060191 | 0.0028 | 4.6591 | 1.4139 | 6 | 63 | regulation of lipase activity |
| GO:0048747 | 0.0029 | 5.663 | 0.9875 | 5 | 44 | muscle fiber development |
| GO:2000243 | 0.0029 | 5.663 | 0.9875 | 5 | 44 | positive regulation of reproductive process |
| GO:0003415 | 0.0029 | 43.8475 | 0.0898 | 2 | 4 | chondrocyte hypertrophy |
| GO:0014826 | 0.0029 | 43.8475 | 0.0898 | 2 | 4 | vein smooth muscle contraction |
| GO:0060018 | 0.0029 | 43.8475 | 0.0898 | 2 | 4 | astrocyte fate commitment |
| GO:0019217 | 0.0033 | 4.5004 | 1.4587 | 6 | 65 | regulation of fatty acid metabolic process |
| GO:0031998 | 0.0034 | 11.9907 | 0.3142 | 3 | 14 | regulation of fatty acid beta-oxidation |
| GO:0006936 | 0.0034 | 2.4311 | 6.1043 | 14 | 272 | muscle contraction |
| GO:0072376 | 0.0036 | 5.3859 | 1.0323 | 5 | 46 | protein activation cascade |
| GO:0015695 | 0.0038 | 7.0509 | 0.6508 | 4 | 29 | organic cation transport |
| GO:0055007 | 0.0041 | 3.7382 | 2.0198 | 7 | 90 | cardiac muscle cell differentiation |
| GO:0071805 | 0.0045 | 2.8363 | 3.7478 | 10 | 167 | potassium ion transmembrane transport |
| GO:0030900 | 0.0045 | 2.2716 | 6.9795 | 15 | 311 | forebrain development |
| GO:0007601 | 0.0047 | 3.0085 | 3.1868 | 9 | 142 | visual perception |
| GO:0055085 | 0.005 | 1.6406 | 24.6864 | 38 | 1100 | transmembrane transport |
| GO:0032331 | 0.005 | 10.1444 | 0.3591 | 3 | 16 | negative regulation of chondrocyte differentiation |
| GO:0042693 | 0.005 | 10.1444 | 0.3591 | 3 | 16 | muscle cell fate commitment |
| GO:0015672 | 0.0051 | 2.0701 | 9.1789 | 18 | 409 | monovalent inorganic cation transport |
| GO:0023061 | 0.006 | 2.1354 | 7.8997 | 16 | 352 | signal release |
| GO:0042053 | 0.006 | 9.4191 | 0.3815 | 3 | 17 | regulation of dopamine metabolic process |
| GO:0046883 | 0.0069 | 2.5132 | 4.6231 | 11 | 206 | regulation of hormone secretion |
| GO:0031340 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | positive regulation of vesicle fusion |
| GO:0071503 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | response to heparin |
| GO:0090324 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | negative regulation of oxidative phosphorylation |
| GO:0090385 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | phagosome-lysosome fusion |
| GO:0097623 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | potassium ion export across plasma membrane |
| GO:1905446 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | regulation of mitochondrial ATP synthesis coupled electron transport |
| GO:2000020 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | positive regulation of male gonad development |
| GO:2000794 | 0.0071 | 21.9203 | 0.1347 | 2 | 6 | regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0007268 | 0.0074 | 1.9152 | 10.9967 | 20 | 490 | chemical synaptic transmission |
| GO:0099537 | 0.0075 | 1.911 | 11.0191 | 20 | 491 | trans-synaptic signaling |
| GO:0001708 | 0.0081 | 3.6841 | 1.7505 | 6 | 78 | cell fate specification |
| GO:0043266 | 0.0081 | 3.6841 | 1.7505 | 6 | 78 | regulation of potassium ion transport |
| GO:0007202 | 0.0083 | 8.2404 | 0.4264 | 3 | 19 | activation of phospholipase C activity |
| GO:0044381 | 0.0083 | 8.2404 | 0.4264 | 3 | 19 | glucose import in response to insulin stimulus |
| GO:0060322 | 0.0094 | 1.7852 | 13.5551 | 23 | 604 | head development |
| GO:0015844 | 0.0096 | 4.1626 | 1.3016 | 5 | 58 | monoamine transport |
| GO:0031290 | 0.0096 | 7.7551 | 0.4488 | 3 | 20 | retinal ganglion cell axon guidance |
| GO:1901029 | 0.0098 | 17.5349 | 0.1571 | 2 | 7 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042126 | 1e-04 | 94.5184 | 0.1239 | 3 | 4 | nitrate metabolic process |
| GO:0051092 | 9e-04 | 3.3719 | 3.5628 | 11 | 115 | positive regulation of NF-kappaB transcription factor activity |
| GO:0010529 | 9e-04 | 11.476 | 0.4647 | 4 | 15 | negative regulation of transposition |
| GO:0002408 | 0.001 | Inf | 0.062 | 2 | 2 | myeloid dendritic cell chemotaxis |
| GO:1900155 | 0.001 | Inf | 0.062 | 2 | 2 | negative regulation of bone trabecula formation |
| GO:0048762 | 0.0013 | 2.8435 | 4.9259 | 13 | 159 | mesenchymal cell differentiation |
| GO:0001676 | 0.0015 | 4.031 | 2.1996 | 8 | 71 | long-chain fatty acid metabolic process |
| GO:0051240 | 0.0019 | 1.5873 | 37.0404 | 55 | 1201 | positive regulation of multicellular organismal process |
| GO:0016553 | 0.0022 | 15.7469 | 0.2788 | 3 | 9 | base conversion or substitution editing |
| GO:0009887 | 0.0027 | 1.6762 | 25.3113 | 40 | 817 | animal organ morphogenesis |
| GO:0046959 | 0.0028 | 62.8578 | 0.0929 | 2 | 3 | habituation |
| GO:0051410 | 0.0028 | 62.8578 | 0.0929 | 2 | 3 | detoxification of nitrogen compound |
| GO:0061107 | 0.0028 | 62.8578 | 0.0929 | 2 | 3 | seminal vesicle development |
| GO:2001199 | 0.0028 | 62.8578 | 0.0929 | 2 | 3 | negative regulation of dendritic cell differentiation |
| GO:0003337 | 0.003 | 13.4963 | 0.3098 | 3 | 10 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0035878 | 0.003 | 13.4963 | 0.3098 | 3 | 10 | nail development |
| GO:0071941 | 0.003 | 13.4963 | 0.3098 | 3 | 10 | nitrogen cycle metabolic process |
| GO:0009605 | 0.0032 | 1.4859 | 48.2371 | 67 | 1557 | response to external stimulus |
| GO:0061430 | 0.004 | 11.8084 | 0.3408 | 3 | 11 | bone trabecula morphogenesis |
| GO:0048729 | 0.0041 | 1.8029 | 16.3888 | 28 | 529 | tissue morphogenesis |
| GO:0060192 | 0.0053 | 10.4955 | 0.3718 | 3 | 12 | negative regulation of lipase activity |
| GO:0071625 | 0.0053 | 10.4955 | 0.3718 | 3 | 12 | vocalization behavior |
| GO:0009972 | 0.0055 | 31.4265 | 0.1239 | 2 | 4 | cytidine deamination |
| GO:0010572 | 0.0055 | 31.4265 | 0.1239 | 2 | 4 | positive regulation of platelet activation |
| GO:0035609 | 0.0055 | 31.4265 | 0.1239 | 2 | 4 | C-terminal protein deglutamylation |
| GO:0046087 | 0.0055 | 31.4265 | 0.1239 | 2 | 4 | cytidine metabolic process |
| GO:0070383 | 0.0055 | 31.4265 | 0.1239 | 2 | 4 | DNA cytosine deamination |
| GO:0050922 | 0.0059 | 6.3074 | 0.7435 | 4 | 24 | negative regulation of chemotaxis |
| GO:0021543 | 0.006 | 2.572 | 4.5542 | 11 | 147 | pallium development |
| GO:0048754 | 0.0061 | 2.7152 | 3.9346 | 10 | 127 | branching morphogenesis of an epithelial tube |
| GO:0030855 | 0.0065 | 1.7559 | 16.172 | 27 | 522 | epithelial cell differentiation |
| GO:0007275 | 0.0065 | 1.8583 | 13.1649 | 23 | 459 | multicellular organism development |
| GO:0009749 | 0.0067 | 2.5343 | 4.6161 | 11 | 149 | response to glucose |
| GO:0034198 | 0.0067 | 4.6442 | 1.2083 | 5 | 39 | cellular response to amino acid starvation |
| GO:0033559 | 0.0068 | 3.4095 | 2.2306 | 7 | 72 | unsaturated fatty acid metabolic process |
| GO:0032502 | 0.0069 | 1.2932 | 148.7079 | 173 | 4800 | developmental process |
| GO:0002686 | 0.0079 | 5.7331 | 0.8055 | 4 | 26 | negative regulation of leukocyte migration |
| GO:0048731 | 0.0085 | 1.3021 | 112.956 | 135 | 3646 | system development |
| GO:0006526 | 0.009 | 20.9493 | 0.1549 | 2 | 5 | arginine biosynthetic process |
| GO:0060839 | 0.009 | 20.9493 | 0.1549 | 2 | 5 | endothelial cell fate commitment |
| GO:0070257 | 0.009 | 20.9493 | 0.1549 | 2 | 5 | positive regulation of mucus secretion |
| GO:1900454 | 0.009 | 20.9493 | 0.1549 | 2 | 5 | positive regulation of long term synaptic depression |
| GO:0051496 | 0.0092 | 4.2666 | 1.3012 | 5 | 42 | positive regulation of stress fiber assembly |
| GO:0060688 | 0.0092 | 4.2666 | 1.3012 | 5 | 42 | regulation of morphogenesis of a branching structure |
| GO:0031669 | 0.0093 | 2.4107 | 4.833 | 11 | 156 | cellular response to nutrient levels |
| GO:0006805 | 0.0096 | 3.5786 | 1.8279 | 6 | 59 | xenobiotic metabolic process |
| GO:0034284 | 0.0097 | 2.394 | 4.864 | 11 | 157 | response to monosaccharide |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001807 | 8e-04 | Inf | 0.0568 | 2 | 2 | regulation of type IV hypersensitivity |
| GO:0060168 | 8e-04 | Inf | 0.0568 | 2 | 2 | positive regulation of adenosine receptor signaling pathway |
| GO:0019098 | 9e-04 | 7.8633 | 0.7671 | 5 | 27 | reproductive behavior |
| GO:1903020 | 9e-04 | 11.5108 | 0.4546 | 4 | 16 | positive regulation of glycoprotein metabolic process |
| GO:0016486 | 0.0014 | 9.8648 | 0.5114 | 4 | 18 | peptide hormone processing |
| GO:0030917 | 0.0017 | 17.2279 | 0.2557 | 3 | 9 | midbrain-hindbrain boundary development |
| GO:0006342 | 0.0017 | 3.5586 | 2.7559 | 9 | 97 | chromatin silencing |
| GO:0051410 | 0.0024 | 68.754 | 0.0852 | 2 | 3 | detoxification of nitrogen compound |
| GO:0097756 | 0.0034 | 3.9152 | 1.9604 | 7 | 69 | negative regulation of blood vessel diameter |
| GO:0042711 | 0.0041 | 11.4826 | 0.3409 | 3 | 12 | maternal behavior |
| GO:0001992 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0002865 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
| GO:0090071 | 0.0047 | 34.3743 | 0.1136 | 2 | 4 | negative regulation of ribosome biogenesis |
| GO:0001696 | 0.0053 | 10.3335 | 0.3694 | 3 | 13 | gastric acid secretion |
| GO:0007271 | 0.0058 | 6.2737 | 0.7387 | 4 | 26 | synaptic transmission, cholinergic |
| GO:0010863 | 0.0058 | 6.2737 | 0.7387 | 4 | 26 | positive regulation of phospholipase C activity |
| GO:0048853 | 0.0066 | 9.3934 | 0.3978 | 3 | 14 | forebrain morphogenesis |
| GO:0002548 | 0.0067 | 6.0005 | 0.7671 | 4 | 27 | monocyte chemotaxis |
| GO:0045907 | 0.0067 | 6.0005 | 0.7671 | 4 | 27 | positive regulation of vasoconstriction |
| GO:0002524 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | hypersensitivity |
| GO:0071462 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | cellular response to water stimulus |
| GO:2000739 | 0.0076 | 22.9144 | 0.1421 | 2 | 5 | regulation of mesenchymal stem cell differentiation |
| GO:0002090 | 0.0077 | 5.75 | 0.7955 | 4 | 28 | regulation of receptor internalization |
| GO:0046653 | 0.008 | 8.6099 | 0.4262 | 3 | 15 | tetrahydrofolate metabolic process |
| GO:0034728 | 0.008 | 2.5944 | 4.0913 | 10 | 144 | nucleosome organization |
| GO:0006335 | 0.0087 | 5.5196 | 0.8239 | 4 | 29 | DNA replication-dependent nucleosome assembly |
| GO:1903727 | 0.0087 | 5.5196 | 0.8239 | 4 | 29 | positive regulation of phospholipid metabolic process |
| GO:0002861 | 0.0097 | 7.947 | 0.4546 | 3 | 16 | regulation of inflammatory response to antigenic stimulus |
| GO:0008210 | 0.0097 | 7.947 | 0.4546 | 3 | 16 | estrogen metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003352 | 0.0028 | 13.0097 | 0.2957 | 3 | 13 | regulation of cilium movement |
| GO:0060219 | 0.0035 | 11.8261 | 0.3184 | 3 | 14 | camera-type eye photoreceptor cell differentiation |
| GO:0032026 | 0.0052 | 10.0052 | 0.3639 | 3 | 16 | response to magnesium ion |
| GO:1903510 | 0.0053 | 3.5568 | 2.1152 | 7 | 93 | mucopolysaccharide metabolic process |
| GO:0045055 | 0.0061 | 1.8592 | 13.0553 | 23 | 574 | regulated exocytosis |
| GO:0006068 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | ethanol catabolic process |
| GO:0048312 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | intracellular distribution of mitochondria |
| GO:0072038 | 0.0073 | 21.6204 | 0.1365 | 2 | 6 | mesenchymal stem cell maintenance involved in nephron morphogenesis |
| GO:0018149 | 0.0074 | 8.6698 | 0.4094 | 3 | 18 | peptide cross-linking |
| GO:0042474 | 0.0074 | 8.6698 | 0.4094 | 3 | 18 | middle ear morphogenesis |
| GO:0050482 | 0.0074 | 8.6698 | 0.4094 | 3 | 18 | arachidonic acid secretion |
| GO:0098660 | 0.0086 | 1.7778 | 14.2153 | 24 | 625 | inorganic ion transmembrane transport |
| GO:0000041 | 0.0086 | 3.6331 | 1.7741 | 6 | 78 | transition metal ion transport |
| GO:1902254 | 0.0086 | 8.1273 | 0.4321 | 3 | 19 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0006811 | 0.0088 | 1.5584 | 27.2478 | 40 | 1198 | ion transport |
| GO:0043302 | 0.01 | 7.6486 | 0.4549 | 3 | 20 | positive regulation of leukocyte degranulation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002663 | 7e-04 | Inf | 0.0517 | 2 | 2 | positive regulation of B cell tolerance induction |
| GO:0014036 | 7e-04 | Inf | 0.0517 | 2 | 2 | neural crest cell fate specification |
| GO:0060487 | 8e-04 | 11.7242 | 0.4393 | 4 | 17 | lung epithelial cell differentiation |
| GO:0021892 | 9e-04 | 22.8088 | 0.2067 | 3 | 8 | cerebral cortex GABAergic interneuron differentiation |
| GO:0048865 | 9e-04 | 22.8088 | 0.2067 | 3 | 8 | stem cell fate commitment |
| GO:0046942 | 9e-04 | 2.7305 | 5.8921 | 15 | 228 | carboxylic acid transport |
| GO:0021670 | 0.0013 | 19.0059 | 0.2326 | 3 | 9 | lateral ventricle development |
| GO:0021877 | 0.0018 | 16.2895 | 0.2584 | 3 | 10 | forebrain neuron fate commitment |
| GO:0021530 | 0.002 | 75.8294 | 0.0775 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0023021 | 0.002 | 75.8294 | 0.0775 | 2 | 3 | termination of signal transduction |
| GO:0034421 | 0.002 | 75.8294 | 0.0775 | 2 | 3 | post-translational protein acetylation |
| GO:0021532 | 0.0025 | 5.9625 | 0.9562 | 5 | 37 | neural tube patterning |
| GO:0002643 | 0.0032 | 12.6676 | 0.3101 | 3 | 12 | regulation of tolerance induction |
| GO:0003415 | 0.0039 | 37.9118 | 0.1034 | 2 | 4 | chondrocyte hypertrophy |
| GO:0007161 | 0.0039 | 37.9118 | 0.1034 | 2 | 4 | calcium-independent cell-matrix adhesion |
| GO:0021555 | 0.0039 | 37.9118 | 0.1034 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0060164 | 0.0039 | 37.9118 | 0.1034 | 2 | 4 | regulation of timing of neuron differentiation |
| GO:0010596 | 0.0039 | 5.2984 | 1.0595 | 5 | 41 | negative regulation of endothelial cell migration |
| GO:0006978 | 0.0062 | 9.4985 | 0.3876 | 3 | 15 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0032309 | 0.0062 | 6.0909 | 0.7494 | 4 | 29 | icosanoid secretion |
| GO:0009744 | 0.0063 | 25.2725 | 0.1292 | 2 | 5 | response to sucrose |
| GO:0021779 | 0.0063 | 25.2725 | 0.1292 | 2 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0.0063 | 25.2725 | 0.1292 | 2 | 5 | glial cell fate specification |
| GO:0046533 | 0.0063 | 25.2725 | 0.1292 | 2 | 5 | negative regulation of photoreceptor cell differentiation |
| GO:0010631 | 0.0066 | 2.4181 | 5.246 | 12 | 203 | epithelial cell migration |
| GO:0015908 | 0.007 | 3.819 | 1.7056 | 6 | 66 | fatty acid transport |
| GO:1901571 | 0.0071 | 5.8562 | 0.7753 | 4 | 30 | fatty acid derivative transport |
| GO:0090130 | 0.0082 | 2.3433 | 5.4011 | 12 | 209 | tissue migration |
| GO:0051590 | 0.0089 | 8.1403 | 0.4393 | 3 | 17 | positive regulation of neurotransmitter transport |
| GO:0006685 | 0.0093 | 18.9529 | 0.1551 | 2 | 6 | sphingomyelin catabolic process |
| GO:0051136 | 0.0093 | 18.9529 | 0.1551 | 2 | 6 | regulation of NK T cell differentiation |
| GO:0051791 | 0.0093 | 18.9529 | 0.1551 | 2 | 6 | medium-chain fatty acid metabolic process |
| GO:0072174 | 0.0093 | 18.9529 | 0.1551 | 2 | 6 | metanephric tubule formation |
| GO:0051453 | 0.0093 | 3.5792 | 1.809 | 6 | 70 | regulation of intracellular pH |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010726 | 3e-04 | Inf | 0.036 | 2 | 2 | positive regulation of hydrogen peroxide metabolic process |
| GO:0009650 | 9e-04 | 20.7255 | 0.1978 | 3 | 11 | UV protection |
| GO:0015891 | 0.001 | 110.1271 | 0.054 | 2 | 3 | siderophore transport |
| GO:0046010 | 0.001 | 110.1271 | 0.054 | 2 | 3 | positive regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0040018 | 0.0015 | 9.2393 | 0.5036 | 4 | 28 | positive regulation of multicellular organism growth |
| GO:0006572 | 0.0019 | 55.0593 | 0.0719 | 2 | 4 | tyrosine catabolic process |
| GO:0042536 | 0.0019 | 55.0593 | 0.0719 | 2 | 4 | negative regulation of tumor necrosis factor biosynthetic process |
| GO:0070911 | 0.0019 | 8.5273 | 0.5395 | 4 | 30 | global genome nucleotide-excision repair |
| GO:0051188 | 0.0024 | 3.3432 | 2.8774 | 9 | 160 | cofactor biosynthetic process |
| GO:0071824 | 0.0027 | 2.8671 | 4.0824 | 11 | 227 | protein-DNA complex subunit organization |
| GO:0034080 | 0.0038 | 6.9252 | 0.6474 | 4 | 36 | CENP-A containing nucleosome assembly |
| GO:0000717 | 0.0052 | 9.7464 | 0.3597 | 3 | 20 | nucleotide-excision repair, DNA duplex unwinding |
| GO:0030198 | 0.0053 | 2.6088 | 4.46 | 11 | 248 | extracellular matrix organization |
| GO:0051290 | 0.0056 | 6.1538 | 0.7194 | 4 | 40 | protein heterotetramerization |
| GO:1901678 | 0.0064 | 22.0186 | 0.1259 | 2 | 7 | iron coordination entity transport |
| GO:0019935 | 0.0066 | 3.8374 | 1.6725 | 6 | 93 | cyclic-nucleotide-mediated signaling |
| GO:0071616 | 0.0073 | 5.6792 | 0.7733 | 4 | 43 | acyl-CoA biosynthetic process |
| GO:0043044 | 0.008 | 4.3361 | 1.2409 | 5 | 69 | ATP-dependent chromatin remodeling |
| GO:0060124 | 0.0084 | 18.3475 | 0.1439 | 2 | 8 | positive regulation of growth hormone secretion |
| GO:0006294 | 0.0088 | 7.8875 | 0.4316 | 3 | 24 | nucleotide-excision repair, preincision complex assembly |
| GO:0032392 | 0.0095 | 4.141 | 1.2948 | 5 | 72 | DNA geometric change |
| GO:0034724 | 0.0099 | 5.1493 | 0.8452 | 4 | 47 | DNA replication-independent nucleosome organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 3e-04 | Inf | 0.0357 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
| GO:0006298 | 0.0014 | 9.3204 | 0.4993 | 4 | 28 | mismatch repair |
| GO:0006699 | 0.0014 | 9.3204 | 0.4993 | 4 | 28 | bile acid biosynthetic process |
| GO:0051146 | 0.0021 | 2.9628 | 3.9589 | 11 | 222 | striated muscle cell differentiation |
| GO:0010830 | 0.0025 | 5.8396 | 0.9451 | 5 | 53 | regulation of myotube differentiation |
| GO:0045429 | 0.003 | 7.4529 | 0.6063 | 4 | 34 | positive regulation of nitric oxide biosynthetic process |
| GO:0055001 | 0.003 | 3.528 | 2.4253 | 8 | 136 | muscle cell development |
| GO:0006545 | 0.0031 | 37.0228 | 0.0892 | 2 | 5 | glycine biosynthetic process |
| GO:2000402 | 0.0045 | 27.765 | 0.107 | 2 | 6 | negative regulation of lymphocyte migration |
| GO:0042267 | 0.006 | 6.0396 | 0.7311 | 4 | 41 | natural killer cell mediated cytotoxicity |
| GO:0048743 | 0.0063 | 22.2103 | 0.1248 | 2 | 7 | positive regulation of skeletal muscle fiber development |
| GO:1904684 | 0.0063 | 22.2103 | 0.1248 | 2 | 7 | negative regulation of metalloendopeptidase activity |
| GO:1903426 | 0.0072 | 4.4441 | 1.2126 | 5 | 68 | regulation of reactive oxygen species biosynthetic process |
| GO:0048747 | 0.0077 | 5.5853 | 0.7846 | 4 | 44 | muscle fiber development |
| GO:0032781 | 0.0083 | 5.4487 | 0.8025 | 4 | 45 | positive regulation of ATPase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048167 | 0.001 | 3.84 | 2.5344 | 9 | 130 | regulation of synaptic plasticity |
| GO:0043605 | 0.0011 | 101.3672 | 0.0585 | 2 | 3 | cellular amide catabolic process |
| GO:0051030 | 0.0011 | 101.3672 | 0.0585 | 2 | 3 | snRNA transport |
| GO:0006572 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | tyrosine catabolic process |
| GO:0044854 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | plasma membrane raft assembly |
| GO:0034123 | 0.0023 | 13.8663 | 0.2729 | 3 | 14 | positive regulation of toll-like receptor signaling pathway |
| GO:0010038 | 0.0023 | 2.647 | 5.2247 | 13 | 268 | response to metal ion |
| GO:0002645 | 0.0036 | 33.7839 | 0.0975 | 2 | 5 | positive regulation of tolerance induction |
| GO:1900454 | 0.0036 | 33.7839 | 0.0975 | 2 | 5 | positive regulation of long term synaptic depression |
| GO:0009072 | 0.0041 | 10.8924 | 0.3314 | 3 | 17 | aromatic amino acid family metabolic process |
| GO:0061074 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | regulation of neural retina development |
| GO:0070886 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0070206 | 0.0068 | 5.8227 | 0.7603 | 4 | 39 | protein trimerization |
| GO:0006749 | 0.0074 | 5.6605 | 0.7798 | 4 | 40 | glutathione metabolic process |
| GO:0002634 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | regulation of germinal center formation |
| GO:0014883 | 0.0075 | 20.2672 | 0.1365 | 2 | 7 | transition between fast and slow fiber |
| GO:0071222 | 0.0076 | 3.2921 | 2.2614 | 7 | 116 | cellular response to lipopolysaccharide |
| GO:0046470 | 0.0081 | 4.3267 | 1.2477 | 5 | 64 | phosphatidylcholine metabolic process |
| GO:0009410 | 0.0098 | 4.1164 | 1.3062 | 5 | 67 | response to xenobiotic stimulus |
| GO:0009404 | 0.0098 | 16.888 | 0.156 | 2 | 8 | toxin metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001786 | 0 | 9.5855 | 0.9369 | 7 | 30 | phosphatidylserine binding |
| GO:0098631 | 0 | 8.8173 | 0.9994 | 7 | 32 | cell adhesion mediator activity |
| GO:0005509 | 2e-04 | 2.1572 | 15.9904 | 32 | 512 | calcium ion binding |
| GO:0036461 | 0.001 | Inf | 0.0625 | 2 | 2 | BLOC-2 complex binding |
| GO:0098641 | 0.001 | 11.3798 | 0.4685 | 4 | 15 | cadherin binding involved in cell-cell adhesion |
| GO:0050840 | 0.0014 | 5.5396 | 1.2492 | 6 | 40 | extracellular matrix binding |
| GO:0008823 | 0.0029 | 62.3341 | 0.0937 | 2 | 3 | cupric reductase activity |
| GO:0022851 | 0.0029 | 62.3341 | 0.0937 | 2 | 3 | GABA-gated chloride ion channel activity |
| GO:0035651 | 0.0029 | 62.3341 | 0.0937 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0052851 | 0.0029 | 62.3341 | 0.0937 | 2 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0004890 | 0.0041 | 11.7096 | 0.3435 | 3 | 11 | GABA-A receptor activity |
| GO:0005178 | 0.0046 | 3.3097 | 2.6234 | 8 | 84 | integrin binding |
| GO:0005253 | 0.0052 | 3.6035 | 2.1237 | 7 | 68 | anion channel activity |
| GO:0002020 | 0.0052 | 2.9816 | 3.248 | 9 | 104 | protease binding |
| GO:0016520 | 0.0056 | 31.1646 | 0.1249 | 2 | 4 | growth hormone-releasing hormone receptor activity |
| GO:0030023 | 0.0056 | 31.1646 | 0.1249 | 2 | 4 | extracellular matrix constituent conferring elasticity |
| GO:0030151 | 0.0056 | 31.1646 | 0.1249 | 2 | 4 | molybdenum ion binding |
| GO:0035650 | 0.0056 | 31.1646 | 0.1249 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0019838 | 0.0079 | 2.7755 | 3.4667 | 9 | 111 | growth factor binding |
| GO:0043546 | 0.0091 | 20.7748 | 0.1562 | 2 | 5 | molybdopterin cofactor binding |
| GO:0008235 | 0.0095 | 4.2307 | 1.3117 | 5 | 42 | metalloexopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047617 | 5e-04 | 9.8805 | 0.6934 | 5 | 17 | acyl-CoA hydrolase activity |
| GO:0005520 | 6e-04 | 6.783 | 1.1013 | 6 | 27 | insulin-like growth factor binding |
| GO:0047844 | 0.0017 | Inf | 0.0816 | 2 | 2 | deoxycytidine deaminase activity |
| GO:1901612 | 0.0021 | 17.7301 | 0.2855 | 3 | 7 | cardiolipin binding |
| GO:0005102 | 0.0031 | 1.4885 | 46.2544 | 65 | 1134 | receptor binding |
| GO:0030545 | 0.0033 | 1.9658 | 12.3998 | 23 | 304 | receptor regulator activity |
| GO:0005125 | 0.0041 | 2.6009 | 4.9762 | 12 | 122 | cytokine activity |
| GO:0008028 | 0.0042 | 5.3851 | 1.1013 | 5 | 27 | monocarboxylic acid transmembrane transporter activity |
| GO:0004888 | 0.0044 | 1.6215 | 25.9824 | 40 | 637 | transmembrane signaling receptor activity |
| GO:0004126 | 0.0048 | 47.2037 | 0.1224 | 2 | 3 | cytidine deaminase activity |
| GO:0008940 | 0.0048 | 47.2037 | 0.1224 | 2 | 3 | nitrate reductase activity |
| GO:0016174 | 0.0048 | 47.2037 | 0.1224 | 2 | 3 | NAD(P)H oxidase activity |
| GO:0004872 | 0.0054 | 1.5146 | 35.4454 | 51 | 869 | receptor activity |
| GO:0045503 | 0.0079 | 5.9154 | 0.8158 | 4 | 20 | dynein light chain binding |
| GO:0016790 | 0.009 | 4.3862 | 1.3052 | 5 | 32 | thiolester hydrolase activity |
| GO:0001851 | 0.0094 | 23.6 | 0.1632 | 2 | 4 | complement component C3b binding |
| GO:0004111 | 0.0094 | 23.6 | 0.1632 | 2 | 4 | creatine kinase activity |
| GO:0030151 | 0.0094 | 23.6 | 0.1632 | 2 | 4 | molybdenum ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000993 | 6e-04 | 8.188 | 0.7071 | 5 | 36 | RNA polymerase II core binding |
| GO:0070063 | 9e-04 | 5.9866 | 1.1196 | 6 | 57 | RNA polymerase binding |
| GO:0004029 | 0.0014 | 16.8191 | 0.2357 | 3 | 12 | aldehyde dehydrogenase (NAD) activity |
| GO:0004028 | 0.0022 | 50.2896 | 0.0786 | 2 | 4 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0001098 | 0.0024 | 5.8975 | 0.9428 | 5 | 48 | basal transcription machinery binding |
| GO:0016651 | 0.0051 | 4.0634 | 1.591 | 6 | 81 | oxidoreductase activity, acting on NAD(P)H |
| GO:0016175 | 0.0055 | 25.1409 | 0.1179 | 2 | 6 | superoxide-generating NADPH oxidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070991 | 0 | Inf | 0.0756 | 3 | 3 | medium-chain-acyl-CoA dehydrogenase activity |
| GO:0004466 | 1e-04 | 117.0361 | 0.1008 | 3 | 4 | long-chain-acyl-CoA dehydrogenase activity |
| GO:0016627 | 2e-04 | 6.5605 | 1.2353 | 7 | 49 | oxidoreductase activity, acting on the CH-CH group of donors |
| GO:0004104 | 6e-04 | Inf | 0.0504 | 2 | 2 | cholinesterase activity |
| GO:0004683 | 0.002 | 8.6841 | 0.5546 | 4 | 22 | calmodulin-dependent protein kinase activity |
| GO:0043422 | 0.0029 | 12.996 | 0.3025 | 3 | 12 | protein kinase B binding |
| GO:0005518 | 0.0058 | 4.7716 | 1.1597 | 5 | 46 | collagen binding |
| GO:0016790 | 0.0082 | 5.5783 | 0.8067 | 4 | 32 | thiolester hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000293 | 0.0019 | 77.7898 | 0.0756 | 2 | 3 | ferric-chelate reductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050750 | 0.0029 | 8.1817 | 0.6205 | 4 | 17 | low-density lipoprotein particle receptor binding |
| GO:0004185 | 0.0034 | 13.2749 | 0.3285 | 3 | 9 | serine-type carboxypeptidase activity |
| GO:0004832 | 0.0039 | 53.0104 | 0.1095 | 2 | 3 | valine-tRNA ligase activity |
| GO:0016807 | 0.0039 | 53.0104 | 0.1095 | 2 | 3 | cysteine-type carboxypeptidase activity |
| GO:0031708 | 0.0039 | 53.0104 | 0.1095 | 2 | 3 | endothelin B receptor binding |
| GO:0098631 | 0.0057 | 4.929 | 1.168 | 5 | 32 | cell adhesion mediator activity |
| GO:0035613 | 0.0064 | 9.9546 | 0.4015 | 3 | 11 | RNA stem-loop binding |
| GO:0017034 | 0.0076 | 26.5031 | 0.146 | 2 | 4 | Rap guanyl-nucleotide exchange factor activity |
| GO:0098639 | 0.0076 | 26.5031 | 0.146 | 2 | 4 | collagen binding involved in cell-matrix adhesion |
| GO:0004683 | 0.0076 | 5.9067 | 0.803 | 4 | 22 | calmodulin-dependent protein kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016175 | 1e-04 | 54.3417 | 0.1097 | 3 | 6 | superoxide-generating NADPH oxidase activity |
| GO:0051870 | 3e-04 | Inf | 0.0366 | 2 | 2 | methotrexate binding |
| GO:0016176 | 5e-04 | 27.1646 | 0.1646 | 3 | 9 | superoxide-generating NADPH oxidase activator activity |
| GO:0015464 | 0.0023 | 13.576 | 0.2743 | 3 | 15 | acetylcholine receptor activity |
| GO:0004844 | 0.0032 | 36.0775 | 0.0914 | 2 | 5 | uracil DNA N-glycosylase activity |
| GO:0030250 | 0.0032 | 36.0775 | 0.0914 | 2 | 5 | guanylate cyclase activator activity |
| GO:0005539 | 0.0042 | 3.3302 | 2.5602 | 8 | 140 | glycosaminoglycan binding |
| GO:0010851 | 0.0048 | 27.056 | 0.1097 | 2 | 6 | cyclase regulator activity |
| GO:0030246 | 0.0059 | 2.8956 | 3.2917 | 9 | 180 | carbohydrate binding |
| GO:0005542 | 0.0066 | 21.6432 | 0.128 | 2 | 7 | folic acid binding |
| GO:0030548 | 0.0066 | 21.6432 | 0.128 | 2 | 7 | acetylcholine receptor regulator activity |
| GO:0031404 | 0.0066 | 21.6432 | 0.128 | 2 | 7 | chloride ion binding |
| GO:0016614 | 0.0091 | 3.5644 | 1.7921 | 6 | 98 | oxidoreductase activity, acting on CH-OH group of donors |
| GO:0098772 | 0.0095 | 1.5847 | 24.962 | 37 | 1365 | molecular function regulator |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001228 | 3e-04 | 2.4696 | 9.5901 | 22 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0004303 | 0.0015 | 18.0461 | 0.2445 | 3 | 9 | estradiol 17-beta-dehydrogenase activity |
| GO:0004095 | 0.0043 | 36.0028 | 0.1087 | 2 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0043565 | 0.0087 | 1.5807 | 24.668 | 37 | 908 | sequence-specific DNA binding |
| GO:0016835 | 0.0089 | 3.6245 | 1.793 | 6 | 66 | carbon-oxygen lyase activity |
| GO:0050839 | 0.0093 | 1.9013 | 10.4866 | 19 | 386 | cell adhesion molecule binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050291 | 8e-04 | 27.3198 | 0.2131 | 3 | 6 | sphingosine N-acyltransferase activity |
| GO:0070780 | 0.0013 | Inf | 0.071 | 2 | 2 | dihydrosphingosine-1-phosphate phosphatase activity |
| GO:0016627 | 0.0016 | 4.5785 | 1.7405 | 7 | 49 | oxidoreductase activity, acting on the CH-CH group of donors |
| GO:0019887 | 0.0024 | 2.5468 | 5.8964 | 14 | 166 | protein kinase regulator activity |
| GO:0004165 | 0.0037 | 54.5319 | 0.1066 | 2 | 3 | dodecenoyl-CoA delta-isomerase activity |
| GO:0008200 | 0.0038 | 5.4779 | 1.0656 | 5 | 30 | ion channel inhibitor activity |
| GO:0005044 | 0.0044 | 5.2668 | 1.1011 | 5 | 31 | scavenger receptor activity |
| GO:0098631 | 0.005 | 5.0714 | 1.1367 | 5 | 32 | cell adhesion mediator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043024 | 0.0011 | 11.4029 | 0.4911 | 4 | 13 | ribosomal small subunit binding |
| GO:0008092 | 0.0014 | 1.7103 | 26.7094 | 43 | 707 | cytoskeletal protein binding |
| GO:0019992 | 0.0053 | 10.9754 | 0.3778 | 3 | 10 | diacylglycerol binding |
| GO:0016790 | 0.0065 | 4.7541 | 1.2089 | 5 | 32 | thiolester hydrolase activity |
| GO:0032947 | 0.0079 | 3.3342 | 2.3045 | 7 | 61 | protein complex scaffold activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022838 | 2e-04 | 2.6324 | 8.1951 | 20 | 332 | substrate-specific channel activity |
| GO:0022803 | 5e-04 | 2.4397 | 8.7875 | 20 | 356 | passive transmembrane transporter activity |
| GO:0030594 | 6e-04 | 5.4131 | 1.4564 | 7 | 59 | neurotransmitter receptor activity |
| GO:0046982 | 0.0014 | 2.2047 | 10.1451 | 21 | 411 | protein heterodimerization activity |
| GO:0004930 | 0.0018 | 2.3083 | 8.2938 | 18 | 336 | G-protein coupled receptor activity |
| GO:0003987 | 0.0018 | 79.5031 | 0.0741 | 2 | 3 | acetate-CoA ligase activity |
| GO:0004090 | 0.0018 | 79.5031 | 0.0741 | 2 | 3 | carbonyl reductase (NADPH) activity |
| GO:0004984 | 0.0021 | 5.0124 | 1.3329 | 6 | 54 | olfactory receptor activity |
| GO:0005230 | 0.0021 | 5.0124 | 1.3329 | 6 | 54 | extracellular ligand-gated ion channel activity |
| GO:0005261 | 0.0033 | 2.4354 | 6.0969 | 14 | 247 | cation channel activity |
| GO:0015269 | 0.0044 | 10.8663 | 0.3456 | 3 | 14 | calcium-activated potassium channel activity |
| GO:0016917 | 0.0044 | 10.8663 | 0.3456 | 3 | 14 | GABA receptor activity |
| GO:0022849 | 0.0058 | 26.4969 | 0.1234 | 2 | 5 | glutamate-gated calcium ion channel activity |
| GO:0070405 | 0.0064 | 4.6501 | 1.1848 | 5 | 48 | ammonium ion binding |
| GO:0022839 | 0.0076 | 5.7019 | 0.7899 | 4 | 32 | ion gated channel activity |
| GO:0022836 | 0.0079 | 2.3528 | 5.3772 | 12 | 220 | gated channel activity |
| GO:0016409 | 0.0094 | 5.321 | 0.8393 | 4 | 34 | palmitoyltransferase activity |
| GO:0042393 | 0.01 | 2.4999 | 4.221 | 10 | 171 | histone binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004126 | 0.003 | 60.5176 | 0.0964 | 2 | 3 | cytidine deaminase activity |
| GO:0043177 | 0.0042 | 2.7161 | 4.3381 | 11 | 135 | organic acid binding |
| GO:0070402 | 0.0058 | 10.1038 | 0.3856 | 3 | 12 | NADPH binding |
| GO:1990782 | 0.0068 | 3.8856 | 1.7031 | 6 | 53 | protein tyrosine kinase binding |
| GO:0005070 | 0.007 | 4.6058 | 1.2211 | 5 | 38 | SH3/SH2 adaptor activity |
| GO:0000976 | 0.0079 | 1.6606 | 19.6019 | 31 | 610 | transcription regulatory region sequence-specific DNA binding |
| GO:0033293 | 0.0097 | 4.221 | 1.3175 | 5 | 41 | monocarboxylic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | Inf | 0.0912 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0912 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0005132 | 9e-04 | Inf | 0.0608 | 2 | 2 | type I interferon receptor binding |
| GO:0050501 | 0.0053 | 32.0448 | 0.1216 | 2 | 4 | hyaluronan synthase activity |
| GO:0008569 | 0.0079 | 8.7552 | 0.4256 | 3 | 14 | ATP-dependent microtubule motor activity, minus-end-directed |
| GO:0016798 | 0.0088 | 2.9376 | 2.9187 | 8 | 96 | hydrolase activity, acting on glycosyl bonds |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017137 | 0 | 6.0555 | 2.8352 | 15 | 161 | Rab GTPase binding |
| GO:0004556 | 0 | Inf | 0.0528 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0528 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0038023 | 2e-04 | 2.3266 | 12.6791 | 27 | 720 | signaling receptor activity |
| GO:0060089 | 3e-04 | 2.1229 | 15.9722 | 31 | 907 | molecular transducer activity |
| GO:0016623 | 3e-04 | Inf | 0.0352 | 2 | 2 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor |
| GO:0005096 | 7e-04 | 3.2432 | 3.9798 | 12 | 226 | GTPase activator activity |
| GO:0099600 | 7e-04 | 2.2023 | 11.7634 | 24 | 668 | transmembrane receptor activity |
| GO:0008233 | 8e-04 | 2.4359 | 8.3823 | 19 | 476 | peptidase activity |
| GO:0070008 | 0.0011 | 18.824 | 0.2113 | 3 | 12 | serine-type exopeptidase activity |
| GO:0015440 | 0.0018 | 56.2586 | 0.0704 | 2 | 4 | peptide-transporting ATPase activity |
| GO:0042605 | 0.0021 | 14.1147 | 0.2641 | 3 | 15 | peptide antigen binding |
| GO:0042043 | 0.003 | 37.5029 | 0.088 | 2 | 5 | neurexin family protein binding |
| GO:0043546 | 0.003 | 37.5029 | 0.088 | 2 | 5 | molybdopterin cofactor binding |
| GO:0032395 | 0.0044 | 28.125 | 0.1057 | 2 | 6 | MHC class II receptor activity |
| GO:0060589 | 0.0048 | 2.5212 | 5.0364 | 12 | 286 | nucleoside-triphosphatase regulator activity |
| GO:0004930 | 0.0066 | 2.3185 | 5.9169 | 13 | 336 | G-protein coupled receptor activity |
| GO:0031267 | 0.0075 | 2.0845 | 8.1005 | 16 | 460 | small GTPase binding |
| GO:0005102 | 0.0078 | 1.679 | 19.719 | 31 | 1129 | receptor binding |
| GO:0036459 | 0.0084 | 3.6282 | 1.761 | 6 | 100 | thiol-dependent ubiquitinyl hydrolase activity |
| GO:0008237 | 0.0099 | 3.1141 | 2.3773 | 7 | 135 | metallopeptidase activity |
| GO:0070405 | 0.0099 | 5.1423 | 0.8453 | 4 | 48 | ammonium ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050501 | 0.0035 | 39.7485 | 0.0987 | 2 | 4 | hyaluronan synthase activity |
| GO:0003779 | 0.0049 | 2.1865 | 7.7261 | 16 | 313 | actin binding |
| GO:0004180 | 0.0053 | 6.3877 | 0.7158 | 4 | 29 | carboxypeptidase activity |
| GO:0030621 | 0.0058 | 26.4969 | 0.1234 | 2 | 5 | U4 snRNA binding |
| GO:0044877 | 0.0091 | 1.6456 | 19.8459 | 31 | 804 | macromolecular complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048018 | 2e-04 | 2.9056 | 6.8235 | 18 | 161 | receptor ligand activity |
| GO:0046982 | 4e-04 | 1.9984 | 17.6921 | 33 | 411 | protein heterodimerization activity |
| GO:0005125 | 8e-04 | 2.929 | 5.2517 | 14 | 122 | cytokine activity |
| GO:0001972 | 0.0013 | 11.1866 | 0.5166 | 4 | 12 | retinoic acid binding |
| GO:0005021 | 0.0024 | 16.7557 | 0.3013 | 3 | 7 | vascular endothelial growth factor-activated receptor activity |
| GO:1901612 | 0.0024 | 16.7557 | 0.3013 | 3 | 7 | cardiolipin binding |
| GO:0102991 | 0.0038 | 13.4035 | 0.3444 | 3 | 8 | myristoyl-CoA hydrolase activity |
| GO:0047617 | 0.0052 | 6.8814 | 0.7318 | 4 | 17 | acyl-CoA hydrolase activity |
| GO:0004126 | 0.0054 | 44.614 | 0.1291 | 2 | 3 | cytidine deaminase activity |
| GO:0005166 | 0.0054 | 44.614 | 0.1291 | 2 | 3 | neurotrophin p75 receptor binding |
| GO:0005184 | 0.0064 | 6.3893 | 0.7748 | 4 | 18 | neuropeptide hormone activity |
| GO:0017075 | 0.0064 | 6.3893 | 0.7748 | 4 | 18 | syntaxin-1 binding |
| GO:0070300 | 0.0064 | 6.3893 | 0.7748 | 4 | 18 | phosphatidic acid binding |
| GO:0004629 | 0.0095 | 5.5898 | 0.8609 | 4 | 20 | phospholipase C activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005520 | 7e-04 | 6.6663 | 1.1196 | 6 | 27 | insulin-like growth factor binding |
| GO:0047844 | 0.0017 | Inf | 0.0829 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0005021 | 0.0022 | 17.4266 | 0.2903 | 3 | 7 | vascular endothelial growth factor-activated receptor activity |
| GO:1901612 | 0.0022 | 17.4266 | 0.2903 | 3 | 7 | cardiolipin binding |
| GO:0004888 | 0.0034 | 1.6377 | 26.4138 | 41 | 637 | transmembrane signaling receptor activity |
| GO:0030545 | 0.004 | 1.9309 | 12.6057 | 23 | 304 | receptor regulator activity |
| GO:0047617 | 0.0045 | 7.1574 | 0.7049 | 4 | 17 | acyl-CoA hydrolase activity |
| GO:0008028 | 0.0046 | 5.2926 | 1.1196 | 5 | 27 | monocarboxylic acid transmembrane transporter activity |
| GO:0005125 | 0.0047 | 2.5556 | 5.0589 | 12 | 122 | cytokine activity |
| GO:0004872 | 0.0047 | 1.5204 | 36.0339 | 52 | 869 | receptor activity |
| GO:0004126 | 0.005 | 46.3971 | 0.1244 | 2 | 3 | cytidine deaminase activity |
| GO:0008940 | 0.005 | 46.3971 | 0.1244 | 2 | 3 | nitrate reductase activity |
| GO:0045503 | 0.0083 | 5.814 | 0.8293 | 4 | 20 | dynein light chain binding |
| GO:0001851 | 0.0097 | 23.1967 | 0.1659 | 2 | 4 | complement component C3b binding |
| GO:0004111 | 0.0097 | 23.1967 | 0.1659 | 2 | 4 | creatine kinase activity |
| GO:0030151 | 0.0097 | 23.1967 | 0.1659 | 2 | 4 | molybdenum ion binding |
| GO:0031406 | 0.0098 | 2.3021 | 5.5564 | 12 | 134 | carboxylic acid binding |
| GO:0005102 | 0.0099 | 1.4062 | 47.0224 | 63 | 1134 | receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016860 | 5e-04 | 6.8376 | 1.0182 | 6 | 41 | intramolecular oxidoreductase activity |
| GO:0008823 | 0.0018 | 79.0061 | 0.0745 | 2 | 3 | cupric reductase activity |
| GO:0052851 | 0.0018 | 79.0061 | 0.0745 | 2 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0004888 | 0.0025 | 1.88 | 15.8195 | 28 | 637 | transmembrane signaling receptor activity |
| GO:0043274 | 0.0028 | 13.1998 | 0.298 | 3 | 12 | phospholipase binding |
| GO:0030023 | 0.0036 | 39.5 | 0.0993 | 2 | 4 | extracellular matrix constituent conferring elasticity |
| GO:0004872 | 0.0057 | 1.6677 | 21.5811 | 34 | 869 | receptor activity |
| GO:0016416 | 0.0059 | 26.3313 | 0.1242 | 2 | 5 | O-palmitoyltransferase activity |
| GO:0022803 | 0.0078 | 2.0218 | 8.8411 | 17 | 356 | passive transmembrane transporter activity |
| GO:0004871 | 0.0079 | 1.5944 | 24.5364 | 37 | 988 | signal transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000293 | 0.0019 | 77.5509 | 0.0759 | 2 | 3 | ferric-chelate reductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 3e-04 | Inf | 0.0349 | 2 | 2 | MHC class Ib receptor activity |
| GO:1903231 | 5e-04 | 5.6104 | 1.3793 | 7 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0016702 | 0.0025 | 13.1438 | 0.2793 | 3 | 16 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
| GO:0005542 | 0.006 | 22.6974 | 0.1222 | 2 | 7 | folic acid binding |
| GO:0043295 | 0.006 | 22.6974 | 0.1222 | 2 | 7 | glutathione binding |
| GO:0004843 | 0.0066 | 4.5427 | 1.1872 | 5 | 68 | thiol-dependent ubiquitin-specific protease activity |
| GO:0003707 | 0.0077 | 5.5691 | 0.7857 | 4 | 45 | steroid hormone receptor activity |
| GO:0102991 | 0.0079 | 18.913 | 0.1397 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 0 | 111.2538 | 0.175 | 4 | 5 | molybdopterin cofactor binding |
| GO:0030151 | 2e-04 | 83.2597 | 0.14 | 3 | 4 | molybdenum ion binding |
| GO:0047844 | 0.0012 | Inf | 0.07 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0031492 | 0.0028 | 4.7761 | 1.4348 | 6 | 41 | nucleosomal DNA binding |
| GO:0004126 | 0.0036 | 55.3866 | 0.105 | 2 | 3 | cytidine deaminase activity |
| GO:0008940 | 0.0036 | 55.3866 | 0.105 | 2 | 3 | nitrate reductase activity |
| GO:0016174 | 0.0036 | 55.3866 | 0.105 | 2 | 3 | NAD(P)H oxidase activity |
| GO:0070573 | 0.0036 | 55.3866 | 0.105 | 2 | 3 | metallodipeptidase activity |
| GO:0070915 | 0.0036 | 55.3866 | 0.105 | 2 | 3 | lysophosphatidic acid receptor activity |
| GO:0005523 | 0.0043 | 11.8887 | 0.3499 | 3 | 10 | tropomyosin binding |
| GO:0016684 | 0.0047 | 5.1514 | 1.1198 | 5 | 32 | oxidoreductase activity, acting on peroxide as acceptor |
| GO:0004867 | 0.0051 | 4.1775 | 1.6097 | 6 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0001733 | 0.007 | 27.6911 | 0.14 | 2 | 4 | galactosylceramide sulfotransferase activity |
| GO:0004111 | 0.007 | 27.6911 | 0.14 | 2 | 4 | creatine kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036461 | 9e-04 | Inf | 0.0604 | 2 | 2 | BLOC-2 complex binding |
| GO:0005509 | 0.0018 | 1.9237 | 15.4509 | 28 | 512 | calcium ion binding |
| GO:0043565 | 0.0022 | 1.6693 | 27.4013 | 43 | 908 | sequence-specific DNA binding |
| GO:0035651 | 0.0027 | 64.5915 | 0.0905 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0022803 | 0.0027 | 2.0706 | 10.7432 | 21 | 356 | passive transmembrane transporter activity |
| GO:0005539 | 0.0034 | 2.7895 | 4.2249 | 11 | 140 | glycosaminoglycan binding |
| GO:0000977 | 0.0036 | 1.8218 | 16.2356 | 28 | 538 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0005201 | 0.0038 | 4.4337 | 1.5089 | 6 | 50 | extracellular matrix structural constituent |
| GO:0005546 | 0.0042 | 4.3349 | 1.5391 | 6 | 51 | phosphatidylinositol-4,5-bisphosphate binding |
| GO:0022836 | 0.0042 | 2.2278 | 7.6048 | 16 | 252 | gated channel activity |
| GO:0051015 | 0.0048 | 2.8157 | 3.8024 | 10 | 126 | actin filament binding |
| GO:0030547 | 0.0049 | 10.7856 | 0.3621 | 3 | 12 | receptor inhibitor activity |
| GO:0005237 | 0.0052 | 32.2932 | 0.1207 | 2 | 4 | inhibitory extracellular ligand-gated ion channel activity |
| GO:0016520 | 0.0052 | 32.2932 | 0.1207 | 2 | 4 | growth hormone-releasing hormone receptor activity |
| GO:0031014 | 0.0052 | 32.2932 | 0.1207 | 2 | 4 | troponin T binding |
| GO:0035650 | 0.0052 | 32.2932 | 0.1207 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0022838 | 0.0058 | 1.9981 | 10.019 | 19 | 332 | substrate-specific channel activity |
| GO:0005528 | 0.0062 | 9.7063 | 0.3923 | 3 | 13 | FK506 binding |
| GO:0043236 | 0.0072 | 5.8919 | 0.7846 | 4 | 26 | laminin binding |
| GO:0045309 | 0.0075 | 4.5072 | 1.2373 | 5 | 41 | protein phosphorylated amino acid binding |
| GO:0030594 | 0.0085 | 3.6782 | 1.7805 | 6 | 59 | neurotransmitter receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001786 | 0 | 9.7331 | 0.9234 | 7 | 30 | phosphatidylserine binding |
| GO:0098631 | 0 | 8.953 | 0.9849 | 7 | 32 | cell adhesion mediator activity |
| GO:0005509 | 1e-04 | 2.272 | 15.7592 | 33 | 512 | calcium ion binding |
| GO:0098641 | 9e-04 | 11.5538 | 0.4617 | 4 | 15 | cadherin binding involved in cell-cell adhesion |
| GO:0036461 | 9e-04 | Inf | 0.0616 | 2 | 2 | BLOC-2 complex binding |
| GO:0050840 | 0.0013 | 5.6247 | 1.2312 | 6 | 40 | extracellular matrix binding |
| GO:0008823 | 0.0028 | 63.2826 | 0.0923 | 2 | 3 | cupric reductase activity |
| GO:0022851 | 0.0028 | 63.2826 | 0.0923 | 2 | 3 | GABA-gated chloride ion channel activity |
| GO:0035651 | 0.0028 | 63.2826 | 0.0923 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0052851 | 0.0028 | 63.2826 | 0.0923 | 2 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0004890 | 0.004 | 11.8882 | 0.3386 | 3 | 11 | GABA-A receptor activity |
| GO:0005178 | 0.0043 | 3.3608 | 2.5855 | 8 | 84 | integrin binding |
| GO:0002020 | 0.0047 | 3.0278 | 3.2011 | 9 | 104 | protease binding |
| GO:0005253 | 0.0048 | 3.659 | 2.093 | 7 | 68 | anion channel activity |
| GO:0030023 | 0.0054 | 31.6388 | 0.1231 | 2 | 4 | extracellular matrix constituent conferring elasticity |
| GO:0030151 | 0.0054 | 31.6388 | 0.1231 | 2 | 4 | molybdenum ion binding |
| GO:0035650 | 0.0054 | 31.6388 | 0.1231 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0047756 | 0.0054 | 31.6388 | 0.1231 | 2 | 4 | chondroitin 4-sulfotransferase activity |
| GO:0019838 | 0.0072 | 2.8185 | 3.4165 | 9 | 111 | growth factor binding |
| GO:0001537 | 0.0089 | 21.0909 | 0.1539 | 2 | 5 | N-acetylgalactosamine 4-O-sulfotransferase activity |
| GO:0043546 | 0.0089 | 21.0909 | 0.1539 | 2 | 5 | molybdopterin cofactor binding |
| GO:0008235 | 0.009 | 4.2956 | 1.2927 | 5 | 42 | metalloexopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005542 | 1e-04 | 50.3308 | 0.1043 | 3 | 7 | folic acid binding |
| GO:0051371 | 5e-04 | 25.1577 | 0.1639 | 3 | 11 | muscle alpha-actinin binding |
| GO:0042805 | 7e-04 | 11.2251 | 0.4172 | 4 | 28 | actinin binding |
| GO:0019104 | 8e-04 | 20.1231 | 0.1937 | 3 | 13 | DNA N-glycosylase activity |
| GO:0097493 | 8e-04 | 20.1231 | 0.1937 | 3 | 13 | structural molecule activity conferring elasticity |
| GO:0008517 | 0.0013 | 66.7755 | 0.0596 | 2 | 4 | folic acid transporter activity |
| GO:0004844 | 0.0021 | 44.5136 | 0.0745 | 2 | 5 | uracil DNA N-glycosylase activity |
| GO:0030414 | 0.0028 | 4.6172 | 1.4007 | 6 | 94 | peptidase inhibitor activity |
| GO:0061135 | 0.0031 | 4.5139 | 1.4305 | 6 | 96 | endopeptidase regulator activity |
| GO:0008237 | 0.0041 | 3.7113 | 2.0116 | 7 | 135 | metallopeptidase activity |
| GO:0004867 | 0.0048 | 6.4055 | 0.6854 | 4 | 46 | serine-type endopeptidase inhibitor activity |
| GO:0030246 | 0.0056 | 3.1623 | 2.6821 | 8 | 180 | carbohydrate binding |
| GO:0003779 | 0.0073 | 2.4908 | 4.6639 | 11 | 313 | actin binding |
| GO:0045294 | 0.0074 | 19.0714 | 0.1341 | 2 | 9 | alpha-catenin binding |
| GO:0033130 | 0.0092 | 16.6862 | 0.149 | 2 | 10 | acetylcholine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016175 | 0 | 69.4086 | 0.1698 | 4 | 6 | superoxide-generating NADPH oxidase activity |
| GO:0001972 | 3e-04 | 17.3441 | 0.3396 | 4 | 12 | retinoic acid binding |
| GO:0016651 | 5e-04 | 4.3733 | 2.292 | 9 | 81 | oxidoreductase activity, acting on NAD(P)H |
| GO:0016176 | 0.0017 | 17.3003 | 0.2547 | 3 | 9 | superoxide-generating NADPH oxidase activator activity |
| GO:0031005 | 0.0017 | 17.3003 | 0.2547 | 3 | 9 | filamin binding |
| GO:0005166 | 0.0024 | 69.0428 | 0.0849 | 2 | 3 | neurotrophin p75 receptor binding |
| GO:0001159 | 0.0027 | 2.1564 | 9.3377 | 19 | 330 | core promoter proximal region DNA binding |
| GO:0001012 | 0.003 | 1.8737 | 15.2517 | 27 | 539 | RNA polymerase II regulatory region DNA binding |
| GO:0019841 | 0.0031 | 12.9732 | 0.3113 | 3 | 11 | retinol binding |
| GO:0019840 | 0.0036 | 7.2965 | 0.6508 | 4 | 23 | isoprenoid binding |
| GO:0000978 | 0.0038 | 2.1356 | 8.9133 | 18 | 315 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0000975 | 0.0041 | 1.7035 | 21.109 | 34 | 746 | regulatory region DNA binding |
| GO:0000976 | 0.0044 | 1.7737 | 17.2607 | 29 | 610 | transcription regulatory region sequence-specific DNA binding |
| GO:0003690 | 0.0068 | 1.6681 | 20.2035 | 32 | 714 | double-stranded DNA binding |
| GO:0016416 | 0.0075 | 23.0107 | 0.1415 | 2 | 5 | O-palmitoyltransferase activity |
| GO:0015026 | 0.0075 | 5.7742 | 0.7923 | 4 | 28 | coreceptor activity |
| GO:0031210 | 0.0079 | 8.6461 | 0.4244 | 3 | 15 | phosphatidylcholine binding |
| GO:0043565 | 0.0098 | 1.5561 | 25.693 | 38 | 908 | sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036132 | 0.0018 | 80.2601 | 0.0734 | 2 | 3 | 13-prostaglandin reductase activity |
| GO:0047192 | 0.0018 | 80.2601 | 0.0734 | 2 | 3 | 1-alkylglycerophosphocholine O-acetyltransferase activity |
| GO:0047522 | 0.0018 | 80.2601 | 0.0734 | 2 | 3 | 15-oxoprostaglandin 13-oxidase activity |
| GO:0043141 | 0.0035 | 40.1269 | 0.0978 | 2 | 4 | ATP-dependent 5'-3' DNA helicase activity |
| GO:0047184 | 0.0035 | 40.1269 | 0.0978 | 2 | 4 | 1-acylglycerophosphocholine O-acyltransferase activity |
| GO:0016409 | 0.0091 | 5.372 | 0.8316 | 4 | 34 | palmitoyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016175 | 3e-04 | 37.0573 | 0.1589 | 3 | 6 | superoxide-generating NADPH oxidase activity |
| GO:0016176 | 0.0014 | 18.5244 | 0.2384 | 3 | 9 | superoxide-generating NADPH oxidase activator activity |
| GO:0008201 | 0.0021 | 3.4373 | 2.8344 | 9 | 107 | heparin binding |
| GO:0097109 | 0.0066 | 24.6343 | 0.1325 | 2 | 5 | neuroligin family protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1901611 | 1e-04 | 23.1932 | 0.2822 | 4 | 10 | phosphatidylglycerol binding |
| GO:0008294 | 8e-04 | Inf | 0.0564 | 2 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
| GO:0031995 | 0.0011 | 20.8194 | 0.2258 | 3 | 8 | insulin-like growth factor II binding |
| GO:0046872 | 0.0036 | 1.3708 | 94.766 | 118 | 3358 | metal ion binding |
| GO:0031994 | 0.0041 | 11.5627 | 0.3387 | 3 | 12 | insulin-like growth factor I binding |
| GO:0005432 | 0.0046 | 34.6139 | 0.1129 | 2 | 4 | calcium:sodium antiporter activity |
| GO:0008525 | 0.0075 | 23.0742 | 0.1411 | 2 | 5 | phosphatidylcholine transporter activity |
| GO:0003700 | 0.0075 | 1.5368 | 30.2529 | 44 | 1072 | DNA binding transcription factor activity |
| GO:0004653 | 0.0095 | 8.0025 | 0.4515 | 3 | 16 | polypeptide N-acetylgalactosaminyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019785 | 8e-04 | Inf | 0.0552 | 2 | 2 | ISG15-specific protease activity |
| GO:0004126 | 0.0022 | 70.7945 | 0.0829 | 2 | 3 | cytidine deaminase activity |
| GO:0004995 | 0.0022 | 70.7945 | 0.0829 | 2 | 3 | tachykinin receptor activity |
| GO:0016722 | 0.0038 | 11.8242 | 0.3314 | 3 | 12 | oxidoreductase activity, oxidizing metal ions |
| GO:0001733 | 0.0044 | 35.3945 | 0.1105 | 2 | 4 | galactosylceramide sulfotransferase activity |
| GO:0030151 | 0.0044 | 35.3945 | 0.1105 | 2 | 4 | molybdenum ion binding |
| GO:0019215 | 0.0049 | 10.6409 | 0.359 | 3 | 13 | intermediate filament binding |
| GO:0043546 | 0.0072 | 23.5945 | 0.1381 | 2 | 5 | molybdopterin cofactor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | Inf | 0.0725 | 3 | 3 | alpha-amylase activity |
| GO:0103025 | 0 | Inf | 0.0725 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
| GO:0030545 | 2e-04 | 2.7996 | 7.3438 | 19 | 304 | receptor regulator activity |
| GO:0005021 | 5e-04 | 30.5731 | 0.1691 | 3 | 7 | vascular endothelial growth factor-activated receptor activity |
| GO:0005125 | 7e-04 | 3.6906 | 2.9472 | 10 | 122 | cytokine activity |
| GO:0005164 | 0.0012 | 10.2137 | 0.4831 | 4 | 20 | tumor necrosis factor receptor binding |
| GO:0097603 | 0.0017 | 81.2915 | 0.0725 | 2 | 3 | temperature-gated ion channel activity |
| GO:0016798 | 0.0022 | 3.7406 | 2.3191 | 8 | 96 | hydrolase activity, acting on glycosyl bonds |
| GO:0005198 | 0.0028 | 1.9658 | 12.9482 | 24 | 536 | structural molecule activity |
| GO:0019205 | 0.0036 | 5.3835 | 1.0388 | 5 | 43 | nucleobase-containing compound kinase activity |
| GO:0005102 | 0.0049 | 1.6098 | 27.1137 | 41 | 1129 | receptor binding |
| GO:0042043 | 0.0055 | 27.093 | 0.1208 | 2 | 5 | neurexin family protein binding |
| GO:0033764 | 0.0062 | 9.4006 | 0.3865 | 3 | 16 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0070006 | 0.0062 | 9.4006 | 0.3865 | 3 | 16 | metalloaminopeptidase activity |
| GO:0001530 | 0.0074 | 8.7284 | 0.4107 | 3 | 17 | lipopolysaccharide binding |
| GO:0015278 | 0.0087 | 8.1459 | 0.4348 | 3 | 18 | calcium-release channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030151 | 1e-04 | 98.4046 | 0.1192 | 3 | 4 | molybdenum ion binding |
| GO:0043546 | 3e-04 | 49.1985 | 0.149 | 3 | 5 | molybdopterin cofactor binding |
| GO:0047844 | 9e-04 | Inf | 0.0596 | 2 | 2 | deoxycytidine deaminase activity |
| GO:0004126 | 0.0026 | 65.4365 | 0.0894 | 2 | 3 | cytidine deaminase activity |
| GO:0008940 | 0.0026 | 65.4365 | 0.0894 | 2 | 3 | nitrate reductase activity |
| GO:0030160 | 0.0026 | 65.4365 | 0.0894 | 2 | 3 | GKAP/Homer scaffold activity |
| GO:0008201 | 0.0046 | 3.0361 | 3.1887 | 9 | 107 | heparin binding |
| GO:0032190 | 0.0051 | 32.7157 | 0.1192 | 2 | 4 | acrosin binding |
| GO:0050840 | 0.0064 | 4.6975 | 1.1921 | 5 | 40 | extracellular matrix binding |
| GO:0038132 | 0.0083 | 21.8088 | 0.149 | 2 | 5 | neuregulin binding |
| GO:0016408 | 0.0092 | 8.1934 | 0.447 | 3 | 15 | C-acyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004096 | 8e-04 | Inf | 0.0575 | 2 | 2 | catalase activity |
| GO:0072341 | 0.003 | 4.6647 | 1.4374 | 6 | 50 | modified amino acid binding |
| GO:0005000 | 0.0078 | 22.6368 | 0.1437 | 2 | 5 | vasopressin receptor activity |
| GO:0046982 | 0.0079 | 1.8669 | 11.8153 | 21 | 411 | protein heterodimerization activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003810 | 0.003 | 43.5772 | 0.0903 | 2 | 4 | protein-glutamine gamma-glutamyltransferase activity |
| GO:0031705 | 0.003 | 43.5772 | 0.0903 | 2 | 4 | bombesin receptor binding |
| GO:0097371 | 0.003 | 43.5772 | 0.0903 | 2 | 4 | MDM2/MDM4 family protein binding |
| GO:0008144 | 0.0094 | 3.5615 | 1.8061 | 6 | 80 | drug binding |
| GO:0016881 | 0.0098 | 7.7071 | 0.4515 | 3 | 20 | acid-amino acid ligase activity |
| GO:0005221 | 0.0099 | 17.4268 | 0.158 | 2 | 7 | intracellular cyclic nucleotide activated cation channel activity |
| GO:0039706 | 0.0099 | 17.4268 | 0.158 | 2 | 7 | co-receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016747 | 4e-04 | 3.271 | 4.3113 | 13 | 168 | transferase activity, transferring acyl groups other than amino-acyl groups |
| GO:0031014 | 0.0038 | 38.1858 | 0.1026 | 2 | 4 | troponin T binding |
| GO:0046912 | 0.0038 | 38.1858 | 0.1026 | 2 | 4 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer |
| GO:0034236 | 0.0049 | 10.4379 | 0.3593 | 3 | 14 | protein kinase A catalytic subunit binding |
| GO:0048306 | 0.0069 | 4.5723 | 1.2061 | 5 | 47 | calcium-dependent protein binding |
| GO:0016406 | 0.0092 | 19.09 | 0.154 | 2 | 6 | carnitine O-acyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097677 | 6e-04 | 31.0821 | 0.1883 | 3 | 6 | STAT family protein binding |
| GO:0016623 | 0.001 | Inf | 0.0628 | 2 | 2 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor |
| GO:0048407 | 0.0022 | 15.5374 | 0.2824 | 3 | 9 | platelet-derived growth factor binding |
| GO:0031994 | 0.0055 | 10.3559 | 0.3766 | 3 | 12 | insulin-like growth factor I binding |
| GO:0005219 | 0.0057 | 31.0096 | 0.1255 | 2 | 4 | ryanodine-sensitive calcium-release channel activity |
| GO:0048763 | 0.0057 | 31.0096 | 0.1255 | 2 | 4 | calcium-induced calcium release activity |
| GO:0043546 | 0.0092 | 20.6715 | 0.1569 | 2 | 5 | molybdopterin cofactor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005518 | 0.0091 | 5.2943 | 0.8239 | 4 | 46 | collagen binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 3e-04 | Inf | 0.0352 | 2 | 2 | MHC class Ib receptor activity |
| GO:1903231 | 5e-04 | 5.5601 | 1.3912 | 7 | 79 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0030983 | 8e-04 | 21.1786 | 0.1937 | 3 | 11 | mismatched DNA binding |
| GO:0005542 | 0.0061 | 22.4983 | 0.1233 | 2 | 7 | folic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042806 | 3e-04 | Inf | 0.0372 | 2 | 2 | fucose binding |
| GO:0000293 | 0.001 | 106.449 | 0.0558 | 2 | 3 | ferric-chelate reductase activity |
| GO:0003810 | 0.002 | 53.2204 | 0.0744 | 2 | 4 | protein-glutamine gamma-glutamyltransferase activity |
| GO:0004857 | 0.0048 | 2.5201 | 5.0374 | 12 | 271 | enzyme inhibitor activity |
| GO:0004860 | 0.005 | 4.0849 | 1.58 | 6 | 85 | protein kinase inhibitor activity |
| GO:0051393 | 0.0066 | 8.8955 | 0.3904 | 3 | 21 | alpha-actinin binding |
| GO:0044325 | 0.009 | 3.5826 | 1.7845 | 6 | 96 | ion channel binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030511 | 0.0063 | 220.1449 | 0.0063 | 1 | 24 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032456 | 0.0086 | 158.1354 | 0.0087 | 1 | 33 | endocytic recycling |
| GO:0048536 | 0.0094 | 144.5524 | 0.0095 | 1 | 36 | spleen development |
| GO:0031670 | 0.01 | 136.7207 | 0.01 | 1 | 38 | cellular response to nutrient |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 99.7351 | 0.0607 | 3 | 154 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 90.6325 | 0.0666 | 3 | 169 | DNA packaging |
| GO:0071824 | 1e-04 | 66.3053 | 0.0903 | 3 | 229 | protein-DNA complex subunit organization |
| GO:0006334 | 3e-04 | 117.0698 | 0.029 | 2 | 88 | nucleosome assembly |
| GO:0034622 | 0.0042 | 15.1133 | 0.3734 | 3 | 947 | cellular macromolecular complex assembly |
| GO:0051276 | 0.0063 | 12.9679 | 0.4306 | 3 | 1092 | chromosome organization |
| GO:0001580 | 0.0071 | 178.7529 | 0.0071 | 1 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0002227 | 0.0075 | 168.8111 | 0.0075 | 1 | 19 | innate immune response in mucosa |
| GO:0006335 | 0.0094 | 132.0696 | 0.0095 | 1 | 24 | DNA replication-dependent nucleosome assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034472 | 0.0026 | 633.4167 | 0.0026 | 1 | 13 | snRNA 3'-end processing |
| GO:1903830 | 0.0028 | 584.6538 | 0.0028 | 1 | 14 | magnesium ion transmembrane transport |
| GO:0016338 | 0.0043 | 361.7381 | 0.0043 | 1 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0090503 | 0.0069 | 223.2353 | 0.0069 | 1 | 35 | RNA phosphodiester bond hydrolysis, exonucleolytic |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 0 | Inf | 4e-04 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0050435 | 0 | 1012.2667 | 0.0063 | 2 | 32 | amyloid-beta metabolic process |
| GO:0006475 | 2e-04 | 221.7353 | 0.0272 | 2 | 138 | internal protein amino acid acetylation |
| GO:0018394 | 3e-04 | 218.4928 | 0.0276 | 2 | 140 | peptidyl-lysine acetylation |
| GO:0043543 | 5e-04 | 157.3089 | 0.038 | 2 | 193 | protein acylation |
| GO:2000535 | 0.0012 | 1520.9 | 0.0012 | 1 | 6 | regulation of entry of bacterium into host cell |
| GO:0045091 | 0.0018 | 950.375 | 0.0018 | 1 | 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0050930 | 0.0026 | 633.4167 | 0.0026 | 1 | 13 | induction of positive chemotaxis |
| GO:0036499 | 0.0039 | 399.8684 | 0.0039 | 1 | 20 | PERK-mediated unfolded protein response |
| GO:0039694 | 0.0045 | 345.2727 | 0.0045 | 1 | 23 | viral RNA genome replication |
| GO:0090023 | 0.0045 | 345.2727 | 0.0045 | 1 | 23 | positive regulation of neutrophil chemotaxis |
| GO:0050926 | 0.0049 | 316.4583 | 0.0049 | 1 | 25 | regulation of positive chemotaxis |
| GO:0001702 | 0.0053 | 292.0769 | 0.0053 | 1 | 27 | gastrulation with mouth forming second |
| GO:1902622 | 0.0059 | 261.8103 | 0.0059 | 1 | 30 | regulation of neutrophil migration |
| GO:0048566 | 0.0069 | 223.2353 | 0.0069 | 1 | 35 | embryonic digestive tract development |
| GO:0045744 | 0.0073 | 210.8056 | 0.0073 | 1 | 37 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0043066 | 0.0078 | 36.7125 | 0.1554 | 2 | 788 | negative regulation of apoptotic process |
| GO:0071622 | 0.0079 | 194.5513 | 0.0079 | 1 | 40 | regulation of granulocyte chemotaxis |
| GO:0060548 | 0.0097 | 32.5773 | 0.1739 | 2 | 882 | negative regulation of cell death |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018298 | 0 | 760.1 | 0.0046 | 2 | 10 | protein-chromophore linkage |
| GO:0060011 | 0.0014 | 1267.3333 | 0.0014 | 1 | 3 | Sertoli cell proliferation |
| GO:0042713 | 0.0028 | 506.8333 | 0.0028 | 1 | 6 | sperm ejaculation |
| GO:0033015 | 0.0032 | 422.3333 | 0.0032 | 1 | 7 | tetrapyrrole catabolic process |
| GO:0042167 | 0.0032 | 422.3333 | 0.0032 | 1 | 7 | heme catabolic process |
| GO:0044706 | 0.0035 | 30.1729 | 0.0925 | 2 | 201 | multi-multicellular organism process |
| GO:0032927 | 0.0037 | 361.9762 | 0.0037 | 1 | 8 | positive regulation of activin receptor signaling pathway |
| GO:0043084 | 0.0041 | 316.7083 | 0.0041 | 1 | 9 | penile erection |
| GO:0051187 | 0.0087 | 140.6667 | 0.0087 | 1 | 19 | cofactor catabolic process |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006120 | 0.0028 | Inf | 0.0028 | 1 | 43 | mitochondrial electron transport, NADH to ubiquinone |
| GO:0032981 | 0.0036 | Inf | 0.0036 | 1 | 55 | mitochondrial respiratory chain complex I assembly |
| GO:0042773 | 0.005 | Inf | 0.005 | 1 | 76 | ATP synthesis coupled electron transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051103 | 7e-04 | Inf | 7e-04 | 1 | 11 | DNA ligation involved in DNA repair |
| GO:0006303 | 0.0043 | Inf | 0.0043 | 1 | 66 | double-strand break repair via nonhomologous end joining |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006824 | 7e-04 | 3802.75 | 7e-04 | 1 | 5 | cobalt ion transport |
| GO:0015889 | 0.0011 | 2172.5714 | 0.0011 | 1 | 8 | cobalamin transport |
| GO:0009235 | 0.0026 | 799.7895 | 0.0026 | 1 | 20 | cobalamin metabolic process |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1901625 | 7e-04 | Inf | 7e-04 | 1 | 1 | cellular response to ergosterol |
| GO:0021985 | 0.0013 | 1689.5556 | 0.0013 | 1 | 2 | neurohypophysis development |
| GO:0051692 | 0.0013 | 1689.5556 | 0.0013 | 1 | 2 | cellular oligosaccharide catabolic process |
| GO:0006334 | 0.0023 | 34.3114 | 0.0736 | 2 | 112 | nucleosome assembly |
| GO:0050770 | 0.0038 | 26.7128 | 0.094 | 2 | 143 | regulation of axonogenesis |
| GO:0001957 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | intramembranous ossification |
| GO:0006689 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | ganglioside catabolic process |
| GO:0021869 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | forebrain ventricular zone progenitor cell division |
| GO:0021979 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | hypothalamus cell differentiation |
| GO:0048639 | 0.0042 | 25.095 | 0.0999 | 2 | 152 | positive regulation of developmental growth |
| GO:0006333 | 0.0043 | 24.7615 | 0.1012 | 2 | 154 | chromatin assembly or disassembly |
| GO:0006323 | 0.0052 | 22.515 | 0.1111 | 2 | 169 | DNA packaging |
| GO:0045653 | 0.0085 | 140.6944 | 0.0085 | 1 | 13 | negative regulation of megakaryocyte differentiation |
| GO:0019377 | 0.0092 | 129.8632 | 0.0092 | 1 | 14 | glycolipid catabolic process |
| GO:0071824 | 0.0094 | 16.4978 | 0.1505 | 2 | 229 | protein-DNA complex subunit organization |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 1e-04 | Inf | 0.0202 | 2 | 154 | chromatin assembly or disassembly |
| GO:0006323 | 1e-04 | Inf | 0.0222 | 2 | 169 | DNA packaging |
| GO:0071824 | 2e-04 | Inf | 0.0301 | 2 | 229 | protein-DNA complex subunit organization |
| GO:0006335 | 0.0032 | 660.5217 | 0.0032 | 1 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0.0034 | 607.6 | 0.0034 | 1 | 26 | chromatin silencing at rDNA |
| GO:0034622 | 0.0039 | Inf | 0.1245 | 2 | 947 | cellular macromolecular complex assembly |
| GO:0038111 | 0.0043 | 474.4688 | 0.0043 | 1 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0043 | 474.4688 | 0.0043 | 1 | 33 | response to interleukin-7 |
| GO:0051290 | 0.0046 | 446.5 | 0.0046 | 1 | 35 | protein heterotetramerization |
| GO:0051276 | 0.0051 | Inf | 0.1435 | 2 | 1092 | chromosome organization |
| GO:0006334 | 0.0058 | Inf | 0.0058 | 1 | 88 | nucleosome assembly |
| GO:0045652 | 0.0087 | 233.0769 | 0.0087 | 1 | 66 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0.0092 | 219.5072 | 0.0092 | 1 | 70 | positive regulation of gene expression, epigenetic |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031497 | 4e-04 | 116.9302 | 0.0344 | 2 | 131 | chromatin assembly |
| GO:0034728 | 5e-04 | 110.0438 | 0.0365 | 2 | 139 | nucleosome organization |
| GO:0065004 | 0.001 | 75.8333 | 0.0526 | 2 | 200 | protein-DNA complex assembly |
| GO:0071103 | 0.0015 | 61.8636 | 0.0641 | 2 | 244 | DNA conformation change |
| GO:0002227 | 0.005 | 281.3889 | 0.005 | 1 | 19 | innate immune response in mucosa |
| GO:0006335 | 0.0063 | 220.1449 | 0.0063 | 1 | 24 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0.0068 | 202.5067 | 0.0068 | 1 | 26 | chromatin silencing at rDNA |
| GO:0002251 | 0.0076 | 180.7738 | 0.0076 | 1 | 29 | organ or tissue specific immune response |
| GO:0019731 | 0.0079 | 174.5287 | 0.0079 | 1 | 30 | antibacterial humoral response |
| GO:0038111 | 0.0086 | 158.1354 | 0.0087 | 1 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0086 | 158.1354 | 0.0087 | 1 | 33 | response to interleukin-7 |
| GO:0051290 | 0.0092 | 148.8137 | 0.0092 | 1 | 35 | protein heterotetramerization |
| GO:0061844 | 0.0097 | 140.5278 | 0.0097 | 1 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002587 | 4e-04 | 7606.5 | 4e-04 | 1 | 2 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II |
| GO:0002580 | 8e-04 | 2535.1667 | 8e-04 | 1 | 4 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0002583 | 0.001 | 1901.25 | 0.001 | 1 | 5 | regulation of antigen processing and presentation of peptide antigen |
| GO:0002578 | 0.0014 | 1267.3333 | 0.0014 | 1 | 7 | negative regulation of antigen processing and presentation |
| GO:0032456 | 0.0065 | 237.2188 | 0.0065 | 1 | 33 | endocytic recycling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018003 | 0 | Inf | 4e-04 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0050435 | 0 | 1012.2667 | 0.0063 | 2 | 32 | amyloid-beta metabolic process |
| GO:0006475 | 2e-04 | 221.7353 | 0.0272 | 2 | 138 | internal protein amino acid acetylation |
| GO:0018394 | 3e-04 | 218.4928 | 0.0276 | 2 | 140 | peptidyl-lysine acetylation |
| GO:0043543 | 5e-04 | 157.3089 | 0.038 | 2 | 193 | protein acylation |
| GO:2000535 | 0.0012 | 1520.9 | 0.0012 | 1 | 6 | regulation of entry of bacterium into host cell |
| GO:0045091 | 0.0018 | 950.375 | 0.0018 | 1 | 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0050930 | 0.0026 | 633.4167 | 0.0026 | 1 | 13 | induction of positive chemotaxis |
| GO:0036499 | 0.0039 | 399.8684 | 0.0039 | 1 | 20 | PERK-mediated unfolded protein response |
| GO:0039694 | 0.0045 | 345.2727 | 0.0045 | 1 | 23 | viral RNA genome replication |
| GO:0090023 | 0.0045 | 345.2727 | 0.0045 | 1 | 23 | positive regulation of neutrophil chemotaxis |
| GO:0050926 | 0.0049 | 316.4583 | 0.0049 | 1 | 25 | regulation of positive chemotaxis |
| GO:0001702 | 0.0053 | 292.0769 | 0.0053 | 1 | 27 | gastrulation with mouth forming second |
| GO:1902622 | 0.0059 | 261.8103 | 0.0059 | 1 | 30 | regulation of neutrophil migration |
| GO:0048566 | 0.0069 | 223.2353 | 0.0069 | 1 | 35 | embryonic digestive tract development |
| GO:0045744 | 0.0073 | 210.8056 | 0.0073 | 1 | 37 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0043066 | 0.0078 | 36.7125 | 0.1554 | 2 | 788 | negative regulation of apoptotic process |
| GO:0071622 | 0.0079 | 194.5513 | 0.0079 | 1 | 40 | regulation of granulocyte chemotaxis |
| GO:0060548 | 0.0097 | 32.5773 | 0.1739 | 2 | 882 | negative regulation of cell death |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0.0075 | 270.6964 | 0.0075 | 1 | 57 | detection of chemical stimulus involved in sensory perception of smell |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032788 | 0.0011 | Inf | 0.0011 | 1 | 1 | saturated monocarboxylic acid metabolic process |
| GO:0032789 | 0.0011 | Inf | 0.0011 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
| GO:2000494 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
| GO:0035669 | 0.0022 | 949.9375 | 0.0022 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
| GO:0006104 | 0.0045 | 316.6042 | 0.0045 | 1 | 4 | succinyl-CoA metabolic process |
| GO:0051725 | 0.0045 | 316.6042 | 0.0045 | 1 | 4 | protein de-ADP-ribosylation |
| GO:1902412 | 0.0045 | 316.6042 | 0.0045 | 1 | 4 | regulation of mitotic cytokinesis |
| GO:2000609 | 0.0056 | 237.4375 | 0.0056 | 1 | 5 | regulation of thyroid hormone generation |
| GO:0034128 | 0.0067 | 189.9375 | 0.0067 | 1 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0071351 | 0.0067 | 189.9375 | 0.0067 | 1 | 6 | cellular response to interleukin-18 |
| GO:2000535 | 0.0067 | 189.9375 | 0.0067 | 1 | 6 | regulation of entry of bacterium into host cell |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030511 | 0.0047 | 330.2391 | 0.0047 | 1 | 24 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0048536 | 0.0071 | 216.8429 | 0.0071 | 1 | 36 | spleen development |
| GO:0031670 | 0.0075 | 205.0946 | 0.0075 | 1 | 38 | cellular response to nutrient |
| GO:0007566 | 0.0096 | 157.9792 | 0.0097 | 1 | 49 | embryo implantation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002526 | 7e-04 | 77.3436 | 0.0434 | 2 | 132 | acute inflammatory response |
| GO:0045919 | 0.0033 | 422.3056 | 0.0033 | 1 | 10 | positive regulation of cytolysis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1902358 | 0.0017 | 1266.9167 | 0.0017 | 1 | 13 | sulfate transmembrane transport |
| GO:0072348 | 0.0046 | 446.5 | 0.0046 | 1 | 35 | sulfur compound transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008207 | 2e-04 | 114.9545 | 0.023 | 2 | 35 | C21-steroid hormone metabolic process |
| GO:0045660 | 7e-04 | Inf | 7e-04 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0070377 | 7e-04 | Inf | 7e-04 | 1 | 1 | negative regulation of ERK5 cascade |
| GO:0009719 | 0.0011 | 9.9482 | 0.9161 | 5 | 1394 | response to endogenous stimulus |
| GO:0017143 | 0.0013 | 1689.5556 | 0.0013 | 1 | 2 | insecticide metabolic process |
| GO:0030812 | 0.0013 | 1689.5556 | 0.0013 | 1 | 2 | negative regulation of nucleotide catabolic process |
| GO:0030821 | 0.0013 | 1689.5556 | 0.0013 | 1 | 2 | negative regulation of cAMP catabolic process |
| GO:0048545 | 0.0015 | 17.427 | 0.2418 | 3 | 368 | response to steroid hormone |
| GO:0019933 | 0.0017 | 40.1941 | 0.0631 | 2 | 96 | cAMP-mediated signaling |
| GO:0018963 | 0.002 | 844.7222 | 0.002 | 1 | 3 | phthalate metabolic process |
| GO:0070859 | 0.002 | 844.7222 | 0.002 | 1 | 3 | positive regulation of bile acid biosynthetic process |
| GO:0071373 | 0.002 | 844.7222 | 0.002 | 1 | 3 | cellular response to luteinizing hormone stimulus |
| GO:0072249 | 0.002 | 844.7222 | 0.002 | 1 | 3 | metanephric glomerular visceral epithelial cell development |
| GO:0072312 | 0.002 | 844.7222 | 0.002 | 1 | 3 | metanephric glomerular epithelial cell differentiation |
| GO:0009617 | 0.0026 | 14.1842 | 0.2951 | 3 | 449 | response to bacterium |
| GO:0018879 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | biphenyl metabolic process |
| GO:0018894 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | dibenzo-p-dioxin metabolic process |
| GO:0030805 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | regulation of cyclic nucleotide catabolic process |
| GO:0033121 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | regulation of purine nucleotide catabolic process |
| GO:0051344 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | negative regulation of cyclic-nucleotide phosphodiesterase activity |
| GO:0042542 | 0.0028 | 31.4312 | 0.0802 | 2 | 122 | response to hydrogen peroxide |
| GO:0009891 | 0.0028 | 7.8982 | 1.1264 | 5 | 1714 | positive regulation of biosynthetic process |
| GO:0030814 | 0.003 | 30.164 | 0.0835 | 2 | 127 | regulation of cAMP metabolic process |
| GO:0051534 | 0.0033 | 422.3056 | 0.0033 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:1904753 | 0.0033 | 422.3056 | 0.0033 | 1 | 5 | negative regulation of vascular associated smooth muscle cell migration |
| GO:0051384 | 0.0033 | 28.5511 | 0.0881 | 2 | 134 | response to glucocorticoid |
| GO:0006701 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | progesterone biosynthetic process |
| GO:0009635 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | response to herbicide |
| GO:0045906 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | negative regulation of vasoconstriction |
| GO:0060992 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | response to fungicide |
| GO:0097647 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | amylin receptor signaling pathway |
| GO:0048468 | 0.004 | 7.2111 | 1.2203 | 5 | 1857 | cell development |
| GO:0061370 | 0.0046 | 281.5 | 0.0046 | 1 | 7 | testosterone biosynthetic process |
| GO:0071499 | 0.0046 | 281.5 | 0.0046 | 1 | 7 | cellular response to laminar fluid shear stress |
| GO:0097084 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | vascular smooth muscle cell development |
| GO:2000035 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | regulation of stem cell division |
| GO:0042445 | 0.0058 | 21.2288 | 0.1176 | 2 | 179 | hormone metabolic process |
| GO:0009187 | 0.0059 | 21.1081 | 0.1183 | 2 | 180 | cyclic nucleotide metabolic process |
| GO:0034115 | 0.0059 | 211.0972 | 0.0059 | 1 | 9 | negative regulation of heterotypic cell-cell adhesion |
| GO:0035457 | 0.0059 | 211.0972 | 0.0059 | 1 | 9 | cellular response to interferon-alpha |
| GO:0042747 | 0.0059 | 211.0972 | 0.0059 | 1 | 9 | circadian sleep/wake cycle, REM sleep |
| GO:0070586 | 0.0066 | 187.6296 | 0.0066 | 1 | 10 | cell-cell adhesion involved in gastrulation |
| GO:1904706 | 0.0066 | 187.6296 | 0.0066 | 1 | 10 | negative regulation of vascular smooth muscle cell proliferation |
| GO:2001214 | 0.0066 | 187.6296 | 0.0066 | 1 | 10 | positive regulation of vasculogenesis |
| GO:0070848 | 0.0067 | 10.0326 | 0.4114 | 3 | 626 | response to growth factor |
| GO:0043116 | 0.0072 | 168.8556 | 0.0072 | 1 | 11 | negative regulation of vascular permeability |
| GO:0060712 | 0.0072 | 168.8556 | 0.0072 | 1 | 11 | spongiotrophoblast layer development |
| GO:0071372 | 0.0072 | 168.8556 | 0.0072 | 1 | 11 | cellular response to follicle-stimulating hormone stimulus |
| GO:0006703 | 0.0079 | 153.4949 | 0.0079 | 1 | 12 | estrogen biosynthetic process |
| GO:0060670 | 0.0079 | 153.4949 | 0.0079 | 1 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0072310 | 0.0079 | 153.4949 | 0.0079 | 1 | 12 | glomerular epithelial cell development |
| GO:1904251 | 0.0079 | 153.4949 | 0.0079 | 1 | 12 | regulation of bile acid metabolic process |
| GO:0071560 | 0.008 | 17.9402 | 0.1387 | 2 | 211 | cellular response to transforming growth factor beta stimulus |
| GO:0002031 | 0.0085 | 140.6944 | 0.0085 | 1 | 13 | G-protein coupled receptor internalization |
| GO:0071872 | 0.0085 | 140.6944 | 0.0085 | 1 | 13 | cellular response to epinephrine stimulus |
| GO:0042180 | 0.0086 | 17.2696 | 0.1439 | 2 | 219 | cellular ketone metabolic process |
| GO:0042981 | 0.0091 | 6.685 | 0.9089 | 4 | 1383 | regulation of apoptotic process |
| GO:0071236 | 0.0092 | 129.8632 | 0.0092 | 1 | 14 | cellular response to antibiotic |
| GO:0043207 | 0.0095 | 8.8027 | 0.4659 | 3 | 709 | response to external biotic stimulus |
| GO:0045765 | 0.0095 | 16.3515 | 0.1518 | 2 | 231 | regulation of angiogenesis |
| GO:0032868 | 0.0096 | 16.2793 | 0.1525 | 2 | 232 | response to insulin |
| GO:0030852 | 0.0098 | 120.5794 | 0.0099 | 1 | 15 | regulation of granulocyte differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034157 | 3e-04 | 15214 | 3e-04 | 1 | 2 | positive regulation of toll-like receptor 7 signaling pathway |
| GO:1904808 | 3e-04 | 15214 | 3e-04 | 1 | 2 | positive regulation of protein oxidation |
| GO:0032461 | 0.003 | 690.5909 | 0.003 | 1 | 23 | positive regulation of protein oligomerization |
| GO:0034121 | 0.0075 | 270.6964 | 0.0075 | 1 | 57 | regulation of toll-like receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007606 | 0.0087 | Inf | 0.0087 | 1 | 132 | sensory perception of chemical stimulus |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1902600 | 0.0062 | Inf | 0.0062 | 1 | 94 | hydrogen ion transmembrane transport |
| GO:0006818 | 0.0091 | Inf | 0.0091 | 1 | 138 | hydrogen transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007606 | 0.0087 | Inf | 0.0087 | 1 | 132 | sensory perception of chemical stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002138 | 0.0024 | 633.5417 | 0.0024 | 1 | 9 | retinoic acid biosynthetic process |
| GO:0006776 | 0.0024 | 633.5417 | 0.0024 | 1 | 9 | vitamin A metabolic process |
| GO:0016114 | 0.0032 | 460.6667 | 0.0032 | 1 | 12 | terpenoid biosynthetic process |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045660 | 3e-04 | Inf | 3e-04 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0002573 | 8e-04 | 87.9649 | 0.0455 | 2 | 173 | myeloid leukocyte differentiation |
| GO:0033594 | 0.0011 | 1690 | 0.0011 | 1 | 4 | response to hydroxyisoflavone |
| GO:0045637 | 0.0012 | 69.4306 | 0.0573 | 2 | 218 | regulation of myeloid cell differentiation |
| GO:0032571 | 0.0013 | 1267.4167 | 0.0013 | 1 | 5 | response to vitamin K |
| GO:1902105 | 0.0014 | 65.1435 | 0.061 | 2 | 232 | regulation of leukocyte differentiation |
| GO:2000035 | 0.0021 | 724.0952 | 0.0021 | 1 | 8 | regulation of stem cell division |
| GO:0009629 | 0.0024 | 633.5417 | 0.0024 | 1 | 9 | response to gravity |
| GO:0017187 | 0.0026 | 563.1111 | 0.0026 | 1 | 10 | peptidyl-glutamic acid carboxylation |
| GO:0030852 | 0.0039 | 361.881 | 0.0039 | 1 | 15 | regulation of granulocyte differentiation |
| GO:0002076 | 0.0042 | 337.7333 | 0.0042 | 1 | 16 | osteoblast development |
| GO:0006465 | 0.0047 | 297.9608 | 0.0047 | 1 | 18 | signal peptide processing |
| GO:0071305 | 0.005 | 281.3889 | 0.005 | 1 | 19 | cellular response to vitamin D |
| GO:0071157 | 0.0058 | 241.1429 | 0.0058 | 1 | 22 | negative regulation of cell cycle arrest |
| GO:0045124 | 0.0086 | 158.1354 | 0.0087 | 1 | 33 | regulation of bone resorption |
| GO:0033574 | 0.0097 | 140.5278 | 0.0097 | 1 | 37 | response to testosterone |
| GO:0031670 | 0.01 | 136.7207 | 0.01 | 1 | 38 | cellular response to nutrient |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004861 | 0.0039 | 346.1364 | 0.0039 | 1 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0043014 | 0.0085 | 152.16 | 0.0085 | 1 | 26 | alpha-tubulin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031849 | 0.0016 | 1015.8 | 0.0016 | 1 | 4 | olfactory receptor binding |
| GO:0070330 | 0.0082 | 152.2 | 0.0083 | 1 | 21 | aromatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004535 | 0.0043 | 317.2708 | 0.0043 | 1 | 13 | poly(A)-specific ribonuclease activity |
| GO:0015095 | 0.0049 | 271.9107 | 0.0049 | 1 | 15 | magnesium ion transmembrane transporter activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004468 | 0 | 3809.5 | 0.0016 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0016407 | 2e-04 | 176.2326 | 0.0231 | 2 | 88 | acetyltransferase activity |
| GO:0016410 | 2e-04 | 176.2326 | 0.0231 | 2 | 88 | N-acyltransferase activity |
| GO:0047198 | 3e-04 | Inf | 3e-04 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0005153 | 5e-04 | 5080.3333 | 5e-04 | 1 | 2 | interleukin-8 receptor binding |
| GO:0016746 | 0.0013 | 65.559 | 0.0606 | 2 | 231 | transferase activity, transferring acyl groups |
| GO:0008009 | 0.0078 | 174.8621 | 0.0079 | 1 | 30 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046904 | 5e-04 | Inf | 5e-04 | 1 | 1 | calcium oxalate binding |
| GO:0019862 | 0.0016 | 1088.2857 | 0.0016 | 1 | 3 | IgA binding |
| GO:0034711 | 0.0021 | 725.4762 | 0.0021 | 1 | 4 | inhibin binding |
| GO:0098821 | 0.0031 | 435.2286 | 0.0031 | 1 | 6 | BMP receptor activity |
| GO:0017002 | 0.0037 | 362.6667 | 0.0037 | 1 | 7 | activin-activated receptor activity |
| GO:0008020 | 0.0047 | 271.9643 | 0.0047 | 1 | 9 | G-protein coupled photoreceptor activity |
| GO:0019855 | 0.0058 | 217.5429 | 0.0058 | 1 | 11 | calcium channel inhibitor activity |
| GO:0048185 | 0.0063 | 197.7532 | 0.0063 | 1 | 12 | activin binding |
| GO:0004602 | 0.0089 | 135.9107 | 0.0089 | 1 | 17 | glutathione peroxidase activity |
| GO:0044877 | 0.0098 | 9.3595 | 0.4833 | 3 | 921 | macromolecular complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035939 | 4e-04 | 7621 | 4e-04 | 1 | 3 | microsatellite binding |
| GO:0000983 | 0.0025 | 845.8889 | 0.0025 | 1 | 19 | transcription factor activity, RNA polymerase II core promoter sequence-specific |
| GO:0001102 | 0.0048 | 422.4444 | 0.0049 | 1 | 37 | RNA polymerase II activating transcription factor binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047025 | 0.001 | 2176.7143 | 0.001 | 1 | 2 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity |
| GO:0070404 | 0.0016 | 1088.2857 | 0.0016 | 1 | 3 | NADH binding |
| GO:0047035 | 0.0031 | 435.2286 | 0.0031 | 1 | 6 | testosterone dehydrogenase (NAD+) activity |
| GO:0003857 | 0.0042 | 310.8367 | 0.0042 | 1 | 8 | 3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0004303 | 0.0058 | 217.5429 | 0.0058 | 1 | 11 | estradiol 17-beta-dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008137 | 0.0024 | Inf | 0.0024 | 1 | 36 | NADH dehydrogenase (ubiquinone) activity |
| GO:0003954 | 0.0025 | Inf | 0.0025 | 1 | 38 | NADH dehydrogenase activity |
| GO:0016655 | 0.0032 | Inf | 0.0032 | 1 | 49 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032947 | 0.0045 | Inf | 0.0045 | 1 | 69 | protein complex scaffold activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031419 | 0.001 | 2176.7143 | 0.001 | 1 | 8 | cobalamin binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0052794 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | exo-alpha-(2->3)-sialidase activity |
| GO:0052795 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | exo-alpha-(2->6)-sialidase activity |
| GO:0052796 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | exo-alpha-(2->8)-sialidase activity |
| GO:0016997 | 0.0039 | 338.4667 | 0.0039 | 1 | 6 | alpha-sialidase activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 9e-04 | Inf | 0.059 | 2 | 450 | protein heterodimerization activity |
| GO:0097677 | 9e-04 | 2539.6667 | 9e-04 | 1 | 7 | STAT family protein binding |
| GO:0031492 | 0.0051 | 400.1579 | 0.0051 | 1 | 39 | nucleosomal DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0.005 | 33.0223 | 0.1181 | 2 | 450 | protein heterodimerization activity |
| GO:0070330 | 0.0055 | 253.7 | 0.0055 | 1 | 21 | aromatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032395 | 0.0014 | 1269.75 | 0.0014 | 1 | 7 | MHC class II receptor activity |
| GO:0023026 | 0.0028 | 585.7692 | 0.0028 | 1 | 14 | MHC class II protein complex binding |
| GO:0043014 | 0.0051 | 304.36 | 0.0051 | 1 | 26 | alpha-tubulin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004468 | 0 | 3809.5 | 0.0016 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0016407 | 2e-04 | 176.2326 | 0.0231 | 2 | 88 | acetyltransferase activity |
| GO:0016410 | 2e-04 | 176.2326 | 0.0231 | 2 | 88 | N-acyltransferase activity |
| GO:0047198 | 3e-04 | Inf | 3e-04 | 1 | 1 | cysteine-S-conjugate N-acetyltransferase activity |
| GO:0005153 | 5e-04 | 5080.3333 | 5e-04 | 1 | 2 | interleukin-8 receptor binding |
| GO:0016746 | 0.0013 | 65.559 | 0.0606 | 2 | 231 | transferase activity, transferring acyl groups |
| GO:0008009 | 0.0078 | 174.8621 | 0.0079 | 1 | 30 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005520 | 0.0037 | 563.5926 | 0.0037 | 1 | 28 | insulin-like growth factor binding |
| GO:0004984 | 0.0075 | 271.2143 | 0.0075 | 1 | 57 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004778 | 0.0011 | Inf | 0.0011 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0047273 | 0.0011 | Inf | 0.0011 | 1 | 1 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity |
| GO:0003875 | 0.0022 | 951.75 | 0.0022 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GO:0005153 | 0.0022 | 951.75 | 0.0022 | 1 | 2 | interleukin-8 receptor binding |
| GO:0102991 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | myristoyl-CoA hydrolase activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004861 | 0.0031 | 461.5455 | 0.0031 | 1 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001594 | 4e-04 | Inf | 4e-04 | 1 | 1 | trace-amine receptor activity |
| GO:0031731 | 4e-04 | Inf | 4e-04 | 1 | 1 | CCR6 chemokine receptor binding |
| GO:0005178 | 7e-04 | 72.0714 | 0.0421 | 2 | 107 | integrin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005549 | 0.0036 | 380.775 | 0.0036 | 1 | 11 | odorant binding |
| GO:0042056 | 0.0092 | 140.8704 | 0.0092 | 1 | 28 | chemoattractant activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015382 | 4e-04 | 7621 | 4e-04 | 1 | 2 | sodium:sulfate symporter activity |
| GO:0050786 | 0.0016 | 1088.2857 | 0.0016 | 1 | 8 | RAGE receptor binding |
| GO:0015116 | 0.0028 | 585.7692 | 0.0028 | 1 | 14 | sulfate transmembrane transporter activity |
| GO:0005509 | 0.0051 | 46.0852 | 0.1251 | 2 | 636 | calcium ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031700 | 6e-04 | Inf | 6e-04 | 1 | 1 | adrenomedullin receptor binding |
| GO:0070016 | 0.0059 | 211.5 | 0.0059 | 1 | 10 | armadillo repeat domain binding |
| GO:0005549 | 0.0065 | 190.3375 | 0.0065 | 1 | 11 | odorant binding |
| GO:0004707 | 0.0082 | 146.3846 | 0.0083 | 1 | 14 | MAP kinase activity |
| GO:0017127 | 0.01 | 118.9141 | 0.01 | 1 | 17 | cholesterol transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017147 | 0.002 | Inf | 0.002 | 1 | 30 | Wnt-protein binding |
| GO:0004222 | 0.0069 | Inf | 0.0069 | 1 | 105 | metalloendopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001594 | 1e-04 | Inf | 1e-04 | 1 | 1 | trace-amine receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004129 | 0.0014 | Inf | 0.0014 | 1 | 22 | cytochrome-c oxidase activity |
| GO:0016675 | 0.0015 | Inf | 0.0015 | 1 | 23 | oxidoreductase activity, acting on a heme group of donors |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001594 | 1e-04 | Inf | 1e-04 | 1 | 1 | trace-amine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1904768 | 4e-04 | 7621 | 4e-04 | 1 | 2 | all-trans-retinol binding |
| GO:0016918 | 0.0028 | 585.7692 | 0.0028 | 1 | 14 | retinal binding |
| GO:0019840 | 0.0065 | 237.6719 | 0.0065 | 1 | 33 | isoprenoid binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008147 | 1e-04 | Inf | 1e-04 | 1 | 1 | structural constituent of bone |
| GO:0046848 | 4e-04 | 7621 | 4e-04 | 1 | 3 | hydroxyapatite binding |
| GO:0004984 | 0.0075 | 271.2143 | 0.0075 | 1 | 57 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005153 | 3e-04 | 15243 | 3e-04 | 1 | 2 | interleukin-8 receptor binding |
| GO:0008009 | 0.0039 | 524.6552 | 0.0039 | 1 | 30 | chemokine activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018242 | 5e-04 | Inf | 5e-04 | 1 | 6 | protein O-linked glycosylation via serine |
| GO:0018243 | 5e-04 | Inf | 5e-04 | 1 | 6 | protein O-linked glycosylation via threonine |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071824 | 0 | 20.7453 | 0.3945 | 6 | 227 | protein-DNA complex subunit organization |
| GO:0006333 | 0 | 24.187 | 0.2694 | 5 | 155 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 21.4366 | 0.3024 | 5 | 174 | DNA packaging |
| GO:0051276 | 2e-04 | 6.314 | 1.8023 | 8 | 1037 | chromosome organization |
| GO:0006334 | 3e-04 | 25.6843 | 0.1399 | 3 | 88 | nucleosome assembly |
| GO:0034622 | 5e-04 | 6.2136 | 1.5224 | 7 | 876 | cellular macromolecular complex assembly |
| GO:0006335 | 0.0011 | 46.5044 | 0.0504 | 2 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0.0014 | 41.8444 | 0.0556 | 2 | 32 | chromatin silencing at rDNA |
| GO:0038111 | 0.0015 | 40.4916 | 0.0574 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0015 | 40.4916 | 0.0574 | 2 | 33 | response to interleukin-7 |
| GO:0048855 | 0.0017 | Inf | 0.0017 | 1 | 1 | adenohypophysis morphogenesis |
| GO:0070367 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0090038 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of protein kinase C signaling |
| GO:0051290 | 0.0022 | 33.015 | 0.0695 | 2 | 40 | protein heterotetramerization |
| GO:0043486 | 0.0034 | 26.1171 | 0.0869 | 2 | 50 | histone exchange |
| GO:0042335 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | cuticle development |
| GO:0045652 | 0.0058 | 19.564 | 0.1147 | 2 | 66 | regulation of megakaryocyte differentiation |
| GO:0048863 | 0.0068 | 8.7363 | 0.3928 | 3 | 226 | stem cell differentiation |
| GO:0045815 | 0.0069 | 17.8789 | 0.1251 | 2 | 72 | positive regulation of gene expression, epigenetic |
| GO:0048852 | 0.0069 | 200.1212 | 0.007 | 1 | 4 | diencephalon morphogenesis |
| GO:0006526 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | arginine biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903225 | 0.0014 | 1322.6 | 0.0014 | 1 | 3 | negative regulation of endodermal cell differentiation |
| GO:0002523 | 0.0045 | 293.7556 | 0.0045 | 1 | 10 | leukocyte migration involved in inflammatory response |
| GO:0006750 | 0.0059 | 220.2667 | 0.0059 | 1 | 13 | glutathione biosynthetic process |
| GO:0002092 | 0.0077 | 165.15 | 0.0077 | 1 | 17 | positive regulation of receptor internalization |
| GO:0050901 | 0.0077 | 165.15 | 0.0077 | 1 | 17 | leukocyte tethering or rolling |
| GO:0007202 | 0.0086 | 146.7778 | 0.0086 | 1 | 19 | activation of phospholipase C activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032237 | 0.0012 | 1469.6667 | 0.0012 | 1 | 4 | activation of store-operated calcium channel activity |
| GO:1901339 | 0.0018 | 881.6667 | 0.0018 | 1 | 6 | regulation of store-operated calcium channel activity |
| GO:2001256 | 0.0021 | 734.6667 | 0.0021 | 1 | 7 | regulation of store-operated calcium entry |
| GO:0005513 | 0.0027 | 550.9167 | 0.0027 | 1 | 9 | detection of calcium ion |
| GO:0070166 | 0.0027 | 550.9167 | 0.0027 | 1 | 9 | enamel mineralization |
| GO:1901021 | 0.0069 | 200.1212 | 0.007 | 1 | 23 | positive regulation of calcium ion transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007032 | 0.0051 | Inf | 0.0051 | 1 | 67 | endosome organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048846 | 0.0024 | 881.1333 | 0.0024 | 1 | 16 | axon extension involved in axon guidance |
| GO:0008045 | 0.0027 | 777.3529 | 0.0027 | 1 | 18 | motor neuron axon guidance |
| GO:0031290 | 0.003 | 695.4211 | 0.003 | 1 | 20 | retinal ganglion cell axon guidance |
| GO:0007157 | 0.0054 | 377.0571 | 0.0054 | 1 | 36 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1904706 | 0.0075 | 165.1875 | 0.0075 | 1 | 11 | negative regulation of vascular smooth muscle cell proliferation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046032 | 4e-04 | Inf | 4e-04 | 1 | 1 | ADP catabolic process |
| GO:0046709 | 8e-04 | 3307 | 8e-04 | 1 | 2 | IDP catabolic process |
| GO:0009137 | 0.0015 | 1102.1667 | 0.0015 | 1 | 4 | purine nucleoside diphosphate catabolic process |
| GO:0035610 | 0.0015 | 1102.1667 | 0.0015 | 1 | 4 | protein side chain deglutamylation |
| GO:0009158 | 0.0019 | 826.5625 | 0.0019 | 1 | 5 | ribonucleoside monophosphate catabolic process |
| GO:0009128 | 0.0023 | 661.2 | 0.0023 | 1 | 6 | purine nucleoside monophosphate catabolic process |
| GO:0009191 | 0.0023 | 661.2 | 0.0023 | 1 | 6 | ribonucleoside diphosphate catabolic process |
| GO:0034656 | 0.0049 | 275.3542 | 0.0049 | 1 | 13 | nucleobase-containing small molecule catabolic process |
| GO:0048240 | 0.0064 | 206.4531 | 0.0064 | 1 | 17 | sperm capacitation |
| GO:0009261 | 0.009 | 143.5435 | 0.0091 | 1 | 24 | ribonucleotide catabolic process |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003158 | 0.001 | 57.1087 | 0.0497 | 2 | 94 | endothelium development |
| GO:0014036 | 0.0011 | 2204.3333 | 0.0011 | 1 | 2 | neural crest cell fate specification |
| GO:1902309 | 0.0016 | 1102.0833 | 0.0016 | 1 | 3 | negative regulation of peptidyl-serine dephosphorylation |
| GO:1903589 | 0.0016 | 1102.0833 | 0.0016 | 1 | 3 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0002175 | 0.0021 | 734.6667 | 0.0021 | 1 | 4 | protein localization to paranode region of axon |
| GO:0044537 | 0.0021 | 734.6667 | 0.0021 | 1 | 4 | regulation of circulating fibrinogen levels |
| GO:0071205 | 0.0026 | 550.9583 | 0.0026 | 1 | 5 | protein localization to juxtaparanode region of axon |
| GO:1903142 | 0.0026 | 550.9583 | 0.0026 | 1 | 5 | positive regulation of establishment of endothelial barrier |
| GO:0002064 | 0.0029 | 33.5154 | 0.0836 | 2 | 158 | epithelial cell development |
| GO:0045162 | 0.0032 | 440.7333 | 0.0032 | 1 | 6 | clustering of voltage-gated sodium channels |
| GO:0030913 | 0.0037 | 367.25 | 0.0037 | 1 | 7 | paranodal junction assembly |
| GO:0048865 | 0.0042 | 314.7619 | 0.0042 | 1 | 8 | stem cell fate commitment |
| GO:0017187 | 0.0048 | 275.3958 | 0.0048 | 1 | 9 | peptidyl-glutamic acid carboxylation |
| GO:1901550 | 0.0058 | 220.2833 | 0.0058 | 1 | 11 | regulation of endothelial cell development |
| GO:0000712 | 0.0063 | 200.2424 | 0.0063 | 1 | 12 | resolution of meiotic recombination intermediates |
| GO:0014029 | 0.0063 | 200.2424 | 0.0063 | 1 | 12 | neural crest formation |
| GO:0051382 | 0.0069 | 183.5417 | 0.0069 | 1 | 13 | kinetochore assembly |
| GO:0006465 | 0.0079 | 157.2976 | 0.0079 | 1 | 15 | signal peptide processing |
| GO:0042474 | 0.0095 | 129.5098 | 0.0095 | 1 | 18 | middle ear morphogenesis |
| GO:0045603 | 0.0095 | 129.5098 | 0.0095 | 1 | 18 | positive regulation of endothelial cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042694 | 2e-04 | Inf | 2e-04 | 1 | 1 | muscle cell fate specification |
| GO:0098735 | 5e-04 | 6615 | 5e-04 | 1 | 3 | positive regulation of the force of heart contraction |
| GO:0055003 | 0.0021 | 1016.8462 | 0.0021 | 1 | 14 | cardiac myofibril assembly |
| GO:0030049 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | muscle filament sliding |
| GO:0055010 | 0.006 | 338.2821 | 0.006 | 1 | 40 | ventricular cardiac muscle tissue morphogenesis |
| GO:0048747 | 0.0066 | 306.7209 | 0.0066 | 1 | 44 | muscle fiber development |
| GO:0055006 | 0.009 | 223.2712 | 0.0091 | 1 | 60 | cardiac cell development |
| GO:0060415 | 0.0095 | 212.4194 | 0.0095 | 1 | 63 | muscle tissue morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042309 | 3e-04 | 13231 | 3e-04 | 1 | 2 | homoiothermy |
| GO:0010193 | 6e-04 | 4409.6667 | 6e-04 | 1 | 4 | response to ozone |
| GO:0080184 | 6e-04 | 4409.6667 | 6e-04 | 1 | 4 | response to phenylpropanoid |
| GO:0033591 | 8e-04 | 3307 | 8e-04 | 1 | 5 | response to L-ascorbic acid |
| GO:0020027 | 0.0014 | 1653 | 0.0014 | 1 | 9 | hemoglobin metabolic process |
| GO:0009642 | 0.0015 | 1469.2222 | 0.0015 | 1 | 10 | response to light intensity |
| GO:0009650 | 0.0017 | 1322.2 | 0.0017 | 1 | 11 | UV protection |
| GO:0033197 | 0.0017 | 1322.2 | 0.0017 | 1 | 11 | response to vitamin E |
| GO:0045475 | 0.0017 | 1322.2 | 0.0017 | 1 | 11 | locomotor rhythm |
| GO:0014854 | 0.0018 | 1201.9091 | 0.0018 | 1 | 12 | response to inactivity |
| GO:0033189 | 0.0018 | 1201.9091 | 0.0018 | 1 | 12 | response to vitamin A |
| GO:0010288 | 0.0024 | 881.1333 | 0.0024 | 1 | 16 | response to lead ion |
| GO:0055093 | 0.0024 | 881.1333 | 0.0024 | 1 | 16 | response to hyperoxia |
| GO:0042744 | 0.0027 | 777.3529 | 0.0027 | 1 | 18 | hydrogen peroxide catabolic process |
| GO:0060259 | 0.003 | 695.4211 | 0.003 | 1 | 20 | regulation of feeding behavior |
| GO:0055078 | 0.0047 | 440.0667 | 0.0047 | 1 | 31 | sodium ion homeostasis |
| GO:0007622 | 0.006 | 338.2821 | 0.006 | 1 | 40 | rhythmic behavior |
| GO:0046686 | 0.0069 | 293.0444 | 0.007 | 1 | 46 | response to cadmium ion |
| GO:0032922 | 0.0071 | 286.6522 | 0.0071 | 1 | 47 | circadian regulation of gene expression |
| GO:0014823 | 0.0072 | 280.5319 | 0.0073 | 1 | 48 | response to activity |
| GO:0014068 | 0.0078 | 258.451 | 0.0079 | 1 | 52 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0032088 | 0.0081 | 248.6604 | 0.0082 | 1 | 54 | negative regulation of NF-kappaB transcription factor activity |
| GO:0009060 | 0.0086 | 235.2857 | 0.0086 | 1 | 57 | aerobic respiration |
| GO:0070542 | 0.0089 | 227.1379 | 0.0089 | 1 | 59 | response to fatty acid |
| GO:0030819 | 0.009 | 223.2712 | 0.0091 | 1 | 60 | positive regulation of cAMP biosynthetic process |
| GO:0006641 | 0.0098 | 205.75 | 0.0098 | 1 | 65 | triglyceride metabolic process |
| GO:0051781 | 0.0098 | 205.75 | 0.0098 | 1 | 65 | positive regulation of cell division |
| GO:0051289 | 0.0099 | 202.5692 | 0.01 | 1 | 66 | protein homotetramerization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0090659 | 2e-04 | 109.9833 | 0.0236 | 2 | 26 | walking behavior |
| GO:0008088 | 8e-04 | 59.9 | 0.0417 | 2 | 46 | axo-dendritic transport |
| GO:0090386 | 9e-04 | Inf | 9e-04 | 1 | 1 | phagosome maturation involved in apoptotic cell clearance |
| GO:0090389 | 9e-04 | Inf | 9e-04 | 1 | 1 | phagosome-lysosome fusion involved in apoptotic cell clearance |
| GO:0007412 | 0.0027 | 600.9091 | 0.0027 | 1 | 3 | axon target recognition |
| GO:0007198 | 0.0036 | 400.5758 | 0.0036 | 1 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0048489 | 0.0043 | 24.2852 | 0.0997 | 2 | 110 | synaptic vesicle transport |
| GO:0006828 | 0.0045 | 300.4091 | 0.0045 | 1 | 5 | manganese ion transport |
| GO:0014062 | 0.0045 | 300.4091 | 0.0045 | 1 | 5 | regulation of serotonin secretion |
| GO:0071901 | 0.0047 | 22.9965 | 0.1052 | 2 | 116 | negative regulation of protein serine/threonine kinase activity |
| GO:0051656 | 0.0047 | 10.9099 | 0.3582 | 3 | 395 | establishment of organelle localization |
| GO:0099111 | 0.0054 | 21.4754 | 0.1124 | 2 | 124 | microtubule-based transport |
| GO:0035754 | 0.0054 | 240.3091 | 0.0054 | 1 | 6 | B cell chemotaxis |
| GO:0042428 | 0.0063 | 200.2424 | 0.0063 | 1 | 7 | serotonin metabolic process |
| GO:0006906 | 0.0066 | 19.3881 | 0.1242 | 2 | 137 | vesicle fusion |
| GO:0030705 | 0.0072 | 18.4225 | 0.1306 | 2 | 144 | cytoskeleton-dependent intracellular transport |
| GO:0001845 | 0.0072 | 171.6234 | 0.0073 | 1 | 8 | phagolysosome assembly |
| GO:0007210 | 0.0072 | 171.6234 | 0.0073 | 1 | 8 | serotonin receptor signaling pathway |
| GO:0007610 | 0.0078 | 9.064 | 0.428 | 3 | 472 | behavior |
| GO:0014051 | 0.0081 | 150.1591 | 0.0082 | 1 | 9 | gamma-aminobutyric acid secretion |
| GO:0006837 | 0.009 | 133.4646 | 0.0091 | 1 | 10 | serotonin transport |
| GO:0019896 | 0.009 | 133.4646 | 0.0091 | 1 | 10 | axonal transport of mitochondrion |
| GO:0008283 | 0.0092 | 5.2935 | 1.43 | 5 | 1577 | cell proliferation |
| GO:0048284 | 0.0095 | 15.9244 | 0.1505 | 2 | 166 | organelle fusion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016254 | 0.0036 | 440.5333 | 0.0036 | 1 | 16 | preassembly of GPI anchor in ER membrane |
| GO:0000470 | 0.0048 | 330.275 | 0.0048 | 1 | 21 | maturation of LSU-rRNA |
| GO:0000460 | 0.0066 | 235.7679 | 0.0066 | 1 | 29 | maturation of 5.8S rRNA |
| GO:0006505 | 0.007 | 220.0167 | 0.007 | 1 | 31 | GPI anchor metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019730 | 0.0039 | Inf | 0.0039 | 1 | 51 | antimicrobial humoral response |
| GO:2000117 | 0.006 | Inf | 0.006 | 1 | 80 | negative regulation of cysteine-type endopeptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000244 | 0.0018 | 1201.9091 | 0.0018 | 1 | 12 | spliceosomal tri-snRNP complex assembly |
| GO:0048025 | 0.0027 | 777.3529 | 0.0027 | 1 | 18 | negative regulation of mRNA splicing, via spliceosome |
| GO:0006376 | 0.0038 | 550.3333 | 0.0038 | 1 | 25 | mRNA splice site selection |
| GO:0006501 | 0.008 | 253.4615 | 0.008 | 1 | 53 | C-terminal protein lipidation |
| GO:1903312 | 0.0096 | 209.0317 | 0.0097 | 1 | 64 | negative regulation of mRNA metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 15.0405 | 0.5622 | 7 | 155 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 13.3099 | 0.6311 | 7 | 174 | DNA packaging |
| GO:0071824 | 0 | 10.0623 | 0.8233 | 7 | 227 | protein-DNA complex subunit organization |
| GO:0045814 | 0 | 14.3484 | 0.4026 | 5 | 111 | negative regulation of gene expression, epigenetic |
| GO:0006335 | 2e-04 | 33.7436 | 0.1052 | 3 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 2e-04 | 30.246 | 0.1161 | 3 | 32 | chromatin silencing at rDNA |
| GO:0006334 | 2e-04 | 15.187 | 0.2999 | 4 | 88 | nucleosome assembly |
| GO:0038111 | 2e-04 | 29.2356 | 0.1197 | 3 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 2e-04 | 29.2356 | 0.1197 | 3 | 33 | response to interleukin-7 |
| GO:1905205 | 4e-04 | 95.5072 | 0.029 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:0051290 | 4e-04 | 23.6919 | 0.1451 | 3 | 40 | protein heterotetramerization |
| GO:1903244 | 5e-04 | 81.8571 | 0.0326 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0071345 | 6e-04 | 4.3245 | 2.4555 | 9 | 677 | cellular response to cytokine stimulus |
| GO:0014744 | 7e-04 | 63.657 | 0.0399 | 2 | 11 | positive regulation of muscle adaptation |
| GO:0042060 | 7e-04 | 5.2935 | 1.5197 | 7 | 419 | wound healing |
| GO:0010612 | 0.0013 | 44.0569 | 0.0544 | 2 | 15 | regulation of cardiac muscle adaptation |
| GO:0045652 | 0.0017 | 13.8868 | 0.2394 | 3 | 66 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0.0022 | 12.6734 | 0.2611 | 3 | 72 | positive regulation of gene expression, epigenetic |
| GO:1903671 | 0.0031 | 27.2567 | 0.0834 | 2 | 23 | negative regulation of sprouting angiogenesis |
| GO:0009115 | 0.0036 | Inf | 0.0036 | 1 | 1 | xanthine catabolic process |
| GO:0010477 | 0.0036 | Inf | 0.0036 | 1 | 1 | response to sulfur dioxide |
| GO:0070367 | 0.0036 | Inf | 0.0036 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0003299 | 0.0037 | 24.8828 | 0.0907 | 2 | 25 | muscle hypertrophy in response to stress |
| GO:0043616 | 0.0043 | 22.8887 | 0.0979 | 2 | 27 | keratinocyte proliferation |
| GO:0060964 | 0.0048 | 9.5934 | 0.3409 | 3 | 94 | regulation of gene silencing by miRNA |
| GO:1902036 | 0.0051 | 9.3857 | 0.3482 | 3 | 96 | regulation of hematopoietic stem cell differentiation |
| GO:0014742 | 0.0056 | 19.7256 | 0.1124 | 2 | 31 | positive regulation of muscle hypertrophy |
| GO:0042418 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | epinephrine biosynthetic process |
| GO:1900155 | 0.0072 | 280.5319 | 0.0073 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:0035194 | 0.008 | 5.4846 | 0.7943 | 4 | 219 | posttranscriptional gene silencing by RNA |
| GO:0060968 | 0.0087 | 7.6444 | 0.4244 | 3 | 117 | regulation of gene silencing |
| GO:0048863 | 0.009 | 5.3088 | 0.8197 | 4 | 226 | stem cell differentiation |
| GO:0014888 | 0.0097 | 14.6566 | 0.1487 | 2 | 41 | striated muscle adaptation |
| GO:0001525 | 0.0099 | 4.1546 | 1.3202 | 5 | 364 | angiogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071824 | 0 | 29.4005 | 0.3088 | 6 | 227 | protein-DNA complex subunit organization |
| GO:0006333 | 0 | 33.5026 | 0.2108 | 5 | 155 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 29.6928 | 0.2367 | 5 | 174 | DNA packaging |
| GO:0051276 | 0 | 9.4748 | 1.4105 | 8 | 1037 | chromosome organization |
| GO:0006334 | 2e-04 | 35.5765 | 0.1066 | 3 | 88 | nucleosome assembly |
| GO:0006335 | 7e-04 | 61.0602 | 0.0394 | 2 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0034622 | 8e-04 | 7.0954 | 1.1915 | 6 | 876 | cellular macromolecular complex assembly |
| GO:0000183 | 8e-04 | 54.9417 | 0.0435 | 2 | 32 | chromatin silencing at rDNA |
| GO:0038111 | 9e-04 | 53.1653 | 0.0449 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 9e-04 | 53.1653 | 0.0449 | 2 | 33 | response to interleukin-7 |
| GO:0051290 | 0.0013 | 43.3487 | 0.0544 | 2 | 40 | protein heterotetramerization |
| GO:0048855 | 0.0014 | Inf | 0.0014 | 1 | 1 | adenohypophysis morphogenesis |
| GO:0070367 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0090038 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of protein kinase C signaling |
| GO:0043486 | 0.0021 | 34.2917 | 0.068 | 2 | 50 | histone exchange |
| GO:0048863 | 0.0033 | 11.6529 | 0.3074 | 3 | 226 | stem cell differentiation |
| GO:0045652 | 0.0036 | 25.6875 | 0.0898 | 2 | 66 | regulation of megakaryocyte differentiation |
| GO:0042335 | 0.0041 | 388.6471 | 0.0041 | 1 | 3 | cuticle development |
| GO:0045815 | 0.0042 | 23.475 | 0.0979 | 2 | 72 | positive regulation of gene expression, epigenetic |
| GO:0048852 | 0.0054 | 259.0784 | 0.0054 | 1 | 4 | diencephalon morphogenesis |
| GO:0060964 | 0.0071 | 17.8315 | 0.1279 | 2 | 94 | regulation of gene silencing by miRNA |
| GO:1902036 | 0.0074 | 17.4495 | 0.1306 | 2 | 96 | regulation of hematopoietic stem cell differentiation |
| GO:0006950 | 0.008 | 3.5667 | 3.9485 | 9 | 2903 | response to stress |
| GO:0001778 | 0.0081 | 155.4235 | 0.0082 | 1 | 6 | plasma membrane repair |
| GO:0035754 | 0.0081 | 155.4235 | 0.0082 | 1 | 6 | B cell chemotaxis |
| GO:0060029 | 0.0081 | 155.4235 | 0.0082 | 1 | 6 | convergent extension involved in organogenesis |
| GO:0034115 | 0.0095 | 129.5098 | 0.0095 | 1 | 7 | negative regulation of heterotypic cell-cell adhesion |
| GO:0045814 | 0.0098 | 15.031 | 0.151 | 2 | 111 | negative regulation of gene expression, epigenetic |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006408 | 0.0018 | 1201.9091 | 0.0018 | 1 | 2 | snRNA export from nucleus |
| GO:0002074 | 0.0027 | 600.9091 | 0.0027 | 1 | 3 | extraocular skeletal muscle development |
| GO:0055002 | 0.0054 | 21.4754 | 0.1124 | 2 | 124 | striated muscle cell development |
| GO:0009249 | 0.0054 | 240.3091 | 0.0054 | 1 | 6 | protein lipoylation |
| GO:0048743 | 0.0063 | 200.2424 | 0.0063 | 1 | 7 | positive regulation of skeletal muscle fiber development |
| GO:0071688 | 0.0099 | 120.1091 | 0.01 | 1 | 11 | striated muscle myosin thick filament assembly |
| GO:0097067 | 0.0099 | 120.1091 | 0.01 | 1 | 11 | cellular response to thyroid hormone stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042403 | 2e-04 | 114.2857 | 0.0226 | 2 | 13 | thyroid hormone metabolic process |
| GO:0006954 | 0.001 | 7.7347 | 0.8047 | 5 | 463 | inflammatory response |
| GO:0042743 | 0.0016 | 39.2232 | 0.0591 | 2 | 34 | hydrogen peroxide metabolic process |
| GO:0009115 | 0.0017 | Inf | 0.0017 | 1 | 1 | xanthine catabolic process |
| GO:0010477 | 0.0017 | Inf | 0.0017 | 1 | 1 | response to sulfur dioxide |
| GO:2000494 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
| GO:0035669 | 0.0035 | 600.4545 | 0.0035 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
| GO:0002457 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | T cell antigen processing and presentation |
| GO:0022614 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | membrane to membrane docking |
| GO:0034128 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0035915 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | pore formation in membrane of other organism |
| GO:0042335 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | cuticle development |
| GO:0051725 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | protein de-ADP-ribosylation |
| GO:0071351 | 0.0052 | 300.2045 | 0.0052 | 1 | 3 | cellular response to interleukin-18 |
| GO:0035989 | 0.0069 | 200.1212 | 0.007 | 1 | 4 | tendon development |
| GO:0046813 | 0.0069 | 200.1212 | 0.007 | 1 | 4 | receptor-mediated virion attachment to host cell |
| GO:0097368 | 0.0069 | 200.1212 | 0.007 | 1 | 4 | establishment of Sertoli cell barrier |
| GO:2000379 | 0.0076 | 16.9073 | 0.1321 | 2 | 76 | positive regulation of reactive oxygen species metabolic process |
| GO:0042816 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | vitamin B6 metabolic process |
| GO:0046113 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | nucleobase catabolic process |
| GO:0070269 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | pyroptosis |
| GO:1904751 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | positive regulation of protein localization to nucleolus |
| GO:2000609 | 0.0087 | 150.0795 | 0.0087 | 1 | 5 | regulation of thyroid hormone generation |
| GO:1903409 | 0.0088 | 15.6321 | 0.1425 | 2 | 82 | reactive oxygen species biosynthetic process |
| GO:0002366 | 0.0096 | 5.4771 | 0.8568 | 4 | 493 | leukocyte activation involved in immune response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018242 | 5e-04 | Inf | 5e-04 | 1 | 6 | protein O-linked glycosylation via serine |
| GO:0018243 | 5e-04 | Inf | 5e-04 | 1 | 6 | protein O-linked glycosylation via threonine |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034374 | 0.0027 | 550.9167 | 0.0027 | 1 | 9 | low-density lipoprotein particle remodeling |
| GO:0000244 | 0.0036 | 400.5758 | 0.0036 | 1 | 12 | spliceosomal tri-snRNP complex assembly |
| GO:0034368 | 0.0054 | 259.0784 | 0.0054 | 1 | 18 | protein-lipid complex remodeling |
| GO:0048025 | 0.0054 | 259.0784 | 0.0054 | 1 | 18 | negative regulation of mRNA splicing, via spliceosome |
| GO:0006376 | 0.0075 | 183.4167 | 0.0076 | 1 | 25 | mRNA splice site selection |
| GO:0071827 | 0.0099 | 137.4792 | 0.01 | 1 | 33 | plasma lipoprotein particle organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035973 | 5e-04 | Inf | 5e-04 | 1 | 7 | aggrephagy |
| GO:0006995 | 8e-04 | Inf | 8e-04 | 1 | 10 | cellular response to nitrogen starvation |
| GO:0097352 | 0.0022 | Inf | 0.0022 | 1 | 29 | autophagosome maturation |
| GO:0000045 | 0.0057 | Inf | 0.0057 | 1 | 75 | autophagosome assembly |
| GO:0000422 | 0.006 | Inf | 0.006 | 1 | 79 | autophagy of mitochondrion |
| GO:1903008 | 0.0074 | Inf | 0.0074 | 1 | 98 | organelle disassembly |
| GO:0007033 | 0.0098 | Inf | 0.0098 | 1 | 130 | vacuole organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0086043 | 0.0011 | 2204.3333 | 0.0011 | 1 | 7 | bundle of His cell action potential |
| GO:0060371 | 0.0014 | 1653 | 0.0014 | 1 | 9 | regulation of atrial cardiac muscle cell membrane depolarization |
| GO:0086016 | 0.0015 | 1469.2222 | 0.0015 | 1 | 10 | AV node cell action potential |
| GO:0086067 | 0.0017 | 1322.2 | 0.0017 | 1 | 11 | AV node cell to bundle of His cell communication |
| GO:0086069 | 0.0018 | 1201.9091 | 0.0018 | 1 | 12 | bundle of His cell to Purkinje myocyte communication |
| GO:0030728 | 0.0027 | 777.3529 | 0.0027 | 1 | 18 | ovulation |
| GO:0019228 | 0.0036 | 574.3043 | 0.0036 | 1 | 24 | neuronal action potential |
| GO:0086019 | 0.0041 | 507.9231 | 0.0041 | 1 | 27 | cell-cell signaling involved in cardiac conduction |
| GO:0086010 | 0.0059 | 347.2105 | 0.0059 | 1 | 39 | membrane depolarization during action potential |
| GO:0055117 | 0.0084 | 239.5818 | 0.0085 | 1 | 56 | regulation of cardiac muscle contraction |
| GO:0042475 | 0.0098 | 205.75 | 0.0098 | 1 | 65 | odontogenesis of dentin-containing tooth |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030241 | 0.0014 | 1322.6 | 0.0014 | 1 | 3 | skeletal muscle myosin thick filament assembly |
| GO:0048769 | 0.0014 | 1322.6 | 0.0014 | 1 | 3 | sarcomerogenesis |
| GO:0030240 | 0.0018 | 881.6667 | 0.0018 | 1 | 4 | skeletal muscle thin filament assembly |
| GO:0035995 | 0.0018 | 881.6667 | 0.0018 | 1 | 4 | detection of muscle stretch |
| GO:0060018 | 0.0018 | 881.6667 | 0.0018 | 1 | 4 | astrocyte fate commitment |
| GO:0060800 | 0.0018 | 881.6667 | 0.0018 | 1 | 4 | regulation of cell differentiation involved in embryonic placenta development |
| GO:0050714 | 0.0025 | 37.7312 | 0.0793 | 2 | 175 | positive regulation of protein secretion |
| GO:0048739 | 0.0027 | 528.92 | 0.0027 | 1 | 6 | cardiac muscle fiber development |
| GO:0060670 | 0.005 | 264.36 | 0.005 | 1 | 11 | branching involved in labyrinthine layer morphogenesis |
| GO:0031034 | 0.0054 | 240.3091 | 0.0054 | 1 | 12 | myosin filament assembly |
| GO:0055003 | 0.0063 | 203.3077 | 0.0063 | 1 | 14 | cardiac myofibril assembly |
| GO:0007076 | 0.0068 | 188.7714 | 0.0068 | 1 | 15 | mitotic chromosome condensation |
| GO:0051047 | 0.0074 | 21.4734 | 0.1374 | 2 | 303 | positive regulation of secretion |
| GO:0002791 | 0.009 | 19.3619 | 0.1519 | 2 | 335 | regulation of peptide secretion |
| GO:0000470 | 0.0095 | 132.08 | 0.0095 | 1 | 21 | maturation of LSU-rRNA |
| GO:0060143 | 0.0099 | 125.781 | 0.01 | 1 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046452 | 0.0012 | 1889.2857 | 0.0012 | 1 | 2 | dihydrofolate metabolic process |
| GO:1900155 | 0.0012 | 1889.2857 | 0.0012 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:0031427 | 0.0018 | 944.5714 | 0.0018 | 1 | 3 | response to methotrexate |
| GO:0050689 | 0.0018 | 944.5714 | 0.0018 | 1 | 3 | negative regulation of defense response to virus by host |
| GO:0006334 | 0.0021 | 38.0029 | 0.0707 | 2 | 117 | nucleosome assembly |
| GO:0043570 | 0.0024 | 629.6667 | 0.0024 | 1 | 4 | maintenance of DNA repeat elements |
| GO:0006545 | 0.003 | 472.2143 | 0.003 | 1 | 5 | glycine biosynthetic process |
| GO:0051096 | 0.003 | 472.2143 | 0.003 | 1 | 5 | positive regulation of helicase activity |
| GO:0006333 | 0.0036 | 28.4815 | 0.0937 | 2 | 155 | chromatin assembly or disassembly |
| GO:0006729 | 0.0042 | 314.7619 | 0.0042 | 1 | 7 | tetrahydrobiopterin biosynthetic process |
| GO:0046654 | 0.0042 | 314.7619 | 0.0042 | 1 | 7 | tetrahydrofolate biosynthetic process |
| GO:0006323 | 0.0046 | 25.2984 | 0.1052 | 2 | 174 | DNA packaging |
| GO:0046629 | 0.0048 | 269.7755 | 0.0048 | 1 | 8 | gamma-delta T cell activation |
| GO:2000121 | 0.006 | 209.7937 | 0.006 | 1 | 10 | regulation of removal of superoxide radicals |
| GO:0061430 | 0.0066 | 188.8 | 0.0066 | 1 | 11 | bone trabecula morphogenesis |
| GO:0071824 | 0.0077 | 19.2607 | 0.1372 | 2 | 227 | protein-DNA complex subunit organization |
| GO:0046655 | 0.0078 | 157.3095 | 0.0079 | 1 | 13 | folic acid metabolic process |
| GO:0051000 | 0.009 | 134.8163 | 0.0091 | 1 | 15 | positive regulation of nitric-oxide synthase activity |
| GO:0002227 | 0.0096 | 125.819 | 0.0097 | 1 | 16 | innate immune response in mucosa |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046597 | 0.0011 | Inf | 0.0011 | 1 | 14 | negative regulation of viral entry into host cell |
| GO:0035455 | 0.0012 | Inf | 0.0012 | 1 | 16 | response to interferon-alpha |
| GO:0035456 | 0.0013 | Inf | 0.0013 | 1 | 17 | response to interferon-beta |
| GO:0045071 | 0.003 | Inf | 0.003 | 1 | 40 | negative regulation of viral genome replication |
| GO:0045669 | 0.0034 | Inf | 0.0034 | 1 | 45 | positive regulation of osteoblast differentiation |
| GO:0060337 | 0.0045 | Inf | 0.0045 | 1 | 60 | type I interferon signaling pathway |
| GO:0034340 | 0.0049 | Inf | 0.0049 | 1 | 65 | response to type I interferon |
| GO:0048525 | 0.0051 | Inf | 0.0051 | 1 | 67 | negative regulation of viral process |
| GO:0034341 | 0.0077 | Inf | 0.0077 | 1 | 102 | response to interferon-gamma |
| GO:1903900 | 0.0078 | Inf | 0.0078 | 1 | 103 | regulation of viral life cycle |
| GO:0030260 | 0.0083 | Inf | 0.0083 | 1 | 110 | entry into host cell |
| GO:0051828 | 0.0083 | Inf | 0.0083 | 1 | 110 | entry into other organism involved in symbiotic interaction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 1e-04 | 14.0301 | 0.4216 | 5 | 155 | chromatin assembly or disassembly |
| GO:0006323 | 1e-04 | 12.4346 | 0.4733 | 5 | 174 | DNA packaging |
| GO:1905205 | 2e-04 | 129.3333 | 0.0218 | 2 | 8 | positive regulation of connective tissue replacement |
| GO:1903244 | 3e-04 | 110.8487 | 0.0245 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0071824 | 3e-04 | 9.4275 | 0.6175 | 5 | 227 | protein-DNA complex subunit organization |
| GO:0014744 | 4e-04 | 86.2026 | 0.0299 | 2 | 11 | positive regulation of muscle adaptation |
| GO:0010612 | 7e-04 | 59.6606 | 0.0408 | 2 | 15 | regulation of cardiac muscle adaptation |
| GO:0030219 | 0.0015 | 14.9068 | 0.2258 | 3 | 83 | megakaryocyte differentiation |
| GO:0006334 | 0.0015 | 14.8987 | 0.2266 | 3 | 88 | nucleosome assembly |
| GO:1903671 | 0.0018 | 36.9104 | 0.0626 | 2 | 23 | negative regulation of sprouting angiogenesis |
| GO:0003299 | 0.0021 | 33.6957 | 0.068 | 2 | 25 | muscle hypertrophy in response to stress |
| GO:0001568 | 0.0023 | 5.0477 | 1.3846 | 6 | 509 | blood vessel development |
| GO:0070286 | 0.0024 | 30.9953 | 0.0734 | 2 | 27 | axonemal dynein complex assembly |
| GO:0009115 | 0.0027 | Inf | 0.0027 | 1 | 1 | xanthine catabolic process |
| GO:0042128 | 0.0027 | Inf | 0.0027 | 1 | 1 | nitrate assimilation |
| GO:0070367 | 0.0027 | Inf | 0.0027 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:1904877 | 0.0027 | Inf | 0.0027 | 1 | 1 | positive regulation of DNA ligase activity |
| GO:0006335 | 0.0028 | 28.695 | 0.0789 | 2 | 29 | DNA replication-dependent nucleosome assembly |
| GO:0001525 | 0.0029 | 5.7683 | 0.9902 | 5 | 364 | angiogenesis |
| GO:0072358 | 0.0029 | 4.7898 | 1.4553 | 6 | 535 | cardiovascular system development |
| GO:0014742 | 0.0032 | 26.712 | 0.0843 | 2 | 31 | positive regulation of muscle hypertrophy |
| GO:0045814 | 0.0034 | 11.0185 | 0.3019 | 3 | 111 | negative regulation of gene expression, epigenetic |
| GO:0000183 | 0.0034 | 25.8196 | 0.087 | 2 | 32 | chromatin silencing at rDNA |
| GO:0038111 | 0.0036 | 24.9848 | 0.0898 | 2 | 33 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0.0036 | 24.9848 | 0.0898 | 2 | 33 | response to interleukin-7 |
| GO:0048771 | 0.0039 | 10.4338 | 0.3183 | 3 | 117 | tissue remodeling |
| GO:0042060 | 0.0052 | 4.9805 | 1.1398 | 5 | 419 | wound healing |
| GO:0051290 | 0.0053 | 20.3715 | 0.1088 | 2 | 40 | protein heterotetramerization |
| GO:1903518 | 0.0054 | 377.0571 | 0.0054 | 1 | 2 | positive regulation of single strand break repair |
| GO:0014888 | 0.0055 | 19.8477 | 0.1115 | 2 | 41 | striated muscle adaptation |
| GO:0051898 | 0.0063 | 18.4258 | 0.1197 | 2 | 44 | negative regulation of protein kinase B signaling |
| GO:0032200 | 0.0076 | 8.127 | 0.4053 | 3 | 149 | telomere organization |
| GO:0007179 | 0.0079 | 8.016 | 0.4108 | 3 | 151 | transforming growth factor beta receptor signaling pathway |
| GO:0006288 | 0.0081 | 188.5143 | 0.0082 | 1 | 3 | base-excision repair, DNA ligation |
| GO:0010836 | 0.0081 | 188.5143 | 0.0082 | 1 | 3 | negative regulation of protein ADP-ribosylation |
| GO:0061819 | 0.0081 | 188.5143 | 0.0082 | 1 | 3 | telomeric DNA-containing double minutes formation |
| GO:1905765 | 0.0081 | 188.5143 | 0.0082 | 1 | 3 | negative regulation of protection from non-homologous end joining at telomere |
| GO:1990414 | 0.0081 | 188.5143 | 0.0082 | 1 | 3 | replication-born double-strand break repair via sister chromatid exchange |
| GO:0051216 | 0.0083 | 7.8549 | 0.4189 | 3 | 154 | cartilage development |
| GO:0034622 | 0.0084 | 3.4246 | 2.383 | 7 | 876 | cellular macromolecular complex assembly |
| GO:0010611 | 0.0084 | 15.7851 | 0.1387 | 2 | 51 | regulation of cardiac muscle hypertrophy |
| GO:0045600 | 0.0088 | 15.4682 | 0.1415 | 2 | 52 | positive regulation of fat cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009249 | 0.0027 | 528.92 | 0.0027 | 1 | 6 | protein lipoylation |
| GO:0048743 | 0.0032 | 440.7333 | 0.0032 | 1 | 7 | positive regulation of skeletal muscle fiber development |
| GO:0042693 | 0.0072 | 176.1733 | 0.0073 | 1 | 16 | muscle cell fate commitment |
| GO:0045663 | 0.0072 | 176.1733 | 0.0073 | 1 | 16 | positive regulation of myoblast differentiation |
| GO:0006271 | 0.0077 | 165.15 | 0.0077 | 1 | 17 | DNA strand elongation involved in DNA replication |
| GO:1901741 | 0.0081 | 155.4235 | 0.0082 | 1 | 18 | positive regulation of myoblast fusion |
| GO:0043403 | 0.0099 | 125.781 | 0.01 | 1 | 22 | skeletal muscle tissue regeneration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004653 | 0.0012 | Inf | 0.0012 | 1 | 16 | polypeptide N-acetylgalactosaminyltransferase activity |
| GO:0008194 | 0.0081 | Inf | 0.0081 | 1 | 108 | UDP-glycosyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001567 | 0.0018 | Inf | 0.0018 | 1 | 1 | cholesterol 25-hydroxylase activity |
| GO:0004042 | 0.0018 | Inf | 0.0018 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0017064 | 0.0018 | Inf | 0.0018 | 1 | 1 | fatty acid amide hydrolase activity |
| GO:0102077 | 0.0018 | Inf | 0.0018 | 1 | 1 | oleamide hydrolase activity |
| GO:0103045 | 0.0018 | Inf | 0.0018 | 1 | 1 | methione N-acyltransferase activity |
| GO:0103073 | 0.0018 | Inf | 0.0018 | 1 | 1 | anandamide amidohydrolase activity |
| GO:0005544 | 0.0021 | 33.404 | 0.0686 | 2 | 38 | calcium-dependent phospholipid binding |
| GO:0031492 | 0.0025 | 30.8275 | 0.0741 | 2 | 41 | nucleosomal DNA binding |
| GO:0042393 | 0.0035 | 11.1361 | 0.3089 | 3 | 171 | histone binding |
| GO:0003998 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | acylphosphatase activity |
| GO:0004040 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | amidase activity |
| GO:0019834 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | phospholipase A2 inhibitor activity |
| GO:0016174 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | NAD(P)H oxidase activity |
| GO:0046982 | 0.0059 | 6.3179 | 0.7423 | 4 | 411 | protein heterodimerization activity |
| GO:0034618 | 0.009 | 144.1304 | 0.009 | 1 | 5 | arginine binding |
| GO:0046923 | 0.009 | 144.1304 | 0.009 | 1 | 5 | ER retention sequence binding |
| GO:0048495 | 0.009 | 144.1304 | 0.009 | 1 | 5 | Roundabout binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003839 | 0.0018 | 885.2667 | 0.0018 | 1 | 4 | gamma-glutamylcyclotransferase activity |
| GO:0033691 | 0.0032 | 442.5333 | 0.0032 | 1 | 7 | sialic acid binding |
| GO:0070492 | 0.0036 | 379.2857 | 0.0036 | 1 | 8 | oligosaccharide binding |
| GO:0043274 | 0.0054 | 241.2909 | 0.0054 | 1 | 12 | phospholipase binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051010 | 0.0036 | 402.2121 | 0.0036 | 1 | 12 | microtubule plus-end binding |
| GO:0005246 | 0.0096 | 142.5054 | 0.0096 | 1 | 32 | calcium channel regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005153 | 3e-04 | 13285 | 3e-04 | 1 | 2 | interleukin-8 receptor binding |
| GO:0008009 | 0.0029 | 737.1111 | 0.0029 | 1 | 19 | chemokine activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005102 | 0.0073 | Inf | 0.1707 | 2 | 1134 | receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003756 | 0.0094 | 130.0392 | 0.0095 | 1 | 18 | protein disulfide isomerase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019144 | 9e-04 | 2656.2 | 9e-04 | 1 | 2 | ADP-sugar diphosphatase activity |
| GO:0043262 | 0.0014 | 1328 | 0.0014 | 1 | 3 | adenosine-diphosphatase activity |
| GO:0047631 | 0.0014 | 1328 | 0.0014 | 1 | 3 | ADP-ribose diphosphatase activity |
| GO:0004181 | 0.0068 | 189.5429 | 0.0068 | 1 | 15 | metallocarboxypeptidase activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0086080 | 0.0053 | 245.7778 | 0.0053 | 1 | 10 | protein binding involved in heterotypic cell-cell adhesion |
| GO:0005251 | 0.0094 | 130.0392 | 0.0095 | 1 | 18 | delayed rectifier potassium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032036 | 8e-04 | Inf | 8e-04 | 1 | 10 | myosin heavy chain binding |
| GO:0003785 | 0.0014 | Inf | 0.0014 | 1 | 19 | actin monomer binding |
| GO:0008307 | 0.0029 | Inf | 0.0029 | 1 | 38 | structural constituent of muscle |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033560 | 5e-04 | Inf | 5e-04 | 1 | 1 | folate reductase activity |
| GO:0000406 | 0.0011 | 2213.3333 | 0.0011 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004146 | 0.0011 | 2213.3333 | 0.0011 | 1 | 2 | dihydrofolate reductase activity |
| GO:0032142 | 0.0011 | 2213.3333 | 0.0011 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.0011 | 2213.3333 | 0.0011 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0051870 | 0.0011 | 2213.3333 | 0.0011 | 1 | 2 | methotrexate binding |
| GO:0000404 | 0.0016 | 1106.5833 | 0.0016 | 1 | 3 | heteroduplex DNA loop binding |
| GO:0005176 | 0.0021 | 737.6667 | 0.0021 | 1 | 4 | ErbB-2 class receptor binding |
| GO:0043125 | 0.0021 | 737.6667 | 0.0021 | 1 | 4 | ErbB-3 class receptor binding |
| GO:0008234 | 0.0028 | 33.8735 | 0.0827 | 2 | 157 | cysteine-type peptidase activity |
| GO:0000403 | 0.0032 | 442.5333 | 0.0032 | 1 | 6 | Y-form DNA binding |
| GO:0030297 | 0.0032 | 442.5333 | 0.0032 | 1 | 6 | transmembrane receptor protein tyrosine kinase activator activity |
| GO:0005542 | 0.0037 | 368.75 | 0.0037 | 1 | 7 | folic acid binding |
| GO:0045499 | 0.0042 | 316.0476 | 0.0042 | 1 | 8 | chemorepellent activity |
| GO:1990825 | 0.0042 | 316.0476 | 0.0042 | 1 | 8 | sequence-specific mRNA binding |
| GO:0030983 | 0.0058 | 221.1833 | 0.0058 | 1 | 11 | mismatched DNA binding |
| GO:0070402 | 0.0063 | 201.0606 | 0.0063 | 1 | 12 | NADPH binding |
| GO:0000900 | 0.0068 | 184.2917 | 0.0068 | 1 | 13 | translation repressor activity, nucleic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004096 | 3e-04 | 13285 | 3e-04 | 1 | 2 | catalase activity |
| GO:0004980 | 3e-04 | 13285 | 3e-04 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
| GO:0004046 | 8e-04 | 3320.5 | 8e-04 | 1 | 5 | aminoacylase activity |
| GO:0042923 | 0.002 | 1106.1667 | 0.002 | 1 | 13 | neuropeptide binding |
| GO:0017046 | 0.0039 | 530.44 | 0.0039 | 1 | 26 | peptide hormone binding |
| GO:0016684 | 0.0048 | 427.5806 | 0.0048 | 1 | 32 | oxidoreductase activity, acting on peroxide as acceptor |
| GO:0050661 | 0.0053 | 389.7647 | 0.0053 | 1 | 35 | NADP binding |
| GO:0016209 | 0.0089 | 228.069 | 0.0089 | 1 | 59 | antioxidant activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008396 | 0.0018 | 1206.8182 | 0.0018 | 1 | 2 | oxysterol 7-alpha-hydroxylase activity |
| GO:0030305 | 0.0018 | 1206.8182 | 0.0018 | 1 | 2 | heparanase activity |
| GO:0090722 | 0.0036 | 402.2121 | 0.0036 | 1 | 4 | receptor-receptor interaction |
| GO:0031694 | 0.0045 | 301.6364 | 0.0045 | 1 | 5 | alpha-2A adrenergic receptor binding |
| GO:0042043 | 0.0045 | 301.6364 | 0.0045 | 1 | 5 | neurexin family protein binding |
| GO:0051378 | 0.0054 | 241.2909 | 0.0054 | 1 | 6 | serotonin binding |
| GO:0070679 | 0.0054 | 241.2909 | 0.0054 | 1 | 6 | inositol 1,4,5 trisphosphate binding |
| GO:0015279 | 0.0063 | 201.0606 | 0.0063 | 1 | 7 | store-operated calcium channel activity |
| GO:0004993 | 0.0072 | 172.3247 | 0.0072 | 1 | 8 | G-protein coupled serotonin receptor activity |
| GO:0004861 | 0.0099 | 120.6 | 0.0099 | 1 | 11 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0008242 | 0.0099 | 120.6 | 0.0099 | 1 | 11 | omega peptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017176 | 8e-04 | 3320.5 | 8e-04 | 1 | 5 | phosphatidylinositol N-acetylglucosaminyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004869 | 0.0047 | 441.8667 | 0.0047 | 1 | 31 | cysteine-type endopeptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050733 | 8e-04 | 3320.5 | 8e-04 | 1 | 5 | RS domain binding |
| GO:0005201 | 0.0075 | 270.1429 | 0.0075 | 1 | 50 | extracellular matrix structural constituent |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 8.8951 | 1.4228 | 10 | 411 | protein heterodimerization activity |
| GO:0031492 | 4e-04 | 24.2424 | 0.1419 | 3 | 41 | nucleosomal DNA binding |
| GO:0004031 | 0.0035 | Inf | 0.0035 | 1 | 1 | aldehyde oxidase activity |
| GO:0004603 | 0.0035 | Inf | 0.0035 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
| GO:0102797 | 0.0035 | Inf | 0.0035 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0035 | Inf | 0.0035 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0070506 | 0.0069 | 294.2444 | 0.0069 | 1 | 2 | high-density lipoprotein particle receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005544 | 0.0013 | 43.2451 | 0.0543 | 2 | 38 | calcium-dependent phospholipid binding |
| GO:0001567 | 0.0014 | Inf | 0.0014 | 1 | 1 | cholesterol 25-hydroxylase activity |
| GO:0031492 | 0.0015 | 39.9095 | 0.0586 | 2 | 41 | nucleosomal DNA binding |
| GO:0042393 | 0.0017 | 14.6217 | 0.2445 | 3 | 171 | histone binding |
| GO:0046982 | 0.0024 | 8.4272 | 0.5877 | 4 | 411 | protein heterodimerization activity |
| GO:0019834 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | phospholipase A2 inhibitor activity |
| GO:0016174 | 0.0043 | 368.5278 | 0.0043 | 1 | 3 | NAD(P)H oxidase activity |
| GO:0046923 | 0.0071 | 184.2361 | 0.0071 | 1 | 5 | ER retention sequence binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016603 | 0.003 | 698.2632 | 0.003 | 1 | 2 | glutaminyl-peptide cyclotransferase activity |
| GO:0098640 | 0.003 | 698.2632 | 0.003 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
| GO:0030023 | 0.006 | 232.7193 | 0.006 | 1 | 4 | extracellular matrix constituent conferring elasticity |
| GO:0097109 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | neuroligin family protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005153 | 2e-04 | Inf | 2e-04 | 1 | 2 | interleukin-8 receptor binding |
| GO:0008009 | 0.0014 | Inf | 0.0014 | 1 | 19 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070888 | 4e-04 | 89.1852 | 0.029 | 2 | 35 | E-box binding |
| GO:0008184 | 0.0025 | 663.75 | 0.0025 | 1 | 3 | glycogen phosphorylase activity |
| GO:0102250 | 0.0025 | 663.75 | 0.0025 | 1 | 3 | linear malto-oligosaccharide phosphorylase activity |
| GO:0102499 | 0.0025 | 663.75 | 0.0025 | 1 | 3 | SHG alpha-glucan phosphorylase activity |
| GO:0015643 | 0.005 | 265.44 | 0.005 | 1 | 6 | toxic substance binding |
| GO:0008253 | 0.0083 | 147.4222 | 0.0083 | 1 | 10 | 5'-nucleotidase activity |
| GO:0051371 | 0.0091 | 132.67 | 0.0091 | 1 | 11 | muscle alpha-actinin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004031 | 0.0017 | Inf | 0.0017 | 1 | 1 | aldehyde oxidase activity |
| GO:0047273 | 0.0017 | Inf | 0.0017 | 1 | 1 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity |
| GO:0102797 | 0.0017 | Inf | 0.0017 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0017 | Inf | 0.0017 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0003875 | 0.0033 | 631.6667 | 0.0033 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GO:0016174 | 0.005 | 315.8095 | 0.005 | 1 | 3 | NAD(P)H oxidase activity |
| GO:0043546 | 0.0083 | 157.881 | 0.0083 | 1 | 5 | molybdopterin cofactor binding |
| GO:0043023 | 0.0099 | 126.2952 | 0.0099 | 1 | 6 | ribosomal large subunit binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050840 | 0.003 | Inf | 0.003 | 1 | 40 | extracellular matrix binding |
| GO:0005518 | 0.0035 | Inf | 0.0035 | 1 | 46 | collagen binding |
| GO:0004860 | 0.0064 | Inf | 0.0064 | 1 | 85 | protein kinase inhibitor activity |
| GO:0047485 | 0.0071 | Inf | 0.0071 | 1 | 94 | protein N-terminus binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004653 | 0.0012 | Inf | 0.0012 | 1 | 16 | polypeptide N-acetylgalactosaminyltransferase activity |
| GO:0008194 | 0.0081 | Inf | 0.0081 | 1 | 108 | UDP-glycosyltransferase activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005248 | 0.0014 | Inf | 0.0014 | 1 | 18 | voltage-gated sodium channel activity |
| GO:0044325 | 0.0072 | Inf | 0.0072 | 1 | 96 | ion channel binding |
| GO:0015081 | 0.0081 | Inf | 0.0081 | 1 | 107 | sodium ion transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005018 | 6e-04 | Inf | 6e-04 | 1 | 1 | platelet-derived growth factor alpha-receptor activity |
| GO:0038085 | 0.0012 | 1897 | 0.0012 | 1 | 2 | vascular endothelial growth factor binding |
| GO:0004351 | 0.0018 | 948.4286 | 0.0018 | 1 | 3 | glutamate decarboxylase activity |
| GO:0005021 | 0.0042 | 316.0476 | 0.0042 | 1 | 7 | vascular endothelial growth factor-activated receptor activity |
| GO:0046624 | 0.0042 | 316.0476 | 0.0042 | 1 | 7 | sphingolipid transporter activity |
| GO:0016595 | 0.0054 | 237 | 0.0054 | 1 | 9 | glutamate binding |
| GO:0048407 | 0.0054 | 237 | 0.0054 | 1 | 9 | platelet-derived growth factor binding |
| GO:0051371 | 0.0066 | 189.5714 | 0.0066 | 1 | 11 | muscle alpha-actinin binding |
| GO:0005161 | 0.0072 | 172.3247 | 0.0072 | 1 | 12 | platelet-derived growth factor receptor binding |
| GO:0097493 | 0.0078 | 157.9524 | 0.0078 | 1 | 13 | structural molecule activity conferring elasticity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050733 | 0.0015 | 1106.6667 | 0.0015 | 1 | 5 | RS domain binding |
| GO:0004857 | 0.0024 | 48.3829 | 0.0816 | 2 | 271 | enzyme inhibitor activity |
| GO:0034185 | 0.0042 | 340.2821 | 0.0042 | 1 | 14 | apolipoprotein binding |
| GO:0001968 | 0.006 | 232.7193 | 0.006 | 1 | 20 | fibronectin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001530 | 0.0026 | 829.375 | 0.0026 | 1 | 17 | lipopolysaccharide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005248 | 0.0027 | 780.5294 | 0.0027 | 1 | 18 | voltage-gated sodium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005164 | 0.0015 | Inf | 0.0015 | 1 | 20 | tumor necrosis factor receptor binding |
| GO:0005125 | 0.0092 | Inf | 0.0092 | 1 | 122 | cytokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031433 | 0.0011 | 1660.125 | 0.0011 | 1 | 3 | telethonin binding |
| GO:0042975 | 0.003 | 474.1429 | 0.003 | 1 | 8 | peroxisome proliferator activated receptor binding |
| GO:0051371 | 0.0041 | 331.825 | 0.0041 | 1 | 11 | muscle alpha-actinin binding |
| GO:0097493 | 0.0049 | 276.4792 | 0.0049 | 1 | 13 | structural molecule activity conferring elasticity |
| GO:0046965 | 0.0053 | 255.1923 | 0.0053 | 1 | 14 | retinoid X receptor binding |
| GO:0140110 | 0.0094 | 13.0222 | 0.5174 | 3 | 1375 | transcription regulator activity |
| GO:0046966 | 0.0097 | 132.58 | 0.0098 | 1 | 26 | thyroid hormone receptor binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033560 | 7e-04 | Inf | 7e-04 | 1 | 1 | folate reductase activity |
| GO:0000406 | 0.0014 | 1659.75 | 0.0014 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004146 | 0.0014 | 1659.75 | 0.0014 | 1 | 2 | dihydrofolate reductase activity |
| GO:0032142 | 0.0014 | 1659.75 | 0.0014 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.0014 | 1659.75 | 0.0014 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0051870 | 0.0014 | 1659.75 | 0.0014 | 1 | 2 | methotrexate binding |
| GO:0000404 | 0.002 | 829.8125 | 0.002 | 1 | 3 | heteroduplex DNA loop binding |
| GO:0000403 | 0.0041 | 331.85 | 0.0041 | 1 | 6 | Y-form DNA binding |
| GO:0005542 | 0.0047 | 276.5208 | 0.0047 | 1 | 7 | folic acid binding |
| GO:1990825 | 0.0054 | 237 | 0.0054 | 1 | 8 | sequence-specific mRNA binding |
| GO:0046703 | 0.0061 | 207.3594 | 0.0061 | 1 | 9 | natural killer cell lectin-like receptor binding |
| GO:0030983 | 0.0074 | 165.8625 | 0.0075 | 1 | 11 | mismatched DNA binding |
| GO:0070402 | 0.0081 | 150.7727 | 0.0081 | 1 | 12 | NADPH binding |
| GO:0000900 | 0.0088 | 138.1979 | 0.0088 | 1 | 13 | translation repressor activity, nucleic acid binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005057 | 0.008 | Inf | 0.008 | 1 | 106 | signal transducer activity, downstream of receptor |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043546 | 1e-04 | 304.6897 | 0.0117 | 2 | 5 | molybdopterin cofactor binding |
| GO:0004031 | 0.0023 | Inf | 0.0023 | 1 | 1 | aldehyde oxidase activity |
| GO:0008482 | 0.0023 | Inf | 0.0023 | 1 | 1 | sulfite oxidase activity |
| GO:0102797 | 0.0023 | Inf | 0.0023 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0023 | Inf | 0.0023 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0046982 | 0.0024 | 6.0871 | 0.9588 | 5 | 411 | protein heterodimerization activity |
| GO:0031492 | 0.0041 | 23.374 | 0.0957 | 2 | 41 | nucleosomal DNA binding |
| GO:0005025 | 0.007 | 220.9167 | 0.007 | 1 | 3 | transforming growth factor beta receptor activity, type I |
| GO:1990599 | 0.007 | 220.9167 | 0.007 | 1 | 3 | 3' overhang single-stranded DNA endodeoxyribonuclease activity |
| GO:0004095 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0016361 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | activin receptor activity, type I |
| GO:0030151 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | molybdenum ion binding |
| GO:0098821 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | BMP receptor activity |
| GO:0046332 | 0.0097 | 14.6774 | 0.1493 | 2 | 64 | SMAD binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033560 | 0.001 | Inf | 0.001 | 1 | 1 | folate reductase activity |
| GO:0090409 | 0.001 | Inf | 0.001 | 1 | 1 | malonyl-CoA synthetase activity |
| GO:0000406 | 0.002 | 1106.1667 | 0.002 | 1 | 2 | double-strand/single-strand DNA junction binding |
| GO:0004146 | 0.002 | 1106.1667 | 0.002 | 1 | 2 | dihydrofolate reductase activity |
| GO:0032142 | 0.002 | 1106.1667 | 0.002 | 1 | 2 | single guanine insertion binding |
| GO:0032181 | 0.002 | 1106.1667 | 0.002 | 1 | 2 | dinucleotide repeat insertion binding |
| GO:0051870 | 0.002 | 1106.1667 | 0.002 | 1 | 2 | methotrexate binding |
| GO:0000404 | 0.0029 | 553.0417 | 0.0029 | 1 | 3 | heteroduplex DNA loop binding |
| GO:0050501 | 0.0039 | 368.6667 | 0.0039 | 1 | 4 | hyaluronan synthase activity |
| GO:0003796 | 0.0049 | 276.4792 | 0.0049 | 1 | 5 | lysozyme activity |
| GO:1903136 | 0.0049 | 276.4792 | 0.0049 | 1 | 5 | cuprous ion binding |
| GO:0000403 | 0.0059 | 221.1667 | 0.0059 | 1 | 6 | Y-form DNA binding |
| GO:0005542 | 0.0068 | 184.2917 | 0.0068 | 1 | 7 | folic acid binding |
| GO:0048156 | 0.0078 | 157.9524 | 0.0078 | 1 | 8 | tau protein binding |
| GO:1990825 | 0.0078 | 157.9524 | 0.0078 | 1 | 8 | sequence-specific mRNA binding |
| GO:0031957 | 0.0088 | 138.1979 | 0.0088 | 1 | 9 | very long-chain fatty acid-CoA ligase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004181 | 0.0045 | 315.9524 | 0.0045 | 1 | 15 | metallocarboxypeptidase activity |
| GO:0046982 | 0.0055 | 31.4792 | 0.1237 | 2 | 411 | protein heterodimerization activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004411 | 0.0011 | Inf | 0.0011 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
| GO:0005153 | 0.0021 | 1021 | 0.0021 | 1 | 2 | interleukin-8 receptor binding |
| GO:1990269 | 0.0021 | 1021 | 0.0021 | 1 | 2 | RNA polymerase II C-terminal domain phosphoserine binding |
| GO:0005094 | 0.0032 | 510.4615 | 0.0032 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0015643 | 0.0063 | 204.1385 | 0.0063 | 1 | 6 | toxic substance binding |
| GO:0005092 | 0.0068 | 184.25 | 0.0068 | 1 | 7 | GDP-dissociation inhibitor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
LOLA Enrichment Analysis [3] was conducted. The plots and tables below show enrichments across annotations in the supplied LOLA reference databases for the following collections:
| comparison | |
| Hypermethylation/hypomethylation | |
| regions | |
| differential methylation measure | |
| color |
Scatter plot showing the effect size (log-odds ratio) vs. the significance (-log10(q-value)), similar to a 'volcano plot' as it is called in other contexts.
| comparison | |
| Hypermethylation/hypomethylation | |
| regions | |
| differential methylation measure |

Boxplots showing log-odds ratios from LOLA enrichment analysis. Shown are those groups of terms per category that share the same putative target. Only terms that exhibit statistical significance (p-value < 0.01) are included. If more than 100 terms are enriched, the 100 terms receiving the highest joined LOLA ranks are shown. Coloring of the bars reflects the putative targets of the terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| regions | |
| differential methylation measure |

Barplots showing log-odds ratios from LOLA enrichment analysis. Shown are those terms that exhibit statistical significance (p-value < 0.01). If more than 100 terms are enriched, the 100 terms receiving the highest joined LOLA ranks are shown. Coloring of the bars reflects the putative targets of the terms.
LOLA enrichment analysis was also conducted for differentially variable regions.
| comparison | |
| Hypermethylation/hypomethylation | |
| regions | |
| differential methylation measure | |
| color |
Barplots showing log-odds ratios from LOLA enrichment analysis. Shown are those terms that exhibit statistical significance (p-value < 0.01). If more than 100 terms are enriched, the 100 terms receiving the highest joined LOLA ranks are shown. Coloring of the bars reflects the putative targets of the terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| regions | |
| differential methylation measure |

Barplots showing log-odds ratios from LOLA enrichment analysis. Shown are those terms that exhibit statistical significance (p-value < 0.01). If more than 100 terms are enriched, the 100 terms receiving the highest joined LOLA ranks are shown. Coloring of the bars reflects the putative targets of the terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| regions | |
| differential methylation measure |

Barplots showing log-odds ratios from LOLA enrichment analysis. Shown are those terms that exhibit statistical significance (p-value < 0.01). If more than 100 terms are enriched, the 100 terms receiving the highest joined LOLA ranks are shown. Coloring of the bars reflects the putative targets of the terms.

